MIM100050		 	AARSKOG SYNDROME, AUTOSOMAL DOMINANT	 
MIM100070	%	19q13	AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 1; AAA1	100329167
MIM100100	#	 	ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY AND CRYPTORCHIDISM	1131
MIM100200		 	ABDUCENS PALSY	 
MIM100300	#	 	ADAMS-OLIVER SYNDROME 1; AOS1	100188340, 57514
MIM100600	%	 	ACANTHOSIS NIGRICANS	 
MIM100640	*	9q21	ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER A1; ALDH1A1	216
MIM100650	+	12q24.2	ALDEHYDE DEHYDROGENASE 2 FAMILY; ALDH2	217
MIM100660	*	17p11.2	ALDEHYDE DEHYDROGENASE, FAMILY 3, SUBFAMILY A, MEMBER 1; ALDH3A1	218
MIM100670	*	9p13	ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER B1; ALDH1B1	219
MIM100675		 	ACETAMINOPHEN METABOLISM	 
MIM100678	*	6q25.3-q26	ACETYL-CoA ACETYLTRANSFERASE 2; ACAT2	39
MIM100690	*	2q24-q32	CHOLINERGIC RECEPTOR, NICOTINIC, ALPHA POLYPEPTIDE 1; CHRNA1	1134
MIM100700		 	ACHARD SYNDROME	 
MIM100710	*	17p12-p11	CHOLINERGIC RECEPTOR, NICOTINIC, BETA POLYPEPTIDE 1; CHRNB1	1140
MIM100720	*	2q33-q34	CHOLINERGIC RECEPTOR, NICOTINIC, DELTA POLYPEPTIDE; CHRND	1144
MIM100725	*	17p13-p12	CHOLINERGIC RECEPTOR, NICOTINIC, EPSILON POLYPEPTIDE; CHRNE	1145
MIM100730	*	2q33-q34	CHOLINERGIC RECEPTOR, NICOTINIC, GAMMA POLYPEPTIDE; CHRNG	1146
MIM100740	*	7q22	ACETYLCHOLINESTERASE; ACHE	43
MIM100790	*	12q22-q23	ACHAETE-SCUTE COMPLEX, DROSOPHILA, HOMOLOG OF, 1; ASCL1	429
MIM100800	#	4p16.3	ACHONDROPLASIA; ACH	2261
MIM100820	%	 	ACHOO SYNDROME	 
MIM100850	*	22q11.21-q13.31	ACONITASE, MITOCHONDRIAL; ACO2	50
MIM100880	*	9p22-p13	ACONITASE 1, SOLUBLE; ACO1	48
MIM101000	#	22q12.2	NEUROFIBROMATOSIS, TYPE II; NF2	4771
MIM101120		 	ACROCEPHALOPOLYSYNDACTYLY TYPE III	 
MIM101200	#	10q26	APERT SYNDROME	2263
MIM101400	#	10q26, 7p21	SAETHRE-CHOTZEN SYNDROME; SCS	2263, 7291
MIM101600	#	10q26, 8p11.2-p11.1	PFEIFFER SYNDROME	2260, 2263
MIM101800	#	 	ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1	5573
MIM101805		 	ACROFACIAL DYSOSTOSIS, CATANIA TYPE	 
MIM101840		 	ACROKERATODERMA, HEREDITARY PAPULOTRANSLUCENT	 
MIM101850	%	2p25-p12	KERATODERMA, PALMOPLANTAR, PUNCTATE TYPE III; PPKP3	 
MIM101900	#	12q23-q24.1	ACROKERATOSIS VERRUCIFORMIS; AKV	488
MIM102000		 	ACROLEUKOPATHY, SYMMETRIC	 
MIM102100	%	 	ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	 
MIM102150	%	 	ACROMEGALOID FACIAL APPEARANCE SYNDROME	 
MIM102200	#	16p13.3, 11q13.3	PITUITARY ADENOMA, GROWTH HORMONE-SECRETING	2778, 6755, 9049
MIM102300	%	12q12-q21	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 1; RLS1	192142
MIM102350	%	 	ACROMIAL DIMPLES	 
MIM102370	#	 	ACROMICRIC DYSPLASIA; ACMICD	2200
MIM102400		 	ACROOSTEOLYSIS	 
MIM102480	*	22q13.3	ACROSIN; ACR	49
MIM102490	^	 	MOVED TO 607323	 
MIM102500	#	 	HAJDU-CHENEY SYNDROME; HJCYS	4853
MIM102510	%	2q36	ACROPECTOROVERTEBRAL DYSPLASIA; ACRPV	414058
MIM102520		 	ACRORENAL SYNDROME	 
MIM102525	*	11p12-q13	ACROSOMAL VESICLE PROTEIN 1; ACRV1	56
MIM102530	#	6q21, 3q26.3	SPERMATOGENIC FAILURE 6; SPGF6	57120, 83893
MIM102540	*	15q14	ACTIN, ALPHA, CARDIAC MUSCLE; ACTC1	70
MIM102545	*	2p13.1	ACTIN, GAMMA-2, SMOOTH MUSCLE, ENTERIC; ACTG2	72
MIM102560	*	17q25.3	ACTIN, GAMMA-1; ACTG1	71
MIM102565	*	7q32	FILAMIN C; FLNC	2318
MIM102573	*	1q42-q43	ACTININ, ALPHA-2; ACTN2	88
MIM102574	+	11q13-q14	ACTININ, ALPHA-3; ACTN3	89
MIM102575	*	14q22-q24	ACTININ, ALPHA-1; ACTN1	87
MIM102576	*	2q23-q24	ACTIVIN A RECEPTOR, TYPE I; ACVR1	90
MIM102577	*	3q27	REPLICATION FACTOR C, SUBUNIT 4; RFC4	5984
MIM102578	*	15q22	ACUTE PROMYELOCYTIC LEUKEMIA, INDUCER OF; PML	5371
MIM102579	*	4p14-p13	REPLICATION FACTOR C, SUBUNIT 1; RFC1	5981
MIM102581	*	2q22.2-q23.3	ACTIVIN A RECEPTOR, TYPE IIA; ACVR2A	92
MIM102582	*	17q21	SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3; STAT3	6774
MIM102593	*	7p14-p12	ACYLOXYACYL HYDROLASE; AOAH	313
MIM102595	*	2p16.2	ACYLPHOSPHATASE 2, MUSCLE TYPE; ACYP2	98
MIM102600	*	16q24.3	ADENINE PHOSPHORIBOSYLTRANSFERASE; APRT	353
MIM102610	*	1q42.1	ACTIN, ALPHA, SKELETAL MUSCLE 1; ACTA1	58
MIM102620	*	10q22-q24	ACTIN, ALPHA-2, SMOOTH MUSCLE, AORTA; ACTA2	59
MIM102630	*	7p22-p12	ACTIN, BETA; ACTB	60
MIM102642	*	1q25	STEROL O-ACYLTRANSFERASE 1; SOAT1	6646
MIM102645	*	3p21	ACYLPEPTIDE HYDROLASE; APH	327
MIM102650		 	ADACTYLIA, UNILATERAL	 
MIM102660		 	ADAMANTINOMA OF LONG BONES	 
MIM102670	*	19p13.3	MUCOSAL VASCULAR ADDRESSIN CELL ADHESION MOLECULE 1; MADCAM1	8174
MIM102680	*	4p16.3	ADDUCIN 1; ADD1	118
MIM102681	*	2p14-p13	ADDUCIN 2; ADD2	119
MIM102699		19q13-qter	ADENO-ASSOCIATED VIRUS INTEGRATION SITE 1; AAVS1	17
MIM102700	#	20q13.11	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	100
MIM102720	*	2q23	DIPEPTIDYL PEPTIDASE IV; DPP4	1803
MIM102750	*	10q11-q24	ADENOSINE KINASE; ADK	132
MIM102770	*	1p21-p13	ADENOSINE MONOPHOSPHATE DEAMINASE 1; AMPD1	270
MIM102771	*	1p13.3	ADENOSINE MONOPHOSPHATE DEAMINASE 2; AMPD2	271
MIM102772	*	11pter-p13	ADENOSINE MONOPHOSPHATE DEAMINASE 3; AMPD3	272
MIM102775	*	1q32.1	ADENOSINE A1 RECEPTOR; ADORA1	134
MIM102776	*	22q11.2	ADENOSINE A2 RECEPTOR; ADORA2A	135
MIM102800	%	 	ADENOSINE TRIPHOSPHATASE DEFICIENCY, ANEMIA DUE TO	 
MIM102900	#	1q21	ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES	5313
MIM102910	*	12p13-qter	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, BETA SUBUNIT; ATP5B	506
MIM102980	*	18p11	ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE 1; ADCYAP1	116
MIM102981	*	7p14	ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE 1, RECEPTOR FOR; ADCYAP1R1	117
MIM103000	*	9q34.1	ADENYLATE KINASE 1; AK1	203
MIM103020	*	1p34	ADENYLATE KINASE 2; AK2	204
MIM103030	*	1p31.3	ADENYLATE KINASE 3-LIKE 1; AK3L1	205
MIM103050	#	22q13.1	ADENYLOSUCCINASE DEFICIENCY	158
MIM103060	*	1cen-q12	ADENYLOSUCCINATE SYNTHETASE; ADSS	159
MIM103070	*	8q24.2	ADENYLATE CYCLASE 8; ADCY8	114
MIM103071	*	5p15.3	ADENYLATE CYCLASE 2; ADCY2	108
MIM103072	*	7p13-p12	ADENYLATE CYCLASE 1; ADCY1	107
MIM103100	#	 	ADIE PUPIL	 
MIM103180	*	1q42	ADP-RIBOSYLATION FACTOR 1; ARF1	375
MIM103188	*	7q31.3	ADP-RIBOSYLATION FACTOR 5; ARF5	381
MIM103190	*	12q13	ADP-RIBOSYLATION FACTOR 3; ARF3	377
MIM103195	*	9p22.1	PERILIPIN 2; PLIN2	123
MIM103200	%	 	ADIPOSIS DOLOROSA	 
MIM103220	*	4q35	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER 4; SLC25A4	291
MIM103230		 	ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL	 
MIM103260	*	11q22	FERREDOXIN 1; FDX1	2230
MIM103270	*	17q24-q25	FERREDOXIN REDUCTASE; FDXR	2232
MIM103275	*	11p15.4	ADRENOMEDULLIN; ADM	133
MIM103280	*	11p15.5	H19 GENE; H19	283120
MIM103285	#	3q27	ADULT SYNDROME	8626
MIM103300	%	 	HYPOGLOSSIA-HYPODACTYLIA	 
MIM103320	*	1pter-p32	AGRIN; AGRN	375790
MIM103390	*	11q12-q13	AHNAK NUCLEOPROTEIN; AHNAK	79026
MIM103400		 	AINHUM	 
MIM103420	%	 	ALACRIMA, CONGENITAL	 
MIM103470	#	11q14-q21, 3p14.1-p12.3	ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS	4286, 7299
MIM103500	#	3p14.1-p12.3	TIETZ SYNDROME	4286
MIM103580	#	20q13.2	PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A	2778
MIM103581	^	 	MOVED TO 103580	 
MIM103600	*	4q11-q13	ALBUMIN; ALB	213
MIM103700	*	4q22	ALCOHOL DEHYDROGENASE 1A, CLASS I, ALPHA POLYPEPTIDE; ADH1A	124
MIM103710	*	4q21-q25	ALCOHOL DEHYDROGENASE 5, CHI POLYPEPTIDE; ADH5	128
MIM103720	+	4q22	ALCOHOL DEHYDROGENASE 1B, CLASS I, BETA POLYPEPTIDE; ADH1B	125
MIM103730	*	4q22	ALCOHOL DEHYDROGENASE 1C, GAMMA POLYPEPTIDE; ADH1C	126
MIM103735	*	4q23-q24	ALCOHOL DEHYDROGENASE 6; ADH6	130
MIM103740	*	4q22	ALCOHOL DEHYDROGENASE 4; ADH4	127
MIM103780	#	13q14-q21, 13q14, 7q31, 4q22, 4q22, 4p13-p12	ALCOHOL DEPENDENCE	125, 126, 217, 2555, 3356, 50833, 55213
MIM103800	^	 	MOVED TO 253200 AND 258870	 
MIM103830	*	1p33-p32	ALDO-KETO REDUCTASE FAMILY 1, MEMBER A1; AKR1A1	10327
MIM103850	*	16p11.2	ALDOLASE A, FRUCTOSE-BISPHOSPHATE; ALDOA	226
MIM103870	*	17cen-q12	ALDOLASE C, FRUCTOSE-BISPHOSPHATE; ALDOC	230
MIM103880	*	7q35	ALDO-KETO REDUCTASE FAMILY 1, MEMBER B1; AKR1B1	231
MIM103900	#	8q21	GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM; GRA	1584
MIM103920		 	ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS, FAMILIAL	 
MIM103950	*	12p13.3-p12.3	ALPHA-2-MACROGLOBULIN; A2M	2
MIM104000	%	18p11.3-p11.2	ALOPECIA AREATA 1	100034700
MIM104100		 	PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA, AUTOSOMAL DOMINANT	 
MIM104110		 	ALOPECIA, FAMILIAL FOCAL	 
MIM104130	%	 	ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY	 
MIM104145	*	4q11-q13	AFAMIN; AFM	173
MIM104150	*	4q11-q13	ALPHA-FETOPROTEIN; AFP	174
MIM104155	*	16q22.3-q23.1	ZINC FINGER HOMEOBOX 3; ZFHX3	463
MIM104160	*	11q13-qter	GLUCOSIDASE, ALPHA, NEUTRAL AB; GANAB	23193
MIM104170	*	22q11	N-ACETYL-ALPHA-D-GALACTOSAMINIDASE; NAGA	4668
MIM104175	*	9q33-q34	GLYCOPROTEIN ALPHA-GALACTOSYLTRANSFERASE 1; GGTA1	2681
MIM104180	*	15q15.1-q15.2	GLUCOSIDASE, ALPHA, NEUTRAL C; GANC	2595
MIM104200	#	 	ALPORT SYNDROME, AUTOSOMAL DOMINANT	1285
MIM104210	*	10q24-q26	ALPHA-2A-ADRENERGIC RECEPTOR; ADRA2A	150
MIM104219	*	20p13	ALPHA-1D-ADRENERGIC RECEPTOR; ADRA1D	146
MIM104220	*	5q33	ALPHA-1B-ADRENERGIC RECEPTOR; ADRA1B	147
MIM104221	*	8p21	ALPHA-1A-ADRENERGIC RECEPTOR; ADRA1A	148
MIM104225	*	4p16.3	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-ASSOCIATED PROTEIN 1; LRPAP1	4043
MIM104230	*	11q21	FUCOSYLTRANSFERASE 4; FUT4	2526
MIM104240	*	Chr.11	ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 4; ST3GAL4	6484
MIM104250	+	4p16.1	ALPHA-2C-ADRENERGIC RECEPTOR; ADRA2C	152
MIM104260	*	2q11.2	ALPHA-2B-ADRENERGIC RECEPTOR; ADRA2B	151
MIM104290	#	1q21-q23	ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	477
MIM104300	#	17q11.2, 12p11.23-q13.12, 12p13.3-p12.3, 11q23.2-q24.2, 10q24, 10q24, 7q36, 7q36, 7q36, 6p21.3, 4p14, 21q21, 20p, 19p13.2, 17q23.1, 17q23	ALZHEIMER DISEASE; AD	1636, 2, 22976, 3077, 323, 351, 4353, 4846, 5328, 642, 6653
MIM104310	#	19q13.2	ALZHEIMER DISEASE 2	348
MIM104311	*	14q24.3	PRESENILIN 1; PSEN1	5663
MIM104350		 	AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	 
MIM104400		 	AMELIA AND TERMINAL TRANSVERSE HEMIMELIA	 
MIM104500	#	4q21	AMELOGENESIS IMPERFECTA, TYPE IB; AI1B	10117
MIM104510	#	17q21.3-q22	AMELOGENESIS IMPERFECTA, TYPE IV; AI4	1747
MIM104530	%	 	AMELOGENESIS IMPERFECTA, HYPOPLASTIC TYPE	 
MIM104570	%	 	AMELOONYCHOHYPOHIDROTIC SYNDROME	 
MIM104600		 	AMENORRHEA-GALACTORRHEA SYNDROME	 
MIM104610	*	7q31-q32	AMILORIDE-BINDING PROTEIN 1; ABP1	26
MIM104613	*	 	CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 6A; CCT6A	908
MIM104614	*	2p16.3	SOLUTE CARRIER FAMILY 3 (CYSTINE, DIBASIC, AND NEUTRAL AMINO ACID TRANSPORTER), MEMBER 1; SLC3A1	6519
MIM104615	*	13q12.3	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 1; SLC7A1	6541
MIM104620	*	3p21.1	AMINOACYLASE 1; ACY1	95
MIM104640	*	4q13-q21	AMPHIREGULIN; AREG	374
MIM104650	*	1p21	AMYLASE, PANCREATIC, A; AMY2A	279
MIM104660	*	1p21	AMYLASE, PANCREATIC, B; AMY2B	280
MIM104700	*	1p21	AMYLASE, SALIVARY, A; AMY1A	276
MIM104701	*	1p21	AMYLASE, SALIVARY, B; AMY1B	277
MIM104702	*	1p21	AMYLASE, SALIVARY, C; AMY1C	278
MIM104750	*	11p15.1	SERUM AMYLOID A1; SAA1	6288
MIM104751	*	11p15.1	SERUM AMYLOID A2; SAA2	6289
MIM104752	*	11p15.1	SERUM AMYLOID A4; SAA4	6291
MIM104760	*	21q21	AMYLOID BETA A4 PRECURSOR PROTEIN; APP	351
MIM104770	*	1q21-q23	AMYLOID P COMPONENT, SERUM; APCS	325
MIM104775	*	19q13.2	AMYLOID BETA A4 PRECURSOR-LIKE PROTEIN 1; APLP1	333
MIM104776	*	11q24	AMYLOID BETA A4 PRECURSOR-LIKE PROTEIN 2; APLP2	334
MIM105120	#	9q34	AMYLOIDOSIS, FINNISH TYPE	2934
MIM105150	#	20p11.2	CEREBRAL AMYLOID ANGIOPATHY, CST3-RELATED	1471
MIM105200	#	12q15, 11q23, 4q28	AMYLOIDOSIS, FAMILIAL VISCERAL	2243, 335, 4069
MIM105210	#	18q11.2-q12.1	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	7276
MIM105250	#	5p13.1	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1; PLCA1	9180
MIM105300		 	AMYOTROPHIC DYSTONIC PARAPLEGIA	 
MIM105400	#	12q12-q13, 2p13, 22q12.2, 21q22.1	AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1	1639, 4744, 5630, 6647
MIM105500	#	15q21	AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1	54822
MIM105550	#	9q21-q22	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS; FTDALS	203228
MIM105563		 	ANAL SPHINCTER DYSPLASIA; ASDP	100187749
MIM105565		 	ANAL SPHINCTER MYOPATHY, INTERNAL	 
MIM105570		 	ANDROSTENONE, ABILITY TO SMELL	 
MIM105580		11q22-qter	ANAL CANAL CARCINOMA	8066
MIM105590	*	2p23	ANAPLASTIC LYMPHOMA KINASE; ALK	238
MIM105600	%	15q21	ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE III; CDAN3	981
MIM105650	#	19q13.2	DIAMOND-BLACKFAN ANEMIA; DBA	 
MIM105800	%	7q11.2	ANEURYSM, INTRACRANIAL BERRY, 1; ANIB1	116833
MIM105805		 	ANEURYSM OF INTERVENTRICULAR SEPTUM	 
MIM105830	#	15q11-q13, Xq28, Xp22	ANGELMAN SYNDROME; AS	10479, 4204, 6638, 6792, 6925, 7337
MIM105835		 	ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA; ASPED	 
MIM105850	*	14q11.2	ANGIOGENIN; ANG	283
MIM106050		 	ANGIOMA SERPIGINOSUM, AUTOSOMAL DOMINANT	 
MIM106070	%	 	ANGIOMA, HEREDITARY NEUROCUTANEOUS	 
MIM106100	#	11q11-q13.1	ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	710
MIM106150	+	1q42-q43	ANGIOTENSINOGEN; AGT	183
MIM106165	*	3q21-q25	ANGIOTENSIN RECEPTOR 1; AGTR1	185
MIM106180	+	17q23	ANGIOTENSIN I-CONVERTING ENZYME; ACE	1636
MIM106195	*	2q36	SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 3; SLC4A3	6508
MIM106200	^	 	MOVED TO 106210	 
MIM106210	#	11p13	ANIRIDIA; AN	5080, 7490
MIM106220		 	ANIRIDIA AND ABSENT PATELLA	 
MIM106230		 	ANIRIDIA, MICROCORNEA, AND SPONTANEOUSLY REABSORBED CATARACT	 
MIM106240		 	ANISOCORIA	 
MIM106250		 	ANKYLOBLEPHARON FILIFORME ADNATUM AND CLEFT PALATE; AFA	170
MIM106260	#	3q27	ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	8626
MIM106280		 	ANKYLOGLOSSIA	 
MIM106300	#	6p21.3	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1	3106
MIM106400		 	ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSIS	 
MIM106410	*	4q25-q27	ANKYRIN 2; ANK2	287
MIM106490	*	4q21	ANNEXIN A3; ANXA3	306
MIM106491	*	2p13	ANNEXIN A4; ANXA4	307
MIM106500		 	ANNULAR ERYTHEMA	 
MIM106600	#	4p16.1	TOOTH AGENESIS, SELECTIVE, 1; STHAG1	4487
MIM106700	%	4q12	TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1; TAPVR1	6893
MIM106750		 	ANONYCHIA WITH FLEXURAL PIGMENTATION	 
MIM106900		 	ANONYCHIA-ECTRODACTYLY	 
MIM106990		 	ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY	 
MIM106995	%	 	ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES	 
MIM107000	%	 	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 6; NDNC6	 
MIM107100	%	 	ANORECTAL ANOMALIES	 
MIM107200	%	18p11.23-q12.2	ANOSMIA, ISOLATED CONGENITAL; ANIC	550625
MIM107250	#	10q25, 1p32	ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS; ASMD	2301, 437, 5309
MIM107254	*	15q11-q22	ANTIGEN IDENTIFIED BY MONOCLONAL ANTIBODY 30.2A8; MIC12	4273
MIM107265	*	16p11.2	CD19 ANTIGEN; CD19	930
MIM107266	*	19q13.1	CD22 ANTIGEN; CD22	933
MIM107269	*	11pter-p13	CD44 ANTIGEN; CD44	960
MIM107270	*	4p15	CD38 ANTIGEN; CD38	952
MIM107271	*	11p13	CD59 ANTIGEN; CD59	966
MIM107272	*	9p	CD72 ANTIGEN; CD72	971
MIM107273	*	12p13-p12	CD69 ANTIGEN; CD69	969
MIM107280	*	14q32.1	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 3; SERPINA3	12
MIM107285	*	 	SECRETORY LEUKOCYTE PROTEASE INHIBITOR; SLPI	6590
MIM107300	*	1q23-q25	SERPIN PEPTIDASE INHIBITOR, CLADE C (ANTITHROMBIN), MEMBER 1; SERPINC1	462
MIM107310	*	1p36.1-p35	SOLUTE CARRIER FAMILY 9, MEMBER 1; SLC9A1	6548
MIM107320		6p21.3	ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	100499532
MIM107323	*	5q31	ALDEHYDE DEHYDROGENASE 7 FAMILY, MEMBER A1; ALDH7A1	501
MIM107325	*	19q13.2-q13.3	CD3-EPSILON-ASSOCIATED PROTEIN; CD3EAP	10849
MIM107400	*	14q32.1	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 1; SERPINA1	5265
MIM107410		14q32.1	PROTEASE INHIBITOR 1-LIKE; PIL	390502
MIM107450	*	21q22.1	INTERFERON, ALPHA, BETA, AND OMEGA, RECEPTOR 1; IFNAR1	3454
MIM107470	*	6q23-q24	INTERFERON, GAMMA, RECEPTOR 1; IFNGR1	3459
MIM107480	#	16q12.1	TOWNES-BROCKS SYNDROME; TBS	6299
MIM107500		 	AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	 
MIM107550		 	AORTIC ARCH INTERRUPTION, FACIAL PALSY, AND RETINAL COLOBOMA	 
MIM107580	*	6p24	TRANSCRIPTION FACTOR AP2-ALPHA; TFAP2A	7020
MIM107600	#	 	APLASIA CUTIS CONGENITA, NONSYNDROMIC; ACC	 
MIM107601	^	 	MOVED TO 100300	 
MIM107640		 	APNEA, CENTRAL SLEEP	 
MIM107650	%	 	APNEA, OBSTRUCTIVE SLEEP	 
MIM107670	+	1q21-q23	APOLIPOPROTEIN A-II; APOA2	336
MIM107680	+	11q23	APOLIPOPROTEIN A-I; APOA1	335
MIM107690	*	11q23	APOLIPOPROTEIN A-IV; APOA4	337
MIM107700		 	APPENDICITIS, PRONENESS TO	 
MIM107710	*	19q13.2	APOLIPOPROTEIN C-I; APOC1	341
MIM107720	*	11q23	APOLIPOPROTEIN C-III; APOC3	345
MIM107730	+	2p24	APOLIPOPROTEIN B; APOB	338
MIM107740	*	3q26.2-qter	APOLIPOPROTEIN D; APOD	347
MIM107741	+	19q13.2	APOLIPOPROTEIN E; APOE	348
MIM107748	*	14q12	APEX NUCLEASE 1; APEX1	328
MIM107760	*	 	APOLIPOPROTEIN F; APOF	319
MIM107770	*	12q13.1-q13.3	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1; LRP1	4035
MIM107773	*	15q26.1-q26.2	NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 2; NR2F2	7026
MIM107776	*	7p14	AQUAPORIN 1; AQP1	358
MIM107777	*	12q13	AQUAPORIN 2; AQP2	359
MIM107800		 	ARCUS CORNEAE	 
MIM107820	*	5pter-q11	ARGINYL-tRNA SYNTHETASE 1; RARS1	5917
MIM107830	*	14q24.1-q24.3	ARGINASE II; ARG2	384
MIM107850		 	ARM FOLDING PREFERENCE	 
MIM107900		 	ARMS, MALFORMATION OF	 
MIM107910	*	15q21.1	CYTOCHROME P450, FAMILY 19, SUBFAMILY A, POLYPEPTIDE 1; CYP19A1	1588
MIM107920		12p	AROMATIC ALPHA-KETO ACID REDUCTASE	8083
MIM107930	*	7p11	DOPA DECARBOXYLASE; DDC	1644
MIM107940	*	11q13	ARRESTIN, BETA, 1; ARRB1	408
MIM107941	*	17p13	ARRESTIN, BETA, 2; ARRB2	409
MIM107950	^	 	MOVED TO 138800	 
MIM107970	#	14q24	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1; ARVD1	7043
MIM108000		 	ARTERIES, ANOMALIES OF	 
MIM108010	#	7p21	ARTERIOVENOUS MALFORMATIONS OF THE BRAIN	3569
MIM108050		 	ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	 
MIM108100		 	ARTHRITIS, SACROILIAC	 
MIM108110		 	ARTHROGRYPOSIS MULTIPLEX CONGENITA; AMC	 
MIM108120	#	9p13.2-p13.1	ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	7169
MIM108130	^	 	MOVED TO 601680	 
MIM108140	^	 	MOVED TO 601680	 
MIM108145	#	 	ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5	 
MIM108200		 	ARTHROGRYPOSIS, DISTAL, TYPE 6; DA6	 
MIM108300	#	12q13.11-q13.2	STICKLER SYNDROME, TYPE I; STL1	1280
MIM108320		 	ARTICHOKE, MODIFICATION OF TASTE BY	 
MIM108330	*	15q24.1	CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 1; CYP1A1	1543
MIM108340	#	 	ARYL HYDROCARBON HYDROXYLASE INDUCIBILITY	 
MIM108345	*	8p23.1-p21.3	N-ACETYLTRANSFERASE 1; NAT1	9
MIM108355	*	17q24-q25	GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2; GRB2	2885
MIM108360	*	17p13-p11	ASIALOGLYCOPROTEIN RECEPTOR 1; ASGR1	432
MIM108361	*	17p	ASIALOGLYCOPROTEIN RECEPTOR 2; ASGR2	433
MIM108370	*	7q21-q31	ASPARAGINE SYNTHETASE; ASNS	440
MIM108390	%	 	ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	 
MIM108410	*	18q21.1-q21.3	ASPARAGINYL-tRNA SYNTHETASE; NARS	4677
MIM108420	%	 	SPERMATOGENIC FAILURE 2; SPGF2	100653377
MIM108450		 	ASYMMETRIC SHORT STATURE SYNDROME	 
MIM108500	#	19p13	EPISODIC ATAXIA, TYPE 2; EA2	773
MIM108600	#	12p13	SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	114610
MIM108650	%	 	SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7	 
MIM108700		 	ATAXIA WITH FASCICULATIONS	 
MIM108720	#	3p14.3	ATELOSTEOGENESIS, TYPE I; AOI	2317
MIM108721	#	3p14.3	ATELOSTEOGENESIS, TYPE III; AOIII	2317
MIM108725	%	19p13.3-p13.2	ATHEROSCLEROSIS SUSCEPTIBILITY; ATHS	470
MIM108728	*	17q21.1	ATP CITRATE LYASE; ACLY	47
MIM108729	*	10p15.1	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, GAMMA SUBUNIT 1; ATP5C1	509
MIM108730	*	16p12	ATPase, Ca(2+)-TRANSPORTING, FAST-TWITCH 1; ATP2A1	487
MIM108731	*	12q21-q23	ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 1; ATP2B1	490
MIM108732	*	1q25-q32	ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 4; ATP2B4	493
MIM108733	*	3p26-p25	ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 2; ATP2B2	491
MIM108740	*	12q23-q24.1	ATPase, Ca(2+)-TRANSPORTING, SLOW-TWITCH; ATP2A2	488
MIM108745	*	16p13.3	ATPase, H+ TRANSPORTING, LYSOSOMAL, 16-KD, V0 SUBUNIT C; ATP6V0C	527
MIM108746	*	22q11.2	ATPase, H+ TRANSPORTING, LYSOSOMAL, 31-KD, V1 SUBUNIT E; ATP6V1E	529
MIM108760	%	 	ATRESIA OF EXTERNAL AUDITORY CANAL AND CONDUCTIVE DEAFNESS	 
MIM108770	#	 	ATRIAL STANDSTILL	 
MIM108780	*	1p36.2	NATRIURETIC PEPTIDE PRECURSOR A; NPPA	4878
MIM108800	%	5p	ATRIAL SEPTAL DEFECT 1; ASD1	431
MIM108900	#	5q34	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS; ASD7	1482
MIM108950		 	ATRIAL TACHYARRHYTHMIA WITH SHORT PR INTERVAL	 
MIM108960	*	1q21-q22	NATRIURETIC PEPTIDE RECEPTOR A/GUANYLATE CYCLASE A; NPR1	4881
MIM108961	*	9p21-p12	NATRIURETIC PEPTIDE RECEPTOR B/GUANYLATE CYCLASE B; NPR2	4882
MIM108962	*	5p14-p12	NATRIURETIC PEPTIDE RECEPTOR C; NPR3	4883
MIM108985	#	11p15.2	SVEINSSON CHORIORETINAL ATROPHY; SCRA	7003
MIM108990	*	15q11-q12	ATTACHED CELL ANTIGEN 28.3.7; MIC7	4270
MIM109000	%	 	AURICULOOSTEODYSPLASIA	 
MIM109050		 	AUROCEPHALOSYNDACTYLY	 
MIM109090	*	2q31.1	SJOGREN SYNDROME ANTIGEN B; SSB	6741
MIM109091	*	19p13.2	CALRETICULIN; CALR	811
MIM109092	*	11p15.5	TRIPARTITE MOTIF-CONTAINING PROTEIN 21; TRIM21	6737
MIM109100	#	 	AUTOIMMUNE DISEASE	 
MIM109120		 	AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	 
MIM109130		 	AXIAL OSTEOMALACIA	 
MIM109135	*	19q13.1-q13.2	AXL RECEPTOR TYROSINE KINASE; AXL	558
MIM109150	#	14q24.3-q31	MACHADO-JOSEPH DISEASE; MJD	4287
MIM109160	%	 	AZOTEMIA, FAMILIAL	 
MIM109170	*	6p21.3-p21.1	LEUKOCYTE-SPECIFIC TRANSCRIPT 1; LST1	7940
MIM109180		Chr.6	BABOON M7 VIRUS INTEGRATION SITE; BEVI	628
MIM109190	*	19q13.3	SOLUTE CARRIER FAMILY 1 (NEUTRAL AMINO ACID TRANSPORTER), MEMBER 5; SLC1A5	6510
MIM109195	*	20q11.23-q12	BACTERICIDAL PERMEABILITY-INCREASING PROTEIN; BPI	671
MIM109200	%	3q26	ALOPECIA, ANDROGENETIC, 1; AGA1	100188784
MIM109270	+	17q21-q22	SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1	6521
MIM109280	*	7q35-q36	SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 2; SLC4A2	6522
MIM109300		 	BANKI SYNDROME	 
MIM109350	%	13q14	GASTROESOPHAGEAL REFLUX; GER	59330
MIM109390	^	 	MOVED TO 301845	 
MIM109400	#	9q22.3	BASAL CELL NEVUS SYNDROME; BCNS	5727
MIM109480	*	19p13.3	BASIGIN; BSG	682
MIM109500	%	 	BASILAR IMPRESSION, PRIMARY	 
MIM109530	*	1q21.3-q22	CD48 ANTIGEN; CD48	962
MIM109535	*	20q12-q13.2	CD40 ANTIGEN; CD40	958
MIM109543	%	13q14	LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 2	8101
MIM109545	*	16p13.1	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 17; TNFRSF17	608
MIM109560	*	19q13	B-CELL LEUKEMIA/LYMPHOMA 3; BCL3	602
MIM109565	*	3q27	B-CELL LYMPHOMA 6; BCL6	604
MIM109580	*	12q22	B-CELL TRANSLOCATION GENE 1; BTG1	694
MIM109610	*	22q13.31	TRANSLOCATOR PROTEIN, 18-KD; TSPO	706
MIM109630	+	10q24-q26	BETA-1-ADRENERGIC RECEPTOR; ADRB1	153
MIM109635	*	11cen-q13	BETA-ADRENERGIC RECEPTOR KINASE 1; ADRBK1	156
MIM109636	*	22q11	BETA-ADRENERGIC RECEPTOR KINASE 2; ADRBK2	157
MIM109650	%	 	BEHCET SYNDROME	 
MIM109660	%	 	BETA-AMINO ACIDS, RENAL TRANSPORT OF; AABT	8212
MIM109670		Chr.21	BETA-ADRENERGIC STIMULATION, RESPONSE TO; BAS	8213
MIM109675	*	3q21-q28	ST6 BETA-GALACTOSAMIDE ALPHA-2,6-SIALYLTRANSFERASE 1; ST6GAL1	6480
MIM109684	*	17q12-q21	17-@BETA-HYDROXYSTEROID DEHYDROGENASE I; HSD17B1	3292
MIM109685	*	16q24.1-q24.2	17-@BETA-HYDROXYSTEROID DEHYDROGENASE II; HSD17B2	3294
MIM109690	+	5q32-q34	BETA-2-ADRENERGIC RECEPTOR; ADRB2	154
MIM109691	*	8p12-p11.2	BETA-3-ADRENERGIC RECEPTOR; ADRB3	155
MIM109700	*	15q21-q22	BETA-2-MICROGLOBULIN; B2M	567
MIM109710	*	15q13-q15	BETA-2-MICROGLOBULIN REGULATOR; B2MR	568
MIM109715	*	1p13.1	3-@BETA-HYDROXYSTEROID DEHYDROGENASE 1; HSD3B1	3283
MIM109720	%	3p12-q13.2	BILIARY CIRRHOSIS, PRIMARY, 1; PBC1	 
MIM109730	#	9q34.3	AORTIC VALVE DISEASE 1; AOVD1	4851
MIM109740		 	BIFID NOSE, AUTOSOMAL DOMINANT	 
MIM109750	*	7p14-cen	BILIVERDIN REDUCTASE A; BLVRA	644
MIM109760	*	5q11.2-q13	5-@HYDROXYTRYPTAMINE RECEPTOR 1A; HTR1A	3350
MIM109770	*	19q13.2	CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 1; CEACAM1	634
MIM109780	*	6q21	BKM DNA	7951
MIM109800	#	13q14.1-q14.2, 12p12.1, 11p15.5, 4p16.3, 4p16.3	BLADDER CANCER	10460, 2261, 3265, 3845, 5925
MIM109820		 	BLADDER DIVERTICULUM	 
MIM109900		 	BLEPHAROCHALASIS AND DOUBLE LIP	 
MIM110000		 	BLEPHAROCHALASIS, SUPERIOR	 
MIM110050		 	BLEPHARONASOFACIAL MALFORMATION SYNDROME	 
MIM110100	#	3q23	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS; BPES	668
MIM110150		 	BLEPHAROPTOSIS, MYOPIA, AND ECTOPIA LENTIS	 
MIM110300	*	9q34	ABO GLYCOSYLTRANSFERASE; ABO	28
MIM110350	%	 	BLOOD GROUP--AHONEN; AN	100187761
MIM110450	#	7p14	BLOOD GROUP--COLTON; CO	358
MIM110500	#	17q21-q22	BLOOD GROUP--DIEGO SYSTEM; DI	6521
MIM110600	*	12p13-p12	ADP-RIBOSYLTRANSFERASE 4; ART4	420
MIM110700	#	1q23.2	BLOOD GROUP, DUFFY SYSTEM; FY	2532
MIM110720		 	BLOOD GROUP--En	 
MIM110750	*	2q14-q21	BLOOD GROUP--GERBICH; Ge	2995
MIM110800	#	6p24-p23	BLOOD GROUP--I SYSTEM; Ii	2651
MIM110900	#	7q33	BLOOD GROUP--KELL SYSTEM; KEL	3792
MIM111000	#	18q11-q12	BLOOD GROUP--KIDD SYSTEM; JK	6563
MIM111100	+	19p13.3	FUCOSYLTRANSFERASE 3; FUT3	2525
MIM111150	#	11p, 19p13.13-p13.12	BLOOD GROUP--LUTHERAN INHIBITOR; INLU	10661
MIM111200	#	19q13.2	BLOOD GROUP--LUTHERAN SYSTEM; LU	4059
MIM111250	#	19p13.3	BLOOD GROUP SYSTEM, LANDSTEINER-WIENER; LW	3386
MIM111300	+	4q28.2-q31.1	BLOOD GROUP--MN LOCUS; MN	2993
MIM111360		 	BLOOD GROUP--NEWFOUNDLAND; NFLD	 
MIM111380	#	19p13.3	BLOOD GROUP--OK; OK	682
MIM111400	#	3q25, 22q13.2	BLOOD GROUP, P SYSTEM	53947, 8706
MIM111500	#	 	BLOOD GROUP--PRIVATE SYSTEMS	 
MIM111600	#	 	BLOOD GROUP, LANGEREIS SYSTEM; LAN	10058
MIM111620	#	1p34	RADIN BLOOD GROUP ANTIGEN; RD	114625
MIM111680	*	1p36.2-p34	RHESUS BLOOD GROUP, D ANTIGEN; RHD	6007
MIM111690	#	 	BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE	6006
MIM111700	+	1p36.2-p34	RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE	6006
MIM111730	*	17q21.2	BETA-1,4-N-ACETYL-GALACTOSAMINYLTRANSFERASE 2; B4GALNT2	124872
MIM111740	+	4q28-q31	BLOOD GROUP--Ss LOCUS; Ss	2994
MIM111750	#	1p34	BLOOD GROUP--SCIANNA SYSTEM; SC	114625
MIM111800	%	4q28-q31	BLOOD GROUP--STOLTZFUS SYSTEM; Sf	6420
MIM112010	#	17q21-q22	BLOOD GROUP--WALDNER TYPE; WD	6521
MIM112050	#	17q21-q22	BLOOD GROUP--WRIGHT ANTIGEN; WR	6521
MIM112100	#	7q22	YT BLOOD GROUP ANTIGEN	43
MIM112200	%	 	BLUE RUBBER BLEB NEVUS	 
MIM112203	*	3q21	CD80 ANTIGEN; CD80	941
MIM112205	*	19q13.2	CD79A ANTIGEN; CD79A	973
MIM112210	*	11q13	MEMBRANE-SPANNING 4 DOMAINS, SUBFAMILY A, MEMBER 1; MS4A1	931
MIM112240		 	BONE FRAGILITY WITH CRANIOSYNOSTOSIS, OCULAR PROPTOSIS, HYDROCEPHALUS, AND DISTINCTIVE FACIAL FEATURES	 
MIM112250	#	9p22-p21	DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	 
MIM112260	*	1q25-q31	GAMMA-CARBOXYGLUTAMIC ACID PROTEIN, BONE; BGLAP	632
MIM112261	*	20p12	BONE MORPHOGENETIC PROTEIN 2; BMP2	650
MIM112262	*	14q22-q23	BONE MORPHOGENETIC PROTEIN 4; BMP4	652
MIM112263	*	4p14-q21	BONE MORPHOGENETIC PROTEIN 3; BMP3	651
MIM112264	*	8p21	BONE MORPHOGENETIC PROTEIN 1; BMP1	649
MIM112265	*	6p12.1	BONE MORPHOGENETIC PROTEIN 5; BMP5	653
MIM112266	*	6p24-p23	BONE MORPHOGENETIC PROTEIN 6; BMP6	654
MIM112267	*	20q13.1-q13.3	BONE MORPHOGENETIC PROTEIN 7; BMP7	655
MIM112270		 	BONE PAIN, PERIODIC	 
MIM112300	%	 	BOOK SYNDROME	 
MIM112310	#	3p14.3	BOOMERANG DYSPLASIA	2317
MIM112350	%	 	BOWING OF LEGS, ANTERIOR, WITH DWARFISM	 
MIM112370		 	BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUS ADDUCTUS, AND DEVELOPMENTAL DELAY	 
MIM112410	%	12p12.2-p11.2	HYPERTENSION WITH BRACHYDACTYLY	8080
MIM112430		 	LONG-THUMB BRACHYDACTYLY SYNDROME	 
MIM112440	%	 	BRACHYDACTYLY, COMBINED B AND E TYPES	 
MIM112450		 	BRACHYDACTYLY, PREAXIAL, WITH HALLUX VARUS AND THUMB ABDUCTION	 
MIM112500	#	5p13.3-p13.2, 2q33-q35	BRACHYDACTYLY, TYPE A1; BDA1	3549
MIM112600	#	4q23-q24, 20q11.2	BRACHYDACTYLY, TYPE A2; BDA2	650, 658, 8200
MIM112700	%	 	BRACHYDACTYLY, TYPE A3; BDA3	 
MIM112800	%	 	BRACHYDACTYLY, TYPE A4; BDA4	 
MIM112900	^	 	BRACHYDACTYLY, TYPE A5, WITH NAIL DYSPLASIA	 
MIM112910		 	BRACHYDACTYLY, TYPE A6; BDA6	 
MIM113000	#	9q22	BRACHYDACTYLY, TYPE B1; BDB1	4920
MIM113100	#	20q11.2	BRACHYDACTYLY, TYPE C; BDC	8200
MIM113200	#	2q31-q32	BRACHYDACTYLY, TYPE D; BDD	3239
MIM113300	#	2q31-q32	BRACHYDACTYLY, TYPE E1; BDE1	3239
MIM113301		 	BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	 
MIM113310		 	BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA	 
MIM113400		 	BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	 
MIM113450		 	BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	 
MIM113470		 	BRACHYMESOMELIA-RENAL SYNDROME	 
MIM113475		 	BRACHYMETATARSUS IV	 
MIM113477		 	BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	 
MIM113480		 	BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	 
MIM113500	#	12q24.1	BRACHYOLMIA TYPE 3	59341
MIM113503	*	14q32.1-q32.2	BRADYKININ RECEPTOR B2; BDKRB2	624
MIM113505	*	11p13	BRAIN-DERIVED NEUROTROPHIC FACTOR; BDNF	627
MIM113508	*	22q12	TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, ETA ISOFORM; YWHAH	7533
MIM113520	*	12p12	BRANCHED-CHAIN AMINOTRANSFERASE 1; BCAT1	586
MIM113530	*	19q13	BRANCHED-CHAIN AMINOTRANSFERASE 2; BCAT2	587
MIM113600		 	BRANCHIAL CLEFT ANOMALIES	 
MIM113610		 	BRANCHIAL MYOCLONUS WITH SPASTIC PARAPARESIS AND CEREBELLAR ATAXIA	 
MIM113620	#	6p24	BRANCHIOOCULOFACIAL SYNDROME; BOFS	7020
MIM113630	^	22q11.21	BREAKPOINT CLUSTER REGION-LIKE 2; BCRL2	400892
MIM113640	^	22q11.21	BREAKPOINT CLUSTER REGION-LIKE 3; BCRL3	644165
MIM113650	#	8q13.3	BRANCHIOOTORENAL SYNDROME 1; BOR1	2138
MIM113660	^	22q11.21	BREAKPOINT CLUSTER REGION-LIKE 4; BCRL4	616
MIM113670	%	 	HYPERTROPHY OF THE BREAST, JUVENILE; JHB	 
MIM113700	%	 	BREASTS AND NIPPLES, ABSENCE OF	 
MIM113703	*	 	RIBOSOMAL PROTEIN L13; RPL13	6137
MIM113705	*	17q21	BREAST CANCER 1 GENE; BRCA1	672
MIM113710	*	21q22.3	TREFOIL FACTOR 1; TFF1	7031
MIM113721	*	17p13.3	BREAST CANCER-RELATED REGULATOR OF TP53	8142
MIM113725	*	4q31.2	POU DOMAIN, CLASS 4, TRANSCRIPTION FACTOR 2; POU4F2	5458
MIM113730	*	4q31	UNCOUPLING PROTEIN 1; UCP1	7350
MIM113750	#	15q21.1	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 4; SHEP4	283652
MIM113800	#	17q21-q22, 12q13	EPIDERMOLYTIC HYPERKERATOSIS; EHK	3848, 3858
MIM113810	*	6p12-p11	DYSTONIN; DST	667
MIM113811	*	10q24.3	COLLAGEN, TYPE XVII, ALPHA-1; COL17A1	1308
MIM113900	#	3p21	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA; PFHB1A	6331
MIM113950	%	 	BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	 
MIM113970	#	8q24.12-q24.13	BURKITT LYMPHOMA; BL	4609
MIM113995	*	19q13.3-q13.4	COMPLEMENT COMPONENT 5 RECEPTOR 1; C5R1	728
MIM114000	#	17q21.31-q22	CAFFEY DISEASE	1277
MIM114010	*	2p21	CARBAMOYL PHOSPHATE SYNTHETASE/ASPARTATE TRANSCARBAMOYLASE/DIHYDROOROTASE; CAD	790
MIM114019	*	16q24.3	CADHERIN 15; CDH15	1013
MIM114020	*	18q11.2	CADHERIN 2; CDH2	1000
MIM114021	*	16q22.1	CADHERIN 3; CDH3	1001
MIM114025	*	2p12-p11.1	CATENIN, ALPHA-2; CTNNA2	1496
MIM114030		 	CAFE-AU-LAIT SPOTS, MULTIPLE	 
MIM114050	*	8q21.3-q22.1	CALBINDIN 1; CALB1	793
MIM114051	*	16q22.1	CALBINDIN 2; CALB2	794
MIM114070	*	5q32-q34	ANNEXIN A6; ANXA6	309
MIM114078	*	5q32	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-ALPHA; CAMK2A	815
MIM114080	*	5q21-q23	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IV; CAMK4	814
MIM114085	*	1q21	S100 CALCIUM-BINDING PROTEIN A10; S100A10	6281
MIM114090	*	5q15-q21	CALPASTATIN; CAST	831
MIM114100	%	 	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET	 
MIM114105	*	4q24-q25	PROTEIN PHOSPHATASE 3, CATALYTIC SUBUNIT, ALPHA ISOFORM; PPP3CA	5530
MIM114106	*	10q21-q22	PROTEIN PHOSPHATASE 3, CATALYTIC SUBUNIT, BETA ISOFORM; PPP3CB	5532
MIM114107	*	Chr.8	PROTEIN PHOSPHATASE 3, CATALYTIC SUBUNIT, GAMMA ISOFORM; PPP3CC	5533
MIM114110	*	1q21	S100 CALCIUM-BINDING PROTEIN A6; S100A6	6277
MIM114120	^	 	MOVED TO 211900	 
MIM114130	*	11p15.2-p15.1	CALCITONIN/CALCITONIN-RELATED POLYPEPTIDE, ALPHA; CALCA	796
MIM114131	*	7q21.3	CALCITONIN RECEPTOR; CALCR	799
MIM114140	%	 	CALLOSITIES, HEREDITARY PAINFUL	 
MIM114150	%	 	CAMPTOBRACHYDACTYLY	 
MIM114160	*	11p15.2-p15.1	CALCITONIN-RELATED POLYPEPTIDE, BETA; CALCB	797
MIM114170	*	19q13.12	CALPAIN, SMALL SUBUNIT 1; CAPNS1	826
MIM114180	*	14q24-q31	CALMODULIN 1; CALM1	801
MIM114182	*	2p21	CALMODULIN 2; CALM2	805
MIM114183	*	19q13.2-q13.3	CALMODULIN 3; CALM3	808
MIM114184	*	10pter-p13	CALMODULIN-LIKE 3; CALML3	810
MIM114190	*	2q31-q32	CALCITONIN RECEPTOR-LIKE GENE; CALCRL	10203
MIM114200	%	3q11.2-q13.12	CAMPTODACTYLY 1; CAMPD1	100381210
MIM114204	*	7q21-q22	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 1; CACNA2D1	781
MIM114205	*	12p13.3	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1C SUBUNIT; CACNA1C	775
MIM114206	*	3p14.3	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1D SUBUNIT; CACNA1D	776
MIM114207	*	17q21-q22	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-1 SUBUNIT; CACNB1	782
MIM114208	*	1q32	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1S SUBUNIT; CACNA1S	779
MIM114209	*	17q24	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-1 SUBUNIT; CACNG1	786
MIM114210	*	1q21	S100 CALCIUM-BINDING PROTEIN A4; S100A4	6275
MIM114212	*	19p13.3	CALCYPHOSINE; CAPS	828
MIM114213	*	7q33	CALDESMON 1; CALD1	800
MIM114217	*	5q35	CALNEXIN; CANX	821
MIM114220	*	11q13	CALPAIN 1; CAPN1	823
MIM114230	*	1q41-q42	CALPAIN 2; CAPN2	824
MIM114240	*	15q15.1-q21.1	CALPAIN 3; CAPN3	825
MIM114250	*	1q21	CALSEQUESTRIN 1; CASQ1	844
MIM114251	*	1p13.3-p11	CALSEQUESTRIN 2; CASQ2	845
MIM114280	*	 	CAMPATH-1 ANTIGEN; CDW52	1043
MIM114290	#	17q24.3-q25.1	CAMPOMELIC DYSPLASIA	6662
MIM114300	#	 	ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	 
MIM114350	*	9q34.1	NUCLEOPORIN, 214-KD; NUP214	8021
MIM114400	^	 	MOVED TO 120435	 
MIM114450		 	CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE	8105
MIM114480	#	17q21, 17p13.1, 16q22.1, 16p12, 15q15.1, 14q32.3, 13q12.3, 12p12.1, 11q22.3, 11p15.5, 8q11, 1p32, 6p25, 5q33.2, 3q26.3, 2q34-q35, 2q33, 22q12.1, 17q22-q23, 17q22	BREAST CANCER	11200, 207, 3161, 3845, 472, 4835, 5002, 5245, 5290, 580, 5888, 675, 7157, 7251, 7517, 79728, 83990, 841, 8438, 8493, 9821, 999
MIM114500	#	17p11.2, 17p13.1, 15q15, 14q32.3, 14q24.3, 11q13, 11p11.2, 9q32-q33, 1p13.2, 8p22-p21.3, 5q21-q22, 4q32, 3q26.3, 1p35, 2p25, 22q13, 20q13.2-q13.3, 17q24	COLORECTAL CANCER; CRC	201163, 2033, 207, 2261, 25788, 27030, 324, 4893, 4953, 5157, 5290, 5320, 5782, 5795, 595, 6790, 701, 7097, 7099, 7157, 8313, 8915
MIM114550	#	17p13.1, 16p13.3, 8p22-p21.3, 7q31, 5q21-q22, 3q26.3, 3p22-p21.3, 2q33	HEPATOCELLULAR CARCINOMA	1499, 324, 4233, 5157, 5290, 7157, 8312, 841
MIM114580	%	2p22.3-p21	CANDIDIASIS, FAMILIAL, 1; CANDF1	117084
MIM114600	%	 	CANINE TEETH, ABSENCE OF UPPER PERMANENT	 
MIM114610	*	6q14-q15	CANNABINOID RECEPTOR 1; CNR1	1268
MIM114620		 	CRANIOFACIOFRONTODIGITAL SYNDROME	 
MIM114650		 	CAR FACTOR DEFICIENCY	 
MIM114700		 	CARABELLI ANOMALY OF MAXILLARY MOLAR TEETH	 
MIM114750	*	8q22	CARBONIC ANHYDRASE III; CA3	761
MIM114760	*	17q23	CARBONIC ANHYDRASE IV; CA4	762
MIM114761	*	16q24.3	CARBONIC ANHYDRASE V; CA5A	763
MIM114770	*	16q21-q23	CARBONIC ANHYDRASE VII; CA7	766
MIM114780	*	1p36.33-p36.22	CARBONIC ANHYDRASE VI; CA6	765
MIM114800	*	8q22	CARBONIC ANHYDRASE I; CA1	759
MIM114815	*	8q11-q12	CARBONIC ANHYDRASE VIII; CA8	767
MIM114830	*	21q22.12	CARBONYL REDUCTASE 1; CBR1	873
MIM114835	+	16q13-q22.1	CARBOXYLESTERASE 1; CES1	1066
MIM114840	*	9q34.3	CARBOXYL-ESTER LIPASE; CEL	1056
MIM114850	*	7q32-qter	CARBOXYPEPTIDASE A1; CPA1	1357
MIM114851	*	3q24	CARBOXYPEPTIDASE A3, MAST CELL; CPA3	1359
MIM114852	*	 	CARBOXYPEPTIDASE B1, TISSUE; CPB1	1360
MIM114855	*	4q32.3	CARBOXYPEPTIDASE E; CPE	1363
MIM114860	*	12q15	CARBOXYPEPTIDASE M; CPM	1368
MIM114890	*	19q13.2	CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5; CEACAM5	1048
MIM114900	#	11q23	CARCINOID TUMORS, INTESTINAL	6392
MIM115000		 	CARDIAC ARRHYTHMIA	 
MIM115080	#	17p11.1	CARDIAC CONDUCTION DEFECT	11216
MIM115150	#	15q21, 12p12.1, 7q34, 19p13.3	CARDIOFACIOCUTANEOUS SYNDROME	3845, 5604, 5605, 673
MIM115195	#	1q32	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2; CMH2	7139
MIM115196	#	15q22.1	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3; CMH3	7168
MIM115197	#	11p11.2	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	4607
MIM115198	^	 	MOVED TO 192600 AND 115197	 
MIM115200	#	1q21.2, 11p11.2	CARDIOMYOPATHY, DILATED, 1A; CMD1A	4000, 4607
MIM115210	#	19q13.4	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1; RCM1	7137
MIM115250		 	COLLAGENOMA, FAMILIAL CUTANEOUS	 
MIM115300	#	16q21-q23	HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL DOMINANT	53630
MIM115310	#	1p36.1-p35	PARAGANGLIOMAS 4; PGL4	6390
MIM115400		 	CARPAL DISPLACEMENT	 
MIM115430	#	18q11.2-q12.1	CARPAL TUNNEL SYNDROME; CTS1	7276
MIM115435	*	5q13-q14.1	HYALURONAN AND PROTEOGLYCAN LINK PROTEIN 1; HAPLN1	1404
MIM115437	*	1p35	MATRILIN 1; MATN1	4146
MIM115440	*	20p13	CASEIN KINASE II, ALPHA-1; CSNK2A1	1457
MIM115441	*	6p21.3	CASEIN KINASE II, BETA; CSNK2B	1460
MIM115442	*	16p13.3-p13.2	CASEIN KINASE II, ALPHA-2; CSNK2A2	1459
MIM115450	*	4q21.1	CASEIN, ALPHA; CSN1	1446
MIM115460	*	4q21.1	CASEIN, BETA; CSN2	1447
MIM115470	#	22q11	CAT EYE SYNDROME; CES	1055
MIM115500	*	11p13	CATALASE; CAT	847
MIM115501	*	9p23	TYROSINASE-RELATED PROTEIN 1; TYRP1	7306
MIM115645		 	CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	 
MIM115650	%	14q24-qter	CATARACT, ANTERIOR POLAR, 1; CTAA1	1483
MIM115660	%	17q24	CATARACT, CONGENITAL, CERULEAN TYPE, 1; CCA1	878
MIM115665	%	1pter-p36.13	CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	7792
MIM115700	#	2q33-q35	CATARACT, CRYSTALLINE ACULEIFORM	1421
MIM115800	%	 	CATARACT, CRYSTALLINE CORALLIFORM	 
MIM115900	#	 	CATARACT, FLORIFORM	 
MIM116100	#	 	CATARACT, MEMBRANOUS	 
MIM116150	^	1q21.1	CATARACT-MICROCORNEA SYNDROME	2703
MIM116200	#	1q21.1	CATARACT, ZONULAR PULVERULENT 1; CZP1	2703
MIM116300	#	 	CATARACT, NUCLEAR DIFFUSE NONPROGRESSIVE	 
MIM116400	#	 	CATARACT, NUCLEAR TOTAL	 
MIM116600	#	1pter-p36.1	CATARACT, POSTERIOR POLAR, 1; CTPP1	10306, 1969
MIM116700		 	CATARACT, TOTAL CONGENITAL; CC	1969
MIM116790	+	22q11.2	CATECHOL-O-METHYLTRANSFERASE; COMT	1312
MIM116800	#	16q21-q22.1	CATARACT, LAMELLAR	3299
MIM116805	*	5q31	CATENIN, ALPHA-1; CTNNA1	1495
MIM116806	*	3p22-p21.3	CATENIN, BETA-1; CTNNB1	1499
MIM116810	*	8p22	CATHEPSIN B; CTSB	1508
MIM116820	*	15q24-q25	CATHEPSIN H; CTSH	1512
MIM116830	*	14q11.2	CATHEPSIN G; CTSG	1511
MIM116831	*	14q11.2	GRANZYME H; GZMH	2999
MIM116840	*	11p15.5	CATHEPSIN D; CTSD	1509
MIM116845	*	1q21	CATHEPSIN S; CTSS	1520
MIM116850		 	CATATRICHY	 
MIM116860	#	7q11.2-q21	CEREBRAL CAVERNOUS MALFORMATIONS; CCM	 
MIM116870		 	CELIAC ARTERY STENOSIS FROM COMPRESSION BY MEDIAN ARCUATE LIGAMENT OF DIAPHRAGM	 
MIM116880	*	9q21-q22	CATHEPSIN L; CTSL	1514
MIM116890	*	1q31	CATHEPSIN E; CTSE	1510
MIM116896	*	7q22	CUT-LIKE 1; CUTL1	1523
MIM116897	*	19q13.1	CCAAT/ENHANCER-BINDING PROTEIN, ALPHA; CEBPA	1050
MIM116898	*	8p11.2-p11.1	CCAAT/ENHANCER-BINDING PROTEIN, DELTA; CEBPD	1052
MIM116899	*	6p21.2	CYCLIN-DEPENDENT KINASE INHIBITOR 1A; CDKN1A	1026
MIM116900	*	1q21.3	CDC28 PROTEIN KINASE 1B; CKS1B	1163
MIM116901	*	 	CDC2-ASSOCIATED PROTEIN CKS2; CKS2	1164
MIM116920	#	21q22.3	LEUKOCYTE ADHESION DEFICIENCY, TYPE I; LAD	3689
MIM116930	*	11q23.1	CELL ADHESION MOLECULE, NEURAL, 1; NCAM1	4684
MIM116940	*	10q21.1	CYCLIN-DEPENDENT KINASE 1; CDK1	983
MIM116945	*	3q21	MINICHROMOSOME MAINTENANCE, S. CEREVISIAE, HOMOLOG OF, 2; MCM2	4171
MIM116946	*	17q12-q23.2	CELL DIVISION CYCLE 27; CDC27	996
MIM116947	*	3p21	CELL DIVISION CYCLE 25A; CDC25A	993
MIM116948	*	19p13.3	CELL DIVISION CYCLE 34, S. CEREVISIAE, HOMOLOG OF; CDC34	997
MIM116949	*	20p13	CELL DIVISION CYCLE 25B; CDC25B	994
MIM116950		 	TEMPERATURE-SENSITIVE AF8 COMPLEMENT; AF8T	169
MIM116951	*	1p36.3	CYCLIN-DEPENDENT KINASE 11A; CDK11A	728642
MIM116952	*	1p36.1	CELL DIVISION CYCLE 42; CDC42	998
MIM116953	*	12q13	CYCLIN-DEPENDENT KINASE 2; CDK2	1017
MIM116955	*	3q13.3-q24	ZINC FINGER PROTEIN 9; ZNF9	7555
MIM116957	*	20q11.2	RETINOBLASTOMA-LIKE 1; RBL1	5933
MIM116960	*	4q33-q34.1	MORTALITY FACTOR 4; MORF4	10934
MIM117000	#	19q13.1	CENTRAL CORE DISEASE OF MUSCLE	6261
MIM117100	%	11p13	CENTRALOPATHIC EPILEPSY	100379198
MIM117139	*	2p24-p21	CENTROMERIC PROTEIN A; CENPA	1058
MIM117140	*	20p13	CENTROMERIC PROTEIN B; CENPB	1059
MIM117141	*	4q12-q13.3	CENTROMERIC PROTEIN C1; CENPC1	1060
MIM117143	*	4q24-q25	CENTROMERIC PROTEIN E; CENPE	1062
MIM117210	#	16q21	SPINOCEREBELLAR ATAXIA 31; SCA31	100312950, 146227
MIM117300	#	13q14	CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 2	9445
MIM117340	*	16p13.1-p12	CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 2; CDR2	1039
MIM117350	^	 	MOVED TO 183090	 
MIM117360	#	3p26	SPINOCEREBELLAR ATAXIA 29; SCA29	100038747
MIM117400	^	 	MOVED TO 164400 AND 117210	 
MIM117550	#	5q35	SOTOS SYNDROME 1; SOTOS1	64324
MIM117600		 	CEREBRAL SARCOMA	 
MIM117650		 	CEREBROCOSTOMANDIBULAR SYNDROME	 
MIM117700	*	3q23-q24	CERULOPLASMIN; CP	1356
MIM117800	#	16q12.1	APOCRINE GLAND SECRETION, VARIATION IN	85320
MIM117850		 	CERVICAL HYPERTRICHOSIS WITH UNDERLYING KYPHOSCOLIOSIS	 
MIM117900		 	CERVICAL RIB	 
MIM118000		 	CERVICAL VERTEBRAL BRIDGE	 
MIM118005		 	CERVICAL VERTEBRAL DYSPLASIA	 
MIM118100	#	8q22.1	KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	392255
MIM118190	*	2q33.1	HEAT-SHOCK 60-KD PROTEIN 1; HSPD1	3329
MIM118200	#	1q22	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	1785, 4359
MIM118210	#	1p36.2	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1; CMT2A1	23095
MIM118220	#	17p11.2	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A; CMT1A	5376
MIM118300	#	17p11.2	CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS	5376
MIM118330		 	CHEILITIS GLANDULARIS	 
MIM118350		 	CHEMODECTOMA, INTRAABDOMINAL, WITH CUTANEOUS ANGIOLIPOMAS	 
MIM118400	#	4p16.3	CHERUBISM	6452
MIM118420	%	 	CHIARI MALFORMATION TYPE I	 
MIM118423	*	2q31-q32.1	CHIMERIN 1; CHN1	1123
MIM118425	*	7q35	CHLORIDE CHANNEL 1, SKELETAL MUSCLE; CLCN1	1180
MIM118430		 	CHLORPROPAMIDE-ALCOHOL FLUSHING; CPAF	 
MIM118440	*	3pter-p21	CHOLECYSTOKININ; CCK	885
MIM118444	*	4p15.2-p15.1	CHOLECYSTOKININ A RECEPTOR; CCKAR	886
MIM118445	*	11p15.5-p15.4	CHOLECYSTOKININ B RECEPTOR; CCKBR	887
MIM118450	#	20p12	ALAGILLE SYNDROME 1; ALGS1	182
MIM118455	*	8q11-q12	CYTOCHROME P450, SUBFAMILY VIIA, POLYPEPTIDE 1; CYP7A1	1581
MIM118470	*	16q21	CHOLESTERYL ESTER TRANSFER PROTEIN, PLASMA; CETP	1071
MIM118485	*	15q23-q24	CYTOCHROME P450, SUBFAMILY XIA, POLYPEPTIDE 1; CYP11A1	1583
MIM118490	*	10q11.2	CHOLINE ACETYLTRANSFERASE; CHAT	1103
MIM118491	*	 	CHOLINE KINASE, ALPHA; CHKA	1119
MIM118493	*	7q35-q36	CHOLINERGIC RECEPTOR, MUSCARINIC, 2; CHRM2	1129
MIM118494	*	1q41-q44	CHOLINERGIC RECEPTOR, MUSCARINIC, 3; CHRM3	1131
MIM118495	*	11p12-p11.2	CHOLINERGIC RECEPTOR, MUSCARINIC, 4; CHRM4	1132
MIM118496	*	15q26	CHOLINERGIC RECEPTOR, MUSCARINIC, 5; CHRM5	1133
MIM118502	*	8p21	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 2; CHRNA2	1135
MIM118503	*	15q25.1	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 3; CHRNA3	1136
MIM118504	*	20q13.2-q13.3	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 4; CHRNA4	1137
MIM118505	*	15q25.1	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 5; CHRNA5	1138
MIM118507	*	1q21	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPTIDE 2; CHRNB2	1141
MIM118508	*	8p11.2	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPTIDE 3; CHRNB3	1142
MIM118509	*	15q24	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPTIDE 4; CHRNB4	1143
MIM118510	*	11q13	CHOLINERGIC RECEPTOR, MUSCARINIC, 1; CHRM1	1128
MIM118511	*	15q14	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 7; CHRNA7	1139
MIM118600	#	5p15.2-p14.1	CHONDROCALCINOSIS 2; CCAL2	56172
MIM118610		 	CHONDROCALCINOSIS DUE TO APATITE CRYSTAL DEPOSITION	 
MIM118650		 	CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANT	 
MIM118651	%	 	CHONDRODYSPLASIA PUNCTATA, TIBIA-METACARPAL TYPE	 
MIM118661	*	5q12-q14	VERSICAN; VCAN	1462
MIM118700	#	14q13	CHOREA, BENIGN HEREDITARY; BHC	7080
MIM118750		 	CHOREOATHETOSIS, FAMILIAL INVERTED	 
MIM118800	#	2q35	PAROXYSMAL NONKINESIGENIC DYSKINESIA 1; PNKD1	25953
MIM118820	*	17q22-q24	CHORIONIC SOMATOMAMMOTROPIN HORMONE 2; CSH2	1443
MIM118825	*	1q43	CHM-LIKE; CHML	1122
MIM118840	%	5q35	CHROMATE RESISTANCE; CHR	1125
MIM118850	*	6q12-q21	CHORIONIC GONADOTROPIN, ALPHA CHAIN; CGA	1081
MIM118860	*	19q13.32	CHORIONIC GONADOTROPIN, BETA CHAIN; CGB	1082
MIM118865		 	CHOROIDAL OSTEOMA, BILATERAL	 
MIM118870	*	Chr.16	CHROMOSOMAL PROTEIN, NONHISTONE 1; NHCP1	4805
MIM118888	*	16q22.1	CHYMOTRYPSIN-LIKE PROTEASE; CTRL	1506
MIM118890	*	16q23.2-q23.3	CHYMOTRYPSINOGEN B1; CTRB1	1504
MIM118900		 	CIRRHOSIS, FAMILIAL	 
MIM118910	*	14q32	CHROMOGRANIN A; CHGA	1113
MIM118920	*	20pter-p12	CHROMOGRANIN B; CHGB	1114
MIM118930	*	2q35-q36	SECRETOGRANIN II; SCG2	7857
MIM118938	*	14q11.2	CHYMASE 1; CMA1	1215
MIM118943		1p13.3	CHYMOSIN PSEUDOGENE; CYMP	643160
MIM118945	*	11q12.2	CILIARY NEUROTROPHIC FACTOR; CNTF	1270
MIM118946	*	9p13	CILIARY NEUROTROPHIC FACTOR RECEPTOR; CNTFR	1271
MIM118950	*	12q13.2-q13.3	CITRATE SYNTHASE, MITOCHONDRIAL; CS	1431
MIM118955	*	17q23	CLATHRIN, HEAVY POLYPEPTIDE; CLTC	1213
MIM118960	*	9p13.3	CLATHRIN, LIGHT POLYPEPTIDE A; CLTA	1211
MIM118970	*	5q32.2	CLATHRIN, LIGHT POLYPEPTIDE B; CLTB	1212
MIM118980		 	CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	 
MIM118990	*	 	SPERM-SPECIFIC ANTIGEN 2; SSFA2	6744
MIM119000	%	 	CLEFT CHIN	 
MIM119100	%	1q42.2-q43	SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 1; SHFLD1	791121
MIM119300	#	1q32-q41	VAN DER WOUDE SYNDROME 1; VWS1	3664
MIM119500	#	1q32-q41	POPLITEAL PTERYGIUM SYNDROME; PPS	3664
MIM119530	%	6p24.3	OROFACIAL CLEFT 1; OFC1	4963
MIM119540	%	17p12-p11.1, 2q33	CLEFT PALATE, ISOLATED; CPI	23314, 7314
MIM119550	%	 	SYNGNATHIA	 
MIM119570		 	CLEFT SOFT PALATE	 
MIM119580	%	 	BLEPHAROCHEILODONTIC SYNDROME	 
MIM119600	#	6p21	CLEIDOCRANIAL DYSPLASIA; CCD	860
MIM119650		 	CLEIDORHIZOMELIC SYNDROME	 
MIM119800	#	5q31	CLUBFOOT, CONGENITAL, WITH OR WITHOUT DEFICIENCY OF LONG BONES AND/OR MIRROR-IMAGE POLYDACTYLY; CCF	5307
MIM119900	#	4q34-q35	DIGITAL CLUBBING, ISOLATED CONGENITAL	3248
MIM119915	%	 	CLUSTER HEADACHE, FAMILIAL	 
MIM120000		 	COARCTATION OF AORTA	 
MIM120040		 	COCHLEOSACCULAR DEGENERATION WITH PROGRESSIVE CATARACTS	 
MIM120050	%	19pter-q13	COXSACKIEVIRUS B3 SUSCEPTIBILITY; CXB3S	1526
MIM120070	*	2q36-q37	COLLAGEN, TYPE IV, ALPHA-3; COL4A3	1285
MIM120080	#	 	COLCHICINE RESISTANCE	5243
MIM120090	*	13q34	COLLAGEN, TYPE IV, ALPHA-2; COL4A2	1284
MIM120100	#	1q44	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1; FCAS1	114548
MIM120105	*	6pter-p21.1	COLIPASE, PANCREATIC; CLPS	1208
MIM120110	*	6q21-q22.3	COLLAGEN, TYPE X, ALPHA-1; COL10A1	1300
MIM120120	*	3p21.3	COLLAGEN, TYPE VII, ALPHA-1; COL7A1	1294
MIM120130	*	13q34	COLLAGEN, TYPE IV, ALPHA-1; COL4A1	1282
MIM120131	*	2q36-q37	COLLAGEN, TYPE IV, ALPHA-4; COL4A4	1286
MIM120140	+	12q13.11-q13.2	COLLAGEN, TYPE II, ALPHA-1; COL2A1	1280
MIM120150	+	17q21.31-q22	COLLAGEN, TYPE I, ALPHA-1; COL1A1	1277
MIM120160	*	7q22.1	COLLAGEN, TYPE I, ALPHA-2; COL1A2	1278
MIM120165	*	6q12-q14	COLLAGEN, TYPE XIX, ALPHA-1; COL19A1	1310
MIM120180	*	2q31	COLLAGEN, TYPE III, ALPHA-1; COL3A1	1281
MIM120190	*	2q31	COLLAGEN, TYPE V, ALPHA-2; COL5A2	1290
MIM120200	#	11p13, 7q36	COLOBOMA, OCULAR	 
MIM120210	*	6q13	COLLAGEN, TYPE IX, ALPHA-1; COL9A1	1297
MIM120215	*	9q34.2-q34.3	COLLAGEN, TYPE V, ALPHA-1; COL5A1	1289
MIM120216	*	19p13.2	COLLAGEN, TYPE V, ALPHA-3; COL5A3	50509
MIM120220	*	21q22.3	COLLAGEN, TYPE VI, ALPHA-1; COL6A1	1291
MIM120240	*	21q22.3	COLLAGEN, TYPE VI, ALPHA-2; COL6A2	1292
MIM120250	*	2q37	COLLAGEN, TYPE VI, ALPHA-3; COL6A3	1293
MIM120251	*	3q12-q13.1	COLLAGEN, TYPE VIII, ALPHA-1; COL8A1	1295
MIM120252	*	1p34.3-p32.3	COLLAGEN, TYPE VIII, ALPHA-2; COL8A2	1296
MIM120260	*	1p33-p32.2	COLLAGEN, TYPE IX, ALPHA-2; COL9A2	1298
MIM120270	*	20q13.3	COLLAGEN, TYPE IX, ALPHA-3; COL9A3	1299
MIM120280	*	1p21	COLLAGEN, TYPE XI, ALPHA-1; COL11A1	1301
MIM120290	*	6p21.3	COLLAGEN, TYPE XI, ALPHA-2; COL11A2	1302
MIM120300	%	 	COLOBOMA OF MACULA	 
MIM120320	*	 	COLLAGEN, TYPE XII, ALPHA-1; COL12A1	1303
MIM120324	*	8q23	COLLAGEN, TYPE XIV, ALPHA-1; COL14A1	7373
MIM120325	*	9q21-q22	COLLAGEN, TYPE XV, ALPHA-1; COL15A1	1306
MIM120326	*	1p34	COLLAGEN, TYPE XVI, ALPHA-1; COL16A1	1307
MIM120328	*	21q22.3	COLLAGEN, TYPE XVIII, ALPHA-1; COL18A1	80781
MIM120330	#	10q24.3-q25.1	PAPILLORENAL SYNDROME	5076
MIM120340	*	Chr.15	COLLAGEN, TYPE I, ALPHA, RECEPTOR; COL1AR	1279
MIM120350	*	10q22	COLLAGEN, TYPE XIII, ALPHA-1; COL13A1	1305
MIM120353	*	11q22-q23	MATRIX METALLOPROTEINASE 1; MMP1	4312
MIM120355	*	11q21-q22	MATRIX METALLOPROTEINASE 8; MMP8	4317
MIM120360	*	16q13	MATRIX METALLOPROTEINASE 2; MMP2	4313
MIM120361	*	20q11.2-q13.1	MATRIX METALLOPROTEINASE 9; MMP9	4318
MIM120400		 	COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY	 
MIM120420	*	1p21-p13	COLONY-STIMULATING FACTOR 1; CSF1	1435
MIM120430	#	11p13	COLOBOMA OF OPTIC NERVE	5080
MIM120433	#	 	COLOBOMA, UVEAL, WITH CLEFT LIP AND PALATE AND MENTAL RETARDATION	 
MIM120435	#	2p22-p21	LYNCH SYNDROME I	4436, 5378
MIM120436	*	3p21.3	MutL, E. COLI, HOMOLOG OF, 1; MLH1	4292
MIM120440		 	COLONIC VARICES WITHOUT PORTAL HYPERTENSION	 
MIM120450	%	 	COMEDONES, FAMILIAL DYSKERATOTIC	 
MIM120470	*	18q21.3	DELETED IN COLORECTAL CARCINOMA; DCC	1630
MIM120500		 	COMMISSURAL LIP PITS	 
MIM120502	%	1q31	BRANCHIOOTIC SYNDROME 2	64585
MIM120520	*	3q21-q27	MEMBRANE METALLOENDOPEPTIDASE; MME	4311
MIM120550	*	1p36.3-p34.1	COMPLEMENT COMPONENT 1, q SUBCOMPONENT, A CHAIN; C1QA	712
MIM120570	*	1p36.3-p34.1	COMPLEMENT COMPONENT 1, q SUBCOMPONENT, B CHAIN; C1QB	713
MIM120575	*	1p36.3-p34.1	COMPLEMENT COMPONENT 1, q SUBCOMPONENT, C CHAIN; C1QC	714
MIM120577	*	 	COMPLEMENT COMPONENT 1, q SUBCOMPONENT, RECEPTOR 1; C1QR1	22918
MIM120580	*	12p13	COMPLEMENT COMPONENT 1, s SUBCOMPONENT; C1S	716
MIM120620	*	1q32	COMPLEMENT COMPONENT RECEPTOR 1; CR1	1378
MIM120650	*	1q32	COMPLEMENT COMPONENT RECEPTOR 2; CR2	1380
MIM120700	*	19p13.3-p13.2	COMPLEMENT COMPONENT 3; C3	718
MIM120790	#	11q11-q13.1	COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF	710
MIM120810	*	6p21.3	COMPLEMENT COMPONENT 4A; C4A	720
MIM120820	*	6p21.3	COMPLEMENT COMPONENT 4B; C4B	721
MIM120830	*	1q32	COMPLEMENT COMPONENT 4-BINDING PROTEIN, ALPHA; C4BPA	722
MIM120831	*	1q32	COMPLEMENT COMPONENT 4-BINDING PROTEIN, BETA CHAIN; C4BPB	725
MIM120900	*	9q34.1	COMPLEMENT COMPONENT 5; C5	727
MIM120920	*	1q32	CD46 ANTIGEN; CD46	4179
MIM120930	*	9q34.3	COMPLEMENT COMPONENT 8, GAMMA SUBUNIT; C8G	733
MIM120940	*	5p13	COMPLEMENT COMPONENT 9; C9	735
MIM120950	*	1p32	COMPLEMENT COMPONENT 8, ALPHA SUBUNIT; C8A	731
MIM120960	*	1p32	COMPLEMENT COMPONENT 8, BETA SUBUNIT; C8B	732
MIM120970	#	19q13.3	CONE-ROD DYSTROPHY 2; CORD2	1406
MIM120980	*	16p11.2	INTEGRIN, ALPHA-M; ITGAM	3684
MIM121009	*	6q23.1	CONNECTIVE TISSUE GROWTH FACTOR; CTGF	1490
MIM121010	*	4q12-q13	PRO-PLATELET BASIC PROTEIN; PPBP	5473
MIM121011	*	13q11-q12	GAP JUNCTION PROTEIN, BETA-2; GJB2	2706
MIM121012	*	1p35.1	GAP JUNCTION PROTEIN, ALPHA-4; GJA4	2701
MIM121013	*	1q21.1	GAP JUNCTION PROTEIN, ALPHA-5; GJA5	2702
MIM121014	*	6q21-q23.2	GAP JUNCTION PROTEIN, ALPHA-1; GJA1	2697
MIM121015	*	13q11	GAP JUNCTION PROTEIN, ALPHA-3; GJA3	2700
MIM121050	#	5q23-q31	ARTHROGRYPOSIS, DISTAL, TYPE 9; DA9	2201
MIM121070		 	ARTHROGRYPOSIS, DISTAL, TYPE 2E	 
MIM121200	#	20q13.3	SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1	3785
MIM121201	#	8q24	SEIZURES, BENIGN FAMILIAL NEONATAL, 2; BFNS2	3786
MIM121210	%	8q13-q21	FEBRILE SEIZURES, FAMILIAL, 1; FEB1	2233
MIM121270		 	COPPER DEFICIENCY, FAMILIAL BENIGN	 
MIM121300	#	3q12	COPROPORPHYRIA, HEREDITARY; HCP	1371
MIM121350		 	CORACOCLAVICULAR JOINT, ANOMALOUS	 
MIM121360	*	16q22	CORE-BINDING FACTOR, BETA SUBUNIT; CBFB	865
MIM121390	%	 	CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	 
MIM121400	%	 	CORNEA PLANA 1; CNA1	1255
MIM121450		 	CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS	 
MIM121700	%	20p11.2-q11.2	CORNEAL ENDOTHELIAL DYSTROPHY 1, AUTOSOMAL DOMINANT; CHED1	8197
MIM121800	#	1p36.3	CORNEAL DYSTROPHY, CRYSTALLINE, OF SCHNYDER	29914
MIM121820	#	5q31	CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE; EBMD	7045
MIM121850	#	2q35	CORNEAL DYSTROPHY, FLECK	200576
MIM121900	#	5q31	CORNEAL DYSTROPHY, GROENOUW TYPE I; CDGG1	7045
MIM122000	#	20p11.2	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1; PPCD1	30813
MIM122100	#	17q12, 12q13	CORNEAL DYSTROPHY, MEESMANN; MECD	3850, 3859
MIM122200	#	5q31	CORNEAL DYSTROPHY, LATTICE TYPE I; LCD1	7045
MIM122400	%	 	EPITHELIAL RECURRENT EROSION DYSTROPHY; ERED	 
MIM122430		 	CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS, UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION	 
MIM122440		 	CORNEODERMATOOSSEOUS SYNDROME	 
MIM122450	%	 	CORNEAL HYPESTHESIA, FAMILIAL	 
MIM122455		 	CORONARY ARTERY DISSECTION, SPONTANEOUS	 
MIM122460	%	15q11-qter	HUMAN CORONAVIRUS SENSITIVITY; HCVS	3063
MIM122470	#	5p13.1	CORNELIA DE LANGE SYNDROME 1; CDLS1	25836, 55869, 5885, 8243
MIM122500	*	14q32.1	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 6; SERPINA6	866
MIM122550		6p	CORTICOSTERONE SIDE-CHAIN ISOMERASE; CSCI	7944
MIM122559	*	5q11.2-q13.3	CORTICOTROPIN-RELEASING HORMONE-BINDING PROTEIN; CRHBP	1393
MIM122560	*	8q13	CORTICOTROPIN-RELEASING HORMONE; CRH	1392
MIM122561	*	17q12-q22	CORTICOTROPIN-RELEASING HORMONE RECEPTOR 1; CRHR1	1394
MIM122580		 	COSTOCORACOID LIGAMENT, CONGENITALLY SHORT	 
MIM122600	#	 	SPONDYLOCOSTAL DYSOSTOSIS 5, AUTOSOMAL DOMINANT; SCDO5	 
MIM122700	#	16p11.2, 10q24, Xq27.1-q27.2, 19q13.2	COUMARIN RESISTANCE	1548, 1559, 2158, 79001
MIM122720	+	19q13.2	CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6; CYP2A6	1548
MIM122750	%	 	COXA VARA	 
MIM122780		 	COXOAURICULAR SYNDROME	 
MIM122850		 	CRANIOACROFACIAL SYNDROME	 
MIM122860	#	 	CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	50964
MIM122880	#	2q35	CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	5077
MIM122900		 	CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	 
MIM122920	^	 	MOVED TO 304110	 
MIM123000	#	5p15.2-p14.1	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CMDD	56172
MIM123050		 	CRANIORHINY	 
MIM123100	#	7p21	CRANIOSYNOSTOSIS, TYPE 1; CRS1	1403, 7291
MIM123101	*	5q34-q35	MUSCLE SEGMENT HOMEOBOX, DROSOPHILA, HOMOLOG OF, 2; MSX2	4488
MIM123150	#	10q26, 8p11.2-p11.1	JACKSON-WEISS SYNDROME; JWS	2260, 2263
MIM123155	%	 	HYDROCEPHALUS	 
MIM123260	*	1q21-q23	C-REACTIVE PROTEIN, PENTRAXIN-RELATED; CRP	1401
MIM123270		14q32	CREATINE KINASE, BRAIN TYPE, ECTOPIC EXPRESSION OF; CKBE	1156
MIM123280	*	14q32	CREATINE KINASE, BRAIN TYPE; CKB	1152
MIM123290	*	15q15	CREATINE KINASE, MITOCHONDRIAL 1B; CKMT1B	1159
MIM123295	*	5q13.3	CREATINE KINASE, MITOCHONDRIAL 2; CKMT2	1160
MIM123310	*	19q13	CREATINE KINASE, MUSCLE TYPE; CKM	1158
MIM123320	#	3p25	CREATINE PHOSPHOKINASE, ELEVATED SERUM	859
MIM123400	#	6p21.3, 20pter-p12	CREUTZFELDT-JAKOB DISEASE; CJD	3119, 5621
MIM123450	#	5p15.2	CRI-DU-CHAT SYNDROME	1501
MIM123500	#	10q26	CROUZON SYNDROME	2263
MIM123540		 	CRYOFIBRINOGENEMIA, FAMILIAL PRIMARY	 
MIM123550	%	 	CRYOGLOBULINEMIA, FAMILIAL MIXED	 
MIM123557		 	CRYPTOTIA, FAMILIAL	 
MIM123560		 	CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME	 
MIM123570	%	 	CRYPTOPHTHALMOS, UNILATERAL OR BILATERAL, ISOLATED	 
MIM123580	*	21q22.3	CRYSTALLIN, ALPHA-A; CRYAA	1409
MIM123590	*	11q22.3-q23.1	CRYSTALLIN, ALPHA-B; CRYAB	1410
MIM123610	*	17q11.1-q12	CRYSTALLIN, BETA-A1; CRYBA1	1411
MIM123620	*	22q11.2-q12.2	CRYSTALLIN, BETA-B2; CRYBB2	1415
MIM123630	*	22q11.2-q12.2	CRYSTALLIN, BETA-B3; CRYBB3	1417
MIM123631	*	22q11.2-q13.1	CRYSTALLIN, BETA-A4; CRYBA4	1413
MIM123660	*	2q33-q35	CRYSTALLIN, GAMMA-A; CRYGA	1418
MIM123670	*	2q33-q35	CRYSTALLIN, GAMMA-B; CRYGB	1419
MIM123680	*	2q33-q35	CRYSTALLIN, GAMMA-C; CRYGC	1420
MIM123690	*	2q33-q35	CRYSTALLIN, GAMMA-D; CRYGD	1421
MIM123691	*	1p31-p22	CRYSTALLIN, ZETA; CRYZ	1429
MIM123695	*	3q	PHOSPHATE CYTIDYLYLTRANSFERASE 1, CHOLINE, ALPHA ISOFORM; PCYT1A	5130
MIM123700	#	14q32.1, 7q11.2	CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	10516, 2006
MIM123730	*	3q27	CRYSTALLIN, GAMMA-S; CRYGS	1427
MIM123740	*	16p13.11-p12.3	CRYSTALLIN, MU; CRYM	1428
MIM123790	#	10q26	BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	2263
MIM123803	*	12q13	ACTIVATING TRANSCRIPTION FACTOR 1; ATF1	466
MIM123805	*	 	PHOSPHODIESTERASE 3A, cGMP-INHIBITED; PDE3A	5139
MIM123810	*	2q32.3-q34	cAMP RESPONSE ELEMENT-BINDING PROTEIN 1; CREB1	1385
MIM123811	*	2q32	ACTIVATING TRANSCRIPTION FACTOR 2; ATF2	1386
MIM123812	*	10p12.1-p11.2	cAMP RESPONSE ELEMENT MODULATOR; CREM	1390
MIM123825	*	4p12-cen	CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-1; CNGA1	1259
MIM123828	*	17q22-qter	CYCLIN-DEPENDENT KINASE 3; CDK3	1018
MIM123829	*	12q14	CYCLIN-DEPENDENT KINASE 4; CDK4	1019
MIM123830	*	17q21	CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CNP	1267
MIM123831	*	7q36	CYCLIN-DEPENDENT KINASE 5; CDK5	1020
MIM123832	*	14q22	CYCLIN-DEPENDENT KINASE INHIBITOR 3; CDKN3	1033
MIM123833	*	12p13	CYCLIN D2; CCND2	894
MIM123834	*	6p21	CYCLIN D3; CCND3	896
MIM123835	*	4q27	CYCLIN A2; CCNA2	890
MIM123836	*	5q12	CYCLIN B1; CCNB1	891
MIM123837	*	19q13.1	CYCLIN E1; CCNE1	898
MIM123838	*	6q21	CYCLIN C; CCNC	892
MIM123840	*	7p13	PEPTIDYL-PROLYL ISOMERASE A; PPIA	5478
MIM123841	*	15q21-q22	PEPTIDYL-PROLYL ISOMERASE B; PPIB	5479
MIM123842	*	5q23.2	PEPTIDYL-PROLYL ISOMERASE C; PPIC	5480
MIM123853		 	CYPRUS FACIAL NEUROMUSCULOSKELETAL SYNDROME	 
MIM123855	*	20p11.2	CYSTATIN 1; CST1	1469
MIM123856	*	20p11.2	CYSTATIN 2; CST2	1470
MIM123857	*	20p11.2	CYSTATIN 4; CST4	1472
MIM123858	*	20p11.21	CYSTATIN 5; CST5	1473
MIM123859	*	11p15.5	CYSTEINYL-tRNA SYNTHETASE; CARS	833
MIM123860	*	1p34.1	CYTIDINE 5-PRIME TRIPHOSPHATE SYNTHETASE; CTPS	1503
MIM123864	*	16q22-qter	CYTOCHROME c OXIDASE, SUBUNIT IV, ISOFORM 1; COX4I1	1327
MIM123866	*	2cen-q13	CYTOCHROME c OXIDASE, SUBUNIT Vb; COX5B	1329
MIM123870	*	11q13	CYTOCHROME c OXIDASE, SUBUNIT VIII; COX8	1351
MIM123875	*	14q32.33	CYSTEINE-RICH INTESTINAL PROTEIN 1; CRIP1	1396
MIM123876	*	1q32	CYSTEINE- AND GLYCINE-RICH PROTEIN 1; CSRP1	1465
MIM123880		 	CYSTIC ANGIOMATOSIS OF BONE, DIFFUSE	 
MIM123885	*	1q21	S100 CALCIUM-BINDING PROTEIN A8; S100A8	6279
MIM123886	*	1q12-q22	S100 CALCIUM-BINDING PROTEIN A9; S100A9	6280
MIM123889	*	21q22.1	INTERLEUKIN 10 RECEPTOR, BETA; IL10RB	3588
MIM123890	*	2q33	CYTOTOXIC T LYMPHOCYTE-ASSOCIATED 4; CTLA4	1493
MIM123900	*	6q25-q26	VILLIN 2; VIL2	7430
MIM123910	*	14q11.2	GRANZYME B; GZMB	3002
MIM123920	*	1p36.2-p35	CYTIDINE DEAMINASE; CDA	978
MIM123930	*	19q13.2	CYTOCHROME P450, SUBFAMILY IIB, POLYPEPTIDE 6; CYP2B6	1555
MIM123940	*	12q13	KERATIN 4; KRT4	3851
MIM123970	*	7p15.2	CYTOCHROME C, SOMATIC; CYCS	54205
MIM123980	*	8q24.3	CYTOCHROME C1; CYC1	1537
MIM123995	*	19q13.12	CYTOCHROME c OXIDASE, SUBUNIT VIIa, POLYPEPTIDE 1; COX7A1	1346
MIM123996	*	6q12	CYTOCHROME c OXIDASE, SUBUNIT VIIa, POLYPEPTIDE 2; COX7A2	1347
MIM123997	*	4q22	CYTOCHROME c OXIDASE, SUBUNIT VIIa, POLYPEPTIDE 3; COX7A3	1348
MIM124000	#	8q22, 5q31.1, 2q33	MITOCHONDRIAL COMPLEX III DEFICIENCY	27089, 54902, 617, 7381
MIM124010	*	7q22.1	CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 4; CYP3A4	1576
MIM124015	*	7q11.2	CYTOCHROME P450 OXIDOREDUCTASE; POR	 
MIM124020	*	10q24.1-q24.3	CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19	1557
MIM124030	*	22q13.1	CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6; CYP2D6	1565
MIM124040	*	10q24.3-qter	CYTOCHROME P450, SUBFAMILY IIE; CYP2E1	1571
MIM124050	*	12q24	D-AMINO ACID OXIDASE; DAO	1610
MIM124060	+	15q24.1	CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2; CYP1A2	1544
MIM124070	*	19q13.2	CYTOCHROME P450, SUBFAMILY IIF, POLYPEPTIDE 1; CYP2F1	1572
MIM124075	*	1p34-p12	CYTOCHROME P450, SUBFAMILY IVB, MEMBER 1; CYP4B1	1580
MIM124080	*	8q21	CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 2; CYP11B2	1585
MIM124089	*	19q13.1	CYTOCHROME c OXIDASE, SUBUNIT VIb, POLYPEPTIDE 1; COX6B1	1340
MIM124090	*	8q22-q23	CYTOCHROME c OXIDASE, SUBUNIT VIc; COX6C	1345
MIM124092	*	1q31-q32	INTERLEUKIN 10; IL10	3586
MIM124095	*	15q23-q25	CYTOPLASMIC TYROSINE KINASE; CSK	1445
MIM124097	*	19q13.3	D SITE OF ALBUMIN PROMOTER-BINDING PROTEIN; DBP	1628
MIM124100		 	DANUBIAN ENDEMIC FAMILIAL NEPHROPATHY	 
MIM124200	#	12q23-q24.1	DARIER-WHITE DISEASE; DAR	488
MIM124300	%	 	DARWINIAN TUBERCLE OF PINNA	 
MIM124400		 	DARWINIAN TUBERCLE OF PINNA	 
MIM124450	*	 	D-ASPARTATE OXIDASE; DDO	8528
MIM124480	%	 	DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT; DDOD	 
MIM124490		 	DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY	 
MIM124500	#	13q11-q12	DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OF FINGERS AND TOES	2706
MIM124700	%	 	DEAFNESS, MID-TONE NEURAL	 
MIM124800	^	 	MOVED TO 600994	 
MIM124900	#	5q31	DEAFNESS, AUTOSOMAL DOMINANT 1; DFNA1	1729
MIM124910	^	 	MOVED TO 124900	 
MIM125000		 	DEAFNESS, UNILATERAL	 
MIM125050		 	DEAFNESS WITH ANHIDROTIC ECTODERMAL DYSPLASIA	 
MIM125100	^	 	MOVED TO 602588	 
MIM125220	*	8p23.1	DEFENSIN, ALPHA, 1; DEFA1	1667
MIM125230		 	DEAFNESS-CRANIOFACIAL SYNDROME	 
MIM125240	*	1q32	CD55 ANTIGEN; CD55	1604
MIM125250	#	3q28-q29	OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	4976
MIM125255	*	12q21.3	DECORIN; DCN	1634
MIM125260	%	Chr.16	DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	7420
MIM125263	*	19q13.3	SULFOTRANSFERASE FAMILY 2A, DEHYDROEPIANDROSTERONE-PREFERRING, MEMBER 1; SULT2A1	6822
MIM125264	*	6p23	DEK ONCOGENE; DEK	7913
MIM125265	*	5q22-q23	RECEPTOR EXPRESSION-ENHANCING PROTEIN 5; REEP5	7905
MIM125270	*	9q34	DELTA-AMINOLEVULINATE DEHYDRATASE; ALAD	210
MIM125280		 	DENS EVAGINATUS	 
MIM125290	*	3p21.1	DELTA-AMINOLEVULINATE SYNTHASE 1; ALAS1	211
MIM125300		 	DENS IN DENTE AND PALATAL INVAGINATIONS	 
MIM125305	*	8p21.1	ERYTHROCYTE MEMBRANE PROTEIN BAND 4.9; EPB49	2039
MIM125310	#	19p13.2-p13.1	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CADASIL	4854
MIM125320		 	DEMENTIA/PARKINSONISM WITH NON-ALZHEIMER AMYLOID PLAQUES	 
MIM125350	#	3p22-p21.1	FAILURE OF TOOTH ERUPTION, PRIMARY; PFE	5745
MIM125370	#	12p13.31	DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA	1822
MIM125400	#	 	DENTIN DYSPLASIA, TYPE I; DTDP1	64094
MIM125420	#	4q21.3	DENTIN DYSPLASIA, TYPE II	1834
MIM125440	%	 	DENTIN DYSPLASIA WITH SCLEROTIC BONES	 
MIM125450	*	4q13.3-q21.1	DEOXYCYTIDINE KINASE; DCK	1633
MIM125460		 	DEOXYRIBOSE-5-PHOSPHATE ALDOLASE DEFICIENCY	 
MIM125480	%	5p15.3, 18p	MAJOR AFFECTIVE DISORDER 1; MAFD1	4095, 6531
MIM125485	*	4q21.3	DENTIN SIALOPHOSPHOPROTEIN; DSPP	1834
MIM125490	#	4q21.3	DENTINOGENESIS IMPERFECTA 1; DGI1	1834
MIM125500	#	4q21.3	DENTINOGENESIS IMPERFECTA, SHIELDS TYPE III	1834
MIM125505	*	16p13.3	DEOXYRIBONUCLEASE I; DNASE1	1773
MIM125520	%	22q11	CAYLER CARDIOFACIAL SYNDROME	387569
MIM125530		 	DERMAL RIDGES, NELSON SYNDROME	 
MIM125540	%	 	DERMAL RIDGES, PATTERNLESS	 
MIM125550	%	 	DERMAL RIDGES-OFF-THE-END; ROES	 
MIM125570		 	DERMATOGLYPHICS--ARCH ON ANY DIGIT	 
MIM125580		 	DERMATOGLYPHICS--FINGER RIDGE COUNT	 
MIM125590	%	 	DERMATOGLYPHICS--FINGERPRINT PATTERN	 
MIM125595	#	17q12-q21	DERMATOPATHIA PIGMENTOSA RETICULARIS; DPR	3861
MIM125597	*	1q12-q23	DERMATOPONTIN; DPT	1805
MIM125600		 	DERMATOSIS PAPULOSA NIGRA	 
MIM125630		 	DERMODISTORTIVE URTICARIA; DDU	29764
MIM125635		 	DERMOGRAPHISM, FAMILIAL	 
MIM125640		 	DERMOODONTODYSPLASIA	 
MIM125643	*	18q12.1	DESMOCOLLIN 1; DSC1	1823
MIM125645	*	18q12.1	DESMOCOLLIN 2; DSC2	1824
MIM125647	*	6p24	DESMOPLAKIN; DSP	1832
MIM125660	*	2q35	DESMIN; DES	1674
MIM125670	*	18q12.1-q12.2	DESMOGLEIN 1; DSG1	1828
MIM125671	*	18q12.1-q12.2	DESMOGLEIN 2; DSG2	1829
MIM125700	#	20p13	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL	551
MIM125800	#	12q13	DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	359
MIM125850	#	20q12-q13.1	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1; MODY1	3172
MIM125851	#	7p15-p13	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MODY2	2645
MIM125852	#	11p15.5	DIABETES MELLITUS, INSULIN-DEPENDENT, 2	3401, 3630
MIM125853	#	17q12, 17p13, 15q21-q23, 13q34, 13q12.1, 12q24.2, 11p12-p11.2, 11p15.1, 11p15.1, 10q25.3, 8q24.11, 7q32, 7p15-p13, 7p21, 6q22-q23, 6p22.3, 5q34-q35.2, 4p16.1, 3q28, 3p25, 2q36, 2q32, 2q24.1, 20q13.1-q13.2, 217q12, 17p13, 15q21-q23, 13q34, 13q12.1, 12q24.2, 11p12-p11.2, 11p15.1, 11p15.1, 10q25.3, 8q24.11, 7q32, 7p15-p13, 7p21, 6q22-q23, 6p22.3, 5q34-q35.2, 4p16.1, 3q28, 3p25, 2q36, 2q32, 2q24.1, 20q13.1-q13.2,	DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM	10644, 169026, 208, 2642, 2645, 2820, 3159, 3172, 3569, 3643, 3651, 3667, 3767, 3990, 4544, 4760, 5078, 5167, 5468, 54901, 56729, 5770, 6517, 6833, 6927, 6928, 6934, 7466, 8660, 9479
MIM125855	*	12q13.3	DIACYLGLYCEROL KINASE, ALPHA, 80-KD; DGKA	1606
MIM125860	+	16q22.1	NAD(P)H DEHYDROGENASE, QUINONE 1; NQO1	1728
MIM125890		 	DIARRHEA, GLUCOSE-STIMULATED SECRETORY, WITH COMMON VARIABLE IMMUNODEFICIENCY	 
MIM125900		 	DIASTEMA, DENTAL MEDIAL	 
MIM125950	*	2q12-q21	DIAZEPAM BINDING INHIBITOR; DBI	1622
MIM126050	%	 	DIGITOTALAR DYSMORPHISM	 
MIM126060	*	5q11.2-q13.2	DIHYDROFOLATE REDUCTASE; DHFR	1719
MIM126063	*	14q24.3	DIHYDROLIPOAMIDE S-SUCCINYLTRANSFERASE; DLST	1743
MIM126064	*	16q22	DIHYDROOROTATE DEHYDROGENASE; DHODH	1723
MIM126065	*	20q13.2-q13.3	CYTOCHROME P450, FAMILY 24, SUBFAMILY A, POLYPEPTIDE 1; CYP24A1	1591
MIM126070	%	 	DILUTION, PIGMENTARY	 
MIM126090	*	10q22	PTERIN-4-ALPHA-CARBINOLAMINE DEHYDRATASE 1; PCBD1	5092
MIM126100		 	DIMPLES, FACIAL	 
MIM126110	*	1q21	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; ARNT	405
MIM126141	*	7q36.2	DIPEPTIDYL PEPTIDASE VI; DPP6	1804
MIM126150	*	5q23	HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; HBEGF	1839
MIM126180		 	DISCRIMINATION, TWO-POINT, REDUCTION IN	 
MIM126190		 	DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	 
MIM126200	#	6q21, 6p21.3, 6p21.3, 2q37.3	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS	100133941, 3119, 3123, 4397, 5133
MIM126250		 	DISTAL OSTEOSCLEROSIS	 
MIM126255	*	2q32	DISTAL-LESS HOMEOBOX 2; DLX2	1746
MIM126300	%	 	DISTICHIASIS	 
MIM126320		 	DISTICHIASIS WITH CONGENITAL ANOMALIES OF THE HEART AND PERIPHERAL VASCULATURE	 
MIM126330	*	9q12	DNA, CYTOPLASMIC-MEMBRANE; DNCM	1784
MIM126335	*	1p34-p12	GROWTH ARREST- AND DNA DAMAGE-INDUCIBLE GENE GADD45, ALPHA; GADD45A	1647
MIM126337	*	12q13.1-q13.2	DNA DAMAGE-INDUCIBLE TRANSCRIPT 3; DDIT3	1649
MIM126340	*	19q13.2-q13.3	EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 2; ERCC2	2068
MIM126350	*	19p13.2-q13.4	DEOXYRIBONUCLEASE II, LYSOSOMAL; DNASE2	1777
MIM126375	*	19p13.3-p13.2	DNA METHYLTRANSFERASE 1; DNMT1	1786
MIM126380	*	19q13.2-q13.3	EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 1; ERCC1	2067
MIM126391	*	19q13.2-q13.3	LIGASE I, DNA, ATP-DEPENDENT; LIG1	3978
MIM126420	*	20q12-q13.1	TOPOISOMERASE, DNA, I; TOP1	7150
MIM126430	*	17q21-q22	TOPOISOMERASE, DNA, II, ALPHA; TOP2A	7153
MIM126431	*	3p24	TOPOISOMERASE, DNA, II, BETA; TOP2B	7155
MIM126449	*	5q35.1	DOPAMINE RECEPTOR D1; DRD1	1812
MIM126450	*	11q23.1	DOPAMINE RECEPTOR D2; DRD2	1813
MIM126451	*	3q13.3	DOPAMINE RECEPTOR D3; DRD3	1814
MIM126452	*	11p15.5	DOPAMINE RECEPTOR D4; DRD4	1815
MIM126453	+	4p16.1-p15.3	DOPAMINE RECEPTOR D5; DRD5	1816
MIM126455	*	5p15.3	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, DOPAMINE), MEMBER 3; SLC6A3	6531
MIM126500		 	DOUBLE NAIL FOR FIFTH TOE	 
MIM126550	%	 	DOUGHNUT LESIONS OF SKULL, FAMILIAL	 
MIM126600	#	2p16	DOYNE HONEYCOMB RETINAL DYSTROPHY; DHRD	2202
MIM126650	*	7q22-q31.1	SOLUTE CARRIER FAMILY 26, MEMBER 3; SLC26A3	1811
MIM126660	*	5q35.3	DREBRIN E; DBN1	1627
MIM126700	#	1q32	BASAL LAMINAR DRUSEN	3075
MIM126800	%	8q13	DUANE RETRACTION SYNDROME 1; DURS1	10674
MIM126840		 	DUODENAL ULCER DUE TO ANTRAL G-CELL HYPERFUNCTION	 
MIM126850	%	 	DUODENAL ULCER, HYPERPEPSINOGENEMIC I	 
MIM126900	%	16q11.1-q22	DUPUYTREN CONTRACTURE	780895
MIM126950		 	DWARFISM WITH TALL VERTEBRAE	 
MIM127000	#	 	KENNY-CAFFEY SYNDROME, TYPE 2	 
MIM127100		 	DWARFISM, LEVI TYPE	 
MIM127200		 	DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES	 
MIM127300	#	Ypter-p11.2, Xpter-p22.32	LERI-WEILL DYSCHONDROSTEOSIS; LWD	6473
MIM127350		 	DYSCHONDROSTEOSIS AND NEPHRITIS	 
MIM127400	#	1q21.3	DYSCHROMATOSIS SYMMETRICA HEREDITARIA 1	103
MIM127500	%	6q24.2-q25.2	DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 1; DUH1	387570
MIM127550	#	14q12, 5p15.33, 3q21-q28	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1; DKCA1	26277, 7012, 7015
MIM127600	%	4q35	DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL	80870
MIM127700	#	15q21	DYSLEXIA, SUSCEPTIBILITY TO, 1; DYX1	161582, 1867
MIM127750	#	5q35, 4q21	DEMENTIA, LEWY BODY; DLB	2629, 6620, 6622
MIM127800		 	DYSPLASIA EPIPHYSEALIS HEMIMELICA	 
MIM127820		 	DYSPLASIA EPIPHYSEALIS HEMIMELICA WITH CHONDROMAS AND OSTEOCHONDROMAS	 
MIM128000	%	 	DYSTELEPHALANGY	 
MIM128100	#	9q34	DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT; DYT1	1861
MIM128101	#	 	DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	1864
MIM128200	#	16p11.2-q12.1	EPISODIC KINESIGENIC DYSKINESIA 1; EKD1	112476, 50818
MIM128230	#	 	DYSTONIA, DOPA-RESPONSIVE; DRD	2643
MIM128235	#	19q12-q13.2	DYSTONIA 12; DYT12	478
MIM128239	*	3p21	DYSTROPHIN-ASSOCIATED GLYCOPROTEIN 1; DAG1	1605
MIM128240	*	6q24	UTROPHIN; UTRN	7402
MIM128260	*	1q32	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE E; SNRPE	6635
MIM128300		 	EAR EXOSTOSES	 
MIM128400		 	EAR FLARE	 
MIM128500		 	EAR FOLDING	 
MIM128600	%	 	EAR MALFORMATION	 
MIM128700	%	8q11.1-q13.3	PREAURICULAR FISTULAE, CONGENITAL	404715
MIM128710		 	EAR PITS, POSTERIOR HELICAL	 
MIM128800		 	EAR WITHOUT HELIX	 
MIM128900		 	EARLOBE ATTACHMENT, ATTACHED VS UNATTACHED	 
MIM128980	%	 	EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIAL ABNORMALITIES	 
MIM128990	*	5q31.1	EARLY GROWTH RESPONSE 1; EGR1	1958
MIM128992	*	2p13	EARLY GROWTH RESPONSE 4; EGR4	1961
MIM129000		 	EARRING HOLES, NATURAL	 
MIM129010	*	10q21.1-q22.1	EARLY GROWTH RESPONSE 2; EGR2	1959
MIM129100		 	EARS, ABILITY TO MOVE	 
MIM129150	%	19q13.1-qter	ECHO VIRUS 11 SENSITIVITY; E11S	1878
MIM129190	*	6q14-q21	ECTO-5-PRIME NUCLEOTIDASE; NT5E	4907
MIM129200	%	 	ADERMATOGLYPHIA WITH CONGENITAL FACIAL MILIA AND ACRAL BLISTERS, DIGITAL CONTRACTURES, AND NAIL ABNORMALITIES	 
MIM129400	#	3q27	RAPP-HODGKIN SYNDROME; RHS	8626
MIM129490	#	2q11-q13, 1q42.2-q43	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL DOMINANT; HED	10913, 128178
MIM129500	#	13q12	ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL DOMINANT	10804
MIM129510		 	ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	 
MIM129540		 	ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE AND PREAXIAL POLYDACTYLY OF FEET	 
MIM129550		 	ECTODERMAL DYSPLASIA WITH ADRENAL CYST	 
MIM129600	#	15q21.1	ECTOPIA LENTIS, ISOLATED, AUTOSOMAL DOMINANT; ECTOL1	2200
MIM129750		 	ECTOPIA PUPILLAE	 
MIM129810		 	ECTRODACTYLY AND ECTODERMAL DYSPLASIA WITHOUT CLEFT LIP/PALATE	 
MIM129830		 	ECTRODACTYLY-CLEFT PALATE SYNDROME	 
MIM129840		 	EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	 
MIM129850	#	 	EDINBURGH MALFORMATION SYNDROME	 
MIM129900	%	7q11.2-q21.3	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1; EEC1	1913
MIM130000	#	9q34.2-q34.3, 2q31, 17q21.31-q22	EHLERS-DANLOS SYNDROME, TYPE I	1277, 1289, 1290
MIM130010	#	9q34.2-q34.3	EHLERS-DANLOS SYNDROME, TYPE II	1289, 1290
MIM130020	#	6p21.3, 2q31	EHLERS-DANLOS SYNDROME, TYPE III	1281, 7148
MIM130050	#	2q31	EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT	1281
MIM130060	#	7q22.1, 17q21.31-q22	EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL DOMINANT	1277, 1278
MIM130070	#	5q35.2-q35.3	EHLERS-DANLOS SYNDROME, PROGEROID FORM	11285
MIM130080	%	12p13	EHLERS-DANLOS SYNDROME, TYPE VIII	791254
MIM130090		 	EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	 
MIM130100		 	ELASTOSIS PERFORANS SERPIGINOSA; EPS	 
MIM130120	*	12q13	CHYMOTRYPSIN-LIKE ELASTASE FAMILY, MEMBER 1; CELA1	1990
MIM130130	*	19p13.3	ELASTASE, NEUTROPHIL-EXPRESSED; ELANE	1991
MIM130135	*	6pter-p24	SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 1; SERPINB1	1992
MIM130160	*	7q11.2	ELASTIN; ELN	2006
MIM130180	%	20q13.2-q13.3	ELECTROENCEPHALOGRAM, LOW-VOLTAGE	1940
MIM130190	%	 	ELECTROENCEPHALOGRAPHIC PATTERN, BETA FREQUENCY, QUANTITATIVE TRAIT LOCUS; EEGBQTL	 
MIM130410	*	19q13.3	ELECTRON TRANSFER FLAVOPROTEIN, BETA POLYPEPTIDE; ETFB	2109
MIM130500	*	1p36.2-p34	ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1; EPB41	2035
MIM130590	*	6q14	EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, ALPHA-1; EEF1A1	1915
MIM130592	*	8q24.3	EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, DELTA; EEF1D	1936
MIM130593	*	11q12.3	EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, GAMMA; EEF1G	1937
MIM130600	#	1q21	ELLIPTOCYTOSIS 2; EL2	6708
MIM130610	*	19pter-q12	EUKARYOTIC TRANSLATION ELONGATION FACTOR 2; EEF2	1938
MIM130620	*	5q32	RIBOSOMAL PROTEIN S14; RPS14	6208
MIM130650	#	11p15.5, 11p15.5, 11p15.5, 5q35	BECKWITH-WIEDEMANN SYNDROME; BWS	1028, 10984, 283120, 3481, 3784, 64324
MIM130660	*	2p23.3-p23.2	ELASTIN MICROFIBRIL INTERFACER 1; EMILIN1	11117
MIM130700		 	EMPHYSEMA, HEREDITARY PULMONARY	 
MIM130710		 	EMPHYSEMA, CONGENITAL LOBAR; CLE	 
MIM130900	#	8q24.3	AMELOGENESIS IMPERFECTA, TYPE III; AI3	286077
MIM130950		 	ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	 
MIM131100	#	11q13	MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1	4221
MIM131170	*	7q11.2	ENDOGENOUS RETROVIRAL SEQUENCE 3; ERV3	2086
MIM131180	*	 	ENDOGENOUS RETROVIRAL POL-LIKE SEQUENCE-2; ERPL2	2083
MIM131190	*	1pter-p36	ENDOGENOUS RETROVIRAL POL-LIKE SEQUENCE-1; ERPL1	2082
MIM131195	*	9q34.1	ENDOGLIN; ENG	2022
MIM131200	%	10q26	ENDOMETRIOSIS, SUSCEPTIBILITY TO, 1	100188863
MIM131210	*	1q23-q25	SELECTIN E; SELE	6401
MIM131220	*	5q31	FIBROBLAST GROWTH FACTOR 1; FGF1	2246
MIM131222	*	22q13.32-qter	THYMIDINE PHOSPHORYLASE: TYMP	1890
MIM131230	*	4q26-q28	ANNEXIN A5; ANXA5	308
MIM131235	*	 	KDEL ENDOPLASMIC RETICULUM PROTEIN RETENTION RECEPTOR 1; KDELR1	10945
MIM131240	+	6p24-p23	ENDOTHELIN 1; EDN1	1906
MIM131241	*	1p34	ENDOTHELIN 2; EDN2	1907
MIM131242	*	20q13.2-q13.3	ENDOTHELIN 3; EDN3	1908
MIM131243	*	4q31.2	ENDOTHELIN RECEPTOR, TYPE A; EDNRA	1909
MIM131244	*	13q22	ENDOTHELIN RECEPTOR, TYPE B; EDNRB	1910
MIM131290	*	2q13-q21	ENGRAILED 1; EN1	2019
MIM131300	#	19q13.1	CAMURATI-ENGELMANN DISEASE; CAEND	7040
MIM131310	*	7q36	ENGRAILED 2; EN2	2020
MIM131320	*	10p15	GATA-BINDING PROTEIN 3; GATA3	2625
MIM131330	*	8q23-q24	PROENKEPHALIN; PENK	5179
MIM131340	*	20p13	PRODYNORPHIN; PDYN	5173
MIM131360	*	12p13	ENOLASE 2; ENO2	2026
MIM131370	*	17pter-p12	ENOLASE 3; ENO3	2027
MIM131390	*	1q43	NIDOGEN; NID	4811
MIM131398	*	14q11.2	RIBONUCLEASE A FAMILY, 3; RNASE3	6037
MIM131399	*	17q23.1	EOSINOPHIL PEROXIDASE; EPX	8288
MIM131400	%	5q31-q33	EOSINOPHILIA, FAMILIAL	7908
MIM131410	*	14q11.2	RIBONUCLEASE A FAMILY, 2; RNASE2	6036
MIM131430		 	EOSINOPHILOPENIA	 
MIM131440	#	5q31-q32	MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA	5159
MIM131445	^	 	EPENDYMOMA	 
MIM131450		 	EPIBLEPHARON OF LOWER LID	 
MIM131460		 	EPIBLEPHARON OF UPPER LID	 
MIM131500	%	 	EPICANTHUS	 
MIM131530	*	4q25	EPIDERMAL GROWTH FACTOR; EGF	1950
MIM131550	*	7p12.3-p12.1	EPIDERMAL GROWTH FACTOR RECEPTOR; EGFR	1956
MIM131560	*	17q11-q12	FLOTILLIN 2; FLOT2	2319
MIM131600		 	EPIDERMOID CYSTS	 
MIM131705	#	3p21.3	TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN; TBDN	1294
MIM131750	#	3p21.3	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT; DDEB	1294
MIM131760	#	17q12-q21, 12q13	EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE	3852, 3861
MIM131800	#	17q12-q21, 17q11-qter, 12q13	EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED	3691, 3852, 3861
MIM131850	#	3p21.3	EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	1294
MIM131880		 	EPIDERMOLYSIS BULLOSA WITH DEFICIENCY OF GALACTOSYLHYDROXYLYSYL GLUCOSYLTRANSFERASE	 
MIM131900	#	17q12-q21, 12q13	EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED	3852, 3861
MIM131950	#	8q24	EPIDERMOLYSIS BULLOSA SIMPLEX, OGNA TYPE	5339
MIM131960	#	12q13	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MOTTLED PIGMENTATION; EBS-MP	3852
MIM132000	#	3p21.3	EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND DEFORMITY OF NAILS	1294
MIM132090		 	EPILEPSY, BENIGN OCCIPITAL; BOE	 
MIM132100	%	6p21.1	PHOTOPAROXYSMAL RESPONSE; PPR	100528023
MIM132300		 	EPILEPSY, READING	 
MIM132350	*	12q24.33	SYNTAXIN 2; STX2	2054
MIM132400	#	19p13.1	EPIPHYSEAL DYSPLASIA, MULTIPLE, 1; EDM1	1311
MIM132450	#	12q13.11-q13.2	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS	1280
MIM132500		 	EPISTAXIS, HEREDITARY	 
MIM132600	#	1p34.3-p32.1, 3p22-p21.3	PILOMATRIXOMA	1499, 4595
MIM132700	#	16q12-q13	CYLINDROMATOSIS, FAMILIAL	1540
MIM132800	#	9q31	MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO; MSSE	4484, 7046
MIM132810	+	1q42.1	EPOXIDE HYDROLASE 1, MICROSOMAL; EPHX1	2052
MIM132811	*	8p21-p12	EPOXIDE HYDROLASE 2, CYTOSOLIC; EPHX2	2053
MIM132850		1p35	EPSTEIN-BARR VIRUS INSERTION SITE 1; EBVS1	1888
MIM132880	*	19p13.1	NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 6; NR2F6	2063
MIM132890	*	5q14	NUCLEAR RECEPTOR SUBFAMILY 2, GROUP F, MEMBER 1; NR2F1	7025
MIM132900	#	16p13.13-p13.12	AORTIC ANEURYSM, FAMILIAL THORACIC 4; AAT4	4629
MIM132990		 	ERYTHEMA NODOSUM, FAMILIAL	 
MIM133000	%	 	ERYTHEMA PALMARE HEREDITARIUM	 
MIM133020	#	2q24	ERYTHERMALGIA, PRIMARY	6335
MIM133090	*	9q34.1	ERYTHROCYTE SURFACE PROTEIN BAND 7.2; EPB72	2040
MIM133100	#	19p13.3-p13.2	ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1	10019, 2057
MIM133170	*	7q21	ERYTHROPOIETIN; EPO	2056
MIM133171	*	19p13.3-p13.2	ERYTHROPOIETIN RECEPTOR; EPOR	2057
MIM133180		 	ERYTHROLEUKEMIA, FAMILIAL	 
MIM133190	#	 	SPINOCEREBELLAR ATAXIA 34; SCA34	100750330
MIM133200	#	1p35.1, 1p35.1	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA; EKVP	127534, 2707
MIM133220	*	11q13-q22	ESTERASE A-4; ESA4	2090
MIM133239	#	16q23.3-q24.1, 13q12.11, 9q32, 8p22, 3p22-p21.3, 3p22	ESOPHAGEAL CANCER	11178, 50514, 51741, 6049, 7048, 9940
MIM133240		 	ESOPHAGEAL RING, LOWER	 
MIM133250	^	Chr.14	MOVED TO 172460	2096
MIM133280	*	13q14.11	ESTERASE D; ESD	2098
MIM133290	*	Chr.16	ESTERASE B3; ESB3	2097
MIM133430	+	6q25.1	ESTROGEN RECEPTOR 1; ESR1	2099
MIM133435	*	8q22	RUNT-RELATED TRANSCRIPTION FACTOR 1, TRANSLOCATED TO, 1; RUNX1T1	862
MIM133440	*	4q21-q25	EUKARYOTIC TRANSLATION INITIATION FACTOR 4E; EIF4E	1977
MIM133450	*	22q12	EWING SARCOMA BREAKPOINT REGION 1; EWSR1	2130
MIM133500	%	 	EXCHONDROSIS OF PINNA, POSTERIOR	 
MIM133510	*	2q21	EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 3; ERCC3	2071
MIM133520	*	16p13.3-p13.13	EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 4; ERCC4	2072
MIM133530	*	13q33	EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 5; ERCC5	2073
MIM133535	*	 	EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN MOUSE CELLS; ERCM1	2076
MIM133540	#	10q11	COCKAYNE SYNDROME, TYPE B; CSB	2074
MIM133550	*	9p24	SOLUTE CARRIER FAMILY 1 (NEURONAL/EPITHELIAL HIGH AFFINITY GLUTAMATE TRANSPORTER), MEMBER 1; SLC1A1	6505
MIM133600		 	EXOSTOSES OF HEEL	 
MIM133690		 	EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E	 
MIM133700	#	8q24.11-q24.13	EXOSTOSES, MULTIPLE, TYPE I	2131
MIM133701	#	11p12-p11	EXOSTOSES, MULTIPLE, TYPE II	2132
MIM133705		 	EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICAL TALUS	 
MIM133750		 	EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATION AND MICROCEPHALY	 
MIM133780	#	11q14-q21	EXUDATIVE VITREORETINOPATHY 1; EVR1	4041, 8322
MIM133800		 	EYEBROW, WHORL IN	 
MIM133900		 	HEMIFACIAL HYPERPLASIA	 
MIM134000		 	FACIAL HYPERTRICHOSIS	 
MIM134100	^	 	MOVED TO 601471	 
MIM134200	%	 	FACIAL PALSY, FAMILIAL RECURRENT PERIPHERAL	 
MIM134300		 	FACIAL SPASM	 
MIM134350	*	19p13.3	COMPLEMENT FACTOR D; CFD	1675
MIM134370	*	1q32	COMPLEMENT FACTOR H; CFH	3075
MIM134371	*	1q31-q32.1	COMPLEMENT FACTOR H-RELATED 1; CFHR1	3078
MIM134390	*	1p22-p21	COAGULATION FACTOR III; F3	2152
MIM134400		 	FACTOR V EXCESS WITH SPONTANEOUS THROMBOSIS	 
MIM134430		 	FACTOR VII AND FACTOR VIII, COMBINED DEFICIENCY OF	 
MIM134450	^	8p23.3-p23.1	MOVED TO 613878	2156
MIM134500		 	FACTOR VIII DEFICIENCY	 
MIM134510		 	FACTOR VIII AND FACTOR IX, COMBINED DEFICIENCY OF; F8F9D	 
MIM134520		 	FACTORS VIII, IX AND XI, COMBINED DEFICIENCY OF	 
MIM134540		 	FACTOR IX AND FACTOR XI, COMBINED DEFICIENCY OF	 
MIM134570	*	6p25-p24	FACTOR XIII, A1 SUBUNIT; F13A1	2162
MIM134580	*	1q31-q32.1	FACTOR XIII, B SUBUNIT; F13B	2165
MIM134600	%	15q15.3	FANCONI RENOTUBULAR SYNDROME 1; FRTS1	65211
MIM134610	#	16p13	FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT	4210
MIM134629	*	1q24-q31	FARNESYL DIPHOSPHATE SYNTHASE; FDPS	2224
MIM134635	*	8p22-q11	FARNESYLTRANSFERASE, CAAX BOX, ALPHA; FNTA	2339
MIM134636	*	14q23-q24	FARNESYLTRANSFERASE, CAAX BOX, BETA; FNTB	2342
MIM134637	*	10q24.1	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 6; TNFRSF6	355
MIM134638	*	1q23	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 6; TNFSF6	356
MIM134640	*	4q28-q31	FATTY ACID-BINDING PROTEIN 2; FABP2	2169
MIM134650	*	2p11	FATTY ACID-BINDING PROTEIN 1; FABP1	2168
MIM134651	*	1p33-p31	FATTY ACID-BINDING PROTEIN 3; FABP3	2170
MIM134660	*	11q13	GLUTATHIONE S-TRANSFERASE, PI; GSTP1	2950
MIM134690	*	11q13	FAU GENE; FAU	2197
MIM134700		 	FAVISM, SUSCEPTIBILITY TO	 
MIM134720		4q21-q25	FECUNDITY GENE, BOOROOLA, OF SHEEP, HOMOLOG OF	7892
MIM134750		 	FELTY SYNDROME	 
MIM134770	*	11q12-q13	FERRITIN HEAVY CHAIN 1; FTH1	2495
MIM134780		 	FEMORAL-FACIAL SYNDROME; FFS	 
MIM134790	*	19q13.3-q13.4	FERRITIN LIGHT CHAIN; FTL	2512
MIM134795	*	19q13.2	FIBRILLARIN; FBL	2091
MIM134797	*	15q21.1	FIBRILLIN 1; FBN1	2200
MIM134820	*	4q28	FIBRINOGEN, A ALPHA POLYPEPTIDE; FGA	2243
MIM134830	*	4q28	FIBRINOGEN, B BETA POLYPEPTIDE; FGB	2244
MIM134850	*	4q28	FIBRINOGEN, G GAMMA POLYPEPTIDE; FGG	2266
MIM134900		 	FIBRINOLYTIC DEFECT	 
MIM134920	*	4q25-q27	FIBROBLAST GROWTH FACTOR 2; FGF2	2247
MIM134921	*	12p13	FIBROBLAST GROWTH FACTOR 6; FGF6	2251
MIM134934	*	4p16.3	FIBROBLAST GROWTH FACTOR RECEPTOR 3; FGFR3	2261
MIM134935	*	5q35.1-qter	FIBROBLAST GROWTH FACTOR RECEPTOR 4; FGFR4	2264
MIM135100	#	2q23-q24	FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	90
MIM135150	#	17p11.2	BIRT-HOGG-DUBE SYNDROME; BHD	201163
MIM135290	#	5q21-q22	DESMOID DISEASE, HEREDITARY	324
MIM135300	#	2p22-p21	FIBROMATOSIS, GINGIVAL, 1; GINGF1	6654
MIM135400	#	17q24.2-q24.3	HYPERTRICHOSIS TERMINALIS, GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	100302716
MIM135500	%	3p14.3	ZIMMERMANN-LABAND SYNDROME; ZLS	353173
MIM135550	%	 	FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS	 
MIM135580		 	FIBROMUSCULAR DYSPLASIA OF ARTERIES	 
MIM135600	*	2q34	FIBRONECTIN 1; FN1	2335
MIM135610		11q12.1-q13.5	FIBRONECTIN-LIKE 2; FNL2	8060
MIM135620	*	12q11-q13	INTEGRIN, ALPHA-5; ITGA5	3678
MIM135630	*	10p11.2	INTEGRIN, BETA-1; ITGB1	3688
MIM135700	#	12q12	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	55605
MIM135750	#	14q13, 14q13	LAURIN-SANDROW SYNDROME	145282
MIM135800		 	FIBULA, RECURRENT DISLOCATION OF HEAD OF	 
MIM135820	*	22q13.3	FIBULIN 1; FBLN1	2192
MIM135821	*	3p25-p24	FIBULIN 2; FBLN2	2199
MIM135900	#	 	COFFIN-SIRIS SYNDROME; CSS	57492
MIM135940	*	1q21	FILAGGRIN; FLG	2312
MIM135950		 	FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION AND PROPORTIONATE SHORT STATURE	 
MIM136000	#	 	ADERMATOGLYPHIA; ADERM	56916
MIM136100		 	FINGERS, RELATIVE LENGTH OF	 
MIM136120	#	16q22.1	FISH-EYE DISEASE; FED	3931
MIM136130	*	1q23-q25	FLAVIN-CONTAINING MONOOXYGENASE 1; FMO1	2326
MIM136131	*	1q23-q25	FLAVIN-CONTAINING MONOOXYGENASE 4; FMO4	2329
MIM136132	*	1q23-q25	FLAVIN-CONTAINING MONOOXYGENASE 3; FMO3	2328
MIM136140	#	 	FLOATING-HARBOR SYNDROME; FLHS	10847
MIM136150		 	FLOOD FACTOR DEFICIENCY	 
MIM136200		 	FLUSHING OF EARS AND SOMNOLENCE	 
MIM136300	%	 	FLYNN-AIRD SYNDROME	 
MIM136350	*	8p11.2-p11.1	FIBROBLAST GROWTH FACTOR RECEPTOR 1; FGFR1	2260
MIM136351	*	13q12	FMS-RELATED TYROSINE KINASE 3; FLT3	2322
MIM136352	*	5q35.3	FMS-LIKE TYROSINE KINASE 4; FLT4	2324
MIM136400		 	FOCAL EPITHELIAL HYPERPLASIA OF THE ORAL MUCOSA	 
MIM136425	*	11q13.3-q13.5	FOLATE RECEPTOR 2, FETAL; FOLR2	2350
MIM136430	*	11q13.3-q13.5	FOLATE RECEPTOR 1, ADULT; FOLR1	2348
MIM136435	*	2p21-p16	FOLLICLE-STIMULATING HORMONE RECEPTOR; FSHR	2492
MIM136440	*	18q21.3	FOLLICULAR LYMPHOMA VARIANT TRANSLOCATION 1; FVT1	2531
MIM136470	*	5q11.2	FOLLISTATIN; FST	10468
MIM136480		 	FOURTH CRANIAL NERVE PALSY, FAMILIAL CONGENITAL	 
MIM136500	%	 	BRAUER SYNDROME	 
MIM136510	*	9cen-q34	FOLYLPOLYGLUTAMATE SYNTHETASE; FPGS	2356
MIM136515	*	11q13	FOS-LIKE ANTIGEN 1; FOSL1	8061
MIM136520	#	11p13	FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROME	5080
MIM136530	*	11p13	FOLLICLE-STIMULATING HORMONE, BETA POLYPEPTIDE; FSHB	2488
MIM136533	*	13q14.1	FORKHEAD BOX O1A; FOXO1A	2308
MIM136535	*	15q13-q14	FORMIN 1; FMN1	342184
MIM136537	*	19q13.4	FORMYL PEPTIDE RECEPTOR 1; FPR1	2357
MIM136538	*	19q13.3-q13.4	FORMYL PEPTIDE RECEPTOR 2; FPR2	2358
MIM136539	*	19q13.3-q13.4	FORMYL PEPTIDE RECEPTOR 3; FPR3	2359
MIM136540	#	 	FRAGILE SITE 10q23	 
MIM136550	%	6q14-q16.2	MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE; MCDR1	4167
MIM136570	#	 	CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KB	2460
MIM136580	#	 	FRAGILE SITE 16q22; FRA16A	2461
MIM136590	#	 	FRAGILE SITE 20p11	2471
MIM136600		 	FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURAL DEAFNESS	 
MIM136610	^	 	FRAGILE SITE 2q11	2373
MIM136620	#	 	FRAGILE SITE 10q25; FRA10B	2431
MIM136630	#	12q13.12	MENTAL RETARDATION, FRA12A TYPE	2448, 57609
MIM136640	#	 	FRAGILE SITE 9q32	2426
MIM136660	#	 	FRAGILE SITE 17p12	2465
MIM136680	#	11p13	FRASIER SYNDROME	7490
MIM136760	#	1p21-p13	FRONTONASAL DYSPLASIA 1; FND1	257
MIM136800	#	1p34.3-p32.3	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1; FECD1	1296
MIM136820	*	6q25-qter	FUCOSIDASE, ALPHA-L, 2; FUCA2	2519
MIM136835	*	19p13.3	FUCOSYLTRANSFERASE 5; FUT5	2527
MIM136836	*	19p13.3	FUCOSYLTRANSFERASE 6; FUT6	2528
MIM136850	*	1q42.1	FUMARATE HYDRATASE; FH	2271
MIM136880	#	15q26, 12q13-q14, 6p21.1-cen, 3q21-q24	FUNDUS ALBIPUNCTATUS	5959, 5961, 6010, 6017
MIM136900	#	22q12.1-q13.2	FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, OF SORSBY; SFD	7078
MIM136950	*	15q25-q26	FURIN; FUR	5045
MIM137000		 	FUTCHER LINE	 
MIM137010	*	Chr.6	F9 EMBRYONIC ANTIGEN; FEA	7959
MIM137020	*	8q24.3	TISSUE-SPECIFIC TRANSPLANTATION ANTIGEN 3; TSTA3	7264
MIM137025	*	6q21	FYN ONCOGENE RELATED TO SRC, FGR, YES; FYN	2534
MIM137026	*	4p16.3	G PROTEIN-COUPLED RECEPTOR KINASE 4; GRK4	2868
MIM137028	*	Chr.15	GALACTOKINASE 2; GALK2	2585
MIM137030	*	2p22-p11	GALACTOSE ENZYME ACTIVATOR; GLAT	2718
MIM137035	*	11q13.3-q13.5	GALANIN; GAL	51083
MIM137040		 	GALLBLADDER, AGENESIS OF	 
MIM137050		 	GAMMA-A-GLOBULIN, DEFECT IN ASSEMBLY OF	 
MIM137060	*	9p13	UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 1; B4GALT1	2683
MIM137070	*	16p11.2	FUSED IN SARCOMA; FUS	2521
MIM137100	%	6p21.3	IMMUNOGLOBULIN A DEFICIENCY 1; IGAD1	10986
MIM137130		 	GASTRIC SNEEZING	 
MIM137140	*	4p13-p12	GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-2; GABRA2	2555
MIM137141	*	4p14-q12	GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-4; GABRA4	2557
MIM137142	*	15q11.2-q12	GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-5; GABRA5	2558
MIM137143	*	5q31.1-q35	GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-6; GABRA6	2559
MIM137150	*	16p13.3	4-@AMINOBUTYRATE AMINOTRANSFERASE; ABAT	18
MIM137160	*	5q34-q35	GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-1; GABRA1	2554
MIM137161	*	6q14-q21	GAMMA-AMINOBUTYRIC ACID RECEPTOR, RHO-1; GABRR1	2569
MIM137162	*	6q14-q21	GAMMA-AMINOBUTYRIC ACID RECEPTOR, RHO-2; GABRR2	2570
MIM137163	*	1p36.3	GAMMA-AMINOBUTYRIC ACID RECEPTOR, DELTA; GABRD	2563
MIM137164	*	5q31.1-q33.1	GAMMA-AMINOBUTYRIC ACID RECEPTOR, GAMMA-2; GABRG2	2566
MIM137165	*	3p25-p24	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GABA), MEMBER 1; SLC6A1	6529
MIM137166	*	4p14-q21.1	GAMMA-AMINOBUTYRIC ACID RECEPTOR, GAMMA-1; GABRG1	2565
MIM137167	*	2p12	GAMMA-GLUTAMYL CARBOXYLASE; GGCX	2677
MIM137168	*	22q11.2	GAMMA-GLUTAMYLTRANSFERASE 5; GGT5	2687
MIM137170	*	7p15-p14	GAMMA-GLUTAMYL CYCLOTRANSFERASE; GGCT	79017
MIM137181	*	22q11.1	GAMMA-GLUTAMYLTRANSFERASE 2; GGT2	728441
MIM137190	*	4p13-p12	GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-1; GABRB1	2560
MIM137192	*	15q11.2-q12	GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-3; GABRB3	2562
MIM137200	#	 	NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE; NMAN	 
MIM137207	*	11q13.5-q14	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 32; LRRC32	2615
MIM137210		 	GASTRIC VOLVULUS, INTRATHORACIC	 
MIM137215	#	17q21.1, 16q22.1, 12p12.1, 10q26, 10p15, 5q31.1, 1p34.3-p32.1, 3q26.3, 2q33-q34, 2q14.2, 2q14	GASTRIC CANCER, HEREDITARY DIFFUSE; HDGC	1316, 2064, 2263, 3553, 3557, 3659, 3845, 4595, 5290, 843, 999
MIM137216	*	19q13.1	ATPase, H+,K+ EXCHANGING, ALPHA SUBUNIT; ATP4A	495
MIM137217	*	13q34	ATPase, H+,K+ EXCHANGING, BETA POLYPEPTIDE; ATP4B	496
MIM137240	*	17q21.3-q22	GASTRIC INHIBITORY POLYPEPTIDE; GIP	2695
MIM137241	+	19q13.3	GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR; GIPR	2696
MIM137245		 	GASTRIC LYMPHOMA, PRIMARY	8915
MIM137250	*	17q21	GASTRIN; GAS	2520
MIM137260	*	18q21	GASTRIN-RELEASING POLYPEPTIDE; GRP	2922
MIM137270		 	GASTROCUTANEOUS SYNDROME	 
MIM137280		 	GASTRITIS, FAMILIAL GIANT HYPERTROPHIC	 
MIM137290	*	1p32	TUMOR-ASSOCIATED CALCIUM SIGNAL TRANSDUCER 2; TACSTD2	4070
MIM137295	*	3q21	GATA-BINDING PROTEIN 2; GATA2	2624
MIM137350	*	9q34	GELSOLIN; GSN	2934
MIM137357	^	 	MOVED TO 194072	 
MIM137360	%	 	GENOCHONDROMATOSIS	 
MIM137370		 	GENU VALGUM, ST. HELENA FAMILIAL	 
MIM137400		 	GEOGRAPHIC TONGUE AND FISSURED TONGUE	 
MIM137440	#	20pter-p12	GERSTMANN-STRAUSSLER DISEASE; GSD	5621
MIM137500	%	 	GIANT NEUTROPHIL LEUKOCYTES	 
MIM137550	#	 	GIANT PIGMENTED HAIRY NEVUS; GPHN	 
MIM137560		 	GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA	 
MIM137570	*	2q11-q14	SOLUTE CARRIER FAMILY 20 (PHOSPHATE TRANSPORTER), MEMBER 1; SLC20A1	6574
MIM137575	%	 	GIGANTIFORM CEMENTOMA, FAMILIAL	 
MIM137580	#	13q31, 11q23	GILLES DE LA TOURETTE SYNDROME; GTS	114798, 2973
MIM137600	#	4q25-q26	IRIDOGONIODYSGENESIS, TYPE 2; IRID2	5308
MIM137700		 	GLAUCOMA WITH ELEVATED EPISCLERAL VENOUS PRESSURE	 
MIM137750	#	1q24.3-q25.2, 2p22-p21	GLAUCOMA 1, OPEN ANGLE, A; GLC1A	1545, 4653
MIM137760	#	10p15-p14, 2cen-q13, 2p22-p21	GLAUCOMA, PRIMARY OPEN ANGLE; POAG	10133, 1545
MIM137763		 	GLAUCOMA AND SLEEP APNEA	 
MIM137765	^	 	MOVED TO 608328	 
MIM137780	*	17q21	GLIAL FIBRILLARY ACIDIC PROTEIN; GFAP	2670
MIM137800	#	17q21.1, 3p25	GLIOMA SUSCEPTIBILITY 1; GLM1	2064, 5468
MIM137920	#	17q12	RENAL CYSTS AND DIABETES SYNDROME	6928
MIM137950	%	 	GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	100689213
MIM137960	*	2p23-p21	MPV17, MOUSE, HOMOLOG OF; MPV17	4358
MIM138000	#	1p22-p21	GLOMUVENOUS MALFORMATIONS; GVM	11146
MIM138030	*	2q36-q37	GLUCAGON; GCG	2641
MIM138032	*	6p21	GLUCAGON-LIKE PEPTIDE 1 RECEPTOR; GLP1R	2740
MIM138033	*	17q25	GLUCAGON RECEPTOR; GCGR	2642
MIM138040	*	5q31	GLUCOCORTICOID RECEPTOR; GCCR	2908
MIM138060		Chr.16	GLUCOCORTICOID RECEPTOR-LIKE 1; GRLL1	2910
MIM138070		 	GLUCOGLYCINURIA	 
MIM138079	*	7p15-p13	GLUCOKINASE; GCK	2645
MIM138090	*	1p36	HEXOSE-6-PHOSPHATE DEHYDROGENASE; H6PD	9563
MIM138110		Chr.17	GLUCOSE-6-PHOSPHATE DEHYDROGENASE-LIKE; G6PDL	2540
MIM138120	*	9q34	HEAT-SHOCK 70-KD PROTEIN 5; HSPA5	3309
MIM138130	*	10q23.3	GLUTAMATE DEHYDROGENASE 1; GLUD1	2746
MIM138140	*	1p35-p31.3	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 1; SLC2A1	6513
MIM138150	*	16q21	GLUTAMATE OXALOACETATE TRANSAMINASE, MITOCHONDRIAL; GOT2	2806
MIM138160	*	3q26.1-q26.3	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 2; SLC2A2	6514
MIM138170	*	12p13.3	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 3; SLC2A3	6515
MIM138180	*	10q24.1-q25.1	GLUTAMATE OXALOACETATE TRANSAMINASE, SOLUBLE; GOT1	2805
MIM138190	*	17p13	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 4; SLC2A4	6517
MIM138200	*	8q24.3	GLUTAMATE PYRUVATE TRANSAMINASE; GPT	2875
MIM138210	*	16q12.1	GLUTAMATE PYRUVATE TRANSAMINASE 2; GPT2	84706
MIM138230	*	1p36.2	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE/FRUCTOSE TRANSPORTER), MEMBER 5; SLC2A5	6518
MIM138243	*	1p34-p33	GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 3; GRIK3	2899
MIM138244	*	6q21	GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 2; GRIK2	2898
MIM138245	*	21q22	GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 1; GRIK1	2897
MIM138246	*	11q22-q23	GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 4; GRIA4	2893
MIM138247	*	4q32-q33	GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 2; GRIA2	2891
MIM138248	*	5q33	GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 1; GRIA1	2890
MIM138249	*	9q34.3	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 1; GRIN1	2902
MIM138250	*	10q24.3	ALDEHYDE DEHYDROGENASE 18 FAMILY, MEMBER A1; ALDH18A1	5832
MIM138251	*	8q24.3	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, ASSOCIATED PROTEIN; GRINA	2907
MIM138252	*	12p12	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2B; GRIN2B	2904
MIM138253	*	16p13	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2A; GRIN2A	2903
MIM138254	*	17q25	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2C; GRIN2C	2905
MIM138275	*	10p11.23	GLUTAMATE DECARBOXYLASE 2; GAD2	2572
MIM138280	*	2q32-q34	GLUTAMINASE, PHOSPHATE-ACTIVATED; GLS	2744
MIM138290	*	1q31	GLUTAMATE-AMMONIA LIGASE; GLUL	2752
MIM138292	*	2p13	GLUTAMINE:FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE 1; GFPT1	2673
MIM138295	*	1q41-q42	GLUTAMYL-PROLYL-tRNA SYNTHETASE; EPRS	2058
MIM138297	*	4q25	GLUTAMYL AMINOPEPTIDASE; ENPEP	2028
MIM138300	+	8p21.1	GLUTATHIONE REDUCTASE; GSR	2936
MIM138319	*	14q24.1	GLUTATHIONE PEROXIDASE 2; GPX2	2877
MIM138320	*	3p21.3	GLUTATHIONE PEROXIDASE; GPX1	2876
MIM138321	*	5q32-q33.1	GLUTATHIONE PEROXIDASE 3; GPX3	2878
MIM138322	*	19p13.3	GLUTATHIONE PEROXIDASE 4; GPX4	2879
MIM138330	*	Chr.12	GLUTATHIONE S-TRANSFERASE, MICROSOMAL, 1; MGST1	4257
MIM138333	*	1p13.3	GLUTATHIONE S-TRANSFERASE, MU-4; GSTM4	2948
MIM138350	*	1p13.3	GLUTATHIONE S-TRANSFERASE, MU-1; GSTM1	2944
MIM138359	*	6p12.2	GLUTATHIONE S-TRANSFERASE, ALPHA-1; GSTA1	2938
MIM138360	*	6p12.2	GLUTATHIONE S-TRANSFERASE, ALPHA-2; GSTA2	2939
MIM138380	*	1p13.3	GLUTATHIONE S-TRANSFERASE, MU-2; GSTM2	2946
MIM138385	*	1p13.3	GLUTATHIONE S-TRANSFERASE, MU-5; GSTM5	2949
MIM138390	*	1p13.3	GLUTATHIONE S-TRANSFERASE, MU-3; GSTM3	2947
MIM138400	*	12p13.31-p13.1	GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; GAPDH	2597
MIM138420	*	12q12-q13	GLYCEROL-3-PHOSPHATE DEHYDROGENASE 1; GPD1	2819
MIM138430	*	2q24.1	GLYCEROL-3-PHOSPHATE DEHYDROGENASE 2; GPD2	2820
MIM138440	*	21q22.1	PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE/PHOSPHORIBOSYLGLYCINAMIDE SYNTHETASE/PHOSPHORIBOSYLAMINOIMIDAZOLE SYNTHETASE; GART	2618
MIM138450	*	12q13	SERINE HYDROXYMETHYLTRANSFERASE, MITOCHONDRIAL; SHMT2	6472
MIM138470	*	6p21.3	COMPLEMENT FACTOR B; CFB	629
MIM138480	*	8q21.1-qter	GLYCINE AUXOTROPH B, HUMAN COMPLEMENT FOR HAMSTER; GLY B+; GLYB	2757
MIM138491	*	5q32	GLYCINE RECEPTOR, ALPHA-1 SUBUNIT; GLRA1	2741
MIM138492	*	4q31.3	GLYCINE RECEPTOR, BETA SUBUNIT; GLRB	2743
MIM138500	#	5q33.1, 5p15.33, 3p21.3	HYPERGLYCINURIA	153201, 340024, 54716
MIM138550	*	20p11.2-p11.1	GLYCOGEN PHOSPHORYLASE, BRAIN TYPE; PYGB	5834
MIM138570	*	19q13.3	GLYCOGEN SYNTHASE 1; GYS1	2997
MIM138571	*	12p12.2	GLYCOGEN SYNTHASE 2; GYS2	2998
MIM138590	*	4q28-q31	GLYCOPHORIN E; GYPE	2996
MIM138600	*	9q34.1-q34.3	OROSOMUCOID 1; ORM1	5004
MIM138610	*	9q34.1-q34.3	OROSOMUCOID 2; ORM2	5005
MIM138670	*	19cen-q13.2	ALPHA-1-B-GLYCOPROTEIN; A1BG	1
MIM138680	*	3q27	ALPHA-2-HS-GLYCOPROTEIN; AHSG	197
MIM138700	*	17q23-qter	APOLIPOPROTEIN H; APOH	350
MIM138720	*	22q11.2	GLYCOPROTEIN Ib, PLATELET, BETA POLYPEPTIDE; GP1BB	2812
MIM138750	*	6p21.3-p21.2	GLYOXALASE I; GLO1	2739
MIM138760	*	16p13	HYDROXYACYL GLUTATHIONE HYDROLASE; HAGH	3029
MIM138770		 	GMS SYNDROME	 
MIM138800	#	14q	GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS; MNG1	23405, 4333
MIM138850	*	4q21.2	GONADOTROPIN-RELEASING HORMONE RECEPTOR; GNRHR	2798
MIM138890	*	14q32.1	GOOSECOID; GSC	145258
MIM138900	#	4q25	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; UAQTL1	9429
MIM138920		 	GRANDDAD SYNDROME	 
MIM138930		 	GRANT SYNDROME	 
MIM138945	*	17q21.32	GRANULIN PRECURSOR; GRN	2896
MIM138960	*	5q31.1	COLONY-STIMULATING FACTOR 2; CSF2	1437
MIM138965	*	4q12-q13	CHEMOKINE, CXC MOTIF, LIGAND 6; CXCL6	6372
MIM138970	*	17q11.2-q12	COLONY-STIMULATING FACTOR 3; CSF3	1440
MIM138971	*	1p35-p34.3	COLONY-STIMULATING FACTOR 3 RECEPTOR, GRANULOCYTE; CSF3R	1441
MIM138972	*	 	CCAAT/ENHANCER-BINDING PROTEIN, GAMMA; CEBPG	1054
MIM138981	*	22q12.2-q13.1	GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR, BETA; CSF2RB	1439
MIM139000		 	GRANULOSIS RUBRA NASI	 
MIM139080	*	10q21.3-q22.1	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, GRAVES DISEASE AUTOANTIGEN), MEMBER 16; SLC25A16	8034
MIM139090	#	 	GRAY PLATELET SYNDROME; GPS	23218
MIM139100	%	 	GRAYING OF HAIR, PRECOCIOUS	 
MIM139110	*	4q12-q13	CHEMOKINE, CXC MOTIF, LIGAND 2; CXCL2	2920
MIM139111	*	4q12-q13	CHEMOKINE, CXC MOTIF, LIGAND 3; CXCL3	2921
MIM139130	*	12p13	GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-3; GNB3	2784
MIM139139	*	12q13	NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; NR4A1	3164
MIM139150	*	5q13.3	RAS p21 PROTEIN ACTIVATOR 1; RASA1	5921
MIM139160	*	22q11.2	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA Z POLYPEPTIDE; GNAZ	2781
MIM139180	*	Chr.12	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING, POLYPEPTIDE-h; GNAIH	2772
MIM139185	*	9q21.3-q22.1	GROWTH ARREST-SPECIFIC 1; GAS1	2619
MIM139190	*	20q11.2	GROWTH HORMONE-RELEASING HORMONE; GHRH	2691
MIM139191	*	7p15-p14	GROWTH HORMONE-RELEASING HORMONE RECEPTOR; GHRHR	2692
MIM139200	*	4q12	GROUP-SPECIFIC COMPONENT; GC	2638
MIM139210	#	 	MYHRE SYNDROME; MYHRS	4089
MIM139240	*	17q22-q24	GROWTH HORMONE 2; GH2	2689
MIM139250	*	17q22-q24	GROWTH HORMONE 1; GH1	2688
MIM139255	*	16q13	METALLOTHIONEIN 3; MT3	4504
MIM139259	*	16p13.1	G1- TO S-PHASE TRANSITION 1; GSPT1	2935
MIM139260	*	 	GUANINE DEAMINASE; GDA	9615
MIM139265	*	6p23	GUANOSINE MONOPHOSPHATE REDUCTASE; GMPR	2766
MIM139270	*	1q32.1-q42	GUANYLATE KINASE 1; GUK1	2987
MIM139280		1q32.1-q42	GUANYLATE KINASE 2; GUK2	2988
MIM139300	#	15q21.1	AROMATASE EXCESS SYNDROME; AEXS	1588
MIM139310	*	7q21	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING ACTIVITY POLYPEPTIDE 1; GNAI1	2770
MIM139311	*	16q13	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-ACTIVATING ACTIVITY POLYPEPTIDE O; GNAO1	2775
MIM139312	*	18p	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-ACTIVATING ACTIVITY POLYPEPTIDE, OLFACTORY TYPE; GNAL	2774
MIM139313	*	19p13	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-11; GNA11	2767
MIM139314	*	19p13	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-15; GNA15	2769
MIM139320	*	20q13.2	GNAS COMPLEX LOCUS; GNAS	2778
MIM139330	*	3p21	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING ACTIVITY POLYPEPTIDE 1; GNAT1	2779
MIM139340	*	1p13	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING ACTIVITY POLYPEPTIDE 2; GNAT2	2780
MIM139350	*	12q13	KERATIN 1; KRT1	3848
MIM139360	*	3p21	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING ACTIVITY POLYPEPTIDE 2; GNAI2	2771
MIM139370	*	1p13	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING ACTIVITY POLYPEPTIDE 3; GNAI3	2773
MIM139380	*	1pter-p31.2	GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-1; GNB1	2782
MIM139390	*	7q21	GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-2; GNB2	2783
MIM139391	*	17q21	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-TRANSDUCING ACTIVITY POLYPEPTIDE 2; GNGT2	2793
MIM139392	*	1p35-p34	GUANYLATE CYCLASE ACTIVATOR 2A; GUCA2A	2980
MIM139393	#	 	GUILLAIN-BARRE SYNDROME, FAMILIAL; GBS	5376
MIM139395	*	 	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING ACTIVITY POLYPEPTIDE 3; GNAT3	346562
MIM139396	*	4q32	GUANYLATE CYCLASE 1, SOLUBLE, ALPHA-3; GUCY1A3	2982
MIM139397	*	4q32	GUANYLATE CYCLASE 1, SOLUBLE, BETA-3; GUCY1B3	2983
MIM139400		 	HAIR WHORL	 
MIM139450	%	1q21.3	HAIR MORPHOLOGY 2; HRM2	100379199
MIM139500		 	HAIRY EARS	 
MIM139600	%	 	HAIRY ELBOWS	 
MIM139605	*	3q28-q29	HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 1; HES1	3280
MIM139630		 	HAIRY NOSE TIP	 
MIM139650	%	 	HAIRY PALMS AND SOLES	 
MIM139750		 	HAND AND FOOT DEFORMITY WITH FLAT FACIES	 
MIM139800		 	HAND CLASPING PATTERN	 
MIM139900	%	2p12-q22	HAND SKILL, RELATIVE; HSR	338386
MIM140000	#	7p15-p14.2	HAND-FOOT-UTERUS SYNDROME	3209
MIM140050	*	5q11-q12	GRANZYME A; GZMA	3001
MIM140100	*	16q22.1	HAPTOGLOBIN; HP	3240
MIM140210	*	16q22.1	HAPTOGLOBIN-RELATED PROTEIN GENE; HPR	3250
MIM140300	%	8q23-q24, 2q33	HASHIMOTO THYROIDITIS	140805, 1493, 3106
MIM140340	^	 	MOVED TO 125370	 
MIM140350	#	12q24-qter	HAWKINSINURIA	3242
MIM140400	%	 	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE II; PFHB2	 
MIM140450		 	HEART-HAND SYNDROME, SPANISH TYPE	 
MIM140500		 	HEART, MALFORMATION OF	 
MIM140550	*	6p21.3	HEAT-SHOCK 70-KD PROTEIN 1A; HSPA1A	3303
MIM140555	*	1q	HEAT-SHOCK 70-KD PROTEIN 6; HSPA6	3310
MIM140556	*	1q	HEAT-SHOCK 70-KD PROTEIN 7; HSPA7	3311
MIM140559	*	6p21.3	HEAT-SHOCK 70-KD PROTEIN-LIKE 1; HSPA1L	3305
MIM140560	*	14q24.1	HEAT-SHOCK 70-KD PROTEIN 2; HSPA2	3306
MIM140571	*	14q32.2	HEAT-SHOCK PROTEIN, 90-KD, ALPHA, CLASS A, MEMBER 1; HSP90AA1	3320
MIM140572	*	6p21.1	HEAT-SHOCK PROTEIN, 90-KD, ALPHA, CLASS B, MEMBER 1; HSP90AB1	3326
MIM140575	*	11p14.1	HEAT-SHOCK PROTEIN, 90-KD, ALPHA, CLASS A, MEMBER 2; HSP90AA2	3324
MIM140580	*	8q24.3	HEAT-SHOCK TRANSCRIPTION FACTOR 1; HSF1	3297
MIM140581	*	6q22.3	HEAT-SHOCK TRANSCRIPTION FACTOR 2; HSF2	3298
MIM140600	#	2q12-q13, 2p24-p23	OSTEOARTHRITIS SUSCEPTIBILITY 2; OS2	4148
MIM140700	#	16pter-p13.3, 16pter-p13.3, 11p15.5	HEINZ BODY ANEMIAS	3039, 3040, 3043
MIM140750	*	11p15	SUPPRESSOR OF TUMORIGENICITY 5; ST5	6764
MIM140850		 	HEMANGIOMAS, CAVERNOUS, OF FACE AND SUPRAUMBILICAL MIDLINE RAPHE	 
MIM140900		 	HEMANGIOMAS OF SMALL INTESTINE	 
MIM141000		 	HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	 
MIM141180	*	12q13.1	HEMATOPOIETIC PROTEIN HEM-1; HEM1	3071
MIM141200	#	2q36-q37	HEMATURIA, BENIGN FAMILIAL; BFH	1285, 1286
MIM141250	*	22q12	HEME OXYGENASE 1; HMOX1	3162
MIM141251	*	16p13.3	HEME OXYGENASE 2; HMOX2	3163
MIM141300	%	 	HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	 
MIM141350	%	 	HEMIFACIAL HYPERPLASIA WITH STRABISMUS	 
MIM141400	%	 	HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	7971
MIM141405		 	HEMIFACIAL SPASM, FAMILIAL	 
MIM141500	#	19p13	MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1	773
MIM141700		 	HEMOLYTIC POIKILOCYTIC ANEMIA DUE TO REDUCED ANKYRIN BINDING SITES	 
MIM141749	#	11p15.5, 11p15.5	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1; HBFQTL1	3043, 3047, 3048
MIM141750	#	16pter-p13.3	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	8129
MIM141800	+	16pter-p13.3	HEMOGLOBIN--ALPHA LOCUS 1; HBA1	3039
MIM141850	*	16pter-p13.3	HEMOGLOBIN--ALPHA LOCUS 2; HBA2	3040
MIM141900	+	11p15.5	HEMOGLOBIN--BETA LOCUS; HBB	3043
MIM142000	*	11p15.5	HEMOGLOBIN--DELTA LOCUS; HBD	3045
MIM142100	*	11p15.5	HEMOGLOBIN--EPSILON LOCUS; HBE1	3046
MIM142200	*	11p15.5	HEMOGLOBIN, GAMMA A; HBG1	3047
MIM142210	*	6p21.3	HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER D; HIST1H1D	3007
MIM142220	*	6p21.3	HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER E; HIST1H1E	3008
MIM142230	*	1q32	HEMATOPOIETIC PROGENITOR CELL ANTIGEN CD34; CD34	947
MIM142240	*	16pter-p13.3	HEMOGLOBIN--THETA-1 LOCUS; HBQ1	3049
MIM142250	*	11p15.5	HEMOGLOBIN, GAMMA G; HBG2	3048
MIM142290	*	11p15.5-p15.4	HEMOPEXIN; HPX	3263
MIM142310	*	16pter-p13.3	HEMOGLOBIN--ZETA LOCUS; HBZ	3050
MIM142330	#	12q24.2	HEPATIC ADENOMAS, FAMILIAL	6927
MIM142335	%	7q36	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 5; HBFQTL5	3247
MIM142340	%	15q26.1	DIAPHRAGMATIC HERNIA, CONGENITAL	1732
MIM142350		 	HERNIA, DOUBLE INGUINAL	 
MIM142360	*	22q11	HEPARIN COFACTOR II; HCF2	3053
MIM142370	*	20q11-q12	HEMOPOIETIC CELL KINASE; HCK	3055
MIM142385	*	17q22	HEPATIC LEUKEMIA FACTOR; HLF	3131
MIM142395	#	 	HEPATITIS B VACCINE, RESPONSE TO	 
MIM142400	%	 	HERNIA, HIATUS	 
MIM142408	*	3p21	MACROPHAGE STIMULATING 1; MST1	4485
MIM142409	*	7q21.1	HEPATOCYTE GROWTH FACTOR; HGF	3082
MIM142410	*	12q24.2	HNF1 HOMEOBOX A; HNF1A	6927
MIM142440	*	19q11-q13.2	HEPSIN; HPN	3249
MIM142445	*	8p22-p11	NEUREGULIN 1; NRG1	3084
MIM142450	^	 	MOVED TO 600644	 
MIM142460	*	8q22-q24	SYNDECAN 2; SDC2	6383
MIM142461	*	1p36.1	HEPARAN SULFATE PROTEOGLYCAN OF BASEMENT MEMBRANE; HSPG2	3339
MIM142470	%	6q22.3-q23.1	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2; HBFQTL2	7954
MIM142500		 	HETEROCHROMIA IRIDIS	 
MIM142560	*	6p21.3	DEAD BOX POLYPEPTIDE 39B; DDX39B	7919
MIM142570	*	5q35.2	HEXOKINASE 3; HK3	3101
MIM142580	*	6p21.3	PROLINE-RICH COILED-COIL PROTEIN 2A; PRRC2A	7916
MIM142590	*	6p21.3	BCL2-ASSOCIATED ATHANOGENE 6; BAG6	7917
MIM142600	*	10q22	HEXOKINASE 1; HK1	3098
MIM142610	*	6p21.3	G-PATCH DOMAIN- AND ANKYRIN REPEATS-CONTAINING PROTEIN 1; GPANK1	7918
MIM142620	*	6p21.3	ABHYDROLASE DOMAIN-CONTAINING 16A; ABHD16A	7920
MIM142622	*	1p35-p34.2	HIPPOCALCIN; HPCA	3208
MIM142623	#	10q11.2, 4p12, Xq28	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	5979
MIM142625		 	HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	 
MIM142630		 	HISTIOCYTOSIS, PROGRESSIVE MUCINOUS	 
MIM142640	*	3q27	HISTIDINE-RICH GLYCOPROTEIN; HRG	3273
MIM142669	%	4q35	HIP DYSPLASIA, BEUKES TYPE	50947
MIM142680	#	12p13.2	PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	7132
MIM142690	#	1q22-q23	ACNE INVERSA, FAMILIAL, 1; ACNINV1	23385
MIM142695	*	2q37	HIGH DENSITY LIPOPROTEIN-BINDING PROTEIN; HDLBP	3069
MIM142700	%	13q22	ACETABULAR DYSPLASIA	780896
MIM142701	*	4q13	HISTATIN 1; HTN1	3346
MIM142702	*	4q13	HISTATIN 3; HTN3	3347
MIM142703	*	 	HISTAMINE RECEPTOR H2; HRH2	3274
MIM142704	*	15q21-q22	HISTIDINE DECARBOXYLASE; HDC	3067
MIM142705	*	19q13.3	HISTIDINE-RICH CALCIUM-BINDING PROTEIN; HRC	3270
MIM142708	*	22q13.1	H1 HISTONE FAMILY, MEMBER 0; H1F0	3005
MIM142709	*	6p21.3	HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER A; HIST1H1A	3024
MIM142710	*	6p21.3	HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER C; HIST1H1C	3006
MIM142711	*	6p22-p21.3	HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER B; HIST1H1B	3009
MIM142712	*	6p21.3	HISTONE GENE CLUSTER 1, H1 HISTONE FAMILY, MEMBER T; HIST1H1T	3010
MIM142720	*	1q21	HISTONE GENE CLUSTER 2, H2A HISTONE FAMILY, MEMBER A3; HIST2H2AA3	8337
MIM142730		 	HISTIOCYTIC DERMATOARTHRITIS	 
MIM142750	*	1q21	HISTONE GENE CLUSTER 2, H4 HISTONE FAMILY, MEMBER A; HIST2H4A	8370
MIM142763	*	4q24	H2A HISTONE FAMILY, MEMBER Z; H2AFZ	3015
MIM142765	*	19p13.3-p13.2	REGULATORY FACTOR X, 2; RFX2	5990
MIM142780	*	1q21	HISTONE GENE CLUSTER 2, H3 HISTONE FAMILY, MEMBER C; HIST2H3C	126961
MIM142790	*	5q32	CD74 ANTIGEN; CD74	972
MIM142800	*	6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, A; HLA-A	3105
MIM142810	*	5q31.3	HISTIDYL-tRNA SYNTHETASE; HARS	3035
MIM142830	+	6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, B; HLA-B	3106
MIM142840	*	6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, C; HLA-C	3107
MIM142855	*	6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DM ALPHA; HLA-DMA	3108
MIM142856	*	6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DM BETA; HLA-DMB	3109
MIM142857	*	6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR BETA-1; HLA-DRB1	3123
MIM142858	*	6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DP BETA-1; HLA-DPB1	3115
MIM142860	*	6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR ALPHA; HLA-DRA	3122
MIM142871	*	6p21.3	HLA-G HISTOCOMPATIBILITY ANTIGEN, CLASS I; HLA-G	3135
MIM142880	*	6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DP ALPHA-1; HLA-DPA1	3113
MIM142900	#	12q24.1	HOLT-ORAM SYNDROME; HOS	6910
MIM142910	+	5q13.3-q14	3-@HYDROXY-3-METHYLGLUTARYL-CoA REDUCTASE; HMGCR	3156
MIM142930	*	6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DN ALPHA; HLA-DNA	3111
MIM142940	*	5p14-p13	3-@HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 1; HMGCS1	3157
MIM142945	#	7q36	HOLOPROSENCEPHALY 3; HPE3	6469
MIM142946	#	18p11.3	HOLOPROSENCEPHALY 4; HPE4	7050
MIM142950	*	7p15-p14.2	HOMEOBOX A7; HOXA7	3204
MIM142951	*	7p15-p14.2	HOMEOBOX A6; HOXA6	3203
MIM142952	*	7p15-p14.2	HOMEOBOX A5; HOXA5	3202
MIM142953	*	7p15-p14.2	HOMEOBOX A4; HOXA4	3201
MIM142954	*	7p15-p14.2	HOMEOBOX A3; HOXA3	3200
MIM142955	*	7p15.3	HOMEOBOX A1; HOXA1	3198
MIM142956	*	7p15-p14.2	HOMEOBOX A9; HOXA9	3205
MIM142957	*	7p15-p14.2	HOMEOBOX A10; HOXA10	3206
MIM142958	*	7p15-p14.2	HOMEOBOX A11; HOXA11	3207
MIM142959	*	7p15-p14.2	HOMEOBOX A13; HOXA13	3209
MIM142960	*	17q21-q22	HOMEOBOX B5; HOXB5	3215
MIM142961	*	17q21-q22	HOMEOBOX B6; HOXB6	3216
MIM142962	*	17q21-q22	HOMEOBOX B7; HOXB7	3217
MIM142963	*	17q21-q22	HOMEOBOX B8; HOXB8	3218
MIM142964	*	17q21-q22	HOMEOBOX B9; HOXB9	3219
MIM142965	*	17q21-q22	HOMEOBOX B4; HOXB4	3214
MIM142966	*	17q21-q22	HOMEOBOX B3; HOXB3	3213
MIM142967	*	17q21-q22	HOMEOBOX B2; HOXB2	3212
MIM142968	*	17q21-q22	HOMEOBOX B1; HOXB1	3211
MIM142970	*	12q13	HOMEOBOX C8; HOXC8	3224
MIM142971	*	12q13	HOMEOBOX C9; HOXC9	3225
MIM142972	*	12q13	HOMEOBOX C6; HOXC6	3223
MIM142973	*	12q13	HOMEOBOX 3D; HOX3D	3222
MIM142974	*	12q13	HOMEOBOX C4; HOXC4	3221
MIM142975	*	12q13	HOMEOBOX C12; HOXC12	3228
MIM142976	*	12q13	HOMEOBOX C13; HOXC13	3229
MIM142980	*	2q31-q32	HOMEOBOX D3; HOXD3	3232
MIM142981	*	2q31-q32	HOMEOBOX D4; HOXD4	3233
MIM142982	*	2q31-q32	HOMEOBOX D9; HOXD9	3235
MIM142983	*	4p16.1	MUSCLE SEGMENT HOMEOBOX, DROSOPHILA, HOMOLOG OF, 1; MSX1	4487
MIM142984	*	2q31-q32	HOMEOBOX D10; HOXD10	3236
MIM142985	*	2q31-q32	HOMEOBOX D8; HOXD8	3234
MIM142986	*	2q31-q32	HOMEOBOX D11; HOXD11	3237
MIM142987	*	2q31-q32	HOMEOBOX D1; HOXD1	3231
MIM142988	*	2q31-q32	HOMEOBOX D12; HOXD12	3238
MIM142989	*	2q31-q32	HOMEOBOX D13; HOXD13	3239
MIM142991	*	2q31-q32	EVEN-SKIPPED HOMEOBOX 2; EVX2	344191
MIM142992	*	4p16.1	H6 FAMILY HOMEOBOX 1; HMX1	3166
MIM142993	*	14q24.3	CEH10 HOMEODOMAIN-CONTAINING HOMOLOG; CHX10	338917
MIM142994	*	7q36	MOTOR NEURON AND PANCREAS HOMEOBOX 1; MNX1	3110
MIM142995	*	1q41-q42.1	H.20-LIKE HOMEOBOX 1; HLX1	3142
MIM142996	*	7p15-p14	EVEN-SKIPPED HOMEOBOX 1; EVX1	2128
MIM143000	%	 	HORNER SYNDROME, CONGENITAL	 
MIM143010	*	6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, E; HLA-E	3133
MIM143023	*	11p15.5	RAS ASSOCIATION DOMAIN FAMILY, MEMBER 7; RASSF7	8045
MIM143024	*	6p21.3	GUANINE NUCLEOTIDE-BINDING PROTEIN-LIKE 1; GNL1	2794
MIM143025	*	1q42	HTLV-RELATED ENDOGENOUS SEQUENCE 1; HRES1	3272
MIM143030	*	12p13	CD9 ANTIGEN; CD9	928
MIM143050		 	HUMERORADIAL SYNOSTOSIS	 
MIM143054	*	6q23-q24	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ENHANCER-BINDING PROTEIN 2; HIVEP2	3097
MIM143055	*	12q11-q13.3	CYCLIN T1; CCNT1	904
MIM143089	*	2p22-p16	HUMAN T-CELL LEUKEMIA VIRUS ENHANCER FACTOR; HTLF	3344
MIM143090	*	17q21-q23	HUMAN T-CELL LEUKEMIA VIRUS RECEPTOR; HTLVR	3345
MIM143095	#	10q22.1	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	 
MIM143100	#	4p16.3	HUNTINGTON DISEASE; HD	3064
MIM143110	*	6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, F; HLA-F	3134
MIM143170	*	6p23-q12	MALE-ENHANCED ANTIGEN 1; MEA1	4201
MIM143200	#	5q12-q14	WAGNER SYNDROME 1; WGN1	1462
MIM143400	%	6p	MULTICYSTIC RENAL DYSPLASIA, BILATERAL; MCRD	7945
MIM143450	*	2p23	HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE, BETA SUBUNIT; HADHB	3032
MIM143460		Chr.21	5-@HYDROXYTRYPTAMINE OXYGENASE REGULATOR; HTOR	3349
MIM143465	#	17p11, 16p13, 11p15.5, 6q12, 5p13, 5p15.3, 4p16.1-p15.3	ATTENTION DEFICIT-HYPERACTIVITY DISORDER; ADHD	1815, 1816, 6531
MIM143470	#	16q21	HYPERALPHALIPOPROTEINEMIA 1; HALP1	1071
MIM143500	#	2q37	GILBERT SYNDROME	54658
MIM143850	%	18q	ORTHOSTATIC HYPOTENSIVE DISORDER, STREETEN TYPE	50948
MIM143860	#	15q22	HYPERCHLORHIDROSIS, ISOLATED	771
MIM143870	#	1q24	HYPERCALCIURIA, ABSORPTIVE, 2; HCA2	55811
MIM143880	#	 	HYPERCALCEMIA, INFANTILE	1591
MIM143890	#	1q21-q23, 9q22-q31, 8p21-p12, 7p15, 5p13-p12, 3p21.2-p14.1, 19p13.2	HYPERCHOLESTEROLEMIA, FAMILIAL	10842, 19, 2053, 255738, 2690, 336, 338, 3700, 3949
MIM144010	#	2p24	HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, TYPE B	338
MIM144050		 	HYPERHEPARINEMIA	 
MIM144100		 	HYPERHIDROSIS, GUSTATORY; HYPRG	 
MIM144110	%	 	HYPERHIDROSIS PALMARIS ET PLANTARIS; HYPRPP	100861529
MIM144120		14q32.33	HYPERIMMUNOGLOBULIN G1(A1) SYNDROME	 
MIM144150	%	 	HYPERKERATOSIS LENTICULARIS PERSTANS; HLP	100188397
MIM144190		 	HYPERKERATOSIS-HYPERPIGMENTATION SYNDROME	 
MIM144200	#	17q12-q21, 17q12-q21, 12q13	PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC; EPPK	3848, 3857, 3868
MIM144250	#	8p22	HYPERLIPIDEMIA, FAMILIAL COMBINED; FCHL	4023
MIM144300		 	HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	 
MIM144400	^	 	MOVED TO 143890	 
MIM144600		 	HYPERLIPOPROTEINEMIA, TYPE IV	 
MIM144650	#	11q23	HYPERLIPOPROTEINEMIA, TYPE V	116519
MIM144700	#	17q12, 17p11.2, 12q24.2, 8q24.1, 3q21, 3p26-p25, 3p26.2	RENAL CELL CARCINOMA, NONPAPILLARY; RCC	11236, 201163, 4968, 6927, 6928, 7428, 84925
MIM144750	#	11q13.4	HYPEROSTOSIS CORTICALIS GENERALISATA, BENIGN FORM OF WORTH, WITH TORUS PALATINUS	4041
MIM144755	%	 	HYPEROSTOSIS CRANIALIS INTERNA	 
MIM144800		 	HYPEROSTOSIS FRONTALIS INTERNA	 
MIM145000	#	1q25-q31	HYPERPARATHYROIDISM 1; HRPT1	3278, 4221, 79577
MIM145001	#	1q25-q31	HYPERPARATHYROIDISM 2; HRPT2	79577
MIM145100	%	 	HYPERPIGMENTATION OF EYELIDS	 
MIM145200		 	HYPERPIGMENTATION OF FULDAUER AND KUIJPERS	 
MIM145250	#	12q22, 19pter-p13.1	HYPERPIGMENTATION, FAMILIAL PROGRESSIVE, 2; FPH2	4254, 780897
MIM145260	%	17q21-q22, 12p13, 1q31-q42	PSEUDOHYPOALDOSTERONISM, TYPE IIA; PHA2A	65125, 65266, 7830
MIM145290		7q	HYPERREFLEXIA; HRX	7974
MIM145295		 	HYPERSECRETION OF ADRENAL ANDROGENS, FAMILIAL	 
MIM145300		 	HYPERSENSITIVITY PNEUMONITIS, FAMILIAL	 
MIM145350		 	HYPERTAURINURIC CARDIOMYOPATHY	 
MIM145400	%	 	HYPERTELORISM	 
MIM145410	#	22q11.2	OPITZ GBBB SYNDROME, AUTOSOMAL DOMINANT	8221
MIM145420	%	 	HYPERTELORISM, TEEBI TYPE	 
MIM145500	#	17q21-q22, 17q, 17cen-q11.2, 1q23-q25, 1q23, 1q22-q25, 15q, 12p12.2-p12.1, 12p13, 7q36, 7q22.1, 5p13-q12, 4p16.3, 3q21-q25, 1p36.1, 2p25-p24, 1q42-q43, 20q13.11-q13.13, 20q11-q13	HYPERTENSION, ESSENTIAL	118, 1577, 183, 185, 1889, 2784, 481, 4843, 4846, 5409, 5740, 6401, 8490
MIM145505	*	16p13.11	ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 3; ACSM3	6296
MIM145590		 	HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	 
MIM145600	#	19q13.1	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1	6261
MIM145650	#	3p24.3	THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY; PRTH	7068
MIM145680	#	18q11.2-q12.1	DYSTRANSTHYRETINEMIC EUTHYROIDAL HYPERTHYROXINEMIA	7276
MIM145700	%	 	HYPERTRICHOSIS UNIVERSALIS	3341
MIM145701	%	8q22	HYPERTRICHOSIS UNIVERSALIS CONGENITA, AMBRAS TYPE; HTC1	100188785
MIM145750	#	15q11.2-q13.1, 11q23, 8q11-q13, 21q11.2	HYPERTRIGLYCERIDEMIA, FAMILIAL	116519, 149998, 56797, 6101
MIM145800	%	 	HYPERTROPHIA MUSCULORUM VERA	 
MIM145900	#	17p11.2, 1q22, 10q21.1-q22.1, 19q13.1-q13.2	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	1959, 4359, 5376, 57716
MIM145980	#	3q13.3-q21	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE I; HHC1	846
MIM145981	#	19p13.3	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II; HHC2	3086
MIM146000	#	4p16.3	HYPOCHONDROPLASIA; HCH	2261
MIM146110	#	12q13-q21, 9q34.3, 8q12.1, 8p11.2-p11.1, 4q25, 3p21.1, 19p13.3	HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7	2253, 2260, 26012, 2796, 2798, 3814, 55636, 60675, 6866, 6870, 84634
MIM146160		 	HYPOMELIA WITH MULLERIAN DUCT ANOMALIES	 
MIM146200	#	11p15.3-p15.1, 6p24.2, 3q13.3-q21	HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	5741, 846, 9247
MIM146255	#	10p15	HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE; HDR	2625
MIM146300	#	1p36.1-p34	HYPOPHOSPHATASIA, ADULT	249
MIM146350	%	 	HYPOPHOSPHATEMIC BONE DISEASE; HBD	100187828
MIM146390	#	18p	CHROMOSOME 18p DELETION SYNDROME	100240747
MIM146400		 	HYPOPLASIA OF TEETH ROOTS	 
MIM146450	%	 	HYPOSPADIAS 3, AUTOSOMAL; HYSP3	100689211
MIM146500	#	 	MULTIPLE SYSTEM ATROPHY; MSA	 
MIM146510	#	7p13	PALLISTER-HALL SYNDROME; PHS	2737
MIM146520	#	6p21.3	HYPOTRICHOSIS 2; HYPT2	1041
MIM146530	^	 	MOVED TO 301845	 
MIM146550	#	8p21.2	HYPOTRICHOSIS 4; HYPT4	50823, 55806
MIM146590	#	 	ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE; IHCM	3848
MIM146600		 	ICHTHYOSIS HYSTRIX GRAVIOR	 
MIM146630	*	17q23-q25	INTERCELLULAR ADHESION MOLECULE 2; ICAM2	3384
MIM146631	*	19p13.3-p13.2	INTERCELLULAR ADHESION MOLECULE 3; ICAM3	3385
MIM146640	*	10p15	INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 2; ITIH2	3698
MIM146650	*	3p21.2-p21.1	INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 3; ITIH3	3699
MIM146660	*	8q12-q13	INTERLEUKIN 7; IL7	3574
MIM146661	*	5p13	INTERLEUKIN 7 RECEPTOR; IL7R	3575
MIM146680	*	10q23-q25	INSULIN-DEGRADING ENZYME; IDE	3416
MIM146690	*	7q31.3-q32	IMP DEHYDROGENASE 1; IMPDH1	3614
MIM146691	+	3p21.2	IMP DEHYDROGENASE 2; IMPDH2	3615
MIM146700	#	1q21	ICHTHYOSIS VULGARIS	2312
MIM146710	*	22q11.2-q13	INTERLEUKIN 2 RECEPTOR, BETA; IL2RB	3560
MIM146720		 	ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	 
MIM146730	*	7p14-p12	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 1; IGFBP1	3484
MIM146731	*	2q33-q34	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 2; IGFBP2	3485
MIM146732	*	7p14-p12	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3; IGFBP3	3486
MIM146733	*	17q12-q21	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 4; IGFBP4	3487
MIM146734	*	2q33-q36	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 5; IGFBP5	3488
MIM146735	*	Chr.12	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 6; IGFBP6	3489
MIM146738	*	19p13.2	INSULIN-LIKE 3; INSL3	3640
MIM146740	*	1q23	Fc FRAGMENT OF IgG, LOW AFFINITY IIIa, RECEPTOR FOR; FCGR3A	2214
MIM146750		 	ICHTHYOSIS, LAMELLAR, AUTOSOMAL DOMINANT	 
MIM146760	*	1q21.2-q21.3	Fc FRAGMENT OF IgG, HIGH AFFINITY Ia, RECEPTOR FOR; FCGR1A	2209
MIM146770	*	22q11.21	IMMUNOGLOBULIN LAMBDA-LIKE POLYPEPTIDE 1; IGLL1	3543
MIM146780	*	2p12	IMMUNOGLOBULIN KAPPA DELETING ELEMENT; IGKDEL	3515
MIM146790	*	1q21-q23	Fc FRAGMENT OF IgG, LOW AFFINITY IIa, RECEPTOR FOR; FCGR2A	2212
MIM146800	#	12q11-q13	ICHTHYOSIS, BULLOUS TYPE	3849
MIM146820		6p21.3	IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGAT; IGAT	7927
MIM146830		 	IMMUNE DEFICIENCY, FAMILIAL VARIABLE	 
MIM146840		 	IMMUNODEFICIENCY WITH DEFECTIVE LEUKOCYTE AND LYMPHOCYTE FUNCTION AND WITH RESPONSE TO HISTAMINE-1 ANTAGONIST	 
MIM146850		6p21.3	IMMUNE SUPPRESSION; IS	7928
MIM146880	*	6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ ALPHA-1; HLA-DQA1	3117
MIM146900	*	14q32.33	IgA CONSTANT HEAVY CHAIN 1; IGHA1	3493
MIM146910	*	14q32.33	IMMUNOGLOBULIN HEAVY CHAIN DIVERSITY GENE CLUSTER; IGHD@	50648
MIM146920	*	1q21.3	ADENOSINE DEAMINASE, RNA-SPECIFIC; ADAR	103
MIM146928	*	2q35	CHEMOKINE, CXC MOTIF, RECEPTOR 2; CXCR2	3579
MIM146929	*	2q35	CHEMOKINE, CXC MOTIF, RECEPTOR 1; CXCR1	3577
MIM146930	*	4q12-q13	INTERLEUKIN 8; IL8	3576
MIM146931	*	5q31.1	INTERLEUKIN 9; IL9	3578
MIM146933	*	11q23.3	INTERLEUKIN 10 RECEPTOR, ALPHA; IL10RA	3587
MIM146970	*	2p12	IMMUNOGLOBULIN KAPPA LIGHT CHAIN JOINING GENE CLUSTER; IGKJ@	7842
MIM146980	*	2p12	IMMUNOGLOBULIN KAPPA LIGHT CHAIN VARIABLE GENE CLUSTER; IGKV@	3519
MIM146990		15q11-q12	IMMUNOGLOBULIN HEAVY CHAIN DIVERSITY REGION 2; IGHDY2	3496
MIM147000	*	14q32.33	IgA CONSTANT HEAVY CHAIN 2; IGHA2	3494
MIM147010	*	14q32.33	IMMUNOGLOBULIN HEAVY CHAIN JOINING GENE CLUSTER; IGHJ@	3506
MIM147020	*	14q32.33	IMMUNOGLOBULIN HEAVY CHAIN CONSTANT REGION MU; IGHM	3507
MIM147040	*	10q23.3	INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 2; IFIT2	3433
MIM147045	*	19q13.4	Fc FRAGMENT OF IgA, RECEPTOR FOR; FCAR	2204
MIM147050	#	16p11, 1q23-q25, 16p12.1-p11.2, 13q14.1, 11q13, 6p21.2-p12, 5q33.2, 5q32	IgE RESPONSIVENESS, ATOPIC; IGER	11005, 2206, 26762, 3566, 50615, 51131, 6403, 7941
MIM147060	#	17q21	HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	6774
MIM147061	%	5q31.1	IMMUNOGLOBULIN E CONCENTRATION, SERUM; IGES	3478
MIM147070	*	14q32.33	IMMUNOGLOBULIN HEAVY CHAIN VARIABLE GENE CLUSTER; IGHV@	3509
MIM147080		6p21.3	IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGLPHE 1; IGLP1	7925
MIM147090		6p21.3	IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGLPHE 2; IGLP2	7926
MIM147100	*	14q32.33	IgG HEAVY CHAIN LOCUS; IGHG1	3500
MIM147110	*	14q32.33	IMMUNOGLOBULIN Gm2; IGHG2	3501
MIM147120	*	14q32.33	IMMUNOGLOBULIN Gm3; IGHG3	3502
MIM147130	*	14q32.33	IMMUNOGLOBULIN Gm4; IGHG4	3503
MIM147138	*	11q13	MEMBRANE-SPANNING 4 DOMAINS, SUBFAMILY A, MEMBER 2; MS4A2	2206
MIM147139	*	1q23	Fc FRAGMENT OF IgE, HIGH AFFINITY I, RECEPTOR FOR, GAMMA SUBUNIT; FCER1G	2207
MIM147140	*	1q23	Fc FRAGMENT OF IgE, HIGH AFFINITY I, RECEPTOR FOR, ALPHA SUBUNIT; FCER1A	2205
MIM147141	*	19p13.3	TRANSCRIPTION FACTOR 3; TCF3	6929
MIM147150	*	21q22.3	MYXOVIRUS RESISTANCE 1, MOUSE, HOMOLOG OF; MX1	4599
MIM147170	*	14q32.33	IMMUNOGLOBULIN: HEAVY DELTA CHAIN; IGHD	3495
MIM147180	*	14q32.33	IMMUNOGLOBULIN: HEAVY EPSILON CHAIN; IGHE	3497
MIM147183	*	4p15.2	RECOMBINATION SIGNAL-BINDING PROTEIN FOR IMMUNOGLOBULIN KAPPA J REGION; RBPJ	3516
MIM147185	*	2q12-q14	IMMUNOGLOBULIN KAPPA VARIABLE 1/OR2-108; IGKV1OR2108	28862
MIM147200	*	2p12	IMMUNOGLOBULIN KAPPA LIGHT CHAIN CONSTANT REGION; IGKC	3514
MIM147220	*	22q11.2	IMMUNOGLOBULIN LAMBDA CONSTANT REGION 1; IGLC1	3537
MIM147230	*	22q11.2	IMMUNOGLOBULIN LAMBDA LIGHT CHAIN JOINING GENE CLUSTER; IGLJ@	8217
MIM147240	*	22q11.2	IMMUNOGLOBULIN LAMBDA LIGHT CHAIN VARIABLE GENE CLUSTER; IGLV@	3546
MIM147245	*	17q23	CD79B ANTIGEN; CD79B	974
MIM147250	#	7q36	SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	6469
MIM147251		 	INCISORS, FUSED MANDIBULAR	 
MIM147263	*	2q32	INOSITOL POLYPHOSPHATE-1-PHOSPHATASE; INPP1	3628
MIM147264	*	1p34	INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 75-KD; INPP5B	3633
MIM147265	*	3p26-p25	INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 1; ITPR1	3708
MIM147267	*	6pter-p21	INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 3; ITPR3	3710
MIM147270	*	3p21.2-p21.1	INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 1; ITIH1	3697
MIM147280	*	6q26	INSULIN-LIKE GROWTH FACTOR II RECEPTOR; IGF2R	3482
MIM147290	*	7p15-p13	INHIBIN, BETA A; INHBA	3624
MIM147300		 	INCISORS, LONG UPPER CENTRAL	 
MIM147310	*	4q21	CHEMOKINE, CXC MOTIF, LIGAND 10; CXCL10	3627
MIM147330		 	INCISORS, LOWER CENTRAL, ABSENCE OF	 
MIM147350		 	INCISORS, ROTATION OF UPPER CENTRAL	 
MIM147360	*	1q21	INVOLUCRIN; IVL	3713
MIM147370	*	15q25-q26	INSULIN-LIKE GROWTH FACTOR I RECEPTOR; IGF1R	3480
MIM147380	*	2q33-q36	INHIBIN, ALPHA; INHA	3623
MIM147390	*	2cen-q13	INHIBIN, BETA B; INHBB	3625
MIM147400	%	 	INCISORS, SHOVEL-SHAPED	 
MIM147420	^	 	MOVED TO 601419	 
MIM147421	%	 	INCLUSION BODY MYOSITIS	 
MIM147430	%	 	INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL DOMINANT	 
MIM147435	*	8p12-p11	INDOLEAMINE 2,3-DIOXYGENASE; IDO1	3620
MIM147440	*	12q22-q24.1	INSULIN-LIKE GROWTH FACTOR I; IGF1	3479
MIM147450	*	21q22.1	SUPEROXIDE DISMUTASE 1; SOD1	6647
MIM147460	*	6q25.3	SUPEROXIDE DISMUTASE 2; SOD2	6648
MIM147470	*	11p15.5	INSULIN-LIKE GROWTH FACTOR II; IGF2	3481
MIM147480	#	7q21.1	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY; ICP	5205, 5244
MIM147485	*	1p32-p22	INTRACISTERNAL A PARTICLE-PROMOTED POLYPEPTIDE; IPP	3652
MIM147510	*	11p15.5	INSULIN-RELATED DNA POLYMORPHISM; IRDN	 
MIM147520	*	20p	INOSINE TRIPHOSPHATASE; ITPA	3704
MIM147521	*	15q14-q21	INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE A; ITPKA	3706
MIM147522	*	1q41-q43	INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE B; ITPKB	3707
MIM147530		 	INSENSITIVITY TO PAIN WITH HYPERPLASTIC MYELINOPATHY	 
MIM147540		 	INSECT STINGS, HYPERSENSITIVITY TO	 
MIM147545	+	2q36	INSULIN RECEPTOR SUBSTRATE 1; IRS1	3667
MIM147553	*	9p21	INTERFERON, OMEGA-1; IFNW1	3467
MIM147556	*	2q31.1	INTEGRIN, ALPHA-6; ITGA6	3655
MIM147557	*	17q11-qter	INTEGRIN, BETA-4; ITGB4	3691
MIM147558	*	2q24.2	INTEGRIN, BETA-6; ITGB6	3694
MIM147559	*	12q13.13	INTEGRIN, BETA-7; ITGB7	3695
MIM147561	*	 	INTEGRIN, BETA-5; ITGB5	3693
MIM147562	*	9p22	INTERFERON, ALPHA-2; IFNA2	3440
MIM147563	*	4q21-q25	INTEGRIN-BINDING SIALOPROTEIN; IBSP	3381
MIM147564	*	9p22	INTERFERON, ALPHA-4; IFNA4	3441
MIM147565	*	9p22	INTERFERON, ALPHA-5; IFNA5	3442
MIM147566	*	9p22	INTERFERON, ALPHA-6; IFNA6	3443
MIM147567	*	9p22	INTERFERON, ALPHA-7; IFNA7	3444
MIM147568	*	9p22	INTERFERON, ALPHA-8; IFNA8	3445
MIM147569	*	21q22.1-q22.2	INTERFERON, GAMMA, RECEPTOR 2; IFNGR2	3460
MIM147570	*	12q14	INTERFERON, GAMMA; IFNG	3458
MIM147571	*	1p36.33	UBIQUITIN-LIKE MODIFIER ISG15; ISG15	9636
MIM147572	*	1p35	INTERFERON-ALPHA-INDUCIBLE PROTEIN 6; IFI6	2537
MIM147573	*	Chr.16	INTERFERON PRODUCTION REGULATOR; IFNR	3466
MIM147574	*	14q11.2	INTERFERON-STIMULATED TRANSCRIPTION FACTOR 3, GAMMA; ISGF3G	10379
MIM147575	*	5q31.1	INTERFERON REGULATORY FACTOR 1; IRF1	3659
MIM147576	*	4q35.1	INTERFERON REGULATORY FACTOR 2; IRF2	3660
MIM147577	*	9p22	INTERFERON, ALPHA-10; IFNA10	3446
MIM147578	*	9p22	INTERFERON, ALPHA-13; IFNA13	3447
MIM147579	*	9p22	INTERFERON, ALPHA-14; IFNA14	3448
MIM147580	*	9p22	INTERFERON, ALPHA-16; IFNA16	3449
MIM147582	*	15q25.1	IRON-RESPONSIVE ELEMENT-BINDING PROTEIN 2; IREB2	3658
MIM147583	*	9p22	INTERFERON, ALPHA-17; IFNA17	3451
MIM147584	*	9p22	INTERFERON, ALPHA-21; IFNA21	3452
MIM147586	*	1q22	INTERFERON-GAMMA-INDUCIBLE PROTEIN 16; IFI16	3428
MIM147610		 	IRIS PIGMENT LAYER, CLEAVAGE OF	 
MIM147620	*	7p21	INTERLEUKIN 6; IL6	3569
MIM147625	*	7p22	ISLET CELL AUTOANTIGEN 1; ICA1	3382
MIM147630		 	ISLET CELL ADENOMATOSIS	 
MIM147640	*	9p21	INTERFERON, BETA-1; IFNB1	3456
MIM147650	*	15q26.1	ISOCITRATE DEHYDROGENASE 2; IDH2	3418
MIM147660	*	9p22	INTERFERON, ALPHA-1; IFNA1	3439
MIM147670	*	19p13.2	INSULIN RECEPTOR; INSR	3643
MIM147671	*	1q21-q23	INSULIN RECEPTOR-RELATED RECEPTOR; INSRR	3645
MIM147678	*	11q22.2-q22.3	CASPASE 1, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP1	834
MIM147679	*	2q14.2	INTERLEUKIN 1 RECEPTOR ANTAGONIST; IL1RN	3557
MIM147680	*	4q26-q27	INTERLEUKIN 2; IL2	3558
MIM147681	*	19q13.3-q13.4	INTERLEUKIN 11; IL11	3589
MIM147683	*	5q31	INTERLEUKIN 13; IL13	3596
MIM147685	*	17q25	FORKHEAD BOX K2; FOXK2	3607
MIM147690	*	10q23.3	INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 1; IFIT1	3434
MIM147700	*	2q33.3	ISOCITRATE DEHYDROGENASE 1; IDH1	3417
MIM147710		 	INTUSSUSCEPTION	 
MIM147720	*	2q14	INTERLEUKIN 1-BETA; IL1B	3553
MIM147730	*	10p15.1	INTERLEUKIN 2 RECEPTOR, ALPHA; IL2RA	3559
MIM147740	*	5q31.1	INTERLEUKIN 3; IL3	3562
MIM147750	#	20q13.13-q13.2	IVIC SYNDROME	57167
MIM147760	*	2q14	INTERLEUKIN 1-ALPHA; IL1A	3552
MIM147770	%	 	JOHNSON NEUROECTODERMAL SYNDROME	 
MIM147780	*	5q31.1	INTERLEUKIN 4; IL4	3565
MIM147781	*	16p12.1-p11.2	INTERLEUKIN 4 RECEPTOR; IL4R	3566
MIM147790	*	4q21	IMMUNOGLOBULIN J POLYPEPTIDE, LINKER PROTEIN FOR IMMUNOGLOBULIN ALPHA AND MU POLYPEPTIDES; IGJ	3512
MIM147791	#	11q23	JACOBSEN SYNDROME; JBS	3719
MIM147795	*	1p31.3	JANUS KINASE 1; JAK1	3716
MIM147796	*	9p24	JANUS KINASE 2; JAK2	3717
MIM147800	%	 	AASE-SMITH SYNDROME I	 
MIM147810	*	2q12	INTERLEUKIN 1 RECEPTOR, TYPE I; IL1R1	3554
MIM147811	*	2q12-q22	INTERLEUKIN 1 RECEPTOR, TYPE II; IL1R2	7850
MIM147820		 	INTERNAL CAROTID ARTERY, SPONTANEOUS DISSECTION OF	 
MIM147830	*	7p12-cen	INVASION AND METASTASIS FACTORS ON CHROMOSOME 7; INM7	7271
MIM147840	*	19p13.3-p13.2	INTERCELLULAR ADHESION MOLECULE 1; ICAM1	3383
MIM147850	*	5q31.1	INTERLEUKIN 5; IL5	3567
MIM147851	*	3p26-p24	INTERLEUKIN 5 RECEPTOR, ALPHA; IL5RA	3568
MIM147870	*	7q31	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 2; WNT2	7472
MIM147880	*	1q21.3	INTERLEUKIN 6 RECEPTOR; IL6R	3570
MIM147890	*	21q22.3	MYXOVIRUS RESISTANCE 2, MOUSE, HOMOLOG OF; MX2	4600
MIM147891	#	17q21-q22	SMALL PATELLA SYNDROME; SPS	9496
MIM147892	+	1p33-p32	DEIODINASE, IODOTHYRONINE, TYPE I; DIO1	1733
MIM147900	%	 	JOINT LAXITY, FAMILIAL	 
MIM147910	*	19q13.4	KALLIKREIN 1; KLK1	3816
MIM147920	#	12q12-q14	KABUKI SYNDROME 1; KABUK1	8085
MIM147935	*	14q31-q32.1	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 4; SERPINA4	5267
MIM147940	*	12p12.3-p12.1	ISLET AMYLOID POLYPEPTIDE; IAPP	3375
MIM147950	#	8p11.2-p11.1	HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA; HH2	2260
MIM147960	*	19q13.4	KALLIKREIN-RELATED PEPTIDASE 2; KLK2	3817
MIM148000	#	7p21	KAPOSI SARCOMA, SUSCEPTIBILITY TO	3569
MIM148020	*	17q21-q22	KERATIN 19; KRT19	3880
MIM148021	*	11q13.5	KERATIN ASSOCIATED PROTEIN 5-9; KRTAP5-9	3846
MIM148022	*	11p15.5	KERATIN-ASSOCIATED PROTEIN 5-1; KRTAP5-1	387264
MIM148030	*	17q21-q22	KERATIN 15; KRT15	3866
MIM148040	*	12q13	KERATIN 5; KRT5	3852
MIM148041	*	12q13	KERATIN 6A; KRT6A	3853
MIM148042	*	12q13	KERATIN 6B; KRT6B	3854
MIM148043	*	12q13	KERATIN 3; KRT3	3850
MIM148050	#	 	KBG SYNDROME; KBGS	29123
MIM148059	*	12q12-q14	KERATIN 7; KRT7	3855
MIM148060	*	12q13	KERATIN 8; KRT8	3856
MIM148065	*	17q21-q22	KERATIN 13; KRT13	3860
MIM148066	*	17q12-q21	KERATIN 14; KRT14	3861
MIM148067	*	17q12-q21	KERATIN 16; KRT16	3868
MIM148069	*	17q12-q21	KERATIN 17; KRT17	3872
MIM148070	*	12q13	KERATIN 18; KRT18	3875
MIM148080	*	17q21-q22	KERATIN 10; KRT10	3858
MIM148100	%	 	KELOID FORMATION	 
MIM148180	*	15q15-q21.1	FIBROBLAST GROWTH FACTOR 7; FGF7	2252
MIM148190	#	11p13	KERATITIS, HEREDITARY	5080
MIM148200	%	 	KERATITIS FUGAX HEREDITARIA	 
MIM148210	#	13q11-q12	KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT	2706
MIM148300	#	20p11.2	KERATOCONUS 1; KTCN1	30813
MIM148350	#	13q11-q12	KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	2706
MIM148360		 	KERATODERMA, PALMOPLANTAR, WITH NAIL DYSTROPHY AND HEREDITARY MOTOR-SENSORY NEUROPATHY	 
MIM148370	%	8p23-p22	KERATOLYTIC WINTER ERYTHEMA	3896
MIM148390		 	KERATOSIS, FAMILIAL ACTINIC	 
MIM148500	#	17q25	TYLOSIS WITH ESOPHAGEAL CANCER; TOC	7149, 79651
MIM148520		 	KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	 
MIM148600	#	15q22-q24	KERATODERMA, PALMOPLANTAR, PUNCTATE TYPE I; PPKP1	619540
MIM148700	#	18q12.1-q12.2	KERATOSIS PALMOPLANTARIS STRIATA I; PPKS1	1828
MIM148730	%	 	KERATOSIS, FOCAL PALMOPLANTAR AND GINGIVAL	 
MIM148750	*	7q22-q32	KINASE-LIKE PROTEIN G7P1; G7P1	2546
MIM148760	*	10q24.1	KINESIN FAMILY MEMBER 11; KIF11	3832
MIM148800		 	KLEEBLATTSCHAEDEL	 
MIM148820	#	2q35	WAARDENBURG SYNDROME, TYPE 3; WS3	5077
MIM148840	%	 	KLEINE-LEVIN HIBERNATION SYNDROME	 
MIM148860	^	 	MOVED TO 601076	 
MIM148870	^	 	MOVED TO 118100	 
MIM148900	^	 	MOVED TO 118100	 
MIM149000	%	8q22.3	KLIPPEL-TRENAUNAY-WEBER SYNDROME	791122
MIM149100	#	 	KNUCKLE PADS	 
MIM149200	#	13q11-q12	KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	2706
MIM149300	%	 	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 2; NDNC2	 
MIM149400	#	14q24, 11p15.2-p15.1, 5q32, 4q31.3	HYPEREKPLEXIA, HEREDITARY 1; HKPX1	10243, 2741, 2743, 9152
MIM149600		 	LABIA MINORA, INCOMPLETE ADHESION OF	 
MIM149700		 	LACRIMAL DUCT DEFECT	 
MIM149730	#	5p13-p12, 4p16.3	LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	2255, 2261, 2263
MIM149750	*	12q13	LACTALBUMIN, ALPHA; LALBA	3906
MIM150000	*	11p15.4	LACTATE DEHYDROGENASE A; LDHA	3939
MIM150100	*	12p12.2-p12.1	LACTATE DEHYDROGENASE B; LDHB	3945
MIM150150	*	11p15.5-p15.3	LACTATE DEHYDROGENASE C; LDHC	3948
MIM150170		 	LACTIC ACIDOSIS, CHRONIC ADULT FORM	 
MIM150200	*	17q22-q24	CHORIONIC SOMATOMAMMOTROPIN HORMONE 1; CSH1	1442
MIM150205	*	17q23.1	LACTOPEROXIDASE; LPO	4025
MIM150210	*	3p21.31	LACTOTRANSFERRIN; LTF	4057
MIM150220	^	 	MOVED TO 223000	 
MIM150230	#	8q24.11-q24.13	TRICHORHINOPHALANGEAL SYNDROME, TYPE II; TRPS2	 
MIM150240	*	7q31.1-q31.3	LAMININ, BETA-1; LAMB1	3912
MIM150250	#	3p14.3	LARSEN SYNDROME; LRS	2317
MIM150260	%	 	LARYNGEAL ABDUCTOR PARALYSIS	 
MIM150270	%	6p21.3-p21.2	LARYNGEAL ADDUCTOR PARALYSIS; LAP	7939
MIM150280		 	LARYNGOMALACIA	 
MIM150290	*	1q31	LAMININ, GAMMA-1; LAMC1	3915
MIM150292	*	1q25-q31	LAMININ, GAMMA-2; LAMC2	3918
MIM150300		 	LARYNX, CONGENITAL PARTIAL ATRESIA OF	 
MIM150310	*	1q32	LAMININ, BETA-3; LAMB3	3914
MIM150320	*	18p11.31	LAMININ, ALPHA-1; LAMA1	284217
MIM150325	*	3p21	LAMININ, BETA-2; LAMB2	3913
MIM150330	*	1q21.2	LAMIN A/C; LMNA	4000
MIM150340	*	5q23.3-q31.1	LAMIN B1; LMNB1	4001
MIM150341	*	19p13.3	LAMIN B2; LMNB2	84823
MIM150360		 	LARYNGEAL WEB, FAMILIAL	 
MIM150370	*	3p21.3	LAMININ RECEPTOR 1; LAMR1	3921
MIM150390	*	2p12-q22	LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 1; LTBP1	4052
MIM150400	#	 	TOOTH AGENESIS, SELECTIVE, 4; STHAG4	80326
MIM150500		 	LATTICE DEGENERATION OF RETINA LEADING TO RETINAL DETACHMENT	 
MIM150550		 	LAZY LEUKOCYTE SYNDROME	 
MIM150570	*	22q12-q13.1	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 1; LGALS1	3956
MIM150571	*	22q13.1	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 2; LGALS2	3957
MIM150590		 	LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	 
MIM150600	#	 	LEGG-CALVE-PERTHES DISEASE; LCPD	1280
MIM150699	#	 	LEIOMYOMA, UTERINE; UL	8091
MIM150700		 	LEIOMYOMA OF VULVA AND ESOPHAGUS	 
MIM150800	#	1q42.1	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; HLRCC	 
MIM150900		 	LENTIGINES	 
MIM151000		 	LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	 
MIM151001	%	 	LENTIGINOSIS, INHERITED PATTERNED	619539
MIM151020	*	Chr.14	LENTIL AGGLUTININ BINDING	8118
MIM151050	#	 	LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	 
MIM151100	#	12q24.1	LEOPARD SYNDROME 1	5781
MIM151200	#	 	LERI PLEONOSTEOSIS	 
MIM151210	#	 	PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, TORRANCE TYPE; PLSDT	1280
MIM151290	*	11q25	BETA-1,3-GLUCURONYLTRANSFERASE 1; B3GAT1	27087
MIM151300	*	5q14.2-q15	LEUCYL-CYSTINYL AMINOPEPTIDASE; LNPEP	4012
MIM151310	*	Chr.20	LEUCINE TRANSPORT, HIGH; LEUT	3343
MIM151350	*	5cen-q11	LEUCYL-tRNA SYNTHETASE; LARS	51520
MIM151380		 	LEUKEMIA, ACUTE MONOCYTIC	 
MIM151385	*	21q22.3	RUNT-RELATED TRANSCRIPTION FACTOR 1; RUNX1	861
MIM151390	^	 	MOVED TO 180385	 
MIM151400	#	 	LEUKEMIA, CHRONIC LYMPHOCYTIC; CLL	 
MIM151410	*	22q11.21	BREAKPOINT CLUSTER REGION; BCR	613
MIM151430	+	18q21.3	B-CELL CLL/LYMPHOMA 2; BCL2	596
MIM151440	*	19p13.2-p13.1	LYMPHOBLASTIC LEUKEMIA-DERIVED SEQUENCE 1; LYL1	4066
MIM151441	*	17q22	LEUKEMIA/LYMPHOMA, CHRONIC B-CELL, 5; BCL5	603
MIM151442	*	1p36.1-p35	STATHMIN 1; STMN1	3925
MIM151443	*	5p13.1	LEUKEMIA INHIBITORY FACTOR RECEPTOR; LIFR	3977
MIM151445	*	19p13.3	Fc FRAGMENT OF IgE, LOW AFFINITY II, RECEPTOR FOR; FCER2	2208
MIM151450	*	Chr.4	LEUKOCYTE ANTIGEN GROUP FIVE; LAG5	7895
MIM151460	*	1q31-q32	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, C; PTPRC	5788
MIM151500		 	LEUKOCYTE NUCLEAR APPENDAGES, HEREDITARY PREVALENCE OF	 
MIM151510	*	16p11.2	INTEGRIN, ALPHA-X; ITGAX	3687
MIM151520	*	15q15.1-q21.1	LEUKOCYTE TYROSINE KINASE; LTK	4058
MIM151523	*	19p13-q13.4	LEUKOCYTE SURFACE ANTIGEN CD37; CD37	951
MIM151525	*	1p21-p13.3	LEUKOCYTE SURFACE ANTIGEN CD53; CD53	963
MIM151530	*	15q25-q26	ALANYL AMINOPEPTIDASE; ANPEP	290
MIM151550	^	 	REMOVED FROM DATABASE	 
MIM151570	*	12q22	LEUKOTRIENE A4 HYDROLASE; LTA4H	4048
MIM151590		 	LICHEN SCLEROSUS ET ATROPHICUS; LSA	 
MIM151600	#	 	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3; NDNC3	5333
MIM151610		 	LEVATOR-MEDIAL RECTUS SYNKINESIS	 
MIM151620		 	LICHEN PLANUS, FAMILIAL	 
MIM151623	#	17p13.1, 9p21	LI-FRAUMENI SYNDROME 1; LFS1	1029, 7157
MIM151625	*	 	LIGATIN; LGTN	100529141
MIM151626	*	22q11-q12	LINE RETROTRANSPOSABLE ELEMENT 1; LRE1	4029
MIM151628	*	1q	LINE RETROTRANSPOSABLE ELEMENT 2; LRE2	4030
MIM151630	%	 	LIP, MEDIAN NODULE OF UPPER	 
MIM151640		 	LIP, HAMARTOMATOUS	 
MIM151660	#	1q21.2	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2; FPLD2	4000
MIM151670	*	15q21-q23	LIPASE, HEPATIC; LIPC	3990
MIM151675	*	9q34	LIPOCALIN 1; LCN1	3933
MIM151690	*	9q11-q22	ANNEXIN A1; ANXA1	301
MIM151700		 	LIPOMA OF THE CONJUNCTIVA	 
MIM151740	*	15q21-q22	ANNEXIN A2; ANXA2	302
MIM151750	*	19q13.1-q13.2	LIPASE, HORMONE-SENSITIVE; LIPE	3991
MIM151800		 	LIPOMATOSIS, MULTIPLE SYMMETRIC; MSL	 
MIM151900	%	 	LIPOMATOSIS, MULTIPLE	 
MIM151990	*	20q11.23-q12	LIPOPOLYSACCHARIDE-BINDING PROTEIN; LBP	3929
MIM152200	+	6q27	APOLIPOPROTEIN(a); LPA	4018
MIM152310	*	2q31-q32.1	TISSUE FACTOR PATHWAY INHIBITOR; TFPI	7035
MIM152390	*	10q11.2	ARACHIDONATE 5-LIPOXYGENASE; ALOX5	240
MIM152391	*	17p13.1	ARACHIDONATE 12-OXIDOREDUCTASE; ALOX12	239
MIM152392	*	17p13.3	ARACHIDONATE 15-LIPOXYGENASE; ALOX15	246
MIM152420		 	LITHIUM TRANSPORT	 
MIM152424	*	11p15.5	LOCUS CONTROL REGION, BETA	387281
MIM152425	*	4q34-q35	ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 1; ACSL1	2180
MIM152427	*	12p11.1, 7q35-q36	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 2; KCNH2	3757
MIM152430	%	4q25	LONGEVITY 1	140802
MIM152445	*	1q21	LORICRIN; LOR	4014
MIM152460	^	 	MOVED TO 137950	 
MIM152550		 	LUMBAR STENOSIS, FAMILIAL	 
MIM152600		 	LUNULAE OF FINGERNAILS	 
MIM152690	*	22q11-q13	X-RAY REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 6; XRCC6	2547
MIM152700	#	1q23, 16p13.3, 1q23, 1q22, 11q14, 1p13, 6p21.3, 4q22-q24, 4p16-p15.2, 3p21.3-p21.2	SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	11277, 1773, 2213, 2214, 26191, 356, 55024, 720
MIM152760	*	8p21-p11.2	GONADOTROPIN-RELEASING HORMONE 1; GNRH1	2796
MIM152780	+	19q13.32	LUTEINIZING HORMONE, BETA POLYPEPTIDE; LHB	3972
MIM152790	*	2p21	LUTEINIZING HORMONE/CHORIOGONADOTROPIN RECEPTOR; LHCGR	3973
MIM152800	%	 	LYMPHANGIECTASIA, INTESTINAL	 
MIM152900		 	LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	 
MIM152950	#	 	MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	3832
MIM153000	^	 	MOVED TO 153400	 
MIM153100	#	5q35.3	LYMPHEDEMA, HEREDITARY, IA	2324
MIM153200	%	 	LYMPHEDEMA, HEREDITARY, II	 
MIM153240	*	1q23-q25	SELECTIN L; SELL	6402
MIM153243	*	1p36	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 8; TNFRSF8	943
MIM153245	+	4q23-q25	LYMPHOID ENHANCER-BINDING FACTOR 1; LEF1	51176
MIM153300	%	 	YELLOW NAIL SYNDROME	 
MIM153310	*	19q13.1	CHARCOT-LEYDEN CRYSTAL PROTEIN; CLC	1178
MIM153330	*	13q34	LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 1; LAMP1	3916
MIM153337	*	12p13.32	LYMPHOCYTE ACTIVATION GENE 3; LAG3	3902
MIM153340	*	11q13	LYMPHOCYTE ANTIGEN CD5; CD5	921
MIM153370	*	16p11.2	INTEGRIN, ALPHA-L; ITGAL	3683
MIM153380	*	6p21.3-p21.2	LYMPHOCYTE CYTOSOL POLYPEPTIDE, 20-KD	7938
MIM153390	*	1p35-p34.3	LYMPHOCYTE-SPECIFIC PROTEIN-TYROSINE KINASE; LCK	3932
MIM153400	#	16q24.3	LYMPHEDEMA-DISTICHIASIS SYNDROME	2303
MIM153420	*	1p13	CD58 MOLECULE; CD58	965
MIM153430	*	13q14.1-q14.3	LYMPHOCYTE CYTOSOLIC PROTEIN 1; LCP1	3936
MIM153432	*	11p15.5	LYMPHOCYTE-SPECIFIC PROTEIN; LSP1	4046
MIM153435	*	Chr.6	LYMPHOKINE-ACTIVATED KILLER CELL LIGAND; LAKL	3905
MIM153440	*	6p21.3	LYMPHOTOXIN-ALPHA; LTA	4049
MIM153450	*	12q15	LYSOZYME; LYZ	4069
MIM153454	*	1p36.3-p36.2	PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE; PLOD1	5351
MIM153455	*	5q23.3-q31.2	LYSYL OXIDASE; LOX	4015
MIM153456	*	15q22	LYSYL OXIDASE-LIKE 1; LOXL1	4016
MIM153470		 	MACROCEPHALY, BENIGN FAMILIAL	 
MIM153480	#	10q23.31	BANNAYAN-RILEY-RUVALCABA SYNDROME; BRRS	5728
MIM153550	#	5q32	CHROMOSOME 5q DELETION SYNDROME	6208
MIM153600	%	6p21.3	MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 1; WM1	100188787, 4615
MIM153615	*	2cen-q24	CAPPING PROTEIN, GELSOLIN-LIKE; CAPG	822
MIM153618	*	10p13	MANNOSE RECEPTOR, C-TYPE, 1; MRC1	4360
MIM153619	*	14q21-q22	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 3; LGALS3	3958
MIM153620	*	22q11.2	MACROPHAGE MIGRATION INHIBITORY FACTOR; MIF	4282
MIM153622	*	8p22	MACROPHAGE SCAVENGER RECEPTOR; MSR1	4481
MIM153630	%	 	MACROGLOSSIA	 
MIM153634	*	17p13	MACROPHAGE ANTIGEN CD68; CD68	968
MIM153640	#	22q11.2	FECHTNER SYNDROME; FTNS	4627
MIM153650	#	22q11.2	EPSTEIN SYNDROME	4627
MIM153670	#	17pter-p12	BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2	2811
MIM153700	#	11q13	MACULAR DYSTROPHY, VITELLIFORM; VMD	7439
MIM153800	#	1p22.1	MACULAR DEGENERATION, AGE-RELATED, 2; ARMD2	24
MIM153840	%	8q24	MACULAR DYSTROPHY, ATYPICAL VITELLIFORM; VMD1	7438
MIM153870	%	 	MACULAR DYSTROPHY, CONCENTRIC ANNULAR	 
MIM153880	%	7p21-p15	MACULAR EDEMA, CYSTOID	1541
MIM153890		 	MACULAR DYSTROPHY, FENESTRATED SHEEN TYPE	 
MIM154000		 	MACULES, HEREDITARY CONGENITAL HYPOPIGMENTED AND HYPERPIGMENTED	 
MIM154020	#	11q23	HYPOMAGNESEMIA 2, RENAL; HOMG2	486
MIM154030	*	1p34	NUCLEASE-SENSITIVE ELEMENT-BINDING PROTEIN 1; NSEP1	4904
MIM154040	*	6p21.3	RD RNA-BINDING PROTEIN; RDBP	7936
MIM154045	*	19q13.4	LENS INTRINSIC MEMBRANE PROTEIN 2, 19-KD; LIM2	3982
MIM154050	*	12q13	MAJOR INTRINSIC PROTEIN OF LENS FIBER; MIP	4284
MIM154100	*	7cen-q22	MALATE DEHYDROGENASE, MITOCHONDRIAL; MDH2	4191
MIM154200	*	2p16	MALATE DEHYDROGENASE, SOLUBLE; MDH1	4190
MIM154230	#	9p24.3	46,XY SEX REVERSAL 4; SRXY4	 
MIM154235	*	6q22	MALE GERM CELL-ASSOCIATED KINASE; MAK	4117
MIM154250	*	6q12	MALIC ENZYME 1; ME1	4199
MIM154270	*	18q21	MALIC ENZYME 2; ME2	4200
MIM154275	%	17q11.2-q24	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	4264
MIM154276	%	7q21-q22	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	7977
MIM154280	*	1pter-p22.1	SUPPRESSOR OF ANCHORAGE INDEPENDENCE 1; SAI1	6298
MIM154300		 	MALOCCLUSION DUE TO PROTUBERANT UPPER FRONT TEETH	 
MIM154360	*	7q34	MALTASE-GLUCOAMYLASE; MGAM	8972
MIM154365	*	7q22.1-q22.3	PROTEASOME 26S SUBUNIT, ATPase, 2; PSMC2	5701
MIM154400	#	9q32	ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	10262, 171
MIM154500	#	5q32-q33.1	TREACHER COLLINS SYNDROME 1; TCS1	6949
MIM154540	*	12p13	MANNOSE 6-PHOSPHATE RECEPTOR, CATION-DEPENDENT; M6PR	4074
MIM154545	*	10q11.2-q21	LECTIN, MANNOSE-BINDING, SOLUBLE, 2; MBL2	4153
MIM154550	*	15q22-qter	MANNOSEPHOSPHATE ISOMERASE; MPI	4351
MIM154580	*	15q11-q13	MANNOSIDASE, ALPHA, CLASS 2C, MEMBER 1; MAN2C1	4123
MIM154582	*	5q21-q22	MANNOSIDASE, ALPHA, CLASS 2A, MEMBER 1; MAN2A1	4124
MIM154600		 	MARCUS GUNN PHENOMENON	 
MIM154700	#	15q21.1	MARFAN SYNDROME; MFS	2200
MIM154705	^	 	MOVED TO 610380	 
MIM154750		 	MARFANOID HYPERMOBILITY SYNDROME	 
MIM154780	#	1p21	MARSHALL SYNDROME; MRSHS	1301
MIM154790	*	18q21.3	PROTEASE INHIBITOR 5; PI5	5268
MIM154800		 	MAST CELL DISEASE	3815
MIM154850		 	MASTICATORY MUSCLES, HYPERTROPHY OF	 
MIM154870	*	12p13.1-p12.3	MATRIX GAMMA-CARBOXYGLUTAMIC ACID; MGP	4256
MIM154950	*	14q23	MAX PROTEIN; MAX	4149
MIM155000	%	 	MAXILLOFACIAL DYSOSTOSIS	 
MIM155050	%	 	MAXILLONASAL DYSPLASIA, BINDER TYPE	 
MIM155100	#	22q11.2	MAY-HEGGLIN ANOMALY; MHA	4627
MIM155120	*	17q21.3	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 11; ADAM11	4185
MIM155140		 	MECKEL DIVERTICULUM	 
MIM155145	%	 	CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	 
MIM155150		 	MEDIAN-ULNAR NERVE COMMUNICATIONS	 
MIM155200		 	MEDIOSTERNAL DEPIGMENTATION LINE	 
MIM155240	#	1q21-q22, 10q11.2	THYROID CARCINOMA, FAMILIAL MEDULLARY; MTC	4914, 5979
MIM155255	#	13q12.3, 10q24-q25, 1p32	MEDULLOBLASTOMA; MDB	51684, 675, 8643
MIM155310	#	 	MEGADUODENUM AND/OR MEGACYSTIS	 
MIM155350	%	 	MEGALENCEPHALY	 
MIM155500		 	MEGALODACTYLY	 
MIM155540	*	20q13.2	MELANOCORTIN 3 RECEPTOR; MC3R	4159
MIM155541	*	18q22	MELANOCORTIN 4 RECEPTOR; MC4R	4160
MIM155550	*	12q13-q14	SILVER, MOUSE, HOMOLOG OF; SILV	6490
MIM155555	*	16q24.3	MELANOCORTIN 1 RECEPTOR; MC1R	4157
MIM155600	%	1p36	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 1; CMM1	1243, 5728
MIM155601	#	9p21	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2; CMM2	1029
MIM155700		 	MELANOMA, MALIGNANT FAMILIAL INTRAOCULAR	 
MIM155720	#	 	MELANOMA, UVEAL	 
MIM155730	*	4q12-q13	CHEMOKINE, CXC MOTIF, LIGAND 1; CXCL1	2919
MIM155735	*	 	MELANOMA ADHESION MOLECULE; MCAM	4162
MIM155740	*	12q12-q13	CD63 ANTIGEN; CD63	967
MIM155750	*	3q29	MELANOMA-ASSOCIATED ANTIGEN p97; MFI2	4241
MIM155755	#	9p21	MELANOMA-ASTROCYTOMA SYNDROME	1029
MIM155760	*	15q26.1	AGGRECAN; ACAN	176
MIM155800	%	 	MELANOSIS, UNIVERSAL	 
MIM155900	%	9p11	MELKERSSON-ROSENTHAL SYNDROME	8011
MIM155950	%	12q14	MELORHEOSTOSIS, ISOLATED	23592
MIM155970	*	3q12-q13	MEMBRANE GLYCOPROTEIN MRC OX-2; MOX2	4345
MIM155980	%	 	MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	 
MIM156000		 	MENIERE DISEASE	 
MIM156100	*	22q12.3-qter	MENINGIOMA 1 GENE; MN1	4330
MIM156190		 	MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	 
MIM156200	#	2q23.1	MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1	100820633, 55777
MIM156220		 	MERALGIA PARAESTHETICA, FAMILIAL	 
MIM156225	*	6q22-q23	LAMININ, ALPHA-2; LAMA2	3908
MIM156230	%	 	MESOMELIC DWARFISM OF HYPOPLASTIC TIBIA AND RADIUS TYPE	 
MIM156232	%	2q24-q32	MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	10305
MIM156240	#	9p	MESOTHELIOMA, MALIGNANT; MESOM	338340, 7490, 8915
MIM156250	#	12q24.1	METACHONDROMATOSIS; METCDS	5781
MIM156349	*	16q13	METALLOTHIONEIN 1B; MT1B	4490
MIM156350	*	16q13	METALLOTHIONEIN 1A; MT1A	4489
MIM156351	*	16q13	METALLOTHIONEIN 1E; MT1E	4493
MIM156352	*	16q13	METALLOTHIONEIN 1F; MT1F	4494
MIM156353	*	16q13	METALLOTHIONEIN 1G; MT1G	4495
MIM156354	*	16q13	METALLOTHIONEIN 1H; MT1H	4496
MIM156355	*	16q13	METALLOTHIONEIN 1I; MT1I	644314
MIM156356	*	16q13	METALLOTHIONEIN 1J; MT1J	4498
MIM156357	*	16q13	METALLOTHIONEIN 1K; MT1K	4499
MIM156358	*	16q13	METALLOTHIONEIN 1L; MT1L	4500
MIM156359	*	16q13	METALLOTHIONEIN 1X; MT1X	4501
MIM156360	*	16q13	METALLOTHIONEIN 2A; MT2A	4502
MIM156400	#	3p22-p21.1	METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	5745
MIM156490	*	17q21.3	NONMETASTATIC CELLS 1, PROTEIN EXPRESSED IN; NME1	4830
MIM156491	*	17q21.3	NONMETASTATIC CELLS 2, PROTEIN EXPRESSED IN; NME2	4831
MIM156500	#	 	METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE; MCDS	1300
MIM156510	#	 	METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	 
MIM156520	%	 	METATARSUS VARUS, TYPE I	 
MIM156530	#	12q24.1	METATROPIC DYSPLASIA	59341
MIM156535	*	18q21.1	METHYL-CpG-BINDING DOMAIN PROTEIN 1; MBD1	4152
MIM156540	*	9p21	METHYLTHIOADENOSINE PHOSPHORYLASE; MTAP	4507
MIM156550	#	12q13.11-q13.2	KNIEST DYSPLASIA	1280
MIM156560	*	Chr.12	METHIONYL-tRNA SYNTHETASE; MARS	4141
MIM156565	*	16pter-p13.3	N-@METHYLPURINE DNA GLYCOSYLASE; MPG	4350
MIM156569	*	10q26	METHYLGUANINE-DNA METHYLTRANSFERASE; MGMT	4255
MIM156570	*	1q43	5-@METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; MTR	4548
MIM156575	^	 	MOVED TO 600682	 
MIM156580	%	 	MICROCEPHALY, AUTOSOMAL DOMINANT	 
MIM156590	^	 	MOVED TO 152950	 
MIM156600	%	13q31-q32	MICROCORIA, CONGENITAL	8104
MIM156610	%	 	SKIN CREASES, MULTIPLE BENIGN RING-SHAPED, OF LIMBS	 
MIM156620		 	MICROCEPHALY-DEAFNESS SYNDROME	 
MIM156700		 	MICROCORNEA, GLAUCOMA, AND ABSENT FRONTAL SINUSES	 
MIM156790	*	1p36.1-p35	MICROFIBRILLAR-ASSOCIATED PROTEIN 2; MFAP2	4237
MIM156810		 	MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	 
MIM156830		 	MICROMELIC BONE DYSPLASIA WITH CLOVERLEAF SKULL	 
MIM156845	*	3p14.1-p12.3	MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MITF	4286
MIM156850	%	16p13.3	MICROPHTHALMIA, ISOLATED, WITH CATARACT 1; MCOPCT1	8130
MIM156900		 	MICROPHTHALMIA, ISOLATED, WITH CORECTOPIA; MCOPCR	 
MIM157100	^	 	MOVED TO 193220	 
MIM157129	*	5q13	MICROTUBULE-ASSOCIATED PROTEIN 1B; MAP1B	4131
MIM157130	*	2q34-q35	MICROTUBULE-ASSOCIATED PROTEIN 2; MAP2	4133
MIM157132	*	3p21	MICROTUBULE-ASSOCIATED PROTEIN 4; MAP4	4134
MIM157140	*	17q21.1	MICROTUBULE-ASSOCIATED PROTEIN TAU; MAPT	4137
MIM157145	*	10q11.2	MICROSEMINOPROTEIN, BETA; MSMB	4477
MIM157147	*	4q22-q24	MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN, 88-KD; MTP	4547
MIM157150		 	MICROSPHEROPHAKIA WITH HERNIA	 
MIM157151		 	MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	 
MIM157170	#	2p21	HOLOPROSENCEPHALY 2; HPE2	6496
MIM157200		 	MIDPHALANGEAL HAIR	 
MIM157300	%	6q25.1, 6p21.3, 4q31.2, 4q24	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	1909, 192115, 2099, 7124
MIM157400	%	 	MILIA, MULTIPLE ERUPTIVE	 
MIM157560	*	1q23	MINISATELLITE 33.6	7824
MIM157600	#	18q21.3	MIRROR MOVEMENTS 1; MRMV1	1630
MIM157640	#	15q25	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 1; PEOA1	5428
MIM157655	*	2q33-q34	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 1; NDUFS1	4719
MIM157660	*	9p21-p12	MITOCHONDRIAL RNA-PROCESSING ENDORIBONUCLEASE, RNA COMPONENT OF; RMRP	6023
MIM157680	*	5q31	CELL DIVISION CYCLE 25C; CDC25C	995
MIM157700	%	16p12.1-p11.2	MITRAL VALVE PROLAPSE, FAMILIAL; MVP	50951
MIM157800		 	MITRAL REGURGITATION, CONDUCTIVE DEAFNESS, AND FUSION OF CERVICAL VERTEBRAE AND OF CARPAL AND TARSAL BONES	 
MIM157860	^	 	MOVED TO 142860	 
MIM157900	%	13q12.2-q13	MOEBIUS SYNDROME; MBS	4156
MIM157910	^	 	MOVED TO 157900	 
MIM157950	%	 	PERMANENT MOLARS, SECONDARY RETENTION OF	 
MIM157960		5p14	MOLONEY LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF; MLVI2	4309
MIM157970	*	16q23-q24	PROTEASOME 26S SUBUNIT, NON-ATPase, 7; PSMD7	5713
MIM157980		 	MOMO SYNDROME	 
MIM158000	#	12q13, 12q13, 12q13	MONILETHRIX	3887, 3889, 3892
MIM158050		Chr.6	MONKEY RED BLOOD CELL RECEPTOR; MRBC	7960
MIM158070	*	11q13	SOLUTE CARRIER FAMILY 3 (ACTIVATOR OF DIBASIC AND NEUTRAL AMINO ACID TRANSPORT), MEMBER 2; SLC3A2	6520
MIM158100		 	MONOPHALANGY OF GREAT TOE	 
MIM158105	+	17q11.2-q12	CHEMOKINE, CC MOTIF, LIGAND 2; CCL2	6347
MIM158106	*	17q11.2-q12	CHEMOKINE, CC MOTIF, LIGAND 7; CCL7	6354
MIM158120	*	5q31.1	MONOCYTE DIFFERENTIATION ANTIGEN CD14; CD14	929
MIM158170	#	9p	CHROMOSOME 9p DELETION SYNDROME	100240748
MIM158250		 	NONDISJUNCTION	 
MIM158270	*	6p21.3	MOTILIN; MLN	4295
MIM158280		 	MOTION SICKNESS	 
MIM158300	#	17p13.1	ARTHROGRYPOSIS, DISTAL, TYPE 7; DA7	4626
MIM158310	%	 	MUCOEPITHELIAL DYSPLASIA, HEREDITARY	 
MIM158320	#	3p21.3, 2p22-p21	MUIR-TORRE SYNDROME; MRTES	4292, 4436
MIM158330	#	1p35	MULLERIAN APLASIA AND HYPERANDROGENISM	54361
MIM158340	*	1q21	MUCIN 1, TRANSMEMBRANE; MUC1	4582
MIM158343	*	16p13.1	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 1; ABCC1	4363
MIM158345		 	MULTIPLE EXOSTOSES WITH SPASTIC TETRAPARESIS	 
MIM158350	#	10q23.31	COWDEN DISEASE; CD	5728
MIM158370	*	11p15.5	MUCIN 2, INTESTINAL; MUC2	4583
MIM158371	*	7q22	MUCIN 3A, INTESTINAL; MUC3A	4584
MIM158372	*	3q29	MUCIN 4, TRACHEOBRONCHIAL; MUC4	4585
MIM158373	*	11p15.5	MUCIN 5, SUBTYPES A AND C, TRACHEOBRONCHIAL; MUC5AC	4586
MIM158374	*	11p15.5-p15.4	MUCIN 6, GASTRIC; MUC6	4588
MIM158375	*	4q13-q21	MUCIN 7, SALIVARY; MUC7	4589
MIM158378	*	8p12-q12	SOLUTE CARRIER FAMILY 20 (PHOSPHATE TRANSPORTER), MEMBER 2; SLC20A2	6575
MIM158380	*	17q11.2	ECOTROPIC VIRAL INTEGRATION SITE 2A; EVI2A	2123
MIM158381	*	17q11.2	ECOTROPIC VIRAL INTEGRATION SITE 2B; EVI2B	2124
MIM158400	%	 	MUSCLE CRAMPS, FAMILIAL	 
MIM158500	%	 	MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	 
MIM158580	#	2q14	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA; HMN7A	50952
MIM158590	#	12q24	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A	26353
MIM158600	#	14q32	SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY, AUTOSOMAL DOMINANT; SMALED	100529225, 1778
MIM158650		 	MUSCULAR ATROPHY, MALIGNANT NEUROGENIC	 
MIM158700	^	 	MOVED TO 105400	 
MIM158800		 	MUSCULAR DYSTROPHY, BARNES TYPE	 
MIM158810	#	2q37, 21q22.3, 21q22.3	BETHLEM MYOPATHY	1291, 1292, 1293
MIM158900	#	4q35	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A; FSHMD1A	22947, 2483, 2489
MIM158901	#	 	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1B; FSHMD1B	2490
MIM159000	#	5q31	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1A; LGMD1A	9499
MIM159001	#	1q21.2	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1B; LGMD1B	4000
MIM159050	%	 	MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC, WITH INTERNALIZED CAPILLARIES	 
MIM159100		 	MUSCULAR HYPOPLASIA, CONGENITAL UNIVERSAL, OF KRABBE	 
MIM159300	%	 	MUSICAL PERFECT PITCH	 
MIM159350	*	5q21	MUTATED IN COLORECTAL CANCERS; MCC	4163
MIM159400		 	MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	 
MIM159405	*	8q22	V-MYB AVIAN MYELOBLASTOSIS VIRAL ONCOGENE HOMOLOG-LIKE 1; MYBL1	4603
MIM159410		 	MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	 
MIM159420		 	MYDRIASIS, CONGENITAL	 
MIM159430	*	18q22-qter	MYELIN BASIC PROTEIN; MBP	4155
MIM159440	*	1q22	MYELIN PROTEIN ZERO; MPZ	4359
MIM159460	*	19q13.1	MYELIN-ASSOCIATED GLYCOPROTEIN; MAG	4099
MIM159465	*	6p21.3	MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; MOG	4340
MIM159500		 	MYELINATED OPTIC NERVE FIBERS	 
MIM159530	*	1p34	MYELOPROLIFERATIVE LEUKEMIA VIRUS ONCOGENE; MPL	4352
MIM159540	*	22q12.1-q12.2	LEUKEMIA-INHIBITORY FACTOR; LIF	3976
MIM159550		 	MYELOCEREBELLAR DISORDER	 
MIM159552	*	1q21	MYELOID CELL LEUKEMIA SEQUENCE 1; MCL1	4170
MIM159553	*	1q22	MYELOID CELL NUCLEAR DIFFERENTIATION ANTIGEN; MNDA	4332
MIM159555	+	11q23	MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA GENE; MLL	4297
MIM159556	*	19p13.3	MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 1; MLLT1	4298
MIM159557	*	4q21	AF4/FMR2 FAMILY, MEMBER 1; AFF1	4299
MIM159558	*	9p22	MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 3; MLLT3	4300
MIM159559	*	6q27	MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 4; MLLT4	4301
MIM159580		 	MYELOPATHY, HTLV-1-ASSOCIATED; HAM	 
MIM159590	*	19q13.3-q13.4	CD33 ANTIGEN; CD33	945
MIM159595	%	21q11.2	MYELOPROLIFERATIVE SYNDROME, TRANSIENT	8205
MIM159600	%	 	MYOCLONIC EPILEPSY, HARTUNG TYPE	 
MIM159700		 	MYOCLONUS AND ATAXIA	 
MIM159800		 	MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	 
MIM159900	#	11q23.1, 7q21	MYOCLONIC DYSTONIA	1813, 8910
MIM159950	#	 	SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY; SMAPME	427
MIM159970	*	11p15.4	MYOGENIC DIFFERENTIATION ANTIGEN 1; MYOD1	4654
MIM159980	*	1q31-q41	MYOGENIC FACTOR 4; MYOG	4656
MIM159990	*	12q21	MYOGENIC FACTOR 5; MYF5	4617
MIM159991	*	12q21	MYOGENIC FACTOR 6; MYF6	4618
MIM160000	*	22q11.2-q13	MYOGLOBIN; MB	4151
MIM160010	%	 	MYOGLOBINURIA, AUTOSOMAL DOMINANT	 
MIM160120	#	12p13	EPISODIC ATAXIA, TYPE 1; EA1	3736
MIM160150	#	12q21, 3p25.3, 19p13.2	MYOPATHY, CENTRONUCLEAR, 1; CNM1	1785, 4618, 64419
MIM160200	^	 	MOVED TO 161800	 
MIM160300	%	 	MYOPATHY, DISTAL, WITH ONSET IN INFANCY	 
MIM160500	#	14q12	MYOPATHY, DISTAL, 1; MPD1	4625
MIM160550	^	 	MOVED TO 157640	 
MIM160565	#	 	MYOPATHY, TUBULAR AGGREGATE	 
MIM160700	%	18p11.31	MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	4658
MIM160710	*	14q12	MYOSIN, HEAVY CHAIN 6, CARDIAC MUSCLE, ALPHA; MYH6	4624
MIM160720	*	17p13.1	MYOSIN, HEAVY CHAIN 3, SKELETAL MUSCLE, EMBRYONIC; MYH3	4621
MIM160730	*	17p13.1	MYOSIN, HEAVY CHAIN 1, SKELETAL MUSCLE, ADULT; MYH1	4619
MIM160740	*	17p13.1	MYOSIN, HEAVY CHAIN 2, SKELETAL MUSCLE, ADULT; MYH2	4620
MIM160741	*	17p13.1	MYOSIN, HEAVY CHAIN 8, SKELETAL MUSCLE, PERINATAL; MYH8	4626
MIM160742	*	17p13.1	MYOSIN, HEAVY CHAIN 4, SKELETAL MUSCLE; MYH4	4622
MIM160745	*	16p13.13-p13.12	MYOSIN, HEAVY CHAIN 11, SMOOTH MUSCLE; MYH11	4629
MIM160750	%	 	MYOSITIS	 
MIM160760	*	14q12	MYOSIN, HEAVY CHAIN 7, CARDIAC MUSCLE, BETA; MYH7	4625
MIM160770	*	Chr.17	MYOSIN, LIGHT CHAIN 4, ALKALI, ATRIAL, EMBRYONIC; MYL4	4635
MIM160775	*	22q11.2	MYOSIN, HEAVY CHAIN 9, NONMUSCLE; MYH9	4627
MIM160776	*	17p13	MYOSIN, HEAVY CHAIN 10, NONMUSCLE; MYH10	4628
MIM160777	*	15q21	MYOSIN VA; MYO5A	4644
MIM160780	*	2q32.1-qter	MYOSIN, LIGHT POLYPEPTIDE 1, ALKALI, SKELETAL, FAST; MYL1	4632
MIM160781	*	12q23-q24.3	MYOSIN, LIGHT CHAIN 2, REGULATORY, CARDIAC, SLOW; MYL2	4633
MIM160782	*	4p16.3	MYOSIN, LIGHT CHAIN 5, REGULATORY; MYL5	4636
MIM160790	*	3p	MYOSIN, LIGHT CHAIN 3, ALKALI, VENTRICULAR, SKELETAL, SLOW; MYL3	4634
MIM160793	*	19q13.33	MYOSIN-BINDING PROTEIN C, FAST TYPE; MYBPC2	4606
MIM160794	*	Chr.12	MYOSIN-BINDING PROTEIN C, SLOW TYPE; MYBPC1	4604
MIM160795	*	1q32.1	MYOSIN-BINDING PROTEIN H; MYBPH	4608
MIM160800	#	7q35	MYOTONIA CONGENITA, AUTOSOMAL DOMINANT	1180
MIM160900	#	19q13.2-q13.3	MYOTONIC DYSTROPHY 1; DM1	1760
MIM160980	#	17q23-q24	CARNEY COMPLEX, TYPE 1; CNC1	5573
MIM160990		 	MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	 
MIM160993	*	17q21.31	N-MYRISTOYLTRANSFERASE 1; NMT1	4836
MIM160994	*	19p13.3-p13.2	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN M; HNRNPM	4670
MIM160995	*	5q35	ALPHA-1,3-@MANNOSYL-GLYCOPROTEIN BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE; MGAT1	4245
MIM160998	*	6p25	NAD(P)H DEHYDROGENASE, QUINONE 2; NQO2	4835
MIM161000	#	17q12-q21	NAEGELI SYNDROME	3861
MIM161015	*	11q13	NADH-UBIQUINONE OXIDOREDUCTASE FLAVOPROTEIN 1; NDUFV1	4723
MIM161050	%	 	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 1; NDNC1	 
MIM161100		 	NAILBEDS, PIGMENTATION OF	 
MIM161200	#	9q34.1	NAIL-PATELLA SYNDROME; NPS	4010
MIM161400	#	17q21	NARCOLEPSY 1; NRCLP1	3060
MIM161470		 	NASAL ALAR COLLAPSE, BILATERAL	 
MIM161480		 	NASAL BONES, ABSENCE OF	 
MIM161500	%	 	NASAL GROOVE, FAMILIAL TRANSVERSE	 
MIM161530		 	NASAL HYPERPIGMENTATION, FAMILIAL TRANSVERSE	 
MIM161550	%	6p21.3	NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 2	100312951
MIM161555	*	12p13.2-p12.3	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 1; KLRC1	3821
MIM161560	*	3p12-q13.2	INTERLEUKIN 12A; IL12A	3592
MIM161561	*	5q31.1-q33.1	INTERLEUKIN 12B; IL12B	3593
MIM161565	*	3p23-p21	NATURAL KILLER TUMOR RECOGNITION SEQUENCE; NKTR	4820
MIM161600		 	NAVICULAR BONE, ACCESSORY	 
MIM161650	*	2q22	NEBULIN; NEB	4703
MIM161700		 	NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	 
MIM161800	#	1q42.1	NEMALINE MYOPATHY 3; NEM3	58
MIM161900	%	1q21	RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION	59331
MIM161950	%	1q23-q25, 1q23-q25, 6q22-q23, 1q31-q42	IgA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	5284, 60498, 6401, 6402
MIM162000	#	16p12.3	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1; HNFJ1	7369
MIM162010	*	17q21-q22	NERVE GROWTH FACTOR RECEPTOR; NGFR	4804
MIM162030	*	1p13.1	NERVE GROWTH FACTOR, BETA SUBUNIT; NGFB	4803
MIM162040	^	19q13.3	NERVE GROWTH FACTOR, GAMMA SUBUNIT; NGFG	8188
MIM162060	*	3q13	GROWTH-ASSOCIATED PROTEIN 43; GAP43	2596
MIM162080	+	14q11.1-q11.2	NEURAL RETINA LEUCINE ZIPPER; NRL	4901
MIM162091	#	22q12.2	SCHWANNOMATOSIS	4771
MIM162095	*	7q33	PLEIOTROPHIN; PTN	5764
MIM162096	*	11p11.2	MIDKINE; MDK	4192
MIM162100	#	17q25	AMYOTROPHY, HEREDITARY NEURALGIC; HNA	10801
MIM162150	*	5q15-q21	PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 1; PCSK1	5122
MIM162151	*	20p11.2	PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 2; PCSK2	5126
MIM162200	#	17q11.2	NEUROFIBROMATOSIS, TYPE I; NF1	4763
MIM162210	#	17q11.2	NEUROFIBROMATOSIS, FAMILIAL SPINAL	4763
MIM162220	^	 	MOVED TO 162200 AND 606764	 
MIM162230	*	22q12.2	NEUROFILAMENT PROTEIN, HEAVY POLYPEPTIDE; NEFH	4744
MIM162240		 	NEUROFIBROMATOSIS-PHEOCHROMOCYTOMA-DUODENAL CARCINOID SYNDROME	 
MIM162250	*	8p21	NEUROFILAMENT 3; NEF3	4741
MIM162260		 	NEUROFIBROMATOSIS, TYPE III, MIXED CENTRAL AND PERIPHERAL; NF3A	 
MIM162270		 	NEUROFIBROMATOSIS, TYPE IV, OF RICCARDI; NF4	 
MIM162280	*	8p21	NEUROFILAMENT PROTEIN, LIGHT POLYPEPTIDE; NEFL	4747
MIM162300	#	10q11.2	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	5979
MIM162320	*	7q21-q22	TACHYKININ 1; TAC1	6863
MIM162321	*	10q11-q21	TACHYKININ RECEPTOR 2; TACR2	6865
MIM162323	*	2p11	TACHYKININ RECEPTOR 1; TACR1	6869
MIM162330	*	12q13-q21	TACHYKININ 3; TAC3	6866
MIM162332	*	4q25	TACHYKININ RECEPTOR 3; TACR3	6870
MIM162340	*	15q22-qter	NEUROMEDIN B; NMB	4828
MIM162341	*	6q21-qter	NEUROMEDIN B RECEPTOR; NMBR	4829
MIM162350	#	 	CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	80331
MIM162360	*	1q22	NESCIENT HELIX LOOP HELIX 1; NHLH1	4807
MIM162361	*	1p12-p11	NESCIENT HELIX LOOP HELIX 2; NHLH2	4808
MIM162370	%	 	NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	 
MIM162380		 	NEUROPATHY, HEREDITARY SENSORIMOTOR, WITH UPPER MOTOR NEURON, VISUAL PATHWAY AND AUTONOMIC DISTURBANCE	 
MIM162400	#	9q22.1-q22.3	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	10558
MIM162500	#	17p11.2	NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP	5376
MIM162640	*	7p15.1	NEUROPEPTIDE Y; NPY	4852
MIM162641	*	4q31.3-q32	NEUROPEPTIDE Y RECEPTOR Y1; NPY1R	4886
MIM162642	*	4q31	NEUROPEPTIDE Y RECEPTOR Y2; NPY2R	4887
MIM162643	*	2q21	CHEMOKINE, CXC MOTIF, RECEPTOR 4; CXCR4	7852
MIM162650	*	12q21	NEUROTENSIN; NTS	4922
MIM162651	*	20q13	NEUROTENSIN RECEPTOR 1; NTSR1	4923
MIM162660	*	12p13	NEUROTROPHIN 3; NTF3	4908
MIM162662	*	19q13.3	NEUROTROPHIN 4; NTF4	4909
MIM162700	%	 	NEUTROPENIA, CHRONIC FAMILIAL	 
MIM162800	#	19p13.3	CYCLIC NEUTROPENIA	1991, 51119
MIM162815	*	19p13.3	NEUTROPHIL AZUROCIDIN; NAZC	566
MIM162820	%	7q22-qter	NEUTROPHIL MIGRATION; NM	4827
MIM162830	#	1p35-p34.3	NEUTROPHILIA, HEREDITARY	1441
MIM162860	*	19q13.2	NEUTROPHIL-SPECIFIC ANTIGEN 1	57126
MIM162900	#	4p16.3, 3q26.3	NEVUS, EPIDERMAL	2261, 3265, 5290
MIM163000	#	5q13-q22	CAPILLARY MALFORMATIONS, CONGENITAL, 1	246230
MIM163050		 	NEVUS ANEMICUS	 
MIM163100	%	 	NEVUS FLAMMEUS OF NAPE OF NECK	 
MIM163200	#	 	SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	3265, 3845
MIM163260	*	17q21.3	NUCLEAR FACTOR ERYTHROID 2-LIKE 1; NFE2L1	4779
MIM163400	%	 	NIEVERGELT SYNDROME	 
MIM163500	#	4p16.3	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2; CSNBAD2	5158
MIM163600		 	NIPPLES INVERTED	 
MIM163700	%	 	NIPPLES, SUPERNUMERARY	 
MIM163729	+	7q36	NITRIC OXIDE SYNTHASE 3; NOS3	4846
MIM163730	*	17cen-q11.2	NITRIC OXIDE SYNTHASE 2A; NOS2A	4843
MIM163731	*	12q24.2-q24.31	NITRIC OXIDE SYNTHASE 1; NOS1	4842
MIM163800	#	15q24-q25	SICK SINUS SYNDROME 2, AUTOSOMAL DOMINANT; SSS2	10021
MIM163850		 	NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	 
MIM163890	*	4q21	SYNUCLEIN, ALPHA; SNCA	6622
MIM163905	*	13q12	HIGH MOBILITY GROUP BOX 1; HMGB1	3146
MIM163906	*	4q31	HIGH MOBILITY GROUP BOX 2; HMGB2	3148
MIM163910	*	1p36.1	HIGH MOBILITY GROUP NUCLEOSOMAL BINDING PROTEIN 2; HMGN2	3151
MIM163920	*	21q22.3	HIGH MOBILITY GROUP NUCLEOSOMAL BINDING PROTEIN 1; HMGN1	3150
MIM163950	#	12q24.1	NOONAN SYNDROME 1; NS1	5781
MIM163955	^	 	MOVED TO 163950 AND 610733	 
MIM163970	*	16q12.2	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, NORADRENALINE), MEMBER 2; SLC6A2	6530
MIM163980	*	19q13.2	CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 6; CEACAM6	4680
MIM164000		 	NOSE, ANOMALOUS SHAPE OF	 
MIM164005	*	19p13.3	NUCLEAR FACTOR I/X; NFIX	4784
MIM164008	*	14q13	NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS INHIBITOR, ALPHA; NFKBIA	4792
MIM164009	*	11q13	NUCLEAR MITOTIC APPARATUS PROTEIN 1; NUMA1	4926
MIM164010	*	16q24.3	CHMP FAMILY, MEMBER 1A; CHMP1A	5119
MIM164011	*	4q23-q24	NUCLEAR FACTOR KAPPA-B, SUBUNIT 1; NFKB1	4790
MIM164012	*	10q24	NUCLEAR FACTOR KAPPA-B, SUBUNIT 2; NFKB2	4791
MIM164013	*	11q24-q25	NUCLEAR FACTOR RELATED TO KAPPA-B BINDING PROTEIN; NFRKB	4798
MIM164014	*	11q12-q13	V-REL AVIAN RETICULOENDOTHELIOSIS VIRAL ONCOGENE HOMOLOG A; RELA	5970
MIM164015	*	5q31.2	MATRIN 3; MATR3	9782
MIM164017	*	12q13.1	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1; HNRNPA1	3178
MIM164020	*	 	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C; HNRNPC	3183
MIM164031	*	12p13	NUCLEOLAR PROTEIN 1; NOL1	4839
MIM164035	*	2q12-qter	NUCLEOLIN; NCL	4691
MIM164040	*	5q35	NUCLEOPHOSMIN/NUCLEOPLASMIN FAMILY, MEMBER 1; NPM1	4869
MIM164050	*	14q13.1	PURINE NUCLEOSIDE PHOSPHORYLASE; PNP	4860
MIM164060	*	12q21.2	NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 1; NAP1L1	4673
MIM164100	%	6p12	NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	4933
MIM164150	%	 	NYSTAGMUS, HEREDITARY VERTICAL	 
MIM164160	*	7q31.3	LEPTIN; LEP	3952
MIM164170	%	 	NYSTAGMUS, VOLUNTARY	 
MIM164175	*	1q22-q23	POU DOMAIN, CLASS 2, TRANSCRIPTION FACTOR 1; POU2F1	5451
MIM164176	*	19q13.2	POU DOMAIN, CLASS 2, TRANSCRIPTION FACTOR 2; POU2F2	5452
MIM164177	*	6p21.3	POU DOMAIN, CLASS 5, TRANSCRIPTION FACTOR 1; POU5F1	5460
MIM164180		 	OCULOCEREBROCUTANEOUS SYNDROME	 
MIM164185		 	OCULAR CICATRICIAL PEMPHIGOID; OCP	 
MIM164190		 	OCULAR DOMINANCE	 
MIM164200	#	6q21-q23.2	OCULODENTODIGITAL DYSPLASIA; ODDD	2697
MIM164210	%	14q32	HEMIFACIAL MICROSOMIA; HFM	170474
MIM164220	%	 	SCHILBACH-ROTT SYNDROME	 
MIM164230	#	17q11.1-q12, 13q14-q21, 11p13	OBSESSIVE-COMPULSIVE DISORDER; OCD	3356, 627, 6532
MIM164280	#	2p24.1	FEINGOLD SYNDROME 1; FGLDS1	 
MIM164300	#	14q11.2-q13	OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD	8106
MIM164310	%	 	OCULOPHARYNGODISTAL MYOPATHY; OPDM	 
MIM164320	*	9q34	ODORANT-BINDING PROTEIN 2A; OBP2A	29991
MIM164330		 	ODONTOMA-DYSPHAGIA SYNDROME	 
MIM164340	*	11q13.4-q14.1	OLFACTORY MARKER PROTEIN; OMP	4975
MIM164342	*	17p13.3	OLFACTORY RECEPTOR, FAMILY 1, SUBFAMILY D, MEMBER 2; OR1D2	4991
MIM164343	*	5q34	EARLY B-CELL FACTOR 1; EBF1	1879
MIM164345	*	17q11.2	OLIGODENDROCYTE-MYELIN GLYCOPROTEIN; OMG	4974
MIM164350	*	12q24.2	2-PRIME,5-PRIME-@OLIGOADENYLATE SYNTHETASE 1; OAS1	4938
MIM164360	*	18q12-q21	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, ALPHA SUBUNIT 1; ATP5A1	498
MIM164400	#	6p23	SPINOCEREBELLAR ATAXIA 1; SCA1	6310
MIM164500	#	3p21.1-p12	SPINOCEREBELLAR ATAXIA 7; SCA7	6314
MIM164600	^	 	MOVED TO 164400	 
MIM164680		 	ONYCHOGRYPOSIS, PEDAL, WITH KERATOSIS PLANTARIS AND COARSE HAIR	 
MIM164690	*	1q24-q25	V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 2; ABL2	27
MIM164700		 	OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V	 
MIM164720	*	11q23.3	V-ETS AVIAN ERYTHROBLASTOSIS VIRUS E26 ONCOGENE HOMOLOG 1; ETS1	2113
MIM164730	*	14q32.3	V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 1; AKT1	207
MIM164731	*	19q13.1-q13.2	V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 2; AKT2	208
MIM164740	*	21q22.3	V-ETS AVIAN ERYTHROBLASTOSIS VIRUS E26 ONCOGENE HOMOLOG 2; ETS2	2114
MIM164745	%	 	OMODYSPLASIA 2; OMOD2	 
MIM164750	#	 	OMPHALOCELE, AUTOSOMAL	 
MIM164755	*	2q14-q21	VIRAL INTEGRATION SITE 1; VIS1	7435
MIM164757	*	7q34	V-RAF MURINE SARCOMA VIRAL ONCOGENE HOMOLOG B1; BRAF	673
MIM164760	*	3p25	V-RAF-1 MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; RAF1	5894
MIM164761	+	10q11.2	REARRANGED DURING TRANSFECTION PROTOONCOGENE; RET	5979
MIM164762	*	17p13.3	V-CRK AVIAN SARCOMA VIRUS CT10 ONCOGENE HOMOLOG; CRK	1398
MIM164765	*	11q13	CORTACTIN; CTTN	2017
MIM164770	*	5q33.2-q33.3	COLONY-STIMULATING FACTOR 1 RECEPTOR; CSF1R	1436
MIM164772	*	19q13.3	V-FOS FBJ MURINE OSTEOSARCOMA VIRAL ONCOGENE HOMOLOG B; FOSB	2354
MIM164780	*	1p36.3	V-SKI AVIAN SARCOMA VIRAL ONCOGENE HOMOLOG; SKI	6497
MIM164785	*	12q14.3-q15	MOUSE DOUBLE MINUTE 2 HOMOLOG; MDM2	4193
MIM164790	*	1p13.2	NEUROBLASTOMA RAS VIRAL ONCOGENE HOMOLOG; NRAS	4893
MIM164795	*	7p13-p11	ONCOMODULIN; OCM	654231
MIM164800	%	 	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 5; NDNC5	 
MIM164810	*	14q24.3	V-FOS FBJ MURINE OSTEOSARCOMA VIRAL ONCOGENE HOMOLOG; FOS	2353
MIM164820	*	12q12-q13	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 1; WNT1	7471
MIM164831	*	10p13	LEUKEMIA VIRAL BMI-1 ONCOGENE, MOUSE, HOMOLOG OF; BMI1	648
MIM164840	*	2p24.1	V-MYC AVIAN MYELOCYTOMATOSIS VIRAL-RELATED ONCOGENE, NEUROBLASTOMA-DERIVED; MYCN	4613
MIM164850	*	1p34.3	V-MYC AVIAN MYELOCYTOMATOSIS VIRAL ONCOGENE HOMOLOG 1, LUNG CARCINOMA-DERIVED; MYCL1	4610
MIM164860	*	7q31	MET PROTOONCOGENE; MET	4233
MIM164865	*	7p15	V-MYC AVIAN MYELOCYTOMATOSIS VIRAL ONCOGENE HOMOLOG-LIKE 1; MYCLK1	4612
MIM164870	*	17q21.1	V-ERB-B2 AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 2; ERBB2	2064
MIM164873	*	1q21-q23	ETS VARIANT GENE 3; ETV3	2117
MIM164874	*	14q13	FORKHEAD BOX G1; FOXG1	2290
MIM164875	*	19p13.3-p13.2	VAV1 ONCOGENE; VAV1	7409
MIM164880	*	18p11.3	V-YES-1 YAMAGUCHI SARCOMA VIRAL ONCOGENE; YES1	7525
MIM164900	%	 	OPHTHALMOMANDIBULOMELIC DYSPLASIA	 
MIM164910	*	2p13-p12	V-REL AVIAN RETICULOENDOTHELIOSIS VIRAL ONCOGENE HOMOLOG; REL	5966
MIM164920	*	4q12	V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG; KIT	3815
MIM164940	*	1p36.2-p36.1	GARDNER-RASHEED FELINE SARCOMA VIRAL ONCOGENE HOMOLOG; FGR	2268
MIM164950	*	11q13	FIBROBLAST GROWTH FACTOR 3; FGF3	2248
MIM164951	*	6p21.3	NOTCH, DROSOPHILA, HOMOLOG OF, 4; NOTCH4	4855
MIM164953	*	19p13.2-q13.3	ONCOGENE LIPOSARCOMA; LPSA	8177
MIM164958	*	8q24.1	NEPHROBLASTOMA OVEREXPRESSED GENE; NOV	4856
MIM164960	*	6p21.2	ONCOGENE PIM 1; PIM1	5292
MIM164975	*	3p21-p14	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 5A; WNT5A	7474
MIM164980	*	11q13	FIBROBLAST GROWTH FACTOR 4; FGF4	2249
MIM165000	%	 	OPHTHALMOPLEGIA, FAMILIAL STATIC	 
MIM165020	*	6q22	V-ROS AVIAN UR2 SARCOMA VIRUS ONCOGENE HOMOLOG 1; ROS1	6098
MIM165040	*	19p13.2-cen	RAS-ASSOCIATED PROTEIN RAB8A; RAB8A	4218
MIM165060	*	19q13.2-q13.3	TRANSFER RNA SELENOCYSTEINE 1; TRNAU1	7234
MIM165070	*	13q12	FMS-RELATED TYROSINE KINASE 1; FLT1	2321
MIM165080	*	21q22.3	V-ETS AVIAN ERYTHROBLASTOSIS VIRUS E26 ONCOGENE HOMOLOG; ERG	2078
MIM165090	*	19q13.3-qter	RELATED RAS VIRAL ONCOGENE HOMOLOG; RRAS	6237
MIM165095	*	22q12.1-q12.2	ONCOSTATIN M; OSM	5008
MIM165098		 	OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	 
MIM165110	*	11q13	S13 AVIAN ERYTHROBLASTOSIS ONCOGENE HOMOLOG; SEA	6395
MIM165120	*	8q13-qter	V-YES-1 YAMAGUCHI SARCOMA VIRAL RELATED ONCOGENE HOMOLOG; LYN	4067
MIM165140	*	8q24	ONCOGENE PVT-1; PVT1	5820
MIM165150		 	OPHTHALMOPLEGIA, PROGRESSIVE, WITH SCROTAL TONGUE AND MENTAL DEFICIENCY	 
MIM165160	*	1p32-p31	V-JUN AVIAN SARCOMA VIRUS 17 ONCOGENE HOMOLOG; JUN	3725
MIM165161	*	19p13.2	ONCOGENE JUN-B; JUNB	3726
MIM165162	*	19p13.1-p12	ONCOGENE JUN-D; JUND	3727
MIM165170	*	11p11.2	SPLEEN FOCUS FORMING VIRUS PROVIRAL INTEGRATION ONCOGENE SPI1; SPI1	6688
MIM165180	*	6q24-q27	MAS1 ONCOGENE; MAS1	4142
MIM165190	*	4q21	FIBROBLAST GROWTH FACTOR 5; FGF5	2250
MIM165195	*	1p36.1-p34.3	OPIOID RECEPTOR, DELTA-1; OPRD1	4985
MIM165196	*	8q11.2	OPIOID RECEPTOR, KAPPA-1; OPRK1	4986
MIM165199		 	OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMAL DOMINANT	 
MIM165215	*	3q26	ECOTROPIC VIRAL INTEGRATION SITE 1; EVI1	2122
MIM165220	*	12q13.2-q13.3	GLIOMA-ASSOCIATED ONCOGENE HOMOLOG; GLI	2735
MIM165230	*	2q14	GLI-KRUPPEL FAMILY MEMBER 2; GLI2	2736
MIM165240	*	7p13	GLI-KRUPPEL FAMILY MEMBER 3; GLI3	2737
MIM165250	*	19q13.12	GLI-KRUPPEL FAMILY MEMBER HKR1; HKR1	284459
MIM165260	*	19q13.43	ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 22; ZSCAN22	342945
MIM165270	*	1p36.3	GLI-KRUPPEL FAMILY MEMBER HKR3; HKR3	3104
MIM165280	*	8q24.3	GLI-KRUPPEL FAMILY MEMBER 4; GLI4	2738
MIM165300	#	19q13.2-q13.3	OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	80207
MIM165320	*	2q14-q21	LIVER CANCER ONCOGENE; LCO	3935
MIM165330	*	17q21	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 3; WNT3	7473
MIM165340	*	 	SKI-LIKE; SKIL	6498
MIM165360	*	11q23.3	CAS-BR-M MURINE ECOTROPIC RETROVIRAL TRANSFORMING SEQUENCE HOMOLOG; CBL	867
MIM165370	*	2pter-p12	RAS HOMOLOG GENE FAMILY, MEMBER B; RHOB	388
MIM165380	*	1p21-p13	RAS HOMOLOG GENE FAMILY, MEMBER C; RHOC	389
MIM165390	*	3p21.3	RAS HOMOLOG GENE FAMILY, MEMBER A; RHOA	387
MIM165490	^	 	MOVED TO 165500	 
MIM165500	#	3q28-q29	OPTIC ATROPHY 1; OPA1	4976
MIM165510		 	OPTIC ATROPHY WITH NEGATIVE ELECTRORETINOGRAMS	 
MIM165550	#	11p13	OPTIC NERVE HYPOPLASIA, BILATERAL	5080
MIM165590		 	OROFACIODIGITAL SYNDROME X; OFD10	 
MIM165600		 	ORBITAL MARGIN, HYPOPLASIA OF	 
MIM165630	^	 	MOVED TO 163200	 
MIM165640	*	2p25	ORNITHINE DECARBOXYLASE 1; ODC1	4953
MIM165660	%	 	OSLAM SYNDROME	 
MIM165670		 	OSSIFIED EAR CARTILAGES	 
MIM165680		 	OSSICULAR MALFORMATIONS, FAMILIAL	 
MIM165700	%	 	THIEMANN DISEASE	 
MIM165720	#	2q31-q33	OSTEOARTHRITIS SUSCEPTIBILITY 1; OS1	2487
MIM165800	#	15q26.1	OSTEOCHONDRITIS DISSECANS, SHORT STATURE, AND EARLY-ONSET OSTEOARTHRITIS; OD	176
MIM166000	%	 	ENCHONDROMATOSIS, MULTIPLE, OLLIER TYPE	 
MIM166200	#	17q21.31-q22	OSTEOGENESIS IMPERFECTA, TYPE I	1277
MIM166210	#	7q22.1, 17q21.31-q22	OSTEOGENESIS IMPERFECTA, TYPE II	1277, 1278
MIM166220	#	7q22.1, 17q21.31-q22	OSTEOGENESIS IMPERFECTA, TYPE IV	1277, 1278
MIM166230		 	OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES	 
MIM166240	^	 	MOVED TO 166200	 
MIM166250	#	8p11.2-p11.1	OSTEOGLOPHONIC DYSPLASIA; OGD	2260
MIM166260	#	11p14.3	GNATHODIAPHYSEAL DYSPLASIA; GDD	203859
MIM166300	#	 	MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	9935
MIM166350	#	20q13.2	OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	2778
MIM166400		 	OSTEOMAS OF MANDIBLE	 
MIM166450		 	OSTEOMESOPYKNOSIS	 
MIM166490	*	4q21-q25	SECRETED PHOSPHOPROTEIN 1; SPP1	6696
MIM166500	^	 	MOVED TO 300373	 
MIM166600	#	16p13	OSTEOPETROSIS, AUTOSOMAL DOMINANT 2; OPTA2	1186
MIM166700	#	12q14	BUSCHKE-OLLENDORFF SYNDROME; BOS	23592
MIM166705		 	OSTEOPOIKILOSIS AND DACRYOCYSTITIS	 
MIM166710	#	12q12-q14, 11q13.4, 11p12, 7q22.1, 7q21.3, 5q31.1, 20p12.3, 17q21.31-q22	OSTEOPOROSIS	1277, 1278, 4041, 7421, 799, 8572
MIM166740		 	OSTEOSCLEROSIS WITH ICHTHYOSIS AND FRACTURES	 
MIM166750	#	 	OTODENTAL DYSPLASIA	100885788
MIM166760	%	10q26.3	OTITIS MEDIA, SUSCEPTIBILITY TO	619538
MIM166780	#	8q13.3	OTOFACIOCERVICAL SYNDROME	2138
MIM166800	%	15q26.1-qter	OTOSCLEROSIS 1; OTSC1	5012
MIM166900		 	OVALOCYTOSIS, HEREDITARY HEMOLYTIC	 
MIM166910		 	OVALOCYTOSIS, HEREDITARY HEMOLYTIC, WITH DEFECTIVE ERYTHROPOIESIS	 
MIM166945	*	17q21.1	NEIGHBOR OF BRCA1 GENE 1; NBR1	4077
MIM166950		 	TERATOMA, OVARIAN	 
MIM166970		 	OVARIAN FIBROMATA	 
MIM166990		 	OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA, HYDROCEPHALUS, AND HYPERTENSION	 
MIM167000	#	16q22.1, 11q25, 6q26-q27, 3p22-p21.3	OVARIAN CANCER	1499, 207, 4978, 5071, 5290, 6765, 999
MIM167040	*	11q12.1	OXYSTEROL-BINDING PROTEIN; OSBP	5007
MIM167050	*	20p13	OXYTOCIN; OXT	5020
MIM167055	*	3p26.2	OXYTOCIN RECEPTOR; OXTR	5021
MIM167100	%	 	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT; PHOAD	 
MIM167200	#	17q12-q21, 12q13	PACHYONYCHIA CONGENITA, TYPE 1; PC1	3853, 3868
MIM167210	#	17q12-q21, 12q13	PACHYONYCHIA CONGENITA, TYPE 2; PC2	3854, 3872
MIM167220		 	PACMAN DYSPLASIA	 
MIM167250		6p21.3	PAGET DISEASE OF BONE 1; PDB1	5131
MIM167320	#	9p13-p12	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA; IBMPFD	7415
MIM167400	#	2q24	PAROXYSMAL EXTREME PAIN DISORDER	6335
MIM167405	*	15q26	PAIRED BASIC AMINO ACID CLEAVING ENZYME 4; PACE4	5046
MIM167409	*	10q24.3-q25.1	PAIRED BOX GENE 2; PAX2	5076
MIM167410	*	1p36.2-p36.12	PAIRED BOX GENE 7; PAX7	5081
MIM167411	*	20p11.2	PAIRED BOX GENE 1; PAX1	5075
MIM167413	*	7q32	PAIRED BOX GENE 4; PAX4	5078
MIM167414	*	9p13	PAIRED BOX GENE 5; PAX5	5079
MIM167415	*	2q12-q14	PAIRED BOX GENE 8; PAX8	7849
MIM167416	*	14q12-q13	PAIRED BOX GENE 9; PAX9	5083
MIM167420	*	1q24	PAIRED-RELATED HOMEOBOX GENE 1; PRRX1	5396
MIM167500	%	 	PALATOPHARYNGEAL INCOMPETENCE	 
MIM167600		 	PALMARIS LONGUS MUSCLE, ABSENCE OF	 
MIM167700		 	PALMOMENTAL REFLEX	 
MIM167730	%	 	PALPEBRAL COLOBOMA-LIPOMA SYNDROME	 
MIM167750		 	PANCREAS, ANNULAR	 
MIM167755		 	PANCREAS, DORSAL, AGENESIS OF	 
MIM167770	*	2p12	REGENERATING ISLET-DERIVED 1-ALPHA; REG1A	5967
MIM167771	*	2p12	REGENERATING ISLET-DERIVED 1-BETA; REG1B	5968
MIM167780	*	17q12-q21	PANCREATIC POLYPEPTIDE/PANCREATIC ICOSAPEPTIDE; PPY	5539
MIM167790	*	5q32	SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 1; SPINK1	6690
MIM167800	#	1p36.21, 7q35, 7q31.2, 5q32	PANCREATITIS, HEREDITARY; PCTT	1080, 11330, 5644, 5645, 6690
MIM167805	*	2p12	REGENERATING ISLET-DERIVED 3-ALPHA; REG3A	5068
MIM167870	%	13q22-q32, 22q11.2	PANIC DISORDER 1; PAND1	1312, 387572
MIM167900	%	 	PAPILLOMATOSIS, CONFLUENT AND RETICULATED; CARP	 
MIM167950		 	PAPILLOMATOSIS, FLORID, OF NIPPLE	 
MIM167959		8q24	HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 1; HPV18I1	3260
MIM167960		12q13	HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 2; HPV18I2	3261
MIM168000	#	11q23	PARAGANGLIOMAS 1; PGL1	6392
MIM168100		 	PARALYSIS AGITANS, JUVENILE, OF HUNT	 
MIM168200		 	PARAMOLAR TUBERCLE OF BOLK	 
MIM168300	#	17q23.1-q25.3	PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC	6329
MIM168360	*	1p34	EMBRYONIC LETHAL, ABNORMAL VISION, DROSOPHILA, HOMOLOG-LIKE 4; ELAVL4	1996
MIM168400	#	 	PARASTREMMATIC DWARFISM	59341
MIM168440	*	12p13.31	PARATHYMOSIN; PTMS	5763
MIM168450	*	11p15.3-p15.1	PARATHYROID HORMONE; PTH	5741
MIM168461	*	11q13	CYCLIN D1; CCND1	595
MIM168468	*	3p22-p21.1	PARATHYROID HORMONE 1 RECEPTOR; PTH1R	5745
MIM168470	+	12p12.1-p11.2	PARATHYROID HORMONE-LIKE HORMONE; PTHLH	5744
MIM168500	#	5q34-q35	PARIETAL FORAMINA; PFM	4488
MIM168550	#	5q34-q35	PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA; PFMCCD	4488
MIM168600	#	17q21.1, 6q27, 4q22	PARKINSON DISEASE, LATE-ONSET; PD	126, 2629, 4137, 4929, 6908, 9627
MIM168601	#	4q21	PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	6622
MIM168605	#	2p13	PERRY SYNDROME	1639
MIM168610	^	 	MOVED TO 600274	 
MIM168710		12p13.2	PAROTID PROLINE-RICH SALIVARY PROTEIN Pc	8075
MIM168730	*	12p13.2	PROLINE-RICH PROTEIN, HaeIII SUBFAMILY, 1; PRH1	5554
MIM168790	*	12p13.2	PROLINE-RICH PROTEIN, HaeIII SUBFAMILY, 2; PRH2	5555
MIM168800		 	PAROTIDOMEGALY, HEREDITARY BILATERAL	 
MIM168810	*	12p13.2	PROLINE-RICH PROTEIN, BstNI SUBFAMILY, 2; PRB2	653247
MIM168820	+	7q21.3	PARAOXONASE 1; PON1	5444
MIM168840	*	12p13.2	PROLINE-RICH PROTEIN, BstNI SUBFAMILY, 3; PRB3	5544
MIM168850		 	PATELLA APLASIA, COXA VARA, AND TARSAL SYNOSTOSIS	 
MIM168860	%	17q21-q22	PATELLA APLASIA-HYPOPLASIA; PTLAH	8830
MIM168885		 	PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	 
MIM168890	*	22q12-q13.1	PARVALBUMIN; PVALB	5816
MIM168900	%	 	PATELLA, CHONDROMALACIA OF	 
MIM169000	%	 	PATELLA, FAMILIAL RECURRENT DISLOCATION OF	 
MIM169100	#	6p12	CHAR SYNDROME	7021
MIM169150	#	6p21.1-cen	PATTERNED DYSTROPHY OF RETINAL PIGMENT EPITHELIUM	5961
MIM169170		 	PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	 
MIM169190	*	1q31-q32	PCTAIRE PROTEIN KINASE 3; PCTK3	5129
MIM169200		 	PECHET FACTOR DEFICIENCY	 
MIM169300		 	PECTUS EXCAVATUM	 
MIM169400	#	1q42.1	PELGER-HUET ANOMALY; PHA	3930
MIM169500	#	5q23.3-q31.1	LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	4001
MIM169545	%	 	PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	 
MIM169550		 	PELVIS-SHOULDER DYSPLASIA	 
MIM169600	#	3q21-q24	BENIGN CHRONIC PEMPHIGUS; BCPM	27032
MIM169610		 	PEMPHIGUS VULGARIS, FAMILIAL	 
MIM169615	*	18q12.1-q12.2	DESMOGLEIN 3; DSG3	1830
MIM169710		11q13	PEPSINOGEN 3, GROUP I; PGA3	643834
MIM169720	*	11q13	PEPSINOGEN 4, GROUP I; PGA4	643847
MIM169730	*	11q13	PEPSINOGEN 5, GROUP I; PGA5	5222
MIM169740	*	6p21.3-p21.1	PEPSINOGEN C	5225
MIM169800	*	18q23	PEPTIDASE A; PEPA	55748
MIM169900	*	12q21	PEPTIDASE B; PEPB	5182
MIM170000	*	1q42	PEPTIDASE C; PEPC	5183
MIM170100	#	19cen-q13.11	PROLIDASE DEFICIENCY	5184
MIM170200	*	17q23-qter	PEPTIDASE E; PEPE	5185
MIM170250	*	4p11-q12	LEUCINE AMINOPEPTIDASE 3; LAP3	51056
MIM170260	*	6p21.3	TRANSPORTER, ATP-BINDING CASSETTE, MAJOR HISTOCOMPATIBILITY COMPLEX, 1; TAP1	6890
MIM170261	*	6p21.3	TRANSPORTER, ATP-BINDING CASSETTE, MAJOR HISTOCOMPATIBILITY COMPLEX, 2; TAP2	6891
MIM170270	*	5q14-q21	PEPTIDYLGLYCINE ALPHA-AMIDATING MONOOXYGENASE; PAM	5066
MIM170280	*	10q22	PERFORIN 1; PRF1	5551
MIM170285	*	17q25	NUCLEOPORIN, 85-KD; NUP85	79902
MIM170290	*	15q26	PERILIPIN 1; PLIN1	5346
MIM170390	#	17q23.1-q24.2	ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	3759
MIM170400	#	1q32	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1; HOKPP1	779
MIM170500	#	 	HYPERKALEMIC PERIODIC PARALYSIS; HYPP	6329
MIM170600		 	NORMOKALEMIC PERIODIC PARALYSIS	 
MIM170650	#	11q14.1-q14.3	PERIODONTITIS, AGGRESSIVE, 1	1075
MIM170700		 	PERIPHERAL DYSOSTOSIS	 
MIM170710	*	12q12-q13	PERIPHERIN; PRPH	5630
MIM170715	*	8q21.3-q22.1	PERIPHERAL MYELIN PROTEIN 2; PMP2	5375
MIM170900		 	PERNICIOUS ANEMIA	 
MIM170980		 	PERONEAL NERVE, ACCESSORY DEEP	 
MIM170993	*	8q21.1	PEROXISOME BIOGENESIS FACTOR 2; PEX2	5828
MIM170995	*	1p22-p21	ATP-BINDING CASSETTE, SUBFAMILY D, MEMBER 3; ABCD3	5825
MIM170998	+	22q12-q13.1	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA; PPARA	5465
MIM171050	*	7q21.1	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 1; ABCB1	5243
MIM171060	*	7q21.1	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 4; ABCB4	5244
MIM171100		 	PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	 
MIM171150	*	16p12.1-p11.2	SULFOTRANSFERASE FAMILY 1A, PHENOL-PREFERRING, MEMBER 1; SULT1A1	6817
MIM171190	*	17q21-q22	PHENYLETHANOLAMINE N-METHYLTRANSFERASE; PNMT	5409
MIM171200	#	7q35-q36	THIOUREA TASTING	5726
MIM171300	#	1p36.2, 11q23, 10q11.2, 5p13.1-p12, 3p26-p25, 1p36.1-p35, 2q11	PHEOCHROMOCYTOMA	23095, 2668, 4149, 55654, 5979, 6390, 6392, 7428
MIM171350	^	 	MOVED TO 115310	 
MIM171400	#	10q11.2	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	5979
MIM171420		 	PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	 
MIM171450		 	PHLEBECTASIA OF LIPS	 
MIM171480		 	PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	 
MIM171490	*	1q25-q31.1	PHOSDUCIN; PDC	5132
MIM171500	*	2p25	ACID PHOSPHATASE 1, SOLUBLE; ACP1	52
MIM171640	*	19p13.3-p13.1	PHOSPHATASE, ACID, TYPE 5, TARTRATE-RESISTANT; ACP5	54
MIM171650	*	11p12-p11	ACID PHOSPHATASE 2, LYSOSOMAL; ACP2	53
MIM171720	%	9q34.13	ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1	100196909
MIM171740	*	2q37.1	ALKALINE PHOSPHATASE, INTESTINAL; ALPI	248
MIM171760	*	1p36.1-p34	ALKALINE PHOSPHATASE, LIVER; ALPL	249
MIM171790	*	3q21-q23	PHOSPHATASE, PROSTATE-SPECIFIC ACID; ACPP	55
MIM171800	*	2q37	ALKALINE PHOSPHATASE, PLACENTAL; ALPP	250
MIM171810	*	2q37	ALKALINE PHOSPHATASE, PLACENTAL-LIKE 2; ALPPL2	251
MIM171833	*	5q13	PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 1; PIK3R1	5295
MIM171834	*	3q26.3	PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, ALPHA; PIK3CA	5290
MIM171835	*	1q31	6-@PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 2; PFKFB2	5208
MIM171840	*	10p15.3-p15.2	PHOSPHOFRUCTOKINASE, PLATELET TYPE; PFKP	5214
MIM171860	*	21q22.3	PHOSPHOFRUCTOKINASE, LIVER TYPE; PFKL	5211
MIM171885	*	8q13-q22	PHOSPHODIESTERASE 7A, cAMP-SPECIFIC, HIGH-AFFINITY; PDE7A	5150
MIM171890	*	2q32.1	PHOSPHODIESTERASE 1A; PDE1A	5136
MIM171891	*	12q13	PHOSPHODIESTERASE 1B; PDE1B	5153
MIM171900	*	1p31	PHOSPHOGLUCOMUTASE 1; PGM1	5236
MIM172000	*	4p14-q12	PHOSPHOGLUCOMUTASE 2; PGM2	55276
MIM172100	*	6q12	PHOSPHOGLUCOMUTASE 3; PGM3	5238
MIM172150	%	 	6-@PHOSPHOGLUCONOLACTONASE DEFICIENCY	 
MIM172200	*	1p36.2-p36.13	6-@PHOSPHOGLUCONATE DEHYDROGENASE, ERYTHROCYTE; PGD	5226
MIM172250	*	10q25.3	PHOSPHOGLYCERATE MUTASE 1; PGAM1	5223
MIM172270	*	6p21.1-p12	PHOSPHOGLYCERATE KINASE 2; PGK2	5232
MIM172280	*	16p13.3	PHOSPHOGLYCOLATE PHOSPHATASE; PGP	283871
MIM172400	*	19q13.1	GLUCOSE-6-PHOSPHATE ISOMERASE; GPI	2821
MIM172405	*	6q22.1	PHOSPHOLAMBAN; PLN	5350
MIM172410	*	12q23-q24.1	PHOSPHOLIPASE A2, GROUP IB; PLA2G1B	5319
MIM172411	*	1p35	PHOSPHOLIPASE A2, GROUP IIA; PLA2G2A	5320
MIM172420	*	20q12-q13.1	PHOSPHOLIPASE C, GAMMA-1; PLCG1	5335
MIM172425	+	20q12-q13.1	PHOSPHOLIPID TRANSFER PROTEIN; PLTP	5360
MIM172430	*	1pter-p36.13	ENOLASE 1; ENO1	2023
MIM172439	*	4q12	PHOSPHORIBOSYLAMINOIMIDAZOLE CARBOXYLASE; PAICS	10606
MIM172450	*	4q12	PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE; PPAT	5471
MIM172460	*	14q24	METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1; MTHFD1	4522
MIM172470	*	7p12-q21	PHOSPHORYLASE KINASE, MUSCLE, GAMMA-1; PHKG1	5260
MIM172471	*	16p12.1-p11.2	PHOSPHORYLASE KINASE, TESTIS/LIVER, GAMMA-2; PHKG2	5261
MIM172480	*	7p15.2-p15.1	PHOSPHOSERINE PHOSPHATASE; PSPH	5723
MIM172490	*	16q12-q13	PHOSPHORYLASE KINASE, BETA SUBUNIT; PHKB	5257
MIM172500		 	PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRAL DYSFUNCTION	 
MIM172700	#	17q21.1, 14q24.3	PICK DISEASE OF BRAIN	4137, 5663
MIM172800	#	8q11	PIEBALD TRAIT; PBT	3815, 6591
MIM172850		 	PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	 
MIM172860	*	17p13.3	SERPIN PEPTIDASE INHIBITOR, CLADE F, MEMBER 1; SERPINF1	5176
MIM172870	#	1q31-q32.1	PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY; PPCRA	23418
MIM172880		 	PIERRE ROBIN SYNDROME AND OLIGODACTYLY	 
MIM172900	%	 	PIGMENTED PURPURIC ERUPTION	 
MIM173000		 	PILONIDAL SINUS	 
MIM173100	#	17q22-q24	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II; IGHD2	2688
MIM173110	*	3p11	POU DOMAIN, CLASS 1, TRANSCRIPTION FACTOR 1; POU1F1	5449
MIM173120	*	15q11-q15	SECRETORY GRANULE NEUROENDOCRINE PROTEIN 1; SGNE1	6447
MIM173200	#	 	PITYRIASIS RUBRA PILARIS; PRP	79092
MIM173310	*	9q34	PROGESTAGEN-ASSOCIATED ENDOMETRIAL PROTEIN; PAEP	5047
MIM173320	*	11p15.5	RIBONUCLEASE/ANGIOGENIN INHIBITOR; RNH	6050
MIM173321	*	6p25	SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 6; SERPINB6	5269
MIM173325	*	17q21	JUNCTION PLAKOGLOBIN; JUP	3728
MIM173335	*	6q22-q23	ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1; ENPP1	5167
MIM173340	*	2p11-q11	PLASMINOGEN-LIKE B1; PLGLB1	5343
MIM173350	*	6q26	PLASMINOGEN; PLG	5340
MIM173360	*	7q21.3-q22	SERPIN PEPTIDASE INHIBITOR, CLADE E (NEXIN, PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1), MEMBER 1; SERPINE1	5054
MIM173370	*	8p12	PLASMINOGEN ACTIVATOR, TISSUE; PLAT	5327
MIM173390	*	18q21.3	SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 2; SERPINB2	5055
MIM173391	*	19q13	PLASMINOGEN ACTIVATOR RECEPTOR, UROKINASE-TYPE; PLAUR	5329
MIM173393	*	1p35-p34.3	PLATELET-ACTIVATING FACTOR RECEPTOR; PTAFR	5724
MIM173400		 	PLATELET AGGREGATION, SPONTANEOUS	 
MIM173410	*	5q31-q32	PLATELET-DERIVED GROWTH FACTOR RECEPTOR, BETA; PDGFRB	5159
MIM173420		 	PLATELET DISORDER, UNDEFINED	 
MIM173430	*	7p22	PLATELET-DERIVED GROWTH FACTOR, ALPHA POLYPEPTIDE; PDGFA	5154
MIM173445	*	17q23	PLATELET-ENDOTHELIAL CELL ADHESION MOLECULE 1; PECAM1	5175
MIM173450		 	PLATELET FACTOR 3 DEFICIENCY	 
MIM173460	*	4q12-q13	PLATELET FACTOR 4; PF4	5196
MIM173461	*	4q12-q13	PLATELET FACTOR 4, VARIANT 1; PF4V1	5197
MIM173470	+	17q21.32	INTEGRIN, BETA-3; ITGB3	3690
MIM173490	*	4q12	PLATELET-DERIVED GROWTH FACTOR RECEPTOR, ALPHA; PDGFRA	5156
MIM173500	*	 	PLATELET GROUPS--Ko SYSTEM; HPA-2	 
MIM173510	*	7q11.2	CD36 ANTIGEN; CD36	948
MIM173511	*	 	GLYCOPROTEIN V, PLATELET; GP5	2814
MIM173515	*	3q21	GLYCOPROTEIN IX, PLATELET; GP9	2815
MIM173560		 	PLATELET MEMBRANE FLUIDITY; PMF	 
MIM173570	*	2p	PLECKSTRIN; PLEK	5341
MIM173580		 	PLATELET RESPONSIVENESS TO ADRENALINE, DEPRESSED	 
MIM173590		 	PLATELET SIGNAL PROCESSING DEFECT	 
MIM173600	#	17p11.2	PNEUMOTHORAX, PRIMARY SPONTANEOUS	201163
MIM173610	*	1q23-q25	SELECTIN P; SELP	6403
MIM173650	#	20p13	KINDLER SYNDROME	55612
MIM173700		 	POIKILODERMA, HEREDITARY SCLEROSING	 
MIM173800	%	 	POLAND SYNDROME	 
MIM173850	*	19q13.2-q13.3	POLIOVIRUS RECEPTOR; PVR	5817
MIM173865	*	3q22-q25	POLYADENYLATE-BINDING PROTEIN-LIKE 1; PABPL1	285314
MIM173870	*	1q42	POLY(ADP-RIBOSE) POLYMERASE 1; PARP1	142
MIM173880	*	1q31-q42	POLYMERIC IMMUNOGLOBULIN RECEPTOR; PIGR	5284
MIM173900	#	16p13.3-p13.12	POLYCYSTIC KIDNEY DISEASE 1; PKD1	5310
MIM173910	*	4q21-q23	POLYCYSTIN 2; PKD2	5311
MIM174000	#	1q21	MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1	4169
MIM174050	#	6q21, 19p13.2-p13.1	POLYCYSTIC LIVER DISEASE; PCLD	11231, 5589
MIM174100	^	 	MOVED TO 192350	 
MIM174200	#	7p13	POLYDACTYLY, POSTAXIAL, TYPE A1; PAPA1	2737
MIM174300	#	 	OROFACIODIGITAL SYNDROME V; OFD5	 
MIM174310		 	POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA	 
MIM174400	%	 	POLYDACTYLY, PREAXIAL I	 
MIM174500	#	7q36	POLYDACTYLY, PREAXIAL II; PPD2	64327
MIM174600	%	 	POLYDACTYLY, PREAXIAL III	 
MIM174700	#	7p13	POLYDACTYLY, PREAXIAL IV	2737
MIM174750		 	POLYKARYOCYTOSIS INDUCER; FUSE	2522
MIM174760	*	8p11.2	POLYMERASE, DNA, BETA; POLB	5423
MIM174761	*	19q13.3-q13.4	POLYMERASE (DNA-DIRECTED), DELTA 1, CATALYTIC SUBUNIT; POLD1	5424
MIM174762	*	12q24.3	POLYMERASE, DNA, EPSILON; POLE	5426
MIM174763	*	15q25	POLYMERASE, DNA, GAMMA; POLG	5428
MIM174770	%	 	ACTINIC PRURIGO	 
MIM174800	#	20q13.2	MCCUNE-ALBRIGHT SYNDROME; MAS	2778
MIM174810	#	18q22.1	FAMILIAL EXPANSILE OSTEOLYSIS; FEO	8792
MIM174900	#	10q22.3, 18q21.1	JUVENILE POLYPOSIS SYNDROME; JPS	4089, 657
MIM175020	%	 	POLYPOSIS, GASTRIC	 
MIM175050	#	18q21.1	JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	4089
MIM175100	#	5q21-q22	FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1	324, 4595
MIM175200	#	19p13.3	PEUTZ-JEGHERS SYNDROME; PJS	6794
MIM175400		 	POLYPOSIS, INTESTINAL, SCATTERED AND DISCRETE	 
MIM175450		 	POLYPOSIS, INTESTINAL, WITH MULTIPLE EXOSTOSES	 
MIM175500		 	POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES	 
MIM175505		 	POLYPOSIS OF GASTRIC FUNDUS WITHOUT POLYPOSIS COLI	 
MIM175510		 	POLYPS, MULTIPLE AND RECURRENT INFLAMMATORY FIBROID, GASTROINTESTINAL	 
MIM175690	%	 	POLYSYNDACTYLY, CROSSED	 
MIM175700	#	7p13	GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; GCPS	2737
MIM175750		 	POPLITEAL CYST	 
MIM175780	#	13q34	PORENCEPHALY 1; POREN1	1282
MIM175800	%	 	POROKERATOSIS OF MIBELLI	 
MIM175850	%	12q24.1-q24.2	POROKERATOSIS, PALMAR, PLANTAR, AND DISSEMINATED, 1; PPPD1	100196910
MIM175860	%	 	KERATODERMA, PALMOPLANTAR, PUNCTATE TYPE II; PPKP2	 
MIM175900	#	12q24.1	POROKERATOSIS, DISSEMINATED SUPERFICIAL ACTINIC, 1; DSAP1	9733
MIM176000	#	11q23.3	PORPHYRIA, ACUTE INTERMITTENT	3145
MIM176010	^	 	MOVED TO 176000	 
MIM176090		 	PORPHYRIA CUTANEA TARDA, TYPE I	 
MIM176100	#	6p21.3, 1p34	PORPHYRIA CUTANEA TARDA	3077, 7389
MIM176200	#	1q22, 6p21.3	PORPHYRIA VARIEGATA	3077, 5498
MIM176240		 	POSTAXIAL OLIGODACTYLY, TETRAMELIC	 
MIM176250		 	POSTERIOR COLUMN ATAXIA	 
MIM176256	*	Chr.12	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAW-RELATED SUBFAMILY, MEMBER 2; KCNC2	3747
MIM176257	*	12p13	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 6; KCNA6	3742
MIM176258	*	11p15	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAW-RELATED SUBFAMILY, MEMBER 1; KCNC1	3746
MIM176260	*	12p13	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 1; KCNA1	3736
MIM176261	*	21q22.1-q22.2	POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 1; KCNE1	3753
MIM176262	*	 	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 2; KCNA2	3737
MIM176263	*	1p21-p13.3	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 3; KCNA3	3738
MIM176264	*	19q13.3-q13.4	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAW-RELATED SUBFAMILY, MEMBER 3; KCNC3	3748
MIM176265	*	1p21	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAW-RELATED SUBFAMILY, MEMBER 4; KCNC4	3749
MIM176266	*	11q13.4-q14.1	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 4; KCNA4	3739
MIM176267	*	12p13	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 5; KCNA5	3741
MIM176268	*	19q13.3	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 7; KCNA7	3743
MIM176270	#	15q12, 15q11-q13	PRADER-WILLI SYNDROME; PWS	100033413, 10108, 145624, 23742, 338433, 3653, 4692, 54551, 6638, 7681, 791114, 8924
MIM176290	*	14q32	DELTA, DROSOPHILA, HOMOLOG-LIKE 1; DLK1	8788
MIM176300	*	18q11.2-q12.1	TRANSTHYRETIN; TTR	7276
MIM176305	#	7p15-p14.2	PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	3209
MIM176310	*	1q23	PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 1; PBX1	5087
MIM176311	*	6p21.3	PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 2; PBX2	5089
MIM176312	*	9q33-q34	PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 3; PBX3	5090
MIM176385	*	9q33.1	PREGNANCY-ASSOCIATED PLASMA PROTEIN A; PAPPA	5069
MIM176390	*	19q13.2	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 1; PSG1	5669
MIM176391	*	19q13.2	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 2; PSG2	5670
MIM176392	*	19q13.2	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 3; PSG3	5671
MIM176393	*	19q13.2	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 4; PSG4	5672
MIM176394	*	19q13.2	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 5; PSG5	5673
MIM176395	*	19q13.2	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 6; PSG6	5675
MIM176396	*	19q13.2	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 7; PSG7	5676
MIM176397	*	19q13.2	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 8; PSG8	440533
MIM176398	*	19q13.2	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 9; PSG9	5678
MIM176399	*	19q13.2	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 10; PSG10	653492
MIM176400	#	19p13.3	PRECOCIOUS PUBERTY, CENTRAL	84634
MIM176401	*	19q13.2	PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 11; PSG11	5680
MIM176410	#	2p21	PRECOCIOUS PUBERTY, MALE-LIMITED	3973
MIM176420	*	12p13-p12.2	PREGNANCY ZONE PROTEIN; PZP	5858
MIM176430	#	15q15	PREMATURE CHROMATID SEPARATION TRAIT; PCS	701
MIM176450	#	7q36	CURRARINO SYNDROME	3110
MIM176500	#	13q14	CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1	9445
MIM176590	*	3q25.1-q25.2	PROFILIN 2; PFN2	5217
MIM176600		 	PRESENILE DEMENTIA, KRAEPELIN TYPE	 
MIM176610	*	17p13.3	PROFILIN 1; PFN1	5216
MIM176620		 	PRIAPISM, FAMILIAL IDIOPATHIC	 
MIM176635	*	12q13	PRIMASE POLYPEPTIDE 1; PRIM1	5557
MIM176636	*	6p12-p11.1	PRIMASE POLYPEPTIDE 2A; PRIM2A	5558
MIM176640	*	20pter-p12	PRION PROTEIN; PRNP	5621
MIM176670	#	1q21.2	HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS	4000
MIM176690		 	PROGEROID SHORT STATURE WITH PIGMENTED NEVI	 
MIM176700	%	 	PROGNATHISM, MANDIBULAR	 
MIM176705	*	17q21	PROHIBITIN; PHB	5245
MIM176710	*	10q21.3-q23.1	PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE-4-DIOXYGENASE, ALPHA SUBUNIT, ISOFORM 1; P4HA1	5033
MIM176720	*	7q32-q36	PROLACTIN-INDUCIBLE PROTEIN; PIP	5304
MIM176730	+	11p15.5	INSULIN; INS	3630
MIM176740	*	20p12	PROLIFERATING CELL NUCLEAR ANTIGEN; PCNA	5111
MIM176741	*	10q25-qter	PROLIFERATION-RELATED Ki-67 ANTIGEN; MKI67	4288
MIM176760	*	6p22.2-p21.3	PROLACTIN; PRL	5617
MIM176761	*	5p13-p12	PROLACTIN RECEPTOR; PRLR	5618
MIM176763	*	1p34.1	PEROXIREDOXIN 1; PRDX1	5052
MIM176770		 	PROLINE-NEGATIVE AUXOTROPH OF HAMSTER, COMPLEMENTATION OF; PROA	8039
MIM176780	%	1q31	PELVIC ORGAN PROLAPSE, SUSCEPTIBILITY TO	100312952
MIM176785	*	11q14	PROLYLCARBOXYPEPTIDASE; PRCP	5547
MIM176790	*	17q25	PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE-4-DIOXYGENASE, BETA SUBUNIT; P4HB	5034
MIM176793	*	5p14	PRO-MELANIN-CONCENTRATING HORMONE-LIKE 1; PMCHL1	5369
MIM176794	*	5q12-q13	PRO-MELANIN-CONCENTRATING HORMONE-LIKE 2; PMCHL2	5370
MIM176795	*	12q23-q24	PRO-MELANIN-CONCENTRATING HORMONE; PMCH	5367
MIM176797	*	11q23.1	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 16; ZBTB16	7704
MIM176800		 	PRONATION-SUPINATION OF THE FOREARM, IMPAIRMENT OF	 
MIM176801	*	10q22.1	PROSAPOSIN; PSAP	5660
MIM176802	*	19p13.1	PROSTAGLANDIN E RECEPTOR 1, EP1 SUBTYPE; PTGER1	5731
MIM176803	*	9q34.2-q34.3	PROSTAGLANDIN D2 SYNTHASE, BRAIN; PTGDS	5730
MIM176804	*	14q22	PROSTAGLANDIN E RECEPTOR 2, EP2 SUBTYPE; PTGER2	5732
MIM176805	*	9q32-q33.3	PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1; PTGS1	5742
MIM176806	*	1p31.2	PROSTAGLANDIN E RECEPTOR 3, EP3 SUBTYPE; PTGER3	5733
MIM176807	#	1q25, 17p11, 16q22.3-q23.1, 16q22.1, 13q12.3, 11p11.2, 10q25, 10p15, 8p22, 7q11.23, 7p11-q21, 7p22, 3p26, Xq11-q12, 1q42.2-q43, 22q12.3, 22q12.1, 20q13, 19q	PROSTATE CANCER	11200, 1316, 3092, 367, 3732, 4481, 4601, 463, 5728, 6041, 60528, 675, 8379, 999
MIM176820	*	19q13.4	KALLIKREIN-RELATED PEPTIDASE 3; KLK3	354
MIM176830	*	2p23.3	PROOPIOMELANOCORTIN; POMC	5443
MIM176842	*	7p13	PROTEASOME SUBUNIT, ALPHA-TYPE, 2; PSMA2	5683
MIM176843	*	14q23	PROTEASOME SUBUNIT, ALPHA-TYPE, 3; PSMA3	5684
MIM176844	*	1p13	PROTEASOME SUBUNIT, ALPHA-TYPE, 5; PSMA5	5686
MIM176846	*	15q25.1	PROTEASOME SUBUNIT, ALPHA-TYPE, 4; PSMA4	5685
MIM176847	*	16q22.1	PROTEASOME SUBUNIT, BETA-TYPE, 10; PSMB10	5699
MIM176851	*	6q22.3-q24	PROTEIN CARBOXYL METHYLTRANSFERASE 1; PCMT1	5110
MIM176860	#	2q13-q14	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT; THPH3	5624
MIM176870	*	9q32-q33	ALPHA-1 MICROGLOBULIN/BIKUNIN PRECURSOR; AMBP	259
MIM176871	*	2p21	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 2; EIF2AK2	5610
MIM176872	*	15q21	MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1; MAP2K1	5604
MIM176873	*	1p36.3	CYCLIN-DEPENDENT KINASE 11B; CDK11B	984
MIM176875	*	11q13	PROTEIN PHOSPHATASE 1, CATALYTIC SUBUNIT, ALPHA ISOFORM; PPP1CA	5499
MIM176876	*	12q24.1	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 11; PTPN11	5781
MIM176877	*	 	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 3; PTPN3	5774
MIM176878	*	 	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 4; PTPN4	5775
MIM176879	*	11p15.2-p15.1	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 5; PTPN5	84867
MIM176880	*	3q11.2	PROTEIN S; PROS1	5627
MIM176882	*	12q15-q21	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, BETA; PTPRB	5787
MIM176883	*	12p13	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 6; PTPN6	5777
MIM176884	*	20p13	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, ALPHA; PTPRA	5786
MIM176885	*	20q13.1-q13.2	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 1; PTPN1	5770
MIM176886	*	3p14.2	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, GAMMA; PTPRG	5793
MIM176887	*	18p11.3-p11.2	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 2; PTPN2	5771
MIM176888	*	18p11.2	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, MU; PTPRM	5797
MIM176889	*	1q32.1	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 7; PTPN7	5778
MIM176891	*	7q31.3	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, ZETA-1; PTPRZ1	5803
MIM176892	*	1p36.1	PROTEIN KINASE, cAMP-DEPENDENT, CATALYTIC, BETA; PRKACB	5567
MIM176893	*	9q13	PROTEIN KINASE, cAMP-DEPENDENT, CATALYTIC, GAMMA; PRKACG	5568
MIM176894	*	10q11.2	PROTEIN KINASE, cGMP-DEPENDENT, REGULATORY, TYPE I; PRKG1	5592
MIM176895	*	 	PROTEIN Z; PROZ	8858
MIM176900		 	PROTEOLYTIC CAPACITY OF PLASMA	 
MIM176910	*	3p21.3-p21.2	PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE II, ALPHA; PRKAR2A	5576
MIM176911	*	7pter-p22	PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE I, BETA; PRKAR1B	5575
MIM176912	*	7q22	PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE II, BETA; PRKAR2B	5577
MIM176914	*	12q24.1-q24.2	PROTEIN PHOSPHATASE 1, CATALYTIC SUBUNIT, GAMMA ISOFORM; PPP1CC	5501
MIM176915	*	5q23-q31	PROTEIN PHOSPHATASE 2, CATALYTIC SUBUNIT, ALPHA ISOFORM; PPP2CA	5515
MIM176916	*	8p12-p11.2	PROTEIN PHOSPHATASE 2, CATALYTIC SUBUNIT, BETA ISOFORM; PPP2CB	5516
MIM176920	#	 	PROTEUS SYNDROME	207
MIM176930	*	11p11-q12	COAGULATION FACTOR II; F2	2147
MIM176940	*	1q21	S100 CALCIUM-BINDING PROTEIN A1; S100A1	6271
MIM176941	*	19p13.2	TYROSINE KINASE 2; TYK2	7297
MIM176942	*	5q21-q22	FPS/FES-RELATED TYROSINE KINASE; FER	2241
MIM176943	*	10q26	FIBROBLAST GROWTH FACTOR RECEPTOR 2; FGFR2	2263
MIM176945	*	1p36.12	EPHRIN RECEPTOR EphA8; EPHA8	2046
MIM176946	*	1p36.1	EPHRIN RECEPTOR EphA2; EPHA2	1969
MIM176947	*	2q12	ZETA-CHAIN-ASSOCIATED PROTEIN KINASE; ZAP70	7535
MIM176948	*	22q11.2	MITOGEN-ACTIVATED PROTEIN KINASE 1; MAPK1	5594
MIM176949	*	18q12-q21	MITOGEN-ACTIVATED PROTEIN KINASE 4; MAPK4	5596
MIM176950	^	 	MOVED TO 262890	 
MIM176960	*	17q22-q23.2	PROTEIN KINASE C, ALPHA; PRKCA	5578
MIM176970	*	16p11.2	PROTEIN KINASE C, BETA-1; PRKCB1	5579
MIM176975	*	2p21	PROTEIN KINASE C, EPSILON; PRKCE	5581
MIM176977	*	3p	PROTEIN KINASE C, DELTA; PRKCD	5580
MIM176980	*	19q13.4	PROTEIN KINASE C, GAMMA; PRKCG	5582
MIM176981	*	 	GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-2-LIKE 1; GNB2L1	10399
MIM176982	*	1p36	PROTEIN KINASE C, ZETA FORM; PRKCZ	5590
MIM176990	*	21q22.2-q22.3	S100 CALCIUM-BINDING PROTEIN, BETA; S100B	6285
MIM176991	*	1q21	S100 CALCIUM-BINDING PROTEIN A5; S100A5	6276
MIM176992	*	1q21	S100 CALCIUM-BINDING PROTEIN A3; S100A3	6274
MIM176993	*	1q21	S100 CALCIUM-BINDING PROTEIN A2; S100A2	6273
MIM177000	#	18q21.3	PROTOPORPHYRIA, ERYTHROPOIETIC; EPP	2235
MIM177010	*	2q33-q35	SERPIN PEPTIDASE INHIBITOR, CLADE E (NEXIN, PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1), MEMBER 2; SERPINE2	5270
MIM177015	*	16q22.1	PROTEIN SERINE KINASE H1; PSKH1	5681
MIM177020	*	19p13.3	PROTEINASE 3; PRTN3	5657
MIM177040	*	10q22.1	SERGLYCIN; SRGN	5552
MIM177045	*	6p21.3	PROTEASOME SUBUNIT, BETA-TYPE, 9; PSMB9	5698
MIM177046	*	6p21.3	PROTEASOME SUBUNIT, BETA-TYPE, 8; PSMB8	5696
MIM177050	%	 	PROTRUSIO ACETABULI	 
MIM177060	*	19p13.2-p13.1	PROTEIN KINASE C SUBSTRATE, 80-KD, HEAVY CHAIN; PRKCSH	5589
MIM177061	*	6q22.2	MYRISTOYLATED ALANINE-RICH PROTEIN KINASE C SUBSTRATE; MARCKS	4082
MIM177070	*	15q15	PROTEIN 4.2, ERYTHROCYTIC; EPB42	2038
MIM177075	*	16q22-q23	V-MAF AVIAN MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE HOMOLOG; MAF	4094
MIM177100		 	PRURITUS, HEREDITARY LOCALIZED	 
MIM177150	^	 	MOVED TO 177170	 
MIM177170	#	19p13.1	PSEUDOACHONDROPLASIA; PSACH	1311
MIM177200	#	16p13-p12, 16p13-p12	LIDDLE SYNDROME	6338, 6340
MIM177300		 	PSEUDOARTHROGRYPOSIS	 
MIM177350		 	PSEUDOATROPHODERMA COLLI	 
MIM177400	+	3q26.1-q26.2	BUTYRYLCHOLINESTERASE; BCHE	590
MIM177500	*	2q33-q35	CHOLINESTERASE, SERUM, 2; CHE2	1110
MIM177650	#	15q22	EXFOLIATION SYNDROME; XFS	4016
MIM177700	#	 	PSEUDOGLAUCOMA	 
MIM177720	^	16q23-q24	PSEUDOHYPERKALEMIA, FAMILIAL, 1, DUE TO RED CELL LEAK	 
MIM177735	#	4q31.1	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A	4306
MIM177750	%	 	PSEUDOMONILETHRIX	 
MIM177800		 	PSEUDOPAPILLEDEMA	 
MIM177820	#	17pter-p12	PSEUDO-VON WILLEBRAND DISEASE; VWDP	2811
MIM177850	#	16p13.1	PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	368
MIM177860	^	 	REMOVED FROM DATABASE	 
MIM177900	#	1p31.3, 6p21.3	PSORIASIS SUSCEPTIBILITY 1; PSORS1	149233, 3107
MIM177980	#	 	PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES	 
MIM177990		 	PTERYGIUM COLLI, ISOLATED	 
MIM178000		 	PTERYGIUM OF CONJUNCTIVA AND CORNEA	 
MIM178110	%	 	ARTHROGRYPOSIS, DISTAL, TYPE 8; DA8	 
MIM178200	%	 	PTERYGIUM, ANTECUBITAL	 
MIM178300	%	8q21.12, 1p34.1-p32	PTOSIS, HEREDITARY CONGENITAL 1; PTOS1	5765, 79776
MIM178330		 	PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	 
MIM178350	%	 	PUBIC BONE DYSPLASIA	 
MIM178370		 	PULMONARY ATRESIA WITH VENTRICULAR SEPTAL DEFECT	 
MIM178400		 	PULMONARY EDEMA OF MOUNTAINEERS	 
MIM178500	#	10q22.2-q23.1, 10q22-q23, 5p15.33, 3q21-q28	PULMONARY FIBROSIS, IDIOPATHIC; IPF	6440, 653509, 7012, 7015, 727897, 729238
MIM178550		 	PULMONARY HEMOSIDEROSIS	 
MIM178600	#	13q12-q14, 2q33	PULMONARY HYPERTENSION, PRIMARY, 1; PPH1	4093, 659
MIM178610		 	PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	 
MIM178620	*	8p21	SURFACTANT, PULMONARY-ASSOCIATED PROTEIN C; SFTPC	6440
MIM178630	*	10q22.2-q23.1	SURFACTANT, PULMONARY-ASSOCIATED PROTEIN A1; SFTPA1	653509
MIM178635	*	10q23.3	SURFACTANT, PULMONARY-ASSOCIATED PROTEIN D; SFTPD	6441
MIM178640	*	2p12-p11.2	SURFACTANT, PULMONARY-ASSOCIATED PROTEIN B; SFTPB	6439
MIM178642	*	10q22-q23	SURFACTANT, PULMONARY-ASSOCIATED PROTEIN A2; SFTPA2	729238
MIM178650		 	PULMONIC STENOSIS, ATRIAL SEPTAL DEFECT, AND UNIQUE ELECTROCARDIOGRAPHIC ABNORMALITIES	 
MIM178651		 	PULMONIC STENOSIS AND DEAFNESS	 
MIM178800		 	PUPIL, EGG-SHAPED	 
MIM178900		 	PUPILLARY MEMBRANE, PERSISTENCE OF	 
MIM178990	*	11q21-q22	MATRIX METALLOPROTEINASE 7; MMP7	4316
MIM178995		 	PRURITIC URTICARIAL PAPULES AND PLAQUES OF PREGNANCY; PUPPP	 
MIM179000		 	PURPURA SIMPLEX	 
MIM179010	%	12q	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 1; IHPS1	 
MIM179020	*	21q22.3	PYRIDOXAL KINASE; PDXK	8566
MIM179030	*	10q21.3	PYROPHOSPHATASE, INORGANIC, 1; PPA1	5464
MIM179035	*	17q25.3	PYRROLINE-5-CARBOXYLATE REDUCTASE 1; PYCR1	5831
MIM179050	*	15q22	PYRUVATE KINASE, MUSCLE, 2; PKM2	5315
MIM179060	*	3p13-q23	PYRUVATE DEHYDROGENASE, BETA POLYPEPTIDE; PDHB	5162
MIM179061	*	4q22-q23	PYRUVATE DEHYDROGENASE, ALPHA-2; PDHA2	5161
MIM179080	*	1p31	RAB GERANYLGERANYL TRANSFERASE, BETA SUBUNIT; RABGGTB	5876
MIM179095	*	5q23-q31	UBIQUITIN-CONJUGATING ENZYME E2B; UBE2B	7320
MIM179200	%	 	RADIAL HEADS, POSTERIOR DISLOCATION OF	 
MIM179250		 	RADIAL HYPOPLASIA, TRIPHALANGEAL THUMBS, HYPOSPADIAS, AND MAXILLARY DIASTEMA	 
MIM179270		 	RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA	 
MIM179280		 	RADIAL-RENAL SYNDROME	 
MIM179300		 	RADIOULNAR SYNOSTOSIS	 
MIM179400		 	RADIUS, APLASIA OF, WITH CLEFT LIP/PALATE	 
MIM179410	*	11q23	RADIXIN; RDX	5962
MIM179450		6p21.3	RAGWEED SENSITIVITY	7937
MIM179490	*	19p13.1-p12	RAS-ASSOCIATED PROTEIN RAB3A; RAB3A	5864
MIM179500		 	RAINDROP HYPOPIGMENTATION	 
MIM179502	*	4q21-q25	RAP1, GTPase-GDP DISSOCIATION STIMULATOR 1; RAP1GDS1	5910
MIM179503	*	16q22	RAS-RELATED ASSOCIATED WITH DIABETES; RRAD	6236
MIM179505	*	11p15.5-p15.4	RAS HOMOLOG GENE FAMILY, MEMBER G; RHOG	391
MIM179508	*	2p14	RAS-ASSOCIATED PROTEIN RAB1; RAB1	5861
MIM179509	*	8q12.1	RAS-ASSOCIATED PROTEIN RAB2; RAB2	5862
MIM179510	*	1p32-p31	RAS-ASSOCIATED PROTEIN RAB3B; RAB3B	5865
MIM179511	*	1q42-q43	RAS-ASSOCIATED PROTEIN RAB4; RAB4	5867
MIM179512	*	3p24-p22	RAS-ASSOCIATED PROTEIN RAB5A; RAB5A	5868
MIM179513	*	11q13.4	RAS-ASSOCIATED PROTEIN RAB6A; RAB6A	5870
MIM179514	*	12q13	RAS-ASSOCIATED PROTEIN RAB5B; RAB5B	5869
MIM179520	*	1p13.3	RAS-RELATED PROTEIN 1A; RAP1A	5906
MIM179530	*	12q14	RAS-RELATED PROTEIN RAP1B; RAP1B	5908
MIM179540	*	13q34	RAS-RELATED PROTEIN 2A; RAP2A	5911
MIM179541	*	 	RAS-RELATED PROTEIN 2B; RAP2B	5912
MIM179550	*	7p22-p15	V-RAL SIMIAN LEUKEMIA VIRAL ONCOGENE HOMOLOG A; RALA	5898
MIM179551	*	2cen-q13	V-RAL SIMIAN LEUKEMIA VIRAL ONCOGENE HOMOLOG B; RALB	5899
MIM179555	*	10p13	RAS SUPPRESSOR PROTEIN 1; RSU1	6251
MIM179590	*	1p32	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F; PTPRF	5792
MIM179600	%	 	RAYNAUD DISEASE	 
MIM179605	*	6p21.1-cen	PERIPHERIN 2, MOUSE, HOMOLOG OF; PRPH2	5961
MIM179610	*	7q32-q36	EPHRIN RECEPTOR EphA1; EPHA1	2041
MIM179611	*	3p11.2	EPHRIN RECEPTOR EphA3; EPHA3	2042
MIM179613	#	 	RECOMBINANT CHROMOSOME 8 SYNDROME	 
MIM179615	*	11p13	RECOMBINATION-ACTIVATING GENE 1; RAG1	5896
MIM179616	*	11p13	RECOMBINATION-ACTIVATING GENE 2; RAG2	5897
MIM179617	*	15q15.1	RAD51, S. CEREVISIAE, HOMOLOG OF; RAD51	5888
MIM179618	*	17p13.1	RECOVERIN; RCV1	5957
MIM179620	#	11p15.5	RAPH BLOOD GROUP SYSTEM	977
MIM179650	%	 	RED CELL PERMEABILITY DEFECT	 
MIM179700	%	 	RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS	 
MIM179710	*	1p36.1	REGULATOR OF CHROMOSOME CONDENSATION 1; RCC1	1104
MIM179730	*	9pter-q12	RELAXIN 1; RLN1	6013
MIM179740	*	9pter-q12	RELAXIN 2; RLN2	6019
MIM179755	*	1q21	PAPILLARY RENAL CELL CARCINOMA TRANSLOCATION-ASSOCIATED GENE; PRCC	5546
MIM179760	^	 	MOVED TO 144700	 
MIM179770	^	 	MOVED TO 144700	 
MIM179780	*	16q24.3	DIPEPTIDASE 1; DPEP1	1800
MIM179800	#	17q21-q22	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	6521
MIM179820	*	1q32	RENIN; REN	5972
MIM179830		 	RENAL TUBULAR ACIDOSIS, PROXIMAL	 
MIM179835	*	17p13.3	REPLICATION PROTEIN A1, 70-KD; RPA1	6117
MIM179836	*	1p35	REPLICATION PROTEIN A2, 32-KD; RPA2	6118
MIM179837	*	7p22	REPLICATION PROTEIN A3, 14-KD; RPA3	6119
MIM179838	*	12q24.31-q24.33	RESTIN; RSN	6249
MIM179840		 	RETICULAR DYSTROPHY OF RETINAL PIGMENT EPITHELIUM	 
MIM179850	#	12q13	DOWLING-DEGOS DISEASE; DDD	3852
MIM179900	%	 	RETINAL APLASIA	 
MIM180000	%	 	RETINAL ARTERIES, TORTUOSITY OF	 
MIM180020	%	6q25-q26	RETINAL CONE DYSTROPHY 1; RCD1	5953
MIM180040	*	1q32.3	RETINAL DEGENERATION 3, MOUSE, HOMOLOG OF; RD3	343035
MIM180050	%	 	RETINAL DETACHMENT	 
MIM180069	*	1p31	RETINAL PIGMENT EPITHELIUM-SPECIFIC PROTEIN, 65-KD; RPE65	6121
MIM180070	^	 	RETINAL NONATTACHMENT AND FALCIFORM DETACHMENT	 
MIM180071	*	5q31.2-q34	PHOSPHODIESTERASE 6A, cGMP-SPECIFIC, ROD, ALPHA; PDE6A	5145
MIM180072	*	4p16.3	PHOSPHODIESTERASE 6B, cGMP-SPECIFIC, ROD, BETA; PDE6B	5158
MIM180073	*	17q25	PHOSPHODIESTERASE 6G, cGMP-SPECIFIC, ROD, GAMMA; PDE6G	5148
MIM180080		 	RETINAL VENOUS BEADING	 
MIM180090	*	15q26	RETINALDEHYDE-BINDING PROTEIN 1; RLBP1	6017
MIM180100	#	8q11-q13	RETINITIS PIGMENTOSA 1; RP1	6101
MIM180104	#	7p14.2	RETINITIS PIGMENTOSA 9; RP9	6100
MIM180105	#	7q31.3-q32	RETINITIS PIGMENTOSA 10; RP10	3614
MIM180190	*	12q13	RETINOIC ACID RECEPTOR, GAMMA; RARG	5916
MIM180200	#	13q14.1-q14.2	RETINOBLASTOMA; RB1	5925
MIM180201	*	14q23.1	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 4A; ARID4A	5926
MIM180202	*	12p11	LYSINE-SPECIFIC DEMETHYLASE 5A; KDM5A	5927
MIM180203	*	16q12.2	RETINOBLASTOMA-LIKE 2; RBL2	5934
MIM180210		 	RETINOPATHY, PERICENTRAL PIGMENTARY, DOMINANT	 
MIM180220	*	3p24	RETINOIC ACID RECEPTOR, BETA; RARB	5915
MIM180230	*	15q24	RETINOIC ACID-BINDING PROTEIN, CELLULAR, TYPE I; CRABP1	1381
MIM180231	*	1q21.3	RETINOIC ACID-BINDING PROTEIN, CELLULAR, TYPE II; CRABP2	1382
MIM180240	*	17q21.1	RETINOIC ACID RECEPTOR, ALPHA; RARA	5914
MIM180245	*	9q34.3	RETINOID X RECEPTOR, ALPHA; RXRA	6256
MIM180246	*	6p21.3	RETINOID X RECEPTOR, BETA; RXRB	6257
MIM180247	*	1q22-q23	RETINOID X RECEPTOR, GAMMA; RXRG	6258
MIM180250	*	10q24	RETINOL-BINDING PROTEIN 4; RBP4	5950
MIM180260	*	3q21-q22	RETINOL-BINDING PROTEIN 1; RBP1	5947
MIM180270		 	RETINOSCHISIS, AUTOSOMAL DOMINANT	 
MIM180280	*	3q21-qter	RETINOL-BINDING PROTEIN 2; RBP2	5948
MIM180290	*	10q11.2	RETINOL-BINDING PROTEIN 3; RBP3	5949
MIM180295	#	 	RHABDOMYOSARCOMA, EMBRYONAL, 2; RMSE2	 
MIM180297	*	6p21.1-p11	RHESUS BLOOD GROUP-ASSOCIATED GLYCOPROTEIN; RHAG	6005
MIM180300	#	16p13, 1q22, 1p13, 6q23, 6p21.3, 6p21.3, 5q31, 2q32.2-q32.3, 1p36.13, 1q31-q32	RHEUMATOID ARTHRITIS; RA	23569, 26191, 3123, 3586, 4261, 4795, 51744, 6583, 6775
MIM180350		 	RHEUMATOID NODULOSIS	 
MIM180360		 	RHINY	 
MIM180370	*	22q11.2-qter	THIOSULFATE SULFURTRANSFERASE; TST	7263
MIM180380	*	3q21-q24	RHODOPSIN; RHO	6010
MIM180381	*	13q34	G PROTEIN-COUPLED RECEPTOR KINASE 1; GRK1	6011
MIM180385	*	11p13	LIM DOMAIN ONLY 2; LMO2	4005
MIM180386	*	12p13	LIM DOMAIN ONLY 3; LMO3	55885
MIM180390	*	2p25-p24	RIBONUCLEOTIDE REDUCTASE, M2 SUBUNIT; RRM2	6241
MIM180410	*	11p15.5	RIBONUCLEOTIDE REDUCTASE, M1 SUBUNIT; RRM1	6240
MIM180420	*	1q42.11-q42.13	RNA, 5S RIBOSOMAL, GENE CLUSTER 1; RN5S1@	6025
MIM180430	*	2p11.2	RIBOSE 5-PHOSPHATE ISOMERASE A; RPIA	22934
MIM180435	*	1q25	RIBONUCLEASE L; RNASEL	6041
MIM180440	*	14q11.2	RIBONUCLEASE A FAMILY, 1; RNASE1	6035
MIM180450	*	13p12	RIBOSOMAL RNA 1; RNR1	6052
MIM180451	*	14p12	RIBOSOMAL RNA 2; RNR2	6053
MIM180452	*	15p12	RIBOSOMAL RNA 3; RNR3	6054
MIM180453	*	21p12	RIBOSOMAL RNA 4; RNR4	6055
MIM180454	*	22p12	RIBOSOMAL RNA 5; RNR5	6056
MIM180460	*	9p21	RIBOSOMAL PROTEIN S6; RPS6	6194
MIM180463	*	5q13-q23	RIBOSOMAL PROTEIN S20A; RPS20A	6225
MIM180464	*	5q33-qter	RIBOSOMAL PROTEIN S20B; RPS20B	6226
MIM180465	*	11q23.3	RIBOSOMAL PROTEIN S25; RPS25	6230
MIM180466	*	17q11	RIBOSOMAL PROTEIN L19; RPL19	6143
MIM180467	*	Chr.8	RIBOSOMAL PROTEIN L30; RPL30	6156
MIM180468	*	3q29-qter	RIBOSOMAL PROTEIN L35A; RPL35A	6165
MIM180469	*	Chr.14	RIBOSOMAL PROTEIN L36A-LIKE; RPL36AL	6166
MIM180470	*	3q	RIBOPHORIN I; RPN1	6184
MIM180471	*	19q	RIBOSOMAL PROTEIN S11; RPS11	6205
MIM180472	*	15q	RIBOSOMAL PROTEIN S17; RPS17	6218
MIM180473	*	6p21.3	RIBOSOMAL PROTEIN S18; RPS18	6222
MIM180474	*	1p36.31	RIBOSOMAL PROTEIN L22; RPL22	6146
MIM180475	*	9q33.3	RIBOSOMAL PROTEIN L12; RPL12	6136
MIM180476	*	11p	RIBOSOMAL PROTEIN S13; RPS13	6207
MIM180477	*	20q13.3	RIBOSOMAL PROTEIN S21; RPS21	6227
MIM180478	*	4q31.2-q31.3	RIBOSOMAL PROTEIN S3a; RPS3A	6189
MIM180479	*	15q	RIBOSOMAL PROTEIN L4; RPL4	6124
MIM180480	*	2q32-q33.3	RIBULOSE 5-PHOSPHATE 3-EPIMERASE; RPE	6120
MIM180490	*	20q12-q13.1	RIBOPHORIN II; RPN2	6185
MIM180500	#	4q25-q26	AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	5308
MIM180510	*	Chr.12	RIBOSOMAL PHOSPHOPROTEIN, LARGE, P0; RPLP0	6175
MIM180520	*	Chr.15	RIBOSOMAL PHOSPHOPROTEIN, LARGE, P1; RPLP1	6176
MIM180530	*	 	RIBOSOMAL PHOSPHOPROTEIN, LARGE, P2; RPLP2	6181
MIM180535	*	19p	RIBOSOMAL PROTEIN S15; RPS15	6209
MIM180550	#	4q25-q26	RING DERMOID OF CORNEA; RDC	5308
MIM180600	%	 	RINGED HAIR	 
MIM180610	*	1p32	REARRANGED LMYC FUSION; RLF	6018
MIM180620	*	6p23-q12	TRANSFER RNA METHIONINE 2; TRNAM2	7212
MIM180621	*	6p23-q12	TRANSFER RNA METHIONINE 1; TRNAM1	7210
MIM180630	*	17q23-q25	DEAD/H BOX 5; DDX5	1655
MIM180640	*	1p36	TRANSFER RNA GLUTAMIC ACID; TRNAE1	7193
MIM180645	*	1p36.1	SMALL NUCLEOLAR RNA, H/ACA BOX, 73A; SNORA73A	6080
MIM180646	*	 	SMALL NUCLEOLAR RNA, H/ACA BOX, 62; SNORA62	6044
MIM180647	*	 	SMALL NUCLEOLAR RNA, H/ACA BOX, 63; SNORA63	6043
MIM180660	*	17p13.1	POLYMERASE II, RNA, SUBUNIT A; POLR2A	5430
MIM180661	*	4q12	POLYMERASE II, RNA, SUBUNIT B; POLR2B	5431
MIM180662	*	19q12	POLYMERASE II, RNA, SUBUNIT I; POLR2I	5438
MIM180663	*	16q13-q21	POLYMERASE II, RNA, SUBUNIT C; POLR2C	5432
MIM180664	*	19p13.3	POLYMERASE II, RNA, SUBUNIT E; POLR2E	5434
MIM180680	*	1p36.3	RNA, U1A SMALL NUCLEAR; RNU1A	6060
MIM180690	*	17q21-q22	RNA, U2 SMALL NUCLEAR, 1; RNU2-1	6066
MIM180691	*	15q22.31	RNA, U5A SMALL NUCLEAR; RNU5A	26831
MIM180692	*	15q23	RNA, U6 SMALL NUCLEAR, 1; RNU6-1	26827
MIM180700	#	 	ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS	7474
MIM180710	*	17p11.2	SMALL NUCLEOLAR RNA, C/D BOX, 3A; SNORD3A	780851
MIM180721	*	11q13	ROD OUTER SEGMENT PROTEIN 1; ROM1	6094
MIM180730		 	ROMBO SYNDROME	 
MIM180740	*	19q13.3	SMALL NUCLEAR RIBONUCLEOPROTEIN, 70-KD; SNRP70	6625
MIM180750	#	 	ROBINOW-SORAUF SYNDROME	7291
MIM180800	#	17p11.2, 1q22	ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	4359, 5376
MIM180849	#	16p13.3	RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	1387, 2033
MIM180860	#	11p15.5, 7p11.2	SILVER-RUSSELL SYNDROME; SRS	140821, 283120, 3481
MIM180870		 	RUVALCABA SYNDROME	 
MIM180900	%	 	RUTHERFURD SYNDROME	 
MIM180901	*	19q13.1	RYANODINE RECEPTOR 1; RYR1	6261
MIM180902	*	1q42.1-q43	RYANODINE RECEPTOR 2; RYR2	6262
MIM180903	*	15q14-q15	RYANODINE RECEPTOR 3; RYR3	6263
MIM180920	#	5p13-p12	APLASIA OF LACRIMAL AND SALIVARY GLANDS; ALSG	2255
MIM180950	%	 	SALIVARY SUBSTANCE, CLOSTRIDIUM BOTULINUM TYPE	 
MIM180960	*	20cen-q13.1	S-ADENOSYLHOMOCYSTEINE HYDROLASE; AHCY	191
MIM180980	*	6q21-q22	S-ADENOSYLMETHIONINE DECARBOXYLASE; AMD1	262
MIM180989	*	12p13.2	PROLINE-RICH PROTEIN, BstNI SUBFAMILY, 1; PRB1	5542
MIM180990	*	12p13.2	PROLINE-RICH PROTEIN, BstNI SUBFAMILY, 4; PRB4	5545
MIM181000	#	6p21.3	SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	3123
MIM181010		 	SALIVARY DUCT CALCULI	 
MIM181030	#	8q12	SALIVARY GLAND ADENOMA, PLEOMORPHIC	5324
MIM181031	*	2q37.1	S-ANTIGEN; SAG	6295
MIM181035	*	12q13-q14	TETRASPANIN 31; TSPAN31	6302
MIM181180		 	SAY SYNDROME	 
MIM181200		 	SC(1) TRAIT OF SALIVA	 
MIM181250		 	SCALP DEFECTS AND POSTAXIAL POLYDACTYLY	 
MIM181270	#	 	SCALP-EAR-NIPPLE SYNDROME	 
MIM181300		 	SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	 
MIM181350	#	1q21.2	EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT; EDMD2	4000
MIM181400	#	2q35	SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE; SCPNK	1674
MIM181405	#	12q24.1	SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	59341
MIM181430	#	14q12	SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM	4625, 8090
MIM181440	%	 	SCHEUERMANN DISEASE	 
MIM181450	#	12q24.1	ULNAR-MAMMARY SYNDROME; UMS	6926
MIM181460	%	5q31-q33	SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	7911
MIM181500	#	1p36.2, 15q15, 14q32.3, 13q34, 13q32, 13q14-q21, 12q24, 11q14-q21, 11p14-p13, 10q22.3, 8p21, 6q13-q26, 1p36.3, 6p22.3, 6p23, 5q23-q35, 3q13.3, 3p25, 1q42.1, 1q42.1, 22q12.3, 22q12.3, 22q11.2, 22q11, 1q32.1, 11p36.2, 15q15, 14q32.3, 13q34, 13q32, 13q14-q21, 12q24, 11q14-q21, 11p14-p13, 10q22.3, 8p21, 6q13-q26, 1p36.3, 6p22.3, 6p23, 5q23-q35, 3q13.3, 3p25, 1q42.1, 1q42.1, 22q12.3, 22q12.3, 22q11.2, 22q11, 1q32.1,	SCHIZOPHRENIA; SCZD	1116, 1312, 1610, 1814, 207, 23780, 267012, 27184, 27185, 3356, 4524, 55366, 65078, 6854, 80832, 84062
MIM181510	%	5q23-q35	SCHIZOPHRENIA 1; SCZD1	6377
MIM181515	%	 	SCHOLTE SYNDROME	 
MIM181590	*	1p32	SCL/TAL1-INTERRUPTING LOCUS; STIL	6491
MIM181600	%	4q23	SCLEROTYLOSIS	7303
MIM181700		 	SCLEROCORNEA, AUTOSOMAL DOMINANT	 
MIM181750	%	 	SCLERODERMA, FAMILIAL PROGRESSIVE	 
MIM181800	%	19p13.3	SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 1; IS1	260402
MIM182000	#	3q26.3	KERATOSIS, SEBORRHEIC	5290
MIM182090	*	18q21	SIMIAN SARCOMA-ASSOCIATED VIRUS-1/GIBBON APE LEUKEMIA VIRUS; SSAV1	6739
MIM182098	*	2q14.1	SECRETIN RECEPTOR; SCTR	6344
MIM182099	*	11p15.5	SECRETIN; SCT	6343
MIM182100	+	19q13.3	FUCOSYLTRANSFERASE 2; FUT2	2524
MIM182115	*	17q25	CYTOHESIN 1; CYTH1	9267
MIM182120	*	5q31.3-q32	SECRETED PROTEIN, ACIDIC, CYSTEINE-RICH; SPARC	6678
MIM182125	*	2p14-p12	SEPIAPTERIN REDUCTASE; SPR	6697
MIM182128	*	 	SERINE DEHYDRATASE; SDS	10993
MIM182131	*	6q13	5-@HYDROXYTRYPTAMINE RECEPTOR 1B; HTR1B	3351
MIM182132	*	6q14-q15	5-@HYDROXYTRYPTAMINE RECEPTOR 1E; HTR1E	3354
MIM182133	*	1p36.3-p34.3	5-@HYDROXYTRYPTAMINE RECEPTOR 1D; HTR1D	3352
MIM182134	*	3p12	5-@HYDROXYTRYPTAMINE RECEPTOR 1F; HTR1F	3355
MIM182135	*	13q14-q21	5-@HYDROXYTRYPTAMINE RECEPTOR 2A; HTR2A	3356
MIM182137	*	10q21-q24	5-@HYDROXYTRYPTAMINE RECEPTOR 7; HTR7	3363
MIM182138	*	17q11.1-q12	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, SEROTONIN), MEMBER 4; SLC6A4	6532
MIM182139	*	11q23.1-q23.2	5-@HYDROXYTRYPTAMINE RECEPTOR 3A; HTR3A	3359
MIM182140	*	20q12-q13.1	SEMENOGELIN; SEMG	6406
MIM182141	*	20q12-q13.1	SEMENOGELIN II; SEMG2	6407
MIM182144	*	17p11.2	SERINE HYDROXYMETHYLTRANSFERASE, CYTOSOLIC; SHMT1	6470
MIM182150		 	SIMOSA CRANIOFACIAL SYNDROME	 
MIM182160	*	16p11.2	SIALOPHORIN; SPN	6693
MIM182170		 	ANEMIA, SIDEROBLASTIC, AUTOSOMAL DOMINANT	 
MIM182175	*	5q21-q22	SIGNAL RECOGNITION PARTICLE, 19-KD; SRP19	6728
MIM182180	*	11q23-q24	SIGNAL RECOGNITION PARTICLE RECEPTOR; SRPR	6734
MIM182200		 	SELLA TURCICA, BRIDGED	 
MIM182205	*	17p13-p12	SEX HORMONE-BINDING GLOBULIN; SHBG	6462
MIM182210		 	SHPRINTZEN OMPHALOCELE SYNDROME	 
MIM182212	#	15q21.1	SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	2200, 6497
MIM182220		 	SISTER CHROMATID EXCHANGE, FREQUENCY OF	 
MIM182230	#	3p21.2-p21.1	SEPTOOPTIC DYSPLASIA	8820
MIM182250	%	 	SINGLETON-MERTEN SYNDROME	 
MIM182255		 	SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	 
MIM182257	*	20q12-q13	PROTEINASE INHIBITOR 3; PI3	5266
MIM182260		 	SLIPPED FEMORAL CAPITAL EPIPHYSES	 
MIM182265	*	1q21-q22	SMALL PROLINE-RICH PROTEIN 1A; SPRR1A	6698
MIM182266	*	1q21-q22	SMALL PROLINE-RICH PROTEIN 1B; SPRR1B	6699
MIM182267	*	1q21-q22	SMALL PROLINE-RICH PROTEIN 2A; SPRR2A	6700
MIM182268	*	1q21-q22	SMALL PROLINE-RICH PROTEIN 2B; SPRR2B	6701
MIM182269		1q21-q22	SMALL PROLINE-RICH PROTEIN 2C; SPRR2C	6702
MIM182271	*	1q21-q22	SMALL PROLINE-RICH PROTEIN 3; SPRR3	6707
MIM182279	*	15q12	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE N; SNRPN	6638
MIM182280	%	3p23-p21	SMALL CELL CANCER OF THE LUNG	5925, 7864
MIM182281	*	Chr.17	CHEMOKINE, CC MOTIF, LIGAND 1; CCL1	6346
MIM182282	*	 	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDES B AND B1; SNRPB	6628
MIM182283	*	17q12	CHEMOKINE, CC MOTIF, LIGAND 3; CCL3	6348
MIM182284	*	17q12	CHEMOKINE, CC MOTIF, LIGAND 4; CCL4	6351
MIM182285	*	19q13.1	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE A; SNRPA	6626
MIM182290	#	17p11.2	SMITH-MAGENIS SYNDROME; SMS	10743
MIM182305	*	2p23-p22	SOLUTE CARRIER FAMILY 8 (SODIUM-CALCIUM EXCHANGER), MEMBER 1; SLC8A1	6546
MIM182307	*	5p15.3	SOLUTE CARRIER FAMILY 9, MEMBER 3; SLC9A3	6550
MIM182308	*	6p23-p21.3	SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 1; SLC17A1	6568
MIM182309	*	5q35	SOLUTE CARRIER FAMILY 34 (SODIUM/PHOSPHATE COTRANSPORTER), MEMBER 1; SLC34A1	6569
MIM182310	*	1p13-p11	ATPase, Na+/K+ TRANSPORTING, ALPHA-1 POLYPEPTIDE; ATP1A1	476
MIM182330	*	1q22-q25	ATPase, Na+/K+ TRANSPORTING, BETA-1 POLYPEPTIDE; ATP1B1	481
MIM182331	*	17p	ATPase, Na+/K+ TRANSPORTING, BETA-2 POLYPEPTIDE; ATP1B2	482
MIM182340	*	1q21-q23	ATPase, Na+/K+ TRANSPORTING, ALPHA-2 POLYPEPTIDE; ATP1A2	477
MIM182350	*	19q12-q13.2	ATPase, Na+/K+ TRANSPORTING, ALPHA-3 POLYPEPTIDE; ATP1A3	478
MIM182360	*	13q12.1-q12.3	ATPase, H+/K+ TRANSPORTING, NONGASTRIC, ALPHA POLYPEPTIDE; ATP12A	479
MIM182380	*	22q13.1	SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 1; SLC5A1	6523
MIM182381	*	16p11.2	SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 2; SLC5A2	6524
MIM182389	*	2q24	SODIUM CHANNEL, NEURONAL TYPE I, ALPHA SUBUNIT; SCN1A	6323
MIM182390	*	2q23-q24.3	SODIUM CHANNEL, VOLTAGE-GATED, TYPE II, ALPHA SUBUNIT; SCN2A	6326
MIM182391	*	2q24	SODIUM CHANNEL, VOLTAGE-GATED, TYPE III, ALPHA SUBUNIT; SCN3A	6328
MIM182392	*	2q21-q23	SODIUM CHANNEL, VOLTAGE-GATED, TYPE VII, ALPHA SUBUNIT; SCN7A	6332
MIM182396	*	14q24.1	SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 1; SLC10A1	6554
MIM182410	#	 	SNEDDON SYNDROME	 
MIM182450	*	3q28	SOMATOSTATIN; SST	6750
MIM182451	*	14q13	SOMATOSTATIN RECEPTOR 1; SSTR1	6751
MIM182452	*	17q24	SOMATOSTATIN RECEPTOR 2; SSTR2	6752
MIM182453	*	22q13.1	SOMATOSTATIN RECEPTOR 3; SSTR3	6753
MIM182454	*	20p11.2	SOMATOSTATIN RECEPTOR 4; SSTR4	6754
MIM182455	*	16p13.3	SOMATOSTATIN RECEPTOR 5; SSTR5	6755
MIM182465	*	21q22.1-q22.2	SON DNA-BINDING PROTEIN; SON	6651
MIM182500	*	15q15.3	SORBITOL DEHYDROGENASE; SORD	6652
MIM182520	*	7q21.1	SORCIN; SRI	6717
MIM182530	*	2p22-p21	SON OF SEVENLESS, DROSOPHILA, HOMOLOG 1; SOS1	6654
MIM182590	*	21q22.3	TREFOIL FACTOR 2; TFF2	7032
MIM182600	#	14q11-q21	SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A	51062
MIM182601	#	2p22-p21	SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4	6683
MIM182610		 	SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	 
MIM182690		 	SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND PROGRESSIVE NEPHROPATHY	 
MIM182790	*	2p21	SPECTRIN, BETA, NONERYTHROCYTIC, 1; SPTBN1	6711
MIM182800		 	SPASTIC PARAPLEGIA WITH ASSOCIATED EXTRAPYRAMIDAL SIGNS	 
MIM182810	*	9q33-q34	SPECTRIN, ALPHA, NONERYTHROCYTIC 1; SPTAN1	6709
MIM182815		 	SPASTIC PARAPLEGIA WITH NEUROPATHY AND POIKILODERMA	 
MIM182820		 	SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	 
MIM182830		 	SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA	 
MIM182860	*	1q21	SPECTRIN, ALPHA, ERYTHROCYTIC 1; SPTA1	6708
MIM182870	+	14q22-q23.2	SPECTRIN, BETA, ERYTHROCYTIC; SPTB	6710
MIM182878	*	8q22	OUTER DENSE FIBER OF SPERM TAILS 1; ODF1	4956
MIM182880	*	16p13.3	SPERM PROTAMINE P1; PRM1	5619
MIM182888	*	16p12	ZONA PELLUCIDA GLYCOPROTEIN 2; ZP2	7783
MIM182889	*	7q11.23	ZONA PELLUCIDA GLYCOPROTEIN 3; ZP3	7784
MIM182890	*	16p13.3	SPERM PROTAMINE P2; PRM2	5620
MIM182891	*	1p36-p22	SPERMIDINE SYNTHASE; SRM	6723
MIM182900	#	8p11.2	SPHEROCYTOSIS, TYPE 1; SPH1	286
MIM182920	#	5q31	MYOPATHY, SPHEROID BODY	9499
MIM182930	^	 	MOVED TO 167800	 
MIM182940	#	17q11.2-q12, 1p13, 6q27	NEURAL TUBE DEFECTS	6347, 6862, 80199, 81839
MIM182950	%	 	SPINAL ARACHNOIDITIS	 
MIM182970	%	 	SPINAL MUSCULAR ATROPHY, FACIOSCAPULOHUMERAL TYPE	 
MIM182980	#	20q13.3	SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL DOMINANT	9217
MIM182990		 	SPINAL INTRADURAL ARACHNOID CYSTS	 
MIM183000	^	 	MOVED TO 137440	 
MIM183020		 	SPINAL MUSCULAR ATROPHY, SEGMENTAL	 
MIM183050	%	 	SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	 
MIM183086	#	19p13	SPINOCEREBELLAR ATAXIA 6; SCA6	773
MIM183090	#	12q24	SPINOCEREBELLAR ATAXIA 2; SCA2	6311
MIM183100		 	SPINOCEREBELLAR ATROPHY WITH PUPILLARY PARALYSIS	 
MIM183300		 	SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	 
MIM183350		 	SPLENOMEGALY SYNDROME WITH SPLENIC GERMINAL CENTER HYPOPLASIA AND REDUCED CIRCULATING T-HELPER CELLS	 
MIM183400		 	SPLIT LOWER LIP	 
MIM183500		 	SPLIT-HAND AND SPLIT-FOOT WITH HYPODONTIA	 
MIM183600	#	7q21.2-q21.3	SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	7979
MIM183700		 	SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	 
MIM183800		 	SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS	 
MIM183802		 	SPLIT-HAND WITH OBSTRUCTIVE UROPATHY, SPINA BIFIDA, AND DIAPHRAGMATIC DEFECTS	 
MIM183840	%	9q31-q34	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2; SPDA2	791255
MIM183849		 	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH HYPOTRICHOSIS	 
MIM183850		 	SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	 
MIM183900	#	12q13.11-q13.2	SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA; SEDC	1280
MIM184000		 	SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	 
MIM184095	#	 	SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE	59341
MIM184100	%	 	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT	 
MIM184200		 	SPONDYLOLISTHESIS	 
MIM184250	#	12q13.11-q13.2	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK	1280
MIM184252	#	12q24.1	SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE; SMDK	59341
MIM184253		 	SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	 
MIM184255	%	 	SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE	 
MIM184260		 	SPONDYLOMETAPHYSEAL DYSPLASIA WITH DENTINOGENESIS IMPERFECTA	 
MIM184300		 	SPONDYLOSIS, CERVICAL	 
MIM184400	%	 	SPRENGEL DEFORMITY	 
MIM184420	*	8p23.1-p22	FARNESYLDIPHOSPHATE FARNESYLTRANSFERASE 1; FDFT1	2222
MIM184429	*	3q26.3-q27	SRY-BOX 2; SOX2	6657
MIM184430	*	6p22.3	SRY-BOX 4; SOX4	6659
MIM184450	%	18p11.3-p11.2	STUTTERING, FAMILIAL PERSISTENT, 1; STUT1	100049541
MIM184460	#	17q22	STAPES ANKYLOSIS WITH BROAD THUMB AND TOES	9241
MIM184470	*	4q11-q13	STATHERIN; STATH	6779
MIM184500	#	17q12-q21	STEATOCYSTOMA MULTIPLEX	3872
MIM184510		 	STEATOCYSTOMA MULTIPLEX WITH NATAL TEETH	 
MIM184600	*	3q21	CYSTATIN A; CSTA	1475
MIM184700	%	5q11.2	POLYCYSTIC OVARY SYNDROME 1; PCOS1	5120
MIM184705		 	STEINFELD SYNDROME	 
MIM184745	*	12q22	KIT LIGAND; KITLG	4254
MIM184753	*	5p15	STEROID 5-ALPHA-REDUCTASE 1; SRD5A1	6715
MIM184755	*	1p32	STEROL CARRIER PROTEIN 2; SCP2	6342
MIM184756	*	17p11.2	STEROL REGULATORY ELEMENT-BINDING TRANSCRIPTION FACTOR 1; SREBF1	6720
MIM184757	+	9q33	NUCLEAR RECEPTOR SUBFAMILY 5, GROUP A, MEMBER 1; NR5A1	2516
MIM184800		 	STERNUM, PREMATURE OBLITERATION OF SUTURES OF	 
MIM184840	#	6p21.3	STICKLER SYNDROME, TYPE III; STL3	1302
MIM184850	%	 	STIFF-PERSON SYNDROME; SPS	 
MIM184900	#	15q21.1	STIFF SKIN SYNDROME; SSKS	2200
MIM185000	%	9q34.1	STOMATOCYTOSIS I	2040
MIM185010	^	 	STOMATOCYTOSIS II	 
MIM185020		 	PSEUDOHYPERKALEMIA CARDIFF	 
MIM185050	%	 	STORAGE POOL PLATELET DISEASE	 
MIM185069		 	STORM SYNDROME	 
MIM185070	#	 	STORMORKEN SYNDROME	 
MIM185100	%	7p22.1	STRABISMUS, SUSCEPTIBILITY TO	100188805
MIM185120		 	STRATTON-PARKER SYNDROME	 
MIM185200	%	 	STRIAE DISTENSAE, FAMILIAL	 
MIM185250	*	11q23	MATRIX METALLOPROTEINASE 3; MMP3	4314
MIM185260	*	11q22.3-q23	MATRIX METALLOPROTEINASE 10; MMP10	4319
MIM185261	*	22q11.2	MATRIX METALLOPROTEINASE 11; MMP11	4320
MIM185300	#	 	STURGE-WEBER SYNDROME; SWS	 
MIM185400	^	 	MOVED TO 150360	 
MIM185430	*	8p21-p12	CLUSTERIN; CLU	1191
MIM185440	*	11p14.3-p12	SUPPRESSOR OF TUMORIGENICITY 2; ST2	6761
MIM185450	^	 	REMOVED FROM DATABASE	 
MIM185460		 	SULFHEMOGLOBINEMIA, CONGENITAL	 
MIM185470	*	1p36.1-p35	SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT B, IRON SULFUR PROTEIN; SDHB	6390
MIM185480		 	SUPRABULBAR PARESIS, CONGENITAL	 
MIM185490	*	4p15.3-p15.1	SUPEROXIDE DISMUTASE 3; SOD3	6649
MIM185500	#	7q11.2	SUPRAVALVULAR AORTIC STENOSIS; SVAS	2006
MIM185535	*	2p21	EPITHELIAL CELLULAR ADHESION MOLECULE; EPCAM	4072
MIM185600		 	SYMPHALANGISM OF TOES	 
MIM185605	*	12cen-q21	SYNAPTOTAGMIN 1; SYT1	6857
MIM185620	*	9q34	SURFEIT 1; SURF1	6834
MIM185630	*	9q34	SURFEIT 2; SURF2	6835
MIM185640	*	9q34	RIBOSOMAL PROTEIN L7a; RPL7A	6130
MIM185641	*	9q34	MEDIATOR COMPLEX SUBUNIT 22; MED22	6837
MIM185642	*	9q34	SURFEIT 6; SURF6	6838
MIM185650		 	SYMPHALANGISM, C. S. LEWIS TYPE	 
MIM185660	*	9q34	SURFEIT 4; SURF4	6836
MIM185700	%	 	SYMPHALANGISM, DISTAL	 
MIM185750		 	SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	 
MIM185800	#	20q11.2, 17q22	SYMPHALANGISM, PROXIMAL; SYM1	8200, 9241
MIM185860	*	 	SYNAPTIC VESICLE GLYCOPROTEIN 2A; SV2A	9900
MIM185861	*	 	SYNAPTIC VESICLE GLYCOPROTEIN 2B; SV2B	9899
MIM185880	*	12p	VESICLE-ASSOCIATED MEMBRANE PROTEIN 1; VAMP1	6843
MIM185881	*	17p12	VESICLE-ASSOCIATED MEMBRANE PROTEIN 2; VAMP2	6844
MIM185900	#	2q34-q36	SYNDACTYLY, TYPE I	57306
MIM186000	#	2q31-q32	SYNPOLYDACTYLY 1; SPD1	3239
MIM186100	#	6q21-q23.2	SYNDACTYLY, TYPE III	2697
MIM186200	#	7q36	SYNDACTYLY, TYPE IV	64327
MIM186300	#	2q31-q32	SYNDACTYLY, TYPE V	3239
MIM186350	%	 	SYNDACTYLY-POLYDACTYLY-EARLOBE SYNDROME	 
MIM186355	*	2p24.1	SYNDECAN 1; SDC1	6382
MIM186357	*	1pter-p22.3	SYNDECAN 3; SDC3	9672
MIM186360	*	10q21.1-q21.2	ANNEXIN A7; ANXA7	310
MIM186400	%	 	SYNOSTOSES, TARSAL, CARPAL, AND DIGITAL	 
MIM186500	#	17q22	MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1	9241
MIM186550	#	 	SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	 
MIM186570	#	17q22	TARSAL-CARPAL COALITION SYNDROME; TCC	9241
MIM186575		 	SYNOVIAL CHONDROMATOSIS, FAMILIAL, WITH DWARFISM	 
MIM186580	#	16q12	BLAU SYNDROME	64127
MIM186590	*	7q11.2	SYNTAXIN 1A; STX1A	6804
MIM186591	*	16p11.2	SYNTAXIN 4; STX4	6810
MIM186600		 	SYRINGOMAS, MULTIPLE	 
MIM186700	%	 	SYRINGOMYELIA, ISOLATED	 
MIM186710	*	11pter-p11.2	T-CELL ACTIVATION ANTIGEN p250; TP250	8041
MIM186711	*	12p13	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 7; TNFRSF7	939
MIM186720	*	Chr.11	CD6 ANTIGEN; CD6	923
MIM186730	*	2p12	CD8 ANTIGEN, BETA POLYPEPTIDE; CD8B	926
MIM186740	*	11q23	CD3 ANTIGEN, GAMMA SUBUNIT; CD3G	917
MIM186745	*	9p	TALIN 1; TLN1	7094
MIM186750		 	TALONAVICULAR COALITION	 
MIM186760	*	2q33-q34	ANTIGEN CD28; CD28	940
MIM186770	*	10q24	T-CELL LEUKEMIA, HOMEOBOX 1; TLX1	3195
MIM186780	*	1q22-q23	CD247 ANTIGEN; CD247	919
MIM186790	*	11q23	CD3 ANTIGEN, DELTA SUBUNIT; CD3D	915
MIM186810	*	14q11.2	T-CELL ANTIGEN RECEPTOR, DELTA SUBUNIT; TCRD	6964
MIM186820	*	17q25.2-q25.3	T-CELL ANTIGEN CD7; CD7	924
MIM186830	*	11q23	CD3 ANTIGEN, EPSILON SUBUNIT; CD3E	916
MIM186845	*	11p	CD81 ANTIGEN; CD81	975
MIM186850	%	 	TARSAL COALITION	 
MIM186852	*	11p13-p12	PROTEASOME 26S SUBUNIT, ATPase, 3; PSMC3	5702
MIM186854	*	3p25-q24	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, TAURINE), MEMBER 6; SLC6A6	6533
MIM186855	*	9q31	T-CELL ACUTE LYMPHOCYTIC LEUKEMIA 2; TAL2	6887
MIM186860	*	2q34	T-CELL LEUKEMIA/LYMPHOMA 4; TCL4	6946
MIM186880	*	14q11.2	T-CELL ANTIGEN RECEPTOR, ALPHA SUBUNIT; TCRA	6955
MIM186910	*	2p12	CD8 ANTIGEN, ALPHA POLYPEPTIDE; CD8A	925
MIM186921	*	11p15	LIM DOMAIN ONLY 1; LMO1	4004
MIM186930	*	7q35	T-CELL ANTIGEN RECEPTOR, BETA SUBUNIT; TCRB	6957
MIM186940	*	12pter-p12	CD4 ANTIGEN; CD4	920
MIM186945	*	20p13	FK506-BINDING PROTEIN 1A; FKBP1A	2280
MIM186946	*	11q13.1-q13.3	FK506-BINDING PROTEIN 2; FKBP2	2286
MIM186947	*	 	FK506-BINDING PROTEIN 3; FKBP3	2287
MIM186950		 	T-CELL SUBGROUPS, NON-HLA-LINKED	 
MIM186960	*	14q32.1	T-CELL LEUKEMIA/LYMPHOMA 1A; TCL1A	8115
MIM186970	*	7p15-p14	T-CELL ANTIGEN RECEPTOR, GAMMA SUBUNIT; TCRG	6965
MIM186973	*	5q32	IL2-INDUCIBLE T-CELL KINASE; ITK	3702
MIM186975	*	6p21.3-cen	T COMPLEX-ASSOCIATED TESTIS-EXPRESSED 1; TCTE1	202500
MIM186977	*	6q27	T COMPLEX-ASSOCIATED TESTIS-EXPRESSED 3; TCTE3	6991
MIM186980	*	6q25.3-q26	T-COMPLEX 1; TCP1	6950
MIM186982	*	6p21.3-p21.2	T-COMPLEX HOMOLOG TCP11; TCP11	6954
MIM186990	*	1p13.1	T-LYMPHOCYTE SURFACE CD2 ANTIGEN; CD2	914
MIM187000	%	 	TEETH, ODD SHAPES OF	 
MIM187011	*	17q11.2-q12	CHEMOKINE, CC MOTIF, LIGAND 5; CCL5	6352
MIM187020	*	6q27	T-COMPLEX 10; TCP10	6953
MIM187040	*	1p32	T-CELL ACUTE LYMPHOCYTIC LEUKEMIA 1; TAL1	6886
MIM187050		 	TEETH PRESENT AT BIRTH	 
MIM187100		 	TEETH, SUPERNUMERARY	 
MIM187260	%	 	TELANGIECTASIA, HEREDITARY BENIGN	338411
MIM187270	+	5p15.33	TELOMERASE REVERSE TRANSCRIPTASE; TERT	7015
MIM187280	*	8q21	TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, tsBN51; BN51T	661
MIM187290		Chr.9	TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, H142; H142T	8023
MIM187300	#	9q34.1	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER; HHT	2022, 4089, 94
MIM187310		Chr.14	TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, K12	3729
MIM187320		Chr.4	TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, ts13; TS13	7896
MIM187330		Chr.6	TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, ts546; TS546	7963
MIM187340		 	TEMPERATURE-SENSITIVE LETHAL MUTATION	 
MIM187350		 	TELECANTHUS	 
MIM187360		 	TEMPORAL ARTERITIS	 
MIM187370	%	 	ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10	 
MIM187380	*	9q33	TENASCIN C; TNC	3371
MIM187390		 	TENDONS, EXTENSOR, OF FINGERS, ANOMALOUS INSERTION OF	 
MIM187395	+	3p23-p21	TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	6997
MIM187400		 	TESTICULAR TORSION	 
MIM187410	*	10q23-q24	DEOXYNUCLEOTIDYLTRANSFERASE, TERMINAL; DNTT	1791
MIM187430	*	6p12	CYSTEINE-RICH SECRETORY PROTEIN 2; CRISP2	7180
MIM187500	#	8q23, 5q34, 20p12, 19p12	TETRALOGY OF FALLOT; TOF	1482, 182, 23414, 2627, 2657
MIM187501		 	TETRALOGY OF FALLOT AND GLAUCOMA	 
MIM187510		 	TETRAMELIC MONODACTYLY	 
MIM187520	*	3p22-p21.3	TETRANECTIN; TNA	7123
MIM187600	#	4p16.3	THANATOPHORIC DYSPLASIA, TYPE I; TD1	2261
MIM187601	#	 	THANATOPHORIC DYSPLASIA, TYPE II; TD2	2261
MIM187680	*	6p22.3	THIOPURINE S-METHYLTRANSFERASE; TPMT	7172
MIM187700	*	9q31	THIOREDOXIN; TXN	7295
MIM187750		 	THORACIC DYSOSTOSIS, ISOLATED	 
MIM187760		 	THORACOLARYNGOPELVIC DYSPLASIA; TLPD	 
MIM187770		 	THORACOPELVIC DYSOSTOSIS	 
MIM187790	*	5p13-cen	THREONYL-tRNA SYNTHETASE; TARS	6897
MIM187800	#	 	GLANZMANN THROMBASTHENIA, AUTOSOMAL DOMINANT	 
MIM187900	#	 	THROMBASTHENIA-THROMBOCYTOPENIA, HEREDITARY	 
MIM187930	*	5q13	COAGULATION FACTOR II RECEPTOR; F2R	2149
MIM187950	#	9p24, 1p34, 3q26.3-q27	THROMBOCYTHEMIA 1; THCYT1	10019, 3717, 4352, 7066
MIM188000	#	10p12.1	THROMBOCYTOPENIA 2; THC2	22852, 84930
MIM188020		 	THROMBOCYTOPENIA, CYCLIC	 
MIM188025	#	11q23	THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT	140892
MIM188030		1q23	THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP	9103
MIM188035	*	4q12-q13	PRO-PLATELET BASIC PROTEIN-LIKE 1; PPBPL1	728045
MIM188040	*	20p11.2	THROMBOMODULIN; THBD	7056
MIM188050	#	11p11-q12, 10q25-q26, 1p36.3	THROMBOPHILIA DUE TO THROMBIN DEFECT; THPH1	2147, 2153, 2162, 3026, 4524
MIM188055	#	1q23	THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE; THPH2	2147, 2153
MIM188060	*	15q15	THROMBOSPONDIN I; THBS1	7057
MIM188061	*	6q27	THROMBOSPONDIN II; THBS2	7058
MIM188062	*	1q21	THROMBOSPONDIN III; THBS3	7059
MIM188070	*	19p13.3	THROMBOXANE A2 RECEPTOR, PLATELET; TBXA2R	6915
MIM188100		 	THUMB DEFORMITY	 
MIM188150		 	THUMB DEFORMITY AND ALOPECIA	 
MIM188200	^	 	MOVED TO 107000	 
MIM188201		 	THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	 
MIM188230	*	11q23.3	THY-1 T-CELL ANTIGEN; THY1	7070
MIM188250	*	16q22	THYMIDINE KINASE, MITOCHONDRIAL; TK2	7084
MIM188300	*	17q25.2-q25.3	THYMIDINE KINASE, SOLUBLE; TK1	7083
MIM188340	*	1q21-q23	THYMOCYTE ANTIGEN CD1C; CD1C	911
MIM188345	*	 	DEOXYTHYMIDYLATE KINASE; DTYMK	1841
MIM188350	*	18p11.32	THYMIDYLATE SYNTHETASE; TYMS	7298
MIM188360	*	1q21-q23	THYMOCYTE ANTIGEN CD1B; CD1B	910
MIM188370	*	1q21-q23	THYMOCYTE ANTIGEN CD1A; CD1A	909
MIM188380	*	12q22	THYMOPOIETIN; TMPO	7112
MIM188390	*	2q36-q37	PROTHYMOSIN, ALPHA; PTMA	5757
MIM188399	*	 	THYMOSIN, BETA-10; TMSB10	9168
MIM188400	#	22q11.2	DIGEORGE SYNDROME; DGS	1714, 6899
MIM188410	*	1q21-q23	THYMOCYTE ANTIGEN CD1D; CD1D	912
MIM188411	*	1q21-q23	THYMOCYTE ANTIGEN CD1E; CD1E	913
MIM188450	*	8q24.2-q24.3	THYROGLOBULIN; TG	7038
MIM188455		 	THYROGLOSSAL DUCT CYST, FAMILIAL	 
MIM188470	%	11p15.5, 10q23, 1p13.2	THYROID CARCINOMA, FOLLICULAR; FTC	3265, 4893, 5728, 9562
MIM188540	*	1p13	THYROID-STIMULATING HORMONE, BETA CHAIN; TSHB	7252
MIM188545	+	8q23	THYROTROPIN-RELEASING HORMONE RECEPTOR; TRHR	7201
MIM188550	#	14q, 10q21, 10q11.2, 1p13, 8p22-p21.3, 7q32-q34, 17q23-q24	THYROID CARCINOMA, PAPILLARY	5108, 51592, 5573, 8030, 8031, 8805, 9950
MIM188560		 	THYROID HORMONE PLASMA MEMBRANE TRANSPORT DEFECT	 
MIM188570	#	3p24.3	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT; GRTH	7068
MIM188580	#	1q32	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1	779
MIM188595	*	22q13	THYROTROPH EMBRYONIC FACTOR; TEF	7008
MIM188700		 	BLOUNT DISEASE, INFANTILE	 
MIM188740	#	 	TIBIA, ABSENCE OF, WITH POLYDACTYLY	 
MIM188770	^	 	TIBIA, HYPOPLASIA OF, WITH POLYDACTYLY	 
MIM188800	%	 	TIBIAL TORSION, BILATERAL MEDIAL	 
MIM188825	*	17q25	TISSUE INHIBITOR OF METALLOPROTEINASE 2; TIMP2	7077
MIM188826	*	22q12.1-q13.2	TISSUE INHIBITOR OF METALLOPROTEINASE 3; TIMP3	7078
MIM188830	*	17q23-q24	PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE I, ALPHA; PRKAR1A	5573
MIM188840	*	2q31	TITIN; TTN	7273
MIM188855	*	2p12-q11	GRANULYSIN; GNLY	10578
MIM188860	*	2cen-q13	MYELIN AND LYMPHOCYTE PROTEIN; MAL	4118
MIM188890	#	9q22.1, 5p15.3, 20q13.2-q13.3, 19q13.2	TOBACCO ADDICTION, SUSCEPTIBILITY TO	1137, 1548, 6531, 9568
MIM189000		 	TOE, FIFTH, NUMBER OF PHALANGES IN	 
MIM189100		 	TOE, MISSHAPEN	 
MIM189150		 	TOE, ROTATED FIFTH	 
MIM189200		 	TOES, RELATIVE LENGTH OF FIRST AND SECOND	 
MIM189230		 	TOES, SPACE BETWEEN FIRST AND SECOND	 
MIM189300		 	TONGUE CURLING, FOLDING, OR ROLLING	 
MIM189490		 	MALPOSITION OF TEETH WITH OR WITHOUT HYPODONTIA/OLIGODONTIA	 
MIM189500	#	4p16.1	WITKOP SYNDROME	4487
MIM189600		 	TORTICOLLIS	 
MIM189700	%	 	TORUS PALATINUS AND TORUS MANDIBULARIS	 
MIM189800	%	7q36, 2p13, 1q42.1	PREECLAMPSIA/ECLAMPSIA 1; PEE1	2052, 4846, 5177
MIM189880	*	1p36.1	TRANSFER RNA ASPARAGINE 1; TRNAN1	7214
MIM189889	*	12q13	TRANSCRIPTION FACTOR CP2; TFCP2	7024
MIM189901	*	2p11.2-p11.1	TRANSCRIPTION FACTOR 9; TCF9	6936
MIM189902	*	13q34	TRANSCRIPTION FACTOR DP1; TFDP1	7027
MIM189903	*	6p21.3	NUCLEAR TRANSCRIPTION FACTOR Y, ALPHA; NFYA	4800
MIM189904	*	12q22-q23	NUCLEAR TRANSCRIPTION FACTOR Y, BETA; NFYB	4801
MIM189905	*	11q11-q12	TRANSCOBALAMIN I; TCN1	6947
MIM189906	*	12q13.1	TRANSCRIPTION FACTOR Sp1; SP1	6667
MIM189907	*	17q12	HNF1 HOMEOBOX B; HNF1B	6928
MIM189908	*	5q31.1	TRANSCRIPTION FACTOR 7; TCF7	6932
MIM189909	*	10p11.2	ZINC FINGER E BOX-BINDING HOMEOBOX 1; ZEB1	6935
MIM189910	*	 	TRANSFER RNA SERINE 2; TRNAS2	23437
MIM189911	*	Chr.16	TRANSFER RNA GLYCINE 1; TRNAG1	7195
MIM189912	*	Chr.5	TRANSFER RNA PROLINE 3; TRNAP3	7219
MIM189913	*	Chr.5	TRANSFER RNA THREONINE 1; TRNAT1	7236
MIM189918	*	17p13.1	TRANSFER RNA LYSINE 1 (ANTICODON UUU); TRNAK1	7206
MIM189919	*	17p13.1	TRANSFER RNA GLUTAMINE 1; TRNAQ1	7228
MIM189920	*	17p13.1	TRANSFER RNA LEUCINE 2; TRNAL2	7208
MIM189921	*	 	TRANSFER RNA VALINE 1; TRNAV1	7239
MIM189923	*	 	TRANSFER RNA GLUTAMINE 2; TRNAQ2	7229
MIM189930	*	14q11	TRANSFER RNA PROLINE 1; TRNAP1	7217
MIM189931	*	14q11-q12	TRANSFER RNA PROLINE 2; TRNAP2	7218
MIM189932	*	14q11-q12	TRANSFER RNA LEUCINE 1; TRNAL1	7207
MIM189933	*	14q11-q12	TRANSFER RNA THREONINE 2; TRNAT2	7237
MIM189940	*	1q25	TRANSLOCATED PROMOTER REGION; TPR	7175
MIM189960		 	TRACHEOESOPHAGEAL FISTULA WITH OR WITHOUT ESOPHAGEAL ATRESIA	 
MIM189961		 	TRACHEOPATHIA OSTEOPLASTICA	 
MIM189962	*	 	GENERAL TRANSCRIPTION FACTOR IIE, POLYPEPTIDE 1; GTF2E1	2960
MIM189963	*	1p22-p21	GENERAL TRANSCRIPTION FACTOR IIB; GTF2B	2959
MIM189964	*	8p21-p12	GENERAL TRANSCRIPTION FACTOR IIE, POLYPEPTIDE 2; GTF2E2	2961
MIM189965	*	20q13.1	CCAAT/ENHANCER-BINDING PROTEIN, BETA; CEBPB	1051
MIM189967	*	11p15.2	TEA DOMAIN FAMILY MEMBER 1; TEAD1	7003
MIM189968	*	19p13.3	GENERAL TRANSCRIPTION FACTOR IIF, POLYPEPTIDE 1, 74-KD; GTF2F1	2962
MIM189969	*	 	GENERAL TRANSCRIPTION FACTOR IIF, POLYPEPTIDE 2, 30-KD; GTF2F2	2963
MIM189970	*	7q21.3	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-TRANSDUCING ACTIVITY POLYPEPTIDE 1; GNGT1	2792
MIM189971	*	20q11.2	E2F TRANSCRIPTION FACTOR 1; E2F1	1869
MIM189972	*	11p15.1-p14	GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 1; GTF2H1	2965
MIM189973	*	 	E74-LIKE FACTOR 1; ELF1	1997
MIM189980	*	9q34.1	ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; ABL1	25
MIM189990	*	6q22	V-MYB AVIAN MYELOBLASTOSIS VIRAL ONCOGENE HOMOLOG; MYB	4602
MIM190000	*	6p21.3, 3q21	TRANSFERRIN; TF	7018
MIM190010	*	3q29	TRANSFERRIN RECEPTOR; TFRC	7037
MIM190020	*	11p15.5	V-HA-RAS HARVEY RAT SARCOMA VIRAL ONCOGENE HOMOLOG; HRAS	3265
MIM190030	*	15q26.1	V-FES FELINE SARCOMA VIRAL/V-FPS FUJINAMI AVIAN SARCOMA VIRAL ONCOGENE HOMOLOG; FES	2242
MIM190040	*	22q12.3-q13.1	PLATELET-DERIVED GROWTH FACTOR, BETA POLYPEPTIDE; PDGFB	5155
MIM190060	*	8q11	V-MOS MOLONEY MURINE SARCOMA VIRAL ONCOGENE HOMOLOG; MOS	4342
MIM190070	*	12p12.1	V-KI-RAS2 KIRSTEN RAT SARCOMA VIRAL ONCOGENE HOMOLOG; KRAS	3845
MIM190080	*	8q24.12-q24.13	V-MYC AVIAN MYELOCYTOMATOSIS VIRAL ONCOGENE HOMOLOG; MYC	4609
MIM190090	*	20q12-q13	V-SRC AVIAN SARCOMA (SCHMIDT-RUPPIN A-2) VIRAL ONCOGENE; SRC	6714
MIM190100	%	9q13-q21	GENIOSPASM 1; GSM1	2933
MIM190120	*	17q11.2	THYROID HORMONE RECEPTOR, ALPHA-1; THRA	7067
MIM190151	*	12q13	V-ERB-B2 AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 3; ERBB3	2065
MIM190160	*	3p24.3	THYROID HORMONE RECEPTOR, BETA; THRB	7068
MIM190170	*	2p13	TRANSFORMING GROWTH FACTOR, ALPHA; TGFA	7039
MIM190180	*	19q13.1	TRANSFORMING GROWTH FACTOR, BETA-1; TGFB1	7040
MIM190181	*	9q22	TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE I; TGFBR1	7046
MIM190182	*	3p22	TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE II; TGFBR2	7048
MIM190195	*	14q11.2	TRANSGLUTAMINASE 1; TGM1	7051
MIM190196	*	20q11.2-q12	TRANSGLUTAMINASE 2; TGM2	7052
MIM190197	*	1q32.1	CONTACTIN 2; CNTN2	6900
MIM190198	*	9q34.3	NOTCH, DROSOPHILA, HOMOLOG OF, 1; NOTCH1	4851
MIM190200		 	TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	 
MIM190220	*	1q41	TRANSFORMING GROWTH FACTOR, BETA-2; TGFB2	7042
MIM190230	*	14q24	TRANSFORMING GROWTH FACTOR, BETA-3; TGFB3	7043
MIM190231	*	2q35-q36	TRANSITION PROTEIN 1; TNP1	7141
MIM190232	*	16p13.3	TRANSITION PROTEIN 2; TNP2	7142
MIM190300	#	3q13.3	TREMOR, HEREDITARY ESSENTIAL, 1; ETM1	1814
MIM190310	%	 	TREMOR, NYSTAGMUS, AND DUODENAL ULCER	 
MIM190315	*	22q11	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, CITRATE TRANSPORTER), MEMBER 1; SLC25A1	6576
MIM190320	#	17q21.3-q22	TRICHODENTOOSSEOUS SYNDROME	1747
MIM190330	#	 	TRICHOMEGALY	 
MIM190340	%	 	DISCOID FIBROMAS, FAMILIAL MULTIPLE; FMDF	 
MIM190345		 	TRICHOEPITHELIOMAS, MULTIPLE DESMOPLASTIC	 
MIM190350	#	8q24.12	TRICHORHINOPHALANGEAL SYNDROME, TYPE I; TRPS1	7227
MIM190351	#	8q24.12	TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	7227
MIM190360		 	TRICHODYSPLASIA-XERODERMA	 
MIM190370	*	1q21.3	TRICHOHYALIN; TCHH	7062
MIM190400		 	TRIGEMINAL NEURALGIA	 
MIM190410		 	TRIGGER THUMB	 
MIM190440	#	8p11.2-p11.1	TRIGONOCEPHALY 1; TRIGNO1	2260
MIM190445		 	TRIIODOTHYRONINE RECEPTOR AUXILIARY PROTEIN; TRAP	100187907
MIM190450	*	12p13	TRIOSEPHOSPHATE ISOMERASE 1; TPI1	7167
MIM190470	*	13q32-q33	TRIPEPTIDYL PEPTIDASE II; TPP2	7174
MIM190500		 	TRIPHALANGEAL THUMB WITH DOUBLE PHALANGES	 
MIM190600	%	 	TRIPHALANGEAL THUMB, NONOPPOSABLE	 
MIM190605	^	 	MOVED TO 174500	 
MIM190650		 	TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA	 
MIM190680	%	 	TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY	 
MIM190685	#	1q43, Xp11.23, 21q22.3	DOWN SYNDROME	1637, 2623, 4548
MIM190700	*	19q13.1	ZINC FINGER PROTEIN 36, MOUSE, HOMOLOG OF; ZFP36	7538
MIM190800		 	TRISTICHIASIS	 
MIM190900	#	7q31.3-q32	TRITANOPIA	611
MIM190920	*	6q14-q15	TROPHOBLAST GLYCOPROTEIN; TPBG	7162
MIM190930	*	9q22.3	TROPOMODULIN; TMOD	7111
MIM190990	*	9p13.2-p13.1	TROPOMYOSIN 2; TPM2	7169
MIM191000		 	TROCHLEA OF THE HUMERUS, APLASIA OF	 
MIM191010	*	15q22.1	TROPOMYOSIN 1; TPM1	7168
MIM191030	*	1q22-q23	TROPOMYOSIN 3; TPM3	7170
MIM191039	*	20q12-q13.11	TROPONIN C, FAST; TNNC2	7125
MIM191040	*	3p21.3-p14.3	TROPONIN C, SLOW; TNNC1	7134
MIM191041	*	19q13.4	TROPONIN T1, SKELETAL, SLOW; TNNT1	7138
MIM191042	*	1q31.3	TROPONIN I, SLOW-TWITCH SKELETAL MUSCLE ISOFORM; TNNI1	7135
MIM191043	*	11p15.5	TROPONIN I, FAST-TWITCH SKELETAL MUSCLE ISOFORM; TNNI2	7136
MIM191044	*	19q13.4	TROPONIN I, CARDIAC; TNNI3	7137
MIM191045	*	1q32	TROPONIN T2, CARDIAC; TNNT2	7139
MIM191050	*	14q32.31	TRYPTOPHANYL-tRNA SYNTHETASE; WARS	7453
MIM191060	*	11p15.3-p14	TRYPTOPHAN HYDROXYLASE 1; TPH1	7166
MIM191070	*	4q31-q32	TRYPTOPHAN 2,3-DIOXYGENASE; TDO2	6999
MIM191080	*	16p13.3	TRYPTASE, ALPHA/BETA-1; TPSAB1	7177
MIM191081	*	16p13.3	TRYPTASE, BETA-2; TPSB2	64499
MIM191090	^	 	MOVED TO 191100	 
MIM191091	^	 	MOVED TO 191100	 
MIM191092	*	16p13.3	TSC2 GENE; TSC2	7249
MIM191100	#	16p13.3, 9q34	TUBEROUS SCLEROSIS 1; TSC1	7248, 7249
MIM191110	*	 	TUBULIN, ALPHA-4A; TUBA4A	7277
MIM191130	*	6p21.3	TUBULIN, BETA; TUBB	203068
MIM191135	*	17q21	TUBULIN, GAMMA-1; TUBG1	7283
MIM191150		 	TUFTSIN DEFICIENCY	 
MIM191155	*	3q21-q25	TRANSMEMBRANE 4 SUPERFAMILY, MEMBER 1; TM4SF1	4071
MIM191160	*	6p21.3	TUMOR NECROSIS FACTOR; TNF	7124
MIM191161	*	17q22-q23	TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 1; TNFAIP1	7126
MIM191163	*	6q23	TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 3; TNFAIP3	7128
MIM191164	*	1q21-q22	EPHRIN A1; EFNA1	1942
MIM191170	*	17p13.1	TUMOR PROTEIN p53; TP53	7157
MIM191175	*	12q23.3	HEAT-SHOCK PROTEIN, 90-KD, BETA, 1; HSP90B1	7184
MIM191181	%	11q13	SUPPRESSOR OF TUMORIGENICITY 3; ST3	6762
MIM191190	*	12p13.2	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 1A; TNFRSF1A	7132
MIM191191	*	1p36.3-p36.2	TUMOR NECROSIS FACTOR RECEPTOR SUBFAMILY, MEMBER 1B; TNFRSF1B	7133
MIM191195	*	10p11.2	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 8; MAP3K8	1326
MIM191200	%	 	TUNE DEAFNESS	 
MIM191250		 	TWINNING DUE TO SUPERFETATION	 
MIM191270		11p11.2	TYROSINASE-LIKE; TYRL	7300
MIM191275	*	13q31-q32	DOPACHROME TAUTOMERASE; DCT	1638
MIM191290	*	11p15.5	TYROSINE HYDROXYLASE; TH	7054
MIM191305	*	8p23-p22	TYROSINE KINASE, B-LYMPHOCYTE SPECIFIC; BLK	640
MIM191306	*	4q12	KINASE INSERT DOMAIN RECEPTOR; KDR	3791
MIM191311	*	1q12-qter	DISCOIDIN DOMAIN RECEPTOR FAMILY, MEMBER 2; DDR2	4921
MIM191315	*	1q21-q22	NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 1; NTRK1	4914
MIM191316	*	15q25	NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 3; NTRK3	4916
MIM191317	*	21q22.3	U2 SMALL NUCLEAR RNA AUXILIARY FACTOR 1; U2AF1	7307
MIM191318	*	 	U2 SMALL NUCLEAR RNA AUXILIARY FACTOR 2; U2AF2	11338
MIM191321	*	19p13.1-p12	UBIQUITIN A-52-RESIDUE RIBOSOMAL PROTEIN FUSION PRODUCT; UBA52	7311
MIM191325	*	3p21	UBIQUITIN-ACTIVATING ENZYME E1-LIKE; UBE1L	7318
MIM191327	*	19q12	UBIQUINOL-CYTOCHROME c REDUCTASE, RIESKE IRON-SULFUR; UQCRFS1	7386
MIM191328	*	3p21.3	UBIQUINOL-CYTOCHROME c REDUCTASE CORE PROTEIN I; UQCRC1	7384
MIM191329	*	16p12	UBIQUINOL-CYTOCHROME c REDUCTASE CORE PROTEIN II; UQCRC2	7385
MIM191330	*	8q22	UBIQUINOL-CYTOCHROME c REDUCTASE-BINDING PROTEIN; UQCRB	7381
MIM191339	*	17p12-p11.1	UBIQUITIN B; UBB	7314
MIM191340	*	12q24.3	UBIQUITIN C; UBC	7316
MIM191342	*	4p14	UBIQUITIN CARBOXYL-TERMINAL ESTERASE L1; UCHL1	7345
MIM191343	*	 	RIBOSOMAL PROTEIN S27a; RPS27A	6233
MIM191350	*	11q23.3	DOLICHYL-PHOSPHATE N-ACETYLGLUCOSAMINE PHOSPHOTRANSFERASE; DPAGT1	1798
MIM191390	%	7q22	INFLAMMATORY BOWEL DISEASE 11; IBD11	100529151
MIM191400		 	ULNA AND FIBULA, HYPOPLASIA OF	 
MIM191420		 	ULNA METAPHYSEAL DYSPLASIA SYNDROME	 
MIM191440	%	 	ULNAR HYPOPLASIA	 
MIM191480	%	 	UNCOMBABLE HAIR SYNDROME	 
MIM191482		 	UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, AND BRACHYDACTYLY	 
MIM191500	%	 	UNDRITZ ANOMALY	 
MIM191510	*	1p22	COLD-SHOCK DOMAIN-CONTAINING E1, RNA-BINDING; CSDE1	7812
MIM191520	%	 	UPINGTON DISEASE	 
MIM191523	*	1q22-q23	UPSTREAM STIMULATORY FACTOR 1; USF1	7391
MIM191525	*	12q23-q24.1	URACIL-DNA GLYCOSYLASE; UNG	7374
MIM191540		1p22	URATE OXIDASE, PSEUDOGENE; UOX	391051
MIM191550	%	 	URETER, BIFID OR DOUBLE	 
MIM191600		 	URETER, CANCER OF	 
MIM191650		 	URETEROCELE	 
MIM191700		 	UROLITHIASIS, URIC ACID, AUTOSOMAL DOMINANT	 
MIM191710	*	1p32	CYTIDINE MONOPHOSPHATE (UMP-CMP) KINASE 1, CYTOSOLIC; CMPK1	51727
MIM191720	*	17q23-q25	5-PRIME,3-PRIME-@NUCLEOTIDASE, CYTOSOLIC; NT5C	30833
MIM191730	*	7p12.3	URIDINE PHOSPHORYLASE 1; UPP1	7378
MIM191740	*	2q37	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1	54658
MIM191750	^	1q21-q22	URIDYL DIPHOSPHATE GLUCOSE PYROPHOSPHORYLASE 1; UGP1	7359
MIM191760	*	2p14-p13	URIDYL DIPHOSPHATE GLUCOSE PYROPHOSPHORYLASE 2; UGP2	7360
MIM191800		 	URINARY BLADDER, ATONY OF	 
MIM191830	#	10q11.2, 22q13.31	RENAL ADYSPLASIA	5979, 7380
MIM191840	*	10q24	PLASMINOGEN ACTIVATOR, URINARY; PLAU	5328
MIM191845	*	16p12.3	UROMODULIN; UMOD	7369
MIM191850		 	URTICARIA, AQUAGENIC	 
MIM191900	#	1q44	MUCKLE-WELLS SYNDROME; MWS	114548
MIM191950		 	URTICARIA, FAMILIAL LOCALIZED HEAT	 
MIM192000		 	UTERINE ANOMALIES	 
MIM192020	*	11q12.3-q13.1	SECRETOGLOBIN, FAMILY 1A, MEMBER 1; SCGB1A1	7356
MIM192050		 	UTERUS BICORNIS BICOLLIS WITH PARTIAL VAGINAL SEPTUM AND UNILATERAL HEMATOCOLPOS WITH IPSILATERAL RENAL AGENESIS	 
MIM192090	*	16q22.1	CADHERIN 1; CDH1	999
MIM192100		 	UVULA, BIFID	 
MIM192130	*	17q21	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A1; ATP6V0A1	535
MIM192132	*	2cen-q13	ATPase, H+ TRANSPORTING, LYSOSOMAL, 56/58-KD, V1 SUBUNIT B, ISOFORM 1; ATP6V1B1	525
MIM192150	*	6p21.3	VALYL-tRNA SYNTHETASE; VARS	7407
MIM192200		 	VARICOSE VEINS	619537
MIM192225	*	1p32-p31	VASCULAR CELL ADHESION MOLECULE 1; VCAM1	7412
MIM192240	+	6p12	VASCULAR ENDOTHELIAL GROWTH FACTOR A; VEGFA	7422
MIM192300		 	VASCULAR HELIX OF UMBILICAL CORD	 
MIM192310		 	VASCULITIS, LYMPHOCYTIC, NODULAR	 
MIM192315	#	3p21.3-p21.2	VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	11277
MIM192320	*	6q26-q27	VASOACTIVE INTESTINAL PEPTIDE; VIP	7432
MIM192321	*	3p22	VASOACTIVE INTESTINAL PEPTIDE RECEPTOR 1; VIPR1	7433
MIM192340	*	20p13	ARGININE VASOPRESSIN; AVP	551
MIM192350	#	2q31-q32	VATER ASSOCIATION	3239
MIM192400		 	VEINS, PATTERN OF, ON ANTERIOR THORAX	 
MIM192430	#	22q11.2	VELOCARDIOFACIAL SYNDROME	1714, 54487, 6899, 8214, 8220, 9993
MIM192445		 	VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE	 
MIM192500	#	11p15.5	LONG QT SYNDROME 1; LQT1	3784
MIM192600	#	14q12, 4q35, 3p25, 20q13.3	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1	291, 4624, 4625, 85366, 859
MIM192605	#	3p21	VENTRICULAR TACHYCARDIA, FAMILIAL	2771
MIM192700		 	VENULAR INSUFFICIENCY, SYSTEMIC	 
MIM192800		 	VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	 
MIM192900	%	 	VERTEBRAL HYPOPLASIA WITH LUMBAR KYPHOSIS	 
MIM192950	#	2q31-q32	VERTICAL TALUS, CONGENITAL; CVT	3236
MIM192968	*	5q11.2	INTEGRIN, ALPHA-1; ITGA1	3672
MIM192974	*	5q23-q31	INTEGRIN, ALPHA-2; ITGA2	3673
MIM192975	*	2q31-q32	INTEGRIN, ALPHA-4; ITGA4	3676
MIM192977	*	9p24	VERY LOW DENSITY LIPOPROTEIN RECEPTOR; VLDLR	7436
MIM193000	%	1p13	VESICOURETERAL REFLUX 1; VUR1	54113
MIM193001	*	10q25	SOLUTE CARRIER FAMILY 18 (VESICULAR MONOAMINE), MEMBER 2; SLC18A2	6571
MIM193002	*	8p21.3	SOLUTE CARRIER FAMILY 18 (VESICULAR MONOAMINE), MEMBER 1; SLC18A1	6570
MIM193003	%	13q31-q33	NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4	317685
MIM193005		 	VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	 
MIM193007	%	6q	VERTIGO, BENIGN RECURRENT; BRV	619536
MIM193040	*	2q35-q36	VILLIN; VIL	7429
MIM193050		 	VIBRATORY ANGIOEDEMA	 
MIM193060	*	10p13	VIMENTIN; VIM	7431
MIM193065	*	10q22.1-q23	VINCULIN; VCL	7414
MIM193067	*	11q24	FRIEND LEUKEMIA VIRUS INTEGRATION 1; FLI1	2313
MIM193100	#	12p13.3	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT; ADHR	8074
MIM193190	*	17q11	VITRONECTIN; VTN	7448
MIM193200	%	6p21.3	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 6; VAMAS6	246319
MIM193210	*	2q31	INTEGRIN, ALPHA-V; ITGAV	3685
MIM193220	#	11q13	VITREORETINOCHOROIDOPATHY; VRCP	7439
MIM193230	#	2q37	VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD	3769
MIM193235	#	11q13	VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY; VRNI	7445
MIM193240		 	VOCAL CORD PARALYSIS AND PTOSIS	 
MIM193245	*	10q22	VOLTAGE-DEPENDENT ANION CHANNEL 2; VDAC2	7417
MIM193250	%	 	VOLVULUS OF MIDGUT	 
MIM193300	#	11q13, 3p26-p25	VON HIPPEL-LINDAU SYNDROME; VHL	595, 7428
MIM193400	#	12p13.3	VON WILLEBRAND DISEASE, TYPE 1; VWD1	7450
MIM193450		 	VULVOVAGINITIS, ALLERGIC SEMINAL	 
MIM193500	#	2q35	WAARDENBURG SYNDROME, TYPE 1; WS1	5077
MIM193510	#	3p14.1-p12.3	WAARDENBURG SYNDROME, TYPE 2A; WS2A	4286
MIM193520	#	17q11.2	WATSON SYNDROME	4763
MIM193525	*	11p15.3-p15.1	WEE1, S. POMBE, HOMOLOG OF; WEE1	7465
MIM193530	#	4p16	WEYERS ACROFACIAL DYSOSTOSIS	2121
MIM193670	#	2q21	WHIM SYNDROME	7852
MIM193680	^	 	WHISPERING DYSPHONIA, HEREDITARY	 
MIM193700	#	17p13.1	ARTHROGRYPOSIS, DISTAL, TYPE 2A; DA2A	4621
MIM193900	#	17q21-q22, 12q13	WHITE SPONGE NEVUS; WSN	3851, 3860
MIM194000		 	WIDOW'S PEAK	 
MIM194050	#	7q11.23	WILLIAMS-BEUREN SYNDROME; WBS	2006, 51085
MIM194070	#	13q12.3, 11p13, Xq26	WILMS TUMOR 1; WT1	2719, 283120, 5080, 675, 7490
MIM194071	#	11p15.5	WILMS TUMOR 2; WT2	283120, 7491
MIM194072	#	11p13	WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATION SYNDROME; WAGR	100528024, 5080, 7490
MIM194080	#	11p13	DENYS-DRASH SYNDROME; DDS	7490
MIM194090	%	16q	WILMS TUMOR 3; WT3	8136
MIM194100	^	 	MOVED TO 106600	 
MIM194190	#	4p16.3	WOLF-HIRSCHHORN SYNDROME; WHS	7467, 7468
MIM194200	#	7q36	WOLFF-PARKINSON-WHITE SYNDROME	51422
MIM194300	#	12q13	WOOLLY HAIR, AUTOSOMAL DOMINANT; ADWH	121391
MIM194320		 	WORONETS TRAIT	 
MIM194350	%	 	WT LIMB-BLOOD SYNDROME	 
MIM194355	*	22q12	X BOX-BINDING PROTEIN 1; XBP1	7494
MIM194360	*	19q13.2	X-RAY REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 1; XRCC1	7515
MIM194363	*	5q13-q14	X-RAY REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 4; XRCC4	7518
MIM194364	*	2q35	X-RAY REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 5; XRCC5	7520
MIM194370		13q14	X-RAY SENSITIVITY; XRS	8102
MIM194380	#	16q23-q24	DEHYDRATED HEREDITARY STOMATOCYTOSIS; DHS	10774
MIM194400		 	XERODERMA PIGMENTOSUM, AUTOSOMAL DOMINANT, MILD	 
MIM194460	*	7q22.1	ALPHA-2-GLYCOPROTEIN, ZINC; AZGP1	563
MIM194470	%	4q11-q13	ZINC, ELEVATED PLASMA	213
MIM194480	*	17pter-p12	ZINC FINGER PROTEIN 3, MOUSE, HOMOLOG OF; ZFP3	124961
MIM194500	*	2q11.2	ZINC FINGER PROTEIN 2; ZNF2	7549
MIM194510	*	7q22.1	ZINC FINGER PROTEIN 3; ZNF3	7551
MIM194521	*	10q11.2	ZINC FINGER PROTEIN 33A; ZNF33A	7581
MIM194522	*	10q11.2	ZINC FINGER PROTEIN 33B; ZNF33B	7582
MIM194524	*	17p13-p12	ZINC FINGER PROTEIN 18; ZNF18	7566
MIM194525	*	16q22	ZINC FINGER PROTEIN 19; ZNF19	7567
MIM194526	*	8q24.12-q24.13	ZINC FINGER PROTEIN 34; ZNF34	80778
MIM194527	*	16q22	ZINC FINGER PROTEIN 23; ZNF23	7571
MIM194528	*	10p11.2-q11.2	ZINC FINGER PROTEIN 25; ZNF25	219749
MIM194529	*	10q11.2	ZINC FINGER PROTEIN 22; ZNF22	7570
MIM194531	*	8q24	ZINC FINGER PROTEIN 7; ZNF7	7553
MIM194532	*	19q13.43	ZINC FINGER PROTEIN 8; ZNF8	7554
MIM194533	*	3p22-p21	ZINC FINGER PROTEIN 35; ZNF35	7584
MIM194534	*	18q12	ZINC FINGER PROTEIN 24; ZNF24	7572
MIM194535	*	17p13-p12	ZINC FINGER PROTEIN 29; ZNF29	7577
MIM194536	*	7p22-p21	ZINC FINGER PROTEIN 12; ZNF12	7559
MIM194537	*	12q24.33	ZINC FINGER PROTEIN 26; ZNF26	7574
MIM194538	*	12q13-qter	ZINC FINGER PROTEIN 10; ZNF10	7556
MIM194539	*	10q23-q24	ZINC FINGER PROTEIN 32; ZNF32	7580
MIM194540	*	6p24-p22.3	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ENHANCER-BINDING PROTEIN 1; HIVEP1	3096
MIM194541	*	14q23-q24	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 25; ZBTB25	7597
MIM194542	*	19p13.2	ZINC FINGER PROTEIN 44; ZNF44	51710
MIM194543	*	19p13.2	ZINC FINGER PROTEIN 69; ZNF69	7620
MIM194544	*	22q11.2	ZINC FINGER PROTEIN 70; ZNF70	7621
MIM194545	*	19q13.4	ZINC FINGER PROTEIN 71; ZNF71	58491
MIM194546	*	22p	ZINC FINGER PROTEIN 72; ZNF72	100287084
MIM194547	*	22p	ZINC FINGER PROTEIN 73; ZNF73	7624
MIM194548	*	22q11.2	ZINC FINGER PROTEIN 74; ZNF74	7625
MIM194549	*	6p21.3-p21.2	ZINC FINGER PROTEIN 76; ZNF76	7629
MIM194550	*	19q13.2-q13.4	MYELOID ZINC FINGER GENE 1; MZF1	7593
MIM194551	*	19p	ZINC FINGER PROTEIN 77; ZNF77	58492
MIM194552	*	9q34	ZINC FINGER PROTEIN 79; ZNF79	7633
MIM194553	*	3p12-qter	ZINC FINGER PROTEIN 80; ZNF80	7634
MIM194554	*	19q13.2	ZINC FINGER PROTEIN 45; ZNF45	7596
MIM194555	*	19q13.2-qter	ZINC FINGER PROTEIN 224; ZNF224	7767
MIM194556	*	19p13.3-p13.2	ZINC FINGER PROTEIN 14; ZNF14	7561
MIM194557	*	19p13.3-p13.2	ZINC FINGER PROTEIN 20; ZNF20	7568
MIM194558	*	19q13.3-q13.4	ZINC FINGER PROTEIN 83; ZNF83	55769
MIM194624	*	7q11.2	ZINC FINGER PROTEIN 117; ZNF117	51351
MIM194628	*	19p	ZINC FINGER PROTEIN 121; ZNF121	7675
MIM194630	*	11q23.1-q23.2	ZINC FINGER PROTEIN 123; ZNF123	100188891
MIM194631	*	1q44	ZINC FINGER PROTEIN 124; ZNF124	7678
MIM194648	*	4p16.3	ZINC FINGER PROTEIN 141; ZNF141	7700
MIM195000	*	11q12.2	ZONA PELLUCIDA GLYCOPROTEIN 1; ZP1	22917
MIM200100	#	4q22-q24	ABETALIPOPROTEINEMIA; ABL	4547
MIM200110	%	 	ABLEPHARON-MACROSTOMIA SYNDROME	 
MIM200130		 	ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	 
MIM200150	#	9q21	CHOREOACANTHOCYTOSIS; CHAC	23230
MIM200170		 	ACANTHOSIS NIGRICANS WITH MUSCLE CRAMPS AND ACRAL ENLARGEMENT	 
MIM200300		 	ACETOPHENETIDIN SENSITIVITY	 
MIM200350	*	17q21	ACETYL-CoA CARBOXYLASE-ALPHA; ACACA	31
MIM200400	%	 	ACHALASIA, FAMILIAL ESOPHAGEAL	 
MIM200450		 	ACHALASIA-MICROCEPHALY SYNDROME	 
MIM200500	#	7q36	ACHEIROPODY	64327
MIM200600	#	14q31-q32	ACHONDROGENESIS, TYPE IA; ACG1A	9321
MIM200610	#	12q13.11-q13.2	ACHONDROGENESIS, TYPE II; ACG2	1280
MIM200700	#	20q11.2	CHONDRODYSPLASIA, GREBE TYPE	8200
MIM200710	^	 	MOVED TO 200610	 
MIM200720	^	 	MOVED TO 200610	 
MIM200900		 	SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY	 
MIM200950		11p12-p11	ACID PHOSPHATASE DEFICIENCY	53
MIM200970		 	ACKERMAN SYNDROME	 
MIM200980		 	ACRORENAL-MANDIBULAR SYNDROME	 
MIM200990	#	7p13	ACROCALLOSAL SYNDROME; ACLS	2737, 374654, 46
MIM200995		 	ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	 
MIM201000	#	6p11	CARPENTER SYNDROME	51715
MIM201020		 	ACROCEPHALOPOLYSYNDACTYLY TYPE IV	 
MIM201050		 	ACROCRANIOFACIAL DYSOSTOSIS	 
MIM201100	#	8q24.3	ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE; AEZ	55630
MIM201170	%	 	ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	 
MIM201180		 	ACROFRONTOFACIONASAL DYSOSTOSIS 1	 
MIM201200		 	ACROGERIA, GOTTRON TYPE	 
MIM201250	#	20q11.2	ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	8200
MIM201300	#	12p13	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA; HSAN2A	65125
MIM201310		 	ACRORENAL SYNDROME, AUTOSOMAL RECESSIVE	 
MIM201400	#	1q23-q24	ACTH DEFICIENCY, ISOLATED; IAD	9095
MIM201450	#	1p31	ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF; ACADMD	34
MIM201460	^	2q34-q35	MOVED TO 201475	 
MIM201470	#	12q22-qter	ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF; ACADSD	35
MIM201475	#	17p13	ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF; ACADVLD	37
MIM201550	%	 	ADDUCTED THUMBS SYNDROME	 
MIM201710	#	15q23-q24, 8p11.2	LIPOID CONGENITAL ADRENAL HYPERPLASIA; LCAH	6770
MIM201750	#	7q11.2	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	5447
MIM201810	#	1p13.1	3-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II, DEFICIENCY OF	3284
MIM201910	#	6p21.3	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	1589
MIM202010	#	8q21	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY	1584
MIM202110	#	10q24.3	ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	1586
MIM202150		 	ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZING HORMONE	 
MIM202155		 	ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE	 
MIM202200	#	18p11.2	GLUCOCORTICOID DEFICIENCY 1; GCCD1	4158
MIM202300	#	17p13.1	ADRENOCORTICAL CARCINOMA, HEREDITARY; ADCC	7157
MIM202370	#	12p13.3, 7q21-q22, 1p36.32, 2p15, 22q11.21	ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM	5189, 5192, 5194, 55670, 5830
MIM202400	#	4q28, 4q28	AFIBRINOGENEMIA, CONGENITAL	2243, 2244
MIM202550		 	AGANGLIONOSIS, TOTAL INTESTINAL	 
MIM202600		 	AGENESIS OF CEREBRAL WHITE MATTER	 
MIM202650	#	 	AGNATHIA-OTOCEPHALY COMPLEX; AGOTC	5396
MIM202660		 	PAGOD SYNDROME	 
MIM202700	#	19p13.3	NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT; SCN1	1991
MIM202900		 	ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	 
MIM203000		 	FRONTONASAL DYSPLASIA WITH ALAR CLEFTS	 
MIM203100	#	11q14-q21	ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	7299
MIM203200	#	16q24.3, 15q11.2-q12	ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	4157, 4948
MIM203280	^	 	MOVED TO 606952	 
MIM203285	^	 	MOVED TO 608233	 
MIM203290	#	9p23	ALBINISM, OCULOCUTANEOUS, TYPE III; OCA3	7306
MIM203300	#	11p15-p13, 10q24.32, 10q23.1, 6p22.3, 3q24, 22q11.2-q12.2, 19q13	HERMANSKY-PUDLAK SYNDROME 1; HPS1	3257
MIM203310	^	 	MOVED TO 203200	 
MIM203330	%	 	PSEUDOHYPOPARATHYROIDISM, TYPE II; PHP2	 
MIM203340		 	ALBINISM-MICROCEPHALY-DIGITAL ANOMALIES SYNDROME	 
MIM203400	#	8q21	CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY	1585
MIM203450	#	17q21, 11q13	ALEXANDER DISEASE	2670, 4723
MIM203500	#	3q21-q23	ALKAPTONURIA	3081
MIM203550		 	ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	 
MIM203600		 	ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN	 
MIM203650	%	3q26.3-q27.3	ALOPECIA-MENTAL RETARDATION SYNDROME 1; APMR1	780898
MIM203655	#	8p21.2	ALOPECIA UNIVERSALIS CONGENITA; ALUNC	55806
MIM203700	#	15q25	MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE); MTDPS4A	5428
MIM203740	%	7p14-p13	ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	4967
MIM203750	#	11q22.3-q23.1	ALPHA-METHYLACETOACETIC ACIDURIA	38
MIM203780	#	2q36-q37, 2q36-q37	ALPORT SYNDROME, AUTOSOMAL RECESSIVE	1285, 1286
MIM203800	#	2p13	ALSTROM SYNDROME; ALMS	7840
MIM204000	#	17p13.1	LEBER CONGENITAL AMAUROSIS 1; LCA1	3000
MIM204100	#	1p31	LEBER CONGENITAL AMAUROSIS 2; LCA2	6121
MIM204110		 	AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	 
MIM204200	#	16p12.1	CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	1201
MIM204300	#	 	CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE; CLN4A	54982
MIM204500	#	11p15.5	CEROID LIPOFUSCINOSIS, NEURONAL, 2; CLN2	1200
MIM204650	#	4q21	AMELOGENESIS IMPERFECTA, TYPE IC; AI1C	10117
MIM204690	#	 	ENAMEL-RENAL SYNDROME; ERS	 
MIM204700	#	19q13.4	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA1; AI2A1	9622
MIM204730		 	AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY, OSTEOPOROSIS, AND ACIDOSIS	 
MIM204750	#	 	AMINOADIPIC ACIDURIA	 
MIM204800	%	 	AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	 
MIM204850		 	AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	 
MIM204870	#	1p32	CORNEAL DYSTROPHY, GELATINOUS DROP-LIKE; GDLD	4070
MIM204900		 	AMYLOIDOSIS, CUTANEOUS BULLOUS	 
MIM205000		 	AMYOTONIA CONGENITA	 
MIM205100	#	2q33	AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	57679
MIM205200	%	 	AMYOTROPHIC LATERAL SCLEROSIS, JUVENILE, WITH DEMENTIA	 
MIM205250		 	AMYOTROPHIC LATERAL SCLEROSIS WITH POLYGLUCOSAN BODIES	 
MIM205400	#	9q22-q31	TANGIER DISEASE; TGD	19
MIM205600	^	 	MOVED TO 105650	 
MIM205700		 	ANEMIA, AUTOIMMUNE HEMOLYTIC	 
MIM205900	^	 	MOVED TO 105650	 
MIM205950	#	14q32, 3p22.1	ANEMIA, SIDEROBLASTIC, PYRIDOXINE-REFRACTORY, AUTOSOMAL RECESSIVE	51218, 54977
MIM206000		 	ANEMIA, SIDEROBLASTIC, PYRIDOXINE-RESPONSIVE, AUTOSOMAL RECESSIVE	 
MIM206100	#	12q13	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD	4891
MIM206200	#	22q12-q13	IRON-REFRACTORY IRON DEFICIENCY ANEMIA; IRIDA	164656
MIM206300		 	ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF RED CELL MEMBRANE	 
MIM206400		 	ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRIN METABOLISM	 
MIM206500	%	 	ANENCEPHALY	 
MIM206550		 	ANGIOLIPOMATOSIS, FAMILIAL	 
MIM206570	%	 	ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	 
MIM206600		 	ANHIDROSIS	 
MIM206700	#	11p13	ANIRIDIA, CEREBELLAR ATAXIA, AND MENTAL RETARDATION	5080
MIM206750		 	ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTOR RETARDATION	 
MIM206780	%	 	ANODONTIA OF PERMANENT DENTITION	 
MIM206800	#	20p13	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4; NDNC4	343637
MIM206900	#	3q26.3-q27	MICROPHTHALMIA, SYNDROMIC 3; MCOPS3	4990, 6657
MIM206920	#	 	MICROPHTHALMIA WITH LIMB ANOMALIES	64093
MIM207000		 	ANOSMIA FOR ISOBUTYRIC ACID	 
MIM207300		 	ANTITHROMBIN, FAMILIAL HEMORRHAGIC DIATHESIS DUE TO	 
MIM207410	#	10q26	ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	2263, 5447
MIM207500		 	ANUS, IMPERFORATE	 
MIM207600		 	TAKAYASU ARTERITIS	 
MIM207620		 	APHALANGY WITH HEMIVERTEBRAE	 
MIM207700	^	 	MOVED TO 107600	 
MIM207720		 	APNEA, CENTRAL SLEEP	 
MIM207731		 	APLASIA CUTIS CONGENITA WITH INTESTINAL LYMPHANGIECTASIA	 
MIM207750	#	19q13.2	APOLIPOPROTEIN C-II DEFICIENCY	344
MIM207765	^	 	MOVED TO 218030	 
MIM207770		 	APROSENCEPHALY SYNDROME	 
MIM207780		 	AREDYLD	 
MIM207790		 	ARACHNOID CYSTS, INTRACRANIAL	 
MIM207800	#	6q23	ARGININEMIA	383
MIM207900	#	7cen-q11.2	ARGININOSUCCINIC ACIDURIA	435
MIM207950	%	 	CHIARI MALFORMATION TYPE II	 
MIM208000	#	6q22-q23	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	5167
MIM208050	#	20q13.1	ARTERIAL TORTUOSITY SYNDROME; ATS	81031
MIM208060	%	 	ARTERIOSCLEROSIS, SEVERE JUVENILE	 
MIM208080		 	ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION, AND FACIAL ANOMALIES	 
MIM208081		 	ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTIC FACIES	 
MIM208085	#	15q26.1	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1; ARCS1	26276
MIM208100	%	5q35	ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	261
MIM208150	#	11p11.2-p11.1, 4p16.2	FETAL AKINESIA DEFORMATION SEQUENCE; FADS	285489, 5913
MIM208155		 	ILLUM SYNDROME	 
MIM208158		 	ARTHROGRYPOSIS WITH HYPERKERATOSIS	 
MIM208200	%	 	ARTHROGRYPOSIS-LIKE DISORDER	 
MIM208230	#	6q22-q23	ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD; PPAC	8838
MIM208250	#	1q24-q25	CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME; CACP	10216
MIM208300		 	ASCITES, CHYLOUS	 
MIM208400	#	4q32-q33	ASPARTYLGLUCOSAMINURIA; AGU	175
MIM208500	%	15q13	ASPHYXIATING THORACIC DYSTROPHY 1; ATD1	465
MIM208530	#	 	ASPLENIA WITH CARDIOVASCULAR ANOMALIES	 
MIM208540	#	3q22	RENAL-HEPATIC-PANCREATIC DYSPLASIA; RHPD	27031
MIM208550	#	14q22, 17q21.3	ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	30009, 5732
MIM208600		 	ASTHMA, SHORT STATURE, AND ELEVATED IgA	 
MIM208700		 	ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	 
MIM208750	%	 	ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	 
MIM208850		 	ATAXIA-DEAFNESS-RETARDATION SYNDROME	 
MIM208870		 	ATAXIA-MICROCEPHALY-CATARACT SYNDROME	 
MIM208900	#	11q22.3	ATAXIA-TELANGIECTASIA; AT	472
MIM208920	#	9p13.3	ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	54840
MIM209000	^	 	MOVED TO 613179	 
MIM209050		 	ATHROMBIA, ESSENTIAL	 
MIM209100	%	 	ATONIC-ASTATIC SYNDROME OF FOERSTER	 
MIM209300	#	3q21	ATRANSFERRINEMIA	7018
MIM209500	#	8p21.2	ATRICHIA WITH PAPULAR LESIONS; APL	55806
MIM209600		 	ATRIOVENTRICULAR DISSOCIATION	 
MIM209700	%	 	ATROPHODERMIA VERMICULATA	 
MIM209770		 	AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	 
MIM209850	%	7q22	AUTISM	100188832, 54413, 57502, 6638
MIM209880	#	12q22-q23, 11p13, 10q11.2, 5p13.1-p12, 4p12, 20q13.2-q13.3	CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	1908, 2668, 429, 5979, 627, 8929
MIM209885	%	 	BARBER-SAY SYNDROME	 
MIM209900	#	16q21, 15q22.3-q23, 14q32.1, 12q21.3, 12q21.2, 11q13, 9q31-q34.1, 8q21.13-q22.1, 7p14, 4q27, 4q27, 3p12-q13, 2q31, 2p15, 20p12, 17q23	BARDET-BIEDL SYNDROME; BBS	10806, 123016, 129880, 166379, 22954, 27241, 51057, 54903, 55212, 582, 583, 585, 79140, 79738, 80184, 8195, 84100, 91147
MIM209901	*	11q13	BBS1 GENE; BBS1	582
MIM209920	#	16p13, 1q21.1-q21.3, 13q14, 19p12	BARE LYMPHOCYTE SYNDROME, TYPE II	4261, 5993, 5994, 8625
MIM209950	#	6q23-q24, 5q31.1-q33.1, 2q32.2-q32.3, 21q22.1-q22.2, 19p13.1	ATYPICAL MYCOBACTERIOSIS, FAMILIAL	3459, 3460, 3593, 3594, 6772
MIM209970		 	BEEMER LETHAL MALFORMATION SYNDROME	 
MIM210000	%	 	BEHR SYNDROME	 
MIM210050		 	BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	 
MIM210200	#	3q25-q27	3-@METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY	56922
MIM210210	#	5q12-q13	3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY	64087
MIM210250	#	2p21, 2p21	SITOSTEROLEMIA	64240, 64241
MIM210350		 	BIEMOND SYNDROME II	 
MIM210370	#	4q35.1	BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY	285440
MIM210400		 	BIFID NOSE, AUTOSOMAL RECESSIVE	 
MIM210450	^	 	MOVED TO 607765	 
MIM210500	%	 	BILIARY ATRESIA, EXTRAHEPATIC; EHBA	 
MIM210550		 	BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	 
MIM210600	#	3q22-q24	SECKEL SYNDROME 1; SCKL1	22995, 5116, 545, 55835
MIM210700		 	MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	 
MIM210710	#	2q14.2-q14.3	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I; MOPD1	100151683
MIM210720	#	21q22.3	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	5116
MIM210730	%	 	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	 
MIM210740		 	BANGSTAD SYNDROME	 
MIM210745	%	 	BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	 
MIM210750	#	14q32	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6; SHEP6	123041
MIM210900	#	15q26.1	BLOOM SYNDROME; BLM	641
MIM211000		 	BLUE DIAPER SYNDROME	 
MIM211100	+	19q13.3	FUCOSYLTRANSFERASE 1; FUT1	2523
MIM211120		 	BONE DYSPLASIA, LETHAL, HOLMGREN TYPE	 
MIM211170	%	 	BORRONE DERMATOCARDIOSKELETAL SYNDROME	 
MIM211180	#	12p13, 12p13.3	BOWEN-CONRADI SYNDROME; BWCNS	10436
MIM211200		 	BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	 
MIM211350	%	 	KYPHOMELIC DYSPLASIA	 
MIM211355		 	BOWING OF LONG BONES, ASYMMETRIC AND SYMMETRIC	 
MIM211369		 	BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	 
MIM211370		 	BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	 
MIM211380		 	BRACHIOSKELETOGENITAL SYNDROME	 
MIM211390	%	 	SABINAS BRITTLE HAIR SYNDROME	 
MIM211400	#	16p13-p12, 7q31.2	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1	1080, 6338
MIM211410		 	CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE	8105
MIM211450		 	BRONCHOMALACIA	 
MIM211500	#	20p13	FAZIO-LONDE DISEASE	113278
MIM211530	#	20p13	BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	113278
MIM211600	#	18q21	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 1; PFIC1	5205
MIM211750	#	3q13.13	C SYNDROME	10225
MIM211770		 	CAHMR SYNDROME	 
MIM211800	#	6q14-q21	CALCIFICATION OF JOINTS AND ARTERIES; CALJA	4907
MIM211890	%	 	CAMPOMELIA, CUMMING TYPE	 
MIM211900	#	13q12, 12p13.3, 2q24-q31	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL; HFTC	 
MIM211910		 	CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1	 
MIM211920		 	CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	 
MIM211930		 	CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	 
MIM211965		 	CAMPTODACTYLY-ICHTHYOSIS SYNDROME	 
MIM211980	#	17q21.1, 12p12.1, 11q22-q24, 11p15.5, 10q11, 10p11.2, 7q34, 7p12.3-p12.1, 6q25.2-q27, 5q31.1, 3q26.3, 3p21.3, 3p22-p21.3, 2q33, 19q13.2	LUNG CANCER	11186, 1326, 1548, 1956, 2064, 2074, 356, 3659, 3845, 5002, 5071, 5290, 5519, 673, 841, 9940
MIM211990		 	CAMPTOMELIC SYNDROME, LONG-LIMB TYPE	 
MIM212050	#	9q34.3	CANDIDIASIS, FAMILIAL, 2; CANDF2	64170
MIM212060		 	CARBIMAZOLE SENSITIVITY	 
MIM212065	#	16p13.3-p13.2	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	5373
MIM212066	#	14q21	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	4247
MIM212067		 	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx	 
MIM212070	#	10q24.2	CARBOXYPEPTIDASE N DEFICIENCY	1369
MIM212080		 	CARDIAC LIPIDOSIS, FAMILIAL	 
MIM212090		 	CARDIAC SEPTAL DEFECTS WITH COARCTATION OF THE AORTA	 
MIM212093		 	CARDIAC VALVULAR DEFECT, DEVELOPMENTAL	 
MIM212100		 	CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS	 
MIM212110	^	 	MOVED TO 611880	10060, 11155, 1674, 1829, 2070, 2218, 27063, 282996, 4000, 4607, 4624, 5350, 5663, 5664, 6444, 6901, 70, 7112, 7139, 7168, 7273, 7414, 8048, 8557, 88, 91624, 9531
MIM212112	#	 	CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	4000
MIM212120	^	 	MOVED TO 212112	 
MIM212130	%	 	CARDIOMYOPATHY ASSOCIATED WITH MYOPATHY AND SUDDEN DEATH	 
MIM212135		 	CARDIOSKELETAL SYNDROME, KUWAITI TYPE	 
MIM212138	#	3p21.31	CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	788
MIM212140	#	5q31.1	CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP	6584
MIM212160	%	 	CARNITINE DEFICIENCY, MYOPATHIC	 
MIM212200	%	18q21.3	CARNOSINEMIA	8173
MIM212350	#	 	SENGERS SYNDROME	55750
MIM212360		 	PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA, AUTOSOMAL RECESSIVE	 
MIM212400	%	 	CATARACT AND CONGENITAL ICHTHYOSIS	 
MIM212500	%	 	CATARACT, CONGENITAL OR JUVENILE	 
MIM212540		 	CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME	 
MIM212550	#	14q23	MICROPHTHALMIA, ISOLATED, WITH CATARACT 2; MCOPCT2	4990
MIM212710		 	CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	 
MIM212720	#	1q41	MARTSOLF SYNDROME	25782
MIM212750	#	6p21.3, 6p21.3	CELIAC DISEASE; CD	3117, 3119
MIM212780	#	11p12-p11.2	CENANI-LENZ SYNDACTYLY SYNDROME; CLSS	4038
MIM212790	%	 	PREMATURE CENTROMERE DIVISION; PCD	 
MIM212800		 	CEPHALIN LIPIDOSIS	 
MIM212835		 	CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA	 
MIM212840	#	 	CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM	 
MIM212850		 	CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	 
MIM212890		 	CEREBELLAR ATAXIA, BENIGN, WITH THERMOANALGESIA	 
MIM212895	%	 	CEREBELLAR ATAXIA, EARLY-ONSET, WITH RETAINED TENDON REFLEXES; EOCA	 
MIM212900	^	 	MOVED TO 258450	 
MIM213000	%	 	CEREBELLAR HYPOPLASIA	283989, 4983, 57038, 7443, 79042, 80746, 8573
MIM213002		 	CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	 
MIM213010		 	CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZ SYNDROME AND MECKEL SYNDROME	 
MIM213100	%	 	CEREBELLOPARENCHYMAL DISORDER II; CPD2	 
MIM213200	%	9q34-qter	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	1165
MIM213300	#	9q34.3, 9q34.3	JOUBERT SYNDROME; JBTS	51524, 65250, 79809, 79867, 95681
MIM213400		 	CEREBELLOPARENCHYMAL DISORDER V; CPD5	 
MIM213500		 	CEREBRAL ANGIOPATHY, DYSPHORIC	 
MIM213600	#	14q	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	23706, 6575
MIM213700	#	2q33-qter	CEREBROTENDINOUS XANTHOMATOSIS; CTX	1593
MIM213820		 	CEREBRAL MALFORMATION, SEIZURES, HYPERTRICHOSIS, AND OVERLAPPING FINGERS	 
MIM213950		 	CEREBROCORTICAL DEGENERATION OF INFANCY	 
MIM213980	#	 	CEREBROFACIOTHORACIC DYSPLASIA	 
MIM214100	#	1p36.2, 1q22, 12p13.3, 7q21-q22, 6q23-q24, 1p36.32, 2p15, 22q11.21	ZELLWEGER SYNDROME; ZS	5189, 5192, 5194, 5195, 55670, 5824, 5830, 8504
MIM214110	#	 	CEREBROHEPATORENAL SYNDROME, VARIANT TYPES	 
MIM214150	#	10q11	CEREBROOCULOFACIOSKELETAL SYNDROME 1; COFS1	2074
MIM214200		 	CEROID STORAGE DISEASE	1200, 1201, 1203, 1509, 2055, 256471, 54982
MIM214290		 	CERVICAL VERTEBRAE, AGENESIS OF	 
MIM214300	#	5q11.2	KLIPPEL-FEIL SYNDROME 2, AUTOSOMAL RECESSIVE; KFS2	 
MIM214350		 	CHANDS	 
MIM214370	%	 	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION, AND ABSENT SENSORY LARGE MYELINATED FIBERS	 
MIM214400	#	8q13-q21.1	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	54332
MIM214450	#	15q21	GRISCELLI SYNDROME, TYPE 1; GS1	4644
MIM214500	#	1q42.1-q42.2	CHEDIAK-HIGASHI SYNDROME; CHS	1130
MIM214700	#	7q22-q31.1	DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1	1811
MIM214800	#	8q12.1, 7q21.11	CHARGE SYNDROME	55636, 9723
MIM214900	%	15q	CHOLESTASIS-LYMPHEDEMA SYNDROME	84565
MIM214950	#	5p13.2-q11.1	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4; CBAS4	23600
MIM214980		 	CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	 
MIM215030		 	CHOLESTEROL PNEUMONIA	 
MIM215045	#	3p22-p21.1	CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	5745
MIM215050		 	CHONDRODYSPLASIA CALCIFICANS METAPHYSEALIS	 
MIM215100	#	6q22-q24	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1	5191
MIM215105		 	CHONDRODYSPLASIA PUNCTATA SYNDROME	 
MIM215140	#	1q42.1	HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA	3930
MIM215150	#	6p21.3	OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED	1280, 1302
MIM215250		 	CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	 
MIM215300	#	8q24.11-q24.13	CHONDROSARCOMA	2131
MIM215400	#	7q33	CHORDOMA, SUSCEPTIBILITY TO; CHDM	121775
MIM215450		 	CHOREA, BENIGN FAMILIAL	 
MIM215470	#	 	CHORIORETINAL DYSTROPHY, SPINOCEREBELLAR ATAXIA, AND HYPOGONADOTROPIC HYPOGONADISM	 
MIM215480		 	CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	 
MIM215500	%	17p	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 1; CACD1	772
MIM215510		 	CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	 
MIM215518		 	CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	 
MIM215520	%	 	CILIARY DYSKINESIA WITH TRANSPOSITION OF CILIARY MICROTUBULES	 
MIM215550		 	CIRCUMVALLATE PLACENTA SYNDROME	 
MIM215600	#	12q13, 12q13	CIRRHOSIS, FAMILIAL	 
MIM215700	#	9q34.1	CITRULLINEMIA, CLASSIC	445
MIM215720		 	CITRULLINE TRANSPORT DEFECT	 
MIM215800		 	CLEFT LARYNX, POSTERIOR	 
MIM215850		 	CLEFT-LIMB-HEART MALFORMATION SYNDROME	 
MIM216100		 	CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	 
MIM216300		 	CLEFT PALATE, DEAFNESS, AND OLIGODONTIA	 
MIM216330		 	CLEIDOCRANIAL DYSPLASIA, RECESSIVE FORM	 
MIM216340	#	 	CLEIDOCRANIAL DYSPLASIA WITH MICROGNATHIA, ABSENT THUMBS, AND DISTAL APHALANGIA	 
MIM216360	#	16q12.2, 8q21.13-q22.1, 4p15.3	COACH SYNDROME	23322, 57545, 91147
MIM216400	#	5q12	COCKAYNE SYNDROME, TYPE A; CSA	1161
MIM216411		 	COCKAYNE SYNDROME, TYPE III	 
MIM216550	#	8q22-q23	COHEN SYNDROME; COH1	157680
MIM216700	%	 	COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING; RPC	 
MIM216800		 	COLOBOMA OF MACULA AND SKELETAL ANOMALIES	 
MIM216820	#	 	COLOBOMA, OCULAR	 
MIM216900	#	2q11	ACHROMATOPSIA 2; ACHM2	1261
MIM216920		 	COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	 
MIM216950	%	12p13	COMPLEMENT COMPONENT C1r/C1s DEFICIENCY	715
MIM217000	#	6p21.3	COMPLEMENT COMPONENT 2 DEFICIENCY; C2D	717
MIM217030	*	4q25	COMPLEMENT FACTOR I; CFI	3426
MIM217050	*	5p13	COMPLEMENT COMPONENT 6; C6	729
MIM217070	*	5p13	COMPLEMENT COMPONENT 7; C7	730
MIM217080	#	2q11.2	JALILI SYNDROME	26504
MIM217085		 	CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	 
MIM217090	#	6q26	PLASMINOGEN DEFICIENCY, TYPE I	5340
MIM217095	#	8p21, 2q21.1, 22q11.2, 19p12	CONOTRUNCAL HEART MALFORMATIONS; CTHM	137814, 1482, 2627, 2657, 55997, 6899
MIM217100	%	 	CONSTRICTING BANDS, CONGENITAL	 
MIM217150		 	CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA	 
MIM217200		 	CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	 
MIM217300	#	12q22	CORNEA PLANA 2; CNA2	11081
MIM217400	#	20p13-p12, 20p13	CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	83959
MIM217500	%	 	CORNEAL DYSTROPHY, BAND-SHAPED	 
MIM217520		 	CORNEAL DEGENERATION, BAND-SHAPED SPHEROID	 
MIM217600		 	CENTRAL CLOUDY DYSTROPHY OF FRANCOIS; CCDF	 
MIM217700	#	20p13-p12	CORNEAL ENDOTHELIAL DYSTROPHY 2, AUTOSOMAL RECESSIVE; CHED2	83959
MIM217800	#	16q22	MACULAR DYSTROPHY, CORNEAL, 1; MCDC1	4166
MIM217980	%	 	CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	 
MIM217990	%	 	CORPUS CALLOSUM, AGENESIS OF	 
MIM218000	#	15q13-q14	AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN	9990
MIM218010		 	CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	 
MIM218030	#	16q22	APPARENT MINERALOCORTICOID EXCESS; AME	3291
MIM218040	#	11p15.5	COSTELLO SYNDROME	3265
MIM218050		 	CRAMPS, FAMILIAL ADOLESCENT	 
MIM218090		 	CRANE-HEISE SYNDROME	 
MIM218100	%	 	CRANIAL NERVES, CONGENITAL PARESIS OF	 
MIM218200		 	CRANIAL NERVES, RECURRENT PARESIS OF	 
MIM218300		 	CRANIODIAPHYSEAL DYSPLASIA; CDD	 
MIM218330	#	3q21	CRANIOECTODERMAL DYSPLASIA 1; CED1	55764
MIM218340	#	 	CRANIOFACIAL DYSMORPHISM WITH OCULAR COLOBOMA, ABSENT CORPUS CALLOSUM, AND AORTIC DILATATION	 
MIM218350		 	CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	 
MIM218400	#	6q21-q22	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR	64588
MIM218450		 	CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	 
MIM218455	^	 	MOVED TO 251200	 
MIM218500	^	 	MOVED TO 123100 AND 123150	 
MIM218600	#	8q24.3	BALLER-GEROLD SYNDROME; BGS	9401
MIM218649		 	CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	 
MIM218650		 	CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	 
MIM218670		 	CRANIOTELENCEPHALIC DYSPLASIA	 
MIM218700	#	2q12-q14	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2; CHNG2	7849
MIM218800	#	2q37	CRIGLER-NAJJAR SYNDROME, TYPE I	54658
MIM218900	%	 	CROME SYNDROME	 
MIM219000	#	13q13.3, 4q21	FRASER SYNDROME	341640, 80144
MIM219050	#	13q13.1, 19p13.2	CRYPTORCHIDISM, UNILATERAL OR BILATERAL	122042, 3640
MIM219070		 	CURVED NAIL OF FOURTH TOE	 
MIM219080	#	 	ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH	2778
MIM219090	#	11q13.3	PITUITARY ADENOMA, ACTH-SECRETING	9049
MIM219095		 	CUTANEOUS PHOTOSENSITIVITY AND COLITIS, LETHAL	 
MIM219100	#	14q32.1, 11q13	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A	 
MIM219150	#	 	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA; ARCL3A	5832
MIM219200	#	12q24.3	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	23545
MIM219250		 	CUTIS MARMORATA TELANGIECTATICA CONGENITA; CMTC	 
MIM219300		 	CUTIS VERTICIS GYRATA AND MENTAL RETARDATION; CVG/MR	 
MIM219500	#	1p31.1	CYSTATHIONINURIA	1491
MIM219550		 	CYSTEINE PEPTIDURIA	 
MIM219700	#	7q31.2, 19q13.1	CYSTIC FIBROSIS; CF	1080, 7040, 89845
MIM219721		 	CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND SUBNORMAL MENTALITY	 
MIM219750	#	17p13	CYSTINOSIS, ADULT NONNEPHROPATHIC	1497
MIM219800	#	17p13	CYSTINOSIS, NEPHROPATHIC; CTNS	1497
MIM219900	#	17p13	CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE	1497
MIM220100	#	2p16.3, 19q13.1	CYSTINURIA	11136, 6519
MIM220110	#	2q33.3, 19q13.1	MITOCHONDRIAL COMPLEX IV DEFICIENCY	1340, 22868, 493753, 84987
MIM220111	#	2p21-p16	LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	10128
MIM220120	#	 	D-GLYCERIC ACIDURIA	132158
MIM220150	#	11q13	HYPOURICEMIA, RENAL, 1; RHUC1	116085
MIM220200	%	3q24, 3q24	DANDY-WALKER SYNDROME; DWS	1858
MIM220210	#	 	DANDY-WALKER-LIKE MALFORMATION WITH ATRIOVENTRICULAR SEPTAL DEFECT	 
MIM220219		 	DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	 
MIM220220		 	DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	 
MIM220290	#	13q12, 13q11-q12, 1p35.1	DEAFNESS, AUTOSOMAL RECESSIVE 1A; DFNB1A	10804, 2706, 2707
MIM220300		 	DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	 
MIM220400	#	11p15.5	JERVELL AND LANGE-NIELSEN SYNDROME 1; JLNS1	3784
MIM220500	#	 	DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, AND MENTAL RETARDATION SYNDROME	 
MIM220600	#	7q21.2-q21.3	SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS; SHFM1D	1749
MIM220700	^	 	MOVED TO 220290	 
MIM220900		 	DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	 
MIM221200	#	 	DEAFNESS, COCHLEAR, WITH MYOPIA AND INTELLECTUAL IMPAIRMENT	 
MIM221300	%	 	DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	 
MIM221320		 	DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	 
MIM221350	%	 	DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	 
MIM221400		 	DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL AND PROGRESSIVE SENSORY NEUROPATHY	 
MIM221500		 	DEAFNESS, NEURAL, CONGENITAL MODERATE	 
MIM221600	^	 	MOVED TO 220290	 
MIM221650	^	 	MOVED TO 220290	 
MIM221700		 	DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS	 
MIM221740		 	DEAFNESS-OLIGODONTIA SYNDROME	 
MIM221750	#	9q34.3	PITUITARY HORMONE DEFICIENCY, COMBINED, 3; CPHD3	8022
MIM221760		 	DERMATOGLYPHICS--PALMAR TRIRADIUS d, ABSENCE OF	 
MIM221770	#	6p21.2, 19q13.1	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	54209, 7305
MIM221780		 	DERMATOGLYPHICS--HYPOTHENAR RADIAL ARCH	 
MIM221790		 	DERMATOLEUKODYSTROPHY	 
MIM221800	%	 	DERMOCHONDROCORNEAL DYSTROPHY	 
MIM221810		 	DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	 
MIM221820	#	17q21-q22	LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS; HDLS	1436, 8156
MIM221900	#	10q21	RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL; RNANC	54719
MIM221950		 	DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	 
MIM221995		 	DIABETES INSIPIDUS, NEPHROGENIC, WITH MENTAL RETARDATION AND INTRACEREBRAL CALCIFICATION	 
MIM222000	^	 	MOVED TO 125800	 
MIM222100	%	12q24.2, 12q24.2, 1p13, 7p21, 6p21.3, 6pter-p21, Xp11.23-q13.3	DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	26191, 3569, 3710, 4938, 50943, 6927
MIM222300	#	4p16.1	WOLFRAM SYNDROME 1; WFS1	7466
MIM222350		 	DIAMINOPENTANURIA	 
MIM222400	%	8p23.1	DIAPHRAGMATIC HERNIA 2; DIH2	780899
MIM222448	#	2q24-q31	DONNAI-BARROW SYNDROME	4036
MIM222470	#	 	TRICHOHEPATOENTERIC SYNDROME 1; THES1	9652
MIM222500		 	DIASTEMATOMYELIA	 
MIM222600	#	5q32-q33.1	DIASTROPHIC DYSPLASIA	1836
MIM222690	%	 	DIBASIC AMINO ACIDURIA I	 
MIM222700	#	14q11.2	LYSINURIC PROTEIN INTOLERANCE; LPI	9056
MIM222730	#	9p24	DICARBOXYLICAMINO ACIDURIA	6505
MIM222745	*	8q21.3	2,4-@DIENOYL-CoA REDUCTASE 1; DECR1	1666
MIM222748	#	8q22	DIHYDROPYRIMIDINASE DEFICIENCY	1807
MIM222760	^	 	MOVED TO 220500	 
MIM222765	#	1q42	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2; RCDP2	8443
MIM222800	#	7q31-q34	BISPHOSPHOGLYCERATE MUTASE DEFICIENCY	669
MIM222900	#	3q25-q26	SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL; CSID	6476
MIM223000	#	2q21	LACTASE DEFICIENCY, CONGENITAL	3938
MIM223100	#	2q21	LACTOSE INTOLERANCE, ADULT TYPE	4175
MIM223300		 	DISSEMINATED SCLEROSIS WITH NARCOLEPSY	 
MIM223320		 	DIVERTICULOSIS, SMALL-INTESTINAL	 
MIM223330		 	DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	 
MIM223340		 	DK PHOCOMELIA SYNDROME	 
MIM223350		 	DOHLE BODIES AND LEUKEMIA	 
MIM223360	#	9q34	DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL	1621
MIM223370	%	 	DUBOWITZ SYNDROME	 
MIM223400		 	DUODENAL ATRESIA	 
MIM223500		 	DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	 
MIM223540		 	DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY	 
MIM223550		 	DWARFISM, PROPORTIONATE, WITH HIP DISLOCATION	 
MIM223610	^	 	MOVED TO 228900	 
MIM223800	#	18q12-q21.1	DYGGVE-MELCHIOR-CLAUSEN DISEASE; DMC	54808
MIM223900	#	9q31	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3	8518
MIM224000		 	DYSAUTONOMIA-LIKE DISORDER	 
MIM224050	#	9p24	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	7436
MIM224100	#	20p11.2	ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II; CDAN2	10483
MIM224120	#	15q15	ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE I; CDAN1	146059
MIM224200	^	 	MOVED TO 229200	 
MIM224230	#	15q14-q15, 5q35.3	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 1; DKCB1	55505, 55651
MIM224250		 	DYSMYELINATION WITH JAUNDICE	 
MIM224300	%	 	DYSOSTEOSCLEROSIS	 
MIM224400	%	 	DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	 
MIM224410	#	1p36.1	DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	3339
MIM224500	%	 	DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	1862
MIM224550		 	DYSTONIA WITH RINGBINDEN	 
MIM224690	#	 	MEIER-GORLIN SYNDROME 1; MGORS1	4998
MIM224700		 	EBSTEIN ANOMALY	 
MIM224750	#	2q35	SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	80326
MIM224800		 	ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	 
MIM224900	#	2q11-q13, 1q42.2-q43	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL RECESSIVE	10913, 128178
MIM225000	%	 	ROSSELLI-GULIENETTI SYNDROME	 
MIM225040		 	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESIS OF THE CORPUS CALLOSUM	 
MIM225050		 	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARY DYSKINESIA	 
MIM225060	#	11q23-q24	CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	5818
MIM225100	#	1q21	ECTOPIA LENTIS, ISOLATED, AUTOSOMAL RECESSIVE; ECTOL2	54507
MIM225200	#	 	ECTOPIA LENTIS ET PUPILLAE	 
MIM225250	#	5q34	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5	1482
MIM225280	#	16q22.1	EEM SYNDROME	1001
MIM225290		 	ECTRODACTYLY-POLYDACTYLY	 
MIM225300	#	12q13	SPLIT-HAND/FOOT MALFORMATION 6; SHFM6	7480
MIM225310		 	EHLERS-DANLOS SYNDROME WITH PLATELET DYSFUNCTION FROM FIBRONECTIN ABNORMALITY	 
MIM225320	#	7q22.1	EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM	1278
MIM225400	#	1p36.3-p36.2	EHLERS-DANLOS SYNDROME, TYPE VI; EDS6	5351
MIM225410	#	5q23	EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE	9509
MIM225450		 	ELLIPTOCYTOSIS, ATYPICAL	 
MIM225500	#	4p16, 4p16	ELLIS-VAN CREVELD SYNDROME; EVC	132884, 2121
MIM225700		 	ENCEPHALOMALACIA, MULTILOCULAR	 
MIM225740		 	ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	 
MIM225750	#	3p21.3-p21.2	AICARDI-GOUTIERES SYNDROME 1; AGS1	11277
MIM225753	#	17q25.1	PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	283989
MIM225755		 	ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	 
MIM225790	#	14q24.3	PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	55640
MIM226000		 	ENDOCARDIAL FIBROELASTOSIS; EFE	 
MIM226100		 	ENDOCARDIAL FIBROELASTOSIS AND COARCTATION OF ABDOMINAL AORTA	 
MIM226110		 	ENDOTHELIAL DYSTROPHY, CONGENITAL HEREDITARY, WITH NAIL HYPOPLASIA	 
MIM226150		 	ENTEROCOLITIS	 
MIM226200	#	21q21	ENTEROKINASE DEFICIENCY	5651
MIM226300	%	 	ENTEROPATHY, PROTEIN-LOSING	 
MIM226350		 	EOSINOPHILIC FASCIITIS	 
MIM226400	#	17q25, 17q25	EPIDERMODYSPLASIA VERRUCIFORMIS; EV	11322, 147138
MIM226440		 	EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTAL RETARDATION	 
MIM226450	^	 	MOVED TO 226600 AND 226650	 
MIM226500	%	 	EPIDERMOLYSIS BULLOSA DYSTROPHICA NEUROTROPHICA	1884
MIM226600	#	11q22-q23, 3p21.3	EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB	1294, 4312
MIM226650	#	1q25-q31, 17q11-qter, 10q24.3, 1q32, 18q11.2	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	1308, 3691, 3909, 3914, 3918
MIM226670	#	8q24	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	5339
MIM226700	#	1q25-q31, 1q32, 18q11.2	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	3909, 3914, 3918
MIM226730	#	17q11-qter, 2q31.1	EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA	3655, 3691, 5339
MIM226735		 	EPIDERMOLYSIS BULLOSA WITH DIAPHRAGMATIC HERNIA	 
MIM226750	#	 	KOHLSCHUTTER-TONZ SYNDROME; KTZS	79641
MIM226800		 	EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	 
MIM226810		 	EPILEPSY WITH BILATERAL OCCIPITAL CALCIFICATIONS	 
MIM226850		 	EPILEPSY-TELANGIECTASIA	 
MIM226900	#	5q32-q33.1	EPIPHYSEAL DYSPLASIA, MULTIPLE, 4; EDM4	1836
MIM226950		 	EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	 
MIM226960	%	 	EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	 
MIM226980	#	2p12	EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	9451
MIM226985		 	EPITHELIAL SQUAMOUS DYSPLASIA, KERATINIZING DESQUAMATIVE, OF URINARY TRACT	 
MIM226990		 	EPSTEIN-BARR VIRUS, SUSCEPTIBILITY TO CHRONIC INFECTION BY	 
MIM227000		 	ERYTHEMA OF ACRAL REGIONS	 
MIM227010		 	ERMINE PHENOTYPE	 
MIM227050	%	19q13.2	TRANSIENT ERYTHROBLASTOPENIA OF CHILDHOOD; TEC	100124696
MIM227090	%	 	ERYTHRODERMA, LETHAL CONGENITAL	 
MIM227100	^	 	MOVED TO 120900	 
MIM227150	%	 	ETHANOLAMINOSIS	 
MIM227200		8p21-p11.2	EUNUCHOIDISM, FAMILIAL HYPOGONADOTROPIC	2796
MIM227210		 	EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY	 
MIM227220	#	15q13.1, 15q11.2-q12	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1	4948, 8924
MIM227240	#	5p13.3	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5; SHEP5	51151
MIM227250		 	FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	 
MIM227255		 	FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	 
MIM227260	#	 	SETLEIS SYNDROME	117581
MIM227270		 	FACIOCARDIOMELIC DYSPLASIA, LETHAL	 
MIM227280		 	FACIOCARDIORENAL SYNDROME	 
MIM227290	^	 	MOVED TO 222448	 
MIM227300	#	18q21.3-q22	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1; F5F8D1	3998
MIM227320		 	FACIOTHORACOGENITAL SYNDROME	 
MIM227330	%	 	FACIODIGITOGENITAL SYNDROME, RECESSIVE	 
MIM227400	#	1q23	FACTOR V DEFICIENCY	2153
MIM227500	#	13q34	FACTOR VII DEFICIENCY	2155
MIM227600	#	13q34	FACTOR X DEFICIENCY	2159
MIM227645	#	9q22.3	FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC	2176
MIM227646	#	3p25.3	FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2	2177
MIM227650	#	16q24.3	FANCONI ANEMIA, COMPLEMENTATION GROUP A; FANCA	2175
MIM227810	#	3q26.1-q26.3	FANCONI-BICKEL SYNDROME; FBS	6514
MIM227850		 	FANCONI-LIKE SYNDROME	 
MIM228000	#	8p22-p21.3	FARBER LIPOGRANULOMATOSIS	427
MIM228020		 	FASCIAL DYSTROPHY, CONGENITAL	 
MIM228100	%	 	VISCERAL STEATOSIS, CONGENITAL	 
MIM228200		 	FEMUR-FIBULA-ULNA SYNDROME	 
MIM228250	%	 	FEMUR, UNILATERAL BIFID, WITH MONODACTYLOUS ECTRODACTYLY	 
MIM228300	#	4q21.2	FERTILE EUNUCH SYNDROME	2798
MIM228355		 	FETAL IODINE DEFICIENCY DISORDER; FIDD	 
MIM228400		 	FEVER, FAMILIAL LIFELONG PERSISTENT	 
MIM228520	#	 	FIBROCHONDROGENESIS 1; FBCG1	1301
MIM228560		 	FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	 
MIM228600	#	4q21	FIBROMATOSIS, JUVENILE HYALINE	118429
MIM228800		 	FIBROSCLEROSIS, MULTIFOCAL	 
MIM228900	#	20q11.2	FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY	8200
MIM228930	#	3p25	FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	7476
MIM228940		 	FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	 
MIM228960	#	3q27	HIGH MOLECULAR WEIGHT KININOGEN DEFICIENCY	3827
MIM228980	#	 	FLECK RETINA, FAMILIAL BENIGN; FRFB	5322
MIM228990		 	FLECK RETINA OF KANDORI	 
MIM229000	*	4q35	KALLIKREIN B, PLASMA, 1; KLKB1	3818
MIM229045		 	FOCAL EPITHELIAL HYPERPLASIA, ORAL	 
MIM229050	#	17q11.1	FOLATE MALABSORPTION, HEREDITARY	113235
MIM229070	#	11p13	FOLLICLE-STIMULATING HORMONE DEFICIENCY, ISOLATED	2488
MIM229100	#	21q22.3	FORMIMINOTRANSFERASE DEFICIENCY	10841
MIM229120	%	 	FOUNTAIN SYNDROME	 
MIM229200	#	16q24	BRITTLE CORNEA SYNDROME 1; BCS1	84627
MIM229250		 	FREESIA FLOWERS, INABILITY TO SMELL	 
MIM229300	#	9q13	FRIEDREICH ATAXIA 1; FRDA	2395
MIM229310		 	FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	 
MIM229400	%	 	FRONTOFACIONASAL DYSPLASIA	 
MIM229500	%	 	FRUCTOSE AND GALACTOSE INTOLERANCE	 
MIM229600	#	9q22.3	FRUCTOSE INTOLERANCE, HEREDITARY	229
MIM229700	#	9q22.2-q22.3	FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	2203
MIM229800	#	2p23.3-p23.2	FRUCTOSURIA, ESSENTIAL	3795
MIM229850	%	 	FRYNS SYNDROME; FRNS	 
MIM229900	^	 	MOVED TO 258870	 
MIM230000	#	1p34	FUCOSIDOSIS	2517
MIM230200	#	17q24	GALACTOKINASE DEFICIENCY	2584
MIM230300		 	GALACTORRHEA	 
MIM230350	#	1p36-p35	GALACTOSE EPIMERASE DEFICIENCY	2582
MIM230400	#	9p13	GALACTOSEMIA	2592
MIM230430	^	 	MOVED TO 300622	 
MIM230450	#	6p12	GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO	2729
MIM230500	#	3p21.33	GM1-GANGLIOSIDOSIS, TYPE I	2720
MIM230600	#	3p21.33	GM1-GANGLIOSIDOSIS, TYPE II	2720
MIM230650	#	3p21.33	GM1-GANGLIOSIDOSIS, TYPE III	2720
MIM230700	^	 	MOVED TO 272800	 
MIM230710	^	 	MOVED TO 272800	 
MIM230740	#	 	GAPO SYNDROME	 
MIM230750		 	GASTROSCHISIS	 
MIM230800	#	1q21	GAUCHER DISEASE, TYPE I	2629
MIM230900	#	1q21	GAUCHER DISEASE, TYPE II	2629
MIM231000	#	1q21	GAUCHER DISEASE, TYPE III	2629
MIM231005	#	1q21	GAUCHER DISEASE, TYPE IIIC	2629
MIM231050	#	9q34.2	GELEOPHYSIC DYSPLASIA 1; GPHYSD1	9719
MIM231060		 	GENITOPALATOCARDIAC SYNDROME	 
MIM231070	#	1q24.2	GERODERMA OSTEODYSPLASTICUM; GO	92344
MIM231080		 	GERMAN SYNDROME	 
MIM231090	#	19q13.4	HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	199713
MIM231095	#	7q34	GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD	6916
MIM231100		 	HEMOCHROMATOSIS, NEONATAL	 
MIM231200	#	17pter-p12, 3q21, 22q11.2	BERNARD-SOULIER SYNDROME; BSS	2811, 2812, 2815
MIM231300	#	2p22-p21	GLAUCOMA 3, PRIMARY CONGENITAL, A; GLC3A	1545
MIM231520	^	 	MOVED TO 273750	 
MIM231530	#	4q22-q26	3-@HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	3033
MIM231550	#	12q13	ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS	8086
MIM231630		 	GLUTAMATE MONOSODIUM SENSITIVITY	 
MIM231670	#	19p13.2	GLUTARIC ACIDEMIA I	2639
MIM231675	*	4q32-qter	ELECTRON TRANSFER FLAVOPROTEIN DEHYDROGENASE; ETFDH	2110
MIM231680	#	15q23-q25, 4q32-qter, 19q13.3	MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	2108, 2109, 2110
MIM231690	#	 	GLUTARIC ACIDURIA III	79783
MIM231900	#	20q11.2	GLUTATHIONE SYNTHETASE DEFICIENCY OF ERYTHROCYTES, HEMOLYTIC ANEMIA DUE TO	2937
MIM231950		22q11.1-q11.2	GLUTATHIONURIA	 
MIM231970		 	GLUTEAL MUSCLES, ABSENCE OF	 
MIM232000	*	13q32	PROPIONYL-CoA CARBOXYLASE, ALPHA SUBUNIT; PCCA	5095
MIM232050	*	3q21-q22	PROPIONYL-CoA CARBOXYLASE, BETA SUBUNIT; PCCB	5096
MIM232200	#	17q21	GLYCOGEN STORAGE DISEASE Ia	2538
MIM232220	#	11q23	GLYCOGEN STORAGE DISEASE Ib	2542
MIM232240	#	11q23, 6p21.3	GLYCOGEN STORAGE DISEASE Ic	10786, 2542
MIM232300	#	17q25.2-q25.3	GLYCOGEN STORAGE DISEASE II	2548
MIM232400	#	1p21	GLYCOGEN STORAGE DISEASE III	178
MIM232500	#	3p12	GLYCOGEN STORAGE DISEASE IV	2632
MIM232600	#	11q13	GLYCOGEN STORAGE DISEASE V	5837
MIM232700	#	14q21-q22	GLYCOGEN STORAGE DISEASE VI	5836
MIM232800	#	12q13.3	GLYCOGEN STORAGE DISEASE VII	5213
MIM233100	#	16p11.2	RENAL GLUCOSURIA; GLYS1	2759, 6524
MIM233270		 	GOMBO SYNDROME	 
MIM233300	#	2p21-p16	OVARIAN DYSGENESIS 1; ODG1	2492
MIM233400	#	 	PERRAULT SYNDROME; PRLTS	3295
MIM233420	#	12q13.1	46,XY SEX REVERSAL 7; SRXY7	50846
MIM233430		 	GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	 
MIM233450		 	GOODPASTURE SYNDROME	 
MIM233500		 	GORLIN-CHAUDHRY-MOSS SYNDROME	 
MIM233600		 	GRANULOCYTOPENIA WITH IMMUNOGLOBULIN ABNORMALITY	 
MIM233650	#	11p13, 11p13	COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS; CCHIDG	5896, 5897
MIM233690	#	16q24	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	1535
MIM233700	#	7q11.23	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I	653361
MIM233710	#	1q25	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II	4688
MIM233800		 	GROUPED PIGMENTATION OF THE RETINA	 
MIM233810		 	GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	 
MIM233910	#	14q22.1-q22.2	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	2643
MIM234000	#	5q33-qter	FACTOR XII DEFICIENCY	2161
MIM234030		 	HAIR DEFECT WITH PHOTOSENSITIVITY AND MENTAL RETARDATION	 
MIM234050	#	7p14	TRICHOTHIODYSTROPHY, NONPHOTOSENSITIVE 1; TTDN1	136647
MIM234100	%	6q21-q23.2	HALLERMANN-STREIFF SYNDROME; HSS	2697
MIM234200	#	20p13-p12.3	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	80025
MIM234250		 	HALL-RIGGS MENTAL RETARDATION SYNDROME	 
MIM234280		 	HALLUX VARUS AND PREAXIAL POLYSYNDACTYLY	 
MIM234300		 	HALO NEVI	 
MIM234350		 	HALOTHANE HEPATITIS	 
MIM234500	#	5p15.33	HARTNUP DISORDER	340024
MIM234580		 	HEARING LOSS, SENSORINEURAL, WITH ENAMEL HYPOPLASIA AND NAIL DEFECTS	 
MIM234700		 	HEART BLOCK, CONGENITAL	 
MIM234800		 	HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	 
MIM234810	#	 	HEMANGIOMATOSIS, FAMILIAL PULMONARY CAPILLARY	 
MIM234820		 	HEMANGIOPERICYTOMA, MALIGNANT	 
MIM235000	%	11p15	HEMIHYPERPLASIA, ISOLATED; IH	100188864
MIM235200	#	6p21.3, 20p12	HEMOCHROMATOSIS; HFE	3077, 650
MIM235255	%	 	MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	 
MIM235360	^	 	MOVED TO 219100	 
MIM235370		 	HEMOLYTIC ANEMIA WITH THERMAL SENSITIVITY OF RED CELLS	 
MIM235400	#	1q32, 1q31-q32.1, 1q31-q32.1	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1	10878, 3075, 3078, 3426, 4179, 629, 7056, 718, 81494, 8862
MIM235500		 	HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	 
MIM235510	#	18q21.32	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	147372
MIM235550	#	2q37.1	HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY; VODI	3431
MIM235555	#	7q32-q33	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2; CBAS2	6718
MIM235600	^	 	MOVED TO 400045	 
MIM235700	#	10q22	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	3098
MIM235730	#	2q22	MOWAT-WILSON SYNDROME	9839
MIM235800	#	12q22-q23	HISTIDINEMIA	3034
MIM235830	%	 	HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	 
MIM235900	%	 	HISTIOCYTOSIS, FAMILIAL LIPOCHROME	 
MIM236000	#	3p21.31	LYMPHOMA, HODGKIN	200942
MIM236100	%	21q22.3	HOLOPROSENCEPHALY	3244, 4838, 8928
MIM236110		 	HOLZGREVE SYNDROME	 
MIM236130		 	HOMOCARNOSINOSIS	 
MIM236200	#	21q22.3	HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	875
MIM236250	#	1p36.3	HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY	4524
MIM236270	#	5p15.3-p15.2	HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA DUE TO DEFECT IN COBALAMIN METABOLISM, cblE COMPLEMENTATION TYPE	4552
MIM236400	%	 	HUMERORADIAL SYNOSTOSIS	 
MIM236410		 	HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	 
MIM236450		 	HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME	 
MIM236490	^	4q21	HYALINOSIS, INFANTILE SYSTEMIC; ISH	118429
MIM236500		 	HYDRANENCEPHALY WITH RENAL APLASIA-DYSPLASIA	 
MIM236600	#	 	HYDROCEPHALUS	 
MIM236635		 	HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	 
MIM236640		 	HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	 
MIM236660		 	HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	 
MIM236670	#	9q34.1	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MDDGA1	10585, 2218, 29954, 79147, 9215
MIM236680	#	11q24.2	HYDROLETHALUS SYNDROME 1; HLS1	219844
MIM236690		 	HYDROCEPHALUS, NORMAL-PRESSURE	 
MIM236700	#	20p12	MCKUSICK-KAUFMAN SYNDROME; MKKS	8195
MIM236730	#	10q23-q24	UROFACIAL SYNDROME; UFS	60495
MIM236750	#	 	HYDROPS FETALIS, NONIMMUNE; NIHF	 
MIM236792	#	14q22.1	L-2-HYDROXYGLUTARIC ACIDURIA	79944
MIM236795	%	 	3-@HYDROXYISOBUTYRIC ACIDURIA	 
MIM236800	#	 	HYDROXYKYNURENINURIA	 
MIM236900	%	 	HYDROXYLYSINURIA	 
MIM237000		 	HYDROXYPROLINEMIA	 
MIM237100		 	HYMEN, IMPERFORATE	 
MIM237300	#	2q35	CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO	1373
MIM237310	#	17q21.31	N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	162417
MIM237400		 	HYPER-BETA-ALANINEMIA	 
MIM237450	#	 	HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR	10599, 28234
MIM237500	#	10q24	DUBIN-JOHNSON SYNDROME; DJS	1244
MIM237550		 	HYPERBILIRUBINEMIA, CONJUGATED, TYPE III	 
MIM237800	%	 	HYPERBILIRUBINEMIA, SHUNT	 
MIM237900	#	2q37	HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN	54658
MIM238200	^	 	MOVED TO 220100	 
MIM238300	*	9p22	GLYCINE DECARBOXYLASE; GLDC	2731
MIM238310	*	3p21.2-p21.1	AMINOMETHYLTRANSFERASE; AMT	275
MIM238320	#	2p21	LEYDIG CELL HYPOPLASIA, TYPE I	3973
MIM238330	*	16q24	GLYCINE CLEAVAGE SYSTEM H PROTEIN; GCSH	2653
MIM238331	*	7q31-q32	DIHYDROLIPOAMIDE DEHYDROGENASE; DLD	1738
MIM238340		 	HYPERLEUCINE-ISOLEUCINEMIA	 
MIM238350		 	HYPERLEXIA	 
MIM238400	^	 	MOVED TO 144650	 
MIM238500	^	 	MOVED TO 144650	 
MIM238600	#	8p22	HYPERLIPOPROTEINEMIA, TYPE I	344, 4023
MIM238700	#	7q31.3	HYPERLYSINEMIA	10157
MIM238710		 	HYPERLYSINEMIA DUE TO DEFECT IN LYSINE TRANSPORT INTO MITOCHONDRIA	 
MIM238750		 	HYPERLYSINURIA WITH HYPERAMMONEMIA	 
MIM238800		 	HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	 
MIM238950		 	HYPEROPIA, HIGH	 
MIM238970	#	13q14	HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	10166
MIM239000	#	8q24	PAGET DISEASE, JUVENILE	4982
MIM239100	#	17q12-q21	HYPEROSTOSIS CORTICALIS GENERALISATA	50964
MIM239199		 	HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	 
MIM239200	#	3q13.3-q21	HYPERPARATHYROIDISM, NEONATAL SEVERE PRIMARY; NSHPT	846
MIM239300	#	 	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1; HPMRS1	55650
MIM239350		 	HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	 
MIM239400	^	 	HYPERPIPECOLATEMIA	 
MIM239500	#	22q11.2	HYPERPROLINEMIA, TYPE I; HPI	5625
MIM239510	#	1p36	HYPERPROLINEMIA, TYPE II; HPII	8659
MIM239710		 	ACROFRONTOFACIONASAL DYSOSTOSIS 2	 
MIM239711		 	HYPERTELORISM AND TETRALOGY OF FALLOT	 
MIM239800	%	 	HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	 
MIM239840		 	HYPERTRICHOSIS, CONGENITAL ANTERIOR CERVICAL, WITH PERIPHERAL SENSORY AND MOTOR NEUROPATHY	 
MIM239850	#	 	HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	10060
MIM239900		 	HYPERTROPHIC NEUROPATHY AND CATARACT	 
MIM240150		 	HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	 
MIM240200	%	 	HYPOADRENOCORTICISM, FAMILIAL	 
MIM240300	#	21q22.3	AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I; APS1	326
MIM240400		8p21.1	HYPOASCORBEMIA	2989
MIM240500	#	17p11.2	IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	115650, 1380, 23495, 29851, 930
MIM240600	#	12p12.2	GLYCOGEN STORAGE DISEASE 0, LIVER	2998
MIM240800	#	11p15.1	HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	6833
MIM240900	#	 	HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	208
MIM240950		 	HYPOGONADISM-CATARACT SYNDROME	 
MIM241000		 	HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	 
MIM241080	#	2q22.3-q35	WOODHOUSE-SAKATI SYNDROME	80067
MIM241090	%	 	HYPERGONADOTROPIC HYPOGONADISM AND PARTIAL ALOPECIA	 
MIM241100		 	HYPOGONADISM, MALE	 
MIM241120		 	HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES	 
MIM241150	%	 	HYPOKALEMIA, FAMILIAL	 
MIM241200	#	11q24	BARTTER SYNDROME, ANTENATAL, TYPE 2	3758
MIM241310	%	 	HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	 
MIM241410	#	1q42-q43	HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME; HRD	6905
MIM241500	#	1p36.1-p34	HYPOPHOSPHATASIA, INFANTILE	249
MIM241510	#	1p36.1-p34	HYPOPHOSPHATASIA, CHILDHOOD	249
MIM241519		 	HYPOPHOSPHATEMIA, RENAL, WITH INTRACEREBRAL CALCIFICATIONS	 
MIM241520	#	4q21	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 1; ARHR1	1758
MIM241530	#	9q34	HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY; HHRH	142680
MIM241540		 	HYPOPITUITARISM, CONGENITAL, WITH CENTRAL DIABETES INSIPIDUS	 
MIM241550	#	6q21-q23.2	HYPOPLASTIC LEFT HEART SYNDROME 1; HLHS1	2697
MIM241600	#	15q21-q22	HYPOPROTEINEMIA, HYPERCATABOLIC	567
MIM241760		 	HYPOSPADIAS-MENTAL RETARDATION SYNDROME	 
MIM241800		7p13	HYPOTHALAMIC HAMARTOMAS	2737
MIM241850	#	9q22	HYPOTHYROIDISM, ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE	2304
MIM242100	#	17p13.1, 17p13.1, 14q11.2	ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL, NONBULLOUS, 1; NCIE1	242, 59344, 7051
MIM242150		 	ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	 
MIM242300	#	14q11.2	ICHTHYOSIS, LAMELLAR, 1; LI1	7051
MIM242500	#	2q34	ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE	26154
MIM242510		 	ICHTHYOSIS WITH ALOPECIA, ECLABION, ECTROPION, AND MENTAL RETARDATION	 
MIM242520		 	ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	 
MIM242530		 	ICHTHYOSIS, MENTAL RETARDATION, DWARFISM, AND RENAL IMPAIRMENT	 
MIM242550		 	ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	 
MIM242600	#	5q33.1, 5p15.33, 3p21.3	IMINOGLYCINURIA	153201, 340024, 54716
MIM242650	^	 	MOVED TO 244400	 
MIM242670	%	 	CILIARY DYSKINESIA WITH DEFECTIVE RADIAL SPOKES	 
MIM242680		 	CILIARY DYSKINESIA WITH EXCESSIVELY LONG CILIA	 
MIM242700	%	 	IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	 
MIM242840	#	 	IMMUNODEFICIENCY WITH CLEFT LIP/PALATE, CATARACT, HYPOPIGMENTATION, AND ABSENT CORPUS CALLOSUM	 
MIM242850		 	IMMUNE DEFICIENCY DISEASE	 
MIM242860	#	20q11.2	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1; ICF1	1789
MIM242880		 	IMMUNOERYTHROMYELOID HYPOPLASIA	 
MIM242890		 	IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	 
MIM242900	#	2q34-q36	IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	50485
MIM243000	#	2q24	INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE	6335
MIM243050		 	INDOLYLACROYL GLYCINURIA WITH MENTAL RETARDATION	 
MIM243060	#	19q13.43	SPERMATOGENIC FAILURE 5; SPGF5	6795
MIM243080		 	INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	 
MIM243100		 	INTERNAL CAROTID ARTERIES, HYPOPLASIA OF	 
MIM243110		 	IMMUNODEFICIENCY WITH DEFECTIVE T-CELL RESPONSE TO INTERLEUKIN 1	 
MIM243150	#	 	INTESTINAL ATRESIA, MULTIPLE	 
MIM243185		 	INTESTINAL PSEUDOOBSTRUCTION WITH PATENT DUCTUS ARTERIOSUS AND NATAL TEETH	 
MIM243200		 	INTRACRANIAL HYPERTENSION, IDIOPATHIC	 
MIM243300	#	18q21	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 1; BRIC1	5205
MIM243305	*	9q31	INVERSIN; INVS	27130
MIM243310	#	 	BARAITSER-WINTER SYNDROME 1; BRWS1	60
MIM243320		 	INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	 
MIM243340	^	 	MOVED TO 242860	 
MIM243400	#	8p23.1-p21.3	ACETYLATION, SLOW	10
MIM243440		 	ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME	 
MIM243450		 	ISOVALERIC ACID, INABILITY TO SMELL	 
MIM243500	#	15q14-q15	ISOVALERIC ACIDEMIA; IVA	3712
MIM243600	%	 	JEJUNAL ATRESIA	 
MIM243605		 	JEJUNAL ATRESIA WITH MICROCEPHALY AND OCULAR ANOMALIES	 
MIM243700	#	9p24	HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE	81704
MIM243800	#	15q15-q21.1	JOHANSON-BLIZZARD SYNDROME; JBS	197131
MIM243910	%	 	ARIMA SYNDROME	 
MIM244100		 	JUMPING FRENCHMAN OF MAINE	 
MIM244200	#	20p13	HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	128674
MIM244300	%	 	KAPUR-TORIELLO SYNDROME	 
MIM244400	#	9p21-p13	CILIARY DYSKINESIA, PRIMARY, 1; CILD1	27019
MIM244450	%	 	KAUFMAN OCULOCEREBROFACIAL SYNDROME	 
MIM244460	#	1q42-q43	KENNY-CAFFEY SYNDROME, TYPE 1; KCS1	6905
MIM244510		 	KERATOCONUS AND CONGENITAL HIP DYSPLASIA	 
MIM244600		 	KERATOCONUS POSTICUS CIRCUMSCRIPTUS; KPC	 
MIM244850		 	KERATODERMA, PALMOPLANTAR, NORRBOTTEN RECESSIVE TYPE	 
MIM245000	#	11q14.1-q14.3	PAPILLON-LEFEVRE SYNDROME; PALS	1075
MIM245010	#	11q14.1-q14.3	HAIM-MUNK SYNDROME; HMS	1075
MIM245050	#	5p13	SUCCINYL-CoA:3-OXOACID CoA TRANSFERASE DEFICIENCY	5019
MIM245100	%	 	KETOACIDURIA WITH MENTAL DEFICIENCY AND OTHER FEATURES	 
MIM245130		 	KETOADIPICACIDURIA	 
MIM245150	#	12p13.1-p12.3	KEUTEL SYNDROME	4256
MIM245160		 	KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS	 
MIM245180		 	KIFAFA SEIZURE DISORDER	 
MIM245190		 	KNIEST-LIKE DYSPLASIA, LETHAL	 
MIM245200	#	14q31	KRABBE DISEASE	2581
MIM245300	#	 	KURU, SUSCEPTIBILITY TO	5621
MIM245340	#	1p13.2-p12	ERYTHROCYTE LACTATE TRANSPORTER DEFECT	6566
MIM245348	#	11q23.1	PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	1737
MIM245349	#	11p13	PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY; PDHXD	8050
MIM245400	#	2p11.2	MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA); MTDPS9	8802
MIM245450		 	LACTIC ACIDURIA DUE TO D-LACTIC ACID	 
MIM245480	#	14q11.2	SPECIFIC GRANULE DEFICIENCY; SGD	1053
MIM245550		 	LAMBERT SYNDROME	 
MIM245552		 	LAMBOTTE SYNDROME	 
MIM245570	#	 	LANDAU-KLEFFNER SYNDROME; LKS	 
MIM245590	#	17q11.2	GROWTH HORMONE INSENSITIVITY WITH IMMUNODEFICIENCY	6777
MIM245600	#	 	MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, CRANIOFACIAL DYSMORPHISM, AND CONGENITAL HEART DEFECTS	26229, 9469
MIM245650		 	LARSEN-LIKE SYNDROME, LETHAL TYPE	 
MIM245660	#	18q11.2	LARYNGOONYCHOCUTANEOUS SYNDROME; LOCS	3909
MIM245800		 	LAURENCE-MOON SYNDROME	 
MIM245900	#	16q22.1	LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	3931
MIM246000	%	 	LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	 
MIM246200	#	19p13.2	DONOHUE SYNDROME	3643
MIM246300	#	4q32	LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3	7097
MIM246400	%	 	LETTERER-SIWE DISEASE	 
MIM246450	#	1pter-p33	3-@HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	3155
MIM246470		 	LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	 
MIM246500		 	LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS	 
MIM246530	*	5q35	LEUKOTRIENE C4 SYNTHASE; LTC4S	4056
MIM246550		 	LICHTENSTEIN SYNDROME	 
MIM246555		 	LIMB DEFECTS, DISTAL TRANSVERSE, WITH MENTAL RETARDATION AND SPASTICITY	 
MIM246560	#	10q24	SPLIT-HAND/FOOT MALFORMATION 3; SHFM3	100049542
MIM246570		 	FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	 
MIM246600	*	10q26.1	PANCREATIC LIPASE; PNLIP	5406
MIM246650	#	16p13.3	LIPASE DEFICIENCY, COMBINED	64788
MIM246700	#	5q31.1	CHYLOMICRON RETENTION DISEASE; CMRD	51128
MIM246900	#	 	MOVED TO 238331	 
MIM247100	#	1q21	LIPOID PROTEINOSIS OF URBACH AND WIETHE	1893
MIM247150		 	LIP PRINTS	 
MIM247200	#	17p13.3	MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	 
MIM247410		 	LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	 
MIM247420	#	19q13.2	LUTHERAN NULL	4059
MIM247430		 	LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	 
MIM247440		 	LYMPHEDEMA, CONGENITAL RECESSIVE	 
MIM247450		 	LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	 
MIM247610		 	LYMPHOID INTERSTITIAL PNEUMONIA; LIP	 
MIM247630		 	LYMPHOID SYSTEM DETERIORATION, PROGRESSIVE	 
MIM247640		9p22-p21	LYMPHOBLASTIC LEUKEMIA, ACUTE, WITH LYMPHOMATOUS FEATURES; LALL	8009
MIM247650		 	LYMPHOKINE DEFICIENCY	 
MIM247800	%	 	LYMPHOPENIC HYPERGAMMAGLOBULINEMIA, ANTIBODY DEFICIENCY, AUTOIMMUNE HEMOLYTIC ANEMIA, AND GLOMERULONEPHRITIS	 
MIM247950		 	LYSINE MALABSORPTION SYNDROME	 
MIM247980	*	Chr.16	LIPASE B, LYSOSOMAL ACID; LIPB	3989
MIM247990		 	MACDERMOT-WINTER SYNDROME	 
MIM248000	#	 	MACROCEPHALY	 
MIM248010		 	MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	 
MIM248100		 	MACROSOMIA ADIPOSA CONGENITA	 
MIM248110		 	MACROSOMIA WITH MICROPHTHALMIA, LETHAL	 
MIM248190	#	1p34.2	HYPOMAGNESEMIA 5, RENAL, WITH OCULAR INVOLVEMENT; HOMG5	149461
MIM248200	#	8q21-q22, 1p22.1	STARGARDT DISEASE 1; STGD1	24, 54714
MIM248250	#	3q27	HYPOMAGNESEMIA 3, RENAL; HOMG3	10686
MIM248260		 	MAGNESIUM, ELEVATED RED CELL	 
MIM248300	#	8qter	MAL DE MELEDA	57152
MIM248310	%	5q31-q33	PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL	7910
MIM248340		 	3MC SYNDROME 3; 3MC3	 
MIM248350		 	MALOCCLUSION AND SHORT STATURE	 
MIM248360	#	16q24	MALONYL-CoA DECARBOXYLASE DEFICIENCY	23417
MIM248370	#	1q21.2	MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	4000
MIM248390	#	6p22.3	TREACHER COLLINS SYNDROME 3; TCS3	9533
MIM248400		 	MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL DEFICIENCY	 
MIM248450	#	 	MANITOBA OCULOTRICHOANAL SYNDROME; MOTA	158326
MIM248500	#	19cen-q12	MANNOSIDOSIS, ALPHA B, LYSOSOMAL; MANSA	4125
MIM248510	#	4q22-q25	MANNOSIDOSIS, BETA A, LYSOSOMAL; MANSB	4126
MIM248600	#	7q31-q32, 1p31, 6q14, 19q13.1-q13.2	MAPLE SYRUP URINE DISEASE	1629, 1738, 593, 594
MIM248610	*	1p31	DIHYDROLIPOAMIDE BRANCHED-CHAIN TRANSACYLASE; DBT	1629
MIM248611	*	6q14	BRANCHED-CHAIN KETO ACID DEHYDROGENASE E1, BETA POLYPEPTIDE; BCKDHB	594
MIM248700	#	 	MARDEN-WALKER SYNDROME	 
MIM248760		 	MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	 
MIM248770		 	MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	 
MIM248800	#	5q31	MARINESCO-SJOGREN SYNDROME; MSS	64374
MIM248810	^	 	MOVED TO 248800	 
MIM248900	#	15q21-q22	MAST SYNDROME	51324
MIM248910		 	CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	 
MIM248950		 	MCDONOUGH SYNDROME	 
MIM249000	#	17q23	MECKEL SYNDROME, TYPE 1; MKS1	54903
MIM249100	#	16p13	FAMILIAL MEDITERRANEAN FEVER; FMF	4210
MIM249210	^	 	MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	 
MIM249230		 	MEGAEPIPHYSEAL DWARFISM	 
MIM249240		 	MEGALENCEPHALY WITH DYSMYELINATION	 
MIM249270	#	1q23.3	THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA	10560
MIM249300		 	MEGALOCORNEA	 
MIM249310	%	 	MEGALOCORNEA-MENTAL RETARDATION SYNDROME	 
MIM249400	#	 	MELANOSIS, NEUROCUTANEOUS	 
MIM249420	#	5q35.1	FRANK-TER HAAR SYNDROME; FTHS	285590
MIM249500	#	4q25-q26	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1; MRT1	8492
MIM249599		 	MENTAL RETARDATION SYNDROME, BELGIAN TYPE	 
MIM249600		 	MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	 
MIM249620	%	 	OHDO SYNDROME	 
MIM249630		 	MENTAL RETARDATION, BUENOS AIRES TYPE	 
MIM249650	%	 	MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU	 
MIM249660		 	MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES	 
MIM249670		 	MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	 
MIM249700	#	Ypter-p11.2, Xpter-p22.32	LANGER MESOMELIC DYSPLASIA; LMD	6473
MIM249710		 	MESOMELIC LIMB SHORTENING AND BOWING	 
MIM249900	#	10q22.1	METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	5660
MIM250100	#	22q13.31-qter	METACHROMATIC LEUKODYSTROPHY	410
MIM250215	%	 	METAPHYSEAL ACROSCYPHODYSPLASIA	 
MIM250220	#	 	SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	 
MIM250230		 	METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	 
MIM250250	#	9p21-p12	CARTILAGE-HAIR HYPOPLASIA; CHH	6023
MIM250300		 	METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	 
MIM250400		 	METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	 
MIM250410		 	METAPHYSEAL CHONDRODYSPLASIA WITH RETINITIS PIGMENTOSA	 
MIM250420		 	METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	 
MIM250450		 	METAPHYSEAL DYSPLASIA, ANETODERMA, AND OPTIC ATROPHY	 
MIM250460	#	9p21-p12	METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS	6023
MIM250500		 	METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	 
MIM250600	^	 	MOVED TO 156530	 
MIM250620	#	2q32.2	BETA-HYDROXYISOBUTYRYL CoA DEACYLASE DEFICIENCY	26275
MIM250650		 	METHANE PRODUCTION	 
MIM250700		 	METHEMOGLOBIN REDUCTASE DEFICIENCY	 
MIM250790	#	18q23	METHEMOGLOBINEMIA TYPE IV	1528
MIM250800	#	22q13.31-qter	METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	1727
MIM250850	#	10q22	METHIONINE ADENOSYLTRANSFERASE DEFICIENCY	4143
MIM250900	%	 	METHIONINE MALABSORPTION SYNDROME	 
MIM250940	#	1q43	METHYLCOBALAMIN DEFICIENCY, cblG TYPE	4548
MIM250950	#	Chr.9	3-@METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	549, 6901
MIM250951		 	3-@METHYLGLUTACONIC ACIDURIA, TYPE IV; MGCA4	 
MIM251000	#	6p21	METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY	4594
MIM251100	#	4q31.1-q31.2	METHYLMALONIC ACIDURIA, cblA TYPE	166785
MIM251110	#	12q24	METHYLMALONIC ACIDURIA, cblB TYPE	326625
MIM251120	#	2p13.3	METHYLMALONYL-CoA EPIMERASE DEFICIENCY	84693
MIM251170	*	12q24	MEVALONATE KINASE; MVK	4598
MIM251190		 	MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	 
MIM251200	#	8p23	MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE; MCPH1	79648
MIM251220		 	MICROCEPHALY-CARDIOMYOPATHY	 
MIM251230	%	 	MICROCEPHALY-MICROMELIA SYNDROME	 
MIM251240		 	MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	 
MIM251250		 	MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	 
MIM251255	#	18p11.22-q11.2	JAWAD SYNDROME; JWDS	100192306, 5932
MIM251260	#	8q21	NIJMEGEN BREAKAGE SYNDROME	4683
MIM251270	#	 	MICROCEPHALY AND CHORIORETINOPATHY WITH OR WITHOUT MENTAL RETARDATION, AUTOSOMAL RECESSIVE	85378
MIM251280		 	MICROCEPHALY WITH SPASTIC QUADRIPLEGIA	 
MIM251290	#	5q13.1	BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA; BLCPMG	100506658
MIM251300	%	 	MICROCEPHALY, HIATAL HERNIA, AND NEPHROTIC SYNDROME	 
MIM251400		 	MICROCOLON	 
MIM251450	#	17q25.3, 17q25.3	DESBUQUOIS DYSPLASIA; DBQD	124583
MIM251455	^	 	MOVED TO 258315	 
MIM251500	^	 	MOVED TO 600118	 
MIM251505		 	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 4; MCOPCB4	 
MIM251600	%	14q32	MICROPHTHALMIA, ISOLATED 1; MCOP1	8113
MIM251700		 	MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA, AND DENTAL ANOMALIES	 
MIM251750	#	 	MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	4053
MIM251800	%	 	MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	 
MIM251850	#	18q21	DIARRHEA 2, WITH MICROVILLUS ATROPHY; DIAR2	4645
MIM251880	#	2p13	MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE); MTDPS3	1716
MIM251900		 	MITOCHONDRIAL MYOPATHY	 
MIM251950		 	MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS	 
MIM252010	#	1q23, 14q12, 11q24.2, 11q13, 6q16.1, 5q12.1, 5q11.1, 5pter-p15.33, 3p21.31, 2q33-q34, Xq24, 20p12.1, 19p13.3, 18p11.31-p11.2	MITOCHONDRIAL COMPLEX I DEFICIENCY	126328, 25915, 29078, 4694, 4709, 4719, 4720, 4723, 4724, 4726, 4729, 51103, 55572, 79133, 80224, 91942
MIM252011	#	5p15, 19q12-q13.2	MITOCHONDRIAL COMPLEX II DEFICIENCY	6389, 644096
MIM252030	^	 	REMOVED FROM DATABASE	 
MIM252100	%	 	MOHR SYNDROME	 
MIM252150	#	14q24, 6p21.3, 5q11	MOLYBDENUM COFACTOR DEFICIENCY	10243, 4337, 4338
MIM252200	^	 	MOVED TO 158000 AND 607903	 
MIM252250		 	MONOCYTE CHEMOTACTIC DISORDER	 
MIM252270	#	 	MONOSOMY 7 OF BONE MARROW	100820631
MIM252300		 	MORQUIO SYNDROME C	 
MIM252320		 	MOTOR NEUROPATHY, PERIPHERAL, WITH DYSAUTONOMIA	 
MIM252350	%	3p26-p24.2	MOYAMOYA DISEASE 1; MYMY1	50960
MIM252500	#	12q23.3	MUCOLIPIDOSIS II ALPHA/BETA	79158
MIM252600	#	12q23.3	MUCOLIPIDOSIS III ALPHA/BETA	79158
MIM252605	#	16p	MUCOLIPIDOSIS III GAMMA	84572
MIM252650	#	19p13.3-p13.2	MUCOLIPIDOSIS IV	57192
MIM252700	#	 	MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	 
MIM252800	*	4p16.3	ALPHA-L-IDURONIDASE; IDUA	3425
MIM252900	#	17q25.3	MUCOPOLYSACCHARIDOSIS TYPE IIIA	6448
MIM252920	#	17q21	MUCOPOLYSACCHARIDOSIS TYPE IIIB	4669
MIM252930	#	8p11.1	MUCOPOLYSACCHARIDOSIS TYPE IIIC	138050
MIM252940	#	12q14	MUCOPOLYSACCHARIDOSIS TYPE IIID	2799
MIM253000	#	16q24.3	MUCOPOLYSACCHARIDOSIS TYPE IVA	2588
MIM253010	#	3p21.33	MUCOPOLYSACCHARIDOSIS TYPE IVB	2720
MIM253200	#	5q11-q13	MUCOPOLYSACCHARIDOSIS TYPE VI	411
MIM253220	#	7q21.11	MUCOPOLYSACCHARIDOSIS TYPE VII	2990
MIM253230	^	 	MOVED TO 601492	 
MIM253240	%	 	MUCUS INSPISSATION OF RESPIRATORY TRACT	 
MIM253250	#	17q22-q23	MULIBREY NANISM	4591
MIM253260	#	3p25	BIOTINIDASE DEFICIENCY	686
MIM253270	#	21q22.1	HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	3141
MIM253280	#	1p34-p33	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	55624
MIM253290	#	2q33-q34, 2q33-q34, 2q24-q32	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS	1134, 1144, 1146
MIM253300	#	5q12.2-q13.3	SPINAL MUSCULAR ATROPHY, TYPE I; SMA1	 
MIM253310	#	9q34	LETHAL CONGENITAL CONTRACTURE SYNDROME 1; LCCS1	2733
MIM253320		 	MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPIC HYPOGONADISM	 
MIM253400	#	5q12.2-q13.3, 5q12.2-q13.3	SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	6606, 6607
MIM253550	#	5q12.2-q13.3	SPINAL MUSCULAR ATROPHY, TYPE II; SMA2	6606
MIM253590		 	MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	 
MIM253600	#	15q15.1-q21.1	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	825
MIM253601	#	2p13.3-p13.1	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	8291
MIM253700	#	13q12	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C; LGMD2C	6445
MIM253800	#	9q31	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	2218
MIM253900	%	 	MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	 
MIM254000		 	MUSCULAR DYSTROPHY, CONGENITAL, WITH INFANTILE CATARACT AND HYPOGONADISM	 
MIM254090	#	2q37, 21q22.3, 21q22.3	ULLRICH CONGENITAL MUSCULAR DYSTROPHY; UCMD	1291, 1292, 1293
MIM254100		 	MUSCULAR DYSTROPHY, CONGENITAL, WITH RAPID PROGRESSION	 
MIM254110	#	9q31-q34.1	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H; LGMD2H	22954
MIM254120		 	MUSCULAR HYPERTONIA, LETHAL	 
MIM254130	#	2p13.3-p13.1	MIYOSHI MUSCULAR DYSTROPHY 1; MMD1	8291
MIM254150	%	 	MUSK, INABILITY TO SMELL	 
MIM254200		 	MYASTHENIA GRAVIS; MG	 
MIM254210	#	10q11.2	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH EPISODIC APNEA	1103
MIM254300	#	1pter-p32, 4p16.2	MYASTHENIA, LIMB-GIRDLE, FAMILIAL	285489, 375790
MIM254400		 	MYCOSIS FUNGOIDES	 
MIM254450	#	9p24	MYELOFIBROSIS	10019, 3717, 4352
MIM254500	#	13q22-q34	MYELOMA, MULTIPLE	3662, 3981
MIM254600	#	17q23.1	MYELOPEROXIDASE DEFICIENCY; MPOD	4353
MIM254770	#	6p12-p11	EPILEPSY, MYOCLONIC JUVENILE; EJM	114327
MIM254780	#	6q24, 6p22.3	MYOCLONIC EPILEPSY OF LAFORA	378884, 7957
MIM254800	#	21q22.3	MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	1476
MIM254900	#	4q13-q21	EPILEPSY, PROGRESSIVE MYOCLONIC 4, WITH OR WITHOUT RENAL FAILURE; EPM4	950
MIM254940		 	MYOPATHY, CONGENITAL NONPROGRESSIVE, WITH MOEBIUS SEQUENCE AND ROBIN SEQUENCE	 
MIM254950		 	MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	 
MIM254960		 	MYOPATHY DUE TO MALATE-ASPARTATE SHUTTLE DEFECT	 
MIM255100		 	MYOPATHY WITH ABNORMAL LIPID METABOLISM	 
MIM255110	#	1p32	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET	1376
MIM255120	#	11q13	CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	1374
MIM255125	#	12q24.1	MYOPATHY WITH LACTIC ACIDOSIS, HEREDITARY; HML	23479
MIM255140		 	MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	 
MIM255160		3p22.2-p21.32	MYOPATHY, HYALINE BODY, AUTOSOMAL RECESSIVE	619511
MIM255200	#	2q14	MYOPATHY, CENTRONUCLEAR, 2; CNM2	274
MIM255300	%	 	MYOPATHY, CONGENITAL	 
MIM255310	#	1q42.1	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	57190, 58, 7170
MIM255320	#	19q13.1	MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	6261
MIM255500	%	 	MYOPIA 18, AUTOSOMAL RECESSIVE; MYP18	100359406
MIM255600	#	21q22.3	MYOSCLEROSIS, AUTOSOMAL RECESSIVE	1292
MIM255700	#	7q35	MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	1180
MIM255710		 	MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	 
MIM255800	#	1p36.1	SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	3339
MIM255900		 	MYXEDEMA	 
MIM255960	#	17q23-q24	MYXOMA, INTRACARDIAC	5573
MIM255980	%	 	NASODIGITOACOUSTIC SYNDROME	 
MIM255990		 	NATHALIE SYNDROME	 
MIM255995	#	 	NATIVE AMERICAN MYOPATHY; NAM	 
MIM256000	#	11q24.2, 11q13, 11q13, 11p11.11, 10q24, 9q34, 8q22.1, 7q31-q32, 5q31.2, 5q12.1, 5q11.1, 5p15, 2q33, 19p13	LEIGH SYNDROME; LS	1355, 137682, 1738, 374291, 4695, 4704, 4705, 4722, 4723, 4724, 4728, 55572, 55967, 617, 6389, 6834, 91942
MIM256030	#	2q22	NEMALINE MYOPATHY 2; NEM2	4703
MIM256040	#	 	AUTOINFLAMMATION, LIPODYSTROPHY, AND DERMATOSIS SYNDROME; ALDD	5696
MIM256050	#	5q32-q33.1	ATELOSTEOGENESIS, TYPE II; AOII	1836
MIM256100	#	2q13	NEPHRONOPHTHISIS 1; NPHP1	4867
MIM256120		 	NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM	 
MIM256150		 	NEPHROSIALIDOSIS	 
MIM256200		 	NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS	 
MIM256300	#	19q13.1	NEPHROTIC SYNDROME, TYPE 1; NPHS1	4868
MIM256350	^	 	MOVED TO 600995	 
MIM256370	#	11p13	NEPHROTIC SYNDROME, TYPE 4; NPHS4	7490
MIM256450	#	11p15.1	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1	6833
MIM256500	#	5q32	NETHERTON SYNDROME; NETH	11005
MIM256520	#	 	NEU-LAXOVA SYNDROME; NLS	 
MIM256540	#	20q13.1	GALACTOSIALIDOSIS; GSL	5476
MIM256550	#	6p21.3	NEURAMINIDASE DEFICIENCY	4758
MIM256600	#	22q13.1	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A; NBIA2A	8398
MIM256690		 	NEUROFACIODIGITORENAL SYNDROME	 
MIM256700	#	1p36.2, 17q21.3	NEUROBLASTOMA, SUSCEPTIBILITY TO	23095, 4830
MIM256710	#	 	ELEJALDE DISEASE	 
MIM256730	#	1p32	CEROID LIPOFUSCINOSIS, NEURONAL, 1; CLN1	5538
MIM256731	#	13q21.1-q32	CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5	1203
MIM256800	#	1q21-q22	INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	4914
MIM256810	#	2p23-p21	MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE); MTDPS6	4358
MIM256840	#	5p15.2	NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE	22948, 80208
MIM256850	#	16q24.1	GIANT AXONAL NEUROPATHY 1; GAN1	8139
MIM256851	^	 	MOVED TO 256850	 
MIM256855	%	 	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH EXCESSIVE MYELIN FOLDING COMPLEX, AUTOSOMAL RECESSIVE	 
MIM256860		 	NEUROPATHY, HEREDITARY SENSORY, ATYPICAL	 
MIM256870		 	NEUROPATHY, PAINFUL	 
MIM257100		 	NEUTROPENIA, LETHAL CONGENITAL, WITH EOSINOPHILIA	 
MIM257150	%	 	NEUTROPHIL ACTIN DYSFUNCTION; NAD	 
MIM257200	#	11p15.4-p15.1	NIEMANN-PICK DISEASE, TYPE A	6609
MIM257220	#	18q11-q12	NIEMANN-PICK DISEASE, TYPE C1; NPC1	4864
MIM257270	#	5q35	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B; CSNB1B	2916
MIM257300	#	15q15	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1	701
MIM257320	#	7q22	LISSENCEPHALY 2; LIS2	5649
MIM257350		 	NUCHAL BLEB, FAMILIAL	 
MIM257500		 	OBESITY-HYPOVENTILATION SYNDROME	 
MIM257550	%	2q13	OCULAR MOTOR APRAXIA	266710
MIM257600	%	 	OCULAR MYOPATHY WITH CURARE SENSITIVITY	 
MIM257790		 	OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	 
MIM257800	%	 	OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	 
MIM257850	#	6q21-q23.2	OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	2697
MIM257910	%	 	OCULOPALATOCEREBRAL SYNDROME	 
MIM257920	#	 	3MC SYNDROME 1; 3MC1	5648
MIM257950	^	 	MOVED TO 164300	 
MIM257960		 	OCULOTRICHODYSPLASIA; OTD	 
MIM257970	%	 	OCULORENOCEREBELLAR SYNDROME	 
MIM257980	#	2q35	ODONTOONYCHODERMAL DYSPLASIA; OODD	80326
MIM258040		 	OEIS COMPLEX	 
MIM258100	#	2q37.1	OGUCHI DISEASE 1	6295
MIM258150	%	 	SPERMATOGENIC FAILURE 1; SPGF1	 
MIM258200		 	OLIVER SYNDROME	 
MIM258300	%	 	OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	 
MIM258315	#	13q32	OMODYSPLASIA 1; OMOD1	10082
MIM258320		 	OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL	 
MIM258360	%	 	ONYCHOTRICHODYSPLASIA AND NEUTROPENIA	 
MIM258400	%	 	OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	 
MIM258450	#	15q25	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE; PEOB	5428
MIM258470		 	OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA	 
MIM258480	#	 	OPSISMODYSPLASIA	 
MIM258500	%	8q21-q22	OPTIC ATROPHY 6; OPA6	777778
MIM258501	#	19q13.2-q13.3	3-@METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3	80207
MIM258650		 	OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE	 
MIM258660	#	17pter-p12	NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY, SUSCEPTIBILITY TO	2811
MIM258700	%	 	OPTICOCOCHLEODENTATE DEGENERATION	 
MIM258800		 	ORAL SENSIBILITY, DISTURBANCE OF	 
MIM258840		 	ORAL AND DIGITAL ANOMALIES WITH ICHTHYOSIS	 
MIM258850	%	 	OROFACIODIGITAL SYNDROME III; OFD3	 
MIM258860	#	 	OROFACIODIGITAL SYNDROME IV; OFD4	26123
MIM258865	%	 	OROFACIODIGITAL SYNDROME IX; OFD9	 
MIM258870	#	10q26	GYRATE ATROPHY OF CHOROID AND RETINA; GACR	4942
MIM258900	#	3q13	OROTIC ACIDURIA	7372
MIM258920	^	 	MOVED TO 258900	 
MIM259050	#	 	OSSIFIED EAR CARTILAGES WITH MENTAL DEFICIENCY, MUSCLE WASTING, AND BONY CHANGES	 
MIM259100	#	4q34-q35	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	3248
MIM259200		 	BLOUNT DISEASE, ADOLESCENT	 
MIM259250	%	 	OSTEODYSPLASIA, FAMILIAL, ANDERSON TYPE	 
MIM259270		 	OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	 
MIM259410		 	OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	 
MIM259420	#	7q22.1, 17q21.31-q22	OSTEOGENESIS IMPERFECTA, TYPE III	1277, 1278
MIM259440	#	15q21-q22	OSTEOGENESIS IMPERFECTA, TYPE IX	5479
MIM259450	#	17p12	BRUCK SYNDROME 1; BRKS1	50963
MIM259500	#	17p13.1, 13q14.1-q14.2, 22q12.1, 18q21-q22	OSTEOGENIC SARCOMA	11200, 5925, 7157
MIM259550		 	OSTEOID OSTEOMA	 
MIM259600	#	16q13	TORG-WINCHESTER SYNDROME	4313
MIM259610		 	OSTEOLYSIS SYNDROME, RECESSIVE	 
MIM259650		 	OSTEOMA OF MIDDLE EAR	 
MIM259660		 	OSTEOMALACIA, SCLEROSING, WITH CEREBRAL CALCIFICATION	 
MIM259680		 	CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS; CRMO	 
MIM259690		 	OSTEOPENIA AND SPARSE HAIR	 
MIM259700	#	11q13.4-q13.5	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	10312
MIM259710	#	13q14	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2	8600
MIM259720	#	6q21	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	28962
MIM259730	#	8q22	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	760
MIM259750		 	OSTEOPOROSIS, JUVENILE	 
MIM259770	#	11q13.4	OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; OPPG	4041
MIM259775	#	7p22	RAINE SYNDROME; RNS	56975
MIM259780	%	 	OTOONYCHOPERONEAL SYNDROME	 
MIM259900	#	2q36-q37	HYPEROXALURIA, PRIMARY, TYPE I; HP1	189
MIM260000	#	9cen	HYPEROXALURIA, PRIMARY, TYPE II	9380
MIM260005	#	 	5-@OXOPROLINASE DEFICIENCY; OPLAHD	26873
MIM260130		 	PACHYONYCHIA CONGENITA, AUTOSOMAL RECESSIVE	 
MIM260150		 	PALANT CLEFT PALATE SYNDROME	 
MIM260200		 	PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA	 
MIM260300	#	22q12-q13	PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK15	25793
MIM260350	#	17p13.1, 12p12.1	PANCREATIC CANCER	3845, 7157
MIM260370	#	13q12.1	PANCREATIC AGENESIS, CONGENITAL; PAGEN	3651
MIM260400	#	7q11	SHWACHMAN-DIAMOND SYNDROME; SDS	51119
MIM260450		 	PANCREATIC INSUFFICIENCY, COMBINED EXOCRINE	 
MIM260470		 	PANENCEPHALITIS, SUBACUTE SCLEROSING	 
MIM260480		 	PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	 
MIM260500	#	17p13.1	PAPILLOMA OF CHOROID PLEXUS	7157
MIM260530		 	PARANA HARD-SKIN SYNDROME	 
MIM260540	#	17q21.1	PARKINSON-DEMENTIA SYNDROME	4137
MIM260555		 	PARTINGTON-ANDERSON SYNDROME	 
MIM260565	%	 	PEHO SYNDROME	 
MIM260570		 	PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	 
MIM260600	#	 	LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	9255
MIM260650		 	PELLAGRA-LIKE SYNDROME	 
MIM260660	#	1p13	COUSIN SYNDROME	6913
MIM260800	#	17q25.3	PENTOSURIA	51181
MIM260900		 	PERICARDIAL EFFUSION, CHRONIC	 
MIM260910		 	PERIFOLLICULITIS CAPITIS ABSCEDENS ET SUFFODIENS, FAMILIAL	 
MIM260920	#	12q24	HYPER-IgD SYNDROME; HIDS	4598
MIM260950		 	PERIODONTITIS, CHRONIC	 
MIM260970		 	PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND SPONGY DEGENERATION OF BRAIN	 
MIM261000	#	11q13	INTRINSIC FACTOR DEFICIENCY; IFD	2694
MIM261100	#	14q32, 10p12.1	MEGALOBLASTIC ANEMIA 1	8029, 81693
MIM261400		 	PERONEUS TERTIUS MUSCLE, ABSENCE OF	 
MIM261500	#	17q23.1	PEROXIDASE AND PHOSPHOLIPID DEFICIENCY IN EOSINOPHILS	8288
MIM261515	#	5q2	D-BIFUNCTIONAL PROTEIN DEFICIENCY	3295
MIM261540	#	13q12.3	PETERS-PLUS SYNDROME	145173
MIM261550	#	12q13, 19p13.3-p13.2	PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II; PMDS	268, 269
MIM261560		 	PFEIFFER-PALM-TELLER SYNDROME	 
MIM261575		 	PHAVER SYNDROME	 
MIM261590		 	PHENFORMIN 4-HYDROXYLATION	 
MIM261600	#	12q24.1	PHENYLKETONURIA; PKU	5053
MIM261630	#	4p15.31	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	5860
MIM261640	#	11q22.3-q23.3	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	5805
MIM261650	%	14q11.2-q12	PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, MITOCHONDRIAL	5106
MIM261670	#	7p13-p12.3	GLYCOGEN STORAGE DISEASE X; GSD10	5224
MIM261740	#	7q36	GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	51422
MIM261750	#	16q12-q13	GLYCOGEN STORAGE DISEASE IXb; GSD9B	5257
MIM261800	%	17q24.3-q25.1	PIERRE ROBIN SYNDROME	100301572
MIM261900	%	 	PILI TORTI, EARLY-ONSET	 
MIM261990		 	PILI TORTI AND DEVELOPMENTAL DELAY	 
MIM262000	#	2q33	BJORNSTAD SYNDROME; BJS	617
MIM262020		 	PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	 
MIM262190	#	19p13.2	PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	3643
MIM262300	#	8q21-q22	ACHROMATOPSIA 3; ACHM3	54714
MIM262350	^	 	MOVED TO 194190	 
MIM262400	#	17q22-q24	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IA; IGHD1A	2688
MIM262500	#	5p13-p12	LARON SYNDROME	2690
MIM262600	#	5q	PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2	5626
MIM262650	#	17q22-q24	KOWARSKI SYNDROME	2688
MIM262700	#	1q25	PITUITARY HORMONE DEFICIENCY, COMBINED, 4; CPHD4	89884
MIM262710		 	PITUITARY DWARFISM WITH LARGE SELLA TURCICA	 
MIM262800		 	PLASMA CLOT RETRACTION FACTOR, DEFICIENCY OF	 
MIM262850	#	17pter-p12	ALPHA-2-PLASMIN INHIBITOR DEFICIENCY	5345
MIM262890	#	12q12	SCOTT SYNDROME; SCTS	196527
MIM262900		 	PLEOCONIAL MYOPATHY WITH SALT CRAVING	 
MIM263000	%	 	INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	100188011
MIM263100		 	POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS	 
MIM263200	#	6p21.1-p12	POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE; ARPKD	5314
MIM263210	%	 	POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY, HYPERTELORISM, AND BRACHYMELIA	 
MIM263300	#	9p24	POLYCYTHEMIA VERA	3717
MIM263400	#	3p26-p25	ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2	7428, 8056
MIM263450	%	 	POLYDACTYLY, POSTAXIAL, TYPE A5; PAPA5	 
MIM263510	^	11q13.5	SHORT RIB-POLYDACTYLY SYNDROME, TYPE III	79659
MIM263520	#	11q13.5	SHORT RIB-POLYDACTYLY SYNDROME, TYPE II	4750, 79659
MIM263530	^	 	SHORT RIB-POLYDACTYLY SYNDROME, TYPE I; SRPS1	 
MIM263540		 	POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	 
MIM263550		 	POLYMYOCLONUS, INFANTILE	 
MIM263560	^	 	MOVED TO 214400	 
MIM263570	#	 	POLYGLUCOSAN BODY DISEASE, ADULT FORM; APBD	2632
MIM263610		 	POLYHYDRAMNIOS, CHRONIC IDIOPATHIC	 
MIM263630	%	 	POLYSYNDACTYLY WITH CARDIAC MALFORMATION	 
MIM263650	#	 	POPLITEAL PTERYGIUM SYNDROME, LETHAL TYPE	54101
MIM263700	#	10q25.2-q26.3	PORPHYRIA, CONGENITAL ERYTHROPOIETIC	7390
MIM263750	#	 	POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS	1723
MIM263800	#	16q13	GITELMAN SYNDROME	6559
MIM264010		 	PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY	 
MIM264050		 	PRENATAL BOWING	 
MIM264060		 	PREPAPILLARY VASCULAR LOOPS	 
MIM264070	#	10q22	HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D; HPABH4D	5092
MIM264080		11q22	PROGESTERONE RESISTANCE	5241
MIM264090	%	 	PROGEROID SYNDROME, NEONATAL	 
MIM264110		 	PROLACTIN DEFICIENCY, ISOLATED	 
MIM264120		 	PROLACTIN DEFICIENCY WITH OBESITY AND ENLARGED TESTES	 
MIM264140		 	PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, AND DEAFNESS	 
MIM264150	^	 	MOVED TO 177170	 
MIM264180		 	PSEUDODIASTROPHIC DYSPLASIA	 
MIM264270	%	 	PSEUDOHERMAPHRODITISM, FEMALE, WITH SKELETAL ANOMALIES	 
MIM264300	#	9q22	17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	3293
MIM264350	#	16p13-p12, 16p13-p12, 12p13	PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B	6337, 6338, 6340
MIM264420		 	FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	 
MIM264470	#	17q25	PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY	51
MIM264475		 	PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HAND ANOMALIES	 
MIM264480		 	PSEUDOTRISOMY 13 SYNDROME	 
MIM264500		 	PSEUDOURIDINURIA AND MENTAL DEFECT	 
MIM264600	#	2p23	PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	6716
MIM264700	#	12q13.1-q13.3	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A	1594
MIM264800	#	16p13.1, 16p13.1, 17q21.3-q22	PSEUDOXANTHOMA ELASTICUM; PXE	368, 64131, 64132
MIM264810	^	 	REMOVED FROM DATABASE	 
MIM264900	*	4q35	COAGULATION FACTOR XI; F11	2160
MIM265000	#	2q33-q34	MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS	1146
MIM265050	#	 	3MC SYNDROME 2; 3MC2	78989
MIM265100	#	4p15.31-p15.2	PULMONARY ALVEOLAR MICROLITHIASIS	10568
MIM265120	#	2p12-p11.2	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	6439
MIM265140		 	PULMONARY ARTERIOVENOUS FISTULAS	 
MIM265150		 	PULMONARY ATRESIA WITH INTACT VENTRICULAR SEPTUM	 
MIM265200		 	PULMONARY BULLAE CAUSING PNEUMOTHORAX	 
MIM265300	%	 	LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL	 
MIM265380	#	16q24, 2q35	ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	1373, 2294
MIM265400		 	PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	 
MIM265430		 	LUNG AGENESIS	 
MIM265450	#	2q33	PULMONARY VENOOCCLUSIVE DISEASE; PVOD	659
MIM265500		 	PULMONIC STENOSIS	 
MIM265600		 	PULMONIC STENOSIS AND CONGENITAL NEPHROSIS	 
MIM265800	#	1q21	PYCNODYSOSTOSIS	1513
MIM265850	%	 	PYGMY	 
MIM265880		 	PYKNOACHONDROGENESIS	 
MIM265900	%	 	PYLE DISEASE	 
MIM265950	%	 	PYLORIC ATRESIA	 
MIM266100	#	5q31	EPILEPSY, PYRIDOXINE-DEPENDENT; EPD	501
MIM266120	#	7p15-p14	URIDINE 5-PRIME MONOPHOSPHATE HYDROLASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO	51251
MIM266130	#	20q11.2	GLUTATHIONE SYNTHETASE DEFICIENCY	2937
MIM266140	#	1q21	PYROPOIKILOCYTOSIS, HEREDITARY; HPP	6708
MIM266150	#	11q13.4-q13.5	PYRUVATE CARBOXYLASE DEFICIENCY	5091
MIM266200	#	1q21	PYRUVATE KINASE DEFICIENCY OF RED CELLS	5313
MIM266250	%	 	RADICULONEUROPATHY, FATAL NEONATAL	 
MIM266255		 	RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATION AND HYPOTONIA	 
MIM266265	#	11p11.2	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	55343
MIM266270		 	RAMON SYNDROME	 
MIM266280	#	8q24.3	RAPADILINO SYNDROME	9401
MIM266300	#	16q24.3	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2; SHEP2	3057, 4157
MIM266350	%	 	RED SKIN PIGMENT ANOMALY OF NEW GUINEA	 
MIM266400		 	REESE RETINAL DYSPLASIA	 
MIM266500	#	10pter-p11.2, 6q22-q24	REFSUM DISEASE, ADULT	5191, 5264
MIM266510	#	8q21.1, 7q21-q22, 22q11.21	REFSUM DISEASE, INFANTILE	5189, 55670, 5828
MIM266600	#	16q12, 7p21	INFLAMMATORY BOWEL DISEASE 1; IBD1	3569, 64127
MIM266810		 	RENAL AND MULLERIAN DUCT HYPOPLASIA	 
MIM266900	#	2q13	SENIOR-LOKEN SYNDROME 1; SLSN1	4867
MIM266910		 	RENAL DYSPLASIA-LIMB DEFECTS SYNDROME	 
MIM266920	#	 	MAINZER-SALDINO SYNDROME; MZSDS	9742
MIM267000	#	 	PERLMAN SYNDROME; PRLMNS	129563
MIM267010	#	3q22	MECKEL SYNDROME, TYPE 7; MKS7	27031
MIM267200		 	RENAL TUBULAR ACIDOSIS III	 
MIM267300	#	2cen-q13	RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	525
MIM267400		 	RENAL, GENITAL, AND MIDDLE EAR ANOMALIES	 
MIM267430	#	3q21-q25, 1q42-q43, 1q32, 17q23	RENAL TUBULAR DYSGENESIS; RTD	1636, 183, 185, 5972
MIM267450	#	 	RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS	 
MIM267480		 	RESPIRATORY UNDERRESPONSIVENESS TO HYPOXIA AND HYPERCAPNIA	 
MIM267500	#	1p34	RETICULAR DYSGENESIS	204
MIM267700	%	9q21.3-q22	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1; FHL1	27259
MIM267730		 	RETICULUM CELL SARCOMA	 
MIM267740		 	RETINAL DEGENERATION AND EPILEPSY	 
MIM267750	#	21q22.3	KNOBLOCH SYNDROME 1; KNO1	80781
MIM267760		 	RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION, AND ANGLE CLOSURE GLAUCOMA	 
MIM267800		 	RETINAL DYSTROPHY, RETICULAR PIGMENTARY, OF POSTERIOR POLE	 
MIM267900		 	RETINAL TELANGIECTASIA AND HYPOGAMMAGLOBULINEMIA	 
MIM268000	#	16q13, 14q31.3, 2q14.1, 1q41, 19q13.3	RETINITIS PIGMENTOSA; RP	1259, 1406, 157657, 23746, 5148, 55812, 5949, 6094, 7401, 84100, 9227
MIM268010		 	RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	 
MIM268020		 	RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	 
MIM268025		 	RETINITIS PIGMENTOSA, LATE-ADULT ONSET	 
MIM268040		 	RETINOHEPATOENDOCRINOLOGIC SYNDROME	 
MIM268050		 	RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	 
MIM268060		 	RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	 
MIM268080	%	 	RETINOSCHISIS OF FOVEA	 
MIM268100	#	15q23	ENHANCED S-CONE SYNDROME; ESCS	10002
MIM268130	#	14q12	REVESZ SYNDROME	26277
MIM268150	#	6p21.1-p11	RH-NULL, REGULATOR TYPE; RHN	6005
MIM268200	#	2p21	MYOGLOBINURIA, ACUTE RECURRENT, AUTOSOMAL RECESSIVE	23175
MIM268210	#	11p15.5	RHABDOMYOSARCOMA 1; RMS1	5002
MIM268220	#	1p36.2-p36.12, 13q14.1, 2q35	RHABDOMYOSARCOMA 2; RMS2	2308, 5077, 5081
MIM268250		 	RHIZOMELIC SYNDROME	 
MIM268300	#	8p21.1	ROBERTS SYNDROME; RBS	 
MIM268305	#	 	ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	 
MIM268310	#	9q22	ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS	4920
MIM268315		 	ROD-CONE DYSTROPHY, SENSORINEURAL DEAFNESS, AND FANCONI-TYPE RENAL DYSFUNCTION	 
MIM268320		 	RODRIGUES BLINDNESS	 
MIM268400	#	8q24.3	ROTHMUND-THOMSON SYNDROME; RTS	9401
MIM268500		 	ROWLEY-ROSENBERG SYNDROME	 
MIM268650		 	RUDIGER SYNDROME	 
MIM268670	^	 	MOVED TO 270400	 
MIM268700	%	7q31.3	SACCHAROPINURIA	10157
MIM268800	#	5q13	SANDHOFF DISEASE	3074
MIM268850	%	 	SAO PAULO MCA/MR SYNDROME	 
MIM268900	#	9q33-q34	SARCOSINEMIA	1757
MIM268950	^	 	MOVED TO 254110	 
MIM269000	#	8p21.1	SC PHOCOMELIA SYNDROME	 
MIM269150	#	18q21.1	SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME	26040
MIM269160	#	10q26.1	SCHIZENCEPHALY	2018, 6469, 6496
MIM269200	%	 	AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II; APS2	 
MIM269250	#	1p32-p31	SCHNECKENBECKEN DYSPLASIA	23169
MIM269300		 	SCHWARTZ-LELEK SYNDROME	 
MIM269400	#	 	SCLEROCORNEA, AUTOSOMAL RECESSIVE	 
MIM269500	#	17q12-q21	SCLEROSTEOSIS 1; SOST1	50964
MIM269600	#	19q13.2	SEA-BLUE HISTIOCYTE DISEASE	348
MIM269630		 	SECOND METATARSAL-METACARPAL SYNDROME	 
MIM269650		 	SECRETORY COMPONENT DEFICIENCY	 
MIM269700	#	11q13	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2; CGL2	26580
MIM269720		 	SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	 
MIM269800		 	SENILE PLAQUE FORMATION	 
MIM269840	#	 	SEVERE COMBINED IMMUNODEFICIENCY, ATYPICAL	 
MIM269860	%	 	SHORT RIB-POLYDACTYLY SYNDROME, TYPE IV	 
MIM269870		 	SHORT STATURE-OBESITY SYNDROME; SSOS	 
MIM269880	#	 	SHORT SYNDROME	 
MIM269920	#	6q14-q15	INFANTILE SIALIC ACID STORAGE DISORDER	26503
MIM269921	#	9p13.3	SIALURIA	10020
MIM269950	^	 	MOVED TO 206000	 
MIM270100	#	10q22.1	HETEROTAXY, VISCERAL, 5, AUTOSOMAL; HTX5	4838, 8114
MIM270150	%	 	SJOGREN SYNDROME	 
MIM270200	#	17p11.2	SJOGREN-LARSSON SYNDROME; SLS	224
MIM270220		 	SJOGREN-LARSSON-LIKE ICHTHYOSIS WITHOUT CNS OR EYE INVOLVEMENT	 
MIM270230	^	 	MOVED TO 187600	 
MIM270300	#	 	PEELING SKIN SYNDROME	1041
MIM270350		 	SKUNK N-BUTYLMERCAPTAN, INABILITY TO SMELL	 
MIM270400	#	11q12-q13	SMITH-LEMLI-OPITZ SYNDROME; SLOS	1717
MIM270420	#	19q13.1	DIARRHEA 3, SECRETORY SODIUM, CONGENITAL; DIAR3	10653
MIM270425		 	SODIUM-POTASSIUM-ATPase ACTIVITY OF RED CELL	 
MIM270450	#	15q25-q26	INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO	3480
MIM270460		 	SONODA SYNDROME	 
MIM270500		 	ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	 
MIM270550	#	13q12	SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE; SACS	26278
MIM270600	%	 	SPASTIC DIPLEGIA, INFANTILE TYPE	 
MIM270685	#	11q13	SPASTIC PARAPLEGIA 17; SPG17	26580
MIM270700	#	14q24.1	SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15	23503
MIM270710	%	 	FITZSIMMONS-GUILBERT SYNDROME	 
MIM270750	%	 	SPASTIC PARAPLEGIA 23; SPG23	353293
MIM270800	#	8q21.3	SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	9420
MIM270805		 	SPASTIC PARAPLEGIA WITH MYOCLONIC EPILEPSY	 
MIM270850		 	SPASTIC PARESIS, GLAUCOMA, AND MENTAL RETARDATION	 
MIM270900		 	SPASTIC PSEUDOSCLEROSIS	 
MIM270950		 	SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	 
MIM270960	#	12q23	SPERMATOGENIC FAILURE 4; SPGF4	50511
MIM270970	#	1q21	SPHEROCYTOSIS, TYPE 3; SPH3	6708
MIM271100	^	 	MOVED TO 153400	 
MIM271109		 	SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	 
MIM271110		 	SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	 
MIM271150	#	5q12.2-q13.3	SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4	6606
MIM271200		 	SPINAL MUSCULAR ATROPHY, RYUKYUAN TYPE	 
MIM271220		 	SPINAL MUSCULAR ATROPHY, SCAPULOPERONEAL	 
MIM271225		 	SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	 
MIM271245	#	10q24	MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE); MTDPS7	56652
MIM271250	%	6p23-p21	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3; SCAR3	85502
MIM271270		 	SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	 
MIM271310		 	SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	 
MIM271320		 	SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITAL CATARACTS, AND MYOPIA	 
MIM271322		 	SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	 
MIM271400	#	 	SPLENIC HYPOPLASIA	 
MIM271500		 	SPLENOPORTAL VASCULAR ANOMALIES	 
MIM271510	%	 	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE	 
MIM271520		 	SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	 
MIM271530	%	 	BRACHYOLMIA TYPE 1, HOBAEK TYPE	 
MIM271550	%	 	SPONDYLOENCHONDRODYSPLASIA; SPENCD	 
MIM271600	%	 	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE	 
MIM271620		 	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH MENTAL RETARDATION	 
MIM271630	%	 	BRACHYOLMIA TYPE 1, TOLEDO TYPE	 
MIM271640	#	 	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1; SEMDJL1	 
MIM271650	%	 	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE; SEMDIT	 
MIM271665	#	1q12-qter	SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	4921
MIM271700	#	12q13.11-q13.2	SPONDYLOPERIPHERAL DYSPLASIA	1280
MIM271900	#	17pter-p13	CANAVAN DISEASE	443
MIM271930	#	19q13.33	STRIATONIGRAL DEGENERATION, INFANTILE; SNDI	23636
MIM271950		 	SUBAORTIC STENOSIS, MEMBRANOUS	 
MIM271960		 	SUBAORTIC STENOSIS--SHORT STATURE SYNDROME	 
MIM271980	#	6p22	SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	7915
MIM272000		 	SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	 
MIM272100		 	SUDANOPHILIC CEREBRAL SCLEROSIS	 
MIM272120	#	3p21	SUDDEN INFANT DEATH SYNDROME	6331
MIM272150		 	SUGARMAN BRACHYDACTYLY	 
MIM272200	#	3p26	MULTIPLE SULFATASE DEFICIENCY; MSD	285362
MIM272300	#	Chr.12	SULFOCYSTEINURIA	6821
MIM272350		 	SUMMITT SYNDROME	 
MIM272370	%	6p21.3	SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS; EC1	4819
MIM272430	#	19p12	COLD-INDUCED SWEATING SYNDROME 1; CISS1	9244
MIM272440	%	 	SYNDACTYLY, TYPE I, WITH MICROCEPHALY AND MENTAL RETARDATION	 
MIM272450		 	SYNDESMODYSPLASIC DWARFISM	 
MIM272460	#	3p14.3	SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	2317
MIM272480	^	 	MOVED TO 186700	 
MIM272550	^	 	MOVED TO 138500	 
MIM272600		 	TAPETORETINAL DEGENERATION WITH ATAXIA	 
MIM272620		 	TARDIVE DYSKINESIA	 
MIM272650	%	 	TATSUMI FACTOR DEFICIENCY	 
MIM272700		 	TAURODONTISM	 
MIM272750	#	5q31.3-q33.1	GM2-GANGLIOSIDOSIS, AB VARIANT	2760
MIM272800	#	15q23-q24	TAY-SACHS DISEASE; TSD	3073
MIM272950		 	TEEBI-SHALTOUT SYNDROME	 
MIM272980		 	TEETH, CONGENITAL ABSENCE OF, WITH TAURODONTIA AND SPARSE HAIR	 
MIM273000		 	TEETH, FUSED	 
MIM273050		 	TEETH, NONERUPTION OF, WITH MAXILLARY HYPOPLASIA AND GENU VALGUM	 
MIM273120		 	TERATOMA, PINEAL	 
MIM273150		 	TESTES, RUDIMENTARY	 
MIM273250	%	 	TESTICULAR REGRESSION SYNDROME; TRS	 
MIM273300	#	12q22, 4q12, 19p13.3	TESTICULAR GERM CELL TUMOR; TGCT	2261, 3815, 6794, 8093, 8915
MIM273390		 	TETRAAMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	 
MIM273395	#	17q21	TETRAAMELIA, AUTOSOMAL RECESSIVE	7473
MIM273400		 	TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, AND OTHER ABNORMALITIES	 
MIM273490		 	THALAMIC DEGENERATION, SYMMETRIC INFANTILE	 
MIM273600		 	THALIDOMIDE SUSCEPTIBILITY	 
MIM273680		 	THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	 
MIM273730		 	THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	 
MIM273740		 	THORACOMELIC DYSPLASIA	 
MIM273750	#	6p21.1	THREE M SYNDROME 1; 3M1	9820
MIM273770		 	THREONINEMIA	 
MIM273800	#	17q21.32	GLANZMANN THROMBASTHENIA; GT	3674, 3690
MIM273900	%	 	THROMBOCYTOPENIA 3; THC3	 
MIM274000	#	1q21.1	THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR	100034701, 9939
MIM274150	#	9q34	THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP	11093
MIM274180	*	7q34	THROMBOXANE A SYNTHASE 1; TBXAS1	6916
MIM274190	%	 	THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	 
MIM274200		 	THUMB, DISTAL HYPEREXTENSIBILITY OF	 
MIM274205		 	THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX, AND DEAFNESS	 
MIM274210		 	THYMIC APLASIA WITH FETAL DEATH	 
MIM274230		 	THYMOMA, FAMILIAL	7063
MIM274240		 	THYROCEREBRORETINAL SYNDROME	 
MIM274260	^	 	MOVED TO 274230	 
MIM274265		 	THYMIC-RENAL-ANAL-LUNG DYSPLASIA	 
MIM274270	#	1p22	DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	1806
MIM274300	#	3p24.3	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE; GRTH	7068
MIM274400	#	19p13.2-p12	THYROID DYSHORMONOGENESIS 1; TDH1	6528
MIM274500	#	2p25	THYROID DYSHORMONOGENESIS 2A; TDH2A	7173
MIM274600	#	7q31	PENDRED SYNDROME; PDS	2299, 3766, 5172
MIM274700	#	8q24.2-q24.3	THYROID DYSHORMONOGENESIS 3; TDH3	7038
MIM274800	#	6q24-q25	THYROID DYSHORMONOGENESIS 4; TDH4	389434
MIM274900	#	15q15	THYROID DYSHORMONOGENESIS 5; TDH5	405753
MIM275000	%	14q31	GRAVES DISEASE	100312954
MIM275100	#	1p13	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4; CHNG4	7252
MIM275120	%	3q13.3-q21	THYROTROPIN-RELEASING HORMONE DEFICIENCY	7200
MIM275190		 	TIGLIC ACIDEMIA	 
MIM275200	#	14q31	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1; CHNG1	 
MIM275210	#	1p34	RESTRICTIVE DERMOPATHY, LETHAL	10269, 4000
MIM275220		8q24.1	TIBIAL HEMIMELIA	117193
MIM275230		 	TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	 
MIM275240		 	TINEA IMBRICATA, SUSCEPTIBILITY TO	 
MIM275250	%	 	TONGUE, PIGMENTED FUNGIFORM PAPILLAE OF	 
MIM275300		 	TRACHEOBRONCHOMEGALY	 
MIM275350	#	22q11.2-qter	TRANSCOBALAMIN II DEFICIENCY	6948
MIM275355	#	13q34, 8p22-p21	SQUAMOUS CELL CARCINOMA, HEAD AND NECK; HNSCC	3621, 5728, 8795
MIM275360	*	11q23	TREHALASE; TREH	11181
MIM275370	%	 	TRICARBOXYLIC ACID CYCLE, DEFECT OF	 
MIM275400	%	 	TRICHOMEGALY WITH MENTAL RETARDATION, DWARFISM, AND PIGMENTARY DEGENERATION OF RETINA	 
MIM275450		 	TRICHOODONTOONYCHIAL DYSPLASIA WITH BONE DEFICIENCY	 
MIM275550	^	 	TRICHORRHEXIS NODOSA SYNDROME	 
MIM275595		 	TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIES OF THE HANDS AND FEET	 
MIM275600	^	 	REMOVED FROM DATABASE	 
MIM275630	#	3p21	CHANARIN-DORFMAN SYNDROME; CDS	51099
MIM275900	#	13q12.3	SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20	23111
MIM276000	*	7q35	PROTEASE, SERINE, 1; PRSS1	5644
MIM276100	%	 	TRYPTOPHANURIA WITH DWARFISM	 
MIM276200		 	T-SUBSTANCE ANOMALY	 
MIM276300	#	7p22, 3p21.3, 2p16, 2p22-p21	MISMATCH REPAIR CANCER SYNDROME	2956, 4292, 4436, 5395
MIM276400	%	2p21-p16	TWINNING, DIZYGOTIC	2492
MIM276410		 	TWINNING, MONOZYGOTIC	 
MIM276500	^	 	MOVED TO 276710	 
MIM276600	#	 	TYROSINEMIA, TYPE II	6898
MIM276700	#	15q23-q25	TYROSINEMIA, TYPE I	2184
MIM276710	#	12q24-qter	TYROSINEMIA, TYPE III	3242
MIM276800		 	TYROSINOSIS	 
MIM276820	#	3p25	ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY	7476
MIM276821		 	ULNAR HYPOPLASIA WITH MENTAL RETARDATION	 
MIM276822		 	ULNAR AGENESIS AND ENDOCARDIAL FIBROELASTOSIS	 
MIM276880	#	3q21.3	UROCANASE DEFICIENCY	131669
MIM276900	#	11q13.5	USHER SYNDROME, TYPE I; USH1	10083, 4647, 7393
MIM276901	#	1q41	USHER SYNDROME, TYPE IIA; USH2A	7399, 79955
MIM276902	#	3q21-q25	USHER SYNDROME, TYPE IIIA; USH3A	7401
MIM276903	*	11q13.5	MYOSIN VIIA; MYO7A	4647
MIM276904	#	11p15.1	USHER SYNDROME, TYPE IC; USH1C	10083
MIM276905	^	 	MOVED TO 605472	 
MIM276950	#	10q23.31	VACTERL ASSOCIATION WITH HYDROCEPHALUS	5728
MIM277000	%	 	MAYER-ROKITANSKY-KUSTER-HAUSER SYNDROME	 
MIM277100	%	 	VALINEMIA	 
MIM277150	%	 	VAN BOGAERT-HOZAY SYNDROME	 
MIM277170	#	 	OROFACIODIGITAL SYNDROME VI; OFD6	 
MIM277175		 	VASCULAR HYALINOSIS	 
MIM277180	#	7q31.2	VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD	1080
MIM277200		 	RIGHT VENTRICULAR HYPOPLASIA, ISOLATED	 
MIM277300	#	19q13	SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE; SCDO1	10683, 145873
MIM277320	%	 	VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	 
MIM277350	%	 	HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL RECESSIVE	 
MIM277380	#	6q13	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE	55788
MIM277400	#	1p34.1	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE	25974
MIM277410	#	2q23.2	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE	27249
MIM277420	^	 	MOVED TO 277440	 
MIM277440	#	12q12-q14	VITAMIN D-DEPENDENT RICKETS, TYPE 2A; VDDR2A	7421
MIM277450	#	2p12	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1; VKCFD1	2677
MIM277460	#	8q13.1-q13.3	VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF; VED	7274
MIM277465		 	VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	 
MIM277470	#	17q25.1	PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	283989
MIM277480	#	12p13.3	VON WILLEBRAND DISEASE, TYPE 3; VWD3	7450
MIM277580	#	13q22	WAARDENBURG SYNDROME, TYPE 4A; WS4A	1910
MIM277590	#	5q35	WEAVER SYNDROME 1; WVS1	2146, 64324
MIM277600	#	19p13.3-p13.2	WEILL-MARCHESANI SYNDROME 1; WMS1	81794
MIM277610	#	6p21.3	WEISSENBACHER-ZWEYMULLER SYNDROME; WZS	1302
MIM277700	#	8p12-p11.2	WERNER SYNDROME; WRN	7486
MIM277720	%	 	WHISTLING FACE SYNDROME, RECESSIVE FORM	 
MIM277730	%	 	WERNICKE-KORSAKOFF SYNDROME	 
MIM277740		 	WHITE FORELOCK WITH MALFORMATIONS	 
MIM277900	#	13q14.3-q21.1	WILSON DISEASE	540
MIM277950	#	 	MOVED TO 259600	 
MIM277970		 	WISKOTT-ALDRICH SYNDROME	 
MIM277990		 	WOLFF MENTAL RETARDATION SYNDROME	 
MIM278000	#	10q23.31	LYSOSOMAL ACID LIPASE DEFICIENCY	3988
MIM278150	#	13q14.12-q14.2	HYPOTRICHOSIS 8; HYPT8	 
MIM278200		 	WOOLLY HAIR, HYPOTRICHOSIS, EVERTED LOWER LIP, AND OUTSTANDING EARS	 
MIM278250	#	12q24.3	WRINKLY SKIN SYNDROME; WSS	23545
MIM278300	#	2p23-p22	XANTHINURIA, TYPE I	7498
MIM278400	^	 	MOVED TO 203290	 
MIM278700	#	9q22.3	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	7507
MIM278720	#	3p25	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC	7508
MIM278730	#	19q13.2-q13.3	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	2068
MIM278740	#	11p12-p11	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E	1643
MIM278750	#	6p21.1-p12	XERODERMA PIGMENTOSUM, VARIANT TYPE; XPV	5429
MIM278760	#	16p13.3-p13.13	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	2072
MIM278780	#	13q33	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	2073
MIM278800	#	10q11	DE SANCTIS-CACCHIONE SYNDROME	2074
MIM278810	^	 	MOVED TO 278720	 
MIM278850	#	 	46,XX SEX REVERSAL 2; SRXX2	100653378, 6736
MIM278900		 	XYLOSIDASE DEFICIENCY	 
MIM279000	%	 	YOUNG SYNDROME	 
MIM280000	#	 	COLOBOMA, CONGENITAL HEART DISEASE, ICHTHYOSIFORM DERMATOSIS, MENTAL RETARDATION, AND EAR ANOMALIES SYNDROME; CHIME	9487
MIM300000	#	Xp22	OPITZ GBBB SYNDROME, X-LINKED	4281
MIM300001	%	 	ICHTHYOSIS, X-LINKED, WITHOUT STEROID SULFATASE DEFICIENCY	 
MIM300002	*	Xp22.3	ARYLSULFATASE D; ARSD	414
MIM300003	*	Xp22.3	ARYLSULFATASE F; ARSF	416
MIM300004	#	Xp22.13	CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA	170302
MIM300005	*	Xq28	METHYL-CpG-BINDING PROTEIN 2; MECP2	4204
MIM300006	*	Xq28	CENTRIN, EF-HAND PROTEIN, 2; CETN2	1069
MIM300007	*	Xq28	INTERLEUKIN 9 RECEPTOR; IL9R	3581
MIM300008	*	Xp11.22	CHLORIDE CHANNEL 5; CLCN5	1184
MIM300009	#	Xp11.22	DENT DISEASE 1	1184
MIM300010	*	Xq	A-11 GENE; A11	8248
MIM300011	*	Xq12-q13	ATPase, Cu(2+)-TRANSPORTING, ALPHA POLYPEPTIDE; ATP7A	538
MIM300012	*	Xq26.1	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 1; SMARCA1	6594
MIM300013	*	Xq28	N-ALPHA-ACETYLTRANSFERASE 10, NatA CATALYTIC SUBUNIT; NAA10	8260
MIM300014	*	Xq28	ATPase, Ca(2+)-TRANSPORTING, PLASMA MEMBRANE, 3; ATP2B3	492
MIM300015	*	Xpter-p22.32	ACETYLSEROTONIN METHYLTRANSFERASE, X-CHROMOSOMAL; ASMT	438
MIM300016	*	Xq28	MELANOMA ANTIGEN, FAMILY A, 1; MAGEA1	4100
MIM300017	*	Xq28	FILAMIN A; FLNA	2316
MIM300018	#	Xp21.3-p21.2	46,XY SEX REVERSAL 2; SRXY2	190
MIM300019	*	Xq28	HOST CELL FACTOR C1; HCFC1	3054
MIM300022	*	Xq28	PLEXIN A3; PLXNA3	55558
MIM300023	*	Xq28	RHO GTPase-ACTIVATING PROTEIN 4; ARHGAP4	393
MIM300024	*	Xp11.2	ZINC FINGER PROTEIN 157; ZNF157	7712
MIM300025	*	Xq13.2	CAUDAL-TYPE HOMEOBOX TRANSCRIPTION FACTOR 4; CDX4	1046
MIM300026	*	 	NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 2; NAP1L2	4674
MIM300027	*	Xp11.23	RNA-BINDING MOTIF PROTEIN 3; RBM3	5935
MIM300028	*	Xp22.1	ZINC FINGER-, CCCH DOMAIN-, AND RNA-BINDING MOTIF-CONTAINING SERINE/ARGININE-RICH PROTEIN 2; ZRSR2	8233
MIM300029	#	Xp11.4	RETINITIS PIGMENTOSA 3; RP3	6103
MIM300030	%	Xp21.2	DEAFNESS, X-LINKED 3; DFNX3	1680
MIM300031	*	Xq28	FAMILY WITH SEQUENCE SIMILARITY 11, MEMBER A; FAM11A	84548
MIM300032	*	Xq13	ATR-X GENE; ATRX	546
MIM300033	*	Xq13.1	MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 7; MLLT7	4303
MIM300034	*	Xq22-q23	ANGIOTENSIN II RECEPTOR, TYPE 2; AGTR2	186
MIM300035	*	Xq12	EPHRIN B1; EFNB1	1947
MIM300036	*	Xq28	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, CREATINE), MEMBER 8; SLC6A8	6535
MIM300037	*	Xq26	GLYPICAN 3; GPC3	2719
MIM300038	*	Xq13	PYRIMIDINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 4; P2RY4	5030
MIM300039	*	Xq21.1	POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 4; POU3F4	5456
MIM300040	*	Xp11.22-p11.21	STRUCTURAL MAINTENANCE OF CHROMOSOMES 1A; SMC1A	8243
MIM300041	*	Xq22	GUANYLATE CYCLASE 2F, RETINAL; GUCY2F	2986
MIM300042		 	ALOPECIA, CONGENITAL	 
MIM300044	*	Xq28	TRANSKETOLASE-LIKE 1; TKTL1	8277
MIM300046	%	Xq23-q24	MENTAL RETARDATION, X-LINKED 23; MRX23	4387
MIM300047	%	Xp11-q21	MENTAL RETARDATION, X-LINKED 20; MRX20	4384
MIM300048	#	Xq28, Xq28	INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	2316, 8268
MIM300049	#	Xq28	HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT	2316
MIM300050	*	Xp21.2-p11.2	UBIQUITIN-SPECIFIC PROTEASE 11; USP11	8237
MIM300051	*	Xp22.2	GLYCOPROTEIN M6B; GPM6B	2824
MIM300052	*	Xq22	DYSTROPHIN-RELATED PROTEIN 2; DRP2	1821
MIM300053	*	Xq28	VESICLE-ASSOCIATED MEMBRANE PROTEIN 7: VAMP7	6845
MIM300054		 	BODY LENGTH, MOUSE, HUMAN HOMOLOG	100913186
MIM300055	#	Xq28	MENTAL RETARDATION, X-LINKED, SYNDROMIC 13; MRXS13	4204
MIM300056	*	Xp22	HOLOCYTOCHROME C SYNTHASE; HCCS	3052
MIM300059	*	Xq28	TRANSMEMBRANE PROTEIN 187; TMEM187	8269
MIM300060	*	Xq28	L ANTIGEN FAMILY, MEMBER 3; LAGE3	8270
MIM300061	*	Xq13.1	ZINC FINGER, MYM-TYPE 3; ZMYM3	9203
MIM300062	%	Xp11.3-q13.3	MENTAL RETARDATION, X-LINKED 14; MRX14	4378
MIM300064		 	MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM	 
MIM300065	*	Xq22	CENTROMERIC PROTEIN I; CENPI	2491
MIM300066	#	Xp22	DEAFNESS, X-LINKED 4; DFNX4	1682, 23676
MIM300067	#	Xq22.3-q23	LISSENCEPHALY, X-LINKED, 1; LISX1	1641
MIM300068	#	Xq11-q12	ANDROGEN INSENSITIVITY SYNDROME; AIS	367
MIM300069	^	Xq28	MOVED TO 302060	 
MIM300070	*	Xq26.3	FIBROBLAST GROWTH FACTOR 13; FGF13	2258
MIM300071	#	Xp11.23	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A; CSNB2A	778
MIM300072	*	Xp11.4	UBIQUITIN-SPECIFIC PROTEASE 9, X CHROMOSOME; USP9X	8239
MIM300073		 	FETAL AKINESIA SYNDROME, X-LINKED	 
MIM300074	*	 	X CHROMOSOME-CONTROLLING ELEMENT; XCE	7497
MIM300075	*	Xp22.2-p22.1	RIBOSOMAL PROTEIN S6 KINASE, 90-KD, 3; RPS6KA3	6197
MIM300076	%	Xq26-qter	IMMUNONEUROLOGIC DISORDER, X-LINKED	8259
MIM300077	^	Xp22.3-p21.3	MOVED TO 300419	 
MIM300078	*	Xq24	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 1; NDUFA1	4694
MIM300079	*	Xq25	INHIBITOR OF APOPTOSIS, X-LINKED; XIAP	331
MIM300080	*	Xp11.23	RNA-BINDING MOTIF PROTEIN 10; RBM10	8241
MIM300081	*	Xq28	DEOXYRIBONUCLEASE I-LIKE 1; DNASE1L1	1774
MIM300082	%	Xq	COGNITIVE FUNCTION 1, SOCIAL; CGF1	1083
MIM300083	*	Xp22.3	PROTEIN KINASE, X-LINKED; PRKX	5613
MIM300084	*	Xq13.1	NON-POU DOMAIN-CONTAINING OCTAMER-BINDING PROTEIN; NONO	4841
MIM300085	%	Xq27	CONE-ROD DYSTROPHY, X-LINKED, 2; CORDX2	1275
MIM300086	*	Xq13-q21.1	LYSOPHOSPHATIDIC ACID RECEPTOR 4; LPAR4	2846
MIM300087	#	Xq13.2	X INACTIVATION, FAMILIAL SKEWED, 1; SXI1	7503
MIM300088	#	Xq22	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	57526
MIM300089	*	Xq28	ISOCITRATE DEHYDROGENASE 3, GAMMA SUBUNIT; IDH3G	3421
MIM300090	*	Xq28	SIGNAL SEQUENCE RECEPTOR, DELTA; SSR4	6748
MIM300091	*	Xp22.31	FOS-INDUCED GROWTH FACTOR; FIGF	2277
MIM300092	*	Xq28	TESTIS-EXPRESSED GENE 28; TEX28	1527
MIM300093	*	Xq28	GAMMA-AMINOBUTYRIC ACID RECEPTOR, EPSILON; GABRE	2564
MIM300095	*	Xq13.2	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 2; SLC16A2	6567
MIM300096	*	Xq11	TETRASPANIN 7; TSPAN7	7102
MIM300097	*	Xp21.3	MELANOMA ANTIGEN, FAMILY B, 1; MAGEB1	4112
MIM300098	*	Xp21.3	MELANOMA ANTIGEN, FAMILY B, 2; MAGEB2	4113
MIM300100	#	Xq28	ADRENOLEUKODYSTROPHY; ALD	215
MIM300101	*	Xp22.2	BONE MARROW KINASE, X-LINKED; BMX	660
MIM300102	*	Xp22.3	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 4; PNPLA4	8228
MIM300103	*	Xp22.3	SHROOM FAMILY MEMBER 2; SHROOM2	357
MIM300104	*	Xq28	GDP DISSOCIATION INHIBITOR 1; GDI1	2664
MIM300105	*	Xp22.1	SPERMINE SYNTHASE; SMS	6611
MIM300106		 	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED	 
MIM300107	*	Xq26-q28	BOMBESIN-LIKE RECEPTOR 3; BRS3	680
MIM300108	*	Xq22	DIAPHANOUS, DROSOPHILA, HOMOLOG OF, 2; DIAPH2	1730
MIM300109	*	Xp22.2-p22.1	PROTEIN PHOSPHATASE, EF-HAND CALCIUM-BINDING DOMAIN 1; PPEF1	5475
MIM300110	*	Xp11.23	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-1F SUBUNIT; CACNA1F	778
MIM300111	*	Xp11.23-p11.22	LIM DOMAIN ONLY 6; LMO6	4007
MIM300112	*	Xp11.23-p11.22	PROTEOLIPID PROTEIN 2; PLP2	5355
MIM300114	%	Xp22.3	MENTAL RETARDATION, X-LINKED 49; MRX49	4412
MIM300115	%	Xp11.3-p11.21	MENTAL RETARDATION, X-LINKED 50; MRX50	4413
MIM300116	*	Xq28	MATURE T-CELL PROLIFERATION 1; MTCP1	4515
MIM300117	*	Xq21.3-q22	NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 3; NAP1L3	4675
MIM300118	*	Xp22.3	RHO GTPase-ACTIVATING PROTEIN 6; ARHGAP6	395
MIM300119	*	Chr.X	INTERLEUKIN 13 RECEPTOR, ALPHA-1; IL13RA1	3597
MIM300120	*	Xq28	MASTERMIND-LIKE DOMAIN-CONTAINING PROTEIN 1; MAMLD1	10046
MIM300121	*	Xq22.3-q23	DOUBLECORTIN; DCX	1641
MIM300123	#	Xq26.3	MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISM	6658
MIM300124	*	Xp22.33	GTP-BINDING PROTEIN 6; GTPBP6	8225
MIM300125	%	Xq	MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	8249
MIM300126	*	Xq28	DYSKERIN; DKC1	1736
MIM300127	*	Xq12	OLIGOPHRENIN 1; OPHN1	4983
MIM300128	*	Xp11.2	LYSINE-SPECIFIC DEMETHYLASE 6A; KDM6A	7403
MIM300129		 	HEMATOPOIETIC STEM CELL KINETICS, CONTROL OF	 
MIM300130	*	Xq24	INTERLEUKIN 13 RECEPTOR, ALPHA-2; IL13RA2	3598
MIM300131	*	Chr.X	PLASTIN 3; PLS3	5358
MIM300132	*	Xp11.22-p11.21	TROPHININ; TRO	7216
MIM300133	*	Xq28	VON HIPPEL-LINDAU BINDING PROTEIN 1; VBP1	7411
MIM300134	*	 	DUAL-SPECIFICITY PHOSPHATASE 9; DUSP9	1852
MIM300135	*	Xq13.1-q13.3	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 7; ABCB7	22
MIM300136	%	Xp11	DIABETES MELLITUS, INSULIN-DEPENDENT, X-LINKED, SUSCEPTIBILITY TO	8245
MIM300137	*	Xq25	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 1; IGSF1	3547
MIM300138	*	 	CHLORIDE INTRACELLULAR CHANNEL 2; CLIC2	1193
MIM300139	*	Xq13.1-q13.3	IMMUNOGLOBULIN-BINDING PROTEIN 1; IGBP1	3476
MIM300142	*	Xq21.3-q24	p21 PROTEIN-ACTIVATED KINASE 3; PAK3	5063
MIM300143	#	Xp22.1-p21.3	MENTAL RETARDATION, X-LINKED 21; MRX21	11141
MIM300144	*	Xq25	GLUTAMATE DEHYDROGENASE 2; GLUD2	2747
MIM300145	*	Xq25	X-PROLYL AMINOPEPTIDASE 2; XPNPEP2	7512
MIM300146	*	 	CALPAIN 6; CAPN6	827
MIM300147	%	Xq27-q28	PROSTATE CANCER, HEREDITARY, X-LINKED 1; HPCX1	9566
MIM300148	%	Xp22.13-p21.1	MENTAL RETARDATION, EPILEPTIC SEIZURES, HYPOGONADISM AND HYPOGENITALISM, MICROCEPHALY, AND OBESITY; MEHMO	8422
MIM300149	*	Xq13.1	CBP/p300-INTERACTING TRANSACTIVATOR WITH GLU/ASP-RICH C-TERMINAL DOMAIN, 1; CITED1	4435
MIM300150	*	Xq24-q26	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER A5; SLC25A5	292
MIM300151	*	Xp22.32	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER A6; SLC25A6	293
MIM300152	*	Xp21.3	MELANOMA ANTIGEN, FAMILY B, 3; MAGEB3	4114
MIM300153	*	Xp21.3	MELANOMA ANTIGEN, FAMILY B, 4; MAGEB4	4115
MIM300154	*	Xq22.1-q22.3	ESX1-LIKE PROTEIN; ESX1L	80712
MIM300155	%	Xq26-q27	RETINITIS PIGMENTOSA 24; RP24	6116
MIM300156	*	Xq28	CANCER/TESTIS ANTIGEN 1B; CTAG1B	1485
MIM300157	*	Xq22.3	ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 4; ACSL4	2182
MIM300158	%	 	ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX	619510
MIM300159	*	Xq21.3-q22	THYMOSIN, BETA-4, X CHROMOSOME; TMSB4X	7114
MIM300160	*	Xp11.3-p11.23	DEAD/H BOX 3, X-LINKED; DDX3X	1654
MIM300161	*	Xp22.2-p22.1	EUKARYOTIC TRANSLATION INITIATION FACTOR 2, SUBUNIT 3; EIF2S3	1968
MIM300162	*	Xpter-p22.32	ACETYLSEROTONIN METHYLTRANSFERASE-LIKE; ASMTL	8623
MIM300163	*	Xq27.2	FOUR-AND-A-HALF LIM DOMAINS 1; FHL1	2273
MIM300164	*	 	INACTIVATION ESCAPE 1; INE1	8552
MIM300165	*	 	INACTIVATION ESCAPE 2; INE2	8551
MIM300166	#	Xp11.4	MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	54880
MIM300167	*	Xq11-q12	HEPHAESTIN; HEPH	9843
MIM300168	*	Xq26	GLYPICAN 4; GPC4	2239
MIM300169	*	Xq25-q26	APOPTOSIS-INDUCING FACTOR, MITOCHONDRION-ASSOCIATED, 1; AIFM1	9131
MIM300170	*	Xp22.3-p22.2	OFD1 GENE; OFD1	8481
MIM300171	*	Xq28	MYOTUBULARIN-RELATED PROTEIN 1; MTMR1	8776
MIM300172	*	Xp11.4	CALCIUM/CALMODULIN-DEPENDENT SERINE PROTEIN KINASE; CASK	8573
MIM300173	*	Xq28	MELANOMA ANTIGEN, FAMILY A, 2; MAGEA2	4101
MIM300174	*	Xq28	MELANOMA ANTIGEN, FAMILY A, 3; MAGEA3	4102
MIM300175	*	Xq28	MELANOMA ANTIGEN, FAMILY A, 4; MAGEA4	4103
MIM300176	*	Xq28	MELANOMA ANTIGEN, FAMILY A, 6; MAGEA6	4105
MIM300177	*	Xq28	MELANOMA ANTIGEN, FAMILY A, 12; MAGEA12	4111
MIM300178	*	Xp22.33	ZING FINGER BED DOMAIN-CONTAINING PROTEIN 1; ZBED1	9189
MIM300179	%	Xq25-q26	X INACTIVATION, FAMILIAL SKEWED, 2; SXI2	117237
MIM300180	*	Xp22.3	ARYLSULFATASE E; ARSE	415
MIM300181	*	Xq13.2	X INACTIVATION-SPECIFIC TRANSCRIPT-ANTISENSE; TSIX	9383
MIM300182	*	Xp11.4-p11.2	MEDIATOR COMPLEX SUBUNIT 14; MED14	9282
MIM300183	^	Xq28	MOVED TO 302060	 
MIM300184		 	HYPOTONIA, CONGENITAL NYSTAGMUS, ATAXIA, AND ABNORMAL AUDITORY BRAINSTEM RESPONSES	 
MIM300185	*	Xp11.2	A-KINASE ANCHOR PROTEIN 4; AKAP4	8852
MIM300186	*	Chr.X	EUKARYOTIC TRANSLATION INITIATION FACTOR 1A, X-LINKED; EIF1AX	1964
MIM300187	*	Xp21.1	SUSHI REPEAT-CONTAINING PROTEIN, X-LINKED; SRPX	8406
MIM300188	*	Xq13	MEDIATOR COMPLEX SUBUNIT 12; MED12	9968
MIM300189	*	Xq13.1	DISCS LARGE, DROSOPHILA, HOMOLOG OF, 3; DLG3	1741
MIM300190	*	Xq13.3	SH3-BINDING DOMAIN AND GLUTAMIC ACID-RICH PROTEIN-LIKE PROTEIN; SH3BGRL	6451
MIM300191	*	Xq22	TETRASPANIN 6; TSPAN6	7105
MIM300192	*	Xp11.2	SARCOMA, SYNOVIAL, X BREAKPOINT 2; SSX2	6757
MIM300193	*	Xq28	HIGH MOBILITY GROUP BOX 3; HMGB3	3149
MIM300194	#	Xq22.3	AMME COMPLEX	100499260
MIM300195	*	Xq22.3	AMME CHROMOSOME REGION GENE 1; AMMECR1	9949
MIM300196	*	Xp22.3	TRANSDUCIN-BETA-LIKE 1, X-LINKED; TBL1X	6907
MIM300197	*	Xq28	ATPase, H+ TRANSPORTING, LYSOSOMAL, ACCESSORY PROTEIN 1; ATP6AP1	537
MIM300198	*	Xp22.3	GLYCOGENIN 2; GYG2	8908
MIM300199	*	Xq26	RNA-BINDING MOTIF PROTEIN, X CHROMOSOME; RBMX	27316
MIM300200	#	Xp21.3-p21.2	ADRENAL HYPOPLASIA, CONGENITAL; AHC	190
MIM300201	*	Xq13-q21	CYSTEINYL LEUKOTRIENE RECEPTOR 1; CYSLTR1	10800
MIM300202	*	Xp22.2-p22.1	TRACKING PROTEIN PARTICLE COMPLEX, SUBUNIT 2; TRAPPC2	6399
MIM300203	*	Xp22	CYCLIN-DEPENDENT KINASE-LIKE 5; CDKL5	6792
MIM300204	*	Xq22	MIDLINE 2; MID2	11043
MIM300205	*	Xp11.23-p11.22	EMOPAMIL-BINDING PROTEIN; EBP	10682
MIM300206	*	Xp22.1-p21.3	INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN-LIKE 1; IL1RAPL1	11141
MIM300207	*	Xq28	G PROTEIN-COUPLED RECEPTOR 50; GPR50	9248
MIM300208	*	Xp22	SEX COMB ON MIDLEG, DROSOPHILA, HOMOLOG-LIKE 2; SCML2	10389
MIM300209	#	Xp22, Xp22.3-p22.2	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2	8481
MIM300210	#	Xq11	MENTAL RETARDATION, X-LINKED 58; MRX58	7102
MIM300211	%	Xp22.3	EPISODIC MUSCLE WEAKNESS, X-LINKED; EMWX	10118
MIM300212	*	Xp11.2-q11.2	REGUCALCIN; RGN	9104
MIM300213	*	Xq26	CAAX BOX PROTEIN 1; CXX1	8933
MIM300214	*	Xq28	PLEXIN B3; PLXNB3	5365
MIM300215	#	Xp22.13	LISSENCEPHALY, X-LINKED, 2; LISX2	170302
MIM300216		 	COATS DISEASE	1283
MIM300217	*	Xp22	RETINOIC ACID-INDUCED 2; RAI2	10742
MIM300218	%	Xp11.3-q22	MENTAL RETARDATION, X-LINKED, SYNDROMIC 7; MRXS7	4429
MIM300219	#	 	MYOTUBULAR MYOPATHY WITH ABNORMAL GENITAL DEVELOPMENT	 
MIM300220	#	Xp11.2, Xp11.2	MENTAL RETARDATION, X-LINKED, SYNDROMIC 10; MRXS10	3028
MIM300221	%	Xpter-p22.32	HODGKIN DISEASE, X-LINKED PSEUDOAUTOSOMAL	50829
MIM300222	*	Xq13.3-q21.2	INTEGRAL MEMBRANE PROTEIN 2A; ITM2A	9452
MIM300223	*	Xq26	MELANOMA ANTIGEN, FAMILY C, 1; MAGEC1	9947
MIM300224	*	Xp11.23	MELANOMA ANTIGEN, FAMILY D, 1; MAGED1	9500
MIM300225	*	Xq22	NADPH OXIDASE 1; NOX1	27035
MIM300226	*	Xp22.1	SMALL MUSCLE PROTEIN, X-LINKED; SMPX	23676
MIM300227	*	Xp22.2-p22.1	SEX COMB ON MIDLEG, DROSOPHILA, HOMOLOG-LIKE 1; SCML1	6322
MIM300228	%	Xq27	TESTICULAR GERM CELL TUMOR 1; TGCT1	50830
MIM300229	*	Xp22.3	VARIABLY CHARGED, X CHROMOSOME; VCX	26609
MIM300230	*	Xp22.1	CARBONIC ANHYDRASE VB, MITOCHONDRIAL; CA5B	11238
MIM300231	*	Xq26.3	SOLUTE CARRIER FAMILY 9, MEMBER 6; SLC9A6	10479
MIM300232		 	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION	 
MIM300233		 	RADIOULNAR SYNOSTOSIS, RADIAL RAY ABNORMALITIES, AND SEVERE MALFORMATIONS IN THE MALE	 
MIM300234	*	 	UBIQUITOUSLY EXPRESSED TRANSCRIPT; UXT	8409
MIM300235	*	Xp11.21	ZINC FINGER-ENCODING GENE, X-LINKED, DUPLICATED, A; ZXDA	7789
MIM300236	*	Xp11.21	ZINC FINGER-ENCODING GENE, X-LINKED, DUPLICATED, B; ZXDB	158586
MIM300237	*	Xq22.1	TRANSCRIPTION ELONGATION FACTOR A-LIKE 1; TCEAL1	9338
MIM300238	%	Xq26-q27	MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	50644
MIM300239	*	Xp22	EPIDERMAL GROWTH FACTOR-LIKE 6; EGFL6	25975
MIM300240	^	Xq28	HOYERAAL-HREIDARSSON SYNDROME; HHS	1736
MIM300241	*	Xp11.4	G PROTEIN-COUPLED RECEPTOR 34; GPR34	2857
MIM300242	*	Xq24	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, BRAIN), MEMBER 14; SLC25A14	9016
MIM300243	#	Xq26.3, Xq24-q27.3	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE; MRXSCH	10479
MIM300244	#	Xq27.3-q28	TERMINAL OSSEOUS DYSPLASIA; TOD	2316, 54114
MIM300245	%	Xq24-q27.1	PTOSIS, HEREDITARY CONGENITAL 2	54115
MIM300246	*	Xq21.3	PROTOCADHERIN 11, X-LINKED; PCDH11X	27328
MIM300247	*	Xp11.2	BONE MORPHOGENETIC PROTEIN 15; BMP15	9210
MIM300248	*	Xq28	INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE OF, GAMMA; IKBKG	8517
MIM300249	*	Xp11.2	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 17, YEAST, HOMOLOG OF, B; TIMM17B	10245
MIM300250	^	 	MOVED TO 202200	 
MIM300252	*	Xq13	PEPTIDYL-PROLYL CIS/TRANS ISOMERASE, NIMA-INTERACTING, 4; PIN4	5303
MIM300253	*	Xp11	SUPERCONSERVED RECEPTOR EXPRESSED IN BRAIN 3; SREB3	54328
MIM300254	*	Xp11.23	SUPPRESSOR OF VARIEGATION 3-9, DROSOPHILA, HOMOLOG OF, 1; SUV39H1	6839
MIM300255	*	Xq13	O-LINKED N-ACETYLGLUCOSAMINE TRANSFERASE; OGT	8473
MIM300256	*	Xp11.2	17-@BETA-HYDROXYSTEROID DEHYDROGENASE X; HSD17B10	3028
MIM300257	#	Xq24	DANON DISEASE	3920
MIM300258	%	Chr.X	ROIFMAN SYNDROME	57788
MIM300259		 	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, X-LINKED	57789
MIM300260	#	Xq28, Xq28	LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	4204, 57790
MIM300261	%	Xq28	ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA	57791
MIM300262	%	Xq13.2	ABIDI X-LINKED MENTAL RETARDATION SYNDROME; MRXSAB	57792
MIM300263	#	Xp11.2	SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	23133
MIM300264	*	Xp11.23-p11.1	UBIQUILIN 2; UBQLN2	29978
MIM300265	*	Xq26.2	ZINC FINGER PROTEIN OF CEREBELLUM 3; ZIC3	7547
MIM300266	%	Xq11.2	SPASTIC PARAPLEGIA 16, X-LINKED; SPG16	57760
MIM300267	*	Xq26	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 6; ARHGEF6	9459
MIM300268	^	 	MOVED TO 610618	 
MIM300269	*	Xq13	HISTONE DEACETYLASE 8; HDAC8	55869
MIM300270		 	ADRENOMYODYSTROPHY	 
MIM300271	#	Xq28	MENTAL RETARDATION, X-LINKED 72; MRX72	116442, 23695
MIM300272	*	Xp11.23	HISTONE DEACETYLASE 6; HDAC6	10013
MIM300273	%	Xp22	GOITER, MULTINODULAR 2; MNG2	59081
MIM300274		 	ANDROGEN INSENSITIVITY SYNDROME DUE TO COACTIVATOR DEFICIENCY	 
MIM300275	*	Xq28	NAD(P)H STEROID DEHYDROGENASE-LIKE PROTEIN; NSDHL	50814
MIM300276	*	Xq12	ECTODYSPLASIN A2 RECEPTOR; EDA2R	60401
MIM300277	*	Xq22	INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN-LIKE 2; IL1RAPL2	26280
MIM300278	*	Xp11.4	NYCTALOPIN; NYX	60506
MIM300279	^	 	MOVED TO 300260	 
MIM300280		 	URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME	 
MIM300281	*	 	POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 1; KCND1	3750
MIM300282	*	Xq25-q26.2	ECTO-NOX DISULFIDE-THIOL EXCHANGER 2; ENOX2	10495
MIM300283	*	Xq28	INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 1; IRAK1	3654
MIM300284	*	Xp22.2	RAS-ASSOCIATED PROTEIN RAB9; RAB9	9367
MIM300285	*	Xq22.1-q22.3	RAS-ASSOCIATED PROTEIN 9B; RAB9B	51209
MIM300286	*	Chr.X	KRUPPEL-LIKE FACTOR 8; KLF8	11279
MIM300287	*	Xp11.23	P ANTIGEN FAMILY, MEMBER 4; PAGE4	9506
MIM300288	*	Xp11.23	P ANTIGEN FAMILY, MEMBER 1; PAGE1	8712
MIM300289	*	Chr.X	X ANTIGEN FAMILY, MEMBER 1D; XAGE1D	9503
MIM300290	^	Chr.X	MOVED TO 614732	64589
MIM300291	#	Xq28	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY	8517
MIM300292	*	Xp11.23-q13.3	FORKHEAD BOX P3; FOXP3	50943
MIM300293	^	 	MOVED TO 301410	 
MIM300294	*	Xp22.12-p22.11	MEMBRANE-BOUND TRANSCRIPTION FACTOR PROTEASE, SITE 2; MBTPS2	51360
MIM300295	*	Chr.X	ONCOGENE PIM2; PIM2	11040
MIM300296	*	Xq26	PLACENTA-SPECIFIC GENE 1; PLAC1	10761
MIM300297	*	Xq25-q26.3	APELIN; APLN	8862
MIM300298	*	Xq25-q26	UPF3, YEAST, HOMOLOG OF, B; UPF3B	65109
MIM300299	#	Xp11.23-p11.22	NEUTROPENIA, SEVERE CONGENITAL, X-LINKED; SCNX	7454
MIM300300	*	Xq21.3-q22	BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE; BTK	695
MIM300301	#	Xq28	ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNODEFICIENCY, OSTEOPETROSIS, AND LYMPHEDEMA; OLEDAID	8517
MIM300302	*	Xp21	DYNEIN, LIGHT CHAIN, TCTEX TYPE, 3; DYNLT3	6990
MIM300303	*	Xq21	RIBOSOMAL PROTEIN S6 KINASE, 90-KD, 6; RPS6KA6	27330
MIM300304	*	Xq23	CULLIN 4B; CUL4B	8450
MIM300305	*	Xq27.1	SPERM PROTEIN ASSOCIATED WITH THE NUCLEUS, X CHROMOSOME, FAMILY MEMBER A1; SPANXA1	30014
MIM300306	%	Xq23-q24	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 11; BMIQ11	11254
MIM300307	*	Xq12-q21	T-BOX 22; TBX22	50945
MIM300308	*	Chr.X	FERRITIN HEAVY POLYPEPTIDE-LIKE 17; FTHL17	53940
MIM300309	*	Xq26.2	UBIQUITIN-SPECIFIC PROTEASE 26; USP26	83844
MIM300310	%	Xp22	AGAMMAGLOBULINEMIA, X-LINKED, TYPE 2; AGMX2	179
MIM300311	*	Chr.X	TESTIS-EXPRESSED GENE 11; TEX11	56159
MIM300312	*	Chr.X	TESTIS-EXPRESSED GENE 13A; TEX13A	56157
MIM300313	*	Chr.X	TESTIS-EXPRESSED GENE 13B; TEX13B	56156
MIM300314	*	Chr.X	TAF7-LIKE RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 50-KD; TAF7L	54457
MIM300315	*	Chr.X	NUCLEAR RNA EXPORT FACTOR 2; NXF2	56001
MIM300316	*	Xq21.3-q22.3	NUCLEAR RNA EXPORT FACTOR 3; NXF3	56000
MIM300317	*	Chr.X	RALBP1-ASSOCIATED EPS DOMAIN-CONTAINING PROTEIN 2; REPS2	9185
MIM300318	*	Xq22.1-q22.3	NUCLEAR RNA EXPORT FACTOR 4; NXF4	55999
MIM300319	*	Chr.X	NUCLEAR RNA EXPORT FACTOR 5; NXF5	55998
MIM300320	*	Xq23	NTF2-LIKE EXPORT FACTOR 2; NXT2	55916
MIM300321	#	Xq28, Xq28	FG SYNDROME 2; FGS2	2270, 2316
MIM300322	#	Xq26-q27.2	LESCH-NYHAN SYNDROME; LNS	3251
MIM300323	#	Xq26-q27.2	KELLEY-SEEGMILLER SYNDROME	3251
MIM300324	%	Xq22.2-q26	MENTAL RETARDATION, X-LINKED 53; MRX53	4416
MIM300325	*	Xp11.4-p11.1	SYNOVIAL SARCOMA, X BREAKPOINT 3; SSX3	10214
MIM300326	*	Xp11.2	SYNOVIAL SARCOMA, X BREAKPOINT 4; SSX4	6759
MIM300327	*	 	SYNOVIAL SARCOMA, X BREAKPOINT 5; SSX5	6758
MIM300328	*	Xq22.3	POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED FAMILY, MEMBER 1-LIKE; KCNE1L	23630
MIM300329	*	Xq23	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 33; ZBTB33	10009
MIM300330	*	Xq26.3-q27.1	SPANX FAMILY, MEMBER C; SPANXC	64663
MIM300331	%	Chr.X	THROMBOCYTHEMIA, X-LINKED; THCYTX	84434
MIM300332	*	Xq12-q13	INTEGRIN, BETA-1, BINDING PROTEIN OF, 2; ITGB1BP2	26548
MIM300333	*	Chr.X	RAS-ASSOCIATED PROTEIN RAB33A; RAB33A	9363
MIM300334	*	Xq23	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 5; TRPC5	7224
MIM300335	*	Xp22	ANGIOTENSIN I-CONVERTING ENZYME 2; ACE2	59272
MIM300336	*	Xq13	NEUROLIGIN 3; NLGN3	54413
MIM300337	#	 	HYPOMELANOSIS OF ITO; HMI	3160
MIM300338	*	Xq27	CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-2; CNGA2	1260
MIM300339	*	 	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B-DOUBLE PRIME, BETA; PPP2R3B	28227
MIM300340	*	Xq28	MELANOMA ANTIGEN, FAMILY A, 5; MAGEA5	4104
MIM300341	*	Xq28	MELANOMA ANTIGEN, FAMILY A, 8; MAGEA8	4107
MIM300342	*	Xq28	MELANOMA ANTIGEN, FAMILY A, 9; MAGEA9	4108
MIM300343	*	Xq28	MELANOMA ANTIGEN, FAMILY A, 10; MAGEA10	4109
MIM300344	*	Xq28	MELANOMA ANTIGEN, FAMILY A, 11; MAGEA11	4110
MIM300345	%	Chr.X	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 1; MCOPCB1	85503
MIM300346	*	 	HIV-1 TAT STIMULATORY FACTOR 1; HTATSF1	27336
MIM300347	*	Xq21-q22	EARLY LYMPHOID ACTIVATION GENE	10824
MIM300348	*	 	KELCH-LIKE 4; KLHL4	56062
MIM300349	*	Xq28	GAMMA-AMINOBUTYRIC ACID RECEPTOR, THETA; GABRQ	55879
MIM300350	*	Xq22.1-q23	CHORDIN-LIKE 1; CHRDL1	91851
MIM300351	%	Xp11	GRAVES DISEASE, SUSCEPTIBILITY TO, X-LINKED 1	117189
MIM300352	#	Xq28	CREATINE DEFICIENCY SYNDROME, X-LINKED	6535
MIM300353	*	Xq12	V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 4; VSIG4	11326
MIM300354	#	Xq23	MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE, HYPOGONADISM, AND ABNORMAL GAIT	8450
MIM300355	%	 	MENTAL RETARDATION, X-LINKED 73; MRX73	23694
MIM300356	*	Xq22	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 8, YEAST, HOMOLOG OF, A; TIMM8A	1678
MIM300357	*	Xp22.3	CYTOKINE RECEPTOR-LIKE FACTOR 2; CRLF2	64109
MIM300358	*	Xp11.2	PROTEIN KINASE, LYSINE-DEFICIENT 3; WNK3	65267
MIM300359	*	Xq28	SARCOMA ANTIGEN 1; SAGE1	55511
MIM300360	%	Xq24	MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE	114890
MIM300361	*	Xq22.1-q23	NERVE GROWTH FACTOR RECEPTOR-ASSOCIATED PROTEIN 1; NGFRAP1	27018
MIM300362	*	Xq21.33-q22.2	ARMADILLO REPEAT CONTAINING, X-LINKED 1; ARMCX3	51309
MIM300363	*	Xq21.33-q22.2	ARMADILLO REPEAT CONTAINING, X-LINKED 2; ARMCX2	9823
MIM300364	*	Xq21.33-q22.2	ARMADILLO REPEAT CONTAINING, X-LINKED 3; ARMCX3	51566
MIM300365	*	Xp22.3-p22.2	TOLL-LIKE RECEPTOR 7; TLR7	51284
MIM300366	*	Xp22.3-p22.2	TOLL-LIKE RECEPTOR 8; TLR8	51311
MIM300367	#	Xp11.23	THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA; XLTDA	2623
MIM300368	*	Xp11.3	SOLUTE CARRIER FAMILY 9, MEMBER 7; SLC9A7	84679
MIM300369	*	Xq13.1	ACIDIC REPEAT-CONTAINING GENE; ACRC	93953
MIM300370	*	Xq28	3-PRIME @REPAIR EXONUCLEASE 2; TREX2	11219
MIM300371	*	Xq28	ATP-BINDING CASSETTE, SUBFAMILY D, MEMBER 1; ABCD1	215
MIM300372	%	Xq26	MENTAL RETARDATION, X-LINKED 42; MRX42	4406
MIM300373	#	Xq11.1	OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS; OSCS	139285
MIM300374	*	Xp22.1-p21.3	SH3-DOMAIN KINASE-BINDING PROTEIN 1; SH3KBP1	30011
MIM300375	*	Xp11.3	CARBOHYDRATE SULFOTRANSFERASE 7; CHST7	56548
MIM300376	#	12q21, Xp21.2	MUSCULAR DYSTROPHY, BECKER TYPE; BMD	1756, 4618
MIM300377	*	Xp21.2	DYSTROPHIN; DMD	1756
MIM300378	%	Xq24-q25	RADIAL RAY DEFICIENCY, X-LINKED	266719
MIM300379	*	Xq13-q21	RING FINGER PROTEIN 12; RNF12	51132
MIM300380	*	Xp22	CYTIDINE 5-PRIME TRIPHOSPHATE SYNTHETASE 2; CTPS2	56474
MIM300381	*	Xq28	ZINC FINGER PROTEIN 185; ZNF185	7739
MIM300382	*	Xp22.13	ARISTALESS-RELATED HOMEOBOX, X-LINKED; ARX	170302
MIM300383	*	Xp11.4-p11.23	COMPLEMENT FACTOR PROPERDIN; CFP	5199
MIM300384	*	Xq28	EMERIN; EMD	2010
MIM300385	*	Xq13	NUCLEOSOMAL BINDING PROTEIN 1; NSBP1	79366
MIM300386	*	Xq26	CD40 LIGAND; CD40LG	959
MIM300387	#	Xq22.3	MENTAL RETARDATION, X-LINKED 63; MRX63	2182
MIM300388	%	Xq27.2-q28	POLYMICROGYRIA, BILATERAL PERISYLVIAN; BPP	 
MIM300389	^	 	MOVED TO 300029	 
MIM300390	*	Xq21.2	CHM GENE; CHM	1121
MIM300391	*	Xp22.3-p22.1	AMELOGENIN; AMELX	265
MIM300392	*	Xp11.23-p11.22	WAS GENE; WAS	7454
MIM300393	*	Chr.X	G PROTEIN-COUPLED RECEPTOR 101; GPR101	83550
MIM300394	*	Xq28	TAFAZZIN; TAZ	6901
MIM300395	*	Chr.X	THO COMPLEX, SUBUNIT 2; THOC2	57187
MIM300396	*	 	CANCER/TESTIS ANTIGEN 2; CTAG2	30848
MIM300397	^	 	MOVED TO 300352	 
MIM300398	*	Xq28	B-CELL RECEPTOR-ASSOCIATED PROTEIN 31; BCAP31	10134
MIM300399	*	Xp11.3	PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 1, INHIBITOR OF: PCSK1N	27344
MIM300400	#	Xq13	SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED; SCIDX1	3561
MIM300401	*	Xq22	PROTEOLIPID PROTEIN 1; PLP1	5354
MIM300402	*	Xq27	LEUCINE ZIPPER, DOWNREGULATED IN CANCER 1; LDOC1	23641
MIM300403	*	Xp11.3	NADH DEHYDROGENASE 1 BETA SUBCOMPLEX, 11; NDUFB11	54539
MIM300405	*	Xq22.2	RAS-ASSOCIATED PROTEIN RAB40A-LIKE; RAB40AL	282808
MIM300406	%	Xp22.3	FG SYNDROME 3; FGS3	93985
MIM300407	*	Xq21.3	POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 5; PABPC5	140886
MIM300408	*	Chr.X	GRIP1-ASSOCIATED PROTEIN 1; GRIPAP1	56850
MIM300409	*	Xq22	MORTALITY FACTOR 4-LIKE PROTEIN 2; MORF4L2	9643
MIM300410	*	Chr.X	ANGIOMOTIN; AMOT	154796
MIM300411	*	Xp21.3	TRANSFORMING GROWTH FACTOR-BETA-INDUCED FACTOR 2-LIKE, X-LINKED; TGIF2LX	90316
MIM300412	^	 	MOVED TO 300166	 
MIM300413	*	Xq26	MUSCLEBLIND-LIKE PROTEIN 3; MBNL3	55796
MIM300414	*	Xq26.3	PHD FINGER PROTEIN 6; PHF6	84295
MIM300415	*	Xq28	MYOTUBULARIN; MTM1	4534
MIM300416	*	 	X ANTIGEN FAMILY, MEMBER 2; XAGE2	9502
MIM300417	*	Xq22	G PROTEIN-COUPLED RECEPTOR-ASSOCIATED SORTING PROTEIN 1; GPRASP1	9737
MIM300418	*	Xp11.23-p11.21	G1- TO S-PHASE TRANSITION 2; GSPT2	23708
MIM300419	#	Xp22.13	MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED; MRXARX	170302
MIM300420	*	 	PRAJA 1; PJA1	64219
MIM300421	%	 	WITTWER SYNDROME	619509
MIM300422	#	Xp11.4	FG SYNDROME 4; FGS4	8573
MIM300423	#	Xp11.4	MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	10159
MIM300424	#	Xp22	RETINITIS PIGMENTOSA 23; RP23	6115
MIM300425	#	Xq13	AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	54413
MIM300426	^	 	MOVED TO 300143	 
MIM300427	*	Xp22.33	NEUROLIGIN 4; NLGN4	57502
MIM300428	%	Xp22.3	MENTAL RETARDATION, X-LINKED 2; MRX2	4367
MIM300429	*	Xq22.1	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 9; ARHGEF9	23229
MIM300430	^	 	MOVED TO 300419	 
MIM300431		 	ATKIN-FLAITZ SYNDROME	 
MIM300432	^	 	MOVED TO 308350	 
MIM300433	%	Xp11.2-q12	MENTAL RETARDATION, X-LINKED 81; MRX81	266678
MIM300434	#	Xp11.2	STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME	57477
MIM300435	*	Xq22-q24	PROGESTERONE RECEPTOR MEMBRANE COMPONENT 1; PGRMC1	10857
MIM300436	#	Xq26	MENTAL RETARDATION, X-LINKED 46; MRX46	9459
MIM300437	*	Xp11.2	EMBRYONIC STEM CELL-EXPRESSED RAS; ERAS	3266
MIM300438	#	Xp11.2	17-@BETA-HYDROXYSTEROID DEHYDROGENASE X DEFICIENCY	3028
MIM300439	*	Chr.X	RING FINGER PROTEIN 128; RNF128	79589
MIM300440	*	Xq24	NFKB-REPRESSING FACTOR; NKRF	55922
MIM300441	*	 	SH3 PROTEIN EXPRESSED IN LYMPHOCYTES	54440
MIM300442	^	 	MOVED TO 311900	 
MIM300443	*	 	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 3; SLC7A3	84889
MIM300444	*	Xq23-q24	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 14; SLC6A14	11254
MIM300445	*	 	H2A HISTONE FAMILY, MEMBER B; H2AFB	83740
MIM300446	*	Xq24	RHOX HOMEOBOX FAMILY, MEMBER 1; RHOXF1	158800
MIM300447	*	Xq24	RHOX HOMEOBOX FAMILY, MEMBER 2; RHOXF2	84528
MIM300448	#	Xq13	ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME; ATMDS	546
MIM300450	*	 	FETAL AND ADULT TESTIS-EXPRESSED GENE 1; FATE1	89885
MIM300451	*	Xq12-q13.1	ECTODYSPLASIN A; EDA	1896
MIM300452	*	Xq12	INHIBITOR OF GROWTH, X-LINKED; INGX	27160
MIM300453	*	 	FAMILY WITH SEQUENCE SIMILARITY 50, MEMBER A; FAM50A	9130
MIM300454	%	Xq12-q21.3	MENTAL RETARDATION, X-LINKED 77; MRX77	93991
MIM300455	#	Xp11.4	RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITH OR WITHOUT DEAFNESS	6103
MIM300456	*	Xp11.22	CYCLIN B3; CCNB3	85417
MIM300457	*	Xp22.13	NHS GENE; NHS	4810
MIM300458	^	 	MOVED TO 300055	 
MIM300459	*	Xq22	TENOMODULIN; TNMD	64102
MIM300460	*	Xq22	PROTOCADHERIN 19; PCDH19	57526
MIM300461	*	Xp21.1	ORNITHINE CARBAMOYLTRANSFERASE; OTC	5009
MIM300462	*	Xq24	A-KINASE ANCHOR PROTEIN 14; AKAP14	158798
MIM300463	*	Xp11.23	POLYGLUTAMINE-BINDING PROTEIN 1; PQBP1	10084
MIM300464	%	Xq23-q26	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 3	387573
MIM300465	^	 	MOVED TO 301040	 
MIM300466	*	Xp22	MELANOMA ANTIGEN, FAMILY B, 5; MAGEB5	347541
MIM300467	*	Xp22	MELANOMA ANTIGEN, FAMILY B, 6; MAGEB6	158809
MIM300468	*	Xq27	MELANOMA ANTIGEN, FAMILY C, 2; MAGEC2	51438
MIM300469	*	Xq27	MELANOMA ANTIGEN, FAMILY C, 3; MAGEC3	139081
MIM300470	*	Xp11.2	MELANOMA ANTIGEN, FAMILY D, 2; MAGED2	10916
MIM300471	%	Chr.X	CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	494028
MIM300472	#	Xq13.1-q13.3	CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA, AND MICROGNATHIA	3476
MIM300473	*	Xp21.3-p21.2	NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 1; NR0B1	190
MIM300474	*	Xp21.3-p21.2	GLYCEROL KINASE; GK	2710
MIM300475	#	Xq28	CHROMOSOME Xq28 DELETION SYNDROME	100302680
MIM300476	#	Xp11.23, Xp11.4-q13.1	CONE-ROD DYSTROPHY, X-LINKED, 3; CORDX3	778
MIM300477	*	Xp22.33-p22.32	FAMILY WITH SEQUENCE SIMILARITY 9, MEMBER A; FAM9A	171482
MIM300478	*	Xp22.32	FAMILY WITH SEQUENCE SIMILARITY 9, MEMBER B; FAM9B	171483
MIM300479	*	Xp22.31	FAMILY WITH SEQUENCE SIMILARITY 9, MEMBER C; FAM9C	171484
MIM300480	*	 	TAK1-BINDING PROTEIN 3; TAB3	257397
MIM300481	*	Xp21.1	CYTOCHROME b(-245), BETA SUBUNIT; CYBB	1536
MIM300482	*	 	GRB2-ASSOCIATED BINDING PROTEIN 3; GAB3	139716
MIM300484	%	 	OROFACIODIGITAL SYNDROME VIII; OFD8	 
MIM300485	*	Xp11.4	BCL6 COREPRESSOR; BCOR	54880
MIM300486	#	Xq12	MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	4983
MIM300487	*	Xq25	ACTIN-RELATED PROTEIN T1; ACTRT1	139741
MIM300488	%	Xp21.3	MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 1; MENOQ1	494029
MIM300489	#	Xq13.1-q21, Xq12-q13	SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3; SMAX3	538
MIM300490	*	Xq25	SH2 DOMAIN PROTEIN 1A; SH2D1A	4068
MIM300491	#	Xp11.4-p11.2	EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIOR DISORDERS	6853
MIM300492	*	 	FAMILY WITH SEQUENCE SIMILARITY 3, MEMBER A; FAM3A	60343
MIM300493	*	Xq27.2	SPERM PROTEIN ASSOCIATED WITH THE NUCLEUS, X CHROMOSOME, FAMILY MEMBER A2; SPANXA2	728712
MIM300494	#	Xq13	ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1	54413
MIM300495	#	Xp22.33	AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	57502
MIM300496	#	Xq28	AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	4204
MIM300497	#	Xp22.33	ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2	57502
MIM300498	#	Xp22.1-p11	MENTAL RETARDATION, X-LINKED 45; MRX45	347344
MIM300499	*	Xp11.23	FTSJ HOMOLOG 1; FTSJ1	24140
MIM300500	#	Xp22.3	ALBINISM, OCULAR, TYPE I; OA1	4935
MIM300501	^	 	MOVED TO 309549	 
MIM300502	*	Xp22.2-p22.1	PYRUVATE DEHYDROGENASE, ALPHA-1; PDHA1	5160
MIM300503	^	 	MOVED TO 300419	 
MIM300504	%	Xp11.21-q22.3	MENTAL RETARDATION, X-LINKED 52; MRX52	4415
MIM300505	%	Xp11.3-q22.3	MENTAL RETARDATION, X-LINKED 84; MRX84	378882
MIM300506	*	Xq22.2	TSC22 DOMAIN FAMILY, MEMBER 3; TSC22D3	1831
MIM300507	*	 	H2B HISTONE FAMILY, MEMBER W, TESTIS-SPECIFIC; H2BFWT	158983
MIM300508	*	 	UTP14, S. CEREVISIAE, HOMOLOG OF, A; UTP14A	10813
MIM300509	%	Xq27.3	DYSLEXIA, SUSCEPTIBILITY TO, 9; DYX9	474159
MIM300510	#	Xp11.2	OVARIAN DYSGENESIS 2; ODG2	9210
MIM300511	#	Xq22	PREMATURE OVARIAN FAILURE 2A; POF2A	1730
MIM300512	*	Xp11.23	WD REPEAT-CONTAINING PROTEIN 13; WDR13	64743
MIM300513	*	 	G PROTEIN-COUPLED RECEPTOR 119; GPR119	139760
MIM300514	#	Xp22.31	FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	2187
MIM300515	*	Xp22.31	FANCB GENE; FANCB	2187
MIM300516	*	 	ATPase, CLASS VI, TYPE 11C; ATP11C	286410
MIM300517	*	 	SPINDLIN FAMILY, MEMBER 2	474343
MIM300518	%	Xq24-q25	MENTAL RETARDATION, X-LINKED 82; MRX82	378484
MIM300519	%	Xq11-q21	MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE; MRXSMP	282808, 574047
MIM300520	*	 	CLAUDIN 2; CLDN2	9075
MIM300521	*	Xq13.1	KINESIN FAMILY MEMBER 4A; KIF4A	24137
MIM300522	*	Xp11.22	IQ MOTIF- AND SEC7 DOMAIN-CONTAINING PROTEIN 2; IQSEC2	23096
MIM300523	#	Xq13.2	ALLAN-HERNDON-DUDLEY SYNDROME; AHDS	6567
MIM300524	*	 	KIAA2022	340533
MIM300525	*	 	PYRIMIDINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 8; P2RY8	286530
MIM300526	*	 	WD REPEAT-CONTAINING PROTEIN 45; WDR45	11152
MIM300527	*	Xp11.23	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 10; NUDT10	170685
MIM300528	*	Xp11.23	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 11; NUDT11	55190
MIM300529	*	 	PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 10; P2RY10	27334
MIM300531	*	Xq28	SPROUTY, DROSOPHILA, HOMOLOG OF, 3; SPRY3	10251
MIM300532	*	Xp22.3	VARIABLY CHARGED, X CHROMOSOME, 2; VCX2	51480
MIM300533	*	Xp22.3	VARIABLY CHARGED, X CHROMOSOME, 3A; VCX3A	51481
MIM300534	#	Xp11.22-p11.21	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ	8242
MIM300535	*	Xq26.1	OCRL GENE; OCRL	4952
MIM300536	%	Xq27	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 4; BMND4	554316
MIM300537	#	Xq28	HETEROTOPIA, PERIVENTRICULAR, EHLERS-DANLOS VARIANT	2316
MIM300538	*	Xq28	ARGININE VASOPRESSIN RECEPTOR 2; AVPR2	554
MIM300539	#	Xq28	NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	554
MIM300540	*	Xq28	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 7; HAUS7	55559
MIM300541	*	 	SARCOMA, SYNOVIAL, X BREAKPOINT 6; SSX6	280657
MIM300542	*	 	SARCOMA, SYNOVIAL, X BREAKPOINT 7; SSX7	280658
MIM300543	*	 	SARCOMA, SYNOVIAL, X BREAKPOINT 8; SSX8	280659
MIM300544	*	 	SARCOMA, SYNOVIAL, X BREAKPOINT 9; SSX9	280660
MIM300545	*	Xq26.2	HEPARAN SULFATE 6-O-SULFOTRANSFERASE 2; HS6ST2	90161
MIM300546	*	Xp11.21	FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 1; FGD1	2245
MIM300547	*	 	MST3- AND SOK1-RELATED KINASE	51765
MIM300548	*	 	MELANOMA ANTIGEN, FAMILY H, 1; MAGEH1	28986
MIM300549	*	 	MELANOMA ANTIGEN, FAMILY A, 2B; MAGEA2B	266740
MIM300550	*	Xp22.2-p22.1	PHOSPHATE-REGULATING ENDOPEPTIDASE HOMOLOG, X-LINKED; PHEX	5251
MIM300551	%	Xp11.4-p11.23	MENTAL RETARDATION, X-LINKED 78; MRX78	170530
MIM300552	*	Xp22	MIDLINE 1; MID1	4281
MIM300553	*	Xq13	BROMODOMAIN- AND WD REPEAT-CONTAINING PROTEIN 3; BRWD3	254065
MIM300554	#	Xp11.22	HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	1184
MIM300555	#	Xq26.1	DENT DISEASE 2	4952
MIM300556	*	Xp11.4	ATPase, H+ TRANSPORTING, LYSOSOMAL, ACCESSORY PROTEIN 2; ATP6AP2	10159
MIM300557	%	Xq21-q25	PARKINSON DISEASE 12; PARK12	677662
MIM300558	#	Xq21.3-q24	MENTAL RETARDATION, X-LINKED 30; MRX30	5063
MIM300559	#	Xq13	GLYCOGEN STORAGE DISEASE, TYPE IXd; GSD9D	5255
MIM300560	*	Xp11.2	PHD FINGER PROTEIN 8; PHF8	23133
MIM300561	*	Xq27	SLIT- AND NTRK-LIKE FAMILY, MEMBER 2; SLITRK2	84631
MIM300562	*	Xq27	SLIT- AND NTRK-LIKE FAMILY, MEMBER 4; SLITRK4	139065
MIM300564	*	Xp11.2	TSPY-LIKE 2; TSPYL2	64061
MIM300565	*	Xq27	CHROMOSOME X OPEN READING FRAME 1; CXORF1	9142
MIM300566	*	Xq23	LHFP-LIKE PROTEIN 1; LHFPL1	340596
MIM300567	*	Xq13.3	PHOSPHOGLYCERATE MUTASE FAMILY MEMBER 4; PGAM4	441531
MIM300568	*	Xp11.3	MICRO RNA 221; MIR221	407006
MIM300569	*	Xp11.3	MICRO RNA 222; MIR222	407007
MIM300570	*	 	TRANSCRIPTION FACTOR YY2; YY2	404281
MIM300572	*	Xp21.3	G PROTEIN-COUPLED RECEPTOR 64; GPR64	10149
MIM300573	*	Xp11	ZINC FINGER PROTEIN 674; ZNF674	641339
MIM300574	*	Xq13	CHEMOKINE, CXC MOTIF, RECEPTOR 3; CXCR3	2833
MIM300575	*	Xq22.3	RIPPLY1, ZEBRAFISH, HOMOLOG OF; RIPPLY1	92129
MIM300576	*	Xq13.3	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 15; ZDHHC15	158866
MIM300577	#	Xq13.3	MENTAL RETARDATION, X-LINKED 91; MRX91	158866
MIM300578	#	Xp11.3	CHROMOSOME Xp11.3 DELETION SYNDROME	100271686
MIM300579	*	Xp11.2	SHROOM FAMILY MEMBER 4; SHROOM4	57477
MIM300580	%	Xq13.1-q22.1	MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	100188765
MIM300581	%	Xq22.3	FG SYNDROME 5; FGS5	780900
MIM300582	#	Ypter-p11.2, Xpter-p22.32	SHORT STATURE, IDIOPATHIC, X-LINKED; ISS	6473
MIM300583	*	Xq26.1-q27.2	VESTIGIAL-LIKE 1; VGLL1	51442
MIM300584	#	Xq28	IMMUNODEFICIENCY WITHOUT ANHIDROTIC ECTODERMAL DYSPLASIA	8517
MIM300585	*	Xp11.3	ZINC FINGER PROTEIN 673; ZNF673	55634
MIM300586	*	Xp22.3	ARYLSULFATASE H; ARSH	347527
MIM300587	*	Xq22-q24	MALIGNANT T-CELL AMPLIFIED SEQUENCE 1; MCTS1	28985
MIM300588	*	 	ODZ, DROSOPHILA, HOMOLOG OF, 1; ODZ1	10178
MIM300589	%	Xp11.4	NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	780901
MIM300590	#	Xp11.22-p11.21	CORNELIA DE LANGE SYNDROME 2; CDLS2	8243
MIM300591	%	Xq24-q25	STATURE QUANTITATIVE TRAIT LOCUS 6; STQTL6	100037264
MIM300592	*	Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A11; CT47A11	255313
MIM300593	*	Xp11.23	SPERM ACROSOME-ASSOCIATED PROTEIN 5; SPACA5	389852
MIM300594	*	Xp11.23	G ANTIGEN 1; GAGE1	2543
MIM300595	*	Xp11.23	G ANTIGEN 2C; GAGE2C	2574
MIM300596	*	 	G ANTIGEN 3; GAGE3	2575
MIM300597	*	 	G ANTIGEN 4; GAGE4	2576
MIM300598	*	 	G ANTIGEN 5; GAGE5	2577
MIM300599	*	 	G ANTIGEN 6; GAGE6	2578
MIM300600	#	Xp11.23	ALAND ISLAND EYE DISEASE; AIED	778
MIM300601	*	Xp11.23	G ANTIGEN 7; GAGE7	2579
MIM300603	*	Xq21	ACTIN-BINDING PROTEIN, 34-KD	79983
MIM300604	#	Xq21	PREMATURE OVARIAN FAILURE 2B; POF2B	79983
MIM300605	%	Xq28	RETINITIS PIGMENTOSA 34; RP34	777642
MIM300607	#	Xq22.1	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8	23229
MIM300608	*	 	DACHSHUND, DROSOPHILA, HOMOLOG OF, 2; DACH2	117154
MIM300609	*	Xp22.3	MALE-SPECIFIC LETHAL 3, DROSOPHILA, HOMOLOG OF; MSL3	10943
MIM300610	*	Xq22	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H2; HNRNPH2	3188
MIM300611	*	Xq23	C1GALT1-SPECIFIC CHAPERONE 1; C1GALT1C1	29071
MIM300613	%	Xq23-q27.2	MYOPIA 13, X-LINKED; MYP13	677764
MIM300614	%	Xq23-q27.3	DEAFNESS, X-LINKED 5; DFNX5	751798
MIM300615	#	Xp11.23	BRUNNER SYNDROME	4128
MIM300616	*	 	LEUCINE ZIPPER PROTEIN 4; LUZP4	51213
MIM300617	*	 	BRCA1/BRCA2-CONTAINING COMPLEX, SUBUNIT 3; BRCC3	79184
MIM300618	*	 	PHD FINGER PROTEIN 16; PHF16	9767
MIM300620	*	 	V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 1; VSIG1	340547
MIM300621	*	 	DXF34 GENE	54466
MIM300622	#	Xq23	TN SYNDROME	29071
MIM300623	#	Xq27.3	FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	2332
MIM300624	#	Xq27.3	FRAGILE X MENTAL RETARDATION SYNDROME	2332
MIM300625	*	Xq22	KITA-KYUSHU LUNG CANCER ANTIGEN 1	203413
MIM300626	*	Xp22.31	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 11; ASB11	140456
MIM300627	*	Xq26.3	ZINC FINGER PROTEIN 449; ZNF449	203523
MIM300628	*	Xq26.2	FERM DOMAIN-CONTAINING PROTEIN 7; FRMD7	90167
MIM300629	*	Xp22	ADAPTOR-RELATED PROTEIN COMPLEX 1, SIGMA-2 SUBUNIT; AP1S2	8905
MIM300630	^	Xp22	MENTAL RETARDATION, X-LINKED, SYNDROMIC, FRIED TYPE; MRXSF	8905
MIM300631	*	Xp22	TRANSMEMBRANE PROTEIN 27; TMEM27	57393
MIM300632	*	Xq13.1	PDZ DOMAIN-CONTAINING 11; PDZD11	51248
MIM300633	#	Xq11-q12	HYPOSPADIAS 1, X-LINKED; HYSP1	367
MIM300634	*	Xq28	PDZ DOMAIN-CONTAINING 4; PDZD4	57595
MIM300635	#	Xq25	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	331
MIM300636	#	Xq28	ATYPICAL MYCOBACTERIOSIS, FAMILIAL, X-LINKED 1; AMCBX1	8517
MIM300637	*	Xp11.23	G ANTIGEN 12I; GAGE12I	26748
MIM300638	*	Xp11.4-p11.2	G ANTIGEN 8; GAGE8	100101629
MIM300639	^	 	MOVED TO 300354	 
MIM300640	#	 	INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 2; IPD2	8517
MIM300641	*	Xq24	SOLUTE CARRIER FAMILY 25, MEMBER 43; SLC25A43	203427
MIM300642	*	Xq21.33-q23	SUSHI REPEAT-CONTAINING PROTEIN, X-LINKED, 2; SRPX2	27286
MIM300643	#	Xq21.33-q23	ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED; RESDX	27286
MIM300644	*	Xq22	GALACTOSIDASE, ALPHA; GLA	2717
MIM300645	#	Xp21.2-q26.3	ATYPICAL MYCOBACTERIOSIS, FAMILIAL, X-LINKED 2; AMCBX2	1536
MIM300646	*	Xq26.1	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 9; ZDHHC9	51114
MIM300647	*	Xq11.1	FAMILY WITH SEQUENCE SIMILARITY 123, MEMBER B; FAM123B	139285
MIM300648	*	Xq26.3	CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A1; CT45A1	541466
MIM300649	*	Xp11.23	SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 5; SLC38A5	92745
MIM300650		Xp22.3	ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS; OASD	4941
MIM300651	*	Xp11.23	PORCUPINE, DROSOPHILA, HOMOLOG OF; PORCN	64840
MIM300652	%	Xp11.3-q12	ANGIOMA SERPIGINOSUM, X-LINKED	100188767
MIM300653	#	Xq13	PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	5230
MIM300654	*	Xp11	FATTY ACID AMIDE HYDROLASE 2; FAAH2	158584
MIM300655	*	 	KELCH-LIKE 13; KLHL13	90293
MIM300656	*	 	URACIL PHOSPHORIBOSYLTRANSFERASE, S. CEREVISIAE, HOMOLOG OF; UPRT	139596
MIM300657	*	 	CANCER/TESTIS ANTIGEN 1A; CTAG1A	246100
MIM300658	*	Xp11.4	NDP GENE; NDP	4693
MIM300659	#	Xq13	MENTAL RETARDATION, X-LINKED 93; MRX93	254065
MIM300660	%	Xq25-q27	LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	100302058
MIM300661	#	Xq22-q24	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	5631
MIM300662	*	 	SMALL NUCLEOLAR RNA, H/ACA BOX, 11; SNORA11	677799
MIM300663	*	 	AUTOPHAGY 4, S. CEREVISIAE, HOMOLOG OF, A; ATG4A	115201
MIM300664	*	 	SPANX FAMILY, MEMBER N1; SPANXN1	494118
MIM300665	*	 	SPANX FAMILY, MEMBER N2; SPANXN2	494119
MIM300666	*	 	SPANX FAMILY, MEMBER N3; SPANXN3	139067
MIM300667	*	 	SPANX FAMILY, MEMBER N4; SPANXN4	441525
MIM300668	*	 	SPANX FAMILY, MEMBER N5; SPANXN5	494197
MIM300669	*	 	SPANX FAMILY, MEMBER B1; SPANXB1	728695
MIM300670	*	 	SPANX FAMILY, MEMBER D; SPANXD	64648
MIM300671	*	 	SPANX FAMILY, MEMBER E; SPANXE	171489
MIM300672	#	Xp22	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2	6792
MIM300673	#	Xq28	ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	4204
MIM300674	*	 	MOTILE SPERM DOMAIN-CONTAINING PROTEIN 1; MOSPD1	56180
MIM300675	*	 	PARANEOPLASTIC ANTIGEN MA3; PNMA3	29944
MIM300676	#	Xq25-q26	MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	65109
MIM300677	*	 	CHROMOSOME X OPEN READING FRAME 15; CXORF15	55787
MIM300678	*	 	DUAL-SPECIFICITY PHOSPHATASE 21; DUSP21	63904
MIM300679	#	Xp21	CHROMOSOME Xp21 DELETION SYNDROME	100505389
MIM300680	*	Xq28	PREGNANCY-UPREGULATED, NONUBIQUITOUS, CAM KINASE; PNCK	139728
MIM300681	*	 	DEDICATOR OF CYTOKINESIS 11; DOCK11	139818
MIM300682	*	Xq26.3	MICRO RNA 424; MIRN424	494336
MIM300683	*	Xq24	SEPTIN 6; SEPT6	23157
MIM300684	*	Xq22.1	X KELL BLOOD GROUP PRECURSOR-RELATED, X-LINKED; XKRX	402415
MIM300685	*	Xq28	PROLINE-RICH GAMMA-CARBOXYGLUTAMIC ACID PROTEIN 3; PRRG3	79057
MIM300686	*	Xq23	MICRO RNA 448; MIRN448	554212
MIM300687	*	Xq13.1	ERCC6-LIKE; ERCC6L	54821
MIM300688	*	Xq25-q26.1	BCL6 COREPRESSOR-LIKE 1; BCORL1	63035
MIM300689	*	Xq13.1	START DOMAIN-CONTAINING PROTEIN 8; STARD8	9754
MIM300690	*	Xq22.1-q22.2	BRAIN-EXPRESSED X-LINKED GENE 1; BEX1	55859
MIM300691	*	Xq22	BRAIN-EXPRESSED X-LINKED GENE 2; BEX2	84707
MIM300692	*	Xq22.2	BEX FAMILY MEMBER 4; BEX4	56271
MIM300693	*	Xq22.1	BEX FAMILY MEMBER 5; BEX5	340542
MIM300694	*	Xq12	MICRO RNA 223; MIR223	407008
MIM300695	#	Xq27.2	SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT; SPM	2273
MIM300696	#	Xq27.2	MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY; XMPMA	2273
MIM300697	*	Xp11.2	HECT, UBA, AND WWE DOMAINS-CONTAINING PROTEIN 1; HUWE1	10075
MIM300698	*	Xp11.4	TRANSMEMBRANE PROTEIN 47; TMEM47	83604
MIM300699	#	Xq25-q26	MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	2892
MIM300700	%	Xq26.3-q27.1	ALBINISM-DEAFNESS SYNDROME; ADFN	122
MIM300701	*	Xq24	ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 12; ZCCHC12	170261
MIM300702	*	Xp11	MELANOMA ANTIGEN, FAMILY D, 4; MAGED4	728239
MIM300703	%	Xq25-q27.1	SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	100188768
MIM300704	%	Xp11.22	PROSTATE CANCER, HEREDITARY, X-LINKED 2; HPCX2	100188769
MIM300705	#	Xp11.2	MENTAL RETARDATION, X-LINKED 17; MRX17	3028
MIM300706	#	Xp11.2	MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	10075
MIM300707	#	Xq28	TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	92002
MIM300708	*	Xq28	FAMILY WITH SEQUENCE SIMILARITY 58, MEMBER A; FAM58A	92002
MIM300710	%	Xq11-q12	ALOPECIA, ANDROGENETIC, 2; AGA2	100188771
MIM300711	%	Xq23	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 4; IHPS4	100188772
MIM300712	%	Xq26-q27	CRANIOFACIOSKELETAL SYNDROME	100188773
MIM300713	*	Xp11.23	OTU DOMAIN-CONTAINING PROTEIN 5; OTUD5	55593
MIM300714	*	Xq13.1	OTU DOMAIN-CONTAINING PROTEIN 6A; OTUD6A	139562
MIM300715	*	Xq13.1-q13.2	MAGNESIUM TRANSPORTER 1; MAGT1	84061
MIM300716	%	Xq13.1-q13.2	MENTAL RETARDATION, X-LINKED 95; MRX95	84061
MIM300717	#	Xq27.2	MYOPATHY, REDUCING BODY, X-LINKED, EARLY-ONSET, SEVERE	2273
MIM300718	#	Xq27.2	MYOPATHY, REDUCING BODY, X-LINKED, CHILDHOOD-ONSET	2273
MIM300719	%	Chr.X	DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES	100188774
MIM300720	*	Xp11.23	G ANTIGEN 2A; GAGE2A	729447
MIM300721	*	Xp11.22	MICRO RNA LET7F2; MIRNLET7F2	406889
MIM300722	*	Xq26.2	MICRO RNA 19B2; MIR19B2	406981
MIM300723	*	Xq21.33	SYNAPTOTAGMIN-LIKE 4; SYTL4	94121
MIM300724	*	Xp22.12	CONNECTOR ENHANCER OF KSR 2; CNKSR2	22866
MIM300725	*	Xp11.21	RAS-RELATED GTP-BINDING PROTEIN B; RRAGB	10325
MIM300726	*	Xp11.23	G ANTIGEN 2B; GAGE2B	645037
MIM300727	*	Xp11.23	G ANTIGEN 12C; GAGE12C	729422
MIM300728	*	Xp11.23	G ANTIGEN 12D; GAGE12D	100132399
MIM300729	*	Xp11.23	G ANTIGEN 12E; GAGE12E	729431
MIM300730	*	Xp11.23	G ANTIGEN 12F; GAGE12F	100008586
MIM300731	*	Xp11.23	G ANTIGEN 12G; GAGE12G	645073
MIM300732	*	Xp11.23	G ANTIGEN 12H; GAGE12H	729442
MIM300733	*	Xp11.23	G ANTIGEN 12J; GAGE12J	729396
MIM300734	*	Xp11.23	G ANTIGEN 13; GAGE13	645051
MIM300735	*	Xp11.23	G ANTIGEN 2D; GAGE2D	729408
MIM300736	*	Xp11.23	G ANTIGEN 2E; GAGE2E	26749
MIM300737	*	Xp11.23	G ANTIGEN 10; GAGE10	643832
MIM300738	*	Xp11.21	P ANTIGEN FAMILY, MEMBER 2; PAGE2	203569
MIM300739	*	Xp11.21	P ANTIGEN FAMILY, MEMBER 3; PAGE3	139793
MIM300740	*	Xp11.22	X ANTIGEN FAMILY, MEMBER 3; XAGE3	170626
MIM300741	*	Xp11.2	FAMILY WITH SEQUENCE SIMILARITY 120, MEMBER C; FAM120C	54954
MIM300742	*	Xp11.22	X ANTIGEN FAMILY, MEMBER 1A; XAGE1A	653219
MIM300743	*	Xp11.22	X ANTIGEN FAMILY, MEMBER 1B; XAGE1B	653220
MIM300744	*	Xp11.22	X ANTIGEN FAMILY, MEMBER 1C; XAGE1C	653048
MIM300745	*	Xp11.22	X ANTIGEN FAMILY, MEMBER 1E; XAGE1E	653067
MIM300746	*	Xq27.1-q27.2	COAGULATION FACTOR IX; F9	2158
MIM300747	*	Xp22.32	STEROID SULFATASE; STS	412
MIM300748	*	Xp11.4	G PROTEIN-COUPLED RECEPTOR 82; GPR82	27197
MIM300749	#	Xp11.4	MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	8573
MIM300750	%	Xq24-q25	SPASTIC PARAPLEGIA 34, X-LINKED; SPG34	724110
MIM300751	#	Xp11.21	ANEMIA, SIDEROBLASTIC, X-LINKED; XLSA	212
MIM300752	#	Xp11.21	PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED; XLEPP	212
MIM300753	*	Xp22.1	APOLIPOPROTEIN O; APOO	79135
MIM300754	*	Xq13.1-q22.1	TAF9B RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 31-KD; TAF9B	51616
MIM300755	#	Xq21.3-q22	AGAMMAGLOBULINEMIA, X-LINKED; XLA	695
MIM300756	%	Xq21.3	ALZHEIMER DISEASE 16; AD16	100271718
MIM300757	*	Xp11.23	RP2 GENE; RP2	6102
MIM300758	#	Xq28	HYPOSPADIAS 2, X-LINKED; HYSP2	10046
MIM300759	*	Xq13.1	MELANOMA ANTIGEN, FAMILY E, 1; MAGEE1	57692
MIM300760	*	Xq13.1	MELANOMA ANTIGEN, FAMILY E, 2; MAGEE2	139599
MIM300761	*	Xp21.3	MELANOMA ANTIGEN, FAMILY B, 10; MAGEB10	139422
MIM300762	*	Xp21.3	MELANOMA ANTIGEN, FAMILY B, 16; MAGEB16	139604
MIM300763	*	Xp21.3	MELANOMA ANTIGEN, FAMILY B, 17; MAGEB17	645864
MIM300764	*	Xq28	MELANOMA ANTIGEN, FAMILY A, 9B; MAGEA9B	728269
MIM300765	*	Xp11	MELANOMA ANTIGEN, FAMILY D, 4B; MAGED4B	81557
MIM300766	*	Xq24	NFKB-ACTIVATING PROTEIN; NKAP	79576
MIM300767	*	Xq21.33	REPLICATION PROTEIN A4; RPA4	29935
MIM300768	*	Xq21.1	CYLICIN 1; CYLC1	1538
MIM300769	*	Xq28	MICRO RNA 224; MIR224	407009
MIM300770	#	Xp22.32	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4; SMDP4	1438
MIM300771	*	Xq22.1-q22.3	TRANSCRIPTION ELONGATION FACTOR A-LIKE 7; TCEAL7	56849
MIM300772	*	Xq26.2	TRANSCRIPTION FACTOR DP FAMILY, MEMBER 3; TFDP3	51270
MIM300773	*	Xp11.21	APEX NUCLEASE (APURINIC/APYRIMIDINIC ENDONUCLEASE) 2; APEX2	27301
MIM300774	*	Xq28	RAS-ASSOCIATED PROTEIN RAB39B; RAB39B	116442
MIM300775	*	Xq26	E74-LIKE FACTOR 4; ELF4	2000
MIM300776	*	Xq23	ALG13, S. CEREVISIAE, HOMOLOG OF; ALG13	79868
MIM300777	*	Xq28	EPSILON-TRIMETHYLLYSINE HYDROXYLASE; TMLHE	55217
MIM300778	%	Xp22.3	CORNEAL DYSTROPHY, LISCH EPITHELIAL; LECD	100302509
MIM300779	%	Xq25	CORNEAL DYSTROPHY, ENDOTHELIAL, X-LINKED; XECD	100302510
MIM300780	*	Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A1; CT47A1	728096
MIM300781	*	Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A2; CT47A2	728090
MIM300782	*	Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A3; CT47A3	728082
MIM300783	*	Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A4; CT47A4	728075
MIM300784	*	Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A5; CT47A5	728072
MIM300785	*	Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A6; CT47A6	728062
MIM300786	*	Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A7; CT47A7	653282
MIM300787	*	Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A8; CT47A8	728049
MIM300788	*	Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A9; CT47A9	728042
MIM300789	*	Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER A10; CT47A10	728036
MIM300790	*	Xq24	CANCER/TESTIS ANTIGEN FAMILY 47, MEMBER B1; CT47B1	643311
MIM300791	*	Xq22.3	NIK-RELATED KINASE; NRK	203447
MIM300792	*	Xq26.2	MICRO RNA 106A; MIR106A	406899
MIM300793	*	Xq26.3	CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A2; CT45A2	728911
MIM300794	*	Xq26.3	CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A3; CT45A3	441519
MIM300795	*	Xq26.3	CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A4; CT45A4	441520
MIM300796	*	Xq26.3	CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A5; CT45A5	441521
MIM300797	*	Xq26.3	CANCER/TESTIS ANTIGEN FAMILY 45, MEMBER A6; CT45A6	541465
MIM300798	*	Xp22.2-p22.1	PHOSPHORYLASE KINASE, LIVER, ALPHA-2 SUBUNIT; PHKA2	5256
MIM300799	#	Xq26.1	MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR	51114
MIM300801	#	Xp11.23-p11.22	CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME	100310754
MIM300802	#	Xp11.23-p11.22	MENTAL RETARDATION, X-LINKED 96; MRX96	6855
MIM300803	#	 	MENTAL RETARDATION, X-LINKED 97; MRX97	7552
MIM300804	#	Xp22.3-p22.2	JOUBERT SYNDROME 10; JBTS10	8481
MIM300805	*	Xq27	FMR1 ANTISENSE RNA 1; FMR1AS1	100126270
MIM300806	*	Xq28	AF4/FMR2 FAMILY, MEMBER 2; AFF2	2334
MIM300807	#	Xq27.1-q27.2	THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; THPH8	2158
MIM300808	*	Xp22.3	G PROTEIN-COUPLED RECEPTOR 143; GPR143	4935
MIM300809	%	Xq28	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 15; SLEB15	100379200
MIM300810	*	Xp11.22	MICRO RNA 98; MIR98	407054
MIM300811	*	Xq28	MICRO RNA 105-1; MIR105-1	406897
MIM300812	*	Xq28	MICRO RNA 105-2; MIR105-2	406898
MIM300814	#	Xp22.3	NYSTAGMUS 6, CONGENITAL, X-LINKED; NYS6	4935
MIM300815	#	Xq28	CHROMOSOME Xq28 DUPLICATION SYNDROME	100415893
MIM300816	#	Xq25-q26	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	9131
MIM300817	*	Xp11.3	EF-HAND DOMAIN (C-TERMINAL)-CONTAINING PROTEIN 2; EFHC2	80258
MIM300818	#	Xp22.1	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PNH	5277
MIM300819	*	Xp11.23	ZINC FINGER PROTEIN 630; ZNF630	57232
MIM300820	*	Xp22.12	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 15; MAP3K15	389840
MIM300821	*	Xq28	OPSIN 1, MEDIUM-WAVE-SENSITIVE; OPN1MW	2652
MIM300822	*	Xq28	OPSIN 1, LONG-WAVE-SENSITIVE; OPN1LW	5956
MIM300823	*	Xq28	IDURONATE 2-SULFATASE; IDS	3423
MIM300824	*	Xq28	OPN1LW AND OPN1MW GENES, CONTROLLER OF	100534624
MIM300825	*	Xp22.2	RETINOBLASTOMA-BINDING PROTEIN 7; RBBP7	5931
MIM300826	*	Xq25	STROMAL ANTIGEN 2; STAG2	10735
MIM300827	*	Xq21.1	FIBROBLAST GROWTH FACTOR 16; FGF16	8823
MIM300828	*	Xp22.11	PATCHED DOMAIN-CONTAINING PROTEIN 1; PTCHD1	139411
MIM300830	#	Xp22.11	CHROMOSOME Xp22 DELETION SYNDROME	100529118
MIM300831	#	Xq28	CK SYNDROME	50814
MIM300832	*	Xq13.2	JUST PROXIMAL TO XIST; JPX	554203
MIM300833	#	 	46,XX SEX REVERSAL 3; SRXX3	100653372
MIM300834	#	 	MACULAR DEGENERATION, X-LINKED ATROPHIC	6103
MIM300835	#	 	ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES; XLANP	2623
MIM300836	*	 	KAL1 GENE; KAL1	3730
MIM300837	*	 	DIACYLGLYCEROL KINASE, KAPPA, 142-KD; DGKK	139189
MIM300838	*	 	FERM AND PDZ DOMAINS-CONTAINING PROTEIN 4; FRMPD4	9758
MIM300839	*	 	RETINOSCHISIN; RS1	6247
MIM300840	*	 	PRA1 DOMAIN FAMILY, MEMBER 2; PRAF2	11230
MIM300841	*	 	COAGULATION FACTOR VIII; F8	2157
MIM300842	#	 	MCLEOD SYNDROME; MCLDS	7504
MIM300843	%	 	BORNHOLM EYE DISEASE; BED	100653365
MIM300844	#	 	MENTAL RETARDATION, X-LINKED 19; MRX19	6197
MIM300845	#	 	MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM, AND FACIAL DYSMORPHISM; MYMY4	100653379
MIM300846	*	 	CD99 ANTIGEN-LIKE 2; CD99L2	83692
MIM300847	#	 	AUTISM, SUSCEPTIBILITY TO, X-LINKED 5; AUTSX5	6134
MIM300848	%	 	MENTAL RETARDATION, X-LINKED 89; MRX89	7592
MIM300849	#	 	MENTAL RETARDATION, X-LINKED 41; MRX41	2664
MIM300850	#	 	MENTAL RETARDATION, X-LINKED 90; MRX90	1741
MIM300851	%	 	MENTAL RETARDATION, X-LINKED 92; MRX92	641339
MIM300852	%	 	MENTAL RETARDATION, X-LINKED 88; MRX88	186
MIM300853	#	 	IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN	84061
MIM300854	#	 	RENAL CELL CARCINOMA, Xp11-ASSOCIATED; RCCX1	7030
MIM300855	#	 	OGDEN SYNDROME; OGDNS	8260
MIM300856	%	 	HYPOSPADIAS 4, X-LINKED, SUSCEPTIBILITY TO; HYSP4	100689214
MIM300857	#	 	AMYOTROPHIC LATERAL SCLEROSIS 15, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15	29978
MIM300858	%	 	MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17	100739996
MIM300859	*	 	COILED-COIL DOMAIN-CONTAINING PROTEIN 22; CCDC22	28952
MIM300860	#	 	MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN	7319
MIM300861	%	 	MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS	100820761
MIM300862	*	 	ACYL-CoA THIOESTERASE 9; ACOT9	23597
MIM300863	#	 	CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	100820762
MIM300864		 	CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	100820758
MIM300865	*	 	MICRO RNA 503; MIR503	574506
MIM300866	*	 	MICRO RNA 510; MIR510	574515
MIM300867	#	 	KABUKI SYNDROME 2; KABUK2	7403
MIM300868	#	 	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	5277
MIM300869	#	 	CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	100874533
MIM300871	*	 	FUN14 DOMAIN-CONTAINING PROTEIN 1; FUNDC1	139341
MIM300872	#	 	EPSILON-TRIMETHYLLYSINE HYDROXYLASE DEFICIENCY; TMLHED	55217
MIM300873	*	 	GUANINE NUCLEOTIDE-BINDING PROTEIN-LIKE 3-LIKE PROTEIN; GNL3L	54552
MIM300874	*	 	MICRO RNA 508; MIR508	574513
MIM300875	*	 	MICRO RNA 509-1; MIR509-1	574514
MIM300876	*	 	MICRO RNA 509-3; MIR509-3	100126337
MIM300877	*	 	MICRO RNA 506; MIR506	574511
MIM300878	*	 	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR C1; DMRTC1	63947
MIM300879	*	 	XG GLYCOPROTEIN; XG	7499
MIM300882	#	 	CORNELIA DE LANGE SYNDROME 5; CDLS5	55869
MIM300883	*	 	SORTING NEXIN 12; SNX12	29934
MIM300885	*	 	CYTOCHROME c OXIDASE, SUBUNIT VIIb; COX7B	1349
MIM301000	#	Xp11.23-p11.22	WISKOTT-ALDRICH SYNDROME; WAS	7454
MIM301040	#	Xq13	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	546
MIM301050	#	Xq22.3	ALPORT SYNDROME, X-LINKED; ATS	1287
MIM301090	^	 	MOVED TO 273395	 
MIM301100	^	 	MOVED TO 301200	 
MIM301200	#	Xp22.3-p22.1	AMELOGENESIS IMPERFECTA, TYPE IE; AI1E	265
MIM301201	%	Xq22-q28	AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 2	201
MIM301220	%	Xp22-p21	PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS; PDR	5171
MIM301300	*	Xp11.21	DELTA-AMINOLEVULINATE SYNTHASE 2; ALAS2	212
MIM301310	#	Xq13.1-q13.3	ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA; ASAT	22
MIM301410		 	NEURAL TUBE DEFECTS, X-LINKED	 
MIM301500	#	Xq22	FABRY DISEASE	2717
MIM301590	%	Xq27-q28	MICROPHTHALMIA, SYNDROMIC 4; MCOPS4	289
MIM301700		 	ANOSMIA	 
MIM301770	*	Xcen-q21	ARRESTIN 3, RETINAL; ARR3	407
MIM301780	*	Xpter-p22.32	ARYLSULFATASE C, ISOZYME F; ARSC2	413
MIM301790		 	SPINOCEREBELLAR ATAXIA, X-LINKED 3	727715
MIM301800		 	ANUS, IMPERFORATE	 
MIM301815		 	ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	 
MIM301830	#	Xp11.23	SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2	7317
MIM301835	#	Xq22-q24, Xq21.2-q24	ARTS SYNDROME; ARTS	5631
MIM301840		 	SPINOCEREBELLAR ATAXIA, X-LINKED 4	727716
MIM301845	%	Xq24-q27	BAZEX SYNDROME; BZX	8255
MIM301870	*	Xq28	BIGLYCAN; BGN	633
MIM301900	#	Xq26.3	BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	84295
MIM301940		 	BRACHYDACTYLY, MONONEN TYPE	 
MIM301950		 	BRANCHIAL ARCH SYNDROME, X-LINKED	 
MIM302000	%	Xq27.3-qter	BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	1881
MIM302020	*	Xp	CALBINDIN 3; CALB3	795
MIM302030		 	CALVARIAL HYPEROSTOSIS	 
MIM302045	#	Xp21.2	CARDIOMYOPATHY, DILATED, 3B; CMD3B	1756
MIM302060	#	Xq28	BARTH SYNDROME; BTHS	6901
MIM302200	#	Xp22.13	CATARACT, CONGENITAL, X-LINKED; CXN	4810, 907
MIM302300	^	 	MICROPHTHALMIA, ISOLATED, WITH CATARACT 3; MCOPCT3	 
MIM302350	#	Xp22.13	NANCE-HORAN SYNDROME; NHS	4810
MIM302380	%	 	CATEL-MANZKE SYNDROME	100862706
MIM302400		 	CENTRAL INCISORS, ABSENCE OF	 
MIM302500	#	Xp11.21-q21.3	SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	1166
MIM302600		 	SPINOCEREBELLAR ATAXIA, X-LINKED 2	727714
MIM302650	*	Xq27.1-q27.2	CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 1; CDR1	1038
MIM302700		 	CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	 
MIM302800	#	Xq13.1	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1	2705
MIM302801	%	Xp22.2	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2; CMTX2	1253
MIM302802	%	Xq26	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	1254
MIM302803		 	CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED, WITH APLASIA CUTIS CONGENITA	 
MIM302900		 	CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA, COMBINED	 
MIM302905	#	 	CHARGE-LIKE SYNDROME, X-LINKED	 
MIM302910	*	Xp22.3	CHLORIDE CHANNEL 4; CLCN4	1183
MIM302950	#	Xp22.3	CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE; CDPX1	415
MIM302960	#	Xp11.23-p11.22	CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	10682
MIM303100	#	Xq21.2	CHOROIDEREMIA; CHM	1121
MIM303110	#	 	CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION	100887743
MIM303350	#	Xq28	MASA SYNDROME	3897
MIM303400	#	Xq12-q21	CLEFT PALATE, X-LINKED; CPX	50945
MIM303600	#	Xp22.2-p22.1	COFFIN-LOWRY SYNDROME; CLS	6197
MIM303630	*	Xq22.3	COLLAGEN, TYPE IV, ALPHA-5; COL4A5	1287
MIM303631	*	Xq22.3	COLLAGEN, TYPE IV, ALPHA-6; COL4A6	1288
MIM303650		 	COLONIC ATRESIA	 
MIM303700	#	Xq28, Xq28	BLUE CONE MONOCHROMACY; BCM	2652, 5956
MIM303800	#	Xq28	COLORBLINDNESS, PARTIAL, DEUTAN SERIES; CBD	2652
MIM303900	#	Xq28	COLORBLINDNESS, PARTIAL, PROTAN SERIES; CBP	5956
MIM304000	^	 	MOVED TO 613522	 
MIM304020	#	Xp11.4	CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	6103
MIM304030		 	CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	 
MIM304040	*	Xq13.1	GAP JUNCTION PROTEIN, BETA-1; GJB1	2705
MIM304050	%	Xp22	AICARDI SYNDROME; AIC	192
MIM304100	#	Xq28	CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	3897
MIM304110	#	Xq12	CRANIOFRONTONASAL SYNDROME; CFNS	1947
MIM304120	#	Xq28	OTOPALATODIGITAL SYNDROME, TYPE II; OPD2	2316
MIM304150	#	Xq12-q13	OCCIPITAL HORN SYNDROME; OHS	538
MIM304200		 	CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	 
MIM304300		 	CYANIDE, INABILITY TO SMELL	 
MIM304340	#	Xq25-q27	DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, BASAL GANGLIA DISEASE, AND SEIZURES	5242
MIM304350		 	DEAFNESS-HYPOGONADISM SYNDROME; DHS	 
MIM304400	#	Xq21.1	DEAFNESS, X-LINKED 2; DFNX2	10804, 2706, 5456
MIM304500	#	Xq22-q24	DEAFNESS, X-LINKED 1; DFNX1	5631
MIM304590	^	 	DEAFNESS, HIGH-FREQUENCY SENSORINEURAL, X-LINKED	 
MIM304700	#	Xq22	MOHR-TRANEBJAERG SYNDROME; MTS	1678
MIM304730	%	Xq24-qter	DERMOIDS OF CORNEA; CND	8231
MIM304790	#	Xp11.23-q13.3	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	50943
MIM304800	#	Xq28	DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	554
MIM304900		 	DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	 
MIM304950		 	DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	 
MIM305000	#	Xq28	DYSKERATOSIS CONGENITA, X-LINKED; DKCX	1736
MIM305100	#	Xq12-q13.1	ECTODERMAL DYSPLASIA, HYPOHIDROTIC, X-LINKED; XHED	1896
MIM305200	%	 	EHLERS-DANLOS SYNDROME, TYPE V	 
MIM305300	^	 	MOVED TO 302060	 
MIM305350		 	EPIDERMODYSPLASIA VERRUCIFORMIS, X-LINKED; EDVX; EDV2	 
MIM305360	*	Xq28	MEMBRANE PROTEIN, PALMITOYLATED 1; MPP1	4354
MIM305370	*	Xp11.3-p11.23	TISSUE INHIBITOR OF METALLOPROTEINASE 1; TIMP1	7076
MIM305371	*	Xp11.23	GATA-BINDING PROTEIN 1; GATA1	2623
MIM305390	#	Xp11.4	EXUDATIVE VITREORETINOPATHY 2, X-LINKED; EVR2	4693
MIM305400	#	Xp11.21	AARSKOG-SCOTT SYNDROME; AAS	2245
MIM305423	*	Xq28	FACTOR VIII-ASSOCIATED GENE 1; F8A	8263
MIM305435	%	Xp22.2	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3; HBFQTL3	2221
MIM305450	#	Xq13	OPITZ-KAVEGGIA SYNDROME; OKS	9968
MIM305550		 	FINGERPRINT BODY MYOPATHY	 
MIM305600	#	Xp11.23	FOCAL DERMAL HYPOPLASIA; FDH	64840
MIM305620	#	Xq28	FRONTOMETAPHYSEAL DYSPLASIA; FMD	2316
MIM305645	^	 	MOVED TO 136760	 
MIM305660	*	Xq28	GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-3; GABRA3	2556
MIM305670	*	Xp22.3-p21.2	GASTRIN-RELEASING PEPTIDE RECEPTOR; GRPR	2925
MIM305690		 	GENITOURINARY TRACT ANOMALIES	 
MIM305700		 	SPERMATOGENIC FAILURE, X-LINKED, 1; SPGFX1	 
MIM305800		 	MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	 
MIM305900	*	Xq28	GLUCOSE-6-PHOSPHATE DEHYDROGENASE; G6PD	2539
MIM305915	*	Xq25-q26	GLUTAMATE RECEPTOR, IONOTROPIC, AMPA 3; GRIA3	2892
MIM305990	*	Xp22.1-p21.2	GLYCINE RECEPTOR, ALPHA-2 SUBUNIT; GLRA2	2742
MIM306000	#	Xp22.2-p22.1	GLYCOGEN STORAGE DISEASE IXa1; GSD9A1	5256
MIM306100	^	Xp22.11-p21.2	MOVED TO 400044	 
MIM306190	^	 	MOVED TO 300200	 
MIM306250	*	Xp22.32	COLONY-STIMULATING FACTOR 2 RECEPTOR, ALPHA; CSF2RA	1438
MIM306300		 	GRANULOMAS, CONGENITAL CEREBRAL	 
MIM306400	#	Xp21.1	GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CGD	1536
MIM306480	*	Xp22.32	HALOACID DEHALOGENASE-LIKE HYDROLASE DOMAIN-CONTAINING 1A; HDHD1A	8226
MIM306500		 	GYNECOMASTIA, FAMILIAL	 
MIM306700	#	Xq28	HEMOPHILIA A; HEMA	 
MIM306800		 	HEMOPHILIA A WITH VASCULAR ABNORMALITY	 
MIM306900	#	Xq27.1-q27.2	HEMOPHILIA B; HEMB	2158
MIM306930		 	HEMOPOIETIC PROLIFERATION	 
MIM306950		 	HERNIA, ANTERIOR DIAPHRAGMATIC	 
MIM306955	#	Xq26.2	HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	7547
MIM306960	%	 	HHHH SYNDROME	 
MIM306995		Xq28	HOMOSEXUALITY 1; HMS1	 
MIM307000	#	Xq28	HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS; HSAS	3897
MIM307010		 	HYDROCEPHALUS WITH CEREBELLAR AGENESIS	 
MIM307030	#	Xp21.3-p21.2	HYPERGLYCEROLEMIA	2710
MIM307150	#	Xq24-q27.1	HYPERTRICHOSIS, CONGENITAL GENERALIZED; HTC2	3342
MIM307200	#	Xq21.3-q22	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3	695
MIM307300		 	HYPOGONADISM, MALE	 
MIM307500		 	HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES	 
MIM307700	%	Xq26-q27	HYPOPARATHYROIDISM, X-LINKED; HYPX	3258
MIM307800	#	Xp22.2-p22.1	HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR	5251
MIM307810	^	 	MOVED TO 307800 AND 300550	 
MIM307830		 	HYPOURICEMIA, FAMILIAL RENAL, DUE TO TUBULAR HYPERSECRETION	 
MIM308000	*	Xq26-q27.2	HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE 1; HPRT1	3251
MIM308050	#	Xq28	CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	50814
MIM308100	#	Xp22.32	ICHTHYOSIS, X-LINKED; XLI	412
MIM308200		 	ICHTHYOSIS AND MALE HYPOGONADISM	 
MIM308205	#	Xp22.12-p22.11	IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	51360
MIM308220		 	IMMUNODEFICIENCY, X-LINKED, WITH DEFICIENCY OF 115,000 DALTON SURFACE GLYCOPROTEIN	 
MIM308230	#	Xq26	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1; HIGM1	959
MIM308240	#	Xq25	LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	331, 4068
MIM308250	%	 	IMMUNOGLOBULIN M, LEVEL OF	 
MIM308280	%	 	IMPACTED TEETH, MULTIPLE	 
MIM308300	#	Xq28	INCONTINENTIA PIGMENTI; IP	8517, 8518
MIM308350	#	Xp22.13	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	170302
MIM308370	^	 	MOVED TO 312300	 
MIM308380	*	Xq13	INTERLEUKIN 2 RECEPTOR, GAMMA; IL2RG	3561
MIM308385	*	Xp22.3	INTERLEUKIN 3 RECEPTOR, ALPHA; IL3RA	3563
MIM308500		 	IRIS HYPOPLASIA WITH GLAUCOMA; IHG	2296, 3548
MIM308600		 	JAUNDICE, FAMILIAL OBSTRUCTIVE, OF INFANCY	182, 5205, 5244, 5265, 8647
MIM308700	#	Xp22.3	HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	3730
MIM308750		 	KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	 
MIM308800	#	Xp22.1	KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	51360, 6303
MIM308830		 	KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	 
MIM308840	*	Xq28	L1 CELL ADHESION MOLECULE; L1CAM	3897
MIM308850		 	LARYNGEAL ABDUCTOR PARALYSIS	 
MIM308905	%	Xp11	LEBER OPTIC ATROPHY, SUSCEPTIBILITY TO	100188775
MIM308930	^	Xp22.2-p22.1	LEIGH SYNDROME, X-LINKED	5160
MIM308940	#	Xq22.3	LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS	1288
MIM308950		 	LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT	 
MIM308960		 	LEUKEMIA, ACUTE, ?X-LINKED	 
MIM308990	#	Xp11.22	PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	1184
MIM309000	#	Xq26.1	LOWE OCULOCEREBRORENAL SYNDROME; OCRL	4952
MIM309050		Xp21.2-q21.1	LUTHERAN SUPPRESSOR, X-LINKED; XS	7523
MIM309060	*	Xq24	LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 2; LAMP2	3920
MIM309100	%	 	MACULAR DYSTROPHY, X-LINKED	 
MIM309120		 	SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	100820759
MIM309150	^	 	MOVED TO 614279	6994
MIM309200	%	Xq28	MAJOR AFFECTIVE DISORDER 2; MAFD2	4096
MIM309300	#	Xq21.3-q22	MEGALOCORNEA; MGC1	4251
MIM309350	#	Xq28	MELNICK-NEEDLES SYNDROME; MNS	2316
MIM309400	#	Xq12-q13	MENKES DISEASE	538
MIM309470	^	 	MOVED TO 309500	 
MIM309480		 	MENTAL RETARDATION AND PSORIASIS	 
MIM309490	^	 	MOVED TO 309580	 
MIM309500	#	Xp11.23	RENPENNING SYNDROME 1; RENS1	10084
MIM309510	#	Xp22.13	PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS	170302
MIM309520	#	Xq13	LUJAN-FRYNS SYNDROME	9968
MIM309530	#	Xp11.22, Xp11.3-q21.1	MENTAL RETARDATION, X-LINKED 1; MRX1	23096, 4365
MIM309541	#	Xq28	MENTAL RETARDATION, X-LINKED 3; MRX3	2664
MIM309545	%	Xp11	MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	8246
MIM309548	#	Xq28	MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE	2334
MIM309549	#	Xp11.23	MENTAL RETARDATION, X-LINKED 9; MRX9	24140
MIM309550	*	Xq27.3	FMR1 GENE; FMR1	2332
MIM309555	%	Xq26	MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	8258
MIM309560	%	 	MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	 
MIM309580	#	Xq13	MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	546
MIM309583	#	Xp22.1	MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE; MRXSSR	6611
MIM309585	#	Xp21.1-q22	WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	55869, 7492
MIM309590	^	 	MOVED TO 309580	 
MIM309600	^	 	MOVED TO 300523	 
MIM309605	%	Xq13-q22	MILES-CARPENTER X-LINKED MENTAL RETARDATION SYNDROME; MCS	4183
MIM309610	%	Xp11-q21	PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	5640
MIM309620	%	Xq28	MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD	4364
MIM309630	#	 	METACARPAL 4-5 FUSION; MF4	4235
MIM309640		 	MENTAL RETARDATION WITH SPASTIC PARAPLEGIA	 
MIM309645	^	 	MOVED TO 602111	 
MIM309660	^	 	MOVED TO 300257	 
MIM309700	^	 	MOVED TO 310600	 
MIM309800	#	Xq27-q28	MICROPHTHALMIA, SYNDROMIC 1; MCOPS1	4080, 54880
MIM309801	#	Xp22	MICROPHTHALMIA, SYNDROMIC 7; MCOPS7	3052
MIM309840		 	MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	 
MIM309845	*	Xq11.2-q12	MOESIN; MSN	4478
MIM309850	+	Xp11.23	MONOAMINE OXIDASE A; MAOA	4128
MIM309860	*	Xp11.23	MONOAMINE OXIDASE B; MAOB	4129
MIM309900	#	Xq28	MUCOPOLYSACCHARIDOSIS TYPE II	3423
MIM309930		 	MUSCULAR DYSTROPHY, CARDIAC TYPE	 
MIM309950		 	MUSCULAR DYSTROPHY, HEMIZYGOUS LETHAL TYPE	 
MIM310000		 	MUSCULAR DYSTROPHY, MABRY TYPE	 
MIM310095		 	MUSCULAR DYSTROPHY, PROGRESSIVE PECTORODORSAL	 
MIM310200	#	Xp21.2	MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	1756
MIM310300	#	Xq28	EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	2010
MIM310310	*	Xq22-q23	MYCL-RELATED PROCESSED GENE; MYCL2	4611
MIM310350		 	MYELOLYMPHATIC INSUFFICIENCY	 
MIM310370		 	MYOCLONIC EPILEPSY, PROGRESSIVE	 
MIM310400	#	Xq28	MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	4534
MIM310440	%	Xq28	MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX	203547
MIM310450	^	 	MOVED TO 159000	 
MIM310460	%	Xq28	MYOPIA 1, X-LINKED; MYP1	4657
MIM310465		Xp22.3-p21.1	N SYNDROME; NSX	4906, 5422
MIM310468	#	Xp11.22	NEPHROLITHIASIS, X-LINKED RECESSIVE, WITH RENAL FAILURE; XRN	1184
MIM310470		 	NEUROPATHY, HEREDITARY SENSORY, X-LINKED	 
MIM310490	#	Xq24-q26.1	COWCHOCK SYNDROME	4672
MIM310500	#	Xp11.4	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A	60506
MIM310600	#	Xp11.4	NORRIE DISEASE; ND	4693
MIM310700	#	Xq26.2	NYSTAGMUS 1, CONGENITAL, X-LINKED; NYS1	90167
MIM310800		 	NYSTAGMUS, MYOCLONIC	 
MIM310900		 	OCCIPITAL HAIR, WHITE LOCK OF	 
MIM310980		 	OMPHALOCELE, X-LINKED	 
MIM311000	%	 	OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA; OPEM	4981
MIM311010	*	Xp11.4-p11.2	V-RAF MURINE SARCOMA 3611 VIRAL ONCOGENE HOMOLOG 1; ARAF1	369
MIM311030	*	Xq27	MCF.2 CELL LINE-DERIVED TRANSFORMING SEQUENCE; MCF2	4168
MIM311040	*	Xp11.2	ELK1, MEMBER OF ETS ONCOGENE FAMILY; ELK1	2002
MIM311050	%	Xp11.4-p11.21	OPTIC ATROPHY 2; OPA2	4977
MIM311070	#	Xq22-q24	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5; CMTX5	5631
MIM311100		 	OPTIC ATROPHY--SPASTIC PARAPLEGIA SYNDROME	 
MIM311150	#	Xq22	OPTICOACOUSTIC NERVE ATROPHY WITH DEMENTIA	1678
MIM311200	#	Xp22.3-p22.2	OROFACIODIGITAL SYNDROME I; OFD1	8481
MIM311240	*	Xp11.3-p11.23	TBC1 DOMAIN FAMILY, MEMBER 25; TBC1D25	4943
MIM311250	#	Xp21.1	ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO	5009
MIM311280	^	 	MOVED TO 300373	 
MIM311300	#	Xq28	OTOPALATODIGITAL SYNDROME, TYPE I; OPD1	2316
MIM311350		 	OUABAIN RESISTANCE; OUBR	 
MIM311360	#	Xq26-q28	PREMATURE OVARIAN FAILURE 1; POF1	2332
MIM311400		 	PAINE SYNDROME	4434
MIM311450		 	PALLISTER W SYNDROME	 
MIM311510	%	Xq28	PARKINSONISM, EARLY-ONSET, WITH MENTAL RETARDATION	7489
MIM311550	*	Xp11.3-p11.23	PCTAIRE PROTEIN KINASE 1; PCTK1	5127
MIM311601	^	 	MOVED TO 312080	 
MIM311750	^	 	MOVED TO 170650	 
MIM311770	*	Xp22.1	PHOSPHATIDYLINOSITOL GLYCAN, CLASS A; PIGA	5277
MIM311790	*	Xp11.21	6-@PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 1; PFKFB1	5207
MIM311800	*	Xq13	PHOSPHOGLYCERATE KINASE 1; PGK1	5230
MIM311850	*	Xq22-q24	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE I; PRPS1	5631
MIM311860	*	Xp22.3-p22.2	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE II; PRPS2	5634
MIM311870	*	Xq13	PHOSPHORYLASE KINASE, MUSCLE, ALPHA-1 SUBUNIT; PHKA1	5255
MIM311895		 	PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	 
MIM311900	#	Xp11.23-q13.3, Xp11.23	TARP SYNDROME; TARPS	8241
MIM312000	#	Xq27.2-q27.3, Xq26.3	PANHYPOPITUITARISM, X-LINKED; PHPX	6658
MIM312040	*	Xp22.3-p21.1	POLYMERASE, DNA, ALPHA-1; POLA1	5422
MIM312060	#	Xp11.4-p11.23	PROPERDIN DEFICIENCY, X-LINKED; CFPD	5199
MIM312070	*	Xq28	UBIQUITIN-LIKE 4A; UBL4A	8266
MIM312080	#	Xq22	PELIZAEUS-MERZBACHER DISEASE; PMD	5354
MIM312090	*	Xq28	SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY) MEMBER 3; SLC10A3	8273
MIM312095	*	Xp22.32	SPLICING FACTOR, ARGININE/SERINE-RICH, 17A; SFRS17A	8227
MIM312100		 	PSEUDOHERMAPHRODITISM, INCOMPLETE MALE, TYPE I	 
MIM312150	%	 	MULTIPLE PTERYGIUM SYNDROME, X-LINKED	 
MIM312170	#	Xp22.2-p22.1	PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	5160
MIM312173	*	Xq28	RIBOSOMAL PROTEIN L10; RPL10	6134
MIM312180	*	Xq24-q25	UBIQUITIN-CONJUGATING ENZYME E2A; UBE2A	7319
MIM312190		 	RADIAL APLASIA, X-LINKED	 
MIM312200		 	RADIAL LOOP, PLAIN, ON RIGHT INDEX FINGER	 
MIM312210		 	RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	 
MIM312300	#	Xq11-q12	ANDROGEN INSENSITIVITY, PARTIAL; PAIS	367
MIM312420	*	Xq28	RENIN-BINDING PROTEIN; RENBP	5973
MIM312450	^	 	MOVED TO 252010	 
MIM312500	%	 	RETICULOENDOTHELIOSIS, X-LINKED	 
MIM312530	^	 	RETINAL DETACHMENT	 
MIM312550		 	RETINAL DYSPLASIA, PRIMARY; PRD	5548
MIM312600	#	Xp11.23	RETINITIS PIGMENTOSA 2; RP2	6102
MIM312610	*	Xp11.4	RETINITIS PIGMENTOSA GTPase REGULATOR; RPGR	6103
MIM312612	%	Xp21.3-p21.2	RETINITIS PIGMENTOSA 6; RP6	6104
MIM312700	#	Xp22.2-p22.1	RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1	6247
MIM312750	#	Xq28	RETT SYNDROME; RTT	2290, 4204, 4208, 6792
MIM312760	*	Xq13.1	RIBOSOMAL PROTEIN S4, X-LINKED; RPS4X	6191
MIM312780		 	RUSSELL-SILVER SYNDROME, X-LINKED	 
MIM312800	^	 	MOVED TO 600145	 
MIM312820	*	Xp11.2	SARCOMA, SYNOVIAL, X BREAKPOINT 1; SSX1	6756
MIM312830		 	SCARF SYNDROME	 
MIM312840		 	SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	 
MIM312860	^	 	SCOTT CRANIODIGITAL SYNDROME WITH MENTAL RETARDATION	 
MIM312861	*	Xq24	5-@HYDROXYTRYPTAMINE RECEPTOR 2C; HTR2C	3358
MIM312863	#	Xq13	COMBINED IMMUNODEFICIENCY, X-LINKED; CIDX	3561
MIM312865	*	Xpter-p22.32	SHORT STATURE HOMEOBOX; SHOX	6473
MIM312870	#	Xq26	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1; SGBS1	2239, 2719
MIM312910		 	SPASTIC PARAPARESIS AND DEAFNESS	 
MIM312920	#	Xq22	SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	5354
MIM313000	%	Xp22.33	SPATIAL VISUALIZATION, APTITUDE FOR	59332
MIM313020	*	Xp22.1	SPERMIDINE/SPERMINE N(1)-ACETYLTRANSFERASE 1; SAT1	6303
MIM313200	#	Xq11-q12	SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1; SMAX1	367
MIM313350	%	Xq26	SPLIT-HAND/FOOT MALFORMATION 2; SHFM2	6463
MIM313400	#	Xp22.2-p22.1	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED; SEDT	6399
MIM313420	%	 	SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	 
MIM313430	*	Xq26.3	SRY-BOX 3; SOX3	6658
MIM313440	*	Xp11.4-p11.2	SYNAPSIN I; SYN1	6853
MIM313470	*	Xpter-p22.32	CD99 ANTIGEN, X CHROMOSOME; CD99	4267
MIM313475	*	Xp11.23-p11.22	SYNAPTOPHYSIN; SYP	6855
MIM313490		 	TAURODONTISM, MICRODONTIA, AND DENS INVAGINATUS	 
MIM313500	#	Xq12-q13.1	TOOTH AGENESIS, SELECTIVE, X-LINKED, 1; STHAGX1	1896
MIM313550	^	 	REMOVED FROM DATABASE	 
MIM313650	*	Xq13	TAF1 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 250-KD; TAF1	6872
MIM313700	*	Xq11-q12	ANDROGEN RECEPTOR; AR	367
MIM313850	%	Xq25-q26.1	THORACOABDOMINAL SYNDROME; THAS	7055
MIM313900	#	Xp11.23-p11.22	THROMBOCYTOPENIA 1; THC1	7454
MIM314050	#	Xp11.23	THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT	2623
MIM314100		 	THUMBS, CONGENITAL CLASPED	 
MIM314200	+	Xq22.2	THYROXINE-BINDING GLOBULIN OF SERUM; TBG	6906
MIM314240		 	TOOTH SIZE	 
MIM314250	#	Xq13	DYSTONIA 3, TORSION, X-LINKED; DYT3	6872
MIM314300	%	Xq28	TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	7085
MIM314310	*	Xp11.22	TRANSCRIPTION FACTOR FOR IMMUNOGLOBULIN HEAVY-CHAIN ENHANCER 3; TFE3	7030
MIM314320		 	TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	 
MIM314360		 	ULNAR HYPOPLASIA WITH LOBSTER-CLAW DEFORMITY OF FEET	 
MIM314370	*	Xp11.23	UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 1; UBA1	7317
MIM314375	*	Xp11.23-p11.22	SOLUTE CARRIER FAMILY 35 (UDP-GALACTOSE TRANSPORTER), MEMBER 2; SLC35A2	7355
MIM314380	%	 	UNIQUE GREEN PHENOMENON	 
MIM314390	#	 	VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	2187, 7547
MIM314400	#	Xq28	CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	2316
MIM314500	%	 	VAN DEN BOSCH SYNDROME	 
MIM314550		 	VESICOURETERAL REFLUX, X-LINKED; VURX	 
MIM314570		 	WIDOW'S PEAK SYNDROME	 
MIM314580	#	Xq13-q21	WIEACKER SYNDROME	7493
MIM314600	%	 	WILDERVANCK SYNDROME	 
MIM314670	*	Xq13.2	X INACTIVATION-SPECIFIC TRANSCRIPT; XIST	7503
MIM314690	*	Xp11.22-p11.21	LYSINE-SPECIFIC DEMETHYLASE 5C; KDM5C	8242
MIM314700		Xpter-p22.32	BLOOD GROUP, XG SYSTEM; XG	 
MIM314705	%	Xp22.32	XG REGULATOR; XGR	7501
MIM314850	*	Xp21.2-p21.1	KELL BLOOD GROUP PROTEIN, MCLEOD SYNDROME-ASSOCIATED; XK	7504
MIM314900	%	Xq28	XM SYSTEM	7506
MIM314980	*	Xp22.2-p21.3	ZINC FINGER PROTEIN, X-LINKED; ZFX	7543
MIM314990	*	Xq21.1-q21.3	ZINC FINGER PROTEIN 711; ZNF711	7552
MIM314993	*	Xp11.3	ZINC FINGER PROTEIN 21; ZNF21	7569
MIM314995	*	Xp22.1-cen	ZINC FINGER PROTEIN 41; ZNF41	7592
MIM314997	*	Xq26	ZINC FINGER PROTEIN 75D; ZNF75D	7626
MIM314998	*	Xp22.1-p11	ZINC FINGER PROTEIN 81; ZNF81	347344
MIM315000	^	 	ZONULAR CATARACT AND NYSTAGMUS	 
MIM400003	*	Yq11	DELETED IN AZOOSPERMIA; DAZ	1617
MIM400004	%	Chr.Y	RETINITIS PIGMENTOSA, Y-LINKED; RPY	79051
MIM400005	*	Yq11.2	UBIQUITIN-SPECIFIC PROTEASE 9, Y CHROMOSOME; USP9Y	8287
MIM400006	*	Yq11	RNA-BINDING MOTIF PROTEIN, Y CHROMOSOME, FAMILY 1, MEMBER A1; RBMY1A1	5940
MIM400008	*	Yp11.2	PROTEIN KINASE, Y-LINKED; PRKY	5616
MIM400009	*	Yq11	UBIQUITOUSLY TRANSCRIBED TETRATRICOPEPTIDE REPEAT GENE ON Y CHROMOSOME; UTY	7404
MIM400010	*	Yq11	DEAD/H BOX 3, Y-LINKED; DDX3Y	8653
MIM400011	*	Ypter-p11.2	ACETYLSEROTONIN METHYLTRANSFERASE-LIKE, Y-LINKED	8623
MIM400012	*	Yq11.221	VARIABLY CHARGED, Y CHROMOSOME; VCY	9084
MIM400013	*	Yq	BASIC PROTEIN, Y CHROMOSOME, 2; BPY2	9083
MIM400014	*	Yq11.223	EUKARYOTIC TRANSLATION INITIATION FACTOR 1A, Y-LINKED; EIF1AY	9086
MIM400015	*	Yq11.222	XK-RELATED PROTEIN ON Y CHROMOSOME	9082
MIM400016	*	Yq11.23	CHROMODOMAIN PROTEIN, Y CHROMOSOME, 1; CDY1	9085
MIM400017	*	Yq11.221	THYMOSIN, BETA-4, Y CHROMOSOME; TMSB4Y	9087
MIM400018	*	Yq11.221	CHROMODOMAIN PROTEIN, Y CHROMOSOME, 2; CDY2	9426
MIM400019	*	Yq11.223	PTPBL-RELATED GENE ON Y; PRY	9081
MIM400020	*	Ypter-p11.2	SHORT STATURE HOMEOBOX, Y-LINKED; SHOXY	6473
MIM400022	*	Yp11.2	PROTOCADHERIN 11, Y-LINKED; PCDH11Y	83259
MIM400023	*	Yp11.3	CYTOKINE RECEPTOR-LIKE FACTOR 2, Y-LINKED; CRLF2Y	64109
MIM400025	*	Yp11.2	TRANSFORMING GROWTH FACTOR-BETA-INDUCED FACTOR 2-LIKE, Y-LINKED; TGIF2LY	90655
MIM400026	*	Yq11.2	DELETED IN AZOOSPERMIA 2; DAZ2	57055
MIM400027	*	Yq11.2	DELETED IN AZOOSPERMIA 3; DAZ3	57054
MIM400028	*	Yq11.2	NEUROLIGIN 4, Y-LINKED; NLGN4Y	22829
MIM400029	*	Yq11.2	HEAT-SHOCK TRANSCRIPTION FACTOR, Y-LINKED; HSFY	86614
MIM400030	*	Yq11.2	RIBOSOMAL PROTEIN S4, Y-LINKED, 2; RPS4Y2	140032
MIM400031	*	Yq11.2	CHROMOSOME Y OPEN READING FRAME 15A; CYORF15A	246126
MIM400033	*	Yp11.2	TRANSDUCIN-BETA-LIKE 1, Y-LINKED; TBL1Y	90665
MIM400034	*	 	CHONDROITIN SULFATE PROTEOGLYCAN 4-LIKE, Y-LINKED; CSPG4LY	114758
MIM400035	*	 	GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 2-LIKE, Y-LINKED; GOLGA2LY	84559
MIM400036	*	 	TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 3; TTTY3	114760
MIM400037	*	 	TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 4; TTTY4	114761
MIM400038	*	 	TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 5; TTTY5	83863
MIM400039	*	 	TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 6; TTTY6	84672
MIM400040	*	 	TESTIS-SPECIFIC TRANSCRIPT, Y-LINKED, 17; TTTY17	252949
MIM400041	*	Yq11.2	PTPBL-RELATED GENE ON Y, 2; PRY2	442862
MIM400042	#	3q21	SPERMATOGENIC FAILURE, Y-LINKED, 1; SPGFY1	619469, 7707
MIM400043	%	Chr.Y	DEAFNESS, Y-LINKED 1; DFNY1	724074
MIM400044	#	Yp11.3	46,XY SEX REVERSAL 1; SRXY1	6736
MIM400045	#	Yp11.3	46,XX SEX REVERSAL 1; SRXX1	6736
MIM402500	*	Ypter-p11.2	ACETYLSEROTONIN METHYLTRANSFERASE, Y-CHROMOSOMAL; ASMT	438
MIM403000	*	Yp	ADENINE NUCLEOTIDE TRANSLOCATOR 3, Y-CHROMOSOMAL; ANT3Y	293
MIM410000	*	Yp11	AMELOGENIN, Y-CHROMOSOMAL; AMELY	266
MIM415000	#	Yq11.2	SPERMATOGENIC FAILURE, Y-LINKED, 2; SPGFY2	140032, 1617, 442862, 560, 57054, 57055, 5940, 8284, 8287, 8653, 86614, 9081, 9082, 9083, 9084, 9085, 9426
MIM424500	%	 	GONADOBLASTOMA; GBY	 
MIM425000	*	Yp11	GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR, ALPHA SUBUNIT, Y-CHROMOSOMAL; CSF2RY	1438
MIM425500		Yq	HAIRY EARS, Y-LINKED	100188776
MIM426000	*	Yq11	LYSINE-SPECIFIC DEMETHYLASE 5D; KDM5D	8284
MIM430000	*	Yp11.3	INTERLEUKIN 3 RECEPTOR, Y-CHROMOSOMAL; IL3RA	3563
MIM450000	*	Ypter-p11.2	CD99 ANTIGEN, Y CHROMOSOME	4267
MIM465000	*	Ypter-p11.2	SPLICING FACTOR, ARGININE/SERINE RICH, 17A; SFRS17A	8227
MIM470000	*	Yp11.3	RIBOSOMAL PROTEIN S4, Y-LINKED, 1; RPS4Y1	6192
MIM475000	%	Yq12	GROWTH CONTROL, Y-CHROMOSOME INFLUENCED; GCY	2656
MIM480000	*	Yp11.3	SEX-DETERMINING REGION Y; SRY	6736
MIM480100	*	Ypter-p11.2	TESTIS-SPECIFIC PROTEIN, Y-LINKED, 1; TSPY1	7258
MIM489500	*	Yp11	XG REGULATOR; XGR	7501
MIM490000	*	Yp11.3	ZINC FINGER PROTEIN, Y-LINKED; ZFY	7544
MIM500000	#	 	CARDIOMYOPATHY, INFANTILE HISTIOCYTOID	 
MIM500001	#	 	LEBER OPTIC ATROPHY AND DYSTONIA	 
MIM500002	#	 	MITOCHONDRIAL MYOPATHY WITH DIABETES	 
MIM500003	#	 	STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	 
MIM500004	#	 	RETINITIS PIGMENTOSA-DEAFNESS SYNDROME	 
MIM502000	#	 	AGING	 
MIM510000	^	 	REMOVED FROM DATABASE	 
MIM515000	#	 	CHLORAMPHENICOL TOXICITY	 
MIM520000	#	 	DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED	 
MIM520100	#	 	DIARRHEA, CHRONIC, WITH VILLOUS ATROPHY	 
MIM530000	#	 	KEARNS-SAYRE SYNDROME; KSS	 
MIM535000	#	 	LEBER OPTIC ATROPHY	 
MIM540000	#	 	MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	 
MIM545000	#	 	MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS; MERRF	 
MIM550000	^	 	MOVED TO 157640	 
MIM550500	#	 	MYOGLOBINURIA, RECURRENT	 
MIM551000	#	 	MITOCHONDRIAL MYOPATHY, LETHAL, INFANTILE; LIMM	 
MIM551200	#	 	NEPHROPATHY, CHRONIC TUBULOINTERSTITIAL	 
MIM551500	#	 	NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	 
MIM553000	#	 	ONCOCYTOMA	 
MIM556500	#	 	PARKINSON DISEASE, MITOCHONDRIAL	 
MIM557000	#	 	PEARSON MARROW-PANCREAS SYNDROME	 
MIM560000	#	 	RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	 
MIM580000	#	22q13	DEAFNESS, AMINOGLYCOSIDE-INDUCED	55687
MIM598500	#	 	WOLFRAM SYNDROME, MITOCHONDRIAL FORM	 
MIM600000		 	SPONDYLOCAMPTODACTYLY	 
MIM600001	#	 	PANCREATIC AGENESIS AND CONGENITAL HEART DEFECTS; PACHD	2627
MIM600002	#	3p22-p21.1	EIKEN SKELETAL DYSPLASIA	5745
MIM600003	*	10p12	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-2 SUBUNIT; CACNB2	783
MIM600004	*	4q13	EPHRIN RECEPTOR EphA5; EPHA5	2044
MIM600005	*	16p13	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, TRANSACTIVATOR; MHC2TA	4261
MIM600006	*	19p13.1	REGULATORY FACTOR X, 1; RFX1	5989
MIM600007	*	 	FMS-RELATED TYROSINE KINASE 3 LIGAND; FLT3LG	2323
MIM600008	*	11q23.1	NICOTINAMIDE N-METHYLTRANSFERASE; NNMT	4837
MIM600009	*	14q32	INTERFERON-ALPHA-INDUCIBLE PROTEIN 27; IFI27	3429
MIM600010	*	20p11.2	INSULINOMA-ASSOCIATED 1; INSM1	3642
MIM600011	*	7q22	EPHRIN RECEPTOR EphB4; EPHB4	2050
MIM600012	*	14q24.3	UBIQUITIN-CONJUGATING ENZYME E2L 1; UBE2L1	283556
MIM600013	*	14q	TRANSCRIPTION FACTOR YY1; YY1	7528
MIM600014	*	9p24-p23	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 2; SMARCA2	6595
MIM600016	*	12q11-q12	CONTACTIN 1; CNTN1	1272
MIM600017	*	20q12-q13	SYNDECAN 4; SDC4	6385
MIM600018	*	6q24-q25	OPIOID RECEPTOR, MU-1; OPRM1	4988
MIM600019	*	17q11-qter	CYTOCHROME b561; CYB561	1534
MIM600020	*	10q25	MAX-INTERACTING PROTEIN 1; MXI1	4601
MIM600021	*	2p13	MAX DIMERIZATION PROTEIN 1; MXD1	4084
MIM600022	*	19q13.3	PROSTAGLANDIN I2 RECEPTOR; PTGIR	5739
MIM600023	*	16q21-q22.1	CADHERIN 11; CDH11	1009
MIM600024	*	1q42.1	LAMIN B RECEPTOR; LBR	3930
MIM600025	*	14q32.3	KINESIN LIGHT CHAIN 1; KLC1	3831
MIM600026	*	8q23-q24	SYNTROPHIN, BETA-1; SNTB1	6641
MIM600027	*	16q22-q23	SYNTROPHIN, BETA-2; SNTB2	6645
MIM600028	*	7q22	DISTAL-LESS HOMEOBOX 5; DLX5	1749
MIM600029	*	2q32	DISTAL-LESS HOMEOBOX 1; DLX1	1745
MIM600030	*	7q22	DISTAL-LESS HOMEOBOX 6; DLX6	1750
MIM600031	*	1q31-q32	CHITINASE 1; CHIT1	1118
MIM600033	*	7q22	TISSUE FACTOR PATHWAY INHIBITOR 2; TFPI2	7980
MIM600034	*	2p14-p13	EMPTY SPIRACLES, DROSOPHILA, HOMOLOG OF, 1; EMX1	2016
MIM600035	*	10q26.1	EMPTY SPIRACLES, DROSOPHILA, 2, HOMOLOG OF; EMX2	2018
MIM600036	*	2p13	ORTHODENTICLE, DROSOPHILA, HOMOLOG OF, 1; OTX1	5013
MIM600037	*	14q21-q22	ORTHODENTICLE, DROSOPHILA, HOMOLOG OF, 2; OTX2	5015
MIM600038	*	19p13.3	MEGAKARYOCTYE-ASSOCIATED TYROSINE KINASE; MATK	4145
MIM600039	*	20q11.21	BCL2-LIKE 1; BCL2L1	598
MIM600040	*	19q13.3-q13.4	BCL2-ASSOCIATED X PROTEIN; BAX	581
MIM600041	*	11q13.5	PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 2; P2RY2	5029
MIM600042	*	18p11.2	MELANOCORTIN 5 RECEPTOR; MC5R	4161
MIM600043	*	4q13.1	SULFOTRANSFERASE, ESTROGEN-PREFERRING; STE	6783
MIM600044	*	3q26.3-q27	THROMBOPOIETIN; THPO	7066
MIM600045	*	11q12-q13	DNA DAMAGE-BINDING PROTEIN 1; DDB1	1642
MIM600046	+	9q22-q31	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 1; ABCA1	19
MIM600047	*	9q34	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 2; ABCA2	20
MIM600048	%	11q23	BREAST CANCER, 11-22 TRANSLOCATION-ASSOCIATED; BRCATA	8068
MIM600049	*	3q26	MDS1 GENE; MDS1	 
MIM600050	*	11q13.1-q13.3	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 11; MAP3K11	4296
MIM600051	*	1p32	EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 15; EPS15	2060
MIM600052	*	11q12	ANGIOTENSIN RECEPTOR-LIKE 1; AGTRL1	187
MIM600053	*	2q11	CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-3; CNGA3	1261
MIM600057	%	 	EXSTROPHY OF BLADDER	 
MIM600058	*	4p12	PROTEIN TYROSINE KINASE TXK; TXK	7294
MIM600059	#	17p13.3	RETINITIS PIGMENTOSA 13; RP13	10594
MIM600060	#	11q13.5	DEAFNESS, AUTOSOMAL RECESSIVE 2; DFNB2	4647
MIM600061	*	19p13.2	RAD23, YEAST, HOMOLOG OF, A; RAD23A	5886
MIM600062	*	Chr.9	RAD23, YEAST, HOMOLOG OF, B; RAD23B	5887
MIM600063	*	1q31	TROVE DOMAIN FAMILY, MEMBER 2; TROVE2	6738
MIM600064	*	21q22.11	KERATIN-ASSOCIATED PROTEIN 11-1; KRTAP11-1	337880
MIM600065	*	21q22.3	INTEGRIN, BETA-2; ITGB2	3689
MIM600066	*	 	EPHRIN RECEPTOR EphA6; EPHA6	285220
MIM600067	*	4q13	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B4; UGT2B4	7363
MIM600068	*	4q13	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B7; UGT2B7	7364
MIM600069	*	4q13	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B15; UGT2B15	7366
MIM600070	*	 	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B10; UGT2B10	7365
MIM600072	#	20pter-p12	FATAL FAMILIAL INSOMNIA; FFI	5621
MIM600073	*	2q24-q31	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 2; LRP2	4036
MIM600074	*	6q21	CD24 ANTIGEN; CD24	100133941
MIM600075	*	6q27	TATA BOX-BINDING PROTEIN; TBP	6908
MIM600076	*	2q35-q36	TENSIN 1; TNS1	7145
MIM600079	*	7q11.23	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 12; PTPN12	5782
MIM600080		 	MYELOCYTIC LEUKEMIA-LIKE SYNDROME, FAMILIAL, CHRONIC	 
MIM600081	#	11p15.2	VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B; VDDR1B	120227
MIM600082	%	 	PROSTATIC HYPERPLASIA, BENIGN; BPH	 
MIM600084		 	MACROCYTOSIS, FAMILIAL	 
MIM600085	*	9q22	PROTEIN-TYROSINE KINASE SYK; SYK	6850
MIM600086	*	4q23-q24	ALCOHOL DEHYDROGENASE 7; ADH7	131
MIM600087	*	1q21	TUFTELIN; TUFT1	7286
MIM600089		6p21.3	PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS	7962
MIM600092		 	CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	 
MIM600093		 	SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	 
MIM600095	^	 	MOVED TO 246560	 
MIM600096		 	PUERTO RICAN INFANT HYPOTONIA SYNDROME	 
MIM600098	*	11pter-p15.5	RELATED RAS VIRAL ONCOGENE HOMOLOG 2; RRAS2	22800
MIM600101	#	1p34	DEAFNESS, AUTOSOMAL DOMINANT 2A; DFNA2A	9132
MIM600103	*	18q12.3	SYNAPTOTAGMIN 4; SYT4	6860
MIM600104	*	1q	SYNAPTOTAGMIN 2; SYT2	127833
MIM600105	#	1q31-q32.1	RETINITIS PIGMENTOSA 12; RP12	23418
MIM600106	*	10q26.3	INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 40-KD; INPP5A	3632
MIM600108	*	11q22.3	MATRIX METALLOPROTEINASE 13; MMP13	4322
MIM600110	#	6q14	STARGARDT DISEASE 3; STGD3	6785
MIM600111	*	5p13	SOLUTE CARRIER FAMILY 1 (GLIAL HIGH AFFINITY GLUTAMATE TRANSPORTER), MEMBER 3; SLC1A3	6507
MIM600112	*	14q32	DYNEIN, CYTOPLASMIC 1, HEAVY CHAIN 1; DYNC1H1	1778
MIM600114	*	1q23	CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 3; CCT3	7203
MIM600116	#	6q25.2-q27	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2	5071
MIM600117		 	DYSPHASIA, FAMILIAL DEVELOPMENTAL	 
MIM600118	#	2q21.3	WARBURG MICRO SYNDROME 1; WARBM1	22930, 22931, 25782
MIM600119	*	17q12-q21.33	SARCOGLYCAN, ALPHA; SGCA	6442
MIM600121	#	2q31	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3; RCDP3	8540
MIM600122		 	MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	 
MIM600123		 	ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL AND RADIAL DEFECTS	 
MIM600124	*	7p15	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2/B1; HNRNPA2B1	3181
MIM600126	*	19p13.2	PHOSPHODIESTERASE 4A, cAMP-SPECIFIC; PDE4A	5141
MIM600127	*	1p31	PHOSPHODIESTERASE 4B, cAMP-SPECIFIC; PDE4B	5142
MIM600128	*	19p13.1	PHOSPHODIESTERASE 4C, cAMP-SPECIFIC; PDE4C	5143
MIM600129	*	5q12	PHOSPHODIESTERASE 4D, cAMP-SPECIFIC; PDE4D	5144
MIM600130	*	12p13.1	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE 1; APOBEC1	339
MIM600131	%	8q24	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	50966
MIM600132	#	6p21.3	RETINITIS PIGMENTOSA 14; RP14	7287
MIM600133	*	6q21	LAMININ, ALPHA-4; LAMA4	3910
MIM600135	*	19p13.2	CORTEXIN 1; CTXN1	404217
MIM600136	*	14q24.3-q31	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9; MAP3K9	4293
MIM600137	*	19q13.1-q13.2	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 10; MAP3K10	4294
MIM600138	#	19q13.4	RETINITIS PIGMENTOSA 11; RP11	26121
MIM600139	^	 	SUBEPENDYMOMA	 
MIM600140	*	16p13.3	CREB-BINDING PROTEIN; CREBBP	1387
MIM600141	*	2q33.1	HEAT-SHOCK 10-KD PROTEIN; HSPE1	3336
MIM600142	#	 	CEREBRAL AUTOSOMAL RECESSIVE ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	5654
MIM600143	#	8p23	CEROID LIPOFUSCINOSIS, NEURONAL, 8; CLN8	2055
MIM600144	*	12p11	INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 2; ITPR2	3709
MIM600145	#	1p13	SACRAL DEFECT WITH ANTERIOR MENINGOCELE	81839
MIM600146		 	SPASTIC PARAPLEGIA 5B, AUTOSOMAL RECESSIVE; SPG5B	6685
MIM600147	*	17q21	MESENCHYME HOMEOBOX 1; MEOX1	4222
MIM600148		 	GLYCEROL KINASE, TESTICULAR, TYPE A	2712
MIM600149		 	GLYCEROL KINASE, TESTICULAR, TYPE B	2713
MIM600150	*	10q22.3	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, ALPHA MEMBER 1; KCNMA1	3778
MIM600151	#	 	MOVED TO 209900	 
MIM600152	*	3p25-p24	SEC13-LIKE PROTEIN 1; SEC13L1	6396
MIM600153	*	2p21-p16	PHOSPHATIDYLINOSITOL GLYCAN, CLASS F; PIGF	5281
MIM600154	*	14q11-q24	PHOSPHATIDYLINOSITOL GLYCAN, CLASS H; PIGH	5283
MIM600155	#	13q22	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2; HSCR2	1910
MIM600156	%	9q31	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 5; HSCR5	404720
MIM600157	*	22q12	ADAPTOR-RELATED PROTEIN COMPLEX 1, BETA-1 SUBUNIT; AP1B1	162
MIM600159		 	PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	 
MIM600160	*	9p21	CYCLIN-DEPENDENT KINASE INHIBITOR 2A; CDKN2A	1029
MIM600161	*	15q11-q13	PRADER-WILLI/ANGELMAN REGION TRANSCRIPT 1	145624
MIM600162	*	15q11-q13	PRADER-WILLI/ANGELMAN REGION TRANSCRIPT 5	8123
MIM600163	*	3p21	SODIUM CHANNEL, VOLTAGE-GATED, TYPE V, ALPHA SUBUNIT; SCN5A	6331
MIM600164	*	8q13-q21	GTP-BINDING MITOGEN-INDUCED T-CELL PROTEIN; GEM	2669
MIM600165	%	11p	NANOPHTHALMOS 1; NNO1	23691
MIM600166		 	HYPERPARATHYROIDISM, PRIMARY, CAUSED BY WATER CLEAR CELL HYPERPLASIA	 
MIM600167	*	3p21-p14	HISTAMINE RECEPTOR H1; HRH1	3269
MIM600168	*	3p21.3	MACROPHAGE STIMULATING 1 RECEPTOR; MST1R	4486
MIM600169	*	6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I CHAIN-RELATED GENE A; MICA	100507436
MIM600170	*	9p13	AQUAPORIN 3; AQP3	360
MIM600171		 	GONADAL AGENESIS	 
MIM600172	*	1p33	METAL-REGULATORY TRANSCRIPTION FACTOR 1; MTF1	4520
MIM600173	*	19p13.1	JANUS KINASE 3; JAK3	3718
MIM600174	*	17p13.3	PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, ALPHA; PITPNA	5306
MIM600175	#	12q23-q24	SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE	59341, 8094
MIM600176	%	19q13.12	PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS	 
MIM600178	*	15q13-qter	MICROTUBULE-ASSOCIATED PROTEIN 1A; MAP1A	4130
MIM600179	*	17p13.1	GUANYLATE CYCLASE 2D, MEMBRANE; GUCY2D	3000
MIM600181	*	9q34	LIPOCALIN 2; LCN2	3934
MIM600182	*	16q24.3	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 5; SLC7A5	8140
MIM600183	*	17q21	DUAL-SPECIFICITY PHOSPHATASE 3; DUSP3	1845
MIM600184	*	9q34.1	CARNITINE ACETYLTRANSFERASE; CRAT	1384
MIM600185	*	13q12.3	BRCA2 GENE; BRCA2	675
MIM600187	*	17p13-p12	EUKARYOTIC TRANSLATION INITIATION FACTOR 5A; EIF5A	1984
MIM600188	*	19p13.3	AMINO-TERMINAL ENHANCER OF SPLIT; AES	166
MIM600189	*	9q21.3	TRANSDUCIN-LIKE ENHANCER OF SPLIT 1; TLE1	7088
MIM600190	*	15q22	TRANSDUCIN-LIKE ENHANCER OF SPLIT 3; TLE3	7090
MIM600192	*	18q11.2	SYNOVIAL SARCOMA TRANSLOCATION, CHROMOSOME 18; SS18	6760
MIM600193	%	1p21-p13.3	WAARDENBURG SYNDROME, TYPE 2B; WS2B	7488
MIM600194	*	12q11-q13	KERATIN 2; KRT2	3849
MIM600195	#	9p21	VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL; VMCM	7010
MIM600197	*	7p22	V-MAF AVIAN MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE FAMILY, PROTEIN K; MAFK	7975
MIM600201	*	20q11.2	AGOUTI SIGNALING PROTEIN; ASIP	434
MIM600202	%	6p22.2	DYSLEXIA, SUSCEPTIBILITY TO, 2; DYX2	9856
MIM600204	#	1p33-p32.2	EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2	1298
MIM600206	*	12p12.3	EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 8; EPS8	2059
MIM600207	*	2p25.1	HIPPOCALCIN-LIKE 1; HPCAL1	3241
MIM600208	#	22q11.2	MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	4627
MIM600209	%	19p	EXOSTOSES, MULTIPLE, TYPE III; EXT3	2133
MIM600210	*	1p36	RUNT-RELATED TRANSCRIPTION FACTOR 3; RUNX3	864
MIM600211	*	6p21	RUNT-RELATED TRANSCRIPTION FACTOR 2; RUNX2	860
MIM600212	*	17q25	FATTY ACID SYNTHASE; FASN	2194
MIM600214	*	6p21.3	ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; AGER	177
MIM600215	*	15q15-q12	MICROFIBRILLAR-ASSOCIATED PROTEIN 1; MFAP1	4236
MIM600220	*	16q24.1	PHOSPHOLIPASE C, GAMMA-2; PLCG2	5336
MIM600221	*	9p21	TEK TYROSINE KINASE, ENDOTHELIAL; TEK	7010
MIM600222	*	1p34-p33	TYROSINE KINASE WITH IMMUNOGLOBULIN AND EGF FACTOR HOMOLOGY DOMAINS 1; TIE1	7075
MIM600223	%	16q22.1	SPINOCEREBELLAR ATAXIA 4; SCA4	 
MIM600224	#	11q13	SPINOCEREBELLAR ATAXIA 5; SCA5	6712
MIM600225	*	14q22.1-q22.2	GTP CYCLOHYDROLASE I; GCH1	2643
MIM600227	*	16p13.3	CYCLIN F; CCNF	899
MIM600228	*	12p13	SODIUM CHANNEL, NONVOLTAGE-GATED 1, ALPHA SUBUNIT; SCNN1A	6337
MIM600229	*	2p14	SOLUTE CARRIER FAMILY 1 (GLUTAMATE/NEUTRAL AMINO ACID TRANSPORTER), MEMBER 4; SLC1A4	6509
MIM600230	*	11q13	PHOSPHOLIPASE C, BETA-3; PLCB3	5331
MIM600231	#	12q11-q13	PALMOPLANTAR KERATODERMA, BOTHNIAN TYPE; PPKB	8084
MIM600232	*	5q34-q35	GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-2; GABRB2	2561
MIM600233	*	15q11.2-q12	GAMMA-AMINOBUTYRIC ACID RECEPTOR, GAMMA-3; GABRG3	2567
MIM600234	*	1p13-p12	3-@HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 2; HMGCS2	3158
MIM600235	*	19q13.1	SODIUM CHANNEL, VOLTAGE-GATED, TYPE I, BETA SUBUNIT; SCN1B	6324
MIM600236	*	1q32-q41	CENTROMERIC PROTEIN F; CENPF	1063
MIM600237	*	22q11	HISTONE CELL CYCLE REGULATION DEFECTIVE, S. CEREVISIAE, HOMOLOG OF, A; HIRA	7290
MIM600238	*	20q12	TRANSGLUTAMINASE 3; TGM3	7053
MIM600239	*	2q33.3	G PROTEIN-COUPLED RECEPTOR 1; GPR1	2825
MIM600240	*	17q21.1-q21.3	G PROTEIN-COUPLED RECEPTOR 2; GPR2	2826
MIM600241	*	1p36.1-p34.3	G PROTEIN-COUPLED RECEPTOR 3; GPR3	2827
MIM600242	*	17q12-q21.2	CHEMOKINE, CC MOTIF, RECEPTOR 7; CCR7	1236
MIM600243	*	14q11-q12	DEFENDER AGAINST CELL DEATH 1; DAD1	1603
MIM600244	*	2q37.3	PROGRAMMED CELL DEATH 1; PDCD1	5133
MIM600245	*	1q32.1	FIBROMODULIN; FMOD	2331
MIM600246	*	1q32	ELK4, ETS-DOMAIN PROTEIN; ELK4	2005
MIM600247	*	12q23	ELK3, ETS-DOMAIN PROTEIN; ELK3	2004
MIM600249	*	3q21.3	ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER L1; ALDH1L1	10840
MIM600250	*	1q23	CHEMOKINE, C MOTIF, LIGAND 1; XCL1	6375
MIM600251	#	 	FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	23384
MIM600252		 	LOWRY-MACLEAN SYNDROME	 
MIM600253	*	7p15	ARYL HYDROCARBON RECEPTOR; AHR	196
MIM600256	^	 	HYDROCEPHALUS, AUTOSOMAL DOMINANT	 
MIM600257	#	 	CHROMOSOME 8q12.1-q21.2 DELETION SYNDROME	100885787
MIM600258	*	2q31-q33	POSTMEIOTIC SEGREGATION INCREASED, S. CEREVISIAE, 1; PMS1	5378
MIM600259	*	7p22	POSTMEIOTIC SEGREGATION INCREASED, S. CEREVISIAE, 2; PMS2	5395
MIM600262	*	1q25.2-q25.3	PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2; PTGS2	5743
MIM600263	#	7q31.3, 6q23-q24	HELICOBACTER PYLORI INFECTION, SUSCEPTIBILITY TO	3459, 5803
MIM600264	*	1q32	ARGININE VASOPRESSIN RECEPTOR 1B; AVPR1B	553
MIM600266	*	2q35	SOLUTE CARRIER FAMILY 11 (PROTON-COUPLED DIVALENT METAL ION TRANSPORTER), MEMBER 1; SLC11A1	6556
MIM600267	*	4q21.3	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 13; PTPN13	5783
MIM600268	%	 	APLASIA CUTIS CONGENITA WITH EPIBULBAR DERMOIDS	 
MIM600269		 	SHORT TARSUS WITH ABSENCE OF LOWER EYELASHES; STALE	 
MIM600270	*	7q21.3-q22	PROCOLLAGEN C-ENDOPEPTIDASE ENHANCER; PCOLCE	5118
MIM600271	*	18q12.1	DESMOCOLLIN 3; DSC3	1825
MIM600272	*	17q22-q23	COILIN; COIL	8161
MIM600273	#	16p13.3	POLYCYSTIC KIDNEY DISEASE, INFANTILE SEVERE, WITH TUBEROUS SCLEROSIS; PKDTS	8132
MIM600274	#	17q21.1, 14q24.3	FRONTOTEMPORAL DEMENTIA; FTD	4137, 5663
MIM600275	*	1p13-p11	NOTCH, DROSOPHILA, HOMOLOG OF, 2; NOTCH2	4853
MIM600276	*	19p13.2-p13.1	NOTCH, DROSOPHILA, HOMOLOG OF, 3; NOTCH3	4854
MIM600277	*	1p36.13-p36.12	INHIBITOR OF DNA BINDING 3; ID3	3399
MIM600278	*	1p36.1-p35	RAP1, GTPase-ACTIVATING PROTEIN 1; RAP1GA1	5909
MIM600279	*	1q22	PEROXISOME BIOGENESIS FACTOR 19; PEX19	5824
MIM600280	*	16p13.1	NUCLEOTIDE-BINDING PROTEIN 1; NUBP1	4682
MIM600281	*	20q12-q13.1	HEPATOCYTE NUCLEAR FACTOR 4-ALPHA; HNF4A	3172
MIM600282	*	11q22.3	GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 4; GRIK4	2900
MIM600283	*	19q13.2	GLUTAMATE RECEPTOR, IONOTROPIC, KAINATE 5; GRIK5	2901
MIM600284	*	19p13.1	ELONGATION FACTOR RNA POLYMERASE II; ELL	8178
MIM600285	*	5q31.1	EUKARYOTIC TRANSLATION TERMINATION FACTOR 1; ETF1	2107
MIM600286	*	22q11.21	PHOSPHATIDYLINOSITOL 4-KINASE, CATALYTIC, ALPHA; PI4KA	5297
MIM600287	*	7p15	GLYCYL-tRNA SYNTHETASE; GARS	2617
MIM600288	*	20p11	FORKHEAD BOX A2; FOXA2	3170
MIM600289	*	6p21.3-p21.2	MITOGEN-ACTIVATED PROTEIN KINASE 14; MAPK14	1432
MIM600291	*	2p24-p22	ADENYLATE CYCLASE 3; ADCY3	109
MIM600292	*	14q11.2	ADENYLATE CYCLASE 4; ADCY4	196883
MIM600293	*	3q13.2-q21	ADENYLATE CYCLASE 5; ADCY5	111
MIM600294	*	12q12-q13	ADENYLATE CYCLASE 6; ADCY6	112
MIM600295	*	1p36.2	NATRIURETIC PEPTIDE PRECURSOR B; NPPB	4879
MIM600296	*	2q24-qter	NATRIURETIC PEPTIDE PRECURSOR C; NPPC	4880
MIM600297	*	13q12.3	CAUDAL-TYPE HOMEOBOX TRANSCRIPTION FACTOR 2; CDX2	1045
MIM600298	*	1q22-q23	LIM HOMEOBOX TRANSCRIPTION FACTOR 1, ALPHA; LMX1A	4009
MIM600299	*	8p22-p21.3	PERICENTRIOLAR MATERIAL 1; PCM1	5108
MIM600300	*	11p13-p12	SOLUTE CARRIER FAMILY 1 (GLIAL HIGH AFFINITY GLUTAMATE TRANSPORTER), MEMBER 2; SLC1A2	6506
MIM600301	*	10q25-q26	ACYL-CoA DEHYDROGENASE, SHORT/BRANCHED CHAIN; ACADSB	36
MIM600302		 	FRYNS MACROCEPHALY	 
MIM600303	*	9q34.3	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; RAPGEF1	2889
MIM600305	*	16p13.3	DODECENOYL-CoA DELTA ISOMERASE; DCI	1632
MIM600306	*	14q11.2	PROTEASOME SUBUNIT, BETA-TYPE, 5; PSMB5	5693
MIM600307	*	 	PROTEASOME SUBUNIT, BETA-TYPE, 6; PSMB6	5694
MIM600308	*	18q11.2-q12.1	AQUAPORIN 4; AQP4	361
MIM600309	#	1p31-p21, 6q21-q23.2	ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3	2697
MIM600310	*	19p13.1	CARTILAGE OLIGOMERIC MATRIX PROTEIN; COMP	1311
MIM600311	*	19p13.3	GRANZYME M; GZMM	3004
MIM600312	*	7p22	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 1; NUDT1	4521
MIM600314	*	9p12-p11	SHB ADAPTOR PROTEIN; SHB	6461
MIM600315	*	1p36	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 4; TNFRSF4	7293
MIM600316	#	17p11.2	DEAFNESS, AUTOSOMAL RECESSIVE 3; DFNB3	51168
MIM600317	*	19p13.1	TROPOMYOSIN 4; TPM4	7171
MIM600318	%	15q26	DIABETES MELLITUS, INSULIN-DEPENDENT, 3; IDDM3	3402
MIM600319	%	11q13	DIABETES MELLITUS, INSULIN-DEPENDENT, 4; IDDM4	3403
MIM600320	#	6q25	DIABETES MELLITUS, INSULIN-DEPENDENT, 5; IDDM5	387082
MIM600321	%	2q31	DIABETES MELLITUS, INSULIN-DEPENDENT, 7; IDDM7	3406
MIM600322	*	20p11.2	SYNAPTOSOMAL-ASSOCIATED PROTEIN, 25-KD; SNAP25	6616
MIM600323	*	1q31	REGULATOR OF G PROTEIN SIGNALING 1; RGS1	5996
MIM600324	*	4q12-q13	CHEMOKINE, CXC MOTIF, LIGAND 5; CXCL5	6374
MIM600325	%	 	AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA	 
MIM600326	*	11q23.3	DEAD/H BOX 6; DDX6	1656
MIM600327	*	19q	SYNAPTOTAGMIN 3; SYT3	84258
MIM600328	*	17q21	MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 6; MLLT6	4302
MIM600329		 	OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	 
MIM600330	^	 	MOVED TO 102500	 
MIM600331		 	PARC SYNDROME	 
MIM600332	%	1q41	RIPPLING MUSCLE DISEASE 1; RMD1	6022
MIM600334	#	2q31	TIBIAL MUSCULAR DYSTROPHY, TARDIVE	7273
MIM600335		 	SUCCINIC ACIDEMIA	 
MIM600336	*	10q11.2	SOLUTE CARRIER FAMILY 18 (VESICULAR ACETYLCHOLINE), MEMBER 3; SLC18A3	6572
MIM600337	*	14q32.1-q32.2	BRADYKININ RECEPTOR B1; BDKRB1	623
MIM600338	*	3q21.3-q25.2	ARYLACETAMIDE DEACETYLASE; AADAC	13
MIM600339	*	1q21	HEPATOMA-DERIVED GROWTH FACTOR; HDGF	3068
MIM600340	*	16q13	PLASMA MEMBRANE PROTEOLIPID; PLLP	51090
MIM600341	*	15q15.1-q21.1	TYRO3 PROTEIN TYROSINE KINASE; TYRO3	7301
MIM600342	*	10q23	G PROTEIN-COUPLED RECEPTOR, RETINAL; RGR	5995
MIM600345	*	4q13-q21	BETACELLULIN; BTC	685
MIM600346	*	17q12	POLYCOMB GROUP RING FINGER PROTEIN 2; PCGF2	7703
MIM600347		 	BREVICAN	63827
MIM600348		 	BAND HETEROTOPIA OF BRAIN	 
MIM600349	*	20q11	INHIBITOR OF DNA BINDING 1; ID1	3397
MIM600351		 	ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	 
MIM600353	*	1q21	S100 CALCIUM-BINDING PROTEIN A7; S100A7	6278
MIM600354	*	5q12.2-q13.3	SURVIVAL OF MOTOR NEURON 1; SMN1	6606
MIM600355	*	5q12.2-q13.3	NEURONAL APOPTOSIS INHIBITORY PROTEIN; NAIP	4671
MIM600356		 	PACHYDERMODACTYLY, FAMILIAL	 
MIM600357	*	1p34.1-p32	RIBOSOMAL PROTEIN S8; RPS8	6202
MIM600358	*	3q24	GUANINE MONOPHOSPHATE SYNTHETASE; GMPS	8833
MIM600359	*	11q24	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 1; KCNJ1	3758
MIM600360	%	 	APLASIA CUTIS CONGENITA OF LIMBS, AUTOSOMAL RECESSIVE	 
MIM600361	%	 	HEREDITARY MOTOR AND SENSORY NEUROPATHY V	101059903
MIM600362	*	17p11.2	FLIGHTLESS I, DROSOPHILA, HOMOLOG OF; FLII	2314
MIM600363	#	15q11.1	SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT; SPG6	123606
MIM600364	*	6p21.1	GUANYLATE CYCLASE ACTIVATOR 1A; GUCA1A	2978
MIM600365	*	17p13.3	ACTIVE BCR-RELATED GENE; ABR	29
MIM600366	*	5q	ISL LIM HOMEOBOX 1; ISL1	3670
MIM600367	*	 	CLEAVAGE STIMULATION FACTOR, 3-PRIME PRE-RNA, SUBUNIT 3, 77-KD; CSTF3	1479
MIM600368	^	 	CLEAVAGE STIMULATION FACTOR, 3-PRIME PRE-RNA, SUBUNIT 2, 64-KD; CSTF2	1478
MIM600369	*	 	CLEAVAGE STIMULATION FACTOR, 3-PRIME PRE-RNA, SUBUNIT 1, 50-KD; CSTF1	1477
MIM600370	*	12q23	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 3; SLC25A3	5250
MIM600372	*	12q22	NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 1; NEDD1	121441
MIM600373		 	CODAS SYNDROME	 
MIM600374	*	15q22.3-q23	BBS4 GENE; BBS4	585
MIM600375	*	7q36.1	X-RAY REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 2; XRCC2	7516
MIM600376	#	12q11-q14	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	94
MIM600377	*	18q23	GALANIN RECEPTOR 1; GALR1	2587
MIM600378	*	2p11.2	INNER MEMBRANE PROTEIN, MITOCHONDRIAL; IMMT	10989
MIM600379	*	20q13.3	MYELIN TRANSCRIPTION FACTOR 1; MYT1	4661
MIM600380	*	19q13.3	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 2; NR1H2	7376
MIM600381	*	14q22	KINECTIN; KTN1	3895
MIM600382	*	 	MYC PROMOTER-BINDING PROTEIN	10260
MIM600383	#	8q13	MESOMELIA-SYNOSTOSES SYNDROME	100526741
MIM600384	%	 	APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSAL IV	 
MIM600385	*	16q12-q13	ADENYLATE CYCLASE 7; ADCY7	113
MIM600386	*	2p25	INHIBITOR OF DNA BINDING 2; ID2	3398
MIM600387	*	4p15.32	BONE MARROW STROMAL CELL ANTIGEN 1; BST1	683
MIM600388	*	6p21.2-p21.1	MEPRIN, ALPHA SUBUNIT; MEP1A	4224
MIM600389	*	18q12.2-q12.3	MEPRIN, BETA SUBUNIT; MEP1B	4225
MIM600390	*	19q13	UPSTREAM STIMULATORY FACTOR 2; USF2	7392
MIM600391	*	9q13	GLUCOSAMINYL (N-ACETYL) TRANSFERASE 1, CORE 2; GCNT1	2650
MIM600392	*	12p13-p12.2	RAD52, YEAST, HOMOLOG OF; RAD52	5893
MIM600393	*	11q12	FLAP STRUCTURE-SPECIFIC ENDONUCLEASE 1; FEN1	2237
MIM600395	*	2q35-q37	GLYPICAN 1; GPC1	2817
MIM600396	*	17q21.31	DEAH BOX POLYPEPTIDE 8; DHX8	1659
MIM600397	*	20q13.2	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAB-RELATED SUBFAMILY, MEMBER 1; KCNB1	3745
MIM600398	*	19q13.3-q13.4	ZINC FINGER PROTEIN 160; ZNF160	90338
MIM600399	%	 	PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	 
MIM600400	*	6q22	PROLYL ENDOPEPTIDASE; PREP	5550
MIM600403	*	2q23	FIBROBLAST ACTIVATION PROTEIN, ALPHA; FAP	2191
MIM600404	*	7q11.23	REPLICATION FACTOR C, SUBUNIT 2; RFC2	5982
MIM600405	*	13q12.3-q13	REPLICATION FACTOR C, SUBUNIT 3; RFC3	5983
MIM600407	*	12q24.2-q24.3	REPLICATION FACTOR C, SUBUNIT 5; RFC5	5985
MIM600408	*	6p21.3	DISCOIDIN DOMAIN RECEPTOR FAMILY, MEMBER 1; DDR1	780
MIM600409	*	6p21.2-p21.1	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-DELTA; PPARD	5467
MIM600410	*	2q23.3	TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 6; TNFAIP6	7130
MIM600411	*	1p22.2	GUANYLATE-BINDING PROTEIN 1, INTERFERON-INDUCIBLE, 67-KD; GBP1	2633
MIM600412	*	1p22.2	GUANYLATE-BINDING PROTEIN 2, INTERFERON-INDUCIBLE; GBP2	2634
MIM600413	*	1p22.2	GUANYLATE-BINDING PROTEIN 3; GBP3	2635
MIM600414	*	12p13.3	PEROXISOME BIOGENESIS FACTOR 5; PEX5	5830
MIM600415	*	8q13.1-q13.3	TOCOPHEROL TRANSFER PROTEIN, ALPHA; TTPA	7274
MIM600416		 	MUSCULAR DYSTROPHY, SCAPULOHUMERAL	 
MIM600417	*	10q24.3	5-PRIME-@NUCLEOTIDASE, CYTOSOLIC II; NT5C2	22978
MIM600418	*	7p14-p13	AMPHIPHYSIN; AMPH	273
MIM600419		 	ANGIOKERATOMA CORPORIS DIFFUSUM WITH ARTERIOVENOUS FISTULAS	 
MIM600421	*	4q33-q34	GLYCINE RECEPTOR, ALPHA-3 SUBUNIT; GLRA3	8001
MIM600422	*	5q23-q35	FATTY ACID-BINDING PROTEIN 6; FABP6	2172
MIM600423	*	1p36.1	ENDOTHELIN-CONVERTING ENZYME 1; ECE1	1889
MIM600424	*	21q22.3	SOLUTE CARRIER FAMILY 19 (FOLATE TRANSPORTER), MEMBER 1; SLC19A1	6573
MIM600426	*	1p36	E2F TRANSCRIPTION FACTOR 2; E2F2	1870
MIM600427	*	6p22	E2F TRANSCRIPTION FACTOR 3; E2F3	1871
MIM600428	*	9q34	VAV2 ONCOGENE; VAV2	7410
MIM600429	*	6p24-p23	GLUCOSAMINYL (N-ACETYL) TRANSFERASE 2, I-BRANCHING ENZYME; GCNT2	2651
MIM600430	#	2q37.2	BRACHYDACTYLY-MENTAL RETARDATION SYNDROME; BDMR	626, 9759
MIM600431	*	9p21	CYCLIN-DEPENDENT KINASE INHIBITOR 2B; CDKN2B	1030
MIM600432	*	16q12.1	PRECEREBELLIN 1; CBLN1	869
MIM600433	*	18q23	PRECEREBELLIN 2; CBLN2	147381
MIM600434	*	8q21	FATTY ACID-BINDING PROTEIN 4; FABP4	2167
MIM600435	*	16p11.2-p11.1	CARDIOTROPHIN 1; CTF1	1489
MIM600436	*	22q11.2	GLUTATHIONE S-TRANSFERASE, THETA-1; GSTT1	2952
MIM600437	*	22q11.2	GLUTATHIONE S-TRANSFERASE, THETA-2; GSTT2	2953
MIM600438	*	10q21	TRANSCRIPTION FACTOR A, MITOCHONDRIAL; TFAM	7019
MIM600439	*	7q34	SINGLE-STRANDED DNA-BINDING PROTEIN 1; SSBP1	6742
MIM600440	*	9q34.1	ENDONUCLEASE G, MITOCHONDRIAL; ENDOG	2021
MIM600441	*	13q34	GROWTH ARREST-SPECIFIC 6; GAS6	2621
MIM600442	*	12q13	AQUAPORIN 5; AQP5	362
MIM600443	*	5q14	GLUTAREDOXIN; GLRX	2745
MIM600444	*	21q22	SOLUTE CARRIER FAMILY 5 (INOSITOL TRANSPORTER), MEMBER 3; SLC5A3	6526
MIM600445	*	1p21-p13	ADENOSINE A3 RECEPTOR; ADORA3	140
MIM600446	*	17p12-p11.2	ADENOSINE A2B RECEPTOR; ADORA2B	136
MIM600447	*	12q13	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 12; MAP3K12	7786
MIM600448	*	10p15	PROTEIN KINASE C, THETA; PRKCQ	5588
MIM600449	*	10p15-p14	ALDO-KETO REDUCTASE FAMILY 1, MEMBER 1; AKR1C1	1645
MIM600450	*	10p15-p14	ALDO-KETO REDUCTASE FAMILY 1, MEMBER C2; AKR1C2	1646
MIM600451	*	10p15-p14	ALDO-KETO REDUCTASE FAMILY 1, MEMBER C4; AKR1C4	1109
MIM600453	*	17q23.1	TRIPARTITE MOTIF-CONTAINING PROTEIN 25; TRIM25	7706
MIM600454	*	11q13.3-q13.5	RIBOSOMAL PROTEIN S3; RPS3	6188
MIM600455	*	11q13.3-q13.5	RNA, U15A SMALL NUCLEOLAR; RNU15A	6079
MIM600456	*	9q22.1	NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 2; NTRK2	4915
MIM600457		 	HYPERTRICHOSIS, ANTERIOR CERVICAL	 
MIM600458		 	ADENOMYOSIS	 
MIM600459		 	ARTERIAL DISSECTION WITH LENTIGINOSIS	 
MIM600460		 	CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY	 
MIM600461		 	HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	 
MIM600462	#	12q24.33	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	80324
MIM600463	*	15q26	ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER A3; ALDH1A3	220
MIM600464	*	 	ADP-RIBOSYLATION FACTOR 6; ARF6	382
MIM600465	*	10q21	ANKYRIN 3; ANK3	288
MIM600466	*	Chr.11	ALDEHYDE DEHYDROGENASE 3 FAMILY, MEMBER B1; ALDH3B1	221
MIM600467	%	3q13.1	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	4265
MIM600469	*	9q22.3-q31	NUCLEAR CAP-BINDING PROTEIN 1; NCBP1	4686
MIM600470	*	3q24	ZINC FINGER PROTEIN OF CEREBELLUM 1; ZIC1	7545
MIM600471	*	8p23.1	DEFENSIN, ALPHA, 6; DEFA6	1671
MIM600472	*	8p23.1	DEFENSIN, ALPHA, 5; DEFA5	1670
MIM600473	*	5q31	PURINE-RICH ELEMENT-BINDING PROTEIN A; PURA	5813
MIM600474	*	3p21.3	CATHELICIDIN ANTIMICROBIAL PEPTIDE; CAMP	820
MIM600475	*	11p15.3	TAF10 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 30-KD; TAF10	6881
MIM600477	*	16q22.1	SOLUTE CARRIER FAMILY 9, MEMBER 5; SLC9A5	6553
MIM600478	*	6p21	SUPERKILLER VIRALICIDIC ACTIVITY 2, S. CEREVISIAE, HOMOLOG-LIKE; SKIV2L	6499
MIM600480	*	15q21	TRANSCRIPTION FACTOR 12; TCF12	6938
MIM600481	*	22q13	STEROL REGULATORY ELEMENT-BINDING TRANSCRIPTION FACTOR 2; SREBF2	6721
MIM600483	*	10q24	FIBROBLAST GROWTH FACTOR 8; FGF8	2253
MIM600487	*	19p13.3	PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 4; PCSK4	54760
MIM600488	*	9q21.3	PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 5; PCSK5	5125
MIM600489	*	18q23	NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 1; NFATC1	4772
MIM600490	*	20q13.2-q13.3	NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 2; NFATC2	4773
MIM600491	*	5q32-q33.3	MICROFIBRILLAR-ASSOCIATED PROTEIN 3; MFAP3	4238
MIM600492	*	2q31	NUCLEAR FACTOR ERYTHROID 2-LIKE 2; NFE2L2	4780
MIM600493	*	19p13.3	EGF-LIKE MODULE-CONTAINING, MUCIN-LIKE HORMONE RECEPTOR 1; EMR1	2015
MIM600494	*	6q16	POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 2; POU3F2	5454
MIM600495	*	3q27	EUKARYOTIC TRANSLATION INITIATION FACTOR 4-GAMMA, 1; EIF4G1	1981
MIM600496	#	12q24.2	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3; MODY3	6927
MIM600497	*	1p31	PROTEIN KINASE, AMP-ACTIVATED, CATALYTIC, ALPHA-2; PRKAA2	5563
MIM600501	#	13q22	ABCD SYNDROME; ABCDS	1910
MIM600502	*	11q13.2-q13.4	IMMUNOGLOBULIN MU-BINDING PROTEIN 2; IGHMBP2	3508
MIM600503	*	 	SUB1, S. CEREVISIAE, HOMOLOG OF; SUB1	10923
MIM600504	*	22q13.1	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 4; KCNJ4	3761
MIM600505	*	5q32	CASEIN KINASE I, ALPHA-1; CSNK1A1	1452
MIM600508	*	3q21	NCK ADAPTOR PROTEIN 1; NCK1	4690
MIM600509	*	11p15.1	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 8; ABCC8	6833
MIM600510	%	7q35-q36	GLAUCOMA-RELATED PIGMENT DISPERSION SYNDROME; GPDS1	7986
MIM600511	%	6p23	SCHIZOPHRENIA 3; SCZD3	6365
MIM600512	#	10q24	EPILEPSY, FAMILIAL TEMPORAL LOBE, 1; ETL1	9211
MIM600513	#	20q13.2-q13.3	EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	1137
MIM600514	*	7q22	REELIN; RELN	5649
MIM600515	*	3q24-q25	PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 12; P2RY12	64805
MIM600516	*	6p21.3-p21.2	BCL2 ANTAGONIST KILLER 1; BAK1	578
MIM600517	*	18q21.3	SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 3; SERPINB3	6317
MIM600518	*	18q21.3	SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 4; SERPINB4	6318
MIM600519	*	 	GENERAL TRANSCRIPTION FACTOR IIA, GAMMA SUBUNIT; GTF2A2	2958
MIM600520	*	 	GENERAL TRANSCRIPTION FACTOR IIA, ALPHA/BETA SUBUNITS; GTF2A1	2957
MIM600521	*	3q27-q28	MANNAN-BINDING LECTIN SERINE PROTEASE 1; MASP1	5648
MIM600522	+	1q25	PHOSPHOLIPASE A2, GROUP IVA; PLA2G4A	5321
MIM600523	*	12q13	SOLUTE CARRIER FAMILY 11 (PROTON-COUPLED DIVALENT METAL ION TRANSPORTER), MEMBER 2; SLC11A2	4891
MIM600524	*	 	RYK RECEPTOR-LIKE TYROSINE KINASE; RYK	6259
MIM600525	*	17q21.3-q22	DISTAL-LESS HOMEOBOX 3; DLX3	1747
MIM600526	*	11q12-q13	MAP/MICROTUBULE AFFINITY-REGULATING KINASE 2; MARK2	2011
MIM600527	*	13q33	EPHRIN B2; EFNB2	1948
MIM600528	*	11q13	CARNITINE PALMITOYLTRANSFERASE I, LIVER; CPT1A	1374
MIM600529	*	Chr.9	AU-SPECIFIC RNA-BINDING PROTEIN; AUH	549
MIM600530	*	2q11.2	SOLUTE CARRIER FAMILY 9, MEMBER 2; SLC9A2	6549
MIM600531	*	2q12.1	SOLUTE CARRIER FAMILY 9, MEMBER 4; SLC9A4	389015
MIM600532	*	18p11.31-p11.2	NADH-UBIQUINONE OXIDOREDUCTASE FLAVOPROTEIN 2; NDUFV2	4729
MIM600533	*	1q21-q23	VANG-LIKE 2; VANGL2	57216
MIM600534	*	19p13.2	BONE MARROW STROMAL CELL ANTIGEN 2; BST2	684
MIM600535	*	7p22.1-p21.3	MESENCHYME HOMEOBOX 2; MEOX2	4223
MIM600536	*	12q13	INTEGRIN, ALPHA-7; ITGA7	3679
MIM600537	*	12p12-p11	RECQ PROTEIN-LIKE; RECQL	5965
MIM600538	*	 	PEROXIREDOXIN 2; PRDX2	7001
MIM600539	*	3p25-q27	PROTEIN KINASE C, IOTA FORM; PRKCI	5584
MIM600540	*	7p15	TRANSCRIPTION FACTOR Sp4; SP4	6671
MIM600541	*	7p22	ETS VARIANT GENE 1; ETV1	2115
MIM600542	*	9q22	NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 3; NR4A3	8013
MIM600543	*	2q33.3-q34	V-ERB-B2 AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 4; ERBB4	2066
MIM600544	*	13q33-q34	SOLUTE CARRIER FAMILY 15 (OLIGOPEPTIDE TRANSPORTER), MEMBER 1; SLC15A1	6564
MIM600547	*	9q34.11	CYSTEINE CONJUGATE BETA-LYASE 1; CCBL1	883
MIM600548	*	5q31.1	HEAT-SHOCK 70-KD PROTEIN 9; HSPA9	3313
MIM600549	*	5q22-q23	IK CYTOKINE, DOWNREGULATOR OF HLA II; IK	3550
MIM600550	*	 	CATHEPSIN O; CTSO	1519
MIM600551	*	19q13.2-q13.3	G PROTEIN-COUPLED RECEPTOR 4; GPR4	2828
MIM600552	*	3p21.3-p21.1	CHEMOKINE, C MOTIF, RECEPTOR 1; XCR1	2829
MIM600553	*	6q21-q22.1	G PROTEIN-COUPLED RECEPTOR 6; GPR6	2830
MIM600554	*	4q31	INTERLEUKIN 15; IL15	3600
MIM600555	*	2q32.2-q32.3	SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1; STAT1	6772
MIM600556	*	12q13.2	SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 2; STAT2	6773
MIM600558	*	2q32.2-q32.3	SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 4; STAT4	6775
MIM600559		 	HYDROCEPHALUS, ENDOCARDIAL FIBROELASTOSIS, AND CATARACTS	 
MIM600560	*	1q21	SHC TRANSFORMING PROTEIN; SHC1	6464
MIM600561		 	SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	 
MIM600562	*	5p14-p13	CADHERIN 12; CDH12	1010
MIM600563	*	1p31.1	PROSTAGLANDIN F RECEPTOR; PTGFR	5737
MIM600564	*	3p21.2-p14.1	INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 4; ITIH4	3700
MIM600565	*	2p16.3	NEUREXIN I; NRXN1	9378
MIM600566	*	11q13	NEUREXIN II; NRXN2	9379
MIM600567	*	14q24.3-q31.1	NEUREXIN III; NRXN3	9369
MIM600568	*	3q26.3	NEUROLIGIN 1; NLGN1	22871
MIM600570	*	3q26	CHLORIDE CHANNEL 2; CLCN2	1181
MIM600571	*	4q12	RE1-SILENCING TRANSCRIPTION FACTOR; REST	5978
MIM600572	*	2p22-p21	SPLICING FACTOR, SERINE/ARGININE-RICH, 7; SRSF7	6432
MIM600573	*	5q31	TAF7 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 55-KD; TAF7	6879
MIM600574	*	22q11.1-q11.2	LEUCINE ZIPPER-LIKE TRANSCRIPTIONAL REGULATOR 1; LZTR1	8216
MIM600575	*	2q21.1	TRANSLIN; TSN	7247
MIM600576	*	8p23.1-p22	GATA-BINDING PROTEIN 4; GATA4	2626
MIM600577	*	9q34.3	LIM HOMEOBOX GENE 3; LHX3	8022
MIM600578	*	6p21.3	OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY H, MEMBER 3; OR2H3	7932
MIM600579	*	12p13-p12	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, O; PTPRO	5800
MIM600580	*	4q33	CHLORIDE CHANNEL 3; CLCN3	1182
MIM600581	*	6p22-p21.3	INHIBITOR OF DNA BINDING 4; ID4	3400
MIM600582	*	8q12.1	ASPARTATE BETA-HYDROXYLASE; ASPH	444
MIM600583	*	4p12	TEC PROTEIN TYROSINE KINASE; TEC	7006
MIM600584	*	5q34	NK2 HOMEOBOX 5; NKX2-5	1482
MIM600585	*	3p22-p21.33	TRANSGLUTAMINASE 4; TGM4	7047
MIM600586	*	3q26.1-q26.2	EPITHELIAL CELL TRANSFORMING SEQUENCE 2 ONCOGENE; ECT2	1894
MIM600587	*	7q11.2	POM121/ZP3 FUSION PROTEIN; POMZP3	22932
MIM600588	^	 	MOVED TO 188025	 
MIM600589	*	 	SERUM RESPONSE FACTOR; SRF	6722
MIM600590	*	2p23	PROTEIN PHOSPHATASE 1, CATALYTIC SUBUNIT, BETA ISOFORM; PPP1CB	5500
MIM600591	*	 	SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 1; SNAPC1	6617
MIM600592	*	7q21.3-q22.1	MINICHROMOSOME MAINTENANCE, S. CEREVISIAE, HOMOLOG OF, 7; MCM7	4176
MIM600593	%	4p16	CRANIOSYNOSTOSIS, ADELAIDE TYPE; CRSA	7885
MIM600594	*	22q11.2	DIGEORGE SYNDROME CRITICAL REGION GENE 2; DGCR2	9993
MIM600595	*	13q12.1	INTRAFLAGELLAR TRANSPORT 88, CHLAMYDOMONAS, HOMOLOG OF; IFT88	8100
MIM600596	*	17p11.2	MICROFIBRILLAR-ASSOCIATED PROTEIN 4; MFAP4	4239
MIM600597	*	2q33	PHOSPHOLIPASE C-LIKE 1; PLCL1	5334
MIM600598		 	SETTING-SUN PHENOMENON, FAMILIAL BENIGN	 
MIM600599	*	19p13.13-p13.12	KRUPPEL-LIKE FACTOR 1; KLF1	10661
MIM600600	*	3q21-q23	EPHRIN RECEPTOR EphB1; EPHB1	2047
MIM600605	*	1q21	METAXIN 1; MTX1	4580
MIM600607	*	1q21	VACUOLAR PROTEIN SORTING 72, YEAST, HOMOLOG OF; VPS72	6944
MIM600608	*	5q31	PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE-4-DIOXYGENASE, ALPHA SUBUNIT, ISOFORM 2; P4HA2	8974
MIM600609	*	21q21-q22.1	GA-BINDING PROTEIN TRANSCRIPTION FACTOR, ALPHA SUBUNIT; GABPA	2551
MIM600610	*	15q21.2	GA-BINDING PROTEIN TRANSCRIPTION FACTOR, BETA SUBUNIT; GABPB	2553
MIM600611	*	 	FK506-BINDING PROTEIN 4; FKBP4	2288
MIM600613	*	1p36.13-p36.11	NEUROBLASTOMA CANDIDATE REGION, SUPPRESSION OF TUMORIGENICITY 1; NBL1	4681
MIM600614	*	4p16	S100 CALCIUM-BINDING PROTEIN P; S100P	6286
MIM600615	*	19q13.2	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 7; LGALS7	3963
MIM600616	*	12q21.3-q22	LUMICAN; LUM	4060
MIM600617	*	8p11.2	STEROIDOGENIC ACUTE REGULATORY PROTEIN; STAR	6770
MIM600618	*	12p13	ETS VARIANT GENE 6; ETV6	2120
MIM600620	*	2p23.3	FK506-BINDING PROTEIN 1B; FKBP1B	2281
MIM600621	*	Chr.8	STATHMIN-LIKE 2; STMN2	11075
MIM600623	*	11p11.2	CD82 ANTIGEN; CD82	3732
MIM600624	%	18q21.1-q21.3	CONE-ROD DYSTROPHY 1; CORD1	1319
MIM600625	#	14q22-q23	OROFACIAL CLEFT 11; OFC11	652
MIM600626	*	17q25	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 3 BINDING PROTEIN; LGALS3BP	3959
MIM600627		 	HYPERTRYPTOPHANEMIA, FAMILIAL	 
MIM600628		 	LOOSE ANAGEN HAIR SYNDROME	 
MIM600629	*	6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DO BETA; HLA-DOB	3112
MIM600630	#	10q11	UV-SENSITIVE SYNDROME 1; UVSS1	2074
MIM600631	%	13q13-q14.3	ENURESIS, NOCTURNAL, 1; ENUR1	2031
MIM600632	*	11q25	OPIOID-BINDING PROTEIN/CELL ADHESION MOLECULE-LIKE; OPCML	4978
MIM600633	*	21q22.3	TREFOIL FACTOR 3; TFF3	7033
MIM600634	#	11q13.3	PITUITARY ADENOMA, PROLACTIN-SECRETING	9049
MIM600635	*	14q13	NK2 HOMEOBOX 1; NKX2-1	7080
MIM600636	*	4q35	CASPASE 3, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP3	836
MIM600637	*	 	SOLUTE CARRIER FAMILY 1 (HIGH AFFINITY ASPARTATE/GLUTAMATE TRANSPORTER), MEMBER 6; SLC1A6	6511
MIM600638	#	16q24.3, 16q24.2-q24.3	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT; CFEOM3A	10381
MIM600639	*	7q35	CASPASE 2, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP2	835
MIM600641	*	16p11.2	SULFOTRANSFERASE FAMILY 1A, PHENOL-PREFERRING, MEMBER 3; SULT1A3	6818
MIM600642	*	6p21.3	MINOR HISTOCOMPATIBILITY ANTIGEN HA-2	7921
MIM600644	*	11q23-q24	POLIOVIRUS RECEPTOR-LIKE 1; PVRL1	5818
MIM600646	*	20q11.2	PROTEIN C RECEPTOR; PROCR	10544
MIM600647	*	10q25.2-q26.3	H6 FAMILY HOMEOBOX 2; HMX2	3167
MIM600648	^	 	MOVED TO 113800	 
MIM600649	#	1p32	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	1376
MIM600650	*	1p32	CARNITINE PALMITOYLTRANSFERASE II; CPT2	1376
MIM600651	#	 	FRAGILE SITE 11B; FRA11B	 
MIM600652	#	19q13.33	DEAFNESS, AUTOSOMAL DOMINANT 4A; DFNA4A	79784
MIM600654	*	14q11.2	PROTEASOME ACTIVATOR SUBUNIT 1; PSME1	5720
MIM600655	*	2q33-q34	EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, BETA-2; EEF1B2	1933
MIM600658	*	19q13.3	PROTEIN PHOSPHATASE 5, CATALYTIC SUBUNIT; PPP5C	5536
MIM600659	*	16q22.1	E2F TRANSCRIPTION FACTOR 4; E2F4	1874
MIM600660	*	15q26	MADS BOX TRANSCRIPTION ENHANCER FACTOR 2, POLYPEPTIDE A; MEF2A	4205
MIM600661	*	19p12	MADS BOX TRANSCRIPTION ENHANCER FACTOR 2, POLYPEPTIDE B; MEF2B	100271849
MIM600662	*	5q14	MADS BOX TRANSCRIPTION ENHANCER FACTOR 2, POLYPEPTIDE C; MEF2C	4208
MIM600663	*	1q12-q23	MADS BOX TRANSCRIPTION ENHANCER FACTOR 2, POLYPEPTIDE D; MEF2D	4209
MIM600664	*	10q24	CONSERVED HELIX-LOOP-HELIX UBIQUITOUS KINASE; CHUK	1147
MIM600665	*	4q35.1	MELATONIN RECEPTOR 1A; MTNR1A	4543
MIM600666		 	POLYCYSTIC KIDNEY DISEASE 3, AUTOSOMAL DOMINANT; PKD3	5312
MIM600667	*	17q21.1	FRIZZLED, DROSOPHILA, HOMOLOG OF, 2; FZD2	2535
MIM600668	%	8q	CHONDROCALCINOSIS 1; CCAL1	882
MIM600669	%	8q24, 18q21	EPILEPSY, IDIOPATHIC GENERALIZED; EIG	1957, 4200
MIM600670		 	VARICELLA, SEVERE RECURRENT	 
MIM600673	*	17q21.3	UPSTREAM BINDING TRANSCRIPTION FACTOR (RNA POLYMERASE I); UBTF	7343
MIM600674	%	 	MICROTIA-ANOTIA	 
MIM600675	*	14q32.3	X-RAY REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 3; XRCC3	7517
MIM600676	*	7q32	CATR TUMORIGENIC CONVERSION 1; CATR1	856
MIM600678	*	2p16	MutS, E. COLI, HOMOLOG OF, 6; MSH6	2956
MIM600679		 	DERMOID CYSTS, FAMILIAL FRONTONASAL	 
MIM600680	^	 	MOVED TO 256730	 
MIM600681	*	17q23.1-q24.2	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 2; KCNJ2	3759
MIM600682	*	1p13.2-p12	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 1; SLC16A1	6566
MIM600684	*	1q21.3-q22	T-LYMPHOCYTE SURFACE ANTIGEN LY-9; LY9	4063
MIM600685	*	17q23-q24	KARYOPHERIN ALPHA-2; KPNA2	3838
MIM600686	*	3q21	KARYOPHERIN ALPHA-1; KPNA1	3836
MIM600687	*	21q22.1	T-CELL LYMPHOMA INVASION AND METASTASIS 1; TIAM1	7074
MIM600688	*	7q32	CARBOXYPEPTIDASE A2, PANCREATIC; CPA2	1358
MIM600690	*	3p21	T-CELL LEUKEMIA TRANSLOCATION-ASSOCIATED GENE; TCTA	6988
MIM600691	*	19p13.1	SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 1; SLC27A1	376497
MIM600692	*	11p15.5	TROPONIN T3, FAST SKELETAL; TNNT3	7140
MIM600693	*	19p13.3	POLYPYRIMIDINE TRACT-BINDING PROTEIN 1; PTBP1	5725
MIM600694	*	5q11	INTERLEUKIN 6 SIGNAL TRANSDUCER; IL6ST	3572
MIM600696	*	19q13	ENOYL-CoA HYDRATASE, PEROXISOMAL; ECH1	1891
MIM600697	*	1q32	RETINOBLASTOMA-BINDING PROTEIN 5; RBBP5	5929
MIM600698	*	12q14.3	HIGH MOBILITY GROUP AT-HOOK 2; HMGA2	8091
MIM600700	*	3q28	LIM DOMAIN-CONTAINING PREFERRED TRANSLOCATION PARTNER IN LIPOMA; LPP	4026
MIM600701	*	6p21	HIGH MOBILITY GROUP AT-HOOK 1; HMGA1	3159
MIM600702	*	12q13	SODIUM CHANNEL, VOLTAGE-GATED, TYPE VIII, ALPHA SUBUNIT; SCN8A	6334
MIM600705		 	SATOYOSHI SYNDROME	 
MIM600706		 	PROXIMAL MYOPATHY WITH FOCAL DEPLETION OF MITOCHONDRIA	 
MIM600707	*	 	SIGNAL RECOGNITION PARTICLE, 9-KD; SRP9	6726
MIM600708	*	15q22	SIGNAL RECOGNITION PARTICLE, 14-KD; SRP14	6727
MIM600709	*	9q21	ISOLEUCYL-tRNA SYNTHETASE; IARS	3376
MIM600711	*	17q21	ETS VARIANT GENE 4; ETV4	2118
MIM600712	*	9q21.32-q21.33	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; HNRNPK	3190
MIM600713	*	1q32-q41	11-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE I; HSD11B1	3290
MIM600714	*	5q34	DUAL-SPECIFICITY PHOSPHATASE 1; DUSP1	1843
MIM600715	*	 	THROMBOSPONDIN IV; THBS4	7060
MIM600716	*	1p13	PROTEIN TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 22; PTPN22	26191
MIM600719	*	17p13.1-q25	NITRIC OXIDE SYNTHASE 2B; NOS2B	201288
MIM600720	*	17p13.1-q25	NITRIC OXIDE SYNTHASE 2C; NOS2C	645740
MIM600721	#	2q37.3	D-2-@HYDROXYGLUTARIC ACIDURIA 1	728294
MIM600722	*	1p32	PALMITOYL-PROTEIN THIOESTERASE 1; PPT1	5538
MIM600723	*	17q12-q21	MEMBRANE PROTEIN, PALMITOYLATED 2; MPP2	4355
MIM600724	*	16q13	CYCLIC NUCLEOTIDE-GATED CHANNEL, BETA-1; CNGB1	1258
MIM600725	*	7q36	SONIC HEDGEHOG; SHH	6469
MIM600726	*	2q33-q35	INDIAN HEDGEHOG; IHH	3549
MIM600727	*	1p31.3-p31.2	NUCLEAR FACTOR I/A; NFIA	4774
MIM600728	*	9p24.1	NUCLEAR FACTOR I/B; NFIB	4781
MIM600729	*	19p13.3	NUCLEAR FACTOR I/C; NFIC	4782
MIM600730	*	8q11.23	NEUROPEPTIDES B AND W RECEPTOR 1; NPBWR1	2831
MIM600731	*	20q13.3	G PROTEIN-COUPLED RECEPTOR 8; GPR8	2832
MIM600732	*	17q12-q21	ADP-RIBOSYLATION FACTOR-LIKE 4D; ARL4D	379
MIM600733	*	13q12.1	PANCREAS/DUODENUM HOMEOBOX PROTEIN 1; PDX1	3651
MIM600734	*	11q24	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 5; KCNJ5	3762
MIM600735	*	17q21	INTERFERON-INDUCED PROTEIN 35; IFI35	3430
MIM600736		 	VELOFACIOSKELETAL SYNDROME	 
MIM600737	#	9p13.3	INCLUSION BODY MYOPATHY 2, AUTOSOMAL RECESSIVE; IBM2	10020
MIM600738	*	12q24	SELECTIN P LIGAND; SELPLG	6404
MIM600739	*	17q21-q22	SHC-LIKE PROTEIN; SHCL1	6466
MIM600740	#	19q13	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III; HHC3	9151
MIM600742	*	1p33-p32	TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE III; TGFBR3	7049
MIM600743	*	16p13	TRANSCRIPTION FACTOR AP4; TFAP4	7023
MIM600744	*	6p21	T-CELL TRANSCRIPTION FACTOR EB; TFEB	7942
MIM600745	*	19q13.2	APOLIPOPROTEIN C-IV; APOC4	346
MIM600746	*	5q31-q33	CAUDAL-TYPE HOMEOBOX TRANSCRIPTION FACTOR 1; CDX1	1044
MIM600747	*	17q23	T-BOX 2; TBX2	6909
MIM600748	*	12q12-q13	TESTIS-ENHANCED GENE TRANSCRIPT; TEGT	7009
MIM600749	*	14q11.2	CCAAT/ENHANCER-BINDING PROTEIN, EPSILON; CEBPE	1053
MIM600750	*	7q21.3-q22.1	PENTRAXIN II, NEURONAL; NPTX2	4885
MIM600751	*	20p13	SIALOADHESIN; SN	6614
MIM600752	*	13q12	G PROTEIN-COUPLED RECEPTOR 12; GPR12	2835
MIM600753	*	16q22-q23	GOLGI APPARATUS PROTEIN 1; GLG1	2734
MIM600754	*	14q11-q12	MATRIX METALLOPROTEINASE 14; MMP14	4323
MIM600755	*	3p25	SYNAPSIN II; SYN2	6854
MIM600756	*	9q34	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B-PRIME; PPP2R4	5524
MIM600757	%	19q13	OROFACIAL CLEFT 3; OFC3	4965
MIM600758	*	8q24-qter	PROTEIN-TYROSINE KINASE, CYTOPLASMIC; PTK2	5747
MIM600759	*	1q31-q42	PRESENILIN 2; PSEN2	5664
MIM600760	*	16p13-p12	SODIUM CHANNEL, NONVOLTAGE-GATED 1, BETA SUBUNIT; SCNN1B	6338
MIM600761	*	16p13-p12	SODIUM CHANNEL, NONVOLTAGE-GATED 1, GAMMA SUBUNIT; SCNN1G	6340
MIM600762	*	7p14-p13	HUMAN PAPILLOMAVIRUS E5 CENTRAL SEQUENCE-LIKE 1; HPVC1	3262
MIM600763	*	13q12-q14	TUMOR PROTEIN, TRANSLATIONALLY-CONTROLLED 1; TPT1	7178
MIM600764	*	1q25.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I-RELATED; MR1	3140
MIM600767	*	10p15	GDP-DISSOCIATION INHIBITOR 2; GDI2	2665
MIM600768	*	 	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 9; PTPN9	5780
MIM600769	*	12q14.1-q21.1	TETRASPANIN 8; TSPAN8	7103
MIM600770	*	11p15	MUCIN 5, SUBTYPE B, TRACHEOBRONCHIAL; MUC5B	727897
MIM600771	%	 	DWARFISM, FAMILIAL, WITH MUSCLE SPASMS	 
MIM600772	*	6p21.31	TAF11 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 28-KD; TAF11	6882
MIM600773	*	1p35.3	TAF12 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 20-KD; TAF12	6883
MIM600774	*	 	TAF13 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 18-KD; TAF13	6884
MIM600775	#	 	LAMBDOID SYNOSTOSIS	 
MIM600776		 	FRYNS MICROPHTHALMIA SYNDROME	 
MIM600777	*	 	TRANSCRIPTION TERMINATION FACTOR, RNA POLYMERASE I; TTF1	7270
MIM600778	*	12p13	CYCLIN-DEPENDENT KINASE INHIBITOR 1B; CDKN1B	1027
MIM600781	+	17q21	PEPTIDE YY; PYY	5697
MIM600782	*	19q13.42	SYNAPTOTAGMIN 5; SYT5	6861
MIM600783	*	5q31.3	HISTIDYL-tRNA SYNTHETASE 2; HARS2	23438
MIM600784	*	 	GRANZYME K; GZMK	3003
MIM600786	*	1p36.1	TRANSCRIPTION ELONGATION FACTOR B, POLYPEPTIDE 3; TCEB3	6924
MIM600787	*	 	TRANSCRIPTION ELONGATION FACTOR B, POLYPEPTIDE 2; TCEB2	6923
MIM600788	*	Chr.8	TRANSCRIPTION ELONGATION FACTOR B, POLYPEPTIDE 1; TCEB1	6921
MIM600789	*	11p15.5	RIBOSOMAL PROTEIN L23-LIKE; RPL23L	6150
MIM600790	%	6q14-q16.2	CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	7948
MIM600791	#	7q31, 5q34	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT; DFNB4	2299, 3766, 5172
MIM600792	%	14q12	DEAFNESS, AUTOSOMAL RECESSIVE 5; DFNB5	1697
MIM600794	#	11q13, 7p15	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A	2617, 26580
MIM600795	#	3p11.2	FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	25978
MIM600796	*	19p13.3-p13.2	SPLICING FACTOR 3A, SUBUNIT 2; SF3A2	8175
MIM600797	*	13q34	INSULIN RECEPTOR SUBSTRATE 2; IRS2	8660
MIM600798	*	19q13.2	POLIOVIRUS RECEPTOR-LIKE 2; PVRL2	5819
MIM600799	*	2q33	BONE MORPHOGENETIC PROTEIN RECEPTOR, TYPE II; BMPR2	659
MIM600800	*	2q32.3-q33	NGFIA-BINDING PROTEIN; NAB1	4664
MIM600801		 	ISOPROTERENOL-MEDIATED VASODILATATION	 
MIM600802	#	 	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE	3718
MIM600803	#	7q21.1	GALLBLADDER DISEASE 1; GBD1	5244
MIM600804	*	11q21-q22	MELATONIN RECEPTOR 1B; MTNR1B	4544
MIM600805	*	18q11.2	LAMININ, ALPHA-3; LAMA3	3909
MIM600806	*	19p13.2	CALPONIN 1; CNN1	1264
MIM600807	#	17q21.1-q21.2, 13q14.1, 11q12.3-q13.1, 10q11.2, 6p21.2-p12, 6p21.3, 6p21.3, 5q32-q34, 5q31.1-q33.1, 5q31-q34, 5q31, 4q13-q21, 2q22	ASTHMA, SUSCEPTIBILITY TO	117156, 154, 240, 3135, 3176, 3593, 3596, 4589, 51131, 6356, 7124, 7356, 7941
MIM600808	%	12q13-q21	ENURESIS, NOCTURNAL, 2; ENUR2	2032
MIM600810	*	20p12	PHOSPHOLIPASE C, BETA-4; PLCB4	5332
MIM600811	*	11p12-p11	DNA DAMAGE-BINDING PROTEIN 2; DDB2	1643
MIM600812	*	17q21.3-q22	SPLICING FACTOR, SERINE/ARGININE-RICH, 1; SRSF1	6426
MIM600813	*	17q25	SPLICING FACTOR, SERINE/ARGININE-RICH, 2; SRSF2	6427
MIM600814	*	11q21	MEIOTIC RECOMBINATION 11, S. CEREVISIAE, HOMOLOG OF, A; MRE11A	4361
MIM600815	*	7p13	POLYMERASE (DNA-DIRECTED), DELTA 2, REGULATORY SUBUNIT; POLD2	5425
MIM600816	*	11q23.3-q25	HEAT-SHOCK 70-KD PROTEIN 8; HSPA8	3312
MIM600817	*	2p	VISININ-LIKE 1; VSNL1	7447
MIM600818	*	11q23.2	TRANSGELIN; TAGLN	6876
MIM600819	*	3q28	FRAGILE X MENTAL RETARDATION, AUTOSOMAL HOMOLOG 1; FXR1	8087
MIM600820	*	11q23.3	ARCHAIN 1; ARCN1	372
MIM600821	*	12q14-q15	ARGININE VASOPRESSIN RECEPTOR 1A; AVPR1A	552
MIM600822	*	5q11.2-q13.1	TAF9 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 32-KD; TAF9	6880
MIM600823	*	16p11.2	PROTEASE, SERINE, 8; PRSS8	5652
MIM600824	*	11p15.1	CYSTEINE- AND GLYCINE-RICH PROTEIN 3; CSRP3	8048
MIM600825	*	15q21-q22	RAR-RELATED ORPHAN RECEPTOR A; RORA	6095
MIM600826	*	19p12	CHONDROITIN SULFATE PROTEOGLYCAN 3; CSPG3	1463
MIM600827	*	10q24	PHOSPHODIESTERASE 6C, cGMP-SPECIFIC, CONE, ALPHA-PRIME; PDE6C	5146
MIM600828	*	21q22.1-q22.2	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, O SUBUNIT; ATP5O	539
MIM600829	*	11q23	INOSITOL POLYPHOSPHATE PHOSPHATASE-LIKE 1; INPPL1	3636
MIM600830	*	6p21.3	TRIPARTITE MOTIF-CONTAINING PROTEIN 26; TRIM26	7726
MIM600831	*	9q34.1	DEATH-ASSOCIATED PROTEIN KINASE 1; DAPK1	1612
MIM600832	*	15q22.3-q23	ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER A; ANP32A	8125
MIM600833	*	7q31.1	SUPPRESSOR OF TUMORIGENICITY 7; ST7	7982
MIM600834	*	6p21.3	ZINC FINGER PROTEIN 165; ZNF165	7718
MIM600835	*	10q11.1	CHEMOKINE, CXC MOTIF, LIGAND 12; CXCL12	6387
MIM600836	*	2q34-q36	CRYSTALLIN, BETA-A2; CRYBA2	1412
MIM600837	*	5p13.1-p12	GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GDNF	2668
MIM600838	*	17q11-q12	FORKHEAD BOX N1; FOXN1	8456
MIM600839	*	15q15-q21.1	SOLUTE CARRIER FAMILY 12 (SODIUM/POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 1; SLC12A1	6557
MIM600840	*	5q23.3	SOLUTE CARRIER FAMILY 12 (SODIUM/POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 2; SLC12A2	6558
MIM600842	*	2p23.3-p23.2	GLUCOKINASE REGULATORY PROTEIN; GCKR	2646
MIM600843	*	11q12	PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 3; P2RX3	5024
MIM600844	*	 	PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 2; P2RX2	22953
MIM600845	*	17p13.3	PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 1; P2RX1	5023
MIM600846	*	12q24.32	PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 4; P2RX4	5025
MIM600848	*	12q24	NUCLEAR RECEPTOR COREPRESSOR 2; NCOR2	9612
MIM600849	*	 	NUCLEAR RECEPTOR COREPRESSOR 1; NCOR1	9611
MIM600850	#	22q11.2	SCHIZOPHRENIA 4; SCZD4	5625
MIM600852	#	17q23	RETINITIS PIGMENTOSA 17; RP17	762
MIM600853	*	5q32-q33.3	N-DEACETYLASE/N-SULFOTRANSFERASE 1; NDST1	3340
MIM600855	*	21q22.1	DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 1A; DYRK1A	1859
MIM600856	*	11p15.5	CYCLIN-DEPENDENT KINASE INHIBITOR 1C; CDKN1C	1028
MIM600857	*	5p15	SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT A, FLAVOPROTEIN; SDHA	6389
MIM600858	#	7q36	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6; CMH6	51422
MIM600859	*	7p22	JTV1 GENE	7965
MIM600860	*	13q12.3-q13.1	GENERAL TRANSCRIPTION FACTOR IIIA; GTF3A	2971
MIM600861	*	1q31	REGULATOR OF G PROTEIN SIGNALING 2; RGS2	5997
MIM600862	*	2q36	HIV-1 REV-BINDING PROTEIN; HRB	3267
MIM600863	*	22q12-q13	CASEIN KINASE I, EPSILON; CSNK1E	1454
MIM600864	*	17q25	CASEIN KINASE I, DELTA; CSNK1D	1453
MIM600865	*	14q21-q22	RETICULON 1; RTN1	6252
MIM600866	*	6q27	PROGRAMMED CELL DEATH 2; PDCD2	5134
MIM600867	*	1q21-q23	SIGNAL SEQUENCE RECEPTOR, BETA; SSR2	6746
MIM600868	*	 	SIGNAL SEQUENCE RECEPTOR, ALPHA; SSR1	6745
MIM600869	*	5q35	G PROTEIN-COUPLED RECEPTOR KINASE 6; GRK6	2870
MIM600870	*	10q24-qter	G PROTEIN-COUPLED RECEPTOR KINASE 5; GRK5	2869
MIM600871	*	1p22	GROWTH FACTOR-INDEPENDENT 1; GFI1	2672
MIM600873	*	1p22	CHITOBIASE, DI-N-ACETYL-; CTBS	1486
MIM600874	*	1p22	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-5; GNG5	2787
MIM600875	*	14q24.3	ACYLPHOSPHATASE, ERYTHROCYTE; ACYP1	97
MIM600876	*	11q12.1	SYNTAXIN 3; STX3	6809
MIM600877	*	21q22.1	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 6; KCNJ6	3763
MIM600879	*	7q32	NUCLEAR RESPIRATORY FACTOR 1; NRF1	4899
MIM600880	#	1q23, 9p24	BUDD-CHIARI SYNDROME; BDCHS	2153, 3717
MIM600881	#	17q11.1-q12	CATARACT, CONGENITAL ZONULAR, WITH SUTURAL OPACITIES; CCZS	1411
MIM600882	#	3q21	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B	7879
MIM600883	%	6q25-q27	DIABETES MELLITUS, INSULIN-DEPENDENT, 8; IDDM8	3407
MIM600884	%	9q13	CARDIOMYOPATHY, DILATED, 1B; CMD1B	1218
MIM600885	^	 	MOVED TO 251260	 
MIM600886	#	19q13.3-q13.4	HYPERFERRITINEMIA-CATARACT SYNDROME	2512
MIM600887	*	5q11-q12	MutS, E. COLI, HOMOLOG OF, 3; MSH3	4437
MIM600888	*	7q33-q35	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 5; ARHGEF5	7984
MIM600889	*	1q31-q32.1	COMPLEMENT FACTOR H-RELATED 2; CFHR2	3080
MIM600890	*	2p23	HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE, ALPHA SUBUNIT; HADHA	3030
MIM600892	*	21q22.2	SINGLE-MINDED, DROSOPHILA, HOMOLOG OF, 2; SIM2	6493
MIM600895	*	10q25.3-q26	PROLACTIN-RELEASING HORMONE RECEPTOR; PRLHR	2834
MIM600896	*	17q25.3	G PROTEIN-COUPLED RECEPTOR 14; GPR14	2837
MIM600897	*	1q21.1	GAP JUNCTION PROTEIN, ALPHA-8; GJA8	2703
MIM600898	*	2p25	SRY-BOX 11; SOX11	6664
MIM600899	*	8q11	PROTEIN KINASE, DNA-ACTIVATED, CATALYTIC SUBUNIT; PRKDC	5591
MIM600900	*	4q12	SARCOGLYCAN, BETA; SGCB	6443
MIM600901	#	6p22-p21	FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	2178
MIM600902	*	 	SELENOPHOSPHATE SYNTHETASE 1; SEPHS1	22929
MIM600903		 	WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	 
MIM600904	*	1q25	ASTROTACTIN 1; ASTN1	460
MIM600906		 	ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	 
MIM600907		 	ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	 
MIM600908		 	AGONADISM, 46,XY, WITH MENTAL RETARDATION, SHORT STATURE, RETARDED BONE AGE, AND MULTIPLE EXTRAGENITAL MALFORMATIONS	 
MIM600909	*	21q22.3	LANOSTEROL SYNTHASE; LSS	4047
MIM600910	*	9p24	INSULIN-LIKE 4; INSL4	3641
MIM600911	*	11p14-p13	METALLOPHOSPHOESTERASE DOMAIN-CONTAINING PROTEIN 2; MPPED2	744
MIM600912	*	6p21.3	TRANSCRIPTION FACTOR 19; TCF19	6941
MIM600914	*	 	SPLICING FACTOR, SERINE/ARGININE-RICH, 5; SRSF5	6430
MIM600915	*	 	NESTIN; NES	10763
MIM600916	*	2q11.2	INOSITOL POLYPHOSPHATE-4-PHOSPHATASE, TYPE I, 107-KD; INPP4A	3631
MIM600917	*	7q11.23-q21.11	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3A; PPP1R3A	5506
MIM600918	^	 	MOVED TO 220100	 
MIM600919	#	4q25-q27	CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED	287
MIM600920	#	 	VAN DEN ENDE-GUPTA SYNDROME; VDEGS	91179
MIM600921	*	13q11-q12	FIBROBLAST GROWTH FACTOR 9; FGF9	2254
MIM600922	*	3q21	MYOSIN LIGHT CHAIN KINASE; MYLK	4638
MIM600923	*	1q22	PROTOPORPHYRINOGEN OXIDASE; PPOX	5498
MIM600924	*	16p13.3-p13.12	GROWTH FACTOR, ERV1-LIKE; GFER	2671
MIM600925	*	11p11.2	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, J; PTPRJ	5795
MIM600926	*	10q26	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, EPSILON; PTPRE	5791
MIM600927	*	19p13	CYCLIN-DEPENDENT KINASE INHIBITOR 2D; CDKN2D	1032
MIM600928	*	16p13.3	CONSERVED GENE TELOMERIC TO ALPHA GLOBIN CLUSTER	8131
MIM600929	*	22q11.2-q12.1	CRYSTALLIN, BETA-B1; CRYBB1	1414
MIM600930	*	7q31	SPERM ADHESION MOLECULE 1; SPAM1	6677
MIM600932	*	1q21-q23	G PROTEIN-COUPLED INWARD RECTIFIER POTASSIUM CHANNEL	3765
MIM600933	*	5q13	COAGULATION FACTOR II RECEPTOR-LIKE 1; F2RL1	2150
MIM600934	*	11p11.2	FOLATE HYDROLASE 1; FOLH1	2346
MIM600935	*	12p11.23	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 8; KCNJ8	3764
MIM600936	*	5q33.2	HYALURONAN-MEDIATED MOTILITY RECEPTOR; HMMR	3161
MIM600937	*	11p15.1	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 11; KCNJ11	3767
MIM600938	*	16p12-p11.2	RETINOBLASTOMA-BINDING PROTEIN 6; RBBP6	5930
MIM600939	*	9p13	INTERLEUKIN 11 RECEPTOR, ALPHA; IL11RA	3590
MIM600940	*	17q11.2-q12	LIGASE III, DNA, ATP-DEPENDENT; LIG3	3980
MIM600941	*	19q13.13-q13.2	BILIVERDIN REDUCTASE B; BLVRB	645
MIM600943	*	11q13.5	SERPIN PEPTIDASE INHIBITOR, CLADE H, MEMBER 1; SERPINH1	871
MIM600944	*	19p13.12-p13.11	DEOXYHYPUSINE SYNTHASE; DHPS	1725
MIM600945	*	2p23-p21	UROCORTIN; UCN	7349
MIM600946	*	5p13-p12	GROWTH HORMONE RECEPTOR; GHR	2690
MIM600947	*	17q21.2-q21.3	HUNTINGTIN-ASSOCIATED PROTEIN 1; HAP1	9001
MIM600948	*	3p22-p21	MYELIN-ASSOCIATED OLIGODENDROCYTE BASIC PROTEIN; MOBP	4336
MIM600950	*	17q25	ARYLALKYLAMINE N-ACETYLTRANSFERASE; AANAT	15
MIM600951	*	8q13	TELOMERIC REPEAT-BINDING FACTOR 1; TERF1	7013
MIM600952		 	TRANSSEXUALITY	 
MIM600953	*	11q22.2-q22.3	INTERLEUKIN 18; IL18	3606
MIM600954	*	5p15.2	DEATH-ASSOCIATED PROTEIN; DAP	1611
MIM600955	#	5q15-q21	PROPROTEIN CONVERTASE 1/3 DEFICIENCY	5122
MIM600956	*	12q13	ANTI-MULLERIAN HORMONE TYPE II RECEPTOR; AMHR2	269
MIM600957	*	19p13.3-p13.2	ANTI-MULLERIAN HORMONE; AMH	268
MIM600958	*	11p11.2	MYOSIN-BINDING PROTEIN C, CARDIAC; MYBPC3	4607
MIM600959	*	11p15.2	COATOMER PROTEIN COMPLEX, SUBUNIT BETA; COPB	1315
MIM600960	*	9q34	SET TRANSLOCATION, MYELOID LEUKEMIA-ASSOCIATED; SET	6418
MIM600962	#	17q12-q21, 12q13	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC; NEPPK	3848, 3868
MIM600963	*	19q13.3	SINE OCULIS HOMEOBOX, DROSOPHILA, HOMOLOG OF, 5; SIX5	147912
MIM600964	^	10pter-p11.2	REFSUM DISEASE WITH INCREASED PIPECOLIC ACIDEMIA; RDPA	8024
MIM600965	#	4p16.1	DEAFNESS, AUTOSOMAL DOMINANT 6; DFNA6	7466
MIM600966	*	17p12-p11.2	LETHAL GIANT LARVAE, DROSOPHILA, HOMOLOG OF, 1; LLGL1	3996
MIM600967	*	 	E2F TRANSCRIPTION FACTOR 5; E2F5	1875
MIM600968	*	16q13	SOLUTE CARRIER FAMILY 12 (SODIUM/CHLORIDE TRANSPORTER), MEMBER 3; SLC12A3	6559
MIM600969	#	20q13.3	EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3	1299
MIM600970	*	6q13	MYOSIN VI; MYO6	4646
MIM600971	#	3p21	DEAFNESS, AUTOSOMAL RECESSIVE 6; DFNB6	259236
MIM600972	#	5q32-q33.1	ACHONDROGENESIS, TYPE IB; ACG1B	1836
MIM600974	#	9q13-q21	DEAFNESS, AUTOSOMAL RECESSIVE 7; DFNB7	117531
MIM600975	%	1p36.2-p36.1	GLAUCOMA 3, PRIMARY INFANTILE, B; GLC3B	2728
MIM600976	*	4q34-q35	FAT TUMOR SUPPRESSOR, DROSOPHILA, HOMOLOG OF, 1; FAT1	2195
MIM600977	#	17p13.1	CONE-ROD DYSTROPHY 5; CORD5	83394
MIM600978	*	6p21.3	LYMPHOTOXIN-BETA; LTB	4050
MIM600979	*	12p13	LYMPHOTOXIN B RECEPTOR; LTBR	4055
MIM600980	*	4q21	DENTIN MATRIX ACIDIC PHOSPHOPROTEIN 1; DMP1	1758
MIM600981	*	9p12-q12	PHOSPHOGLUCOMUTASE 5; PGM5	5239
MIM600982	*	5q11.2	MITOGEN-ACTIVATED KINASE KINASE KINASE 1; MAP3K1	4214
MIM600983	*	4q31.1	NUCLEAR RECEPTOR SUBFAMILY 3, GROUP C, MEMBER 2; NR3C2	4306
MIM600984	*	6p21.3	ACTIVATING TRANSCRIPTION FACTOR 6, BETA; ATF6B	1388
MIM600985	*	6p21.3	TENASCIN XB; TNXB	7148
MIM600986	*	1q21	TRIPARTITE MOTIF-CONTAINING PROTEIN 46; TRIM46	80128
MIM600987		 	CARDIAC MALFORMATION, CLEFT LIP-PALATE, MICROCEPHALY AND DIGITAL ANOMALIES	 
MIM600988	*	15q25	MANNOSIDASE, ALPHA, CLASS 2A, MEMBER 2; MAN2A2	4122
MIM600989		 	INFUNDIBULOPELVIC DYSGENESIS	 
MIM600990	^	 	MOVED TO 119580	 
MIM600991		 	HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	 
MIM600992	^	 	MOVED TO 206900	 
MIM600993	*	18q21.1	MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 4; SMAD4	4089
MIM600994	#	7p15	DEAFNESS, AUTOSOMAL DOMINANT 5; DFNA5	1687
MIM600995	#	1q25-q31	NEPHROTIC SYNDROME, TYPE 2; NPHS2	7827
MIM600996	#	1q42.1-q43	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2; ARVD2	6262
MIM600997	*	1p36.1-p35	EPHRIN RECEPTOR EphB2; EPHB2	2048
MIM600998	*	9q21	GUANINE NUCLEOTIDE-BINDING PROTEIN, Q POLYPEPTIDE; GNAQ	2776
MIM600999	*	16p11.2	MYC-ASSOCIATED ZINC FINGER PROTEIN; MAZ	4150
MIM601001	#	17q12-q21	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE	3861
MIM601002	*	20q11.2	GLUTATHIONE SYNTHETASE; GSS	2937
MIM601003	#	16p12	BRODY MYOPATHY	487
MIM601004		 	PORTAL VEIN, CAVERNOUS TRANSFORMATION OF	 
MIM601005	#	12p13.3	TIMOTHY SYNDROME; TS	775
MIM601007	*	1p31	LEPTIN RECEPTOR; LEPR	3953
MIM601009	*	15q13	TIGHT JUNCTION PROTEIN 1; TJP1	7082
MIM601010	*	20p13	TRANSCRIPTION FACTOR 15; TCF15	6939
MIM601011	*	19p13	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, P/Q TYPE, ALPHA-1A SUBUNIT; CACNA1A	773
MIM601012	*	9q34	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, N TYPE, ALPHA-1B SUBUNIT; CACNA1B	774
MIM601013	*	1q25-q31	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-1E SUBUNIT; CACNA1E	777
MIM601014	*	3q29	DISCS LARGE, DROSOPHILA, HOMOLOG OF, 1; DLG1	1739
MIM601015	*	14q24.3	NPC2 GENE; NPC2	10577
MIM601016		 	MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM	 
MIM601017	*	20q11.2	SYNTROPHIN, ALPHA-1; SNTA1	6640
MIM601019	*	1p33	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GLYCINE), MEMBER 9; SLC6A9	6536
MIM601020	*	3q21	CD86 ANTIGEN; CD86	942
MIM601021	*	11p15	NUCLEOPORIN, 98-KD; NUP98	4928
MIM601022	*	6p21.3	NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS INHIBITOR-LIKE 1; NFKBIL1	4795
MIM601023	*	9p13-p12	VALOSIN-CONTAINING PROTEIN; VCP	7415
MIM601024	*	3q28	ADAPTOR-RELATED PROTEIN COMPLEX 2, MU-1 SUBUNIT; AP2M1	1173
MIM601025	*	17q11.2-q12	ADAPTOR-RELATED PROTEIN COMPLEX 2, BETA-1 SUBUNIT; AP2B1	163
MIM601026	*	19q13.3	ADAPTOR-RELATED PROTEIN COMPLEX 2, ALPHA-1 SUBUNIT; AP2A1	160
MIM601027		 	TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	 
MIM601028	*	3q13.1-q13.2	CD47 ANTIGEN; CD47	961
MIM601029	*	7q32	MESODERM-SPECIFIC TRANSCRIPT, MOUSE, HOMOLOG OF; MEST	4232
MIM601030	*	14q11.2	RIBONUCLEASE A FAMILY, 4; RNASE4	6038
MIM601031	*	 	RHOPHILIN 1; RHPN1	114822
MIM601032	*	19p12	PROTEIN KINASE N1; PKN1	5585
MIM601033	*	20q13.2-q13.3	LAMININ, ALPHA-5; LAMA5	3911
MIM601035	*	5q35.3	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H1; HNRNPH1	3187
MIM601037	*	10q11.21-q11.22	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN F; HNRNPF	3185
MIM601038	*	14q32	DEIODINASE, IODOTHYRONINE, TYPE III; DIO3	1735
MIM601039		 	ICHTHYOSIS-MENTAL RETARDATION SYNDROME WITH LARGE KERATOHYALIN GRANULES IN THE SKIN	 
MIM601040	*	12q24.31	SCAVENGER RECEPTOR CLASS B, MEMBER 1; SCARB1	949
MIM601041	*	19p13.3	TRANSDUCIN-LIKE ENHANCER OF SPLIT 2; TLE2	7089
MIM601042	#	1p	DYSTONIA 9; DYT9	1433
MIM601045	*	11q11	CATENIN, DELTA-1; CTNND1	1500
MIM601046	*	11q22.2-q22.3	MATRIX METALLOPROTEINASE 12; MMP12	4321
MIM601047	*	7q31.1	CAVEOLIN 1; CAV1	857
MIM601048	*	7q31.1	CAVEOLIN 2; CAV2	858
MIM601051	*	Chr.16	MESOTHELIN; MSLN	10232
MIM601052	*	19p13	PEPTIDYL-PROLYL CIS/TRANS ISOMERASE, NIMA-INTERACTING, 1; PIN1	5300
MIM601053	*	3pter-p14	PLEXIN B1; PLXNB1	5364
MIM601054	*	1q32.2	PLEXIN A2; PLXNA2	5362
MIM601055	*	3q21-qter	PLEXIN A1; PLXNA1	5361
MIM601056	*	15q24.3	BCL2-RELATED PROTEIN A1; BCL2A1	597
MIM601057	*	 	PROGRAMMED CELL DEATH 6; PDCD6	10016
MIM601058	*	17q25	H3 HISTONE, FAMILY 3B; H3F3B	3021
MIM601059	^	 	MOVED TO 146920	 
MIM601060	*	8q24.1	ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 2; ENPP2	5168
MIM601061	*	 	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE D2; SNRPD2	6633
MIM601062	*	 	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE D3; SNRPD3	6634
MIM601063	*	 	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE D1; SNRPD1	6632
MIM601064	*	14q22-q24	ZINC FINGER PROTEIN 36-LIKE 1; ZFP36L1	677
MIM601065	*	16q22	ALANYL-tRNA SYNTHETASE; AARS	16
MIM601066	*	14q11.2	OXIDASE, CYTOCHROME c, ASSEMBLY 1-LIKE; OXA1L	5018
MIM601067	#	10q21-q22, 10q21-q22	USHER SYNDROME, TYPE ID; USH1D	64072, 65217
MIM601068	%	8q24	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	50968
MIM601069	*	10q11.2	ZINC FINGER PROTEIN 239; ZNF239	8187
MIM601070	*	10p15-p14	INTERLEUKIN 15 RECEPTOR, ALPHA; IL15RA	3601
MIM601071	#	2p23-p22	DEAFNESS, AUTOSOMAL RECESSIVE 9; DFNB9	9381
MIM601072	#	21q22.3	DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8; DFNB8	64699
MIM601074	*	11p11	CUG TRIPLET REPEAT, RNA-BINDING PROTEIN 1; CUGBP1	10658
MIM601075		 	APLASIA CUTIS CONGENITA, HIGH MYOPIA, AND CONE-ROD DYSFUNCTION	 
MIM601076	%	 	MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACIC SOMITE ANOMALIES; MURCS	 
MIM601077	*	17q12-q21	KERATIN 31; KRT31	3881
MIM601078	*	 	KERATIN 82; KRT82	3888
MIM601079	*	5q22	ZINC FINGER-, CCCH DOMAIN-, AND RNA-BINDING MOTIF-CONTAINING SERINE/ARGININE-RICH PROTEIN 1; ZRSR1	7310
MIM601080	*	19p13.2	U2 SMALL NUCLEAR RIBONUCLEOPROTEIN AUXILIARY FACTOR, SMALL SUBUNIT 3; U2AF1RS3	199746
MIM601081	*	12q11-q12	ATP-BINDING CASSETTE, SUBFAMILY 3, MEMBER 2; ABCD2	225
MIM601082	*	7q32	UBIQUITIN-CONJUGATING ENZYME E2H; UBE2H	7328
MIM601083		 	CD4/CD8 T-CELL RATIO	 
MIM601085	^	 	ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, AUTOSOMAL DOMINANT; RESDAD	 
MIM601086	%	6p21	LATERALITY DEFECTS, AUTOSOMAL DOMINANT	207115
MIM601088		 	CATARACTS, CONGENITAL, WITH SENSORINEURAL DEAFNESS, DOWN SYNDROME-LIKE FACIAL APPEARANCE, SHORT STATURE, AND MENTAL RETARDATION	 
MIM601089	*	16q24	FORKHEAD BOX F1; FOXF1	2294
MIM601090	*	6p25	FORKHEAD BOX C1; FOXC1	2296
MIM601091	*	5q12-q13	FORKHEAD BOX D1; FOXD1	2297
MIM601092	*	9p1-q1	FORKHEAD BOX D4; FOXD4	2298
MIM601093	*	5q34	FORKHEAD BOX I1; FOXI1	2299
MIM601094	*	1p32	FORKHEAD BOX E3; FOXE3	2301
MIM601095		 	HARROD SYNDROME	 
MIM601096		 	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	 
MIM601097	*	17p11.2	PERIPHERAL MYELIN PROTEIN 22; PMP22	5376
MIM601098	#	16p13.3-p12	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C	9516
MIM601099	*	8q24.2-q24.3	SRC-LIKE ADAPTOR; SLA	6503
MIM601100	*	21q11.1	HEAT SHOCK 70-KD PROTEIN 13; HSPA13	6782
MIM601101	%	5q31.3-q32	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 3; HHT3	780903
MIM601102	*	3q28	EUKARYOTIC TRANSLATION INITIATION FACTOR 4A, ISOFORM 2; EIF4A2	1974
MIM601103	*	12p13.1-p12.3	MICROFIBRILLAR-ASSOCIATED PROTEIN 5; MFAP5	8076
MIM601104	#	17q21.1	SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	4137
MIM601105	*	1q21	CATHEPSIN K; CTSK	1513
MIM601107	*	10q24	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 2; ABCC2	1244
MIM601109	*	1p36-p35	5-@HYDROXYTRYPTAMINE RECEPTOR 6; HTR6	3362
MIM601110	#	3q27	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	10195
MIM601112	*	12q23-q24.1	THIOREDOXIN REDUCTASE 1; TXNRD1	7296
MIM601113	*	5q31.1-q31.2	HEAT-SHOCK 70-KD PROTEIN 4; HSPA4	3308
MIM601114	*	17q12-q21	MEMBRANE PROTEIN, PALMITOYLATED 3; MPP3	4356
MIM601115	*	7q21.1-q21.2	GLUTAMATE RECEPTOR, METABOTROPIC, 3; GRM3	2913
MIM601116	*	7q31.3-q32.1	GLUTAMATE RECEPTOR, METABOTROPIC, 8; GRM8	2918
MIM601117	*	19p13.3	THIMET OLIGOPEPTIDASE 1; THOP1	7064
MIM601118	*	5q23	CALCIUM-MODULATING CYCLOPHILIN LIGAND; CAMLG	819
MIM601119	*	19p13.3	CLpP, E. COLI, HOMOLOG OF; CLPP	8192
MIM601120	*	16q22.1	CADHERIN 5; CDH5	1003
MIM601121	*	14q24-q31	PLACENTAL GROWTH FACTOR; PGF	5228
MIM601122	*	2q36.3-q37.1	5-@HYDROXYTRYPTAMINE RECEPTOR 2B; HTR2B	3357
MIM601123	*	12p12.1-p11.2	ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 1; ST8SIA1	6489
MIM601124	*	3p21.3	SEMAPHORIN 3F; SEMA3F	6405
MIM601125	*	2p12	HEXOKINASE 2; HK2	3099
MIM601126	*	3p21-p12	TATA ELEMENT MODULATORY FACTOR 1; TMF1	7110
MIM601127		 	FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	 
MIM601128	*	1q41	H3 HISTONE, FAMILY 3A; H3F3A	3020
MIM601129	+	10q23.3	CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 8; CYP2C8	1558
MIM601130	*	10q24	CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9	1559
MIM601131	*	 	CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 18; CYP2C18	1562
MIM601132	*	17q11.2	KINASE SUPPRESSOR OF RAS 1; KSR1	8844
MIM601133	*	 	CYTOCHROME P450, SUBFAMILY IIG, POLYPEPTIDE 1; CYP2G1	22952
MIM601134	*	11q23.3	INTEGRAL MEMBRANE PROTEIN 1; ITM1	3703
MIM601135	*	2q36-q37	GASTRULATION BRAIN HOMEOBOX 2; GBX2	2637
MIM601136	*	Chr.2	TRANSSUPPRESSOR OF EXPRESSION 2	57324
MIM601138		 	GUANYLATE CYCLASE 2E; GUCY2E	390226
MIM601139	*	19q13.4	ZINC FINGER PROTEIN 175; ZNF175	7728
MIM601140	*	11q13	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 14B; PPP1R14B	26472
MIM601141	*	3q26.1	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, BETA MEMBER 1; KCNAB1	7881
MIM601142	*	1p36.3	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, BETA MEMBER 2; KCNAB2	8514
MIM601143	*	2p13	DYNACTIN 1; DCTN1	1639
MIM601144	#	3p21	BRUGADA SYNDROME 1; BRGDA1	6331
MIM601145	*	21q22.3	CYSTATIN B; CSTB	1476
MIM601146	*	20q11.2	GROWTH/DIFFERENTIATION FACTOR 5; GDF5	8200
MIM601147	*	8q22.1	GROWTH/DIFFERENTIATION FACTOR 6; GDF6	392255
MIM601148	*	1q21	SPERM MITOCHONDRIA-ASSOCIATED CYSTEINE-RICH PROTEIN; SMCP	4184
MIM601149	*	15q25.1-q25.2	ISOCITRATE DEHYDROGENASE 3, ALPHA SUBUNIT; IDH3A	3419
MIM601150	*	12p11	DEAD/H BOX 11; DDX11	1663
MIM601151	*	12p13	DEAD/H BOX 12; DDX12	440081
MIM601152	#	1p36.2	HEREDITARY MOTOR AND SENSORY NEUROPATHY VI	9927
MIM601153	*	3p14.2	FRAGILE HISTIDINE TRIAD GENE; FHIT	2272
MIM601154	#	3p21	CARDIOMYOPATHY, DILATED, 1E; CMD1E	6331
MIM601155	*	19p13.3	MINOR HISTOCOMPATIBILITY ANTIGEN HA-1; HMHA1	23526
MIM601156	*	17q21.1-q21.2	CHEMOKINE, CC MOTIF, LIGAND 11; CCL11	6356
MIM601157	*	8p23	DEFENSIN, ALPHA, 4; DEFA4	1669
MIM601158	*	10q11.2	MITOGEN-ACTIVATED PROTEIN KINASE 8; MAPK8	5599
MIM601159	*	3p21	CHEMOKINE, CC MOTIF, RECEPTOR 1; CCR1	1230
MIM601160		 	LISSENCEPHALY TYPE III AND BONE DYSPLASIA	 
MIM601161		 	TRISOMY 18-LIKE SYNDROME	 
MIM601162	%	10q23.3-q24.1	SPASTIC PARAPLEGIA 9, AUTOSOMAL DOMINANT; SPG9	9193
MIM601163	%	 	DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	 
MIM601164	^	 	MOVED TO 241080	 
MIM601166	*	3q11.2-q13.1	G PROTEIN-COUPLED RECEPTOR 15; GPR15	2838
MIM601167	*	3q25	PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 1; P2RY1	5028
MIM601168	*	5q32	DIHYDROPYRIMIDINASE-LIKE 3; DPYSL3	1809
MIM601170		 	MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	 
MIM601172	*	Chr.15	CHONDROITIN SULFATE PROTEOGLYCAN 4; CSPG4	1464
MIM601175	*	11q13	ADP-RIBOSYLATION FACTOR-LIKE 2; ARL2	402
MIM601176	*	1p22.1	GLUTAMATE-CYSTEINE LIGASE, MODIFIER SUBUNIT; GCLM	2730
MIM601177	*	3p14.1	ADP-RIBOSYLATION FACTOR 4; ARF4	378
MIM601178	*	11p13	GPI-ANCHORED MEMBRANE PROTEIN 1; GPIAP1	4076
MIM601179	*	12q24.3	RAS-RELATED NUCLEAR PROTEIN; RAN	5901
MIM601180	*	 	RAN-BINDING PROTEIN 1; RANBP1	5902
MIM601181	*	2q11-q13	RAN-BINDING PROTEIN 2; RANBP2	5903
MIM601182	*	2q33	ORIGIN RECOGNITION COMPLEX, SUBUNIT 2, S. CEREVISIAE, HOMOLOG OF; ORC2	4999
MIM601183	*	14q32.3	CYSTEINE-RICH INTESTINAL PROTEIN 2; CRIP2	1397
MIM601184	*	13q32	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 3; DNAJC3	5611
MIM601185	*	8p21-p11.2	STANNIOCALCIN 1; STC1	6781
MIM601186	#	15q24.1	MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	64220
MIM601187		 	GURRIERI SYNDROME	 
MIM601189	*	11p15	POLYMERASE II, RNA, SUBUNIT L; POLR2L	5441
MIM601190	*	12p13	PHOSPHODIESTERASE 6H, cGMP-SPECIFIC, CONE, GAMMA; PDE6H	5149
MIM601191	*	14q24.1	ENHANCER OF RUDIMENTARY, DROSOPHILA, HOMOLOG OF; ERH	2079
MIM601192	*	1p36-p34	PHOSPHOLIPASE A2, GROUP V; PLA2G5	5322
MIM601193	*	6p21.2-p21.1	CYSTEINE-RICH SECRETORY PROTEIN 1; CRISP1	167
MIM601194	*	4p14	TOLL-LIKE RECEPTOR 1; TLR1	7096
MIM601195		 	IRON OVERLOAD IN AFRICA	 
MIM601196	*	1p36	PR DOMAIN-CONTAINING PROTEIN 2; PRDM2	7799
MIM601197	*	 	TUBBY, MOUSE, HOMOLOG OF; TUB	7275
MIM601199	+	3q13.3-q21	CALCIUM-SENSING RECEPTOR; CASR	846
MIM601200	#	14q31	PLEUROPULMONARY BLASTOMA; PPB	23405
MIM601201	*	1p36.1-p35	METHYLATION MODIFIER FOR CLASS I HLA	7795
MIM601202	%	17p13	CATARACT, ANTERIOR POLAR, 2; CTAA2	1484
MIM601203	*	2q11.2	INTERLEUKIN 1 RECEPTOR-LIKE 1; IL1RL1	9173
MIM601204	*	1p13.1-q21.3	PROSTAGLANDIN F2 RECEPTOR NEGATIVE REGULATOR; PTGFRN	5738
MIM601205	*	14q23	SINE OCULIS HOMEOBOX, DROSOPHILA, HOMOLOG OF, 1; SIX1	6495
MIM601206	*	11q23.1	POU DOMAIN, CLASS 2, ASSOCIATING FACTOR 1; POU2AF1	5450
MIM601207	*	4p16.3	DIACYLGLYCEROL KINASE, THETA, 110-KD; DGKQ	1609
MIM601208	%	14q24.3-q31	DIABETES MELLITUS, INSULIN-DEPENDENT, 11; IDDM11	3410
MIM601209	*	2p13-p12	POLY(rC)-BINDING PROTEIN 1; PCBP1	5093
MIM601210	*	12q13.12-q13.13	POLY(rC)-BINDING PROTEIN 2; PCBP2	5094
MIM601211	*	19p13.2-p13.12	CD97 ANTIGEN; CD97	976
MIM601212	*	8p22-p11.2	PROTEIN-TYROSINE KINASE 2, BETA; PTK2B	2185
MIM601213	*	4q31	RIBONUCLEASE 4 INHIBITOR; RNS4I	6059
MIM601214	#	17q21	NAXOS DISEASE	3728
MIM601215	*	3q22-q24	ATR GENE; ATR	545
MIM601216		 	PLATYSPONDYLY WITH AMELOGENESIS IMPERFECTA	 
MIM601217		 	ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPIC HYPOGONADISM	 
MIM601218	*	21q22.3	ADENOSINE DEAMINASE, RNA-SPECIFIC, B1; ADARB1	104
MIM601220		 	OSTEOPOROSIS AND OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME; OOCH	 
MIM601222	^	 	CRANIOSYNOSTOSIS, PHILADELPHIA TYPE	 
MIM601223		 	NEURONAL INTESTINAL DYSPLASIA, TYPE B	 
MIM601224	#	11p11.2	POTOCKI-SHAFFER SYNDROME	780904
MIM601225	*	22q11	DISHEVELLED 1-LIKE 1; DVL1L1	8215
MIM601228	#	15q15.3-q22.1	POLYPOSIS SYNDROME, HEREDITARY MIXED, 1; HMPS1	338377
MIM601230		 	DERMATITIS HERPETIFORMIS, FAMILIAL	 
MIM601231	*	1p36.2	FKBP12-RAPAMYCIN COMPLEX-ASSOCIATED PROTEIN 1; FRAP1	2475
MIM601232	*	7q22	PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, GAMMA; PIK3CG	5294
MIM601233	*	12q13.1	INHIBIN, BETA C; INHBC	3626
MIM601234	*	12q23-q24.1	NASCENT POLYPEPTIDE-ASSOCIATED COMPLEX, ALPHA POLYPEPTIDE; NACA	4666
MIM601235	*	11q22-q23	DEAD/H BOX 10; DDX10	1662
MIM601236	*	5p13	DISABLED, DROSOPHILA, HOMOLOG OF, 2; DAB2	1601
MIM601237	*	17p11.2	ZINC FINGER PROTEIN 179; ZNF179	7732
MIM601238	#	19p13.3	CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	85300
MIM601239	*	18q12.1-q12.2	DYSTROBREVIN, ALPHA; DTNA	1837
MIM601240	*	19p13.3	GUANIDINOACETATE METHYLTRANSFERASE; GAMT	2593
MIM601241	*	1p34.1	HISTONE DEACETYLASE 1; HDAC1	3065
MIM601242	*	20cen-q13	MICROTUBULE-ASSOCIATED PROTEIN 1, LIGHT CHAIN 3, ALPHA; MAP1LC3A	84557
MIM601243	*	17p12-p11.2	TOPOISOMERASE, DNA, III, ALPHA; TOP3A	7156
MIM601244	*	11q21-q22	GUANYLATE CYCLASE 1, SOLUBLE, ALPHA-2; GUCY1A2	2977
MIM601245	*	21q22.2	CHROMATIN ASSEMBLY FACTOR I, SUBUNIT B; CHAF1B	8208
MIM601246	*	 	CHROMATIN ASSEMBLY FACTOR I, SUBUNIT A; CHAF1A	10036
MIM601247	*	14q21	SON OF SEVENLESS, DROSOPHILA, HOMOLOG 2; SOS2	6655
MIM601248	*	2q14	BRIDGING INTEGRATOR 1; BIN1	274
MIM601249	*	17q24-q25	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE-ASSOCIATED PROTEIN 1; PRPSAP1	5635
MIM601250	*	 	PEPTIDE METHIONINE SULFOXIDE REDUCTASE; MSRA	4482
MIM601251	^	 	MOVED TO 601777	 
MIM601252	*	9q34	FICOLIN 1; FCN1	2219
MIM601253	*	3p25	CAVEOLIN 3; CAV3	859
MIM601254	*	17q24.3	MITOGEN-ACTIVATED PROTEIN KINASE KINASE 6; MAP2K6	5608
MIM601255	*	2q37	KINESIN FAMILY MEMBER 1A; KIF1A	547
MIM601257	*	2p24	DEAD/H BOX 1; DDX1	1653
MIM601258	*	1p31.3-p31.2	CYTOCHROME P450, SUBFAMILY IIJ, POLYPEPTIDE 2; CYP2J2	1573
MIM601259	*	4q21	AMELOBLASTIN ENAMEL MATRIX PROTEIN; AMBN	258
MIM601260	*	7q21-q22	ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 1; ZKSCAN1	7586
MIM601261	*	7q21-q22	ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 21; ZSCAN21	7589
MIM601262	*	8q24	ZINC FINGER PROTEIN 16; ZNF16	7564
MIM601263	*	19p13.3	MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2; MAP2K2	5605
MIM601265	*	10q22.1	NODAL, MOUSE, HOMOLOG OF; NODAL	4838
MIM601266	*	15q15-q21.1	dUTP PYROPHOSPHATASE; DUT	1854
MIM601267	*	3p21	CHEMOKINE, CC MOTIF, RECEPTOR 2; CCR2	729230
MIM601268	*	3p21.3	CHEMOKINE, CC MOTIF, RECEPTOR 3; CCR3	1232
MIM601269	*	17p13.3	COMPLEMENT COMPONENT C1q-BINDING PROTEIN; C1QBP	708
MIM601270	*	19p13.2	CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 3; CYP4F3	4051
MIM601271	*	1p34-p33	GUANYLATE CYCLASE ACTIVATOR 2B; GUCA2B	2981
MIM601272	*	15q22.3	SORTING NEXIN 1; SNX1	6642
MIM601273	*	22q11.2	CLATHRIN, HEAVY POLYPEPTIDE-LIKE 1; CLTCL1	8218
MIM601274	*	 	LEUKOTRIENE B4 12-HYDROXYDEHYDROGENASE; LTB4DH	22949
MIM601275	*	4q34	GLYCOPROTEIN M6A; GPM6A	2823
MIM601276	*	19p13	ZINC FINGER PROTEIN 177; ZNF177	7730
MIM601277	#	2q34	ICHTHYOSIS, LAMELLAR, 2; LI2	26154
MIM601278	*	4q35	FSHD REGION GENE 1; FRG1	2483
MIM601279	*	22q11	DIGEORGE SYNDROME CRITICAL REGION GENE 6; DGCR6	8214
MIM601280	*	13q13	MAB21, C. ELEGANS, HOMOLOG-LIKE 1; MAB21L1	4081
MIM601281	*	3p21.3	SEMAPHORIN 3B; SEMA3B	7869
MIM601282	*	8q24	PLECTIN 1; PLEC1	5339
MIM601283	#	2q37.3	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 1; NIDDM1	11132, 4812
MIM601284	*	12q11-q14	ACTIVIN A RECEPTOR, TYPE II-LIKE 1; ACVRL1	94
MIM601285	*	7q21.3-q22.1	DELETED IN SPLIT-HAND/SPLIT-FOOT 1 REGION	 
MIM601286	^	2q33-q35	CATARACT, NONNUCLEAR POLYMORPHIC CONGENITAL, AUTOSOMAL DOMINANT	1421
MIM601287	#	5q33	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F; LGMD2F	6444
MIM601288	*	8q22.3	TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, ZETA ISOFORM; YWHAZ	7534
MIM601289	*	20q13.1	TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, BETA ISOFORM; YWHAB	7529
MIM601290	*	 	STRATIFIN; SFN	2810
MIM601291	*	4q26	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 8; UGT8	7368
MIM601292	*	16p12.1-p11.2	SULFOTRANSFERASE FAMILY 1A, PHENOL-PREFERRING, MEMBER 2; SULT1A2	6799
MIM601293	*	7q36	RAS HOMOLOG ENRICHED IN BRAIN; RHEB	6009
MIM601295	*	13q33	SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 2; SLC10A2	6555
MIM601296	*	9q31.3-q32	MUSCLE, SKELETAL, RECEPTOR TYROSINE KINASE; MUSK	4593
MIM601297	*	17p13	SRY-BOX 15; SOX15	6665
MIM601299	*	10q22.3	BONE MORPHOGENETIC PROTEIN RECEPTOR, TYPE IA; BMPR1A	657
MIM601300	*	12q13	ACTIVIN A RECEPTOR, TYPE IB; ACVR1B	91
MIM601301	*	6p21.1	PEPTIDYL-PROLYL ISOMERASE-LIKE 1; PPIL1	51645
MIM601302	*	2p16-p15	PROTEIN PHOSPHATASE 3, REGULATORY SUBUNIT B, ALPHA; PPP3R1	5534
MIM601303	*	19q13.11-q13.12	CYTOSKELETON-ASSOCIATED PROTEIN 1; CKAP1	1155
MIM601304	*	22q13.2	NON-HISTONE CHROMOSOME PROTEIN 2, S. CEREVISIAE, HOMOLOG-LIKE 1; NHP2L1	4809
MIM601305	*	7q36.1	5-@HYDROXYTRYPTAMINE RECEPTOR 5A; HTR5A	3361
MIM601306	*	3q13	HEMATOPOIETIC CELL-SPECIFIC LYN SUBSTRATE 1; HCLS1	3059
MIM601308	%	20q11.2-q12	MYELOID TUMOR SUPPRESSOR	8201
MIM601309	*	9q22.3	PATCHED, DROSOPHILA, HOMOLOG OF, 1; PTCH1	5727
MIM601310	*	1p33	CYTOCHROME P450, SUBFAMILY IVA, POLYPEPTIDE 11; CYP4A11	1579
MIM601311	*	12q13	STEROL O-ACYLTRANSFERASE 2; SOAT2	8435
MIM601313	*	16p13.3-p13.12	POLYCYSTIN 1; PKD1	5310
MIM601314	*	5q31.2	HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1; HINT1	3094
MIM601316	#	6q23	DEAFNESS, AUTOSOMAL DOMINANT 10; DFNA10	2070
MIM601317	#	11q13.5	DEAFNESS, AUTOSOMAL DOMINANT 11; DFNA11	4647
MIM601318	%	2q34	DIABETES MELLITUS, INSULIN-DEPENDENT, 13; IDDM13	3412
MIM601319		 	ODONTOMICRONYCHIAL DYSPLASIA	 
MIM601321	#	17q11.2	NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	4763
MIM601322		 	PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS	 
MIM601323	*	19q13.2-q13.4	NUCLEOBINDIN 1; NUCB1	4924
MIM601324	*	4q21.1-q21.2	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HNRNPD	3184
MIM601325	*	3p26	CONTACTIN 3; CNTN3	5067
MIM601326	*	3q26.2-q26.3	CLAUDIN 11; CLDN11	5010
MIM601327	*	11q23	SODIUM CHANNEL, VOLTAGE-GATED, TYPE II, BETA SUBUNIT; SCN2B	6327
MIM601328	*	1p36.3-p36.2	SODIUM CHANNEL, NONVOLTAGE-GATED 1, DELTA SUBUNIT; SCNN1D	6339
MIM601329	*	7q11.23	LIM DOMAIN KINASE 1; LIMK1	3984
MIM601330	*	12p12	GUANYLATE CYCLASE 2C; GUCY2C	2984
MIM601331	#	 	RENAL DYSPLASIA, CYSTIC, SUSCEPTIBILITY TO; CYSRD	80114
MIM601332	*	10p12.1	MOHAWK HOMEOBOX; MKX	283078
MIM601333	*	17q11.2	SUPPRESSOR OF TY 6, S. CEREVISIAE, HOMOLOG OF; SUPT6H	6830
MIM601334	*	19q13.2-q13.3	KINESIN LIGHT CHAIN 3; KLC3	147700
MIM601335	*	17p11.2	MITOGEN-ACTIVATED PROTEIN KINASE KINASE 4; MAP2K4	6416
MIM601336	*	2p13-p12	GLUCOSIDASE I; GCS1	7841
MIM601337	*	 	REGULATORY FACTOR X, 3; RFX3	5991
MIM601338	#	 	CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS	 
MIM601340	*	19q13.32-q13.33	MELANOMA INHIBITORY ACTIVITY PROTEIN; MIA	8190
MIM601341		 	ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL; AMVC	 
MIM601342	*	20q13	CHROMOSOME SEGREGATION 1-LIKE; CSE1L	1434
MIM601344		 	SPINAL DYSPLASIA, ANHALT TYPE	 
MIM601345		 	ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	 
MIM601346	%	 	PANCREATIC HYPOPLASIA, INTESTINAL ATRESIA, AND GALLBLADDER APLASIA OR HYPOPLASIA, WITH OR WITHOUT TRACHEOESOPHAGEAL FISTULA	222546
MIM601347		 	MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE, AND PSYCHOMOTOR DELAY	 
MIM601348		 	ECTRODACTYLY OF LOWER LIMBS, CONGENITAL HEART DEFECT, AND MICROGNATHIA	 
MIM601349	%	6q21	MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	 
MIM601350		 	SHORT STATURE SYNDROME, BRUSSELS TYPE	 
MIM601351		 	GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	 
MIM601352		 	MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	 
MIM601353		 	BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	 
MIM601356	%	 	LETHAL SHORT-LIMB SKELETAL DYSPLASIA, AL GAZALI TYPE	 
MIM601357	%	 	BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	 
MIM601358	#	 	NICOLAIDES-BARAITSER SYNDROME; NCBRS	6595
MIM601359	^	 	MOVED TO 163200	 
MIM601360		 	AMELIA, AUTOSOMAL RECESSIVE	 
MIM601361	*	 	GROWTH/DIFFERENTIATION FACTOR 10; GDF10	2662
MIM601362	%	10p14-p13	DIGEORGE SYNDROME/VELOCARDIOFACIAL SYNDROME COMPLEX 2	8026
MIM601363	%	17q12-q21	WILMS TUMOR 4	8151
MIM601364	*	16q24.2-q24.3	CADHERIN 13; CDH13	1012
MIM601365	*	1p36	DISHEVELLED 1; DVL1	1855
MIM601366	*	18q21	MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 2; SMAD2	4087
MIM601367	#	1q23, 14q22-q23, 13q12, 11p11-q12, 7q36	STROKE, ISCHEMIC	2147, 2153, 241, 4846, 5583
MIM601368	*	3q27	DISHEVELLED 3; DVL3	1857
MIM601369	#	14q12-q13	DEAFNESS, AUTOSOMAL DOMINANT 9; DFNA9	1690
MIM601370		 	HOLOPROSENCEPHALY, SEMILOBAR, WITH CRANIOSYNOSTOSIS	 
MIM601371		 	CATARACT, AGE-RELATED NUCLEAR	 
MIM601372		 	CHOREA, REMITTING, WITH NYSTAGMUS AND CATARACT	 
MIM601373	*	3p21	CHEMOKINE, CC MOTIF, RECEPTOR 5; CCR5	1234
MIM601374		 	APROSENCEPHALY AND CEREBELLAR DYSGENESIS	 
MIM601375		 	ECTODERMAL DYSPLASIA, HIDROTIC, CHRISTIANSON-FOURIE TYPE	 
MIM601376		 	CHONDRODYSPLASIA, LETHAL, WITH LONG BONE ANGULATION AND MIXED BONE DENSITY	 
MIM601378	^	19p12	CRISPONI SYNDROME	9244
MIM601379		 	HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	 
MIM601380	*	1q21-q22	EPHRIN A4; EFNA4	1945
MIM601381	*	1q21-q22	EPHRIN A3; EFNA3	1944
MIM601382	#	11q22	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	8898
MIM601383	*	12q13	AQUAPORIN 6; AQP6	363
MIM601384	*	8q24.3	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS E; LY6E	4061
MIM601385	*	8p22	TUMOR SUPPRESSOR CANDIDATE 3; TUSC3	7991
MIM601386	#	10q21-q22, 3p26-p25	DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	491, 64072
MIM601387	*	11p15.2-p15.1	TUMOR SUSCEPTIBILITY GENE 101; TSG101	7251
MIM601388	#	2q33	DIABETES MELLITUS, INSULIN-DEPENDENT, 12; IDDM12	1493
MIM601389		 	CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	 
MIM601390	#	 	CEREBROFACIOARTICULAR SYNDROME	 
MIM601391	*	17q11.2	CHEMOKINE, CC MOTIF, LIGAND 13; CCL13	6357
MIM601392	*	17q11.2	CHEMOKINE, CC MOTIF, LIGAND 14; CCL14	6358
MIM601393	*	17q11.2	CHEMOKINE, CC MOTIF, LIGAND 15; CCL15	6359
MIM601394	*	17q11.2	CHEMOKINE, CC MOTIF, LIGAND 16; CCL16	6360
MIM601395	*	17q11.2	CHEMOKINE, CC MOTIF, LIGAND 3-LIKE 1; CCL3L1	6349
MIM601396	*	10q24	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 8B; WNT8B	7479
MIM601397	*	6q27	T BRACHYURY, MOUSE, HOMOLOG OF; T	6862
MIM601398	*	11q13	VASCULAR ENDOTHELIAL GROWTH FACTOR B; VEGFB	7423
MIM601399	#	21q22.3	PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	861
MIM601400	^	 	MOVED TO 275355	 
MIM601401	*	12p13	MYELOID LEUKEMIA FACTOR 2; MLF2	8079
MIM601402	*	3q25.1	MYELOID LEUKEMIA FACTOR 1; MLF1	4291
MIM601403	*	10q26.13-q26.3	DEDICATOR OF CYTOKINESIS 1; DOCK1	1793
MIM601404	*	14q31	G PROTEIN-COUPLED RECEPTOR 68; GPR68	8111
MIM601405	*	1p36.21	CHYMOTRYPSIN C; CTRC	11330
MIM601406	*	12q24.1	B-CELL CLL/LYMPHOMA 7A; BCL7A	605
MIM601407	%	12q24.2	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 2; NIDDM2	4813
MIM601408	*	8p11	HISTONE ACETYLTRANSFERASE MYST3; MYST3	7994
MIM601409	*	11q13	K(LYSINE) ACETYLTRANSFERASE 5; KAT5	10524
MIM601410	#	6q24, 6p22.1	DIABETES MELLITUS, TRANSIENT NEONATAL, 1	346171, 5325, 57061, 7952
MIM601411	*	5q33	SARCOGLYCAN, DELTA; SGCD	6444
MIM601412	%	1q21-q23	DEAFNESS, AUTOSOMAL DOMINANT 7; DFNA7	1689
MIM601413	*	14q24.3	DEIODINASE, IODOTHYRONINE, TYPE II; DIO2	1734
MIM601414	#	1q21.2	RETINITIS PIGMENTOSA 18; RP18	9129
MIM601415	*	20q13.1	V-MYB AVIAN MYELOBLASTOSIS VIRAL ONCOGENE HOMOLOG-LIKE 2; MYBL2	4605
MIM601416	*	6p21.3	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 7; SLC39A7	7922
MIM601417	*	6p21.3	17-@BETA-HYDROXYSTEROID DEHYDROGENASE VIII; HSD17B8	7923
MIM601418	*	20p12-p11.2	RIBOSOME BINDING PROTEIN 1; RRBP1	6238
MIM601419	#	2q35	MYOPATHY, MYOFIBRILLAR, 1; MFM1	1674
MIM601420		 	MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	 
MIM601421	*	16q22.2-q22.3	LYSYL-tRNA SYNTHETASE; KARS	3735
MIM601422	*	1p36	LEUCINE ZIPPER PROTEIN 1; LUZP1	7798
MIM601423	*	12q24.1	THYMINE-DNA GLYCOSYLASE; TDG	6996
MIM601424	*	5p13	3-@OXOACID CoA TRANSFERASE 1; OXCT1	5019
MIM601425	*	8q11.23	TRANSCRIPTION ELONGATION FACTOR A, 1; TCEA1	6917
MIM601426	*	3p25	NUCLEAR RECEPTOR SUBFAMILY 2, GROUP C, MEMBER 2; NR2C2	7182
MIM601427		 	ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	 
MIM601428	*	 	RNA, U4ATAC SMALL NUCLEAR; RNU4ATAC	100151683
MIM601429	*	 	RNA, U6ATAC SMALL NUCLEAR; RNU6ATAC	100151684
MIM601430	*	19p13.2-p13.11	UPF1, YEAST, HOMOLOG OF; UPF1	5976
MIM601431	*	6p22.3-p21.1	TRANSFER RNA ALANINE 1; TRNAA1	7154
MIM601432	*	6p22.3-p21.1	TRANSFER RNA ARGININE 3; TRNAR3	7232
MIM601434	*	5q31	S-PHASE KINASE-ASSOCIATED PROTEIN 1A; SKP1A	6500
MIM601435	*	12p12	S-PHASE KINASE-ASSOCIATED PROTEIN 1B; SKP1B	728622
MIM601436	*	5p13	S-PHASE KINASE-ASSOCIATED PROTEIN 2; SKP2	6502
MIM601437	*	19q13.3	Fc FRAGMENT OF IgG, RECEPTOR TRANSPORTER, ALPHA; FCGRT	2217
MIM601438		 	RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	 
MIM601439	*	12p12.1	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 9; ABCC9	10060
MIM601440	*	17q22	DIACYLGLYCEROL KINASE, EPSILON, 64-KD; DGKE	8526
MIM601441	*	 	DIACYLGLYCEROL KINASE, ZETA, 104-KD: DGKZ	8525
MIM601442	*	11q13	COFILIN 1; CFL1	1072
MIM601443	*	14q12	COFILIN 2; CFL2	1073
MIM601444	*	12q13-q14	BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 1; BLOC1S1	2647
MIM601445	*	8q13.3	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 9; NDUFB9	4715
MIM601446	^	 	MOVED TO 300707	 
MIM601447	*	12p13	UBIQUITIN-SPECIFIC PROTEASE 5; USP5	8078
MIM601448	*	11q22.3	NUCLEAR PROTEIN, ATAXIA-TELANGIECTASIA LOCUS; NPAT	4863
MIM601449		 	DEAFNESS, PROGRESSIVE, WITH STAPES FIXATION	 
MIM601450		 	DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERS AND FACIAL DYSMORPHISM	 
MIM601451	^	1p36.3-p36.2	NEVO SYNDROME	5351
MIM601452	%	 	OCULOAURICULOFRONTONASAL SYNDROME; OAFNS	 
MIM601453		 	TRICHODENTAL DYSPLASIA	 
MIM601454	%	4q	PSORIASIS SUSCEPTIBILITY 3; PSORS3	7889
MIM601455	#	8q24.3	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D	10397
MIM601456	*	 	MULTIMERIN 1; MMRN1	22915
MIM601457	#	11p13, 11p13	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	5896, 5897
MIM601458	%	12p13.2-q24.1	INFLAMMATORY BOWEL DISEASE 2; IBD2	3378
MIM601459	*	8p21	PREPRONOCICEPTIN; PNOC	5368
MIM601460	*	3q21	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 2A1; SLCO2A1	6578
MIM601461	*	4q22	ATONAL, DROSOPHILA, HOMOLOG OF, 1; ATOH1	474
MIM601462	#	17p12-p11, 17p13-p12, 2q33-q34, 2q24-q32	MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL; SCCMS	1134, 1140, 1144, 1145
MIM601463	*	19q13.3-q13.4	HYALURONAN SYNTHASE 1; HAS1	3036
MIM601464	*	2q11.2-q12	AF4/FMR2 FAMILY, MEMBER 3; AFF3	3899
MIM601465	*	2p13	DEOXYGUANOSINE KINASE; DGUOK	1716
MIM601466		 	PATENT DUCTUS VENOSUS; PDV	 
MIM601467	*	4q27	MITOTIC ARREST-DEFICIENT 2, S. CEREVISIAE, HOMOLOG-LIKE 1; MAD2L1	4085
MIM601468	*	2p11.2	METHIONINE ADENOSYLTRANSFERASE II, ALPHA; MAT2A	4144
MIM601469	*	2q33	PARATHYROID HORMONE RECEPTOR 2; PTHR2	5746
MIM601470	*	3pter-p21	CHEMOKINE, CX3C MOTIF, RECEPTOR 1; CX3CR1	1524
MIM601471	%	3q21-q22	FACIAL PARESIS, HEREDITARY CONGENITAL, 1; HCFP1	7880
MIM601472	#	7p15	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	2617
MIM601473	*	16pter-p11	ZINC FINGER PROTEIN 75A; ZNF75A	7627
MIM601475	*	21q22.3	PERIODIC TRYPTOPHAN PROTEIN 2, YEAST, HOMOLOG OF; PWP2H	5822
MIM601476	*	1p34	LYSOSOME-ASSOCIATED PROTEIN, TRANSMEMBRANE 5; LAPTM5	7805
MIM601478	*	12q13-q15	MYOSIN IA; MYO1A	4640
MIM601479	*	15q21-q22	MYOSIN IE; MYO1E	4643
MIM601480	*	19p13.3-p13.2	MYOSIN IF; MYO1F	4542
MIM601481	*	5p15.1-p14.3	MYOSIN X; MYO10	4651
MIM601482	*	1p22.1	DOWNREGULATOR OF TRANSCRIPTION 1, TBP-BINDING; DR1	1810
MIM601483	*	19q13.4	PATERNALLY EXPRESSED GENE 3; PEG3	5178
MIM601484	*	5p11	SELENOPROTEIN P, PLASMA, 1; SEPP1	6414
MIM601485	*	16p11.2	SYNTAXIN 1B; STX1B	112755
MIM601486	*	3p24	DELETED IN AZOOSPERMIA-LIKE; DAZL	1618
MIM601487	*	3p25	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA; PPARG	5468
MIM601488	*	22q13.1	NEUTROPHIL CYTOSOLIC FACTOR 4; NCF4	4689
MIM601489	*	16p13.3	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN, ACID-LABILE SUBUNIT; IGFALS	3483
MIM601490	*	12q13	NUCLEAR FACTOR ERYTHROID 2, p45 SUBUNIT; NFE2	4778
MIM601491	*	15q11-q13	IMPRINTED IN PRADER-WILLI SYNDROME; IPW	3653
MIM601492	#	3p21.3-p21.2	MUCOPOLYSACCHARIDOSIS TYPE IX	3373
MIM601493	#	10q22.2-q23.3	CARDIOMYOPATHY, DILATED, 1C; CMD1C	11155, 1219
MIM601494	#	1q32	CARDIOMYOPATHY, DILATED, 1D; CMD1D	7139
MIM601495	#	14q32.33	AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE; AGM1	3507
MIM601496	*	10q26	GDNF FAMILY RECEPTOR ALPHA-1; GFRA1	2674
MIM601497	*	9p12	BCL2-ASSOCIATED ATHANOGENE 1; BAG1	573
MIM601498	*	6p21.1	PEROXISOME BIOGENESIS FACTOR 6; PEX6	5190
MIM601499	%	13q14	AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2	6012
MIM601500	*	7q31-q32	SMOOTHENED, DROSOPHILA, HOMOLOG OF; SMOH	6608
MIM601501	*	16q12	VACUOLAR PROTEIN SORTING 35, YEAST, HOMOLOG OF; VPS35	55737
MIM601502	*	1p12	Fc FRAGMENT OF IgG, HIGH AFFINITY Ib, RECEPTOR FOR; FCGR1B	2210
MIM601503	*	1q21	Fc FRAGMENT OF IgG, HIGH AFFINITY Ic, RECEPTOR FOR; FCGR1C	100132417
MIM601504	*	17q25.1-q25.2	SEC14-LIKE 1; SEC14L1	6397
MIM601505	*	19q13.1	ZINC FINGER PROTEIN 146; ZNF146	7705
MIM601506	*	2q37	SEPTIN 2; SEPT2	4735
MIM601507	*	5q23.1	ADAPTOR-RELATED PROTEIN COMPLEX 3, SIGMA-1 SUBUNIT; AP3S1	1176
MIM601509	*	8q12.3	GAMMA-GLUTAMYL HYDROLASE; GGH	8836
MIM601510	*	3p21.31	SREBP CLEAVAGE-ACTIVATING PROTEIN; SCAP	22937
MIM601511	*	 	SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 5A; STAT5A	6776
MIM601512	*	12q13	SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6; STAT6	6778
MIM601513	*	3q28	FIBROBLAST GROWTH FACTOR 12; FGF12	2257
MIM601514	*	17q21	FIBROBLAST GROWTH FACTOR 11; FGF11	2256
MIM601515	*	13q34	FIBROBLAST GROWTH FACTOR 14; FGF14	2259
MIM601516	*	11q13	SPLICING FACTOR 1; SF1	7536
MIM601517	*	12q24	ATAXIN 2; ATXN2	6311
MIM601518	#	1q25	PROSTATE CANCER, HEREDITARY, 1; HPC1	6041
MIM601519	*	 	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL FO COMPLEX, SUBUNIT E; ATP5I	521
MIM601520	*	16q13	CHEMOKINE, CC MOTIF, LIGAND 17; CCL17	6361
MIM601521	*	 	ENDOTHELIAL CELL-SPECIFIC MOLECULE 1; ESM1	11082
MIM601522	*	17q21-q22	GROWTH FACTOR RECEPTOR-BOUND PROTEIN 7; GRB7	2886
MIM601523	*	7p12-p11.2	GROWTH FACTOR RECEPTOR-BOUND PROTEIN 10; GRB10	2887
MIM601524	*	2q22-q24	GROWTH FACTOR RECEPTOR-BOUND PROTEIN 14; GRB14	2888
MIM601525	*	1q32.1	CHITINASE 3-LIKE 1; CHI3L1	1116
MIM601526	*	 	CHITINASE 3-LIKE 2; CHI3L2	1117
MIM601527	*	12q21.3-q22	ARISTALESS-LIKE HOMEOBOX 1; ALX1	8092
MIM601528	*	 	VASCULAR ENDOTHELIAL GROWTH FACTOR C; VEGFC	7424
MIM601529	*	 	NUCLEAR RECEPTOR SUBFAMILY 2, GROUP C, MEMBER 1; NR2C1	7181
MIM601530	*	5q35	SEQUESTOSOME 1; SQSTM1	8878
MIM601531	*	14q11.2-q12	LEUKOTRIENE B4 RECEPTOR; LTB4R	1241
MIM601532	*	4q25-q25	CASPASE 6, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP6	839
MIM601533	*	8p11.2	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 2; ADAM2	2515
MIM601534	*	2q24.1	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 3; KCNJ3	3760
MIM601535	*	 	EPHRIN A5; EFNA5	1946
MIM601536	#	7p15.3	ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS	3198
MIM601537	%	 	MICROCEPHALY, RETINITIS PIGMENTOSA, AND SUTURAL CATARACT	 
MIM601538	*	5q	PROPHET OF PIT1, PAIRED-LIKE HOMEODOMAIN TRANSCRIPTION FACTOR; PROP1	5626
MIM601539	#	 	PEROXISOME BIOGENESIS DISORDERS; PBD	5189, 5190, 5192, 5193, 55670, 5828, 9409
MIM601540	*	6p21.3	BROMODOMAIN-CONTAINING PROTEIN 2; BRD2	6046
MIM601541	*	9q34	BROMODOMAIN-CONTAINING PROTEIN 3; BRD3	8019
MIM601542	*	4q25-q26	PAIRED-LIKE HOMEODOMAIN TRANSCRIPTION FACTOR 2; PITX2	5308
MIM601543	#	11q22-q24	DEAFNESS, AUTOSOMAL DOMINANT 12; DFNA12	7007
MIM601544	#	13q11-q12	DEAFNESS, AUTOSOMAL DOMINANT 3A; DFNA3A	2706
MIM601545	*	17p13.3	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, ISOFORM 1B, ALPHA SUBUNIT; PAFAH1B1	5048
MIM601546	*	1q32.2-q32.3	PROSPERO-RELATED HOMEOBOX 1; PROX1	5629
MIM601547	#	22q11.2-q12.2	CATARACT, CONGENITAL, CERULEAN TYPE, 2; CCA2	1415
MIM601548	*	2p16	EGF-CONTAINING FIBULIN-LIKE EXTRACELLULAR MATRIX PROTEIN 1; EFEMP1	2202
MIM601549	%	 	ALACRIMA, CONGENITAL	 
MIM601550	#	 	BLOOD GROUP--SWANN SYSTEM; SW	6521
MIM601551	#	17q21-q22	BLOOD GROUP--FROESE	6521
MIM601552	#	 	ECTOPIA LENTIS, SPONTANEOUS FILTERING BLEBS, AND CRANIOFACIAL DYSMORPHISM	 
MIM601553	#	16q22.1	HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY; HJMD	1001
MIM601554	*	6q25.2-q25.3	DYNEIN, LIGHT CHAIN, TCTEX TYPE, 1; DYNLT1	6993
MIM601555	*	17q21	RHO FAMILY GTPase 2; RND2	8153
MIM601556	*	6p23	ATAXIN 1; ATXN1	6310
MIM601557	*	12q24.1	ACETYL-CoA CARBOXYLASE-BETA; ACACB	32
MIM601558	*	8p12-p11	RNA-BINDING PROTEIN GENE WITH MULTIPLE SPLICING; RBPMS	11030
MIM601559	#	5p13.1	STUVE-WIEDEMANN SYNDROME	3977
MIM601560		 	MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	 
MIM601561		 	DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	 
MIM601562	*	12q24.2	DYNEIN, LIGHT CHAIN, LC8 TYPE, 1; DYNLL1	8655
MIM601564	*	7q35	PROTEASE, SERINE, 2; PRSS2	5645
MIM601565	*	 	INTERFERON REGULATORY FACTOR 8; IRF8	3394
MIM601566	*	13q34	INHIBITOR OF GROWTH 1; ING1	3621
MIM601567	*	18q21.3-q22	LECTIN, MANNOSE-BINDING, 1; LMAN1	3998
MIM601568	*	10q24.2-q24.3	ADDUCIN 3; ADD3	120
MIM601569	*	Chr.17	UBIQUITIN-CONJUGATING ENZYME E2G 1; UBE2G1	7326
MIM601570	*	3p25	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 7A; WNT7A	7476
MIM601571	*	7q31.2-q31.3	CAPPING PROTEIN, ALPHA-2; CAPZA2	830
MIM601572	*	1p36.1	CAPPING PROTEIN, BETA; CAPZB	832
MIM601573	*	7q35	ENHANCER OF ZESTE, DROSOPHILA, HOMOLOG 2; EZH2	2146
MIM601574	*	17q11.1-q11.2	TAF15 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 68-KD; TAF15	8148
MIM601575	*	2p23-p22	FOS-LIKE ANTIGEN 2; FOSL2	2355
MIM601576	*	19p13.3	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, SIGMA; PTPRS	5802
MIM601577	*	11q13.3	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, C POLYPEPTIDE-ASSOCIATED PROTEIN; PTPRCAP	5790
MIM601578	*	5q32-q34	CYCLIN G1; CCNG1	900
MIM601579	*	19p13.3	ORNITHINE DECARBOXYLASE ANTIZYME 1; OAZ1	4946
MIM601580	*	1p13.2	CAPPING PROTEIN, ALPHA-1; CAPZA1	829
MIM601581	*	7q31.1-q31.2	NEURONAL CELL ADHESION MOLECULE; NRCAM	4897
MIM601582	*	2q36-q37	INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 145-KD; INPP5D	3635
MIM601583	#	7p14-p13	WILMS TUMOR 5; WT5	11281
MIM601584	*	1p35	PROTEIN-TYROSINE PHOSPHATASE, TYPE 4A, 2; PTP4A2	8073
MIM601585	*	6q12	PROTEIN-TYROSINE PHOSPHATASE, TYPE 4A, 1; PTP4A1	7803
MIM601586	*	5p13.1	PROSTAGLANDIN E RECEPTOR 4, EP4 SUBTYPE; PTGER4	5734
MIM601587	^	 	THYMOSIN, BETA-15; TMSB15A	11013
MIM601589	*	3q22-q23	RAS p21 PROTEIN ACTIVATOR 2; RASA2	5922
MIM601590	*	17q25	ENVOPLAKIN; EVPL	2125
MIM601591	*	4q13.1-q21.1	PROTEIN KINASE, cGMP-DEPENDENT, TYPE II; PRKG2	5593
MIM601592	*	11p11.2-p11.1	RECEPTOR-ASSOCIATED PROTEIN OF THE SYNAPSE, 43-KD; RAPSN	5913
MIM601593	*	2q34-q35	BRCA1-ASSOCIATED RING DOMAIN 1; BARD1	580
MIM601594	*	6p24-p23	JUMONJI, AT-RICH INTERACTIVE DOMAIN 2; JARID2	3720
MIM601595	*	4q28	MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 1; SMAD1	4086
MIM601596	#	5q32	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	79628
MIM601597	*	1q32	B-CELL TRANSLOCATION GENE 2; BTG2	7832
MIM601598	*	9p24.3-p23	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, DELTA; PTPRD	5789
MIM601599	*	12p11.2	SARCOSPAN; SSPN	8082
MIM601600	*	3q28	ETS VARIANT GENE 5; ETV5	2119
MIM601601	*	6p12	TRANSCRIPTION FACTOR AP2-BETA; TFAP2B	7021
MIM601602	*	20q13.2	TRANSCRIPTION FACTOR AP2-GAMMA; TFAP2C	7022
MIM601603	*	5q33.1-qter	LYMPHOCYTE CYTOSOLIC PROTEIN 2; LCP2	3937
MIM601604	*	19p13.1	INTERLEUKIN 12 RECEPTOR, BETA-1; IL12RB1	3594
MIM601606	#	16q12-q13	TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1	1540
MIM601607	*	22q11	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY B, MEMBER 1; SMARCB1	6598
MIM601608		 	SPASTIC PARAPLEGIA AND EVANS SYNDROME	 
MIM601609	*	4q22-q26	3-@HYDROXYACYL-CoA DEHYDROGENASE; HADH	3033
MIM601610	*	6p22.1	BUTYROPHILIN, SUBFAMILY 1, MEMBER A1; BTN1A1	696
MIM601611	*	18q12.1-q21.1	SOLUTE CARRIER FAMILY 14 (UREA TRANSPORTER), MEMBER 2; SLC14A2	8170
MIM601612	%	 	LUNG AGENESIS, CONGENITAL HEART DEFECTS, AND THUMB ANOMALIES SYNDROME; LACHT	 
MIM601613	*	11q23.3	CHEMOKINE, CXC MOTIF, RECEPTOR 5; CXCR5	643
MIM601614	*	 	NETRIN 1, MOUSE, HOMOLOG OF; NTN1	9423
MIM601615	*	16p13.3	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 3; ABCA3	21
MIM601616	%	 	IRIS PIGMENT EPITHELIUM ANOMALIES	 
MIM601617	*	12q13-q14	RETINOL DEHYDROGENASE 5; RDH5	5959
MIM601618	*	20q13.33	SRY-BOX 18; SOX18	54345
MIM601619	*	9q34	RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR; RALGDS	5900
MIM601620	*	12q24.1	T-BOX 5; TBX5	6910
MIM601621	*	12q24.1	T-BOX 3; TBX3	6926
MIM601622	*	7p21	TWIST, DROSOPHILA, HOMOLOG OF, 1; TWIST1	7291
MIM601623	*	15q11-q13	UBIQUITIN-PROTEIN LIGASE E3A; UBE3A	7337
MIM601624	*	9q34	FICOLIN 2; FCN2	2220
MIM601625	*	11p15	ADP-RIBOSYLTRANSFERASE 1; ART1	417
MIM601626	#	16q22, 13q12, 12p13, 11q23.3, 11q14, 10p12, 9q34.1, 9p24, 8p12, 5q35, 5q35, 4q12, 4q11-q12, 3q28, 3q25.1, 3q24, 21q22.3, 19q13.1, 19p13.3	LEUKEMIA, ACUTE MYELOID; AML	1050, 2120, 2322, 23365, 2624, 26511, 3717, 3815, 4026, 4291, 4869, 54904, 64324, 6455, 7015, 8021, 8028, 8301, 861, 865, 8833, 9163
MIM601627	*	5q12.2-q13.3	SURVIVAL OF MOTOR NEURON 2; SMN2	6607
MIM601629	*	21q22.3	PURKINJE CELL PROTEIN 4; PCP4	5121
MIM601631	#	6p25	IRIDOGONIODYSGENESIS, TYPE 1; IRID1	2296
MIM601632	*	13q21.1-q22	POU DOMAIN, CLASS 4, TRANSCRIPTION FACTOR 1; POU4F1	5457
MIM601633	*	17q21-q22	N-ETHYLMALEIMIDE-SENSITIVE FACTOR; NSF	4905
MIM601634	#	14q24, 1p36.3, 5p15.3-p15.2, 1q43	NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	4522, 4524, 4548, 4552
MIM601635	^	 	MOVED TO 608317	 
MIM601636	*	8q24.12	HYALURONAN SYNTHASE 2; HAS2	3037
MIM601637	*	7q21.2-q21.3	CYTOCHROME P450, FAMILY 51, SUBFAMILY A, POLYPEPTIDE 1; CYP51A1	1595
MIM601638	*	 	ADP-RIBOSYLATION FACTOR-INTERACTING PROTEIN 2; ARFIP2	23647
MIM601639	*	19p13.1	PROTEIN KINASE, cAMP-DEPENDENT, CATALYTIC, ALPHA; PRKACA	5566
MIM601641	*	3p14.3	ACYL-CoA OXIDASE 2, BRANCHED-CHAIN; ACOX2	8309
MIM601642	*	1p31.2	INTERLEUKIN 12 RECEPTOR, BETA-2; IL12RB2	3595
MIM601643	*	1q41	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), ALPHA; PPP2R5A	5525
MIM601644	*	11q13	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), BETA; PPP2R5B	5526
MIM601645	*	14q32.31	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), GAMMA; PPP2R5C	5527
MIM601646	*	6p21.1	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), DELTA; PPP2R5D	5528
MIM601647	*	14q23.1	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B (B56), EPSILON; PPP2R5E	5529
MIM601648	*	 	PROTEASOME 26S SUBUNIT, NON-ATPase, 4; PSMD4	5710
MIM601650	#	11q13.1	PARAGANGLIOMAS 2; PGL2	54949
MIM601651	*	11p15.5	NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 4; NAP1L4	4676
MIM601652	*	1q24.3-q25.2	MYOCILIN; MYOC	4653
MIM601653	*	8q13.3	EYES ABSENT 1; EYA1	2138
MIM601654	*	20q13.1	EYES ABSENT 2; EYA2	2139
MIM601655	*	1p36	EYES ABSENT 3; EYA3	2140
MIM601656	*	18q11.1-q11.2	GATA-BINDING PROTEIN 6; GATA6	2627
MIM601657	*	12q21	DERMATAN SULFATE PROTEOGLYCAN 3; DSPG3	1833
MIM601658	*	8q24	OTOCONIN 90; OC90	729330
MIM601659	*	21q22.3	ES1, ZEBRAFISH, HOMOLOG OF; ES1	8209
MIM601661	*	16p13.3	UBIQUITIN-CONJUGATING ENZYME E2I; UBE2I	7329
MIM601662	*	3q13.1-q13.2	ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALCAM	214
MIM601663	*	14q	ESTROGEN RECEPTOR 2; ESR2	2100
MIM601664	*	2q11.2	SMALL NUCLEAR RIBONUCLEOPROTEIN, 200-KD; SNRNP200	23020
MIM601665	#	17q21, 16q22, 1pter-p22.3, 11q13, 8p12-p11.2, 6q22-q23, 6q16.3-q21, 5q33, 5q32-q34, 5q13.2, 4q31, 3p25, 3p26-p25, 1p36.1, 2p23.3, 18q22	OBESITY	133522, 154, 155, 181, 4160, 5167, 51738, 5443, 5468, 5697, 6492, 7350, 7352, 8431, 9607, 9672
MIM601666	%	6q21	DIABETES MELLITUS, INSULIN-DEPENDENT, 15; IDDM15	3414
MIM601667	*	8q22	ANGIOPOIETIN 1; ANGPT1	284
MIM601668		 	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	 
MIM601670	*	19q13.13-q13.2	D4, ZINC, AND DOUBLE PHD FINGERS FAMILY, MEMBER 1; DPF1	8193
MIM601671	*	11q13	D4, ZINC, AND DOUBLE PHD FINGERS FAMILY, MEMBER 2; DPF2	5977
MIM601672	*	14q24.3-q31.1	D4, ZINC, AND DOUBLE PHD FINGERS FAMILY, MEMBER 3; DPF3	8110
MIM601673	*	9p21	EMBRYONIC LETHAL, ABNORMAL VISION, DROSOPHILA, HOMOLOG-LIKE 2; ELAVL2	1993
MIM601674	*	17q21.1-q21.3	ENHANCER OF ZESTE, DROSOPHILA, HOMOLOG 1; EZH1	2145
MIM601675	#	6q25.3, 2q21, 19q13.2-q13.3	TRICHOTHIODYSTROPHY, PHOTOSENSITIVE; TTDP	2068, 2071, 404672
MIM601676	%	1p31	ACUTE INSULIN RESPONSE	7808
MIM601677	*	7q32	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 5; NDUFA5	4698
MIM601678	#	15q15-q21.1	BARTTER SYNDROME, ANTENATAL, TYPE 1	6557
MIM601679	*	7q11.23	GENERAL TRANSCRIPTION FACTOR II-I; GTF2I	2969
MIM601680	#	17p13.1, 11p15.5, 11p15.5, 9p13.2-p13.1	ARTHROGRYPOSIS, DISTAL, TYPE 2B; DA2B	4621, 7136, 7140, 7169
MIM601681	*	17q24-q25	PROTEASOME 26S SUBUNIT, ATPase, 5; PSMC5	5705
MIM601682	%	3q21-q24	GLAUCOMA 1, OPEN ANGLE, C; GLC1C	2723
MIM601683	*	16p13.1-p12	COQ7, S. CEREVISIAE, HOMOLOG OF; COQ7	10229
MIM601684	*	1p36.1	RIBOSOMAL PROTEIN S6 KINASE, 90-KD, 1; RPS6KA1	6195
MIM601685	*	6q27	RIBOSOMAL PROTEIN S6 KINASE, 90-KD, 2; RPS6KA2	6196
MIM601686	*	14q11.2	TELOMERASE-ASSOCIATED PROTEIN 1; TEP1	7011
MIM601687	*	17q12	KERATIN 12; KRT12	3859
MIM601688	*	4q34-q35	15-@HYDROXYPROSTAGLANDIN DEHYDROGENASE; HPGD	3248
MIM601689	*	18q11.2	TAF4B RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 105-KD; TAF4B	6875
MIM601690	*	6p21.2-p12	PHOSPHOLIPASE A2, GROUP VII; PLA2G7	7941
MIM601691	*	1p22.1	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 4; ABCA4	24
MIM601692	*	5q31	TRANSFORMING GROWTH FACTOR, BETA-INDUCED, 68-KD; TGFBI	7045
MIM601693	*	11q13	UNCOUPLING PROTEIN 2; UCP2	7351
MIM601694	%	2p21	LEPTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; LEPQTL1	7839
MIM601695	*	4q13-q21	CASEIN, KAPPA; CSN10	1448
MIM601696		11p15.5	NOVELTY SEEKING PERSONALITY TRAIT	1815
MIM601697	*	18q21.3	PROTEASE INHIBITOR 8; PI8	5271
MIM601698	*	7q36	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, N, POLYPEPTIDE 2; PTPRN2	5799
MIM601699	*	20q13.11-q13.13	PROSTAGLANDIN I2 SYNTHASE; PTGIS	5740
MIM601700	%	 	SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	 
MIM601701		 	ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	 
MIM601702	*	18q11.1	RHO-ASSOCIATED COILED-COIL-CONTAINING PROTEIN KINASE 1; ROCK1	6093
MIM601703	*	19q13.2-q13.3	VASODILATOR-STIMULATED PHOSPHOPROTEIN; VASP	7408
MIM601704	*	4q21	CHEMOKINE, CXC MOTIF, LIGAND 9; CXCL9	4283
MIM601705	#	17q11-q12	T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY	8456
MIM601706		 	YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME	 
MIM601707		 	CRANIOFACIAL MALFORMATIONS, ASYMMETRIC, WITH POLYSYNDACTYLY AND ABNORMAL SKIN AND GUT DEVELOPMENT	 
MIM601708		 	SUPERIOR TRANSVERSE SCAPULAR LIGAMENT, CALCIFICATION OF, FAMILIAL	 
MIM601709	#	 	QUEBEC PLATELET DISORDER; QPD	5328
MIM601710	*	14q32.3	EUKARYOTIC TRANSLATION INITIATION FACTOR 5; EIF5	1983
MIM601711	*	9q33-q34	TNF RECEPTOR-ASSOCIATED FACTOR 1; TRAF1	7185
MIM601712	*	11q22-q23	BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 2; BIRC2	329
MIM601713	*	 	GLIA MATURATION FACTOR, BETA; GMFB	2764
MIM601714	*	12p13.3-p13.2	TEA DOMAIN FAMILY MEMBER 4; TEAD4	7004
MIM601716	*	20q13.1	STAUFEN, DROSOPHILA, HOMOLOG OF, 1; STAU1	6780
MIM601717	*	19p13.3-p13.2	SYNTAXIN-BINDING PROTEIN 2; STXBP2	6813
MIM601718	#	1p22.1	RETINITIS PIGMENTOSA 19; RP19	24
MIM601719	*	17q21-q22	T-BOX 4; TBX4	9496
MIM601720	*	10p15-p14	ANTIGENIC DETERMINANT OF RECOMBINATION PROTEIN A, MOUSE, HOMOLOG OF; KIN	22944
MIM601721	*	11q22-q23	BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 3; BIRC3	330
MIM601723	*	2q33-q34	FRIZZLED, DROSOPHILA, HOMOLOG OF, 5; FZD5	7855
MIM601724	*	2q32	NEUROGENIC DIFFERENTIATION 1; NEUROD1	4760
MIM601725	*	17q12	NEUROGENIC DIFFERENTIATION 2; NEUROD2	4761
MIM601726	*	5q23-q31	NEUROGENIN 1; NEUROG1	4762
MIM601728	+	10q23.31	PHOSPHATASE AND TENSIN HOMOLOG; PTEN	5728
MIM601729	*	19q13.3	TEA DOMAIN FAMILY MEMBER 2; TEAD2	8463
MIM601730	*	1q23-q25	PHOSPHATIDYLINOSITOL GLYCAN, CLASS C; PIGC	5279
MIM601731	*	2q35	5-@AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOTIDE FORMYLTRANSFERASE/IMP CYCLOHYDROLASE; ATIC	471
MIM601732	*	3p23-p21	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY C, MEMBER 1; SMARCC1	6599
MIM601733	*	4q28-q31	GLUTATHIONE S-TRANSFERASE, MICROSOMAL, 2; MGST2	4258
MIM601734	*	12q13-q14	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY C, MEMBER 2; SMARCC2	6601
MIM601735	*	12q13-q14	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY D, MEMBER 1; SMARCD1	6602
MIM601736	*	17q23-q24	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY D, MEMBER 2; SMARCD2	6603
MIM601737	*	7q35-q36	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY D, MEMBER 3; SMARCD3	6604
MIM601738	*	1p36.1	EXOSTOSIN-LIKE 1; EXTL1	2134
MIM601739	*	2p14-p13	MEIS1, MOUSE, HOMOLOG OF, 1; MEIS1	4211
MIM601740	*	15q14-q25	MEIS1, MOUSE, HOMOLOG OF, 2; MEIS2	4212
MIM601741	*	11q22-q23	CULLIN 5; CUL5	8065
MIM601742	*	 	TRIPARTITE MOTIF-CONTAINING PROTEIN 28; TRIM28	10155
MIM601743	*	5p13.1	ONCOSTATIN M RECEPTOR; OSMR	9180
MIM601744	#	1q41-q42	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 1; SLEB1	7100, 7833
MIM601745	*	1q42-q43	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 1; KCNK1	3775
MIM601746	*	Chr.11	HYPOXIA UP-REGULATED 1; HYOU1	10525
MIM601747	*	 	TRIPARTITE MOTIF-CONTAINING PROTEIN 23; TRIM23	373
MIM601748	*	5q12.2-q13.3	GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 2; GTF2H2	2966
MIM601749	*	1p22-p21	GLOMULIN; GLMN	11146
MIM601750	*	 	GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 3; GTF2H3	2967
MIM601751	*	22q13.3	MELANIN-CONCENTRATING HORMONE RECEPTOR 1; MCHR1	2847
MIM601752	*	10q24	ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1; ENTPD1	953
MIM601753	*	4q31.3	PEPTIDYL-PROLYL ISOMERASE D; PPID	5481
MIM601754	*	22q11.2	UBIQUITIN FUSION DEGRADATION 1-LIKE; UFD1L	7353
MIM601755	*	22q11.2	DIGEORGE SYNDROME CRITICAL REGION GENE 14; DGCR14	8220
MIM601756	*	2q24-q31	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 3; GALNT3	2591
MIM601757	*	6q22-q24	PEROXISOME BIOGENESIS FACTOR 7; PEX7	5191
MIM601758	*	Chr.17	PEROXISOME BIOGENESIS FACTOR 12; PEX12	5193
MIM601759		 	PREAXIAL HALLUCAL POLYDACTYLY	 
MIM601760	*	6p21.3	GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 4; GTF2H4	2968
MIM601761	*	10q25.1-q25.2	CASPASE 7, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP7	840
MIM601762	*	2q33-q34	CASPASE 10, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP10	843
MIM601763	*	2q33	CASPASE 8, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP8	841
MIM601764	%	19q	SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	8181
MIM601766	*	7q11.23	FRIZZLED, DROSOPHILA, HOMOLOG OF, 9; FZD9	8326
MIM601767	*	7q11.23	HUNTINGTIN-INTERACTING PROTEIN 1; HIP1	3092
MIM601768	*	19p13.3	SH3 DOMAIN, GRB2-LIKE, 1; SH3GL1	6455
MIM601769	*	12q12-q14	VITAMIN D RECEPTOR; VDR	7421
MIM601770	*	5q31	NEUROPEPTIDE Y RECEPTOR Y6; NPY6R	4888
MIM601771	*	2p22-p21	CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 1; CYP1B1	1545
MIM601772	*	11q23.2-q23.3	H2A HISTONE FAMILY, MEMBER X; H2AFX	3014
MIM601773	*	2q35-q36.1	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, N; PTPRN	5798
MIM601774	*	2q21	ALPHA-1,6-@MANNOSYL-GLYCOPROTEIN BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE; MGAT5	4249
MIM601775		 	FOLATE LEVEL IN ERYTHROCYTES	 
MIM601776	#	15q14	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE	113189
MIM601777	#	17p13.1	CONE-ROD DYSTROPHY 6; CORD6	3000
MIM601778	*	19p13.3	POLYMERASE, RNA, MITOCHONDRIAL; POLRMT	5442
MIM601779	^	 	MOVED TO 258450	 
MIM601780	#	15q21-q23	CEROID LIPOFUSCINOSIS, NEURONAL, 6; CLN6	54982
MIM601782	*	9p13	TESTIS-SPECIFIC PROTEIN KINASE 1; TESK1	7016
MIM601783	*	 	MICROTUBULE-ASSOCIATED PROTEIN 6; MAP6	4135
MIM601784	*	17q11.2-q12	CATION CHANNEL, AMILORIDE-SENSITIVE, NEURONAL, 1; ACCN1	40
MIM601785	*	16p13.3-p13.2	PHOSPHOMANNOMUTASE 2; PMM2	5373
MIM601786	*	22q13.1	PHOSPHOMANNOMUTASE 1; PMM1	5372
MIM601787	*	10q24-q25.2	TAF5 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 100-KD; TAF5	6877
MIM601788	*	2q32.2	MYOSTATIN; MSTN	2660
MIM601789	*	2p15	PEROXISOME BIOGENESIS FACTOR 13; PEX13	5194
MIM601790	*	10q11.2-q21.2	PANCREATIC POLYPEPTIDE RECEPTOR 1; PPYR1	5540
MIM601791	*	1p36.2	PEROXISOME BIOGENESIS FACTOR 14; PEX14	5195
MIM601792	*	3q29	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 2; PPP1R2	5504
MIM601794	%	 	COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	 
MIM601795	*	16p11.2	MITOGEN-ACTIVATED PROTEIN KINASE 3; MAPK3	5595
MIM601796	*	20q13.33	TAF4 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 135-KD; TAF4	6874
MIM601797	*	6q21	ABSENT IN MELANOMA 1; AIM1	202
MIM601798	*	5q31	GLUCOSAMINE-6-PHOSPHATE DEAMINASE 1; GNPDA1	10007
MIM601799	*	6p25	PROTEASE INHIBITOR 9, OVALBUMIN TYPE; PI9	5272
MIM601800	#	11q14-q21	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 3; SHEP3	7299
MIM601801	*	 	TRANSCRIPTION FACTOR Sp2; SP2	6668
MIM601802	*	3p21.2-p21.1	HOMEOBOX GENE EXPRESSED IN ES CELLS; HESX1	8820
MIM601803	#	 	PALLISTER-KILLIAN SYNDROME; PKS	 
MIM601804	*	2q31	TRANSCRIPTION FACTOR Sp3; SP3	6670
MIM601805	*	7p22	G PROTEIN-COUPLED ESTROGEN RECEPTOR; GPER	2852
MIM601806	*	2q21	MINICHROMOSOME MAINTENANCE, S. POMBE, HOMOLOG OF, 6; MCM6	4175
MIM601807	*	12q14	MATRIX METALLOPROTEINASE 19; MMP19	4327
MIM601808	#	18q	CHROMOSOME 18q DELETION SYNDROME	100216483
MIM601809		 	SPONDYLOSPINAL THORACIC DYSOSTOSIS	 
MIM601810	*	10q21.3-q22.1	DNA REPLICATION HELICASE 2, YEAST, HOMOLOG OF; DNA2	1763
MIM601811		 	PREMATURE AGING SYNDROME, OKAMOTO TYPE	 
MIM601812		 	PREMATURE AGING SYNDROME, PENTTINEN TYPE	 
MIM601813	#	11q13.4	EXUDATIVE VITREORETINOPATHY 4; EVR4	4041
MIM601814	*	11q23	FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 2; FXYD2	486
MIM601815	#	1q12	PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	26227
MIM601816	#	2q37	BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1	54658
MIM601817	*	16q13	NONMETASTATIC CELLS 3, PROTEIN EXPRESSED IN; NME3	4832
MIM601818	*	16p13.3	NONMETASTATIC CELLS 4, PROTEIN EXPRESSED IN; NME4	4833
MIM601819	*	17q24	FETAL ALZHEIMER ANTIGEN; FALZ	2186
MIM601820	#	11p15.1	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2	3767
MIM601821	*	7q36	RNA, Y1 SMALL CYTOPLASMIC; RNY1	6084
MIM601822	*	7q36	RNA, Y3 SMALL CYTOPLASMIC; RNY3	6085
MIM601823	*	7q36	RNA, Y4 SMALL CYTOPLASMIC; RNY4	6086
MIM601824	*	7q36	RNA, Y5 SMALL CYTOPLASMIC; RNY5	6090
MIM601825	*	19p13	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 7; NDUFS7	374291
MIM601826	*	2q37.1	DIACYLGLYCEROL KINASE, DELTA, 130-KD; DGKD	8527
MIM601828	*	2q22-q23	NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; NR4A2	4929
MIM601829		 	ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	 
MIM601831	*	1q21-q23	HISTONE GENE CLUSTER 2, H2B HISTONE FAMILY, MEMBER E; HIST2H2BE	8349
MIM601832	*	3q29-qter	RIBOSOMAL PROTEIN L29; RPL29	6159
MIM601833	*	6p21.3	ALLOGRAFT INFLAMMATORY FACTOR 1; AIF1	199
MIM601834	*	3p22	CHEMOKINE, CC MOTIF, RECEPTOR 8; CCR8	1237
MIM601835	*	6q27	CHEMOKINE, CC MOTIF, RECEPTOR 6; CCR6	1235
MIM601836	*	1q24.2	KINESIN-ASSOCIATED PROTEIN 3; KIFAP3	22920
MIM601837	*	13q22-q34	LIGASE IV, DNA, ATP-DEPENDENT; LIG4	3981
MIM601838	*	 	INOSITOL 1,3,4-TRISPHOSPHATE 5/6-KINASE; ITPK1	3705
MIM601839	*	3q21-qter	EPHRIN RECEPTOR EphB3; EPHB3	2049
MIM601841	*	14q32.1	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 5; SERPINA5	5104
MIM601842	^	 	MOVED TO 601543	 
MIM601843	*	19p13.2-p12	SOLUTE CARRIER FAMILY 5 (SODIUM IODIDE SYMPORTER), MEMBER 5; SLC5A5	6528
MIM601844	*	17q21-q22	PROTEIN KINASE, LYSINE-DEFICIENT 4; WNK4	65266
MIM601845	*	22q11.2	GOOSECOID-LIKE; GSCL	2928
MIM601846	%	19p13.3	VACUOLAR NEUROMYOPATHY	4195
MIM601847	#	2q24	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2; PFIC2	8647
MIM601848	*	 	MAS20P, S. CEREVISIAE, HOMOLOG OF	9804
MIM601849	^	 	MOVED TO 228930	 
MIM601851	*	4q12	CIRCADIAN LOCOMOTOR OUTPUT CYCLES KAPUT; CLOCK	9575
MIM601852	*	19p13.2	INTERCELLULAR ADHESION MOLECULE 5; ICAM5	7087
MIM601853		 	CEREBELLOTRIGEMINAL DERMAL DYSPLASIA	 
MIM601854	*	3q27-q28	DIACYLGLYCEROL KINASE, GAMMA, 90-KD; DGKG	1608
MIM601855	*	19q13.13	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; ARHGEF1	9138
MIM601856	*	19q13.4	ZINC FINGER PROTEIN 211; ZNF211	10520
MIM601858	*	 	CALMEGIN; CLGN	1047
MIM601859	#	10q24.1	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; ALPS	355
MIM601860	*	5q2	17-@BETA-HYDROXYSTEROID DEHYDROGENASE IV; HSD17B4	3295
MIM601861	*	13q14	REGULATORY FACTOR X-ASSOCIATED PROTEIN; RFXAP	5994
MIM601863	*	1q21.1-q21.3	REGULATORY FACTOR X, 5; RFX5	5993
MIM601865	*	3q23-q24	PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE 2; PLOD2	5352
MIM601866	*	 	SEMAPHORIN 4D; SEMA4D	10507
MIM601867	*	3q22-q23	ATPase, Na+/K+ TRANSPORTING, BETA-3 POLYPEPTIDE; ATP1B3	483
MIM601868	#	6p21.3	DEAFNESS, AUTOSOMAL DOMINANT 13; DFNA13	1302
MIM601869	#	3q	DEAFNESS, AUTOSOMAL RECESSIVE 15; DFNB15	126326
MIM601870	*	 	METHIONINE AMINOPEPTIDASE 2; METAP2	10988
MIM601871	*	12q21.1	CYSTEINE- AND GLYCINE-RICH PROTEIN 2; CSRP2	1466
MIM601872	*	8p22	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 2; SLC7A2	6542
MIM601873	*	12q13.3	BETA-1,4-N-ACETYLGALACTOSAMINYLTRANSFERASE 1; B4GALNT1	2583
MIM601874	*	5q15	ELONGATION FACTOR, RNA POLYMERASE II, 2; ELL2	22936
MIM601877	+	1q42.1	LEFT-RIGHT DETERMINATION FACTOR 2; LEFTY2	7044
MIM601878	*	 	KRUPPEL-LIKE FACTOR 10; KLF10	7071
MIM601879	*	17q11.2	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 9; LGALS9	3965
MIM601880	*	16q	CHEMOKINE, CX3C MOTIF, LIGAND 1; CX3CL1	6376
MIM601881	*	18q21.3	RETINA AND ANTERIOR NEURAL FOLD HOMEOBOX GENE; RAX	30062
MIM601882	*	1p36.3-p36.2	DNA FRAGMENTATION FACTOR, 45-KD, ALPHA SUBUNIT; DFFA	1676
MIM601883	*	1p36.3	DNA FRAGMENTATION FACTOR, 40-KD, BETA SUBUNIT; DFFB	1677
MIM601884	#	11q13.4	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1; BMND1	4041
MIM601885	#	13q11	CATARACT, ZONULAR PULVERULENT 3; CZP3	2700
MIM601886	*	11p15.5	ACHAETE-SCUTE COMPLEX, DROSOPHILA, HOMOLOG OF, 2; ASCL2	430
MIM601887	#	1q32	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5	779
MIM601888	%	5p	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 6	4266
MIM601889	*	15q11-q13	B-CELL CLL/LYMPHOMA 8; BCL8	606
MIM601890	*	6p21.1-p12.2	PROTEIN-TYROSINE KINASE PTK7; PTK7	5754
MIM601891	*	11q13	CYSTATIN 6; CST6	1474
MIM601892	*	13q14.3	KARYOPHERIN ALPHA-3; KPNA3	3839
MIM601893	*	5p15.1-p14	TRIPLE FUNCTIONAL DOMAIN; TRIO	7204
MIM601894	#	2q34, 1q32	GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2	2335
MIM601895	*	 	TNF RECEPTOR-ASSOCIATED FACTOR 2; TRAF2	7186
MIM601896	*	 	TNF RECEPTOR-ASSOCIATED FACTOR 3; TRAF3	7187
MIM601897	*	3q21	ZINC FINGER PROTEIN 148; ZNF148	7707
MIM601898	*	3q26.3	GROWTH HORMONE SECRETAGOGUE RECEPTOR; GHSR	2693
MIM601899	*	10p14-p13	SIGNAL-TRANSDUCING ADAPTOR MOLECULE 1; STAM	8027
MIM601900	*	6p25-p23	INTERFERON REGULATORY FACTOR 4; IRF4	3662
MIM601901	*	19q13.3	SOLUTE CARRIER FAMILY 8 (SODIUM-CALCIUM EXCHANGER), MEMBER 2; SLC8A2	6543
MIM601902	*	1p32	ORIGIN RECOGNITION COMPLEX, SUBUNIT 1, S. CEREVISIAE, HOMOLOG OF; ORC1	4998
MIM601903	*	4q13	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B17; UGT2B17	7367
MIM601904	^	 	RIBOSOMAL PROTEIN L39; RPL39	6170
MIM601905	*	14q11.2	RAB GERANYLGERANYL TRANSFERASE, ALPHA SUBUNIT; RABGGTA	5875
MIM601906	*	12q13	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 10B; WNT10B	7480
MIM601907	*	15q22.3-q23	NEOGENIN; NEO1	4756
MIM601908	*	8q24.2-q24.3	G PROTEIN-COUPLED RECEPTOR 20; GPR20	2843
MIM601909	*	9q33	G PROTEIN-COUPLED RECEPTOR 21; GPR21	2844
MIM601910	*	7q22-q31.1	G PROTEIN-COUPLED RECEPTOR 22; GPR22	2845
MIM601911	*	17q21.3-q22	DISTAL-LESS HOMEOBOX 4; DLX4	1748
MIM601912	*	2q32.2-q33	SMALL UBIQUITIN-LIKE MODIFIER 1; SUMO1	7341
MIM601913	*	19q13.3	arsA ARSENITE TRANSPORTER, ATP-BINDING, E. COLI, HOMOLOG OF, 1; ASNA1	439
MIM601914	*	1q32	PROLINE ARGININE-RICH END LEUCINE-RICH REPEAT PROTEIN; PRELP	5549
MIM601915	*	3p25	TISSUE INHIBITOR OF METALLOPROTEINASE 4; TIMP4	7079
MIM601916	*	3p21.1	ARGININE-RICH PROTEIN MUTATED IN EARLY STAGE TUMORS; ARMET	7873
MIM601917	*	Chr.11	ALDEHYDE DEHYDROGENASE 3 FAMILY, MEMBER B2; ALDH3B2	222
MIM601918	*	 	GROWTH/DIFFERENTIATION FACTOR 9; GDF9	2661
MIM601919	*	5q13	COAGULATION FACTOR II RECEPTOR-LIKE 2; F2RL2	2151
MIM601920	+	20p12	JAGGED 1; JAG1	182
MIM601922	*	8p23	ANGIOPOIETIN 2; ANGPT2	285
MIM601924	*	1q23-q25	COATOMER PROTEIN COMPLEX, SUBUNIT ALPHA; COPA	1314
MIM601925	*	17q25.3	RHO GDP-DISSOCIATION INHIBITOR ALPHA; ARHGDIA	396
MIM601926	*	11q13.5	THYROID HORMONE-RESPONSIVE SPOT14, RAT, HOMOLOG OF; THRSP	7069
MIM601927	%	 	LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES	 
MIM601928	*	12q13	KERATIN 86; KRT86	3892
MIM601929	*	17p13.3	ATPase, Ca(2+)-TRANSPORTING, UBIQUITOUS; ATP2A3	489
MIM601930	*	15q25.1	BASONUCLIN 1; BNC1	646
MIM601931	*	14q11.2-q12	BCL2-LIKE 2; BCL2L2	599
MIM601932	*	12q24.3	MUCIN 8, TRACHEOBRONCHIAL; MUC8	4590
MIM601933	*	12q23-q24.1	CRYPTOCHROME 1; CRY1	1407
MIM601934	*	17q25.3	G PROTEIN PATHWAY SUPPRESSOR 1; GPS1	2873
MIM601935	*	 	G PROTEIN PATHWAY SUPPRESSOR 2; GPS2	2874
MIM601936	*	12q21	PRKC, APOPTOSIS, WT1, REGULATOR; PAWR	5074
MIM601937	*	20q12	NUCLEAR RECEPTOR COACTIVATOR 3; NCOA3	8202
MIM601939	*	 	PROTEIN KINASE, SERINE/ARGININE-SPECIFIC, 1; SRPK1	6732
MIM601940	*	 	SPLICING FACTOR, SERINE/ARGININE-RICH, 4; SRSF4	6429
MIM601941	%	18q21	DIABETES MELLITUS, INSULIN-DEPENDENT, 6; IDDM6	3405
MIM601942	#	10p15.1	DIABETES MELLITUS, INSULIN-DEPENDENT, 10; IDDM10	3409, 3559
MIM601943	*	 	SPLICING FACTOR, SERINE/ARGININE-RICH, 9; SRSF9	8683
MIM601944	*	 	SPLICING FACTOR, SERINE/ARGININE-RICH, 6; SRSF6	6431
MIM601945	*	 	SPLICING FACTOR, ARGININE/SERINE-RICH, 8; SFRS8	6433
MIM601947	*	20p13	SRY-BOX 12; SOX12	6666
MIM601949	*	2q22-q23	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-4 SUBUNIT; CACNB4	785
MIM601950	*	16q24.3	ZINC FINGER PROTEIN, MULTITYPE 1; ZFPM1	161882
MIM601951	*	2q33	CDC-LIKE KINASE 1; CLK1	1195
MIM601952	#	13q12.3	KERATOSIS LINEARIS WITH ICHTHYOSIS CONGENITA AND SCLEROSING KERATODERMA	51371
MIM601953	*	5q13.3-q14	CYCLIN H; CCNH	902
MIM601954	#	17q12	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G; LGMD2G	8557
MIM601955	*	5q13.2	CYCLIN-DEPENDENT KINASE 7; CDK7	1022
MIM601956	*	8p21	GDNF FAMILY RECEPTOR ALPHA-2; GFRA2	2675
MIM601957		 	ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME	 
MIM601958	*	12q13	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-3 SUBUNIT; CACNB3	784
MIM601959	*	3p21.1	NEVER IN MITOSIS GENE A-RELATED KINASE 4; NEK4	6787
MIM601960	*	2q33-q37	CHEMOKINE, CC MOTIF, LIGAND 20; CCL20	6364
MIM601961	*	21q22.3	PROTEIN ARGININE N-METHYLTRANSFERASE 2; PRMT2	3275
MIM601962	*	6p21.3	TAP-BINDING PROTEIN; TAPBP	6892
MIM601963	*	5q32-q33.2	TETRATRICOPEPTIDE REPEAT DOMAIN 1; TTC1	7265
MIM601964	*	17q11-q23	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 7; DNAJC7	7266
MIM601965	*	9q22.1-q22.2	SPHINGOSINE 1-PHOSPHATE RECEPTOR 3; S1PR3	1903
MIM601966	*	1p36.1	REGULATORY SOLUTE CARRIER PROTEIN, FAMILY 1, MEMBER 1; RSC1A1	6248
MIM601967	*	22q13	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 7B; WNT7B	7477
MIM601968	*	1p13	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 2B; WNT2B	7482
MIM601969	*	10q25.3-q26.1	DELETED IN MALIGNANT BRAIN TUMORS 1; DMBT1	1755
MIM601970	*	7q36.3	VASOACTIVE INTESTINAL PEPTIDE RECEPTOR 2; VIPR2	7434
MIM601972	*	9q22	RAR-RELATED ORPHAN RECEPTOR B; RORB	6096
MIM601973	*	7q36.1	RETINOIC ACID RECEPTOR RESPONDER 2; RARRES2	5919
MIM601974	*	1p21	SPHINGOSINE 1-PHOSPHATE RECEPTOR 1; S1PR1	1901
MIM601975	*	1q32	PLAKOPHILIN 1; PKP1	5317
MIM601976		 	OTOFACIOOSSEOUS-GONADAL SYNDROME	 
MIM601977	#	 	THROMBOCYTHEMIA 2; THCYT2	4352
MIM601978	*	9p13	SIGMA NONOPIOID INTRACELLULAR RECEPTOR 1; SIGMAR1	10280
MIM601979		 	HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION	 
MIM601980	*	 	LIPASE, GASTRIC; LIPF	8513
MIM601981	*	14q11.2	RIBONUCLEASE A FAMILY, 6; RNASE6	6039
MIM601982	*	3p26.2	8-@OXOGUANINE DNA GLYCOSYLASE; OGG1	4968
MIM601983	*	19q13.1-q13.4	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 1; MAP4K1	11184
MIM601984	*	10q11.2	NUCLEAR RECEPTOR COACTIVATOR 4; NCOA4	8031
MIM601985	*	10q21	COILED-COIL DOMAIN-CONTAINING PROTEIN 6; CCDC6	8030
MIM601987	*	22q13	CARNITINE PALMITOYLTRANSFERASE I, MUSCLE; CPT1B	1375
MIM601988	*	 	LIM DOMAIN KINASE 2; LIMK2	3985
MIM601989	*	1q21	S100 CALCIUM-BINDING PROTEIN A13; S100A13	6284
MIM601990	*	1p36	TUMOR PROTEIN p73; TP73	7161
MIM601991	*	19q13.3	NEUROONCOLOGIC VENTRAL ANTIGEN 2; NOVA2	4858
MIM601992	%	9p23-p11	FRIEDREICH ATAXIA 2	2420
MIM601993	*	8q13.2-q13.3	NUCLEAR RECEPTOR COACTIVATOR 2; NCOA2	10499
MIM601994	*	3p21.3	TRANSFER RNA ARGININE	7870
MIM601995	*	1q24	TENASCIN R; TNR	7143
MIM601997	*	22q11.2	BH3-INTERACTING DOMAIN DEATH AGONIST; BID	637
MIM601998	*	11q12	ESTROGEN-RELATED RECEPTOR, ALPHA; ESRRA	2101
MIM601999	*	17q12	LIM HOMEOBOX GENE 1; LHX1	3975
MIM602000	*	 	POLYMERASE I, RNA, SUBUNIT B; POLR1B	84172
MIM602001	*	4q31-q32	NEUROPEPTIDE Y RECEPTOR Y5; NPY5R	4889
MIM602002	*	7q34-q35	ZYXIN; ZYX	7791
MIM602003	*	 	LYMPHOID-RESTRICTED MEMBRANE PROTEIN; LRMP	4033
MIM602004	*	 	PROTEIN-TYROSINE KINASE 6; PTK6	5753
MIM602005	*	11q23.2-q24.2	SORTILIN-RELATED RECEPTOR; SORL1	6653
MIM602006	*	 	MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 2; MAPKAPK2	9261
MIM602007	*	22q11	V-CRK AVIAN SARCOMA VIRUS CT10 ONCOGENE HOMOLOG-LIKE; CRKL	1399
MIM602008	*	 	RAN-BINDING PROTEIN 5; RANBP5	3843
MIM602009	*	 	CYTOCHROME c OXIDASE, SUBUNIT VIa, POLYPEPTIDE 2; COX6A2	1339
MIM602010	*	 	SPLICING FACTOR, SERINE/ARGININE-RICH, 11; SRSF11	9295
MIM602011	*	3p25	SUPPRESSOR OF TUMORIGENICITY 11; ST11	8466
MIM602012	*	9q34	ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 2; ENTPD2	954
MIM602013	*	11q13.1	POLYMERASE II, RNA, SUBUNIT G; POLR2G	5436
MIM602014	#	9q22	HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	140803
MIM602015	*	9q34	OUTER DENSE FIBER OF SPERM TAILS 2; ODF2	4957
MIM602016	*	19p13.1	KRUPPEL-LIKE FACTOR 2; KLF2	10365
MIM602017	*	6q27	PROTEASOME SUBUNIT, BETA-TYPE, 1; PSMB1	5689
MIM602018	*	19p13.3	NEURTURIN; NRTN	4902
MIM602019	*	8q24.1	SQUALENE EPOXIDASE; SQLE	6713
MIM602020	*	17q25	V-MAF AVIAN MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE FAMILY, PROTEIN G; MAFG	4097
MIM602021	*	12q15-q21.2	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 12A; PPP1R12A	4659
MIM602022	*	2q13	MAL-LIKE; MALL	7851
MIM602023	*	1p36	CHLORIDE CHANNEL, KIDNEY, B; CLCNKB	1188
MIM602024	*	1p36	CHLORIDE CHANNEL, KIDNEY, A; CLCNKA	1187
MIM602025	#	20q13.2, 20q13.11-q13.2	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 9; BMIQ9	4159
MIM602026	*	10pter-p11.2	PHYTANOYL-CoA HYDROXYLASE; PHYH	5264
MIM602027	*	16q22.1	TELOMERIC REPEAT-BINDING FACTOR 2; TERF2	7014
MIM602030	*	Chr.9	FUCOSYLTRANSFERASE 7; FUT7	2529
MIM602031	*	 	PROTEIN GERANYLGERANYLTRANSFERASE TYPE I, BETA SUBUNIT; PGGT1B	5229
MIM602032	#	12q13	ECTODERMAL DYSPLASIA, 'PURE' HAIR-NAIL TYPE	3891
MIM602033	*	14q32	ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 1; EML1	2009
MIM602034	*	7p21-p15	CORTICOTROPIN-RELEASING HORMONE RECEPTOR 2; CRHR2	1395
MIM602035	*	16p12-p11	PROTEIN PHOSPHATASE 4, CATALYTIC SUBUNIT; PPP4C	5531
MIM602036	^	 	MOVED TO 133200	 
MIM602037	*	4p13	RAS HOMOLOG GENE FAMILY, MEMBER H; RHOH	399
MIM602038	*	11p15.5	DUAL-SPECIFICITY PHOSPHATASE 8; DUSP8	1850
MIM602039	*	10q26	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT A; EIF3A	8661
MIM602040	*	21q21	CELL ADHESION MOLECULE, NEURAL, 2; NCAM2	4685
MIM602041	*	8p21	NK3 HOMEOBOX 1; NKX3-1	4824
MIM602042	*	13q32	G PROTEIN-COUPLED RECEPTOR 18; GPR18	2841
MIM602043	*	6q27	G PROTEIN-COUPLED RECEPTOR 31; GPR31	2853
MIM602044	*	11q13	UNCOUPLING PROTEIN 3; UCP3	7352
MIM602045	*	6p21.3	RING FINGER PROTEIN 1; RING1	6015
MIM602046	*	15q15	PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 3; PDIA3	2923
MIM602047	*	11p15	PHOSPHODIESTERASE 3B, cGMP-INHIBITED; PDE3B	5140
MIM602048	*	 	RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 1; RAC1	5879
MIM602049	*	22q12.3-q13.2	RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 2; RAC2	5880
MIM602050	*	17q25.3	RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 3; RAC3	5881
MIM602051	*	1p31	PEPTIDYL-PROLYL CIS/TRANS ISOMERASE, NIMA-INTERACTING, 1-LIKE; PIN1L	5301
MIM602052	*	4p16	CYCLIN G-ASSOCIATED KINASE; GAK	2580
MIM602053	*	10p15	KRUPPEL-LIKE FACTOR 6; KLF6	1316
MIM602054	*	22q11.2	T-BOX 1; TBX1	6899
MIM602055	*	7q36	INSULIN-INDUCED GENE 1; INSIG1	3638
MIM602056	*	8p23.1	DEFENSIN, BETA, 1; DEFB1	1672
MIM602058	*	18q21.3	PROTEASE INHIBITOR 10; PI10	5273
MIM602059	*	15q23-q24	IMMUNOGLOBULIN SUPERFAMILY CONTAINING LEUCINE-RICH REPEAT; ISLR	3671
MIM602060	*	21q22.3	TRANSMEMBRANE PROTEASE, SERINE 2; TMPRSS2	7113
MIM602061	*	 	EPIREGULIN; EREG	2069
MIM602062	*	9q22	NERVE INJURY-INDUCED PROTEIN 1; NINJ1	4814
MIM602063	*	11p15.5-p15.4	TRANSALDOLASE 1; TALDO1	6888
MIM602064	*	8q21.13-q21.3	MYO-INOSITOL MONOPHOSPHATASE 1; IMPA1	3612
MIM602065	*	10p15	ADENOSINE DEAMINASE, RNA-SPECIFIC, B2; ADARB2	105
MIM602066	#	16p12-q12	CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS; ICCA	3387
MIM602067	^	6q23	MOVED TO 601419	1222, 1674
MIM602068		 	LEISHMANIASIS, TEGUMENTARY, SUSCEPTIBILITY TO	 
MIM602069	*	10p12	NEUROPILIN 1; NRP1	8829
MIM602070	*	2q34	NEUROPILIN 2; NRP2	8828
MIM602071	%	 	BROAD TERMINAL PHALANGES, FAMILIAL	 
MIM602072	*	12q24.2	CYTOCHROME c OXIDASE, SUBUNIT VIa, POLYPEPTIDE 1; COX6A1	1337
MIM602074	*	1q21	DEATH-ASSOCIATED PROTEIN 3; DAP3	7818
MIM602075	*	3p23	SPECIAL AT-RICH SEQUENCE-BINDING PROTEIN 1; SATB1	6304
MIM602076	*	17p13	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 1; TRPV1	7442
MIM602077	^	 	MOVED TO 604292	 
MIM602078	#	11q13.3-q13.4	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	401
MIM602079	#	1q23-q25	TRIMETHYLAMINURIA; TMAU	2328
MIM602080	#	5q35, 5q31, 18q22.1	PAGET DISEASE OF BONE; PDB	8792, 8878
MIM602081	#	7q31	SPEECH-LANGUAGE DISORDER 1; SPCH1	93986
MIM602082	%	10q24, 5q31	CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE II; CDB2	7045, 982
MIM602083	#	10q21-q22	USHER SYNDROME, TYPE IF; USH1F	65217
MIM602085	%	13q21-q32	POLYDACTYLY, POSTAXIAL, TYPE A2; PAPA2	8103
MIM602086	%	14q12-q22	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 3; ARVD3	424
MIM602087	%	2q32.1-q32.3	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 4; ARVD4	425
MIM602088	#	9q31	NEPHRONOPHTHISIS 2; NPHP2	27130
MIM602089	#	5q35.3, 5q31-q33, 4q12, 2p13.1	HEMANGIOMA, CAPILLARY INFANTILE	2324, 3791, 7909, 84168
MIM602090	*	11q12	LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 3; LTBP3	4054
MIM602091	*	14q24	LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 2; LTBP2	4053
MIM602092	#	11p15.1	DEAFNESS, AUTOSOMAL RECESSIVE 18; DFNB18	10083
MIM602093	#	6p21.1	CONE DYSTROPHY 3; COD3	2978
MIM602095	*	15q21.1	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 4; SLC30A4	7782
MIM602096	%	12p11.23-q13.12	ALZHEIMER DISEASE 5	8081
MIM602097	%	21q21	USHER SYNDROME, TYPE IE; USH1E	7396
MIM602098	*	 	POLO-LIKE KINASE 1; PLK1	5347
MIM602099	%	15q15.1-q21.1	AMYOTROPHIC LATERAL SCLEROSIS 5; ALS5	255
MIM602100	*	21q22.3	PBX/KNOTTED 1 HOMEOBOX 1; PKNOX1	5316
MIM602101	*	22q11.2	CLAUDIN 5; CLDN5	7122
MIM602102	*	19q13.1-q13.2	SUPPRESSOR OF TY 5, S. CEREVISIAE, HOMOLOG OF; SUPT5H	6829
MIM602103	*	21q22.3	TRANSMEMBRANE PROTEIN 1; TMEM1	7109
MIM602104	*	4p16.3	SH3 DOMAIN-BINDING PROTEIN 2; SH3BP2	6452
MIM602105	*	1p31	MutS, E. COLI, HOMOLOG OF, 4; MSH4	4438
MIM602106	*	21q22.2	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 15; KCNJ15	3772
MIM602107		 	NEUROPATHY, HEREDITARY THERMOSENSITIVE	 
MIM602108	*	8q22	MATRILIN 2; MATN2	4147
MIM602109	*	2p24-p23	MATRILIN 3; MATN3	4148
MIM602110	*	11q13	SOLUTE CARRIER FAMILY 29 (NUCLEOSIDE TRANSPORTER), MEMBER 2; SLC29A2	3177
MIM602111	#	11q22.3	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE	4322
MIM602112	*	22q13.31	METALLOPHOSPHOESTERASE DOMAIN-CONTAINING PROTEIN 1; MPPED1	758
MIM602113	*	12q12-q14	MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA 2; MLL2	8085
MIM602115	*	5p13-p12	FIBROBLAST GROWTH FACTOR 10; FGF10	2255
MIM602116	*	12q13-q15	YEATS DOMAIN-CONTAINING PROTEIN 4; YEATS4	8089
MIM602117	*	15q11-q13	NECDIN; NDN	4692
MIM602118	*	5q15-q21	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 1; CHD1	1105
MIM602119	*	15q26	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 2; CHD2	1106
MIM602120	*	17p13	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 3; CHD3	1107
MIM602121	*	5q31	DIAPHANOUS, DROSOPHILA, HOMOLOG OF, 1; DIAPH1	1729
MIM602122	*	4q11	SIGNAL RECOGNITION PARTICLE, 72-KD; SRP72	6731
MIM602123	*	10q22	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-GAMMA; CAMK2G	818
MIM602124	%	18p	DYSTONIA 7, TORSION; DYT7	1866
MIM602125	*	17p12-p11.2	CYTOCHROME c OXIDASE ASSEMBLY PROTEIN COX10; COX10	1352
MIM602126	*	18p11.21	ZINC FINGER PROTEIN 161, MOUSE, HOMOLOG OF; ZFP161	7541
MIM602127	*	22q12.3	SMOOTHELIN; SMTN	6525
MIM602128	*	22q12	GROWTH ARREST-SPECIFIC 2-LIKE 1; GAS2L1	10634
MIM602129	*	19p13.1	MYOSIN IXB; MYO9B	4650
MIM602130	*	3p21.3	MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 3; MAPKAPK3	7867
MIM602131	*	11p15.5	PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY A, MEMBER 2; PHLDA2	7262
MIM602132	*	14q	CUTANEOUS T-CELL LYMPHOMA-ASSOCIATED ANTIGEN 5; CTAGE5	4253
MIM602133	*	Chr.17	PHOSPHORIBOSYLFORMYLGLYCINAMIDINE SYNTHASE; PFAS	5198
MIM602134	%	2p25-p22	TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	2112
MIM602135	*	1p35.1	DYNEIN, AXONEMAL, LIGHT INTERMEDIATE POLYPEPTIDE 1; DNALI1	7802
MIM602136	*	7q21-q22	PEROXISOME BIOGENESIS FACTOR 1; PEX1	5189
MIM602137	*	5q31.2	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 2; NDUFA2	4695
MIM602138	*	22q13.1	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 6; NDUFA6	4700
MIM602139	*	19p13.2	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 7; NDUFA7	4701
MIM602140	*	10q23.2-q23.33	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 8; NDUFB8	4714
MIM602141	*	11q13	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 8; NDUFS8	4728
MIM602142	*	3p22-p21.3	PHOSPHOLIPASE C, DELTA-1; PLCD1	5333
MIM602143	*	1q42.1	TUMOR PROTEIN p53-BINDING PROTEIN 2; TP53BP2	7159
MIM602144	*	1p	BROMODOMAIN, TESTIS-SPECIFIC; BRDT	676
MIM602145	*	12q13	PROLIFERATION-ASSOCIATED 2G4, 38-KD; PA2G4	5036
MIM602146	*	1q25	LIM HOMEOBOX GENE 4; LHX4	89884
MIM602148	*	13q34	SRY-BOX 1; SOX1	6656
MIM602149	*	5q31	PAIRED-LIKE HOMEODOMAIN TRANSCRIPTION FACTOR 1; PITX1	5307
MIM602150	*	8q11	SNAIL, DROSOPHILA, HOMOLOG OF, 2; SNAI2	6591
MIM602151	*	 	DISHEVELLED 2; DVL2	1856
MIM602152		 	RHYNS SYNDROME	 
MIM602153	*	12q13	KERATIN 81; KRT81	3887
MIM602154	*	6q23-q24	NONCODING TRANSCRIPT IN T CELLS	7956
MIM602155	*	8p12-p11.2	UBX DOMAIN PROTEIN 8; UBXN8	7993
MIM602157	*	14q	NEUROONCOLOGIC VENTRAL ANTIGEN 1; NOVA1	4857
MIM602158	*	11q13.5-q14.1	CHLORIDE CHANNEL, NUCLEOTIDE SENSITIVE, 1A; CLNS1A	1207
MIM602159	*	9q22.3	CORONIN 2A; CORO2A	7464
MIM602160	*	3q23	TRANSCRIPTION FACTOR DP2; TFDP2	7029
MIM602161	*	14q11.2	PROTEASOME ACTIVATOR SUBUNIT 2; PSME2	5721
MIM602162	*	1p13	SYNAPTONEMAL COMPLEX PROTEIN 1; SYCP1	6847
MIM602163	*	3p24.2	UBIQUITIN-CONJUGATING ENZYME E2E 2; UBE2E2	7325
MIM602164	*	5q31-q33	5-@HYDROXYTRYPTAMINE RECEPTOR 4; HTR4	3360
MIM602165	*	6p22	TRIPARTITE MOTIF-CONTAINING PROTEIN 27; TRIM27	5987
MIM602166	*	15q	ADAPTOR-RELATED PROTEIN COMPLEX 3, BETA-2 SUBUNIT; AP3B2	8120
MIM602167	*	14q24.3	ESTROGEN-RELATED RECEPTOR, BETA; ESRRB	2103
MIM602168	*	14q32	VACCINIA-RELATED KINASE 1; VRK1	7443
MIM602169	*	2p16-p15	VACCINIA-RELATED KINASE 2; VRK2	7444
MIM602170	*	3p22-p21.3	MYELOID DIFFERENTIATION PRIMARY RESPONSE GENE 88; MYD88	4615
MIM602171	*	 	GLYCOPROTEIN A33; GPA33	10223
MIM602172	*	3p22-p21.3	CYTOCHROME P450, SUBFAMILY VIIIB, POLYPEPTIDE 1; CYP8B1	1582
MIM602173	*	3q26.2	SEC62, S. CEREVISIAE, HOMOLOG OF; SEC62	7095
MIM602174	*	1q32.1	G PROTEIN-COUPLED RECEPTOR 25; GPR25	2848
MIM602175	*	1p34.2	PROTEASOME SUBUNIT, BETA-TYPE, 2; PSMB2	5690
MIM602176	*	17q12	PROTEASOME SUBUNIT, BETA-TYPE, 3; PSMB3	5691
MIM602177	*	1q21	PROTEASOME SUBUNIT, BETA-TYPE, 4; PSMB4	5692
MIM602178	*	17q21.33	CHONDROADHERIN; CHAD	1101
MIM602179	*	11q22-q23	HEAT-SHOCK 27-KD PROTEIN 2; HSPB2	3316
MIM602180	*	11q13.3	SIGNAL-INDUCED PROLIFERATION-ASSOCIATED GENE 1; SIPA1	6494
MIM602181	*	7q31.3	EBNA2 COACTIVATOR p100	27044
MIM602182	*	6q22	ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 3; ENPP3	5169
MIM602183	*	4p16.1	NK3 HOMEOBOX 2; NKX3-2	579
MIM602184	*	21q22.3	NADH-UBIQUINONE OXIDOREDUCTASE FLAVOPROTEIN 3; NDUFV3	4731
MIM602186	*	7q22	VGF, NERVE GROWTH FACTOR-INDUCIBLE; VGF	7425
MIM602187	*	11p15.5	ZINC FINGER PROTEIN 195; ZNF195	7748
MIM602188	*	 	EPHRIN RECEPTOR EphA4; EPHA4	2043
MIM602189	*	9q31-q33	REGULATOR OF G PROTEIN SIGNALING 3; RGS3	5998
MIM602190	*	 	EPHRIN RECEPTOR EphA7; EPHA7	2045
MIM602191	*	1q32	E74-LIKE FACTOR 3; ELF3	1999
MIM602192	*	15q21.3-q23	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 10; ADAM10	102
MIM602193	*	6p21.2-p21.1	SOLUTE CARRIER FAMILY 29 (NUCLEOSIDE TRANSPORTER), MEMBER 1; SLC29A1	2030
MIM602194	*	10q25.3-q26.2	HTRA SERINE PEPTIDASE 1; HTRA1	5654
MIM602195	*	7q11.23	HEAT-SHOCK 27-KD PROTEIN 1; HSPB1	3315
MIM602196	%	 	PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	 
MIM602197		17q25	CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 3	8163
MIM602198	*	12q24.31	CDK2-ASSOCIATED PROTEIN 1; CDK2AP1	8099
MIM602199	%	 	MEDIUM CHAIN 3-KETOACYL-CoA THIOLASE DEFICIENCY	 
MIM602200	%	 	VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY	 
MIM602201	*	1q21	EXTRACELLULAR MATRIX PROTEIN 1; ECM1	1893
MIM602202	*	1p36.1	DOLICHYL-DIPHOSPHOOLIGOSACCHARIDE-PROTEIN GLYCOSYLTRANSFERASE; DDOST	1650
MIM602203	*	11q22-q23	SARCOLIPIN; SLN	6588
MIM602204	*	12p11.2-p11.1	BICAUDAL D, DROSOPHILA, HOMOLOG OF, 1; BICD1	636
MIM602206	*	2q37.3	RAS-ASSOCIATED PROTEIN RAB17; RAB17	64284
MIM602207	*	10p12.1	RAS-ASSOCIATED PROTEIN RAB18; RAB18	22931
MIM602208	*	1q23.2	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 10; KCNJ10	3766
MIM602209	*	6p25	RAS-RESPONSIVE ELEMENT BINDING PROTEIN 1; RREB1	6239
MIM602210	*	8q22-q23	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT E; EIF3E	3646
MIM602211	*	1p34-p32	FORKHEAD, DROSOPHILA, HOMOLOG-LIKE 17; FKHL17	2306
MIM602212	*	16q12	SEVEN IN ABSENTIA, DROSOPHILA, HOMOLOG OF, 1; SIAH1	6477
MIM602213	*	3q25	SEVEN IN ABSENTIA, DROSOPHILA, HOMOLOG OF, 2; SIAH2	6478
MIM602214	*	19p13.3	CASEIN KINASE I, GAMMA-2; CSNK1G2	1455
MIM602215	*	8p23.1	DEFENSIN, BETA, 4A; DEFB4A	1673
MIM602216	*	19p13.3	SERINE/THREONINE PROTEIN KINASE 11; STK11	6794
MIM602217	*	 	SYNDECAN-BINDING PROTEIN; SDCBP	6386
MIM602218	*	16q12.1	SAL-LIKE 1; SALL1	6299
MIM602219	*	14q11.1-q12	SAL-LIKE 2; SALL2	6297
MIM602220	*	22q12	RAS-LIKE, FAMILY 10, MEMBER A; RASL10A	10633
MIM602221	*	13q11-q12	ZINC FINGER, MYM-TYPE 2; ZMYM2	7750
MIM602223	*	8p12	EUKARYOTIC TRANSLATION INITIATION FACTOR 4E-BINDING PROTEIN 1; EIF4EBP1	1978
MIM602224	*	10q21-q22	EUKARYOTIC TRANSLATION INITIATION FACTOR 4E-BINDING PROTEIN 2; EIF4EBP2	1979
MIM602225	*	19q13.3	CONE-ROD HOMEOBOX-CONTAINING GENE; CRX	1406
MIM602226	*	5q12	LYMPHOCYTE ANTIGEN 64, RADIOPROTECTIVE, 105-KD; LY64	4064
MIM602227	*	9p13	CHEMOKINE, CC MOTIF, LIGAND 19; CCL19	6363
MIM602228	*	10q25.3	TRANSCRIPTION FACTOR 7-LIKE 2; TCF7L2	6934
MIM602229	*	22q13	SRY-BOX 10; SOX10	6663
MIM602230	*	21q22.3	SH3-BINDING DOMAIN AND GLUTAMIC ACID-RICH PROTEIN; SH3BGR	6450
MIM602231	*	21q22.3	SMALL UBIQUITIN-LIKE MODIFIER 3; SUMO3	6612
MIM602232	*	8q24	POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 3; KCNQ3	3786
MIM602233	*	12q23	APOPTOTIC PROTEASE ACTIVATING FACTOR 1; APAF1	317
MIM602234	*	1p36.3-p36.1	CASPASE 9, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP9	842
MIM602235	*	20q13.3	POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 2; KCNQ2	3785
MIM602238	*	 	EXOSOME COMPONENT 2; EXOSC2	23404
MIM602239	*	10q23-q24	CYTOCHROME P450, SUBFAMILY XXVIA, POLYPEPTIDE 1; CYP26A1	1592
MIM602240	*	6p21.3	ZINC FINGER PROTEIN 192; ZNF192	7745
MIM602241	*	13q12	MITOCHONDRIAL INTERMEDIATE PEPTIDASE; MIPEP	4285
MIM602242	*	19q13.2-q13.3	ADAPTOR-RELATED PROTEIN COMPLEX 2, SIGMA-1 SUBUNIT; AP2S1	1175
MIM602243	*	11p15.5	CD151 ANTIGEN; CD151	977
MIM602244	*	3p21.1-p14.3	DEOXYRIBONUCLEASE I-LIKE 3; DNASE1L3	1776
MIM602245	*	22q12-q13.1	GTP-BINDING PROTEIN 1; GTPBP1	9567
MIM602246	*	6p21.3	ZINC FINGER PROTEIN 193; ZNF193	7746
MIM602247	%	 	XANTHOMATOSIS, SUSCEPTIBILITY TO	 
MIM602248	%	 	MALIGNANT ATROPHIC PAPULOSIS	 
MIM602249		 	PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	 
MIM602250	*	1p36	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 9; TNFRSF9	3604
MIM602251	*	11q12.1-q12.3	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 10, YEAST, HOMOLOG OF; TIMM10	26519
MIM602253	*	9q31	KRUPPEL-LIKE FACTOR 4; KLF4	9314
MIM602254	*	22q12.1	SRR1 DOMAIN-CONTAINING PROTEIN; SRRD	402055
MIM602255	*	 	SERINE/THREONINE PROTEIN KINASE 25; STK25	10494
MIM602256	*	4q21.1	PROTEIN PHOSPHATASE, EF-HAND CALCIUM-BINDING DOMAIN 2; PPEF2	5470
MIM602257	*	4q13-q21	SCAVENGER RECEPTOR CLASS B, MEMBER 2; SCARB2	950
MIM602259	*	21q22.2	TETRATRICOPEPTIDE REPEAT DOMAIN 3; TTC3	7267
MIM602260	*	17p12	PERIOD, DROSOPHILA, HOMOLOG OF; PER1	5187
MIM602261	*	16q13-q21	MATRIX METALLOPROTEINASE 15; MMP15	4324
MIM602262	*	8q21	MATRIX METALLOPROTEINASE 16; MMP16	4325
MIM602264	*	5q31	SPARC/OSTEONECTIN, CWCV, AND KAZAL-LIKE DOMAINS PROTEOGLYCAN; SPOCK	6695
MIM602265	*	6p25-p24	NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 9; NEDD9	4739
MIM602267	*	10q26.3	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 8; ADAM8	101
MIM602268	*	17q21	AMINE OXIDASE, COPPER-CONTAINING, 2; AOC2	314
MIM602269	*	22q11	ARMADILLO REPEAT GENE DELETED IN VCFS; ARVCF	421
MIM602270	*	5q32	ANTIOXIDANT PROTEIN 1; ATOX1	475
MIM602271		 	SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL	 
MIM602272	*	18q21.2	TRANSCRIPTION FACTOR 4; TCF4	6925
MIM602273	*	18q12.1	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 1; GALNT1	2589
MIM602274	*	1q41-q42	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 2; GALNT2	2590
MIM602275	*	6p21.1	GUANYLATE CYCLASE ACTIVATOR 1B; GUCA1B	2979
MIM602276	*	17q12-q21	TRANSCRIPTIONAL ADAPTOR 2A; TADA2A	6871
MIM602277	*	6p21.3	ZINC FINGER PROTEIN 184; ZNF184	7738
MIM602278	*	15q	NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 4; NEDD4	4734
MIM602279	*	14q11.2-q13	POLYADENYLATE-BINDING PROTEIN, NUCLEAR, 1; PABPN1	8106
MIM602280	*	6p21.3	TUBBY-LIKE PROTEIN 1; TULP1	7287
MIM602281	*	15q25	MILK FAT GLOBULE-EGF FACTOR 8; MFGE8	4240
MIM602282	*	9q31.3	LYSOPHOSPHATIDIC ACID RECEPTOR 1; LPAR1	1902
MIM602283	*	17q11.2	CHEMOKINE, CC MOTIF, LIGAND 8; CCL8	6355
MIM602284	*	1p35-p32	BONE MORPHOGENETIC PROTEIN 8; BMP8B	656
MIM602285	*	12q24.33	MATRIX METALLOPROTEINASE 17; MMP17	4326
MIM602286	*	11q23.3	STEROL C5-DESATURASE-LIKE; SC5DL	6309
MIM602287	*	Chr.12	ENDOPLASMIC RETICULUM PROTEIN, 29-KD; ERP29	10961
MIM602288	*	2p13	RHOTEKIN; RTKN	6242
MIM602289	*	 	DR1-ASSOCIATED PROTEIN 1; DRAP1	10589
MIM602290	*	9q31-q34.1	TRIPARTITE MOTIF-CONTAINING PROTEIN 32; TRIM32	22954
MIM602291	*	17q22-q25	FORKHEAD BOX J1; FOXJ1	2302
MIM602292	*	10q26.2-q26.3	ENOYL-CoA HYDRATASE, SHORT-CHAIN, 1, MITOCHONDRIAL; ECHS1	1892
MIM602293	*	15q25.3-q26.1	CALCIUM- AND INTEGRIN-BINDING PROTEIN 1; CIB1	10519
MIM602294	*	14q13	FORKHEAD BOX A1; FOXA1	3169
MIM602295	*	19q13.2-q13.4	FORKHEAD BOX A3; FOXA3	3171
MIM602296	*	7q22.1	ADAPTOR-RELATED PROTEIN COMPLEX 4, MU-1 SUBUNIT; AP4M1	9179
MIM602297	*	17p13.1-p11.2	EPHRIN B3; EFNB3	1949
MIM602298	*	3q21	RAS-ASSOCIATED PROTEIN RAB7; RAB7	7879
MIM602300	*	22q12.2	GALACTOSE-3-O-SULFOTRANSFERASE 1; GAL3ST1	9514
MIM602301	*	17q21	K(LYSINE) ACETYLTRANSFERASE 2A; KAT2A	2648
MIM602302	*	8p21.2	HAIRLESS, MOUSE, HOMOLOG OF; HR	55806
MIM602303	*	3p24	K(LYSINE) ACETYLTRANSFERASE 2B; KAT2B	8850
MIM602304	*	 	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP D, MEMBER 2; NR1D2	9975
MIM602306	*	6p21.3	RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 2; RGL2	5863
MIM602307	*	8q21	WW DOMAIN-CONTAINING PROTEIN 1; WWP1	11059
MIM602308	*	16q21	WW DOMAIN-CONTAINING PROTEIN 2; WWP2	11060
MIM602309	*	19q13.1	TUBBY-LIKE PROTEIN 2; TULP2	7288
MIM602310	*	 	RNA-BINDING MOTIF PROTEIN, SINGLE STRAND-INTERACTING, 1; RBMS1	5937
MIM602311	*	16q22	AGOUTI-RELATED PROTEIN, MOUSE, HOMOLOG OF; AGRP	181
MIM602313	*	11q13	OVO, DROSOPHILA, HOMOLOG-LIKE, 1; OVOL1	5017
MIM602314	*	1q25.1-q32.3	LADININ 1; LAD1	3898
MIM602315	*	17q11.2	MITOGEN-ACTIVATED PROTEIN KINASE KINASE 3; MAP2K3	5606
MIM602316	*	1q25.1	PEROXIREDOXIN 6; PRDX6	9588
MIM602317	*	3p24-p22	SRC HOMOLOGY 3 AND CYSTEINE-RICH DOMAIN; STAC	6769
MIM602318	*	7q21-q22	TRANSCRIPTION TERMINATION FACTOR, MITOCHONDRIAL; MTERF	7978
MIM602319	*	11p15.2-p15.1	NEL-LIKE 1; NELL1	4745
MIM602320	*	12q13.11-q13.12	NEL-LIKE 2; NELL2	4753
MIM602321	*	 	GLUTATHIONE S-TRANSFERASE, KAPPA-1; GSTK1	373156
MIM602322	*	3q21-q28	TELOMERASE RNA COMPONENT; TERC	7012
MIM602323	*	17p11.2-p11.1	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 12; KCNJ12	3768
MIM602324	*	10q22	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H3; HNRNPH3	3189
MIM602325	*	11p15	EUKARYOTIC TRANSLATION INITIATION FACTOR 4-GAMMA, 2; EIF4G2	1982
MIM602326	*	17q11	RIBOSOMAL PROTEIN L23A; RPL23A	6147
MIM602327	*	10q24	PLECKSTRIN AND SEC7 DOMAINS-CONTAINING PROTEIN; PSD	5662
MIM602329	*	14q31	SUPPRESSOR OF LIN12-LIKE; SEL1L	6400
MIM602330	*	10q25	ACTIN-BINDING LIM PROTEIN FAMILY, MEMBER 1; ABLIM1	3983
MIM602331	*	7q22.1	ORIGIN RECOGNITION COMPLEX, SUBUNIT 5, S. CEREVISIAE, HOMOLOG OF; ORC5	5001
MIM602332	*	2q11.2	NON-SMC CONDENSIN I COMPLEX SUBUNIT H; NCAPH	23397
MIM602333	*	12p12.3	EPITHELIAL MEMBRANE PROTEIN 1; EMP1	2012
MIM602334	*	16p13.2	EPITHELIAL MEMBRANE PROTEIN 2; EMP2	2013
MIM602335	*	19q13.3	EPITHELIAL MEMBRANE PROTEIN 3; EMP3	2014
MIM602336	*	1p32-p31	RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTOR 1; ROR1	4919
MIM602337	*	9q22	RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTOR 2; ROR2	4920
MIM602338	*	6p25.2	PRECURSOR mRNA-PROCESSING FACTOR 4, S. POMBE, HOMOLOG OF, B; PRPF4B	8899
MIM602339	*	 	SOLUTE CARRIER FAMILY 15 (H+/PEPTIDE TRANSPORTER), MEMBER 2; SLC15A2	6565
MIM602340		 	SENSORINEURAL HEARING LOSS, RETINAL PIGMENT EPITHELIUM LESIONS, DISCOLORED TEETH	 
MIM602341	*	12p13	FORKHEAD BOX M1; FOXM1	2305
MIM602342	%	 	PLANTAR LIPOMATOSIS, UNUSUAL FACIES, AND DEVELOPMENTAL DELAY	 
MIM602343	*	3q22-q24	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 1; TRPC1	7220
MIM602344	*	 	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE 2; PAFAH2	5051
MIM602345	*	 	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 3; TRPC3	7222
MIM602346	*	17q21	CONTACTIN-ASSOCIATED PROTEIN 1; CNTNAP1	8506
MIM602347	#	7q21.1	CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	5244
MIM602348	*	 	SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 3; SNAPC3	6619
MIM602349	*	16p13.3	NETRIN 2, CHICKEN, HOMOLOG-LIKE; NTN2L	4917
MIM602350	*	11q24	NEUROGRANIN; NRGN	4900
MIM602351	*	12q24.1	CHEMOKINE-LIKE RECEPTOR 1; CMKLR1	1240
MIM602352	*	20p13	GONADOTROPIN-RELEASING HORMONE 2; GNRH2	2797
MIM602353	*	16p11.2	TRANSFORMING GROWTH FACTOR, BETA-1-INDUCED 1; TGFB1I1	7041
MIM602354	*	16p11.2	LINKER FOR ACTIVATION OF T CELLS; LAT	27040
MIM602355	*	11p12	TNF RECEPTOR-ASSOCIATED FACTOR 6; TRAF6	7189
MIM602356	*	1q32	TNF RECEPTOR-ASSOCIATED FACTOR 5; TRAF5	7188
MIM602357	*	 	WAS/WASL-INTERACTING PROTEIN FAMILY, MEMBER 1; WIPF1	7456
MIM602358	*	17q21	HYPOCRETIN; HCRT	3060
MIM602359	*	19q13.1	FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 1; FXYD1	5348
MIM602360	*	15q15.3	L-ARGININE:GLYCINE AMIDINOTRANSFERASE; GATM	2628
MIM602361	#	 	GRACILE BONE DYSPLASIA	 
MIM602362	*	 	GTPase-ACTIVATING PROTEIN, RAN, 1; RANGAP1	5905
MIM602364	*	11q13.1	CATHEPSIN W; CTSW	1521
MIM602365	*	11q14.1-q14.3	CATHEPSIN C; CTSC	1075
MIM602366	*	11p15.5-p15.4	INTEGRIN-LINKED KINASE; ILK	3611
MIM602367	*	17q25.1-q25.2	PENTRAXIN I, NEURONAL; NPTX1	4884
MIM602368	*	4q22	GLUTAMATE RECEPTOR, IONOTROPIC, DELTA 2; GRID2	2895
MIM602369	*	1p22.3	CYSTEINE-RICH, ANGIOGENIC INDUCER, 61; CYR61	3491
MIM602370	*	8q24.3	GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED MOLECULE-LIKE PROTEIN; GML	2765
MIM602371	*	2q34-q35	ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 3; ACSL3	2181
MIM602372	*	7q22	ZONADHESIN; ZAN	7455
MIM602373	*	19p13.3	CALPONIN 2; CNN2	1265
MIM602374	*	1p22-p21	CALPONIN 3; CNN3	1266
MIM602375	*	17q25-qter	MITOCHONDRIAL RIBOSOMAL PROTEIN L12; MRPL12	6182
MIM602376	*	21q22.1	INTERFERON, ALPHA, BETA, AND OMEGA, RECEPTOR 2; IFNAR2	3455
MIM602377	*	9q34	DYNAMIN 1; DNM1	1759
MIM602378	*	19p13.2	DYNAMIN 2; DNM2	1785
MIM602380	*	3q13.3-q21	UROPLAKIN 1B; UPK1B	7348
MIM602381	*	12q13.3-q14.1	NGFIA-BINDING PROTEIN 2; NAB2	4665
MIM602382	*	3q26	PHOSPHOLIPASE D1, PHOSPHATIDYLCHOLINE-SPECIFIC; PLD1	5337
MIM602383	*	9q22.3	OSTEOGLYCIN; OGN	4969
MIM602384	*	17p13.1	PHOSPHOLIPASE D2; PLD2	5338
MIM602385	*	2q11.1-q11.2	SULFOTRANSFERASE FAMILY 1C, MEMBER 1; SULT1C1	6819
MIM602386	*	7q36.1	ZINC FINGER PROTEIN 212; ZNF212	7988
MIM602387	*	 	RNA-BINDING MOTIF PROTEIN, SINGLE STRAND-INTERACTING, 2; RBMS2	5939
MIM602388	*	19q13.3	SYMPLEKIN	8189
MIM602389	*	16p11.2	Tu TRANSLATION ELONGATION FACTOR, MITOCHONDRIAL; TUFM	7284
MIM602390	#	1q21	HEMOCHROMATOSIS, TYPE 2A; HFE2A	148738
MIM602391	*	 	PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; PEMT	10400
MIM602392	*	 	HYPOCRETIN RECEPTOR 1; HCRTR1	3061
MIM602393	*	 	HYPOCRETIN RECEPTOR 2; HCRTR2	3062
MIM602394	*	 	NUCLEOLAR AND COILED-BODY PHOSPHOPROTEIN 1; NOLC1	9221
MIM602395	*	10q24-q26	GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE, MITOCHONDRIAL; GPAM	57678
MIM602396	*	10q11.2	ANNEXIN A8; ANXA8	653145
MIM602397	*	18q21	ATPase, CLASS I, TYPE 8B, MEMBER 1; ATP8B1	5205
MIM602398	#	1p33-p31.1	DESMOSTEROLOSIS	1718
MIM602399	*	22q13.3	MITOGEN-ACTIVATED PROTEIN KINASE 12; MAPK12	6300
MIM602400	#	 	ICHTHYOSIS, FOLLICULAR ATROPHODERMA, HYPOTRICHOSIS, AND HYPOHIDROSIS	 
MIM602401	%	 	ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL RECESSIVE	 
MIM602402	*	16q24.3	FORKHEAD BOX C2; FOXC2	2303
MIM602403	*	17q11.2	BLEOMYCIN HYDROLASE; BLMH	642
MIM602404	%	2p13	PARKINSON DISEASE 3, AUTOSOMAL DOMINANT; PARK3	5072
MIM602406	*	 	HEART- AND NEURAL CREST DERIVATIVES-EXPRESSED 1; HAND1	9421
MIM602407	*	4q33	HEART- AND NEURAL CREST DERIVATIVES-EXPRESSED 2; HAND2	9464
MIM602408	*	17q11.2	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP D, MEMBER 1; NR1D1	9572
MIM602409	*	10p12	MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA, TRANSLOCATED TO, 10; MLLT10	8028
MIM602410	*	3p26-p25	BROMODOMAIN AND PHD FINGER-CONTAINING PROTEIN; BRPF1	7862
MIM602411	*	1p12-p11	EXOSTOSIN-LIKE 2; EXTL2	2135
MIM602412	*	10q22-q23	RIBOSOMAL PROTEIN S24; RPS24	6229
MIM602413	*	1q21	SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT C, INTEGRAL MEMBRANE PROTEIN, 15-KD; SDHC	6391
MIM602414	*	9q21.11-q21.12	AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER 1; APBA1	320
MIM602415	*	2p23-p22	DYSTROBREVIN, BETA; DTNB	1838
MIM602416	*	 	ADAPTOR-RELATED PROTEIN COMPLEX 3, SIGMA-2 SUBUNIT; AP3S2	10239
MIM602418		 	WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	 
MIM602419	*	8p23-p21	EARLY GROWTH RESPONSE 3; EGR3	1960
MIM602420	*	1p13.1	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER 10; KCNA10	3744
MIM602421	*	7q31.2	CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR	1080
MIM602422	*	4p16.3	STEM-LOOP BINDING PROTEIN; SLBP	7884
MIM602423	*	 	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 3; NR1H3	10062
MIM602424	*	9p24.3	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR 1; DMRT1	1761
MIM602425	*	6q26	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 4; MAP3K4	4216
MIM602426	*	1q41-q42.2	NUCLEAR VALOSIN-CONTAINING PROTEIN-LIKE; NVL	4931
MIM602427	*	16p11.2	T-BOX 6; TBX6	6911
MIM602428	*	16q22.1	HYALURONAN SYNTHASE 3; HAS3	3038
MIM602429	%	8q23	GLAUCOMA 1, OPEN ANGLE, D; GLC1D	2724
MIM602430	*	3p12	ROUNDABOUT, DROSOPHILA, HOMOLOG OF, 1; ROBO1	6091
MIM602431	*	3p12.3	ROUNDABOUT, DROSOPHILA, HOMOLOG OF, 2; ROBO2	6092
MIM602432	*	10p15-p14	OPTINEURIN; OPTN	10133
MIM602433	#	9q34	AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE; ALS4	23064
MIM602434	*	2p13	ANCIENT UBIQUITOUS PROTEIN 1; AUP1	550
MIM602435	*	 	PEPTIDYL-PROLYL ISOMERASE E; PPIE	10450
MIM602436	*	6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I CHAIN-RELATED GENE B; MICB	4277
MIM602437	*	 	GTP CYCLOHYDROLASE I FEEDBACK REGULATORY PROTEIN; GCHFR	2644
MIM602438	*	16q21-q22.1	HEAT-SHOCK TRANSCRIPTION FACTOR 4; HSF4	3299
MIM602439	^	16q22	ACUTE MYELOGENOUS LEUKEMIA	9163
MIM602440	%	 	AMYOTROPHY, MONOMELIC	 
MIM602441	*	3p21.3	CYTOKINE-INDUCIBLE SH2-CONTAINING PROTEIN; CISH	1154
MIM602442	*	21q22.1-q22.2	INTERSECTIN 1; ITSN1	6453
MIM602443	*	10q25.3	X-PROLYL AMINOPEPTIDASE 1; XPNPEP1	7511
MIM602444	*	5q35.3	TRANSCRIPTION FACTOR 17; TCF17	6940
MIM602445	*	3q26	SERINE PROTEASE INHIBITOR, CLADE I, MEMBER 1; SERPINI1	5274
MIM602446	*	13q32	GLYPICAN 5; GPC5	2262
MIM602447	*	7q21.3	PARAOXONASE 2; PON2	5445
MIM602448	*	6q22.33	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5; MAP3K5	4217
MIM602449	*	Chr.17	A-KINASE ANCHOR PROTEIN 1; AKAP1	8165
MIM602450	#	10p	SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	3981, 64421
MIM602451	*	11q13.5	PYRIMIDINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 6; P2RY6	5031
MIM602452	*	2q14	BUDDING UNINHIBITED BY BENZIMIDAZOLES 1, S. CEREVISIAE, HOMOLOG OF; BUB1	699
MIM602453	*	16p11.2	INTEGRIN, ALPHA-D; ITGAD	3681
MIM602454	*	1p35.3	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, U; PTPRU	10076
MIM602457	*	11q13.3	FAS-ASSOCIATED VIA DEATH DOMAIN; FADD	8772
MIM602458	*	1p21.3-p13.1	SORTILIN; SORT1	6272
MIM602459	#	5q31	DEAFNESS, AUTOSOMAL DOMINANT 15; DFNA15	5459
MIM602460	*	5q31	POU DOMAIN, CLASS 4, TRANSCRIPTION FACTOR 3; POU4F3	5459
MIM602461	*	20p13	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR TYPE, SUBSTRATE 1; PTPNS1	140885
MIM602462	*	4p16.1-p15	COLLAPSIN RESPONSE MEDIATOR PROTEIN 1; CRMP1	1400
MIM602463	*	8p21	DIHYDROPYRIMIDINASE-LIKE 2; DPYSL2	1808
MIM602464	*	 	TNF RECEPTOR-ASSOCIATED FACTOR 4; TRAF4	9618
MIM602465	*	4q28.1	SPROUTY, DROSOPHILA, HOMOLOG OF, 1; SPRY1	10252
MIM602466	*	13q31.1	SPROUTY, DROSOPHILA, HOMOLOG OF, 2; SPRY2	10253
MIM602468	*	7q21.3	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 9A; PPP1R9A	55607
MIM602469	*	 	FOLATE RECEPTOR 3; FOLR3	2352
MIM602470	*	8q24.2	PROSTATE STEM CELL ANTIGEN; PSCA	8000
MIM602471	#	 	SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, SKELETAL ABNORMALITIES	 
MIM602473	#	19q13.32	ENCEPHALOPATHY, ETHYLMALONIC; EE	23474
MIM602474	*	 	PROTEIN KINASE, MEMBRANE-ASSOCIATED TYROSINE/THREONINE, 1; PKMYT1	9088
MIM602475	%	6q22-q23, 21q22.3	OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL	1291, 5167, 7933
MIM602477	%	19p13.3	FEBRILE SEIZURES, FAMILIAL, 2; FEB2	2234
MIM602478	*	10p15.1	tRNA ASPARTIC ACID METHYLTRANSFERASE 1; TRDMT1	1787
MIM602479	*	1p34.1	POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 1; POU3F1	5453
MIM602480	*	2q12.1	POU DOMAIN, CLASS 3, TRANSCRIPTION FACTOR 3; POU3F3	5455
MIM602481	#	1q21-q23	MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	477
MIM602482	#	6p25	AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3	2296
MIM602483	#	1p21.1-q23.3	AURICULOCONDYLAR SYNDROME 1; ARCND1	100381211, 2773
MIM602484		 	PELVIC HYPOPLASIA WITH LOWER-LIMB ARTHROGRYPOSIS	 
MIM602485	#	7p15-p13	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	2645
MIM602486	*	 	PROCESSING OF PRECURSOR 1, S. CEREVISIAE, HOMOLOG OF; POP1	10940
MIM602487	*	8q22	HEAT-RESPONSIVE PROTEIN 12; HRSP12	10247
MIM602488	*	19q13	CYTOHESIN 2; CYTH2	9266
MIM602489	*	 	KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED PROTEIN 1; KHDRBS1	10657
MIM602490	*	21q11	NUCLEAR RECEPTOR-INTERACTING PROTEIN 1; NRIP1	8204
MIM602491	#	1q22-q23	HYPERLIPIDEMIA, COMBINED, 1	7391
MIM602492	*	3q25	PENTRAXIN 3, LONG; PTX3	5806
MIM602493	*	11q13	UV RADIATION RESISTANCE-ASSOCIATED GENE; UVRAG	7405
MIM602494	*	17q21.1-q21.2	CHEMOKINE, CC MOTIF, LIGAND 23; CCL23	6368
MIM602495	*	7q11.23	CHEMOKINE, CC MOTIF, LIGAND 24; CCL24	6369
MIM602496	*	22q11.2-qter	MERCAPTOPYRUVATE SULFURTRANSFERASE; MPST	4357
MIM602497		 	CHONDRODYSPLASIA PUNCTATA, BRACHYTELEPHALANGIC, AUTOSOMAL	 
MIM602498	*	3q11-q12	TRK-FUSED GENE; TFG	10342
MIM602499	%	 	MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	791229
MIM602500	*	3q13	GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY B, 1; GOLGB1	2804
MIM602501	#	 	MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME; MCAP	 
MIM602502	*	 	GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 1; GOLGA1	2800
MIM602503	*	 	FREQUENTLY REARRANGED IN ADVANCED T-CELL LYMPHOMAS; FRAT1	10023
MIM602504	*	3q25-q26	SHORT STATURE HOMEOBOX 2; SHOX2	6474
MIM602505	*	12q24	PAXILLIN; PXN	5829
MIM602507	*	2p11.2	ZINC FINGER PROTEIN 103, MOUSE, HOMOLOG OF; ZFP103	7844
MIM602508	*	11q23	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, ISOFORM 1B, BETA SUBUNIT; PAFAH1B2	5049
MIM602509	*	3p22-p21.3	GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 4; GOLGA4	2803
MIM602510	*	19q13.4	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, H; PTPRH	5794
MIM602511		 	PSEUDOACROMEGALY WITH SEVERE INSULIN RESISTANCE	 
MIM602512	*	 	REGULATOR OF G PROTEIN SIGNALING 12; RGS12	6002
MIM602513	*	5q35.3	REGULATOR OF G PROTEIN SIGNALING 14; RGS14	10636
MIM602514	*	1q25-q31	REGULATOR OF G PROTEIN SIGNALING 16; RGS16	6004
MIM602515	*	6p22.1	PHOSPHOLIPASE D1, GLYCOSYLPHOSPHATIDYLINOSITOL-SPECIFIC; GPLD1	2822
MIM602516	*	1q23.3	REGULATOR OF G PROTEIN SIGNALING 4; RGS4	5999
MIM602517	*	 	REGULATOR OF G PROTEIN SIGNALING 7; RGS7	6000
MIM602518	*	19q13.2	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 4; LGALS4	3960
MIM602519	*	16p13.3	UBIQUITIN-SPECIFIC PROTEASE 7; USP7	7874
MIM602520	*	15q23	MITOGEN-ACTIVATED PROTEIN KINASE KINASE 5; MAP2K5	5607
MIM602521	*	17p11.2	MITOGEN-ACTIVATED PROTEIN KINASE 7; MAPK7	5598
MIM602522	#	1p31, 1p36	BARTTER SYNDROME, TYPE 4A	1188, 7809
MIM602523	*	21q22.2-q22.3	DOWN SYNDROME CELL ADHESION MOLECULE; DSCAM	1826
MIM602524	*	 	PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 1; PDK1	5163
MIM602525	*	 	PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 2; PDK2	5164
MIM602526	^	 	PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 3; PDK3	5165
MIM602527	*	7q21.3-q22.1	PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 4; PDK4	5166
MIM602528	*	13q11	TUBULIN, ALPHA-3C; TUBA3C	7278
MIM602529	*	12q12-q14	TUBULIN, ALPHA-1A; TUBA1A	7846
MIM602530	*	 	TUBULIN, ALPHA-1B; TUBA1B	10376
MIM602532	*	6q23	SIX-TWELVE LEUKEMIA GENE	7955
MIM602533	*	1p36	ONCOGENE DJ1; DJ1	11315
MIM602534	*	15q21-q22	SYNAPTOSOMAL-ASSOCIATED PROTEIN, 23-KD; SNAP23	8773
MIM602535	#	 	MARSHALL-SMITH SYNDROME; MRSHSS	4784
MIM602536	*	2q21.3	RAB3 GTPase-ACTIVATING PROTEIN, CATALYTIC SUBUNIT; RAB3GAP1	22930
MIM602537	*	11q14	CALPAIN 5; CAPN5	726
MIM602538	*	10p13	CUG TRIPLET REPEAT, RNA-BINDING PROTEIN 2; CUGBP2	10659
MIM602539	*	 	MITOGEN-ACTIVATED KINASE KINASE KINASE 3; MAP3K3	4215
MIM602540	#	13q11-q12	ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS	2706
MIM602541	#	 	MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC	1120
MIM602542	*	 	BASIC TRANSCRIPTION FACTOR 3; BTF3	689
MIM602543	*	13q22	BASIC TRANSCRIPTION FACTOR 3-LIKE 1; BTF3L1	690
MIM602544	*	6q25.2-q27	PARKIN; PARK2	5071
MIM602545	*	6q22.2-q22.3	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, KAPPA; PTPRK	5796
MIM602546	*	15q26	ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 2; ST8SIA2	8128
MIM602547	*	5q21	ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 4; ST8SIA4	7903
MIM602548	*	 	OPIOID RECEPTOR-LIKE 1; OPRL1	4987
MIM602549	*	1p22.2	PROTEIN KINASE N2; PKN2	5586
MIM602550	*	11p15	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR-LIKE PROTEIN; ARNTL	406
MIM602551		 	JEJUNAL ATRESIA WITH RENAL ADYSPLASIA	 
MIM602552	*	17p13	NUCLEOPORIN, 88-KD; NUP88	4927
MIM602553		 	ANAL ATRESIA, HYPOSPADIAS, AND PENOSCROTAL INVERSION	 
MIM602554		 	TORSION DYSTONIA WITH ONSET IN INFANCY	 
MIM602555		 	MICROCEPHALY, MACROTIA, AND MENTAL RETARDATION	 
MIM602556		 	FACIAL DYSMORPHISM, CLEFT PALATE, HEARING LOSS, AND CAMPTODACTYLY	 
MIM602557		 	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	 
MIM602558		 	CRANIOMICROMELIC SYNDROME	 
MIM602559	*	2p16	EXPORTIN 1; XPO1	7514
MIM602561		 	BRACHYDACTYLY, INTRAVENTRICULAR SEPTAL DEFECT, AND DEAFNESS	 
MIM602562		 	MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	 
MIM602563	*	4q21.2-q22	NK6, DROSOPHILA, HOMOLOG OF, 1; NKX6-1	4825
MIM602564		 	EMPHYSEMA, CONGENITAL, WITH DEAFNESS, PENOSCROTAL WEB, AND MENTAL RETARDATION	 
MIM602565	*	19p13.2	CHEMOKINE, CC MOTIF, LIGAND 25; CCL25	6370
MIM602566	*	12q24	PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 7; P2RX7	5027
MIM602567	*	 	LIM AND SENESCENT CELL ANTIGEN-LIKE DOMAINS 1; LIMS1	3987
MIM602568	*	5p15.3-p15.2	METHIONINE SYNTHASE REDUCTASE; MTRR	4552
MIM602569	*	5q35	SYNUCLEIN, BETA; SNCB	6620
MIM602570	*	14q32	JAGGED 2; JAG2	3714
MIM602571	*	11q13	RNA-BINDING MOTIF PROTEIN 4; RBM4	5936
MIM602572	*	10q22.3-q23.1	ANNEXIN A11; ANXA11	311
MIM602573	*	8q24.1-q24.2	ANNEXIN A13; ANXA13	312
MIM602574	*	11q22-q24	TECTORIN, ALPHA; TECTA	7007
MIM602575	*	9q34.1	LIM HOMEOBOX TRANSCRIPTION FACTOR 1, BETA; LMX1B	4010
MIM602576	*	7p22	LUNATIC FRINGE; LFNG	3955
MIM602577	*	22q12	MANIC FRINGE; MFNG	4242
MIM602578	*	17q25	RADICAL FRINGE; RFNG	5986
MIM602579	#	15q22-qter	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	4351
MIM602580	*	 	GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 2; GOLGA2	2801
MIM602581	*	Chr.12	GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 3; GOLGA3	2802
MIM602582	*	12q24	DELTEX, DROSOPHILA, HOMOLOG OF, 1; DTX1	1840
MIM602583	*	7q31	G PROTEIN-COUPLED RECEPTOR 37; GPR37	2861
MIM602584	*	15q23	RETICULOCALBIN 2; RCN2	5955
MIM602585	^	2p24.1	MOVED TO 164280	 
MIM602587	*	1p36	ACYL-CoA THIOESTERASE 7; ACOT7	11332
MIM602588	#	 	BRANCHIOOTIC SYNDROME 1; BOS1	2138
MIM602589	*	14q23	FUCOSYLTRANSFERASE 8; FUT8	2530
MIM602590	*	11q13-q14	p21 PROTEIN-ACTIVATED KINASE 1; PAK1	5058
MIM602591	*	5q12-q13	KINESIN HEAVY CHAIN MEMBER 2A; KIF2A	3796
MIM602592	*	1q21-q23	LYMPHOCYTE ANTIGEN CD5-LIKE; CD5L	922
MIM602593	*	6p21.3	CORNEODESMOSIN; CDSN	1041
MIM602594	%	16p12.3-p12.1	RETINITIS PIGMENTOSA 22; RP22	6114
MIM602595	*	14q13-q21	SMN-INTERACTING PROTEIN 1; SIP1	8487
MIM602596		 	PANCREATIC LYMPHOMA, FAMILIAL	 
MIM602597	*	1q21	B-CELL CLL/LYMPHOMA 9; BCL9	607
MIM602598	*	4q21-q22	PROSTAGLANDIN D2 SYNTHASE, HEMATOPOIETIC; HPGDS	27306
MIM602600	*	1p34	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 8; LRP8	7804
MIM602601	*	12p13-p12	LOW DENSITY LIPOPROTEIN, OXIDIZED, RECEPTOR 1; OLR1	4973
MIM602602	*	17q25.2-q25.3	SECRETED AND TRANSMEMBRANE 1; SECTM1	6398
MIM602603	*	1p34-p33	MAGO NASHI, DROSOPHILA, HOMOLOG OF; MAGOH	4116
MIM602606	*	5q13.2	COCAINE- AND AMPHETAMINE-REGULATED TRANSCRIPT	9607
MIM602607	*	6q26	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 1; SLC22A1	6580
MIM602608	*	6q26	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 2; SLC22A2	6582
MIM602609	*	 	PHOSPHATIDYLINOSITOL 3-KINASE, CLASS 3; PIK3C3	5289
MIM602610	*	 	PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 4; PIK3R4	30849
MIM602611		 	SPONDYLOEPIPHYSEAL DYSPLASIA WITH CORONAL CRANIOSYNOSTOSIS, CATARACTS, CLEFT PALATE, AND MENTAL RETARDATION	 
MIM602612		 	CAMPTODACTYLY, MYOPIA, AND FIBROSIS OF THE MEDIAL RECTUS MUSCLE OF EYE	 
MIM602613		 	SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	 
MIM602614	*	6q14-q21	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7; MAP3K7	6885
MIM602615	*	22q13.1	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7-INTERACTING PROTEIN 1; MAP3K7IP1	10454
MIM602616	*	14q21	ALPHA-1,6-@MANNOSYL-GLYCOPROTEIN BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE; MGAT2	4247
MIM602617	*	9q22	FORKHEAD BOX E1; FOXE1	2304
MIM602618	*	4p16	C-TERMINAL-BINDING PROTEIN 1; CTBP1	1487
MIM602619	*	10q26.13	C-TERMINAL-BINDING PROTEIN 2; CTBP2	1488
MIM602620	*	14q32.1	LEGUMAIN; LGMN	5641
MIM602621	*	21q11.2	COXSACKIEVIRUS AND ADENOVIRUS RECEPTOR; CXADR	1525
MIM602622	*	 	DEOXYRIBONUCLEASE I-LIKE 2; DNASE1L2	1775
MIM602623	*	6p21.3-p21.2	FK506-BINDING PROTEIN 5; FKBP5	2289
MIM602625	*	3p14.1	MEMBRANE-ASSOCIATED GUANYLATE KINASE, WW AND PDZ DOMAINS-CONTAINING, 1; MAGI1	9223
MIM602626	*	3q28	INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; IL1RAP	3556
MIM602627	*	17q21.3	CELL DIVISION CYCLE 6, S. CEREVISIAE, HOMOLOG OF; CDC6	990
MIM602628	*	14q24.3-q31	FORKHEAD BOX N3; FOXN3	1112
MIM602629	#	8p11.21	DYSTONIA 6, TORSION; DYT6	55145
MIM602630	*	18p11.3	TRANSFORMING GROWTH FACTOR-BETA-INDUCED FACTOR; TGIF	7050
MIM602631	*	11p15.5	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 18; SLC22A18	5002
MIM602632	*	7q32-q33	PODOCALYXIN-LIKE; PODXL	5420
MIM602633	*	2q12-q14	FOUR-AND-A-HALF LIM DOMAINS 2; FHL2	2274
MIM602634	*	7q31.1	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 9; DNAJB9	4189
MIM602635	*	 	DEAF1, DROSOPHILA, HOMOLOG OF; DEAF1	10522
MIM602636	*	1p35	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 8; PPP1R8	5511
MIM602637	*	2q37-qter	SECRETED PHOSPHOPROTEIN 2; SPP2	6694
MIM602638	*	8q11.2	MINICHROMOSOME MAINTENANCE, S. CEREVISIAE, HOMOLOG OF, 4; MCM4	4173
MIM602639	%	16q12.1	TOOTH AGENESIS, SELECTIVE, 2; STHAG2	8137
MIM602640	*	11q12	N-ACETYLATED ALPHA-LINKED ACIDIC DIPEPTIDASE-LIKE 1; NAALADL1	10004
MIM602641	*	17p13	EUKARYOTIC TRANSLATION INITIATION FACTOR 4A, ISOFORM 1; EIF4A1	1973
MIM602642	*	13q14	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 11; TNFSF11	8600
MIM602643	*	8q24	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 11B; TNFRSF11B	4982
MIM602644	*	11p15.5	TETRASPANIN 4; TSPAN4	7106
MIM602645	*	 	SEMAPHORIN 3C; SEMA3C	10512
MIM602646	*	2q37.3	G PROTEIN-COUPLED RECEPTOR 35; GPR35	2859
MIM602647	*	11q12-q13	NUCLEAR RNA EXPORT FACTOR 1; NXF1	10482
MIM602648	*	3p21.3	CHEMOKINE-BINDING PROTEIN 2; CCBP2	1238
MIM602649	*	19p13.3	COLD-INDUCIBLE RNA-BINDING PROTEIN; CIRBP	1153
MIM602650	*	 	SPECKLE-TYPE POZ PROTEIN; SPOP	8405
MIM602651	*	1p32.2	NARDILYSIN; NRD1	4898
MIM602652	*	19q13.4	KALLIKREIN-RELATED PEPTIDASE 6; KLK6	5653
MIM602653	*	 	TECTORIN, BETA; TECTB	6975
MIM602654	*	 	FERM, ARHGEF, AND PLECKSTRIN DOMAIN-CONTAINING PROTEIN 1; FARP1	10160
MIM602655	*	2p23.3-p23.2	SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1, ADAPTOR PROTEIN; SLC4A1AP	22950
MIM602656	*	16p13.3-p13.2	ENDONUCLEASE III-LIKE 1; NTHL1	4913
MIM602658	*	 	PHOSPHODIESTERASE 2A, cGMP-STIMULATED; PDE2A	5138
MIM602659	*	14q23	MENAGE A TROIS 1; MNAT1	4331
MIM602660	*	 	TUBULIN, BETA-2C; TUBB2C	10383
MIM602661	*	16q24.3	TUBULIN, BETA-3; TUBB3	10381
MIM602662	*	 	TUBULIN, BETA-4; TUBB4	10382
MIM602663	*	 	PROLACTIN-RELEASING HORMONE; PRLH	51052
MIM602664	*	11q22.2-q22.3	CASPASE 4, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP4	837
MIM602665	*	11q22.2-q22.3	CASPASE 5, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP5	838
MIM602666	*	17p11.2	MYOSIN XVA; MYO15A	51168
MIM602667	*	8q21	NIBRIN; NBN	4683
MIM602668	#	3q13.3-q24	MYOTONIC DYSTROPHY 2; DM2	7555
MIM602669	*	10q25	PAIRED-LIKE HOMEODOMAIN TRANSCRIPTION FACTOR 3; PITX3	5309
MIM602670	*	14q13-q21	POLYMERASE, DNA, EPSILON-2; POLE2	5427
MIM602671	*	11q23	SOLUTE CARRIER FAMILY 37 (GLUCOSE-6-PHOSPHATE TRANSPORTER), MEMBER 4; SLC37A4	2542
MIM602672	*	1q21.3	RAS-ASSOCIATED PROTEIN RAB13; RAB13	5872
MIM602673	*	19q13.4	KALLIKREIN-RELATED PEPTIDASE 10; KLK10	5655
MIM602675	*	1q32.1-q32.2	ARGINYL AMINOPEPTIDASE; RNPEP	6051
MIM602676	*	2q36-q37	PHOSPHODIESTERASE 6D, cGMP-SPECIFIC, ROD, DELTA; PDE6D	5147
MIM602677	*	6p21.3	RING FINGER PROTEIN 5; RNF5	6048
MIM602678	*	14q32.3	MAP/MICROTUBULE AFFINITY-REGULATING KINASE 3; MARK3	4140
MIM602679	*	 	PHOSPHATE CYTIDYLYLTRANSFERASE 2, ETHANOLAMINE; PCYT2	5833
MIM602680	*	14q12	RHO GTPase-ACTIVATING PROTEIN 5; ARHGAP5	394
MIM602681	*	6q21	FORKHEAD BOX O3A; FOXO3A	2309
MIM602682	*	8q24	BRAIN-SPECIFIC ANGIOGENESIS INHIBITOR 1; BAI1	575
MIM602683	*	1p35	BRAIN-SPECIFIC ANGIOGENESIS INHIBITOR 2; BAI2	576
MIM602684	*	6q12	BRAIN-SPECIFIC ANGIOGENESIS INHIBITOR 3; BAI3	577
MIM602685	%	15q24	MENTAL RETARDATION, SEVERE, WITH SPASTICITY AND PIGMENTARY TAPETORETINAL DEGENERATION	8126
MIM602686	*	7p22	MITOTIC ARREST-DEFICIENT 1, YEAST, HOMOLOG-LIKE 1; MAD1L1	8379
MIM602688	*	 	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A/B; HNRNPAB	3182
MIM602689	*	7p22	FASCIN, SEA URCHIN, HOMOLOG OF, 1; FSCN1	6624
MIM602690	*	11q23	SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT D, INTEGRAL MEMBRANE PROTEIN; SDHD	6392
MIM602691	*	2p23	NUCLEAR RECEPTOR COACTIVATOR 1; NCOA1	8648
MIM602692	*	12q21	GLIOMA PATHOGENESIS-RELATED PROTEIN 1; GLIPR1	11010
MIM602693	*	6p12	MINICHROMOSOME MAINTENANCE, S. CEREVISIAE, HOMOLOG OF, 3; MCM3	4172
MIM602694	*	5q11.1	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 4; NDUFS4	4724
MIM602695	*	17p13.3	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 12; TNFSF12	8742
MIM602696	*	22q13.1	MINICHROMOSOME MAINTENANCE, S. CEREVISIAE, HOMOLOG OF, 5; MCM5	4174
MIM602697	*	19p13	PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 11; P2RY11	5032
MIM602698	*	Chr.16	NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 3; NFATC3	4775
MIM602699	*	Chr.14	NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 4; NFATC4	4776
MIM602700	*	22q13	E1A-BINDING PROTEIN, 300-KD; EP300	2033
MIM602701	*	3p21.2-p14.3	SARCOLEMMAL-ASSOCIATED PROTEIN; SLMAP	7871
MIM602702	*	19p13.3	PERILIPIN 3; PLIN3	10226
MIM602703	*	 	KATANIN, p80 SUBUNIT, B1; KATNB1	10300
MIM602704	*	1q32	MOUSE DOUBLE MINUTE 4 HOMOLOG; MDM4	4194
MIM602705	*	22q12.3	SYNAPSIN III; SYN3	8224
MIM602706	*	14q32.11	PROTEASOME 26S SUBUNIT, ATPase, 1; PSMC1	5700
MIM602707	*	19q13.11-q13.13	PROTEASOME 26S SUBUNIT, ATPase, 4; PSMC4	5704
MIM602708	*	14q22.1	PROTEASOME 26S SUBUNIT, ATPase, 6; PSMC6	5706
MIM602709	*	11p15	AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY B, MEMBER 1; APBB1	322
MIM602710	*	4p14	AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY B, MEMBER 2; APBB2	323
MIM602711	*	5q31	AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY B, MEMBER 3; APBB3	10307
MIM602712	*	15q	AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER 2; APBA2	321
MIM602713	*	8p11.23	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 9; ADAM9	8754
MIM602714	*	10q26.3	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 12; ADAM12	8038
MIM602715	*	 	LEIOMODIN 1; LMOD1	25802
MIM602716	*	19q13.1	NEPHRIN; NPHS1	4868
MIM602717	*	19q13.1-qter	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2D; GRIN2D	2906
MIM602718	*	 	TRANSFORMER 2, DROSOPHILA, HOMOLOG OF, ALPHA	29896
MIM602719	*	3q26.2-q27	SPLICING FACTOR, ARGININE/SERINE-RICH, 10; SFRS10	6434
MIM602720	*	7q21.3	PARAOXONASE 3; PON3	5446
MIM602721	*	 	DISRUPTED MEIOTIC cDNA 1, YEAST, HOMOLOG OF; DMC1	11144
MIM602722	#	7q33-q34	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR	50617
MIM602723	#	17q25	PSORIASIS SUSCEPTIBILITY 2; PSORS2	5722, 79092
MIM602724	*	22q11.2	SEPTIN 5; SEPT5	5413
MIM602725	*	3p21.3	INTERFERON-RELATED DEVELOPMENTAL REGULATOR 2; IFRD2	7866
MIM602726	*	1p36	CHLORIDE CHANNEL 6; CLCN6	1185
MIM602727	*	16p13	CHLORIDE CHANNEL 7; CLCN7	1186
MIM602728	*	8p21	SCAVENGER RECEPTOR CLASS A, MEMBER 3; SCARA3	51435
MIM602729	*	5q32-q33	GAMMA-AMINOBUTYRIC ACID RECEPTOR, PI; GABRP	2568
MIM602730	*	3p22-p21.3	ACTIVIN A RECEPTOR, TYPE IIB; ACVR2B	93
MIM602731	*	 	FYN-BINDING PROTEIN; FYB	2533
MIM602732	*	11p12-q12	RHO GTPase-ACTIVATING PROTEIN 1; ARHGAP1	392
MIM602733	*	1q22-q23	ALDEHYDE DEHYDROGENASE, FAMILY 9, SUBFAMILY A, MEMBER 1; ALDH9A1	223
MIM602734	*	3q23	PLASTIN 1; PLS1	5357
MIM602735	*	11p13	RETICULOCALBIN 1; RCN1	5954
MIM602736	*	2q31.1	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL FO COMPLEX, SUBUNIT C, ISOFORM 3; ATP5G3	518
MIM602737	*	9p13	CHEMOKINE, CC MOTIF, LIGAND 21; CCL21	6366
MIM602738	*	17q21	KARYOPHERIN BETA-1; KPNB1	3837
MIM602739	*	5p12	PROTEIN KINASE, AMP-ACTIVATED, CATALYTIC, ALPHA-1; PRKAA1	5562
MIM602740	*	12q24.1	PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, BETA-1; PRKAB1	5564
MIM602741	*	 	PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, BETA-2; PRKAB2	5565
MIM602742	*	12q13.1	PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, GAMMA-1; PRKAG1	5571
MIM602743	*	7q36	PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, GAMMA-2; PRKAG2	51422
MIM602744	*	1q42	GLYCERONEPHOSPHATE O-ACYLTRANSFERASE; GNPAT	8443
MIM602745	*	9q13	PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE, TYPE I, BETA; PIP5K1B	8395
MIM602746	*	1p36.3-p36.2	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 14; TNFRSF14	8764
MIM602747	*	8p12-p11	DUAL-SPECIFICITY PHOSPHATASE 4; DUSP4	1846
MIM602748	*	12q22-q23	DUAL-SPECIFICITY PHOSPHATASE 6; DUSP6	1848
MIM602749	*	3p21	DUAL-SPECIFICITY PHOSPHATASE 7; DUSP7	1849
MIM602750	*	22q11.2	D-DOPACHROME TAUTOMERASE; DDT	1652
MIM602751	*	21q22.1	BTB AND CNC HOMOLOGY 1; BACH1	571
MIM602752	*	2q12.3-q13	RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 8; RGPD8	727851
MIM602753	*	11q13.3-q13.4	ARISTALESS HOMEOBOX, DROSOPHILA, HOMOLOG OF; ARIX	401
MIM602754	*	19q13.2	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 4; KCNN4	3783
MIM602755	*	 	CYCLIN B2; CCNB2	9133
MIM602756	*	19p13.3	EPHRIN A2; EFNA2	1943
MIM602757	*	7q33-q35	EPHRIN RECEPTOR EphB6; EPHB6	2051
MIM602758	*	1q21.1-q21.3	PHOSPHATIDYLINOSITOL 4-KINASE, CATALYTIC, BETA; PIK4CB	5298
MIM602759	%	1q42.2-q43	PROSTATE CANCER, HEREDITARY, 8	7834
MIM602760	*	17q12-q21	KERATIN 32; KRT32	3882
MIM602761	*	17q12-q21	KERATIN 33A; KRT33A	3883
MIM602762	*	17q12-q21	KERATIN 33B; KRT33B	3884
MIM602763	*	17q12-q21	KERATIN 34; KRT34	3885
MIM602764	*	17q12-q21	KERATIN 35; KRT35	3886
MIM602765	*	12q13	KERATIN 83; KRT83	3889
MIM602766	*	 	KERATIN 84; KRT84	3890
MIM602767	*	12q13	KERATIN 85; KRT85	3891
MIM602768	*	19q13	DELTA-LIKE 3; DLL3	10683
MIM602769	*	2p23	DNA METHYLTRANSFERASE 3A; DNMT3A	1788
MIM602770	*	17q25	CHROMOBOX HOMOLOG 2, DROSOPHILA POLYCOMB CLASS; CBX2	84733
MIM602771	#	1p36-p35	RIGID SPINE MUSCULAR DYSTROPHY 1; RSMD1	57190
MIM602772	#	6q12	RETINITIS PIGMENTOSA 25; RP25	346007
MIM602773	*	3q21	DISRUPTED IN RENAL CARCINOMA 2; DIRC2	84925
MIM602774	*	17q22	RAD51, S. CEREVISIAE, HOMOLOG OF, C; RAD51C	5889
MIM602775	*	10q25	SUPPRESSOR OF CLEAR, C. ELEGANS, HOMOLOG OF; SHOC2	8036
MIM602776	*	6q21	REV3, S. CEREVISIAE, HOMOLOG OF; REV3L	5980
MIM602777	*	 	SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 4; SNAPC4	6621
MIM602778	*	9q33-q34.1	NUCLEAR RECEPTOR SUBFAMILY 6, GROUP A, MEMBER 1; NR6A1	2649
MIM602779	*	19p12	COAGULATION FACTOR II RECEPTOR-LIKE 3; F2RL3	9002
MIM602780	*	 	HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 1; HCN1	348980
MIM602781	*	19p13.3	HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 2; HCN2	610
MIM602782	#	11q25	HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	55315
MIM602783	*	16q24.3	SPG7 GENE; SPG7	6687
MIM602784	*	1p36	CORTISTATIN; CORT	1325
MIM602785	*	 	H1 HISTONE FAMILY, MEMBER X; H1FX	8971
MIM602786	*	6p21.3	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER E; HIST1H2AE	3012
MIM602787	*	6p22-p21.3	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER I; HIST1H2AI	8329
MIM602788	*	6p22-p21.3	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER K; HIST1H2AK	8330
MIM602790	*	1p34	FOUR-AND-A-HALF LIM DOMAINS 3; FHL3	2275
MIM602791	*	6p22-p21.3	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER J; HIST1H2AJ	8331
MIM602792	*	6p21.3	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER D; HIST1H2AD	3013
MIM602793	*	6p22-p21.3	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER L; HIST1H2AL	8332
MIM602794	*	6p21.3	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER C; HIST1H2AC	8334
MIM602795	*	6p21.3	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER B; HIST1H2AB	8335
MIM602796	*	6p22-p21.3	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER M; HIST1H2AM	8336
MIM602797	*	1q21-q23	HISTONE GENE CLUSTER 2, H2A HISTONE FAMILY, MEMBER C; HIST2H2AC	8338
MIM602798	*	6p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER G; HIST1H2BG	8339
MIM602799	*	6p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER D; HIST1H2BD	3017
MIM602800	*	6p22-p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER L; HIST1H2BL	8340
MIM602801	*	6p22-p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER N; HIST1H2BN	8341
MIM602802	*	6p22-p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER M; HIST1H2BM	8342
MIM602803	*	6p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER B; HIST1H2BB	3018
MIM602804	*	6p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER F; HIST1H2BF	8343
MIM602805	*	6p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER E; HIST1H2BE	8344
MIM602806	*	6p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER H; HIST1H2BH	8345
MIM602807	*	6p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER I; HIST1H2BI	8346
MIM602808	*	6p22-p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER O; HIST1H2BO	8348
MIM602809	*	10p12-cen	KINESIN FAMILY MEMBER 5B; KIF5B	3799
MIM602810	*	6p21.3	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER A; HIST1H3A	8350
MIM602811	*	6p21.3	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER D; HIST1H3D	8351
MIM602812	*	6p21.3	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER C; HIST1H3C	8352
MIM602813	*	6p21.3	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER E; HIST1H3E	8353
MIM602814	*	6p22-p21.3	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER I; HIST1H3I	8354
MIM602815	*	6p21.3	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER G; HIST1H3G	8355
MIM602816	*	6p21.3	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER F; HIST1H3F	8968
MIM602817	*	6p22-p21.3	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER J; HIST1H3J	8356
MIM602818	*	6p22-p21.3	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER H; HIST1H3H	8357
MIM602819	*	6p21.3	HISTONE GENE CLUSTER 1, H3 HISTONE FAMILY, MEMBER B; HIST1H3B	8358
MIM602820	*	1q42	HISTONE GENE CLUSTER 3, H3 HISTONE; HIST3H3	8290
MIM602821	*	12q13	KINESIN FAMILY MEMBER 5A; KIF5A	3798
MIM602822	*	6p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER A; HIST1H4A	8359
MIM602823	*	6p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER D; HIST1H4D	8360
MIM602824	*	6p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER F; HIST1H4F	8361
MIM602825	*	6p22-p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER K; HIST1H4K	8362
MIM602826	*	6p22-p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER J; HIST1H4J	8363
MIM602827	*	6p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER C; HIST1H4C	8364
MIM602828	*	6p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER H; HIST1H4H	8365
MIM602829	*	6p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER B; HIST1H4B	8366
MIM602830	*	6p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER E; HIST1H4E	8367
MIM602831	*	6p22-p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER L; HIST1H4L	8368
MIM602832	*	6p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER G; HIST1H4G	8369
MIM602833	*	6p21.3	HISTONE GENE CLUSTER 1, H4 HISTONE FAMILY, MEMBER I; HIST1H4I	8294
MIM602835	*	11p15.2-p14.3	GROWTH ARREST-SPECIFIC 2; GAS2	2620
MIM602836	*	 	PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 5; P2RX5	5026
MIM602837	*	 	DNAJ/HSP40 HOMOLOG, SUBFAMILY A, MEMBER 1; DNAJA1	3301
MIM602838	*	1q32	PHOSPHATIDYLINOSITOL 3-KINASE, CLASS 2, BETA; PIK3C2B	5287
MIM602839	*	1p36.2	PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, DELTA; PIK3CD	5293
MIM602840	*	19p13	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 7; TNFSF7	970
MIM602841	*	2q33	ALDEHYDE OXIDASE 1; AOX1	316
MIM602842	*	 	GEMININ; GMNN	51053
MIM602843	*	12p12.3	RHO GDP-DISSOCIATION INHIBITOR BETA; ARHGDIB	397
MIM602844	*	 	RHO GDP-DISSOCIATION INHIBITOR GAMMA; ARHGDIG	398
MIM602845	*	2p23	KINESIN FAMILY MEMBER 3C; KIF3C	3797
MIM602846	*	4p14	HUNTINGTIN-INTERACTING PROTEIN 2; HIP2	3093
MIM602847	*	6p21.3	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER C; HIST1H2BC	8347
MIM602848	*	 	BROMODOMAIN-CONTAINING PROTEIN 8; BRD8	10902
MIM602849	#	4p16.3	MUENKE SYNDROME; MNKES	2261
MIM602850	*	4p16.3	RING FINGER PROTEIN 4; RNF4	6047
MIM602851	*	5q14.3	G PROTEIN-COUPLED RECEPTOR 98; GPR98	84059
MIM602852	*	9p13	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 2; NUDT2	318
MIM602853	*	 	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, R; PTPRR	5801
MIM602854	*	11p15.1	PROTEASOME SUBUNIT, ALPHA-TYPE, 1; PSMA1	5682
MIM602855	*	14q13	PROTEASOME SUBUNIT, ALPHA-TYPE, 6; PSMA6	5687
MIM602856	*	 	REGULATOR OF G PROTEIN SIGNALING 10; RGS10	6001
MIM602857	*	7p15.3	CHIMERIN 2; CHN2	1124
MIM602858	*	11q12-q13	7-@DEHYDROCHOLESTEROL REDUCTASE; DHCR7	1717
MIM602859	*	1p36.32	PEROXISOME BIOGENESIS FACTOR 10; PEX10	5192
MIM602860	*	15q15	BUDDING UNINHIBITED BY BENZIMIDAZOLES 1, S. CEREVISIAE, HOMOLOG OF, BETA; BUB1B	701
MIM602861	*	12p11	PLAKOPHILIN 2; PKP2	5318
MIM602862	*	 	UDP-N-ACETYLGLUCOSAMINE PYROPHOSPHORYLASE 1; UAP1	6675
MIM602863	*	1q42	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 9A; WNT9A	7483
MIM602864	*	17q21	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 9B; WNT9B	7484
MIM602865	*	9q32-q33	DELETED IN BLADDER CANCER 1; DBC1	1620
MIM602866	*	12q12	CATION CHANNEL, AMILORIDE-SENSITIVE, NEURONAL, 2; ACCN2	41
MIM602867	*	4q12	INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 7; IGFBP7	3490
MIM602868	*	6p21	CELL DIVISION CYCLE 5, S. POMBE, HOMOLOG OF; CDC5L	988
MIM602869	*	 	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN U; HNRNPU	3192
MIM602870	*	6q13-q15	INTERPHOTORECEPTOR MATRIX PROTEOGLYCAN 1; IMPG1	3617
MIM602871	*	16p13	PERIPLAKIN; PPL	5493
MIM602872	*	 	CHLORIDE INTRACELLULAR CHANNEL 1; CLIC1	1192
MIM602873	*	10q24-q26	NEBULIN-RELATED ANCHORING PROTEIN; NRAP	4892
MIM602874	*	9q31	UDP-GLUCOSE CERAMIDE GLUCOSYLTRANSFERASE; UGCG	7357
MIM602875	#	9p21-p12	ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE; AMDM	4882
MIM602876	*	5q13.1	OCCLUDIN; OCLN	100506658
MIM602877	*	2q37.3	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 7; PPP1R7	5510
MIM602878	*	2p23.3	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 3; SLC30A3	7781
MIM602879	*	 	ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 1; EPB41L1	2036
MIM602880	*	19p12	GROWTH/DIFFERENTIATION FACTOR 1; GDF1	2657
MIM602881	*	6p21.3	PHD FINGER PROTEIN 1; PHF1	5252
MIM602882	*	5q31.1-q32	LEUKOCYTE CELL-DERIVED CHEMOTAXIN 2; LECT2	3950
MIM602883	*	12p12	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1A2; SLCO1A2	6579
MIM602884	*	6p25	GDP-MANNOSE 4,6-DEHYDRATASE; GMDS	2762
MIM602885	*	13q14-q21	MOTILIN RECEPTOR; MLNR	2862
MIM602886	*	2q21-q22	G PROTEIN-COUPLED RECEPTOR 39; GPR39	2863
MIM602887	*	17p13.1	DISCS LARGE, DROSOPHILA, HOMOLOG OF, 4; DLG4	1742
MIM602888	*	5q13.1-q13.2	BETAINE-HOMOCYSTEINE METHYLTRANSFERASE; BHMT	635
MIM602890	*	12p13-p12	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 1; KLRB1	3820
MIM602891	*	12p13.2-p12.3	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 2; KLRC2	3822
MIM602892	*	12p13.2-p12.3	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 3; KLRC3	3823
MIM602893	*	12p13.2-p12.3	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 4; KLRC4	8302
MIM602894	*	12p13.2-p12.3	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY D, MEMBER 1; KLRD1	3824
MIM602895	*	19p13.3-p13.2	SCAFFOLD ATTACHMENT FACTOR B; SAFB	6294
MIM602896	*	5q35	MITOGEN-ACTIVATED PROTEIN KINASE 9; MAPK9	5601
MIM602897	*	4q21.3	MITOGEN-ACTIVATED PROTEIN KINASE 10; MAPK10	5602
MIM602898	*	 	MITOGEN-ACTIVATED PROTEIN KINASE 11; MAPK11	5600
MIM602899	*	 	MITOGEN-ACTIVATED PROTEIN KINASE 13; MAPK13	5603
MIM602900	*	20q11.2	DNA METHYLTRANSFERASE 3B; DNMT3B	1789
MIM602901	*	5q13.2	TRANSPORTIN 1; TNPO1	3842
MIM602902	*	9q13	KRUPPEL-LIKE FACTOR 9; KLF9	687
MIM602903	*	 	KRUPPEL-LIKE FACTOR 5; KLF5	688
MIM602904	*	 	MITOGEN-ACTIVATED PROTEIN KINASE 6; MAPK6	5597
MIM602905	*	 	POTASSIUM CHANNEL, VOLTAGE-GATED, DELAYED-RECTIFIER, SUBFAMILY S, MEMBER 1; KCNS1	3787
MIM602906	*	8q22	POTASSIUM CHANNEL, VOLTAGE-GATED, DELAYED-RECTIFIER, SUBFAMILY S, MEMBER 2; KCNS2	3788
MIM602907	*	 	CENTRIN 3; CETN3	1070
MIM602908	*	20p11.2	RETINOBLASTOMA-BINDING PROTEIN 9; RBBP9	10741
MIM602909	*	7q11.23	CLAUDIN 4; CLDN4	1364
MIM602910	*	7q11	CLAUDIN 3; CLDN3	1365
MIM602911	*	22q13.1	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-2 SUBUNIT; CACNG2	10369
MIM602912	*	20q11.2	EUKARYOTIC TRANSLATION INITIATION FACTOR 6; EIF6	3692
MIM602913	*	1p34.1	POLO-LIKE KINASE 3; PLK3	1263
MIM602914	*	15q22	AQUAPORIN 9; AQP9	366
MIM602915	*	21q22.3	TRYPTOPHAN-RICH BASIC PROTEIN; WRB	7485
MIM602916	*	 	UBIQUITIN-CONJUGATING ENZYME E2E 1; UBE2E1	7324
MIM602917	*	21q22.1-q22.2	REGULATOR OF CALCINEURIN 1; RCAN1	1827
MIM602918	*	 	PHENYLALANINE-tRNA SYNTHETASE, ALPHA SUBUNIT; FARSA	2193
MIM602919	*	2p13	DOCKING PROTEIN 1; DOK1	1796
MIM602920	*	17q21	LIM AND SH3 PROTEIN 1; LASP1	3927
MIM602921	*	19p13.3	PERSEPHIN; PSPN	5623
MIM602923	*	 	RETINOBLASTOMA-BINDING PROTEIN 4; RBBP4	5928
MIM602924	*	 	RHO FAMILY GTPase 3; RND3	390
MIM602925	*	3q22.3	PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, BETA; PIK3CB	5291
MIM602926	*	9q34.1	SYNTAXIN-BINDING PROTEIN 1; STXBP1	6812
MIM602927	*	12p13.2-p12.3	G PROTEIN-COUPLED RECEPTOR 19; GPR19	2842
MIM602928	*	15q21.1-q21.2	TROPOMODULIN 2; TMOD2	29767
MIM602929	*	11q23	VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 5A; VWA5A	4013
MIM602930	*	9q34	RNA EXONUCLEASE 4, S. CEREVISIAE, HOMOLOG OF; REXO4	57109
MIM602931	*	15q21-q22	MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 6; SMAD6	4091
MIM602932	*	18q21.1	MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 7; SMAD7	4092
MIM602933	*	7q22	THYROID HORMONE RECEPTOR INTERACTOR 6; TRIP6	7205
MIM602934	*	17q11.2	STROMAL CELL-DERIVED FACTOR 2; SDF2	6388
MIM602935	*	1p35-p34	FATTY ACID AMIDE HYDROLASE; FAAH	2166
MIM602937	*	6q23.3	CBP/p300-INTERACTING TRANSACTIVATOR, WITH GLU/ASP-RICH C-TERMINAL DOMAIN, 2; CITED2	10370
MIM602938	*	9q22.3	BILE ACID CoA:AMINO ACID N-ACYLTRANSFERASE; BAAT	570
MIM602939	*	 	FORKHEAD BOX S1; FOXS1	2307
MIM602940	*	1p34	MARCKS-LIKE PROTEIN 1; MARCKSL1	65108
MIM602941	*	16q23.1	BREAST CANCER ANTIESTROGEN RESISTANCE 1; BCAR1	9564
MIM602942	*	1p22	ECOTROPIC VIRAL INTEGRATION SITE 5; EVI5	7813
MIM602943	*	1q21	RAR-RELATED ORPHAN RECEPTOR C; RORC	6097
MIM602944	*	 	E2F TRANSCRIPTION FACTOR 6; E2F6	1876
MIM602945	*	3p25.3	TRANSCRIPTIONAL ADAPTOR 3; TADA3	10474
MIM602946	*	 	TAF6-LIKE RNA POLYMERASE II; TAF6L	10629
MIM602947	*	 	SUPPRESSOR OF TY 3, S. CEREVISIAE, HOMOLOG OF; SUPT3H	8464
MIM602948	*	14q23.3-q24	RAD51, S. CEREVISIAE, HOMOLOG OF, B; RAD51L1	5890
MIM602949	*	 	SIN3-ASSOCIATED POLYPEPTIDE, 18-KD; SAP18	10284
MIM602950	*	19q13	PROTEIN ARGININE N-METHYLTRANSFERASE 1; PRMT1	3276
MIM602951	*	9q32	ZINC FINGER PROTEIN 37, MOUSE, HOMOLOG OF; ZFP37	7539
MIM602952	*	4p16.3	WHS CANDIDATE 1 GENE; WHSC1	7468
MIM602953	*	 	HAIRY/ENHANCER OF SPLIT-RELATED WITH YRPW MOTIF 1; HEY1	23462
MIM602954	*	17q11	RAD51, S. CEREVISIAE, HOMOLOG OF, D; RAD51D	5892
MIM602955	*	7q22.1	TAF6 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 80-KD; TAF6	6878
MIM602956	*	9p13	FANCG GENE; FANCG	2189
MIM602957	*	16q13	CHEMOKINE, CC MOTIF, LIGAND 22; CCL22	6367
MIM602958	*	6q23	SERUM/GLUCOCORTICOID-REGULATED KINASE 1; SGK1	6446
MIM602959	*	20q13	EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, ALPHA-2; EEF1A2	1917
MIM602961	*	10q11.2-q21	UBIQUITIN-CONJUGATING ENZYME E2D 1; UBE2D1	7321
MIM602962	*	 	UBIQUITIN-CONJUGATING ENZYME E2D 2; UBE2D2	7322
MIM602963	*	 	UBIQUITIN-CONJUGATING ENZYME E2D 3; UBE2D3	7323
MIM602964	*	1q41	TRANSLIN-ASSOCIATED FACTOR X; TSNAX	7257
MIM602965	*	6q22-q23	FATTY ACID-BINDING PROTEIN 7; FABP7	2173
MIM602966	%	2p13	OROFACIAL CLEFT 2; OFC2	4964
MIM602967	*	20q13.2	ZINC FINGER PROTEIN 217; ZNF217	7764
MIM602968	*	20q13.2	BREAST CARCINOMA AMPLIFIED SEQUENCE 1; BCAS1	8537
MIM602969	*	1q41	ESTROGEN-RELATED RECEPTOR, GAMMA; ESRRG	2104
MIM602970	*	3q26.1	KARYOPHERIN ALPHA-4; KPNA4	3840
MIM602971	*	 	TUBULIN-SPECIFIC CHAPERONE C; TBCC	6903
MIM602972	*	15q25.3-q26.1	PHOSPHODIESTERASE 8A; PDE8A	5151
MIM602973	*	21q22.3	PHOSPHODIESTERASE 9A; PDE9A	5152
MIM602974	*	9p13	AQUAPORIN 7; AQP7	364
MIM602976	*	17q21.1	MAX-LIKE PROTEIN X; MLX	6945
MIM602977	*	16p12.3	GLYCOPROTEIN 2, ZYMOGEN GRANULE MEMBRANE; GP2	2813
MIM602978	*	 	POLYHOMEOTIC-LIKE 1; PHC1	1911
MIM602979	*	 	POLYHOMEOTIC-LIKE 2; PHC2	1912
MIM602980	*	 	PROTEIN KINASE, SERINE/ARGININE-SPECIFIC, 2; SRPK2	6733
MIM602981	*	 	AE-BINDING PROTEIN 1; AEBP1	165
MIM602982	*	 	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 1; KCNN1	3780
MIM602983	*	1q21.3	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 3; KCNN3	3782
MIM602984	*	 	MEDIATOR COMPLEX SUBUNIT 6; MED6	10001
MIM602985	*	1q23	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 2; NDUFS2	4720
MIM602986	*	17p11.2	DEVELOPMENTALLY REGULATED GTP-BINDING PROTEIN 2; DRG2	1819
MIM602987	*	7p14.3	PHOSPHODIESTERASE 1C; PDE1C	5137
MIM602988	*	4p15	PROTOCADHERIN 7; PCDH7	5099
MIM602989	*	1p31	CDC-LIKE KINASE 2; CLK2	1196
MIM602990	*	15q24	CDC-LIKE KINASE 3; CLK3	1198
MIM602991	*	17q22	NOGGIN, MOUSE, HOMOLOG OF; NOG	9241
MIM602992	*	19q13.4	LEUKOCYTE-ASSOCIATED IMMUNOGLOBULIN-LIKE RECEPTOR 1; LAIR1	3903
MIM602993	*	 	LEUKOCYTE-ASSOCIATED IMMUNOGLOBULIN-LIKE RECEPTOR 2; LAIR2	3904
MIM602995	*	20q13.2	UBIQUITIN-CONJUGATING ENZYME E2 VARIANT 1; UBE2V1	7335
MIM602996	*	6p21.3	IMMEDIATE-EARLY RESPONSE 3; IER3	8870
MIM602997	*	10p12.1	CUBILIN; CUBN	8029
MIM602998	*	10q23.2-q23.3	SYNUCLEIN, GAMMA; SNCG	6623
MIM602999	*	10q23-q24	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3C; PPP1R3C	5507
MIM603000	*	 	IMMATURE COLON CARCINOMA TRANSCRIPT 1; ICT1	3396
MIM603001	*	 	UBIQUITIN-CONJUGATING ENZYME E2 VARIANT 2; UBE2V2	7336
MIM603002	*	19p13.13	TRANSPORTIN 2; TNPO2	30000
MIM603003	%	 	BILE DUCT CYSTS	 
MIM603004	*	7p12	GLIOBLASTOMA AMPLIFIED SEQUENCE; GBAS	2631
MIM603005	*	10q22-q24	3-PRIME-@PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE SYNTHASE 2; PAPSS2	9060
MIM603006	*	20q13.3	CADHERIN 4; CDH4	1002
MIM603007	*	5p15.1-p14	CADHERIN 6; CDH6	1004
MIM603008	*	16q21-q22.1	CADHERIN 8; CDH8	1006
MIM603009	*	2p13.3-p13.1	DYSFERLIN; DYSF	8291
MIM603010	%	7q31	DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17	1709
MIM603011	*	5q12.2-q13.3	SMALL EDRK-RICH FACTOR 1A; SERF1A	8293
MIM603012	*	6p21.3	HEAT-SHOCK 70-KD PROTEIN 1B; HSPA1B	3304
MIM603013	%	8p21, 8p22-p11	SCHIZOPHRENIA 6; SCZD6	3084, 8400
MIM603014	*	 	MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7; MAP2K7	5609
MIM603015	*	7q21.2-q22.1	TRANSFORMATION/TRANSCRIPTION DOMAIN-ASSOCIATED PROTEIN; TRRAP	8295
MIM603016	*	18q22-q23	CADHERIN 19; CDH19	28513
MIM603017	*	8q22.1	CADHERIN 17; CDH17	1015
MIM603018	*	1q31	UDP-GAL:BETA-GlcNAc BETA-1,3-GALACTOSYLTRANSFERASE, POLYPEPTIDE 2; B3GALT2	8707
MIM603019	*	5p15.2-p15.1	CADHERIN 18; CDH18	1016
MIM603020	*	16q24	ATPase FAMILY GENE 3-LIKE 1; AFG3L1	172
MIM603021	*	19q13.1	MITOCHONDRIAL RIBOSOMAL PROTEIN S12; MRPS12	6183
MIM603022	*	16p13.3	E4F TRANSCRIPTION FACTOR 1; E4F1	1877
MIM603023	*	7p12	IKAROS FAMILY ZINC FINGER 1; IKZF1	10320
MIM603024	*	1p36.1-p35	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 1A; ARID1A	8289
MIM603025	*	11q14	PHOSPHATIDYLINOSITOL-BINDING CLATHRIN ASSEMBLY PROTEIN; PICALM	8301
MIM603026	*	8q12	PLEOMORPHIC ADENOMA GENE 1; PLAG1	5324
MIM603027	*	Chr.9	FRUCTOSE-1,6-BISPHOSPHATASE 2; FBP2	8789
MIM603028	*	4q32	TOLL-LIKE RECEPTOR 2; TLR2	7097
MIM603029	*	4q35	TOLL-LIKE RECEPTOR 3; TLR3	7098
MIM603030	+	9q32-q33	TOLL-LIKE RECEPTOR 4; TLR4	7099
MIM603031	*	1q41-q42	TOLL-LIKE RECEPTOR 5; TLR5	7100
MIM603032	*	16p13	STANNIN; SNN	8303
MIM603033	*	3p25	COLLAGENIC TAIL OF ENDPLATE ACETYLCHOLINESTERASE; COLQ	8292
MIM603034	#	3p25	ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY; EAD	8292
MIM603035	*	15q26.1	INTERLEUKIN 16; IL16	3603
MIM603037	*	1q42.1	LEFT-RIGHT DETERMINATION FACTOR 1; LEFTY1	10637
MIM603038	*	20q11.2	SPERM-ASSOCIATED ANTIGEN 4; SPAG4	6676
MIM603039	*	17p13.3	MAX-BINDING PROTEIN; MNT	4335
MIM603040	%	11q23	TUMOR SUPPRESSOR GENE ON CHROMOSOME 11	50970
MIM603041	#	22q13.32-qter	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	1890
MIM603042	*	 	SMALL UBIQUITIN-LIKE MODIFIER 2; SUMO2	6613
MIM603043	*	8q12-q13	NEUTRAL SPHINGOMYELINASE ACTIVATION-ASSOCIATED FACTOR; NSMAF	8439
MIM603044	*	6q24	PLEOMORPHIC ADENOMA GENE-LIKE 1; PLAGL1	5325
MIM603046	*	8q24.1	RING FINGER PROTEIN 139; RNF139	11236
MIM603047	%	 	ASTIGMATISM	 
MIM603048	*	8q24	GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR ATTACHMENT PROTEIN 1; GPAA1	8733
MIM603049	*	 	THIOREDOXIN-LIKE 1; TXNL1	9352
MIM603050	*	10p11.2	ABL INTERACTOR 1; ABI1	10006
MIM603051	*	2q31	ALKYLGLYCERONE-PHOSPHATE SYNTHASE; AGPS	8540
MIM603052	*	7q21-q22	CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 4; CPSF4	10898
MIM603053	*	2q31.2-q33.1	HISTONE ACETYLTRANSFERASE 1; HAT1	8520
MIM603054	*	15q13-q15	GREMLIN 1 HOMOLOG, CYSTINE KNOT SUPERFAMILY; GREM1	26585
MIM603055	*	 	SKI-INTERACTING PROTEIN; SKIIP	22938
MIM603056	*	2q22-q23	ORIGIN RECOGNITION COMPLEX, SUBUNIT 4, S. CEREVISIAE, HOMOLOG OF; ORC4	5000
MIM603057	*	 	DACHSOUS, DROSOPHILA, HOMOLOG OF, 1; DCHS1	8642
MIM603058	*	5q31	PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 4; PCDHGB4	8641
MIM603059	*	5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 12; PCDHGA12	26025
MIM603060	*	 	KINESIN FAMILY MEMBER 1C; KIF1C	10749
MIM603061	*	1q21.2	ENDOSULFINE, ALPHA; ENSA	2029
MIM603062	*	2p11.2	TRANS-GOLGI NETWORK PROTEIN 2; TGOLN2	10618
MIM603063	*	 	3-@HYDROXYBUTYRATE DEHYDROGENASE 1; BDH1	622
MIM603064	*	 	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B11; UGT2B11	10720
MIM603065	*	3q13-q21	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP I, MEMBER 2; NR1I2	8856
MIM603066	*	7q22	PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE 3; PLOD3	8985
MIM603068	*	2q11	DUAL-SPECIFICITY PHOSPHATASE 2; DUSP2	1844
MIM603069	*	10q25	DUAL-SPECIFICITY PHOSPHATASE 5; DUSP5	1847
MIM603070	*	12p13.2-p13.1	RAD51-ASSOCIATED PROTEIN 1; RAD51AP1	10635
MIM603071	*	2q21	G PROTEIN-COUPLED RECEPTOR 17; GPR17	2840
MIM603072	*	20q13.2-q13.3	AURORA KINASE A; AURKA	6790
MIM603073	*	13q32	ZINC FINGER PROTEIN OF CEREBELLUM 2; ZIC2	7546
MIM603074	*	19q13.1	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, ISOFORM 1B, GAMMA SUBUNIT; PAFAH1B3	5050
MIM603075	#	1q24-q25, 10q25.3-q26.2, 6p21.3, 6p21.3, 3pter-p21, 19q13.2, 1q31-q32.1, 1q31-q32.1	MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1	10878, 3078, 348, 59338, 629, 717, 83872
MIM603076	*	21q22.3	ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 1; ABCG1	9619
MIM603078	*	11q22-q23	CHECKPOINT, S. POMBE, HOMOLOG OF, 1; CHEK1	1111
MIM603079	*	 	CHROMOBOX HOMOLOG 4, DROSOPHILA POLYCOMB CLASS; CBX4	8535
MIM603080	*	12p13	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, BETAINE/GABA), MEMBER 12; SLC6A12	6539
MIM603081	*	 	ADP-RIBOSYLARGININE HYDROLASE; ADPRH	141
MIM603083	*	 	HETEROGENEOUS NUCLEAR RIBOPROTEIN L; HNRNPL	3191
MIM603084	*	 	ASPARTYL-tRNA SYNTHETASE; DARS	1615
MIM603085	*	9q31-q32	SOLUTE CARRIER FAMILY 31 (COPPER TRANSPORTER), MEMBER 1; SLC31A1	1317
MIM603086	*	4p15.1-p14	ADP-RIBOSYLTRANSFERASE 3; ART3	419
MIM603088	*	9q31-q32	SOLUTE CARRIER FAMILY 31 (COPPER TRANSPORTER), MEMBER 2; SLC31A2	1318
MIM603089	*	3p21.3	BRCA1-ASSOCIATED PROTEIN 1; BAP1	8314
MIM603090	*	13q22	UBIQUITIN CARBOXYL-TERMINAL ESTERASE L3; UCHL3	7347
MIM603091	*	5q34	UBIQUITIN-SPECIFIC PROTEASE 12; USP12	9959
MIM603092	*	2p13.1	DUAL-SPECIFICITY PHOSPHATASE 11; DUSP11	8446
MIM603093	*	 	UDP-GAL:BETA-GlcNAc BETA-1,3-GALACTOSYLTRANSFERASE, POLYPEPTIDE 1; B3GALT1	8708
MIM603094	*	3q25	BETA-1,3-N-ACETYLGALACTOSAMINYLTRANSFERASE 1; B3GALNT1	8706
MIM603095	*	6p21.3	UDP-GAL:BETA-GlcNAc BETA-1,3-GALACTOSYLTRANSFERASE, POLYPEPTIDE 4; B3GALT4	8705
MIM603096	^	 	MOVED TO 262300	 
MIM603097	*	8q22.3	ATPase, H+ TRANSPORTING, LYSOSOMAL, 42-KD, V1 SUBUNIT C, ISOFORM 1; ATP6V1C1	528
MIM603098	%	7q34-q36	DEAFNESS, AUTOSOMAL RECESSIVE 13; DFNB13	1705
MIM603099	*	6p21.3	1-@ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 1; AGPAT1	10554
MIM603100	*	9q34.3	1-@ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 2; AGPAT2	10555
MIM603101	*	13q14.11	CARBOXYPEPTIDASE B2, PLASMA; CPB2	1361
MIM603102	*	17p11.1-q11.1	CARBOXYPEPTIDASE D; CPD	1362
MIM603103	*	10q24.2	CARBOXYPEPTIDASE N, POLYPEPTIDE 1, 50-KD; CPN1	1369
MIM603104	*	3q29	CARBOXYPEPTIDASE N, POLYPEPTIDE 2, 83-KD; CPN2	1370
MIM603105	*	 	CARBOXYPEPTIDASE Z; CPZ	8532
MIM603106	*	20q11.2-q12	NEURONATIN; NNAT	4826
MIM603107	*	22q13.3	TRANSCRIPTION FACTOR 20; TCF20	6942
MIM603108	*	20q11.1-q11.23	MICROTUBULE-ASSOCIATED PROTEIN, RP/EB FAMILY, MEMBER 1; MAPRE1	22919
MIM603109	*	15q21-q22	MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 3; SMAD3	4088
MIM603110	*	5q31	MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 5; SMAD5	4090
MIM603111	*	 	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY E, MEMBER 1; SMARCE1	6605
MIM603112	*	1q21	S100 CALCIUM-BINDING PROTEIN A12; S100A12	6283
MIM603113	*	11q22-q24	PROTEIN PHOSPHATASE 2, STRUCTURAL/REGULATORY SUBUNIT A, BETA; PPP2R1B	5519
MIM603114	*	1q21	S100 CALCIUM-BINDING PROTEIN A11; S100A11	6282
MIM603115	*	1q25	DEAH BOX POLYPEPTIDE 9; DHX9	1660
MIM603116	%	22q12-q13	CDAGS SYNDROME	574043
MIM603117		 	SPASTIC PARAPLEGIA, OPTIC ATROPHY, MICROCEPHALY, AND XY SEX REVERSAL	 
MIM603118	*	16q22.1	CADHERIN 16; CDH16	1014
MIM603119		 	APRAXIA OF EYELID OPENING	 
MIM603120	*	 	QUIESCIN Q6 SULFHYDRYL OXIDASE 1; QSOX1	5768
MIM603122	*	5q35.1	DEDICATOR OF CYTOKINESIS 2; DOCK2	1794
MIM603123	*	3p14	DEDICATOR OF CYTOKINESIS 3; DOCK3	1795
MIM603124	*	21q22.3	UBIQUITIN-CONJUGATING ENZYME E2G 2; UBE2G2	7327
MIM603125	*	7q11.21	TYROSYLPROTEIN SULFOTRANSFERASE 1; TPST1	8460
MIM603126	*	22q12.1	TYROSYLPROTEIN SULFOTRANSFERASE 2; TPST2	8459
MIM603127	*	17p	GROWTH ARREST-SPECIFIC 7; GAS7	8522
MIM603128	*	6q16.3-q21	SINGLE-MINDED, DROSOPHILA, HOMOLOG OF, 1; SIM1	6492
MIM603129	*	1p22.3	LIM DOMAIN ONLY 4; LMO4	8543
MIM603130	*	20p13	ATTRACTIN; ATRN	8455
MIM603131	*	7q22-q31.1	PEPTIDASE, MITOCHONDRIAL PROCESSING, BETA; PMPCB	9512
MIM603132	*	9q22-q31	ZINC FINGER PROTEIN 189; ZNF189	7743
MIM603133		 	DISLOCATED ELBOWS, BOWED TIBIAS, SCOLIOSIS, DEAFNESS, CATARACT, MICROCEPHALY, AND MENTAL RETARDATION	 
MIM603134	*	 	CULLIN 1; CUL1	8454
MIM603135	*	10p11.2-p11.1	CULLIN 2; CUL2	8453
MIM603136	*	2q36	CULLIN 3; CUL3	8452
MIM603137	*	13q34	CULLIN 4A; CUL4A	8451
MIM603139	*	5q13	RAD17, S. POMBE, HOMOLOG OF; RAD17	5884
MIM603140	*	10p12.2	PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE, TYPE II, ALPHA; PIP5K2A	5305
MIM603141	*	 	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F POLYPEPTIDE-INTERACTING PROTEIN-BINDING PROTEIN 1; PPFIBP1	8496
MIM603142	*	 	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F POLYPEPTIDE-INTERACTING PROTEIN-BINDING PROTEIN 2; PPFIBP2	8495
MIM603143	*	 	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F POLYPEPTIDE-INTERACTING PROTEIN ALPHA-2; PPFIA2	8499
MIM603144	*	19q13.33	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F POLYPEPTIDE-INTERACTING PROTEIN ALPHA 3; PPFIA3	8541
MIM603145	*	 	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F POLYPEPTIDE-INTERACTING PROTEIN ALPHA 4; PPFIA4	8497
MIM603146	*	12q24.2-q24.3	PROTEASOME 26S SUBUNIT, NON-ATPase, 9; PSMD9	5715
MIM603147	#	1p22.3	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	29929
MIM603148	*	1q32.3	ACTIVATING TRANSCRIPTION FACTOR 3; ATF3	467
MIM603149	*	6p12.2	INTERLEUKIN 17A; IL17A	3605
MIM603150	*	 	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, DELTA SUBUNIT; ATP5D	513
MIM603151	*	7p14	SEPTIN 7; SEPT7	989
MIM603152	*	21q21.3	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL FO COMPLEX, SUBUNIT F6; ATP5J	522
MIM603153	*	5p13.3-p13.2	RAD1, S. POMBE, HOMOLOG OF; RAD1	5810
MIM603154	*	Chr.14	PININ; PNN	5411
MIM603155	*	1q32	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 14; PTPN14	5784
MIM603156	*	6p25	BIPHENYL HYDROLASE-LIKE; BPHL	670
MIM603157	*	19q13.2-q13.4	PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 2; PIK3R2	5296
MIM603158	*	 	UBIQUITIN-SPECIFIC PROTEASE 8; USP8	9101
MIM603159	*	19q12-q13.2	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 3; LRP3	4037
MIM603160	*	20q11.2	ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 6; ENTPD6	955
MIM603161	*	3p21.3	ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 3; ENTPD3	956
MIM603162	*	14q24	ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 5; ENTPD5	957
MIM603163	*	 	SCRAPIE-RESPONSIVE GENE 1	11341
MIM603164	*	6q23-q24	PEROXISOME BIOGENESIS FACTOR 3; PEX3	8504
MIM603165	%	3q21	DERMATITIS, ATOPIC	64069
MIM603166	*	11q13	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 2; MAP4K2	5871
MIM603167	*	11q13.1	BCL2 ANTAGONIST OF CELL DEATH; BAD	572
MIM603168	*	12q24.3	UNC51-LIKE KINASE 1; ULK1	8408
MIM603169	*	20q13	CATHEPSIN Z; CTSZ	1522
MIM603170	*	6p21.3	TEA DOMAIN FAMILY MEMBER 3; TEAD3	7005
MIM603171	*	 	NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 8; NEDD8	4738
MIM603172	*	 	UBIQUITIN-ACTIVATING ENZYME E1C; UBE1C	9039
MIM603173	*	 	UBIQUITIN-CONJUGATING ENZYME E2M; UBE2M	9040
MIM603174		 	HOMOCYSTEINEMIA	 
MIM603175	%	6q13-q26	SCHIZOPHRENIA 5; SCZD5	 
MIM603176	%	13q32	SCHIZOPHRENIA 7; SCZD7	8401
MIM603177	*	2p12-p11.2	VESICLE-ASSOCIATED MEMBRANE PROTEIN 8; VAMP8	8673
MIM603178	*	14q24.3	METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE; MMSDH	4329
MIM603179	*	9p13.3	CARBONIC ANHYDRASE IX; CA9	768
MIM603180	*	 	EXPORTIN, tRNA; XPOT	11260
MIM603181	*	 	INTERLEUKIN ENHANCER-BINDING FACTOR 2; ILF2	3608
MIM603182	*	19p13	INTERLEUKIN ENHANCER-BINDING FACTOR 3; ILF3	3609
MIM603183	*	19q13.3	RETICULON 2; RTN2	6253
MIM603184	*	13q12	CYCLIN-DEPENDENT KINASE 8; CDK8	1024
MIM603185	*	 	NUCLEAR AUTOANTIGENIC SPERM PROTEIN; NASP	4678
MIM603186	*	6p21.3	DEATH-ASSOCIATED PROTEIN 6; DAXX	1616
MIM603187	*	18p11.32	CENTRIN 1; CETN1	1068
MIM603188	%	10p	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 8; BMIQ8	56694
MIM603189	*	11q12.3	SYNTAXIN 5; STX5	6811
MIM603190	*	 	PROTEIN ARGININE N-METHYLTRANSFERASE 3; PRMT3	10196
MIM603191	*	21q22.3	CHROMOSOME 21 OPEN READING FRAME 2; C21ORF2	755
MIM603192	*	Chr.17	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL FO COMPLEX, SUBUNIT C, ISOFORM 1; ATP5G1	516
MIM603193	*	Chr.12	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL FO COMPLEX, SUBUNIT C, ISOFORM 2; ATP5G2	517
MIM603194	#	11q13	MECKEL SYNDROME, TYPE 2; MKS2	51259
MIM603195	*	19q13.3	G PROTEIN-COUPLED RECEPTOR 32; GPR32	2854
MIM603196	*	14q12-q13	COCHLIN; COCH	1690
MIM603197	*	19p13.3	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 6; PNPLA6	10908
MIM603198	*	17q21	RNA POLYMERASE I AND TRANSCRIPT RELEASE FACTOR; PTRF	284119
MIM603199	*	1p31.3	INAD-LIKE; INADL	10207
MIM603200	*	19p12	REGULATORY FACTOR X, ANKYRIN REPEAT-CONTAINING; RFXANK	8625
MIM603201	*	2q24	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 11; ABCB11	8647
MIM603202	*	2q21	LACTASE; LCT	3938
MIM603203	*	 	CYCLIN G2; CCNG2	901
MIM603204	%	15q24	EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 2	50971
MIM603205	*	3q13	MORC FAMILY CW-TYPE ZINC FINGER 1; MORC1	27136
MIM603206	%	18p	SCHIZOPHRENIA 8; SCZD8	8806
MIM603207	*	 	VTI1, S. CEREVISIAE, HOMOLOG OF, B; VTI1B	10490
MIM603208	*	2q37	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 13; KCNJ13	3769
MIM603209		6p22.3-p22.2	CYTIDINE MONOPHOSPHO-N-ACETYLNEURAMINIC ACID HYDROXYLASE, PSEUDOGENE; CMAH	8418
MIM603210	*	8q24	JERKY, MOUSE, HOMOLOG OF; JRK	8629
MIM603211	*	11q21	JERKY, MOUSE, HOMOLOG-LIKE; JRKL	8690
MIM603212	*	3q21-q25	BEADED FILAMENT STRUCTURAL PROTEIN 2; BFSP2	8419
MIM603213	*	16p11.2	KINESIN FAMILY MEMBER 22; KIF22	3835
MIM603214	*	14q24.3	ATP-BINDING CASSETTE, SUBFAMILY D, MEMBER 4; ABCD4	5826
MIM603215	*	19q13.3	N-ETHYLMALEIMIDE-SENSITIVE FACTOR ATTACHMENT PROTEIN, ALPHA; NAPA	8775
MIM603216	*	 	SOLUBLE NSF-ATTACHMENT PROTEIN, GAMMA; NAPG	8774
MIM603217	*	6q23.2	SYNTAXIN 7; STX7	8417
MIM603218	#	20pter-p12	HUNTINGTON DISEASE-LIKE 1; HDL1	5621
MIM603219	*	1q41	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 2; KCNK2	3776
MIM603220	*	2p23	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 3; KCNK3	3777
MIM603221	%	12q21-q23	MYOPIA 3, AUTOSOMAL DOMINANT; MYP3	8782
MIM603222	*	11q13	U22 HOST GENE	23642
MIM603223	*	 	RNA, U22 SMALL NUCLEOLAR; RNU22	9304
MIM603224	*	 	RNA, U25 SMALL NUCLEOLAR; RNU25	9303
MIM603225	*	 	RNA, U26 SMALL NUCLEOLAR; RNU26	9302
MIM603226	*	 	RNA, U27 SMALL NUCLEOLAR; RNU27	9301
MIM603227	*	 	RNA, U28 SMALL NUCLEOLAR; RNU28	9300
MIM603228	*	 	RNA, U29 SMALL NUCLEOLAR; RNU29	9297
MIM603229	*	 	RNA, U30 SMALL NUCLEOLAR; RNU30	9299
MIM603230	*	 	RNA, U31 SMALL NUCLEOLAR; RNU31	9298
MIM603231	*	16p13	ZINC FINGER PROTEIN 200; ZNF200	7752
MIM603232	*	16p13	OLFACTORY RECEPTOR, FAMILY 1, SUBFAMILY F, MEMBER 1; OR1F1	4992
MIM603233	#	20q13.32, 20q13.2, 20q13.2	PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B	149775, 2778, 8675
MIM603234	*	16p13.1	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 6; ABCC6	368
MIM603235	*	19q13.3	SELENOPROTEIN W, 1; SEPW1	6415
MIM603236	*	 	MEVALONATE PYROPHOSPHATE DECARBOXYLASE; MVD	4597
MIM603237	*	6q22-q23	ERYTHROCYTE MEMBRANE PROTEIN 4.1-LIKE 2; EPB41L2	2037
MIM603238	*	1p36.1	RNA, U17D SMALL NUCLEOLAR; RNU17D	8420
MIM603239	*	1p36.1	SMALL NUCLEOLAR RNA, H/ACA BOX, 73B; SNORA73B	6081
MIM603240	*	11p15.5	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 18, ANTISENSE; SLC22A18AS	5003
MIM603241	*	3q13.2-q21	LIMBIC SYSTEM-ASSOCIATED MEMBRANE PROTEIN; LSAMP	4045
MIM603242	*	12p13-p12	C-TYPE LECTIN DOMAIN FAMILY 2, MEMBER B; CLEC2B	9976
MIM603243	*	16q21	AUTOCRINE MOTILITY FACTOR RECEPTOR; AMFR	267
MIM603244	*	 	HEPARAN SULFATE D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE 1; HS3ST1	9957
MIM603245	*	14q12-q13	NK2 HOMEOBOX 8; NKX2-8	26257
MIM603246	*	 	GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 1; GTF3C1	2975
MIM603247	*	15q21.2	SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 2; SLC27A2	11001
MIM603248	*	4q23-q24	BONE MORPHOGENETIC PROTEIN RECEPTOR, TYPE IB; BMPR1B	658
MIM603249	*	22q12	NIPSNAP, C. ELEGANS, HOMOLOG OF, 1; NIPSNAP1	8508
MIM603250	*	6p25.3	FORKHEAD BOX F2; FOXF2	2295
MIM603251	*	9q34.1	CYCLIN-DEPENDENT KINASE 9; CDK9	1025
MIM603252	*	16q24.1	FORKHEAD BOX L1; FOXL1	2300
MIM603253	*	 	CYSTATIN 7; CST7	8530
MIM603254	*	19p13.2	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 4; SMARCA4	6597
MIM603255	*	 	NUCLEAR TRANSCRIPTION FACTOR, X BOX-BINDING, 1; NFX1	4799
MIM603256	*	 	LEUCINE-RICH REPEAT IN FLII-INTERACTING PROTEIN 1; LRRFIP1	9208
MIM603257	*	3q25.1-q26.1	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 3; SMARCA3	6596
MIM603258	*	8p11.2	INHIBITOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS, KINASE OF, BETA; IKBKB	3551
MIM603260	*	9q12	BarH-LIKE HOMEOBOX GENE 1; BARX1	56033
MIM603261	*	 	PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE, TYPE II, BETA; PIP5K2B	8396
MIM603262	*	4q24	3-PRIME-@PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE SYNTHASE 1; PAPSS1	9061
MIM603263	*	15q22	CARBONIC ANHYDRASE XII; CA12	771
MIM603264	*	16p13.3	RHOMBOID-LIKE 1; RHBDL1	9028
MIM603265	*	19p13.3	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 3A; ARID3A	1820
MIM603266	%	10q25	DIABETES MELLITUS, INSULIN-DEPENDENT, 17; IDDM17	8691
MIM603267	*	16p13.3	SMALL OPTIC LOBES, DROSOPHILA, HOMOLOG OF; SOLH	6650
MIM603268	*	10q22	N-DEACETYLASE/N-SULFOTRANSFERASE 2; NDST2	8509
MIM603269	*	11q22	SPLICING FACTOR, SERINE/ARGININE-RICH, 8; SRSF8	10929
MIM603270	*	 	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL FO COMPLEX, SUBUNIT B, ISOFORM 1; ATP5F1	515
MIM603271	*	 	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 21; PTPN21	11099
MIM603272	*	 	CONNECTOR ENHANCER OF KSR 1; CNKSR1	10256
MIM603273	*	3q27	TUMOR PROTEIN p63; TP63	8626
MIM603275	*	1q22-q24	PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE, TYPE I, ALPHA; PIP5K1A	8394
MIM603276	*	1q23	REGULATOR OF G PROTEIN SIGNALING 5; RGS5	8490
MIM603277	*	12p13	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 4; CHD4	1108
MIM603278	#	19q13	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1; FSGS1	81
MIM603279	*	17q21.3	EXPANDED REPEAT DOMAIN, CAG/CTG, 1; ERDA1	9030
MIM603280	^	 	MOVED TO 157640	 
MIM603281	*	12q24.2	2-PRIME,5-PRIME-@OLIGOADENYLATE SYNTHETASE-LIKE; OASL	8638
MIM603282		6p21.3	ZINC FINGER PROTEIN 204; ZNF204	7754
MIM603283	*	6q22-q23	TRIADIN; TRDN	10345
MIM603284	#	7p13	CEREBRAL CAVERNOUS MALFORMATIONS 2; CCM2	83605
MIM603285	#	3q26.1	CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	11235
MIM603286	*	1q32	KISS1 METASTASIS SUPPRESSOR; KISS1	3814
MIM603287	*	17q21.32	PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE; PNPO	55163
MIM603288	*	12q22	KERATOCAN; KERA	11081
MIM603289	*	19q13.3	DEATH-ASSOCIATED PROTEIN KINASE 3; DAPK3	1613
MIM603290	*	11q13.3-q13.4	SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 2; SHANK2	22941
MIM603291	*	 	BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 1; BNIP1	662
MIM603292	*	 	BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 2; BNIP2	663
MIM603293	*	 	BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 3; BNIP3	664
MIM603294	*	21q22.3	MINICHROMOSOME MAINTENANCE 3-ASSOCIATED PROTEIN; MCM3AP	8888
MIM603295	*	13q12-q14	MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 9; SMAD9	4093
MIM603296	*	 	LATE ENDOSOMAL/LYSOSOMAL ADAPTOR, MITOGEN-ACTIVATED PROTEIN KINASE AND MAMMALIAN TARGET OF RAPAMYCIN ACTIVATOR 3; LAMTOR3	8649
MIM603297	*	11q13.5	DYNEIN, CYTOPLASMIC 2, HEAVY CHAIN 1; DYNC2H1	79659
MIM603298	*	6p21.3	PALMITOYL-PROTEIN THIOESTERASE 2; PPT2	9374
MIM603300	*	14q32	TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 2; TNFAIP2	7127
MIM603301	*	2p25	KRUPPEL-LIKE FACTOR 11; KLF11	8462
MIM603302	*	16p13.3	ADENYLATE CYCLASE 9; ADCY9	115
MIM603303	*	Chr.8	TRF1-INTERACTING, ANKYRIN-RELATED ADP-RIBOSE POLYMERASE; TNKS	8658
MIM603304	*	3p25.3	INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 2; IRAK2	3656
MIM603305	*	1q32-q41	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 1; KCNH1	3756
MIM603306	*	6q23-q24	TRANSCRIPTION FACTOR 21; TCF21	6943
MIM603307	*	20p12.1-p11.23	BEADED FILAMENT STRUCTURAL PROTEIN 1; BFSP1	631
MIM603308	*	9q22.2	CATHEPSIN L2; CTSL2	1515
MIM603309	*	 	CYCLIN-DEPENDENT KINASE 13; CDK13	8621
MIM603310	*	4q26	PHOSPHODIESTERASE 5A; PDE5A	8654
MIM603311	*	1p22	CELL DIVISION CYCLE 7, S. CEREVISIAE, HOMOLOG-LIKE 1; CDC7L1	8317
MIM603312	*	Chr.11	BUTYROBETAINE-GAMMA,2-OXOGLUTARATE DIOXYGENASE 1; BBOX1	8424
MIM603313	*	12p11.1	ALG10, S. CEREVISIAE, HOMOLOG OF; ALG10	84920
MIM603314	*	19q13.43	SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 5; SLC27A5	10998
MIM603315	*	9q34	FREQUENIN, DROSOPHILA, HOMOLOG OF; FREQ	23413
MIM603316	*	12p12.1	CYTIDINE 5-PRIME-MONOPHOSPHATE N-ACETYLNEURAMINIC ACID SYNTHETASE; CMAS	55907
MIM603317	*	12q21.2	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, Q; PTPRQ	374462
MIM603319	*	1q21	ANNEXIN A9; ANXA9	8416
MIM603320	*	1p36.3	MATRIX METALLOPROTEINASE 23A; MMP23A	8511
MIM603321	*	1p36.3	MATRIX METALLOPROTEINASE 23B; MMP23B	8510
MIM603322	*	 	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 6; NDUFB6	4712
MIM603323		 	MUSCULAR DYSTROPHY, CONGENITAL, WITH CEREBELLAR ATROPHY	 
MIM603324	+	1p35.1	GAP JUNCTION PROTEIN, BETA-3; GJB3	2707
MIM603325	*	 	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 9B; PPP1R9B	84687
MIM603326	*	20q13.3	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3D; PPP1R3D	5509
MIM603327	*	19p13.3	RAN-BINDING PROTEIN 3; RANBP3	8498
MIM603328	*	12q24.1-q24.31	MUSASHI, DROSOPHILA, HOMOLOG OF, 1; MSI1	4440
MIM603329	^	 	PIRIN; PIR	8544
MIM603330	*	17p12	DYNEIN, AXONEMAL, HEAVY CHAIN 9; DNAH9	1770
MIM603331	*	2q31.1	DYNEIN, CYTOPLASMIC 1, INTERMEDIATE CHAIN 2; DYNC1I2	1781
MIM603332	*	3p21.3	DYNEIN, AXONEMAL, HEAVY CHAIN 1; DNAH1	25981
MIM603333	*	17p13	DYNEIN, AXONEMAL, HEAVY CHAIN 2; DNAH2	146754
MIM603334	*	16p12	DYNEIN, AXONEMAL, HEAVY CHAIN 3; DNAH3	55567
MIM603335	*	5p15-p14	DYNEIN, AXONEMAL, HEAVY CHAIN 5; DNAH5	1767
MIM603336	*	2p11.2	DYNEIN, AXONEMAL, HEAVY CHAIN 6; DNAH6	1768
MIM603337	*	6p21	DYNEIN, AXONEMAL, HEAVY CHAIN 8; DNAH8	1769
MIM603339	*	7p21	DYNEIN, AXONEMAL, HEAVY CHAIN 11; DNAH11	8701
MIM603340	*	3p21.1	DYNEIN, AXONEMAL, HEAVY CHAIN 12; DNAH12	201625
MIM603341	*	1q42	DYNEIN, AXONEMAL, HEAVY CHAIN 14; DNAH14	127602
MIM603342	%	11q14-q21	SCHIZOPHRENIA 2; SCZD2	6378
MIM603343	*	 	RNA EXPORT 1, S. POMBE, HOMOLOG OF; RAE1	8480
MIM603344	*	 	USO1 VESICLE DOCKING PROTEIN, S. CEREVISIAE, HOMOLOG OF; USO1	8615
MIM603345	*	4q21	SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 4; SLC4A4	8671
MIM603346	*	19q13.2-q13.3	NEURONAL PAS DOMAIN PROTEIN 1; NPAS1	4861
MIM603347	*	2q13	NEURONAL PAS DOMAIN PROTEIN 2; NPAS2	4862
MIM603348	*	14q21-q24	HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; HIF1A	3091
MIM603349	*	2p21-p16	ENDOTHELIAL PAS DOMAIN PROTEIN 1; EPAS1	2034
MIM603350	*	12q24.2	2-PRIME,5-PRIME-@OLIGOADENYLATE SYNTHETASE 2; OAS2	4939
MIM603351	*	12q24.2	2-PRIME,5-PRIME-@OLIGOADENYLATE SYNTHETASE 3; OAS3	4940
MIM603352	*	17q25	BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 5; BIRC5	332
MIM603353	*	3p22	SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 7; SLC4A7	9497
MIM603354	*	7q36	GASTRULATION BRAIN HOMEOBOX 1; GBX1	2636
MIM603355	*	16q24	MEMBRANE-BOUND TRANSCRIPTION FACTOR PROTEASE, SITE 1; MBTPS1	8720
MIM603356	*	6q21	CD164 ANTIGEN; CD164	8763
MIM603357	*	19q21.3	SERPIN PEPTIDASE INHIBITOR, CLADE B (OVALBUMIN), MEMBER 7; SERPINB7	8710
MIM603358	#	2q33	GRACILE SYNDROME	617
MIM603359	*	9q33.2-q34.11	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 8; NDUFA8	4702
MIM603360	*	11p12-p11.2	PEROXISOME BIOGENESIS FACTOR 16; PEX16	9409
MIM603361	*	20q13	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 6B; TNFRSF6B	8771
MIM603362	*	15q24	SH3 DOMAIN, GRB2-LIKE, 3; SH3GL3	6457
MIM603363	*	3p12-p11.1	CGG-BINDING PROTEIN 1; CGGBP1	8545
MIM603364	*	6p21	SPLICING FACTOR, SERINE/ARGININE-RICH, 3; SRSF3	6428
MIM603365	*	 	HIRA-INTERACTING PROTEIN 3; HIRIP3	8479
MIM603366	*	1p36.3	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 25; TNFRSF25	8718
MIM603368	*	7q21-q22	CYCLIN-DEPENDENT KINASE 6; CDK6	1021
MIM603369	*	1p32	CYCLIN-DEPENDENT KINASE INHIBITOR 2C; CDKN2C	1031
MIM603370	*	4p15.1	UDP-GLUCOSE DEHYDROGENASE; UGDH	7358
MIM603371	*	9q34	GLE1, S. CEREVISIAE, HOMOLOG-LIKE; GLE1L	2733
MIM603372	+	14q31	THYROID-STIMULATING HORMONE RECEPTOR; TSHR	7253
MIM603373	#	14q31	HYPERTHYROIDISM, FAMILIAL GESTATIONAL	7253
MIM603375	*	4q31.1-q31.2	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 5; SMARCA5	8467
MIM603376		 	LONG CHAIN FATTY ACIDS, DEFECT IN TRANSPORT OF	 
MIM603377	*	5q31.1	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 5; SLC22A5	6584
MIM603378	*	 	SIN3-ASSOCIATED POLYPEPTIDE, 30-KD; SAP30	8819
MIM603379	*	15q26	IQ MOTIF-CONTAINING GTPase-ACTIVATING PROTEIN 1; IQGAP1	8826
MIM603380	*	 	LIN7, C. ELEGANS, HOMOLOG OF, A; LIN7A	8825
MIM603381	*	3p14.3	FILAMIN B; FLNB	2317
MIM603382	*	 	MutS, E. COLI, HOMOLOG OF, 5; MSH5	4439
MIM603383	#	7q35-q36	GLAUCOMA 1, OPEN ANGLE, F; GLC1F	2726
MIM603384	*	6p21.3	SYNAPTIC RAS-GTPase-ACTIVATING PROTEIN 1; SYNGAP1	8831
MIM603385	*	16q22	NEDD8-ACTIVATING ENZYME E1, SUBUNIT 1; NAE1	8883
MIM603386	%	19p13.2	THYROID CARCINOMA, NONMEDULLARY, WITH OR WITHOUT CELL OXYPHILIA	50975
MIM603387	#	 	MEGALENCEPHALY POLYMICROGYRIA-POLYDACTYLY HYDROCEPHALUS SYNDROME; MPPH	 
MIM603388	%	20q13.11	GRAVES DISEASE, SUSCEPTIBILITY TO, 2	50976
MIM603389		 	OSEBOLD SKELETAL DYSPLASIA/OSTEOLYSIS SYNDROME	 
MIM603390	*	5q13	PHOSPHODIESTERASE 8B; PDE8B	8622
MIM603391	^	 	MOVED TO 139210	 
MIM603392	*	22q13.3	BCL2-INTERACTING KILLER; BIK	638
MIM603393		 	OSTEOSCLEROTIC CHONDRODYSPLASIA, LETHAL, WITH INTRACELLULAR INCLUSIONS	 
MIM603394		 	MICROCEPHALY, SEVERE, WITH SKELETAL ANOMALIES INCLUDING POSTERIOR RIB-GAP DEFECTS	 
MIM603395	*	8q22	SPERM-ASSOCIATED ANTIGEN 1; SPAG1	6674
MIM603396		 	TONOKI SYNDROME	 
MIM603397	*	 	ZINC FINGER PROTEIN 282; ZNF282	8427
MIM603398	*	8q24.1-q24.3	WNT1-INDUCIBLE SIGNALING PATHWAY PROTEIN 1; WISP1	8840
MIM603399	*	20q12-q13	WNT1-INDUCIBLE SIGNALING PATHWAY PROTEIN 2; WISP2	8839
MIM603400	*	6q22-q23	WNT1-INDUCIBLE SIGNALING PATHWAY PROTEIN 3; WISP3	8838
MIM603401	*	5q14.1	ADAPTOR-RELATED PROTEIN COMPLEX 3, BETA-1 SUBUNIT; AP3B1	8546
MIM603402	*	4p15.3	ACYL-CoA OXIDASE 3, PRISTANOYL; ACOX3	8310
MIM603403	*	4p15.3	DEAH BOX POLYPEPTIDE 15; DHX15	1665
MIM603404	*	9q22.3	ZINC FINGER PROTEIN 169; ZNF169	169841
MIM603405	*	6p21.3	DEAH BOX POLYPEPTIDE 16; DHX16	8449
MIM603406	*	7q32-q34	TRIPARTITE MOTIF-CONTAINING PROTEIN 24; TRIM24	8805
MIM603407	*	1p36-p32	POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 4; PABPC4	8761
MIM603408	*	7q21	FRIZZLED, DROSOPHILA, HOMOLOG OF, 1; FZD1	8321
MIM603409	*	8q22.3-q23.1	FRIZZLED, DROSOPHILA, HOMOLOG OF, 6; FZD6	8323
MIM603410	*	2q33	FRIZZLED, DROSOPHILA, HOMOLOG OF, 7; FZD7	8324
MIM603412	*	1q41-q42	CDC42-BINDING PROTEIN KINASE, ALPHA; CDC42BPA	8476
MIM603413	*	10q	TIA1 CYTOTOXIC GRANULE-ASSOCIATED RNA-BINDING PROTEIN-LIKE 1; TIAL1	7073
MIM603414	*	11q13	TRANSMEMBRANE 7 SUPERFAMILY, MEMBER 2; TM7SF2	7108
MIM603415	*	2q24	SODIUM CHANNEL, VOLTAGE-GATED, TYPE IX, ALPHA SUBUNIT; SCN9A	6335
MIM603417	*	1q32-q41	RAB-INTERACTING FACTOR; RABIF	5877
MIM603418	*	 	ALDO-KETO REDUCTASE FAMILY 7, MEMBER A2; AKR7A2	8574
MIM603419	*	19p13	SMALL GLUTAMINE-RICH TETRATRICOPEPTIDE REPEAT-CONTAINING PROTEIN, ALPHA; SGTA	6449
MIM603420	*	7q32	CALUMENIN; CALU	813
MIM603421	*	9q31	TRANSMEMBRANE PROTEIN WITH EGF-LIKE AND 2 FOLLISTATIN-LIKE DOMAINS 1; TMEFF1	8577
MIM603422	*	5q31.1	PDZ AND LIM DOMAIN PROTEIN 4; PDLIM4	8572
MIM603423	*	6q21-q22.1	PR DOMAIN-CONTAINING PROTEIN 1; PRDM1	639
MIM603424	*	2q31.3	PROTEIN KINASE, INTERFERON-INDUCIBLE DOUBLE-STRANDED RNA-DEPENDENT ACTIVATOR; PRKRA	8575
MIM603425	*	 	ADP-RIBOSYLATION FACTOR-LIKE 1; ARL1	400
MIM603426	*	2q37.3	PERIOD, DROSOPHILA, HOMOLOG OF, 2; PER2	8864
MIM603427	*	 	PERIOD, DROSOPHILA, HOMOLOG OF, 3; PER3	8863
MIM603428	*	17q11.2	ZINC FINGER PROTEIN 207; ZNF207	7756
MIM603429	*	6p21.33	ATP-BINDING CASSETTE, SUBFAMILY F, MEMBER 1; ABCF1	23
MIM603430	*	11q23.3	ZINC FINGER PROTEIN 202; ZNF202	7753
MIM603431	*	7q11.23	EUKARYOTIC TRANSLATION INITIATION FACTOR 4H; EIF4H	7458
MIM603432	*	7q11.23	CAP-GLY DOMAIN-CONTAINING LINKER PROTEIN 2; CLIP2	7461
MIM603433	*	11p15.4-p15.3	ZINC FINGER PROTEIN 143; ZNF143	7702
MIM603434	*	1q21.1	PHOSPHOPROTEIN ENRICHED IN ASTROCYTES, 15-KD; PEA15	8682
MIM603435	*	 	GLUTATHIONE PEROXIDASE 5; GPX5	2880
MIM603436	*	16p13.3	ZINC FINGER PROTEIN 205; ZNF205	7755
MIM603437	*	12p13.1	COLD-SHOCK DOMAIN PROTEIN A; CSDA	8531
MIM603438		 	RADIOULNAR SYNOSTOSIS WITH MICROCEPHALY, SHORT STATURE, SCOLIOSIS, AND MENTAL RETARDATION	 
MIM603439		 	EXPANSILE BONE LESIONS	 
MIM603440	*	 	PCTAIRE PROTEIN KINASE 2; PCTK2	5128
MIM603441	*	 	CYCLIN-DEPENDENT KINASE-LIKE 1; CDKL1	8814
MIM603442	*	 	CYCLIN-DEPENDENT KINASE-LIKE 2; CDKL2	8999
MIM603443	*	6p21.3	SUPPRESSOR OF ACTIN MUTATIONS 2, S. CEREVISIAE, HOMOLOG-LIKE; SACM2L	6293
MIM603444	*	1p31.1	FAR UPSTREAM ELEMENT-BINDING PROTEIN 1; FUBP1	8880
MIM603445	*	19p13.3	KH-TYPE SPLICING REGULATORY PROTEIN; KHSRP	8570
MIM603446		 	OROACRAL SYNDROME, VERLOES-KOULISCHER TYPE	 
MIM603447	*	 	HARAKIRI; HRK	8739
MIM603448	*	1p32-p31	DISABLED, DROSOPHILA, HOMOLOG OF, 1; DAB1	1600
MIM603449	*	3q21	RUVB, E. COLI, HOMOLOG-LIKE 1; RUVBL1	8607
MIM603450	*	4p15	LIM DOMAIN-BINDING 2; LDB2	9079
MIM603451	*	10q24-q25	LIM DOMAIN-BINDING 1; LDB1	8861
MIM603453	*	 	RECEPTOR-INTERACTING SERINE/THREONINE KINASE 1; RIPK1	8737
MIM603454	*	12q21.33-q23.1	CASP2 AND RIPK1 DOMAIN-CONTAINING ADAPTOR WITH DEATH DOMAIN; CRADD	8738
MIM603455	*	 	RECEPTOR-INTERACTING SERINE/THREONINE KINASE 2; RIPK2	8767
MIM603456	*	1p34	DPH2, S. CEREVISIAE, HOMOLOG OF; DPH2	1802
MIM603457		 	ARHINIA, CHOANAL ATRESIA, AND MICROPHTHALMIA	 
MIM603458	*	19p13.2	EMBRYONIC LETHAL, ABNORMAL VISION, DROSOPHILA, HOMOLOG-LIKE 3; ELAVL3	1995
MIM603460	*	 	CYCLIN-DEPENDENT KINASE 5, REGULATORY SUBUNIT 1; CDK5R1	8851
MIM603461	*	 	CELL DIVISION CYCLE 16, S. CEREVISIAE, HOMOLOG OF; CDC16	8881
MIM603462	*	5q31.1	CELL DIVISION CYCLE 23; CDC23	8697
MIM603463		 	HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARING LOSS	 
MIM603464	*	16q24	CYCLIN-DEPENDENT KINASE 10; CDK10	8558
MIM603465	*	22q11.2	CELL DIVISION CYCLE 45, S. CEREVISIAE, HOMOLOG-LIKE; CDC45L	8318
MIM603466	*	19p13.2	EMBRYONIC LETHAL, ABNORMAL VISION, DROSOPHILA, HOMOLOG-LIKE 1; ELAVL1	1994
MIM603467	#	11p15	FANCONI ANEMIA, COMPLEMENTATION GROUP F; FANCF	2188
MIM603470	*	9q34.1	ARGININOSUCCINATE SYNTHETASE 1; ASS1	445
MIM603471	#	7q21.3	CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2	10165
MIM603473	*	 	LARGE TUMOR SUPPRESSOR, DROSOPHILA, HOMOLOG OF, 1; LATS1	9113
MIM603474	*	19q13.2	RIBOSOMAL PROTEIN S19; RPS19	6223
MIM603475	*	3q27	CHORDIN; CHRD	8646
MIM603476	*	12p13	cAMP RESPONSE ELEMENT-BINDING PROTEIN-LIKE 2; CREBL2	1389
MIM603477	*	 	G10 MATERNAL TRANSCRIPT, XENOPUS, HOMOLOG OF	8896
MIM603478	*	1p32.1-p31.3	UBIQUITIN-SPECIFIC PROTEASE 1; USP1	7398
MIM603479	*	9q22.3	EXTRACELLULAR MATRIX PROTEIN 2; ECM2	1842
MIM603480	^	 	MOVED TO 300880	5716
MIM603481	*	 	PROTEASOME 26S SUBUNIT, NON-ATPase, 13; PSMD13	5719
MIM603482	*	10q24-q25	BETA-TRANSDUCIN REPEAT-CONTAINING PROTEIN; BTRC	8945
MIM603483	*	 	EUKARYOTIC TRANSLATION INITIATION FACTOR 4E-BINDING PROTEIN 3; EIF4EBP3	8637
MIM603484	*	15q26.1	PROTEIN REGULATING CYTOKINESIS 1; PRC1	9055
MIM603485	*	20pter-p12.3	NITROGEN FIXATION GENE 1; NFS1	9054
MIM603486	*	3p21.31	UBIQUITIN-SPECIFIC PROTEASE 4; USP4	7375
MIM603487	*	17p13.1-p12	MYOSIN, SKELETAL MUSCLE, HEAVY CHAIN 13; MYH13	8735
MIM603488	*	 	ANGIO-ASSOCIATED MIGRATORY CELL PROTEIN; AAMP	14
MIM603489	*	15q22	CARTILAGE INTERMEDIATE LAYER PROTEIN; CILP	8483
MIM603490	*	1p35	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 4; WNT4	54361
MIM603491	*	1p13	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 3; IGSF3	3321
MIM603492	*	1q22-q23	SLAM FAMILY, MEMBER 1; SLAMF1	6504
MIM603493	*	6p21	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 5; KCNK5	8645
MIM603494	*	19q12	NNX3 PROTEIN	8725
MIM603495	*	19q13.43	AURORA KINASE C; AURKC	6795
MIM603496	*	12q14	DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 2; DYRK2	8445
MIM603497	*	1q32.2	DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 3; DYRK3	8444
MIM603498	*	 	SPHINGOMYELIN PHOSPHODIESTERASE 2, NEUTRAL MEMBRANE; SMPD2	6610
MIM603499	*	18q22.1	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 11A; TNFRSF11A	8792
MIM603500	*	16q22	TUMOR NECROSIS FACTOR RECEPTOR 1-ASSOCIATED DEATH DOMAIN PROTEIN; TRADD	8717
MIM603501	*	10q11.23	POLY(ADP-RIBOSE) GLYCOHYDROLASE; PARG	8505
MIM603502	*	7q22-q31	INTERFERON-RELATED DEVELOPMENTAL REGULATOR 1; IFRD1	3475
MIM603503	*	20q13.13	DOLICHYL-PHOSPHATE MANNOSYLTRANSFERASE 1, CATALYTIC SUBUNIT; DPM1	8813
MIM603504	*	1p21	CELL DIVISION CYCLE 14, S. CEREVISIAE, HOMOLOG A; CDC14A	8556
MIM603505	*	Chr.9	CELL DIVISION CYCLE 14, S. CEREVISIAE, HOMOLOG B; CDC14B	8555
MIM603506	*	11q13.4	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 5; LRP5	4041
MIM603507	*	12p13.3-p11.2	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 6; LRP6	4040
MIM603508	*	 	MYOMESIN 1; MYOM1	8736
MIM603509	*	8p23.3	MYOMESIN 2; MYOM2	9172
MIM603510	^	 	INSULIN RECEPTOR SUBSTRATE 4; IRS4	8471
MIM603511	#	7q	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E; LGMD1E	10049, 9186
MIM603512	*	6q16	RNA GUANYLYLTRANSFERASE AND 5-PRIME-PHOSPHATASE; RNGTT	8732
MIM603513	#	2q31	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 1; CPSQ1	2571
MIM603514	*	18p11.23-p11.22	RNA GUANINE-7-METHYLTRANSFERASE; RNMT	8731
MIM603515	*	17q22-q24	CHORIONIC SOMATOMAMMOTROPIN HORMONE-LIKE 1; CSHL1	1444
MIM603516	#	22q13	SPINOCEREBELLAR ATAXIA 10; SCA10	25814
MIM603517	*	1p22	B-CELL CLL/LYMPHOMA 10; BCL10	8915
MIM603518	*	2p13	TIA1 CYTOTOXIC GRANULE-ASSOCIATED RNA-BINDING PROTEIN; TIA1	7072
MIM603519	*	10q23	SURVIVAL OF MOTOR NEURON-RELATED PROTEIN	10285
MIM603520	*	 	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE B-DOUBLE PRIME; SNRPB2	6629
MIM603521	*	15q26.3	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE A-PRIME; SNRPA1	6627
MIM603522	*	6p21.31	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE C; SNRPC	6631
MIM603523		 	CHYLOTHORAX, CONGENITAL	 
MIM603524	*	13q14.3	RCC1 DOMAIN- AND BTB DOMAIN-CONTAINING PROTEIN 2; RCBTB2	1102
MIM603525	*	2q23.3	NMYC INTERACTOR; NMI	9111
MIM603526	*	14q32.3	METASTASIS-ASSOCIATED GENE 1; MTA1	9112
MIM603527	*	17p13.3	DPH1, S. CEREVISIAE, HOMOLOG OF; DPH1	1801
MIM603528	^	16q23-q24	DEHYDRATED HEREDITARY STOMATOCYTOSIS, PSEUDOHYPERKALEMIA, AND PERINATAL EDEMA	 
MIM603529		 	DYSERYTHROPOIESIS, CONGENITAL, WITH INTERNUCLEAR CHROMATIN BRIDGES AND ULTRASTRUCTURALLY NORMAL ERYTHROBLAST HETEROCHROMATIN	 
MIM603530		 	LIGHT FIXATION SEIZURE SYNDROME	 
MIM603531	*	7q22.1	ADAPTOR-RELATED PROTEIN COMPLEX 1, SIGMA-1 SUBUNIT; AP1S1	1174
MIM603533	*	16q23	ADAPTOR-RELATED PROTEIN COMPLEX 1, GAMMA-1 SUBUNIT; AP1G1	164
MIM603534	*	 	ADAPTOR-RELATED PROTEIN COMPLEX 1, GAMMA-2 SUBUNIT; AP1G2	8906
MIM603535	*	19p13.12	ADAPTOR-RELATED PROTEIN COMPLEX 1, MU-1 SUBUNIT; AP1M1	8907
MIM603536	*	 	FAR UPSTREAM ELEMENT-BINDING PROTEIN 3; FUBP3	8939
MIM603537	*	1p34	POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 4; KCNQ4	9132
MIM603538	*	1q43	KYNURENINE 3-MONOOXYGENASE; KMO	8564
MIM603539	*	11q13.1	CATHEPSIN F; CTSF	8722
MIM603540	*	 	GAMMA-AMINOBUTYRIC ACID B RECEPTOR 1; GABBR1	2550
MIM603541	*	 	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE F; SNRPF	6636
MIM603542	*	 	SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE G; SNRPG	6637
MIM603543	#	3q27	LIMB-MAMMARY SYNDROME; LMS	8626
MIM603544	*	14q32	CYCLIN K; CCNK	8812
MIM603545	^	 	MOVED TO 600791	 
MIM603546	#	 	SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY TYPE 2; SEMDJL2	3835
MIM603547	*	18q21	METHYL-CpG-BINDING DOMAIN PROTEIN 2; MBD2	8932
MIM603548	*	4q21	CDP-DIACYLGLYCEROL SYNTHASE 1; CDS1	1040
MIM603549	*	20p13	CDP-DIACYLGLYCEROL SYNTHASE 2; CDS2	8760
MIM603550	*	6q23	EYES ABSENT 4; EYA4	2070
MIM603551	*	3p21.3	HYALURONOGLUCOSAMINIDASE 2; HYAL2	8692
MIM603552	#	6q24	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4; FHL4	8676
MIM603553	#	10q22	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2; FHL2	5551
MIM603554	#	11p13, 11p13, 10p	OMENN SYNDROME	5896, 5897, 64421
MIM603555	*	 	SUPPRESSOR OF TY 4, S. CEREVISIAE, HOMOLOG OF, 1; SUPT4H1	6827
MIM603557	*	11q22	MYOTUBULARIN-RELATED PROTEIN 2; MTMR2	8898
MIM603558	*	22q12	MYOTUBULARIN-RELATED PROTEIN 3; MTMR3	8897
MIM603559	*	Chr.17	MYOTUBULARIN-RELATED PROTEIN 4; MTMR4	9110
MIM603560	*	22qter	SET-BINDING FACTOR 1; SBF1	6305
MIM603561	*	13q12	MYOTUBULARIN-RELATED PROTEIN 6; MTMR6	9107
MIM603562	*	8p22	MYOTUBULARIN-RELATED PROTEIN 7; MTMR7	9108
MIM603563	#	8q24.13	SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT; SPG8	9897
MIM603564	*	 	DOLICHYL-PHOSPHATE MANNOSYLTRANSFERASE 2, REGULATORY SUBUNIT; DPM2	8818
MIM603565	*	12q21.3-q22	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 4; GALNT4	8693
MIM603566	*	15q22	PROTEIN INHIBITOR OF ACTIVATED STAT1; PIAS1	8554
MIM603567	*	 	PROTEIN INHIBITOR OF ACTIVATED STAT2; PIAS2	9063
MIM603568	*	 	RNA, U73 SMALL NUCLEOLAR; RNU73	8944
MIM603569		 	TRACHEOBRONCHIAL STENOSIS, CONGENITAL	 
MIM603570	+	6q23-q24	VANIN 1; VNN1	8876
MIM603571	*	6q23-q24	VANIN 2; VNN2	8875
MIM603572		 	MICROCEPHALY, FACIAL ABNORMALITIES, MICROMELIA, AND MENTAL RETARDATION	 
MIM603573	*	19p13.3	METHYL-CpG-BINDING DOMAIN PROTEIN 3; MBD3	53615
MIM603574	*	3q21-q22	METHYL-CpG-BINDING DOMAIN PROTEIN 4; MBD4	8930
MIM603575	*	5q23-q31	NONMETASTATIC CELLS 5, PROTEIN EXPRESSED IN; NME5	8382
MIM603576	*	15q13-q14	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 1; TRPM1	4308
MIM603577	*	 	NUCLEOLAR PROTEIN 4; NOL4	8715
MIM603578	*	 	OVIDUCTAL GLYCOPROTEIN 1; OVGP1	5016
MIM603579	*	18q11.2	SUDD, ASPERGILLUS NIDULANS, HOMOLOG OF; SUDD	8780
MIM603580	*	13q14.3	PROTOCADHERIN 8; PCDH8	5100
MIM603581	*	13q21.1	PROTOCADHERIN 9; PCDH9	5101
MIM603582	*	22q11	TOPOISOMERASE, DNA, III, BETA; TOP3B	8940
MIM603583	*	11q21	DISCS LARGE, DROSOPHILA, HOMOLOG OF, 2; DLG2	1740
MIM603584	*	11p11.2	MAP KINASE-ACTIVATING DEATH DOMAIN; MADD	8567
MIM603585	#	6q15	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	10559
MIM603587		 	FOLLICULAR ATROPHODERMA, PERIORAL PIGMENTED, WITH MILIA AND EPIDERMOID CYSTS	 
MIM603588		 	PAROTITIS, JUVENILE RECURRENT	 
MIM603589		 	FACIAL DYSMORPHISM, SELECTIVE TOOTH AGENESIS, AND CHOROID CALCIFICATION	 
MIM603590	*	22q12.3-q13.1	ACETYLGLUCOSAMINYLTRANSFERASE-LIKE PROTEIN; LARGE	9215
MIM603591	*	3q26.2-q26.3	UBIQUITIN-SPECIFIC PROTEASE 13; USP13	8975
MIM603593	*	14q11.2	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 7; SLC7A7	9056
MIM603594	*	1q25	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 4; TNFSF4	7292
MIM603595		 	CRANIOSYNOSTOSIS WITH ECTOPIA LENTIS	 
MIM603596	#	 	POLYDACTYLY	 
MIM603597	*	16p13.2	SUPPRESSOR OF CYTOKINE SIGNALING 1; SOCS1	8651
MIM603598	*	3q26	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 10; TNFSF10	8743
MIM603599	*	2q33	CASP8- AND FADD-LIKE APOPTOSIS REGULATOR; CFLAR	8837
MIM603600		 	OSTEOMA OF CRANIAL VAULT, FAMILIAL	 
MIM603601	*	 	PHOSPHATIDYLINOSITOL 3-KINASE, CLASS 2, ALPHA; PIK3C2A	5286
MIM603602	*	19q13.3	PHOSPHOLIPASE A2, GROUP IVC; PLA2G4C	8605
MIM603603	*	16p13.1-p12	PHOSPHOLIPASE A2, GROUP X; PLA2G10	8399
MIM603604	*	22q13.1	PHOSPHOLIPASE A2, GROUP VI; PLA2G6	8398
MIM603605	*	4q24	AMINOACYL-tRNA SYNTHETASE COMPLEX-INTERACTING MULTIFUNCTIONAL PROTEIN 1; AIMP1	9255
MIM603606	*	 	RIBOSOMAL PROTEIN S6 KINASE, 90-KD, 4; RPS6KA4	8986
MIM603607	*	14q31-q32	RIBOSOMAL PROTEIN S6 KINASE, 90-KD, 5; RPS6KA5	9252
MIM603608	*	21q22.2	CARBONYL REDUCTASE 3; CBR3	874
MIM603609	*	 	FUCOSE-1-PHOSPHATE GUANYLYLTRANSFERASE; FPGT	8790
MIM603610	*	4q21-q23	UNC5, C. ELEGANS, HOMOLOG OF, C; UNC5C	8633
MIM603611	*	8p21	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10A; TNFRSF10A	8797
MIM603612	*	8p22-p21	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10B; TNFRSF10B	8795
MIM603613	*	8p22-p21	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10C; TNFRSF10C	8794
MIM603614	*	8p21	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 10D; TNFRSF10D	8793
MIM603615	*	1p32	RAD54, S. CEREVISIAE, HOMOLOG-LIKE; RAD54L	8438
MIM603616	*	17p13	RAB GTPase-BINDING EFFECTOR PROTEIN 1; RABEP1	9135
MIM603617	*	15q22	SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 1; SLC24A1	9187
MIM603618	*	1p34.2-p33	CELL DIVISION CYCLE 20, S. CEREVISIAE, HOMOLOG OF; CDC20	991
MIM603619	*	19p13.3	FIZZY-RELATED PROTEIN, DROSOPHILA, HOMOLOG OF, 1; FZR1	51343
MIM603620	*	9p22.2	PC4- AND SFRS1-INTERACTING PROTEIN 1; PSIP1	11168
MIM603621	*	8q24.3	FORKHEAD BOX H1; FOXH1	8928
MIM603622	#	22q11.2	DEAFNESS, AUTOSOMAL DOMINANT 17; DFNA17	4627
MIM603623	*	1p35	TYROSYL-tRNA SYNTHETASE; YARS	8565
MIM603624	*	16p13.3	RIBOSOMAL PROTEIN S2; RPS2	6187
MIM603625	*	8q24.3	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS H; LY6H	4062
MIM603626	*	5q32-q33	PROTOCADHERIN 1; PCDH1	5097
MIM603627	*	5q31	PROTOCADHERIN-GAMMA, SUBFAMILY C, MEMBER 3; PCDHGC3	5098
MIM603628	*	 	MUSCULIN; MSC	9242
MIM603629	#	11q22-q24	DEAFNESS, AUTOSOMAL RECESSIVE 21; DFNB21	7007
MIM603630	*	19q13.4	RIBOSOMAL PROTEIN S5; RPS5	6193
MIM603631	*	19q13.4	RIBOSOMAL PROTEIN S9; RPS9	6203
MIM603632	*	6p	RIBOSOMAL PROTEIN S10; RPS10	6204
MIM603633	*	14q	RIBOSOMAL PROTEIN S29; RPS29	6235
MIM603634	*	1p22.1	RIBOSOMAL PROTEIN L5; RPL5	6125
MIM603635	*	 	RNA, U21 SMALL NUCLEOLAR; RNU21	6083
MIM603636	*	13q	RIBOSOMAL PROTEIN L21; RPL21	6144
MIM603637	*	11p15	RIBOSOMAL PROTEIN L27a; RPL27A	6157
MIM603638	*	19q13.4	RIBOSOMAL PROTEIN L28; RPL28	6158
MIM603639	*	2p25	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 17; ADAM17	6868
MIM603640	*	5q32-q33	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 19; ADAM19	8728
MIM603641		 	NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA	 
MIM603642		 	ATRIAL SEPTAL DEFECT, SECUNDUM, WITH VARIOUS CARDIAC AND NONCARDIAC DEFECTS	 
MIM603643		 	SITUS INVERSUS TOTALIS WITH CYSTIC DYSPLASIA OF KIDNEYS AND PANCREAS	 
MIM603644	*	17p13-p12	SCO1, S. CEREVISIAE, HOMOLOG OF; SCO1	6341
MIM603645	*	4q27-q28	PET112, S. CEREVISIAE, HOMOLOG-LIKE; PET112L	5188
MIM603646	*	10q24	CYTOCHROME c OXIDASE ASSEMBLY PROTEIN COX15; COX15	1355
MIM603647	*	2q33	BCS1, S. CEREVISIAE, HOMOLOG-LIKE; BCS1L	617
MIM603648	*	17q22	CYTOCHROME c OXIDASE ASSEMBLY PROTEIN COX11; COX11	1353
MIM603649	#	6q12-q13	CONE-ROD DYSTROPHY 7; CORD7	22999
MIM603650	*	2q31	BBS5 GENE; BBS5	129880
MIM603651	*	13q13.1-q13.2	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 4; TRPC4	7223
MIM603652	*	11q21-q22	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 6; TRPC6	7225
MIM603654	*	12q13	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 7; SLC16A7	9194
MIM603656		 	EXOSTOSIS, DUPUYTREN SUBUNGUAL	 
MIM603657	*	1p36	VESICLE-ASSOCIATED MEMBRANE PROTEIN 3; VAMP3	9341
MIM603658	*	2p25	RIBOSOMAL PROTEIN S7; RPS7	6201
MIM603659	*	17p13.3	GLUCAGON-LIKE PEPTIDE 2 RECEPTOR; GLP2R	9340
MIM603660	*	6q	RIBOSOMAL PROTEIN S12; RPS12	6206
MIM603661	*	18q	RIBOSOMAL PROTEIN L17; RPL17	6139
MIM603662	*	17q	RIBOSOMAL PROTEIN L23; RPL23	9349
MIM603663	%	4p	MENTAL HEALTH WELLNESS 1	10386
MIM603664		4q	MENTAL HEALTH WELLNESS 2	50979
MIM603665	*	 	STANNIOCALCIN 2; STC2	8614
MIM603666	*	20q13.32	SYNTAXIN 16; STX16	8675
MIM603667	*	2q24	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ARALAR), MEMBER 12; SLC25A12	8604
MIM603668	*	12q12-q13.11	SR-RELATED C-TERMINAL DOMAIN-ASSOCIATED FACTOR 11; SCAF11	9169
MIM603669		 	ECCRINE SYRINGOFIBROADENOMATOSIS WITH EYELID ABNORMALITIES	 
MIM603670		 	BLUE NEVI, FAMILIAL MULTIPLE	 
MIM603671	#	 	ACROMELIC FRONTONASAL DYSOSTOSIS	 
MIM603672	*	20q11.2	CORE-BINDING FACTOR, RUNT DOMAIN, ALPHA SUBUNIT 2, TRANSLOCATED TO, 2; CBFA2T2	9139
MIM603673	*	1p32	PATCHED, DROSOPHILA, HOMOLOG OF, 2; PTCH2	8643
MIM603674	*	16p	RIBOSOMAL PROTEIN S15a; RPS15A	6210
MIM603675	*	19q	RIBOSOMAL PROTEIN S16; RPS16	6217
MIM603678	%	7q31	DEAFNESS, AUTOSOMAL RECESSIVE 14; DFNB14	1706
MIM603679	*	 	UBIQUITIN-CONJUGATING ENZYME E2N; UBE2N	7334
MIM603680	*	13q21	ATAXIN 8 OPPOSITE STRAND; ATXN8OS	6315
MIM603681	*	2p23-p22	OTOFERLIN; OTOF	9381
MIM603682	*	8q	RIBOSOMAL PROTEIN S20; RPS20	6224
MIM603683	*	5q	RIBOSOMAL PROTEIN S23; RPS23	6228
MIM603684	*	18q21.1	LIPASE, ENDOTHELIAL; LIPG	9388
MIM603685	*	19p13.2	RIBOSOMAL PROTEIN S28; RPS28	6234
MIM603686	*	4p13	RIBOSOMAL PROTEIN L9; RPL9	6133
MIM603687	*	Chr.15	ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER A2; ALDH1A2	8854
MIM603688	#	1p36.1-p35	PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY	2048
MIM603689	#	2q31	HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE; HMERF	7273
MIM603690	*	3q25.31	SOLUTE CARRIER FAMILY 33 (ACETYL-CoA TRANSPORTER), MEMBER 1; SLC33A1	9197
MIM603691	*	17q25.3	GALANIN RECEPTOR 2; GALR2	8811
MIM603692	*	22q12.2-q13.1	GALANIN RECEPTOR 3; GALR3	8484
MIM603693	*	8q23	ZINC FINGER PROTEIN, MULTITYPE 2; ZFPM2	23414
MIM603694	%	20q12-q13.1	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 3	50982
MIM603695	*	13q14.3	GUANYLATE CYCLASE 1, SOLUBLE, BETA-2; GUCY1B2	2974
MIM603696	*	17q23	SEPTIN 4; SEPT4	5414
MIM603697	*	 	ARACHIDONATE 15-LIPOXYGENASE, SECOND TYPE; ALOX15B	247
MIM603698	*	10q24	GOLGI-SPECIFIC BREFELDIN-A RESISTANCE FACTOR 1; GBF1	8729
MIM603699	*	11q13.5	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 11; WNT11	7481
MIM603700	*	13q12	ARACHIDONATE 5-LIPOXYGENASE-ACTIVATING PROTEIN; ALOX5AP	241
MIM603701	*	12q	RIBOSOMAL PROTEIN S26; RPS26	6231
MIM603702	*	1q21	RIBOSOMAL PROTEIN S27; RPS27	6232
MIM603703	*	12q	RIBOSOMAL PROTEIN L6; RPL6	6128
MIM603704	*	17p	RIBOSOMAL PROTEIN L26; RPL26	6154
MIM603705	*	20p13	ANGIOPOIETIN 4; ANGPT4	51378
MIM603706	*	2p13	SEMAPHORIN 4F; SEMA4F	10505
MIM603707	*	6p21.3	MOLYBDENUM COFACTOR SYNTHESIS GENE 1; MOCS1	4337
MIM603708	*	5q11	MOLYBDENUM COFACTOR SYNTHESIS GENE 2; MOCS2	4338
MIM603709	*	7q21	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 22; ADAM22	53616
MIM603710	*	2q33	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 23; ADAM23	8745
MIM603711	*	8q21.3	CYTOCHROME P450, FAMILY 7, SUBFAMILY B, POLYPEPTIDE 1; CYP7B1	9420
MIM603712	*	14q24.1	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 20; ADAM20	8748
MIM603713	*	14q24.1	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 21; ADAM21	8747
MIM603714	*	2p21	SINE OCULIS HOMEOBOX, DROSOPHILA, HOMOLOG OF, 3; SIX3	6496
MIM603715	*	 	GLIAL CELLS MISSING, DROSOPHILA, HOMOLOG OF, 1; GCM1	8521
MIM603716	*	6p24.2	GLIAL CELLS MISSING, DROSOPHILA, HOMOLOG OF, 2; GCM2	9247
MIM603717	*	1p32.3	ATPase, H+ TRANSPORTING, LYSOSOMAL, 21-KD, V0 SUBUNIT C-PRIME, PRIME; ATP6V0B	533
MIM603718	*	3q28-q29	CLAUDIN 1; CLDN1	9076
MIM603719	*	10q24-q26	BUDDING UNINHIBITED BY BENZIMIDAZOLES 3, S. CEREVISIAE, HOMOLOG OF; BUB3	9184
MIM603720	#	15q15	DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16	161497
MIM603721	*	22q11.2-q13.1	UBIQUITIN-CONJUGATING ENZYME E2L 3; UBE2L3	7332
MIM603722	*	9q31	INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE COMPLEX-ASSOCIATED PROTEIN; IKBKAP	8518
MIM603725	*	 	FIBROBLAST GROWTH FACTOR 17; FGF17	8822
MIM603726	*	5q34	FIBROBLAST GROWTH FACTOR 18; FGF18	8817
MIM603727	*	3p21	GLUTAMINYL-tRNA SYNTHETASE; QARS	5859
MIM603728	*	14q24.3	NUMB, DROSOPHILA, HOMOLOG OF; NUMB	8650
MIM603729	*	10q21	SPHINGOSINE-1-PHOSPHATE LYASE 1; SGPL1	8879
MIM603730	*	17q25.2	SPHINGOSINE KINASE 1; SPHK1	8877
MIM603731	*	5q31-q33	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 8; CNOT8	9337
MIM603732	*	Chr.11	CRYPTOCHROME 2; CRY2	1408
MIM603733	*	11p11.2-p11.1	SOLUTE CARRIER FAMILY 43 (L-TYPE AMINO ACID TRANSPORTER), MEMBER 1; SLC43A1	8501
MIM603734	*	19q13.3-q13.4	INTERFERON REGULATORY FACTOR 3; IRF3	3661
MIM603735	*	17q21	AMINE OXIDASE, COPPER-CONTAINING, 3; AOC3	8639
MIM603736	#	 	OHDO SYNDROME, SBBYS VARIANT; SBBYSS	23522
MIM603737		 	OVARIAN GERM CELL CANCER	 
MIM603738	*	 	BASIC TRANSCRIPTION FACTOR 3-LIKE 2; BTF3L2	652963
MIM603739	*	 	BASIC TRANSCRIPTION FACTOR 3-LIKE 3; BTF3L3	132556
MIM603740		 	ACRODYSPLASIA WITH OSSIFICATION ABNORMALITIES, SHORT STATURE, AND FIBULAR HYPOPLASIA	 
MIM603741	*	17p13.1	ARACHIDONATE 12-LIPOXYGENASE, R TYPE; ALOX12B	242
MIM603742	*	 	SLIT, DROSOPHILA, HOMOLOG OF, 1; SLIT1	6585
MIM603743	*	22q12.3	APOLIPOPROTEIN L-I; APOL1	8542
MIM603744		 	PAPILLARY THYROID MICROCARCINOMA	 
MIM603745	*	5q35	SLIT, DROSOPHILA, HOMOLOG OF, 3; SLIT3	6586
MIM603746	*	4p15.2	SLIT, DROSOPHILA, HOMOLOG OF, 2; SLIT2	9353
MIM603747	*	20q13.2-q13.3	TUMOR PROTEIN D52-LIKE 2; TPD52L2	7165
MIM603749	*	21q22.3	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 2; TRPM2	7226
MIM603750	*	16p12-p11.2	AQUAPORIN 8; AQP8	343
MIM603751	*	19p13.3	SPHINGOSINE 1-PHOSPHATE RECEPTOR 4; S1PR4	8698
MIM603752	*	22q11.2	SOLUTE CARRIER FAMILY 7 (CARIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 4; SLC7A4	6545
MIM603753	*	Chr.11	UBIQUITINATION FACTOR E4A; UBE4A	9354
MIM603754	*	20q11.21	KINESIN FAMILY MEMBER 3B; KIF3B	9371
MIM603755	*	 	MADH-INTERACTING PROTEIN; MADHIP	9372
MIM603756	*	4q22	ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 2; ABCG2	9429
MIM603757	*	17q11.2	CHEMOKINE, CC MOTIF, LIGAND 18; CCL18	6362
MIM603758	*	14q24.3	GLUTATHIONE S-TRANSFERASE, ZETA-1; GSTZ1	2954
MIM603759	*	9q33-q34.1	LIM HOMEOBOX GENE 2; LHX2	9355
MIM603760	*	7p13-p12	HYDROXYUREA-SENSITIVE 1, S. POMBE, HOMOLOG OF; HUS1	3364
MIM603761	*	11q13.1-q13.2	RAD9, S. POMBE, HOMOLOG OF, A; RAD9A	5883
MIM603762	*	17p12-p11.2	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE-ASSOCIATED PROTEIN 2; PRPSAP2	5636
MIM603763	*	6p21.3	KINESIN FAMILY MEMBER C1; KIFC1	3833
MIM603764	*	2q35	CYCLIN-DEPENDENT KINASE 5, REGULATORY SUBUNIT 2; CDK5R2	8941
MIM603765	*	 	SYNTAXIN 10; STX10	8677
MIM603766	*	2p16-p14	MITOCHONDRIAL TRANSLATIONAL INITIATION FACTOR 2; MTIF2	4528
MIM603767	*	19q13.4	KALLIKREIN-RELATED PEPTIDASE 4; KLK4	9622
MIM603768	*	1q32.1	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 12B; PPP1R12B	4660
MIM603769	*	14q32.1	T-CELL LYMPHOMA/LEUKEMIA 1B; TCL1B	9623
MIM603770	*	2p21	PROTEIN PHOSPHATASE, MAGNESIUM-DEPENDENT, 1B; PPM1B	5495
MIM603771	*	 	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 10; PPP1R10	5514
MIM603772	*	7q21.3-q22.1	DYNEIN, CYTOPLASMIC 1, INTERMEDIATE CHAIN 1; DYNC1I1	1780
MIM603773	*	15q25	CYTOCHROME c OXIDASE, SUBUNIT Va; COX5A	9377
MIM603774	*	5q14	CYTOCHROME c OXIDASE, SUBUNIT VIIc; COX7C	1350
MIM603775	*	 	CYCLIN E2; CCNE2	9134
MIM603776	#	1p34.1-p32	HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, 3; HCHOLA3	255738
MIM603777	*	9p22	CERBERUS 1 HOMOLOG, CYSTINE KNOT SUPERFAMILY; CER1	9350
MIM603778	*	6p25.1	CHROMODOMAIN PROTEIN ON Y CHROMOSOME-LIKE; CDYL	9425
MIM603779	*	5q23.1-q23.3	SYNUCLEIN-ALPHA-INTERACTING PROTEIN; SNCAIP	9627
MIM603780	*	8q24.3	RECQ PROTEIN-LIKE 4; RECQL4	9401
MIM603781	*	17q25	RECQ PROTEIN-LIKE 5; RECQL5	9400
MIM603782	*	17q12	CHEMOKINE, CC MOTIF, LIGAND 4-LIKE 1; CCL4L1	9560
MIM603783	%	4p16-q34	INTELLIGENCE QUANTITATIVE TRAIT LOCUS 1	100462721
MIM603784	*	21q22.3	PITUITARY TUMOR-TRANSFORMING GENE 1 PROTEIN-INTERACTING PROTEIN; PTTG1IP	754
MIM603785	*	9p24-p22	MULTIPLE PDZ DOMAIN PROTEIN; MPDZ	8777
MIM603786	#	4p, 4p15.3	STARGARDT DISEASE 4; STGD4	8842
MIM603787	*	2p25	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY F, MEMBER 1; KCNF1	3754
MIM603788	*	20q13	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY G, MEMBER 1; KCNG1	3755
MIM603790	*	5q31.2-q31.3	SOLUTE CARRIER FAMILY 23 (NUCLEOBASE TRANSPORTER), MEMBER 1; SLC23A1	9963
MIM603791	*	20p13-p12	SOLUTE CARRIER FAMILY 23 (NUCLEOBASE TRANSPORTER), MEMBER 2; SLC23A2	9962
MIM603794		 	HYDROA VACCINIFORME, FAMILIAL	 
MIM603795	*	16p13.3-p12	LIPOPOLYSACCHARIDE-INDUCED TUMOR NECROSIS FACTOR-ALPHA FACTOR; LITAF	9516
MIM603796	*	21q22.1	POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 2; KCNE2	9992
MIM603797	*	11p11.2-p11.1	CARBOHYDRATE SULFOTRANSFERASE 1; CHST1	8534
MIM603798	*	3q24	CARBOHYDRATE SULFOTRANSFERASE 2; CHST2	9435
MIM603799	*	10q22.1	CARBOHYDRATE SULFOTRANSFERASE 3; CHST3	9469
MIM603800	*	12p11.23	MEDIATOR COMPLEX SUBUNIT 21; MED21	9412
MIM603801	*	10p13	N-MYRISTOYLTRANSFERASE 2; NMT2	9397
MIM603802	%	 	MICROCEPHALY WITH SIMPLIFIED GYRAL PATTERN	 
MIM603803	*	13q22	DACHSHUND, DROSOPHILA, HOMOLOG OF, 1; DACH1	1602
MIM603804	*	10q25.1	NEURALIZED, DROSOPHILA, HOMOLOG-LIKE; NEURL	9148
MIM603805	*	15q15.2	TRANSGLUTAMINASE 5; TGM5	9333
MIM603806		 	URINARY TRACT INFECTIONS, RECURRENT, SUSCEPTIBILITY TO	 
MIM603807	^	 	MOVED TO 107250	 
MIM603808	*	17q22-q23	MEDIATOR COMPLEX SUBUNIT 13; MED13	9969
MIM603809	*	 	THYROID HORMONE RECEPTOR-ASSOCIATED PROTEIN 3; THRAP3	9967
MIM603810	*	11q21	MEDIATOR COMPLEX SUBUNIT 17; MED17	9440
MIM603811	*	Chr.11	BARRIER-TO-AUTOINTEGRATION FACTOR 1; BANF1	8815
MIM603812	*	14q24.1-q24.2	DDB1- AND CUL4-ASSOCIATED FACTOR 5; DCAF5	8816
MIM603813	#	1p36-p35	HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE; ARH	26119
MIM603814	*	 	RING-BOX 1; RBX1	9978
MIM603815	*	6q27	KINESIN FAMILY MEMBER 25; KIF25	3834
MIM603816	*	16p13.3	AXIS INHIBITOR 1; AXIN1	8312
MIM603817	*	2p24	DEVELOPMENT- AND DIFFERENTIATION-ENHANCING FACTOR 2; DDEF2	8853
MIM603818	*	5q23-q33	NEUREGULIN 2; NRG2	9542
MIM603819	*	5q31.3	STEROID RECEPTOR RNA ACTIVATOR 1; SRA1	10011
MIM603820	*	19q13.1	G PROTEIN-COUPLED RECEPTOR 40; GPR40	2864
MIM603821	*	19q13.1	G PROTEIN-COUPLED RECEPTOR 41; GPR41	2865
MIM603822	*	19q13.1	G PROTEIN-COUPLED RECEPTOR 42; GPR42	2866
MIM603823	*	19q13.1	G PROTEIN-COUPLED RECEPTOR 43; GPR43	2867
MIM603824	*	9p13.3	UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE	10020
MIM603825	*	17p13.3	HYPERMETHYLATED IN CANCER 1; HIC1	3090
MIM603826	*	12q	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 4; NR1H4	9971
MIM603827	*	2q12-q13	BCL2-LIKE 11; BCL2L11	10018
MIM603828		 	BRITTLE BONE DISORDER	 
MIM603829	#	3p21	VENTRICULAR FIBRILLATION DURING MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO	6331
MIM603830	#	3p21	LONG QT SYNDROME 3; LQT3	6331
MIM603831	*	1q21	PDZ DOMAIN-CONTAINING 1; PDZK1	5174
MIM603832	*	 	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 3; NDUFA3	4696
MIM603833	*	 	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 4; NDUFA4	4697
MIM603834	*	12p	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 9; NDUFA9	4704
MIM603835	*	2q37.3	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 10; NDUFA10	4705
MIM603836	*	16p12.3-p12.1	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA/BETA SUBCOMPLEX, 1; NDUFAB1	4706
MIM603837	*	 	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 1; NDUFB1	4707
MIM603838	*	 	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 2; NDUFB2	4708
MIM603839	*	2q31.3	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 3; NDUFB3	4709
MIM603840	*	 	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 4; NDUFB4	4710
MIM603841	*	 	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 5; NDUFB5	4711
MIM603842	*	19p13.12-p13.11	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 7; NDUFB7	4713
MIM603843	*	16p13.3	NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 10; NDUFB10	4716
MIM603844	*	4q28.2-q31.1	NADH-UBIQUINONE OXIDOREDUCTASE 1, SUBUNIT C1; NDUFC1	4717
MIM603845	*	 	NADH-UBIQUINONE OXIDOREDUCTASE 1, SUBUNIT C2; NDUFC2	4718
MIM603846	*	11p11.11	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 3; NDUFS3	4722
MIM603847	*	1p34.2-p33	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 5; NDUFS5	4725
MIM603848	*	5pter-p15.33	NADH-UBIQUINONE OXIDOREDUCTASE Fe-S PROTEIN 6; NDUFS6	4726
MIM603849	*	6q21	NUCLEAR RECEPTOR SUBFAMILY 2, GROUP E, MEMBER 1; NR2E1	7101
MIM603850	*	12p11.21	DYNAMIN 1-LIKE; DNM1L	10059
MIM603851	*	4p12	PAIRED-LIKE HOMEOBOX 2B; PHOX2B	8929
MIM603852	*	11p15.5	TUMOR-SUPPRESSING SUBCHROMOSOMAL TRANSFERABLE FRAGMENT CANDIDATE GENE 4; TSSC4	10078
MIM603853	*	11p15.5	TETRASPANIN 32; TSPAN32	10077
MIM603854	*	6p23	RAN-BINDING PROTEIN 9; RANBP9	10048
MIM603855	%	19q13.2-q13.4	CYSTIC FIBROSIS, MODIFIER OF, 1; CFM1	10167
MIM603856	*	15q11-q13	MAKORIN 3; MKRN3	7681
MIM603857	*	15q11-q13	MKRN3 ANTISENSE RNA; MKRN3AS	10108
MIM603859	*	7q21.3	SOLUTE CARRIER FAMILY 25 (CITRIN), MEMBER 13; SLC25A13	10165
MIM603860	#	16p12.3	MEDULLARY CYSTIC KIDNEY DISEASE 2; MCKD2	7369
MIM603861	*	13q14	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ORNITHINE TRANSPORTER), MEMBER 15; SLC25A15	10166
MIM603862	*	2p14-q21.3	CYCLIN T2; CCNT2	905
MIM603863	*	3q22-q24	RING FINGER PROTEIN 7; RNF7	9616
MIM603864	*	11q13	COPPER CHAPERONE FOR SUPEROXIDE DISMUTASE; CCS	9973
MIM603865	*	5q34-q35	GLUTAMINE:FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE 2; GFPT2	9945
MIM603866	*	Chr.15	PEROXISOME BIOGENESIS FACTOR 11A; PEX11A	8800
MIM603867	*	 	PEROXISOME BIOGENESIS FACTOR 11B; PEX11B	8799
MIM603868	*	15q21	RAS-ASSOCIATED PROTEIN RAB27A; RAB27A	5873
MIM603869	*	 	RAS-ASSOCIATED PROTEIN RAB27B; RAB27B	5874
MIM603870	*	16q24	CORE-BINDING FACTOR, ALPHA SUBUNIT 2, TRANSLOCATED TO, 3; CBFA2T3	863
MIM603871	*	6p21.1	BY THE RIBOSOMAL PROTEIN S6 GENE, DROSOPHILA, HOMOLOG-LIKE; BYSL	705
MIM603872	*	 	TROPHININ-ASSOCIATED PROTEIN; TROAP	10024
MIM603873	*	 	PHOSPHOLIPASE A2-ACTIVATING PROTEIN; PLAA	9373
MIM603874	*	 	ANGIOPOIETIN-LIKE 1; ANGPTL1	9068
MIM603875	*	9q33	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 8; TNFSF8	944
MIM603876	*	1q21-q23	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 4; ADAMTS4	9507
MIM603877	*	 	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 3; SLC16A3	9123
MIM603878	*	 	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 4; SLC16A4	9122
MIM603879	*	 	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 5; SLC16A5	9121
MIM603880	*	 	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 6; SLC16A6	9120
MIM603881	*	 	NUCLEAR RECEPTOR SUBFAMILY 1, GROUP I, MEMBER 3; NR1I3	9970
MIM603882	*	 	BCL2-ASSOCIATED ATHANOGENE 2; BAG2	9532
MIM603883	*	10q25.2-q26.2	BCL2-ASSOCIATED ATHANOGENE 3; BAG3	9531
MIM603884	*	 	BCL2-ASSOCIATED ATHANOGENE 4; BAG4	9530
MIM603885	*	 	BCL2-ASSOCIATED ATHANOGENE 5; BAG5	9529
MIM603886	*	 	ARTEMIN; ARTN	9048
MIM603887	*	12q12-q13	TIMELESS, DROSOPHILA, HOMOLOG OF; TIMELESS	8914
MIM603888	*	2p24	POTASSIUM CHANNEL, VOLTAGE-GATED, DELAYED-RECTIFIER, SUBFAMILY S, MEMBER 3; KCNS3	3790
MIM603889	*	 	SIGNAL REGULATORY PROTEIN, BETA-1; SIRPB1	10326
MIM603890	*	11q12	UBIQUITIN-CONJUGATING ENZYME E2L 6; UBE2L6	9246
MIM603891	*	11q13.1	FIBROBLAST GROWTH FACTOR 19; FGF19	9965
MIM603892	*	17q21.31	ELONGATION FACTOR Tu GTP-BINDING DOMAIN-CONTAINING 2; EFTUD2	9343
MIM603893	*	 	TRAF FAMILY MEMBER-ASSOCIATED NF-KAPPA-B ACTIVATOR; TANK	10010
MIM603894	*	14q24.3	REGULATOR OF G PROTEIN SIGNALING 6; RGS6	9628
MIM603895	*	16p13.3	REGULATOR OF G PROTEIN SIGNALING 11; RGS11	8786
MIM603896	#	14q24, Chr.12, 1p34.1, 3q27, 2p23.3	LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	1967, 8890, 8891, 8892, 8893
MIM603897	*	20q13.1-q13.2	MATRILIN 4; MATN4	8785
MIM603898	*	1q23	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 18; TNFSF18	8995
MIM603899	*	19p13.1-p12	ZINC FINGER PROTEIN 85; ZNF85	7639
MIM603900	*	16p13.3	ZINC FINGER PROTEIN 174; ZNF174	7727
MIM603901	*	 	ZINC FINGER PROTEIN 259; ZNF259	8882
MIM603902	#	11p15.5	BETA-THALASSEMIA, DOMINANT INCLUSION BODY TYPE	3043
MIM603903	#	11p15.5	SICKLE CELL ANEMIA	3043
MIM603904	*	13q14	INTEGRAL MEMBRANE PROTEIN 2B; ITM2B	9445
MIM603905	*	1p36.3	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 18; TNFRSF18	8784
MIM603906	*	1p31-p22	CHLORIDE CHANNEL, CALCIUM-ACTIVATED, 1; CLCA1	1179
MIM603907	*	 	EUKARYOTIC TRANSLATION INITIATION FACTOR 2, SUBUNIT 1; EIF2S1	1965
MIM603908	*	 	EUKARYOTIC TRANSLATION INITIATION FACTOR 2, SUBUNIT 2; EIF2S2	8894
MIM603909	#	2q33-q34	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA; ALPS2A	843
MIM603910	*	15q15.3	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT J; EIF3J	8669
MIM603911	*	1p34.1	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT I; EIF3I	8668
MIM603912	*	8q24.11	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT H; EIF3H	8667
MIM603913	*	19p13.2	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT G; EIF3G	8666
MIM603914	*	11p15.4	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT F; EIF3F	8665
MIM603915	*	22q13.1	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT D; EIF3D	8664
MIM603916	*	16p11.2	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT C; EIF3C	8663
MIM603917	*	7p22.2	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT B; EIF3B	8662
MIM603918	%	17q	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 1	117191
MIM603919	*	5q35.1	SERINE/THREONINE PROTEIN KINASE 10; STK10	6793
MIM603920	*	21q22.1	CRYSTALLIN, ZETA-LIKE 1; CRYZL1	9946
MIM603921	*	13q12.2-q13	SUCCINATE-CoA LIGASE, ADP-FORMING, BETA SUBUNIT; SUCLA2	8803
MIM603922	*	 	SUCCINATE-CoA LIGASE, GDP-FORMING, BETA SUBUNIT; SUCLG2	8801
MIM603924	*	10q25-q26	HYALURONAN-BINDING PROTEIN 2; HABP2	3026
MIM603925	*	22q13	SYNAPTOGYRIN 1; SYNGR1	9145
MIM603926	*	17q25	SYNAPTOGYRIN 2; SYNGR2	9144
MIM603927	*	16pter	SYNAPTOGYRIN 3; SYNGR3	9143
MIM603928	*	 	EUKARYOTIC TRANSLATION INITIATION FACTOR 4B; EIF4B	1975
MIM603929	*	 	EUKARYOTIC TRANSLATION INITIATION FACTOR 4-GAMMA, 3; EIF4G3	8672
MIM603930	*	14q24	GEPHYRIN; GPHN	10243
MIM603931	*	5q35.2	ATPase, H+ TRANSPORTING, LYSOSOMAL, 9-KD, V0 SUBUNIT E1; ATP6V0E1	8992
MIM603932	#	15q22, 9q21.3-q22, 1p21, 6q27, 1p33-p32.2, 20q13.3	INTERVERTEBRAL DISC DISEASE; IDD	1298, 1299, 1301, 54829, 7058, 8483
MIM603933	#	6p12	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1; MVCD1	23771, 7422
MIM603934	*	 	COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1; CARM1	10498
MIM603935	%	1q21	PSORIASIS SUSCEPTIBILITY 4; PSORS4	10547
MIM603936	*	12q13.13	GROWTH/DIFFERENTIATION FACTOR 11; GDF11	10220
MIM603937	*	8q11-q13	RP1 GENE; RP1	6101
MIM603939	*	19q13.1	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 6; KCNK6	9424
MIM603940	*	11q13	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 7; KCNK7	10089
MIM603941	*	1q23.3	SOLUTE CARRIER FAMILY 19 (THIAMINE TRANSPORTER), MEMBER 2; SLC19A2	10560
MIM603942	*	3q24-q25.1	GLYCOGENIN 1; GYG1	2992
MIM603943	*	5q22-q23	CYSTEINE DIOXYGENASE; CDO	1036
MIM603944	*	 	SYNTAXIN 6; STX6	10228
MIM603945	*	3q27	EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 5; EIF2B5	8893
MIM603946	*	10q23.3-q24.2	HELICASE, LYMPHOID-SPECIFIC; HELLS	3070
MIM603947	*	11q12-q13.1	METASTASIS-ASSOCIATED 1-LIKE 1; MTA1L1	9219
MIM603948	*	6p22.3	NUCLEOPORIN, 153-KD; NUP153	9972
MIM603949	*	1q32	RAB7-LIKE 1; RAB7L1	8934
MIM603950	*	 	N-DEACETYLASE/N-SULFOTRANSFERASE 3; NDST3	9348
MIM603951	*	5q34	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, BETA MEMBER 1; KCNMB1	3779
MIM603952	*	 	DEVELOPMENTALLY REGULATED GTP-BINDING PROTEIN 1; DRG1	4733
MIM603953	*	 	POTASSIUM INWARDLY-RECTIFYING CHANNEL, SUBFAMILY J, MEMBER 14; KCNJ14	3770
MIM603954	*	Chr.11	ZESTE-WHITE 10, DROSOPHILA, HOMOLOG OF; ZW10	9183
MIM603955	*	1q23-q25	FLAVIN-CONTAINING MONOOXYGENASE 2; FMO2	2327
MIM603956	#	4p16.3	CERVICAL CANCER	2261
MIM603957	*	1q21.1	FLAVIN-CONTAINING MONOOXYGENASE 5; FMO5	2330
MIM603958	*	 	REGULATORY FACTOR X, 4; RFX4	5992
MIM603959	*	3q27	CLAUDIN 16; CLDN16	10686
MIM603960	*	 	CALICIN; CCIN	881
MIM603961	*	 	SEMAPHORIN 3A; SEMA3A	10371
MIM603962	*	15q15	RAS GUANYL NUCLEOTIDE-RELEASING PROTEIN 1; RASGRP1	10125
MIM603963	*	3p21.3	INTEGRIN, ALPHA-9; ITGA9	3680
MIM603964	%	2q23-q24.3	DEAFNESS, AUTOSOMAL DOMINANT 16; DFNA16	1694
MIM603965	#	11q21-q22	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2	7225
MIM603966	*	10p15-p14	ALDO-KETO REDUCTASE FAMILY 1, MEMBER C3; AKR1C3	8644
MIM603967	*	17q23.1-q25.3	SODIUM CHANNEL, VOLTAGE-GATED, TYPE IV, ALPHA SUBUNIT; SCN4A	6329
MIM603968	*	6p21.1-p12	POLYMERASE, DNA, ETA; POLH	5429
MIM603969	*	13q32-q34	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 13B; TNFSF13B	10673
MIM603970	*	 	PARANEOPLASTIC ANTIGEN MA2; PNMA2	10687
MIM603971	*	19p13.1-p12	ZINC FINGER PROTEIN 91; ZNF91	7644
MIM603972	*	19p13.1-p12	ZINC FINGER PROTEIN 43; ZNF43	7594
MIM603973	*	19p13.1-p12	ZINC FINGER PROTEIN 90; ZNF90	7643
MIM603974	*	7q11.21	ZINC FINGER PROTEIN 92; ZNF92	168374
MIM603975	*	19p13.1-p12	ZINC FINGER PROTEIN 93; ZNF93	81931
MIM603977	*	19p13.1-p12	ZINC FINGER PROTEIN 208; ZNF208	7757
MIM603978	*	6p22.2-p21.3	ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 12; ZSCAN12	9753
MIM603980	*	19p12	ZINC FINGER PROTEIN 98; ZNF98	148198
MIM603981	*	19p12	ZINC FINGER PROTEIN 99; ZNF99	7652
MIM603982	*	19p13.1-p12	ZINC FINGER PROTEIN 100; ZNF100	163227
MIM603983	*	19p13.1-p12	ZINC FINGER PROTEIN 101; ZNF101	94039
MIM603984	*	19p13.1-p12	ZINC FINGER PROTEIN 737; ZNF737	100129842
MIM603989	*	7q11.2	ZINC FINGER PROTEIN 107; ZNF107	51427
MIM603996	*	19q13.33	ZINC FINGER PROTEIN 114; ZNF114	163071
MIM604001	*	7q21-q22	A-KINASE ANCHOR PROTEIN 9; AKAP9	10142
MIM604002	*	2p24	RHO-ASSOCIATED COILED-COIL-CONTAINING PROTEIN KINASE 2; ROCK2	9475
MIM604003	*	1p31-p22	CHLORIDE CHANNEL, CALCIUM-ACTIVATED, 2; CLCA2	9635
MIM604004	#	22q13.33	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1	220296, 23209
MIM604008	*	1p36.3	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, ZETA-2; PTPRZ2	5804
MIM604009	*	16p13.3	BAI1-ASSOCIATED PROTEIN 3; BAIAP3	8938
MIM604010	*	 	PARANEOPLASTIC ANTIGEN MA1; PNMA1	9240
MIM604011	+	17q11.2	UNC119, C. ELEGANS, HOMOLOG OF; UNC119	9094
MIM604012	*	 	RNA, U20 SMALL NUCLEOLAR; RNU20	6082
MIM604013	*	1p33-p32	UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 2; B4GALT2	8704
MIM604014	*	1q23	UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 3; B4GALT3	8703
MIM604015	*	3q13.3	UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 4; B4GALT4	8702
MIM604016	*	20q13.1-q13.2	UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 5; B4GALT5	9334
MIM604017	*	18q11	UDP-GAL:BETA-GlcNAc BETA-1,4-GALACTOSYLTRANSFERASE, POLYPEPTIDE 6; B4GALT6	9331
MIM604018	*	19q13.13-q13.2	NUMB, DROSOPHILA, HOMOLOG-LIKE; NUMBL	9253
MIM604019	*	7q22.1	HIV-1 REV-BINDING PROTEIN-LIKE; HRBL	3268
MIM604020	*	3p21.31	BASSOON, MOUSE, HOMOLOG OF; BSN	8927
MIM604024	*	 	SOLUTE CARRIER FAMILY 5 (SODIUM-DEPENDENT VITAMIN TRANSPORTER), MEMBER 6; SLC5A6	8884
MIM604025	*	17q24	AXIS INHIBITOR 2; AXIN2	8313
MIM604026	*	17q11	GOLGI SNAP RECEPTOR COMPLEX MEMBER 1; GOSR1	9527
MIM604027	*	17q21	GOLGI SNAP RECEPTOR COMPLEX MEMBER 2; GOSR2	9570
MIM604028	*	 	SECRETION DEFICIENT 22, S. CEREVISIAE, HOMOLOG OF, C; SEC22C	9117
MIM604029	*	1q21.2-q21.3	SECRETION DEFICIENT 22, S. CEREVISIAE, HOMOLOG-LIKE 1; SEC22L1	9554
MIM604030	*	9q34.11-q34.12	PROTEASOME SUBUNIT, BETA-TYPE, 7; PSMB7	5695
MIM604031	*	10q24.31	STEAROYL-CoA DESATURASE; SCD	6319
MIM604032	*	2p12	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3; EIF2AK3	9451
MIM604033	*	 	ENDOPLASMIC RETICULUM-TO-NUCLEUS SIGNALING 1; ERN1	2081
MIM604034	*	Chr.16	ENDOPLASMIC RETICULUM-TO-NUCLEUS SIGNALING 2; ERN2	10595
MIM604035	*	9q31.1	CYLICIN 2; CYLC2	1539
MIM604036	*	13q12.3-q13	CYCLIN A1; CCNA1	8900
MIM604037	*	17q21.2	RAS-ASSOCIATED PROTEIN RAB5C; RAB5C	5878
MIM604038	*	3p21.3	HYALURONOGLUCOSAMINIDASE 3; HYAL3	8372
MIM604039	*	10q24.1-q24.3	MENINGIOMA-EXPRESSED ANTIGEN 5; MGEA5	10724
MIM604040	*	5q31	RAD50, S. CEREVISIAE, HOMOLOG OF; RAD50	10111
MIM604041	*	17p13.1-p12	MANNOSE-P-DOLICHOL UTILIZATION DEFECT 1; MPDU1	9526
MIM604042	*	 	INTEGRIN, ALPHA-10; ITGA10	8515
MIM604043	*	1q32.2-q41	NEVER IN MITOSIS GENE A-RELATED KINASE 2; NEK2	4751
MIM604044	*	13q14.2	NEVER IN MITOSIS GENE A-RELATED KINASE 3; NEK3	4752
MIM604045	*	 	PROTEIN ARGININE N-METHYLTRANSFERASE 5; PRMT5	10419
MIM604046	*	3p22-p21.3	OXIDATIVE STRESS-RESPONSIVE 1; OXSR1	9943
MIM604047	*	 	ORGANIC-CATION TRANSPORTER-LIKE 3; ORCTL3	9390
MIM604048	*	 	ORGANIC-CATION TRANSPORTER-LIKE 4; ORCTL4	9389
MIM604049	*	3p22-p21.3	XYLULOKINASE, H. INFLUENZAE, HOMOLOG OF; XYLB	9942
MIM604050	*	3p22-p21.3	DELETED IN LUNG AND ESOPHAGEAL CANCER 1; DLEC1	9940
MIM604051	*	3p22-p21.3	ENDO/EXONUCLEASE, ENDOG-LIKE; EXOG	9941
MIM604052	*	9q32	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 15; TNFSF15	9966
MIM604053	*	 	3-PRIME(2-PRIME),5-PRIME-@BISPHOSPHATE NUCLEOTIDASE 1; BPNT1	10380
MIM604054	*	3p23-p22	ACETYL-CoA ACYLTRANSFERASE 1; ACAA1	30
MIM604055	*	 	ISOPENTENYL-DIPHOSPHATE DELTA-ISOMERASE; IDI1	3422
MIM604056	*	16p12	HEPARAN SULFATE D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE 2; HS3ST2	9956
MIM604057	*	17p12-p11.2	HEPARAN SULFATE D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE 3A1; HS3ST3A1	9955
MIM604058	*	17p12-p11.2	HEPARAN SULFATE D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE 3B1; HS3ST3B1	9953
MIM604059	*	16p11.2	HEPARAN SULFATE D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE 4; HS3ST4	9951
MIM604060	%	11q25-qter	DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20	1713
MIM604061	*	17q25	SEPTIN 9; SEPT9	10801
MIM604062	*	 	MEDIATOR COMPLEX SUBUNIT 16; MED16	10025
MIM604063	*	 	INTEGRIN, ALPHA-8; ITGA8	8516
MIM604064	*	22q13.1	ACTIVATING TRANSCRIPTION FACTOR 4; ATF4	468
MIM604065	*	17q22	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1G SUBUNIT; CACNA1G	8913
MIM604066	*	21q22.3	UDP-GAL:BETA-GlcNAc BETA-1,3-GALACTOSYLTRANSFERASE, POLYPEPTIDE 5; B3GALT5	10317
MIM604067	*	17q23-q24	REGULATOR OF G PROTEIN SIGNALING 9; RGS9	8787
MIM604068	*	 	TUMOR PROTEIN D52; TPD52	7163
MIM604069	*	 	TUMOR PROTEIN D52-LIKE 1; TPD52L1	7164
MIM604070	*	7p21.2	DIACYLGLYCEROL KINASE, BETA, 90-KD; DGKB	1607
MIM604071	*	 	DIACYLGLYCEROL KINASE, ETA, 130-KD; DGKH	160851
MIM604072	*	7q32.3-q33	DIACYLGLYCEROL KINASE, IOTA, 130-KD; DGKI	9162
MIM604073	*	5p12-p11	ZINC FINGER PROTEIN 131; ZNF131	7690
MIM604074	*	19q13.4	ZINC FINGER PROTEIN 132; ZNF132	7691
MIM604075	*	20p11.2	ZINC FINGER PROTEIN 133; ZNF133	7692
MIM604076	*	19q13.4	ZINC FINGER PROTEIN 134; ZNF134	7693
MIM604077	*	19q13.4	ZINC FINGER PROTEIN 135; ZNF135	7694
MIM604078	*	19p13.2-p13.12	ZINC FINGER PROTEIN 136; ZNF136	7695
MIM604079	*	19q13.3-q13.4	ZINC FINGER PROTEIN 137; ZNF137	7696
MIM604080	*	7q11.21-q11.23	ZINC FINGER PROTEIN 138; ZNF138	7697
MIM604082	*	12q24.32-q24.33	ZINC FINGER PROTEIN 140; ZNF140	7699
MIM604083	*	2q34-q35	ZINC FINGER PROTEIN 142; ZNF142	7701
MIM604084	*	1p36.2-p36.1	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 17; ZBTB17	7709
MIM604085	*	19q13.4	ZINC FINGER PROTEIN 154; ZNF154	7710
MIM604086	*	19q13.2-q13.32	ZINC FINGER PROTEIN 155; ZNF155	7711
MIM604087	*	14q32.1	CYTOCHROME P450, FAMILY 46, SUBFAMILY A, POLYPEPTIDE 1; CYP46A1	10858
MIM604088	*	7p15	G-SUBSTRATE	10842
MIM604089	*	19q13.1	HEMATOPOIETIC CELL SIGNAL TRANSDUCER; HCST	10870
MIM604090	*	10q23	DISCS LARGE, DROSOPHILA, HOMOLOG OF, 5; DLG5	9231
MIM604091	#	11q23, 9q22-q31	HYPOALPHALIPOPROTEINEMIA, PRIMARY	19, 335
MIM604092	*	6q13-q21	TTK PROTEIN KINASE; TTK	7272
MIM604093		 	KERATOSIS PILARIS	 
MIM604094	*	1p36	MITOTIC ARREST-DEFICIENT 2, S. CEREVISIAE, HOMOLOG-LIKE 2; MAD2L2	10459
MIM604095	*	2q11-q13	ECTODYSPLASIN A RECEPTOR; EDAR	10913
MIM604096	*	5q35	GLUTAMATE RECEPTOR, METABOTROPIC, 6; GRM6	2916
MIM604097	*	 	UROTENSIN II; UTS2	10911
MIM604098	*	 	SUPPRESSOR OF G2 ALLELE OF SKP1, S. CEREVISIAE, HOMOLOG OF; SUGT1	10910
MIM604099	*	3p21.2-p21.1	GLUTAMATE RECEPTOR, METABOTROPIC, 2; GRM2	2912
MIM604100	*	6p21.3	GLUTAMATE RECEPTOR, METABOTROPIC, 4; GRM4	2914
MIM604101	*	3p26.1-p25.2	GLUTAMATE RECEPTOR, METABOTROPIC, 7; GRM7	2917
MIM604102	*	 	GLUTAMATE RECEPTOR, METABOTROPIC, 5; GRM5	2915
MIM604103	*	5q31	TITIN IMMUNOGLOBULIN DOMAIN PROTEIN; TTID	9499
MIM604104	*	19q13.2	GLIA MATURATION FACTOR, GAMMA; GMFG	9535
MIM604105	*	20q13.33	SYNAPTONEMAL COMPLEX PROTEIN 2; SYCP2	10388
MIM604106	*	1q24	G PROTEIN-COUPLED RECEPTOR 52; GPR52	9293
MIM604107	*	2q37	G PROTEIN-COUPLED RECEPTOR 55; GPR55	9290
MIM604108	*	6q22-q25	MICROTUBULE-ASSOCIATED PROTEIN 7; MAP7	9053
MIM604109	*	8q24	HUMAN ENDOGENOUS RETROVIRUS-H LONG TERMINAL REPEAT-ASSOCIATING 1; HHLA1	10086
MIM604110	*	16q13	G PROTEIN-COUPLED RECEPTOR 56; GPR56	9289
MIM604111	*	17p13.1	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, BETA MEMBER 3; KCNAB3	9196
MIM604112	*	13q22	SCIELLIN; SCEL	8796
MIM604113	*	 	INTERLEUKIN 18-BINDING PROTEIN; IL18BP	10068
MIM604114	*	15q15	PHOSPHOLIPASE C, BETA-2; PLCB2	5330
MIM604115	*	11p15.5	KCNQ1-OVERLAPPING TRANSCRIPT 1; KCNQ1OT1	10984
MIM604116	#	1p22.1	CONE-ROD DYSTROPHY 3; CORD3	24
MIM604117	#	1q21	VOHWINKEL SYNDROME, VARIANT FORM	4014
MIM604118	*	12q23-q24	RAS PROTEIN ACTIVATOR-LIKE 1; RASAL1	8437
MIM604119	*	16q22.1	SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 4; SLC12A4	6560
MIM604121	#	 	CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY	 
MIM604122	*	15q21-q22	PHOSPHATIDYLINOSITOL GLYCAN, CLASS B; PIGB	9488
MIM604123	*	2p25	RIBONUCLEASE H1; RNASEH1	246243
MIM604124	*	18q11.2	RETINOBLASTOMA-BINDING PROTEIN 8; RBBP8	5932
MIM604125	*	19q13.3	SULFOTRANSFERASE FAMILY 2B, MEMBER 1; SULT2B1	6820
MIM604126	*	10p11.2	SUPERVILLIN; SVIL	6840
MIM604127	*	1p13	T-BOX 15; TBX15	6913
MIM604128	*	 	TRANSCRIPTION ELONGATION FACTOR A, 3; TCEA3	6920
MIM604129	#	3p21.3	EPIDERMOLYSIS BULLOSA PRURIGINOSA	1294
MIM604130	*	10q26	UNDIFFERENTIATED EMBRYONIC CELL TRANSCRIPTION FACTOR 1; UTF1	8433
MIM604131	#	16pter-p13.3, 16pter-p13.3, 11p15.5, 11p15.5	ALPHA-THALASSEMIA	3039, 3040, 387281
MIM604134	*	9q34	A DISINTEGRIN-LIKE AND METALLOPROTEASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 13; ADAMTS13	11093
MIM604135	*	7p15-p14	NUCLEAR FACTOR ERYTHROID 2-LIKE 3; NFE2L3	9603
MIM604136	*	1q32	INTERLEUKIN 24; IL24	11009
MIM604138	*	12p13-p12.3	G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 5, MEMBER A; GPRC5A	9052
MIM604139	*	2q32-34	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 2; DNAJB2	3300
MIM604140	*	20q13.33	DEATH INDUCER-OBLITERATOR 1; DIDO1	11083
MIM604141	*	8q13	ADP-RIBOSYLATION FACTOR GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; ARFGEF1	10565
MIM604142	*	19q13.1	TYRO PROTEIN TYROSINE KINASE-BINDING PROTEIN; TYROBP	7305
MIM604143	*	12q13	EXTRA SPINDLE POLES-LIKE 1; ESPL1	9700
MIM604144	*	19q13.1	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 9; SLC7A9	11136
MIM604145	#	2q31	CARDIOMYOPATHY, DILATED, 1G; CMD1G	7273
MIM604146	*	11q13	SYNAPTOTAGMIN 7; SYT7	9066
MIM604147	*	5q33	PITUITARY TUMOR-TRANSFORMING GENE 1; PTTG1	9232
MIM604148	*	17p11.1-q11.1	SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT DICARBOXYLATE TRANSPORTER), MEMBER 2; SLC13A2	9058
MIM604149	*	7q21	SARCOGLYCAN, EPSILON; SGCE	8910
MIM604150	*	7q22-q31.1	POLYMERASE II, RNA, SUBUNIT J; POLR2J	5439
MIM604151	*	2q32.1	UBIQUITIN-CONJUGATING ENZYME E2E 3; UBE2E3	10477
MIM604152	*	 	ORNITHINE DECARBOXYLASE ANTIZYME 2; OAZ2	4947
MIM604153	*	2q37.1	NEUROMEDIN U RECEPTOR 1; NMUR1	10316
MIM604155	*	2q34	LanC-LIKE 1; LANCL1	10314
MIM604156	*	8p12-p11.1	SECRETED FRIZZLED-RELATED PROTEIN 1; SFRP1	6422
MIM604157	*	4q31.3	SECRETED FRIZZLED-RELATED PROTEIN 2; SFRP2	6423
MIM604158	*	10q24.1	SECRETED FRIZZLED-RELATED PROTEIN 5; SFRP5	6425
MIM604159	*	11p15.2-p15.1	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GLYCINE), MEMBER 5; SLC6A5	9152
MIM604160	*	 	INTEGRIN, BETA-8; ITGB8	3696
MIM604161	*	19p13.3	KISS1 RECEPTOR; KISS1R	84634
MIM604163	*	22q	RIBOSOMAL PROTEIN L3; RPL3	6122
MIM604164	*	15q21.1-q21.2	ONE CUT HOMEOBOX 1; ONECUT1	3175
MIM604165	*	17p13.3	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, OXOGLUTARATE CARRIER), MEMBER 11; SLC25A11	8402
MIM604166	*	8q	RIBOSOMAL PROTEIN L7; RPL7	6129
MIM604167	*	16q22.1	CCCTC-BINDING FACTOR; CTCF	10664
MIM604168	#	18q23	CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY	9150
MIM604169	#	18q12.1-q12.2	LEFT VENTRICULAR NONCOMPACTION 1; LVNC1	1837
MIM604170	*	3q23	PHOSPHOLIPID SCRAMBLASE 1; PLSCR1	5359
MIM604171	*	17q25.3	THO COMPLEX, SUBUNIT 4; THOC4	10189
MIM604173	#	16q13	POIKILODERMA WITH NEUTROPENIA; PN	79650
MIM604174	*	3p	RIBOSOMAL PROTEIN L15; RPL15	6138
MIM604175	*	1p36.1-p35	RIBOSOMAL PROTEIN L11; RPL11	6135
MIM604176	*	17q25.3	SUPPRESSOR OF CYTOKINE SIGNALING 3; SOCS3	9021
MIM604177	*	8q	RIBOSOMAL PROTEIN L8; RPL8	6132
MIM604178	*	19p	RIBOSOMAL PROTEIN L18A; RPL18A	6142
MIM604179	*	19q	RIBOSOMAL PROTEIN L18; RPL18	6141
MIM604180	*	3q	RIBOSOMAL PROTEIN L24; RPL24	6152
MIM604181	*	5p	RIBOSOMAL PROTEIN L37; RPL37	6167
MIM604182	*	17q	RIBOSOMAL PROTEIN L38; RPL38	6169
MIM604183		 	CHOLESTEATOMA, CONGENITAL	 
MIM604184	*	15q22.3-q23	PUTATIVE NEURONAL CELL ADHESION MOLECULE; PUNC	9543
MIM604185	%	10q21.3-q22.1	FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	22811
MIM604186	*	5q31	CHEMOKINE, CXC MOTIF, LIGAND 14; CXCL14	9547
MIM604187	#	12q13	SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10	3798
MIM604188	*	1q21-q22	SELENIUM-BINDING PROTEIN 1; SELENBP1	8991
MIM604189	*	11q13	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 4; DNAJC4	3338
MIM604190	*	5q31	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 4; SLC22A4	6583
MIM604191	*	 	ZINC FINGER PROTEIN 263; ZNF263	10127
MIM604193	*	1q21.3	SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 3; SLC27A3	11000
MIM604194	*	9q34	SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 4; SLC27A4	10999
MIM604196	*	 	SOLUTE CARRIER FAMILY 27 (FATTY ACID TRANSPORTER), MEMBER 6; SLC27A6	28965
MIM604197	*	 	5,10-@METHENYLTETRAHYDROFOLATE SYNTHETASE; MTHFS	10588
MIM604198	*	 	RAS-ASSOCIATED PROTEIN RAB11B; RAB11B	9230
MIM604199	*	 	RAS-ASSOCIATED PROTEIN RAB35; RAB35	11021
MIM604200	*	19q13.3	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 5; SIGLEC5	8778
MIM604201	%	6q22-q23	HEPATIC FIBROSIS, SEVERE, SUSCEPTIBILITY TO, DUE TO SCHISTOSOMA MANSONI INFECTION	53366
MIM604202	*	22q11.2	SYNAPTOSOMAL-ASSOCIATED PROTEIN, 29-KD; SNAP29	9342
MIM604203	*	17p12	SYNTAXIN 8; STX8	9482
MIM604204	*	9q31	SYNTAXIN 17; STX17	55014
MIM604205	*	 	COPINE I; CPNE1	8904
MIM604206	*	 	COPINE II; CPNE2	221184
MIM604207	*	8q21.3	COPINE III; CPNE3	8895
MIM604208	*	 	COPINE IV; CPNE4	131034
MIM604209	*	6p21	COPINE V; CPNE5	57699
MIM604210	*	1q31-q32.1	CRUMBS, DROSOPHILA, HOMOLOG OF, 1; CRB1	23418
MIM604212	*	16p13.12	POLYADENYLATE-SPECIFIC RIBONUCLEASE; PARN	5073
MIM604213	#	 	CHUDLEY-MCCULLOUGH SYNDROME; CMCS	29899
MIM604214	*	7q11.2-q21	KREV INTERACTION TRAPPED 1; KRIT1	889
MIM604215	*	4q35.1	INHIBITOR OF GROWTH 2; ING2	3622
MIM604216	*	6p22-p21.3	SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 4; SLC17A4	10050
MIM604217	*	4p15.31-p15.2	SOLUTE CARRIER FAMILY 34 (SODIUM/PHOSPHATE COTRANSPORTER), MEMBER 2; SLC34A2	10568
MIM604218	#	3q26	ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	5274
MIM604219	#	12q13, 11p13, 3q21-q25	CATARACT, AUTOSOMAL DOMINANT	4284, 5080, 8419
MIM604220	*	7q21-q22	ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 1A; ARPC1A	10552
MIM604221	*	 	ACTIN-RELATED PROTEIN 2; ACTR2	10097
MIM604222	*	2q14.1	ACTIN-RELATED PROTEIN 3; ACTR3	10096
MIM604223	*	7q21-q22	ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 1B; ARPC1B	10095
MIM604224	*	2q35	ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 2; ARPC2	10109
MIM604225	*	 	ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 3; ARPC3	10094
MIM604226	*	 	ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 4; ARPC4	10093
MIM604227	*	 	ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 5; ARPC5	10092
MIM604228	^	 	MOVED TO 607624	 
MIM604229	#	11p13, 4q25-q26, 2p22-p21	PETERS ANOMALY	1545, 5080, 5308
MIM604230	*	16q22.2-q22.3	ADENOSINE DEAMINASE, tRNA-SPECIFIC, 1; ADAT1	23536
MIM604231	*	4p12	PITUITARY TUMOR-TRANSFORMING GENE 2; PTTG2	10744
MIM604232	#	14q31.3	LEBER CONGENITAL AMAUROSIS 3; LCA3	55812
MIM604233	#	5q31.1-q33.1, 1p36.3, 2q24, 19q13.1	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1	6324
MIM604234	*	13q33	INTEGRIN, BETA-LIKE 1; ITGBL1	9358
MIM604235	*	14q11.2	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 8; SLC7A8	23428
MIM604237	*	19p12	CYTOKINE RECEPTOR-LIKE FACTOR 1; CRLF1	9244
MIM604238	*	20q13.1	SNAIL, DROSOPHILA, HOMOLOG OF, 1; SNAI1	6615
MIM604239	*	7q11.2	PHOSPHOSERINE PHOSPHATASE-LIKE; PSPHL	8781
MIM604240	*	2p13.1-p12	T-CELL LEUKEMIA, HOMEOBOX 2; TLX2	3196
MIM604241	*	6p12	CD2-ASSOCIATED PROTEIN; CD2AP	23607
MIM604242	*	13q12.11	RING FINGER PROTEIN 6; RNF6	6049
MIM604249	*	11q13	RETICULON 3; RTN3	10313
MIM604250	#	7q22	HEMOCHROMATOSIS, TYPE 3; HFE3	7036
MIM604251	*	22q11.2	CALCINEURIN-BINDING PROTEIN 1	23523
MIM604252	*	11q23.3	BETA-SITE AMYLOID BETA A4 PRECURSOR PROTEIN-CLEAVING ENZYME 1; BACE1	23621
MIM604253	*	5q23	CASEIN KINASE I, GAMMA-3; CSNK1G3	1456
MIM604254	%	2p16-p15	DYSLEXIA, SUSCEPTIBILITY TO, 3; DYX3	11192
MIM604255	*	10q24	LADY BIRD LATE, DROSOPHILA, HOMOLOG OF, 1	10660
MIM604256	*	3p26	BASIC HELIX-LOOP-HELIX FAMILY, MEMBER E40; BHLHE40	8553
MIM604257		 	CAMERA-MARUGO-COHEN SYNDROME	 
MIM604258	*	8p22-p21.3	DELETED IN LIVER CANCER 1; DLC1	10395
MIM604259	*	Chr.12	PLEXIN C1; PLXNC1	10154
MIM604260	*	17q11.2	SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 5B; STAT5B	6777
MIM604261	*	6q21	AUTOPHAGY 5, S. CEREVISIAE, HOMOLOG OF; ATG5	9474
MIM604262	*	 	AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER 3; APBA3	9546
MIM604263	*	20pter-p12	PRION GENE COMPLEX, DOWNSTREAM; PRND	23627
MIM604264	*	3p24.1-p21.2	CADHERIN EGF LAG SEVEN-PASS G-TYPE RECEPTOR 3; CELSR3	1951
MIM604265	*	1p21	CADHERIN EGF LAG SEVEN-PASS G-TYPE RECEPTOR 2; CELSR2	1952
MIM604266	*	1p36.3	MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 6; MEGF6	1953
MIM604267	*	19q12	MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 8; MEGF8	1954
MIM604268	*	9q32-q33.3	MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 9; MEGF9	1955
MIM604269	*	5q32-q33	FAT TUMOR SUPPRESSOR, DROSOPHILA, HOMOLOG OF, 2; FAT2	2196
MIM604270	*	11p12-p11.2	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 4; LRP4	4038
MIM604271	#	5p13-p12, 3q26.3	SHORT STATURE, IDIOPATHIC, AUTOSOMAL	2690, 2693
MIM604272	*	22q13	SCO2, S. CEREVISIAE, HOMOLOG OF; SCO2	9997
MIM604273	#	17p11.2, 8q21.11	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	91647
MIM604274	*	12p13-p12	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 1; KLRA1	10748
MIM604275	*	5p15.2	CATENIN, DELTA-2; CTNND2	1501
MIM604276	*	2q23-q31	PLAKOPHILIN 4; PKP4	8502
MIM604277	*	2p22-p21	SPASTIN; SPAST	6683
MIM604278	#	4q21	RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTAL RETARDATION	8671
MIM604279	*	5q13.2	JUNCTION-MEDIATING AND REGULATORY PROTEIN	133746
MIM604280	*	7q32.3	PLEXIN A4; PLXNA4	91584
MIM604281	*	7q21.3	DBF4, S. CEREVISIAE, HOMOLOG OF; DBF4	10926
MIM604282	*	3q22	PLEXIN D1; PLXND1	23129
MIM604283	*	1q24-q25	PROTEOGLYCAN 4; PRG4	10216
MIM604284	^	 	MOVED TO 137920	 
MIM604285	*	2q36-q37	ALANINE-GLYOXYLATE AMINOTRANSFERASE; AGXT	189
MIM604286	#	4q12	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E; LGMD2E	6443
MIM604287		 	CARNEY TRIAD	 
MIM604288	%	2q14-q22	CARDIOMYOPATHY, DILATED, 1H; CMD1H	23459
MIM604289	*	8q21.3-q22	RAD54, S. CEREVISIAE, HOMOLOG OF, B	25788
MIM604290	#	3q23-q24	ACERULOPLASMINEMIA	1356
MIM604291		 	ASCARIS LUMBRICOIDES INFECTION, SUSCEPTIBILITY TO	 
MIM604292	#	3q27	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	8626
MIM604293	*	22q13.31-q13.33	PLEXIN B2; PLXNB2	23654
MIM604294	*	10q26.1	VENTRAL ANTERIOR HOMEOBOX 1; VAX1	11023
MIM604295	*	2p13	VENTRAL ANTERIOR HOMEOBOX 2; VAX2	25806
MIM604296	*	9cen	GLYOXYLATE REDUCTASE/HYDROXYPYRUVATE REDUCTASE; GRHPR	9380
MIM604297	*	21q22.2	SYNAPTOJANIN 1; SYNJ1	8867
MIM604298	*	 	SIGNAL TRANSDUCING ADAPTOR FAMILY MEMBER 1; STAP1	26228
MIM604299	*	3p21.1-p14.3	ADAPTOR PROTEIN, PHOSPHOTYROSINE INTERACTION, PH DOMAIN, AND LEUCINE ZIPPER-CONTAINING PROTEIN 1; APPL1	26060
MIM604300	*	 	2-@HYDROXYACYL-CoA LYASE 1; HACL1	26061
MIM604301	*	 	OCULOMEDIN; OCLM	10896
MIM604302	#	7p21, 22q11.2	RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE	3569, 4282
MIM604303	*	9q31	ACTIN-LIKE 7A; ACTL7A	10881
MIM604304	*	9q31	ACTIN-LIKE 7B; ACTL7B	10880
MIM604305	*	6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ BETA-1; HLA-DQB1	3119
MIM604306	*	12q13	FAS APOPTOTIC INHIBITORY MOLECULE 2; FAIM2	23017
MIM604307	#	2q33-q35, 22q11.2-q12.2	CATARACT, COPPOCK-LIKE; CCL	1415, 1420
MIM604308	#	15q21.1	MASS SYNDROME	2200
MIM604309	*	7q33	SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT DICARBOXYLATE TRANSPORTER), MEMBER 4; SLC13A4	26266
MIM604310	*	15q15	PALLIDIN; PLDN	26258
MIM604311	*	17q12	MEDIATOR COMPLEX SUBUNIT 1; MED1	5469
MIM604312	*	20p11.2	CYSTATIN 3; CST3	1471
MIM604313	*	17q24	GALACTOKINASE 1; GALK1	2584
MIM604314	%	 	BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	 
MIM604315		 	ANEMIA, CONGENITAL HYPOPLASTIC, WITH MULTIPLE CONGENITAL ANOMALIES/MENTAL RETARDATION SYNDROME	 
MIM604316	%	3q21	PSORIASIS SUSCEPTIBILITY 5; PSORS5	63870
MIM604317	#	19q13.1-q13.2	MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICAL MALFORMATIONS; MCPH2	284403
MIM604318	*	7q11.23	GTF2I REPEAT DOMAIN-CONTAINING PROTEIN 1; GTF2IRD1	9569
MIM604319	*	14q12	TRF1-INTERACTING NUCLEAR FACTOR 2; TINF2	26277
MIM604320	#	11q13.2-q13.4	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	 
MIM604321	#	15q21.1	MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	22995
MIM604322	*	6q14-q15	SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 5; SLC17A5	26503
MIM604323	*	17q22	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 3; ABCC3	8714
MIM604324		 	ACNE, ADULT	 
MIM604325	*	5q31-q33	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B, BETA; PPP2R2B	5521
MIM604326	#	5q31-q33	SPINOCEREBELLAR ATAXIA 12; SCA12	5521
MIM604327	*	5q35.2-q35.3	XYLOSYLPROTEIN 4-BETA-GALACTOSYLTRANSFERASE, POLYPEPTIDE 7; B4GALT7	11285
MIM604328	*	11q12	STRUCTURE-SPECIFIC RECOGNITION PROTEIN 1; SSRP1	6749
MIM604329	%	15q	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 2	50986
MIM604330	*	 	GRB2-RELATED ADAPTOR PROTEIN; GRAP	10750
MIM604331	*	13q14.12-q14.2	INTEGRATOR COMPLEX SUBUNIT 6; INTS6	26512
MIM604332	*	4q11-q12	CYSTEINE-RICH HYDROPHOBIC DOMAIN 2; CHIC2	26511
MIM604333	*	2q11.2	WD40 REPEAT-CONTAINING PROTEIN CIAO1; CIAO1	9391
MIM604334	*	17p13	UBIQUITIN-SPECIFIC PROTEASE 6; USP6	9098
MIM604335		 	REFLEX SYMPATHETIC DYSTROPHY	 
MIM604336	*	21p	TRANSMEMBRANE PHOSPHATASE WITH TENSIN HOMOLOGY; TPTE	7179
MIM604337	*	1p31-p22	CHLORIDE CHANNEL, CALCIUM-ACTIVATED, 3; CLCA3	9629
MIM604344	*	6q22	MANNOSIDASE, ALPHA, CLASS 1A, MEMBER 1; MAN1A1	4121
MIM604345	*	1p13	MANNOSIDASE, ALPHA, CLASS 1A, MEMBER 2; MAN1A2	10905
MIM604346	*	 	MANNOSIDASE, ALPHA, CLASS 1B, MEMBER 1; MAN1B1	11253
MIM604347	*	1p22.1-p21.3	ZINC FINGER PROTEIN 265; ZNF265	9406
MIM604348	#	2q37.3	ADVANCED SLEEP-PHASE SYNDROME, FAMILIAL	8864
MIM604349	*	9q33-q34	LAMININ, GAMMA-3; LAMC3	10319
MIM604350	*	19p13.2	RAS-ASSOCIATED PROTEIN RAB3D; RAB3D	9545
MIM604351	*	9q22	PHD FINGER PROTEIN 2; PHF2	5253
MIM604352	#	5q14.3	FEBRILE SEIZURES, FAMILIAL, 4; FEB4	84059
MIM604353	*	 	CYSTEINE- AND HISTIDINE-RICH DOMAIN-CONTAINING PROTEIN 1; CHORDC1	26973
MIM604354	*	13q14	NUCLEAR FRAGILE X MENTAL RETARDATION PROTEIN-INTERACTING PROTEIN 1; NUFIP1	26747
MIM604355	*	7q32	COATOMER PROTEIN COMPLEX, SUBUNIT GAMMA-2; COPG2	26958
MIM604356	#	2q31-q32.1	DUANE RETRACTION SYNDROME 2; DURS2	1123
MIM604357	*	 	MAB21, C. ELEGANS, HOMOLOG-LIKE 2; MAB21L2	10586
MIM604358	*	 	STROMAL ANTIGEN 1; STAG1	10274
MIM604360	#	15q21.1	SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11	80208
MIM604362	*	13q21-q22	LIM DOMAIN ONLY 7; LMO7	4008
MIM604363		 	MYOCLONIC EPILEPSY, CONGENITAL DEAFNESS, MACULAR DYSTROPHY, AND PSYCHIATRIC DISORDERS	 
MIM604364	#	22q11-q12	EPILEPSY, PARTIAL, WITH VARIABLE FOCI	50987
MIM604365	*	4p15.3	PROMININ 1; PROM1	8842
MIM604366	*	9p21-p13	DYNEIN, AXONEMAL, INTERMEDIATE CHAIN 1; DNAI1	27019
MIM604367	#	7q11.23-q21.11, 3p25	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3	5468, 5506
MIM604368	*	 	GLYCOPROTEIN NMB; GPNMB	10457
MIM604369	#	6q14-q15	SIALURIA, FINNISH TYPE	26503
MIM604370	#	17q21, 14q32.3, 6q25.2-q27, 3q26.3	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1	672
MIM604371	*	 	HUMAN ENDOGENOUS RETROVIRUS-H LONG TERMINAL REPEAT-ASSOCIATING 2; HHLA2	11148
MIM604372	*	 	HUMAN ENDOGENOUS RETROVIRUS-H LONG TERMINAL REPEAT-ASSOCIATING 3; HHLA3	11147
MIM604373	+	22q12.1	CHECKPOINT KINASE 2, S. POMBE, HOMOLOG OF; CHEK2	11200
MIM604374	*	11q13.2-q13.3	METALLOTHIONEIN-LIKE 5, TESTIS-SPECIFIC; MTL5	9633
MIM604375	*	17q25	HUMAN GROWTH FACTOR-REGULATED TYROSINE KINASE SUBSTRATE; HGS	9146
MIM604376	*	 	MYELIN PROTEIN ZERO-LIKE 1; MPZL1	9019
MIM604377	#	22q13	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY	9997
MIM604378	*	17q21	BECLIN 1; BECN1	8678
MIM604379	#	3q27-q28	HYPOTRICHOSIS 7; HYPT7	200879
MIM604380		 	ULNAR RAY DYSGENESIS WITH POSTAXIAL POLYDACTYLY AND RENAL CYSTIC DYSPLASIA	 
MIM604381		 	PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	 
MIM604382		 	LISSENCEPHALY, FAMILIAL, WITH CLEFT PALATE AND CEREBELLAR HYPOPLASIA	 
MIM604383	*	9q34.13	GROWTH FACTOR-INDEPENDENT 1B; GFI1B	8328
MIM604384	*	3q21-q24	ATPase, Ca(2+)-TRANSPORTING, TYPE 2C, MEMBER 1; ATP2C1	27032
MIM604385	*	3p24-p21	SODIUM CHANNEL, VOLTAGE-GATED, TYPE XI, ALPHA SUBUNIT; SCN11A	11280
MIM604386	*	8q24.12	ZINC FINGER TRANSCRIPTION FACTOR TRPS1; TRPS1	7227
MIM604387	#	3q22	NEPHRONOPHTHISIS 3; NPHP3	27031
MIM604388	*	 	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-4; GNG4	2786
MIM604389	*	 	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-10; GNG10	2790
MIM604390	*	 	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-11; GNG11	2791
MIM604391	#	11q21	ATAXIA-TELANGIECTASIA-LIKE DISORDER; ATLD	4361
MIM604392	*	17p13.1	ARYLHYDROCARBON-INTERACTING RECEPTOR PROTEIN-LIKE 1; AIPL1	23746
MIM604393	#	17p13.1	LEBER CONGENITAL AMAUROSIS 4; LCA4	23746
MIM604394	*	7p22.2	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-12; GNA12	2768
MIM604395	*	14q24.3	MutL, E. COLI, HOMOLOG OF, 3; MLH3	27030
MIM604396	*	1q21	SET DOMAIN PROTEIN, BIFURCATED, 1; SETDB1	9869
MIM604397	*	9q21	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-14; GNA14	9630
MIM604398	*	11q13	MAMMAGLOBIN 2; MGB2	4246
MIM604399	*	 	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 1B; PPP1R1B	84152
MIM604400	#	3p21.3, 3p25	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; ARVD5	3921, 79188
MIM604401	%	10p14-p12	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 6; ARVD6	27038
MIM604402	*	2p11.2	ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 5; ST3GAL5	8869
MIM604403	#	2q24, 2q24	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2	6323, 6335
MIM604404	*	13q32	GLYPICAN 6; GPC6	10082
MIM604405	*	19q13.3	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 6; SIGLEC6	946
MIM604406	*	17q24.3	GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-13; GNA13	10672
MIM604407	*	4p16.3	LEUCINE ZIPPER/EF-HAND-CONTAINING TRANSMEMBRANE PROTEIN 1; LETM1	3954
MIM604409	*	1p35.3	GLUCOCORTICOID MODULATORY ELEMENT-BINDING PROTEIN 1; GMEB1	10691
MIM604410	*	19q13.3	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 7; SIGLEC7	27036
MIM604411	*	 	INNER CENTROMERE PROTEIN; INCENP	3619
MIM604412	*	14q32.1	T-CELL LEUKEMIA/LYMPHOMA 6; TCL6	27004
MIM604414	*	22q13.1	POLYMERASE II, RNA, SUBUNIT F; POLR2F	5435
MIM604415	*	7q21	SIX-TRANSMEMBRANE EPITHELIAL ANTIGEN OF PROSTATE; STEAP	26872
MIM604416	#	15q24-q25.1	PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE	9051
MIM604417	*	5q31	AF4/FMR2 FAMILY, MEMBER 4; AFF4	27125
MIM604418	*	13q12	GAP JUNCTION PROTEIN, BETA-6; GJB6	10804
MIM604419	*	3q13.3	POLYMERASE, DNA, THETA; POLQ	10721
MIM604420	*	10q24	HEMATOPOIETICALLY EXPRESSED HOMEOBOX; HHEX	3087
MIM604421	*	Chr.9	PHOSDUCIN-LIKE; PDCL	5082
MIM604422	*	 	PANCREATIC LIPASE-RELATED PROTEIN 1; PNLIPRP1	5407
MIM604423	*	10q25.3	PANCREATIC LIPASE-RELATED PROTEIN 2; PNLIPRP2	5408
MIM604424	*	11p13	HOMEODOMAIN-INTERACTING PROTEIN KINASE 3; HIPK3	10114
MIM604425	*	1p31.1	LIM HOMEOBOX GENE 8; LHX8	431707
MIM604426	*	 	CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 2; CYP4F2	8529
MIM604427	*	3p24.2-p22	SODIUM CHANNEL, VOLTAGE-GATED, TYPE X, ALPHA SUBUNIT; SCN10A	6336
MIM604428	^	 	PROLINE-RICH GAMMA-CARBOXYGLUTAMIC ACID PROTEIN 1; PRRG1	5638
MIM604429	*	 	PROLINE-RICH GAMMA-CARBOXYGLUTAMIC ACID PROTEIN 2; PRRG2	5639
MIM604430	*	 	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-7; GNG7	2788
MIM604431	%	 	POLYNEUROPATHY, LETHAL NEONATAL, AXONAL SENSORIMOTOR, AUTOSOMAL RECESSIVE	 
MIM604432	#	15q15.2	SPINOCEREBELLAR ATAXIA 11; SCA11	146057
MIM604433	*	11q13-q14	POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 3; KCNE3	10008
MIM604434	*	19q13.4	KALLIKREIN-RELATED PEPTIDASE 11; KLK11	11012
MIM604436	*	8p11.2	PROLINE SYNTHETASE COTRANSCRIBED, BACTERIA, HOMOLOG OF; PROSC	11212
MIM604437	*	3p21.3	SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 3; SLC38A3	10991
MIM604438	*	 	KALLIKREIN-RELATED PEPTIDASE 7; KLK7	5650
MIM604439	*	4q13.1	GRB2-ASSOCIATED BINDING PROTEIN 1; GAB1	2549
MIM604440	*	 	CELL DEATH-INDUCING DFFA-LIKE EFFECTOR A; CIDEA	1149
MIM604441	*	 	CELL DEATH-INDUCING DFFA-LIKE EFFECTOR B; CIDEB	27141
MIM604442	^	 	MOVED TO 144700	 
MIM604443	*	5q31	ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 6; ACSL6	23305
MIM604444	*	10p12.3-p11.2	BMP AND ACTIVIN MEMBRANE-BOUND INHIBITOR, XENOPUS, HOMOLOG OF; BAMBI	25805
MIM604445	*	18q21.3	PROTEASE INHIBITOR 13; PI13	5275
MIM604446	*	10p12	PHOSPHOTRIESTERASE-RELATED PROTEIN; PTER	9317
MIM604447	*	Chr.15	GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-5; GNB5	10681
MIM604448	*	2q11.2	CYTOHESIN 1-INTERACTING PROTEIN; CYTIP	9595
MIM604449	*	 	PROTEASOME 26S SUBUNIT, NON-ATPase, 11; PSMD11	5717
MIM604450	*	 	PROTEASOME 26S SUBUNIT, NON-ATPase, 12; PSMD12	5718
MIM604451		 	BASAL CELL CARCINOMA, INFUNDIBULOCYSTIC	 
MIM604452	*	Chr.9	PROTEASOME 26S SUBUNIT, NON-ATPase, 5; PSMD5	5711
MIM604453	*	1q32.1	NUCLEAR RECEPTOR SUBFAMILY 5, GROUP A, MEMBER 2; NR5A2	2494
MIM604454	#	2p13	WELANDER DISTAL MYOPATHY; WDM	50988
MIM604455	*	9q33-q34	SARCOSINE DEHYDROGENASE; SARDH	1757
MIM604456	*	Chr.11	INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 1; IFITM1	8519
MIM604457	*	2q37.1	NUCLEAR BODY PROTEIN SP110; SP110	3431
MIM604459	*	12q14.3	INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 3; IRAK3	11213
MIM604460	*	 	FAS-ASSOCIATED FACTOR 1; FAF1	11124
MIM604461	*	14q13.3-q21.1	HUMAN PAPILLOMAVIRUS TYPE 6A INTEGRATION SITE 1; HPV6AI1	3259
MIM604462	*	 	SEMAPHORIN 4C; SEMA4C	54910
MIM604463	*	 	CD160 ANTIGEN; CD160	11126
MIM604464	*	2p25	INTERSECTIN 2; ITSN2	50618
MIM604465	*	9p22	SH3 DOMAIN, GRB2-LIKE, 2; SH3GL2	6456
MIM604466	*	12q13	METHYLTRANSFERASE-LIKE 1; METTL1	4234
MIM604467	*	 	MONOCYTE-TO-MACROPHAGE DIFFERENTIATION-ASSOCIATED PROTEIN; MMD	23531
MIM604468	*	 	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 6; MAP3K6	9064
MIM604469	*	 	EXOCYST COMPLEX COMPONENT 5; EXOC5	10640
MIM604470	*	 	CD2 ANTIGEN-BINDING PROTEIN 2; CD2BP2	10421
MIM604471	*	 	SOLUTE CARRIER FAMILY 1 (GLUTAMATE TRANSPORTER), MEMBER 7; SLC1A7	6512
MIM604472	*	 	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 13; TNFSF13	8741
MIM604473	*	6q24	GLUTAMATE RECEPTOR, METABOTROPIC, 1; GRM1	2911
MIM604474		 	HUMAN HERPESVIRUS TYPE 6, INTEGRATED	 
MIM604475	*	2p14-p13	RETICULON 4; RTN4	57142
MIM604477	*	 	CHROMOBOX HOMOLOG 3; CBX3	11335
MIM604478	*	 	CHROMOBOX HOMOLOG 5; CBX5	23468
MIM604479	*	10q21.3	SIRTUIN 1; SIRT1	23411
MIM604480	*	19q	SIRTUIN 2; SIRT2	22933
MIM604481	*	11p15.5	SIRTUIN 3; SIRT3	23410
MIM604482	*	12q	SIRTUIN 4; SIRT4	23409
MIM604483	*	6p23	SIRTUIN 5; SIRT5	23408
MIM604484	#	3q13.1	HEREDITARY MOTOR AND SENSORY NEUROPATHY, PROXIMAL TYPE; HMSNP	10342, 50989
MIM604485	*	15q23	NUCLEAR RECEPTOR SUBFAMILY 2, GROUP E, MEMBER 3; NR2E3	10002
MIM604486	*	10q22-q23	PEPTIDYL-PROLYL CIS/TRANS ISOMERASE, MITOCHONDRIAL; PPIF	10105
MIM604487	*	11p14.3	OTOGELIN; OTOG	340990
MIM604488	*	17q12	TITIN-CAP; TCAP	8557
MIM604489	*	5p13.2-q11.1	ALPHA-METHYLACYL-CoA RACEMASE; AMACR	23600
MIM604490	*	13q12	SACSIN; SACS	26278
MIM604491	*	3q	CAS-BR-M MURINE ECOTROPIC RETROVIRAL TRANSFORMING SEQUENCE B; CBLB	868
MIM604492	*	5q31	VOLTAGE-DEPENDENT ANION CHANNEL 1; VDAC1	7416
MIM604493	*	1p35.1	GAP JUNCTION PROTEIN, BETA-5; GJB5	2709
MIM604494	*	2q12	INTERLEUKIN 18 RECEPTOR 1; IL18R1	8809
MIM604495	*	19q13.1	NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS INHIBITOR, BETA; NFKBIB	4793
MIM604496	*	 	NFKB INHIBITOR-INTERACTING RAS-LIKE PROTEIN 1; NKIRAS1	28512
MIM604497	*	 	NFKB INHIBITOR-INTERACTING RAS-LIKE PROTEIN 2; NKIRAS2	28511
MIM604498	#	1p34	AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL; CAMT	4352
MIM604499	%	11p	HYPERLIPIDEMIA, COMBINED, 2	28515
MIM604500	*	17q12	ZINC FINGER HIT DOMAIN-CONTAINING PROTEIN 3; ZNHIT3	9326
MIM604501	*	 	THYROID HORMONE RECEPTOR INTERACTOR 4; TRIP4	9325
MIM604502	*	6q14.1	HIGH MOBILITY GROUP NUCLEOSOMAL BINDING PROTEIN 3; HMGN3	9324
MIM604503	*	 	JUMONJI DOMAIN-CONTAINING PROTEIN 1C; JMJD1C	221037
MIM604504	*	 	THYROID HORMONE RECEPTOR INTERACTOR 10; TRIP10	9322
MIM604505	*	14q31-q32	THYROID HORMONE RECEPTOR INTERACTOR 11; TRIP11	9321
MIM604506	*	2q36.3	THYROID HORMONE RECEPTOR INTERACTOR 12; TRIP12	9320
MIM604507	*	 	THYROID HORMONE RECEPTOR INTERACTOR 13; TRIP13	9319
MIM604508	*	15q21.2	COP9, SUBUNIT 2; COPS2	9318
MIM604509	*	2q12	INTERLEUKIN 18 RECEPTOR ACCESSORY PROTEIN; IL18RAP	8807
MIM604510	*	7q31	HYALURONOGLUCOSAMINIDASE 4; HYAL4	23553
MIM604511	*	 	CHROMOBOX HOMOLOG 1; CBX1	10951
MIM604512	*	2q12	INTERLEUKIN 1 RECEPTOR-LIKE 2; IL1RL2	8808
MIM604513	*	 	CD84 ANTIGEN; CD84	8832
MIM604514	*	1q21	SH2 DOMAIN PROTEIN 2A; SH2D2A	9047
MIM604515	*	10q23.2	B-CELL LINKER PROTEIN; BLNK	29760
MIM604516	*	 	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 2; IGSF2	9398
MIM604517	*	4p15.1	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR 1, ALPHA; PPARGC1A	10891
MIM604518	*	22q12-qter	GRB2-RELATED ADAPTOR PROTEIN 2; GRAP2	9402
MIM604519	%	6p21.3	INFLAMMATORY BOWEL DISEASE 3; IBD3	30829
MIM604520	*	19p13.3	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 14; TNFSF14	8740
MIM604521	*	 	3-@HYDROXYANTHRANILATE 3,4-DIOXYGENASE; HAAO	23498
MIM604522	*	 	DEFENSIN, ALPHA, 3; DEFA3	1668
MIM604523	*	22q13.3	CADHERIN EGF LAG SEVEN-PASS G-TYPE RECEPTOR 1; CELSR1	9620
MIM604524	*	 	LYMPHOCYTE ANTIGEN 75; LY75	4065
MIM604525	*	 	HISTAMINE RECEPTOR H3; HRH3	11255
MIM604526	*	20p13	ISOCITRATE DEHYDROGENASE 3, BETA SUBUNIT; IDH3B	3420
MIM604527	*	12q13	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 3; KCNH3	23416
MIM604528	*	 	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 4; KCNH4	23415
MIM604529	*	5q13.3	ORTHOPEDIA, DROSOPHILA, HOMOLOG OF; OTP	23440
MIM604530	*	19q13.42	NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NCR1	9437
MIM604531	*	6p21.1	NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NCR2	9436
MIM604532	*	10q24-q25	POLYCYSTIN 2-LIKE 1; PKD2L1	9033
MIM604533	*	15q26	INTERFERON-STIMULATED GENE, 20-KD; ISG20	3669
MIM604534	*	6p23	CD83 ANTIGEN; CD83	9308
MIM604535	*	16q13-q21	KINESIN FAMILY MEMBER C3; KIFC3	3801
MIM604536	#	1q32	ECTODERMAL DYSPLASIA/SKIN FRAGILITY SYNDROME	5317
MIM604537	#	6q14.1	LEBER CONGENITAL AMAUROSIS 5; LCA5	167691
MIM604538	*	1p34.1	KINESIN FAMILY MEMBER 2C; KIF2C	11004
MIM604539	*	5q23	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 2; ADAMTS2	9509
MIM604540	*	17q12-q21	KERATIN 36; KRT36	8689
MIM604541	*	17q12-q21	KERATIN 37; KRT37	8688
MIM604542	*	17q12-q21	KERATIN 38; KRT38	8687
MIM604543	*	3p21.3	LIM DOMAIN-CONTAINING PROTEIN 1; LIMD1	8994
MIM604544	*	3p21.3	LEUCYL-tRNA SYNTHETASE 2; LARS2	23395
MIM604545	*	 	KARYOPHERIN ALPHA-5; KPNA5	3841
MIM604546	*	8q24.3	NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS INHIBITOR-LIKE 2; NFKBIL2	4796
MIM604547	%	17p11.2-p11.2	VAN DER WOUDE SYNDROME 1, MODIFIER OF	100917
MIM604548	*	 	NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS INHIBITOR, EPSILON; NFKBIE	4794
MIM604550	*	 	DENSITY-REGULATED PROTEIN; DENR	8562
MIM604551	*	10q23	CHOLESTEROL 25-HYDROXYLASE; CH25H	9023
MIM604552	*	4p16	HEPATOCYTE GROWTH FACTOR ACTIVATOR; HGFAC	3083
MIM604553	*	 	HEAT-SHOCK FACTOR-BINDING PROTEIN 1; HSBP1	3281
MIM604554	*	21q22.3	HEAT-SHOCK TRANSCRIPTION FACTOR 2-BINDING PROTEIN; HSF2BP	11077
MIM604555	*	5p14-p13	CADHERIN 10; CDH10	1008
MIM604556	*	19q12-q13.11	DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 1B; DYRK1B	9149
MIM604557	*	16q12	ZINC FINGER PROTEIN 423; ZNF423	23090
MIM604558	*	2q33	INDUCIBLE T-CELL COSTIMULATOR; ICOS	29851
MIM604559	#	19q13.32	PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IB; PFHB1B	54795, 8184
MIM604561	*	5q35	ALPHA-1,3-@MANNOSYL-GLYCOPROTEIN BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE, ISOZYME B; MGAT4B	11282
MIM604562	*	Chr.14	ACINUS	22985
MIM604563	#	11p15	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	81846
MIM604564	*	1q23	GLUTATHIONE S-TRANSFERASE, MICROSOMAL, 3; MGST3	4259
MIM604565	*	 	ALG5, S. CEREVISIAE, HOMOLOG OF; ALG5	29880
MIM604566	*	1p22.3	ALG6, S. CEREVISIAE, HOMOLOG OF; ALG6	29929
MIM604567	*	16p11.2	DOUBLE C2-LIKE DOMAIN-CONTAINING PROTEIN, ALPHA; DOC2A	8448
MIM604568	*	17p13.3	DOUBLE C2-LIKE DOMAIN-CONTAINING PROTEIN, BETA; DOC2B	8447
MIM604569	*	7q35-q36	CONTACTIN-ASSOCIATED PROTEIN-LIKE 2; CNTNAP2	26047
MIM604570	*	4q21.1	SHROOM FAMILY MEMBER 3; SHROOM3	57619
MIM604571	#	6p21.3, 6p21.3, 6p21.3	BARE LYMPHOCYTE SYNDROME, TYPE I	6890, 6891, 6892
MIM604572	*	19p13.2	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 1; DNAJB1	3337
MIM604573	*	14q32.33	CHROMOSOME 14 OPEN READING FRAME 2; C14ORF2	9556
MIM604574	*	9q31-q33	CHROMOSOME 9 OPEN READING FRAME 4; C9ORF4	23732
MIM604575	*	11q13	ZINC FINGER HIT DOMAIN-CONTAINING PROTEIN 2; ZNHIT2	741
MIM604576	*	14q24	CHROMOSOME 14 OPEN READING FRAME 1; C14ORF1	11161
MIM604577	*	6q21	BLOOD VESSEL EPICARDIAL SUBSTANCE; BVES	11149
MIM604578	*	1q22	ABSENT IN MELANOMA 2; AIM2	9447
MIM604579	*	11q14-q21	FRIZZLED, DROSOPHILA, HOMOLOG OF, 4; FZD4	8322
MIM604580	*	14q32.1	FIBULIN 5; FBLN5	10516
MIM604581	*	18p11	ATPase FAMILY GENE 3-LIKE 2; AFG3L2	10939
MIM604582	*	9q31-q33	A-KINASE ANCHOR PROTEIN 2; AKAP2	11217
MIM604583	*	 	PROGRAMMED CELL DEATH 5; PDCD5	9141
MIM604584	*	8p22-p21.3	PLATELET-DERIVED GROWTH FACTOR RECEPTOR-LIKE; PDGFRL	5157
MIM604585	*	2q37.1	NUCLEAR BODY PROTEIN SP100; SP100	6672
MIM604586	*	6q24.3	SYNTAXIN-BINDING PROTEIN 5; STXBP5	134957
MIM604587	*	 	CALCIUM BINDING AND COILED-COIL DOMAIN PROTEIN 2; CALCOCO2	10241
MIM604588	*	4q33	NEVER IN MITOSIS GENE A-RELATED KINASE 1; NEK1	4750
MIM604589	*	22q13	BROMODOMAIN-CONTAINING PROTEIN 1; BRD1	23774
MIM604590	*	1q22	Fc FRAGMENT OF IgG, LOW AFFINITY IIb, RECEPTOR FOR; FCGR2B	2213
MIM604591	*	12q24.23	PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN 1; PEBP1	5037
MIM604592	*	11q13.4-q13.5	T CELL IMMUNE REGULATOR 1; TCIRG1	10312
MIM604593	*	2q23.1	KINESIN FAMILY MEMBER 5C; KIF5C	3800
MIM604594	*	 	CYSTEINE-RICH INTERACTOR OF PDZ3	9419
MIM604595	%	13q	CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1	54501
MIM604596	*	 	CMT1A DUPLICATED REGION TRANSCRIPT 1; CDRT1	374286
MIM604597	*	12q14.3	GLUTAMATE RECEPTOR-INTERACTING PROTEIN 1; GRIP1	23426
MIM604598	*	8q21	CHROMOSOME 8 OPEN READING FRAME 1; C8ORF1	734
MIM604599	*	 	EUCHROMATIC HISTONE-LYSINE N-METHYLTRANSFERASE 2; EHMT2	10919
MIM604600	*	11p15.5	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 5; TRPM5	29850
MIM604601	*	13q14.1-q14.3	TRANSLATIONAL RELEASE FACTOR, MITOCHONDRIAL, 1; MTRF1	9617
MIM604602	*	9q32-q34.1	RIBOSOME-RECYCLING FACTOR, MITOCHONDRIAL; MRRF	92399
MIM604603	*	 	FER-1, C. ELEGANS, HOMOLOG-LIKE 3; FER1L3	26509
MIM604604	*	4p13-p12	CHROMOSOME 4 OPEN READING FRAME 1; C4ORF1	10463
MIM604605	*	 	KALIRIN; KALRN	8997
MIM604606	*	9q34	ODORANT-BINDING PROTEIN 2B; OBP2B	29989
MIM604607	*	17q21.2	HOMEOBOX B13; HOXB13	10481
MIM604609	*	7q22	MUCIN 12; MUC12	10071
MIM604610	*	15q26.1	RECQ PROTEIN-LIKE 3; RECQL3	641
MIM604611	*	8p12-p11.2	RECQ PROTEIN-LIKE 2; RECQL2	7486
MIM604612	*	20p11	NK2 HOMEOBOX 2; NKX2-2	4821
MIM604613	*	 	T-BOX 18; TBX18	9096
MIM604614	*	1q23-q24	T-BOX 19; TBX19	9095
MIM604615	*	3p21.3-p21.2	EOMESODERMIN, XENOPUS, HOMOLOG OF; EOMES	8320
MIM604616	*	2q23-q37	T-BOX, BRAIN, 1; TBR1	10716
MIM604617	*	11q13.5	NEURAMINIDASE 3; NEU3	10825
MIM604618	*	1q21-q22	NITRILASE 1; NIT1	4817
MIM604619	*	10q24	LEUCINE-RICH GENE, GLIOMA-INACTIVATED, 1; LGI1	9211
MIM604620	*	14q31-q32.1	G PROTEIN-COUPLED RECEPTOR 65; GPR65	8477
MIM604621	*	22q13.1	BETA-1,4-@MANNOSYL-GLYCOPROTEIN BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE; MGAT3	4248
MIM604622	^	 	AORTIC ANEURYSM, GIANT CONGENITAL	 
MIM604623	*	2q12	ALPHA-1,3-@MANNOSYL-GLYCOPROTEIN BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE, ISOZYME A; MGAT4A	11320
MIM604624	*	5q11.2	HEAT-SHOCK 27-KD PROTEIN 3; HSPB3	8988
MIM604625	#	14q12-q13	TOOTH AGENESIS, SELECTIVE, 3; STHAG3	5083
MIM604626	*	11cen-q22.3	MALIC ENZYME 3; ME3	10873
MIM604627	*	5q32-q34	INTERLEUKIN 17B; IL17B	27190
MIM604628	*	16q24	INTERLEUKIN 17C; IL17C	27189
MIM604629	*	11q22.3-q23	MATRIX METALLOPROTEINASE 20; MMP20	9313
MIM604630	*	1p36.1	NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 2; NR0B2	8431
MIM604631	*	17q21	VESICLE AMINE TRANSPORT PROTEIN 1	10493
MIM604632	*	16q22.1	VAC14, S. CEREVISIAE, HOMOLOG OF; VAC14	55697
MIM604633	*	11q13	EGF-CONTAINING FIBULIN-LIKE EXTRACELLULAR MATRIX PROTEIN 2; EFEMP2	30008
MIM604634	*	1q21-q25	TRANSGELIN 2; TAGLN2	8407
MIM604635	*	 	NEUREXOPHILIN 2; NXPH2	11249
MIM604636	*	 	NEUREXOPHILIN 3; NXPH3	11248
MIM604637	*	 	NEUREXOPHILIN 4; NXPH4	11247
MIM604638	*	19q13	ACTININ, ALPHA-4; ACTN4	81
MIM604639	*	 	NEUREXOPHILIN 1; NXPH1	30010
MIM604640	*	5q35.1	T-CELL LEUKEMIA HOMEOBOX 3; TLX3	30012
MIM604641	*	11p12-p11.2	MITOGEN-ACTIVATED PROTEIN KINASE 8-INTERACTING PROTEIN 1; MAPK8IP1	9479
MIM604642	*	Chr.17	CARBONIC ANHYDRASE X; CA10	56934
MIM604643	*	 	NEUROPEPTIDE FF-AMIDE PEPTIDE; NPFF	8620
MIM604644	*	19q13.2-q13.3	CARBONIC ANHYDRASE XI; CA11	770
MIM604645	*	 	PHOSPHODIESTERASE 7B, cAMP-SPECIFIC, HIGH-AFFINITY; PDE7B	27115
MIM604646	*	22q13.3	NUCLEOPORIN, 50-KD; NUP50	10762
MIM604647	*	 	DOPAMINE RECEPTOR D1-INTERACTING PROTEIN; DRD1IP	50632
MIM604648	*	11q13.1-q13.2	T-BOX 10; TBX10	347853
MIM604649	*	17q25	TUBULIN-SPECIFIC CHAPERONE D; TBCD	6904
MIM604650	*	10q23.3	INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 4; IFIT4	3437
MIM604651	*	2p24-p23	GROWTH/DIFFERENTIATION FACTOR 7; GDF7	151449
MIM604652	*	 	TRANSCRIPTION FACTOR 7-LIKE 1; TCF7L1	83439
MIM604653	*	2q32	SOLUTE CARRIER FAMILY 40 (IRON-REGULATED TRANSPORTER), MEMBER 1; SLC40A1	30061
MIM604654	*	11q23.1	5-@HYDROXYTRYPTAMINE RECEPTOR 3B; HTR3B	9177
MIM604655	*	17q21	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 14; MAP3K14	9020
MIM604656	*	17q21	FORMIN-LIKE; FMNL	752
MIM604657	*	17p13.3	TRANSMEMBRANE 4 SUPERFAMILY, MEMBER 5; TM4SF5	9032
MIM604658	*	1q42-q43	TRANSMEMBRANE 7 SUPERFAMILY, MEMBER 1; TM7SF1	7107
MIM604659	*	7q21-q22	ENDOGENOUS RETROVIRAL FAMILY W, ENV-C7, MEMBER 1; ERVWE1	30816
MIM604660	*	 	POTASSIUM CHANNEL-INTERACTING PROTEIN 1; KCNIP1	30820
MIM604661	*	 	POTASSIUM CHANNEL-INTERACTING PROTEIN 2; KCNIP2	30819
MIM604662	*	2q11.1	POTASSIUM CHANNEL-INTERACTING PROTEIN 3; KCNIP3	30818
MIM604663	*	2q35	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 6; WNT6	7475
MIM604664	*	19p13.11	INTERFERON-GAMMA-INDUCIBLE PROTEIN 30; IFI30	10437
MIM604665	*	17p11.2	COP9, SUBUNIT 3; COPS3	8533
MIM604666	*	 	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4; MAP4K4	9448
MIM604667	*	3p21.1	CALCIUM-DEPENDENT ACTIVATOR PROTEIN FOR SECRETION; CADPS	8618
MIM604668	*	19q13.4	ZINC FINGER PROTEIN 264; ZNF264	9422
MIM604669	*	5q31	POLYCYSTIN 2-LIKE 2; PKD2L2	27039
MIM604670	*	22q13.3	POLYCYSTIN AND SEA URCHIN REJ HOMOLOG-LIKE; PKDREJ	10343
MIM604671	*	1q21	JUMPING TRANSLOCATION BREAKPOINT; JTB	10899
MIM604672	*	19p13.3	CD209 ANTIGEN; CD209	30835
MIM604673	*	 	MURINE RETROVIRUS INTEGRATION SITE 1, HOMOLOG OF; MRVI1	10335
MIM604674	*	6q21	HAIRY/ENHANCER OF SPLIT-RELATED WITH YRPW MOTIF 2; HEY2	23493
MIM604675	*	9q34.1	PAIRED-RELATED HOMEOBOX GENE 2; PRRX2	51450
MIM604676	*	6p21.3	HLA COMPLEX P5 GENE; HCP5	10866
MIM604677	*	 	COLLAGEN, TYPE IV, ALPHA-3 BINDING PROTEIN; COL4A3BP	10087
MIM604678	*	 	TRANSMEMBRANE 9 SUPERFAMILY, MEMBER 2; TM9SF2	9375
MIM604679	*	8q22	POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 1; PABPC1	26986
MIM604680	*	13q11-q12	POLYADENYLATE-BINDING PROTEIN, CYTOPLASMIC, 3; PABPC3	5042
MIM604681	*	12q13-q14	POLYADENYLATE-BINDING PROTEIN-LIKE 2; PABPL2	341315
MIM604682	*	 	INTEGRIN, ALPHA-E; ITGAE	3682
MIM604683	*	5q31	KINESIN FAMILY MEMBER 3A; KIF3A	11127
MIM604684	*	1q21	MYELOID/LYMPHOID OR MIXED-LINEAGE LEUKEMIA, TRANSLOCATED TO, 11; MLLT11	10962
MIM604685	*	7p15-p14	HOMEOBOX A2; HOXA2	3199
MIM604686	*	15q24-q25	A-KINASE ANCHOR PROTEIN 13; AKAP13	11214
MIM604687	*	14q22.1	PROSTAGLANDIN D2 RECEPTOR; PTGDR	5729
MIM604688	*	 	A-KINASE ANCHOR PROTEIN 5; AKAP5	9495
MIM604689	*	 	A-KINASE ANCHOR PROTEIN 3; AKAP3	10566
MIM604690		 	GROWTH AND DEVELOPMENTAL RETARDATION, OCULAR PTOSIS, CARDIAC DEFECT, AND ANAL ATRESIA	 
MIM604691	*	14q	A-KINASE ANCHOR PROTEIN 6; AKAP6	9472
MIM604692	*	 	A-KINASE ANCHOR PROTEIN 8; AKAP8	10270
MIM604693	*	 	A-KINASE ANCHOR PROTEIN 7; AKAP7	9465
MIM604694	*	17p11.1	A-KINASE ANCHOR PROTEIN 10; AKAP10	11216
MIM604695	*	10q23.3	ADP-RIBOSYLATION FACTOR-LIKE 3; ARL3	403
MIM604696	*	 	A-KINASE ANCHOR PROTEIN 11; AKAP11	11215
MIM604697	*	7q11.2	CHEMOKINE, CC MOTIF, LIGAND 26; CCL26	10344
MIM604698	*	 	A-KINASE ANCHOR PROTEIN 12; AKAP12	9590
MIM604699	*	 	ADP-RIBOSYLATION FACTOR-RELATED PROTEIN 1; ARFRP1	10139
MIM604700	*	 	TARGET OF MYB1, CHICKEN, HOMOLOG OF; TOM1	10043
MIM604701	*	 	TOM1-LIKE 1; TOM1L1	10040
MIM604702	*	22q13.1	HMG BOX DOMAIN-CONTAINING 4; HMGXB4	10042
MIM604704	*	 	BREAST CANCER ANTIESTROGEN RESISTANCE 3; BCAR3	8412
MIM604705	*	2q14.1	MER TYROSINE KINASE PROTOONCOGENE; MERTK	10461
MIM604707	*	 	ALDO-KETO REDUCTASE FAMILY 1, MEMBER B10; AKR1B10	57016
MIM604708	*	 	NUCLEAR FACTOR OF ACTIVATED T CELLS 5; NFAT5	10725
MIM604709	*	 	T-CELL LYMPHOMA INVASION AND METASTASIS 2; TIAM2	26230
MIM604710	*	19q13.1-q13.2	LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 4; LTBP4	8425
MIM604711	*	13q12-q13	UBIQUITIN-LIKE 3; UBL3	5412
MIM604712	*	8q23.1	RIBONUCLEOTIDE REDUCTASE, M2 B; RRM2B	50484
MIM604713	*	 	C-TYPE LECTIN DOMAIN FAMILY 11, MEMBER A; CLEC11A	6320
MIM604714	*	6q22-q23	TSPY-LIKE 1; TSPYL1	7259
MIM604715	#	16q12.2	ORTHOSTATIC INTOLERANCE	6530
MIM604716	*	4q13	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER A1; UGT2A1	10941
MIM604717	#	17q25.3	DEAFNESS, AUTOSOMAL DOMINANT 20; DFNA20	71
MIM604718	*	 	TRANSCRIPTION TERMINATION FACTOR, RNA POLYMERASE II; TTF2	8458
MIM604719	*	 	SERINE/THREONINE PROTEIN KINASE 16; STK16	8576
MIM604720	*	7q22	TRANSFERRIN RECEPTOR 2; TFR2	7036
MIM604721	*	 	SH2 DOMAIN-CONTAINING PROTEIN 3A; SH2D3A	10045
MIM604722	*	 	SH2 DOMAIN-CONTAINING PROTEIN 3C; SH2D3C	10044
MIM604723	*	12q13-q14	Ts TRANSLATION ELONGATION FACTOR, MITOCHONDRIAL; TSFM	10102
MIM604724	*	4q21.3	HEPARANASE; HPSE	10855
MIM604725	*	 	UBIQUITIN-SPECIFIC PROTEASE 2; USP2	9099
MIM604726	*	 	SERINE/THREONINE PROTEIN KINASE 17A; STK17A	9263
MIM604727	*	 	SERINE/THREONINE PROTEIN KINASE 17B; STK17B	9262
MIM604728	*	15q22.3	UBIQUITIN-SPECIFIC PROTEASE 3; USP3	9960
MIM604729	*	1q22	UBIQUITIN-SPECIFIC PROTEASE 21; USP21	27005
MIM604730	*	12p13	TUBBY-LIKE PROTEIN 3; TULP3	7289
MIM604731	*	 	UBIQUITIN-SPECIFIC PROTEASE 15; USP15	9958
MIM604732	*	 	TRANSCRIPTION FACTOR EC; TFEC	22797
MIM604733	*	1p13.3-p13.1	TRYPTOPHANYL-tRNA SYNTHETASE 2; WARS2	10352
MIM604734	*	4p	WD REPEAT-CONTAINING PROTEIN 1; WDR1	9948
MIM604735	*	 	UBIQUITIN-SPECIFIC PROTEASE 16; USP16	10600
MIM604736	*	 	UBIQUITIN-SPECIFIC PROTEASE 25; USP25	29761
MIM604737	*	1p13-p12	WD REPEAT-CONTAINING PROTEIN 3; WDR3	10885
MIM604738	*	3p21.3	CHEMOKINE, CC MOTIF, RECEPTOR 9; CCR9	10803
MIM604739	*	 	RNA BINDING MOTIF PROTEIN 39; RBM39	9584
MIM604740	*	1q21	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 1; SLC39A1	27173
MIM604741	*	7q32-q33	ALDO-KETO REDUCTASE FAMILY 1, MEMBER D1; AKR1D1	6718
MIM604742	*	13q13	DOUBLECORTIN-LIKE KINASE 1; DCLK1	9201
MIM604743	*	1p22	DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 1; DDAH1	23576
MIM604744	*	6p21.3	DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 2; DDAH2	23564
MIM604745	*	 	TRANSCRIPTION FACTOR-LIKE 5; TCFL5	10732
MIM604746	*	 	TESTIS-SPECIFIC PROTEIN KINASE 2; TESK2	10420
MIM604747	*	3q23	SRY-BOX 14; SOX14	8403
MIM604748	*	1q32	SRY-BOX 13; SOX13	9580
MIM604749	*	19q13.2	ZINC FINGER PROTEIN 93, MOUSE, HOMOLOG OF; ZFP93	9310
MIM604750	*	 	ZINC FINGER PROTEIN 234; ZNF234	10780
MIM604751	*	19p13.2	ZINC FINGER PROTEIN 266; ZNF266	10781
MIM604752	*	Chr.16	ZINC FINGER PROTEIN 267; ZNF267	10308
MIM604753	*	12q24.3	ZINC FINGER PROTEIN 268; ZNF268	10795
MIM604754	*	18q12	ZINC FINGER PROTEIN 271; ZNF271	10778
MIM604755	*	19q13.4	ZINC FINGER PROTEIN 272; ZNF272	10794
MIM604756	*	 	ZINC FINGER PROTEIN 273; ZNF273	10793
MIM604757	#	5q34-q35	CRANIOSYNOSTOSIS, TYPE 2; CRS2	4488
MIM604758	*	19q13.32	V-REL AVIAN RETICULOENDOTHELIOSIS VIRAL ONCOGENE HOMOLOG B; RELB	5971
MIM604759	*	12q23	SYNAPTONEMAL COMPLEX PROTEIN 3; SYCP3	50511
MIM604760	*	18q22-q23	ZINC FINGER PROTEIN 236; ZNF236	7776
MIM604761	*	9q13-q21	ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 5; ZFAND5	7763
MIM604762	*	11p15	SWITCH-ASSOCIATED PROTEIN 70	23075
MIM604763	*	11q23.3	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 12; ARHGEF12	23365
MIM604764	*	8q	ZINC FINGER AND HOMEODOMAIN PROTEIN 1; ZHX1	11244
MIM604765	#	2q35	CARDIOMYOPATHY, DILATED, 1I; CMD1I	1674
MIM604766	*	1q25-q31	PODOCIN; NPHS2	7827
MIM604767	*	9q32	DELETED IN ESOPHAGEAL CANCER 1; DEC1	50514
MIM604768	*	19p13.12-p13.11	ZINC FINGER PROTEIN 254; ZNF254	9534
MIM604769	*	10q25-q26	PEROXIREDOXIN 3; PRDX3	10935
MIM604770	*	 	ACETYL-CoA ACYLTRANSFERASE 2; ACAA2	10449
MIM604772	#	1q42.1-q43	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	10345, 6262, 845
MIM604773	*	11q25	ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 8; ACAD8	27034
MIM604774	*	1p31	ANGIOPOIETIN-LIKE 3; ANGPTL3	27329
MIM604775	*	8q13	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY A, MEMBER 1; TRPA1	8989
MIM604776	*	6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR BETA-5; HLA-DRB5	3127
MIM604777	#	19p13.12	ICHTHYOSIS, LAMELLAR, 3; LI3	126410
MIM604778	*	4q34	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 29; ADAM29	11086
MIM604779	*	1p13-p11	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 30; ADAM30	11085
MIM604780	*	3p21	ABHYDROLASE DOMAIN-CONTAINING 5; ABHD5	51099
MIM604781	^	19p13.2-p13.1	ICHTHYOSIS, NONLAMELLAR AND NONERYTHRODERMIC, CONGENITAL, AUTOSOMAL RECESSIVE; NNCI	50992
MIM604782	*	8p11.2	ASH2-LIKE; ASH2L	9070
MIM604783	*	 	CLEFT LIP- AND PALATE-ASSOCIATED TRANSMEMBRANE PROTEIN 1; CLPTM1	1209
MIM604784	*	 	TRANSCRIPTION ELONGATION FACTOR A, 2; TCEA2	6919
MIM604785	*	9q31.2	CATENIN, ALPHA-LIKE, 1; CTNNAL1	8727
MIM604786	*	7q	ADP-RIBOSYLATION FACTOR-LIKE 4A; ARL4A	10124
MIM604787	*	 	ADP-RIBOSYLATION FACTOR-LIKE 4C; ARL4C	10123
MIM604788	*	19q13.3	RUVB, E. COLI, HOMOLOG-LIKE 2; RUVBL2	10856
MIM604789	*	15q23	INTEGRIN, ALPHA-11; ITGA11	22801
MIM604790	*	12p13	TASTE RECEPTOR, TYPE 2, MEMBER 14; TAS2R14	50840
MIM604791	*	12p13	TASTE RECEPTOR, TYPE 2, MEMBER 10; TAS2R10	50839
MIM604792	*	12p13	TASTE RECEPTOR, TYPE 2, MEMBER 13; TAS2R13	50838
MIM604793	*	12p13	TASTE RECEPTOR, TYPE 2, MEMBER 7; TAS2R7	50837
MIM604794	*	12p13	TASTE RECEPTOR, TYPE 2, MEMBER 8; TAS2R8	50836
MIM604795	*	12p13	TASTE RECEPTOR, TYPE 2, MEMBER 9; TAS2R9	50835
MIM604796	*	5p15	TASTE RECEPTOR, TYPE 2, MEMBER 1; TAS2R1	50834
MIM604797	*	6p21	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 2; APOBEC2	10930
MIM604798	*	5q14.2	HOMER, DROSOPHILA, HOMOLOG OF, 1; HOMER1	9456
MIM604799	*	15q24.3	HOMER, DROSOPHILA, HOMOLOG OF, 2; HOMER2	9455
MIM604800	*	19p13.11	HOMER, DROSOPHILA, HOMOLOG OF, 3; HOMER3	9454
MIM604801	%	1q42	MUSCULAR DYSTROPHY, CONGENITAL, 1B; MDC1B	53368
MIM604802	%	4p15.3	HUNTINGTON DISEASE-LIKE 3; HDL3	53369
MIM604803	*	21q22.2	DOPEY FAMILY MEMBER 2; DOPEY2	9980
MIM604804	#	9q33.3	MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	55755
MIM604805	#	19q13	SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT; SPG12	6253
MIM604806	*	11q12-q13	FIBRONECTIN-LIKE DOMAIN-CONTAINING LEUCINE-RICH TRANSMEMBRANE PROTEIN 1; FLRT1	23769
MIM604807	*	14q24-q32	FIBRONECTIN-LIKE DOMAIN-CONTAINING LEUCINE-RICH TRANSMEMBRANE PROTEIN 2; FLRT2	23768
MIM604808	*	20p11	FIBRONECTIN-LIKE DOMAIN-CONTAINING LEUCINE-RICH TRANSMEMBRANE PROTEIN 3; FLRT3	23767
MIM604809	%	6p21.3	PANBRONCHIOLITIS, DIFFUSE	 
MIM604810	*	19q13.2	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 1; LILRA1	11024
MIM604811	*	19q13.4	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 1; LILRB1	10859
MIM604812	*	19q13.4	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 2; LILRA2	11027
MIM604813	*	3q	CYTOCHROME c OXIDASE ASSEMBLY PROTEIN COX17; COX17	10063
MIM604814	*	19q13.2	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 5; LILRB5	10990
MIM604815	*	19q13.4	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 2; LILRB2	10288
MIM604817	*	16q22	CARBOHYDRATE SULFOTRANSFERASE 5; CHST5	23563
MIM604818	*	19q13.4	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 3; LILRA3	11026
MIM604819	*	 	POLY-U-BINDING SPLICING FACTOR, 60-KD; PUF60	22827
MIM604820	*	19q13.4	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 3; LILRB3	11025
MIM604821	*	19q13.4	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 4; LILRB4	11006
MIM604822	*	6p12	CALPAIN 11; CAPN11	11131
MIM604823	*	11q25	BarH-LIKE HOMEOBOX GENE 2; BARX2	8538
MIM604824	+	13q12	KLOTHO; KL	9365
MIM604825	*	Chr.11	FASCICULATION AND ELONGATION PROTEIN ZETA 1; FEZ1	9638
MIM604826	*	 	FASCICULATION AND ELONGATION PROTEIN ZETA 2; FEZ2	9637
MIM604827	%	15q14	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 7; EIG7	50715
MIM604828	*	1q23	CHEMOKINE, C MOTIF, LIGAND 2; XCL2	6846
MIM604829	*	21q22.2	DOWN SYNDROME CRITICAL REGION GENE 4; DSCR4	10281
MIM604830		 	MANDIBULOFACIAL DYSOSTOSIS SYNDROME, BAURU TYPE	 
MIM604831	*	4p16	EVC GENE; EVC	2121
MIM604832	*	1q21	CARBONIC ANHYDRASE XIV; CA14	23632
MIM604833	*	9p13	CHEMOKINE, CC MOTIF, LIGAND 27; CCL27	10850
MIM604834	*	 	TANK-BINDING KINASE 1; TBK1	29110
MIM604835	*	1q21-q22	DUAL-SPECIFICITY PHOSPHATASE 12; DUSP12	11266
MIM604836	*	3p24	CHEMOKINE, CC MOTIF, RECEPTOR 4; CCR4	1233
MIM604837	*	11q12-q13.3	G PROTEIN-COUPLED RECEPTOR 44; GPR44	11251
MIM604838	*	2q11.2-q12	G PROTEIN-COUPLED RECEPTOR 45; GPR45	11250
MIM604839	*	7q11.23	FK506-BINDING PROTEIN 6; FKBP6	8468
MIM604840	*	19p12	FK506-BINDING PROTEIN 8; FKBP8	23770
MIM604841	#	1p21	STICKLER SYNDROME, TYPE II; STL2	1301
MIM604842	*	6q27	SOLUTE CARRIER FAMILY 22 (EXTRANEURONAL MONOAMINE TRANSPORTER), MEMBER 3; SLC22A3	6581
MIM604843	*	12p12	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1B1; SLCO1B1	10599
MIM604844	*	1p22	HEPARAN SULFATE 2-O-SULFOTRANSFERASE 1; HS2ST1	9653
MIM604845	*	9q21-q22	PROSTATE CANCER ANTIGEN 3; PCA3	50652
MIM604846	*	2q21	HEPARAN SULFATE 6-O-SULFOTRANSFERASE 1; HS6ST1	9394
MIM604847	*	10q26.2-q26.3	G PROTEIN-COUPLED RECEPTOR 26; GPR26	2849
MIM604849	*	6q24	TRACE AMINE-ASSOCIATED RECEPTOR 2; TAAR2	9287
MIM604850	*	 	COP9, SUBUNIT 5; COPS5	10987
MIM604851	*	4q13	G-RICH RNA SEQUENCE-BINDING FACTOR 1; GRSF1	2926
MIM604852	*	4q21.2	CHEMOKINE, CXC MOTIF, LIGAND 11; CXCL11	6373
MIM604853	*	16p13.3	MITOCHONDRIAL RIBOSOMAL PROTEIN L28; MRPL28	10573
MIM604854	*	7p15.3-p15.2	INDOLETHYLAMINE N-METHYLTRANSFERASE; INMT	11185
MIM604855		 	HYALURONAN METABOLISM, DEFECT IN	 
MIM604856		 	LANGERHANS CELL HISTIOCYTOSIS	 
MIM604857	*	14q13.2	SIGNAL RECOGNITION PARTICLE, 54-KD; SRP54	6729
MIM604858	*	17q25.1	SIGNAL RECOGNITION PARTICLE, 68-KD; SRP68	6730
MIM604859	*	3p26-p24	LIM AND CYSTEINE-RICH DOMAINS 1; LMCD1	29995
MIM604860	*	18q21	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION GENE 1; MALT1	10892
MIM604861	*	13q11-q12	LARGE TUMOR SUPPRESSOR, DROSOPHILA, HOMOLOG OF, 2; LATS2	26524
MIM604862	*	2p13	CD207 ANTIGEN; CD207	50489
MIM604863	*	4q31	LECITHIN RETINOL ACYLTRANSFERASE; LRAT	9227
MIM604864	#	12q13.11-q13.2	OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA	1280
MIM604865	*	2q32	KRUPPEL-LIKE FACTOR 7; KLF7	8609
MIM604866	*	 	PLEOMORPHIC ADENOMA GENE-LIKE 2; PLAGL2	5326
MIM604867	+	7q31	TASTE RECEPTOR, TYPE 2, MEMBER 16; TAS2R16	50833
MIM604868	*	7q31.3-q32	TASTE RECEPTOR, TYPE 2, MEMBER 3; TAS2R3	50831
MIM604869	*	7q31.3-q32	TASTE RECEPTOR, TYPE 2, MEMBER 4; TAS2R4	50832
MIM604870	*	2q12-q13	MACROPHAGE RECEPTOR WITH COLLAGENOUS STRUCTURE; MARCO	8685
MIM604871	*	20q11.2	MATRIX METALLOPROTEINASE 24; MMP24	10893
MIM604872	*	 	PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 7; PCSK7	9159
MIM604873	*	11q24	MYELIN PROTEIN ZERO-LIKE 2; MPZL2	10205
MIM604874	*	12p13-p12	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY G, MEMBER 1; KLRG1	10219
MIM604875	*	15q22-q23	MYOSIN IXA; MYO9A	4649
MIM604876	*	6p12.3	REGULATOR OF CALCINEURIN 2; RCAN2	10231
MIM604877	*	22q12.2-q13.2	V-MAF AVIAN MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE FAMILY, PROTEIN F; MAFF	23764
MIM604878	*	15q13-q14	SOLUTE CARRIER FAMILY 12 (SODIUM/CHLORIDE TRANSPORTER), MEMBER 6; SLC12A6	9990
MIM604879	*	5p15.3	SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 7; SLC12A7	10723
MIM604881	*	17p13.3	RABPHILIN 3A-LIKE; RPH3AL	9501
MIM604882	*	10q21.3	NEUROGENIN 3; NEUROG3	50674
MIM604883	*	 	GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 2; GTF3C2	2976
MIM604884	*	9q33.3-q34.11	NEVER IN MITOSIS GENE A-RELATED KINASE 6; NEK6	10783
MIM604885	*	17p13.3	MYB-BINDING PROTEIN 1A; MYBBP1A	10514
MIM604886	*	16q22-qter	COX4, NEIGHBOR OF; NOC4	10328
MIM604887	*	 	METHYLENETETRAHYDROFOLATE DEHYDROGENASE 2; MTHFD2	10797
MIM604888	*	 	GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 3; GTF3C3	9330
MIM604889	*	13q13.2	NEUROBEACHIN; NBEA	26960
MIM604890	*	 	GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 5; GTF3C5	9328
MIM604891	*	2q32.1-q32.2	NCK-ASSOCIATED PROTEIN 1; NCKAP1	10787
MIM604892	*	 	GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 4; GTF3C4	9329
MIM604893	*	6q26	ANTISENSE IGF2R RNA, NONCODING; AIRN	100271873
MIM604894	*	18q21.1-q21.2	ONE CUT HOMEOBOX 2; ONECUT2	9480
MIM604895	*	17q21.3	T-BOX 21; TBX21	30009
MIM604896	*	20p12	MKKS GENE; MKKS	8195
MIM604897	*	5q31	PREFOLDIN 1; PFDN1	5201
MIM604898	*	20q13.2	PREFOLDIN 4; PFDN4	5203
MIM604899	*	12q12	PREFOLDIN 5; PFDN5	5204
MIM604900	*	8qter	DIACYLGLYCEROL O-ACYLTRANSFERASE 1; DGAT1	8694
MIM604901	#	16q22	NORTH AMERICAN INDIAN CHILDHOOD CIRRHOSIS; NAIC	84916
MIM604902	*	14q	BRF1, S. CEREVISIAE, HOMOLOG OF; BRF1	2972
MIM604903	*	1q42	TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1A; TAF1A	9015
MIM604904	*	2p25	TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1B; TAF1B	9014
MIM604905	*	16q24	TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1C; TAF1C	9013
MIM604906	#	1q42.1	SCHIZOPHRENIA 9; SCZD9	27185
MIM604907	*	17p11.2	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 13B; TNFRSF13B	23495
MIM604908	*	18p11.22	PROTEIN PHOSPHATASE 4, REGULATORY SUBUNIT 1; PPP4R1	9989
MIM604909	*	12q15	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 2; CNOT2	4848
MIM604910	*	19q13.4	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 3; CNOT3	4849
MIM604911	*	7q22-qter	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 4; CNOT4	4850
MIM604912	*	 	TAF2 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 150-KD; TAF2	6873
MIM604913	*	8p22-p21.3	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 7; CNOT7	29883
MIM604914	*	17q25	JUMONJI DOMAIN-CONTAINING PROTEIN 6; JMJD6	23210
MIM604915	*	3q27	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 13; MAP3K13	9175
MIM604916		 	HYDRONEPHROSIS, CONGENITAL, WITH CLEFT PALATE, CHARACTERISTIC FACIES, HYPOTONIA, AND MENTAL RETARDATION	 
MIM604917	*	16q21	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 1; CNOT1	23019
MIM604918	*	7q11.23-q21.1	PICCOLO, MOUSE, HOMOLOG OF; PCLO	27445
MIM604919		 	BECKER NEVUS SYNDROME	 
MIM604921	*	 	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 3; MAP4K3	8491
MIM604922		 	CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	 
MIM604923	*	Chr.14	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 5; MAP4K5	11183
MIM604924	*	 	RNA, U SMALL NUCLEAR, EXPORT ADAPTOR; RNUXA	51808
MIM604925	*	19q13.2	RAB ACCEPTOR 1; RABAC1	10567
MIM604926	*	 	PHOSPHATE CYTIDYLYLTRANSFERASE 1, CHOLINE, BETA ISOFORM; PCYT1B	9468
MIM604927	*	18q23	C-TERMINAL DOMAIN OF RNA POLYMERASE II SUBUNIT A, PHOSPHATASE OF, SUBUNIT 1; CTDP1	9150
MIM604928	#	4q22-q24	WOLFRAM SYNDROME 2; WFS2	493856
MIM604929	^	 	MOVED TO 181350	 
MIM604930	*	2q12	NCK ADAPTOR PROTEIN 2; NCK2	8440
MIM604931	#	1p36, 1q32-q41	CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1	3290, 9563
MIM604932	*	20q	PROTEIN KINASE, cAMP-DEPENDENT CATALYTIC, INHIBITOR GAMMA; PKIG	11142
MIM604933	*	1p34.3-p32.1	MutY, E. COLI, HOMOLOG OF; MUTYH	4595
MIM604934	*	1q42-q43	TUBULIN-SPECIFIC CHAPERONE E; TBCE	6905
MIM604935	*	9p24.3	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR 2; DMRT2	10655
MIM604936	*	19q13.4	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 1; KIR2DL1	3802
MIM604937	*	19q13.4	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 2; KIR2DL2	3803
MIM604938	*	19q13.4	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 3; KIR2DL3	3804
MIM604939	*	2q23-q24	PHOSPHOLIPASE A2 RECEPTOR 1; PLA2R1	22925
MIM604941	*	 	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B, ALPHA; PPP2R2A	5520
MIM604942	*	20p13	SYNTAPHILIN; SNPH	9751
MIM604943	*	7q22.1	SOLUTE CARRIER FAMILY 26, MEMBER 5; SLC26A5	375611
MIM604944	*	 	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B-DOUBLE PRIME, ALPHA; PPP2R3A	5523
MIM604945	*	19q13.4	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 4; KIR2DL4	3805
MIM604946	*	19q13.4	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, LONG CYTOPLASMIC TAIL, 1; KIR3DL1	3811
MIM604947	*	19q13.4	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, LONG CYTOPLASMIC TAIL, 2; KIR3DL2	3812
MIM604948	*	19p13.3	GROWTH ARREST- AND DNA DAMAGE-INDUCIBLE GENE GADD45, BETA; GADD45B	4616
MIM604949	*	9q22.1-q22.2	GROWTH ARREST- AND DNA DAMAGE-INDUCIBLE GENE GADD45, GAMMA; GADD45G	10912
MIM604950	*	1p13	PUTATIVE HOMEODOMAIN TRANSCRIPTION FACTOR 1; PHTF1	10745
MIM604951	*	19p13.2	6-@PHOSPHOGLUCONOLACTONASE; PGLS	25796
MIM604952	*	19q13.4	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 1; KIR2DS1	3806
MIM604953	*	19q13.4	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 2; KIR2DS2	100132285
MIM604954	*	19q13.4	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 3; KIR2DS3	3808
MIM604955	*	19q13.4	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 4; KIR2DS4	3809
MIM604956	*	 	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC TAIL, 5; KIR2DS5	3810
MIM604958	*	3q26.3	ACTIN-LIKE 6A; ACTL6A	86
MIM604959	*	 	PHORBOL-12-MYRISTATE-13-ACETATE-INDUCED PROTEIN 1; PMAIP1	5366
MIM604960	*	 	PROTEIN KINASE C AND CASEIN KINASE SUBSTRATE IN NEURONS 2; PACSIN2	11252
MIM604961	*	2q31.2	PHOSPHODIESTERASE 11A; PDE11A	50940
MIM604962	*	3q13	T-CELL RECEPTOR-ASSOCIATED TRANSMEMBRANE ADAPTOR 1; TRAT1	50852
MIM604963	*	19q13	PEPTIDOGLYCAN RECOGNITION PROTEIN 1; PGLYRP1	8993
MIM604964	*	9p13-p12	SHP2-INTERACTING TRANSMEMBRANE ADAPTOR PROTEIN 1; SIT1	27240
MIM604965	*	20q11.2-q13.2	SERINE/THREONINE PROTEIN KINASE 4; STK4	6789
MIM604966	#	5q31	PROTOCADHERIN-ALPHA GENE CLUSTER; PCDHA@	56117
MIM604967	#	5q31	PROTOCADHERIN-BETA GENE CLUSTER; PCDHB@	56116
MIM604968	#	5q31	PROTOCADHERIN-GAMMA GENE CLUSTER; PCDHG@	56115
MIM604969	*	Chr.17	SRC KINASE-ASSOCIATED PHOSPHOPROTEIN 1; SKAP1	8631
MIM604970	*	17p13.1	AURORA KINASE B; AURKB	9212
MIM604971	*	6p21	MYOD FAMILY INHIBITOR; MDFI	4188
MIM604972	*	6q15	ORIGIN RECOGNITION COMPLEX, SUBUNIT 3, S. CEREVISIAE, HOMOLOG OF; ORC3	23595
MIM604973	*	1p36.11	FICOLIN 3; FCN3	8547
MIM604974	*	13q31-q32	SRY-BOX 21; SOX21	11166
MIM604975	*	12p12.1	SRY-BOX 5; SOX5	6660
MIM604976	+	2q35	PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, GAMMA-3; PRKAG3	53632
MIM604977	*	6p21.3	SERINE/THREONINE PROTEIN KINASE 19; STK19	8859
MIM604978	*	Chr.16	CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 5; CPSF5	11051
MIM604979	*	Chr.12	CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 6; CPSF6	11052
MIM604980	*	 	GTPase-ACTIVATING PROTEIN, RAC, 1; RACGAP1	29127
MIM604981	*	 	WW DOMAIN-CONTAINING BINDING PROTEIN 4; WBP4	11193
MIM604982	*	10q23.1	HPS1 GENE; HPS1	3257
MIM604983	*	17q23-q24	POLYMERASE, DNA, GAMMA-2; POLG2	11232
MIM604984	*	13q31.2-q32.3	SERINE/THREONINE PROTEIN KINASE 24; STK24	8428
MIM604985	*	11q13	SPECTRIN, BETA, NONERYTHROCYTIC, 2; SPTBN2	6712
MIM604986	*	12q24	BRCA1-ASSOCIATED PROTEIN; BRAP	8315
MIM604987	*	7q33	C-TYPE LECTIN DOMAIN FAMILY 5, MEMBER A; CLEC5A	23601
MIM604988	*	Chr.11	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 2B1; SLCO2B1	11309
MIM604989	*	Chr.11	SPONDIN 1; SPON1	10418
MIM604990	*	17q25.1	SOLUTE CARRIER FAMILY 9, MEMBER 3, REGULATOR 1; SLC9A3R1	9368
MIM604991	*	5q12	PROSTATE ANDROGEN-REGULATED TRANSCRIPT 1; PART1	25859
MIM604992	*	16p13.3	SARCALUMENIN; SRL	6345
MIM604993	*	10p13	PRECURSOR mRNA-PROCESSING FACTOR 18, S. CEREVISIAE, HOMOLOG OF; PRPF18	8559
MIM604994	*	2p16-p15	SINE OCULIS HOMEOBOX, DROSOPHILA, HOMOLOG OF, 2; SIX2	10736
MIM604995	*	6p21.2-p21.1	SOLUTE CARRIER FAMILY 22 (ORGANIC ANION TRANSPORTER), MEMBER 7; SLC22A7	10864
MIM604996	*	19q13.12	FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 3; FXYD3	5349
MIM604997	*	8p21.3	DOCKING PROTEIN 2; DOK2	9046
MIM604998	*	3p25.3	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I; CAMK1	8536
MIM604999	*	 	SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 1; SHANK1	50944
MIM605000	*	16p11.2	CORONIN 1A; CORO1A	11151
MIM605001	*	 	ANGIOPOIETIN-LIKE 2; ANGPTL2	23452
MIM605002	*	15q23	CORONIN 2B; CORO2B	10391
MIM605003	*	6q13	SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 6; SENP6	26054
MIM605004	*	3q13.3	GLYCOGEN SYNTHASE KINASE 3-BETA; GSK3B	2932
MIM605005	*	4q31.1	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 7; GALNT7	51809
MIM605006	*	10q24.1	FREQUENTLY REARRANGED IN ADVANCED T-CELL LYMPHOMAS 2; FRAT2	23401
MIM605007	*	21q21-q22	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 5; ADAMTS5	11096
MIM605008	*	5q12	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 6; ADAMTS6	11174
MIM605009	*	Chr.15	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 7; ADAMTS7	11173
MIM605010	*	5q32	SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 5; SPINK5	11005
MIM605011	*	4q21	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 3; ADAMTS3	9508
MIM605012	*	 	SUPPRESSOR OF TY 16, S. CEREVISIAE, HOMOLOG OF; SUPT16H	11198
MIM605013	#	16p13.3-p12.1	MICROHYDRANENCEPHALY; MHAC	53341
MIM605014	*	6q24	SYNTAXIN 11; STX11	8676
MIM605015	*	11p15.4	ZINC FINGER PROTEIN 214; ZNF214	7761
MIM605016	*	11p15.4	ZINC FINGER PROTEIN 215; ZNF215	7762
MIM605017	*	22q11	PRE-B-LYMPHOCYTE GENE 3; VPREB3	29802
MIM605018	*	16q12-q13	CYLD GENE; CYLD	1540
MIM605019	#	1p31	HYPOBETALIPOPROTEINEMIA, FAMILIAL, 2; FHBL2	27329
MIM605020	*	20p11.2	VISUAL SYSTEM HOMEOBOX GENE 1, ZEBRAFISH, HOMOLOG OF; VSX1	30813
MIM605021	#	16p13.3	MYOCLONIC EPILEPSY, FAMILIAL INFANTILE; FIME	54119, 57465
MIM605022	*	3q29	p21 PROTEIN-ACTIVATED KINASE 2; PAK2	5062
MIM605023	*	20p12	HYDROXYACID OXIDASE 1; HAO1	54363
MIM605024	*	Chr.12	SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 8; SLC4A8	9498
MIM605025	*	Chr.17	INTEGRIN, ALPHA-3; ITGA3	3675
MIM605026		 	DIABETES MELLITUS, CONGENITAL AUTOIMMUNE	 
MIM605027	#	10q22, 1p32, 2q33-q34	LYMPHOMA, NON-HODGKIN, FAMILIAL	5551, 843, 8438
MIM605029	*	12p13.2-p12.3	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY F, MEMBER 1; KLRF1	51348
MIM605030	*	 	SERINE/THREONINE PROTEIN KINASE 3; STK3	6788
MIM605031	*	4q27-q28	POLO-LIKE KINASE 4; PLK4	10733
MIM605032	*	4p16.3	COMPLEXIN 1; CPLX1	10815
MIM605033	*	5q35.2	COMPLEXIN 2; CPLX2	10814
MIM605034	*	10q11.21-q11.23	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 23, YEAST, HOMOLOG OF; TIMM23	100287932
MIM605035	*	6q21-q22	WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY, MEMBER 1; WASF1	8936
MIM605036	*	14q11	ZINC FINGER PROTEIN 219; ZNF219	51222
MIM605037	*	 	KINESIN FAMILY MEMBER 17; KIF17	57576
MIM605038	*	 	POSTMEIOTIC SEGREGATION INCREASED 2-LIKE 1; PMS2L1	5379
MIM605039	#	3q13.13	BOHRING-OPITZ SYNDROME; BOPS	10225, 171023
MIM605040		 	CLAVICULAR HYPOPLASIA, ZYGOMATIC ARCH HYPOPLASIA, AND MICROGNATHIA	 
MIM605041	#	16q12-q13, 16q12-q13	BROOKE-SPIEGLER SYNDROME; BRSS	1540
MIM605042	*	 	MEDIATOR COMPLEX SUBUNIT 23; MED23	9439
MIM605043	*	19p13.11	MEDIATOR COMPLEX SUBUNIT 26; MED26	9441
MIM605044	*	9q34	MEDIATOR COMPLEX SUBUNIT 27; MED27	9442
MIM605045	*	5q33.3	MEDIATOR COMPLEX SUBUNIT 7; MED7	9443
MIM605046	*	9q21.2-q21.3	UBIQUILIN 1; UBQLN1	29979
MIM605047	*	 	INTERFERON REGULATORY FACTOR 7; IRF7	3665
MIM605048	*	1q32.1	INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE OF, EPSILON; IKBKE	9641
MIM605049	*	18p11.3-p11.2	TWISTED GASTRULATION HOMOLOG 1; TWSG1	57045
MIM605051	*	1p36	CANNABINOID RECEPTOR 2; CNR2	1269
MIM605052	*	1q42.3	TAR RNA-BINDING PROTEIN 1; TARBP1	6894
MIM605053	*	12p12.1-q13.1	TAR RNA-BINDING PROTEIN 2; TARBP2	6895
MIM605054	*	 	SMALL EDRK-RICH FACTOR 2; SERF2	10169
MIM605055	%	 	ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	 
MIM605056	*	 	WISKOTT-ALDRICH SYNDROME GENE-LIKE; WASL	8976
MIM605057	*	1q32	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 17, YEAST, HOMOLOG OF, A; TIMM17A	10440
MIM605058	*	19p13.3-p13.2	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 44, YEAST, HOMOLOG OF; TIMM44	10469
MIM605060	*	17p13	SEDOHEPTULOKINASE; SHPK	23729
MIM605061	*	16q23.1	TERF2-INTERACTING PROTEIN; TERF2IP	54386
MIM605062	*	7q31.3-q32	TASTE RECEPTOR, TYPE 2, MEMBER 5; TAS2R5	54429
MIM605063	*	11q13	STRESS-INDUCED PHOSPHOPROTEIN 1; STIP1	10963
MIM605064	*	15q23	KINESIN FAMILY MEMBER 23; KIF23	9493
MIM605065	*	 	CELL DIVISION CYCLE 37, S. CEREVISIAE, HOMOLOG OF; CDC37	11140
MIM605066	*	17p13.3	TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, EPSILON ISOFORM; YWHAE	7531
MIM605067		 	TRICUSPID ATRESIA	 
MIM605068	*	13q12	WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY, MEMBER 3; WASF3	10810
MIM605069	*	19p13.3	MITOGEN-ACTIVATED PROTEIN KINASE-INTERACTING SERINE/THREONINE KINASE 2; MKNK2	2872
MIM605070	*	 	EARLY ENDOSOME ANTIGEN 1; EEA1	8411
MIM605071	*	 	REGULATOR OF G PROTEIN SIGNALING 19; RGS19	10287
MIM605072	*	19p13.1	GIPC PDZ DOMAIN-CONTAINING FAMILY, MEMBER 1; GIPC1	10755
MIM605073	*	17q22-q23	TRIPARTITE MOTIF-CONTAINING PROTEIN 37; TRIM37	4591
MIM605074	#	1q21, 7q31, Xp11.22	RENAL CELL CARCINOMA, PAPILLARY, 1; RCCP1	4233, 5546, 7030
MIM605075	^	17q21.32	MOVED TO 605074	 
MIM605076	*	 	SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 2; SNAPC2	6618
MIM605077	*	 	DNMT1-ASSOCIATED PROTEIN 1; DNMAP1	55929
MIM605078	*	1p36.2	TAR DNA-BINDING PROTEIN; TARDBP	23435
MIM605079	*	18q23	SAL-LIKE 3; SALL3	27164
MIM605080	*	8q21-q22	CYCLIC NUCLEOTIDE-GATED CHANNEL, BETA-3; CNGB3	54714
MIM605081	*	7p22.1	CYTOHESIN 3; CYTH3	9265
MIM605082	*	3p21.3	RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1; RASSF1	11186
MIM605083	*	2q31-q33	FRIZZLED-RELATED PROTEIN; FRZB	2487
MIM605084	*	 	CALCIUM-BINDING ATOPY-RELATED AUTOANTIGEN 1; CBARA1	10367
MIM605085	*	6p21.1	TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TREM1	54210
MIM605086	*	6p21.2	TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; TREM2	54209
MIM605087	*	1p31.1	PHOSPHATIDYLINOSITOL GLYCAN, CLASS K; PIGK	10026
MIM605088	*	16p13.1-p11.2	MAJOR VAULT PROTEIN, RAT, HOMOLOG OF; MVP	9961
MIM605089	*	22q11	MITOCHONDRIAL RIBOSOMAL PROTEIN L40; MRPL40	64976
MIM605090	*	3q25.3	RETINOIC ACID RECEPTOR RESPONDER 1; RARRES1	5918
MIM605091	*	 	FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 2; FGD2	221472
MIM605092	*	11q23	RETINOIC ACID RECEPTOR RESPONDER 3; RARRES3	5920
MIM605093	*	12q24	SH2B ADAPTOR PROTEIN 3; SH2B3	10019
MIM605094	*	7q21	SIX-TRANSMEMBRANE EPITHELIAL ANTIGEN OF PROSTATE 2; STEAP2	261729
MIM605096	*	2q37.3	ANOCTAMIN 7; ANO7	50636
MIM605097	*	1q32.1	SOLUTE CARRIER FAMILY 45, MEMBER 3; SLC45A3	85414
MIM605100	*	17q22-q23	PROTEIN PHOSPHATASE, MAGNESIUM-DEPENDENT, 1D; PPM1D	8493
MIM605101	*	6q25	TAK1-BINDING PROTEIN 2; TAB2	23118
MIM605102	*	1p36.3-p36.2	MANNAN-BINDING LECTIN SERINE PROTEASE 2; MASP2	10747
MIM605103	*	 	NEUROMEDIN U; NMU	10874
MIM605104	*	16p13	RNA-BINDING PROTEIN FOX1, C. ELEGANS, HOMOLOG OF, 1; RBFOX1	54715
MIM605106	*	1p31.1-p22.3	LYSOPHOSPHATIDIC ACID RECEPTOR 3; LPAR3	23566
MIM605107	*	 	ENDOTHELIAL DIFFERENTIATION-RELATED FACTOR 1; EDF1	8721
MIM605108	*	5q33.1	NEUROMEDIN U RECEPTOR 2; NMUR2	56923
MIM605109	*	 	HECT DOMAIN AND RCC1-LIKE DOMAIN 1; HERC1	8925
MIM605110	*	19p12	LYSOPHOSPHATIDIC ACID RECEPTOR 2; LPAR2	9170
MIM605111	*	19p13.2	SPHINGOSINE 1-PHOSPHATE RECEPTOR 2; S1PR2	9294
MIM605112	*	15q21.1-q21.2	TROPOMODULIN 3; TMOD3	29766
MIM605113	*	7q31.3	ALPHA-AMINOADIPIC SEMIALDEHYDE SYNTHASE; AASS	10157
MIM605114	*	20q13.2-q13.3	SPO11, S. CEREVISIAE, HOMOLOG OF; SPO11	23626
MIM605115	#	4q31.1	HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATION IN PREGNANCY	4306
MIM605116	*	4p15.1-p14	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 9; CHRNA9	55584
MIM605117	*	 	SUPPRESSOR OF CYTOKINE SIGNALING 2; SOCS2	8835
MIM605118	*	18q21.1	SUPPRESSOR OF CYTOKINE SIGNALING 4; SOCS4	9306
MIM605119	*	 	PROTEIN PHOSPHATASE, MAGNESIUM-DEPENDENT, 1G; PPM1G	5496
MIM605120	*	10q11.22	GROWTH/DIFFERENTIATION FACTOR 2; GDF2	2658
MIM605121	*	16p12	RRN3, S. CEREVISIAE, HOMOLOG OF; RRN3	54700
MIM605122	*	10q22.1	SUV3-LIKE 1; SUPV3L1	6832
MIM605123	*	 	SERINE PROTEASE INHIBITOR, KUNITZ-TYPE, 1; SPINT1	6692
MIM605124	*	19q13.1	SERINE PROTEASE INHIBITOR, KUNITZ-TYPE, 2; SPINT2	10653
MIM605125	*	17p13.1	GABA-A RECEPTOR-ASSOCIATED PROTEIN; GABARAP	11337
MIM605126	*	6q16.1-q16.3	FOUR-AND-A-HALF LIM DOMAINS 5; FHL5	9457
MIM605127	*	 	OPTICIN; OPTC	26254
MIM605128	*	3q13.1	GUANYLATE CYCLASE ACTIVATOR 1C; GUCA1C	9626
MIM605129	*	17q12-q21	PROTEASOME ACTIVATOR SUBUNIT 3; PSME3	10197
MIM605130	#	 	HAIRY ELBOWS, SHORT STATURE, FACIAL DYSMORPHISM, AND DEVELOPMENTAL DELAY	4297
MIM605131	*	16q23.3-q24.1	WW DOMAIN-CONTAINING OXIDOREDUCTASE; WWOX	51741
MIM605132	*	 	TRANSDUCIN-LIKE ENHANCER OF SPLIT 4; TLE4	7091
MIM605133	*	 	NUCLEAR CAP-BINDING PROTEIN 2; NCBP2	22916
MIM605134	*	 	PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, CYTOPLASMIC, 1; PITPNC1	26207
MIM605138	*	 	ORNITHINE DECARBOXYLASE ANTIZYME 3; OAZ3	51686
MIM605139	*	Chr.12	CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 2; CCT2	10576
MIM605140	*	 	CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 7; CCT7	10574
MIM605141	*	22q11.2	PRE-B-LYMPHOCYTE GENE 1; VPREB1	7441
MIM605142	*	2p15	CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 4; CCT4	10575
MIM605143	*	 	ACTIN-RELATED PROTEIN 1A; ACTR1A	10121
MIM605144	*	2q11.1-q11.2	ACTIN-RELATED PROTEIN 1B; ACTR1B	10120
MIM605145	*	5p15.2-p14.1	ANK, MOUSE, HOMOLOG OF; ANKH	56172
MIM605146	*	19p13.2	SPHINGOSINE 1-PHOSPHATE RECEPTOR 5; S1PR5	53637
MIM605147	*	13q14-q21	LEUKOCYTE CELL-DERIVED CHEMOTAXIN 1; LECT1	11061
MIM605148	*	12q13	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 6; GALNT6	11226
MIM605149	*	4q21	CHEMOKINE, CXC MOTIF, LIGAND 13; CXCL13	10563
MIM605152	*	1q22-q24	COILED-COIL DOMAIN-CONTAINING PROTEIN 19; CCDC19	25790
MIM605153	*	2q36-q37.1	RECEPTOR ACTIVITY-MODIFYING PROTEIN 1; RAMP1	10267
MIM605154	*	17q12-q21.1	RECEPTOR ACTIVITY-MODIFYING PROTEIN 2; RAMP2	10266
MIM605155	*	7p13-p12	RECEPTOR ACTIVITY-MODIFYING PROTEIN 3; RAMP3	10268
MIM605156	^	 	MOVED TO 259600	 
MIM605157	*	 	p53-RESPONSIVE GENE 1	23574
MIM605158	*	2p25.3	PEROXIDASIN, DROSOPHILA, HOMOLOG OF; PXDN	7837
MIM605159	*	 	APOPTOSIS-INDUCING FACTOR, MITOCHONDRION-ASSOCIATED, 2; AIFM2	84883
MIM605160	*	 	p53-RESPONSIVE GENE 4	23572
MIM605161	*	20q12-q13.2	WAP 4-DISULFIDE CORE DOMAIN 5; WFDC5	149708
MIM605162	*	19p13.13	GROWTH ARREST- AND DNA DAMAGE-INDUCIBLE GADD45G-INTERACTING PROTEIN; GADD45GIP1	90480
MIM605163	*	3p21	CHEMOKINE, CXC MOTIF, RECEPTOR 6; CXCR6	10663
MIM605164	*	6q21	HISTONE DEACETYLASE 2; HDAC2	3066
MIM605165	*	22q12	ZINC FINGER PROTEIN 278; ZNF278	23598
MIM605166	*	5q31	HISTONE DEACETYLASE 3; HDAC3	8841
MIM605167	*	 	B MELANOMA ANTIGEN; BAGE	574
MIM605168	*	8q21.13	FATTY ACID-BINDING PROTEIN 5; FABP5	2171
MIM605169	*	11p15-p13	E74-LIKE FACTOR 5; ELF5	2001
MIM605170	*	11q23	ETOPOSIDE-INDUCED 1.4 mRNA; EI24	9538
MIM605171	*	2p	TUMOR PROTEIN p53-INDUCIBLE PROTEIN 3; TP53I3	9540
MIM605172	*	9q34.3	PROSTAGLANDIN E SYNTHASE; PTGES	9536
MIM605173	*	5q13	ECTODERMAL-NEURAL CORTEX 1; ENC1	8507
MIM605174	*	21q21.2	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 1; ADAMTS1	9510
MIM605175	*	11q25	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 8; ADAMTS8	11095
MIM605176	*	1p13	HYDROXYACID OXIDASE 2; HAO2	51179
MIM605178	*	16q24.3	GROWTH ARREST-SPECIFIC 8; GAS8	2622
MIM605179	*	16q24.3	CHROMOSOME 16 OPEN READING FRAME 3; C16ORF3	750
MIM605180	*	Chr.12	SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 2; SLC38A2	54407
MIM605181	*	12q11-q12	TRANSMEMBRANE 7 SUPERFAMILY, MEMBER 3; TM7SF3	51768
MIM605182	*	13q34	RAS p21 PROTEIN ACTIVATOR 3; RASA3	22821
MIM605183	*	 	CALMODULIN-LIKE 5; CALML5	51806
MIM605184	*	5p12	POLYADENYLATE-BINDING PROTEIN-INTERACTING PROTEIN 1; PAIP1	10605
MIM605185	*	15q21.1	DELTA-LIKE 4; DLL4	54567
MIM605186	*	Chr.12	WNT INHIBITORY FACTOR 1; WIF1	11197
MIM605187	*	3p21-p14	G PROTEIN-COUPLED RECEPTOR 27; GPR27	2850
MIM605188	*	7q31	G PROTEIN-COUPLED RECEPTOR 85; GPR85	54329
MIM605189	*	10q11.2	DICKKOPF, XENOPUS, HOMOLOG OF, 1; DKK1	22943
MIM605190	*	Chr.8	TRANSLOCATION-ASSOCIATING MEMBRANE PROTEIN 1; TRAM1	23471
MIM605191	*	10q22-q23	BTAF1 RNA POLYMERASE II, B-TFIID TRANSCRIPTION FACTOR-ASSOCIATED, 170-KD; BTAF1	9044
MIM605192	#	14q23	DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23	6495
MIM605193	*	1p31	DIRAS FAMILY, GTP-BINDING RAS-LIKE PROTEIN 3; DIRAS3	9077
MIM605194	*	2q21.1	CRYPTIC PROTEIN; CFC1	55997
MIM605195	*	15q26.1	MESODERM POSTERIOR 2; MESP2	145873
MIM605196	*	 	COQ3, S. CEREVISIAE, HOMOLOG OF; COQ3	51805
MIM605197	*	 	KYNURENINASE; KYNU	8942
MIM605198	*	5p15	POLY(A) POLYMERASE-ASSOCIATED DOMAIN-CONTAINING PROTEIN 7; PAPD7	11044
MIM605199	*	1p34	SPLICING FACTOR, PROLINE- AND GLUTAMINE-RICH; SFPQ	6421
MIM605200	*	 	HECT DOMAIN AND RCC1-LIKE DOMAIN 3; HERC3	8916
MIM605201	%	11q23.3	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 14; HDLCQ14	56801
MIM605202	*	Chr.9	N-ACETYLNEURAMINIC ACID PHOSPHATE SYNTHASE; NANS	54187
MIM605203	^	 	MOVED TO 263650	 
MIM605204	*	9q34	TORSIN 1A; TOR1A	1861
MIM605205	*	1q24	ADENYLYL CYCLASE, SOLUBLE	55811
MIM605206	*	15q24-q25	HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 4; HCN4	10021
MIM605207	*	 	CYTOCHROME P450, SUBFAMILY XXVIB, POLYPEPTIDE 1; CYP26B1	56603
MIM605208	*	19q13	SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 7; SLC17A7	57030
MIM605209	*	12q24.33	CHECKPOINT PROTEIN WITH FHA AND RING FINGER DOMAINS; CHFR	55743
MIM605210	*	1q42.1	DISRUPTED IN SCHIZOPHRENIA 1; DISC1	27185
MIM605211	*	9q34	BARH-LIKE 1; BARHL1	56751
MIM605212	*	 	BARH-LIKE 2; BARHL2	343472
MIM605213	*	16p13.3	3-@PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1; PDPK1	5170
MIM605214	*	 	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, BETA MEMBER 2; KCNMB2	10242
MIM605215	*	7p21-p15	SKAP55-RELATED PROTEIN	8935
MIM605216	*	2q22	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 4; ARHGEF4	50649
MIM605217	*	 	SHC TRANSFORMING PROTEIN 2; SHC2	25759
MIM605218	#	2q37.3	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 2; SLEB2	5133, 56179
MIM605219	*	Chr.12	DIRECT IAP-BINDING PROTEIN WITH LOW pI; DIABLO	56616
MIM605220	*	16p11.2	APOLIPOPROTEIN B48 RECEPTOR	55911
MIM605221	*	1p36.1	SPLICING FACTOR, SERINE/ARGININE-RICH, 10; SRSF10	10772
MIM605222	*	3q26.3-q27.1	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, BETA MEMBER 3; KCNMB3	27094
MIM605223	*	12q14.1-q15	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, BETA MEMBER 4; KCNMB4	27345
MIM605224	*	4q	RHODOPSIN HOMOLOG, RETINAL PIGMENT EPITHELIUM-DERIVED; RRH	10692
MIM605225	%	1p36	INFLAMMATORY BOWEL DISEASE 7; IBD7	57042
MIM605226	*	1p36.2-p36.1	RE REPEATS-ENCODING GENE; RERE	473
MIM605227	*	9p13-p12	REVERSION-INDUCING CYSTEINE-RICH PROTEIN WITH KAZAL MOTIFS; RECK	8434
MIM605228	*	 	COREPRESSOR INTERACTING WITH RBPJ, 1; CIR1	9541
MIM605229	%	3q27-q28	SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE; SPG14	57309
MIM605230	*	15q15-q21	TUMOR PROTEIN p53-BINDING PROTEIN 1; TP53BP1	7158
MIM605232	*	12p13	PROTEIN KINASE, LYSINE-DEFICIENT 1; WNK1	65125
MIM605233	%	 	DIANZANI AUTOIMMUNE LYMPHOPROLIFERATIVE DISEASE	 
MIM605234	*	19q13.4	VOMERONASAL 1 RECEPTOR 1; VN1R1	57191
MIM605235	*	16q21-q23	NUCLEOLAR PROTEIN 3; NOL3	8996
MIM605236	*	4p13-p12	CORIN, SERINE PEPTIDASE; CORIN	10699
MIM605237	*	1q25.1	XENOTROPIC AND POLYTROPIC RETROVIRUS RECEPTOR; XPR1	9213
MIM605238	*	2q22	HISTAMINE N-METHYLTRANSFERASE; HNMT	3176
MIM605239	*	7q33-q34	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A, ISOFORM 4; ATP6V0A4	50617
MIM605240	*	5p12	CHEMOKINE, CC MOTIF, LIGAND 28; CCL28	56477
MIM605241	*	 	LYMPHOCYTE ANTIGEN 86; LY86	9450
MIM605242	*	11p15.1	USH1C GENE; USH1C	10083
MIM605243	*	 	LYMPHOCYTE ANTIGEN 96; LY96	23643
MIM605244	%	2p16	CARNEY COMPLEX, TYPE 2; CNC2	1257
MIM605245	*	Chr.9	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 8; SLC2A8	29988
MIM605246	*	 	COMPLEMENT COMPONENT 3a RECEPTOR 1; C3AR1	719
MIM605247	*	 	LEUCINE-RICH REPEATS- AND DEATH DOMAIN-CONTAINING PROTEIN; LRDD	55367
MIM605248	*	19p13.3-p13.2	MUCOLIPIN 1; MCOLN1	57192
MIM605249	#	22q11.2	SEBASTIAN SYNDROME; SBS	4627
MIM605250	*	13q32	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 4; ABCC4	10257
MIM605251	*	3q27	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 5; ABCC5	10057
MIM605252	*	18q21.1	POLYMERASE, DNA, IOTA; POLI	11201
MIM605253	#	1q22, 10q21.1-q22.1	NEUROPATHY, CONGENITAL HYPOMYELINATING	1959, 4359
MIM605254	*	1q22-q23	NICASTRIN; NCSTN	23385
MIM605255	*	6p21	ETS VARIANT GENE 7; ETV7	51513
MIM605256	*	3p25-p24	RAD18, S. CEREVISIAE, HOMOLOG OF; RAD18	56852
MIM605257	*	12p13	ACTIVATION-INDUCED CYTIDINE DEAMINASE; AICDA	57379
MIM605258	#	12p13	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2; HIGM2	57379
MIM605259	#	19q13.3-q13.4	SPINOCEREBELLAR ATAXIA 13; SCA13	3748
MIM605261	*	11q14.2-q21	NADPH OXIDASE 4; NOX4	50507
MIM605262	*	8q24.3	NMYC DOWNSTREAM-REGULATED GENE 1; NDRG1	10397
MIM605263	*	 	SHC TRANSFORMING PROTEIN 3; SHC3	53358
MIM605264	*	10q23.3-q24.1	SORBIN AND SH3-DOMAINS CONTAINING 1; SORBS1	10580
MIM605265	*	Chr.15	CELL DEATH REGULATOR AVEN	57099
MIM605266	*	8q21	JUNCTOPHILIN 1; JPH1	56704
MIM605267	*	20q12	JUNCTOPHILIN 2; JPH2	57158
MIM605268	*	16q24.3	JUNCTOPHILIN 3; JPH3	57338
MIM605269	*	12q24.1	CORONIN 1C; CORO1C	23603
MIM605270	*	17q25.3	N-SULFOGLUCOSAMINE SULFOHYDROLASE; SGSH	6448
MIM605271	*	14q32.1	SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 10; SERPINA10	51156
MIM605272	*	14q11.2	NMYC DOWNSTREAM-REGULATED GENE 2; NDRG2	57447
MIM605273	*	20q11.21-q11.23	NMYC DOWNSTREAM-REGULATED GENE 3; NDRG3	57446
MIM605274		 	MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	 
MIM605275		 	NOONAN SYNDROME 2; NS2	57762
MIM605276	*	17q25.3	APOPTOSIS-ASSOCIATED TYROSINE KINASE; AATK	9625
MIM605277	*	19q13.2-q13.4	GLUCOCORTICOID RECEPTOR DNA-BINDING FACTOR 1; GRLF1	2909
MIM605278	*	 	CARBOXYLESTERASE 2; CES2	8824
MIM605279	*	16q21	CARBOXYLESTERASE 3; CES3	23491
MIM605280	#	2q33.1	SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT; SPG13	3329
MIM605281	*	5q11.2-q12	DEAD/H BOX 4; DDX4	54514
MIM605282	#	 	TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME; TPBS	22856
MIM605283	*	15q11-q13	MAGE-LIKE 2; MAGEL2	54551
MIM605284	*	9q34	TSC1 GENE; TSC1	7248
MIM605285	#	10q23.2	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE	59333
MIM605286	*	2q37.3	CALPAIN 10; CAPN10	11132
MIM605287	*	2q37.3	ARGINYL AMINOPEPTIDASE-LIKE 1; RNPEPL1	57140
MIM605288	^	 	MOVED TO 273300	 
MIM605289	#	3q27	SPLIT-HAND/FOOT MALFORMATION 4; SHFM4	8626
MIM605290	*	3q28-q29	OPA1 GENE; OPA1	4976
MIM605292	*	17p11.2	5-PRIME-@NUCLEOTIDASE, MITOCHONDRIAL; NT5M	56953
MIM605293	%	18q12.2-q12.3	OPTIC ATROPHY 4; OPA4	58156
MIM605294	*	16q22	CARBOHYDRATE SULFOTRANSFERASE 6; CHST6	4166
MIM605295	*	 	FIDGETIN; FIGN	55137
MIM605296	*	21q22.3	PROTEASOME-ASSEMBLING CHAPERONE 1; PSMG1	8624
MIM605297	*	20q13	TH1-LIKE; TH1L	51497
MIM605298	*	21q22.2	DOWN SYNDROME CRITICAL REGION GENE 3; DSCR3	10311
MIM605299	*	20q11	NUCLEAR RECEPTOR COACTIVATOR 6; NCOA6	23054
MIM605300	*	7q22	SH2B ADAPTOR PROTEIN 2; SH2B2	10603
MIM605301	*	8p11	TRANSFORMING, ACIDIC, COILED-COIL-CONTAINING PROTEIN 1; TACC1	6867
MIM605302	*	10q26	TRANSFORMING, ACIDIC, COILED-COIL-CONTAINING PROTEIN 2; TACC2	10579
MIM605303	*	4p16.3	TRANSFORMING, ACIDIC, COILED-COIL-CONTAINING PROTEIN 3; TACC3	10460
MIM605304	*	14q24	NEUROGLOBIN; NGB	58157
MIM605305	*	19p13.3	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 5; KIR2DL5	57292
MIM605306	*	12p13	C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER A; CLEC4A	50856
MIM605307	*	 	ADRENOMEDULLIN RECEPTOR; ADMR	11318
MIM605308	*	 	ZINC FINGER PROTEIN 346; ZNF346	23567
MIM605309	#	10q23.31	MACROCEPHALY/AUTISM SYNDROME	5728
MIM605310	*	6p21.3	COILED-COIL ALPHA-HELICAL ROD PROTEIN 1; CCHCR1	54535
MIM605311	^	 	MOVED TO 601776	 
MIM605312	*	19p13.2-p13.1	GROWTH/DIFFERENTIATION FACTOR 15; GDF15	9518
MIM605313	*	1q12	RNA-BINDING MOTIF PROTEIN 8A; RBM8A	9939
MIM605314	*	2q37.2	HISTONE DEACETYLASE 4; HDAC4	9759
MIM605315	*	Chr.17	HISTONE DEACETYLASE 5; HDAC5	10014
MIM605316	^	21q22.3	DEAFNESS, AUTOSOMAL RECESSIVE 10; DFNB10	64699
MIM605317	*	7q31	FORKHEAD BOX P2; FOXP2	93986
MIM605319	*	10p15-p14	6-@PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3; PFKFB3	5209
MIM605320	*	3p22-p21	6-@PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 4; PFKFB4	5210
MIM605321		 	FRONTOOCULAR SYNDROME	 
MIM605322	*	16q24.3	WAP 4-DISULFIDE CORE DOMAIN 1; WFDC1	58189
MIM605323	*	2q34	C-TERMINAL DOMAIN OF RNA POLYMERASE II POLYPEPTIDE A, SMALL PHOSPHATASE OF, 1; CTDSP1	58190
MIM605324	*	17q22-q23	AMYLOID BETA PRECURSOR PROTEIN-BINDING PROTEIN 2; APPBP2	10513
MIM605325	*	7q22.1	CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 5; CYP3A5	1577
MIM605326	*	7p15	TAX1-BINDING PROTEIN 1; TAX1BP1	8887
MIM605327	*	9q22.1-q22.3	NUCLEAR FACTOR, INTERLEUKIN 3-REGULATED; NFIL3	4783
MIM605328	*	15q12	KRUPPEL-LIKE FACTOR 13; KLF13	51621
MIM605330	*	12q15	INTERLEUKIN 22; IL22	50616
MIM605331	*	18p11.3	ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 3; EPB41L3	23136
MIM605332	*	13q21	KELCH-LIKE 1; KLHL1	57626
MIM605333	*	13q12.3	PDS5, REGULATOR OF COHESION MAINTENANCE, S. CEREVISIAE, HOMOLOG OF, B; PDS5B	23047
MIM605335	*	12q15-q21.2	PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY A, MEMBER 1; PHLDA1	22822
MIM605336	*	1q31-q32.1	COMPLEMENT FACTOR H-RELATED 3; CFHR3	10878
MIM605337	*	1q31-q32.1	COMPLEMENT FACTOR H-RELATED 4; CFHR4	10877
MIM605338	*	 	INTERNEXIN, ALPHA; INA	9118
MIM605339	*	17p13.1	FRAGILE X MENTAL RETARDATION, AUTOSOMAL HOMOLOG 2; FXR2	9513
MIM605340	*	7q22.1	CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 7; CYP3A7	1551
MIM605341	*	7q22	PAIRED IMMUNOGLOBULIN-LIKE TYPE 2 RECEPTOR, ALPHA; PILRA	29992
MIM605342	*	7q22	PAIRED IMMUNOGLOBULIN-LIKE TYPE 2 RECEPTOR, BETA; PILRB	29990
MIM605343	*	19p13	FOLLISTATIN-LIKE 3; FSTL3	10272
MIM605344	*	1p32	NUCLEAR TRANSCRIPTION FACTOR Y, GAMMA; NFYC	4802
MIM605345	*	14q24	AlkB, E. COLI, HOMOLOG OF, 1; ALKBH1	8846
MIM605347	*	1p36.13	PEPTIDYLARGININE DEIMINASE, TYPE IV; PADI4	23569
MIM605348	*	1p36.2-p34	SMALL MEMBRANE PROTEIN 1	23585
MIM605349	*	 	NUCLEAR PRELAMIN A RECOGNITION FACTOR; NARF	26502
MIM605350	*	19p13.11	INTERLEUKIN 27 RECEPTOR, ALPHA; IL27RA	9466
MIM605351	*	7q11.2	FIBRINOGEN-LIKE 2; FGL2	10875
MIM605352	*	8p23.1	MALIGNANT FIBROUS HISTIOCYTOMA-AMPLIFIED SEQUENCE 1; MFHAS1	9258
MIM605353	*	3p26-p25	GHRELIN; GHRL	51738
MIM605354	*	11q21-q22	CASPASE 1 INHIBITOR	59082
MIM605355	#	19q13.4	NEMALINE MYOPATHY 5; NEM5	7138
MIM605356	*	7q11.23	TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, GAMMA ISOFORM; YWHAG	7532
MIM605357	*	 	STONIN 1; STON1	11037
MIM605358	*	2p16.3	GENERAL TRANSCRIPTION FACTOR IIA, 1-LIKE; GTF2A1L	11036
MIM605359	*	Chr.12	PROLINE-RICH 4; PROL4	11272
MIM605360	*	Chr.11	DELTA ANTIGEN-INTERACTING PROTEIN A	11007
MIM605361	#	19q13.4	SPINOCEREBELLAR ATAXIA 14; SCA14	5582
MIM605362	#	6q23	CARDIOMYOPATHY, DILATED, 1J; CMD1J	2070
MIM605363	*	2q31	GLUTAMATE DECARBOXYLASE 1; GAD1	2571
MIM605364	%	19p13	PSORIASIS SUSCEPTIBILITY 6; PSORS6	63869
MIM605365	%	13q21	BREAST CANCER 3; BRCA3	60500
MIM605366	*	Chr.9	OLFACTOMEDIN 1; OLFM1	10439
MIM605367	*	17p11	ELAC, E. COLI, HOMOLOG OF, 2; ELAC2	60528
MIM605368	*	8p21	BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 3-LIKE; BNIP3L	665
MIM605369	*	 	TRANSMEMBRANE PROTEASE, SERINE 11D; TMPRSS11D	9407
MIM605370	*	5q31	RHO GTPase-ACTIVATING PROTEIN 26; ARHGAP26	23092
MIM605371	*	20q13.13	ADP-RIBOSYLATION FACTOR GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; ARFGEF2	10564
MIM605372	*	2q31.2	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A3; HNRNPA3	220988
MIM605373	#	1q21	PARAGANGLIOMAS 3; PGL3	6391
MIM605374	*	2p24.1	MYCN, OPPOSITE STRAND; MYCNOS	10408
MIM605375	#	1q21	EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 3	1141
MIM605376	#	2q21.1	HETEROTAXY, VISCERAL, 2, AUTOSOMAL; HTX2	55997
MIM605377	*	19q13.2-q13.3	DYSTROPHIA MYOTONICA PROTEIN KINASE; DMPK	1760
MIM605378	*	12q13	AAAS GENE; AAAS	8086
MIM605379	*	16q24.1	GAN GENE; GAN	8139
MIM605380	*	12p13.3	FIBROBLAST GROWTH FACTOR 23; FGF23	8074
MIM605381	*	15q25	RHESUS BLOOD GROUP, C GLYCOPROTEIN; RHCG	51458
MIM605383	*	16p11	INTERLEUKIN 21 RECEPTOR; IL21R	50615
MIM605384	*	4q26-q27	INTERLEUKIN 21; IL21	59067
MIM605385	*	Chr.11	PRENYL PROTEIN PROTEASE RCE1; RCE1	9986
MIM605386	*	9q22.32	MICRO RNA LET7A1; MIRNLET7A1	406881
MIM605387	#	20q11.21	CATARACT, POSTERIOR POLAR, 3; CTPP3	128866
MIM605388	%	9p12-q12	CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	60502
MIM605389	#	18p11.32-p11.23	HYPOTRICHOSIS 1; HYPT1	147495
MIM605390	*	Chr.11	LEUPAXIN; LPXN	9404
MIM605391	*	10q23	MULTIPLE INOSITOL POLYPHOSPHATE PHOSPHATASE 1; MINPP1	9562
MIM605392	*	6q27	FIBROBLAST GROWTH FACTOR RECEPTOR 1 ONCOGENE PARTNER; FGFR1OP	11116
MIM605393	*	1q32	LYSINE-SPECIFIC DEMETHYLASE 5B; KDM5B	10765
MIM605394	*	6q15	BTB AND CNC HOMOLOGY 2; BACH2	60468
MIM605395	*	19p13.2	TRANSMEMBRANE EMP24 TRANSPORT DOMAIN-CONTAINING PROTEIN 1; TMED1	11018
MIM605397	*	18q22.3	CD226 ANTIGEN; CD226	10666
MIM605398	*	17p13	CHEMOKINE, CXC MOTIF, LIGAND 16; CXCL16	58191
MIM605399	*	Chr.14	NIDOGEN 2; NID2	22795
MIM605400		 	FIBROMATOSIS, GINGIVAL, WITH HYPERTRICHOSIS AND MENTAL RETARDATION	 
MIM605401	*	5q11-q13	IQ MOTIF-CONTAINING GTPase-ACTIVATING PROTEIN 2; IQGAP2	10788
MIM605402	*	9p24	PROGRAMMED CELL DEATH 1 LIGAND 1; PDCD1LG1	29126
MIM605403	*	4p14	TOLL-LIKE RECEPTOR 6; TLR6	10333
MIM605404	*	 	BCL2-RELATED OVARIAN KILLER; BOK	666
MIM605405	*	10p13	USP6 N-TERMINAL-LIKE; USP6NL	9712
MIM605406	*	14q24.3	TRANSMEMBRANE EMP24 TRANSPORT DOMAIN-CONTAINING PROTEIN 10; TMED10	10972
MIM605407	#	11p15.5	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	7054
MIM605409	*	5q31	TRANSCRIPTION ELONGATION REGULATOR 1; TCERG1	10915
MIM605410	*	7q31	POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 2; KCND2	3751
MIM605411	*	1p13.3-p13.2	POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 3; KCND3	3752
MIM605412	*	2q13	RAB-LIKE 2A; RABL2A	11159
MIM605413	*	22q13.3	RAB-LIKE 2B; RABL2B	11158
MIM605414	*	19p13.3	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 7; ABCA7	10347
MIM605415	*	 	DICKKOPF, XENOPUS, HOMOLOG OF, 2; DKK2	27123
MIM605416	*	 	DICKKOPF, XENOPUS, HOMOLOG OF, 3; DKK3	27122
MIM605417	*	8p11.2-p11.1	DICKKOPF, XENOPUS, HOMOLOG OF, 4; DKK4	27121
MIM605418	*	19q13.33	DICKKOPF-LIKE 1; DKKL1	27120
MIM605419	%	15q15	SCHIZOPHRENIA 10; SCZD10	63944
MIM605420	*	11p11.2	ARISTALESS-LIKE 4, MOUSE, HOMOLOG OF; ALX4	60529
MIM605421	*	3p14.3-p14.2	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 9; ADAMTS9	56999
MIM605422	*	 	ZINC FINGER PROTEIN 350; ZNF350	59348
MIM605423	*	12q13.1	DESERT HEDGEHOG; DHH	50846
MIM605424	*	5q35	MASTERMIND-LIKE 1; MAML1	9794
MIM605425	*	1p35.1	GAP JUNCTION PROTEIN, BETA-4; GJB4	127534
MIM605426	*	11q24	p53-REGULATED APOPTOSIS-INDUCING PROTEIN 1	63970
MIM605427	*	12q24.1	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 4; TRPV4	59341
MIM605428	%	4q31	DEAFNESS, AUTOSOMAL RECESSIVE 26; DFNB26	23714
MIM605429	%	1q24	DEAFNESS, NONSYNDROMIC, MODIFIER 1; DFNM1	54362
MIM605430	*	17q21.33	SPERM-ASSOCIATED ANTIGEN 9; SPAG9	9043
MIM605431	*	 	MITOGEN-ACTIVATED PROTEIN KINASE 8-INTERACTING PROTEIN 3; MAPK8IP3	23162
MIM605432	#	7p15-p14.2	RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	3207
MIM605433	*	6p23	KINESIN FAMILY MEMBER 13A; KIF13A	63971
MIM605434	*	1p34.3-p34.1	CLASPIN, XENOPUS, HOMOLOG OF; CLSPN	63967
MIM605435	*	14q12	PROTEIN KINASE D1; PRKD1	5587
MIM605436	*	15q11.2	SMALL NUCLEOLAR RNA, C/D BOX, 116-1; SNORD116-1	100033413
MIM605437	*	14q22-q23	PROTEIN KINASE C, ETA; PRKCH	5583
MIM605438	*	8p	DISCS LARGE-ASSOCIATED PROTEIN 2; DLGAP2	9228
MIM605439	*	11p12	ETS HOMOLOGOUS FACTOR; EHF	26298
MIM605440	*	1q21	UBIQUILIN 4; UBQLN4	56893
MIM605441	*	3q27	ADIPOCYTE-, C1q-, AND COLLAGEN DOMAIN-CONTAINING; ADIPOQ	9370
MIM605442	*	6q25-q27	WILMS TUMOR 1-ASSOCIATING PROTEIN; WTAP	9589
MIM605443	*	2q32	PROSTATE-SPECIFIC GENE PCGEM1; PCGEM1	64002
MIM605444	*	11p15	RNA-BINDING MOTIF PROTEIN, X CHROMOSOME, LIKE 2; RBMXL2	27288
MIM605445	*	 	DISCS LARGE-ASSOCIATED PROTEIN 1; DLGAP1	9229
MIM605446	*	14q11	RETINITIS PIGMENTOSA GTPase REGULATOR-INTERACTING PROTEIN; RPGRIP1	57096
MIM605447	*	6p21.3	G8 PROTEIN	50854
MIM605448	*	17q21.3	RUN DOMAIN-CONTAINING 3A; RUNDC3A	10900
MIM605449	*	6p12.2	GLUTATHIONE S-TRANSFERASE, ALPHA-3; GSTA3	2940
MIM605450	*	6p12.2	GLUTATHIONE S-TRANSFERASE, ALPHA-4; GSTA4	2941
MIM605451	*	19q13.2	p21 PROTEIN-ACTIVATED KINASE 4; PAK4	10298
MIM605452	*	2q36	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 6; ABCB6	10058
MIM605453	*	12q24	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 9; ABCB9	23457
MIM605454	*	1q42	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 10; ABCB10	23456
MIM605455	*	16p13.3	RAS-ASSOCIATED PROTEIN RAB26; RAB26	25837
MIM605456	*	 	BET1, S. CEREVISIAE, HOMOLOG OF	10282
MIM605457	*	 	INTERLEUKIN 22 RECEPTOR, ALPHA-1; IL22RA1	58985
MIM605458	*	3p21.1	INTERLEUKIN 17 RECEPTOR B; IL17RB	55540
MIM605459	*	2p21	ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 5; ABCG5	64240
MIM605460	*	2p21	ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 8; ABCG8	64241
MIM605461	*	22q11.22-q11.23	INTERLEUKIN 17 RECEPTOR A; IL17RA	23765
MIM605462	%	9q22.3, 1p32, 5q13.3, 1p36	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1; BCC1	100307118, 5727, 5921, 8643
MIM605463		14q11.2	RADIATION SENSITIVITY/CHROMOSOME INSTABILITY SYNDROME, AUTOSOMAL DOMINANT	64239
MIM605464	*	7q35-q36	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 8; ABCB8	11194
MIM605465	*	7q31.1	ZINC FINGER PROTEIN 277; ZNF277	11179
MIM605466	*	20p13	SIGNAL REGULATORY PROTEIN, GAMMA; SIRPG	55423
MIM605467	*	19q13.4	ZINC FINGER PROTEIN 274; ZNF274	10782
MIM605468	*	17q24-q25	CDC42 EFFECTOR PROTEIN 4; CDC42EP4	23580
MIM605469	*	9p24.1	LYSINE-SPECIFIC DEMETHYLASE 4C; KDM4C	23081
MIM605470	*	11p15	MATRIX METALLOPROTEINASE 26; MMP26	56547
MIM605471	*	14q22-q24	ZINC FINGER PROTEIN, SUBFAMILY 2A, MEMBER 1; ZNFN2A1	53349
MIM605472	#	5q14.3	USHER SYNDROME, TYPE IIC; USH2C	79955, 84059
MIM605473	*	11p15	UBIQUILIN 3; UBQLN3	50613
MIM605474	*	3p21.3	TOLL-LIKE RECEPTOR 9; TLR9	54106
MIM605475	*	17q25	BAI1-ASSOCIATED PROTEIN 2; BAIAP2	10458
MIM605476	*	Chr.12	CENTAURIN, GAMMA-1; CENTG1	116986
MIM605477	*	13q34	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 7; ARHGEF7	8874
MIM605478	*	11p15.5	SINGLE IMMUNOGLOBULIN DOMAIN-CONTAINING IL1R-RELATED PROTEIN; SIGIRR	59307
MIM605479	#	2q24	CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2	8647
MIM605480	%	4p16-p15.2	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 3; SLEB3	64695
MIM605481	*	1q31	ABNORMAL SPINDLE-LIKE, MICROCEPHALY-ASSOCIATED; ASPM	259266
MIM605482	*	10q24-q25	GLUTATHIONE S-TRANSFERASE, OMEGA-1; GSTO1	9446
MIM605483	*	17q25	DYNEIN, AXONEMAL, INTERMEDIATE CHAIN 2; DNAI2	64446
MIM605484	*	1q32.3	Fc FRAGMENT OF IgA AND IgM, RECEPTOR FOR; FCAMR	83953
MIM605485	*	7p14.1	VACUOLAR PROTEIN SORTING 41, YEAST, HOMOLOG OF; VPS41	27072
MIM605487	*	Chr.15	CYCLIC AMP-REGULATED PHOSPHOPROTEIN, 19-KD; ARPP19	10776
MIM605488	*	 	CYCLIC AMP-REGULATED PHOSPHOPROTEIN, 21-KD; ARPP21	10777
MIM605489	*	12q24	CARNITINE DEFICIENCY-ASSOCIATED GENE EXPRESSED IN VENTRICLE 1; CDV1	28981
MIM605490	*	19p13.2	PROTEASE, SERINE, 15; PRSS15	9361
MIM605491	*	10p13-p12	NEBULETTE; NEBL	10529
MIM605492	*	1q32.1	LEUCINE-RICH REPEAT PROTEIN, NEURONAL, 5; LRRN5	10446
MIM605493	*	Chr.11	TRIPARTITE MOTIF-CONTAINING 3; TRIM3	10612
MIM605494	*	1p31.3	INTEGRIN, BETA-3, BINDING PROTEIN OF; ITGB3BP	23421
MIM605495	*	 	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1B3; SLCO1B3	28234
MIM605496	*	9q33	CENTROSOMAL PROTEIN 1; CEP1	11064
MIM605497	*	3p22	CARTILAGE-ASSOCIATED PROTEIN; CRTAP	10491
MIM605498	*	10q22-q24	M-PHASE PHOSPHOPROTEIN 1; MPHOSPH1	9585
MIM605500	*	Chr.16	M-PHASE PHOSPHOPROTEIN 6; MPHOSPH6	10200
MIM605501	*	Chr.12	M-PHASE PHOSPHOPROTEIN 9; MPHOSPH9	10198
MIM605502	*	7q22	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 2; DNAJC2	27000
MIM605503	*	 	M-PHASE PHOSPHOPROTEIN 10; MPHOSPH10	10199
MIM605504	*	19q13.4	KALLIKREIN-RELATED PEPTIDASE 9; KLK9	284366
MIM605505	*	19q13.4	KALLIKREIN-RELATED PEPTIDASE 13; KLK13	26085
MIM605506	*	10q21.1	VACUOLAR PROTEIN SORTING 26, YEAST, HOMOLOG OF, A; VPS26A	9559
MIM605507	*	2q12.1	INTERLEUKIN 36 RECEPTOR ANTAGONIST; IL36RN	26525
MIM605508	*	2q	INTERLEUKIN 36, BETA; IL36B	27177
MIM605509	*	2q	INTERLEUKIN 36, ALPHA; IL36A	27179
MIM605510	*	2q12.1	INTERLEUKIN 37; IL37	27178
MIM605511	*	21q22.3	TRANSMEMBRANE PROTEASE, SERINE 3; TMPRSS3	64699
MIM605512	*	6q14	ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 4; ELOVL4	6785
MIM605513	*	Chr.9	MELAN A; MLANA	2315
MIM605514	*	10q21-q22	PROTOCADHERIN 15; PCDH15	65217
MIM605515	*	3p14.1	FORKHEAD BOX P1; FOXP1	27086
MIM605516	*	10q21-q22	CADHERIN 23; CDH23	64072
MIM605517	*	Chr.11	I-BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE	11041
MIM605518	*	2p21	LIPIN 1; LPIN1	23175
MIM605519	*	18p	LIPIN 2; LPIN2	9663
MIM605520	*	20q	LIPIN 3	64900
MIM605521	*	 	TATA BOX-BINDING PROTEIN-LIKE PROTEIN 1; TBPL1	9519
MIM605522	*	7q36	LIMB REGION 1, MOUSE, HOMOLOG OF; LMBR1	64327
MIM605523	*	17q21	TRANSDUCER OF ERBB2, 1; TOB1	10140
MIM605525	*	 	CHROMATIN LICENSING AND DNA REPLICATION FACTOR 1; CDT1	81620
MIM605526	%	10q24	ALZHEIMER DISEASE 6	64851
MIM605527	*	 	METHIONINE ADENOSYLTRANSFERASE II, BETA; MAT2B	27430
MIM605528	*	2q37	NEURAMINIDASE 2; NEU2	4759
MIM605529	*	10p15-p13	UPF2, YEAST, HOMOLOG OF; UPF2	26019
MIM605530	*	13q34	UPF3, YEAST, HOMOLOG OF, A; UPF3A	65110
MIM605532	*	 	SMAD-SPECIFIC E3 UBIQUITIN PROTEIN LIGASE 2; SMURF2	64750
MIM605533	*	10q22	NEUREGULIN 3; NRG3	10718
MIM605534	*	15q24	HIGH MOBILITY GROUP PROTEIN 20A; HMG20A	10363
MIM605535	*	19p13.3	HIGH MOBILITY GROUP PROTEIN 20B; HMG20B	10362
MIM605536	*	2p13-p12	RAB11 FAMILY-INTERACTING PROTEIN 5; RAB11FIP5	26056
MIM605537	*	1q22-q23	ACTIVATING TRANSCRIPTION FACTOR 6; ATF6	22926
MIM605538	*	 	NEUROTENSIN RECEPTOR 2; NTSR2	23620
MIM605539	*	19q13.4	KALLIKREIN-RELATED PEPTIDASE 12; KLK12	43849
MIM605540	*	 	POLY(A) POLYMERASE-ASSOCIATED DOMAIN-CONTAINING PROTEIN 5; PAPD5	64282
MIM605541	*	1p13.3	VAV3 ONCOGENE; VAV3	10451
MIM605542	*	2q12.1	INTERLEUKIN 36, GAMMA; IL36G	56300
MIM605543	#	4q21	PARKINSON DISEASE 4, AUTOSOMAL DOMINANT; PARK4	60454, 6622
MIM605544	%	5q13-q22	FIBROMATOSIS, GINGIVAL, 2; GINGF2	64644
MIM605545	*	12p13.3	CD163 ANTIGEN; CD163	9332
MIM605546	*	19q13.4	GLYCOPROTEIN VI, PLATELET; GP6	51206
MIM605547	*	3q13.3	FOLLISTATIN-LIKE 1; FSTL1	11167
MIM605548	*	1q21.3	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 15; ADAM15	8751
MIM605549	%	1q12-q24	CONE-ROD DYSTROPHY 8; CORD8	54109
MIM605550	*	17p11.2	RAS PROTEIN, DEXAMETHASONE-INDUCED, 1; RASD1	51655
MIM605551	*	1q23.3	NITRIC OXIDE SYNTHASE 1 (NEURONAL) ADAPTOR PROTEIN; NOS1AP	9722
MIM605552	%	4q22-q24, 3q27	ABDOMINAL OBESITY-METABOLIC SYNDROME	4547, 65076
MIM605553	*	14q32.1-q32.2	POLY(A) POLYMERASE, ALPHA; PAPOLA	10914
MIM605554	*	1q22	CD244 ANTIGEN; CD244	51744
MIM605555	*	11q13.3	ARYL HYDROCARBON RECEPTOR-INTERACTING PROTEIN; AIP	9049
MIM605556	*	2q23-q24	SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE TRANSPORTER-LIKE), MEMBER 10; SLC4A10	57282
MIM605557	*	1p36.3	PR DOMAIN-CONTAINING PROTEIN 16; PRDM16	63976
MIM605558	*	8p22-p21.3	FIBROBLAST GROWTH FACTOR 20; FGF20	26281
MIM605559	*	Chr.12	HOMEOBOX C11; HOXC11	3227
MIM605560	*	Chr.12	HOMEOBOX C10; HOXC10	3226
MIM605561	*	11p15	PLAKOPHILIN 3; PKP3	11187
MIM605562	*	11q12.3-q13.1	SECRETOGLOBIN, FAMILY 2A, MEMBER 2; SCGB2A2	4250
MIM605563	*	 	CALCIUM-BINDING PROTEIN 1; CABP1	9478
MIM605564	*	15q24	CALCIUM- AND INTEGRIN-BINDING PROTEIN 2; CIB2	10518
MIM605565	*	19p13.2	RESISTIN; RETN	56729
MIM605566	*	22q11	RETICULON 4 RECEPTOR; RTN4R	65078
MIM605567	*	 	SIVA APOPTOSIS-INDUCING FACTOR 1; SIVA1	10572
MIM605568	*	7q21.1-q31.1	SMAD-SPECIFIC E3 UBIQUITIN PROTEIN LIGASE 1; SMURF1	57154
MIM605569	*	11q21	G PROTEIN-COUPLED RECEPTOR 83; GPR83	10888
MIM605570	*	15q21.3-q22.31	RAS-ASSOCIATED PROTEIN RAB11A; RAB11A	8766
MIM605571	*	Chr.12	PIWI-LIKE 1; PIWIL1	9271
MIM605572	%	17p12	ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2	65077
MIM605573	*	9q22	17-@BETA HYDROXYSTEROID DEHYDROGENASE III; HSD17B3	3293
MIM605574	*	20q13.12	UBIQUITIN-CONJUGATING ENZYME E2C; UBE2C	11065
MIM605575	*	3q26.1	STRUCTURAL MAINTENANCE OF CHROMOSOMES 4; SMC4	10051
MIM605576	*	Chr.9	STRUCTURAL MAINTENANCE OF CHROMOSOMES 2; SMC2	10592
MIM605577	*	11q13	RAS GUANYL NUCLEOTIDE-RELEASING PROTEIN 2; RASGRP2	10235
MIM605578	*	Chr.11	INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 2; IFITM2	10581
MIM605579	*	Chr.11	INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 3; IFITM3	10410
MIM605580	*	12q13.2	INTERLEUKIN 23-ALPHA; IL23A	51561
MIM605581	*	 	BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE; B3GNT1	10678
MIM605582	%	6q12-q16	CARDIOMYOPATHY, DILATED, 1K; CMD1K	65014
MIM605583	#	12q23	DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25	246213
MIM605584	*	16q21-q22	DEAH BOX POLYPEPTIDE 38; DHX38	9785
MIM605585	*	6q22.1	CELL DIVISION CYCLE 40, S. CEREVISIAE, HOMOLOG OF; CDC40	51362
MIM605586	*	Chr.11	IMPORTIN 7; IPO7	10527
MIM605587	*	3q26.1-q26.2	PROTEASE INHIBITOR 14; PI14	5276
MIM605588	#	1q21.2	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	4000
MIM605589	#	19q13.3	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2; CMT2B2	81857
MIM605590	*	2q33.1	SPLICING FACTOR 3B, SUBUNIT 1; SF3B1	23451
MIM605591	*	Chr.11	SPLICING FACTOR 3B, SUBUNIT 2; SF3B2	10992
MIM605592	*	Chr.16	SPLICING FACTOR 3B, SUBUNIT 3; SF3B3	23450
MIM605593	*	1q12-q21	SPLICING FACTOR 3B, SUBUNIT 4; SF3B4	10262
MIM605594	#	4q21.3	DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1	1834
MIM605595	*	22q12.2	SPLICING FACTOR 3A, SUBUNIT 1; SF3A1	10291
MIM605596	*	 	SPLICING FACTOR 3A, SUBUNIT 3; SF3A3	10946
MIM605597	*	3q23	FORKHEAD TRANSCRIPTION FACTOR FOXL2; FOXL2	668
MIM605598	%	5q31.1-q33.1	DIABETES MELLITUS, INSULIN-DEPENDENT, 18; IDDM18	57044
MIM605599	*	Chr.8	LYSOPHOSPHOLIPASE I; LYPLA1	10434
MIM605600	*	12p11.2	IMPORTIN 8; IPO8	10526
MIM605601	*	11cen-q12	PROTEOGLYCAN 2; PRG2	5553
MIM605602	*	4q26-q27	MYOZENIN 2; MYOZ2	51778
MIM605603	*	10q22.1	MYOZENIN 1; MYOZ1	58529
MIM605604	*	5q31.2	POLYADENYLATE-BINDING PROTEIN-INTERACTING PROTEIN 2; PAIP2	51247
MIM605606	%	1p	PSORIASIS SUSCEPTIBILITY 7; PSORS7	149233, 65245
MIM605607	*	 	CENTROMERIC PROTEIN H; CENPH	64946
MIM605608	*	21q22.3	CLAUDIN 14; CLDN14	23562
MIM605609	*	8q23	OXIDATION RESISTANCE 1; OXR1	55074
MIM605610	*	19q13.4	POLYNUCLEOTIDE KINASE 3-PRIME PHOSPHATASE; PNKP	11284
MIM605611	*	2q37.1-q37.2	SH3 DOMAIN-BINDING PROTEIN 4; SH3BP4	23677
MIM605612	*	3p25.1	SH3 DOMAIN-BINDING PROTEIN 5; SH3BP5	9467
MIM605613	*	12q24.2-q24.3	HUNTINGTIN-INTERACTING PROTEIN 1-RELATED PROTEIN; HIP1R	9026
MIM605614	*	12q24.2	GENERAL CONTROL OF AMINO ACID SYNTHESIS 1, YEAST, HOMOLOG-LIKE 1; GCN1L1	10985
MIM605615	*	3p21	ARIADNE, DROSOPHILA, HOMOLOG OF, 2; ARIH2	10425
MIM605616	*	3p21.3	SOLUTE CARRIER FAMILY 6 (PROLINE IMINO TRANSPORTER), MEMBER 20; SLC6A20	54716
MIM605617	^	 	MOVED TO 220600	 
MIM605618		 	TETRALOGY OF FALLOT SYNDROME, AUTOSOMAL RECESSIVE	 
MIM605619	*	1q32	INTERLEUKIN 20; IL20	50604
MIM605620	*	6q23	INTERLEUKIN 20 RECEPTOR, ALPHA; IL20RA	53832
MIM605621	*	 	INTERLEUKIN 20 RECEPTOR, BETA; IL20RB	53833
MIM605622	*	5q31	PROTOCADHERIN 12; PCDH12	51294
MIM605623	*	7q32	MUSKELIN 1; MKLN1	4289
MIM605624	*	15q24	ARIADNE, DROSOPHILA, HOMOLOG OF, 1; ARIH1	25820
MIM605625	*	11q13.1	MYELOMA OVEREXPRESSED GENE; MYEOV	26579
MIM605626	*	7p22	ENDOGENOUS RETROVIRUS GROUP K, MEMBER 6; ERVK-6	64006
MIM605627	%	 	CEREBROOCULONASAL SYNDROME	 
MIM605628	*	11p15.1	HIV-1 TAT-INTERACTING PROTEIN 2, 30-KD; HTATIP2	10553
MIM605629	*	12q24.1-q24.3	SERINE/THREONINE PROTEIN KINASE 21	11113
MIM605630	*	1p36.12	PHOSPHOLIPASE A2, GROUP IID; PLA2G2D	26279
MIM605631	*	19q13.33	NAPSIN A	9476
MIM605632	*	1p21	SOLUTE CARRIER FAMILY 35 (UDP-N-ACETYLGLUCOSAMINE TRANSPORTER), MEMBER 3; SLC35A3	23443
MIM605633	*	7q22	MUCIN 3B, INTESTINAL; MUC3B	57876
MIM605634	*	6q15	SOLUTE CARRIER FAMILY 35 (CMP-SIALIC ACID TRANSPORTER), MEMBER 1; SLC35A1	10559
MIM605635	%	7p22	HYPERALDOSTERONISM, FAMILIAL, TYPE II	79179
MIM605636	*	14q32.3	MATERNALLY EXPRESSED GENE 3; MEG3	55384
MIM605637	#	17p13.1	INCLUSION BODY MYOPATHY 3, AUTOSOMAL DOMINANT; IBM3	4620
MIM605638	*	2p22-p21	BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 6; BIRC6	57448
MIM605639	*	19q13.33-q13.41	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 8; SIGLEC8	27181
MIM605640	*	19q13.4	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 9; SIGLEC9	27180
MIM605641	*	Chr.16	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 6; SLC7A6	9057
MIM605642	%	1q21	THYROID CARCINOMA, PAPILLARY, WITH PAPILLARY RENAL NEOPLASIA	79052
MIM605643	*	19q13.4	KALLIKREIN-RELATED PEPTIDASE 5; KLK5	25818
MIM605644	*	19q13.4	KALLIKREIN-RELATED PEPTIDASE 8; KLK8	11202
MIM605645	*	 	RESISTIN-LIKE PROTEIN, BETA; RETNLB	84666
MIM605646	*	7q31	SOLUTE CARRIER FAMILY 26, MEMBER 4; SLC26A4	5172
MIM605647	*	1p36.23	F-BOX ONLY PROTEIN 6; FBXO6	26270
MIM605648	*	22q12-q13	F-BOX ONLY PROTEIN 7; FBXO7	25793
MIM605649	*	4q34.1	F-BOX ONLY PROTEIN 8; FBXO8	26269
MIM605650	*	5q13.1	POLYMERASE, DNA, KAPPA; POLK	51426
MIM605651	*	5q35.1	F-BOX AND WD40 DOMAIN PROTEIN 11; FBXW11	23291
MIM605652	*	3p22.3	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 2; FBXL2	25827
MIM605653	*	13q22	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 3; FBXL3	26224
MIM605654	*	6q16.1-q16.3	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 4; FBXL4	26235
MIM605655	*	4p15.33	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 5; FBXL5	26234
MIM605656	*	5p15.1	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 7; FBXL7	23194
MIM605657	*	Chr.11	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 11; FBXL11	22992
MIM605658	*	14q11.2	INTERLEUKIN 25; IL25	64806
MIM605659	*	12p13	C-TYPE LECTIN DOMAIN FAMILY 2, MEMBER D; CLEC2D	29121
MIM605660	*	 	PREFOLDIN 6; PFDN6	10471
MIM605661	*	13q14.3	TRIPARTITE MOTIF-CONTAINING PROTEIN 13; TRIM13	10206
MIM605662	*	22q11.2	RAS-ASSOCIATED PROTEIN RAB36; RAB36	9609
MIM605663	*	22q11.2	RHABDOID TUMOR DELETION REGION GENE 1; RTDR1	27156
MIM605664	*	5q31	KINESIN FAMILY MEMBER 20A; KIF20A	10112
MIM605666	*	13q14	CYSTEINYL LEUKOTRIENE RECEPTOR 2; CYSLTR2	57105
MIM605667	*	1q25.3	RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 1; RGL1	23179
MIM605668	*	21q22.3	BETA-SITE AMYLOID BETA A4 PRECURSOR PROTEIN-CLEAVING ENZYME 2; BACE2	25825
MIM605669	*	6q23-q24	PROSTATE AND BREAST CANCER OVEREXPRESSED 1; PBOV1	59351
MIM605670	#	11q23.3	LATE-ONSET RETINAL DEGENERATION; LORD	114902
MIM605671	*	5q21-q22	DMX-LIKE 1; DMXL1	1657
MIM605672		 	CEREBELLAR ATAXIA AND HYPERGONADOTROPIC HYPOGONADISM	 
MIM605673	*	11q23	B-CELL TRANSLOCATION GENE 4; BTG4	54766
MIM605674	*	21q11.2-q21.1	B-CELL TRANSLOCATION GENE 3; BTG3	10950
MIM605675	*	5q23.3-q31.1	RING FINGER PROTEIN 14; RNF14	9604
MIM605676	#	6p24	CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA	1832
MIM605677	*	10q25.1-q25.2	ACYL-CoA SYNTHETASE LONG CHAIN FAMILY, MEMBER 5; ACSL5	51703
MIM605678	*	7q11.23	MLX-INTERACTING PROTEIN-LIKE; MLXIPL	51085
MIM605679	*	12q15	INTERLEUKIN 26; IL26	55801
MIM605680	*	14q12-q13	BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 1A; BAZ1A	11177
MIM605681	*	7q11-q21	BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 1B; BAZ1B	9031
MIM605682	*	12q24.3-qter	BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 2A; BAZ2A	11176
MIM605683	*	2q23-q24	BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN, 2B; BAZ2B	29994
MIM605684	*	11p15.4-p15.3	TRIPARTITE MOTIF-CONTAINING PROTEIN 34; TRIM34	53840
MIM605685		 	CUTIS VERTICIS GYRATA, RETINITIS PIGMENTOSA, AND SENSORINEURAL DEAFNESS	 
MIM605686	*	11q23.2	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 4; IGSF4	23705
MIM605687	*	1q32	INTERLEUKIN 19; IL19	29949
MIM605688	*	14q11.2	COPINE VI; CPNE6	9362
MIM605689	*	16q24.3	COPINE VII; CPNE7	27132
MIM605690	*	19q13.3	GLIOMA TUMOR SUPPRESSOR CANDIDATE REGION GENE 1; GLTSCR1	29998
MIM605691	*	19q13.3	GLIOMA TUMOR SUPPRESSOR CANDIDATE REGION GENE 2; GLTSCR2	29997
MIM605692	*	15q21	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 7; TRPM7	54822
MIM605693	*	11q12-q14	RAS-ASSOCIATED PROTEIN RAB30; RAB30	27314
MIM605694	*	18p11.3	RAS-ASSOCIATED PROTEIN RAB31; RAB31	11031
MIM605695	*	4p16.1	CAPPUCCINO, MOUSE, HOMOLOG OF; CNO	55330
MIM605696	*	 	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY G, MEMBER 2; KCNG2	26251
MIM605697	*	6q25	UL16-BINDING PROTEIN 1; ULBP1	80329
MIM605698	*	6q25	UL16-BINDING PROTEIN 2; ULBP2	80328
MIM605699	*	6q25	UL16-BINDING PROTEIN 3; ULBP3	79465
MIM605700	*	6p22.1-p21.3	TRIPARTITE MOTIF-CONTAINING PROTEIN 39; TRIM39	56658
MIM605701	*	6p21.3	TRIPARTITE MOTIF-CONTAINING PROTEIN 10; TRIM10	10107
MIM605702	*	Chr.11	LYMPHATIC VESSEL ENDOTHELIAL HYALURONAN RECEPTOR 1	10894
MIM605703	*	18p11.22	VESICLE-ASSOCIATED MEMBRANE PROTEIN-ASSOCIATED PROTEIN A; VAPA	9218
MIM605704	*	20q13.3	VESICLE-ASSOCIATED MEMBRANE PROTEIN-ASSOCIATED PROTEIN B; VAPB	9217
MIM605705	*	21q22.3	SALT-INDUCIBLE KINASE 1; SIK1	150094
MIM605706	*	21q22.3	RECEPTOR-INTERACTING SERINE-THREONINE KINASE 4; RIPK4	54101
MIM605708	*	 	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 11; ARHGEF11	9826
MIM605709	*	3p14	ADP-RIBOSYLATION-LIKE FACTOR 6-INTERACTING PROTEIN 5; ARL6IP5	10550
MIM605710	*	5q31	GDNF FAMILY RECEPTOR ALPHA-3; GFRA3	2676
MIM605711	#	2p14-p13	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	27247, 80767
MIM605712	*	9q22.1-q22.3	SERINE PALMITOYLTRANSFERASE, LONG-CHAIN BASE SUBUNIT 1; SPTLC1	10558
MIM605713	*	14q24.3-q31	SERINE PALMITOYLTRANSFERASE, LONG-CHAIN BASE SUBUNIT 2; SPTLC2	9517
MIM605714	#	21q21	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED	351
MIM605715	*	15q23-q24	CD276 ANTIGEN; CD276	80381
MIM605716	*	Chr.14	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 5; KCNH5	27133
MIM605717	*	21q22.3	INDUCIBLE T-CELL COSTIMULATOR LIGAND; ICOSLG	23308
MIM605718	*	13q14.2	MEDIATOR COMPLEX SUBUNIT 4; MED4	29079
MIM605719	*	7q11.23	LINKER FOR ACTIVATION OF T CELLS FAMILY, MEMBER 2; LAT2	7462
MIM605720	*	11q13	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 4; KCNK4	50801
MIM605721	*	1q21.2-q21.3	JUNCTION ADHESION MOLECULE 1; JAM1	50848
MIM605722	*	17q25	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 16; KCNJ16	3773
MIM605723	*	9p24.2	PROGRAMMED CELL DEATH 1 LIGAND 2; PDCD1LG2	80380
MIM605724	#	13q12.3	FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1	675
MIM605725	*	19q13.1-q13.2	PERIAXIN; PRX	57716
MIM605726	%	9p21.1-p12	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 2; DSMA2	80768
MIM605727	%	7q34-q36	OTOSCLEROSIS 2; OTSC2	93999
MIM605728	%	15q21-q22	CATARACT, CENTRAL SACCULAR, WITH SUTURAL OPACITIES	80770
MIM605729	*	 	AT-HOOK TRANSCRIPTION FACTOR AKNA	80709
MIM605730	*	10p12-p11.2	SPERM-ASSOCIATED ANTIGEN 6; SPAG6	9576
MIM605731	*	9p13-p12	SPERM-ASSOCIATED ANTIGEN 8; SPAG8	26206
MIM605732	*	 	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 21; TNFRSF21	27242
MIM605733	*	5q35.3	PRELI DOMAIN-CONTAINING PROTEIN 1; PRELID1	27166
MIM605734	*	2q32-q33	TRANSMEMBRANE PROTEIN WITH EGF-LIKE AND 2 FOLLISTATIN-LIKE DOMAINS 2; TMEFF2	23671
MIM605735	%	 	BLEEDING DISORDER, PLATELET-TYPE, 12; BDPLT12	 
MIM605736	*	21q22.3	UBIQUITIN-ASSOCIATED AND SH3 DOMAIN-CONTAINING PROTEIN A; UBASH3A	53347
MIM605737	*	20q13.3	BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 7; BIRC7	79444
MIM605738	%	15q12-q15	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 2; MCOPCB2	80771
MIM605739	*	3q21	KYPHOSCOLIOSIS PEPTIDASE; KY	339855
MIM605740	*	17q12-q21	SCLEROSTIN; SOST	50964
MIM605741	*	13q32.3	G PROTEIN-COUPLED RECEPTOR 183; GPR183	1880
MIM605742	*	22q11	TUBULIN, ALPHA-8; TUBA8	51807
MIM605743	*	1q32	HEDGEHOG ACYLTRANSFERASE; HHAT	55733
MIM605744	*	8p21	EXOSTOSIN-LIKE 3; EXTL3	2137
MIM605745	*	 	CYTOCHROME b REDUCTASE 1; CYBRD1	79901
MIM605746	%	16q13-q21	ANISOMASTIA	80871
MIM605747	*	1p36-p35	LOW DENSITY LIPOPROTEIN RECEPTOR ADAPTOR PROTEIN 1; LDLRAP1	26119
MIM605748	*	16q21-q23	BETA-CAROTENE 15,15-PRIME-MONOOXYGENASE 1; BCMO1	53630
MIM605749	%	9q13-q22	CATARACT, AUTOSOMAL RECESSIVE, EARLY-ONSET, PULVERULENT	81863
MIM605750	%	11p13-p12	EXUDATIVE VITREORETINOPATHY 3; EVR3	81864
MIM605751	#	16p12-q12	SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2	81865
MIM605752	*	17q25.1	CHROMOSOME 17 OPEN READING FRAME 28; C7ORF28	283987
MIM605753	*	4p	SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 2; SPINK2	6691
MIM605754	*	 	PHOSPHATIDYLINOSITOL GLYCAN, CLASS Q; PIGQ	9091
MIM605755	*	6p22.1	DOUBLECORTIN DOMAIN-CONTAINING PROTEIN 2; DCDC2	51473
MIM605756		 	OVARIAN DYSGENESIS, HYPERGONADOTROPIC, WITH SHORT STATURE AND RECURRENT METABOLIC ACIDOSIS	 
MIM605757	*	5q11.2	PELOTA, DROSOPHILA, HOMOLOG OF; PELO	53918
MIM605758	*	2q37	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 1; ASB1	51665
MIM605759	*	Chr.14	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 2; ASB2	51676
MIM605760	*	2p16-p14	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 3; ASB3	51130
MIM605761	*	7q21-q22	ANKYRIN REPEAT- AND SOCS BOX-CONTAINING PROTEIN 4; ASB4	51666
MIM605762	*	14q32	RENAL TUMOR ANTIGEN; RAGE	5891
MIM605763	*	1p36.2-p36.1	SOLUTE CARRIER FAMILY 45, MEMBER 1; SLC45A1	50651
MIM605764	*	6p22.3-p22.1	TRAF- AND TNF RECEPTOR-ASSOCIATED PROTEIN; TTRAP	51567
MIM605765	*	13q14	DELETED IN LYMPHOCYTIC LEUKEMIA, 1; DLEU1	10301
MIM605766	*	13q14	DELETED IN LYMPHOCYTIC LEUKEMIA, 2; DLEU2	8847
MIM605767	*	Chr.8	PHOSPHOPROTEIN ASSOCIATED WITH GLYCOSPHINGOLIPID-ENRICHED MICRODOMAINS 1; PAG1	55824
MIM605768	*	4q25-q27	DUAL ADAPTOR OF PHOSPHOTYROSINE AND 3-PHOSPHOINOSITIDES 1	27071
MIM605769	*	1p13	TRIPARTITE MOTIF-CONTAINING PROTEIN 33; TRIM33	51592
MIM605770	*	19p13.1	ILVB-LIKE; ILVBL	10994
MIM605771	*	2p21	CYTOCHROME C OXIDASE SUBUNIT VIIA, POLYPEPTIDE 2-LIKE; COX7A2L	9167
MIM605772	*	8q23	ESTROGEN RECEPTOR-BINDING SITE-ASSOCIATED ANTIGEN, 9; EBAG9	9166
MIM605773	*	14q11.2-q12	LEUKOTRIENE B4 RECEPTOR 2; LTB4R2	56413
MIM605774	*	4q21.2	KELCH-LIKE 2; KLHL2	11275
MIM605775	*	5q31	KELCH-LIKE 3; KLHL3	26249
MIM605776	*	8p22	FIBRINOGEN-LIKE 1; FGL1	2267
MIM605777	*	 	SPHINGOMYELIN PHOSPHODIESTERASE 3, NEUTRAL MEMBRANE; SMPD3	55512
MIM605778	*	2q33	NIF3-LIKE 1; NIF3L1	60491
MIM605779	%	17p13	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 7; NDNC7	81866
MIM605780	*	12q23-q24.1	PR DOMAIN-CONTAINING PROTEIN 4; PRDM4	11108
MIM605781	*	11q14.3	RAS HOMOLOG GENE FAMILY, MEMBER D; RHOD	29984
MIM605782	*	3q25-q27	EUKARYOTIC TRANSLATION INITIATION FACTOR 5A2; EIF5A2	56648
MIM605783	*	1p21-p13.3	BREAST CARCINOMA AMPLIFIED SEQUENCE 2; BCAS2	10286
MIM605784	*	19q13.4	TWEETY, DROSOPHILA, HOMOLOG OF, 1; TTYH1	57348
MIM605785	*	17q21	TUBULIN, GAMMA-2; TUBG2	27175
MIM605786	*	3p24-p23	RNA-BINDING MOTIF PROTEIN, SINGLE STRAND-INTERACTING, 3; RBMS3	27303
MIM605787	*	5q12-q13	ANKYRIN REPEAT-CONTAINING PROTEIN, FAMILY A, MEMBER 2; ANKRA2	57763
MIM605788	*	2p23.3-p23.1	MICROTUBULE-ASSOCIATED PROTEIN, RP/EB FAMILY, MEMBER 3; MAPRE3	22924
MIM605789	*	18q12-q21	MICROTUBULE-ASSOCIATED PROTEIN, RP/EB FAMILY, MEMBER 2; MAPRE2	10982
MIM605790	*	7p15.3	SERINE/THREONINE KINASE 31; STK31	56164
MIM605791	*	Chr.11	TESTIS-EXPRESSED GENE 12; TEX12	56158
MIM605792	*	Chr.17	TESTIS-EXPRESSED GENE 14; TEX14	56155
MIM605793	*	13q12.1	RING FINGER PROTEIN 17; RNF17	56163
MIM605794	*	22q13.33	MOV10-LIKE 1; MOV10L1	54456
MIM605795	*	Chr.8	TESTIS-EXPRESSED GENE 15; TEX15	56154
MIM605796	*	10q25.3	TUDOR DOMAIN-CONTAINING PROTEIN 1; TDRD1	56165
MIM605797	*	7q31.3	ANKYRIN REPEAT, SAM, AND BASIC LEUCINE ZIPPER DOMAIN-CONTAINING 1; ASZ1	136991
MIM605798	*	Chr.9	NEURAL PROLIFERATION, DIFFERENTIATION, AND CONTROL PROTEIN 1; NPDC1	56654
MIM605799	*	14q32	AMNIONLESS, MOUSE, HOMOLOG OF; AMN	81693
MIM605800	*	19q13.2	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN U-LIKE 1; HNRNPUL1	11100
MIM605801	*	18p11	RALA-BINDING PROTEIN 1; RALBP1	10928
MIM605802	*	2q22	ZINC FINGER E BOX-BINDING HOMEOBOX 2; ZEB2	9839
MIM605803	#	1q21	DERMATITIS, ATOPIC, 2; ATOD2	2312
MIM605804	%	20p	DERMATITIS, ATOPIC, 3; ATOD3	117187
MIM605805	%	17q25.3	DERMATITIS, ATOPIC, 4; ATOD4	 
MIM605806	*	18q22-q23	CADHERIN 7; CDH7	1005
MIM605807	*	18q22-q23	CADHERIN 20; CDH20	28316
MIM605808		 	BIRDSHOT CHORIORETINOPATHY	 
MIM605809	%	17p13	MYASTHENIA, FAMILIAL INFANTILE, 1	8144
MIM605810	*	3q23	MITOCHONDRIAL RIBOSOMAL PROTEIN S22; MRPS22	56945
MIM605811	*	20p12-p11.2	NTF2-LIKE EXPORT FACTOR 1; NXT1	29107
MIM605812	*	Chr.16	DEAD/H BOX 19; DDX19	11269
MIM605813	*	 	NUCLEAR TRANSPORT FACTOR 2	10204
MIM605814	#	7q21.3	CITRULLINEMIA, TYPE II, NEONATAL-ONSET	10165
MIM605815	*	19q13.33	NUCLEOPORIN, 62-KD; NUP62	23636
MIM605816	*	19p13.3	EPSTEIN-BARR VIRUS-INDUCED GENE 3; EBI3	10148
MIM605817	*	14q11.2	RECEPTOR-INTERACTING SERINE/THREONINE KINASE 3; RIPK3	11035
MIM605818	%	2q23-q31	DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27	23713
MIM605819	*	22q12.1	PESCADILLO, ZEBRAFISH, HOMOLOG OF, 1; PES1	23481
MIM605820	#	9p13.3	NONAKA MYOPATHY; NM	10020
MIM605821	*	16p11.2	ERYTHROID-ASSOCIATED FACTOR; ERAF	51327
MIM605822		 	SPONDYLOOCULAR SYNDROME, AUTOSOMAL RECESSIVE	 
MIM605823	*	3q13.3	POPEYE DOMAIN-CONTAINING PROTEIN 2; POPDC2	64091
MIM605824	*	6q21	POPEYE DOMAIN-CONTAINING PROTEIN 3; POPDC3	64208
MIM605825	*	6q24	HEME-BINDING PROTEIN 2; HEBP2	23593
MIM605826	*	Chr.12	HEME-BINDING PROTEIN 1; HEBP1	50865
MIM605828	*	17q25	TRANSMEMBRANE CHANNEL-LIKE PROTEIN 6; TMC6	11322
MIM605829	*	17q25	TRANSMEMBRANE CHANNEL-LIKE PROTEIN 8; TMC8	147138
MIM605830	*	4p16	FIBROBLAST GROWTH FACTOR RECEPTOR-LIKE 1; FGFRL1	53834
MIM605831	*	19p13.3	FIBROBLAST GROWTH FACTOR 22; FGF22	27006
MIM605832	*	20q11.22	ACETYL-CoA SYNTHETASE SHORT CHAIN FAMILY, MEMBER 2; ACSS2	55902
MIM605833	%	1q21-q23	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 2; BMND2	338027
MIM605834	*	1q12	TROPOMODULIN 4; TMOD4	29765
MIM605835	*	9q13-q21	TRANSMEMBRANE PROTEIN 2; TMEM2	23670
MIM605836	*	Chr.9	UNC13, C. ELEGANS, HOMOLOG OF, B; UNC13B	10497
MIM605837	*	15q13.1	HECT DOMAIN AND RCC1-LIKE DOMAIN 2; HERC2	8924
MIM605838		 	BABY RATTLE PELVIS DYSPLASIA	 
MIM605839	^	1q42.1	MOVED TO 150800	 
MIM605840	*	 	RING FINGER PROTEIN 111; RNF111	54778
MIM605841	%	4p13-q21	NARCOLEPSY 2, SUSCEPTIBILITY TO; NRCLP2	100918
MIM605842	*	7q11.23	TRANSDUCIN-BETA-LIKE 2; TBL2	26608
MIM605843	*	2q35	PEROXISOMAL TRANS-2-ENOYL-CoA REDUCTASE; PECR	55825
MIM605844	%	13q12-q14	DERMATITIS, ATOPIC, 5; ATOD5	117188
MIM605845	%	5q31-q33	DERMATITIS, ATOPIC, 6; ATOD6	114477
MIM605846	*	7q11.23	B-CELL CLL/LYMPHOMA 7B; BCL7B	9275
MIM605847	*	16p11	B-CELL CLL/LYMPHOMA 7C; BCL7C	9274
MIM605848	*	19p13.1	CASPASE 14, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP14	23581
MIM605849	*	5q12.2-q12.3	DIMETHYLGLYCINE DEHYDROGENASE; DMGDH	29958
MIM605850	#	5q12.2-q12.3	DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY; DMGDHD	29958
MIM605851	*	1p36	ISOPRENYLCYSTEINE CARBOXYLMETHYLTRANSFERASE; ICMT	23463
MIM605852	*	2q14	CYTOPLASMIC LINKER-ASSOCIATED PROTEIN 1; CLASP1	23332
MIM605853	*	3p22.3	CYTOPLASMIC LINKER-ASSOCIATED PROTEIN 2; CLASP2	23122
MIM605854	*	19q	BCL2-BINDING COMPONENT 3; BBC3	27113
MIM605855	*	15q11-q13	ATPase, CLASS V, TYPE 10A; ATP10A	57194
MIM605856	%	 	SHORT STATURE, MENTAL RETARDATION, CALLOSAL AGENESIS, HEMINASAL HYPOPLASIA, MICROPHTHALMIA, AND ATYPICAL CLEFTING	 
MIM605857	*	2p21	RAS HOMOLOG GENE FAMILY, MEMBER Q; RHOQ	23433
MIM605858	*	Chr.8	SCRATCH, MOUSE, HOMOLOG OF; SCRT1	83482
MIM605859	*	19q13.1	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 32; ZBTB32	27033
MIM605860	*	1p35.2-p33	RCAN FAMILY MEMBER 3; RCAN3	11123
MIM605861	*	12q15	CANOPY 2, ZEBRAFISH, HOMOLOG OF; CNPY2	10330
MIM605862	*	12q14.2	TRANSMEMBRANE PROTEIN 5; TMEM5	10329
MIM605863	*	19p	BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 3; B3GNT3	10331
MIM605864	*	12q24.31	BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 4; B3GNT4	79369
MIM605865	*	1p36.33	TASTE RECEPTOR TYPE 1, MEMBER 3; TAS1R3	83756
MIM605866	*	19p13.3	ATPase, CLASS I, TYPE 8B, MEMBER 3; ATP8B3	148229
MIM605867	*	1q21.3	ATPase, CLASS I, TYPE 8B, MEMBER 2; ATP8B2	57198
MIM605868	*	13q34	ATPase, CLASS VI, TYPE 11A; ATP11A	23250
MIM605869	*	3q27	ATPase, CLASS VI, TYPE 11B; ATP11B	23200
MIM605870	*	13q12	ATPase, CLASS I, TYPE 8A, MEMBER 2; ATP8A2	51761
MIM605871	^	 	MOVED TO 193090	 
MIM605872	*	19p13.3	C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER M; CLEC4M	10332
MIM605873	*	14q31	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 10; KCNK10	54207
MIM605874	*	8q24.1-q24.3	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 9; KCNK9	51305
MIM605875	*	1p36.11-p34.3	WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY, MEMBER 2; WASF2	10163
MIM605876	*	1q21	Fc RECEPTOR-LIKE PROTEIN 4; FCRL4	83417
MIM605877	*	1q21	Fc RECEPTOR-LIKE PROTEIN 5; FCRL5	83416
MIM605878	*	19p13.3	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 7; ZBTB7	51341
MIM605879	*	5q21.2-q22.1	POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 2; KCNN2	3781
MIM605880	*	10q22	LYSINE ACETYLTRANSFERASE 6B; KAT6B	23522
MIM605881	*	11p11.2	SOLUTE CARRIER FAMILY 35, MEMBER C1; SLC35C1	55343
MIM605882	*	17q22	BRCA1-INTERACTING PROTEIN 1; BRIP1	83990
MIM605883	*	3q26.3-q27	LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 3; LAMP3	27074
MIM605884	*	12q24.31	DYNEIN, AXONEMAL, HEAVY CHAIN 10; DNAH10	196385
MIM605885	*	 	SEMAPHORIN 6A; SEMA6A	57556
MIM605886	*	1q32	COMPLEMENT COMPONENT RECEPTOR 1-LIKE; CR1L	1379
MIM605888	*	11q13	EH DOMAIN-CONTAINING 1; EHD1	10938
MIM605889	*	4q35	PDZ AND LIM DOMAIN PROTEIN 3; PDLIM3	27295
MIM605890	*	19q13.3	EH DOMAIN-CONTAINING 2; EHD2	30846
MIM605891	*	2p21	EH DOMAIN-CONTAINING 3; EHD3	30845
MIM605892	*	15q11.1	EH DOMAIN-CONTAINING 4; EHD4	30844
MIM605893	*	 	CDP-DIACYLGLYCEROL-INOSITOL 3-PHOSPHATIDYLTRANSFERASE; CDIPT	10423
MIM605894	*	15q21.1-q21.2	CREBBP/EP300 INHIBITORY PROTEIN 1; CRI1	23741
MIM605895	*	2q37.1	EUKARYOTIC TRANSLATION INITIATION FACTOR 4E FAMILY, MEMBER 2; EIF4E2	9470
MIM605896	*	2q36-q37	ENDOTHELIN-CONVERTING ENZYME-LIKE 1; ECEL1	9427
MIM605897	*	2q14.3	UDP-GLUCOSE:GLYCOPROTEIN GLUCOSYLTRANSFERASE 1; UGGT1	56886
MIM605898	*	13q32.1	UDP-GLUCOSE:GLYCOPROTEIN GLUCOSYLTRANSFERASE 2; UGGT2	55757
MIM605899	#	16q24, 9p22, 3p21.2-p21.1	GLYCINE ENCEPHALOPATHY; GCE	2653, 2731, 275
MIM605900	*	10q26	PDZ AND LIM DOMAIN PROTEIN 1; PDLIM1	9124
MIM605901	*	 	UROCORTIN III; UCN3	114131
MIM605902	*	3p21.3	UROCORTIN II; UCN2	90226
MIM605903	*	5q35.3	PDZ AND LIM DOMAIN PROTEIN 7; PDLIM7	9260
MIM605904	*	4q22	PDZ AND LIM DOMAIN PROTEIN 5; PDLIM5	10611
MIM605905	*	3q26.3	DCN1 DOMAIN-CONTAINING PROTEIN 1; DCUN1D1	54165
MIM605906	*	10q22.2-q23.3	LIM DOMAIN-BINDING 3; LDB3	11155
MIM605907	*	16p13.3	ALG1, YEAST, HOMOLOG OF; ALG1	56052
MIM605908	*	22q13.33	MLC1 GENE; MLC1	23209
MIM605909	#	1p36	PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK6	65018
MIM605910	*	19p13.3	ANGIOPOIETIN-LIKE 4; ANGPTL4	51129
MIM605911	#	1p13-p12	3-@HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 2 DEFICIENCY	3158
MIM605912	*	4q21.1	MATRIX, EXTRACELLULAR, PHOSPHOGLYCOPROTEIN; MEPE	56955
MIM605913	%	1q23	BLEEDING DISORDER, EAST TEXAS TYPE	85504
MIM605914	*	16p13.3	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 12A; TNFRSF12A	51330
MIM605915	*	16p13.3	TRANSDUCIN-BETA-LIKE 3; TBL3	10607
MIM605916	*	15q21	SPECTRIN, BETA, NONERYTHROCYTIC, 5; SPTBN5	51332
MIM605917	*	20q11.2	CHROMOSOME 20 OPEN READING FRAME 1; C20ORF1	22974
MIM605918	*	4p16.3	SPONDIN 2; SPON2	10417
MIM605920	*	8q13-q21.1	STAUFEN, DROSOPHILA, HOMOLOG OF, 2; STAU2	27067
MIM605921	*	11p15.5	STROMAL INTERACTION MOLECULE 1; STIM1	6786
MIM605922	*	18p11.2	MYO-INOSITOL MONOPHOSPHATASE 2; IMPA2	3613
MIM605923	*	16p13.3	SRY-BOX 8; SOX8	30812
MIM605924	*	21q22.3	WD REPEAT-CONTAINING PROTEIN 4; WDR4	10785
MIM605925	*	21q22.3	PERICENTRIN; PCNT	5116
MIM605926	*	22q12.3-q13.2	PROTEIN INTERACTING WITH C KINASE 1; PICK1	9463
MIM605927	*	8q24.1-q24.3	MOUSE DOUBLE MINUTE 2 HOMOLOG, BINDING PROTEIN OF; MTBP	27085
MIM605928	*	 	ADP-RIBOSYLATION FACTOR-INTERACTING PROTEIN 1; ARFIP1	27236
MIM605929	*	5q23	SORTING NEXIN 2; SNX2	6643
MIM605930	*	6q21	SORTING NEXIN 3; SNX3	8724
MIM605931	*	3q21.2	SORTING NEXIN 4; SNX4	8723
MIM605932	*	5q13.1-q13.2	BETAINE-HOMOCYSTEINE METHYLTRANSFERASE 2; BHMT2	23743
MIM605933	*	8q22	TRANSMEMBRANE 7 SUPERFAMILY, MEMBER 4; TM7SF4	81501
MIM605934	%	2q37.1-q37.3	HOLOPROSENCEPHALY 6; HPE6	117190
MIM605935		 	ARTHROPATHY, EROSIVE	 
MIM605936	*	12q13.13	BRIDGING INTEGRATOR 2; BIN2	51411
MIM605937	*	20p11	SORTING NEXIN 5; SNX5	27131
MIM605938	*	21q22.1-q22.2	PHOSPHATIDYLINOSITOL GLYCAN, CLASS P; PIGP	51227
MIM605939	*	 	PHOSPHOLIPASE C, DELTA-4; PLCD4	84812
MIM605940	*	5p15.1-p14	BRAIN-ABUNDANT SIGNAL PROTEIN, MEMBRANE-ATTACHED, 1; BASP1	10409
MIM605941	*	Chr.11	SQUAMOUS CELL CARCINOMA ANTIGEN RECOGNIZED BY T CELLS 1; SART1	9092
MIM605942	*	6q22	DERMATAN SULFATE EPIMERASE; DSE	29940
MIM605943	*	16p12-p11.2	GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE 1; GDE1	51573
MIM605945		 	CRUMPLED HELICES AND SMALL MOUTH	 
MIM605946	%	 	METAPHYSEAL DYSPLASIA, BRAUN-TINSCHERT TYPE	 
MIM605947	*	17p12-p11.2	PHOSPHATIDYLINOSITOL GLYCAN, CLASS L; PIGL	9487
MIM605948	*	16p12.3-p12.1	G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 5, MEMBER B; GPRC5B	51704
MIM605949	*	17q25.1-q25.3	G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 5, MEMBER C; GPRC5C	55890
MIM605950	*	 	RAS-ASSOCIATED PROTEIN RAB33B; RAB33B	83452
MIM605951	*	1q12-q21	DOLICHYL-PHOSPHATE MANNOSYLTRANSFERASE 3; DPM3	54344
MIM605952	*	6q26.3	SORTING NEXIN 9; SNX9	51429
MIM605953	*	8q24.1-q24.2	DEVELOPMENT- AND DIFFERENTIATION-ENHANCING FACTOR 1; DDEF1	50807
MIM605954	*	3q27	FETUIN B; FETUB	26998
MIM605955	*	10q26	NK6, DROSOPHILA, HOMOLOG OF, 2; NKX6-2	84504
MIM605956	*	16q12	NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN PROTEIN 2; NOD2	64127
MIM605958	*	3p21.31	TRAF-INTERACTING PROTEIN; TRAIP	10293
MIM605959	*	 	HR44 ANTIGEN	27251
MIM605960	*	1p36.22	EXOSOME COMPONENT 10; EXOSC10	5394
MIM605961	*	4q31.2-q32.1	PLEIOTROPIC REGULATOR 1; PLRG1	5356
MIM605962	*	 	RAB9 EFFECTOR PROTEIN WITH KELCH MOTIFS; RABEPK	10244
MIM605963	*	2p23-p22	SORTING NEXIN 17; SNX17	9784
MIM605964	*	11q13	SORTING NEXIN 15; SNX15	29907
MIM605965	*	 	RAS AND RAB INTERACTOR 1; RIN1	9610
MIM605966	*	8q21	HEPATOCYTE NUCLEAR FACTOR 4-GAMMA; HNF4G	3174
MIM605967	%	7q36	ACROPECTORAL SYNDROME; ACRPS	85505
MIM605968	*	22q12-q13	RET FINGER PROTEIN-LIKE 1; RFPL1	5988
MIM605969	*	22q12-q13	RET FINGER PROTEIN-LIKE 2; RFPL2	10739
MIM605970	*	22q12-q13	RET FINGER PROTEIN-LIKE 3; RFPL3	10738
MIM605971	*	22q12-q13	RET FINGER PROTEIN-LIKE 3, ANTISENSE; RFPL3S	10737
MIM605972	*	22q12-q13	RET FINGER PROTEIN-LIKE 1, ANTISENSE; RFPL1S	10740
MIM605973	*	 	DDB1- AND CUL4-ASSOCIATED FACTOR 7; DCAF7	10238
MIM605974	*	 	SLU7 SPLICING FACTOR, S. CEREVISIAE, HOMOLOG OF; SLU7	10569
MIM605975	*	1p36.11	SERINE/ARGININE REPETITIVE MATRIX PROTEIN 1; SRRM1	10250
MIM605976	*	 	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 6; ZBTB6	10773
MIM605977	*	7q31	INNER MITOCHONDRIAL MEMBRANE PEPTIDASE, SUBUNIT 2, S. CEREVISIAE, HOMOLOG OF; IMMP2L	83943
MIM605978	*	9q21	VACUOLAR PROTEIN SORTING 13, YEAST, HOMOLOG OF, A; VPS13A	23230
MIM605979	*	 	SMALL NUCLEAR RNA-ACTIVATING PROTEIN COMPLEX, POLYPEPTIDE 5; SNAPC5	10302
MIM605980	*	7p15-p14	NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN PROTEIN 1; NOD1	10392
MIM605981	*	15q15-q21.1	UBIQUITIN-PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 1; UBR1	197131
MIM605982	^	 	MOVED TO 194070	 
MIM605983	*	19q13.4	PROTEIN PHOSPHATASE 2, STRUCTURAL/REGULATORY SUBUNIT A, ALPHA; PPP2R1A	5518
MIM605984	*	11q14.2-q22.3	EMBRYONIC ECTODERM DEVELOPMENT PROTEIN, MOUSE, HOMOLOG OF; EED	8726
MIM605986	*	12p12.3	SERINE/THREONINE KINASE RECEPTOR-ASSOCIATED PROTEIN; STRAP	11171
MIM605987	*	1q21	PROTEIN INHIBITOR OF ACTIVATED STAT3	10401
MIM605988	*	10p	DNA CROSS-LINK REPAIR PROTEIN 1C; DCLRE1C	64421
MIM605989	*	 	PROTEIN INHIBITOR OF ACTIVATED STAT4; PIAS4	51588
MIM605990	#	10q21.2	NEPHROLITHIASIS, URIC ACID, SUSCEPTIBILITY TO	22891
MIM605991	*	2q37	NEURONAL GUANINE NUCLEOTIDE EXCHANGE FACTOR; NGEF	25791
MIM605992	*	12q24.31-q24.32	LIM HOMEOBOX PROTEIN 5; LHX5	64211
MIM605993	*	8q22.1	PYRUVATE DEHYDROGENASE PHOSPHATASE CATALYTIC SUBUNIT 1; PDP1	54704
MIM605994	*	6p21.1-p11.2	CYTOCHROME P450, FAMILY 39, SUBFAMILY A, POLYPEPTIDE 1; CYP39A1	51302
MIM605995	*	1p36.2	KINESIN FAMILY MEMBER 1B; KIF1B	23095
MIM605996	*	6p21.3	DOM3, C. ELEGANS, HOMOLOG OF, Z; DOM3Z	1797
MIM605997	*	4p16	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B, GAMMA ISOFORM; PPP2R2C	5522
MIM605998	*	1q21.3	HCLS1-ASSOCIATED PROTEIN X1; HAX1	10456
MIM605999	*	17p13.1	C-TYPE LECTIN DOMAIN FAMILY 10, MEMBER A; CLEC10A	10462
MIM606000	*	6p21.3	BUTYROPHILIN-LIKE PROTEIN 2; BTNL2	56244
MIM606001	*	16p13.3	INTERLEUKIN 32; IL32	9235
MIM606002	#	9q34	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	23064
MIM606003	#	11p15.5-p15.4	TRANSALDOLASE DEFICIENCY	6888
MIM606004	*	22q13.31	GOLGI-ASSOCIATED, GAMMA-ADAPTIN EAR-CONTAINING, ARF-BINDING PROTEIN 1; GGA1	26088
MIM606005	*	 	GOLGI-ASSOCIATED, GAMMA-ADAPTIN EAR-CONTAINING, ARF-BINDING PROTEIN 2; GGA2	23062
MIM606006	*	Chr.17	GOLGI-ASSOCIATED, GAMMA-ADAPTIN EAR-CONTAINING, ARF-BINDING PROTEIN 3; GGA3	23163
MIM606007	*	 	POLYMERASE III, RNA, SUBUNIT K; POLR3K	51728
MIM606008	*	 	NATURAL KILLER CELL GROUP 7 SEQUENCE; NKG7	4818
MIM606009	*	4q35	DOUBLE HOMEOBOX PROTEIN 4; DUX4	22947
MIM606010	*	2p23	NUCLEAR RECEPTOR-BINDING PROTEIN 1; NRBP1	29959
MIM606011	*	 	V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 2; VSIG2	23584
MIM606012	%	3q22	DEAFNESS, AUTOSOMAL DOMINANT 18; DFNA18	85507
MIM606013	*	6q25-q26	F-BOX ONLY PROTEIN 5; FBXO5	26271
MIM606014	*	1p21-p13	ARISTALESS-LIKE HOMEOBOX 3; ALX3	257
MIM606015	*	1q32.2	FAS APOPTOTIC INHIBITORY MOLECULE 3; FAIM3	9214
MIM606016	*	19p13.2	KELCH-LIKE ECH-ASSOCIATED PROTEIN 1; KEAP1	9817
MIM606017	*	 	POLYMERASE II, RNA, SUBUNIT D; POLR2D	5433
MIM606018	*	 	EGF-LIKE REPEATS- AND DISCOIDIN I-LIKE DOMAINS-CONTAINING PROTEIN 3; EDIL3	10085
MIM606019	*	13q13.1	EXOSOME COMPONENT 8; EXOSC8	11340
MIM606020	*	 	OPA-INTERACTING PROTEIN 5; OIP5	11339
MIM606021	*	22q11.22	PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA; PRAME	23532
MIM606022	*	 	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 9; NUDT9	53343
MIM606023	*	3q28	POLYMERASE II, RNA, SUBUNIT H; POLR2H	5437
MIM606025	*	3q13.2	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 20; ZBTB20	26137
MIM606026	*	4p16.3	WHS CANDIDATE 2 GENE; WHSC2	7469
MIM606027	*	 	CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 1; CPSF1	29894
MIM606028	*	 	CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 2; CPSF2	53981
MIM606029	*	 	CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 3; CPSF3	51692
MIM606030	*	 	ENHANCER OF mRNA DECAPPING 4; EDC4	23644
MIM606031	*	3p21.31	WD REPEAT-CONTAINING PROTEIN 6; WDR6	11180
MIM606032	*	Chr.16	SERINE/ARGININE REPETITIVE MATRIX PROTEIN 2; SRRM2	23524
MIM606033	*	8p22	POLYMERASE II, RNA, SUBUNIT K; POLR2K	5440
MIM606034	*	19p13.13	RIBONUCLEASE H2, SUBUNIT A; RNASEH2A	10535
MIM606035	%	6q22-q24	FASTING INSULIN LEVEL QUANTITATIVE TRAIT LOCUS 1; FIQTL1	619503
MIM606036	*	15q24	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR 2; ARNT2	9915
MIM606037	*	3q13.13	CD96 ANTIGEN; CD96	10225
MIM606038	*	6p21.3	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G6D; LY6G6D	58530
MIM606039	*	12q24.31	G PROTEIN-COUPLED RECEPTOR 109B; GPR109B	8843
MIM606040	*	1p36.3	WD REPEAT-CONTAINING PROTEIN 8; WDR8	49856
MIM606041	*	 	SPARC-LIKE PROTEIN 1; SPARCL1	8404
MIM606042	*	 	MYONEURIN; MYNN	55892
MIM606043	*	19q13.3-q13.4	ZINC FINGER PROTEIN 331; ZNF331	55422
MIM606044	*	 	SJOGREN SYNDROME/SCLERODERMA AUTOANTIGEN 1; SSSCA1	10534
MIM606045	*	3q21	INTRAFLAGELLAR TRANSPORT 122, CHLAMYDOMONAS, HOMOLOG OF; IFT122	55764
MIM606046	*	 	SYNTAXIN 18; STX18	53407
MIM606047	*	19q13.4	IMMUNOGLOBULIN-LIKE TRANSCRIPT 11	353514
MIM606048	*	19q13.4	LEUKOCYTE RECEPTOR CLUSTER GENE 4; LENG4	79143
MIM606049	%	Chr.11	ACROMEGALOID FEATURES, OVERGROWTH, CLEFT PALATE, AND HERNIA	93956
MIM606050	*	6p21.3	UBIQUITIN D; UBD	10537
MIM606051	*	11p14	DEAFNESS LOCUS-ASSOCIATED PUTATIVE GUANINE NUCLEOTIDE EXCHANGE FACTOR	26297
MIM606053	%	2q	AUTISM, SUSCEPTIBILITY TO, 5; AUTS5	94313
MIM606054	#	13q32, 3q21-q22	PROPIONIC ACIDEMIA	5095, 5096
MIM606055	*	17q21-q22	PHOSPHATIDYLCHOLINE TRANSFER PROTEIN; PCTP	58488
MIM606056	#	2p13-p12	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb; CDG2B	7841
MIM606057	*	Chr.12	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 3; RAPGEF3	10411
MIM606058	*	 	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR; RAPGEF4	11069
MIM606059	*	Chr.8	PROTEIN KINASE, cAMP-DEPENDENT CATALYTIC, INHIBITOR ALPHA; PKIA	5569
MIM606060	*	10q21.1	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 12; DNAJC12	56521
MIM606061	*	7p15-p14	T-BOX 20; TBX20	57057
MIM606062	*	10q25	STRUCTURAL MAINTENANCE OF CHROMOSOMES 3; SMC3	9126
MIM606063	*	1q42-q43	EXONUCLEASE 1, S. CEREVISIAE, HOMOLOG OF; EXO1	9156
MIM606064	*	11q13	CD248 ANTIGEN; CD248	57124
MIM606065	*	3q22	CHEMOKINE, CC MOTIF, RECEPTOR-LIKE PROTEIN 1; CCRL1	51554
MIM606066	*	1q31-q32	LIM HOMEOBOX GENE 9; LHX9	56956
MIM606067	*	20p11	OTORAPLIN; OTOR	56914
MIM606068	#	2p15-p11, 2p15	RETINITIS PIGMENTOSA 28; RP28	84140
MIM606069	#	2q32	HEMOCHROMATOSIS, TYPE 4; HFE4	30061
MIM606070	#	5q31.2, 5q	MYOPATHY, DISTAL, 2; MPD2	9782
MIM606071	#	12q24.1	HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	59341
MIM606072	#	3p25, 1q41	RIPPLING MUSCLE DISEASE; RMD	859
MIM606073	*	9q34.3	NADPH-DEPENDENT DIFLAVIN OXIDOREDUCTASE 1; NDOR1	27158
MIM606074	*	9q34	GLOBOSIDE ALPHA-1,3-N-ACETYLGALACTOSAMINYLTRANSFERASE; GBGT1	26301
MIM606075	*	10q24	CHROMOSOME 10 OPEN READING FRAME 2; C10ORF2	56652
MIM606076	*	1p34.2	PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 3; PIK3R3	8503
MIM606077	*	1p13	RNA-BINDING MOTIF PROTEIN 15; RBM15	64783
MIM606078	*	22q13	MEGAKARYOBLASTIC LEUKEMIA 1 GENE; MKL1	57591
MIM606079	*	12p13.3	CD163 ANTIGEN-LIKE 1; CD163L1	283316
MIM606080	*	1p21.3-p13.1	CHITINASE, ACIDIC; CHIA	27159
MIM606081	*	 	TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 70, YEAST, HOMOLOG OF, A; TOMM70A	9868
MIM606082	%	3q26.1-q26.3	GOITER, MULTINODULAR 3; MNG3	94337
MIM606083	*	3p21	POLYBROMO 1, CHICKEN, HOMOLOG OF; PBRM1	55193
MIM606084	*	22q13.1	CDC42 EFFECTOR PROTEIN 1; CDC42EP1	11135
MIM606085	*	7q31.2	TESTIS-DERIVED TRANSCRIPT; TES	26136
MIM606086	*	 	EUKARYOTIC TRANSLATION INITIATION FACTOR 5B; EIF5B	9669
MIM606087	*	Chr.15	DESMUSLIN; DMN	23336
MIM606088	*	Chr.15	PHOSPHOLIPASE A2, GROUP IVB; PLA2G4B	100137049
MIM606089	*	 	BRAIN CYTOPLASMIC RNA 1; BCYRN1	618
MIM606090	*	7q21.1	CARNITINE OCTANOYLTRANSFERASE; CROT	54677
MIM606091	*	19q13.4	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 10; SIGLEC10	89790
MIM606092	*	12q13.1-q13.2	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 14; DNAJC14	85406
MIM606093	*	2q31.1	PEPTIDYL-PROLYL ISOMERASE G; PPIG	9360
MIM606094	*	19q13.4	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 12; SIGLEC12	89858
MIM606095	*	1p34.1	PEPTIDYL-PROLYL ISOMERASE H; PPIH	10465
MIM606096	*	11q13	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 12	85329
MIM606097	*	18q21.2	PHOSPHATIDYLINOSITOL GLYCAN, CLASS N; PIGN	23556
MIM606098	*	Chr.14	SORTING NEXIN 6; SNX6	58533
MIM606099	*	1q42-q43	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 8; LGALS8	3964
MIM606100	*	 	EGF-LIKE MODULE-CONTAINING, MUCIN-LIKE HORMONE RECEPTOR 2; EMR2	30817
MIM606101	*	 	EGF-LIKE MODULE-CONTAINING, MUCIN-LIKE HORMONE RECEPTOR 3; EMR3	84658
MIM606102	*	19p13.3	PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE, TYPE I, GAMMA; PIP5K1C	23396
MIM606103	*	6q21	SESTRIN 1; SESN1	27244
MIM606104	^	 	MOVED TO 124000	 
MIM606105	*	9q31.2	SOLUTE CARRIER FAMILY 44, MEMBER 1; SLC44A1	23446
MIM606106	*	19p13.1	SOLUTE CARRIER FAMILY 44, MEMBER 2; SLC44A2	57153
MIM606107	*	6p21.3	SOLUTE CARRIER FAMILY 44, MEMBER 4; SLC44A4	80736
MIM606108	*	 	PROTEIN PHOSPHATASE, MAGNESIUM-DEPENDENT, 1A; PPM1A	5494
MIM606109	*	8q23	NUDC DOMAIN-CONTAINING PROTEIN 1; NUDCD1	84955
MIM606110	*	Chr.8	LY6/NEUROTOXIN 1; LYNX1	66004
MIM606111	*	6q16.2-q21	MELANIN-CONCENTRATING HORMONE RECEPTOR 2; MCHR2	84539
MIM606112	*	 	RIBONUCLEASE P, 14-KD SUBUNIT; RPP14	11102
MIM606113	*	7q22	PROCESSING OF PRECURSOR 7, S. CEREVISIAE, HOMOLOG OF; POP7	10248
MIM606114	*	19q12	PROCESSING OF PRECURSOR 4, S. CEREVISIAE, HOMOLOG OF; POP4	10775
MIM606115	*	10q23.31	RIBONUCLEASE P/MRP, 30-KD SUBUNIT; RPP30	10556
MIM606116	*	10p13	RIBONUCLEASE P/MRP, 38-KD SUBUNIT; RPP38	10557
MIM606117	*	6p25.1	RIBONUCLEASE P, 40-KD SUBUNIT; RPP40	10799
MIM606118	*	3q24	HPS3 GENE; HPS3	84343
MIM606119	*	8qter	SECRETED LY6/PLAUR DOMAIN-CONTAINING PROTEIN 1; SLURP1	57152
MIM606121	*	7q21.3-q22	CALCITONIN GENE-RELATED PEPTIDE RECEPTOR COMPONENT PROTEIN	27297
MIM606122	*	13q12.11-q12.3	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 19; TNFRSF19	55504
MIM606123	*	1q42	RING FINGER PROTEIN 16; RNF16	51127
MIM606124	*	11p11.12-q12	RING FINGER PROTEIN 18; RNF18	57093
MIM606125	*	10q24.3	TRIPARTITE MOTIF-CONTAINING PROTEIN 8; TRIM8	81603
MIM606126	*	12p12	APOPTOSIS REGULATOR BCLG	79370
MIM606127	*	17p11.2	MYOCARDIN; MYOCD	93649
MIM606129	%	8p23.3-p22	DIAMOND-BLACKFAN ANEMIA 2; DBA2	114086
MIM606130	*	11q23	RING FINGER PROTEIN 26; RNF26	79102
MIM606131	*	1p34-p33	RING FINGER PROTEIN 28; RNF28	84676
MIM606132	*	11q12-q13	CDC42 EFFECTOR PROTEIN 2; CDC42EP2	10435
MIM606133	*	2p21	CDC42 EFFECTOR PROTEIN 3; CDC42EP3	10602
MIM606134	*	 	REV1, S. CEREVISIAE, HOMOLOG OF; REV1L	51455
MIM606135	*	19q13.4	KALLIKREIN-RELATED PEPTIDASE 14; KLK14	43847
MIM606136	*	 	RAS PROTEIN ACTIVATOR-LIKE 2; RASAL2	9462
MIM606137	*	 	CELL GROWTH REGULATOR WITH EF-HAND DOMAIN 1; CGREF1	10669
MIM606138	*	14q22.1	CELL GROWTH REGULATOR WITH RING FINGER DOMAIN 1; CGRRF1	10668
MIM606139	*	 	KRUPPEL-LIKE FACTOR 16; KLF16	83855
MIM606140	*	Chr.8	EXPORTIN 7; XPO7	23039
MIM606141	*	5q34	RAN-BINDING PROTEIN 17; RANBP17	64901
MIM606142	*	4p16-p15.3	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 9; SLC2A9	56606
MIM606143	*	8p21	FRIZZLED, DROSOPHILA, HOMOLOG OF, 3; FZD3	7976
MIM606144	*	6p11	RAS-ASSOCIATED PROTEIN RAB23; RAB23	51715
MIM606145	*	20q13.1	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 10; SLC2A10	81031
MIM606146	*	10p11.2	FRIZZLED, DROSOPHILA, HOMOLOG OF, 8; FZD8	8325
MIM606147	*	12q24.33	FRIZZLED, DROSOPHILA, HOMOLOG OF, 10; FZD10	11211
MIM606148	*	11q12-q13.1	FATTY ACID DESATURASE 1; FADS1	3992
MIM606149	*	11q12-q13.1	FATTY ACID DESATURASE 2; FADS2	9415
MIM606150	*	11q12-q13.1	FATTY ACID DESATURASE 3; FADS3	3995
MIM606151	*	16q21	BBS2 GENE; BBS2	583
MIM606152	*	2q36.3	SOLUTE CARRIER FAMILY 19 (THIAMINE TRANSPORTER), MEMBER 3; SLC19A3	80704
MIM606153	*	20q13.3	ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F1 COMPLEX, EPSILON SUBUNIT; ATP5E	514
MIM606154	*	 	MUCIN 16; MUC16	94025
MIM606155		 	FRYNS-AFTIMOS SYNDROME	 
MIM606156		 	SENER SYNDROME	 
MIM606157	*	20p13-p12.3	PANTOTHENATE KINASE 2; PANK2	80025
MIM606158	*	11q13	BSCL2 GENE; BSCL2	26580
MIM606159	#	19q13.3-q13.4	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	2512
MIM606160	*	10q23	PANTOTHENATE KINASE 1; PANK1	53354
MIM606161	*	5q35	PANTOTHENATE KINASE 3; PANK3	79646
MIM606162	*	1p36	PANTOTHENATE KINASE 4; PANK4	55229
MIM606163	^	 	MOVED TO 300829	 
MIM606164	%	 	DIAMOND-BLACKFAN ANEMIA WITH MICROTIA AND CLEFT PALATE	 
MIM606165	*	2q33	BOL-LIKE; BOLL	66037
MIM606167	*	14q32.3	G PROTEIN-COUPLED RECEPTOR 132; GPR132	29933
MIM606168	*	1p21.1-p13.2	DEAD/H BOX 20; DDX20	11218
MIM606169	^	 	MOVED TO 277410	 
MIM606170	#	 	GENITOPATELLAR SYNDROME; GTPTS	23522
MIM606171	*	 	TRANSFER RNA SERINE 1; TRNAS1	94017
MIM606172	*	 	TRANSFER RNA SERINE 3; TRNAS3	23540
MIM606173	*	4p16	GrpE, E. COLI, HOMOLOG OF, 1; GRPEL1	80273
MIM606174		 	BACULUM, CONGENITAL ABSENCE OF	 
MIM606175		 	CARNITINE ACETYLTRANSFERASE DEFICIENCY	 
MIM606176	#	11p15.1, 11p15.1, 11p15.5, 7p15-p13	DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	2645, 3630, 3651, 3767, 6833
MIM606177		 	PARS PLANITIS	 
MIM606178	*	4q28-q32	HEDGEHOG-INTERACTING PROTEIN; HHIP	64399
MIM606179		16q22	ANEURYSMAL BONE CYSTS	114293
MIM606180	*	4q27	EXOSOME COMPONENT 9; EXOSC9	5393
MIM606181	*	14q32	DEAD/H BOX 24; DDX24	57062
MIM606182	*	19p13.3	TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 9; TNFSF9	8744
MIM606183		 	LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	 
MIM606184	*	5q35	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 12; ADAMTS12	81792
MIM606185	*	8q22	TUMOR PROTEIN p53-INDUCIBLE NUCLEAR PROTEIN 1; TP53INP1	94241
MIM606186	*	1q24-q25	CALCYCLIN-BINDING PROTEIN; CACYBP	27101
MIM606187	%	10p13	ALZHEIMER DISEASE 7	114475
MIM606188	*	8p12	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 28; ADAM28	10863
MIM606189	*	2p22-p21	CYSTEINE-RICH MOTOR NEURON PROTEIN 1; CRIM1	51232
MIM606190		1p11	MENINGIOMA, RADIATION-INDUCED	117192
MIM606191	*	9q34	FORMIN-BINDING PROTEIN 1; FNBP1	23048
MIM606192	*	5q35	BUTYROPHILIN-LIKE PROTEIN 3; BTNL3	10917
MIM606193	*	7q31-q32	SOLUTE CARRIER FAMILY 13 (SODIUM/SULFATE SYMPORTER), MEMBER 1; SLC13A1	6561
MIM606194	*	 	KERATIN 23; KRT23	25984
MIM606195	*	16q11.2-q13	IROQUOIS HOMEOBOX PROTEIN 5; IRX5	10265
MIM606196	*	16q11.2-q13	IROQUOIS HOMEOBOX PROTEIN 6; IRX6	79190
MIM606197	*	5p15.3	IROQUOIS HOMEOBOX PROTEIN 1; IRX1	79192
MIM606198	*	5p15.3	IROQUOIS HOMEOBOX PROTEIN 2; IRX2	153572
MIM606199	*	5p15.3	IROQUOIS HOMEOBOX PROTEIN 4; IRX4	50805
MIM606200	*	12p12.1-p11.23	BASIC HELIX-LOOP-HELIX FAMILY, MEMBER E41; BHLHE41	79365
MIM606201	*	4p16.1	WFS1 GENE; WFS1	7466
MIM606202	*	5p13.3	SOLUTE CARRIER FAMILY 45, MEMBER 2; SLC45A2	51151
MIM606203	*	11q13.4-q13.5	GRB2-ASSOCIATED BINDING PROTEIN 2; GAB2	9846
MIM606204	*	8q24-qter	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS D; LY6D	8581
MIM606205	*	5q31-q32	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, L-PROLINE), MEMBER 7; SLC6A7	6534
MIM606206	*	Chr.16	METALLOTHIONEIN 4; MT4	84560
MIM606207	*	15q25-q26	SOLUTE CARRIER FAMILY 28 (SODIUM-COUPLED NUCLEOSIDE TRANSPORTER), MEMBER 1; SLC28A1	9154
MIM606208	*	15q15	SOLUTE CARRIER FAMILY 28 (SODIUM-COUPLED NUCLEOSIDE TRANSPORTER), MEMBER 2; SLC28A2	9153
MIM606209	*	 	YKT6, S. CEREVISIAE, HOMOLOG OF; YKT6	10652
MIM606210	*	1p36-p35	SELENOPROTEIN N, 1; SEPN1	57190
MIM606211	*	19p13.3	SIRTUIN 6; SIRT6	51548
MIM606213	*	 	SIGNAL SEQUENCE RECEPTOR, GAMMA; SSR3	6747
MIM606214	*	19q13.13	SPECTRIN, BETA, NONERYTHROCYTIC, 4; SPTBN4	57731
MIM606215	%	1p31-p21	ATRIOVENTRICULAR SEPTAL DEFECT; AVSD	7446
MIM606216	*	16p13.3	SELENOPROTEIN X, 1; SEPX1	51734
MIM606217	#	3p25.3	ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2; AVSD2	78987
MIM606218	*	16p11.2	SELENOPHOSPHATE SYNTHETASE 2; SEPHS2	22928
MIM606219	*	16p13.3	TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PROTEIN 1; TRAP1	10131
MIM606220		 	MENTAL RETARDATION, SHORT STATURE, FACIAL ANOMALIES, AND JOINT DISLOCATIONS	 
MIM606221	*	17q21	IKAROS FAMILY ZINC FINGER 3; IKZF3	22806
MIM606222	*	16p13	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 6; IGSF6	10261
MIM606223	*	3q27.1	PROTEASOME 26S SUBUNIT, NON-ATPASE, 2; PSMD2	5708
MIM606224	*	7p15-p14	5-PRIME-@NUCLEOTIDASE, CYTOSOLIC III; NT5C3	51251
MIM606225	*	1p36	TASTE RECEPTOR TYPE 1, MEMBER 1; TAS1R1	80835
MIM606226	*	1p36	TASTE RECEPTOR TYPE 1, MEMBER 2; TAS1R2	80834
MIM606227	*	11q23	MEMBRANE-TYPE FRIZZLED-RELATED PROTEIN; MFRP	83552
MIM606228	*	1p35-p34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2C, SUBUNIT 1; EIF2C1	26523
MIM606229	*	8q24	EUKARYOTIC TRANSLATION INITIATION FACTOR 2C, SUBUNIT 2; EIF2C2	27161
MIM606230	*	22q13.3	SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 3; SHANK3	85358
MIM606231	*	12q24.1	ADAPTOR PROTEIN, PHOSPHOTYROSINE INTERACTION, PH DOMAIN, AND LEUCINE ZIPPER-CONTAINING PROTEIN 2; APPL2	55198
MIM606232	#	22q13.3	CHROMOSOME 22q13.3 DELETION SYNDROME	85358
MIM606233	*	1p21	PROKINETICIN 1; PROK1	84432
MIM606234	*	 	IKAROS FAMILY ZINC FINGER 2; IKZF2	22807
MIM606235	*	3q21	THIOREDOXIN REDUCTASE 3; TXNRD3	114112
MIM606236	*	17q25	ALVEOLAR SOFT PART SARCOMA CHROMOSOME REGION, CANDIDATE 1; ASPSCR1	79058
MIM606237	*	2q12.1	TRANSFORMING GROWTH FACTOR-BETA RECEPTOR-ASSOCIATED PROTEIN 1; TGFBRAP1	9392
MIM606238	*	 	IKAROS FAMILY ZINC FINGER 5; IKZF5	64376
MIM606239	*	12q13	IKAROS FAMILY ZINC FINGER 4; IKZF4	64375
MIM606240	%	2q21	THYROID CARCINOMA, NONMEDULLARY, SUSCEPTIBILITY TO, 1	114568
MIM606241	*	14q31	DICER, DROSOPHILA, HOMOLOG OF, 1; DICER1	23405
MIM606242	%	 	MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES, AND FACIAL DYSMORPHISM	100653373
MIM606243	#	17q25	ALVEOLAR SOFT PART SARCOMA; ASPS	79058
MIM606244	*	2q23.3	SIGNAL-TRANSDUCING ADAPTOR MOLECULE 2; STAM2	10254
MIM606245	*	17q11.2	SUPPRESSOR OF ZESTE 12, DROSOPHILA, HOMOLOG OF; SUZ12	23512
MIM606246	*	7p15	JUXTAPOSED WITH ANOTHER ZINC FINGER GENE 1; JAZF1	221895
MIM606247	*	2p13-p12	STAM-BINDING PROTEIN; STAMBP	10617
MIM606248	*	16p11.2	QUINOLINATE PHOSPHORIBOSYLTRANSFERASE; QPRT	23475
MIM606249	*	9q22.3	PROTEIN KINASE, LYSINE-DEFICIENT 2; WNK2	65268
MIM606250	*	12p13.3	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 8; GALNT8	26290
MIM606251	*	 	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 9; GALNT9	50614
MIM606252	*	11q23-q24	TIR DOMAIN-CONTAINING ADAPTOR PROTEIN; TIRAP	114609
MIM606254	*	1p31	SELENOPROTEIN, 15-KD	9403
MIM606255	%	6q24-q25	STATURE AS A QUANTITATIVE TRAIT	 
MIM606256	%	7q31.3	STATURE QUANTITATIVE TRAIT LOCUS 2; STQTL2	192143
MIM606257	%	12p11.2-q14	STATURE QUANTITATIVE TRAIT LOCUS 3; STQTL3	282549
MIM606258	%	13q32-q33	STATURE QUANTITATIVE TRAIT LOCUS 4; STQTL4	282550
MIM606259	*	11q13.1-q13.2	BREAST CANCER METASTASIS SUPPRESSOR 1; BRMS1	25855
MIM606260	*	8p23-p22	MYOTUBULARIN-RELATED PROTEIN 9; MTMR9	66036
MIM606261	*	 	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 6; NUDT6	11162
MIM606263	%	5q31	PAGET DISEASE OF BONE 4; PDB4	94003
MIM606264	*	12p13.2-p12.3	C-TYPE LECTIN DOMAIN FAMILY 7, MEMBER A; CLEC7A	64581
MIM606265	*	12q24.33	E1A-BINDING PROTEIN, 400-KD; EP400	57634
MIM606266	*	15q14	BCL2-MODIFYING FACTOR; BMF	90427
MIM606267	*	 	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 16; WNT16	51384
MIM606268	*	2q35	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 10A; WNT10A	80326
MIM606269	*	22q13.1-q13.31	TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 13C; TNFRSF13C	115650
MIM606270	*	 	TOLL-LIKE RECEPTOR 10; TLR10	81793
MIM606271	*	1q42.1	DISRUPTED IN SCHIZOPHRENIA 2; DISC2	27184
MIM606272	*	17p13	CYSTINOSIN; CTNS	1497
MIM606273	*	1p34.1	EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 3; EIF2B3	8891
MIM606274	*	15q22.1-q22.31	CASEIN KINASE I, GAMMA-1; CSNK1G1	53944
MIM606276	*	 	CARTILAGE ACIDIC PROTEIN 1; CRTAC1	55118
MIM606277	*	11p15.5	TOLL-INTERACTING PROTEIN; TOLLIP	54472
MIM606278	*	4q31.3	F-BOX AND WD40 DOMAIN PROTEIN 7; FBXW7	55294
MIM606279	*	3q12	TARGET OF NESH-SH3	25890
MIM606280	*	4p15.3	NON-SMC CONDENSIN I COMPLEX SUBUNIT G; NCAPG	64151
MIM606281	*	11q13.5-q22.3	RAS-ASSOCIATED PROTEIN RAB38; RAB38	23682
MIM606282	%	4q35-qter	DEAFNESS, AUTOSOMAL DOMINANT 24; DFNA24	23723
MIM606283	*	10q23.3	SORCS RECEPTOR 1; SORCS1	114815
MIM606284	*	4p16.1	SORCS RECEPTOR 2; SORCS2	57537
MIM606285	*	10q23.3	SORCS RECEPTOR 3; SORCS3	22986
MIM606286	*	6q12-q13	DEAD/H BOX 43; DDX43	55510
MIM606288	*	5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 1; PCDHGA1	56114
MIM606289	*	5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 2; PCDHGA2	56113
MIM606290	*	5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 3; PCDHGA3	56112
MIM606291	*	5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 4; PCDHGA4	56111
MIM606292	*	5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 5; PCDHGA5	56110
MIM606293	*	5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 6; PCDHGA6	56109
MIM606294	*	5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 7; PCDHGA7	56108
MIM606295	*	5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 8; PCDHGA8	9708
MIM606296	*	5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 9; PCDHGA9	56107
MIM606297	*	5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 10; PCDHGA10	56106
MIM606298	*	5q31	PROTOCADHERIN-GAMMA, SUBFAMILY A, MEMBER 11; PCDHGA11	56105
MIM606299	*	5q31	PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 1; PCDHGB1	56104
MIM606300	*	5q31	PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 2; PCDHGB2	56103
MIM606301	*	5q31	PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 3; PCDHGB3	56102
MIM606302	*	5q31	PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 5; PCDHGB5	56101
MIM606303	*	5q31	PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 6; PCDHGB6	56100
MIM606304	*	5q31	PROTOCADHERIN-GAMMA, SUBFAMILY B, MEMBER 7; PCDHGB7	56099
MIM606305	*	5q31	PROTOCADHERIN-GAMMA, SUBFAMILY C, MEMBER 4; PCDHGC4	56098
MIM606306	*	5q31	PROTOCADHERIN-GAMMA, SUBFAMILY C, MEMBER 5; PCDHGC5	56097
MIM606307	*	5q31	PROTOCADHERIN-ALPHA 1; PCDHA1	56147
MIM606308	*	5q31	PROTOCADHERIN-ALPHA 2; PCDHA2	56146
MIM606309	*	5q31	PROTOCADHERIN-ALPHA 3; PCDHA3	56145
MIM606310	*	5q31	PROTOCADHERIN-ALPHA 4; PCDHA4	56144
MIM606311	*	5q31	PROTOCADHERIN-ALPHA 5; PCDHA5	56143
MIM606312	*	5q31	PROTOCADHERIN-ALPHA 6; PCDHA6	56142
MIM606313	*	5q31	PROTOCADHERIN-ALPHA 7; PCDHA7	56141
MIM606314	*	5q31	PROTOCADHERIN-ALPHA 8; PCDHA8	56140
MIM606315	*	5q31	PROTOCADHERIN-ALPHA 9; PCDHA9	9752
MIM606316	*	5q31	PROTOCADHERIN-ALPHA 10; PCDHA10	56139
MIM606317	*	5q31	PROTOCADHERIN-ALPHA 11; PCDHA11	56138
MIM606318	*	5q31	PROTOCADHERIN-ALPHA 12; PCDHA12	56137
MIM606319	*	5q31	PROTOCADHERIN-ALPHA 13; PCDHA13	56136
MIM606320	*	5q31	PROTOCADHERIN-ALPHA, SUBFAMILY C, MEMBER 1; PCDHAC1	56135
MIM606321	*	5q31	PROTOCADHERIN-ALPHA, SUBFAMILY C, MEMBER 2; PCDHAC2	56134
MIM606322	*	15q11	CYTOPLASMIC FMRP-INTERACTING PROTEIN 1; CYFIP1	23191
MIM606323	*	5q33.3	CYTOPLASMIC FMRP-INTERACTING PROTEIN 2; CYFIP2	26999
MIM606324	#	1p36	PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK7	11315
MIM606325	%	6q21	HETEROTAXY, VISCERAL, 3, AUTOSOMAL; HTX3	116629
MIM606326	*	14q23	SINE OCULIS HOMEOBOX, DROSOPHILA, HOMOLOG OF, 6; SIX6	4990
MIM606327	*	5q31	PROTOCADHERIN-BETA 1; PCDHB1	29930
MIM606328	*	5q31	PROTOCADHERIN-BETA 2; PCDHB2	56133
MIM606329	*	5q31	PROTOCADHERIN-BETA 3; PCDHB3	56132
MIM606330	*	5q31	PROTOCADHERIN-BETA 4; PCDHB4	56131
MIM606331	*	5q31	PROTOCADHERIN-BETA 5; PCDHB5	26167
MIM606332	*	5q31	PROTOCADHERIN-BETA 6; PCDHB6	56130
MIM606333	*	5q31	PROTOCADHERIN-BETA 7; PCDHB7	56129
MIM606334	*	5q31	PROTOCADHERIN-BETA 8; PCDHB8	56128
MIM606335	*	5q31	PROTOCADHERIN-BETA 9; PCDHB9	56127
MIM606336	*	5q31	PROTOCADHERIN-BETA 10; PCDHB10	56126
MIM606337	*	5q31	PROTOCADHERIN-BETA 11; PCDHB11	56125
MIM606338	*	5q31	PROTOCADHERIN-BETA 12; PCDHB12	56124
MIM606339	*	5q31	PROTOCADHERIN-BETA 13; PCDHB13	56123
MIM606340	*	5q31	PROTOCADHERIN-BETA 14; PCDHB14	56122
MIM606341	*	5q31	PROTOCADHERIN-BETA 15; PCDHB15	56121
MIM606342	*	14q23	SINE OCULIS HOMEOBOX, DROSOPHILA, HOMOLOG OF, 4; SIX4	51804
MIM606343	*	10q23	POLYMERASE, DNA, LAMBDA; POLL	27343
MIM606344	*	 	POLYMERASE, DNA, MU; POLM	27434
MIM606345	*	5q31	PROTOCADHERIN-BETA 16; PCDHB16	57717
MIM606346	#	6q13	DEAFNESS, AUTOSOMAL DOMINANT 22; DFNA22	4646
MIM606347	*	15q24-q25.1	PROLINE/SERINE/THREONINE PHOSPHATASE-INTERACTING PROTEIN 1; PSTPIP1	9051
MIM606348	%	5q31	INFLAMMATORY BOWEL DISEASE 5; IBD5	50941
MIM606349		 	GAMBLING, PATHOLOGIC	 
MIM606350	*	9p13.3	APRATAXIN; APTX	54840
MIM606351	*	1p36.3-p36.1	ESPIN, MOUSE, HOMOLOG OF; ESPN	83715
MIM606352	*	2q33	ALSIN	57679
MIM606353	#	2q33	PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	57679
MIM606355	*	2q14.1	DEAD/H BOX 18; DDX18	8886
MIM606356	*	11q22.1	TRANSMEMBRANE PROTEIN 123; TMEM123	114908
MIM606357	*	10q21	DEAD/H BOX 21; DDX21	9188
MIM606358	*	7p21.3	ANTERIOR GRADIENT 2, XENOPUS, HOMOLOG OF; AGR2	10551
MIM606359	*	1q42	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 3A; WNT3A	89780
MIM606360	*	 	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 8A; WNT8A	7478
MIM606361	*	12p13.3	WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 5B; WNT5B	81029
MIM606362	*	19q13	ACID PHOSPHATASE, TESTICULAR; ACPT	93650
MIM606363	*	17q21.3	NESH PROTEIN	51225
MIM606364	^	 	MOVED TO 606658	 
MIM606365	*	12q13	GLUTAMINASE, LIVER; GLS2	27165
MIM606366	*	1q42	RAS HOMOLOG GENE FAMILY, MEMBER U; RHOU	58480
MIM606367	#	10p15.1	INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF	3559
MIM606368	*	11q23	APOLIPOPROTEIN A-V; APOA5	116519
MIM606369		4q21.3	EPILEPTIC ENCEPHALOPATHY, LENNOX-GASTAUT TYPE	5602
MIM606370	*	7q34	THIAMINE PYROPHOSPHOKINASE; TPK1	27010
MIM606371	*	Chr.12	ACTIVATING TRANSCRIPTION FACTOR 7; ATF7	11016
MIM606372	*	11p15.5	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 10; CHRNA10	57053
MIM606373	*	1q23-q32	FORMIN 2; FMN2	56776
MIM606374	*	11q12-q13	BETA-1,3-GLUCURONYLTRANSFERASE 3; B3GAT3	26229
MIM606376	*	2q11.2	CARBOHYDRATE SULFOTRANSFERASE 10; CHST10	9486
MIM606377	*	 	DIMERIC DIHYDRODIOL DEHYDROGENASE; DHDH	27294
MIM606378	*	9q31	ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 4; ST6GALNAC4	27090
MIM606379	*	3q24	G PROTEIN-COUPLED RECEPTOR 87; GPR87	53836
MIM606380	*	3q24	G PROTEIN-COUPLED RECEPTOR 86; GPR86	53829
MIM606381	*	3q24-q25.1	G PROTEIN-COUPLED RECEPTOR 91; GPR91	56670
MIM606382	*	7q21	MEMBRANE-ASSOCIATED GUANYLATE KINASE, WW AND PDZ DOMAINS-CONTAINING, 2; MAGI2	9863
MIM606383	*	12q13.13	G PROTEIN-COUPLED RECEPTOR 84; GPR84	53831
MIM606384	*	18q21	UBIQUITIN PROTEIN LIGASE NEDD4-LIKE; NEDD4L	23327
MIM606385	*	 	OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 1; OLIG1	116448
MIM606386	*	21q22.11	OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 2; OLIG2	10215
MIM606387	*	8q24.3	TOPOISOMERASE I, MITOCHONDRIAL; TOP1MT	116447
MIM606388	*	1q21	C-TERMINAL MODULATOR PROTEIN	117145
MIM606389	*	11q13.1	CATION CHANNEL, SPERM-ASSOCIATED, 1; CATSPER1	117144
MIM606391	#	 	MATURITY-ONSET DIABETES OF THE YOUNG; MODY	 
MIM606392	#	13q12.1	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 4; MODY4	3651
MIM606393	*	8p12	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN-LIKE PROTEIN DECYSIN 1; ADAMDEC1	27299
MIM606394	#	2q32	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 6; MODY6	4760
MIM606395	*	2p23	PROLACTIN REGULATORY ELEMENT-BINDING PROTEIN; PREB	10113
MIM606396	*	8p21.3	BRIDGING INTEGRATOR 3; BIN3	55909
MIM606397	*	3q21-q25	CLARIN 1; CLRN1	7401
MIM606398	*	19q13.3	ACTIVATING TRANSCRIPTION FACTOR 5; ATF5	22809
MIM606399	*	3p21.1	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 3; CACNA2D3	55799
MIM606400	*	3p24	CALPAIN 7; CAPN7	23473
MIM606401	*	1q42	CALPAIN 9; CAPN9	10753
MIM606402	*	2p13.3	GASTROKINE 1; GKN1	56287
MIM606403	*	16p13.1-p12	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-3 SUBUNIT; CACNG3	10368
MIM606404	*	 	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-4 SUBUNIT; CACNG4	27092
MIM606405	*	17q24	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-5 SUBUNIT; CACNG5	27091
MIM606406	*	16p13.1	NUCLEAR PORE COMPLEX-INTERACTING PROTEIN; NPIP	9284
MIM606407	#	2p21	HYPOTONIA-CYSTINURIA SYNDROME	100415942
MIM606408	#	6p21.3	EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY	7148
MIM606409	*	20q11.22-q11.23	ITCHY E3 UBIQUITIN PROTEIN LIGASE, MOUSE, HOMOLOG OF; ITCH	83737
MIM606410	*	2p13.1	ANTHRAX TOXIN RECEPTOR 1; ANTXR1	84168
MIM606411	*	20q12-q13.1	SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT DICARBOXYLATE TRANSPORTER), MEMBER 3; SLC13A3	64849
MIM606412	*	1p31	BSND GENE	7809
MIM606413	*	1p31.1-p22.3	INSULIN-LIKE 5; INSL5	10022
MIM606414	*	9p24	INSULIN-LIKE 6; INSL6	11172
MIM606416	*	1q44	NLR FAMILY, PYRIN DOMAIN-CONTAINING 3; NLRP3	114548
MIM606417	*	10q26	WD REPEAT-CONTAINING PROTEIN 11; WDR11	55717
MIM606418	*	1p33-p31.1	24-@DEHYDROCHOLESTEROL REDUCTASE; DHCR24	1718
MIM606419	*	19q13.4	PRECURSOR mRNA-PROCESSING FACTOR 31, S. CEREVISIAE, HOMOLOG OF; PRPF31	26121
MIM606420	*	7p14	ENGULFMENT AND CELL MOTILITY GENE 1; ELMO1	9844
MIM606421	*	20q13	ENGULFMENT AND CELL MOTILITY GENE 2; ELMO2	63916
MIM606422	*	Chr.16	ENGULFMENT AND CELL MOTILITY GENE 3; ELMO3	79767
MIM606423	*	2q33	DISRUPTED IN RENAL CARCINOMA 1; DIRC1	116093
MIM606424	*	19q13.2	EGL9, C. ELEGANS, HOMOLOG OF, 2; EGLN2	112398
MIM606425	*	1q42-q43	EGL9, C. ELEGANS, HOMOLOG OF, 1; EGLN1	54583
MIM606426	*	Chr.14	EGL9, C. ELEGANS, HOMOLOG OF, 3; EGLN3	112399
MIM606427	*	19q13.3-q13.4	ZINC FINGER PROTEIN 320; ZNF320	162967
MIM606428	*	2q37	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A3; UGT1A3	54659
MIM606429	*	2q37	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A4; UGT1A4	54657
MIM606430	*	2q37	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A5; UGT1A5	54579
MIM606431	*	2q37	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A6; UGT1A6	54578
MIM606432	*	2q37	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A7; UGT1A7	54577
MIM606433	*	2q37	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A8; UGT1A8	54576
MIM606434	*	2q37	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A9; UGT1A9	54600
MIM606435	*	2q37	UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A10; UGT1A10	54575
MIM606436	*	11q13.2	SYNAPTOTAGMIN 12; SYT12	91683
MIM606437	^	 	MOVED TO 121200	 
MIM606438	#	16q24.3	HUNTINGTON DISEASE-LIKE 2; HDL2	57338
MIM606439	*	14q11-q21	ATLASTIN GTPase 1; ATL1	51062
MIM606440	*	15q15	STEREOCILIN; STRC	161497
MIM606441	*	2p12	HTRA SERINE PEPTIDASE 2; HTRA2	27429
MIM606442	*	 	ABL INTERACTOR 2	10152
MIM606443	*	Chr.9	cAMP RESPONSE ELEMENT-BINDING PROTEIN 3; CREB3	10488
MIM606444	*	 	ZHANGFEI PROTEIN	58487
MIM606445	#	 	PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS	 
MIM606446	*	1q23.1	SLAM FAMILY, MEMBER 6; SLAMF6	114836
MIM606447	*	 	RNA-BINDING PROTEIN S1; RNPS1	10921
MIM606448	*	22q11.2	THIOREDOXIN REDUCTASE 2; TXNRD2	10587
MIM606449	*	8q24.3	PROTEIN-TYROSINE PHOSPHATASE, TYPE 4A, 3; PTP4A3	11156
MIM606450	*	 	NEUROEPITHELIAL CELL TRANSFORMING GENE 1; NET1	10276
MIM606451	%	15q25-q26	DEAFNESS, AUTOSOMAL DOMINANT 30; DFNA30	23719
MIM606452	*	3q26.3-q27	WILDTYPE p53-INDUCED GENE	64393
MIM606453	*	 	LIPOPOLYSACCHARIDE-RESPONSIVE, BEIGE-LIKE ANCHOR PROTEIN; LRBA	987
MIM606454	*	14q24	EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 2; EIF2B2	8892
MIM606455	*	 	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 13B; PPP1R13B	23368
MIM606456	*	10q24-q26	NUCLEOPHOSMIN/NUCLEOPLASMIN FAMILY, MEMBER 3; NPM3	10360
MIM606457	*	6q13-q14	INHIBITOR OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE; IBTK	25998
MIM606458	*	3p22	AXIN1 UPREGULATED; AXUD1	64651
MIM606459	*	 	OPIOID GROWTH FACTOR RECEPTOR; OGFR	11054
MIM606460	%	6q21	LONGEVITY 2	100329168
MIM606461	*	8q11	TRIMETHYLGUANOSINE SYNTHASE, S. CEREVISIAE, HOMOLOG OF; TGS1	96764
MIM606462	*	8q24	RAD21, S. POMBE, HOMOLOG OF; RAD21	5885
MIM606463	*	1q21	GLUCOSIDASE, BETA, ACID; GBA	2629
MIM606464	*	19q13	HEPCIDIN ANTIMICROBIAL PEPTIDE; HAMP	57817
MIM606465	*	3q21-q22	KRUPPEL-LIKE FACTOR 15; KLF15	28999
MIM606466	*	 	PML-RARA TARGET GENE ENCODING AN ADAPTOR MOLECULE 1; PRAM1	84106
MIM606467	*	6q23.2	ALDEHYDE DEHYDROGENASE 8 FAMILY, MEMBER A1; ALDH8A1	64577
MIM606468	*	4q25	NUCLEOLAR PROTEIN FAMILY A, MEMBER 1; NOLA1	54433
MIM606469	*	 	RING FINGER PROTEIN 29; RNF29	84675
MIM606470	*	5q35.3	NUCLEOLAR PROTEIN FAMILY A, MEMBER 2; NOLA2	55651
MIM606471	*	15q14-q15	NUCLEOLAR PROTEIN FAMILY A, MEMBER 3; NOLA3	55505
MIM606472	*	20q13.3	SS18-LIKE GENE 1; SS18L1	26039
MIM606473	*	3p21	SS18-LIKE GENE 2; SS18L2	51188
MIM606474	*	 	RING FINGER PROTEIN 30; RNF30	57159
MIM606475	*	19p13.2	CD320 ANTIGEN; CD320	51293
MIM606476	*	19q13.2	INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE C; ITPKC	80271
MIM606477	*	17p13.3	SERINE RACEMASE; SRR	63826
MIM606478	*	 	PROTECTION OF TELOMERES 1; POT1	25913
MIM606479	*	Chr.17	NEUROLIGIN 2; NLGN2	57555
MIM606480	*	1p34	ZINC METALLOPROTEINASE STE24; ZMPSTE24	10269
MIM606481	*	22q11.2-q13.2	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 5-PHOSPHATASE, A; PIB5PA	27124
MIM606482	#	19p13.2	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB	1785
MIM606483	%	10q24.1-q25.1	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE A; CMTDIA	387574
MIM606484	*	7q33-q35	MYOTROPHIN; MTPN	136319
MIM606485	*	15q22.1	POLYMERASE II, RNA, SUBUNIT M; POLR2M	81488
MIM606486	*	18p11	CHMP FAMILY, MEMBER 1B; CHMP1B	57132
MIM606487	*	3q28-q29	HRAS-LIKE SUPPRESSOR; HRASLS	57110
MIM606488	*	 	EXOSOME COMPONENT 7; EXOSC7	23016
MIM606489	*	 	EXOSOME COMPONENT 3; EXOSC3	51010
MIM606490	*	 	EXOSOME COMPONENT 6; EXOSC6	118460
MIM606491	*	 	EXOSOME COMPONENT 4; EXOSC4	54512
MIM606492	*	 	EXOSOME COMPONENT 5; EXOSC5	56915
MIM606493	*	 	EXOSOME COMPONENT 1; EXOSC1	51013
MIM606494	*	1p34.1	ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 3; ST3GAL3	6487
MIM606495	*	19q13.2	MAP/MICROTUBULE AFFINITY-REGULATING KINASE 4; MARK4	57787
MIM606496	*	6p12	INTERLEUKIN 17F; IL17F	112744
MIM606497	*	4q13.2	URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B28; UGT2B28	54490
MIM606498	*	11q12-q13	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 3; MS4A3	932
MIM606499	*	11q12-q13	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 5; MS4A5	64232
MIM606500	*	5q35	SECRETOGLOBIN, FAMILY 3A, MEMBER 1; SCGB3A1	92304
MIM606501	*	5p13.3	MYOTUBULARIN-RELATED PROTEIN 12; MTMR12	54545
MIM606502	*	11q12-q13	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 7; MS4A7	58475
MIM606503	*	10p13	SUPPRESSOR OF VARIEGATION 3-9, DROSOPHILA, HOMOLOG OF, 2; SUV39H2	79723
MIM606504	*	17q12-q21.3	CANCER SUSCEPTIBILITY CANDIDATE 3; CASC3	22794
MIM606505	*	8p23	PIN2-INTERACTING PROTEIN 1	54984
MIM606506	^	 	PEROXIREDOXIN 4; PRDX4	10549
MIM606508	*	1q21.2-q22	Fc RECEPTOR-LIKE PROTEIN 1; FCRL1	115350
MIM606509	*	1q21.2-q22	Fc RECEPTOR-LIKE PROTEIN 2; FCRL2	79368
MIM606510	*	1q21.2-q22	Fc RECEPTOR-LIKE PROTEIN 3; FCRL3	115352
MIM606511	*	1q41	MAP/MICROTUBULE AFFINITY-REGULATING KINASE 1; MARK1	4139
MIM606512	*	6p21	PROTEIN KINASE C AND CASEIN KINASE SUBSTRATE IN NEURONS 1; PACSIN1	29993
MIM606513	*	11p11	PROTEIN KINASE C AND CASEIN KINASE SUBSTRATE IN NEURONS 3; PACSIN3	29763
MIM606514	*	22q12.3-q13.1	CYTOHESIN 4; CYTH4	27128
MIM606515	*	6p12.1	RNA, 7SK, SMALL NUCLEAR; RN7SK	125050
MIM606516	*	3q25	MUSCLEBLIND-LIKE PROTEIN 1; MBNL1	4154
MIM606517	*	5p15.3	ARYLHYDROCARBON RECEPTOR REPRESSOR; AHRR	57491
MIM606518	*	5q33.2	HEPATITIS A VIRUS CELLULAR RECEPTOR 1; HAVCR1	26762
MIM606519		 	PHACE ASSOCIATION	 
MIM606520	*	 	G6B PROTEIN	80739
MIM606521	*	17q25.3	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL THIAMINE PYROPHOSPHATE CARRIER), MEMBER 19; SLC25A19	60386
MIM606522	*	12p13.1	GROWTH/DIFFERENTIATION FACTOR 3; GDF3	9573
MIM606523	*	Chr.12	SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 1; SRGAP1	57522
MIM606524	*	1q32.1	SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 2; SRGAP2	23380
MIM606525	*	3p25	SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 3; SRGAP3	9901
MIM606526	*	2q37	MELANOPHILIN; MLPH	79083
MIM606527		 	MEGARBANE SYNDROME	 
MIM606528	#	11p15-p14	HOMOZYGOUS 11p15-p14 DELETION SYNDROME	100240736
MIM606529		 	CRANIOSYNOSTOSIS SYNDROME, AUTOSOMAL RECESSIVE	 
MIM606530	*	2q33-qter	CYTOCHROME P450, SUBFAMILY XXVIIA, POLYPEPTIDE 1; CYP27A1	1593
MIM606531	*	5q31-q34	SECRETOGLOBIN, FAMILY 3A, MEMBER 2; SCGB3A2	117156
MIM606532	*	21q22	HORMONALLY UPREGULATED NEU-ASSOCIATED KINASE; HUNK	30811
MIM606533	*	Chr.9	CHLORIDE INTRACELLULAR CHANNEL 3; CLIC3	9022
MIM606534	*	7q22.1	CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 43; CYP3A43	64816
MIM606535	*	1p33-p32.2	MYC-BINDING PROTEIN; MYCBP	26292
MIM606536	*	 	CHLORIDE INTRACELLULAR CHANNEL 4; CLIC4	25932
MIM606537	*	2q32	MYOSIN IB; MYO1B	4430
MIM606538	*	17p13	MYOSIN IC; MYO1C	4641
MIM606539	*	17q11-q12	MYOSIN ID; MYO1D	4642
MIM606540	*	18q21	MYOSIN VB; MYO5B	4645
MIM606541	*	2q21.1	MYOSIN VIIB; MYO7B	4648
MIM606542	*	Chr.12	HISTONE DEACETYLASE 7A; HDAC7A	51564
MIM606543	*	7p21-p15	HISTONE DEACETYLASE 9; HDAC9	9734
MIM606544	*	5q13	MITOCHONDRIAL ELONGATION FACTOR G2; GFM2	84340
MIM606545	#	17p13.2-p13.1	ICHTHYOSIS, LAMELLAR, 5; LI5	140560
MIM606546	*	6q24	HYDATIDIFORM MOLE-ASSOCIATED AND IMPRINTED TRANSCRIPT; HYMAI	57061
MIM606547	*	11q12-q13	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 4A; MS4A4A	51338
MIM606548	*	11q12-q13	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 6A; MS4A6A	64231
MIM606549	*	11q12-q13	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 8B; MS4A8B	83661
MIM606550	*	11q12-q13	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 12	54860
MIM606551	*	8p22	LEUCINE ZIPPER, PUTATIVE TUMOR SUPPRESSOR 1; LZTS1	11178
MIM606552	%	 	EPISODIC ATAXIA, TYPE 4; EA4	 
MIM606553	*	16p13.3	SOLUTE CARRIER FAMILY 9, MEMBER 3, REGULATOR 2; SLC9A3R2	9351
MIM606554	%	1q42	EPISODIC ATAXIA, TYPE 3; EA3	780905
MIM606555	*	14q21-q24	TRIPARTITE MOTIF-CONTAINING PROTEIN 9; TRIM9	114088
MIM606556	*	9q22-q31	TRIPARTITE MOTIF-CONTAINING PROTEIN 14; TRIM14	9830
MIM606557	*	2p16.1	B-CELL CLL/LYMPHOMA 11A; BCL11A	53335
MIM606558	*	14q32.1	B-CELL CLL/LYMPHOMA 11B; BCL11B	64919
MIM606559	*	11p15	TRIPARTITE MOTIF-CONTAINING PROTEIN 22; TRIM22	10346
MIM606560	*	8p23-p22	SPERM-ASSOCIATED ANTIGEN 11; SPAG11	10407
MIM606561	*	5q31-q33	SOLUTE CARRIER FAMILY 36 (PROTON/AMINO ACID SYMPORTER), MEMBER 1; SLC36A1	206358
MIM606562	*	15q24-q26	TRANSMEMBRANE 6 SUPERFAMILY, MEMBER 1; TM6SF1	53346
MIM606563	*	19p12	TRANSMEMBRANE 6 SUPERFAMILY, MEMBER 2; TM6SF2	53345
MIM606564	*	20q13	TRANSMEMBRANE PROSTATE ANDROGEN-INDUCED RNA; TMEPAI	56937
MIM606565	*	11q23.3	TRANSMEMBRANE PROTEASE, SERINE 4; TMPRSS4	56649
MIM606566	*	20q13.3	MYOSIN LIGHT CHAIN KINASE 2; MYLK2	85366
MIM606567	*	3q25	TRANSMEMBRANE 4 SUPERFAMILY, MEMBER 4; TM4SF4	7104
MIM606568	*	3p21.3	LEUCINE ZIPPER TRANSCRIPTION FACTOR-LIKE 1; LZTFL1	54585
MIM606569	*	3p21.3	SUPPRESSOR OF ACTIN MUTATIONS 1-LIKE; SACM1L	22908
MIM606570	*	7p14-p13	SECRETED FRIZZLED-RELATED PROTEIN 4; SFRP4	6424
MIM606571	*	18p11.2	CHROMOSOME 18 OPEN READING FRAME 1; C18ORF1	753
MIM606572	*	Chr.15	NADPH OXIDASE 5; NOX5	79400
MIM606573	*	6q21-q22.3	FYN-RELATED KINASE; FRK	2444
MIM606574	#	5p13.3	ALBINISM, OCULOCUTANEOUS, TYPE IV; OCA4	51151
MIM606575	*	2q31	MEMBRANE PROTEIN, PALMITOYLATED 4; MPP4	58538
MIM606576	*	10p15.1	TAF3 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR, 140-KD; TAF3	83860
MIM606577	*	20q11.23	SRC-LIKE ADAPTOR 2; SLA2	84174
MIM606578	*	 	AQUAPORIN 10; AQP10	89872
MIM606579	#	17p13	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1; VAMAS1	22861
MIM606580	*	19q13.2-q13.3	OPA3 GENE; OPA3	80207
MIM606581	#	 	POLYSUBSTANCE ABUSE, SUSCEPTIBILITY TO	 
MIM606582	*	 	DELTA-LIKE 1; DLL1	28514
MIM606583	*	11q13	PEROXIREDOXIN 5; PRDX5	25824
MIM606584	*	3p21.3	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 23; PTPN23	25930
MIM606585	*	4q21	ENAMELIN; ENAM	10117
MIM606586	*	5p13.3-p13.2	RETINOIC ACID-INDUCED 14; RAI14	26064
MIM606587	*	2q21.1	PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 18; PTPN18	26469
MIM606588	*	21q22.3	DNA METHYLTRANSFERASE 3-LIKE PROTEIN; DNMT3L	29947
MIM606589	*	7p21.1	SORTING NEXIN 13; SNX13	23161
MIM606590	*	17qter	NUCLEAR PROTEIN LOCALIZATION 4, S. CEREVISIAE, HOMOLOG OF; NPLOC4	55666
MIM606591	*	11q13	MUS81, S. CEREVISIAE, HOMOLOG OF; MUS81	80198
MIM606592	*	6q23-q24	VANIN 3; VNN3	55350
MIM606593	#	13q22-q34	LIG4 SYNDROME	3981
MIM606594	*	4q28	SET DOMAIN-CONTAINING PROTEIN 7; SETD7	80854
MIM606595	#	7q11.23	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F	3315
MIM606596	*	19q13.3	FUKUTIN-RELATED PROTEIN; FKRP	79147
MIM606597	*	2q35	PAIRED BOX GENE 3; PAX3	5077
MIM606598	*	8q13-q21.1	GANGLIOSIDE-INDUCED DIFFERENTIATION-ASSOCIATED PROTEIN 1; GDAP1	54332
MIM606599	*	1q21	THIOREDOXIN-INTERACTING PROTEIN; TXNIP	10628
MIM606600	*	 	RAS PROTEIN-SPECIFIC GUANINE NUCLEOTIDE-RELEASING FACTOR 1; RASGRF1	5923
MIM606601	*	17q11	ENDOGENOUS RETROVIRAL SEQUENCE E, 1; ERVE1	85314
MIM606602	*	8q22.3	BRAIN AND ACUTE LEUKEMIA GENE, CYTOPLASMIC; BAALC	79870
MIM606603	*	1q42.2-q43	EDAR-ASSOCIATED DEATH DOMAIN; EDARADD	128178
MIM606604	*	8q24.13	F-BOX ONLY PROTEIN 32; FBXO32	114907
MIM606605	*	3p21.3-p21.2	ATR-INTERACTING PROTEIN; ATRIP	84126
MIM606606	^	 	MOVED TO 262700	 
MIM606607	*	20q13.33	PROTEASOME SUBUNIT, ALPHA-TYPE, 7; PSMA7	5688
MIM606608	*	11q13	YES-ASSOCIATED PROTEIN 1, 65-KD; YAP1	10413
MIM606609	*	3p21.3-p21.2	3-PRIME @REPAIR EXONUCLEASE 1; TREX1	11277
MIM606610	*	20p	NSFL1 COFACTOR; NSFL1C	55968
MIM606611	*	8p23.1	DEFENSIN, BETA, 103A; DEFB103A	55894
MIM606612	#	19q13.3	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUT MENTAL RETARDATION), TYPE B, 5; MDDGB5	79147
MIM606613	%	9p	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1; HDLCQ1	192144
MIM606614	*	5q13	RAS PROTEIN-SPECIFIC GUANINE NUCLEOTIDE-RELEASING FACTOR 2; RASGRF2	5924
MIM606615	*	10q24	HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR; HIF1AN	55662
MIM606616	%	18p11.2	DYSLEXIA, SUSCEPTIBILITY TO, 6; DYX6	266691
MIM606617	^	 	MOVED TO 604169	 
MIM606618	*	Chr.17	DUAL-SPECIFICITY PHOSPHATASE 14; DUSP14	11072
MIM606619	*	4p15.31	GLUCOSIDASE, BETA, ACID 3; GBA3	57733
MIM606620	*	1q21	SLAM FAMILY, MEMBER 8; SLAMF8	56833
MIM606621	*	3p12-q13	INTRAFLAGELLAR TRANSPORT 57, CHLAMYDOMONAS, HOMOLOG OF: IFT57	55081
MIM606622	*	2q34-q36	SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A-LIKE PROTEIN 1; SMARCAL1	50485
MIM606623	*	12q13	17-@BETA-HYDROXYSTEROID DEHYDROGENASE VI; HSD17B6	8630
MIM606624	*	 	NEUROGENIN 2; NEUROG2	63973
MIM606625	*	1q23-q24	SLAM FAMILY, MEMBER 7; SLAMF7	57823
MIM606626	*	Chr.14	DISHEVELLED-ASSOCIATED ACTIVATOR OF MORPHOGENESIS 1; DAAM1	23002
MIM606627	*	6p21.2	DISHEVELLED-ASSOCIATED ACTIVATOR OF MORPHOGENESIS 2; DAAM2	23500
MIM606628	*	6p12	GLYCINE N-METHYLTRANSFERASE; GNMT	27232
MIM606629	*	6q12-q13	PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 1; RIMS1	22999
MIM606630	*	Chr.8	PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 2; RIMS2	9699
MIM606632		 	ODOR, MALE, WOMEN'S CHOICE OF	 
MIM606633	*	 	TRANSCRIPTION FACTOR Sp7; SP7	121340
MIM606634	*	12q13.1	DERMCIDIN; DCD	117159
MIM606635	*	21q21	PROTEASE, SERINE, 7; PRSS7	5651
MIM606636	*	17p13	NLR FAMILY, PYRIN DOMAIN-CONTAINING 1; NLRP1	22861
MIM606637	*	17q11	PEPTIDE YY, 2; PYY2	23615
MIM606638	*	17q11	PANCREATIC POLYPEPTIDE 2; PPY2	23614
MIM606639	*	3q25.1-q26.2	MITOCHONDRIAL ELONGATION FACTOR G1; GFM1	85476
MIM606640	%	18q21	AMYOTROPHIC LATERAL SCLEROSIS 3; ALS3	253
MIM606641	%	7q32.3	BODY MASS INDEX; BMI	170815
MIM606642	^	 	MOVED TO 606641	 
MIM606643	%	13q14	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 2; BMIQ2	192149
MIM606644	*	1q23.1	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 8; IGSF8	93185
MIM606645	*	4p14	CENTAURIN, DELTA-1; CENTD1	116984
MIM606646	*	Chr.11	CENTAURIN, DELTA-2; CENTD2	116985
MIM606647	*	 	CENTAURIN, DELTA-3; CENTD3	64411
MIM606648	*	6q24.1-q24.2	INTERLEUKIN 22 RECEPTOR, ALPHA-2; IL22RA2	116379
MIM606649	*	1p34	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 ENHANCER-BINDING PROTEIN 3; HIVEP3	59269
MIM606650	*	9q31.1	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE 3A; GRIN3A	116443
MIM606651	*	 	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE 3B; GRIN3B	116444
MIM606652	*	5q33.2	HEPATITIS A VIRUS CELLULAR RECEPTOR 2; HAVCR2	84868
MIM606653	*	1q32	LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 6; LGR6	59352
MIM606654	*	4q32	LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 7	59350
MIM606655	*	13q13.1	RELAXIN/INSULIN-LIKE FAMILY PEPTIDE RECEPTOR 2; RXFP2	122042
MIM606656	%	 	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 2; IBGC2	100874532
MIM606657	#	10p15-p14, 3q28-q29	GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO	10133, 4976
MIM606658	#	3p26-p25	SPINOCEREBELLAR ATAXIA 15; SCA15	3708
MIM606659	*	 	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 8, YEAST, HOMOLOG OF, B; TIMM8B	26521
MIM606660	%	3q24-q26	MELANOMA, UVEAL, SUSCEPTIBILITY TO, 1	170592
MIM606661	%	3p25.2-p25.1	MELANOMA, UVEAL, SUSCEPTIBILITY TO, 2	170593
MIM606662	%	8p23	WAARDENBURG SYNDROME, TYPE 2C; WS2C	170594
MIM606663	*	8p21.3-p21.2	LYSYL OXIDASE-LIKE 2; LOXL2	4017
MIM606664	#	6p12	GLYCINE N-METHYLTRANSFERASE DEFICIENCY	27232
MIM606665	*	 	OPSIN 4; OPN4	94233
MIM606666	*	11p14-p13	G PROTEIN-COUPLED RECEPTOR 48; GPR48	55366
MIM606667	*	12q15-q23	LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 5; LGR5	8549
MIM606668	%	16p	INFLAMMATORY BOWEL DISEASE 8; IBD8	170595
MIM606669	*	19q13.12	FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 5; FXYD5	53827
MIM606670	*	6p21.3	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 11; PPP1R11	6992
MIM606671	*	3p21	NCK-INTERACTING PROTEIN WITH SH3 DOMAIN; NCKIPSD	51517
MIM606672	*	17pter-p12	GLYCOPROTEIN Ib, PLATELET, ALPHA POLYPEPTIDE; GP1BA	2811
MIM606673	*	22q11.2	BETA-UREIDOPROPIONASE; UPB1	51733
MIM606674	%	19p13	INFLAMMATORY BOWEL DISEASE 6; IBD6	50942
MIM606675	%	14q11-q12	INFLAMMATORY BOWEL DISEASE 4; IBD4	50608
MIM606676	*	Chr.17	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 2; TRPV2	51393
MIM606677	*	12p13.2-p12.3	C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER C; CLEC4C	170482
MIM606678	*	2q37	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 8; TRPM8	79054
MIM606679	*	7q35	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 5; TRPV5	56302
MIM606680	*	7q33-q34	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 6; TRPV6	55503
MIM606681	*	5q35	NUCLEAR RECEPTOR-BINDING Su-var, ENHANCER OF ZESTE, AND TRITHORAX DOMAIN PROTEIN 1; NSD1	64324
MIM606682	*	22q11.2-q12.2	HPS4 GENE; HPS4	89781
MIM606683	*	Chr.11	FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 6; FXYD6	53826
MIM606684	*	19q13.12	FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 7; FXYD7	53822
MIM606685	#	5q33	CARDIOMYOPATHY, DILATED, 1L; CMD1L	6444
MIM606686	*	Chr.12	EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 1; EIF2B1	1967
MIM606687	*	2p23.3	EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 4; EIF2B4	8890
MIM606688	#	20pter-p12	SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES	5621
MIM606689	%	2cen-q13	GLAUCOMA 1, OPEN ANGLE, B; GLC1B	2722
MIM606690	#	16p13.3, 9q34	LYMPHANGIOLEIOMYOMATOSIS; LAM	7248, 7249
MIM606691	*	 	CARCINOEMBRYONIC ANTIGEN-LIKE 1; CEAL1	56971
MIM606692	*	16p13.3	TNF RECEPTOR-ASSOCIATED FACTOR 7; TRAF7	84231
MIM606693	#	1p36	KUFOR-RAKEB SYNDROME; KRS	23400
MIM606694	*	5p13	NUCLEOPORIN, 155-KD; NUP155	9631
MIM606695	*	1q43	OPSIN 3; OPN3	23596
MIM606696	*	6q25.1	KATANIN, p60 SUBUNIT, A1; KATNA1	11104
MIM606697	*	19p13.2	ZINC FINGER PROTEIN ZK1	10224
MIM606698	*	 	SRY-BOX 30	11063
MIM606699	*	Chr.17	HELICASE WITH ZINC FINGER DOMAIN; HELZ	9931
MIM606700	*	19p13.3	MIDNOLIN, MOUSE, HOMOLOG OF; MIDN	90007
MIM606701	*	10q11.23	DORSAL ROOT GANGLIA HOMEOBOX; DRGX	644168
MIM606702	*	6p21.1-p12	PKHD1 GENE; PKHD1	5314
MIM606703	#	 	DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA; FDFM	111
MIM606704	*	2p16	G PROTEIN-COUPLED RECEPTOR 75; GPR75	10936
MIM606705	#	9q13-q21	DEAFNESS, AUTOSOMAL DOMINANT 36; DFNA36	117531
MIM606706	*	9q13-q21	TRANSMEMBRANE CHANNEL-LIKE PROTEIN 1; TMC1	117531
MIM606707	*	20p13	TRANSMEMBRANE CHANNEL-LIKE PROTEIN 2; TMC2	117532
MIM606708	%	2q31	SPLIT-HAND/FOOT MALFORMATION 5; SHFM5	171157
MIM606709	*	4q25-q26	PROTEASE, SERINE, 12; PRSS12	8492
MIM606710	*	13q12	LIPOMA HMGIC FUSION PARTNER; LHFP	10186
MIM606711	%	16q	SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	171013
MIM606712	%	19q	SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	171014
MIM606713	#	1p34	VAN DER WOUDE SYNDROME 2; VWS2	149465
MIM606714	*	6q15	PROLINE-RICH NUCLEAR RECEPTOR COACTIVATOR 1; PNRC1	10957
MIM606715	*	2q35-q36	CATION CHANNEL, AMILORIDE-SENSITIVE, NEURONAL, 4; ACCN4	55515
MIM606716	*	2p13.1-p12	N-ACETYLTRANSFERASE 8; NAT8	9027
MIM606717	*	17p13.2	XIAP-ASSOCIATED FACTOR 1	54739
MIM606718	*	5q32-q33.1	SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 2; SLC26A2	1836
MIM606719	#	9p21	MELANOMA-PANCREATIC CANCER SYNDROME	1029
MIM606720	*	 	PLACENTAL PROTEIN 11	8909
MIM606721	#	 	LIPODYSTROPHY WITH CONGENITAL CATARACTS AND NEURODEGENERATION	 
MIM606722	*	8q22.2	NEUROCALCIN, DELTA; NCALD	83988
MIM606723	*	12q24.12-q24.13	MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 5; MAPKAPK5	8550
MIM606724	*	1p33	MITOGEN-ACTIVATED PROTEIN KINASE-INTERACTING SERINE/THREONINE KINASE 1; MKNK1	8569
MIM606725	*	15q21-q23	CLN6 GENE; CLN6	54982
MIM606726	*	20q12-q13.1	SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 5; SLC12A5	57468
MIM606727	*	10q24.2	NK2 HOMEOBOX 3; NKX2-3	159296
MIM606728	*	2q32-q33	SERUM DEPRIVATION RESPONSE PHOSPHATIDYLSERINE-BINDING PROTEIN; SDPR	8436
MIM606729	*	22q12	OXYSTEROL-BINDING PROTEIN 2; OSBP2	23762
MIM606730	*	18q11-q12	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 1A; OSBPL1A	114876
MIM606731	*	20q	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 2; OSBPL2	9885
MIM606732	*	7p15	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 3; OSBPL3	26031
MIM606733	*	11p15.4	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 5; OSBPL5	114879
MIM606734	*	2q32.1	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 6; OSBPL6	114880
MIM606735	*	17q21.2	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 7; OSBPL7	114881
MIM606736	*	12p	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 8; OSBPL8	114882
MIM606737	*	1p34.2-p32.2	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 9; OSBPL9	114883
MIM606738	*	3p25.3-p22	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 10; OSBPL10	114884
MIM606739	*	3q21.1	OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 11; OSBPL11	114885
MIM606740	*	19q13.2	ZINC FINGER PROTEIN 180; ZNF180	7733
MIM606741	*	19q13.2	ZINC FINGER PROTEIN 181; ZNF181	339318
MIM606742	*	4q32-q33	TOLLOID-LIKE 1; TLL1	7092
MIM606743	*	10q23-q24	TOLLOID-LIKE 2; TLL2	7093
MIM606744	#	18p11.31-q11.2	SECKEL SYNDROME 2; SCKL2	347729, 5932
MIM606745	*	10p11.21	PARTITIONING-DEFECTIVE PROTEIN 3, C. ELEGANS, HOMOLOG OF; PARD3	56288
MIM606746	*	19p13.3	CHROMOSOME 19 OPEN READING FRAME 10; C19ORF10	56005
MIM606747	*	17q22	VASCULAR ENDOTHELIAL ZINC FINGER 1; VEZF1	7716
MIM606748	*	16q24.1	COACTOSIN-LIKE PROTEIN 1; COTL1	23406
MIM606749	*	6p12-p11.2	TUBULOINTERSTITIAL NEPHRITIS ANTIGEN; TINAG	27283
MIM606750	*	20q13.31	Z-DNA BINDING PROTEIN 1; ZBP1	81030
MIM606751	*	11q23.3	TRANSMEMBRANE PROTEASE, SERINE 5; TMPRSS5	80975
MIM606752		 	ACUTE HEMORRHAGIC LEUKOENCEPHALITIS	 
MIM606753	*	1p31.3	TETRATRICOPEPTIDE REPEAT DOMAIN 4; TTC4	7268
MIM606754	*	20q11.2	SAM DOMAIN- AND HD DOMAIN-CONTAINING PROTEIN 1; SAMHD1	25939
MIM606755	*	1p36.13	PEPTIDYLARGININE DEIMINASE, TYPE III; PADI3	51702
MIM606756	*	1q23.3	17-@BETA-HYDROXYSTEROID DEHYDROGENASE VII; HSD17B7	51478
MIM606757	*	2p13	SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER 5; SLC4A5	57835
MIM606758	*	15q15.3	DUAL OXIDASE 1; DUOX1	53905
MIM606759	*	15q15.3	DUAL OXIDASE 2; DUOX2	50506
MIM606761	*	16q24	MALONYL-CoA DECARBOXYLASE; MLYCD	23417
MIM606762	#	10q23.3	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	2746
MIM606763	#	19q13.3-qter	CILIARY DYSKINESIA, PRIMARY, 2; CILD2	352909, 56162
MIM606764	#	4q12, 4q12	GASTROINTESTINAL STROMAL TUMOR; GIST	3815, 5156, 6390, 6391
MIM606765	*	2p25	THYROID PEROXIDASE; TPO	7173
MIM606766	#	6p21.3	SPERMATOGENIC FAILURE 3; SPGF3	338331
MIM606767	*	2p21	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY G, MEMBER 3; KCNG3	170850
MIM606768	#	2p13.3-p13.1	MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT	8291
MIM606769	*	4q21	HELICASE, POLQ-LIKE; HELQ	113510
MIM606770	%	5p15.2-p14	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 2; ADIPQTL2	171511
MIM606771	%	14p11.2-q13	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 3; ADIPQTL3	171512
MIM606772	%	 	MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKIN ANOMALIES	 
MIM606773		 	HEMIFACIAL MYOHYPERPLASIA; HMH	 
MIM606774	*	 	ALDEHYDE REDUCTASE-LIKE 6; ALDRL6	55586
MIM606775	*	 	CHONDROITIN SULFATE PROTEOGLYCAN 5; CSPG5	10675
MIM606776	*	15q15.2	TRANSGLUTAMINASE 7; TGM7	116179
MIM606777	#	1p35-p31.3	GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1	6513
MIM606778	*	Chr.12	SLINGSHOT, DROSOPHILA, HOMOLOG OF, 1; SSH1	54434
MIM606779	*	Chr.17	SLINGSHOT, DROSOPHILA, HOMOLOG OF, 2; SSH2	85464
MIM606780	*	Chr.11	SLINGSHOT, DROSOPHILA, HOMOLOG OF, 3; SSH3	54961
MIM606781	*	3p14.3	TRANSKETOLASE; TKT	7086
MIM606782	*	12p13	C-TYPE LECTIN DOMAIN FAMILY 1, MEMBER A; CLEC1A	51267
MIM606783	*	12p13	C-TYPE LECTIN DOMAIN FAMILY 1, MEMBER B; CLEC1B	51266
MIM606784	*	 	GLYCOGEN SYNTHASE KINASE 3-ALPHA; GSK3A	2931
MIM606785	#	2q37	CRIGLER-NAJJAR SYNDROME, TYPE II	54658
MIM606786	*	17q22-q24	CD300C ANTIGEN; CD300C	10871
MIM606787	%	1p31	PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1	171513
MIM606788	%	13q14-q21, 11p13, 1p	ANOREXIA NERVOSA, SUSCEPTIBILITY TO, 1; ANON1	171514, 3356, 627
MIM606789	%	8q	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 4; HBFQTL4	171515
MIM606790	*	17q24	CD300A ANTIGEN; CD300A	11314
MIM606791	*	 	TPTE AND PTEN HOMOLOGOUS INOSITOL LIPID PHOSPHATASE; TPIP	93492
MIM606792	*	18q11.2	HISTAMINE RECEPTOR H4; HRH4	59340
MIM606793	*	17q21	AMINOPEPTIDASE, PUROMYCIN-SENSITIVE; NPEPPS	9520
MIM606794	*	17q25.3	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 10; SLC25A10	1468
MIM606795	*	22q13	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 17; SLC25A17	10478
MIM606796	*	22q13	SUPPRESSION OF TUMORIGENICITY 13; ST13	6767
MIM606797	*	11q24-q25	SUPPRESSION OF TUMORIGENICITY 14; ST14	6768
MIM606798	#	4p16.1-p15.3	BLEPHAROSPASM, BENIGN ESSENTIAL	1816
MIM606799	%	5q12	STROKE, SUSCEPTIBILITY TO, 1	5144
MIM606800	*	17q25.2-q25.3	GLUCOSIDASE, ALPHA, ACID; GAA	2548
MIM606801	*	4p16.3	MACROPHAGE ERYTHROBLAST ATTACHER; MAEA	10296
MIM606802	*	19q13.3-q13.4	SPIB TRANSCRIPTION FACTOR; SPIB	6689
MIM606803	*	1p32.3	ACYL-CoA THIOESTERASE 11; ACOT11	26027
MIM606804	*	9q21.33	GOLGI PHOSPHOPROTEIN 2; GOLPH2	51280
MIM606805	*	3q26.2	GOLGI INTEGRAL MEMBRANE PROTEIN 4; GOLIM4	27333
MIM606806	*	21q22.3	FORMIMINOTRANSFERASE CYCLODEAMINASE; FTCD	10841
MIM606807	*	3p14.3-p14.2	INTERLEUKIN 17 RECEPTOR D; IL17RD	54756
MIM606808	*	10p11.1	MYOSIN IIIA; MYO3A	53904
MIM606809	*	1q42.1	ACYL-CoA-BINDING DOMAIN-CONTAINING PROTEIN 3; ACBD3	64746
MIM606810	*	22q11.2	PROLINE DEHYDROGENASE; PRODH	5625
MIM606811	*	1p36	ALDEHYDE DEHYDROGENASE, FAMILY 4, SUBFAMILY A, MEMBER 1; ALDH4A1	8659
MIM606812	#	1q42.1	FUMARASE DEFICIENCY	2271
MIM606813	*	9q34	SOLUTE CARRIER FAMILY 2i (FACILITATED GLUCOSE TRANSPORTER), MEMBER 6; SLC2A6	11182
MIM606814	*	11cen-q12	PROTEOGLYCAN 3; PRG3	10394
MIM606815	*	1p35-p34	CBP/P300-INTERACTING TRANSACTIVATOR, WITH GLU/ASP-RICH CARBOXY TERMINAL DOMAIN, 4; CITED4	163732
MIM606816	*	 	SID1 TRANSMEMBRANE FAMILY, MEMBER 1; SIDT1	54847
MIM606817	*	6p21.3	PRE-T-CELL RECEPTOR, ALPHA-CHAIN PRECURSOR; PTCRA	171558
MIM606818	*	11q12-q13.1	DIPEPTIDYL PEPTIDASE III; DPP3	10072
MIM606819	*	15q22	DIPEPTIDYL PEPTIDASE VIII; DPP8	54878
MIM606820	*	1q31.2-q31.3	GLUTAREDOXIN 2; GLRX2	51022
MIM606821	*	7q31	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 5; COG5	10466
MIM606822	*	1p34-p33	PROTEIN O-MANNOSE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE; POMGNT1	55624
MIM606823	*	8p12	G PROTEIN-COUPLED RECEPTOR 124; GPR124	25960
MIM606824	#	22q13.1	GLUCOSE/GALACTOSE MALABSORPTION; GGM	6523
MIM606825	*	7p12.3	TENSIN 3; TNS3	64759
MIM606826	*	17q21.1	PLEXIN DOMAIN-CONTAINING PROTEIN 1; PLXDC1	57125
MIM606827	*	10p12.3	PLEXIN DOMAIN-CONTAINING PROTEIN 2; PLXDC2	84898
MIM606828	*	2p13.3	N-ACETYLGLUCOSAMINE KINASE; NAGK	55577
MIM606829	*	9q13	FRATAXIN; FXN	2395
MIM606830	*	Chr.9	ATP/GTP-BINDING PROTEIN 1; AGTPBP1	23287
MIM606831	*	2p22-p21	NLR FAMILY, CASPASE RECRUITMENT DOMAIN-CONTAINING 4; NLRC4	58484
MIM606832	*	5q15	ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1; ERAP1	51752
MIM606833	*	7q36	MYELOID/LYMPHOID OR MIXED-LINEAGE LEUKEMIA 3; MLL3	58508
MIM606834	*	19q13.1	MYELOID/LYMPHOID OR MIXED-LINEAGE LEUKEMIA 4	9757
MIM606835	#	 	DIGITAL ARTHROPATHY-BRACHYDACTYLY, FAMILIAL; FDAB	59341
MIM606836	*	15q21.3	GLUCOSAMINYL (N-ACETYL) TRANSFERASE 3, MUCIN-TYPE; GCNT3	9245
MIM606837	*	8q11	RB1-INDUCIBLE COILED-COIL 1; RB1CC1	9821
MIM606838	*	16p12-p11.2	PYD AND CARD DOMAIN-CONTAINING PROTEIN; PYCARD	29108
MIM606839	*	11p15.5	CADHERIN-RELATED FAMILY, MEMBER 5; CDHR5	53841
MIM606840	%	 	PARASOMNIA, SLEEP BRUXISM TYPE; PSMNSB	 
MIM606841	*	1q23.3	DEATH EFFECTOR DOMAIN-CONTAINING PROTEIN; DEDD	9191
MIM606842	%	 	CARDIONEUROMYOPATHY WITH HYALINE MASSES AND NEMALINE RODS	 
MIM606843	#	20q12-q13.2	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3; HIGM3	958
MIM606844	*	2p13	ALMS1 GENE; ALMS1	7840
MIM606845	*	6q21	GOLGI-ASSOCIATED PDZ AND COILED-COIL DOMAINS-CONTAINING PROTEIN; GOPC	57120
MIM606846	*	 	SET AND MYND DOMAIN-CONTAINING PROTEIN 1; SMYD1	150572
MIM606847	*	5q32-q33.1	TCOF1 GENE; TCOF1	6949
MIM606848	*	1q31.3	NEVER IN MITOSIS GENE A-RELATED KINASE 7; NEK7	140609
MIM606849	*	19p13.2	UBIQUITIN-LIKE 5; UBL5	59286
MIM606850	*	14q13	MIRROR-IMAGE POLYDACTYLY GENE 1; MIPOL1	145282
MIM606851		 	CREE MENTAL RETARDATION SYNDROME	 
MIM606852	%	1p32	PARKINSON DISEASE 10; PARK10	170534
MIM606853	*	6p21.3	ATPase, H+ TRANSPORTING, LYSOSOMAL, 13-KD, V1 SUBUNIT G, ISOFORM 2; ATP6V1G2	534
MIM606854	#	16q13	POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	100506658, 10381, 26128, 347733, 51807, 9289
MIM606855	*	19p13.3	RELAXIN 3; RLN3	117579
MIM606856	#	4q32.3	PANCREATIC CANCER, SUSCEPTIBILITY TO, 1	23022
MIM606857	*	6p12	GLUTAMATE-CYSTEINE LIGASE, CATALYTIC SUBUNIT; GCLC	2729
MIM606858	^	8p23	MOVED TO 251200	 
MIM606860	*	11q11-q13.1	COMPLEMENT COMPONENT 1 INHIBITOR; C1NH	710
MIM606861	*	11q24	PROSTATE- AND TESTIS-EXPRESSED GENE	160065
MIM606862	*	19q13.4	OSTEOCLAST-ASSOCIATED RECEPTOR	126014
MIM606863	*	Chr.8	THYMOCYTE SELECTION-ASSOCIATED HIGH MOBILITY GROUP BOX; TOX	9760
MIM606864	#	1q21, 11q23, 1p36.1-p35	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	6390, 6391, 6392
MIM606865	*	6q16	FUCOSYLTRANSFERASE 9; FUT9	10690
MIM606866	*	11q13	MITOCHONDRIAL RIBOSOMAL PROTEIN L49; MRPL49	740
MIM606867	*	3p21.3	GOLGI REASSEMBLY STACKING PROTEIN 1; GORASP1	64689
MIM606868	*	7q33-q34	HOMEODOMAIN-INTERACTING PROTEIN KINASE 2; HIPK2	28996
MIM606869	*	15q23-q24	HEXOSAMINIDASE A; HEXA	3073
MIM606870	*	21q21.2	JUNCTIONAL ADHESION MOLECULE 2; JAM2	58494
MIM606871	*	11q25	JUNCTIONAL ADHESION MOLECULE 3; JAM3	83700
MIM606872	*	7q22.3	CAS-BR-M MURINE ECTOPIC RETROVIRAL TRANSFORMING SEQUENCE LIKE-1; CBLL1	79872
MIM606873	*	5q13	HEXOSAMINIDASE B; HEXB	3074
MIM606874	%	3p21	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 6; HSCR6	246321
MIM606875	%	19q12	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 7; HSCR7	246322
MIM606876	*	22q12.1	PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, BETA; PITPNB	23760
MIM606877	*	4q32.3	ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER C; ANP32C	23520
MIM606878	*	Chr.12	ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER D; ANP32D	23519
MIM606879	*	1q12	PHOSPHOGLYCERATE DEHYDROGENASE; PHGDH	26227
MIM606880	*	6q15	CASPASE 8-ASSOCIATED PROTEIN 2; CASP8AP2	9994
MIM606881	*	16q22	FORMIN HOMOLOGY-2 DOMAIN-CONTAINING PROTEIN 1; FHOD1	29109
MIM606882	*	13q14.3-q21.1	ATPase, Cu(2+)-TRANSPORTING, BETA POLYPEPTIDE; ATP7B	540
MIM606883	*	12q12	INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 4; IRAK4	51135
MIM606884	*	3p21.3	RNA-BINDING MOTIF PROTEIN 5; RBM5	10181
MIM606885	*	12q22-qter	ACYL-CoA DEHYDROGENASE, SHORT-CHAIN; ACADS	35
MIM606886	*	3p21.3	RNA-BINDING MOTIF PROTEIN 6; RBM6	10180
MIM606887	*	Chr.12	SULFITE OXIDASE; SUOX	6821
MIM606888	*	8p11.21	CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 6; CHRNA6	8973
MIM606889	#	1q31-q42	ALZHEIMER DISEASE 4	348, 5664
MIM606890	*	14q31	GALACTOSYLCERAMIDASE; GALC	2581
MIM606891	*	1q23	Fc RECEPTOR-LIKE PROTEIN A; FCRLA	84824
MIM606892	*	 	SYNTAXIN 12; STX12	23673
MIM606893		 	VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	 
MIM606894		 	DUODENOJEJUNAL ATRESIA WITH VOLVULUS, ABSENT DORSAL MESENTERY, AND ABSENT SUPERIOR MESENTERIC ARTERY	 
MIM606895		 	SYMPHALANGISM, DISTAL, WITH MICRODONTIA, DENTAL PULP STONES, AND NARROWED ZYGOMATIC ARCH	 
MIM606896	%	3p12-q13	DYSLEXIA, SUSCEPTIBILITY TO, 5; DYX5	171089
MIM606897	*	1q42.1-q42.2	LYSOSOMAL TRAFFICKING REGULATOR; LYST	1130
MIM606898	*	19q13.4	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-6 SUBUNIT; CACNG6	59285
MIM606899	*	19q13.4	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-7 SUBUNIT; CACNG7	59284
MIM606900	*	19q13.4	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-8 SUBUNIT; CACNG8	59283
MIM606902	*	 	PYGOPUS, DROSOPHILA, HOMOLOG OF, 1	26108
MIM606903	*	1q21.3	PYGOPUS, DROSOPHILA, HOMOLOG OF, 2	90780
MIM606904	^	 	MOVED TO 254770	 
MIM606905	*	20q13.13	PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE-DEPENDENT RAC EXCHANGER 1; PREX1	57580
MIM606906	*	7p22	FTSJ, E. COLI, HOMOLOG OF, 2; FTSJ2	29960
MIM606907	*	 	APOLIPOPROTEIN M; APOM	55937
MIM606908	*	11p11.2-p11.12	ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 2; ARFGAP2	84364
MIM606909	*	1q24-q25	VESICLE-ASSOCIATED MEMBRANE PROTEIN 4; VAMP4	8674
MIM606910	*	15q21	BCL2-LIKE 10; BCL2L10	10017
MIM606911	*	5q13.3-q14.1	SECRETORY CARRIER MEMBRANE PROTEIN 1; SCAMP1	9522
MIM606912	*	Chr.15	SECRETORY CARRIER MEMBRANE PROTEIN 2; SCAMP2	10066
MIM606913	*	1q21	SECRETORY CARRIER MEMBRANE PROTEIN 3; SCAMP3	10067
MIM606914	*	6q22.31	PROTEIN KINASE, cAMP-DEPENDENT CATALYTIC, INHIBITOR BETA; PKIB	5570
MIM606915	*	6q16.1-q16.3	G PROTEIN-COUPLED RECEPTOR 63; GPR63	81491
MIM606916	*	1p13.3	G PROTEIN-COUPLED RECEPTOR 61; GPR61	83873
MIM606917	*	3p21.1	G PROTEIN-COUPLED RECEPTOR 62; GPR62	118442
MIM606918	*	14q	GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 5; GOLGA5	9950
MIM606919	*	19p12	CERAMIDE SYNTHASE 1; CERS1	10715
MIM606920	*	1q11	CERAMIDE SYNTHASE 2; CERS2	29956
MIM606921	*	4p16.1	G PROTEIN-COUPLED RECEPTOR 78; GPR78	27201
MIM606922	*	13q32.1	G PROTEIN-COUPLED RECEPTOR 80; GPR80	27199
MIM606923	*	12q24.31	G PROTEIN-COUPLED RECEPTOR 81; GPR81	27198
MIM606925	*	 	G PROTEIN-COUPLED RECEPTOR 103; GPR103	84109
MIM606926	*	12p13	LYSOPHOSPHATIDIC ACID RECEPTOR 5; LPAR5	57121
MIM606927	*	6q23.2	TRACE AMINE-ASSOCIATED RECEPTOR 8; TAAR8	83551
MIM606928	%	1p36	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 3; BMND3	246259
MIM606929	*	5q35.2	THO COMPLEX, SUBUNIT 3; THOC3	84321
MIM606930	*	18p11.32	THO COMPLEX, SUBUNIT 1; THOC1	9984
MIM606932	*	 	VACUOLAR PROTEIN SORTING 29, YEAST, HOMOLOG OF; VPS29	51699
MIM606933	*	11q14-q21	TYROSINASE; TYR	7299
MIM606934	*	15q13.3	NADH DEHYDROGENASE 1 ALPHA SUBCOMPLEX, ASSEMBLY FACTOR 1; NDUFAF1	51103
MIM606935	*	10p15.1	RNA-BINDING MOTIF PROTEIN 17; RBM17	84991
MIM606936	*	19q13.32	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 4; TRPM4	54795
MIM606937	#	15q25.3	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 5; SCAR5	9640
MIM606938	*	10q25.2-q26.3	UROPORPHYRINOGEN III SYNTHASE; UROS	7390
MIM606939	*	8p21.3	ATPasE, H+ TRANSPORTING, LYSOSOMAL, 56/58-KD, V1 SUBUNIT B, ISOFORM 2; ATP6V1B2	526
MIM606940	*	8q21.12	ZINC FINGER HOMEOBOX 4; ZFHX4	79776
MIM606941	*	11q23	ALG9, S. CEREVISIAE, HOMOLOG OF; ALG9	79796
MIM606942	*	19p13.11	COATOMER PROTEIN COMPLEX, SUBUNIT EPSILON; COPE	11316
MIM606943	#	17q24-q25	USHER SYNDROME, TYPE IG; USH1G	124590
MIM606944	*	5q12	ERBB2 INTERACTING PROTEIN; ERBB2IP	55914
MIM606945	*	19p13.2	LOW DENSITY LIPOPROTEIN RECEPTOR; LDLR	3949
MIM606946	*	Chr.9	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 2; ANAPC2	29882
MIM606947	*	4p15.2	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 4; ANAPC4	29945
MIM606948	*	Chr.12	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 5; ANAPC5	51433
MIM606949	*	 	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 7; ANAPC7	51434
MIM606950	*	12q15-q21	THYROTROPIN-RELEASING HORMONE-DEGRADING ECTOENZYME; TRHDE	29953
MIM606951	*	2q24	INTERFERON-INDUCED HELICASE C DOMAIN-CONTAINING PROTEIN 1; IFIH1	64135
MIM606952	#	11q14-q21	ALBINISM, OCULOCUTANEOUS, TYPE IB; OCA1B	7299
MIM606953	*	1p36-p35	UDP-GALACTOSE-4-EPIMERASE; GALE	2582
MIM606954	*	19p13	ZINC FINGER PROTEIN 253; ZNF253	56242
MIM606956	*	19q13	ZINC FINGER PROTEIN 256; ZNF256	10172
MIM606957	*	19q13	ZINC FINGER PROTEIN 257; ZNF257	113835
MIM606958	*	Chr.14	MEMBRANE PROTEIN, PALMITOYLATED 5; MPP5	64398
MIM606959	*	7p21-p15	MEMBRANE PROTEIN, PALMITOYLATED 6; MPP6	51678
MIM606960	%	22q12.1-q12.2	INSULINOMA TUMOR SUPPRESSOR GENE LOCUS	282551
MIM606961	*	2p12	WW DOMAIN-BINDING PROTEIN 1; WBP1	23559
MIM606962	*	17q25	WW DOMAIN-BINDING PROTEIN 2; WBP2	23558
MIM606963	%	14q32.1, 11q22-q23, 2q, 22q12	PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; COPD	260431, 3162, 4312, 5265
MIM606964	*	6p21	SERINE/THREONINE PROTEIN KINASE 38; STK38	11329
MIM606965	*	7q35	FAS-ACTIVATED SERINE/THREONINE KINASE; FASTK	10922
MIM606966	#	1p36	NEPHRONOPHTHISIS 4; NPHP4	261734
MIM606967	*	16q22.1	LECITHIN:CHOLESTEROL ACYLTRANSFERASE; LCAT	3931
MIM606968	*	Chr.16	EUKARYOTIC ELONGATION FACTOR 2 KINASE; EEF2K	29904
MIM606969	*	 	GEM-ASSOCIATED PROTEIN 4; GEMIN4	50628
MIM606972	%	14q23	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 2; EIG2	353124
MIM606973	*	17q25.1	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 1; COG1	9382
MIM606974	*	1q42.2	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 2; COG2	22796
MIM606975	*	13q14.12	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 3; COG3	83548
MIM606976	*	16q22.1	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 4; COG4	25839
MIM606977	*	13q13.3	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 6; COG6	57511
MIM606978	*	16p	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 7; COG7	91949
MIM606979	*	16q22.1	COMPONENT OF OLIGOMERIC GOLGI COMPLEX 8; COG8	84342
MIM606980	*	1q42.2	AARF DOMAIN-CONTAINING KINASE 3; ADCK3	56997
MIM606981	*	14q21	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-2; GNG2	54331
MIM606982	*	1q43	GERANYLGERANYL DIPHOSPHATE SYNTHASE 1; GGPS1	9453
MIM606983	*	Chr.11	DIACYLGLYCEROL O-ACYLTRANSFERASE 2; DGAT2	84649
MIM606984	%	 	HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 2	 
MIM606985	*	11p13	ELONGATION PROTEIN 4, S. CEREVISIAE, HOMOLOG OF; ELP4	26610
MIM606987	*	3q21-q23	G PROTEIN-COUPLED RECEPTOR KINASE 7; GRK7	131890
MIM606988	*	Chr.15	CALCINEURIN B HOMOLOGOUS PROTEIN	11261
MIM606989	*	17q23.1	MYELOPEROXIDASE; MPO	4353
MIM606990	*	3q23	COATOMER PROTEIN COMPLEX, SUBUNIT BETA-2; COPB2	9276
MIM606991	*	3p21.31	INOSITOL HEXAPHOSPHATE KINASE 1; IHPK1	9807
MIM606992	*	3p21	INOSITOL HEXAPHOSPHATE KINASE 2; IHPK2	51447
MIM606993	*	6p21	INOSITOL HEXAPHOSPHATE KINASE 3; IHPK3	117283
MIM606994	*	3q29	TYROSINE KINASE, NONRECEPTOR, 2; TNK2	10188
MIM606995	%	3q22	SENIOR-LOKEN SYNDROME 3; SLSN3	260432
MIM606996	#	1p36	SENIOR-LOKEN SYNDROME 4; SLSN4	261734
MIM606997	*	2p13-p12	NUCLEAR DNA-BINDING PROTEIN C1D	10438
MIM606998	*	6p21.3	FLOTILLIN 1; FLOT1	10211
MIM606999	*	9p13	GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE; GALT	2592
MIM607000	*	17q21.1	MEDIATOR COMPLEX SUBUNIT 24; MED24	9862
MIM607001	*	9q34.3	EUCHROMATIC HISTONE METHYLTRANSFERASE 1; EHMT1	79813
MIM607002	*	3p21.1	PROKINETICIN 2; PROK2	60675
MIM607003	*	5q22.1	THYMIC STROMAL LYMPHOPOIETIN; TSLP	85480
MIM607004	%	5p13.3-p13.2	BRACHYDACTYLY, TYPE A1, B	246260
MIM607005	*	5q33.2	GEM-ASSOCIATED PROTEIN 5	25929
MIM607006	*	 	GEM-ASSOCIATED PROTEIN 6; GEMIN6	79833
MIM607007	*	1q22	SNARE-ASSOCIATED PROTEIN SNAPIN; SNAPAP	23557
MIM607008	*	1p31	ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN; ACADM	34
MIM607009	*	9q22	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 6; TRPM6	140803
MIM607010	*	3p21.1	DECAPPING ENZYME 1, S. CEREVISIAE, HOMOLOG OF, A; DCP1A	55802
MIM607011	*	4p16.1	UBIQUITIN-SPECIFIC PROTEASE 17; USP17	391627
MIM607012	*	5q13	B-DOUBLE PRIME 1, SUBUNIT OF RNA POLYMERASE III TRANSCRIPTION INITIATION FACTOR IIIB; BDP1	55814
MIM607013	*	8p11.23	BRF2 SUBUNIT OF RNA POLYMERASE III TRANSCRIPTION INITIATION FACTOR; BRF2	55290
MIM607014	#	4p16.3	HURLER SYNDROME	3425
MIM607015	#	4p16.3	HURLER-SCHEIE SYNDROME	3425
MIM607016	#	4p16.3	SCHEIE SYNDROME	3425
MIM607017	%	6p21.3	DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21	192644
MIM607018	*	1p31.1	LATROPHILIN HOMOLOG 1; LPHH1	23266
MIM607019	*	12q14.1	RAS ASSOCIATION DOMAIN FAMILY PROTEIN 3; RASSF3	283349
MIM607020	*	1q32.1	RAS ASSOCIATION DOMAIN FAMILY PROTEIN 5; RASSF5	83593
MIM607021	*	22q12.1	SEIZURE-RELATED 6-LIKE; SEZ6L	23544
MIM607022	*	20q13.2	CCCTC-BINDING FACTOR-LIKE PROTEIN; CTCFL	140690
MIM607023	*	5q12-q13	POLO-LIKE KINASE 2; PLK2	10769
MIM607024	*	 	DEBRANCHING ENZYME 1, S. CEREVISIAE, HOMOLOG OF; DBR1	51163
MIM607025	*	Chr.9	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE; MELK	9833
MIM607026	*	11p15.1	NEURON NAVIGATOR 2; NAV2	89797
MIM607027	*	3p13	ATPase, H+ TRANSPORTING, LYSOSOMAL ALPHA POLYPEPTIDE, 70-KD, ISOFORM 1; ATP6V1A1	523
MIM607028	*	16q22	ATPase, H+ TRANSPORTING, LYSOSOMAL, 38-KD, V0 SUBUNIT D, ISOFORM 1; ATP6V0D1	9114
MIM607029	*	2p11.2	VESICLE-ASSOCIATED MEMBRANE PROTEIN 5; VAMP5	10791
MIM607030	*	2q24.2	GRANCALCIN; GCA	25801
MIM607031	*	4p14	LIPOIC ACID SYNTHASE; LIAS	11019
MIM607032	*	16p12	SMG1, C. ELEGANS, HOMOLOG OF	23049
MIM607033	*	6q25	TRANSCRIPTION FACTOR B1, MITOCHONDRIAL; TFB1M	51106
MIM607034	^	 	MOVED TO 135700	 
MIM607035	*	10q24-q25	SUPPRESSOR OF FUSED, DROSOPHILA, HOMOLOG OF; SUFU	51684
MIM607036	*	15q14-q15	ISOVALERYL-CoA DEHYDROGENASE; IVD	3712
MIM607037	*	3q27	ENOYL-CoA HYDRATASE/3-HYDROXYACYL CoA DEHYDROGENASE; EHHADH	1962
MIM607038	*	16p12.2	OTOANCORIN; OTOA	146183
MIM607039	#	16p12.2	DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22	146183
MIM607040	*	16q12.1	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 11; ABCC11	85320
MIM607041	*	16q12.1	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 12; ABCC12	94160
MIM607042	*	16p12.1	CLN3 GENE; CLN3	1201
MIM607043	*	6q21	TRAF3-INTERACTING PROTEIN 2; TRAF3IP2	10758
MIM607045	*	12q21	RHABDOMYOSARCOMA 2-ASSOCIATED TRANSCRIPT; RMST	196475
MIM607046	*	22q12-q13	TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 22, YEAST, HOMOLOG OF; TOMM22	56993
MIM607047	*	14q24.3-q31	ATAXIN 3; ATXN3	4287
MIM607048	*	17q11-q21	START DOMAIN-CONTAINING PROTEIN 3; STARD3	10948
MIM607049	*	5q22	START DOMAIN-CONTAINING PROTEIN 4; STARD4	134429
MIM607050	*	15q26	START DOMAIN-CONTAINING PROTEIN 5; STARD5	80765
MIM607051	*	18q21	START DOMAIN-CONTAINING PROTEIN 6; STARD6	147323
MIM607052	*	3p21.3	TUMOR SUPPRESSOR CANDIDATE 2; TUSC2	11334
MIM607053	%	8q23	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2; HDLCQ2	353127
MIM607054	*	1q31	PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY A, MEMBER 3; PHLDA3	23612
MIM607055	*	 	TRANSCRIPTION FACTOR B2, MITOCHONDRIAL; TFB2M	64216
MIM607056	*	3q11.2	INTERPHOTORECEPTOR MATRIX PROTEOGLYCAN 2; IMPG2	50939
MIM607057	*	22q11.2	UBIQUITIN-SPECIFIC PROTEASE 18; USP18	11274
MIM607058	*	15q14	GAP JUNCTION PROTEIN, DELTA-2; GJD2	57369
MIM607059	*	8q24.3	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 4; SLC39A4	55630
MIM607060	#	12q12	PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8	120892
MIM607061	*	Chr.12	PROSTAGLANDIN E SYNTHASE 3; PTGES3	10728
MIM607062	*	 	FK506-BINDING PROTEIN 7; FKBP7	51661
MIM607063	*	17q21.2	FK506-BINDING PROTEIN 10; FKBP10	60681
MIM607064	*	3q21-q24	PROCOLLAGEN C-ENDOPEPTIDASE ENHANCER 2; PCOLCE2	26577
MIM607065	*	2p22.2	GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE; QPCT	25797
MIM607066	*	17p13	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 3; TRPV3	162514
MIM607067	*	17q21.1	SAITOHIN	246744
MIM607068	*	3p21.3	CYTOCHROME b561 DOMAIN-CONTAINING PROTEIN 2; CYB561D2	11068
MIM607069	*	 	PL6 GENE	11070
MIM607070	*	3p21.3	ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 10; ZMYND10	51364
MIM607071	*	3p21.3-p21.2	HYALURONOGLUCOSAMINIDASE 1; HYAL1	3373
MIM607072	*	3p21.3	TUMOR SUPPRESSOR CANDIDATE 4; TUSC4	10641
MIM607073	*	3p21.3	FUS2 GENE	24142
MIM607074	*	19q13.3	PROTEIN KINASE D2; PRKD2	25865
MIM607075	*	7q22.1	PDGFA-ASSOCIATED PROTEIN 1; PDAP1	11333
MIM607076	*	 	PROTEASE INHIBITOR 15; PI15	51050
MIM607077	*	2p21	PROTEIN KINASE C, NU; PRKCN	23683
MIM607078	#	2p24-p23	EPIPHYSEAL DYSPLASIA, MULTIPLE, 5; EDM5	4148
MIM607079	*	1q21.3	RHESUS BLOOD GROUP, B GLYCOPROTEIN; RHBG	57127
MIM607080	#	12q13.1	46,XY GONADAL DYSGENESIS, PARTIAL, WITH MINIFASCICULAR NEUROPATHY	50846
MIM607081	*	12p13.3	TAP-BINDING PROTEIN-LIKE; TAPBPL	55080
MIM607082	*	3p21.3	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 2; CACNA2D2	9254
MIM607083	*	8p12	WOLF-HIRSCHHORN SYNDROME CANDIDATE 1-LIKE 1; WHSC1L1	54904
MIM607084	#	9q32-q34	DEAFNESS, AUTOSOMAL RECESSIVE 31; DFNB31	25861
MIM607085	%	6p21.3	MYASTHENIA GRAVIS WITH THYMUS HYPERPLASIA	246750
MIM607086	%	11q23.3-q24	AORTIC ANEURYSM, FAMILIAL THORACIC 1; AAT1	252842
MIM607087	%	5q13-q14	AORTIC ANEURYSM, FAMILIAL THORACIC 2; AAT2	252843
MIM607088	%	11q13	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 3; DSMA3	246751
MIM607089	*	Chr.15	CYCLIN D-TYPE-BINDING PROTEIN 1; CCNDBP1	23582
MIM607090	*	1p36.11	SYF2, S. CEREVISIAE, HOMOLOG OF; SYF2	25949
MIM607091	#	9p13	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IId; CDG2D	2683
MIM607092	*	19q13.2	SPHINGOSINE KINASE 2; SPHK2	56848
MIM607093	*	1p36.3	5,10-@METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR	4524
MIM607094	*	2p21	SUPPRESSOR OF CYTOKINE SIGNALING 5	9655
MIM607095	#	9p21-p12	ANAUXETIC DYSPLASIA	6023
MIM607096	*	11q13	SOLUTE CARRIER FAMILY 22 (URATE TRANSPORTER), MEMBER 12; SLC22A12	116085
MIM607097	*	11q13	SOLUTE CARRIER FAMILY 22 (ORGANIC ANION/CATION TRANSPORTER), MEMBER 11	55867
MIM607099	*	Chr.11	MBD2-INTERACTING ZINC FINGER PROTEIN; MIZF	25988
MIM607100	*	2q13	NEPHROCYSTIN 1; NPHP1	4867
MIM607101	#	10p11.1	DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30	53904
MIM607102	*	11p13	WT1 GENE; WT1	7490
MIM607103	*	 	ARGINYLTRANSFERASE 1; ATE1	11101
MIM607104	*	11q12	TANKYRASE 1-BINDING PROTEIN 1; TNKS1BP1	85456
MIM607105	*	6q25.1	NADPH OXIDASE 3; NOX3	50508
MIM607106	*	20q11.21	MINOR HISTOCOMPATIBILITY 13; HM13	81502
MIM607107	%	17p13.1, 4p15.1-q12	NASOPHARYNGEAL CARCINOMA	257641, 7157
MIM607108	*	11p13	PAIRED BOX GENE 6; PAX6	5080
MIM607109	*	22q13	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3A; APOBEC3A	200315
MIM607110	*	22q13	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3B; APOBEC3B	9582
MIM607111	*	13q12.3	SPG20 GENE; SPG20	23111
MIM607112	*	1p36	F-BOX ONLY PROTEIN 2; FBXO2	26232
MIM607113	*	22q12-q13.2	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3G; APOBEC3G	60489
MIM607114	*	20p13	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 33; ADAM33	80332
MIM607115	#	1q44	CINCA SYNDROME; CINCA	114548
MIM607116	%	20p	ALZHEIMER DISEASE 8	353128
MIM607117	*	8p23	MCPH1 GENE; MCPH1	79648
MIM607118	*	 	MITOCHONDRIAL RIBOSOMAL PROTEIN L3; MRPL3	11222
MIM607119	*	 	DOUBLE RING FINGER PROTEIN	25897
MIM607120	*	20p12	PHOSPHOLIPASE C, BETA-1; PLCB1	23236
MIM607122	*	 	PROKINETICIN RECEPTOR 1; PROKR1	10887
MIM607123	*	20p13	PROKINETICIN RECEPTOR 2; PROKR2	128674
MIM607124	*	 	PHOSPHATIDIC ACID PHOSPHATASE TYPE 2A; PPAP2A	8611
MIM607125	*	 	PHOSPHATIDIC ACID PHOSPHATASE TYPE 2B; PPAP2B	8613
MIM607126	*	 	PHOSPHATIDIC ACID PHOSPHATASE TYPE 2C; PPAP2C	8612
MIM607127	*	 	RAB6-INTERACTING PROTEIN 2; RAB6IP2	23085
MIM607128	*	 	TRF1-INTERACTING ANKYRIN-RELATED ADP-RIBOSE POLYMERASE 2; TNKS2	80351
MIM607129	*	6q16.1	MICROTUBULE-ASSOCIATED MONOOXYGENASE, CALPONIN AND LIM DOMAINS-CONTAINING, 1; MICAL1	64780
MIM607130	*	17q25.3	REGULATORY ASSOCIATED PROTEIN OF MTOR; RPTOR	57521
MIM607131	%	15q26.1	MACROCEPHALY WITH MULTIPLE EPIPHYSEAL DYSPLASIA AND DISTINCTIVE FACIES	260403
MIM607132		 	LARYNGEAL ATRESIA, ENCEPHALOCELE, AND LIMB DEFORMITIES	 
MIM607133	^	22q11.2-q12.2	CATARACT, SUTURAL, WITH PUNCTATE AND CERULEAN OPACITIES	1415
MIM607134	%	13q21	SPECIFIC LANGUAGE IMPAIRMENT 3; SLI3	780906
MIM607135	%	3p	CREATININE CLEARANCE QUANTITATIVE TRAIT LOCUS	261727
MIM607136	#	6q27	SPINOCEREBELLAR ATAXIA 17; SCA17	6908
MIM607137	*	4q13-q21	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D-LIKE PROTEIN; HNRNPDL	9987
MIM607138	*	1q21.3	cAMP RESPONSE ELEMENT-BINDING PROTEIN 3-LIKE 4; CREB3L4	148327
MIM607139	*	16q24.3	FANCA GENE; FANCA	2175
MIM607140	#	 	ANGIOID STREAKS	 
MIM607141	*	9p13-p12	CHROMOSOME 9 OPEN READING FRAME 19; C9ORF19	152007
MIM607143	#	22q13.33	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	79087
MIM607144	*	22q13.33	ALG12, S. CEREVISIAE, HOMOLOG OF; ALG12	79087
MIM607145	*	6p22.3	DYSTROBREVIN-BINDING PROTEIN 1; DTNBP1	84062
MIM607146	*	11q23	PDZ DOMAIN-CONTAINING 3; PDZD3	79849
MIM607147	*	3q13	POLIOVIRUS RECEPTOR-LIKE 3; PVRL3	25945
MIM607149	*	11q23.1-q23.2	RNA EXONUCLEASE 2, S. CEREVISIAE, HOMOLOG OF; REXO2	25996
MIM607150	*	2q36	FIFTH EWING SARCOMA VARIANT; FEV	54738
MIM607151	#	17q25	MOYAMOYA DISEASE 2; MYMY2	57674
MIM607152	%	9q	SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT; SPG19	140907
MIM607153	*	2p25.2	INTEGRIN, BETA-1, BINDING PROTEIN OF, 1; ITGB1BP1	9270
MIM607154	#	5q31	ALLERGIC RHINITIS	260328, 3596
MIM607155	#	19q13.3	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	79147
MIM607156	*	3q12.1	ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 6; ST3GAL6	10402
MIM607157	*	19q13.3-q13.4	SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 11; SIGLEC11	114132
MIM607158	*	10q26.3	VENT-LIKE HOMEOBOX 2; VENTX2	27287
MIM607159	*	10q22.1-q22.3	ZINC FINGER MIZ-DOMAIN CONTAINING 1; ZMIZ1	57178
MIM607160	*	 	ATPase, H+ TRANSPORTING, LYSOSOMAL, 14-KD, V1 SUBUNIT F; ATP6V1F	9296
MIM607161		 	MULTIPLE CONGENITAL ANOMALIES SYNDROME WITH CLOVERLEAF SKULL	 
MIM607162	*	18q21.1	ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 5; ST8SIA5	29906
MIM607163	*	2p13.3	LYSYL OXIDASE-LIKE 3; LOXL3	84695
MIM607164	*	2p13	LADY BIRD-LIKE HOMEOBOX 2; LBX2	85474
MIM607165	*	20q13.1-q13.3	SERINE INCORPORATOR 3; SERINC3	10955
MIM607166	*	2q11.2	TESTIS-SPECIFIC PROTEIN 10; TSGA10	80705
MIM607167	*	20q12-q13.11	DYNEIN, LIGHT CHAIN, ROADBLOCK TYPE, 1; DYNLRB1	83658
MIM607168	*	16q23.3	DYNEIN, LIGHT CHAIN, ROADBLOCK TYPE, 2; DYNLRB2	83657
MIM607169	*	6p22-p21.3	PROTEASE, SERINE, 16; PRSS16	10279
MIM607170	*	3p25.3	CYSTEINE-RICH PROTEIN WITH EGF-LIKE DOMAINS 1; CRELD1	78987
MIM607171	*	 	CYSTEINE-RICH PROTEIN WITH EGF-LIKE DOMAINS 2	79174
MIM607172	*	2q36	SERINE/THREONINE KINASE 11-INTERACTING PROTEIN; STK11IP	114790
MIM607173	*	2q24.2	PROTEASOME 26S SUBUNIT, NON-ATPase, 14; PSMD14	10213
MIM607174	#	10q23.31, 22q12.3-qter, 22q12.2	MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO	4330, 4771, 51684, 5728
MIM607175	*	 	DUAL-SPECIFICITY PHOSPHATASE 16; DUSP16	80824
MIM607176	*	 	CALNEURON 1; CALN1	83698
MIM607177	*	1q25.3	IMMEDIATE-EARLY RESPONSE GENE 5; IER5	51278
MIM607178	*	1p33	MEMBRANE-ASSOCIATED PROTEIN 17	10158
MIM607179	*	 	RNA-BINDING MOTIF PROTEIN 12; RBM12	10137
MIM607180	*	3p21.3	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 2; LRRC2	79442
MIM607181	*	3p21.3	RECEPTOR-TRANSPORTING PROTEIN 3; RTP3	83597
MIM607182	*	 	FYVE AND COILED-COIL DOMAIN CONTAINING 1; FYCO1	79443
MIM607183	*	 	SEC24-RELATED GENE FAMILY, MEMBER A; SEC24A	10802
MIM607184	*	 	SEC24-RELATED GENE FAMILY, MEMBER B; SEC24B	10427
MIM607185	*	 	SEC24-RELATED GENE FAMILY, MEMBER C; SEC24C	9632
MIM607186	*	 	SEC24-RELATED GENE FAMILY, MEMBER D; SEC24D	9871
MIM607187	*	 	ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 1; ST3GAL1	6482
MIM607188	*	 	ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 2; ST3GAL2	6483
MIM607189	*	 	REGULATOR OF G PROTEIN SIGNALING 8; RGS8	85397
MIM607190	*	 	REGULATOR OF G PROTEIN SIGNALING 13; RGS13	6003
MIM607191	*	 	REGULATOR OF G PROTEIN SIGNALING 17; RGS17	26575
MIM607192	*	 	REGULATOR OF G PROTEIN SIGNALING 18; RGS18	64407
MIM607193	*	 	REGULATOR OF G PROTEIN SIGNALING 20; RGS20	8601
MIM607194	*	10p12.3	PANCREAS TRANSCRIPTION FACTOR 1, ALPHA SUBUNIT; PTF1A	256297
MIM607196	#	17q25.3	MICROCEPHALY, AMISH TYPE; MCPHA	60386
MIM607197		 	DEAFNESS, AUTOSOMAL RECESSIVE	 
MIM607198	*	14q31-q32	TYROSYL-DNA PHOSPHODIESTERASE 1; TDP1	55775
MIM607199	*	1q32-q41	INTERFERON REGULATORY FACTOR 6; IRF6	3664
MIM607200	#	15q15.3	THYROID DYSHORMONOGENESIS 6; TDH6	50506
MIM607201	*	1p36.11	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN R; HNRNPR	10236
MIM607202	%	15q11-q13	CELIAC DISEASE, SUSCEPTIBILITY TO, 5; CELIAC5	338332
MIM607203	*	14q13-q23	SALVADOR, DROSOPHILA, HOMOLOG OF; SAV1	60485
MIM607204	*	1p35.2	PUMILIO, DROSOPHILA, HOMOLOG OF, 1; PUM1	9698
MIM607205	*	2p22-p21	PUMILIO, DROSOPHILA, HOMOLOG OF, 2; PUM2	23369
MIM607206	*	17p13.1	ARACHIDONATE LIPOXYGENASE 3; ALOXE3	59344
MIM607207	*	16p13.3	STIP1 HOMOLOGOUS AND U BOX-CONTAINING PROTEIN 1; STUB1	10273
MIM607208	#	5q31.1-q33.1, 2q24	DRAVET SYNDROME	2566, 6323, 6335
MIM607209	*	22q13.1	CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 10; CARD10	29775
MIM607210	*	7p22	CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 11; CARD11	84433
MIM607211	*	 	CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 14; CARD14	79092
MIM607212	*	9q34.3	CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 9; CARD9	64170
MIM607213	*	16q12	ORIGIN RECOGNITION COMPLEX, SUBUNIT 6, S. CEREVISIAE, HOMOLOG OF; ORC6	23594
MIM607214		 	ANONYCHIA, TOTAL, WITH MICROCEPHALY	 
MIM607215	*	1p36	NEPHROCYSTIN 4; NPHP4	261734
MIM607216	*	 	SIDEKICK, DROSOPHILA, HOMOLOG OF, 1; SDK1	221935
MIM607217	*	 	SIDEKICK, DROSOPHILA, HOMOLOG OF, 2; SDK2	54549
MIM607218	*	7q32	INTERFERON REGULATORY FACTOR 5; IRF5	3663
MIM607219	*	11q21-q22.2	CONTACTIN 5; CNTN5	53942
MIM607220	*	3p26-p25	CONTACTIN 6; CNTN6	27255
MIM607221	%	4p15	EPILEPSY, PARTIAL, WITH PERICENTRAL SPIKES; PEPS	266789
MIM607222	*	10p15.1	F-BOX ONLY PROTEIN 18; FBXO18	84893
MIM607223	*	6q72	SPARC-RELATED MODULAR CALCIUM-BINDING PROTEIN 2; SMOC2	64094
MIM607224	*	11q13	ORAL CANCER OVEREXPRESSED GENE 1; ORAOV1	220064
MIM607225	#	2q33	SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	57679
MIM607226	*	 	HISTONE DEACETYLASE 11; HDAC11	79885
MIM607227	*	11p15.1	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER X1; MRGPRX1	259249
MIM607228	*	11p15.1	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER X2; MRGPRX2	117194
MIM607229	*	11p15.1	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER X3; MRGPRX3	117195
MIM607230	*	11p15.1	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER X4; MRGPRX4	117196
MIM607231	*	11q13.2	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER D; MRGPRD	116512
MIM607232	*	11p15.4	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER E; MRGPRE	116534
MIM607233	*	11q13.2	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER F; MRGPRF	116535
MIM607234	*	11p15.5	MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER G; MRGPRG	386746
MIM607235	*	6p21	MAS1 ONCOGENE-LIKE; MAS1L	116511
MIM607236	#	20p13-p12.3	HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA, AND PALLIDAL DEGENERATION	80025
MIM607237	*	3p21	TRANSMEMBRANE INNER EAR-EXPRESSED GENE; TMIE	259236
MIM607238	*	2p16-p13	COMM DOMAIN-CONTAINING PROTEIN 1; COMMD1	150684
MIM607239	%	10p11.23-q21.1	DEAFNESS, AUTOSOMAL RECESSIVE 33; DFNB33	170508
MIM607240	*	 	SET DOMAIN-CONTAINING PROTEIN 8; SETD8	387893
MIM607241	*	 	CHROMOSOME 4 OPEN READING FRAME 7; C4ORF7	260436
MIM607242	*	11p15.5	ADAPTOR-RELATED PROTEIN COMPLEX 2, ALPHA-2 SUBUNIT; AP2A2	161
MIM607243	*	14q12	ADAPTOR-RELATED PROTEIN COMPLEX 4, SIGMA-1 SUBUNIT; AP4S1	11154
MIM607244	*	15q21.2	ADAPTOR-RELATED PROTEIN COMPLEX 4, EPSILON-1 SUBUNIT; AP4E1	23431
MIM607245	*	1p13.2	ADAPTOR-RELATED PROTEIN COMPLEX 4, BETA-1 SUBUNIT; AP4B1	10717
MIM607246	*	 	ADAPTOR-RELATED PROTEIN COMPLEX 3, DELTA-1 SUBUNIT; AP3D1	8943
MIM607247	*	 	CHONDROLECTIN; CHODL	140578
MIM607248	%	15q23-q26.3	GLIOMA SUSCEPTIBILITY 4; GLM4	338030
MIM607249	*	 	CATION CHANNEL, SPERM-ASSOCIATED, 2; CATSPER2	117155
MIM607250	#	14q31-q32	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY; SCAN1	55775
MIM607251	*	Chr.17	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 22, YEAST, HOMOLOG OF; TIMM22	29928
MIM607252	*	22q12.3	APOLIPOPROTEIN L-II; APOL2	23780
MIM607253	*	22q12.3	APOLIPOPROTEIN L-III; APOL3	80833
MIM607254	*	22q12.3	APOLIPOPROTEIN L-IV; APOL4	80832
MIM607255	*	22q12.3	APOLIPOPROTEIN L-V; APOL5	80831
MIM607256	*	22q12.3	APOLIPOPROTEIN L-VI; APOL6	80830
MIM607257	*	11p15.3-p15.2	SRY-BOX 6; SOX6	55553
MIM607258	%	4q33-qter	HYPERCALCIURIA, ABSORPTIVE, 1	266790
MIM607259	#	16q24.3	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7	6687
MIM607260	*	19q13.2	PLACENTAL PROTEIN 13-LIKE PROTEIN	56891
MIM607261	*	4p16	EVC2 GENE; EVC2	132884
MIM607262	*	19q13	EPSIN 1; EPN1	29924
MIM607263	*	Chr.17	EPSIN 2; EPN2	22905
MIM607264	*	Chr.17	EPSIN 3; EPN3	55040
MIM607265	*	5q33.3	CLATHRIN INTERACTOR 1; CLINT1	9685
MIM607267	*	9q33	POLYMERASE, DNA, EPSILON-3; POLE3	54107
MIM607268	*	8q11-q12	CHROMATIN ACCESSIBILITY COMPLEX, SUBUNIT 1; CHRAC1	54108
MIM607269	*	2p12	POLYMERASE, DNA, EPSILON-4; POLE4	56655
MIM607270	*	7q11.2	KIAA0442 GENE; KIAA0442	26053
MIM607271	#	2q33	CASPASE 8 DEFICIENCY	841
MIM607272	*	 	NDC80, S. CEREVISIAE, HOMOLOG OF; NDC80	10403
MIM607273	*	17p11.2	FOLLICULIN; FLCN	201163
MIM607274	*	18p	UBIQUITIN-SPECIFIC PROTEASE 14; USP14	9097
MIM607275	*	4q11-q12	HOP HOMEOBOX; HOPX	84525
MIM607276	#	10q24-q26	RESTING HEART RATE, VARIATION IN	153
MIM607277	#	14q22.1	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 1	5729
MIM607278		 	OSTEOFIBROUS DYSPLASIA	 
MIM607279	%	11q14	SYSTEMIC LUPUS ERYTHEMATOSUS WITH HEMOLYTIC ANEMIA, SUSCEPTIBILITY TO, 1; SLEH1	170682
MIM607280	*	3p26-p25	CONTACTIN 4; CNTN4	152330
MIM607281	*	Chr.8	LSM1 PROTEIN; LSM1	27257
MIM607282	*	6p21.3	LSM2 PROTEIN; LSM2	57819
MIM607283	*	3p25.1	LSM3 PROTEIN; LSM3	27258
MIM607284	*	19p13.11	LSM4 PROTEIN; LSM4	25804
MIM607285	*	7p14.3	LSM5 PROTEIN; LSM5	23658
MIM607286	*	4q31.2	LSM6 PROTEIN; LSM6	11157
MIM607287	*	19p13.3	LSM7 PROTEIN; LSM7	51690
MIM607288	*	 	LSM8 PROTEIN; LSM8	51691
MIM607289	*	6p24.3	MUTED, MOUSE, HOMOLOG OF; MUTED	63915
MIM607290	*	3p21.3	SHISA, XENOPUS, HOMOLOG OF, 5; SHISA5	51246
MIM607291	*	Chr.17	ADAPTOR-RELATED PROTEIN COMPLEX 1 GAMMA SUBUNIT-BINDING PROTEIN 1; AP1GBP1	11276
MIM607292	*	1q22	SEMAPHORIN 4A; SEMA4A	64218
MIM607293	*	6p21.1-p12.1	CHLORIDE INTRACELLULAR CHANNEL 5; CLIC5	53405
MIM607294	*	20q11.2-q12	TRANSFORMING GROWTH FACTOR-BETA-INDUCED FACTOR 2; TGIF2	60436
MIM607295	*	22q12.1	MYOSIN XVIIIB; MYO18B	84700
MIM607296	*	Chr.9	ATPase, H+ TRANSPORTING, LYSOSOMAL, 13-KD, V1 SUBUNIT G, ISOFORM 1; ATP6V1G1	9550
MIM607297	*	12p13	NERVE INJURY-INDUCED PROTEIN 2; NINJ2	4815
MIM607298	*	16p13.3	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-13; GNG13	51764
MIM607299	*	2q37	DELTA- AND NOTCH-LIKE EPIDERMAL GROWTH FACTOR-RELATED RECEPTOR	92737
MIM607300	*	17p13.3	PRECURSOR mRNA-PROCESSING FACTOR 8, S. CEREVISIAE, HOMOLOG OF; PRPF8	10594
MIM607301	*	1q21.2	PRECURSOR mRNA-PROCESSING FACTOR 3, S. CEREVISIAE, HOMOLOG OF; PRPF3	9129
MIM607303	*	15q24	MORTALITY FACTOR 4-LIKE PROTEIN 1; MORF4L1	10933
MIM607304	%	2p12	CATARACT, NUCLEAR PROGRESSIVE	266979
MIM607305	*	1p36.1	MDS2 GENE	259283
MIM607306	+	2p23	STEROID 5-ALPHA-REDUCTASE 2; SRD5A2	6716
MIM607307	*	6q14.1	FILAMIN A-INTERACTING PROTEIN 1; FILIP1	27145
MIM607308	%	 	MAMMOGRAPHIC DENSITY	 
MIM607309	*	19p13.2	ADAPTOR-RELATED PROTEIN COMPLEX 1, MU-2 SUBUNIT; AP1M2	10053
MIM607310	*	8p12	A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 7; ADAM7	8756
MIM607311	*	11q22	PROGESTERONE RECEPTOR; PGR	5241
MIM607312	*	7q34	ZINC FINGER CCCH DOMAIN-CONTAINING ANTIVIRAL PROTEIN 1; ZC3HAV1	56829
MIM607313	#	11q23-q25	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS; HGPPS	64221
MIM607314	*	11q13.1	CALCIUM-BINDING PROTEIN 2; CABP2	51475
MIM607315	*	19q13.33	CALCIUM-BINDING PROTEIN 5; CABP5	56344
MIM607317	%	1p36	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	260415
MIM607318	*	10q24	LYSYL OXIDASE-LIKE 4; LOXL4	84171
MIM607319	*	 	RENAL UBIQUITOUS PROTEIN 1	51460
MIM607320	*	19q13.1	RAS GUANYL NUCLEOTIDE-RELEASING PROTEIN 4; RASGRP4	115727
MIM607321	*	1q21-q32	ATPase, Na+/K+ TRANSPORTING, ALPHA-4 POLYPEPTIDE; ATP1A4	480
MIM607322	^	16q21	MOVED TO 143470	 
MIM607323	#	20q13.13-q13.2	DUANE-RADIAL RAY SYNDROME; DRRS	57167
MIM607324	%	19p13.2-p13.1	POLYDACTYLY, POSTAXIAL, TYPE A3	338333
MIM607325	*	13q32.3	DEDICATOR OF CYTOKINESIS 9; DOCK9	23348
MIM607326	#	18q12-q21.1	SMITH-MCCORT DYSPLASIA; SMC	54808
MIM607327	*	 	MUSCLEBLIND-LIKE PROTEIN 2; MBNL2	10150
MIM607328	*	Chr.17	HEXAMETHYLENE BIS ACETAMIDE-INDUCIBLE PROTEIN 1; HEXIM1	10614
MIM607329	%	2p25-p24	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 3	387575
MIM607330	#	11q23.3	LATHOSTEROLOSIS	6309
MIM607331	*	7p14.2	RP9 GENE; RP9	6100
MIM607332	*	5q22.1	CHROMOSOME 5 OPEN READING FRAME 13; C5ORF13	9315
MIM607333	*	2q33-q34	STE20-RELATED KINASE ADAPTOR BETA; STRADB	55437
MIM607334	*	2q33-q34	TRAFFICKING PROTEIN, KINESIN-BINDING 2; TRAK2	66008
MIM607335	*	19p13.2-p13.12	BESTROPHIN 2; BEST2	54831
MIM607336	*	1p33-p32.3	BESTROPHIN 4; BEST4	266675
MIM607337	*	12q14.2-q15	BESTROPHIN 3; BEST3	144453
MIM607338	*	8p21.2-p21.1	LEPTIN RECEPTOR OVERLAPPING TRANSCRIPT-LIKE 1; LEPROTL1	23484
MIM607339	%	16pter-p13, 3pter-p21	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 1	1524, 338334
MIM607340	*	9q22.1	GAMMA-AMINOBUTYRIC ACID B RECEPTOR 2; GABBR2	9568
MIM607341	#	9q34	FOCAL CORTICAL DYSPLASIA OF TAYLOR; FCDT	7248
MIM607342	*	 	CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 1; CPEB1	64506
MIM607343	*	20q13.13-q13.2	SAL-LIKE 4; SALL4	57167
MIM607344	*	Chr.17	TUBULIN, DELTA-1; TUBD1	51174
MIM607345	*	6q21	TUBULIN, EPSILON-1; TUBE1	51175
MIM607346	#	1p21-q21	SPINOCEREBELLAR ATAXIA 19; SCA19	140452
MIM607347	*	4q25	ALPHA-KINASE 1; ALPK1	80216
MIM607348	*	1p36.31	HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 5; HES5	388585
MIM607349	*	15q15-q21	TALIN 2; TLN2	83660
MIM607350	*	Chr.8	KINESIN FAMILY MEMBER 13B; KIF13B	23303
MIM607351	*	10q21.1	RHO-RELATED BTB DOMAIN-CONTAINING PROTEIN 1; RHOBTB1	9886
MIM607352	*	8p21.2	RHO-RELATED BTB DOMAIN-CONTAINING PROTEIN 2; RHOBTB2	23221
MIM607353	*	5q14.3	RHO-RELATED BTB DOMAIN-CONTAINING PROTEIN 3; RHOBTB3	22836
MIM607354	%	17p11.2	SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 2; IS2	282552
MIM607355	*	1p35-p34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2C, SUBUNIT 3; EIF2C3	192669
MIM607356	*	1p35-p34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2C, SUBUNIT 4; EIF2C4	192670
MIM607357	*	6q14	POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 5; KCNQ5	56479
MIM607358	*	21q22.3	AUTOIMMUNE REGULATOR; AIRE	326
MIM607359	*	8p21	KIAA1967 GENE; KIAA1967	57805
MIM607360	*	12q13	LACRITIN; LACRT	90070
MIM607361	#	8q21.13-q22.1	MECKEL SYNDROME, TYPE 3; MKS3	91147
MIM607362	*	15q26.1	RGM DOMAIN FAMILY, MEMBER A; RGMA	56963
MIM607363	*	12q24.31	KINETOCHORE-ASSOCIATED PROTEIN 1; KNTC1	9735
MIM607364	#	1p36	BARTTER SYNDROME, TYPE 3	1188
MIM607365	*	3q27-q28	LIPASE H; LIPH	200879
MIM607366	*	2p22-p21	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 12; KCNK12	56660
MIM607367	*	14q24.1-q24.3	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 13; KCNK13	56659
MIM607368	*	20q12-q13	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 15; KCNK15	60598
MIM607369	*	6p21.2-p21.1	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 16; KCNK16	83795
MIM607370	*	6p21.2-p21.1	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 17; KCNK17	89822
MIM607371	#	7p22-p12	DYSTONIA, JUVENILE-ONSET	60
MIM607372	*	22q11.2	MEDIATOR COMPLEX SUBUNIT 15; MED15	51586
MIM607373	%	3q25-q27	AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	282553
MIM607374	*	 	PRKR INHIBITOR, REPRESSOR OF; PRKRIR	5612
MIM607375	*	19p13.3	DOT1-LIKE; DOT1L	84444
MIM607376	*	Chr.12	DYNACTIN 2; DCTN2	10540
MIM607377	*	1q22	LENS EPITHELIAL PROTEIN; LENEP	55891
MIM607378	*	 	SERPINE1 mRNA-BINDING PROTEIN 1; SERBP1	26135
MIM607379	*	22q12.2	NEUROFIBROMIN 2; NF2	4771
MIM607380	*	2q37.3	TRAF3-INTERACTING PROTEIN 1; TRAF3IP1	26146
MIM607381	*	 	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 50, YEAST, HOMOLOG OF; TIMM50	92609
MIM607382	*	19q13	CYTOPLASMIC LINKER PROTEIN 170-RELATED PROTEIN, 59-KD	25999
MIM607383	*	19p13.3	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 13, YEAST, HOMOLOG OF; TIMM13	26517
MIM607384	*	14q21	TRANSLOCASE OF INNER MITOCHONDRIAL MEMBRANE 9, YEAST, HOMOLOG OF; TIMM9	26520
MIM607385	*	12q21	UDP-N-ACETYLGLUCOSAMINE:ALPHA-1,3-D-MANNOSIDE BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE IV	25834
MIM607386	*	2p23.3	INTRAFLAGELLAR TRANSPORT 172, CHLAMYDOMONAS, HOMOLOG OF; IFT172	26160
MIM607387	*	9p13	DYNACTIN 3; DCTN3	11258
MIM607388	*	11p15.5-p15.2	FRACTURE CALLUS 1, RAT, HOMOLOG OF; FXC1	26515
MIM607389	*	5q13.3	SINGLE-STRANDED DNA-BINDING PROTEIN 2; SSBP2	23635
MIM607390	*	1p31.3	SINGLE-STRANDED DNA-BINDING PROTEIN 3; SSBP3	23648
MIM607391	*	19p13.1	SINGLE-STRANDED DNA-BINDING PROTEIN 4; SSBP4	170463
MIM607392	*	3q24	WW DOMAIN-CONTAINING TRANSCRIPTION REGULATOR 1; WWTR1	25937
MIM607393	*	1q25-q31	CELL DIVISION CYCLE PROTEIN 73, S. CEREVISIAE, HOMOLOG OF; CDC73	79577
MIM607394	*	11q23.3	POU DOMAIN, CLASS 2, TRANSCRIPTION FACTOR 3; POU2F3	25833
MIM607395		 	STREPTOCOCCUS, GROUP A, SEVERITY OF INFECTION BY	 
MIM607396	*	22q13.1-q13.31	TRANSDUCER OF ERBB2, 2; TOB2	10766
MIM607397	*	18p11.2	MELANOCORTIN 2 RECEPTOR; MC2R	4158
MIM607398	#	21q22.1	GLUCOCORTICOID DEFICIENCY 2; GCCD2	282631, 56246
MIM607399	*	1p22	MUCOLIPIN 2; MCOLN2	255231
MIM607400	*	1p22.3	MUCOLIPIN 3; MCOLN3	55283
MIM607401	*	19q13.13	INTERLEUKIN 28A; IL28A	282616
MIM607402	*	19q13.13	INTERLEUKIN 28B; IL28B	282617
MIM607403	*	19q13.13	INTERLEUKIN 29; IL29	282618
MIM607404	*	1p36.11	INTERLEUKIN 28 RECEPTOR, ALPHA; IL28RA	163702
MIM607405	*	6q23.2	TRACE AMINE-ASSOCIATED RECEPTOR 5; TAAR5	9038
MIM607406	*	4q25-q34	STARCH-BINDING DOMAIN-CONTAINING PROTEIN 1; STBD1	8987
MIM607407	*	10q26.3	EARLY B-CELL FACTOR 3; EBF3	253738
MIM607408	*	13q34	D-AMINO ACID OXIDASE ACTIVATOR; DAOA	267012
MIM607409	*	6p25.1	NEURITIN 1; NRN1	51299
MIM607410	*	 	DIENCEPHALON/MESENCEPHALON HOMEOBOX 1; DMBX1	127343
MIM607411	%	 	PATENT DUCTUS ARTERIOSUS	100996949
MIM607412	*	20q11	BPI FOLD-CONTAINING PROTEIN, FAMILY A, MEMBER 1; BPIFA1	51297
MIM607414	*	3p14.2	FEZ FAMILY ZINC FINGER PROTEIN 2; FEZF2	55079
MIM607415	*	13q34	DAOA ANTISENSE RNA; DAOAAS	282706
MIM607416	*	3p26.1	CHL1, MOUSE, HOMOLOG OF; CHL1	10752
MIM607417	#	3p26.2	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	51185
MIM607418	*	7q32.1	GRIP AND COILED-COIL DOMAINS-CONTAINING PROTEIN 1; GCC1	79571
MIM607419	*	19q13.32	GEM-ASSOCIATED PROTEIN 7; GEMIN7	79760
MIM607420	*	12p12.3	GABA-A RECEPTOR-ASSOCIATED PROTEIN-LIKE PROTEIN 1; GABARAPL1	23710
MIM607421	*	7p14-p13	THIOREDOXIN DOMAIN-CONTAINING PROTEIN 3; TXNDC3	51314
MIM607422	*	22q12-q13	GLYCINE C-ACETYLTRANSFERASE; GCAT	23464
MIM607423	*	9q34.1	PROTEIN O-MANNOSYLTRANSFERASE 1; POMT1	10585
MIM607424	*	Chr.11	GLYCINE N-ACYLTRANSFERASE; GLYAT	10249
MIM607425	*	17q21.1	GAP JUNCTION PROTEIN, DELTA-3; GJD3	125111
MIM607426	#	16q13, 10p12.1, 9p13.3, 6q21, 4q21-q22, 1q42.2	COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	23590, 27235, 54840, 56997, 57017, 57107
MIM607427	*	18p11.32	ENOLASE SUPERFAMILY MEMBER 1; ENOSF1	55556
MIM607428	*	 	KIN OF IRRE-LIKE; KIRREL	55243
MIM607429	*	10p12.1	PRENYL DIPHOSPHATE SYNTHASE, SUBUNIT 1; PDSS1	23590
MIM607430	*	 	DAZ-ASSOCIATED PROTEIN 1; DAZAP1	26528
MIM607431	*	 	DAZ-ASSOCIATED PROTEIN 2; DAZAP2	9802
MIM607432	#	17p13.3	LISSENCEPHALY 1; LIS1	5048
MIM607433	*	3p21.1	TWINFILIN, DROSOPHILA, HOMOLOG OF, 2; TWF2	11344
MIM607434	*	6p21.2-p21.1	GTP-BINDING PROTEIN 2; GTPBP2	54676
MIM607435	*	 	ERA G-PROTEIN-LIKE 1; ERAL1	26284
MIM607436	*	7p22.1	POLY(A) POLYMERASE, BETA; PAPOLB	56903
MIM607437	*	12p13.3	G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 5, MEMBER D; GPRC5D	55507
MIM607439	*	14q24.3	PROTEIN O-MANNOSYLTRANSFERASE 2; POMT2	29954
MIM607440	*	9q31	FUKUTIN; FKTN	2218
MIM607441	*	13q13.3	EPITHELIAL STROMAL INTERACTION 1; EPSTI1	94240
MIM607442	*	2p22-p21	ECHINODERM MICROTUBULE ASSOCIATED PROTEIN LIKE-4; EML4	27436
MIM607443	*	 	EPIDIDYMAL SPERM BINDING PROTEIN 1; ELSPBP1	64100
MIM607444	*	7q11	SBDS GENE; SBDS	51119
MIM607445	*	22q11.2	EUKARYOTIC TRANSLATION INITIATION FACTOR 4E NUCLEAR IMPORT FACTOR 1; EIF4ENIF1	56478
MIM607446	%	6q23-q25	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 3; BMIQ3	337895
MIM607447	#	11q13	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4; BMIQ4	338026, 7351
MIM607448	*	10q21	G PROTEIN-COUPLED RECEPTOR 147; GPR147	64106
MIM607449	*	4q13.2-q13.3	G PROTEIN-COUPLED RECEPTOR 74; GPR74	10886
MIM607450	#	6p24	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8; ARVD8	1832
MIM607451	*	20q13.33	GLUCOCORTICOID MODULATORY ELEMENT-BINDING PROTEIN 2; GMEB2	26205
MIM607452	*	16q22.3-q24.1	GABA-A RECEPTOR-ASSOCIATED PROTEIN-LIKE PROTEIN 2; GABARAPL2	11345
MIM607453	#	3q28	DEAFNESS, AUTOSOMAL DOMINANT 44; DFNA44	152137
MIM607454	#	7p21.3-p15.1	SPINOCEREBELLAR ATAXIA 21; SCA21	170545
MIM607455	*	6pter-p22.3	ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 3; ZFAND3	60685
MIM607456	*	16q22	CIRHIN; CIRH1A	84916
MIM607457	#	9p13	GIL BLOOD GROUP	360
MIM607458	%	7q22-q32	SPINOCEREBELLAR ATAXIA 18; SCA18	94008
MIM607459	#	 	SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	5428, 56652
MIM607460	*	3q13.2-q13.3	PHOSPHATIDYLSERINE-SPECIFIC PHOSPHOLIPASE A1-ALPHA; PLA1A	51365
MIM607461	*	18q12-q21.1	DYMECLIN; DYM	54808
MIM607462	*	12p13.31	ATROPHIN 1; ATN1	1822
MIM607463	*	 	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 13-LIKE; PPP1R13L	10848
MIM607464	#	19p13.2-p13.1	THYROID CARCINOMA, HURTHLE CELL	51079, 619501
MIM607465	*	15q15	CODANIN 1; CDAN1	146059
MIM607466	*	14q11.1-q11.2	RAS-ASSOCIATED PROTEIN RAB2B; RAB2B	84932
MIM607467	*	 	DENDRITIC CELL-ASSOCIATED LECTIN 1	160365
MIM607468	*	 	G PROTEIN-COUPLED RECEPTOR 88; GPR88	54112
MIM607469	*	 	N-ACYLSPHINGOSINE AMIDOHYDROLASE-LIKE PROTEIN; ASAHL	27163
MIM607470	*	 	BREAST CARCINOMA AMPLIFIED SEQUENCE 3; BCAS3	54828
MIM607471	*	20q13.13	BREAST CARCINOMA AMPLIFIED SEQUENCE 4; BCAS4	55653
MIM607472	*	10p14	MITOCHONDRIAL ESCAPE 1-LIKE 1; YME1L1	10730
MIM607473	#	16p11.2	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2; VKCFD2	79001
MIM607474	*	3q21-q23	HOMOGENTISATE 1,2-DIOXYGENASE; HGD	3081
MIM607475	#	15q26	BOTHNIA RETINAL DYSTROPHY	6017
MIM607476	#	15q26	NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD	6017
MIM607477	*	 	G2- AND S-PHASE EXPRESSED GENE 1; GTSE1	51512
MIM607478	*	12q21.1	TRYPTOPHAN HYDROXYLASE 2; TPH2	121278
MIM607479	*	18p11	APC, DOWNREGULATED BY, 1; APCDD1	147495
MIM607481	*	4q31.1-q31.2	MMAA GENE; MMAA	166785
MIM607482	#	11p15.1	CARDIOMYOPATHY, DILATED, 1M; CMD1M	8048
MIM607483	#	2q36.3	THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	80704
MIM607484	*	 	PARTITIONING-DEFECTIVE PROTEIN 6, C. ELEGANS, HOMOLOG OF, ALPHA; PARD6A	50855
MIM607485	#	17q21.32	FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	2896
MIM607486	#	1q32	KNOPS BLOOD GROUP SYSTEM; KN	1378
MIM607487	#	17q12	CARDIOMYOPATHY, DILATED, 1N; CMD1N	8557
MIM607488	%	18p11	DYSTONIA 15, MYOCLONIC; DYT15	317714
MIM607489	*	 	CULLIN 9; CUL9	23113
MIM607490	*	Chr.16	LACTATE DEHYDROGENASE D; LDHD	197257
MIM607491	*	 	PROTEIN O-FUCOSYLTRANSFERASE 1; POFUT1	23509
MIM607492	*	 	PHOSPHOFURIN ACIDIC CLUSTER SORTING PROTEIN 1; PACS1	55690
MIM607493	*	7q31	INHIBITOR OF GROWTH 3; ING3	54556
MIM607494	*	 	INOSITOL POLYPHOSPHATE-4-PHOSPHATASE, TYPE II, 105-KD; INPP4B	8821
MIM607496	*	2q31.1	NITRIC OXIDE SYNTHASE TRAFFICKER; NOSTRIN	115677
MIM607497	*	6q13	BETA-1,3-GLUCURONYLTRANSFERASE 2; B3GAT2	135152
MIM607498	%	6p21.1-p12.2	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	337892
MIM607499	%	11p13, 10p	BULIMIA NERVOSA, SUSCEPTIBILITY TO, 1; BULN1	337893, 627
MIM607500	^	 	MOVED TO 146390	 
MIM607501	%	14q21.2-q22.3	MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	338342
MIM607502	*	1q42	DISPATCHED, DROSOPHILA, HOMOLOG OF, 1; DISP1	84976
MIM607503	*	Chr.15	DISPATCHED, DROSOPHILA, HOMOLOG OF, 2; DISP2	85455
MIM607504		 	HEADACHE ASSOCIATED WITH SEXUAL ACTIVITY; HSA	 
MIM607505	*	2q37.3	PAS DOMAIN-CONTAINING SERINE/THREONINE KINASE; PASK	23178
MIM607506	*	 	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 14; ADAMTS14	140766
MIM607507	#	16q12, 6p21.3	PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO	4049, 64127
MIM607508	%	19p13	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	387576
MIM607509	*	 	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 15; ADAMTS15	170689
MIM607510	*	5p15	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 16; ADAMTS16	170690
MIM607511	*	15q24	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 17; ADAMTS17	170691
MIM607512	*	16q23	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 18; ADAMTS18	170692
MIM607513	*	 	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 19; ADAMTS19	171019
MIM607514	#	10q	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 10; BMIQ10	338557, 353126
MIM607515	*	 	PLACENTA-SPECIFIC GENE 8; PLAC8	51316
MIM607516	%	1q31	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	317773
MIM607517	*	 	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR, SUBFAMILY A, MEMBER 4	23547
MIM607518	*	19p13.2-p12	MONOCYTE AND PLASMACYTOID ACTIVATED MOLECULE	126364
MIM607519	*	13q11	POLY(ADP-RIBOSE) POLYMERASE 4; PARP4	143
MIM607520	*	4p11	ZYGOTE ARREST 1; ZAR1	326340
MIM607521	*	11p15-p13	HPS5 GENE; HPS5	11234
MIM607522	*	10q24.32	HPS6 GENE; HPS6	79803
MIM607523	#	3p21.3	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8; NDNC8	1294
MIM607524	*	6p21.3	RING FINGER PROTEIN 39; RNF39	80352
MIM607525	*	 	ZINC RIBBON DOMAIN-CONTAINING PROTEIN 1; ZNRD1	30834
MIM607526	*	17q21.1-q21.2	RIBOSOMAL PROTEIN L27; RPL27	6155
MIM607527	*	Chr.9	REGULATOR OF DIFFERENTIATION 1; ROD1	9991
MIM607528	*	11q24.2	ROUNDABOUT, DROSOPHILA, HOMOLOG OF, 4; ROBO4	54538
MIM607529	*	1p13	SERYL-tRNA SYNTHETASE; SARS	6301
MIM607530	*	7p15-p14.2	HOMEOBOX A11, ANTISENSE	221883
MIM607531	*	13q22	KRUPPEL-LIKE FACTOR 12; KLF12	11278
MIM607532	*	13q21-q22	PROGESTERONE-INDUCED BLOCKING FACTOR 1	10464
MIM607533	*	13q21-q22	DIS3 MITOTIC CONTROL, S. CEREVISIAE, HOMOLOG OF; DIS3	22894
MIM607534	*	 	YY1-ASSOCIATED FACTOR 2; YAF2	10138
MIM607535	*	3p13	RING1- AND YY1-BINDING PROTEIN; RYBP	23429
MIM607536	*	19p13	CREB-REGULATED TRANSCRIPTION COACTIVATOR 1; CRTC1	23373
MIM607537	*	11q21	MASTERMIND-LIKE 2; MAML2	84441
MIM607538	*	Chr.17	NDE1-LIKE 1; NDEL1	81565
MIM607539	%	 	CAMPTOSYNPOLYDACTYLY, COMPLEX	 
MIM607540		 	SECRETORY DIARRHEA, MYOPATHY, AND DEAFNESS	 
MIM607541	#	5q31	CORNEAL DYSTROPHY, AVELLINO TYPE; CDA	7045
MIM607542	*	11p15.5	POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 1; KCNQ1	3784
MIM607543		 	SPONDYLOMETAPHYSEAL DYSPLASIA WITH BOWED FOREARMS AND FACIAL DYSMORPHISM	 
MIM607544	*	2p21-p16	LEUCINE-RICH PPR MOTIF-CONTAINING PROTEIN; LRPPRC	10128
MIM607545	*	4q32-q34	STEROL C4-METHYLOXIDASE-LIKE; SC4MOL	6307
MIM607546	*	3q13.1	CD200 RECEPTOR 1; CD200R1	131450
MIM607547	*	3q27	RIBOSOMAL PROTEIN L39-LIKE; RPL39L	116832
MIM607548	*	19q13.3	RADIAL SPOKEHEAD-LIKE 1; RSHL1	81492
MIM607549	*	21q11.2	POTE ANKYRIN DOMAIN FAMILY, MEMBER D; POTED	317754
MIM607550	*	6q21-q22	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 10; SLC16A10	117247
MIM607551	*	22q11.2	STROMAL CELL-DERIVED FACTOR 2-LIKE 1; SDF2L1	23753
MIM607552		 	MINICORE MYOPATHY, ANTENATAL ONSET, WITH ARTHROGRYPOSIS	 
MIM607553	*	 	EPIPLAKIN 1; EPPK1	83481
MIM607554	#	11p15.5	ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	3784
MIM607555	*	1q25-q31	TORSIN 3A; TOR3A	64222
MIM607556	*	2q37.3	TWIST, DROSOPHILA, HOMOLOG OF, 2; TWIST2	117581
MIM607557	*	12q23	SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 8; SLC17A8	246213
MIM607558	*	22q12.1-qter	SEC14-LIKE 2; SEC14L2	23541
MIM607559	*	16p13.3	MAHOGUNIN, RING FINGER 1; MGRN1	23295
MIM607560	*	1q21-q22	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; ARHGEF2	9181
MIM607561	^	 	MOVED TO 210720	 
MIM607562	*	1p31.3	INTERLEUKIN 23 RECEPTOR; IL23R	149233
MIM607563	*	11p14.3	SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 6; SLC17A6	57084
MIM607564	*	11p15	TRIPARTITE MOTIF-CONTAINING PROTEIN 6; TRIM6	117854
MIM607565		 	SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	 
MIM607566	*	6q24	EPM2A GENE; EPM2A	7957
MIM607567	*	 	OLFACTOMEDIN 3; OLFM3	118427
MIM607568	*	12q24	MMAB GENE; MMAB	326625
MIM607569		 	MYOPATHY, DISTAL, WITH EARLY RESPIRATORY FAILURE, AUTOSOMAL DOMINANT	 
MIM607570	*	17q23.3	DEAH BOX POLYPEPTIDE 40; DHX40	79665
MIM607571	*	14q11.2	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL OXODICARBOXYLATE CARRIER), MEMBER 21; SLC25A21	89874
MIM607572	%	6q25.2-q27	LEPROSY, SUSCEPTIBILITY TO, 2; LPRS2	5071
MIM607573	*	19p13.11	BPY2-INTERACTING PROTEIN 1; BPY2IP1	55201
MIM607574	*	22q13.31-qter	ARYLSULFATASE A; ARSA	410
MIM607575	*	22q11.2	CAT EYE SYNDROME CHROMOSOME REGION, CANDIDATE 1; CECR1	51816
MIM607576	*	22q11.2	CAT EYE SYNDROME CHROMOSOME REGION, CANDIDATE 2; CECR2	27443
MIM607577	*	Chr.8	LYSOSOMAL APYRASE-LIKE PROTEIN 1; LYSAL1	9583
MIM607578		 	BREATH-HOLDING SPELLS	 
MIM607579	*	 	SOLUTE CARRIER FAMILY 22 (ORGANIC ANION/CATION TRANSPORTER), MEMBER 9; SLC22A9	114571
MIM607580	*	 	SOLUTE CARRIER FAMILY 22 (ORGANIC ANION/CATION TRANSPORTER), MEMBER 10; SLC22A10	387775
MIM607581	*	Chr.11	SOLUTE CARRIER FAMILY 22 (ORGANIC ANION TRANSPORTER), MEMBER 8; SLC22A8	9376
MIM607582	*	11q13.1-q13.2	SOLUTE CARRIER FAMILY 22 (ORGANIC ANION TRANSPORTER), MEMBER 6; SLC22A6	9356
MIM607583	*	19p13.3	PEROXISOME BIOGENESIS FACTOR 11G; PEX11G	92960
MIM607584	%	13q14	SPASTIC PARAPLEGIA 24, AUTOSOMAL RECESSIVE; SPG24	338090
MIM607585	*	11q22.3	ATAXIA-TELANGIECTASIA MUTATED GENE; ATM	472
MIM607586	*	2q33	ALS2 CHROMOSOME REGION GENE 8; ALS2CR8	79800
MIM607587	*	13p11	INTERLEUKIN 17D; IL17D	53342
MIM607588	*	22q11.21	PEPTIDYL-PROLYL ISOMERASE-LIKE 2; PPIL2	23759
MIM607589	*	20q13.2	SERUM/GLUCOCORTICOID-REGULATED KINASE 2; SGK2	10110
MIM607590	*	4q27	BBS7 GENE; BBS7	55212
MIM607591	*	8q12.3-q13.1	SERUM/GLUCOCORTICOID-REGULATED KINASE-LIKE PROTEIN; SGKL	23678
MIM607592	%	19q	PROSTATE CANCER AGGRESSIVENESS QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 19	347747
MIM607593	*	6pter-p21.3	MEDIATOR OF DNA DAMAGE CHECKPOINT PROTEIN 1; MDC1	9656
MIM607594	#	2q33	IMMUNODEFICIENCY, COMMON VARIABLE, 1; CVID1	29851
MIM607595	#	13q34	BRAIN SMALL VESSEL DISEASE WITH HEMORRHAGE	1282
MIM607596	#	14q32	PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	7443
MIM607597		 	MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	 
MIM607598	#	12q13	LETHAL CONGENITAL CONTRACTURE SYNDROME 2; LCCS2	2065
MIM607599	*	Chr.8	RETINOL DEHYDROGENASE 10; RDH10	157506
MIM607600	%	 	EPIDERMOLYSIS BULLOSA SIMPLEX SUPERFICIALIS; EBSS	 
MIM607601	*	19p13.3	TIR DOMAIN-CONTAINING ADAPTOR MOLECULE 1; TICAM1	148022
MIM607602	#	17q21-q22, 12q13	ICHTHYOSIS, CYCLIC, WITH EPIDERMOLYTIC HYPERKERATOSIS	3848, 3858
MIM607603	*	16q24.1	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY G, MEMBER 4; KCNG4	93107
MIM607604	*	9p24.2	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY V, MEMBER 2; KCNV2	169522
MIM607605	*	6p12.2	GLUTATHIONE S-TRANSFERASE, ALPHA-5; GSTA5	221357
MIM607606	*	17q12-q21	KERATIN 9; KRT9	3857
MIM607607	*	4q21.1	NUCLEOPORIN, 54-KD; NUP54	53371
MIM607608	*	11p15.4-p15.1	SPHINGOMYELIN PHOSPHODIESTERASE 1, ACID LYSOSOMAL; SMPD1	6609
MIM607609	*	6q24-q25	PEPTIDYL-PROLYL ISOMERASE-LIKE 4; PPIL4	85313
MIM607610	*	3q23	PHOSPHOLIPID SCRAMBLASE 2; PLSCR2	57047
MIM607611	*	17p13.1	PHOSPHOLIPID SCRAMBLASE 3; PLSCR3	57048
MIM607612	*	3q23	PHOSPHOLIPID SCRAMBLASE 4; PLSCR4	57088
MIM607613	*	1q42.13	NUCLEOPORIN, 133-KD; NUP133	55746
MIM607614	*	Chr.11	NUCLEOPORIN, 160-KD; NUP160	23279
MIM607615	*	13q12.1	NUCLEOPORIN-LIKE 1; NUPL1	9818
MIM607616	#	11p15.4-p15.1	NIEMANN-PICK DISEASE, TYPE B	6609
MIM607617	*	Chr.12	NUCLEOPORIN, 107-KD; NUP107	57122
MIM607618	*	16q22.1	DEAD/H BOX 28; DDX28	55794
MIM607619	*	9q21-q22	FERM DOMAIN-CONTAINING PROTEIN 3; FRMD3	257019
MIM607620	*	8q23-q24.1	COLLECTIN 10; COLEC10	10584
MIM607621	*	18p11.32	COLLECTIN 12; COLEC12	81035
MIM607622	*	1p13-q23	PHOSPHOMEVALONATE KINASE; PMVK	10654
MIM607623	*	18q11-q12	NPC1 GENE; NPC1	4864
MIM607624	#	15q21	GRISCELLI SYNDROME, TYPE 2; GS2	5873
MIM607625	#	14q24.3	NIEMANN-PICK DISEASE, TYPE C2	10577
MIM607626	#	3q28-q29	ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS	9076
MIM607627	*	20q11.21	BREAST CANCER- AND SALIVARY GLAND-EXPRESSED GENE	317716
MIM607628	#	3q26	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 11; EIG11	1181
MIM607629	*	1p36.13-q31.3	ANTERIOR PHARYNX DEFECTIVE 1, C. ELEGANS, HOMOLOG OF, A; APH1A	51107
MIM607630	*	15q22.2	ANTERIOR PHARYNX DEFECTIVE 1, C. ELEGANS, HOMOLOG OF, B; APH1B	83464
MIM607631	#	6p12-p11	EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 1; EJA1	114327
MIM607632	*	19q13.1	PRESENILIN ENHANCER 2, C. ELEGANS, HOMOLOG OF; PSENEN	55851
MIM607633	*	2p23-p22	XANTHINE DEHYDROGENASE; XDH	7498
MIM607634	#	11q13.4	OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	4041
MIM607635	*	7q32	CARBOXYPEPTIDASE A4; CPA4	51200
MIM607636	#	11q13.4	VAN BUCHEM DISEASE, TYPE 2	4041
MIM607637	*	10q26	EMX2 OPPOSITE STRAND; EMX2OS	196047
MIM607638	*	4q35	DEOXYCYTIDYLATE DEAMINASE; DCTD	1635
MIM607639	*	7q11.23	PROTEIN WITH 4 GROUP B SCAVENGER RECEPTOR CYSTEINE-RICH DOMAINS; SRCRB4D	136853
MIM607640	*	3p21.1-p12	ATAXIN 7; ATXN7	6314
MIM607641	#	2p13	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB; HMN7B	1639
MIM607642	*	17p11.2	RETINOIC ACID-INDUCED GENE 1; RAI1	10743
MIM607643	*	17q25	FASCIN, SEA URCHIN, HOMOLOG OF, 2; FSCN2	25794
MIM607644	%	11p13-q12	CANDIDIASIS, FAMILIAL, 3; CANDF3	338434
MIM607645	*	4p16.3	D4S234E GENE; D4S234E	27065
MIM607646	*	 	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 7B; ZBTB7B	51043
MIM607647	*	19p13.2	PLASMALEMMA VESICLE-ASSOCIATED PROTEIN; PLVAP	83483
MIM607648	*	2q24.3	SERINE/THREONINE PROTEIN KINASE 39; STK39	27347
MIM607649	*	6q21	OSTEOPETROSIS-ASSOCIATED TRANSMEMBRANE PROTEIN 1; OSTM1	28962
MIM607650	*	20q11	DEFENSIN, BETA, 118; DEFB118	117285
MIM607651	*	11q13-q14.1	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY B, MEMBER 1; PLEKHB1	58473
MIM607652	*	2q35	SERINE/THREONINE PROTEIN KINASE 36; STK36	27148
MIM607653	*	Chr.14	RAS HOMOLOG GENE FAMILY, MEMBER J; RHOJ	57381
MIM607654	#	12q13	KERATOSIS PALMOPLANTARIS STRIATA III; PPKS3	3848
MIM607655	#	6p24	SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	1832
MIM607656	%	 	CURLY HAIR-ACRAL KERATODERMA-CARIES SYNDROME	 
MIM607657	*	1p31.1	CYSTATHIONINE GAMMA-LYASE; CTH	1491
MIM607658	%	 	HYPOTRICHOSIS-OSTEOLYSIS-PERIODONTITIS-PALMOPLANTAR KERATODERMA SYNDROME	 
MIM607659	*	 	ELL-ASSOCIATED FACTOR 2; EAF2	55840
MIM607660	*	1p35-p34	TESTIS-SPECIFIC SERINE/THREONINE KINASE 3; TSSK3	81629
MIM607662	*	20q13.1-q13.2	SPERMATOGENESIS-ASSOCIATED PROTEIN 2; SPATA2	9825
MIM607663	*	11q24	DEAD BOX POLYPEPTIDE 25; DDX25	29118
MIM607664	*	12q14	N-ACETYLGLUCOSAMINE-6-SULFATASE; GNS	2799
MIM607665		 	TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	 
MIM607666	*	11q22	ANGIOPOIETIN-LIKE 5; ANGPTL5	253935
MIM607667	*	10q21	CATENIN, ALPHA-3; CTNNA3	29119
MIM607668	*	Chr.12	ADP-RIBOSYLATION-LIKE FACTOR 6-INTERACTING PROTEIN 4; ARL6IP4	51329
MIM607669	*	16p12-p11.2	ADP-RIBOSYLATION-LIKE FACTOR 6-INTERACTING PROTEIN 1; ARL6IP1	23204
MIM607670	*	11p15.3	SERINE/THREONINE PROTEIN KINASE 33; STK33	65975
MIM607671	%	1p36.32-p36.13	DYSTONIA 13, TORSION; DYT13	93983
MIM607672	*	11q13.3	CARDIOTROPHIN-LIKE CYTOKINE FACTOR 1; CLCF1	23529
MIM607673	*	3p26.1	ENDOPLASMIC RETICULUM DEGRADATION-ENHANCING ALPHA-MANNOSIDASE-LIKE PROTEIN 1; EDEM1	9695
MIM607674	%	 	CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	 
MIM607675	*	Chr.14	REST COREPRESSOR; RCOR	23186
MIM607676	#	12q12	IRAK4 DEFICIENCY	51135
MIM607677	#	1q22	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I; CMT2I	4359
MIM607678	#	10q21.1-q22.1	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D	1959
MIM607679	*	7q31	DEDICATOR OF CYTOKINESIS 4; DOCK4	9732
MIM607680	*	 	ZINC FINGER PROTEIN 363; ZNF363	25898
MIM607681	#	5q31.1-q33.1	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2; ECA2	2566
MIM607682	#	2q22-q23	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9	785
MIM607683	%	4q28	DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52	170507
MIM607684	#	8p21	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	4747
MIM607685	#	4q12	HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC; HES	5156
MIM607686	*	4q12	FIP1-LIKE 1; FIP1L1	81608
MIM607687	%	16q24.1	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 3	353125
MIM607688	#	2q37.1	PARKINSON DISEASE 11, AUTOSOMAL DOMINANT; PARK11	26058
MIM607689	^	 	MOVED TO 246700	 
MIM607690	*	5q31.1	SAR1, S. CEREVISIAE, HOMOLOG B; SAR1B	51128
MIM607691	*	10q22.1	SAR1, S. CEREVISIAE, HOMOLOG OF, A; SAR1A	56681
MIM607692	^	 	MOVED TO 248800 AND 246700	 
MIM607693	*	9q22.2	SELENOCYSTEINE INSERTION SEQUENCE-BINDING PROTEIN 2; SECISBP2	79048
MIM607694	#	 	LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD7	11128, 55703
MIM607695	*	 	EUKARYOTIC ELONGATION FACTOR, SELENOCYSTEINE-tRNA-SPECIFIC; EEFSEC	60678
MIM607696	*	17q24-q25	USH1G GENE; USH1G	124590
MIM607697	*	11p15	SET-BINDING FACTOR 2; SBF2	81846
MIM607698	*	10q24.1	LIGAND-DEPENDENT NUCLEAR RECEPTOR COREPRESSOR; LCOR	84458
MIM607699	*	 	RING FINGER PROTEIN 20; RNF20	56254
MIM607700	*	 	RING FINGER PROTEIN 40; RNF40	9810
MIM607701	*	2q31.1	KELCH REPEAT AND BTB/POZ DOMAINS-CONTAINING PROTEIN 10; KBTBD10	10324
MIM607702	*	8p11.2	CHROMOSOME 8 OPEN READING FRAME 4; C8ORF4	56892
MIM607703	*	3p25.1	NUCLEOPORIN, 210-KD; NUP210	23225
MIM607704	*	9p24.3	KN MOTIF- AND ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 1; KANK1	23189
MIM607705	*	2p16.2	PROTEASOME ACTIVATOR SUBUNIT 4; PSME4	23198
MIM607706	#	8q13-q21.1	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE	54332
MIM607707	*	7p14	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-BETA; CAMK2B	816
MIM607708	*	4q26	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II-DELTA; CAMK2D	817
MIM607709	*	9q12-q13	TIGHT JUNCTION PROTEIN 2; TJP2	9414
MIM607710	*	9q13-q21	FAMILY WITH SEQUENCE SIMILARITY 189, MEMBER A2; FAM189A2	9413
MIM607711	*	21q22.3	DISCO-INTERACTING PROTEIN 2, DROSOPHILA, HOMOLOG OF, A; DIP2A	23181
MIM607712	*	22q11.2	HYPERMETHYLATED IN CANCER 2; HIC2	23119
MIM607713	*	4p16	KILLER-SPECIFIC SECRETORY PROTEIN, 37-KD	83888
MIM607714	*	5q32-q33.1	TNFAIP3-INTERACTING PROTEIN 1; TNIP1	10318
MIM607715	*	13q14	TSC22 DOMAIN FAMILY, MEMBER 1; TSC22D1	8848
MIM607716	*	Chr.11	SYNAPTOTAGMIN 13; SYT13	57586
MIM607717	*	Chr.12	TENSIN-LIKE C1 DOMAIN-CONTAINING PHOSPHATASE; TENC1	23371
MIM607718	*	1p13.2	SYNAPTOTAGMIN 6; SYT6	148281
MIM607719	*	 	SYNAPTOTAGMIN 8; SYT8	90019
MIM607720	*	 	TRANSLIN-ASSOCIATED FACTOR X-INTERACTING PROTEIN 1; TSNAXIP1	55815
MIM607721	#	10q25	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR; NSLH	8036
MIM607722	*	Chr.8	KIAA0103 GENE; KIAA0103	9694
MIM607723	*	7p22.3	SAD1 AND UNC84 DOMAIN-CONTAINING PROTEIN 1; SUN1	23353
MIM607724	*	12q15	CALCYPHOSINE 2; CAPS2	84698
MIM607725	*	14q11.2	POLY(ADP-RIBOSE) POLYMERASE 2; PARP2	10038
MIM607726	*	3p21.3-p21.1	POLY(ADP-RIBOSE) POLYMERASE 3; PARP3	10039
MIM607727	*	 	CULLIN-ASSOCIATED NEDDYLATION-DISSOCIATED PROTEIN 1; CAND1	55832
MIM607728	%	15q25.1-q26.1	POROKERATOSIS, DISSEMINATED SUPERFICIAL ACTINIC, 2	353147
MIM607729	*	10q24.33	DNA DAMAGE-INDUCIBLE TRANSCRIPT 4; DDIT4	54541
MIM607730	*	4q24-q25	DNA DAMAGE-INDUCIBLE TRANSCRIPT 4-LIKE; DDIT4L	115265
MIM607731		 	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H; CMT2H	619496
MIM607732	*	17q11	STERILE ALPHA AND TIR MOTIFS-CONTAINING PROTEIN 1; SARM1	23098
MIM607733	*	Chr.8	SCRIBBLE, DROSOPHILA, HOMOLOG OF; SCRIB	23513
MIM607734	#	8p21	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F	4747
MIM607735	*	4q26	PROGESTERONE RECEPTOR MEMBRANE COMPONENT 2; PGRMC2	10424
MIM607736	#	1q22	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J; CMT2J	4359
MIM607737	*	4p15.3	FIBROBLAST GROWTH FACTOR-BINDING PROTEIN 1; FGFBP1	9982
MIM607738	*	Chr.8	POTASSIUM CHANNEL, VOLTAGE-GATED, SHAB-RELATED SUBFAMILY, MEMBER 2; KCNB2	9312
MIM607739	^	 	MOVED TO 604563	 
MIM607740	*	17q22	UBIQUITIN-SPECIFIC PROTEASE 32; USP32	84669
MIM607741	*	17q12	TBC1 DOMAIN FAMILY, MEMBER 3; TBC1D3	729873
MIM607742	*	17q11.2	KERATIN 24; KRT24	192666
MIM607743	*	 	FIBROBLAST GROWTH FACTOR RECEPTOR SUBSTRATE 2; FRS2	10818
MIM607744	*	 	FIBROBLAST GROWTH FACTOR RECEPTOR SUBSTRATE 3	10817
MIM607745	#	2q23-q24.3	SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	6326
MIM607746	*	14q22.1	FERMITIN FAMILY (DROSOPHILA) HOMOLOG 2; FERMT2	10979
MIM607747	*	1p36.13	FILAMIN-BINDING LIM PROTEIN 1; FBLP1	54751
MIM607748	#	9q22.3, 9q12-q13, 1q42.1	HYPERCHOLANEMIA, FAMILIAL; FHCA	2052, 570, 9414
MIM607749	*	 	CELL DIVISION CYCLE-ASSOCIATED PROTEIN 3; CDCA3	83461
MIM607750	*	22q13	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3C; APOBEC3C	27350
MIM607751	*	7q35-q36	TASTE RECEPTOR, TYPE 2, MEMBER 38; TAS2R38	5726
MIM607752	*	5p15.2-p13.1	CYCLIN O; CCNO	10309
MIM607753	*	12q	SINGLE-STRAND-SELECTIVE MONOFUNCTIONAL URACIL-DNA GLYCOSYLASE 1	23583
MIM607754	*	 	MAKORIN 1; MKRN1	23608
MIM607755	*	22q13	MITOGEN-ACTIVATED PROTEIN KINASE 8-INTERACTING PROTEIN 2; MAPK8IP2	23542
MIM607756	*	 	ALPHA-AMINOADIPATE SEMIALDEHYDE DEHYDROGENASE-PHOSPHOPANTETHEINYL TRANSFERASE; AASDHPPT	60496
MIM607757	*	22q12-q13	CHIBBY; CBY	25776
MIM607758	*	1p36.22	CATENIN, BETA-INTERACTING PROTEIN 1; CTNNBIP1	56998
MIM607759	*	17q21.32	INTEGRIN, ALPHA-2B; ITGA2B	3674
MIM607760	*	3q22.1	DNA TOPOISOMERASE II-BINDING PROTEIN 1; TOPBP1	11073
MIM607761	*	11q24.2	KIN OF IRRE-LIKE 3; KIRREL3	84623
MIM607762	*	19q13.1	KIN OF IRRE-LIKE 2; KIRREL2	84063
MIM607763	*	Chr.17	CENTAURIN, BETA-1; CENTB1	9744
MIM607764	*	16p12-p11.2	3-@BETA-HYDROXY-DELTA-5-C27-STEROID OXIDOREDUCTASE; HSD3B7	80270
MIM607765	#	16p12-p11.2	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	80270
MIM607766	*	3q29	CENTAURIN, BETA-2; CENTB2	23527
MIM607767	*	1p35.3	SESTRIN 2; SESN2	83667
MIM607768	*	11q21	SESTRIN 3; SESN3	143686
MIM607769	*	19q13.33	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 4; PLEKHA4	57664
MIM607770	*	12p12	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 5; PLEKHA5	54477
MIM607771	*	1q32.1	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 6; PLEKHA6	22874
MIM607772	*	10q25.3-q26.2	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 1; PLEKHA1	59338
MIM607773	*	Chr.8	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 2; PLEKHA2	59339
MIM607774	*	2q31.2	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 3; PLEKHA3	65977
MIM607775	*	2q35-q36	POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 4; KCNE4	23704
MIM607776	*	15q24	SIN3, YEAST, HOMOLOG OF, A; SIN3A	25942
MIM607777	*	19p13.11	SIN3, YEAST, HOMOLOG OF, B; SIN3B	23309
MIM607778	#	2q33-q35	ACROCAPITOFEMORAL DYSPLASIA; ACFD	3549
MIM607779	*	1p36.11	PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 7; PAQR7	164091
MIM607780	*	6p12	PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 8; PAQR8	85315
MIM607781	*	Chr.15	PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 5; PAQR5	54852
MIM607782	*	16p13.3	LUC7, S. CEREVISIAE, HOMOLOG OF; LUC7L	55692
MIM607783	*	Chr.15	MESODERM DEVELOPMENT CANDIDATE GENE 2; MESDC2	23184
MIM607784	*	11q23.3	ATP-BINDING CASSETTE, SUBFAMILY G, MEMBER 4; ABCG4	64137
MIM607785	#	17q11.2, 12q24.1, 5q31	JUVENILE MYELOMONOCYTIC LEUKEMIA; JMML	23092, 4763, 5781
MIM607786	*	1p34.1-p32	PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 9; PCSK9	255738
MIM607787	*	13q31	INTIMAL THICKNESS-RELATED RECEPTOR	160897
MIM607788	*	2p21-p16.3	MULTIPLE COAGULATION FACTOR DEFICIENCY PROTEIN 2; MCFD2	90411
MIM607789	*	6q12	PHD FINGER PROTEIN 3; PHF3	23469
MIM607790	*	10q22	TET ONCOGENE FAMILY, MEMBER 1; TET1	80312
MIM607791	#	1q22	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D; CMTDID	4359
MIM607792	*	3q13	GERMINAL CENTER-EXPRESSED TRANSCRIPT 2; GCET2	257144
MIM607793	*	19p13	PETER PAN, DROSOPHILA, HOMOLOG OF; PPAN	56342
MIM607794	*	 	MEST INTRONIC TRANSCRIPT 1; MESTIT1	317751
MIM607795	*	9q31-q33	PRECURSOR mRNA-PROCESSING FACTOR 4, S. CEREVISIAE, HOMOLOG OF; PRPF4	9128
MIM607796	*	13q14.1	PHD FINGER PROTEIN 11; PHF11	51131
MIM607797	*	1p35.2	SMALL NUCLEAR RIBONUCLEOPROTEIN, 40-KD; SNRNP40	9410
MIM607798	*	 	TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1-LIKE; TAF1L	138474
MIM607799	*	12q14-q15	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 17; ZDHHC17	23390
MIM607800	*	2q34	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 12; ABCA12	26154
MIM607801	#	3p25	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C; LGMD1C	859
MIM607802	*	10q23-q24	CYCLIN M1; CNNM1	26507
MIM607803	*	10q24.33	CYCLIN M2; CNNM2	54805
MIM607804	*	2q11.2	CYCLIN M3; CNNM3	26505
MIM607805	*	2q11.2	CYCLIN M4; CNNM4	26504
MIM607806	*	 	OTOPETRIN 1	133060
MIM607807	*	7p12.3	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 13; ABCA13	154664
MIM607808	*	20p11	NK2 HOMEOBOX 4; NKX2-4	644524
MIM607809	*	11q22.3-q23.1	ACETYL-CoA ACETYLTRANSFERASE 1; ACAT1	38
MIM607810	*	2p25.2	RADICAL S-ADENOSYL METHIONINE DOMAIN-CONTAINING PROTEIN 2; RSAD2	91543
MIM607811	*	6p24.2	p21-ACTIVATED KINASE- AND PHOSPHOLIPASE C-INTERACTING PROTEIN 1; PAK1IP1	55003
MIM607812	#	14q21.1	CRANIOLENTICULOSUTURAL DYSPLASIA; CLSD	10484
MIM607813	*	1p21.3	PLASTICITY-RELATED GENE 1	9890
MIM607814	*	19q13.11	REGULATOR OF G PROTEIN SIGNALING 9-BINDING PROTEIN; RGS9BP	388531
MIM607815	*	12q23.1	ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 1B; ANKS1B	56899
MIM607816	*	10q24.33	POLYCOMB GROUP RING FINGER PROTEIN 6; PCGF6	84108
MIM607817	*	8q22-q23	VACUOLAR PROTEIN SORTING 13, YEAST, HOMOLOG OF, B; VPS13B	157680
MIM607818	*	10q21.2	ZINC FINGER PROTEIN 365; ZNF365	22891
MIM607819	*	5q11.2	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 5; SLC30A5	64924
MIM607820	*	1p32.1	HOOK, DROSOPHILA, HOMOLOG OF, 1; HOOK1	51361
MIM607821	#	6q13	DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37	4646
MIM607822	#	14q24.3	ALZHEIMER DISEASE 3	5663
MIM607823	#	20q13.33	HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	54345
MIM607824	*	19p13.13	HOOK, DROSOPHILA, HOMOLOG OF, 2; HOOK2	29911
MIM607825	*	8p11.21	HOOK, DROSOPHILA, HOMOLOG OF, 3; HOOK3	84376
MIM607826	*	 	S-ADENOSYLHOMOCYSTEINE HYDROLASE-LIKE 1; AHCYL1	10768
MIM607827	*	 	OTOPETRIN 2	92736
MIM607828	*	 	OTOPETRIN 3	347741
MIM607829	%	11p15.4	MITRAL VALVE PROLAPSE, MYXOMATOUS 2; MMVP2	352956
MIM607830	*	4q21	FRAS1 GENE; FRAS1	80144
MIM607831	#	8q13-q21.1	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	54332
MIM607832	#	6p12	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO; FSGS3	23607
MIM607833	*	 	TACHYKININ 4; TAC4	255061
MIM607834	%	17q11.1-q12	ANXIETY	6532
MIM607835	*	 	SPLICING FACTOR 3B, 14-KD SUBUNIT	51639
MIM607836	#	1p31	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1; AIS1	27022, 373071
MIM607837	*	8p23	CLN8 GENE; CLN8	2055
MIM607838	*	16p	N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE, GAMMA SUBUNIT; GNPTG	84572
MIM607839	*	3p12	GLYCOGEN BRANCHING ENZYME; GBE1	2632
MIM607840	*	12q23.3	N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE, ALPHA/BETA SUBUNITS; GNPTAB	79158
MIM607841	#	12q13-q15	DEAFNESS, AUTOSOMAL DOMINANT 48; DFNA48	4640
MIM607842	#	18q22.3-q23	AURAL ATRESIA, CONGENITAL; CAA	10194
MIM607843	*	8q23	PKHD1-LIKE 1; PKHD1L1	93035
MIM607844	*	12q14	LEM DOMAIN-CONTAINING PROTEIN 3; LEMD3	23592
MIM607845	*	6p21.1	EXPORTIN 5; XPO5	57510
MIM607846	*	 	METHYLTRANSFERASE-LIKE 2; METTL2	55798
MIM607847	#	1p22	NEUTROPENIA, NONIMMUNE CHRONIC IDIOPATHIC, OF ADULTS	2672
MIM607848	*	 	RAB-INTERACTING LYSOSOMAL PROTEIN	83547
MIM607849	*	14q23.3	RETINOL DEHYDROGENASE 11; RDH11	51109
MIM607850	#	9q21.3-q22	OSTEOARTHRITIS SUSCEPTIBILITY 3; OS3	54829
MIM607851	*	 	NAKED CUTICLE, DROSOPHILA, HOMOLOG OF, 1; NKD1	85407
MIM607852	*	 	NAKED CUTICLE, DROSOPHILA, HOMOLOG OF, 2; NKD2	85409
MIM607853	%	9q31	PANIC DISORDER 2	619493
MIM607854	*	11q13	BESTROPHIN 1; BEST1	7439
MIM607855	#	6q22-q23	MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	3908
MIM607856	*	15q21.2-q21.3	CINGULIN-LIKE 1; CGNL1	84952
MIM607857	%	4q31-q34	PSORIASIS SUSCEPTIBILITY 9; PSORS9	359825
MIM607858	*	3q27	PRESENILIN-ASSOCIATED RHOMBOID-LIKE PROTEIN; PARL	55486
MIM607859		 	ANGIOMA, TUFTED	 
MIM607860	*	 	YY1 ASSOCIATED PROTEIN 1; YY1AP1	55249
MIM607861	*	14q22.3	DAPPER, ANTAGONIST OF BETA-CATENIN, 1; DACT1	51339
MIM607862	*	 	DIRAS FAMILY, GTP-BINDING RAS-LIKE PROTEIN 1; DIRAS1	148252
MIM607863	*	 	DIRAS FAMILY, GTP-BINDING RAS-LIKE PROTEIN 2; DIRAS2	54769
MIM607864	#	16p13.3	CAUDAL DUPLICATION ANOMALY	8312
MIM607865	*	13q14	SET DOMAIN PROTEIN, BIFURCATED, 2; SETDB2	83852
MIM607866	*	13q14	CHROMOSOME 13 OPEN READING FRAME 1; C13ORF1	57213
MIM607867	*	13q14	RCC1 DOMAIN- AND BTB DOMAIN-CONTAINING PROTEIN 1; RCBTB1	55213
MIM607868	*	 	TRIPARTITE MOTIF-CONTAINING PROTEIN 11; TRIM11	81559
MIM607869	*	5q35.2	UNC5, C. ELEGANS, HOMOLOG OF, A; UNC5A	90249
MIM607870	*	10q21-q22	UNC5, C. ELEGANS, HOMOLOG OF, B; UNC5B	219699
MIM607871	*	2p21	F-BOX ONLY PROTEIN 11; FBXO11	80204
MIM607872	#	1p36	CHROMOSOME 1p36 DELETION SYNDROME	100240737
MIM607873	*	17p13.3	SCAVENGER RECEPTOR CLASS F, MEMBER 1; SCARF1	8578
MIM607874	*	19q13.43	ZINC FINGER PROTEIN 444; ZNF444	55311
MIM607875	*	Chr.17	SKELETAL MUSCLE- AND KIDNEY-ENRICHED INOSITOL PHOSPHATASE	51763
MIM607876	%	2p11.1-q12.2	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2	554188
MIM607877	*	2q37.3	OTOSPIRALIN	150677
MIM607878	*	5p13.1-cen	NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE; NNT	23530
MIM607879	*	4q12	EXOCYST COMPLEX COMPONENT 1; EXOC1	55763
MIM607880	*	2p13.2	EXOCYST COMPLEX COMPONENT 6B; EXOC6B	23233
MIM607881	*	 	SIGNAL-TRANSDUCING ADAPTOR PROTEIN 2	55620
MIM607882	*	8q24.3	SOLUTE CARRIER FAMILY 52 (RIBOFLAVIN TRANSPORTER), MEMBER 2; SLC52A2	79581
MIM607883	*	17p13.2	SOLUTE CARRIER FAMILY 52 (RIBOFLAVIN TRANSPORTER), MEMBER 1; SLC52A1	55065
MIM607884	*	 	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 1; CMTM1	113540
MIM607885	*	 	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 2; CMTM2	146225
MIM607886	*	 	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 3; CMTM3	123920
MIM607887	*	 	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 4; CMTM4	146223
MIM607888	*	 	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 5; CMTM5	116173
MIM607889	*	 	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 6; CMTM6	54918
MIM607890	*	 	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 7; CMTM7	112616
MIM607891	*	 	CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING 8; CMTM8	152189
MIM607892	*	18q12	DESMOGLEIN 4; DSG4	147409
MIM607893	%	3p25-p22	OVARIAN CANCER, SUSCEPTIBILITY TO, 1; OVCAS1	574048
MIM607894	*	 	POLYCYSTIN 1-LIKE 2; PKD1L2	114780
MIM607895	*	16q22	POLYCYSTIN 1-LIKE 3; PKD1L3	342372
MIM607896	*	 	OVARIAN CANCER-ASSOCIATED GENE 2	124641
MIM607897	*	 	MUSASHI, DROSOPHILA, HOMOLOG OF, 2; MSI2	124540
MIM607898	*	 	TRIBBLES, DROSOPHILA, HOMOLOG OF, 3; TRIB3	57761
MIM607899	*	 	WIT1 GENE	51352
MIM607900	*	20p13	FERMITIN FAMILY (DROSOPHILA) HOMOLOG 1; FERMT1	55612
MIM607901	*	11q12	FERMITIN FAMILY (DROSOPHILA) HOMOLOG 3; FERMT3	83706
MIM607902	*	 	RNA, U TRANSPORTER 1; RNUT1	10073
MIM607903	#	18q12	HYPOTRICHOSIS 6; HYPT6	147409
MIM607904	*	16p13.3	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1H SUBUNIT; CACNA1H	8912
MIM607905	*	9q22	ALG2, S. CEREVISIAE, HOMOLOG OF	85365
MIM607906	#	9q22	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	85365
MIM607907	#	 	DERMATOFIBROSARCOMA PROTUBERANS; DFSP	 
MIM607908	*	 	LIM AND SENESCENT CELL ANTIGEN-LIKE DOMAINS 2; LIMS2	55679
MIM607909	*	8q22.3	ANTIZYME INHIBITOR 1; AZIN1	51582
MIM607910	*	 	KINESIN FAMILY MEMBER 9; KIF9	64147
MIM607911	*	 	EPM2A-INTERACTING PROTEIN 1; EPM2AIP1	9852
MIM607912	*	 	SELENOPROTEIN T	51714
MIM607913	*	 	GLUTATHIONE PEROXIDASE 6; GPX6	257202
MIM607914	*	 	SELENOPROTEIN H	280636
MIM607915	*	 	SELENOPROTEIN I	85465
MIM607916	*	 	SELENOPROTEIN K	58515
MIM607917	*	 	SELENOPROTEIN O	83642
MIM607918	*	15q26.3	SELENOPROTEIN S; SEPS1	55829
MIM607919	*	 	SELENOPROTEIN V	348303
MIM607920	^	 	MOVED TO 159001	 
MIM607921	#	17q25	RETINITIS PIGMENTOSA 30; RP30	25794
MIM607922	*	22q13.2	ALPHA-1,4-GALACTOSYLTRANSFERASE; A4GALT	53947
MIM607923	*	 	SYNAPTOSOMAL-ASSOCIATED PROTEIN, 91-KD; SNAP91	9892
MIM607924	*	11q13.1	METASTASIS-ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; MALAT1	378938
MIM607925	*	 	B- AND T-LYMPHOCYTE ATTENUATOR; BTLA	151888
MIM607926	*	12q23.3	HOST CELL FACTOR C2; HCFC2	29915
MIM607927	*	 	ANKYRIN REPEATS- AND FYVE DOMAIN-CONTAINING PROTEIN 1; ANKFY1	51479
MIM607928	*	9q32-q34	WHIRLIN; WHRN	25861
MIM607929	*	7p13	CCM2 GENE; CCM2	83605
MIM607930	*	 	CYTOKINE-LIKE PROTEIN 1; CYTL1	54360
MIM607931	*	16p11	ATAXIN 2-LIKE; ATXN2L	11273
MIM607932	#	14q22-q23	MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	652
MIM607933	*	 	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 11; SLC7A11	23657
MIM607934	*	1p36.13	PEPTIDYLARGININE DEIMINASE, TYPE I; PADI1	29943
MIM607935	*	1p36.13	PEPTIDYLARGININE DEIMINASE, TYPE II; PADI2	11240
MIM607936	#	12q13	EXFOLIATIVE ICHTHYOSIS, AUTOSOMAL RECESSIVE, ICHTHYOSIS BULLOSA OF SIEMENS-LIKE	1475
MIM607937	*	 	HOMEOBOX TRANSCRIPTION FACTOR NANOG; NANOG	79923
MIM607938	*	11q25	NEUROTRIMIN	50863
MIM607939	*	3p26	SULFATASE-MODIFYING FACTOR 1; SUMF1	285362
MIM607940	*	 	SULFATASE-MODIFYING FACTOR 2	25870
MIM607941	#	8p23.1-p22	ATRIAL SEPTAL DEFECT 2; ASD2	2626
MIM607942	*	 	PHOSPHOINOSITIDE 3-KINASE ADAPTOR PROTEIN 1	118788
MIM607943	*	7q22	RAS p21 PROTEIN ACTIVATOR 4; RASA4	10156
MIM607944	#	 	SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	54
MIM607945	*	1p36.13-q41	ADIPONECTIN RECEPTOR 1; ADIPOR1	51094
MIM607946	*	 	ADIPONECTIN RECEPTOR 2; ADIPOR2	79602
MIM607947	*	 	POTASSIUM CHANNEL REGULATOR; KCNRG	283518
MIM607948	#	17q11.2-q12, 12q14, 11q23-q24, 6q23-q24, 5q33.1, 3p21.3, 2q37.1, 2q35, 20q13.2, 19p13.3	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO	114609, 1154, 30835, 3431, 345611, 3458, 3459, 4159, 6347, 6556
MIM607949	%	2q35	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 1	404716
MIM607950	*	 	TESTIS-SPECIFIC PROTEASE 50	29122
MIM607951	*	 	CENTROSOMAL PROTEIN, 57-KD; CEP57	9702
MIM607952	*	3p25.3	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GABA), MEMBER 11; SLC6A11	6538
MIM607953	*	 	NEURONAL PROTEIN, 25-KD, RAT, HOMOLOG OF	29114
MIM607954	*	 	RAN GUANINE NUCLEOTIDE RELEASE FACTOR	29098
MIM607955	*	6q24.3	STERILE ALPHA MOTIFS- AND SH3 DOMAIN-CONTAINING PROTEIN 1; SASH1	23328
MIM607956	*	 	MEDIATOR COMPLEX SUBUNIT 8; MED8	112950
MIM607957	*	 	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I-DELTA; CAMK1D	57118
MIM607958	*	 	SYNTAXIN-BINDING PROTEIN 6; STXBP6	29091
MIM607959	*	 	SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, y+ SYSTEM), MEMBER 10; SLC7A10	56301
MIM607960	*	10q26	DEAH BOX POLYPEPTIDE 32; DHX32	55760
MIM607961	*	15q22.2-q23	SEMAPHORIN 7A; SEMA7A	8482
MIM607962	*	19p13.13	MICRO RNA 23A; MIR23A	407010
MIM607963	*	 	METHYL-CpG BINDING DOMAIN PROTEIN 3-LIKE 1; MBD3L1	85509
MIM607964	*	 	METHYL-CpG BINDING DOMAIN PROTEIN 3-LIKE 2; MBD3L2	125997
MIM607965	%	10q22.3	SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 1; SLEN1	192677
MIM607966	%	2q34-q35	SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 2; SLEN2	192679
MIM607967	%	11p15.5	SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 3; SLEN3	282849
MIM607968	*	7p14	PARATHYROID HORMONE-RESPONSIVE B1 GENE	27241
MIM607969	*	 	CDC-LIKE KINASE 4; CLK4	57396
MIM607970	*	 	G PROTEIN-COUPLED RECEPTOR 135; GPR135	64582
MIM607971	*	 	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 15; SLC6A15	55117
MIM607972	*	 	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 16; SLC6A16	28968
MIM607973	*	18q22-q23	NEUROPILIN- AND TOLLOID-LIKE 1; NETO1	81832
MIM607974	*	16q11	NEUROPILIN- AND TOLLOID-LIKE 2; NETO2	81831
MIM607975	*	 	PREGNANCY-INDUCED GROWTH INHIBITOR OKL38	29948
MIM607976	*	20q11.21	CYTOCHROME c OXIDASE, SUBUNIT IV, ISOFORM 2; COX4I2	84701
MIM607977	*	 	HEADCASE, DROSOPHILA, HOMOLOG OF; HECA	51696
MIM607978	*	21q11.2	SAM DOMAIN, SH3 DOMAIN, AND NUCLEAR LOCALIZATION SIGNALS 1; SAMSN1	64092
MIM607979	*	 	SERINE HYDROLASE-LIKE; SERHL	94009
MIM607980	*	 	TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 7, YEAST, HOMOLOG OF	54543
MIM607981	*	 	NEGATIVE REGULATOR OF UBIQUITIN-LIKE PROTEINS 1; NUB1	51667
MIM607982	*	11q13	SCY1-LIKE 1; SCYL1	57410
MIM607983	*	1q24.2	GOLGIN, RAB6-INTERACTING; GORAB	92344
MIM607984	*	5q31.3	SPROUTY, DROSOPHILA, HOMOLOG OF, 4; SPRY4	81848
MIM607985	*	16p13.3	N-ACETYLGLUCOSAMINE-1-PHOSPHODIESTER ALPHA-N-ACETYLGLUCOSAMINIDASE; NAGPA	51172
MIM607986	*	1q21	S100 CALCIUM-BINDING PROTEIN A14; S100A14	57402
MIM607987	*	2p23.1-p22.1	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 10; DNAJC10	54431
MIM607988	*	10q21-q23	SPARC/OSTEONECTIN, CWCV, AND KAZAL-LIKE DOMAINS PROTEOGLYCAN 2; SPOCK2	9806
MIM607989	*	4q32.3	SPARC/OSTEONECTIN, CWCV, AND KAZAL-LIKE DOMAINS PROTEOGLYCAN 3; SPOCK3	50859
MIM607990	*	19p13.3	UBIQUITIN-LIKE PROTEIN CONTAINING PHD AND RING FINGER DOMAINS 1; UHRF1	29128
MIM607991	*	 	SOLUTE CARRIER FAMILY 8 (SODIUM-CALCIUM EXCHANGER), MEMBER 3; SLC8A3	6547
MIM607992	*	19p13.11	SPLICING FACTOR 4; SF4	57794
MIM607993	*	19p13.11	SPLICING FACTOR, ARGININE/SERINE-RICH, 14; SFRS14	10147
MIM607994	*	3q25-q26.1	5-PRIME,3-PRIME-@EXORIBONUCLEASE 1; XRN1	54464
MIM607995	*	6q27	UNC93, C. ELEGANS, HOMOLOG OF, A; UNC93A	54346
MIM607996	*	 	PREPRONEUROPEPTIDE B	256933
MIM607997	*	 	PREPRONEUROPEPTIDE W	283869
MIM607998	*	11p15.5	TRIPEPTIDYL PEPTIDASE I; TPP1	1200
MIM607999	*	 	ASH1, DROSOPHILA, HOMOLOG OF	55870
MIM608000	*	 	N-ALPHA-ACETYLTRANSFERASE 15, NatA AUXILIARY SUBUNIT; NAA15	80155
MIM608001	*	 	MELANOMA INHIBITORY ACTIVITY PROTEIN 2; MIA2	117153
MIM608002	*	3q22	NEPHROCYSTIN 3; NPHP3	27031
MIM608003	*	 	HOMEODOMAIN-INTERACTING PROTEIN KINASE 1; HIPK1	204851
MIM608004	*	3q13.11	NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS INHIBITOR, ZETA; NFKBIZ	64332
MIM608005	*	5q31	SIL1, S. CEREVISIAE, HOMOLOG OF; SIL1	64374
MIM608006	*	 	LEIOMODIN 2; LMOD2	442721
MIM608007	*	 	PLECKSTRIN 2; PLEK2	26499
MIM608008	*	4q33	ANNEXIN A10; ANXA10	11199
MIM608009	*	1p31	ADENYLATE KINASE 5; AK5	26289
MIM608010	+	7p13	NPC1-LIKE 1; NPC1L1	29881
MIM608011	*	3p21.1	GUANINE NUCLEOTIDE-BINDING PROTEIN-LIKE 3; GNL3	26354
MIM608012	*	16p13.3	PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 2; PDIA2	64714
MIM608013	#	1q21	GAUCHER DISEASE, PERINATAL LETHAL	2629
MIM608014	*	12q24	HEAT-SHOCK 22-KD PROTEIN 8; HSPB8	26353
MIM608015	*	11q13.5	TSUKUSHIN; TSKU	25987
MIM608016	*	11q13.4	COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 8; CHCHD8	51287
MIM608017	*	3q21.1	CHROMOSOME 3 OPEN READING FRAME 28; C3ORF28	26355
MIM608018	*	 	PANCREASIN	83886
MIM608019	*	 	TNFAIP3-INTERACTING PROTEIN 3; TNIP3	79931
MIM608020	*	11p15-p14	NUCLEOBINDIN 2; NUCB2	4925
MIM608021	*	16p13.3	WAP, FOLLISTATIN, IMMUNOGLOBULIN, KUNITZ, AND NTR DOMAINS-CONTAINING PROTEIN 1; WFIKKN1	117166
MIM608022	#	 	DIAPHANOSPONDYLODYSOSTOSIS	168667
MIM608023	*	 	DEAD/H BOX 56; DDX56	54606
MIM608024	*	 	PEROXISOMAL D3,D2-ENOYL-CoA ISOMERASE; PECI	10455
MIM608025	*	2p24-p23	NEUROBLASTOMA-AMPLIFIED SEQUENCE; NBAS	51594
MIM608026	%	9q31-q32	HYPERTENSIVE NEPHROPATHY; HNP1	574045
MIM608027	%	7q11-q21	PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3	373073
MIM608028		 	THAI SYMPHALANGISM SYNDROME	 
MIM608029	%	20q11-q13	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6; SCAR6	1167
MIM608030	#	16p11.2	AMYOTROPHIC LATERAL SCLEROSIS 6, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS6	2521
MIM608031	%	20p13	AMYOTROPHIC LATERAL SCLEROSIS 7; ALS7	406238
MIM608032	^	 	MOVED TO 127500	 
MIM608033	#	2q11-q13	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3	5903
MIM608034	*	17pter-p13	ASPARTOACYLASE; ASPA	443
MIM608035	%	1p22	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 4; CMM4	474388
MIM608036	%	5q34-q35.2	DIABETES MELLITUS, NONINSULIN-DEPENDENT, 4	100188782
MIM608037	*	7q36.1	CHONDROITIN POLYMERIZING FACTOR 2; CHPF2	54480
MIM608038	*	 	p21 PROTEIN-ACTIVATED KINASE 7; PAK7	57144
MIM608039	*	 	NYD-SP16	83890
MIM608040	*	9q	INTRAFLAGELLAR TRANSPORT 74, CHLAMYDOMONAS, HOMOLOG OF; IFT74	80173
MIM608041	*	4q21	ANTHRAX TOXIN RECEPTOR 2; ANTXR2	118429
MIM608042	*	1p36.11	SYNAPTOTAGMIN-LIKE 1; SYTL1	84958
MIM608043	*	5q33.2	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 10; GALNT10	55568
MIM608044	*	12q22-q23	SOLUTE CARRIER FAMILY 5 (IODIDE TRANSPORTER), MEMBER 8; SLC5A8	160728
MIM608045	%	 	REPRESSOR OF TELOMERASE EXPRESSION 1	404685
MIM608046	*	11q13	SYNOVIAL APOPTOSIS INHIBITOR 1; SYVN1	84447
MIM608047	*	 	UBIQUITIN-PROTEIN LIGASE E3B; UBE3B	89910
MIM608048	*	 	SNF2, LINKER HISTONE, PHD FINGER, RING FINGER, AND HELICASE DOMAINS-CONTAINING PROTEIN; SHPRH	257218
MIM608049	%	13q14.2-q14.1	AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	387577
MIM608050	*	9q34	TORSIN 1B; TOR1B	27348
MIM608051	#	4p15.3	MACULAR DYSTROPHY, RETINAL, 2; MCDR2	8842
MIM608052	*	 	TORSIN 2A; TOR2A	27433
MIM608053	*	15q23-q25	ELECTRON TRANSFER FLAVOPROTEIN, ALPHA POLYPEPTIDE; ETFA	2108
MIM608054	*	19q13.2	CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 7; CYP2A7	1549
MIM608055	*	19q13.2	CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 13; CYP2A13	1553
MIM608056	^	 	MOVED TO 151660	 
MIM608057	*	1p22.3	DEOXYRIBONUCLEASE II BETA; DNASE2B	58511
MIM608058	*	2q24-q32	GLUCOSE-6-PHOSPHATASE, CATALYTIC, 2; G6PC2	57818
MIM608059	*	17p13.2	HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 7; HES7	84667
MIM608060	*	1p36.31	HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 4	57801
MIM608061	*	19q13.2	TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 40, YEAST, HOMOLOG OF; TOMM40	10452
MIM608062	*	11p13	DOUBLECORTIN DOMAIN-CONTAINING PROTEIN 1; DCDC1	341019
MIM608063		 	BILE AND PANCREATIC DUCTS, COMPLETE ABSENCE OF	 
MIM608064	*	4p15.1-p13	KELCH-LIKE 5; KLHL5	51088
MIM608065	*	12q13	SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 4; SLC38A4	55089
MIM608066	*	19p13.3	SCAFFOLD ATTACHMENT FACTOR B2; SAFB2	9667
MIM608067	*	1q24.1	RING FINGER AND WD REPEAT DOMAINS-CONTAINING PROTEIN 2; RFWD2	64326
MIM608068	%	 	NEUTROPHILIC DERMATOSIS, ACUTE FEBRILE	 
MIM608069	*	1p36	ERBB RECEPTOR FEEDBACK INHIBITOR 1; ERRFI1	54206
MIM608070	*	16q12.2-q13	HOMOCYSTEINE- AND ENDOPLASMIC RETICULUM STRESS-INDUCIBLE PROTEIN, UBIQUITIN-LIKE DOMAIN-CONTAINING, 1; HERPUD1	9709
MIM608071	*	10q24	F-BOX AND WD40 DOMAIN PROTEIN 4; FBXW4	6468
MIM608072	*	6p22.3	NHL REPEAT-CONTAINING 1 GENE; NHLRC1	378884
MIM608073	*	8p21.3	NUCLEOPHOSMIN/NUCLEOPLASMIN FAMILY, MEMBER 2; NPM2	10361
MIM608074	*	3p22.3	PROGRAMMED CELL DEATH 6-INTERACTING PROTEIN; PDCD6IP	10015
MIM608075	*	12p12.3	PHOSPHOLIPASE C, ZETA-1; PLCZ1	89869
MIM608076	*	17p13.1	TYROSINE KINASE, NONRECEPTOR, 1; TNK1	8711
MIM608077	*	22q11	PURINERGIC RECEPTOR P2X-LIKE 1; P2RXL1	9127
MIM608078	%	10q22.3	SCHIZOPHRENIA 11	404686
MIM608079	*	18q21	ELAC, E. COLI, HOMOLOG OF, 1; ELAC1	55520
MIM608080	*	18q21	MAESTRO; MRO	83876
MIM608081	*	10q11.1	SYNAPTOTAGMIN 15; SYT15	83849
MIM608082	*	22q11.2	YIPPEE-LIKE 1; YPEL1	29799
MIM608083	*	19q13.2	APOLIPOPROTEIN C-II; APOC2	344
MIM608084	*	7q36.1	GTPase, IMAP FAMILY, MEMBER 1; GIMAP1	170575
MIM608085	*	7q36.1	GTPase, IMAP FAMILY, MEMBER 2; GIMAP2	26157
MIM608086	*	7q36.1	GTPase, IMAP FAMILY, MEMBER 5; GIMAP5	55340
MIM608087	*	7q36.1	GTPase, IMAP FAMILY, MEMBER 4; GIMAP4	55303
MIM608088	%	3p24-p22	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	378888
MIM608089	#	16q22.1, 14q24.3, 2p16	ENDOMETRIAL CANCER	27030, 2956, 5728, 999
MIM608090	*	12q21.31	MLX-INTERACTING PROTEIN; MLXIP	22877
MIM608091	#	11q13, 11p12-q13.3	JOUBERT SYNDROME 2; JBTS2	51259
MIM608092	*	4q32.3	PALLADIN, MOUSE, HOMOLOG OF; PALLD	23022
MIM608093	#	11q23.3	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	1798
MIM608094	*	21q22.3	SOLUTE CARRIER FAMILY 37 (GLYCEROL-3-PHOSPHATE TRANSPORTER), MEMBER 1; SLC37A1	54020
MIM608095	*	1q21.3	SODIUM CHANNEL MODIFIER 1; SCNM1	79005
MIM608096	%	12q22-q23.3	EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	619399
MIM608097	#	20q13.13	HETEROTOPIA, PERIVENTRICULAR, AUTOSOMAL RECESSIVE	10564
MIM608098	%	5p15.1	HETEROTOPIA, PERIVENTRICULAR, ASSOCIATED WITH CHROMOSOME 5p ANOMALIES	100302681
MIM608099	#	17q12-q21.33	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D; LGMD2D	6442
MIM608100	*	2p15-p13	NFU1, S. CEREVISIAE, HOMOLOG OF; NFU1	27247
MIM608101	*	17q21.33	SPERMATID-SPECIFIC LINKER HISTONE H1-LIKE PROTEIN	373861
MIM608102	*	13q21.1-q32	CLN5 GENE; CLN5	1203
MIM608103	*	11pter-p15.5	ALG8, S. CEREVISIAE, HOMOLOG OF	79053
MIM608104	#	11pter-p15.5	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	79053
MIM608105	%	16p12-p11.2	EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	574044
MIM608106	#	12q23-q24.1	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5; HIGM5	7374
MIM608107	*	16p13	FAMILIAL MEDITERRANEAN FEVER GENE; MEFV	4210
MIM608108	*	16q22.2-q22.3	CRANIOFACIAL DEVELOPMENT PROTEIN 1; CFDP1	10428
MIM608109	*	12q24.33	PSEUDOURIDINE SYNTHASE 1; PUS1	80324
MIM608110	*	15q14	p21 PROTEIN-ACTIVATED KINASE 6; PAK6	56924
MIM608111	*	2p16.1	FANCL GENE; FANCL	55120
MIM608112	*	3p25.3-p24.1	TRAFFICKING PROTEIN, KINESIN-BINDING 1; TRAK1	22906
MIM608113	*	 	SARCOGLYCAN, ZETA; SGCZ	137868
MIM608114	*	7p22.3	CENTAURIN, ALPHA-1; CENTA1	11033
MIM608115	#	2p21-p16	OVARIAN HYPERSTIMULATION SYNDROME	2492
MIM608116	*	 	CHROMOSOME 3 OPEN READING FRAME 3	57467
MIM608117	*	 	PHOSPHODIESTERASE 4D-INTERACTING PROTEIN; PDE4DIP	9659
MIM608118	#	 	ZINC IN BREAST MILK, REDUCED	 
MIM608119	*	 	HOMEODOMAIN LEUCINE ZIPPER-CONTAINING FACTOR	57594
MIM608120	*	11p15	PARVIN, ALPHA; PARVA	55742
MIM608121	*	22q13.31	PARVIN, BETA; PARVB	29780
MIM608122	*	22q13.31	PARVIN, GAMMA; PARVG	64098
MIM608123	*	20q13.1	ACYL-CoA THIOESTERASE 8; ACOT8	10005
MIM608124	*	16p13.1	XYLOSYLTRANSFERASE 1; XYLT1	64131
MIM608125	*	17q21.3-q22	XYLOSYLTRANSFERASE 2; XYLT2	64132
MIM608126	*	 	ACIDIC NUCLEOPLASMIC DNA-BINDING PROTEIN 1, XENOPUS, HOMOLOG OF	11169
MIM608127	*	 	PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 4; PBX4	80714
MIM608129	*	9q34.3	UBIQUITIN-ASSOCIATED DOMAIN-CONTAINING PROTEIN 1; UBAC1	10422
MIM608130	*	 	NUAK FAMILY, SNF1-LIKE KINASE, 1; NUAK1	9891
MIM608131	*	 	NUAK FAMILY, SNF1-LIKE KINASE, 2; NUAK2	81788
MIM608132	*	14q32.1	TETRATRICOPEPTIDE REPEAT DOMAIN 8; TTC8	123016
MIM608133	#	6p21.1-cen	RETINITIS PIGMENTOSA 7; RP7	5961
MIM608134	*	 	PARALEMMIN; PALM	5064
MIM608135	*	9q21.3-q22	ASPORIN; ASPN	54829
MIM608136	*	8p23	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 10; ARHGEF10	9639
MIM608137	*	9q34.3	NASAL EMBRYONIC LHRH FACTOR; NELF	26012
MIM608138	*	15q22.31	PROGRAMMED CELL DEATH 7; PDCD7	10081
MIM608139	*	17p11.2	CENTROMERE PROTEIN V; CENPV	201161
MIM608140	*	2q32.1	NUCLEOPORIN, 35-KD; NUP35	129401
MIM608141	*	6q24.3	NUCLEOPORIN, 43-KD; NUP43	348995
MIM608142	*	22q11-q12	HSC20, E. COLI, HOMOLOG OF	150274
MIM608143	*	8p11.21	1-@ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 6; AGPAT6	137964
MIM608144	*	6p21.3	SAM POINTED DOMAIN-CONTAINING ETS TRANSCRIPTION FACTOR; SPDEF	25803
MIM608145	*	15q11.1	NONIMPRINTED GENE IN PRADER-WILLI SYNDROME/ANGELMAN SYNDROME CHROMOSOME REGION 1; NIPA1	123606
MIM608146	*	15q11.2	NONIMPRINTED GENE IN PRADER-WILLI SYNDROME/ANGELMAN SYNDROME CHROMOSOME REGION 2; NIPA2	81614
MIM608147	*	15q11.2	TUBULIN-GAMMA COMPLEX-ASSOCIATED PROTEIN 5; TUBGCP5	114791
MIM608148	*	2q33	SPECIAL AT-RICH SEQUENCE-BINDING PROTEIN 2; SATB2	23314
MIM608150	*	12q12	PERIPHILIN 1; PPHLN1	51535
MIM608151	*	4p14-p11	WD REPEAT-CONTAINING PROTEIN 19; WDR19	57728
MIM608152	*	9q34.13	PROSTAGLANDIN E SYNTHASE 2; PTGES2	80142
MIM608153	*	19q13.1	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 14A; PPP1R14A	94274
MIM608154	%	 	LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	 
MIM608155	*	5q33.1	SYNAPTOPODIN; SYNPO	11346
MIM608156	#	 	NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	100885786
MIM608157	*	5q31	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ORNITHINE TRANSPORTER), MEMBER 2; SLC25A2	83884
MIM608158	%	 	CoQ-RESPONSIVE OXPHOS DEFICIENCY	 
MIM608159	*	16p13.3	PROTEASE, SERINE, 21; PRSS21	10942
MIM608160	*	17q24.3-q25.1	SRY-BOX 9; SOX9	6662
MIM608161	#	11q13, 6p21.1-cen	MACULAR DYSTROPHY, VITELLIFORM, ADULT-ONSET	5961, 7439
MIM608162	*	1p13.1	V-SET DOMAIN-CONTAINING T-CELL ACTIVATION INHIBITOR 1; VTCN1	79679
MIM608163	*	17q25.1	EXOCYST COMPLEX COMPONENT 7; EXOC7	23265
MIM608164	*	8q22.3-q24.1	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY V, MEMBER 1; KCNV1	27012
MIM608165	*	2q32.2-q33	PTB DOMAIN-CONTAINING ENGULFMENT ADAPTOR PROTEIN 1; GULP1	51454
MIM608166	*	7q21.11	SEMAPHORIN 3E; SEMA3E	9723
MIM608167	*	9q34.3	POTASSIUM CHANNEL, SUBFAMILY T, MEMBER 1; KCNT1	57582
MIM608168	*	 	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 6; KCNH6	81033
MIM608169	*	2q24.2	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 7; KCNH7	90134
MIM608170	*	5q35.3	DEAD/H BOX 41; DDX41	51428
MIM608171	*	12p13.3	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 4; CACNA2D4	93589
MIM608172	*	1p35	DEHYDRODOLICHYL DIPHOSPHATE SYNTHASE; DHDDS	79947
MIM608173	%	6p11	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 1	387578
MIM608174	%	5q31-q33	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 2	387579
MIM608175	#	8q24.2-q24.3, 8q23-q24	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3	57623, 7038
MIM608176	%	10q	AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 4	387581
MIM608177	*	8q24.11-q24.13	EXOSTOSIN 1; EXT1	2131
MIM608178	*	11p14-p13	LEUCINE ZIPPER PROTEIN 2; LUZP2	338645
MIM608179	*	19p13.3	CAYTAXIN	85300
MIM608180	#	22q13.3	SYNPOLYDACTYLY 2; SPD2	2192
MIM608181	*	15q21-q22	ACIDIC CLUSTER PROTEIN, 33-KD	51324
MIM608182	*	4p15.3	POTASSIUM CHANNEL-INTERACTING PROTEIN 4	80333
MIM608183	*	15q26.3	CHONDROITIN SULFATE SYNTHASE 1; CHSY1	22856
MIM608184		 	IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 4; HIGM4	 
MIM608185	*	7q31	EXOCYST COMPLEX COMPONENT 4; EXOC4	60412
MIM608186	*	 	EXOCYST COMPLEX COMPONENT 3; EXOC3	11336
MIM608187	*	20p13-p12.3	MINICHROMOSOME MAINTENANCE, S. CEREVISIAE, HOMOLOG OF, 8; MCM8	84515
MIM608188	*	20p13-p12.3	CARDIOLIPIN SYNTHASE 1; CRLS1	54675
MIM608189	#	5q32	TROPICAL CALCIFIC PANCREATITIS	6690
MIM608190	*	 	N-ACETYLTRANSFERASE 8B; NAT8B	51471
MIM608191	*	 	RB-ASSOCIATED KRAB REPRESSOR	57786
MIM608192	*	1q23.3	PROTEIN ASSOCIATED WITH THE C-TERMINAL DOMAIN OF EZRIN	57147
MIM608193	*	14q11.2-q12	REC8, S. POMBE, HOMOLOG OF; REC8L1	9985
MIM608194	#	14q11	CONE-ROD DYSTROPHY 13; CORD13	57096
MIM608195	*	6p12.3-p12.2	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 1; LRRC1	55227
MIM608196	*	6p25.2	WERNER HELICASE-INTERACTING PROTEIN 1; WRNIP1	56897
MIM608197	*	1q21	PEPTIDOGLYCAN RECOGNITION PROTEIN 3; PGLYRP3	114771
MIM608198	*	1q21	PEPTIDOGLYCAN RECOGNITION PROTEIN 4; PGLYRP4	57115
MIM608199	*	19p13.12	PEPTIDOGLYCAN RECOGNITION PROTEIN 2; PGLYRP2	114770
MIM608200	*	20q11.2	CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 1; CDK5RAP1	51654
MIM608201	*	9q33.3	CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 2; CDK5RAP2	55755
MIM608202	*	17q21.31	CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 3; CDK5RAP3	80279
MIM608203	#	22q12.3-q13.2	NEUTROPHIL IMMUNODEFICIENCY SYNDROME	5880
MIM608204	*	11q13	UNC93, C. ELEGANS, HOMOLOG OF, B1; UNC93B1	81622
MIM608205	*	1p36.1-p22.3	MITOCHONDRIAL TRANS-2-ENOYL-CoA REDUCTASE; MECR	51102
MIM608206	*	5q32	SH3 DOMAIN AND TETRATRICOPEPTIDE REPEAT DOMAIN 2; SH3TC2	79628
MIM608207	%	22q12	KALA-AZAR, SUSCEPTIBILITY TO, 1; KAZA1	387582
MIM608208	*	2q35	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 4; MARCH4	57574
MIM608209	*	2q12.3-q14.2	DIPEPTIDYL PEPTIDASE X; DPP10	57628
MIM608210	*	11p12-p11	EXOSTOSIN 2; EXT2	2132
MIM608211	*	6p22.1	KIDNEY-ASSOCIATED ANTIGEN 1; KAAG1	353219
MIM608212	*	5q33.1	IMMUNITY-RELATED GTPase FAMILY, M; IRGM	345611
MIM608213	*	11p15.5	CELL CYCLE EXIT AND NEURONAL DIFFERENTIATION 1; CEND1	51286
MIM608214	*	11q23.3	SODIUM CHANNEL, VOLTAGE-GATED, TYPE III, BETA SUBUNIT; SCN3B	55800
MIM608215	*	 	LIM HOMEOBOX GENE 6; LHX6	26468
MIM608216	*	8q24.3	COMM DOMAIN-CONTAINING PROTEIN 5; COMMD5	28991
MIM608217	%	 	SEIZURES, BENIGN FAMILIAL NEONATAL, 3; BFNS3	 
MIM608218	*	17q12-q21	KERATIN 20; KRT20	54474
MIM608219	%	6q26-q27	DEAFNESS, AUTOSOMAL RECESSIVE 38; DFNB38	337991
MIM608220	%	6q23-q24.1	SPASTIC PARAPLEGIA 25, AUTOSOMAL RECESSIVE; SPG25	387583
MIM608221	*	10p12.1	MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE-LIKE; MASTL	84930
MIM608222	*	22q13.1	ADENYLOSUCCINATE LYASE; ADSL	158
MIM608223		 	ASPIRIN RESISTANCE	 
MIM608224	#	12q24.32-qter	DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41	94142
MIM608225	*	2p23.2	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 14; GALNT14	79623
MIM608226	*	10q26.11	NANOS, DROSOPHILA, HOMOLOG OF, 1; NANOS1	340719
MIM608227		 	CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRAL NEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	 
MIM608228	*	 	NANOS, DROSOPHILA, HOMOLOG OF, 2	339345
MIM608229	*	 	NANOS, DROSOPHILA, HOMOLOG OF, 3	342977
MIM608230	*	22q13.1	CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1I SUBUNIT; CACNA1I	8911
MIM608231	*	 	RAS ASSOCIATION DOMAIN FAMILY, MEMBER 8; RASSF8	11228
MIM608232	#	22q11.21	LEUKEMIA, CHRONIC MYELOID; CML	613
MIM608233	#	5q14.1	HERMANSKY-PUDLAK SYNDROME 2; HPS2	8546
MIM608234	*	11q13	GALACTOSE-3-O-SULFOTRANSFERASE 3; GAL3ST3	89792
MIM608235	*	7q22	GALACTOSE-3-O-SULFOTRANSFERASE 4; GAL3ST4	79690
MIM608236	#	8p23	SLOWED NERVE CONDUCTION VELOCITY, AUTOSOMAL DOMINANT	9639
MIM608237	*	2q37.3	GALACTOSE-3-O-SULFOTRANSFERASE 2; GAL3ST2	64090
MIM608238	*	15q15.3	SIGNAL PEPTIDE PEPTIDASE-LIKE 2A	84888
MIM608239	*	19p13.3	SIGNAL PEPTIDE PEPTIDASE-LIKE 2B	56928
MIM608240	*	12q24.31	SIGNAL PEPTIDE PEPTIDASE-LIKE 3	121665
MIM608241	*	1p32.3-p32.2	SMAD NUCLEAR INTERACTING PROTEIN 1; SNIP1	79753
MIM608242	*	4q22.2-q22.3	HECT DOMAIN AND RCC1-LIKE DOMAIN 5; HERC5	51191
MIM608243	*	15q13.1	NECDIN-LIKE GENE 2; NDNL2	56160
MIM608244	%	6p22.3-p21.3	OTOSCLEROSIS 3; OTSC3	170532
MIM608245	*	12q13	KERATIN 71; KRT71	112802
MIM608246	*	12q13	KERATIN 72; KRT72	140807
MIM608247	*	12q13	KERATIN 73; KRT73	319101
MIM608248	*	12q13	KERATIN 74; KRT74	121391
MIM608249	*	14q11.1	CYCLIN B1 INTERACTING PROTEIN 1; CCNB1IP1	57820
MIM608250	*	 	SDS3, YEAST, HOMOLOG OF	64426
MIM608251	%	Chr.14	PHOBIA, SPECIFIC	404684
MIM608252	*	 	ACTIN FILAMENT-ASSOCIATED PROTEIN 1; AFAP1	60312
MIM608253	*	 	TESTIS-SPECIFIC KINASE SUBSTRATE	60385
MIM608254	*	7q36	PAX TRANSCRIPTION ACTIVATION DOMAIN-INTERACTING PROTEIN 1; PAXIP1	22976
MIM608255	*	 	TRAF3-INTERACTING PROTEIN 3; TRAF3IP3	80342
MIM608256	*	11q23	SODIUM CHANNEL, VOLTAGE-GATED, TYPE IV, BETA SUBUNIT; SCN4B	6330
MIM608257		 	MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	 
MIM608258	*	 	DIPEPTIDYL PEPTIDASE IX; DPP9	91039
MIM608259	*	7p15	INSULIN-LIKE GROWTH FACTOR 2 mRNA-BINDING PROTEIN 3; IGF2BP3	10643
MIM608260	*	 	POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 8; KCNH8	131096
MIM608261	*	3q27	SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 2; SENP2	59343
MIM608262	*	 	DISRUPTED IN RENAL CARCINOMA 3; DIRC3	729582
MIM608263	*	 	HEAT-SHOCK 27-KD PROTEIN-ASSOCIATED PROTEIN 1; HSPBAP1	79663
MIM608264	%	22q11.21-q12.1	DEAFNESS, AUTOSOMAL RECESSIVE 40; DFNB40	379003
MIM608265	#	7q21.1	DEAFNESS, AUTOSOMAL RECESSIVE 39; DFNB39	3082
MIM608266	#	1q25-q31	PARATHYROID CARCINOMA	79577
MIM608267	*	1p34	RAS-RELATED GTP-BINDING PROTEIN C; RRAGC	64121
MIM608268	*	6q15-q16	RAS-RELATED GTP-BINDING PROTEIN D; RRAGD	58528
MIM608269	*	9q22.2	SOLUTE CARRIER FAMILY 28 (SODIUM-COUPLED NUCLEOSIDE TRANSPORTER), MEMBER 3; SLC28A3	64078
MIM608270	*	20p12.1	THREONINE ASPARTASE 1; TASP1	55617
MIM608271	*	1p32-p31	MICROTUBULE-ACTIN CROSS-LINKING FACTOR 1; MACF1	23499
MIM608272	*	6p21.3	NEURAMINIDASE 1; NEU1	4758
MIM608273	*	16p11	INTERLEUKIN 27; IL27	246778
MIM608274	*	1p13.3	PROTEIN ARGININE N-METHYLTRANSFERASE 6; PRMT6	55170
MIM608275	*	1p13.1	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 15; SLC22A15	55356
MIM608276	*	6q21	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 16; SLC22A16	85413
MIM608277	*	10q26	CARBOHYDRATE SULFOTRANSFERASE 15; CHST15	51363
MIM608278		 	GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGE JOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLAR ATROPHY	 
MIM608279		 	CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	 
MIM608280	*	1q23.3	GROWTH ARREST-SPECIFIC 5; GAS5	60674
MIM608281		 	SCIMITAR ANOMALY, MULTIPLE CARDIAC MALFORMATIONS, AND CRANIOFACIAL AND CENTRAL NERVOUS SYSTEM ABNORMALITIES	 
MIM608282	*	6q23.2	TRACE AMINE-ASSOCIATED RECEPTOR 9; TAAR9	134860
MIM608283	*	12q12	KINESIN FAMILY MEMBER 21A; KIF21A	55605
MIM608284	*	17q21.31	INTRAMEMBRANE PROTEASE 5	162540
MIM608285	*	11q13.2	NAD SYNTHETASE 1; NADSYN1	55191
MIM608286	*	4q28.3	PROTOCADHERIN 10; PCDH10	57575
MIM608287	*	4q31	PROTOCADHERIN 18; PCDH18	54510
MIM608288	*	17q21.3	INSULIN-LIKE GROWTH FACTOR 2 mRNA-BINDING PROTEIN 1; IGF2BP1	10642
MIM608289	*	3q28	INSULIN-LIKE GROWTH FACTOR 2 mRNA-BINDING PROTEIN 2; IGF2BP2	10644
MIM608290	%	 	LELIS SYNDROME	 
MIM608291	*	2q13	TUBULIN-TYROSINE LIGASE; TTL	150465
MIM608292	*	9p13.1	STOMATIN-LIKE PROTEIN 2; STOML2	30968
MIM608293	*	16p12.2	RHO GTPase-ACTIVATING PROTEIN 17; ARHGAP17	55114
MIM608294	*	3p21.3	NONMETASTATIC CELLS 6, PROTEIN EXPRESSED IN; NME6	10201
MIM608295	*	3p21.1	FAMILY WITH SEQUENCE SIMILARITY 107, MEMBER A; FAM107A	11170
MIM608296	*	11q13.1	FIBROBLAST GROWTH FACTOR, ACIDIC, INTRACELLULAR BINDING PROTEIN; FIBP	9158
MIM608298	*	3q13.2	URB, MOUSE, HOMOLOG OF	151887
MIM608299	*	12q23-q24.1	RING FINGER PROTEIN 34; RNF34	80196
MIM608300	*	17q21.31	N-ACETYLGLUTAMATE SYNTHASE; NAGS	162417
MIM608301	*	4p15.2	LEUCINE-RICH GENE, GLIOMA-INACTIVATED, 2; LGI2	55203
MIM608302	*	8p21.3	LEUCINE-RICH GENE, GLIOMA-INACTIVATED, 3; LGI3	203190
MIM608303	*	19q13.11	LEUCINE-RICH GENE, GLIOMA-INACTIVATED, 4; LGI4	163175
MIM608304	*	6p25.3-p24.1	CANCER/TESTIS ANTIGEN 3; CTAG3	285782
MIM608305	*	17p13-p12	SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT CITRATE TRANSPORTER), MEMBER 5; SLC13A5	284111
MIM608306	*	7p21	TRANSCRIPTION FACTOR Sp8; SP8	221833
MIM608307	+	2q35	CARBAMOYL PHOSPHATE SYNTHETASE I; CPS1	1373
MIM608308	*	3q21	ANKYRIN REPEAT AND BTB/POZ DOMAIN CONTAINING 1; ABTB1	80325
MIM608309	*	1p36	PTEN-INDUCED PUTATIVE KINASE 1; PINK1	65018
MIM608310	*	7cen-q11.2	ARGININOSUCCINATE LYASE; ASL	435
MIM608311	*	4q12	GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL D-ASPARTATE-LIKE 1B; GRINL1B	339970
MIM608312	*	7p21	TWIST NEIGHBOR; TWISTNB	221830
MIM608313	*	6q23	ARGINASE, LIVER; ARG1	383
MIM608314	*	22q13.2	SEPTIN 3; SEPT3	55964
MIM608315	*	3p25.1	ELL-ASSOCIATED FACTOR 1; EAF1	85403
MIM608316	%	2q21.1-q22	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 2	387584
MIM608317	*	1p36.11	GRAINYHEAD-LIKE 3; GRHL3	57822
MIM608318	%	14q32	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 4	387585
MIM608320	#	15q26	CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	4205
MIM608321	*	5q23.1	TIR DOMAIN-CONTAINING ADAPTOR MOLECULE 2; TICAM2	353376
MIM608322	*	1q31-q32	KINESIN FAMILY MEMBER 21B; KIF21B	23046
MIM608323	#	1p35	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC	8565
MIM608324	*	5q32	NGF-INDUCED DIFFERENTIATION CLONE 67	85027
MIM608325	*	11p11.2	PHD FINGER PROTEIN 21A; PHF21A	51317
MIM608326	*	15q22	STOMATIN-LIKE PROTEIN 1; STOML1	9399
MIM608327	*	13q13	STOMATIN-LIKE PROTEIN 3; STOML3	161003
MIM608328	#	15q21.1	WEILL-MARCHESANI SYNDROME 2; WMS2	2200
MIM608329	*	11q12-q13.1	CHROMOSOME 11 OPEN READING FRAME 9; C11ORF9	745
MIM608330	*	11q12.2	PRECURSOR mRNA-PROCESSING FACTOR 19, S. CEREVISIAE, HOMOLOG OF; PRPF19	27339
MIM608331	*	5q33.1	SOLUTE CARRIER FAMILY 36 (PROTON/AMINO ACID SYMPORTER), MEMBER 2; SLC36A2	153201
MIM608332	*	 	SOLUTE CARRIER FAMILY 36 (PROTON/AMINO ACID SYMPORTER), MEMBER 3; SLC36A3	285641
MIM608333	*	16q13	DOCKING PROTEIN 4; DOK4	55715
MIM608334	*	20q13.2	DOCKING PROTEIN 5; DOK5	55816
MIM608335	*	 	CASEIN KINASE II-INTERACTING PROTEIN 1	51177
MIM608336	*	 	TRANSMEMBRANE DOMAIN PROTEIN REGULATED IN ADIPOCYTES, 40-KD	131601
MIM608337	*	11q13.1	OTU DOMAIN-CONTAINING UBIQUITIN ALDEHYDE-BINDING PROTEIN 1; OTUB1	55611
MIM608338	*	14q32.12	OTU DOMAIN-CONTAINING UBIQUITIN ALDEHYDE-BINDING PROTEIN 2; OTUB2	78990
MIM608339	*	 	SYNTAXIN-BINDING PROTEIN 3; STXBP3	6814
MIM608340	#	8q13-q21.1	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A; CMTRIA	54332
MIM608341	*	1q32	CYTOCHROME b5 REDUCTASE 1; CYB5R1	51706
MIM608342	*	11p15.4	CYTOCHROME b5 REDUCTASE 2; CYB5R2	51700
MIM608343	*	6q14-q15	CYTOCHROME b5 REDUCTASE 4; CYB5R4	51167
MIM608344	*	 	HEAT-SHOCK 27-KD PROTEIN 9	94086
MIM608345	%	7p11.2	NYSTAGMUS 3, CONGENITAL, AUTOSOMAL DOMINANT; NYS3	4934
MIM608346	^	 	MOVED TO 236670	 
MIM608347	*	17q25.3	DICARBONYL/L-XYLULOSE REDUCTASE; DCXR	51181
MIM608348	*	19q13.1-q13.2	BRANCHED-CHAIN KETO ACID DEHYDROGENASE E1, ALPHA POLYPEPTIDE; BCKDHA	593
MIM608349	*	 	HEMATOPOIETIC SH2 DOMAIN-CONTAINING PROTEIN	84941
MIM608350	*	 	ENDOMUCIN; EMCN	51705
MIM608351	*	 	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 11; IGSF11	152404
MIM608352	*	 	ACROSIN-BINDING PROTEIN; ACRBP	84519
MIM608353	*	 	ANTIZYME INHIBITOR 2	113451
MIM608354	#	5q13.3	CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION	5921
MIM608355	#	5q13.3	PARKES WEBER SYNDROME	5921
MIM608356	*	11p15.5	OUTER DENSE FIBER OF SPERM TAILS 3; ODF3	113746
MIM608357	*	2q11.2	SULFOTRANSFERASE FAMILY 1C, MEMBER 2; SULT1C2	27233
MIM608358	#	14q12	MYOPATHY, MYOSIN STORAGE	4625
MIM608359	*	22q13.2-q13.31	SULFOTRANSFERASE FAMILY 4A, MEMBER 1; SULT4A1	25830
MIM608360	*	9q34.13	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8A; LRRC8A	56262
MIM608361	#	15q26.1	SPONDYLOEPIPHYSEAL DYSPLASIA, KIMBERLEY TYPE	176
MIM608362	*	20q13.3	STATHMIN-LIKE 3; STMN3	50861
MIM608363	#	22q11.2	CHROMOSOME 22q11.2 DUPLICATION SYNDROME	100240738
MIM608364	*	12q13	LIM DOMAIN AND ACTIN-BINDING PROTEIN 1; LIMA1	51474
MIM608365	*	21q22.1	T-COMPLEX PROTEIN 10-LIKE; TCP10L	140290
MIM608366	*	15q24	KIAA1199 GENE	57214
MIM608367	%	7p15	MYOPIA 17, AUTOSOMAL DOMINANT; MYP17	100359401
MIM608368	*	12q24	RAD9, S. POMBE, HOMOLOG OF, B; RAD9B	144715
MIM608369	*	2q24.1	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 13; GALNT13	114805
MIM608370	*	4q21.1	STEAROYL-CoA DESATURASE 5; SCD5	79966
MIM608371	%	4q21-q31	OROFACIAL CLEFT 4; OFC4	474387
MIM608372	%	1q21-q23	DEAFNESS, AUTOSOMAL DOMINANT 49; DFNA49	317664
MIM608373	*	19q13.3	SYNAPTOGYRIN 4; SYNGR4	23546
MIM608374	*	1q21	HEMOJUVELIN	148738
MIM608375	*	1p32.1-p31.3	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 6; DNAJC6	9829
MIM608376	*	10q22.2	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 12; DNAJB12	54788
MIM608377	*	20q13.33	ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 1; ARFGAP1	55738
MIM608378	*	14q22	SEROLOGICALLY DEFINED COLON CANCER ANTIGEN 1; SDCCAG1	9147
MIM608379	*	3p21	CHEMOKINE, CC MOTIF, RECEPTOR-LIKE PROTEIN 2; CCRL2	9034
MIM608380	#	2q31.2-q32.3	RETINITIS PIGMENTOSA 26; RP26	375298
MIM608381	*	2q31.2-q32.3	CERAMIDE KINASE-LIKE; CERKL	375298
MIM608382	*	16p13.3	DNAJ/HSP40 HOMOLOG, SUBFAMILY A, MEMBER 3; DNAJA3	9093
MIM608383	*	2p23.3	DIHYDROPYRIMIDINASE-LIKE 5; DPYSL5	56896
MIM608384	*	8q24.1-q24.2	GASDERMIN C; GSDMC	56169
MIM608385	*	17q12-q21	TENSIN 4; TNS4	84951
MIM608386	*	19q13.33	TUBEROINFUNDIBULAR PEPTIDE OF 39 AMINO ACIDS	113091
MIM608387	*	16p13.3	ZINC FINGER PROTEIN 213; ZNF213	7760
MIM608388	*	19p13.2	EVOLUTIONARILY-CONSERVED SIGNALING INTERMEDIATE IN TOLL PATHWAY; ECSIT	51295
MIM608389	#	14q23	BRANCHIOOTIC SYNDROME 3; BOS3	6495
MIM608390	#	17q23.1-q25.3	MYOTONIA, POTASSIUM-AGGRAVATED	6329
MIM608391	%	Chr.7	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 2; AIS2	378426
MIM608392	%	Chr.8	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 3; AIS3	378427
MIM608393	#	13q12.2	MICROCEPHALY 6, PRIMARY, AUTOSOMAL RECESSIVE; MCPH6	55835
MIM608394	%	2p12	DEAFNESS, AUTOSOMAL DOMINANT 43; DFNA43	192676
MIM608395	^	 	MOVED TO 610217	 
MIM608396	*	3q24	SOLUTE CARRIER FAMILY 9 (SODIUM/HYDROGEN EXCHANGER), MEMBER 9; SLC9A9	285195
MIM608397	*	8p23	CUB AND SUSHI MULTIPLE DOMAINS 1; CSMD1	64478
MIM608398	*	1p35.3	CUB AND SUSHI MULTIPLE DOMAINS 2; CSMD2	114784
MIM608399	*	8q23.3	CUB AND SUSHI MULTIPLE DOMAINS 3; CSMD3	114788
MIM608400	*	1q41	USH2A GENE; USH2A	7399
MIM608401	*	11q12-q13.1	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 4E; MS4A4E	643680
MIM608402	*	11q12-q13.1	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 6E; MS4A6E	245802
MIM608403	*	11q12-q13.1	MEMBRANE-SPANNING 4-DOMAINS, SUBFAMILY A, MEMBER 10; MS4A10	341116
MIM608404	#	7q11.2	PLATELET GLYCOPROTEIN IV DEFICIENCY	948
MIM608405	*	11p11	1-@AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE; ACCS	84680
MIM608406		 	VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	 
MIM608407	*	10q25.2-q26	DIHYDROPYRIMIDINASE-LIKE 4; DPYSL4	10570
MIM608408	*	12p13.31	DEVELOPMENTAL PLURIPOTENCY-ASSOCIATED GENE 3; DPPA3	359787
MIM608409	*	15q21.1	NORMAL MUCOSA OF ESOPHAGUS-SPECIFIC GENE 1	84419
MIM608410	%	4p15-p14	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 7; BMIQ7	404683
MIM608411	*	16p12.1	EXPORTIN 6; XPO6	23214
MIM608412	*	5q11.2	GC-RICH PROMOTER-BINDING PROTEIN 1; GPBP1	65056
MIM608413	*	8q22.3	E3 UBIQUITIN PROTEIN LIGASE, HECT DOMAIN-CONTAINING, 1; EDD1	51366
MIM608414	*	10q23	PHOSPHOLIPASE C, EPSILON-1; PLCE1	51196
MIM608415	#	19q13.11, 17q23-q24	PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION; PERRS	388531, 8787
MIM608416	*	 	MATRIX METALLOPROTEINASE 21; MMP21	118856
MIM608417	*	 	MATRIX METALLOPROTEINASE 28; MMP28	79148
MIM608418	*	5q31-q33	SEPTIN 8; SEPT8	23176
MIM608419	*	2p13.3	METHYLMALONYL-CoA EPIMERASE; MCEE	84693
MIM608420	*	 	PANNEXIN 1; PANX1	24145
MIM608421	*	 	PANNEXIN 2; PANX2	56666
MIM608422	*	 	PANNEXIN 3; PANX3	116337
MIM608423	#	7q32.1-q32.2	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1F; LGMD1F	404679
MIM608424	*	7q22	MUCIN 17; MUC17	140453
MIM608425	*	 	FRUCTOSAMINE 3-KINASE	64122
MIM608426	*	3p25	MAKORIN 2; MKRN2	23609
MIM608427	*	6q25-q27	PARKIN COREGULATED GENE; PACRG	135138
MIM608428	*	10q23.3	CYTOCHROME P450, SUBFAMILY XXVIC, POLYPEPTIDE 1; CYP26C1	340665
MIM608429	*	15q14	CARBOHYDRATE SULFOTRANSFERASE 14; CHST14	113189
MIM608430	*	20q11.23	TRPC4-ASSOCIATED PROTEIN; TRPC4AP	26133
MIM608431	*	5q33.1	GTPase-ACTIVATING PROTEIN SH3 DOMAIN-BINDING PROTEIN 1; G3BP1	10146
MIM608432		 	CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	 
MIM608433	*	1q44	ZINC FINGER PROTEIN 238; ZNF238	10472
MIM608434	*	17p11.2	G PROTEIN-COUPLED RECEPTOR KINASE-INTERACTING PROTEIN 1; GIT1	28964
MIM608435	*	3q22.3	MUSCLE RAS VIRAL ONCOGENE HOMOLOG; MRAS	22808
MIM608436	*	 	SULFOTRANSFERASE FAMILY 1B, MEMBER 1; SULT1B1	27284
MIM608437	%	12q24	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 4; SLEB4	404714
MIM608438	*	 	TOUSLED-LIKE KINASE 1; TLK1	9874
MIM608439	*	 	TOUSLED-LIKE KINASE 2; TLK2	11011
MIM608440	*	15q22.1	LACTAMASE, BETA; LACTB	114294
MIM608441	*	6q25	SYNAPTIC NUCLEAR ENVELOPE PROTEIN 1; SYNE1	23345
MIM608442	*	14q23	SYNAPTIC NUCLEAR ENVELOPE PROTEIN 2; SYNE2	23224
MIM608443	#	19p13.12	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	54862
MIM608444	*	7q22	MYELOID/LYMPHOID OR MIXED-LINEAGE LEUKEMIA 5; MLL5	55904
MIM608445	%	3p12-q13	SPEECH-SOUND DISORDER	404713
MIM608446	#	1q25, 6q25.1, 6p12, 1p34	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO	2099, 2155, 2162, 2729, 2730, 3690, 3957, 4049, 440823, 4973, 5687, 7056, 7292, 7804
MIM608447	%	12q24	CAROTID INTIMAL MEDIAL THICKNESS 2	404677
MIM608448	%	3p26	INFLAMMATORY BOWEL DISEASE 9; IBD9	317669
MIM608449	*	1p21	POLYPYRIMIDINE TRACT-BINDING PROTEIN 2; PTBP2	58155
MIM608450	*	7q36	B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA-EXPRESSED GENE; BLACE	338436
MIM608451	*	19q13.32	ETHE1 GENE; ETHE1	23474
MIM608452	*	4q32	PLATELET-DERIVED GROWTH FACTOR C; PDGFC	56034
MIM608453	*	19q13.2	CAS-BR-M MURINE ECOTROPIC RETROVIRAL TRANSFORMING SEQUENCE C; CBLC	23624
MIM608454	^	 	KNOBLOCH SYNDROME 2; KNO2	170692
MIM608455	*	11q13	GLYCOGEN PHOSPHORYLASE, MUSCLE; PYGM	5837
MIM608456	#	1p34.3-p32.1	FAMILIAL ADENOMATOUS POLYPOSIS, 2; FAP2	4595
MIM608457	*	22q13.1	CHROMOBOX HOMOLOG 7; CBX7	23492
MIM608458	*	1p34.3	NEUROCHONDRIN; NCDN	23154
MIM608459	*	5q31	CYCLIN-DEPENDENT KINASE-LIKE 3; CDKL3	51265
MIM608460	*	16q24.3	ZINC FINGER PROTEIN 276; ZFP276	92822
MIM608461	*	9q32	COLLAGEN, TYPE XXVII, ALPHA-1; COL27A1	85301
MIM608462	%	16q23	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 8; HSCR8	404719
MIM608463	*	17q11.2-q12	APOPTOSIS-ANTAGONIZING TRANSCRIPTION FACTOR; AATF	26574
MIM608464	*	5q13.3	ANGIOGENIC FACTOR WITH G-PATCH AND FHA DOMAINS 1; AGGF1	55109
MIM608465	*	9q34	SENATAXIN; SETX	23064
MIM608466	*	 	ACTIVATOR OF HEAT-SHOCK 90-KD PROTEIN ATPase 1; AHSA1	10598
MIM608467	*	 	STONIN 2; STON2	85439
MIM608468	*	4q31.1	CARBON CATABOLITE REPRESSION 4-LIKE; CCRN4L	25819
MIM608469	*	22q13.1	DEAD/H BOX 17; DDX17	10521
MIM608470	#	5q31	CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE I; CDB1	7045
MIM608471	#	5q31	CORNEAL DYSTROPHY, LATTICE TYPE IIIA; CDL3A	7045
MIM608472	*	2q11.2-q12.1	ST6 BETA-GALACTOSAMIDE ALPHA-2,6-SIALYLTRANSFERASE 2; ST6GAL2	84620
MIM608473	*	 	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 1; ANAPC1	64682
MIM608474	%	17q21-q22	MYOPIA 5, AUTOSOMAL DOMINANT; MYP5	404682
MIM608475	*	 	3-@HYDROXYISOBUTYRATE DEHYDROGENASE; HIBADH	11112
MIM608476	*	 	TBK1-BINDING PROTEIN 1; TBKBP1	9755
MIM608477	*	 	ALDO-KETO REDUCTASE FAMILY 7, MEMBER A3; AKR7A3	22977
MIM608478	*	 	ALDO-KETO REDUCTASE FAMILY 7, MEMBER A4	246181
MIM608479	*	 	SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 7; SLC26A7	115111
MIM608480	*	 	SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 8; SLC26A8	116369
MIM608481	*	 	SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 9; SLC26A9	115019
MIM608482	*	 	MATRIX METALLOPROTEINASE 25; MMP25	64386
MIM608483	*	16q12.2	AKT-INTERACTING PROTEIN; AKTIP	64400
MIM608484		 	CONGENITAL CORNEAL OPACITIES, CORNEA GUTTATA, AND CORECTOPIA	 
MIM608485	*	 	TRANSLOCATION-ASSOCIATED MEMBRANE PROTEIN 2; TRAM2	9697
MIM608486	*	8q24.1	METASTASIS SUPPRESSOR 1; MTSS1	9788
MIM608487	*	11p15	TRIPARTITE MOTIF-CONTAINING PROTEIN 5; TRIM5	85363
MIM608488	*	14q24.1	SPARC-RELATED MODULAR CALCIUM-BINDING 1; SMOC1	64093
MIM608489	*	7q22	STROMALIN 3; STAG3	10734
MIM608490	*	12q13.11	SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 1; SLC38A1	81539
MIM608491	*	 	CYCLIN D-BINDING MYB-LIKE TRANSCRIPTION FACTOR 1; DMTF1	9988
MIM608492	*	 	OLFACTORY RECEPTOR, FAMILY 5, SUBFAMILY F, MEMBER 1; OR5F1	338674
MIM608493	*	 	OLFACTORY RECEPTOR, FAMILY 10, SUBFAMILY A, MEMBER 1; OR10A1	144124
MIM608494	*	 	OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY D, MEMBER 2; OR2D2	120776
MIM608495	*	 	OLFACTORY RECEPTOR, FAMILY 6, SUBFAMILY A, MEMBER 1; OR6A1	8590
MIM608496	*	 	OLFACTORY RECEPTOR, FAMILY 5, SUBFAMILY I, MEMBER 1; OR5I1	10798
MIM608497	*	 	OLFACTORY RECEPTOR, FAMILY 2, SUBFAMILY F, MEMBER 1; OR2F1	26211
MIM608498	*	 	ZONA PELLUCIDA-BINDING PROTEIN; ZPBP	11055
MIM608499	*	17q12-q21	ZONA PELLUCIDA-BINDING PROTEIN 2; ZPBP2	124626
MIM608500	*	12q12	PRICKLE-LIKE 1; PRICKLE1	144165
MIM608501	*	 	PRICKLE-LIKE 2; PRICKLE2	166336
MIM608502	*	21q22.3	POLY(rC)-BINDING PROTEIN 3; PCBP3	54039
MIM608503	*	 	POLY(rC)-BINDING PROTEIN 4; PCBP4	57060
MIM608504	*	17p13.1	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 15; ARHGEF15	22899
MIM608505	^	 	MOVED TO 225750	 
MIM608506	*	 	MITOFUSIN 1; MFN1	55669
MIM608507	*	1p36.2	MITOFUSIN 2; MFN2	9927
MIM608508	+	16q24	CYTOCHROME b(-245), ALPHA SUBUNIT; CYBA	1535
MIM608509		 	ALOPECIA UNIVERSALIS CONGENITA, XY GONADAL DYSGENESIS, AND LARYNGOMALACIA	 
MIM608510	*	1q22	SH2 DOMAIN-CONTAINING 1B; SH2D1B	117157
MIM608511	*	 	PHYTANOYL-CoA HYDROXYLASE-INTERACTING PROTEIN; PHYHIP	9796
MIM608512	*	7q11.23	NEUTROPHIL CYTOSOLIC FACTOR 1; NCF1	653361
MIM608513	*	 	RIBONUCLEASE P, RNA COMPONENT H1; RPPH1	85495
MIM608514	*	 	ANDROGEN-INDUCED GENE 1; AIG1	51390
MIM608515	*	1q25	NEUTROPHIL CYTOSOLIC FACTOR 2; NCF2	4688
MIM608516	#	15q25.3-q26.2, 13q14-q21, 12q22-q23.2, 12q21.1, 8p21.1, 6p21.3-p21.2	MAJOR DEPRESSIVE DISORDER; MDD	121278, 2289, 3356
MIM608517	*	 	MYOPALLADIN; MYPN	84665
MIM608518		 	OROFACIODIGITAL SYNDROME VII; OFD7	 
MIM608519	*	 	F-BOX ONLY PROTEIN 16; FBXO16	157574
MIM608520	%	12q22-q23.2	MAJOR DEPRESSIVE DISORDER 1	431708
MIM608521	*	1p13.2	HEPATITIS B VIRUS X PROTEIN-INTERACTING PROTEIN; HBXIP	10542
MIM608522	*	11q13	HEPATITIS B VIRUS X-ASSOCIATED PROTEIN; HBXAP	51773
MIM608523	*	14q32	DIO3, OPPOSITE STRAND; DIO3OS	64150
MIM608524	*	12p13.31	INHIBITOR OF GROWTH 4; ING4	51147
MIM608525	*	2q37.3	INHIBITOR OF GROWTH 5; ING5	84289
MIM608526	%	1q25	PERIODONTITIS, AGGRESSIVE, 2	406237
MIM608527	*	 	NEURAMINIDASE 4; NEU4	129807
MIM608528	*	20q11.22	CELL DIVISION CYCLE 91, S. CEREVISIAE, HOMOLOG-LIKE 1; CDC91L1	128869
MIM608529	*	 	FIBRILLIN 3; FBN3	84467
MIM608530	*	 	BTB/POZ DOMAIN-CONTAINING PROTEIN 1; BTBD1	53339
MIM608531	*	 	BTB/POZ DOMAIN-CONTAINING PROTEIN 2; BTBD2	55643
MIM608532	*	 	NON-SMC CONDENSIN II COMPLEX SUBUNIT G2; NCAPG2	54892
MIM608533	*	5q33.1	F-BOX ONLY PROTEIN 38; FBXO38	81545
MIM608534	*	 	ACTIN-RELATED PROTEIN M1	84517
MIM608535	*	1p36.32	ACTIN-RELATED PROTEIN T2; ACTRT2	140625
MIM608536	*	 	GTP-BINDING PROTEIN 3; GTPBP3	84705
MIM608537	*	3p26-p25	VHL GENE; VHL	7428
MIM608538	*	10q21.2	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 5B; ARID5B	84159
MIM608539	*	16p13.3	GLIS FAMILY ZINC FINGER PROTEIN 2; GLIS2	84662
MIM608540	#	16p13.3	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	56052
MIM608541	*	 	RHO GTPase INVOLVED IN BETA-CATENIN, N-CADHERIN, AND NMDA RECEPTOR SIGNALING	9743
MIM608542	%	19q13	ANEURYSM, INTRACRANIAL BERRY, 2; ANIB2	449013
MIM608543	%	1p36.2	SCHIZOPHRENIA 12	619488
MIM608544	*	 	HISTONE DEACETYLASE 10; HDAC10	83933
MIM608545	%	6p25	LARSEN-LIKE SYNDROME	406214
MIM608546	*	 	DEAD/H BOX 48; DDX48	9775
MIM608547	*	16p11.2	VITAMIN K EPOXIDE REDUCTASE COMPLEX, SUBUNIT 1; VKORC1	79001
MIM608548	*	1q24-q25	HEMICENTIN; HMCN1	83872
MIM608549	*	 	VACUOLAR PROTEIN SORTING 11, YEAST, HOMOLOG OF; VPS11	55823
MIM608550	*	 	VACUOLAR PROTEIN SORTING 16, YEAST, HOMOLOG OF; VPS16	64601
MIM608551	*	 	VACUOLAR PROTEIN SORTING 18, YEAST, HOMOLOG OF; VPS18	57617
MIM608552	*	15q26.1	VACUOLAR PROTEIN SORTING 33, YEAST, HOMOLOG OF, B; VPS33B	26276
MIM608553	#	1p36	LEBER CONGENITAL AMAUROSIS 9; LCA9	619483, 64802
MIM608554	*	11q13	NEURONAL PAS DOMAIN PROTEIN 4; NPAS4	266743
MIM608555	*	 	METAXIN 2; MTX2	10651
MIM608556	#	1q41-q42	LEGIONNAIRE DISEASE, SUSCEPTIBILITY TO	7100
MIM608557	%	13q12	MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 2	100233226
MIM608558	%	16p13	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 5; BMIQ5	449016
MIM608559	%	20pter-p11.2	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 6; BMIQ6	449017
MIM608560	*	 	STABILIN 1; STAB1	23166
MIM608561	*	 	STABILIN 2; STAB2	55576
MIM608562	%	7q22	POLYDACTYLY, POSTAXIAL, TYPE A4	450096
MIM608563	^	 	MOVED TO 204650	 
MIM608564	*	 	G PROTEIN-COUPLED RECEPTOR KINASE-INTERACTING PROTEIN 2; GIT2	9815
MIM608565	#	14q24.3	DEAFNESS, AUTOSOMAL RECESSIVE 35; DFNB35	2103
MIM608566	*	 	MUCIN 15, TRANSMEMBRANE; MUC15	143662
MIM608567	#	3p21	SICK SINUS SYNDROME 1, AUTOSOMAL RECESSIVE; SSS1	6331
MIM608568	*	19q13.33	MYOSIN, HEAVY CHAIN 14, NONMUSCLE; MYH14	79784
MIM608569	#	12p12.1	CARDIOMYOPATHY, DILATED, 1O; CMD1O	10060
MIM608570	*	 	AHNAK NUCLEOPROTEIN 2	113146
MIM608571		 	ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	 
MIM608572	%	 	BURN-MCKEOWN SYNDROME	 
MIM608574	*	11q13.4-q13.5	EMSY GENE	56946
MIM608575	*	19p13	RETINOL DEHYDROGENASE 8; RDH8	50700
MIM608576	*	8q22	GRAINYHEAD-LIKE 2; GRHL2	79977
MIM608577	*	 	CHURCHILL DOMAIN-CONTAINING 1; CHURC1	91612
MIM608578	%	 	CEREBROFRONTOFACIAL SYNDROME	 
MIM608579	#	6p21.3, 6p21.3	SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO	3105, 3106
MIM608580		7q22	MYOSIN, HEAVY CHAIN 16, SKELETAL MUSCLE, PSEUDOGENE; MYH16	84176
MIM608581	*	8p23	RP1-LIKE PROTEIN 1; RP1L1	94137
MIM608582	*	9q34.3	EPIDERMAL GROWTH FACTOR-LIKE 7; EGFL7	51162
MIM608583	%	1q21.1, 10q22-q24	ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	2702, 406216
MIM608584	#	7p15-p14	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 2	387129
MIM608585	%	 	BRACHIAL PALSY, FAMILIAL CONGENITAL	 
MIM608586	%	3p14-q13	KERATOCONUS 3; KTCN3	406215
MIM608587	*	 	LGP1, MOUSE, HOMOLOG OF	84514
MIM608588	*	17q21.2	DEXH BOX POLYPEPTIDE 58; DHX58	79132
MIM608589	*	 	SLAM FAMILY, MEMBER 9; SLAMF9	89886
MIM608591	%	12q12-q13.3	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2G; CMT2G	431712
MIM608592	*	 	CTD SMALL PHOSPHATASE-LIKE; CTDSPL	10217
MIM608593	*	1q32	COMPLEMENT FACTOR H-RELATED 5; CFHR5	81494
MIM608594	#	9q34.3	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1; CGL1	10555
MIM608595	*	7p15-p14	NEUROPEPTIDE S RECEPTOR 1; NPSR1	387129
MIM608596	*	7p15-p14	ASTHMA-ASSOCIATED ALTERNATIVELY SPLICED GENE 1	404744
MIM608597	*	 	NEURALIZED-LIKE 2; NEURL2	140825
MIM608598	*	10q26	CANCER SUSCEPTIBILITY CANDIDATE 2; CASC2	255082
MIM608599	*	10q26	RAB11 FAMILY-INTERACTING PROTEIN 2; RAB11FIP2	22841
MIM608600	%	 	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1; FPLD1	 
MIM608601	*	 	FIBROSIN 1; FBS1	64319
MIM608602	*	 	NUCLEAR BODY PROTEIN SP140; SP140	11262
MIM608603	*	15q21.2	GLIOMEDIN; GLDN	342035
MIM608604	*	 	RETINOL-BINDING PROTEIN 7; RBP7	116362
MIM608605	*	 	SOURCE OF IMMUNODOMINANT MAJOR HISTOCOMPATIBILITY COMPLEX-ASSOCIATED PEPTIDES	201595
MIM608606	*	 	BASIC HELIX-LOOP-HELIX PROTEIN MIST1	168620
MIM608607	*	 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 12; NBPF12	149013
MIM608608	*	 	PEPTIDYLPROLYL ISOMERASE A-LIKE PROTEIN 4E; PPIAL4E	730262
MIM608609	*	 	CHROMOSOME 1 OPEN READING FRAME 152; C1ORF152	767846
MIM608610	*	10q24	PROGRAMMED CELL DEATH 4; PDCD4	27250
MIM608611	#	2p11.2	RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY	22934
MIM608612	#	1p34	MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	10269
MIM608613	*	 	TRANSCRIPTION FACTOR Sp6; SP6	80320
MIM608614	*	4q35.1	CYTOCHROME P450, FAMILY 4, SUBFAMILY V, POLYPEPTIDE 2	285440
MIM608615	#	17q24	OLIGODONTIA-COLORECTAL CANCER SYNDROME	8313
MIM608616	*	 	OBSCURIN; OBSCN	84033
MIM608617	*	 	FAMILY WITH SEQUENCE SIMILARITY 3, MEMBER B; FAM3B	54097
MIM608618	*	 	FAMILY WITH SEQUENCE SIMILARITY 3, MEMBER C; FAM3C	10447
MIM608619	*	 	FAMILY WITH SEQUENCE SIMILARITY 3, MEMBER D; FAM3D	131177
MIM608620	^	 	MOVED TO 605232	 
MIM608621	*	 	SPERM AUTOANTIGENIC PROTEIN 17; SPA17	53340
MIM608622	#	5q34	HYPERTENSION, DIASTOLIC, RESISTANCE TO	3779
MIM608623	^	 	MOVED TO 276300	 
MIM608624		 	MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	 
MIM608625	*	17q23.1	PEPTIDYL-tRNA HYDROLASE 2; PTRH2	51651
MIM608626	*	17q23.3	STE20-RELATED KINASE ADAPTOR ALPHA; STRADA	92335
MIM608627	#	20q13.3	AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8	9217
MIM608628	*	 	TRANSDUCIN-BETA-LIKE 1 RECEPTOR 1; TBL1XR1	79718
MIM608629	#	6q23.3	JOUBERT SYNDROME 3; JBTS3	54806
MIM608630	*	11q23-q25	ROUNDABOUT, DROSOPHILA, HOMOLOG OF, 3; ROBO3	64221
MIM608631	%	17p13	ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2	431711
MIM608632	*	17q21-q22	MICRO RNA 196A1; MIRN196A1	406972
MIM608633	*	11q22.3	CASPASE 12, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP12	100506742
MIM608634	#	7q11.23	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B	3315
MIM608635	*	17q11.2	CENTAURIN, ALPHA-2; CENTA2	55803
MIM608636	#	15q11	CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	 
MIM608637	^	 	MOVED TO 143095	 
MIM608638	%	3q25-q27	ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1	431710
MIM608639	*	7p21-p11.2	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 8; PLEKHA8	84725
MIM608640	*	19q13.4	ZINC FINGER PROTEIN 461; ZNF461	92283
MIM608641	#	8q22	DEAFNESS, AUTOSOMAL DOMINANT 28; DFNA28	79977
MIM608642	*	14q24	ZINC-BINDING ALCOHOL DEHYDROGENASE DOMAIN-CONTAINING PROTEIN 1; ZADH1	145482
MIM608643	#	7p11	AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	1644
MIM608644	#	5p15-p14	CILIARY DYSKINESIA, PRIMARY, 3; CILD3	1767
MIM608645	%	6p21.3	DEAFNESS, AUTOSOMAL DOMINANT 31; DFNA31	347737
MIM608646	%	15q13.1-q15.1	CILIARY DYSKINESIA, PRIMARY, 4; CILD4	408257
MIM608647	#	16p12.2-p12.1	CILIARY DYSKINESIA, PRIMARY, 5; CILD5	408258
MIM608648	*	6q21	SEC63, S. CEREVISIAE, HOMOLOG OF; SEC63	11231
MIM608649	#	9q34	ICHTHYOSIS PREMATURITY SYNDROME; IPS	10999
MIM608650	*	 	UNC51-LIKE KINASE 2; ULK2	9706
MIM608651	*	 	CENTAURIN, GAMMA-2; CENTG2	116987
MIM608652	%	9p22-p21	DEAFNESS, AUTOSOMAL DOMINANT 47; DFNA47	246289
MIM608653	%	 	DEAFNESS, AUTOSOMAL RECESSIVE 32; DFNB32	113877
MIM608654	#	1p13.1	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V; HSAN5	4803
MIM608655	*	 	GAP JUNCTION PROTEIN, GAMMA-1; GJC1	10052
MIM608656	%	20q13	PROSTATE CANCER, HEREDITARY, 3	408259
MIM608657	*	 	JUN DIMERIZATION PROTEIN 2; JDP2	122953
MIM608658	%	7p11-q21	PROSTATE CANCER, HEREDITARY, 4	408260
MIM608659	*	 	SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 8; SENP8	123228
MIM608660	*	2q14.1	INSULIN-INDUCED GENE 2; INSIG2	51141
MIM608661	*	1p32.3	PODOCAN; PODN	127435
MIM608662	*	11p14.3	ANOCTAMIN 5; ANO5	203859
MIM608663	*	12q12	ANOCTAMIN 6; ANO6	196527
MIM608664		14q21-q22	SECKEL SYNDROME 3; SCKL3	386616
MIM608665	*	 	PSMC3-INTERACTING PROTEIN; PSMC3IP	29893
MIM608666	*	22q11.21	PEROXISOME BIOGENESIS FACTOR 26; PEX26	55670
MIM608667	*	5p13.1	NIPPED-B-LIKE; NIPBL	25836
MIM608668	*	 	ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 11; ZMYND11	10771
MIM608669	*	9p22.1	BASONUCLIN 2; BNC2	54796
MIM608670		 	ROBIN SEQUENCE WITH DISTINCTIVE FACIAL APPEARANCE AND BRACHYDACTYLY	 
MIM608671	*	 	DAZ-INTERACTING PROTEIN 1; DZIP1	22873
MIM608672	*	 	DAZ-INTERACTING PROTEIN 3	9666
MIM608673	#	12q24	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L	26353
MIM608674	*	4q31.3	SH3 DOMAIN PROTEIN 19	152503
MIM608675	*	 	FUCOKINASE; FUK	197258
MIM608676	*	 	TAXILIN, ALPHA; TXLNA	200081
MIM608677	*	 	MINDBOMB, DROSOPHILA, HOMOLOG OF, 1; MIB1	57534
MIM608678	*	9p24.1	INTERLEUKIN 33; IL33	90865
MIM608679	*	 	TP53-REGULATING KINASE; TP53RK	112858
MIM608680	*	 	PRPK-BINDING PROTEIN	51002
MIM608681	#	15q26.1	SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2	145873
MIM608682	*	 	ADRENOMEDULLIN 2; ADM2	79924
MIM608683	*	 	CYSTATIN 8; CST8	10047
MIM608684	*	 	NINEIN; NIN	51199
MIM608685	*	 	STRUCTURAL MAINTENANCE OF CHROMOSOMES 1B; SMC1B	27127
MIM608686	*	 	RAB3A-INTERACTING PROTEIN; RAB3IP	117177
MIM608687	#	11p13-q11	SPINOCEREBELLAR ATAXIA 20; SCA20	407973
MIM608688	#	2q35	AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	471
MIM608689	*	 	MESODERM POSTERIOR 1	55897
MIM608690	*	 	SSX2-INTERACTING PROTEIN; SSX2IP	117178
MIM608691	%	15q25.3-q26.2	MAJOR DEPRESSIVE DISORDER 2	431709
MIM608692	*	 	BASIC LEUCINE ZIPPER NUCLEAR FACTOR 1; BLZF1	8548
MIM608693	*	 	GOLGI REASSEMBLY STACKING PROTEIN 2; GORASP2	26003
MIM608694	*	 	ZINC FINGER PROTEIN 622; ZNF622	90441
MIM608695	%	9q22	GLAUCOMA 1, OPEN ANGLE, J; GLC1J	574078
MIM608696	%	20p12	GLAUCOMA 1, OPEN ANGLE, K; GLC1K	574077
MIM608697	*	2p12	FACTOR IN GERMLINE ALPHA, MOUSE, HOMOLOG OF; FIGLA	344018
MIM608698	*	 	DISCOIDIN, CUB, AND LCCL DOMAIN-CONTAINING PROTEIN 2; DCBLD2	131566
MIM608699	*	 	BONE MORPHOGENETIC PROTEIN-BINDING ENDOTHELIAL REGULATOR PROTEIN; BMPER	168667
MIM608700	*	 	NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 1; NMNAT1	64802
MIM608701	*	 	NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 2; NMNAT2	23057
MIM608702	*	3q23	NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 3; NMNAT3	349565
MIM608703	%	2p21-p13	SPINOCEREBELLAR ATAXIA 25; SCA25	338435
MIM608704	*	 	NICOTINAMIDE RIBOSIDE KINASE 1	54981
MIM608705	*	 	INTEGRIN, BETA-1, BINDING PROTEIN OF, 3; ITGB1BP3	27231
MIM608706	*	15q21	DYSLEXIA SUSCEPTIBILITY 1 CANDIDATE 1; DYX1C1	161582
MIM608707	*	 	CELL ADHESION MOLECULE-RELATED/DOWNREGULATED BY ONCOGENES; CDON	50937
MIM608708	*	 	BROTHER OF CDON; BOC	91653
MIM608709	#	19p13.3	LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD	84823
MIM608710	%	6p21.3	WEGENER GRANULOMATOSIS	474168
MIM608711	*	 	CTD SMALL PHOSPHATASE 2; CTDSP2	10106
MIM608712	*	 	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, T; PTPRT	11122
MIM608713	*	11p15.2	CYTOCHROME P450, SUBFAMILY IIR, POLYPEPTIDE 1; CYP2R1	120227
MIM608714	*	8q11	SYNTROPHIN, GAMMA-1; SNTG1	54212
MIM608715	*	 	SYNTROPHIN, GAMMA-2; SNTG2	54221
MIM608716	#	1q31	MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE; MCPH5	259266
MIM608717	*	19q13.1	LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 13; LGALS13	29124
MIM608718	*	 	KERATIN-ASSOCIATED PROTEIN 13-1; KRTAP13-1	140258
MIM608719	*	 	TR4-ASSOCIATED PROTEIN, 16-KD	126382
MIM608720		 	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, ADULT-ONSET, WITH ANOSMIA	 
MIM608721	*	3q27.1	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II INHIBITOR 2; CAMK2N2	94032
MIM608722	*	12p12	CAPPING PROTEIN, ALPHA-3; CAPZA3	93661
MIM608723	*	 	PHOSPHATASE AND ACTIN REGULATOR 1; PHACTR1	221692
MIM608724	*	 	PHOSPHATASE AND ACTIN REGULATOR 2; PHACTR2	9749
MIM608725	*	 	PHOSPHATASE AND ACTIN REGULATOR 3; PHACTR3	116154
MIM608726	*	 	PHOSPHATASE AND ACTIN REGULATOR 4; PHACTR4	65979
MIM608727	*	 	DE-ETIOLATED 1, ARABIDOPSIS, HOMOLOG OF; DET1	55070
MIM608728	#	2p24-p23	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 RELATED	4148
MIM608729	*	 	ANGIOTENSIN II RECEPTOR-ASSOCIATED PROTEIN; AGTRAP	57085
MIM608730	*	 	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 5; SLC39A5	283375
MIM608731	*	 	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 6; SLC39A6	25800
MIM608732	*	 	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 8; SLC39A8	64116
MIM608733	*	 	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 10; SLC39A10	57181
MIM608734	*	 	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 12; SLC39A12	221074
MIM608735	*	11p11.2	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 13; SLC39A13	91252
MIM608736	*	 	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 14; SLC39A14	23516
MIM608737	*	8p11.22	RAB11 FAMILY-INTERACTING PROTEIN 1; RAB11FIP1	80223
MIM608738	*	16p13.3	RAB11 FAMILY-INTERACTING PROTEIN 3; RAB11FIP3	9727
MIM608739	*	 	EXORIBONUCLEASE 1; ERI1	90459
MIM608740	*	22q13.2	NFAT ACTIVATING PROTEIN WITH ITAM MOTIF 1; NFAM1	150372
MIM608741	*	 	SYNAPTOTAGMIN 11; SYT11	23208
MIM608742	%	12p12.2-p12.1	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 4	444980
MIM608743	*	 	JP45, MOUSE, HOMOLOG OF	126306
MIM608744	*	 	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PHOSPHATE CARRIER), MEMBER 24; SLC25A24	29957
MIM608745	*	 	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PHOSPHATE CARRIER), MEMBER 25; SLC25A25	114789
MIM608746	*	 	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PHOSPHATE CARRIER), MEMBER 23; SLC25A23	79085
MIM608747	#	12q22-q24.1	INSULIN-LIKE GROWTH FACTOR I DEFICIENCY	3479
MIM608748	*	 	BONE MORPHOGENETIC PROTEIN 10; BMP10	27302
MIM608749	*	19p13.1	BROMODOMAIN-CONTAINING PROTEIN 4; BRD4	23476
MIM608750	*	3q27	ALG3, S. CEREVISIAE, HOMOLOG OF; ALG3	10195
MIM608751	#	3p	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8; CMH8	4634
MIM608752	*	11q23.3	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 5; C1QTNF5	114902
MIM608753	*	3p25.1	tRNA SPLICING ENDONUCLEASE 2, S. CEREVISIAE, HOMOLOG OF; TSEN2	80746
MIM608754	*	19q13.4	tRNA SPLICING ENDONUCLEASE 34, S. CEREVISIAE, HOMOLOG OF; TSEN34	79042
MIM608755	*	17q25.1	tRNA SPLICING ENDONUCLEASE 54, S. CEREVISIAE, HOMOLOG OF; TSEN54	283989
MIM608756	*	 	tRNA SPLICING ENDONUCLEASE 15, S. CEREVISIAE, HOMOLOG OF; TSEN15	116461
MIM608757	*	 	CLP1, YEAST, HOMOLOG OF; CLP1	10978
MIM608758	#	12q23-q24.3	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10; CMH10	4633
MIM608759	*	17q25	CYTOGLOBIN; CYGB	114757
MIM608760	*	 	AUTOPHAGY 7, S. CEREVISIAE, HOMOLOG OF; ATG7	10533
MIM608761	*	 	SOLUTE CARRIER FAMILY 5 (CHOLINE TRANSPORTER), MEMBER 7; SLC5A7	60482
MIM608762	%	9q32-q33	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	432400
MIM608763		 	EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	 
MIM608764	*	7q22.2	NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NAMPT	10135
MIM608765	#	8q12.1	SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 3; IS3	55636
MIM608766	*	 	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1B; LRP1B	53353
MIM608767	*	 	FEM1, C. ELEGANS, HOMOLOG OF, C; FEM1C	56929
MIM608768	#	13q21, 13q21	SPINOCEREBELLAR ATAXIA 8; SCA8	6315, 724066
MIM608769	*	11p13	PYRUVATE DEHYDROGENASE COMPLEX, COMPONENT X; PDHX	8050
MIM608770	*	11q23.1	DIHYDROLIPOAMIDE S-ACETYLTRANSFERASE; DLAT	1737
MIM608771	*	12q24	MEDIATOR COMPLEX SUBUNIT 13-LIKE; MED13L	23389
MIM608772	*	 	INVASION INHIBITORY PROTEIN, 45-KD	60672
MIM608773	*	5p15.3	TUBULIN POLYMERIZATION-PROMOTING PROTEIN; TPPP	11076
MIM608774	+	11q23.2	ANKYRIN REPEAT AND KINASE DOMAIN CONTAINING 1; ANKK1	255239
MIM608775	*	18q21.1	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 1; HAUS1	115106
MIM608776	#	11q23	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	79796
MIM608777	*	13q13.3	PERIOSTIN; POSTN	10631
MIM608778	*	 	KELCH-LIKE 10; KLHL10	317719
MIM608779	#	16p	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	91949
MIM608780	*	6q25.3	GENERAL TRANSCRIPTION FACTOR IIH, POLYPEPTIDE 5; GTF2H5	404672
MIM608781	%	1q21-q22	ASPERGER SYNDROME, SUSCEPTIBILITY TO, 3	449015
MIM608782	#	8q22.1	PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY; PDHPD	54704
MIM608783	*	 	SET AND MYND DOMAIN-CONTAINING PROTEIN 3; SMYD3	64754
MIM608784	*	22q11.21	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 8; ZDHHC8	29801
MIM608785	*	4p16.1	HTRA SERINE PEPTIDASE 3; HTRA3	94031
MIM608786	*	11q13.4-q13.5	PYRUVATE CARBOXYLASE; PC	5091
MIM608787	%	3q22-q24	OTOSCLEROSIS 5; OTSC5	317682
MIM608788	*	 	SUPPRESSOR OF CYTOKINE SIGNALING 7; SOCS7	30837
MIM608789	*	 	NCK-ASSOCIATED PROTEIN 5	344148
MIM608790	*	4p16.1	TRANSCRIPTIONAL ADAPTOR 2B; TADA2B	93624
MIM608791	*	 	NUCLEOREDOXIN-LIKE PROTEIN 1; NXNL1	115861
MIM608792	*	 	GIPC PDZ DOMAIN-CONTAINING FAMILY, MEMBER 3; GIPC3	126326
MIM608793	*	 	SPERM ANTIGEN WITH CALPONIN HOMOLOGY AND COILED-COIL DOMAINS 1; SPECC1	92521
MIM608794	*	 	PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, MEMBRANE-ASSOCIATED, 1; PITPNM1	9600
MIM608795	*	 	PHOSPHOLIPASE C, DELTA-3; PLCD3	113026
MIM608796	%	8q23	MOYAMOYA DISEASE 3; MYMY3	493818
MIM608797	*	 	MEI1, MOUSE, HOMOLOG OF	150365
MIM608798	*	7p15	DFNA5 GENE; DFNA5	1687
MIM608799	#	20q13.13	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie; CDG1E	8813
MIM608800	#	6q22-q23	SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME; SIDDT	7259
MIM608801	*	19p13.2	GLUTARYL-CoA DEHYDROGENASE; GCDH	2639
MIM608802	*	20q12	L3MBT-LIKE; L3MBTL	26013
MIM608803	*	1q41-q42	GAP JUNCTION PROTEIN, GAMMA-2; GJC2	57165
MIM608804	#	1q41-q42	LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2	57165
MIM608805	#	 	AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY	1280
MIM608806	*	3q26.3	N-ACETYLATED ALPHA-LINKED ACIDIC DIPEPTIDASE-LIKE 2	254827
MIM608807	#	2q31	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2J; LGMD2J	7273
MIM608808	#	12q24	TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 1; DTGA1	23389
MIM608809		 	LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA; LACH	 
MIM608810	#	11q22.3-q23.1	MYOPATHY, MYOFIBRILLAR, 2, MFM2	1410
MIM608811		 	METAPHYSEAL UNDERMODELING, SPONDYLAR DYSPLASIA, AND OVERGROWTH	 
MIM608812	#	9q22	COLORECTAL CANCER, SUSCEPTIBILITY TO, 1; CRCS1	79695
MIM608813	*	 	DER1-LIKE DOMAIN FAMILY, MEMBER 1; DERL1	79139
MIM608814		 	LATERAL SEMICIRCULAR CANAL MALFORMATION, FAMILIAL, WITH EXTERNAL AND MIDDLE EAR ABNORMALITIES	 
MIM608815	*	6p12-p11	EF-HAND DOMAIN (C-TERMINAL)-CONTAINING PROTEIN 1; EFHC1	114327
MIM608816	%	6p21	MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 3; EJM3	449018
MIM608817	*	11p12	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 4C; LRRC4C	57689
MIM608818	*	1p13.3	NETRIN G1; NTNG1	22854
MIM608819	*	17q12-q21	KERATIN-ASSOCIATED PROTEIN 1-1; KRTAP1-1	81851
MIM608820	*	17q12-q21	KERATIN-ASSOCIATED PROTEIN 1-3; KRTAP1-3	81850
MIM608821	*	17q12-q21	KERATIN-ASSOCIATED PROTEIN 1-4; KRTAP1-4	728255
MIM608822	*	17q12-q21	KERATIN-ASSOCIATED PROTEIN 1-5; KRTAP1-5	83895
MIM608823	*	 	CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 1; CGB1	114335
MIM608824	*	 	CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 2; CGB2	114336
MIM608825	*	 	CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 5; CGB5	93659
MIM608826	*	 	CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 7; CGB7	94027
MIM608827	*	 	CHORIONIC GONADOTROPIN, BETA POLYPEPTIDE 8; CGB8	94115
MIM608828	*	5p14-p13	RIBONUCLEASE III, NUCLEAR; RNASEN	29102
MIM608829	*	6q25	SMALL UBIQUITIN-LIKE MODIFIER 4; SUMO4	387082
MIM608830	*	14q23.3	RETINOL DEHYDROGENASE 12; RDH12	145226
MIM608831	%	14q13-q21	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 2; RLS2	450097
MIM608832	*	1q43	GREMLIN 2 HOMOLOG, CYSTINE KNOT SUPERFAMILY; GREM2	64388
MIM608833	*	20q13.3	REGULATOR OF TELOMERE ELONGATION HELICASE 1; RTEL1	51750
MIM608834	*	 	cAMP RESPONSE ELEMENT-BINDING PROTEIN 3-LIKE 2; CREB3L2	64764
MIM608835	*	 	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 13; ABCC13	150000
MIM608836	#	1p32	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL	1376
MIM608837	#	17p13.1	CARNEY COMPLEX VARIANT	4626
MIM608838	*	 	VITAMIN K EPOXIDE REDUCTASE COMPLEX, SUBUNIT 1-LIKE 1; VKORC1L1	154807
MIM608839	*	19q13	CALPAIN 12; CAPN12	147968
MIM608840	#	22q12.3-q13.1	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6; MDDGB6	9215
MIM608841	*	 	COMPLEMENT COMPONENT 3- AND PREGNANCY ZONE PROTEIN-LIKE ALPHA-2-MACROGLOBULIN DOMAIN-CONTAINING PROTEIN 8; CPAMD8	27151
MIM608842	*	 	COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 1; CHCHD1	118487
MIM608843	*	16p13.3	VASORIN	114990
MIM608844	*	 	ENDONUCLEASE VIII-LIKE 1; NEIL1	79661
MIM608845	*	3p12-q13	ADP-RIBOSYLATION FACTOR-LIKE 6; ARL6	84100
MIM608846	*	19q13.33	CARNITINE PALMITOYLTRANSFERASE IC; CPT1C	126129
MIM608847	*	5q21.3	FERRITIN, MITOCHONDRIAL; FTMT	94033
MIM608848	*	 	TRANSDUCER OF CDC42-DEPENDENT ACTIN ASSEMBLY 1	54874
MIM608849	*	1q23.1	U2AF HOMOLOGY MOTIF KINASE 1; UHMK1	127933
MIM608850	%	5p15.33-p13.1	MACULAR DYSTROPHY, RETINAL, 3	317668
MIM608851	*	20p11.2-p11.1	5-PRIME,3-PRIME-@EXORIBONUCLEASE 2; XRN2	22803
MIM608852	%	6q21-q22	PULMONARY FUNCTION	450095
MIM608853	*	11q24.1	BH3-LIKE MOTIF-CONTAINING CELL DEATH INDUCER; BLID	414899
MIM608854	*	1p34.2	OXIDORED-NITRO DOMAIN-CONTAINING PROTEIN 1	127700
MIM608855	*	 	TWEETY, DROSOPHILA, HOMOLOG OF, 2; TTYH2	94015
MIM608856	*	 	CUTANEOUS T-CELL LYMPHOMA-ASSOCIATED ANTIGEN 1; CTAGE1	64693
MIM608857	*	 	CUTANEOUS T-CELL LYMPHOMA-ASSOCIATED ANTIGEN 3; CTAGE3	220112
MIM608858	*	 	FIBROBLAST GROWTH FACTOR RECEPTOR 1 ONCOGENE PARTNER 2; FGFR1OP2	26127
MIM608859	*	6q13	CD109 ANTIGEN; CD109	135228
MIM608860	*	 	ASTACIN-LIKE METALLOENDOPEPTIDASE; ASTL	431705
MIM608861	*	 	ATPase, H+ TRANSPORTING, LYSOSOMAL, 50/57-KD, V1 SUBUNIT H; ATP6V1H	51606
MIM608862	*	 	APOLIPOPROTEIN A-I-BINDING PROTEIN; APOA1BP	128240
MIM608863	*	 	PODOPLANIN; PDPN	10630
MIM608864	#	1q32-q41	OROFACIAL CLEFT 6, SUSCEPTIBILITY TO; OFC6	3664
MIM608865	*	 	NPA1, YEAST, HOMOLOG OF	9875
MIM608866	*	10q23.33	FRAGILE SITE, FOLIC ACID-TYPE, RARE, FRA(10)(q23.3), CANDIDATE GENE 1	118924
MIM608867	*	 	DUAL-SPECIFICITY PHOSPHATASE 10; DUSP10	11221
MIM608868	*	3p14	LEUCINE-RICH REPEATS- AND IMMUNOGLOBULIN-LIKE DOMAINS-CONTAINING PROTEIN 1; LRIG1	26018
MIM608869	*	1p13	LEUCINE-RICH REPEATS- AND IMMUNOGLOBULIN-LIKE DOMAINS-CONTAINING PROTEIN 2; LRIG2	9860
MIM608870	*	12q13.2	LEUCINE-RICH REPEATS- AND IMMUNOGLOBULIN-LIKE DOMAINS-CONTAINING PROTEIN 3; LRIG3	121227
MIM608871	*	 	NIPSNAP, C. ELEGANS, HOMOLOG OF, 3A; NIPSNAP3A	25934
MIM608872	*	 	NIPSNAP, C. ELEGANS, HOMOLOG OF, 3B; NIPSNAP3B	55335
MIM608873	*	 	SEMAPHORIN 6B; SEMA6B	10501
MIM608874	#	4p16.1	OROFACIAL CLEFT 5; OFC5	4487
MIM608875	%	14q32	GENE EXPRESSION, VARIATION IN, QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 14	474334
MIM608876	*	 	PCF11, YEAST, HOMOLOG OF	51585
MIM608877	*	 	VACUOLAR PROTEIN SORTING 13, YEAST, HOMOLOG OF, D; VPS13D	55187
MIM608878	%	20q13	GENE EXPRESSION, VARIATION IN, QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 20	474333
MIM608879	*	 	VACUOLAR PROTEIN SORTING 13, YEAST, HOMOLOG OF, C; VPS13C	54832
MIM608880	*	 	ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 16; ZFYVE16	9765
MIM608881	*	11p15.3	MICROTUBULE-ASSOCIATED MONOOXYGENASE, CALPONIN AND LIM DOMAINS-CONTAINING, 2; MICAL2	9645
MIM608882	*	22q11.21	MICROTUBULE-ASSOCIATED MONOOXYGENASE, CALPONIN AND LIM DOMAINS-CONTAINING, 3; MICAL3	57553
MIM608883	^	 	GALACTOSE MUTAROTASE; GALM	130589
MIM608884	*	14q13.2	GTPase-ACTIVATING RAP/RAN-GAP DOMAIN-LIKE 1; GARNL1	253959
MIM608885		 	CRYOHYDROCYTOSIS, STOMATIN-DEFICIENT, WITH MENTAL RETARDATION, SEIZURES, CATARACTS, AND MASSIVE HEPATOSPLENOMEGALY	 
MIM608886	*	5q33	PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR 1, BETA; PPARGC1B	133522
MIM608887	*	 	PURINE-RICH ELEMENT-BINDING PROTEIN B; PURB	5814
MIM608888	*	 	DEVELOPMENTALLY REGULATED RNA-BINDING PROTEIN 1	129831
MIM608889	*	 	AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE; ACMSD	130013
MIM608890	#	8q11	WAARDENBURG SYNDROME, TYPE 2D; WS2D	6591
MIM608891	*	2p24	ODD-SKIPPED-RELATED 1; OSR1	130497
MIM608892	*	8q12.1	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 7; CHD7	55636
MIM608893	*	5p15.33	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 19; SLC6A19	340024
MIM608894	*	6q23.3	ABELSON HELPER INTEGRATION SITE 1; AHI1	54806
MIM608895	#	14q32.1	MACULAR DEGENERATION, AGE-RELATED, 3; ARMD3	10516
MIM608896	*	13q12	SARCOGLYCAN, GAMMA; SGCG	6445
MIM608897	*	17q25.1	UNC13, C. ELEGANS, HOMOLOG OF, D; UNC13D	201294
MIM608898	#	17q25.1	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3	201294
MIM608899	*	 	GTF2I REPEAT DOMAIN-CONTAINING PROTEIN 2, ALPHA	84163
MIM608900	*	 	GTF2I REPEAT DOMAIN-CONTAINING PROTEIN 2, BETA	389524
MIM608901	#	3q13	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 5	8997
MIM608902	#	22q13.1	DRUG METABOLISM, POOR, CYP2D6-RELATED	1565
MIM608903	%	16p13	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 1	450087
MIM608904	%	17p11	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 2	450088
MIM608905	%	6q12	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 3	450089
MIM608906	%	5p13	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 4	450090
MIM608907	%	19p13.2	ALZHEIMER DISEASE 9	450086
MIM608908	#	22q12	MYOPIA 6; MYP6	450094
MIM608909	*	 	ADP-RIBOSYLATION FACTOR-LIKE 5B; ARL5B	221079
MIM608910	*	 	CUTANEOUS T-CELL LYMPHOMA-ASSOCIATED ANTIGEN 4; CTAGE4	100128553
MIM608911	%	 	CHOANAL ATRESIA, POSTERIOR; PCA	 
MIM608912	*	 	POTE ANKYRIN DOMAIN FAMILY, MEMBER B; POTEB	339010
MIM608913	*	22q11.1	POTE ANKYRIN DOMAIN FAMILY, MEMBER H; POTEH	23784
MIM608914	*	2q21.1	POTE ANKYRIN DOMAIN FAMILY, MEMBER E; POTEE	445582
MIM608915	*	 	POTE ANKYRIN DOMAIN FAMILY, MEMBER A; POTEA	340441
MIM608916	*	 	POTE ANKYRIN DOMAIN FAMILY, MEMBER G; POTEG	404785
MIM608917	*	 	ATP SYNTHASE, MITOCHONDRIAL F1 COMPLEX, ASSEMBLY FACTOR 1; ATPAF1	64756
MIM608918	*	17p11.2	ATP SYNTHASE, MITOCHONDRIAL F1 COMPLEX, ASSEMBLY FACTOR 2; ATPAF2	91647
MIM608919	*	 	TWEETY, DROSOPHILA, HOMOLOG OF, 3; TTYH3	80727
MIM608920	*	 	PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, MEMBRANE-ASSOCIATED, 2; PITPNM2	57605
MIM608921	*	17p13.1	PHOSPHATIDYLINOSITOL TRANSFER PROTEIN, MEMBRANE-ASSOCIATED, 3; PITPNM3	83394
MIM608922	*	3q11.2	ADP-RIBOSYLATION FACTOR-LIKE 13B; ARL13B	200894
MIM608923	*	6q23.2	TRACE AMINE-ASSOCIATED RECEPTOR 6; TAAR6	319100
MIM608924	*	6p21.1	FORKHEAD BOX P4; FOXP4	116113
MIM608925	*	 	MULTIMERIN 2; MMRN2	79812
MIM608926	*	 	EMI DOMAIN-CONTAINING PROTEIN 1; EMID1	129080
MIM608927	*	7q22.1	EMI DOMAIN-CONTAINING PROTEIN 2; EMID2	136227
MIM608928	*	 	ELASTIN MICROFIBRIL INTERFACER 2; EMILIN2	84034
MIM608929	*	 	ELASTIN MICROFIBRIL INTERFACER 3; EMILIN3	90187
MIM608930	#	17p13-p12, 2q33-q34, 2q24-q32	MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL	1134, 1144, 1145
MIM608931	#	17p12-p11, 17p13-p12, 11p11.2-p11.1, 9q31.3-q32	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	1140, 1145, 2673, 4593, 5913
MIM608932	%	16q22.3-q23.1	KERATOCONUS 2; KTCN2	450092
MIM608933	*	 	ENDONUCLEASE VIII-LIKE 2; NEIL2	252969
MIM608934	*	 	ENDONUCLEASE VIII-LIKE 3; NEIL3	55247
MIM608935	%	6q23-q25	LUNG CANCER SUSCEPTIBILITY 1; LNCR1	450093
MIM608936	*	 	PROLINE-RICH 1; PROL1	58503
MIM608937	*	 	SH2B ADAPTOR PROTEIN 1; SH2B1	25970
MIM608938	*	17q23.1	RIBOSOMAL PROTEIN S6 KINASE, 70-KD, 1; RPS6KB1	6198
MIM608939	*	 	RIBOSOMAL PROTEIN S6 KINASE, 70-KD, 2; RPS6KB2	6199
MIM608940	#	 	SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY	 
MIM608941	*	 	GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-3; GNG3	2785
MIM608942	*	17q23.2	DYNEIN, LIGHT CHAIN, LC8 TYPE, 2; DYNLL2	140735
MIM608943	*	 	CYTOKINE-INDUCED APOPTOSIS INHIBITOR 1; CIAPIN1	57019
MIM608944	*	9p22.3	FRAS1-RELATED EXTRACELLULAR MATRIX PROTEIN 1; FREM1	158326
MIM608945	*	13q13.3	FRAS1-RELATED EXTRACELLULAR MATRIX PROTEIN 2; FREM2	341640
MIM608946	*	4q31.2	FRAS1-RELATED EXTRACELLULAR MATRIX PROTEIN 3	166752
MIM608947	*	16p11.2	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 13; KCTD13	253980
MIM608948	*	3q24	ZINC FINGER PROTEIN OF CEREBELLUM 4; ZIC4	84107
MIM608949	*	 	GLYCOLIPID TRANSFER PROTEIN	51228
MIM608950	*	7q21	MAGI2 INTRONIC TRANSCRIPT; MAGI2IT	266671
MIM608951	*	5q35.3	CCR4-NOT TRANSCRIPTION COMPLEX, SUBUNIT 6; CNOT6	57472
MIM608952	*	 	RAP1-INTERACTING FACTOR 1, YEAST, HOMOLOG OF	55183
MIM608953	*	 	TEKTIN 2; TEKT2	27285
MIM608954	*	16q23.1	MON1, S. CEREVISIAE, HOMOLOG OF, B; MON1B	22879
MIM608955	*	22q13.1	TUBULIN TYROSINE LIGASE-LIKE FAMILY, MEMBER 1; TTLL1	25809
MIM608956	*	9q31-q34	SOLUTE CARRIER FAMILY 46, MEMBER 2; SLC46A2	57864
MIM608957	#	2p12	CD8 DEFICIENCY, FAMILIAL	925
MIM608958	*	20q13.11	ADENOSINE DEAMINASE; ADA	100
MIM608959	*	3p24.3	DPH3, S. CEREVISIAE, HOMOLOG OF; DPH3	285381
MIM608960	*	2q23-q24.1	ADP-RIBOSYLATION FACTOR-LIKE 5A; ARL5A	26225
MIM608961	*	9q21.12	TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 3; TRPM3	80036
MIM608962	*	 	RHOMBOID-LIKE 2; RHBDL2	54933
MIM608963	*	 	NUCLEAR PROTEIN IN TESTIS	256646
MIM608964	*	 	TATA BOX-BINDING PROTEIN-LIKE PROTEIN 2; TBPL2	387332
MIM608965	*	11q13.1	CALCIUM-BINDING PROTEIN 4; CABP4	57010
MIM608966	*	6q27	DAPPER, ANTAGONIST OF BETA-CATENIN, 2; DACT2	168002
MIM608967	^	9q22	LOEYS-DIETZ SYNDROME, TYPE 2A; LDS2A	7046
MIM608968	*	20q11.2-q13.1	V-MAF MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE FAMILY, PROTEIN B; MAFB	9935
MIM608969	*	 	UTP14, S. CEREVISIAE, HOMOLOG OF, B	9724
MIM608970	%	 	MACULAR DYSTROPHY, BUTTERFLY-SHAPED PIGMENTARY, 2	619480
MIM608971	#	11q23, 11q23, 5p13, 1q31-q32	SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	3575, 5788, 915, 916
MIM608972	*	1q21.3	CREB-REGULATED TRANSCRIPTION COACTIVATOR 2; CRTC2	200186
MIM608973	*	11q23.1	SALT-INDUCIBLE KINASE 2; SIK2	23235
MIM608974	*	12p13.31	COMPLEMENT COMPONENT C1r-LIKE PROTEIN; C1RL	51279
MIM608975	*	20q13.13	PARTITIONING-DEFECTIVE PROTEIN 6, C. ELEGANS, HOMOLOG OF, BETA; PARD6B	84612
MIM608976	*	18q23	PARTITIONING-DEFECTIVE PROTEIN 6, C. ELEGANS, HOMOLOG OF, GAMMA; PARD6G	84552
MIM608977	*	3q26.3	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 19; DNAJC19	131118
MIM608978	#	11p13	MEACHAM SYNDROME	7490
MIM608979	*	3p21.2	PROTEIN PHOSPHATASE, MAGNESIUM-DEPENDENT, 1M; PPM1M	132160
MIM608980	#	9p22.3	BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES; BNAR	158326
MIM608981	*	2q24.1	ACTIVIN A RECEPTOR, TYPE IC; ACVR1C	130399
MIM608982	%	3p26	STATURE QUANTITATIVE TRAIT LOCUS 5; STQTL5	619479
MIM608983	^	2q33-q35	CATARACT, CONGENITAL, CERULEAN TYPE, 3; CCA3	1421
MIM608984	#	8p12-q12.1	ATAXIA, SENSORY, 1, AUTOSOMAL DOMINANT; SNAX1	474386, 81790
MIM608985	*	1q25.3	RING FINGER PROTEIN 2; RNF2	6045
MIM608986	*	15q26.1	CREB-REGULATED TRANSCRIPTION COACTIVATOR 3; CRTC3	64784
MIM608987	*	11q12	PROCOLLAGEN-PROLINE, 2-OXOGLUTARATE-4-DIOXYGENASE, ALPHA SUBUNIT, ISOFORM 3; P4HA3	283208
MIM608988	%	6q14-q16	ATRIAL FIBRILLATION, FAMILIAL, 2; ATFB2	619478
MIM608989	*	8q12.1	RETINAL DEHYDROGENASE, EPIDERMAL, 2	195814
MIM608990	*	19p13.3-p13.2	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 10; ADAMTS10	81794
MIM608991	*	4q28.3	MASTERMIND-LIKE 3; MAML3	55534
MIM608992	*	17p13.1	B-CELL LYMPHOMA 6B; BCL6B	255877
MIM608993	*	22q12-q13.2	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3F; APOBEC3F	200316
MIM608994	*	6p21.3	ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAINS-CONTAINING PROTEIN 1A; ANKS1A	23294
MIM608995	%	1p36-p34	DYSLEXIA, SUSCEPTIBILITY TO, 8; DYX8	406874
MIM608996	#	3q23	PREMATURE OVARIAN FAILURE 3; POF3	668
MIM608998	*	2p25.2	TUMOR-SUPPRESSING SUBTRANSFERABLE FRAGMENT CANDIDATE GENE 1; TSSC1	7260
MIM608999	*	11p15.5	TUMOR-SUPPRESSING SUBTRANSFERABLE FRAGMENT CANDIDATE GENE 2; TSSC2	7261
MIM609000	*	6q23.1-q23.3	MONOOXYGENASE, DBH-LIKE, 1; MOXD1	26002
MIM609001	*	12p12	PHOSPHATIDYLINOSITOL 3-KINASE, CLASS 2, GAMMA; PIK3C2G	5288
MIM609002	*	17p13.1	TEKTIN 1; TEKT1	83659
MIM609003	*	7q22.1	TETRATRICOPEPTIDE REPEAT DOMAIN 11; TTC11	51024
MIM609004	*	11q23.3	B-CELL CLL/LYMPHOMA 9-LIKE; BCL9L	283149
MIM609005	*	4q34	WD REPEAT-CONTAINING PROTEIN 17; WDR17	116966
MIM609006	#	1p36.3-p36.1	DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT; DFNB36	83715
MIM609007	*	12q12	LEUCINE-RICH REPEAT KINASE 2; LRRK2	120892
MIM609008		 	MARFANOID HABITUS WITH SITUS INVERSUS	 
MIM609009	*	 	TYROSINE 3-MONOOXYGENASE/TRYPTOPHAN 5-MONOOXYGENASE ACTIVATION PROTEIN, THETA ISOFORM; YWHAQ	10971
MIM609010	*	3q25-q27	3-@METHYLCROTONYL-CoA CARBOXYLASE 1; MCCC1	56922
MIM609011	*	 	VASOHIBIN 1; VASH1	22846
MIM609012	*	 	WD REPEAT-CONTAINING PROTEIN 5; WDR5	11091
MIM609013	*	 	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 4C1; SLCO4C1	353189
MIM609014	*	5q12-q13	3-@METHYLCROTONYL-CoA CARBOXYLASE 2; MCCC2	64087
MIM609015	#	2p23, 2p23	TRIFUNCTIONAL PROTEIN DEFICIENCY	3030, 3032, 3033
MIM609016	#	2p23	LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	3030
MIM609017	*	1p34	ERYTHROBLAST MEMBRANE-ASSOCIATED PROTEIN; ERMAP	114625
MIM609018	*	21q22.1	HOLOCARBOXYLASE SYNTHETASE; HLCS	3141
MIM609019	*	3p25	BIOTINIDASE; BTD	686
MIM609020	*	11p13-p11.1	FOLATE HYDROLASE 1B; FOLH1B	219595
MIM609021	%	 	PERIPHERAL CONE DYSTROPHY	 
MIM609022	*	 	RAPAMYCIN-INSENSITIVE COMPANION OF MTOR; RICTOR	253260
MIM609023	*	2q35	MYOFIBRILLOGENESIS REGULATOR 1	25953
MIM609024	*	 	KDEL ENDOPLASMIC RETICULUM PROTEIN RETENTION RECEPTOR 2; KDELR2	11014
MIM609025	*	12q13	KERATIN 75; KRT75	9119
MIM609026	%	6p12-q12	CATARACT, AGE-RELATED CORTICAL, 1; ARCC1	493862
MIM609027	#	 	INDIAN BLOOD GROUP SYSTEM; IN	960
MIM609028	*	 	TRAF-INTERACTING PROTEIN WITH FORKHEAD-ASSOCIATED DOMAIN; TIFA	92610
MIM609029	#	22q11.2	EMANUEL SYNDROME	100529146
MIM609030	*	22q11.2	DIGEORGE SYNDROME CRITICAL REGION GENE 8; DGCR8	54487
MIM609031	*	 	SERINE PROTEASE INHIBITOR-LIKE PROTEIN WITH KUNITZ AND WAP DOMAINS 1; SPINLW1	57119
MIM609032	*	4q35	FSHD REGION GENE 2; FRG2	448831
MIM609033	#	1q31.3	POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	28982
MIM609034	*	 	HAIRY/ENHANCER OF SPLIT-RELATED WITH YRPW MOTIF-LIKE PROTEIN; HEYL	26508
MIM609035	*	 	RAS ASSOCIATION AND PLECKSTRIN HOMOLOGY DOMAINS-CONTAINING PROTEIN 1; RAPH1	65059
MIM609036	*	 	APBB1-INTERACTING PROTEIN; APBB1IP	54518
MIM609038	*	 	RHO FAMILY GTPase 1; RND1	27289
MIM609039	%	21q11.2	NARCOLEPSY 3; NRCLP3	494446
MIM609040	#	12p11	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9; ARVD9	5318
MIM609041	%	10q22.1-q24.1	SPASTIC PARAPLEGIA 27, AUTOSOMAL RECESSIVE; SPG27	414886
MIM609042	*	 	OPSIN 5; OPN5	221391
MIM609043	*	 	RELAXIN 3 RECEPTOR 2; RLN3R2	339403
MIM609044	*	 	G PROTEIN-COUPLED RECEPTOR 120; GPR120	338557
MIM609045	*	 	G PROTEIN-COUPLED RECEPTOR 141; GPR141	353345
MIM609046	*	 	G PROTEIN-COUPLED RECEPTOR 142; GPR142	350383
MIM609048	#	12q14	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3; CMM3	1019
MIM609049	#	3p21	PIERSON SYNDROME	3913
MIM609050	*	 	METASTASIS-ASSOCIATED GENE 3; MTA3	57504
MIM609051	*	19q13.3	CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 8; CARD8	22900
MIM609053	#	15q25-q26	FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	55215
MIM609054	#	17q22	FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	83990
MIM609055	%	 	CEROID LIPOFUSCINOSIS, NEURONAL, 9; CLN9	497231
MIM609056	#	2p11.2	AMISH INFANTILE EPILEPSY SYNDROME	8869
MIM609057	#	11p15.5	NEPHROPATHY WITH PRETIBIAL EPIDERMOLYSIS BULLOSA AND DEAFNESS	977
MIM609058	*	6p21	METHYLMALONYL-CoA MUTASE; MUT	4594
MIM609059	*	11p15.5	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 2; PNPLA2	57104
MIM609060	#	3q25.1-q26.2	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1	85476
MIM609061	*	 	ENABLED, DROSOPHILA, HOMOLOG OF; ENAH	55740
MIM609062	*	7p14-p13	POU DOMAIN, CLASS 6, TRANSCRIPTION FACTOR 2; POU6F2	11281
MIM609063	*	 	THIOREDOXIN 2; TXN2	25828
MIM609064	*	18q22.3	CARNOSINE DIPEPTIDASE 1; CNDP1	84735
MIM609066	*	 	AJUBA, MOUSE, HOMOLOG OF; JUB	84962
MIM609067	*	8q24.3	SCLERAXIS, MOUSE, HOMOLOG OF, A; SCXA	100129885
MIM609068	*	 	DAN DOMAIN FAMILY, MEMBER 5; DAND5	199699
MIM609069	#	10p12.3	PANCREATIC AND CEREBELLAR AGENESIS; PACA	256297
MIM609071	*	 	F-BOX AND WD40 DOMAIN PROTEIN 2; FBXW2	26190
MIM609072	*	 	F-BOX AND WD40 DOMAIN PROTEIN 5; FBXW5	54461
MIM609073	*	12q24.23	F-BOX AND WD40 DOMAIN PROTEIN 8; FBXW8	26259
MIM609074	*	 	F-BOX AND WD40 DOMAIN PROTEIN 9; FBXW9	84261
MIM609075	*	3p21	F-BOX AND WD40 DOMAIN PROTEIN 12; FBXW12	285231
MIM609076	*	 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 6; FBXL6	26233
MIM609077	*	 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 8; FBXL8	55336
MIM609078	*	 	LYSINE-SPECIFIC DEMETHYLASE 2B; KDM2B	84678
MIM609079	*	 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 12; FBXL12	54850
MIM609080	*	 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 13; FBXL13	222235
MIM609081	*	 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 14; FBXL14	144699
MIM609082	*	 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 16; FBXL16	146330
MIM609083	*	5q21.3	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 17; FBXL17	64839
MIM609084	*	 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 18; FBXL18	80028
MIM609085	*	 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 19; FBXL19	54620
MIM609086	*	 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 20; FBXL20	84961
MIM609087	*	 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 21; FBXL21	26223
MIM609088	*	 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 22; FBXL22	283807
MIM609089	*	11p13	F-BOX ONLY PROTEIN 3; FBXO3	26273
MIM609090	*	5p12	F-BOX ONLY PROTEIN 4; FBXO4	26272
MIM609091	*	6p12.3-p11.2	F-BOX ONLY PROTEIN 9; FBXO9	26268
MIM609092	*	9p13.1	F-BOX ONLY PROTEIN 10; FBXO10	26267
MIM609093	*	18q22.3	F-BOX ONLY PROTEIN 15; FBXO15	201456
MIM609094	*	19q13.2	F-BOX ONLY PROTEIN 17; FBXO17	115290
MIM609095	*	12q24.23	F-BOX ONLY PROTEIN 21; FBXO21	23014
MIM609096	*	15q23	F-BOX ONLY PROTEIN 22; FBXO22	26263
MIM609097	*	7q22	F-BOX ONLY PROTEIN 24; FBXO24	26261
MIM609098	*	8p23.3	F-BOX ONLY PROTEIN 25; FBXO25	26260
MIM609099	*	19q13.2	F-BOX ONLY PROTEIN 27; FBXO27	126433
MIM609100	*	1q42.12	F-BOX ONLY PROTEIN 28; FBXO28	23219
MIM609101	*	6q24	F-BOX ONLY PROTEIN 30; FBXO30	84085
MIM609102	*	16q24.3	F-BOX ONLY PROTEIN 31; FBXO31	79791
MIM609103	*	14q13.3	F-BOX ONLY PROTEIN 33; FBXO33	254170
MIM609104	*	14q22.2	F-BOX ONLY PROTEIN 34; FBXO34	55030
MIM609105	*	2q37.1	F-BOX ONLY PROTEIN 36; FBXO36	130888
MIM609106	*	17p13.2	F-BOX ONLY PROTEIN 39; FBXO39	162517
MIM609107	*	3q21.1	F-BOX ONLY PROTEIN 40; FBXO40	51725
MIM609108	*	2p13.2	F-BOX ONLY PROTEIN 41; FBXO41	150726
MIM609109	*	1p36.23-p36.11	F-BOX ONLY PROTEIN 42; FBXO42	54455
MIM609110	*	8q22.3	F-BOX ONLY PROTEIN 43; FBXO43	286151
MIM609111	*	1p36.21	F-BOX ONLY PROTEIN 44; FBXO44	93611
MIM609112	*	3q29	F-BOX ONLY PROTEIN 45; FBXO45	200933
MIM609113	%	14q23.2	TELOMERE LENGTH, MEAN LEUKOCYTE	550641
MIM609114	*	20p12.1	DESTRIN; DSTN	11034
MIM609115	#	4q21	LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	553991
MIM609116	%	10q26	RESPIRATORY RHYTHMICITY IN SLEEP	497662
MIM609117	*	19q13.3	F-BOX ONLY PROTEIN 46; FBXO46	23403
MIM609118	*	3q26.1	PROGRAMMED CELL DEATH 10; PDCD10	11235
MIM609119	*	 	THAP DOMAIN-CONTAINING PROTEIN 11; THAP11	57215
MIM609120	*	 	CATION CHANNEL, SPERM-ASSOCIATED, 3; CATSPER3	347732
MIM609121	*	 	CATION CHANNEL, SPERM-ASSOCIATED, 4; CATSPER4	378807
MIM609122	%	1p36.13-p34.3	ANEURYSM, INTRACRANIAL BERRY, 3; ANIB3	497657
MIM609123	*	 	ATPase, CLASS I, TYPE 8B, MEMBER 4; ATP8B4	79895
MIM609124	*	12q13.13	ZINC FINGER PROTEIN 385A; ZNF385A	25946
MIM609125	*	 	MOTILE SPERM DOMAIN-CONTAINING PROTEIN 3; MOSPD3	64598
MIM609126	*	 	ATPase, CLASS II, TYPE 9A; ATP9A	10079
MIM609128	%	 	ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	100188695
MIM609129	#	13q14-q21	AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1; AUNA1	81624
MIM609130	*	1p36.22	APOPTOSIS-INDUCING, TAF9-LIKE DOMAIN 1; APITD1	378708
MIM609131	*	 	CLAUDIN 7; CLDN7	1366
MIM609132	*	1p36.12	LYSINE-SPECIFIC DEMETHYLASE 1A; KDM1A	23028
MIM609133	*	 	FLT3-INTERACTING ZINC FINGER PROTEIN 1; FIZ1	84922
MIM609134	*	6p21.1	UBIQUITIN-PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 2; UBR2	23304
MIM609135	#	12q14, 5p15.33, 3q21-q28	APLASTIC ANEMIA	3458, 7012, 7015
MIM609136	#	22q13	PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	6663
MIM609137	*	 	RECEPTOR-TRANSPORTING PROTEIN 1; RTP1	132112
MIM609138	*	 	RECEPTOR-TRANSPORTING PROTEIN 2; RTP2	344892
MIM609139	*	2p11.2	RECEPTOR EXPRESSION-ENHANCING PROTEIN 1; REEP1	65055
MIM609140	#	1p34.3-p32.3	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 2; PPCD2	1296
MIM609141	#	10p11.2	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 3; PPCD3	6935
MIM609142	*	 	CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 3; CEACAM3	1084
MIM609144	*	1q31.3	FELINE LEUKEMIA VIRUS SUBGROUP C RECEPTOR 1; FLVCR1	28982
MIM609145	*	 	NEUROFASCIN	23114
MIM609146	*	 	RIC8, C. ELEGANS, HOMOLOG OF, A; RIC8A	60626
MIM609147	*	 	RIC8, C. ELEGANS, HOMOLOG OF, B	55188
MIM609148	#	6p21.3, 6p21.3	MALARIA, MILD, SUSCEPTIBILITY TO	259197
MIM609149	*	 	SOLUTE CARRIER FAMILY 29 (MONOAMINE TRANSPORTER), MEMBER 4; SLC29A4	222962
MIM609150	*	 	CXXC FINGER PROTEIN 1; CXXC1	30827
MIM609151	*	 	SOCIUS	91544
MIM609152	#	14q31	HYPERTHYROIDISM, NONAUTOIMMUNE	7253
MIM609153	%	2q35-q36	PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK	541461
MIM609154	*	 	ACHAETE-SCUTE COMPLEX, DROSOPHILA, HOMOLOG OF, 3; ASCL3	56676
MIM609155	*	 	ACHAETE-SCUTE COMPLEX, DROSOPHILA, HOMOLOG OF, 4; ASCL4	121549
MIM609156	*	 	NICALIN, ZEBRAFISH, HOMOLOG OF; NCLN	56926
MIM609157	*	 	NODAL MODULATOR 1; NOMO1	23420
MIM609158	*	 	NODAL MODULATOR 2; NOMO2	283820
MIM609159	*	 	NODAL MODULATOR 3; NOMO3	408050
MIM609160	^	10q22.3	MOVED TO 601419	497658
MIM609161	#	5q13	STRIATAL DEGENERATION, AUTOSOMAL DOMINANT; ADSD	8622
MIM609162	#	 	CZECH DYSPLASIA	1280
MIM609163	*	12q24.31	G PROTEIN-COUPLED RECEPTOR 109A; GPR109A	338442
MIM609165	#	17q21-q22	ERYTHRODERMA, ICHTHYOSIFORM, CONGENITAL RETICULAR; CRIE	3858
MIM609168	*	3p24.3	SHUGOSHIN-LIKE 1; SGOL1	151648
MIM609169	*	19q13.1	GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE, SPERMATOGENIC; GAPDHS	26330
MIM609170	*	 	THIOREDOXIN DOMAIN-CONTAINING PROTEIN 4; TXNDC4	23071
MIM609171	*	 	CDC42 EFFECTOR PROTEIN 5; CDC42EP5	148170
MIM609172	*	 	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 16A; PPP1R16A	84988
MIM609173	*	 	CANCER SUSCEPTIBILITY CANDIDATE 5; CASC5	57082
MIM609174	*	 	CHROMOSOME 1 OPEN READING FRAME 48; C1ORF48	25936
MIM609175	*	 	CHROMOSOME 20 OPEN READING FRAME 172; C20ORF172	79980
MIM609176	*	 	POLYAMINE-MODULATED FACTOR 1; PMF1	11243
MIM609177	*	 	ZW10 INTERACTOR; ZWINT	11130
MIM609178	*	 	MIS12, S. POMBE, HOMOLOG OF; MIS12	79003
MIM609179	%	15q11.2-q12	MIGRAINE WITH AURA, SUSCEPTIBILITY TO, 7	553992
MIM609180	#	17p13.1-p12	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If; CDG1F	9526
MIM609181	*	12pter-p13.31	DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 4; DYRK4	8798
MIM609182	*	9q22.3	SOLUTE CARRIER FAMILY 35, MEMBER D2; SLC35D2	11046
MIM609183	*	1p36.3	AURORA KINASE A-INTERACTING PROTEIN	54998
MIM609184	*	5q33.1	KINESIN FAMILY MEMBER 4B; KIF4B	285643
MIM609185	*	 	ZINC FINGER AND HOMEODOMAIN PROTEIN 2; ZHX2	22882
MIM609186	*	2q37.3	D-2-@HYDROXYGLUTARATE DEHYDROGENASE; D2HGDH	728294
MIM609187	*	7p14	CHROMOSOME 7 OPEN READING FRAME 10; C7ORF10	79783
MIM609188	*	7p14	CHROMOSOME 7 OPEN READING FRAME 11; C7ORF11	136647
MIM609189	*	6q22.31	ANTI-SILENCING FUNCTION 1, S. CEREVISIAE, HOMOLOG OF, A; ASF1A	25842
MIM609190	*	19p13.13	ANTI-SILENCING FUNCTION 1, S. CEREVISIAE, HOMOLOG OF, B; ASF1B	55723
MIM609191	*	11p15.3	PROTEIN KINASE A-INTERACTING PROTEIN 1; AKIP1	56672
MIM609192	#	9q22	LOEYS-DIETZ SYNDROME, TYPE 1A; LDS1A	7046
MIM609193	*	 	PEPTIDYL-PROLYL ISOMERASE-LIKE 5; PPIL5	122769
MIM609194	*	 	CDK5 AND ABL ENZYME SUBSTRATE 1; CABLES1	91768
MIM609195	#	12p11.1-q14	SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	550623
MIM609196	*	21q22.1	MELANOCORTIN 2 RECEPTOR ACCESSORY PROTEIN; MRAP	56246
MIM609197	%	8q11.2-q13.2	GLUCOCORTICOID DEFICIENCY 3; GCCD3	619477
MIM609198	*	9p22.1-p21.2	ADAMTS-LIKE PROTEIN 1; ADAMTSL1	92949
MIM609199	*	15q25.2	ADAMTS-LIKE PROTEIN 3; ADAMTSL3	57188
MIM609200	#	5q31	MYOPATHY, MYOFIBRILLAR, 3; MFM3	9499
MIM609201	*	11q24.1	UBIQUITIN-ASSOCIATED AND SH3 DOMAIN-CONTAINING PROTEIN B; UBASH3B	84959
MIM609202	*	 	SECRETAGOGIN; SCGN	10590
MIM609203	*	 	CLAUDIN 23; CLDN23	137075
MIM609204	*	10q22.1	MITOCHONDRIAL RIBOSOMAL PROTEIN S16: MRPS16	51021
MIM609205	*	9q33	DAB2-INTERACTING PROTEIN; DAB2IP	153090
MIM609206	*	6p25.1-p23	EUKARYOTIC TRANSLATION ELONGATION FACTOR 1, EPSILON-1; EEF1E1	9521
MIM609207	*	2q35	MELANOREGULIN; MREG	55686
MIM609208	*	 	KAZAL-TYPE PROTEASE INHIBITOR DOMAIN-CONTAINING PROTEIN 1; KAZALD1	81621
MIM609209	*	 	INFLUENZA VIRUS NS1A PROTEIN-BINDING PROTEIN; IVNS1ABP	10625
MIM609210	*	 	CLAUDIN 18; CLDN18	51208
MIM609211	*	18p11.31	MYOSIN, LIGHT CHAIN 12B, REGULATORY; MYL12B	103910
MIM609212	*	 	ASPARAGINASE-LIKE PROTEIN 1; ASRGL1	80150
MIM609213	*	 	SEC61 COMPLEX, ALPHA-1 SUBUNIT; SEC61A1	29927
MIM609214	*	 	SEC61 COMPLEX, BETA SUBUNIT; SEC61B	10952
MIM609215	*	 	SEC61 COMPLEX, GAMMA SUBUNIT; SEC61G	23480
MIM609216	*	 	SPIRE, DROSOPHILA, HOMOLOG OF, 1; SPIRE1	56907
MIM609217	*	 	SPIRE, DROSOPHILA, HOMOLOG OF, 2; SPIRE2	84501
MIM609218	#	16q23.2-q24.2	FOVEAL HYPOPLASIA AND ANTERIOR SEGMENT DYSGENESIS; FHASD	550626
MIM609219	*	 	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 14; NUDT14	256281
MIM609220	#	3q23-q24	BRUCK SYNDROME 2; BRKS2	5352
MIM609221	*	 	N-ACETYLTRANSFERASE 10; NAT10	55226
MIM609224	*	 	WD40 REPEAT PROTEIN INTERACTING WITH PHOSPHOINOSITIDES 1; WIPI1	55062
MIM609225	*	 	WD40 REPEAT PROTEIN INTERACTING WITH PHOSPHOINOSITIDES 2	26100
MIM609226	*	 	WD REPEAT-CONTAINING PROTEIN 45-LIKE; WDR45L	56270
MIM609227	#	2q37	GRISCELLI SYNDROME, TYPE 3; GS3	79083
MIM609228	*	 	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 3; NUDT3	11165
MIM609229	*	 	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 4; NUDT4	11163
MIM609230	*	 	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 5; NUDT5	11164
MIM609231	*	 	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 7; NUDT7	283927
MIM609232	*	 	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 12; NUDT12	83594
MIM609233	*	 	NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 13; NUDT13	25961
MIM609234	*	3q25.1	EUKARYOTIC TRANSLATION INITIATION FACTOR 2A; EIF2A	83939
MIM609235	*	19q13.4	BR SERINE/THREONINE KINASE 1; BRSK1	84446
MIM609236	*	 	BR SERINE/THREONINE KINASE 2; BRSK2	9024
MIM609237	*	3q21.1	IQ MOTIF-CONTAINING PROTEIN B1; IQCB1	9657
MIM609238	*	 	RAB GTPase-ACTIVATING PROTEIN 1-LIKE; RABGAP1L	9910
MIM609239	*	13q14.12-q14.2	LYSOPHOSPHATIDIC ACID RECEPTOR 6; LPAR6	10161
MIM609240	*	 	GERM CELL-SPECIFIC GENE 2; GSG2	83903
MIM609241	#	22q11	SCHINDLER DISEASE, TYPE I	4668
MIM609242	#	22q11	KANZAKI DISEASE	4668
MIM609243	*	 	RETINOIC ACID EARLY TRANSCRIPT 1E; RAET1E	135250
MIM609244	*	 	RETINOIC ACID EARLY TRANSCRIPT 1G; RAET1G	353091
MIM609245	*	1p13.1	G PROTEIN SIGNALING MODULATOR 2; GPSM2	29899
MIM609246	*	 	PYRIDOXAL PHOSPHATASE; PDXP	57026
MIM609247	*	 	RING FINGER PROTEIN 13; RNF13	11342
MIM609248	*	 	HECT DOMAIN AND RCC1-LIKE DOMAIN 4; HERC4	26091
MIM609249	*	 	HECT DOMAIN AND RCC1-LIKE DOMAIN 6; HERC6	55008
MIM609251	*	 	Fc RECEPTOR-LIKE PROTEIN B; FCRLB	127943
MIM609252	*	21q11.2	LIPASE I; LIPI	149998
MIM609253	%	18p11.2	FEBRILE SEIZURES, FAMILIAL, 6; FEB6	619397
MIM609254	#	3q21.1	SENIOR-LOKEN SYNDROME 5; SLSN5	9657
MIM609255	%	6q22-q24	FEBRILE SEIZURES, FAMILIAL, 5; FEB5	619398
MIM609256	%	11p13	MYOPIA 7; MYP7	553190
MIM609257	%	3q26	MYOPIA 8; MYP8	553192
MIM609258	%	4q12	MYOPIA 9; MYP9	553194
MIM609259	%	8p23	MYOPIA 10; MYP10	553195
MIM609260	#	1p36.2	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	9927
MIM609261	%	12q24.1	STUTTERING, FAMILIAL PERSISTENT, 2; STUT2	100049543
MIM609262	*	3p26.2	CEREBLON; CRBN	51185
MIM609263	*	18p11.21	SEH1-LIKE PROTEIN; SEH1L	81929
MIM609264	*	12q23.2	NUCLEOPORIN, 37-KD; NUP37	79023
MIM609265	#	22q12.1	LI-FRAUMENI SYNDROME 2; LFS2	11200
MIM609266	%	1q23	LI-FRAUMENI SYNDROME 3; LFS3	553989
MIM609267	*	3q13	MELANOMA ANTIGEN, FAMILY F, 1; MAGEF1	64110
MIM609268	*	5q11.2-q12.1	SPLICING FACTOR, ARGININE/SERINE-RICH, 12; SFRS12	140890
MIM609269	*	6p22.2	KIAA0319 GENE; KIAA0319	9856
MIM609270	#	11p15	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7; SCAR7	727719
MIM609271	%	2p24	KERATOCONUS 4; KTCN4	550624
MIM609272	*	16p13.3	TRYPTASE, DELTA-1; TPSD1	23430
MIM609273	#	15q22.31, 15q15-q25	NEMALINE MYOPATHY 6; NEM6	390594
MIM609274	*	 	NASCENT POLYPEPTIDE-ASSOCIATED COMPLEX, ALPHA POLYPEPTIDE, 2	342538
MIM609275	*	1q41	RAB3 GTPase-ACTIVATING PROTEIN, NONCATALYTIC SUBUNIT; RAB3GAP2	25782
MIM609276	*	11q25	NON-SMC CONDENSIN II COMPLEX SUBUNIT D3; NCAPD3	23310
MIM609277	*	 	MOLYBDENUM COFACTOR SYNTHESIS 3; MOCS3	27304
MIM609278	*	 	IZUMO SPERM-EGG FUSION PROTEIN 1; IZUMO1	284359
MIM609279	*	13q12.2	CENTROMERIC PROTEIN J; CENPJ	55835
MIM609280	*	 	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 4; EIF2AK4	440275
MIM609281	*	 	MOB1-LIKE PROTEIN 1B; MOBKL1B	55233
MIM609282	*	 	MOB1-LIKE PROTEIN 1A; MOBKL1A	92597
MIM609283	#	4q35	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 2; PEOA2	291
MIM609284	#	1q22-q23	NEMALINE MYOPATHY 1; NEM1	7170
MIM609285	#	9p13.2-p13.1	NEMALINE MYOPATHY 4; NEM4	7169
MIM609286	#	10q24	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 3; PEOA3	56652
MIM609287	*	 	SH3 DOMAIN, GRB2-LIKE, ENDOPHILIN B1; SH3GLB1	51100
MIM609288	*	 	SH3 DOMAIN, GRB2-LIKE, ENDOPHILIN B2; SH3GLB2	56904
MIM609290	*	 	ADENYLATE KINASE 3; AK3	50808
MIM609291	*	15q13.2	SPROUTY-RELATED EVH1 DOMAIN-CONTAINING PROTEIN 1; SPRED1	161742
MIM609292	*	2p14	SPROUTY-RELATED EVH1 DOMAIN-CONTAINING PROTEIN 2; SPRED2	200734
MIM609293	*	19q13.13	SPROUTY-RELATED EVH1 DOMAIN-CONTAINING PROTEIN 3; SPRED3	399473
MIM609294	*	 	SEMAPHORIN 6C; SEMA6C	10500
MIM609295	*	 	SEMAPHORIN 6D; SEMA6D	80031
MIM609297	*	5p15.2	SEMAPHORIN 5A; SEMA5A	9037
MIM609298	*	 	SEMAPHORIN 5B; SEMA5B	54437
MIM609299	%	3p26	PROSTATE CANCER, HEREDITARY, 5	619402
MIM609300	*	10q24.3	CYTOCHROME P450, FAMILY 17, SUBFAMILY A, POLYPEPTIDE 1; CYP17A1	1586
MIM609301	*	 	p53 EFFECTOR RELATED TO PMP22; PERP	64065
MIM609302	*	11p15.5	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, GLUTAMATE), MEMBER 22; SLC25A22	79751
MIM609303	*	22q11.2	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, GLUTAMATE), MEMBER 18; SLC25A18	83733
MIM609304	#	11p15.5	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	79751
MIM609305	*	3q25.3	LATEXIN; LXN	56925
MIM609306	#	19p13.3	SPINOCEREBELLAR ATAXIA 26; SCA26	408221
MIM609307	#	13q34	SPINOCEREBELLAR ATAXIA 27; SCA27	2259
MIM609308	#	9q34.1	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1	10585
MIM609309	*	2p22-p21	MutS, E. COLI, HOMOLOG OF, 2; MSH2	4436
MIM609310	#	3p21.3	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2; HNPCC2	4292
MIM609311	#	12p11.2	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	121512
MIM609312	*	9q34	DOPAMINE BETA-HYDROXYLASE, PLASMA; DBH	1621
MIM609313	#	7q22	ERYTHROKERATODERMIA VARIABILIS 3	574017
MIM609314	*	21q22.3	TESTIS-SPECIFIC PROTEIN 2; TSGA2	89765
MIM609315	*	5q35.3	TRIPARTITE MOTIF-CONTAINING PROTEIN 7; TRIM7	81786
MIM609316	*	6p23-p21	TRIPARTITE MOTIF-CONTAINING PROTEIN 31; TRIM31	11074
MIM609317	*	5q22.3	TRIPARTITE MOTIF-CONTAINING PROTEIN 36; TRIM36	55521
MIM609318	*	1p22	TRIPARTITE MOTIF-CONTAINING PROTEIN 45; TRIM45	80263
MIM609319	%	6q23	HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1; HCHGQ1	100381204
MIM609320	%	9q	HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2; HCHGQ2	100381205
MIM609321	*	1p21.2	SAS6, C. ELEGANS, HOMOLOG OF; SASS6	163786
MIM609322	#	22q11	RHABDOID TUMOR PREDISPOSITION SYNDROME 1; RTPS1	6598
MIM609323	*	6q23.3	OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 3; OLIG3	167826
MIM609326	*	 	MICRO RNA 1-1; MIRN1-1	406904
MIM609327	*	8p23.1	MICRO RNA 124-1; MIR124-1	406907
MIM609328	*	9q34.2	URIDINE/CYTIDINE KINASE 1; UCK1	83549
MIM609329	*	1q22-q23.2	URIDINE/CYTIDINE KINASE 2; UCK2	7371
MIM609330	*	10q21.3	ONCOPROTEIN-INDUCED TRANSCRIPT 3, MOUSE, HOMOLOG OF; OIT3	170392
MIM609331	*	20q13	BASIC HELIX-LOOP-HELIX FAMILY, MEMBER E23; BHLHE23	128408
MIM609332	*	2p21	TETRATRICOPEPTIDE REPEAT DOMAIN 7A; TTC7A	57217
MIM609333	*	6q23.1	TRACE AMINE-ASSOCIATED RECEPTOR 1; TAAR1	134864
MIM609334	#	18q22	CHROMOSOME 18 PERICENTRIC INVERSION	100240739
MIM609335	*	 	CHROMOSOME 1 OPEN READING FRAME 27; C1ORF27	54953
MIM609336	*	19p13.2	ANGIOPOIETIN-LIKE 6; ANGPTL6	83854
MIM609337	*	21q21.3	MICRO RNA 155; MIRN155	406947
MIM609338	#	3p25	CAROTID INTIMAL MEDIAL THICKNESS 1	5468
MIM609340	#	14q21.3-q22.3	SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE; SPG28	548316
MIM609341	*	16p13.3	TRYPTASE, GAMMA-1; TPSG1	25823
MIM609342	*	11q13	GASTRIC INTRINSIC FACTOR; GIF	2694
MIM609343	*	16p13.3	PROTEASE, SERINE, 22; PRSS22	64063
MIM609344	*	7q32.3	KIELIN/CHORDIN-LIKE PROTEIN	375616
MIM609346	*	19p13.3	RECEPTOR EXPRESSION-ENHANCING PROTEIN 6; REEP6	92840
MIM609347	*	5q31	RECEPTOR EXPRESSION-ENHANCING PROTEIN 2; REEP2	51308
MIM609348	*	10q21.3	RECEPTOR EXPRESSION-ENHANCING PROTEIN 3; REEP3	221035
MIM609349	*	8p21.3	RECEPTOR EXPRESSION-ENHANCING PROTEIN 4; REEP4	80346
MIM609350	*	3q27	RECEPTOR-TRANSPORTING PROTEIN 4; RTP4	64108
MIM609351	*	13q14.3	ADP-RIBOSYLATION FACTOR-LIKE 11; ARL11	115761
MIM609352	#	12q13	EPIDERMOLYSIS BULLOSA SIMPLEX WITH MIGRATORY CIRCINATE ERYTHEMA	3852
MIM609353	*	8p21.1	ESTABLISHMENT OF COHESION 1, S. CEREVISIAE, HOMOLOG OF, 2; ESCO2	157570
MIM609354	%	11q23	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 5; BMND5	554315
MIM609355	*	9q31.3	MICRO RNA 32; MIRN32	407036
MIM609356	*	17q11.2	NUCLEAR FRAGILE X MENTAL RETARDATION PROTEIN-INTERACTING PROTEIN 2; NUFIP2	57532
MIM609357	*	10p13	MINICHROMOSOME MAINTENANCE 10, S. CEREVISIAE, HOMOLOG OF; MCM10	55388
MIM609358	*	19q13.1	ETS VARIANT GENE 2; ETV2	2116
MIM609359	*	2p24.1	HS1-BINDING PROTEIN 3; HS1BP3	64342
MIM609360	*	10q23.33	RENALASE; RNLS	55328
MIM609361	*	2q33.1	MOB1-LIKE PROTEIN 3; MOBKL3	25843
MIM609362	*	16q22.1	LYSOPHOSPHOLIPASE 3; LYPLA3	23659
MIM609364	*	19q13.4	NLR FAMILY, PYRIN DOMAIN-CONTAINING 2; NLRP2	55655
MIM609365	*	1p34.3	GUANINE NUCLEOTIDE-BINDING PROTEIN-LIKE 2; GNL2	29889
MIM609366	*	11p15.3	SH2 DOMAIN-BINDING PROTEIN 1; SH2BP1	9646
MIM609367	*	10q22.1	KIAA1279 GENE; KIAA1279	26128
MIM609368	*	2p22.3	ATLASTIN GTPase 2; ATL2	64225
MIM609369	*	11q13.1	ATLASTIN GTPase 3; ATL3	25923
MIM609370	*	20p13	SERINE/THREONINE KINASE 35; STK35	140901
MIM609371	*	 	CHROMOSOME 5 OPEN READING FRAME 5; C5ORF5	51306
MIM609372	*	 	FAMILY WITH SEQUENCE SIMILARITY 53, MEMBER C; FAM53C	51307
MIM609373	*	 	LYSINE-SPECIFIC DEMETHYLASE 3B; KDM3B	51780
MIM609374	*	11q12.1	CELL DIVISION CYCLE-ASSOCIATED PROTEIN 5; CDCA5	113130
MIM609375	*	 	LIN9, C. ELEGANS, HOMOLOG OF; LIN9	286826
MIM609376	%	19q13	CATARACT, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE 1; CATCN1	619404
MIM609377	*	16q22.1	ACD, MOUSE, HOMOLOG OF; ACD	65057
MIM609378	%	17q11	AUTISM, SUSCEPTIBILITY TO, 6; AUTS6	554314
MIM609379	*	9q34	LIPOCALIN 6; LCN6	158062
MIM609380	*	 	LEISHMANOLYSIN-LIKE; LMLN	89782
MIM609381	*	3q13.3	SYNTAXIN-BINDING PROTEIN 5-LIKE; STXBP5L	9515
MIM609382	*	 	IMMEDIATE-EARLY RESPONSE 3-INTERACTING PROTEIN 1; IER3IP1	51124
MIM609383	*	5q33	NIPA-LIKE DOMAIN-CONTAINING 4; NIPAL4	348938
MIM609385	*	5q31.3	DEAD END, ZEBRAFISH, HOMOLOG OF, 1; DND1	373863
MIM609386	*	9q21.11	STRUCTURAL MAINTENANCE OF CHROMOSOMES 5; SMC5	23137
MIM609387	*	2p24.2	STRUCTURAL MAINTENANCE OF CHROMOSOMES 6; SMC6	79677
MIM609388	*	 	DORA REVERSE STRAND	51108
MIM609389	*	 	INOSITOL POLYPHOSPHATE 5-PHOSPHATASE F; INPP5F	22876
MIM609390	*	6q21	FIG4, S. CEREVISIAE, HOMOLOG OF; FIG4	9896
MIM609391	*	 	TRANSCRIPTION FACTOR Sp5; SP5	389058
MIM609392	*	 	KRUPPEL-LIKE FACTOR 3; KLF3	51274
MIM609393	*	 	KRUPPEL-LIKE FACTOR 14; KLF14	136259
MIM609394	*	 	SPINDLE POLE BODY COMPONENT 24, S. CEREVISIAE, HOMOLOG OF; SPBC24	147841
MIM609395	*	 	SPINDLE POLE BODY COMPONENT 25, S. CEREVISIAE, HOMOLOG OF; SPBC25	57405
MIM609396	*	 	PH DOMAIN AND LEUCINE-RICH REPEAT PROTEIN PHOSPHATASE; PHLPP	23239
MIM609397	*	10q22.1	STORKHEAD BOX 1; STOX1	219736
MIM609398	*	 	ATPase, H+ TRANSPORTING, LYSOSOMAL, 34-KD, V1 SUBUNIT D; ATP6V1D	51382
MIM609399	*	15q22	SPERM EQUATORIAL SEGMENT PROTEIN 1; SPESP1	246777
MIM609400	%	4q13-q21	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 4; AIS4	619405
MIM609401	*	13q32-q33	HEPARAN SULFATE 6-O-SULFOTRANSFERASE 3; HS6ST3	266722
MIM609402	%	2p25	PREECLAMPSIA/ECLAMPSIA 2; PEE2	780908
MIM609403	%	9p13	PREECLAMPSIA/ECLAMPSIA 3; PEE3	780909
MIM609404	#	 	PREECLAMPSIA/ECLAMPSIA 4; PEE4	219736
MIM609405	*	22q13.31	RHO GTPase-ACTIVATING PROTEIN 8; ARHGAP8	23779
MIM609406	*	22q13.31	PROLINE-RICH PROTEIN 5; PRR5	55615
MIM609407	*	6q22.31	HEPARAN SULFATE 3-O-SULFOTRANSFERASE 5; HS3ST5	222537
MIM609408	%	14q13	HOLOPROSENCEPHALY 8; HPE8	619406
MIM609409	*	5q31	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A0; HNRNPA0	10949
MIM609410	*	6q25.3	SYNAPTOJANIN 2; SYNJ2	8871
MIM609411	*	14q24.2	SYNAPTOJANIN 2-BINDING PROTEIN; SYNJ2BP	55333
MIM609412	*	5q12	EXCISION-REPAIR CROSS-COMPLEMENTING, GROUP 8; ERCC8	1161
MIM609413	*	10q11	EXCISION-REPAIR CROSS-COMPLEMENTING, GROUP 6; ERCC6	2074
MIM609414	*	2q35	PHOSPHOINOSITIDE KINASE, FYVE FINGER-CONTAINING; PIKFYVE	200576
MIM609415	*	13q31.3	MICRO RNA 17 HOST GENE; MIR17HG	407975
MIM609416	*	13q31.3	MICRO RNA 17; MIR17	406952
MIM609417	*	13q31.3	MICRO RNA 18A; MIRN18A	406953
MIM609418	*	13q31.3	MICRO RNA 19A; MIRN19A	406979
MIM609419	*	13q31.3	MICRO RNA 19B1; MIR19B1	406980
MIM609420	*	13q31.3	MICRO RNA 20A; MIR20A	406982
MIM609422	*	13q31.3	MICRO RNA 92A1; MIR92A1	407048
MIM609423	#	17q21.1-q21.2, 17q12, 17q11.2-q12, 17q11.2, 16p12.1-p11.2, 12q14, 10q11.1, 6p21.3, 3pter-p21, 2q35, 19q13.4, 19p13.3	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO	1234, 1524, 30835, 3107, 3458, 3566, 3577, 3586, 3811, 6347, 6348, 6349, 6356, 6387
MIM609424	*	1q25.1	RING FINGER AND CCCH-TYPE ZINC FINGER DOMAINS-CONTAINING 1; RC3H1	149041
MIM609425	#	3q29	CHROMOSOME 3q29 DELETION SYNDROME	100188788
MIM609426	*	17p13.1	MISSHAPEN/NIK-RELATED KINASE 1; MINK1	50488
MIM609427	*	6p21.3	LHFP-LIKE PROTEIN 5; LHFPL5	222662
MIM609428	%	21q22	TUKEL SYNDROME	574049
MIM609429	*	12q24.1	FORKHEAD BOX N4; FOXN4	121643
MIM609430	*	14q13	NEURONAL PAS DOMAIN PROTEIN 3; NPAS3	64067
MIM609431	*	14q13.3	MAP3K12-BINDING INHIBITORY PROTEIN; MBIP	51562
MIM609432	%	 	SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION; MSSD	619407
MIM609433	*	5q35	UBIQUITIN INTERACTION MOTIF-CONTAINING PROTEIN 1; UIMC1	51720
MIM609434	*	17q21.3	LUC7, S. CEREVISIAE, HOMOLOG OF, 3; LUC7L3	51747
MIM609435	*	19p13.2-p13.1	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 13; NDUFA13	51079
MIM609436	*	19q13	FIBROBLAST GROWTH FACTOR 21; FGF21	26291
MIM609437	*	1p34.3	SERINE/THREONINE PROTEIN KINASE 40; STK40	83931
MIM609439	#	 	DEAFNESS, AUTOSOMAL RECESSIVE 48; DFNB48	10518, 404086
MIM609440	*	1p34.3	UTP11-LIKE PROTEIN; UTP11L	51118
MIM609441	#	4q23-q24	CHONDRODYSPLASIA, ACROMESOMELIC, WITH GENITAL ANOMALIES	658
MIM609443	*	1p36.2	CHYMOTRYPSIN-LIKE ELASTASE FAMILY, MEMBER 2A; CELA2A	63036
MIM609444	*	1p36.2	CHYMOTRYPSIN-LIKE ELASTASE FAMILY, MEMBER 2B; CELA2B	51032
MIM609445	*	5p15.1-p14	RELAXIN 3 RECEPTOR 1; RLN3R1	51289
MIM609446	#	10q22.3	GENERALIZED EPILEPSY AND PAROXYSMAL DYSKINESIA; GEPD	3778
MIM609447	*	5q31.2	PROAPOPTOTIC CASPASE ADAPTOR PROTEIN	51237
MIM609448	*	1p32.3	THIOREDOXIN DOMAIN-CONTAINING PROTEIN 12; TXNDC12	51060
MIM609449	*	16p13.1	NUDE, A. NIDULANS, HOMOLOG OF, 1; NDE1	54820
MIM609450	*	5q35.3	MAX DIMERIZATION PROTEIN 3; MXD3	83463
MIM609451	*	16q22.1	ZINC FINGER PROTEIN 90, MOUSE, HOMOLOG OF; ZFP90	146198
MIM609452	#	10q22.2-q23.3	MYOPATHY, MYOFIBRILLAR, 4; MFM4	11155
MIM609453	*	 	GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 7; GOLGA7	51125
MIM609454	%	1q31.1	SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	619408
MIM609455	*	 	PROLINE-, GLUTAMIC ACID-, AND LEUCINE-RICH PROTEIN 1	27043
MIM609456	%	 	MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	619409
MIM609457	*	12q22-q23	HISTIDINE AMMONIA-LYASE; HAL	3034
MIM609458	*	19cen-q12	MANNOSIDASE, ALPHA, CLASS 2B, MEMBER 1; MAN2B1	4125
MIM609459	*	22q11	DIGEORGE SYNDROME CRITICAL REGION GENE 6-LIKE; DGCR6L	85359
MIM609460	#	10q22.1	GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	26128
MIM609461	*	 	TRIBBLES, DROSOPHILA, HOMOLOG OF, 1; TRIB1	10221
MIM609462	*	 	TRIBBLES, DROSOPHILA, HOMOLOG OF, 2; TRIB2	28951
MIM609463	*	 	MKL1/MYOCARDIN-LIKE 2; MKL2	57496
MIM609464	#	16q12	SARCOIDOSIS, EARLY-ONSET	64127
MIM609467	*	 	CHEMOKINE, CC MOTIF, LIGAND 3-LIKE 2; CCL3L2	390788
MIM609468	*	 	CHEMOKINE, CC MOTIF, LIGAND 3-LIKE 3; CCL3L3	414062
MIM609469	%	11q24	NEPHROPATHY, PROGRESSIVE, WITH DEAFNESS	619410
MIM609470	%	11p15	LEFT VENTRICULAR NONCOMPACTION 2; LVNC2	619411
MIM609471	*	 	GLUCOSIDASE, BETA, ACID 2; GBA2	57704
MIM609472	*	 	CYCLIC NUCLEOTIDE-GATED CHANNEL, ALPHA-4; CNGA4	1262
MIM609473	*	 	CINGULIN, XENOPUS, HOMOLOG OF; CGN	57530
MIM609474	*	 	NEURONAL PENTRAXIN RECEPTOR; NPTXR	23467
MIM609475	*	 	A-KINASE ANCHOR PROTEIN 8-LIKE PROTEIN; AKAP8L	26993
MIM609476	*	 	NEMO-LIKE KINASE; NLK	51701
MIM609477	*	 	CHROMOSOME 11 OPEN READING FRAME 75; C11ORF75	56935
MIM609478	*	 	ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 3; ST8SIA3	51046
MIM609479	*	2q24.2	LEUCINE ZIPPER- AND STERILE ALPHA MOTIF-CONTAINING KINASE	51776
MIM609481	*	 	ISL2 TRANSCRIPTION FACTOR, LIM/HOMEODOMAIN; ISL2	64843
MIM609482	*	7p21.3	ANTERIOR GRADIENT 3, XENOPUS, HOMOLOG OF; AGR3	155465
MIM609483	*	8q24.21	FAMILY WITH SEQUENCE SIMILARITY 84, MEMBER B; FAM84B	157638
MIM609484	*	19q13.1-q13.2	LY6/PLAUR DOMAIN-CONTAINING PROTEIN 3; LYPD3	27076
MIM609485	*	 	MODULATOR OF APOPTOSIS 1; MOAP1	64112
MIM609486	*	 	E2F-ASSOCIATED PHOSPHOPROTEIN	55837
MIM609487	*	 	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 2; MAP3K2	10746
MIM609488	*	4q35.1	CANCER/TESTIS ANTIGEN KM-HN-1	256309
MIM609489	*	4q22-q25	MANNOSIDASE, BETA A, LYSOSOMAL; MANBA	4126
MIM609490	*	11q22	INHIBITORY CASPASE RECRUITMENT DOMAIN PROTEIN	440068
MIM609491	*	 	G PROTEIN SIGNALING MODULATOR 1; GPSM1	26086
MIM609492	*	 	RAS ASSOCIATION DOMAIN FAMILY PROTEIN 2; RASSF2	9770
MIM609493	*	 	SLC2A4 REGULATOR; SLC2A4RG	56731
MIM609494	*	 	ZINC FINGER PROTEIN 395; ZNF395	55893
MIM609495	*	 	GAMETOGENETIN-BINDING PROTEIN 1; GGNBP1	449520
MIM609497	*	5q15	LEUKOCYTE-DERIVED ARGININE AMINOPEPTIDASE	64167
MIM609498	*	17q12	F-BOX ONLY PROTEIN 47	494188
MIM609499	*	 	MCF2-LIKE PROTEIN; MCF2L	23263
MIM609501	*	 	TUDOR AND KH DOMAINS-CONTAINING PROTEIN; TDRKH	11022
MIM609502	*	10q23.1	CADHERIN-RELATED FAMILY, MEMBER 1; CDHR1	92211
MIM609503	*	 	TESTICULAR HAPLOID EXPRESSED GENE, MOUSE, HOMOLOG OF; THEG	51298
MIM609504	*	 	MICROSPHERULE PROTEIN 1; MCRS1	10445
MIM609505	*	 	TRIPARTITE MOTIF-CONTAINING PROTEIN 16; TRIM16	10626
MIM609506	*	12q13.1-q13.3	CYTOCHROME P450, SUBFAMILY XXVIIB, POLYPEPTIDE 1; CYP27B1	1594
MIM609507	*	9p21	TOPOISOMERASE I-BINDING ARGININE/SERINE-RICH PROTEIN; TOPORS	10210
MIM609508	#	 	STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR	1280
MIM609509	*	 	INTERLEUKIN 31; IL31	386653
MIM609510	*	5q11.2	INTERLEUKIN 31 RECEPTOR A; IL31RA	133396
MIM609511	*	 	ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 20; ZFYVE20	64145
MIM609512	*	3p11.2	CHMP FAMILY, MEMBER 2B; CHMP2B	25978
MIM609513	*	10q26.2	NEUROPEPTIDE S	594857
MIM609514	*	 	TAUBE NUSS, MOUSE, HOMOLOG OF; TBN	129685
MIM609516	*	 	ZINC FINGER PROTEIN 382; ZNF382	84911
MIM609517	*	17q11.2	TGFB1-INDUCED ANTIAPOPTOTIC FACTOR 1; TIAF1	9220
MIM609518	*	 	THAP DOMAIN-CONTAINING PROTEIN 7; THAP7	80764
MIM609519	*	 	TCF3 FUSION PARTNER; TFPT	29844
MIM609520	*	8p11.21	THAP DOMAIN-CONTAINING PROTEIN 1; THAP1	55145
MIM609521	*	1q32.3	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 1; SLC30A1	7779
MIM609522	*	 	TRANSCRIPTION ELONGATION FACTOR B, POLYPEPTIDE 3B; TCEB3B	51224
MIM609523	*	17p11.2	ALDEHYDE DEHYDROGENASE, FAMILY 3, SUBFAMILY A, MEMBER 2; ALDH3A2	224
MIM609524	#	7q32	MYOPATHY, MYOFIBRILLAR, 5; MFM5	2318
MIM609525	*	 	TENSION-INDUCED/INHIBITED PROTEIN	79828
MIM609526	*	16q22.1	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY G, MEMBER 4; PLEKHG4	25894
MIM609527	*	 	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 5; RAPGEF5	9771
MIM609528	#	22q11.2	CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMA SYNDROME	9342
MIM609529	#	17p11.2	IMMUNOGLOBULIN A DEFICIENCY 2; IGAD2	23495
MIM609530	*	 	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; RAPGEF2	9693
MIM609531	*	 	RAS GUANYL NUCLEOTIDE-RELEASING PROTEIN 3; RASGRP3	25780
MIM609532	#	12q14, 3p21, 19q13.13, 1q31-q32	HEPATITIS C VIRUS, SUSCEPTIBILITY TO	1234, 282617, 3458, 5788
MIM609533	#	10q21-q22	DEAFNESS, AUTOSOMAL RECESSIVE 23; DFNB23	65217
MIM609534	*	 	CHROMOSOME 17 OPEN READING FRAME 41; C17ORF41	79915
MIM609535	#	10q24.1-q24.3	DRUG METABOLISM, POOR, CYP2C19-RELATED	1557
MIM609536	#	9q34.1	COMPLEMENT COMPONENT 5 DEFICIENCY; C5D	727
MIM609538	*	 	PROTEIN-TYROSINE PHOSPHATASE, MITOCHONDRIAL, 1; PTPMT1	114971
MIM609539	*	 	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 2; ARID2	196528
MIM609540	*	 	WD REPEAT-CONTAINING PROTEIN 61; WDR61	80349
MIM609541	%	11q13	SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	619394
MIM609542	*	 	ATPase, CLASS I, TYPE 8A, MEMBER 1; ATP8A1	10396
MIM609543	*	 	BEYLA GENE	497634
MIM609544	*	16p12.3	CENTROSOMAL PROTEIN, 110-KD	9738
MIM609546	*	 	UBIQUITIN-SPECIFIC PROTEASE 29; USP29	57663
MIM609548	*	 	LMAN1-LIKE PROTEIN; LMAN1L	79748
MIM609549	#	 	NANOPHTHALMOS 2; NNO2	83552
MIM609550	*	4q31.1-q31.2	ZINC FINGER PROTEIN 330; ZNF330	27309
MIM609551	*	 	LECTIN, MANNOSE-BINDING, 2; LMAN2	10960
MIM609552	*	 	LMAN2-LIKE PROTEIN; LMAN2L	81562
MIM609553	*	19p13	RETBINDIN	83546
MIM609554	*	2q37	INTEGRAL MEMBRANE PROTEIN 2C; ITM2C	81618
MIM609555	*	 	CARBOXYPEPTIDASE X, M14 FAMILY; CPXM	56265
MIM609556	*	 	ATPase, TYPE 13A4; ATP13A4	84239
MIM609557	*	2p21	PROLYL ENDOPEPTIDASE-LIKE; PREPL	9581
MIM609558	%	22q12.3	PROSTATE CANCER, HEREDITARY, 6	100188789
MIM609559	*	 	CHROMOSOME 2 OPEN READING FRAME 34; C2ORF34	79823
MIM609560	#	16q22	MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE); MTDPS2	7084
MIM609561	*	 	CARBOXYPEPTIDASE A5; CPA5	93979
MIM609562	*	 	CARBOXYPEPTIDASE A6; CPA6	57094
MIM609563	*	 	CARBOXYPEPTIDASE O; CPO	130749
MIM609564	*	 	POLY(ADP-RIBOSE) POLYMERASE 10; PARP10	84875
MIM609565	*	 	MAST CELL-EXPRESSED MEMBRANE PROTEIN 1	199675
MIM609566	%	 	PARIETAL FORAMINA 3; PFM3	619475
MIM609567	*	22q13	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 3; PNPLA3	80339
MIM609568	*	 	RHO GTPase-ACTIVATING PROTEIN 20; ARHGAP20	57569
MIM609569	^	 	MOVED TO 132100	 
MIM609570	%	5q21	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 8	100188790
MIM609571	*	 	ZINC FINGER PROTEIN 699; ZNF699	374879
MIM609572	%	13q31.3	PHOTOPAROXYSMAL RESPONSE 2; PPR2	780910
MIM609573	%	7q32	PHOTOPAROXYSMAL RESPONSE 3; PPR3	619471
MIM609574	*	 	17-@BETA-HYDROXYSTEROID DEHYDROGENASE XII; HSD17B12	51144
MIM609575	*	17p13	ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN; ACADVL	37
MIM609576	*	2q34-q35	ACYL-CoA DEHYDROGENASE, LONG-CHAIN; ACADL	33
MIM609577	*	6p21.1	CULLIN 7; CUL7	9820
MIM609578	%	10q23.3	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 2; RCM2	619468
MIM609579	#	 	SCAPHOCEPHALY, MAXILLARY RETRUSION, AND MENTAL RETARDATION	2263
MIM609580	*	 	NINEIN-LIKE PROTEIN; NINL	22981
MIM609582	*	18q21	MICRO RNA 122A; MIRN122A	406906
MIM609583	#	2q13	JOUBERT SYNDROME 4; JBTS4	4867
MIM609584	*	14q22.1	L-2-HYDROXYGLUTARATE DEHYDROGENASE; L2HGDH	79944
MIM609585	*	 	COMPLEXIN 3; CPLX3	594855
MIM609586	*	 	COMPLEXIN 4; CPLX4	339302
MIM609587	*	 	REGULATOR OF CHROMOSOME CONDENSATION 2; RCC2	55920
MIM609588	*	14q32	GLUTAREDOXIN 5; GLRX5	51218
MIM609589	*	 	MITOCHONDRIAL TUMOR SUPPRESSOR GENE 1; MTUS1	57509
MIM609590	*	 	QUAKING, MOUSE, HOMOLOG OF; QKI	9444
MIM609591	*	 	RIC-LIKE PROTEIN WITHOUT CAAX MOTIF 1; RIT1	6016
MIM609592	*	 	RIC-LIKE PROTEIN WITHOUT CAAX MOTIF 2; RIT2	6014
MIM609593	*	6p22.2	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 16A; LRRC16A	55604
MIM609594	*	3q24-q25	VENTRICULAR ZONE-EXPRESSED PH DOMAIN-CONTAINING PROTEIN, ZEBRAFISH, HOMOLOG OF, 1; VEPH1	79674
MIM609595	*	1p34.3	R-SPONDIN FAMILY, MEMBER 1; RSPO1	284654
MIM609596	*	19q13.2	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT K; EIF3K	27335
MIM609597	#	11p11.2	PARIETAL FORAMINA 2; PFM2	60529
MIM609598	*	20q12	ZINC FINGER AND HOMEODOMAIN PROTEIN 3; ZHX3	23051
MIM609599	*	 	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 1; ANKRD1	27063
MIM609600	*	18q12	ZINC FINGER PROTEIN 396; ZNF396	252884
MIM609601	*	18q12	ZINC FINGER PROTEIN 397; ZNF397	84307
MIM609602	*	1p34.1	ZINC FINGER PROTEIN 393; ZNF393	128209
MIM609603	*	 	CRYSTALLIN, GAMMA-N; CRYGN	155051
MIM609604	*	 	MICROTUBULE-ASSOCIATED PROTEIN 1, LIGHT CHAIN 3, BETA; MAP1LC3B	81631
MIM609605	*	 	MICROTUBULE-ASSOCIATED PROTEIN 1, LIGHT CHAIN 3, GAMMA; MAP1LC3C	440738
MIM609606	*	 	AUTOPHAGY 3, S. CEREVISIAE, HOMOLOG OF; ATG3	64422
MIM609607	*	1q23.3	POLIOVIRUS RECEPTOR-LIKE 4; PVRL4	81607
MIM609608	*	 	AUTOPHAGY 12, S. CEREVISIAE, HOMOLOG OF; ATG12	9140
MIM609610	*	15q15	TUBULIN-GAMMA COMPLEX-ASSOCIATED PROTEIN 4; TUBGCP4	27229
MIM609611	*	1q22	ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER E; ANP32E	81611
MIM609613	*	 	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY M, MEMBER 2; PLEKHM2	23207
MIM609614	*	19p13.3	RNA EXONUCLEASE 1, S. CEREVISIAE, HOMOLOG OF; REXO1	57455
MIM609615	*	19p13.2	QUEUINE tRNA-RIBOSYLTRANSFERASE 1; QTRT1	81890
MIM609617	*	1p36.11	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 2; SLC30A2	7780
MIM609618	*	 	NONCODING REPRESSOR OF NFAT; NRON	641373
MIM609619	*	15q14	GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 8B; GOLGA8B	440270
MIM609620	#	7q35-q36	SHORT QT SYNDROME 1; SQT1	3757
MIM609621	#	11p15.5	SHORT QT SYNDROME 2; SQT2	3784
MIM609622	#	17q23.1-q24.2	SHORT QT SYNDROME 3; SQT3	3759
MIM609623	*	19q13.33	RAS-INTERACTING PROTEIN 1; RASIP1	54922
MIM609624	*	6p21.3	MITOCHONDRIAL COILED-COIL DOMAIN 1; MCCD1	401250
MIM609625	#	10q26	CHROMOSOME 10q26 DELETION SYNDROME	780911
MIM609626	*	6p21	MAM DOMAIN-CONTAINING GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR 1; MDGA1	266727
MIM609627	*	12p13.2	TASTE RECEPTOR, TYPE 2, MEMBER 50; TAS2R50	259296
MIM609628	#	18p	MAJEED SYNDROME	9663
MIM609630	%	11q13.3	LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 1	100188791
MIM609631	*	 	DEAD BOX POLYPEPTIDE 58; DDX58	23586
MIM609632	*	11q13.4-q13.5	GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE DOMAIN-CONTAINING PROTEIN 5; GDPD5	81544
MIM609633	%	21q22.13	MAJOR AFFECTIVE DISORDER 3; MAFD3	100188792
MIM609634	#	2q24	MIGRAINE, FAMILIAL HEMIPLEGIC, 3; FHM3	6323
MIM609635	*	2p24-p23	TRANSCRIPTION FACTOR 23; TCF23	150921
MIM609636	%	7q36	ALZHEIMER DISEASE 10	780912
MIM609637	#	13q32	HOLOPROSENCEPHALY 5; HPE5	7546
MIM609638	#	6p24	EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC	1832
MIM609639	*	16p13.3	HEMOGLOBIN MU	3042
MIM609641	*	11p13	EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT M; EIF3M	10480
MIM609642	*	 	T-CELL ANTIGEN RECEPTOR, GAMMA SUBUNIT, ALTERNATE READING FRAME PROTEIN	445347
MIM609644	*	14q21.3	FANCM GENE; FANCM	57697
MIM609645	*	19q13.4	NLR FAMILY, PYRIN DOMAIN-CONTAINING 4; NLRP4	147945
MIM609646	#	 	DEAFNESS, AUTOSOMAL RECESSIVE 42; DFNB42	286676
MIM609647	%	18p11.32-p11.31	DEAFNESS, AUTOSOMAL RECESSIVE 46; DFNB46	449488
MIM609648	*	19q13.4	NLR FAMILY, PYRIN DOMAIN-CONTAINING 12; NLRP12	91662
MIM609649	%	3p24-p21.2	TRICHILEMMAL CYST 1; TRICY1	94014
MIM609650	*	11p15.5	NLR FAMILY, PYRIN DOMAIN-CONTAINING 6; NLRP6	171389
MIM609651	*	 	GLYCOPROTEIN HORMONE, ALPHA-2; GPHA2	170589
MIM609652	*	 	GLYCOPROTEIN HORMONE, BETA-5; GPHB5	122876
MIM609653	*	5q12.1	NADH DEHYDROGENASE 1 ALPHA SUBCOMPLEX, ASSEMBLY FACTOR 2; NDUFAF2	91942
MIM609656	%	17q23	BONE SIZE QUANTITATIVE TRAIT LOCUS 1	100188793
MIM609657	%	5q	BONE SIZE QUANTITATIVE TRAIT LOCUS 2	100188794
MIM609658	*	19q13	NLR FAMILY, PYRIN DOMAIN-CONTAINING 5; NLRP5	126206
MIM609659	*	19q13.4	NLR FAMILY, PYRIN DOMAIN-CONTAINING 8; NLRP8	126205
MIM609660	*	19q13.4	NLR FAMILY, PYRIN DOMAIN-CONTAINING 13; NLRP13	126204
MIM609661	*	19q13.4	NLR FAMILY, PYRIN DOMAIN-CONTAINING 7; NLRP7	199713
MIM609662	*	11p15	NLR FAMILY, PYRIN DOMAIN-CONTAINING 10; NLRP10	338322
MIM609663	*	19q13.4	NLR FAMILY, PYRIN DOMAIN-CONTAINING 9; NLRP9	338321
MIM609664	*	19q13.4	NLR FAMILY, PYRIN DOMAIN-CONTAINING 11; NLRP11	204801
MIM609665	*	11p15.4	NLR FAMILY, PYRIN DOMAIN-CONTAINING 14; NLRP14	338323
MIM609666	*	12q24.1	TWO-PORE SEGMENT CHANNEL 1; TPCN1	53373
MIM609667	*	6q25.3	T-CELL ACTIVATION GTPase-ACTIVATING PROTEIN; TAGAP	117289
MIM609668	*	12q24.1	PTC7 PROTEIN PHOSPHATASE, S. CEREVISIAE, HOMOLOG OF; PPTC7	160760
MIM609669	*	5q21.3-q22.1	WD REPEAT-CONTAINING PROTEIN 36; WDR36	134430
MIM609670	%	11q24	MIGRAINE WITH AURA, SUSCEPTIBILITY TO, 9	100415943
MIM609671	*	2q14.2	SIX-TRANSMEMBRANE EPITHELIAL ANTIGEN OF PROSTATE 3; STEAP3	55240
MIM609672	*	10q23.33	EXOCYST COMPLEX COMPONENT 6; EXOC6	54536
MIM609673	*	11q22.3	PLATELET-DERIVED GROWTH FACTOR D; PDGFD	80310
MIM609674	*	18q11.2	ESTABLISHMENT OF COHESION 1, S. CEREVISIAE, HOMOLOG OF, 1; ESCO1	114799
MIM609675	*	7p21.2	SCLEROSTIN DOMAIN-CONTAINING PROTEIN 1; SOSTDC1	25928
MIM609676	*	20p13	MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; MAVS	57506
MIM609677	*	12q13	AMPLIFIED IN OSTEOSARCOMA 9	10956
MIM609678	*	13q31	SLIT- AND NTRK-LIKE FAMILY, MEMBER 1; SLITRK1	114798
MIM609679	*	3q26	SLIT- AND NTRK-LIKE FAMILY, MEMBER 3; SLITRK3	22865
MIM609680	*	13q31	SLIT- AND NTRK-LIKE FAMILY, MEMBER 5; SLITRK5	26050
MIM609681	*	13q31	SLIT- AND NTRK-LIKE FAMILY, MEMBER 6; SLITRK6	84189
MIM609682	*	10q25.1	DNA CROSS-LINK REPAIR PROTEIN 1A; DCLRE1A	9937
MIM609683	*	1p13.3-p13.1	DNA CROSS-LINK REPAIR PROTEIN 1B; DCLRE1B	64858
MIM609684	*	 	MAL PROTEOLIPID PROTEIN 2; MAL2	114569
MIM609685	*	7p15	CELL DIVISION CYCLE-ASSOCIATED PROTEIN 7-LIKE; CDCA7L	55536
MIM609686	*	13q32	CITRATE LYASE BETA-LIKE; CLYBL	171425
MIM609687	*	12q13	MICRO RNA 196A2; MIRN196A2	406973
MIM609688	*	7p15-p14.2	MICRO RNA 196B; MIRN196B	442920
MIM609689	*	20q11.2	CENTROSOMAL PROTEIN 2; CEP2	11190
MIM609690	*	2q36	PHENYLALANINE-tRNA SYNTHETASE, BETA SUBUNIT; FARSB	10056
MIM609691	*	18q12.2	FORMIN HOMOLOGY-2 DOMAIN-CONTAINING PROTEIN 3; FHOD3	80206
MIM609692	*	17q21.2	WAS/WASL-INTERACTING PROTEIN FAMILY, MEMBER 2; WIPF2	147179
MIM609693	*	6p21.33	VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 7; VWA7	80737
MIM609694	*	19p12-p11	GEM-INTERACTING PROTEIN; GMIP	51291
MIM609695	*	12q24-qter	4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE; HPD	3242
MIM609696	*	1q42.1-q43	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 4B; ARID4B	51742
MIM609697	*	2q14.3	SIN3A-ASSOCIATED PROTEIN, 130-KD	79595
MIM609698	#	9q22.2	THYROID HORMONE METABOLISM, ABNORMAL	79048
MIM609699	*	3p21.3	MONOGLYCERIDE LIPASE; MGLL	11343
MIM609700	*	7q11.21	RAB GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; RABGEF1	27342
MIM609701	*	17q21	N-ACETYLGLUCOSAMINIDASE, ALPHA-; NAGLU	4669
MIM609702	*	18p11.21	PROTEASOME-ASSEMBLING CHAPERONE 2; PSMG2	56984
MIM609703	*	13q14.3	MICRO RNA 15A; MIR15A	406948
MIM609704	*	13q14.3	MICRO RNA 16-1; MIR16-1	406950
MIM609705	*	9q22.32	MICRO RNA 24-1; MIRN24-1	407012
MIM609706	#	6p21.3	DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53	1302
MIM609707	*	16q22.1	DIHYDROURIDINE SYNTHASE 2-LIKE; DUS2L	54920
MIM609708	+	8p22	LIPOPROTEIN LIPASE; LPL	4023
MIM609709	*	11p11.2	GLYCOSYLTRANSFERASE-LIKE 1B; GYLTL1B	120071
MIM609710	*	5q31.1	DENDRITIC CELL NUCLEAR PROTEIN 1	140947
MIM609711	*	19p13.3	UBIQUINOL-CYTOCHROME c REDUCTASE, 6.4-KD SUBUNIT; UQCR	10975
MIM609712	*	1q21	PYRUVATE KINASE, LIVER AND RED BLOOD CELL; PKLR	5313
MIM609713	*	6p25.3-p25.1	HYDROXYUREA-SENSITIVE 1, S. POMBE, HOMOLOG OF, B; HUS1B	135458
MIM609714	*	6p21.1	TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-LIKE PROTEIN 1; TREML1	340205
MIM609715	*	6p21.1	TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-LIKE PROTEIN 2; TREML2	79865
MIM609716	*	6p21.1	TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-LIKE PROTEIN 3; TREML3	340206
MIM609717	*	4q21.1	GENE DIFFERENTIALLY EXPRESSED IN PROSTATE	118425
MIM609718	*	5q14.1	LHFP-LIKE PROTEIN 2; LHFPL2	10184
MIM609719	*	7q22.1	LHFP-LIKE PROTEIN 3; LHFPL3	375612
MIM609720	*	9q33.3	CRUMBS, DROSOPHILA, HOMOLOG OF, 2; CRB2	286204
MIM609721	*	7p13-p12	POLYCYSTIN 1-LIKE 1; PKD1L1	168507
MIM609722	*	8p21.2	PDZ AND LIM DOMAIN PROTEIN 2; PDLIM2	64236
MIM609723	*	17q23.2	YIPPEE-LIKE 2; YPEL2	388403
MIM609724	*	16p11.2	YIPPEE-LIKE 3; YPEL3	83719
MIM609725	*	11q12.1	YIPPEE-LIKE 4; YPEL4	219539
MIM609726	*	2p23.1	YIPPEE-LIKE 5; YPEL5	51646
MIM609727	%	1p31.1-p21.1	SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT; SPG29	619379
MIM609728	*	2q33.1	METHIONYL-tRNA SYNTHETASE 2; MARS2	92935
MIM609729	*	3p13	PDZ DOMAIN-CONTAINING RING FINGER PROTEIN 3; PDZRN3	23024
MIM609730	*	12q12	PDZ DOMAIN-CONTAINING RING FINGER PROTEIN 4; PDZRN4	29951
MIM609731	*	20p11.21	CYSTATIN 11; CST11	140880
MIM609732	*	4q12	LIGAND OF NUMB PROTEIN X1; LNX1	84708
MIM609733	*	13q12.2	LIGAND OF NUMB PROTEIN X2; LNX2	222484
MIM609734	#	2p23.3	PROOPIOMELANOCORTIN DEFICIENCY	5443
MIM609735	*	17q12	RING FINGER AND FYVE-LIKE DOMAIN CONTAINING 1; RFFL	117584
MIM609736	*	2p16.1	COILED-COIL DOMAIN-CONTAINING PROTEIN 88A; CCDC88A	55704
MIM609737	*	19p13.3	CRUMBS, DROSOPHILA, HOMOLOG OF, 3; CRB3	92359
MIM609738	*	1q22-q23	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 9; IGSF9	57549
MIM609739	*	3q21.1	IMMUNOGLOBULIN-LIKE DOMAIN-CONTAINING RECEPTOR 1; ILDR1	286676
MIM609740	*	9q33.3	PHD FINGER PROTEIN 19; PHF19	26147
MIM609741	#	22q11.2-q12.2	CATARACT, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE 2; CATCN2	1417
MIM609742	*	19q13.3-q13.4	INTERLEUKIN 4-INDUCED GENE 1; IL4I1	259307
MIM609743	*	1q21.2-q22	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 4B; IGSF4B	57863
MIM609744	*	19q13.2	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 4C; IGSF4C	199731
MIM609745	%	15q11-q13	GLAUCOMA 1, OPEN ANGLE, I; GLC1I	497188
MIM609746	*	4q31.2	RHO GTPase-ACTIVATING PROTEIN 10; ARHGAP10	79658
MIM609747	*	8q23	ACTIN-BINDING RHO-ACTIVATING PROTEIN; ABRA	137735
MIM609748	*	15q22.3-q23	UBIQUITIN-LIKE 7; UBL7	84993
MIM609749	*	2q12	UDP-GLUCURONATE DECARBOXYLASE 1; UXS1	80146
MIM609750	%	10q25-q26	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 4; EIG4	780913
MIM609751	*	17q25	ACYL-CoA OXIDASE 1, PALMITOYL; ACOX1	51
MIM609752	*	6q22.33	NUCLEAR RECEPTOR COACTIVATOR 7; NCOA7	135112
MIM609753	#	19p13.1	CELIAC DISEASE, SUSCEPTIBILITY TO, 4; CELIAC4	4650
MIM609754	%	5q31-q33	CELIAC DISEASE, SUSCEPTIBILITY TO, 2; CELIAC2	317782
MIM609755	#	2q33	CELIAC DISEASE, SUSCEPTIBILITY TO, 3; CELIAC3	1493
MIM609756	*	 	CHRNA7/FAM7A FUSION GENE; CHRFAM7A	89832
MIM609757	#	7q11.23	WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	100240730
MIM609758	*	6q21	Na+/K+ TRANSPORTING ATPase-INTERACTING 2; NKAIN2	154215
MIM609759	*	 	PR DOMAIN-CONTAINING PROTEIN 7; PRDM7	11105
MIM609760	*	5p14.2	PR DOMAIN-CONTAINING PROTEIN 9; PRDM9	56979
MIM609761	*	22q13.1	TRIO- AND F-ACTIN-BINDING PROTEIN; TRIOBP	11078
MIM609762	*	19q13	BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 3; BLOC1S3	388552
MIM609763	*	10q24	PHOSPHATIDYLINOSITOL 4-KINASE, TYPE 2, ALPHA; PI4K2A	55361
MIM609764	*	1p34.1	LYSINE-SPECIFIC DEMETHYLASE 4A; KDM4A	9682
MIM609765	*	19p13.3	LYSINE-SPECIFIC DEMETHYLASE 4B; KDM4B	23030
MIM609766	*	11q21	JUMONJI DOMAIN-CONTAINING PROTEIN 2D; JMJD2D	55693
MIM609767	*	10q24	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 28; SLC25A28	81894
MIM609768	*	10q24.31	BIOGENESIS OF LYSOSOME-RELATED ORGANELLES COMPLEX 1, SUBUNIT 2; BLOC1S2	282991
MIM609769	*	12q13.3	ORPHAN SHORT-CHAIN DEHYDROGENASE/REDUCTASE	121214
MIM609770	*	11q23	ADHESION MOLECULE, INTERACTS WITH CXADR ANTIGEN 1; AMICA1	120425
MIM609771	*	16p13.3	UBINUCLEIN 1; UBN1	29855
MIM609772	*	7q31	CORTACTIN-BINDING PROTEIN 2; CTTNBP2	83992
MIM609773	*	19q13.2	CREBBP/EP300 INHIBITORY PROTEIN 2; CRI2	163126
MIM609774	*	11p12	APOPTOSIS INHIBITOR 5; API5	8539
MIM609775	*	6p21.2-p21.1	YIP1 DOMAIN FAMILY, MEMBER 3; YIPF3	25844
MIM609776	*	10q26.3	PROLINE-RICH ACIDIC PROTEIN 1; PRAP1	118471
MIM609777	*	3p22.2	CARDIOMYOPATHY-ASSOCIATED PROTEIN 1; CMYA1	165904
MIM609778	*	2q24.3	CARDIOMYOPATHY-ASSOCIATED PROTEIN 3; CMYA3	129446
MIM609779	*	3q21-q22	NEVER IN MITOSIS GENE A-RELATED KINASE 11; NEK11	79858
MIM609780	*	7p15-p14	CARBOXYPEPTIDASE, VITELLOGENIC-LIKE; CPVL	54504
MIM609782	%	4q31	AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 2; AAA2	100505390
MIM609783	*	10p15	INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 5; ITIH5	80760
MIM609784	*	3p23	UPSTREAM BINDING PROTEIN 1; UBP1	7342
MIM609785	*	2q14	TRANSCRIPTION FACTOR CP2-LIKE 1; TFCP2L1	29842
MIM609786	*	2p25.1	GRAINYHEAD-LIKE 1; GRHL1	29841
MIM609787	*	9p22-p21	UBIQUITIN-ASSOCIATED PROTEIN 1; UBAP1	51271
MIM609788	*	11q13.3	X-RAY RADIATION RESISTANCE-ASSOCIATED 1; XRRA1	143570
MIM609789	*	2q34-q37	AQUAPORIN 12A; AQP12A	375318
MIM609790	%	9p22.1	ALZHEIMER DISEASE 11	100188795
MIM609791	*	15q24	LEUCINE-RICH REPEAT PROTEIN, NEURONAL, 6A; LRRN6A	84894
MIM609792	*	19p13.3	LEUCINE-RICH REPEAT PROTEIN, NEURONAL, 6B; LRRN6B	645191
MIM609793	*	9p21.2-p21.1	LEUCINE-RICH REPEAT PROTEIN, NEURONAL, 6C; LRRN6C	158038
MIM609794	*	 	LEUCINE-RICH REPEAT PROTEIN, NEURONAL, 6D; LRRN6D	339398
MIM609795	*	 	PYROGLUTAMYLATED RF-AMIDE PEPTIDE PRECURSOR PROTEIN; QRFP	347148
MIM609796	#	15q15.2	PEELING SKIN SYNDROME, ACRAL TYPE	9333
MIM609797	*	9q22.3	BICAUDAL D, DROSOPHILA, HOMOLOG OF, 2; BICD2	23299
MIM609798	*	14q24.3	NEVER IN MITOSIS GENE A-RELATED KINASE 9; NEK9	91754
MIM609799	*	17q11.1	NEVER IN MITOSIS GENE A-RELATED KINASE 8; NEK8	284086
MIM609800	%	2p24	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	100188796
MIM609801	*	17q25.1	CD300 ANTIGEN-LIKE FAMILY, MEMBER E; CD300LE	342510
MIM609802	*	15q21.1	SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 5; SLC24A5	283652
MIM609803	*	2q32.2	ANKYRIN AND ARMADILLO REPEATS-CONTAINING PROTEIN; ANKAR	150709
MIM609804	*	17p13.1	WD REPEAT-CONTAINING PROTEIN 16; WDR16	146845
MIM609805	*	11q25	SPERMATOGENESIS-ASSOCIATED PROTEIN 19; SPATA19	219938
MIM609806	*	11q23.3	HYDROXYMETHYLBILANE SYNTHASE; HMBS	3145
MIM609807	*	17q25.1	CD300 ANTIGEN-LIKE FAMILY, MEMBER F; CD300LF	146722
MIM609809	*	20q13.3	LCK-INTERACTING TRANSMEMBRANE ADAPTOR 1; LIME1	54923
MIM609810	*	7q21	PATERNALLY EXPRESSED GENE 10; PEG10	23089
MIM609811	*	4p12	CYTOCHROME C OXIDASE SUBUNIT VIIb2; COX7B2	170712
MIM609812	#	9q34.3	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8	1056
MIM609813	#	7p22	SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	3955
MIM609814	#	1q32	COMPLEMENT FACTOR H DEFICIENCY; CFHD	3075
MIM609815	%	3p21.31	ZYGODACTYLY 1	780914
MIM609816	*	2q33-q34	NEUROBEACHIN-LIKE 1; NBEAL1	65065
MIM609818	*	16q24.1	UBIQUITIN-SPECIFIC PROTEIN 10; USP10	9100
MIM609819	*	17q21.3	PROSTATE, RECTUM, AND COLON GENE; PRAC	84366
MIM609820	#	1q42-q43	ERYTHROCYTOSIS, FAMILIAL, 3; ECYT3	54583
MIM609821	#	3q24-q25	BLEEDING DISORDER, PLATELET-TYPE, 8; BDPLT8	64805
MIM609822	%	1p21	STATURE QUANTITATIVE TRAIT LOCUS 7; STQTL7	100037265
MIM609823	#	22q13.1	DEAFNESS, AUTOSOMAL RECESSIVE 28; DFNB28	11078
MIM609824	*	1q21.3	HORMA DOMAIN-CONTAINING 1; HORMAD1	84072
MIM609825	*	4q21-q22	COQ2, S. CEREVISIAE, HOMOLOG OF; COQ2	27235
MIM609826	*	9q34	SOLUTE CARRIER FAMILY 34 (SODIUM/PHOSPHATE COTRANSPORTER), MEMBER 3; SLC34A3	142680
MIM609827	*	 	PELLINO, DROSOPHILA, HOMOLOG OF, 3; PELI3	246330
MIM609828	*	19p13.3	FIBRONECTIN TYPE III AND SPRY DOMAINS-CONTAINING PROTEIN 1; FSD1	79187
MIM609829	*	9q31	FSD1 N-TERMINUS-LIKE PROTEIN; FSD1NL	83856
MIM609831	*	1p34.1	MMACHC GENE; MMACHC	25974
MIM609832	*	17p11.2	SOLUTE CARRIER FAMILY 47, MEMBER 1; SLC47A1	55244
MIM609833	*	17p11.2	SOLUTE CARRIER FAMILY 47, MEMBER 2; SLC47A2	146802
MIM609834	*	3p26	SET AND MARINER TRANSPOSASE DOMAINS-CONTAINING PROTEIN; SETMAR	6419
MIM609835	*	17q21	MYCBP-ASSOCIATED PROTEIN; MYCBPAP	84073
MIM609836	*	5q31.2	PTERIN-4-ALPHA-CARBINOLAMINE DEHYDRATASE 2; PCBD2	84105
MIM609837	*	15q11.2	SMALL NUCLEOLAR RNA, C/D BOX, 115-1; SNORD115-1	338433
MIM609838	*	9p22	SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 2; SLC24A2	25769
MIM609839	*	20p13	SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 3; SLC24A3	57419
MIM609840	*	14q32	SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 4; SLC24A4	123041
MIM609841	*	12q24	SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER 6; SLC24A6	80024
MIM609842	*	 	ENHANCER OF mRNA DECAPPING 3, S. CEREVISIAE, HOMOLOG OF; EDC3	80153
MIM609843	*	12p13.33	DECAPPING ENZYME 1, S. CEREVISIAE, HOMOLOG OF, B; DCP1B	196513
MIM609844	*	5q21-q22	DECAPPING ENZYME 2, S. CEREVISIAE, HOMOLOG OF; DCP2	167227
MIM609845	*	3q25-q26	SUCRASE-ISOMALTASE; SI	6476
MIM609846	*	1p13.1-p12	REGENERATING ISLET-DERIVED FAMILY, MEMBER 4; REG4	83998
MIM609847	*	17q25.3	NOTUM, DROSOPHILA, HOMOLOG OF; NOTUM	147111
MIM609848	*	17p13.2	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 11; KCTD11	147040
MIM609849	*	11q13.2	CORONIN 1B; CORO1B	57175
MIM609850	*	4p15.1-q21	TBC1 DOMAIN FAMILY, MEMBER 1; TBC1D1	23216
MIM609851	*	10q21	INOSITOL POLYPHOSPHATE MULTIKINASE; IPMK	253430
MIM609852	*	1q42.1	MIX1 HOMEOBOX-LIKE PROTEIN 1; MIXL1	83881
MIM609853	*	1p13.1-p12	PHOSPHOPANTOTHENOYLCYSTEINE SYNTHETASE; PPCS	79717
MIM609854	*	15q24.2	PHOSPHOPANTOTHENOYLCYSTEINE DECARBOXYLASE; PPCDC	60490
MIM609855	*	17q12-q21	COENZYME A SYNTHASE; COASY	80347
MIM609856	*	3q26.3	SPERMATOGENESIS-ASSOCIATED PROTEIN 16; SPATA16	83893
MIM609857	*	19q13.3	DYSTROPHIA MYOTONICA WD REPEAT-CONTAINING PROTEIN; DMWD	1762
MIM609858	*	12p12.1-p11.2	ETHANOLAMINE KINASE 1; ETNK1	55500
MIM609859	*	1q32.1	ETHANOLAMINE KINASE 2; ETNK2	55224
MIM609860	*	12p12.1-p11.2	DAD1-RELATED GENE	56286
MIM609861	*	12q23	I-KAPPA-B KINASE-INTERACTING PROTEIN; IKBIP	121457
MIM609862	*	22q12-q13	TRANSMEMBRANE PROTEASE, SERINE 6; TMPRSS6	164656
MIM609863	*	12q24.1	TECTONIC FAMILY, MEMBER 1; TCTN1	79600
MIM609864	*	8q21.2	TRANSMEMBRANE PROTEIN 55A; TMEM55A	55529
MIM609865	*	 	TRANSMEMBRANE PROTEIN 55B; TMEM55B	90809
MIM609866	*	13q12.3	START DOMAIN-CONTAINING PROTEIN 13; STARD13	90627
MIM609867	*	5q33.3	UBIQUITIN-LIKE DOMAIN-CONTAINING CTD PHOSPHATASE 1; UBLCP1	134510
MIM609868	*	14q31.3	SPERMATOGENESIS-ASSOCIATED PROTEIN 7; SPATA7	55812
MIM609869	*	3p21.2-p21.1	SPERMATOGENESIS-ASSOCIATED PROTEIN 12; SPATA12	353324
MIM609870	*	10p12.3	RHO GTPase-ACTIVATING PROTEIN 21; ARHGAP21	57584
MIM609871	*	9q22.3	TBC1 DOMAIN FAMILY, MEMBER 2; TBC1D2	55357
MIM609872	*	20q12-q13.1	WAP 4-DISULFIDE CORE DOMAIN 12; WFDC12	128488
MIM609873	*	1q21.3-q22	INTELECTIN 1; ITLN1	55600
MIM609874	*	1q21.3-q22	INTELECTIN 2; ITLN2	142683
MIM609875	*	10q21.3-q22.1	ATONAL, DROSOPHILA, HOMOLOG OF, 7; ATOH7	220202
MIM609876	%	21q22.13-qter	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 6; BMND6	100188797
MIM609877	*	13q12.11	CRYSTALLIN, LAMBDA-1; CRYL1	51084
MIM609878	*	17p11.2	MEDIATOR COMPLEX SUBUNIT 9; MED9	55090
MIM609879	*	4q34.1-q34.2	SPERMATOGENESIS-ASSOCIATED PROTEIN 4; SPATA4	132851
MIM609880	*	17q21.32	HISTONE ACETYLTRANSFERASE MYST2; MYST2	11143
MIM609881	*	7q11.2	RNA POLYMERASE II POLYPEPTIDE J-RELATED GENE	246721
MIM609882	*	1p22.1	METAL-REGULATORY TRANSCRIPTION FACTOR 2; MTF2	22823
MIM609883	*	17q23	MKS1 GENE; MKS1	54903
MIM609884	*	8q21.13-q22.1	TRANSMEMBRANE PROTEIN 67; TMEM67	91147
MIM609885	*	15q15.3	ELONGATION FACTOR, RNA POLYMERASE II, 3; ELL3	80237
MIM609886	#	16p12.3	GLOMERULOCYSTIC KIDNEY DISEASE WITH HYPERURICEMIA AND ISOSTHENURIA	7369
MIM609887	#	5q21.3-q22.1	GLAUCOMA 1, OPEN ANGLE, G; GLC1G	134430
MIM609888	%	10p13	LEPROSY, SUSCEPTIBILITY TO, 1; LPRS1	81861
MIM609889	#	11p13	ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY	5896
MIM609890	*	1p36.13	RETINOBLASTOMA-ASSOCIATED FACTOR 600	23352
MIM609891	*	6q26	CHROMOSOME 6 OPEN READING FRAME 59; C6ORF59	134701
MIM609892	*	21q22.2	DOWN SYNDROME CRITICAL REGION GENE 6; DSCR6	53820
MIM609893	%	15q25.3-q26.1	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 3; CHNG3	780915
MIM609894	*	19p13.3	UNC13, C. ELEGANS, HOMOLOG OF, A; UNC13A	23025
MIM609895	*	1p36.22	CASTOR ZINC FINGER PROTEIN 1; CASZ1	54897
MIM609896	*	3p14	EUKARYOTIC TRANSLATION INITIATION FACTOR 4E FAMILY, MEMBER 3; EIF4E3	317649
MIM609897	*	6p21.32	EPIDERMAL GROWTH FACTOR-LIKE 8; EGFL8	80864
MIM609898	*	22q12.1	KRINGLE DOMAIN-CONTAINING TRANSMEMBRANE PROTEIN 1; KREMEN1	83999
MIM609899	*	16p13.3	KRINGLE DOMAIN-CONTAINING TRANSMEMBRANE PROTEIN 2; KREMEN2	79412
MIM609900	*	 	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3D; APOBEC3D	140564
MIM609901	*	16p12.2	ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 4B; ANKS4B	257629
MIM609903	%	13q32	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 5; SLEB5	100188798
MIM609904	*	6p22.2	HISTONE GENE CLUSTER 1, H2B HISTONE FAMILY, MEMBER A; HIST1H2BA	255626
MIM609905	*	20q11.23	MYOSIN LIGHT CHAIN 9, REGULATORY; MYL9	10398
MIM609906	*	14q11.2-q12	EMBRYONAL FYN-ASSOCIATED SUBSTRATE; EFS	10278
MIM609907	*	 	SEMAPHORIN 3D; SEMA3D	223117
MIM609908	*	1q25.3	APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 4; APOBEC4	403314
MIM609909	#	6q22.1	CARDIOMYOPATHY, DILATED, 1P; CMD1P	5350
MIM609910	*	3q13.3-q21.1	AMY1-ASSOCIATED PROTEIN EXPRESSED IN TESTIS 1	89876
MIM609911	*	14q32.31	HEPATOCELLULAR CARCINOMA-DOWNREGULATED MITOCHONDRIAL CARRIER PROTEIN	283600
MIM609912	*	16p11.2	HISTONE ACETYLTRANSFERASE MYST1; MYST1	84148
MIM609913	%	1p21.3-p13.3	RETINITIS PIGMENTOSA 32; RP32	641433
MIM609914	*	11q14	AQUAPORIN 11; AQP11	282679
MIM609915	%	7q22.3-q31.1	CARDIOMYOPATHY, DILATED, 1Q; CMD1Q	664728
MIM609916	*	3p24.1	5-@AZACYTIDINE-INDUCED GENE 2, MOUSE, HOMOLOG OF; AZI2	64343
MIM609917	*	1p32	PRION PROTEIN-INTERACTING PROTEIN; PRNPIP	79033
MIM609918	%	1p36.21	GALLBLADDER DISEASE 2; GBD2	100048905
MIM609919	%	1p34.3	GALLBLADDER DISEASE 3; GBD3	100048906
MIM609920	*	20q13.1	CADHERIN 22; CDH22	64405
MIM609921	*	14q11.2	LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 10; LRP10	26020
MIM609922	*	2p15	EH DOMAIN-BINDING PROTEIN 1; EHBP1	23301
MIM609923	#	9p21	RETINITIS PIGMENTOSA 31; RP31	10210
MIM609924	#	3p21.1	AMINOACYLASE 1 DEFICIENCY	95
MIM609925	*	16q22.1	DIPEPTIDASE 2; DPEP2	64174
MIM609926	*	16q22.1	DIPEPTIDASE 3; DPEP3	64180
MIM609927	*	8p23-p21	VACUOLAR PROTEIN SORTING 37, YEAST, HOMOLOG OF, A; VPS37A	137492
MIM609928	*	20q11.22	MYOSIN, HEAVY CHAIN 7B, CARDIAC MUSCLE, BETA; MYH7B	57644
MIM609929	*	3q13.13	MYOSIN, HEAVY CHAIN 15; MYH15	22989
MIM609930	*	12q13.13	MYOSIN, LIGHT CHAIN 6B, ALKALI, SMOOTH MUSCLE AND NONMUSCLE, SLOW; MYL6B	140465
MIM609931	*	12q13.2	MYOSIN LIGHT CHAIN 6, ALKALI, SMOOTH MUSCLE AND NONMUSCLE; MYL6	4637
MIM609932	*	19q13.33	SPERM ACROSOME-ASSOCIATED PROTEIN 4; SPACA4	171169
MIM609933	*	2p12	REGENERATING ISLET-DERIVED 3-GAMMA; REG3G	130120
MIM609934	*	8p21.2	EARLY B-CELL FACTOR 2; EBF2	64641
MIM609935	*	20p13	EARLY B-CELL FACTOR 4; EBF4	57593
MIM609936	*	9q22.1-q22.3	SPINDLIN; SPIN	10927
MIM609937	*	2q31	CELL DIVISION CYCLE-ASSOCIATED PROTEIN 7; CDCA7	83879
MIM609938	*	3p12	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 4D; IGSF4D	253559
MIM609939	%	16p11.2	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	3684
MIM609941	%	11p13-p12	DEAFNESS, AUTOSOMAL RECESSIVE 51; DFNB51	448963
MIM609942	#	12p12.1	NOONAN SYNDROME 3; NS3	3845
MIM609946	%	2p25.1-p24.3	DEAFNESS, AUTOSOMAL RECESSIVE 47; DFNB47	449489
MIM609947	*	14q13	KIAA0391 GENE; KIAA0391	9692
MIM609948	*	7p22	RING FINGER PROTEIN 216; RNF216	54476
MIM609949	*	19q13.4	G PROTEIN-COUPLED RECEPTOR 77; GPR77	27202
MIM609950	*	19p13.2	RAVER1, MOUSE, HOMOLOG OF	125950
MIM609951	*	12p12	ZINC FINGER PROTEIN 384; ZNF384	171017
MIM609952	%	4q12-q13.2	DEAFNESS, AUTOSOMAL RECESSIVE 55; DFNB55	494148
MIM609953	*	1p31.3	RAVER2, MOUSE, HOMOLOG OF	55225
MIM609954	%	3p24-p21	ASPERGER SYNDROME, SUSCEPTIBILITY TO, 4	100188800
MIM609955	%	2p23.3-p22.3	FIBROMATOSIS, GINGIVAL, 3; GINGF3	780916
MIM609956	*	17q25.1	RAS-ASSOCIATED PROTEIN RAB37; RAB37	326624
MIM609957	*	1p13.2	PROTEIN PHOSPHATASE, MAGNESIUM-DEPENDENT, 1J; PPM1J	333926
MIM609958	%	2p16	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 3	100188801
MIM609959	*	19q13.33-q13.4	MYELOID-ASSOCIATED DIFFERENTIATION MARKER; MYADM	91663
MIM609960	*	9p24.2	KIAA0020 GENE; KIAA0020	9933
MIM609961	*	5q32	MINOR HISTOCOMPATIBILITY ANTIGEN HB-1	57824
MIM609962	*	12p13	C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER E; CLEC4E	26253
MIM609963	*	5q31	CHONDROITIN SULFATE SYNTHASE 3; CHSY3	337876
MIM609964	*	12p13	C-TYPE LECTIN DOMAIN FAMILY 4, MEMBER D; CLEC4D	338339
MIM609965	%	14q11.2-q12	DEAFNESS, AUTOSOMAL DOMINANT 53; DFNA53	353347
MIM609966	*	19q13.2	GAMETOGENETIN, MOUSE, HOMOLOG OF; GGN	199720
MIM609967	*	19p13.11	B-CELL NOVEL PROTEIN 1	199786
MIM609968	#	19p13.2	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	3643
MIM609969	*	19q13.1	SUPRABASIN	374897
MIM609970	*	1p36.31	HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 2; HES2	54626
MIM609971	*	1p36.31	HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 3; HES3	390992
MIM609972	*	14q24.3	ACYL-CoA THIOESTERASE 2; ACOT2	10965
MIM609973	*	1q22	HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 3; HCN3	57657
MIM609974	*	5p14	CADHERIN 9; CDH9	1007
MIM609975	#	4q22-q26	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	3033
MIM609976	*	19q13.2	HYPOXIA-INDUCIBLE FACTOR 3, ALPHA SUBUNIT; HIF3A	64344
MIM609977	*	1p34.3	CELL DIVISION CYCLE-ASSOCIATED PROTEIN 8; CDCA8	55143
MIM609978	*	7q31.3	CALCIUM-DEPENDENT ACTIVATOR PROTEIN FOR SECRETION 2; CADPS2	93664
MIM609979	*	6q21	VESTIGIAL-LIKE 2; VGLL2	245806
MIM609980	*	3p12.1	VESTIGIAL-LIKE 3; VGLL3	389136
MIM609981	#	8p11.23-q11.21	NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT; NKGCD	780917
MIM609982	*	16q22	VACUOLAR PROTEIN SORTING 4, YEAST, HOMOLOG OF, A; VPS4A	27183
MIM609983	*	18q21.3	VACUOLAR PROTEIN SORTING 4, S. CEREVISIAE, HOMOLOG OF, B; VPS4B	9525
MIM609984	*	15q22.3	ZWILCH, DROSOPHILA, HOMOLOG OF; ZWILCH	55055
MIM609985	%	4q31-q34	PANIC DISORDER 3	677663
MIM609986	*	5p13.1-p12	CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 6; CARD6	84674
MIM609987	*	7q31	STIMULATED BY RETINOIC ACID 8, MOUSE, HOMOLOG OF; STRA8	346673
MIM609988	*	4q25	PYROPHOSPHATASE, INORGANIC, 2; PPA2	27068
MIM609991	*	6q25	FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 1; FNDC1	84624
MIM609992	*	12q24.31	PROCESSING OF PRECURSOR 5, S. CEREVISIAE, HOMOLOG OF; POP5	51367
MIM609994	%	4q22-q27	MYOPIA 11, AUTOSOMAL DOMINANT; MYP11	594832
MIM609995	%	2q37.1	MYOPIA 12, AUTOSOMAL DOMINANT; MYP12	664780
MIM609996	*	7p21.3	COLLAGEN, TYPE XXVIII, ALPHA-1; COL28A1	340267
MIM609997	*	9p11.2	HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 2; HINT2	84681
MIM609998	*	6q22.33	HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 3; HINT3	135114
MIM609999	*	14q24.3	SYNAPSE DIFFERENTIATION-INDUCED GENE 1-LIKE; SYNDIG1L	646658
MIM610000	*	10q23.33	CENTROSOMAL PROTEIN, 55-KD; CEP55	55165
MIM610002	*	6p12.3-p11.2	COLLAGEN, TYPE XXI, ALPHA-1; COL21A1	81578
MIM610003	#	8p23	CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	2055
MIM610004	*	4q25	COLLAGEN, TYPE XXV, ALPHA-1; COL25A1	84570
MIM610005	*	3q26.2-q26.3	TRAF2- AND NCK-INTERACTING KINASE; TNIK	23043
MIM610006	#	10q25-q26	2-@METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY	36
MIM610007	*	12q13.12	LIMB REGION 1 HOMOLOG-LIKE; LMBR1L	55716
MIM610008	*	17q24.2	ARYLSULFATASE G; ARSG	22901
MIM610009	*	5q32	ARYLSULFATASE I; ARSI	340075
MIM610010	*	4q26	ARYLSULFATASE J; ARSJ	79642
MIM610011	*	5q15	ARYLSULFATASE K; ARSK	153642
MIM610012	*	8q13.3	SULFATASE 1; SULF1	23213
MIM610013	*	20q13.12	SULFATASE 2; SULF2	55959
MIM610014	*	15q26.3	TM2 DOMAIN-CONTAINING PROTEIN 3; TM2D3	80213
MIM610015	#	1q31	GLUTAMINE DEFICIENCY, CONGENITAL	2752
MIM610016	*	17p13.3	MICRO RNA 132; MIR132	406921
MIM610017	#	 	MULTIPLE SYNOSTOSES SYNDROME 2; SYNS2	8200
MIM610018	*	14q11.2	SOLO GENE	55701
MIM610019	#	3p22-p21	CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 2; CATC2	79443
MIM610020	*	22q12.1-qter	TBC1 DOMAIN FAMILY, MEMBER 10A; TBC1D10A	83874
MIM610021	#	1p13.2-p12	HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	6566
MIM610022	*	15q21	MYOSIN VC; MYO5C	55930
MIM610024	#	12p13	RETINAL CONE DYSTROPHY 3A; RCD3A	5149
MIM610025	*	1p22.3	COLLAGEN, TYPE XXIV, ALPHA-1; COL24A1	255631
MIM610026	*	8q24.2	COLLAGEN, TYPE XXII, ALPHA-1; COL22A1	169044
MIM610027	*	11q25	VACUOLAR PROTEIN SORTING 26, YEAST, HOMOLOG OF, B; VPS26B	112936
MIM610028	*	3q21.1	POLY(ADP-RIBOSE) POLYMERASE 14; PARP14	54625
MIM610029	*	8p11.2	VOLTAGE-DEPENDENT ANION CHANNEL 3; VDAC3	7419
MIM610030	*	1q25.3	VOLTAGE-DEPENDENT ANION CHANNEL 4; VDAC4	7418
MIM610031	#	6p25.2	POLYMICROGYRIA, SYMMETRIC OR ASYMMETRIC; PMGYSA	347733
MIM610032	*	7q32.1	TRANSPORTIN 3; TNPO3	23534
MIM610033	*	1p34	PENTA-EF-HAND DOMAIN-CONTAINING PROTEIN 1; PEF1	553115
MIM610034	*	12q24.31	VACUOLAR PROTEIN SORTING 33, YEAST, HOMOLOG OF, A; VPS33A	65082
MIM610035	*	1q21-q22	VACUOLAR PROTEIN SORTING 45, YEAST, HOMOLOG OF, A; VPS45A	11311
MIM610036	*	1p34.2	CLAUDIN 19; CLDN19	149461
MIM610037	*	12q24.31	VACUOLAR PROTEIN SORTING 37, YEAST, HOMOLOG OF, B; VPS37B	79720
MIM610038	*	11q12.2	VACUOLAR PROTEIN SORTING 37, YEAST, HOMOLOG OF, C; VPS37C	55048
MIM610039	*	7q11.23	VACUOLAR PROTEIN SORTING 37, YEAST, HOMOLOG OF, D; VPS37D	155382
MIM610040	*	2q31.1-q31.2	MYOSIN IIIB; MYO3B	140469
MIM610041	*	13q22.2	NEDD4 FAMILY-INTERACTING PROTEIN 2; NDFIP2	54602
MIM610042	#	7q35-q36	CORTICAL DYSPLASIA-FOCAL EPILEPSY SYNDROME	26047
MIM610043	*	5q35	COLLAGEN, TYPE XXIII, ALPHA-1; COL23A1	91522
MIM610044	*	1q31.3	POTASSIUM CHANNEL, SUBFAMILY T, MEMBER 2; KCNT2	343450
MIM610045	*	6p22	ALDEHYDE DEHYDROGENASE 5 FAMILY, MEMBER A1; ALDH5A1	7915
MIM610046	*	5q23.1	LAEVERIN	206338
MIM610047	*	7q22.1	CANOPY 4, ZEBRAFISH, HOMOLOG OF; CNPY4	245812
MIM610048	#	12q21.3	CORNEAL DYSTROPHY, CONGENITAL STROMAL; CSCD	1634
MIM610049	*	12q13	SAP DOMAIN-CONTAINING RIBONUCLEOPROTEIN; SARNP	84324
MIM610050	*	11q23	TRANSMEMBRANE PROTEIN, SERINE 13; TMPRSS13	84000
MIM610051	*	14q12	CHMP FAMILY, MEMBER 4A; CHMP4A	29082
MIM610052	*	2p24	VACUOLAR PROTEIN SORTING 24, YEAST, HOMOLOG OF; VPS24	51652
MIM610053	*	 	TUBULIN-GAMMA COMPLEX-ASSOCIATED PROTEIN 6; TUBGCP6	85378
MIM610054	*	 	H2A HISTONE FAMILY, MEMBER Y; H2AFY	9555
MIM610055	*	19p13.12	COILED-COIL AND C2 DOMAINS-CONTAINING PROTEIN 1A; CC2D1A	54862
MIM610056	*	 	SPERM-ASSOCIATED ANTIGEN 7; SPAG7	9552
MIM610057	*	 	TRANS-2,3-ENOYL-CoA REDUCTASE; TECR	9524
MIM610058	*	 	TUBULIN-SPECIFIC CHAPERONE A; TBCA	6902
MIM610059	*	 	MITOCHONDRIAL RIBOSOMAL PROTEIN L33; MRPL33	9553
MIM610060	*	6p22.3	POLYMERASE I, RNA, SUBUNIT C; POLR1C	9533
MIM610061	*	 	DYNEIN, AXONEMAL, HEAVY CHAIN 7; DNAH7	56171
MIM610062	*	14q24.3	DYNEIN, AXONEMAL, LIGHT CHAIN 1; DNAL1	83544
MIM610063	*	 	DYNEIN, AXONEMAL, HEAVY CHAIN 17; DNAH17	8632
MIM610064	%	18q21, Chr.17	OPIOID DEPENDENCE, SUSCEPTIBILITY TO, 1	100188802, 4200
MIM610065	%	20p12	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 7; SLEB7	100188803
MIM610066	%	20q13	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 8; SLEB8	100188804
MIM610067	*	17q11.2	MYOSIN XVIIIA; MYO18A	399687
MIM610068	*	3p21.3	SOLUTE CARRIER FAMILY 26 (ANION TRANSPORTER), MEMBER 6: SLC26A6	65010
MIM610069	#	10q22.3	POLYPOSIS SYNDROME, HEREDITARY MIXED, 2; HMPS2	657
MIM610070	*	4q32	ASTER-ASSOCIATED PROTEIN	79884
MIM610071	%	2p14-p13.3	HYPERPARATHYROIDISM 3; HRPT3	780919
MIM610072	*	 	ERMIN	57471
MIM610073	*	2q32.2	ORM1-LIKE PROTEIN 1; ORMDL1	94101
MIM610074	*	12q13.2	ORM1-LIKE PROTEIN 2; ORMDL2	29095
MIM610075	*	17q21.1	ORM1-LIKE PROTEIN 3; ORMDL3	94103
MIM610076	*	9q22.1	CELL CYCLE-RELATED KINASE; CCRK	23552
MIM610077	*	13q12-q14	RESPONSE GENE TO COMPLEMENT 32	28984
MIM610078	*	 	MORC FAMILY CW-TYPE ZINC FINGER 3; MORC3	23515
MIM610079	*	11q24	SIALIC ACID ACETYLESTERASE; SIAE	54414
MIM610080	*	 	TM2 DOMAIN-CONTAINING PROTEIN 1; TM2D1	83941
MIM610081	*	 	TM2 DOMAIN-CONTAINING PROTEIN 2; TM2D2	83877
MIM610082	*	6p23-p22.3	MYOSIN REGULATORY LIGHT CHAIN-INTERACTING PROTEIN; MYLIP	29116
MIM610083	*	 	ODZ, DROSOPHILA, HOMOLOG OF, 3; ODZ3	55714
MIM610084	*	 	ODZ, DROSOPHILA, HOMOLOG OF, 4; ODZ4	26011
MIM610085	*	8p23-p22	FAMILY WITH SEQUENCE SIMILARITY 167, MEMBER A; FAM167A	83648
MIM610086	*	 	PROTEIN ARGININE N-METHYLTRANSFERASE 8; PRMT8	56341
MIM610087	*	 	PROTEIN ARGININE N-METHYLTRANSFERASE 7; PRMT7	54496
MIM610088	*	 	OLFACTOMEDIN-LIKE 3; OLFML3	56944
MIM610089	*	 	RAD50-INTERACTING PROTEIN 1; RINT1	60561
MIM610090	#	17q21.32	PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	55163
MIM610091	*	 	WD REPEAT- AND SOCS BOX-CONTAINING PROTEIN 1; WSB1	26118
MIM610092	#	14q24.3	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 3; MCOPCB3	338917
MIM610093	#	14q24.3	MICROPHTHALMIA, ISOLATED 2; MCOP2	338917
MIM610094	*	 	DEF6, MOUSE, HOMOLOG OF; DEF6	50619
MIM610095	*	 	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, LONG CYTOPLASMIC TAIL, 3; KIR3DL3	115653
MIM610096	*	 	T-CELL IMMUNOGLOBULIN AND MUCIN DOMAINS-CONTAINING PROTEIN 4; TIMD4	91937
MIM610097	*	17p13.1	OUTER DENSE FIBER OF SPERM TAILS 4; ODF4	146852
MIM610098	*	 	MINICHROMOSOME MAINTENANCE DEFICIENT DOMAIN CONTAINING 1; MCMDC1	254394
MIM610099	%	8p22-q11	MYOPATHY, DISTAL, 3; MPD3	780920
MIM610101	*	10q24	CUTC COPPER TRANSPORTER, E. COLI, HOMOLOG OF; CUTC	51076
MIM610102	#	5p13	COMPLEMENT COMPONENT 7 DEFICIENCY; C7D	730
MIM610103	*	5q13.3	S100 CALCIUM-BINDING PROTEIN, ZETA; S100Z	170591
MIM610104	*	11q24.1	MICRO RNA 125B1; MIR125B1	406911
MIM610105	*	21q21.1	MICRO RNA 125B2; MIR125B2	406912
MIM610106	*	 	DREBRIN-LIKE; DBNL	28988
MIM610107	*	14q11.2-q12	O-SIALOGLYCOPROTEIN ENDOPEPTIDASE; OSGEP	55644
MIM610108	*	11q13	ANOCTAMIN 1, CALCIUM-ACTIVATED CHLORIDE CHANNEL; ANO1	55107
MIM610109	*	12p13	ANOCTAMIN 2; ANO2	57101
MIM610110	*	11p14	ANOCTAMIN 3; ANO3	63982
MIM610111	*	12q23	ANOCTAMIN 4; ANO4	121601
MIM610112	*	16q24	C-MAF-INDUCING PROTEIN	80790
MIM610113	*	1q21	ADAMTS-LIKE 4; ADAMTSL4	54507
MIM610114	%	9q22	STATURE QUANTITATIVE TRAIT LOCUS 8; STQTL8	100037266
MIM610115	*	1p32.3	TRANSMEMBRANE PROTEIN 48; TMEM48	55706
MIM610116	*	 	PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 14; P2RY14	9934
MIM610117	*	 	SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 11; SLC26A11	284129
MIM610118	*	 	G PROTEIN-COUPLED RECEPTOR 33; GPR33	2856
MIM610119	*	 	ODZ, DROSOPHILA, HOMOLOG OF, 2; ODZ2	57451
MIM610120	*	 	TETRASPANIN 33; TSPAN33	340348
MIM610121	*	3q27	5-@HYDROXYTRYPTAMINE RECEPTOR 3C; HTR3C	170572
MIM610122	*	3q27	5-@HYDROXYTRYPTAMINE RECEPTOR 3, SUBUNIT D; HTR3D	200909
MIM610123	*	3q27	5-@HYDROXYTRYPTAMINE RECEPTOR 3, SUBUNIT E; HTR3E	285242
MIM610124	*	 	CARBOHYDRATE SULFOTRANSFERASE 13; CHST13	166012
MIM610125	#	14q21-q22	MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	5015
MIM610127	#	11p15.5	CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10	1509
MIM610128	*	 	CARBOHYDRATE SULFOTRANSFERASE 11; CHST11	50515
MIM610129	*	 	CARBOHYDRATE SULFOTRANSFERASE 12; CHST12	55501
MIM610130	*	 	SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 1; SLC26A1	10861
MIM610131	#	17q23-q24	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 4; PEOA4	11232
MIM610132	*	1p13	VANG-LIKE 1; VANGL1	81839
MIM610133	*	 	ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 3; ST6GALNAC3	256435
MIM610134	*	1p31.1	ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 5; ST6GALNAC5	81849
MIM610135	*	 	ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 6; ST6GALNAC6	30815
MIM610137	*	 	ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 2; ST6GALNAC2	10610
MIM610138	*	 	ST6 ALPHA-N-ACETYL-NEURAMINYL-2,3-BETA-GALACTOSYL-1,3-N-ACETYLGALACTOSAMINIDE ALPHA-2,6-SIALYLTRANSFERASE 1; ST6GALNAC1	55808
MIM610139	*	 	ST8 ALPHA-N-ACETYL-NEURAMINIDE ALPHA-2,8-SIALYLTRANSFERASE 6; ST8SIA6	338596
MIM610140	#	 	HEART-HAND SYNDROME, SLOVENIAN TYPE	4000
MIM610141	%	1q23.3	QT INTERVAL, VARIATION IN	100379215
MIM610142	*	12q21.3	CENTROSOMAL PROTEIN, 290-KD; CEP290	80184
MIM610143	%	12p13.2-p11.23	DEAFNESS, AUTOSOMAL RECESSIVE 62; DFNB62	692220
MIM610144	*	17q12	TBC1 DOMAIN FAMILY, MEMBER 3B; TBC1D3B	414059
MIM610145	*	 	ENDOTHELIN-CONVERTING ENZYME 2; ECE2	9718
MIM610146	*	 	INSULIN-LIKE GROWTH FACTOR II, ANTISENSE; IGF2AS	51214
MIM610147	*	2q35	G PROTEIN-COUPLED BILE ACID RECEPTOR 1; GPBAR1	151306
MIM610148	*	12q21.2	BBS10 GENE; BBS10	79738
MIM610149	#	10q25.3-q26.2	MACULAR DEGENERATION, AGE-RELATED, 7; ARMD7	5654
MIM610150	*	5p15.2	CHAPERONIN CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 5; CCT5	22948
MIM610151	*	 	METHIONYL AMINOPEPTIDASE 1; METAP1	23173
MIM610152	*	22q13.31	CENTROMERIC PROTEIN M; CENPM	79019
MIM610153	#	5q13.1	DEAFNESS, AUTOSOMAL RECESSIVE 49; DFNB49	153562
MIM610154	#	7p14.1-q11.22	DEAFNESS, AUTOSOMAL RECESSIVE 44; DFNB44	449484
MIM610155	%	2q24.3	DIABETES MELLITUS, INSULIN-DEPENDENT, 19; IDDM19	 
MIM610156	#	9q34.3	MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS	56623
MIM610158	%	13pter-q12.13	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 2; FECD2	100188278
MIM610159	*	 	ZINC FINGER PROTEIN 366; ZNF366	167465
MIM610160	*	 	ZINC FINGER PROTEIN 367; ZNF367	195828
MIM610161	*	6p21.1-p12.1	TRANSCRIPTION FACTOR AP2-DELTA; TFAP2D	83741
MIM610162	*	 	COILED-COIL DOMAIN-CONTAINING PROTEIN 28B; CCDC28B	79140
MIM610163	#	1q22-q23	IMMUNODEFICIENCY DUE TO DEFECT IN CD3-ZETA	919
MIM610164	*	14q32.31	MICRO RNA 134; MIRN134	406924
MIM610165	*	2q22	GLYCOSYLTRANSFERASE-LIKE DOMAIN-CONTAINING PROTEIN 1; GTDC1	79712
MIM610166	*	 	IQ MOTIF- AND SEC7 DOMAIN-CONTAINING PROTEIN 1; IQSEC1	9922
MIM610167	*	9q34.3	PHOSPHOHISTIDINE PHOSPHATASE 1; PHPT1	29085
MIM610168	#	3p22	LOEYS-DIETZ SYNDROME, TYPE 1B; LDS1B	7048
MIM610169	*	15q15.1	INO80 COMPLEX HOMOLOG 1; INOC1	54617
MIM610170	%	5p13	KYPHOSCOLIOSIS 1; KYPSC1	780921
MIM610171	*	1p36.33	CALMODULIN-LIKE 6; CALML6	163688
MIM610172	*	 	KPL2 GENE	79925
MIM610173	*	 	MICRO RNA 10A; MIRN10A	406902
MIM610174	*	5q35	UBIQUITIN DOMAIN-CONTAINING PROTEIN 2; UBTD2	92181
MIM610175	*	11q12	MICRO RNA 130A; MIR130A	406919
MIM610176	*	 	SECRETOGLOBIN, FAMILY 1C, MEMBER 1; SCGB1C1	147199
MIM610177	*	15q26.1	INTERFERON-STIMULATED EXONUCLEASE GENE 20-KD-LIKE 1; ISG20L1	64782
MIM610178	*	 	KIAA0586 GENE; KIAA0586	9786
MIM610179	*	2p23.2	PHOSPHOLIPASE B1; PLB1	151056
MIM610180	*	9q13-q21	OSTEOCLAST-STIMULATING FACTOR 1; OSTF1	26578
MIM610181	#	13q14.1	AICARDI-GOUTIERES SYNDROME 2; AGS2	79621
MIM610182	*	 	PALMDELPHIN; PALMD	54873
MIM610183	*	15q25.1	ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 6; ZFAND6	54469
MIM610184	*	 	MONOACYLGLYCEROL O-ACYLTRANSFERASE 3; MOGAT3	346606
MIM610185	#	17p	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 2; CAMRQ2	124997, 780925
MIM610186	*	 	DEUBIQUITINATING ENZYME 3	377630
MIM610187	#	8q23	DIAPHRAGMATIC HERNIA 3	23414
MIM610188	#	12q21.3	JOUBERT SYNDROME 5; JBTS5	80184
MIM610189	#	12q21.3	SENIOR-LOKEN SYNDROME 6; SLSN6	80184
MIM610190	*	19q13.1	CARBOHYDRATE SULFOTRANSFERASE 8; CHST8	64377
MIM610191	*	 	CARBOHYDRATE SULFOTRANSFERASE 9; CHST9	83539
MIM610192	*	9p24.3-p23	GLIS FAMILY ZINC FINGER PROTEIN 3; GLIS3	169792
MIM610193	#	18q12.1-q12.2	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10; ARVD10	1829
MIM610194	*	 	BETA-1,3-N-ACETYLGALACTOSAMINYLTRANSFERASE 2; B3GALNT2	148789
MIM610195	*	 	PROSTATE TUMOR OVEREXPRESSED GENE 1; PTOV1	53635
MIM610196	*	4q31.1	ELMO DOMAIN-CONTAINING PROTEIN 2; ELMOD2	255520
MIM610197	*	19q13.3	MEDIATOR COMPLEX SUBUNIT 25; MED25	81857
MIM610198	#	3q26.3	3-@METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5	131118
MIM610199	#	9p24.3-p23	DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM	169792
MIM610200	*	 	MITOCHONDRIAL RIBOSOMAL PROTEIN L13; MRPL13	28998
MIM610201	*	 	KIAA1009 GENE; KIAA1009	22832
MIM610202	#	 	CATARACT, PULVERULENT, JUVENILE-ONSET	4094
MIM610203	*	 	CYSTEINE-RICH INHIBITOR OF PAK1	285464
MIM610205	#	1p13-p11	ALAGILLE SYNDROME 2; ALGS2	4853
MIM610206	*	20p13-p12	SOLUTE CARRIER FAMILY 4 (SODIUM BORATE COTRANSPORTER), MEMBER 11; SLC4A11	83959
MIM610207	*	 	SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 9; SLC4A9	83697
MIM610210	*	8q24.3	MAF1, S. CEREVISIAE, HOMOLOG OF; MAF1	84232
MIM610211	*	14q24.3	SRA STEM LOOP-INTERACTING RNA-BINDING PROTEIN	81892
MIM610212	%	6p22.3-p21.2	DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66	606719
MIM610213	%	5p15.2-p14.3	ANEURYSM, INTRACRANIAL BERRY, 4; ANIB4	724058
MIM610214	*	 	ENDOPLASMIC RETICULUM DEGRADATION-ENHANCING ALPHA-MANNOSIDASE-LIKE PROTEIN 3; EDEM3	80267
MIM610215	*	 	RAC- AND CDC42-SPECIFIC GUANINE NUCLEOTIDE EXCHANGE FACTOR	115557
MIM610216	*	19p13.11	ANOCTAMIN 8; ANO8	57719
MIM610217	#	22q13.1	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	8398
MIM610218	*	17q25.1	SAP30-BINDING PROTEIN; SAP30BP	29115
MIM610219	*	2q31.1-q31.3	DFNB59 GENE	494513
MIM610220	#	2q31.1-q31.3	DEAFNESS, AUTOSOMAL RECESSIVE 59; DFNB59	494513
MIM610221	*	 	AKT1 SUBSTRATE 1, PROLINE-RICH; AKT1S1	84335
MIM610222	*	20p11.22	RAS AND RAB INTERACTOR 2; RIN2	54453
MIM610223	*	 	RAS AND RAB INTERACTOR 3; RIN3	79890
MIM610224	*	 	SPERMATOGENESIS- AND OOGENESIS-SPECIFIC BASIC HELIX-LOOP-HELIX PROTEIN 1; SOHLH1	402381
MIM610225	*	22q13.1	RIBOSOMAL PROTEIN S19 BINDING PROTEIN 1; RPS19BP1	91582
MIM610226	*	17q25.3	ZINC FINGER PROTEIN 750; ZNF750	79755
MIM610227	#	17q25.3	SEBORRHEA-LIKE DERMATITIS WITH PSORIASIFORM ELEMENTS	79755
MIM610228	*	 	CALPAIN 13; CAPN13	92291
MIM610229	*	 	CALPAIN 14; CAPN14	440854
MIM610230	*	22q13	tRNA 5-METHYLAMINOMETHYL-2-THIOURIDYLATE METHYLTRANSFERASE; TRMU	55687
MIM610231	*	 	POLYCOMB GROUP RING FINGER PROTEIN 1; PCGF1	84759
MIM610232	*	 	ATPase, TYPE 13A3; ATP13A3	79572
MIM610233	^	 	MOVED TO 211900	 
MIM610234	%	14q11.2-q12	SYNPOLYDACTYLY 3; SPD3	780922
MIM610235	*	 	MITOCHONDRIAL PROTEIN, 18-KD	51537
MIM610236	*	2q31	LUNAPARK	80856
MIM610237	*	8q24.11	MEDIATOR COMPLEX SUBUNIT 30; MED30	90390
MIM610238	*	 	SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 11; SLC5A11	115584
MIM610239	%	4q32.3	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 4	100188806
MIM610240	*	 	LHFP-LIKE PROTEIN 4; LHFPL4	375323
MIM610241	*	 	RING FINGER PROTEIN 32; RNF32	140545
MIM610242	*	 	CHROMOSOME 7 OPEN READING FRAME 13; C7ORF13	129790
MIM610243	*	10q24.2	ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 27; ZFYVE27	118813
MIM610244	#	10q24.2	SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT; SPG33	118813
MIM610245	#	20p13	SPINOCEREBELLAR ATAXIA 23; SCA23	5173
MIM610246	#	18p11	SPINOCEREBELLAR ATAXIA 28; SCA28	10939
MIM610247	%	17q11.2	ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	100302511
MIM610248	%	20q13.2-q13.3	DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65	692219
MIM610249	*	 	PROTEIN O-FUCOSYLTRANSFERASE 2; POFUT2	23275
MIM610250	#	2p11.2	SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT; SPG31	65055
MIM610251	#	12q24.2	ALCOHOL SENSITIVITY, ACUTE	217
MIM610252	*	 	MICRO RNA 1-2; MIRN1-2	406905
MIM610253	#	9q34.3	KLEEFSTRA SYNDROME	79813
MIM610254	*	 	MICRO RNA 133A1; MIRN133A1	406922
MIM610255	*	 	MICRO RNA 133A2; MIRN133A2	406923
MIM610256	#	1p32	APHAKIA, CONGENITAL PRIMARY	2301
MIM610257	*	 	SEC31, YEAST, HOMOLOG OF, A; SEC31A	22872
MIM610258	*	 	SEC31, YEAST, HOMOLOG OF, B; SEC31B	25956
MIM610259	*	21q22.3	NONCODING RNA 163; NCRNA00163	727699
MIM610260	%	16p13-p12	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 2; IHPS2	780923
MIM610261	%	20q11-q13	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 5	100188807
MIM610262	%	5p13-q12	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 6	100188808
MIM610263	*	 	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 13; DNAJB13	374407
MIM610264	*	 	TESTIS-PROSTATE-PLACENTA-EXPRESSED PROTEIN	374739
MIM610265	#	6p21.3	DEAFNESS, AUTOSOMAL RECESSIVE 67; DFNB67	222662
MIM610266	*	17q11.2	TAO KINASE 1; TAOK1	57551
MIM610267	*	 	METHIONINE AMINOPEPTIDASE 1D	254042
MIM610268	*	 	MONOACYLGLYCEROL O-ACYLTRANSFERASE 1; MOGAT1	116255
MIM610269	#	 	BULIMIA NERVOSA, SUSCEPTIBILITY TO, 2; BULN2	627
MIM610270	*	 	MONOACYLGLYCEROL O-ACYLTRANSFERASE 2; MOGAT2	80168
MIM610271	*	 	PHOSPHATIDYLINOSITOL GLYCAN, CLASS S; PIGS	94005
MIM610272	*	 	PHOSPHATIDYLINOSITOL GLYCAN, CLASS T; PIGT	51604
MIM610273	*	1q23.2	PHOSPHATIDYLINOSITOL GLYCAN, CLASS M; PIGM	93183
MIM610274	*	1p36.11	PHOSPHATIDYLINOSITOL GLYCAN, CLASS V; PIGV	55650
MIM610275	*	17q12	PHOSPHATIDYLINOSITOL GLYCAN, CLASS W; PIGW	284098
MIM610276	*	3q29	PHOSPHATIDYLINOSITOL GLYCAN, CLASS X; PIGX	54965
MIM610277	*	12q24	ORAI CALCIUM RELEASE-ACTIVATED CALCIUM MODULATOR 1; ORAI1	84876
MIM610278	*	 	PLATELET ENDOTHELIAL AGGREGATION RECEPTOR 1	375033
MIM610280	*	 	OSTEOCRIN; OSTN	344901
MIM610281	*	5q35.3	ZINC FINGER PROTEIN 62; ZFP62	643836
MIM610282	#	1q22	RETINITIS PIGMENTOSA 35; RP35	64218
MIM610283	#	1q22	CONE-ROD DYSTROPHY 10; CORD10	64218
MIM610284	*	2q11.2	LIPOYLTRANSFERASE 1; LIPT1	51601
MIM610285	*	4p16.2	DOWNSTREAM OF TYROSINE KINASE 7; DOK7	285489
MIM610286	*	16p12.3-p12.1	LEUCINE CARBOXYL METHYLTRANSFERASE 1; LCMT1	51451
MIM610287	*	 	F-BOX AND LEUCINE-RICH REPEAT PROTEIN 15; FBXL15	79176
MIM610288	*	15q22	GOLGI AUTOANTIGEN, GOLGIN SUBFAMILY A, 6; GOLGA6	342096
MIM610289	*	 	3-@OXOACID CoA TRANSFERASE 2; OXCT2	64064
MIM610290	*	9q22	UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 12; GALNT12	79695
MIM610291	*	 	SYNAPTIC VESICLE GLYCOPROTEIN 2C; SV2C	22987
MIM610292	*	4q22-q24	B-CELL SCAFFOLD PROTEIN WITH ANKYRIN REPEATS 1; BANK1	55024
MIM610293	#	1q23.2	GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	93183
MIM610294	%	6p25.3-p22.3	INTELLIGENCE QUANTITATIVE TRAIT LOCUS 2	100462722
MIM610295	%	2q24.1-q31.1	INTELLIGENCE QUANTITATIVE TRAIT LOCUS 3	100462723
MIM610296	*	 	NUDC DOMAIN-CONTAINING PROTEIN 3; NUDCD3	23386
MIM610297	#	2p12	PARKINSON DISEASE 13, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK13	27429
MIM610298	*	 	PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY B, MEMBER 2; PHLDB2	90102
MIM610299	*	 	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 17; SLC6A17	388662
MIM610300	*	5p15.33	SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 18; SLC6A18	348932
MIM610301	*	 	TRANSMEMBRANE PROTEIN 57; TMEM57	55219
MIM610302	*	 	ENDOPLASMIC RETICULUM DEGRADATION-ENHANCING ALPHA-MANNOSIDASE-LIKE PROTEIN 2; EDEM2	55741
MIM610303	*	8q24	V-MAF AVIAN MUSCULOAPONEUROTIC FIBROSARCOMA ONCOGENE HOMOLOG A; MAFA	389692
MIM610304	*	 	DER1-LIKE DOMAIN FAMILY, MEMBER 2; DERL2	51009
MIM610305	*	 	DER1-LIKE DOMAIN FAMILY, MEMBER 3; DERL3	91319
MIM610306	*	 	NEPHRONECTIN; NPNT	255743
MIM610307	*	 	CERAMIDE KINASE; CERK	64781
MIM610308	*	13q12.3	UDP-GAL:BETA-GlcNAc BETA-1,3-GALACTOSYLTRANSFERASE-LIKE; B3GALTL	145173
MIM610309	*	19q13.42	UBIQUITIN-CONJUGATING ENZYME E2S; UBE2S	27338
MIM610310	*	4q31.1	LOC152586 GENE	152586
MIM610311	*	 	MEDIATOR COMPLEX SUBUNIT 28; MED28	80306
MIM610312	*	8p21.3	PIWI-LIKE 2: PIWIL2	55124
MIM610313	#	11q13.3	COLD-INDUCED SWEATING SYNDROME 2; CISS2	23529
MIM610314	*	 	PIWI-LIKE 3: PIWIL3	440822
MIM610315	*	 	PIWI-LIKE 4; PIWIL4	143689
MIM610316	*	 	POLYRIBONUCLEOTIDE NUCLEOTIDYLTRANSFERASE 1; PNPT1	87178
MIM610317	*	 	CORDON-BLEU, MOUSE, HOMOLOG OF; COBL	23242
MIM610318	*	 	COBL-LIKE PROTEIN 1: COBLL1	22837
MIM610320	%	 	MYOPIA 14; MYP14	100359407
MIM610321	%	15q12	PROSTATE CANCER, HEREDITARY, 7; HPC7	100188809
MIM610322	*	 	TRANSCRIPTIONAL REGULATING FACTOR 1; TRERF1	55809
MIM610323	*	8q22-q23	METADHERIN; MTDH	92140
MIM610324	*	3p24.2	3-@OXOACYL-ACP SYNTHASE, MITOCHONDRIAL; OXSM	54995
MIM610325	*	 	NUCLEAR DISTRIBUTION GENE C, A. NIDULANS, HOMOLOG OF; NUDC	10726
MIM610326	*	13q14.1	RIBONUCLEASE H2, SUBUNIT B; RNASEH2B	79621
MIM610327	*	 	RUN AND FYVE DOMAINS-CONTAINING PROTEIN 1; RUFY1	80230
MIM610328	*	 	RUN AND FYVE DOMAINS-CONTAINING PROTEIN 2; RUFY2	55680
MIM610329	#	11q13.2	AICARDI-GOUTIERES SYNDROME 3; AGS3	84153
MIM610330	*	11q13.2	RIBONUCLEASE H2, SUBUNIT C; RNASEH2C	84153
MIM610331	*	2q37.3	HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 6; HES6	55502
MIM610333	#	19p13.13	AICARDI-GOUTIERES SYNDROME 4; AGS4	10535
MIM610334	*	 	HEPATOCELLULAR CARCINOMA-ASSOCIATED ANTIGEN 112	55365
MIM610335	*	 	PHD FINGER PROTEIN 20; PHF20	51230
MIM610336	*	19p13.3	C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 4C; C2CD4C	126567
MIM610337	*	7p13	UPREGULATOR OF CELL PROLIFERATION; URGCP	55665
MIM610339	*	1p34	LEUCINE- AND PROLINE-ENRICHED PROTEOGLYCAN 1; LEPRE1	64175
MIM610340	*	9q31-q32	ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 4B; EPB41L4B	54566
MIM610341	*	 	LEPRECAN-LIKE 1; LEPREL1	55214
MIM610342	*	 	LEPRECAN-LIKE 2; LEPREL2	10536
MIM610343	*	15q21.3	C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 4A; C2CD4A	145741
MIM610344	*	15q21.3	C2 CALCIUM-DEPENDENT DOMAIN-CONTAINING PROTEIN 4B; C2CD4B	388125
MIM610345	*	7q34	ACYLGLYCEROL KINASE; AGK	55750
MIM610346	*	 	CDC37-LIKE 1; CDC37L1	55664
MIM610347	*	 	REGULATION OF NUCLEAR PRE-mRNA DOMAIN-CONTAINING PROTEIN 1A; RPRD1A	55197
MIM610348	*	10q24	FAMILY WITH SEQUENCE SIMILARITY 178, MEMBER A; FAM178A	55719
MIM610349	*	 	MEF2-ACTIVATING SAP TRANSCRIPTIONAL REGULATOR	284358
MIM610350	*	 	LINES, DROSOPHILA, HOMOLOG OF, 1; LINS1	55180
MIM610351	*	 	SUPPRESSOR OF MEK1, DICTYOSTELIUM, HOMOLOG OF, 1; SMEK1	55671
MIM610352	*	 	SUPPRESSOR OF MEK1, DICTYOSTELIUM, HOMOLOG OF, 2; SMEK2	57223
MIM610353	#	8p21	EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 4	1135
MIM610354	*	 	CONNEXIN 43-INTERACTING PROTEIN, 150-KD; CIP150	57589
MIM610355	*	16p12	PARTNER AND LOCALIZER OF BRCA2; PALB2	79728
MIM610356	#	9p24.2	RETINAL CONE DYSTROPHY 3B; RCD3B	169522
MIM610357	#	 	SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE; SPG30	547
MIM610358	*	 	SIGNAL PEPTIDASE COMPLEX, SUBUNIT 1, S. CEREVISIAE, HOMOLOG OF; SPCS1	28972
MIM610359	#	2q11.2	RETINITIS PIGMENTOSA 33; RP33	23020
MIM610360	*	 	MUCIN 20, CELL SURFACE-ASSOCIATED; MUC20	200958
MIM610361	%	13q33.1-q34	OROFACIAL CLEFT 9; OFC9	100462724
MIM610362	*	19p13.3	RETINA AND ANTERIOR NEURAL FOLD HOMEOBOX-LIKE 1; RAXL1	84839
MIM610363	*	 	PEPTIDYLARGININE DEIMINASE, TYPE VI; PADI6	353238
MIM610364	*	 	TRANSMEMBRANE BAX INHIBITOR MOTIF-CONTAINING PROTEIN 1; TMBIM1	64114
MIM610365	*	 	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 1; C1QTNF1	114897
MIM610366	*	 	ADAPTOR-RELATED PROTEIN COMPLEX 3, MU-1 SUBUNIT; AP3M1	26985
MIM610367	*	 	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 11; SLC2A11	66035
MIM610368	*	13q14	LEUCINE-RICH REPEATS AND CALPONIN HOMOLOGY DOMAIN-CONTAINING 1; LRCH1	23143
MIM610369	*	10p12.3	HEAT-SHOCK 70-KD PROTEIN 14; HSPA14	51182
MIM610370	#	10q21.3	DIARRHEA 4, MALABSORPTIVE, CONGENITAL; DIAR4	50674
MIM610371	*	1p36.2	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 7; SLC2A7	155184
MIM610372	*	 	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 12; SLC2A12	154091
MIM610373	*	 	DEAD/H BOX 50; DDX50	79009
MIM610374	#	11p15.1	DIABETES MELLITUS, TRANSIENT NEONATAL, 2	6833
MIM610375	*	 	C1q DOMAIN-CONTAINING PROTEIN 1; C1QDC1	65981
MIM610376	*	2q37	CHEMOKINE, CXC MOTIF, RECEPTOR 7; CXCR7	57007
MIM610377	#	12q24	MEVALONIC ACIDURIA; MEVA	4598
MIM610378	*	 	GLIS FAMILY ZINC FINGER PROTEIN 1; GLIS1	148979
MIM610379	#	3p21	WEST NILE VIRUS, SUSCEPTIBILITY TO	1234
MIM610380	^	3p22	LOEYS-DIETZ SYNDROME, TYPE 2B; LDS2B	7048
MIM610381	#	19p13.3	CONE-ROD DYSTROPHY 11; CORD11	84839
MIM610383	*	 	RAS ASSOCIATION DOMAIN FAMILY, MEMBER 9; RASSF9	9182
MIM610384	*	 	HECT, C2, AND WW DOMAINS-CONTAINING E3 UBIQUITIN-PROTEIN LIGASE 1; HECW1	23072
MIM610385	*	 	LR8 PROTEIN; LR8	28959
MIM610386	*	14q32.1	BTB/POZ DOMAIN-CONTAINING PROTEIN 7; BTBD7	55727
MIM610387	*	 	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL IRON CARRIER), MEMBER 37; SLC25A37	51312
MIM610388	*	 	RAS (RAD AND GEM)-LIKE GTP-BINDING 1; REM1	28954
MIM610389	*	1q22	MAPBP-INTERACTING PROTEIN	28956
MIM610390	*	 	MACROPHAGE EXPRESSED GENE 1	219972
MIM610391	*	 	PLASTICITY-RELATED GENE 2	79948
MIM610392	*	 	MYC-BINDING PROTEIN 2; MYCBP2	23077
MIM610393	*	 	GON4-LIKE PROTEIN; GON4L	54856
MIM610394	*	 	GLIPR1-LIKE PROTEIN 2; GLIPR1L2	144321
MIM610395	*	 	GLIPR1-LIKE PROTEIN 1; GLIPR1L1	256710
MIM610396	*	 	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 6A; TRAPPC6A	79090
MIM610397	*	 	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 6B; TRAPPC6B	122553
MIM610398	*	 	SAP30-LIKE PROTEIN; SAP30L	79685
MIM610399	*	 	TRANSMEMBRANE PROTEASE, SERINE 11E; TMPRSS11E	28983
MIM610400	*	 	MACRO DOMAIN-CONTAINING 1; MACROD1	28992
MIM610401	*	12q22-q23	NETRIN 4; NTN4	59277
MIM610402	^	2p15-q14	MOVED TO 609122 AND 300870	100188810
MIM610403	*	 	CULLIN-ASSOCIATED NEDDYLATION-DISSOCIATED 2; CAND2	23066
MIM610404	*	9q21.32	RECQ-MEDIATED GENOME INSTABILITY 1, S. CEREVISIAE, HOMOLOG OF; RMI1	80010
MIM610405	*	2q36.1	CHONDROITIN POLYMERIZING FACTOR; CHPF	79586
MIM610406	*	17p13.1	TRANSFER RNA ARGININE 1; TRNAR1	7230
MIM610407	*	17p13.1	TRANSFER RNA GLYCINE 2; TRNAG2	7196
MIM610408	*	 	SOLUTE CARRIER FAMILY 15 (OLIGOPEPTIDE TRANSPORTER), MEMBER 3; SLC15A3	51296
MIM610409	*	 	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 8; SLC16A8	23539
MIM610410	*	 	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 1; DHRS1	115817
MIM610411	*	 	IMPORTIN 13; IPO13	9670
MIM610412	*	 	SERINE PALMITOYLTRANSFERASE, SMALL SUBUNIT, B; SPTSSB	165679
MIM610413	*	 	INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-LIKE 1; IGFBPL1	347252
MIM610414	*	1q21.1	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 15; NBPF15	284565
MIM610415	*	 	SYNTAXIN-BINDING PROTEIN 4; STXBP4	252983
MIM610416	*	 	SCAN DOMAIN-CONTAINING 1; SCAND1	51282
MIM610417	*	 	SCAN DOMAIN-CONTAINING 2; SCAND2	54581
MIM610418	*	 	WD REPEAT- AND FYVE DOMAIN-CONTAINING PROTEIN 2; WDFY2	115825
MIM610419	%	 	DEAFNESS, AUTOSOMAL RECESSIVE 68; DFNB68	751609
MIM610421	*	8q24.2	KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED PROTEIN 3; KHDRBS3	10656
MIM610422	%	3q26.2-q26.31	ALOPECIA-MENTAL RETARDATION SYNDROME 2; APMR2	100049544
MIM610423	*	 	PHOSPHOFURIN ACIDIC CLUSTER SORTING PROTEIN 2; PACS2	23241
MIM610424	#	6q23-q24, 21q22.1, 21q22.1	HEPATITIS B VIRUS, SUSCEPTIBILITY TO	3455, 3459, 3588
MIM610425	#	22q11.2-q13.1	CATARACT, LAMELLAR 2	1413
MIM610426	^	22q11.2-q13.1	MICROPHTHALMIA, ISOLATED, WITH CATARACT 4; MCOPCT4	1413
MIM610427	#	11q13.1	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B; CSNB2B	57010
MIM610428	*	 	CYTOCHROME c OXIDASE ASSEMBLY PROTEIN COX18; COX18	285521
MIM610429	*	 	CYTOCHROME c OXIDASE ASSEMBLY PROTEIN COX19; COX19	90639
MIM610430	%	4q	MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 2; WM2	100188811
MIM610431	*	 	RING FINGER PROTEIN 167; RNF167	26001
MIM610432	*	 	RING FINGER PROTEIN 125; RNF125	54941
MIM610433	*	 	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G5B; LY6G5B	58496
MIM610434	*	 	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G5C; LY6G5C	80741
MIM610435	*	 	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G6C; LY6G6C	80740
MIM610436	*	 	ROTATIN; RTTN	25914
MIM610437	*	 	LYMPHOCYTE ANTIGEN 6 COMPLEX, LOCUS G6E; LY6G6E	79136
MIM610438	%	9p24-p22	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 3; RLS3	100188812
MIM610439	%	2q33	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 4; RLS4	100188813
MIM610440	*	 	SMALL G PROTEIN SIGNALING MODULATOR 3; SGSM3	27352
MIM610441	%	4p15.31-p15.2	TESTICULAR MICROLITHIASIS	10568
MIM610443	#	17q21.31	KOOLEN-DE VRIES SYNDROME; KDVS	284058, 791085
MIM610444	#	3p21	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3	2779
MIM610445	#	3q21-q24	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1; CSNBAD1	6010
MIM610446	#	2q35	BURULI ULCER, SUSCEPTIBILITY TO	6556
MIM610447	*	10q26.3	SHADOW OF PRION PROTEIN; SPRN	503542
MIM610448	#	3p21, 3p21.3-p21.2	CHILBLAIN LUPUS 1; CHBL1	11277
MIM610449	*	 	MITOCHONDRIAL CARRIER HOMOLOG 1; MTCH1	23787
MIM610450	*	 	LY6/PLAUR DOMAIN-CONTAINING PROTEIN 1; LYPD1	116372
MIM610451	*	 	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 35; LRRC35	219899
MIM610453	*	8p11.1	HEPARAN-ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE; HGSNAT	138050
MIM610454	*	 	LEUCINE ZIPPER, PUTATIVE TUMOR SUPPRESSOR 2; LZTS2	84445
MIM610455	#	7q21	TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL; NFTC	54809
MIM610456	*	7q21	STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 9; SAMD9	54809
MIM610457	*	 	SPHINGOMYELIN PHOSPHODIESTERASE 4, NEUTRAL MEMBRANE; SMPD4	55627
MIM610458	*	 	LEUCINE ZIPPER AND CTNNBIP1 DOMAINS-CONTAINING PROTEIN; LZIC	84328
MIM610459	*	 	PROLINE-RICH PROTEIN 13; PRR13	54458
MIM610460	#	6p22.3	THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	7172
MIM610461	*	 	RETICULON 4 RECEPTOR-LIKE 1; RTN4RL1	146760
MIM610462	*	 	RETICULON 4 RECEPTOR-LIKE 2; RTN4RL2	349667
MIM610463	*	6q22.31	NUCLEAR UNDECAPRENYL PYROPHOSPHATE SYNTHASE 1, S. CEREVISIAE, HOMOLOG OF; NUS1	116150
MIM610464	*	3q13-q22	G PROTEIN-COUPLED RECEPTOR 156; GPR156	165829
MIM610465	*	17q21.33	ACYL-CoA SYNTHETASE FAMILY, MEMBER 2; ACSF2	80221
MIM610466	*	 	LIMB EXPRESSION 1, MOUSE, HOMOLOG OF; LIX1	167410
MIM610467	*	10p14-p13	PROTEIN TYROSINE PHOSPHATASE-LIKE (PROLINE INSTEAD OF CATALYTIC ARGININE), MEMBER A; PTPLA	9200
MIM610468	*	1p31.1	INTERFERON-INDUCED PROTEIN 44; IFI44	10561
MIM610469	*	 	ADAPTOR-RELATED PROTEIN COMPLEX 3, MU-2 SUBUNIT; AP3M2	10947
MIM610470	*	11q13	TRANSFER RNA PHOSPHOTRANSFERASE 1; TRPT1	83707
MIM610471	*	 	VASOHIBIN 2; VASH2	79805
MIM610472	*	 	ACYLTRANSFERASE-LIKE 2; AYTL2	79888
MIM610473	*	 	LYSOPHOSPHATIDYLGLYCEROL ACYLTRANSFERASE 1; LPGAT1	9926
MIM610474	#	4p16.3	CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	2261
MIM610475	#	2q31.2	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2; PPNAD2	50940
MIM610476	#	18q12.1	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11; ARVD11	1824
MIM610477	*	 	TRANSMEMBRANE PROTEASE, SERINE 9; TMPRSS9	360200
MIM610478	#	12p13.3	RETINAL CONE DYSTROPHY 4; RCD4	93589
MIM610479	*	5q23.1	SERUM RESPONSE FACTOR BINDING PROTEIN 1; SRFBP1	153443
MIM610480	*	 	LEM DOMAIN-CONTAINING PROTEIN 1; LEMD1	93273
MIM610481	*	 	SH2 DOMAIN-CONTAINING PROTEIN D; SHD	56961
MIM610482	*	 	SH2 DOMAIN-CONTAINING PROTEIN E; SHE	126669
MIM610484	*	 	PROLINE-RICH SYNAPSE-ASSOCIATED PROTEIN-INTERACTING PROTEIN 1	9762
MIM610485	*	 	LOSS OF HETEROZYGOSITY, CHROMOSOME 3, REGION 2, GENE A; LOH3CR2A	29931
MIM610486	*	 	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 4; LRRC4	64101
MIM610487	*	 	KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED PROTEIN 2; KHDRBS2	202559
MIM610488	*	 	TETRATRICOPEPTIDE REPEAT DOMAIN 9; TTC9	23508
MIM610489	#	17q23-q24	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1; PPNAD1	5573
MIM610490	*	 	PURPLE ACID PHOSPHATASE, LONG FORM	390928
MIM610491	*	 	SLAIN MOTIF FAMILY, MEMBER 1; SLAIN1	122060
MIM610492	*	 	SLAIN MOTIF FAMILY, MEMBER 2; SLAIN2	57606
MIM610493	*	 	DIX DOMAIN-CONTAINING PROTEIN 1; DIXDC1	85458
MIM610494	*	 	DDB1- AND CUL4-ASSOCIATED FACTOR 6; DCAF6	55827
MIM610495	*	 	HOM-TES-103 GENE	25900
MIM610496	*	1p22.1	RHO GTPase-ACTIVATING PROTEIN 29; ARHGAP29	9411
MIM610497	*	 	BRAIN AND REPRODUCTIVE ORGAN-EXPRESSED PROTEIN; BRE	9577
MIM610498	#	10q22.1	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	51021
MIM610499	*	5q31.1	RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 6; RAPGEF6	51735
MIM610500	*	5q31.3	ANKYRIN REPEAT AND KH DOMAIN-CONTAINING PROTEIN 1; ANKHD1	54882
MIM610501	*	1p36.2	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 1; NBPF1	55672
MIM610502	*	6q21	RETICULON 4-INTERACTING PROTEIN 1; RTN4IP1	84816
MIM610503	*	16p13.3	CHROMOSOME 16 OPEN READING FRAME 5; C16ORF5	29965
MIM610504	#	11q13.5	PRETERM PREMATURE RUPTURE OF THE MEMBRANES; PPROM	871
MIM610505	#	12q13-q14	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3; COXPD3	10102
MIM610506	*	19q13.2	PAF1 RNA POLYMERASE II-ASSOCIATED FACTOR, S. CEREVISIAE, HOMOLOG OF; PAF1	54623
MIM610507	*	15q15.3	LEO1 RNA POLYMERASE II ASSOCIATED FACTOR, S. CEREVISIAE, HOMOLOG OF; LEO1	123169
MIM610508	#	2p25	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7; MODY7	8462
MIM610509	*	 	RESISTANCE TO INHIBITORS OF CHOLINESTERASE 3, C. ELEGANS, HOMOLOG OF; RIC3	79608
MIM610510	*	 	AURORA BOREALIS; BORA	79866
MIM610511	*	14q21.1	SEC23, S. CEREVISIAE, HOMOLOG OF, A; SEC23A	10484
MIM610512	*	20p11.2	SEC23, S. CEREVISIAE, HOMOLOG OF, B; SEC23B	10483
MIM610513	*	1p36	ATPase, TYPE 13A2; ATP13A2	23400
MIM610514	*	 	PHD FINGER PROTEIN 17; PHF17	79960
MIM610515	*	 	PHD FINGER PROTEIN 15; PHF15	23338
MIM610516	*	3p21	GLYCERATE KINASE; GLYCTK	132158
MIM610517	*	 	CONTACTIN-ASSOCIATED PROTEIN-LIKE 3; CNTNAP3	79937
MIM610518	*	 	CONTACTIN-ASSOCIATED PROTEIN-LIKE 4; CNTNAP4	85445
MIM610519	*	 	CONTACTIN-ASSOCIATED PROTEIN-LIKE 5; CNTNAP5	129684
MIM610520	*	 	CD300 ANTIGEN-LIKE FAMILY, MEMBER G; CD300LG	146894
MIM610521	*	 	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 12; KCTD12	115207
MIM610522	*	 	COORDINATED EXPRESSION TO IRXA2	153571
MIM610523	*	 	CENTROSOMAL PROTEIN, 41-KD; CEP41	95681
MIM610524	*	 	HUMAN ENDOGENOUS RETROVIRUS FRD ENVELOPE PROTEIN	405754
MIM610525	*	 	5-PRIME-@NUCLEOTIDASE, CYTOSOLIC, IA; NT5C1A	84618
MIM610526	*	 	5-PRIME-@NUCLEOTIDASE, CYTOSOLIC, IB; NT5C1B	93034
MIM610527	*	14q22.1	THIOREDOXIN DOMAIN-CONTAINING PROTEIN 1; TXNDC1	81542
MIM610528	*	14q11.2	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 8; CHD8	57680
MIM610529	*	9p21	TUMOR SUPPRESSOR CANDIDATE 1; TUSC1	286319
MIM610530	*	5q35.3	TRIPARTITE MOTIF-CONTAINING 41; TRIM41	90933
MIM610531	*	7p15.3	FAMILY WITH SEQUENCE SIMILARITY 126, MEMBER A; FAM126A	84668
MIM610532	#	7p15.3	LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	84668
MIM610533	*	5q34-q35.2	WW, C2, AND COILED-COIL DOMAIN-CONTAINING 1; WWC1	23286
MIM610534	*	 	DECAPPING ENZYME, SCAVENGER; DCPS	28960
MIM610535	%	5q22.1-q32	GLAUCOMA 1, OPEN ANGLE, M; GLC1M	777643
MIM610536	#	 	MANDIBULOFACIAL DYSOSTOSIS WITH MICROCEPHALY; MFDM	9343
MIM610537	*	 	DIPEPTIDYL PEPTIDASE VII; DPP7	29952
MIM610538	*	1q31	UBIQUITIN-CONJUGATING ENZYME E2T; UBE2T	29089
MIM610539	#	10q22.1	GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	5660
MIM610540	*	20q13.2	GNAS COMPLEX LOCUS, ANTISENSE TRANSCRIPT 1; GNASAS1	149775
MIM610541	*	 	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 3B; PPP1R3B	79660
MIM610542	#	 	MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 1; CMSTA1	2673
MIM610543	#	16p13.3	CHROMOSOME 16p13.3 DELETION SYNDROME, PROXIMAL	100188814
MIM610544	*	19p13.3	IGF-LIKE FAMILY MEMBER 1; IGFL1	374918
MIM610545	*	19p13.3	IGF-LIKE FAMILY MEMBER 2; IGFL2	147920
MIM610546	*	19p13.3	IGF-LIKE FAMILY MEMBER 3; IGFL3	388555
MIM610547	*	19p13.3	IGF-LIKE FAMILY MEMBER 4; IGFL4	444882
MIM610548	*	 	AQUARIUS, MOUSE, HOMOLOG OF; AQR	9716
MIM610549	#	19p13.2	DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS	3643
MIM610550	*	10q22	METHIONINE ADENOSYLTRANSFERASE I, ALPHA; MAT1A	4143
MIM610551	#	11q13	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 1	81622
MIM610552	*	3q22	UBIQUITIN-ACTIVATING ENZYME E1 DOMAIN-CONTAINING 1; UBE1DC1	79876
MIM610553	*	 	UBIQUITIN-FOLD MODIFIER 1; UFM1	51569
MIM610554	*	 	UBIQUITIN-FOLD MODIFIER-CONJUGATING ENZYME 1; UFC1	51506
MIM610555	*	7p14-p13	CORE 1 SYNTHASE, GLYCOPROTEIN-N-ACETYLGALACTOSAMINE 3-BETA-GALACTOSYLTRANSFERASE, 1; C1GALT1	56913
MIM610556	*	20q13.33	HIGHLY ACCELERATED REGION GENE 1A; HAR1A	768096
MIM610557	*	20q13.33	HIGHLY ACCELERATED REGION GENE 1B; HAR1B	768097
MIM610558	*	 	MITOGEN-ACTIVATED PROTEIN KINASE-ASSOCIATED PROTEIN 1; MAPKAP1	79109
MIM610559	*	 	RAS ASSOCIATION DOMAIN FAMILY, MEMBER 4; RASSF4	83937
MIM610560	*	 	PROTEASE, SERINE, 36; PRSS36	146547
MIM610561	*	 	POLYSERASE 3	339105
MIM610562	*	 	ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 12A; ZC3H12A	80149
MIM610563	*	 	KARYOPHERIN ALPHA-6; KPNA6	23633
MIM610564	*	6q21	PRENYL DIPHOSPHATE SYNTHASE, SUBUNIT 2; PDSS2	57107
MIM610565	*	 	DYNEIN, AXONEMAL, LIGHT CHAIN 4; DNAL4	10126
MIM610566	*	5q33.3	MICRO RNA 146A; MIR146A	406938
MIM610567	*	 	MICRO RNA 146B; MIRN146B	574447
MIM610568	*	1q21.2	ZINC FINGER PROTEIN 687; ZNF687	57592
MIM610569	*	1p32.3	UBIQUITIN-SPECIFIC PROTEASE 24; USP24	23358
MIM610570	*	 	UBIQUITIN-SPECIFIC PROTEASE 40; USP40	55230
MIM610571	*	 	FK506-BINDING PROTEIN 11; FKBP11	51303
MIM610572	*	5q13.1	MARVEL DOMAIN-CONTAINING PROTEIN 2; MARVELD2	153562
MIM610573	*	20p13	R-SPONDIN FAMILY, MEMBER 4; RSPO4	343637
MIM610574	*	 	R-SPONDIN FAMILY, MEMBER 3; RSPO3	84870
MIM610575	*	8q23.1	R-SPONDIN FAMILY, MEMBER 2; RSPO2	340419
MIM610576	*	12q14	RHO GTPase-ACTIVATING PROTEIN 9; ARHGAP9	64333
MIM610577	*	10p12	RHO GTPase-ACTIVATING PROTEIN 12; ARHGAP12	94134
MIM610578	*	 	RHO GTPase-ACTIVATING PROTEIN 15; ARHGAP15	55843
MIM610579	*	 	RCSD DOMAIN-CONTAINING PROTEIN 1; RCSD1	92241
MIM610580	*	 	ONCOGENE PIM3; PIM3	415116
MIM610581	*	 	COATOMER PROTEIN COMPLEX, SUBUNIT GAMMA-2, INTRONIC TRANSCRIPT 1; COPG2IT1	53844
MIM610582	#	11p15.1	DIABETES MELLITUS, TRANSIENT NEONATAL, 3	3767
MIM610583	*	6q14-q16	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 6; ANKRD6	22881
MIM610584	*	 	TRIPARTITE MOTIF-CONTAINING PROTEIN 67; TRIM67	440730
MIM610585	*	 	RHO GTPase-ACTIVATING PROTEIN 22; ARHGAP22	58504
MIM610586	*	4q21	RHO GTPase-ACTIVATING PROTEIN 24; ARHGAP24	83478
MIM610587	*	2p13	RHO GTPase-ACTIVATING PROTEIN 25; ARHGAP25	9938
MIM610588	*	12q13.1	DENDRIN; DDN	23109
MIM610589	*	15q13.2	RHO GTPase-ACTIVATING PROTEIN 11A; ARHGAP11A	9824
MIM610590	*	17q12	RHO GTPase-ACTIVATING PROTEIN 23; ARHGAP23	57636
MIM610591	*	17q21	RHO GTPase-ACTIVATING PROTEIN 27; ARHGAP27	201176
MIM610592	*	18p11.31	RHO GTPase-ACTIVATING PROTEIN 28; ARHGAP28	79822
MIM610593	*	3q27	MAP6 DOMAIN-CONTAINING PROTEIN 1; MAP6D1	79929
MIM610594	*	5q23.3	FOLLICULIN-INTERACTING PROTEIN 1; FNIP1	96459
MIM610595	*	1q21.3	FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE, S. CEREVISIAE, HOMOLOG OF; FLAD1	80308
MIM610596	*	8q24	BLOCK OF PROLIFERATION 1; BOP1	23246
MIM610597	*	19q13.3	GLUTAMATE-RICH WD REPEAT-CONTAINING PROTEIN 1; GRWD1	83743
MIM610598	*	17q22	PRCD, DOG, HOMOLOG OF; PRCD	768206
MIM610599	#	17q22	RETINITIS PIGMENTOSA 36; RP36	768206
MIM610600	#	8q21	CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY	1585
MIM610601	*	19q13.4	KALLIKREIN-RELATED PEPTIDASE 15; KLK15	55554
MIM610602	*	12q23.3	AlkB, E. COLI, HOMOLOG OF, 2; ALKBH2	121642
MIM610603	*	11p11.12	AlkB, E. COLI, HOMOLOG OF, 3; ALKBH3	221120
MIM610604	*	19q13.4	KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, THREE DOMAINS, PSEUDOGENE 1; KIR3DP1	548594
MIM610605	*	4q32-q33	CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 2; CPEB2	132864
MIM610606	*	10q23.3	CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 3; CPEB3	22849
MIM610607	*	5q21	CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 4; CPEB4	80315
MIM610608	*	20p11.21	GINS COMPLEX SUBUNIT 1; GINS1	9837
MIM610609	*	16q24.1	GINS COMPLEX SUBUNIT 2; GINS2	51659
MIM610610	*	16q21	GINS COMPLEX SUBUNIT 3; GINS3	64785
MIM610611	*	8p11.21	GINS COMPLEX SUBUNIT 4; GINS4	84296
MIM610612	#	1q32.3	LEBER CONGENITAL AMAUROSIS 12; LCA12	343035
MIM610613	*	8q21	CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 1; CYP11B1	1584
MIM610614	*	11q24.2	TRANSFORMING GROWTH FACTOR-BETA REGULATOR 1; TBRG1	84897
MIM610615	*	9q34.3	PARTNER OF ARF	55684
MIM610616	*	18p11.22	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 12; ANKRD12	23253
MIM610617	*	1q32.1-q32.2	DENTICLELESS, DROSOPHILA, HOMOLOG OF; DTL	51514
MIM610618	#	5q33-qter	ANGIOEDEMA, HEREDITARY, TYPE III; HAE3	2161
MIM610619	*	5q33-qter	COAGULATION FACTOR XII; F12	2161
MIM610620	*	13q31	ADP-RIBOSYLHYDROLASE-LIKE 1; ADPRHL1	113622
MIM610621	*	4q28	INTURNED, DROSOPHILA, HOMOLOG OF; INTU	27152
MIM610622	*	19q13	FUZZY, DROSOPHILA, HOMOLOG OF; FUZ	80199
MIM610623	#	10q25	CATARACT, POSTERIOR POLAR, 4; CTPP4	5309
MIM610624	*	1p35.3-p34.1	ADP-RIBOSYLHYDROLASE-LIKE 2; ADPRHL2	54936
MIM610625	*	11p15	ADP-RIBOSYLTRANSFERASE 5; ART5	116969
MIM610626	*	8p12	PPAP2 DOMAIN-CONTAINING PROTEIN 1B; PPAPDC1B	84513
MIM610627	*	12p13.31	ALPHA-2-MACROGLOBULIN-LIKE 1; A2ML1	144568
MIM610628	#	3p21.1	HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	60675
MIM610629	#	10q22-q23	DIAMOND-BLACKFAN ANEMIA 3; DBA3	6229
MIM610630	*	 	PROTEIN TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 20A; PTPN20A	653129
MIM610631	*	 	PROTEIN TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 20B; PTPN20B	26095
MIM610632	*	 	EF-HAND DOMAIN FAMILY, MEMBER A1; EFHA1	221154
MIM610633	*	 	EF-HAND DOMAIN FAMILY, MEMBER A2; EFHA2	286097
MIM610634	^	14q22-q23	CATARACT, POSTERIOR POLAR, 5; CTPP5	791086
MIM610635	*	8q22.3	COLLAGEN TRIPLE-HELIX REPEAT-CONTAINING PROTEIN 1; CTHRC1	115908
MIM610636	*	9q22.32	MICRO RNA 27B; MIRN27B	407019
MIM610637	*	10q23.3	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 5; MARCH5	54708
MIM610638	*	21q22.2	JUNCTIONAL ADHESION MOLECULE 4	150084
MIM610639	*	 	GRID2-INTERACTING PROTEIN 1; GRID2IP1	392862
MIM610640	*	1p35	YTH DOMAIN FAMILY MEMBER 2; YTHDF2	51441
MIM610641	*	 	TERMINAL URIDYLYL TRANSFERASE 1, U6 snRNA-SPECIFIC; TUT1	64852
MIM610642	*	 	ENDOPLASMIC RETICULUM PROTEIN, 27-KD; ERP27	121506
MIM610643	*	3q13.13	KIAA1524 GENE; KIAA1524	57650
MIM610644	#	1p34.3	PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	284654
MIM610645	*	 	CALCIUM- AND INTEGRIN-BINDING PROTEIN 3; CIB3	117286
MIM610646	*	 	CALCIUM- AND INTEGRIN-BINDING PROTEIN 4	130106
MIM610647	*	 	N-ACETYLTRANSFERASE 8-LIKE; NAT8L	339983
MIM610648	*	 	CUT-LIKE 2; CUTL2	23316
MIM610649	%	8q24	BONE SIZE QUANTITATIVE TRAIT LOCUS 3	100188815
MIM610650	*	 	ADHESION-REGULATING MOLECULE 1; ADRM1	11047
MIM610651	#	2q21	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B; XPB	2071
MIM610652	*	 	PHOSPHODIESTERASE 10A; PDE10A	10846
MIM610653	*	 	RIBOSOMAL RNA-PROCESSING 1, S. CEREVISIAE, HOMOLOG OF; RRP1	8568
MIM610654	*	 	RIBOSOMAL RNA-PROCESSING PROTEIN 1, S. CEREVISIAE, HOMOLOG OF, B; RRP1B	23076
MIM610655	%	7p14	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	791087
MIM610656	*	1p22.2	CYSTEINE CONJUGATE BETA-LYASE 2; CCBL2	56267
MIM610657	*	8q24.13	KIAA0196 GENE; KIAA0196	9897
MIM610658	*	 	TRIPARTITE MOTIF-CONTAINING PROTEIN 29; TRIM29	23650
MIM610659	*	10q22	GLUTAMATE RECEPTOR, IONOTROPIC, DELTA 1; GRID1	2894
MIM610660	*	16p13.3	NUCLEAR PROTEIN, 60-KD	84656
MIM610661	*	3p24	N-GLYCANASE 1; NGLY1	55768
MIM610662	*	 	PHOSPHATIDYLINOSITOL GLYCAN, CLASS Y; PIGY	84992
MIM610663	*	1q41	SET AND MYND DOMAIN-CONTAINING PROTEIN 2; SMYD2	56950
MIM610664	*	 	BREAST CANCER-OVEREXPRESSED GENE 1	9703
MIM610665	*	1q23	Fc FRAGMENT OF IgG, LOW AFFINITY IIIb, RECEPTOR FOR; FCGR3B	2215
MIM610666	*	20p13	NEURENSIN 2; NRSN2	80023
MIM610667	*	1q32	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE L5; UCHL5	51377
MIM610668	*	11p15.2	INSCUTEABLE, DROSOPHILA, HOMOLOG OF; INSC	387755
MIM610669	*	4p16.3	TNFAIP3-INTERACTING PROTEIN 2; TNIP2	79155
MIM610670	*	4q25	CYTOCHROME P450, FAMILY 2, SUBFAMILY U, POLYPEPTIDE 1; CYP2U1	113612
MIM610671	*	19q13.4	ZINC FINGER PROTEIN 628; ZNF628	89887
MIM610672	*	 	BTB/POZ DOMAIN-CONTAINING PROTEIN 14B; BTBD14B	112939
MIM610673	*	9q34.11	CHROMOSOME 9 OPEN READING FRAME 90; C9ORF90	203245
MIM610674	*	20p13	CHROMOSOME 20 OPEN READING FRAME 28; C20ORF28	25876
MIM610675	*	 	HEMATOPOIETIC STEM/PROGENITOR CELL PROTEIN MDS032	55850
MIM610676	%	17q21	AUTISM, SUSCEPTIBILITY TO, 7; AUTS7	100188816
MIM610677	*	 	LSM14A PROTEIN; LSM14A	26065
MIM610678	#	16p11.2	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	7284
MIM610679	*	7q21.13	PFTAIRE PROTEIN KINASE 1; PFTK1	5218
MIM610681	*	12q13.3	PHOSPHOFRUCTOKINASE, MUSCLE TYPE; PFKM	5213
MIM610682	#	3p22, 3p24.1-p22	OSTEOGENESIS IMPERFECTA, TYPE VII	10491
MIM610683	*	4q27	BBS12 GENE; BBS12	166379
MIM610684	*	 	C-TERMINAL DOMAIN NUCLEAR ENVELOPE PHOSPHATASE 1; CTDNEP1	23399
MIM610685	%	6q14.1	SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 2; SHFLD2	791123
MIM610686	*	8q12.1	LOC137886 GENE	137886
MIM610687	#	14q12	NEMALINE MYOPATHY 7; NEM7	1073
MIM610688	#	8q21.13-q22.1	JOUBERT SYNDROME 6; JBTS6	91147
MIM610689	*	9q33.1	DIPLA1, ANTISENSE	493913
MIM610690	*	2q32.2	3-@HYDROXYISOBUTYRYL-CoA HYDROLASE; HIBCH	26275
MIM610691	*	9p13	PRUNE, DROSOPHILA, HOMOLOG OF, 2; PRUNE2	158471
MIM610692	*	1p36.23-p34.3	HEAT-SHOCK 27-KD PROTEIN 7; HSPB7	27129
MIM610693	*	11q24.2	HYLS1 GENE; HYLS1	219844
MIM610694	*	19p13.11	PYROGLUTAMYL PEPTIDASE I; PGPEP1	54858
MIM610695	*	19q13.13	HEAT-SHOCK 27-KD PROTEIN 6; HSPB6	126393
MIM610696	*	15q22.1	PCNA-ASSOCIATED FACTOR, 15-KD	9768
MIM610697	*	5p13.2	PDZ DOMAIN-CONTAINING 2; PDZD2	23037
MIM610698	#	17q21.2, 1q32	MACULAR DEGENERATION, AGE-RELATED, 4; ARMD4	3075, 60681
MIM610699	*	7p22.3	ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 2A; ZFAND2A	90637
MIM610700	*	8p11.23	HTRA SERINE PEPTIDASE 4; HTRA4	203100
MIM610701	*	10q26.12	HEAT-SHOCK 70-KD PROTEIN 12A; HSPA12A	259217
MIM610702	*	20p13	HEAT-SHOCK 70-KD PROTEIN 12B; HSPA12B	116835
MIM610703	*	13q12.3	HEAT-SHOCK 105/110-KD PROTEIN 1; HSPH1	10808
MIM610704	*	12p13	PROHIBITIN 2; PHB2	11331
MIM610705	*	17q25.1	CD300 ANTIGEN-LIKE FAMILY, MEMBER B; CD300LB	124599
MIM610706	#	11q13	DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA	2248
MIM610707	%	16q	PSORIASIS SUSCEPTIBILITY 8; PSORS8	140454
MIM610708	%	22q12.1-q13.1	OPTIC ATROPHY 5; OPA5	692222
MIM610709	*	5q22.2	TESTIS-SPECIFIC SERINE/THREONINE KINASE 1; TSSK1	83942
MIM610710	*	22q11.21	TESTIS-SPECIFIC SERINE/THREONINE KINASE 2; TSSK2	23617
MIM610711	*	14q11.2	TESTIS-SPECIFIC SERINE/THREONINE KINASE 4; TSSK4	283629
MIM610712	*	19p13.11	TESTIS-SPECIFIC SERINE/THREONINE KINASE 6; TSSK6	83983
MIM610713	#	2q31-q32	BRACHYDACTYLY-SYNDACTYLY SYNDROME	3239
MIM610714	*	9q34.11	PROTEIN KINASE N3; PKN3	29941
MIM610715	*	9q22	HEMOGEN; HEMGN	55363
MIM610716	*	15q22.3	TIMELESS-INTERACTING PROTEIN; TIPIN	54962
MIM610717	#	11p15.5	NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	57104
MIM610718	*	17p13.1	MICRO RNA 195; MIR195	406971
MIM610719	*	19p13.2	MICRO RNA 199A1; MIRN199A1	406976
MIM610720	*	1q24.3	MICRO RNA 199A2; MIR199A2	406977
MIM610721	*	1q24.3	MICRO RNA 214; MIR214	406996
MIM610723	*	9q22.32	MICRO RNA 23B; MIRN23B	407011
MIM610724	*	19p13.12	MICRO RNA 24-2; MIRN24-2	407013
MIM610725	#	10q23	NEPHROTIC SYNDROME, TYPE 3; NPHS3	51196
MIM610726	*	10q25.3	TRUB PSEUDOURIDINE SYNTHASE, E. COLI, HOMOLOG OF, 1; TRUB1	142940
MIM610727	*	9q34.11	TRUB PSEUDOURIDINE SYNTHASE, E. COLI, HOMOLOG OF, 2; TRUB2	26995
MIM610728	*	6q22.31	SPHINGOMYELIN PHOSPHODIESTERASE, ACID-LIKE, 3A; SMPDL3A	10924
MIM610729	*	2q14	WD REPEAT-CONTAINING PROTEIN 92; WDR92	116143
MIM610730	*	17q12	CHAPERONIN-CONTAINING T-COMPLEX POLYPEPTIDE 1, SUBUNIT 6B; CCT6B	10693
MIM610731	*	7q31.3	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 7; ANKRD7	56311
MIM610732	*	11q23.2	TETRATRICOPEPTIDE REPEAT DOMAIN 12; TTC12	54970
MIM610733	#	2p22-p21	NOONAN SYNDROME 4; NS4	6654
MIM610734	*	10q23.31-q23.32	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 2; ANKRD2	26287
MIM610735	*	5q31	MYOZENIN 3; MYOZ3	91977
MIM610736	*	2p11.2-q11.1	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 23; ANKRD23	200539
MIM610737	*	12q24.2	KINASE SUPPRESSOR OF RAS 2; KSR2	283455
MIM610738	#	1q21.3	NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	10456
MIM610739	*	16p12	TRINUCLEOTIDE REPEAT-CONTAINING GENE 6A; TNRC6A	27327
MIM610740	*	22q13.1	TRINUCLEOTIDE REPEAT-CONTAINING GENE 6B; TNRC6B	23112
MIM610741	*	17q25.3	TRINUCLEOTIDE REPEAT-CONTAINING GENE 6C; TNRC6C	57690
MIM610742	*	1p13.2	MOLONEY LEUKEMIA VIRUS 10, MOUSE, HOMOLOG OF; MOV10	4343
MIM610743	#	6q25	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	23345
MIM610745	*	15q24.1	STIMULATED BY RETINOIC ACID 6, MOUSE, HOMOLOG OF; STRA6	64220
MIM610746	*	9q34.11	DOLICHOL KINASE; DOLK	22845
MIM610747	*	14q22.2	STERILE ALPHA MOTIF DOMAIN-CONTAINING 4A; SAMD4A	23034
MIM610748	*	11q23	UBIQUITIN-SPECIFIC PROTEASE 28; USP28	57646
MIM610749	*	6p12	KELCH-LIKE 31; KLHL31	401265
MIM610750	*	12q12	ZINC FINGER CCHC DOMAIN- AND RNA-BINDING MOTIF-CONTAINING PROTEIN 1; ZCRB1	85437
MIM610751	*	10p12.1	PHOSPHORIBOSYL TRANSFERASE DOMAIN-CONTAINING PROTEIN 1; PRTFDC1	56952
MIM610752	*	6q25.1	URONYL 2-SULFOTRANSFERASE; UST	10090
MIM610753	%	16q11-q22	ALOPECIA AREATA 2	100034703
MIM610754	*	10q23.2	WINGS APART-LIKE PROTEIN, DROSOPHILA, HOMOLOG OF; WAPAL	23063
MIM610755	#	12p13	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	1027
MIM610756	#	19q13.2-q13.3	CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	2068
MIM610757	*	17q12	CHEMOKINE, CC MOTIF, LIGAND 4-LIKE 2; CCL4L2	388372
MIM610758	#	19q13.2-q13.3	CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	2067
MIM610759	#	10q25	CORNELIA DE LANGE SYNDROME 3; CDLS3	9126
MIM610760	%	2p24-p22	CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2	100188817
MIM610761	%	3q24-q26	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 5	100188818
MIM610762	#	12q24.31	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; HDLCQ6	100188819, 949
MIM610763	*	20p11	N-ACETYLNEURAMINIC ACID PHOSPHATASE; NANP	140838
MIM610764	*	17q23.2	BENZODIAZAPINE RECEPTOR (PERIPHERAL)-ASSOCIATED PROTEIN 1; BZRAP1	9256
MIM610765	^	11q24-q25	ICHTHYOSIS WITH HYPOTRICHOSIS, AUTOSOMAL RECESSIVE	6768
MIM610766	*	15q21.3	MEIOSIS-SPECIFIC NUCLEAR STRUCTURAL PROTEIN 1; MNS1	55329
MIM610767	*	2q37.1	AUTOPHAGY 16-LIKE 1; ATG16L1	55054
MIM610768	#	9q34.11	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M	22845
MIM610769	*	10q24	NUCLEOLAR COMPLEX-ASSOCIATED PROTEIN 3, S. CEREVISIAE, HOMOLOG OF; NOC3L	64318
MIM610770	*	1p36.33	NUCLEOLAR COMPLEX-ASSOCIATED PROTEIN 2, S. CEREVISIAE, HOMOLOG OF; NOC2L	26155
MIM610771	*	1p36	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 5; CHD5	26038
MIM610772	*	8p11.2	NK6 HOMEOBOX 3; NKX6-3	157848
MIM610773	#	12q23	MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY	5250
MIM610774	*	6pter-p12	CANOPY 3, ZEBRAFISH, HOMOLOG OF; CNPY3	10695
MIM610775	*	12p13.3	TP53-INDUCED GLYCOLYSIS AND APOPTOSIS REGULATOR	57103
MIM610776	*	12q23.2	DAMAGE-REGULATED AUTOPHAGY MODULATOR 1; DRAM1	55332
MIM610777	*	14q11.2	NEUROGUIDIN; NGDN	25983
MIM610778	*	22q11.2	GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-1-LIKE; GNB1L	54584
MIM610779	*	16p13.3	NUCLEOTIDE-BINDING PROTEIN 2; NUBP2	10101
MIM610780	*	3q29	LARGE SUBUNIT GTPase 1, S. CEREVISIAE, HOMOLOG OF; LSG1	55341
MIM610781	*	14q11-q21	GUANOSINE MONOPHOSPHATE REDUCTASE 2; GMPR2	51292
MIM610782	*	7q32.3	MICRO RNA 29A; MIR29A	407021
MIM610783	*	7q32.3	MICRO RNA 29B1; MIR29B1	407024
MIM610784	*	1q32.2	MICRO RNA 29C; MIR29C	407026
MIM610785	*	1p35.3	PDLIM1-INTERACTING KINASE 1-LIKE; PDIK1L	149420
MIM610786	*	17q12	SNAP25-INTERACTING PROTEIN	80725
MIM610787	*	17q21.3	HOXB CLUSTER ANTISENSE RNA 5; HOXBAS5	360205
MIM610788	*	6p12.1-p11.2	SOLUTE CARRIER FAMILY 35 (3-PRIME-PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE TRANSPORTER), MEMBER B2; SLC35B2	347734
MIM610789	*	20q11	p53 AND DNA DAMAGE-REGULATED 1; PDRG1	81572
MIM610790	*	17q21.33	SOLUTE CARRIER FAMILY 35, MEMBER B1; SLC35B1	10237
MIM610791	*	17p13.3	SOLUTE CARRIER FAMILY 43 (L-TYPE AMINO ACID TRANSPORTER), MEMBER 2; SLC43A2	124935
MIM610792	*	11q12.3	SOLUTE CARRIER FAMILY 22, MEMBER 25; SLC22A25	387601
MIM610793	*	13q14.11	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, KIDNEY), MEMBER 30; SLC25A30	253512
MIM610794	*	6p22.3-p22.1	ZINC FINGER PROTEIN 323; ZNF323	64288
MIM610795	*	8p21.3	SORBIN AND SH3 DOMAINS-CONTAINING 3; SORBS3	10174
MIM610796	*	4q28.1	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ADENINE NUCLEOTIDE TRANSLOCATOR), MEMBER 31; SLC25A31	83447
MIM610798	#	1q22	IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	28956
MIM610799	#	12q12, 11q23-q24	INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 1; IPD1	114609, 51135
MIM610800	*	5q14.2	AUTOPHAGY 10, S. CEREVISIAE, HOMOLOG OF; ATG10	83734
MIM610801	*	1q31-q32	SOLUTE CARRIER FAMILY 41, MEMBER 1; SLC41A1	254428
MIM610802	*	12q23.3	SOLUTE CARRIER FAMILY 41, MEMBER 2; SLC41A2	84102
MIM610803	*	3q21.2	SOLUTE CARRIER FAMILY 41, MEMBER 3; SLC41A3	54946
MIM610804	*	1p32-p31	SOLUTE CARRIER FAMILY 35 (UDP-GLUCURONIC ACID/UDP-N-ACETYLGALACTOSAMINE DUAL TRANSPORTER), MEMBER D1; SLC35D1	23169
MIM610805	#	1p33-p32	RENAL HYPODYSPLASIA, NONSYNDROMIC, 1; RHDNS1	100034704
MIM610806	*	17q12	TBC1 DOMAIN FAMILY, MEMBER 3C; TBC1D3C	414060
MIM610808	*	17q12	TBC1 DOMAIN FAMILY, MEMBER 3E; TBC1D3E	100302591
MIM610809	*	17q12	TBC1 DOMAIN FAMILY, MEMBER 3F; TBC1D3F	84218
MIM610810	*	17q12	TBC1 DOMAIN FAMILY, MEMBER 3G; TBC1D3G	654341
MIM610811	*	17q12	TBC1 DOMAIN FAMILY, MEMBER 3H; TBC1D3H	729877
MIM610812	*	16q22.2	HYDROCEPHALUS-INDUCING, MOUSE, HOMOLOG OF; HYDIN	54768
MIM610813	*	1q21.1	HYDROCEPHALUS-INDUCING, MOUSE, HOMOLOG OF, 2; HYDIN2	100288805
MIM610815	*	8q21.2	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, FOLATE), MEMBER 32; SLC25A32	81034
MIM610816	*	1p36.22	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER), MEMBER 33; SLC25A33	84275
MIM610817	*	1p36.21	SOLUTE CARRIER FAMILY 25, MEMBER 34; SLC25A34	284723
MIM610818	*	17p13.1	SOLUTE CARRIER FAMILY 25, MEMBER 35; SLC25A35	399512
MIM610819	*	3p22.1	SOLUTE CARRIER FAMILY 25, MEMBER 38; SLC25A38	54977
MIM610820	*	17q12	SOLUTE CARRIER FAMILY 25, MEMBER 39; SLC25A39	51629
MIM610821	*	7q21.12	SOLUTE CARRIER FAMILY 25, MEMBER 40; SLC25A40	55972
MIM610822	*	19p13.3	SOLUTE CARRIER FAMILY 25, MEMBER 41; SLC25A41	284427
MIM610823	*	19p13.11	SOLUTE CARRIER FAMILY 25, MEMBER 42; SLC25A42	284439
MIM610824	*	1q22	SOLUTE CARRIER FAMILY 25, MEMBER 44; SLC25A44	9673
MIM610825	*	11q13.1	SOLUTE CARRIER FAMILY 25, MEMBER 45; SLC25A45	283130
MIM610826	*	5q22.1	SOLUTE CARRIER FAMILY 25, MEMBER 46; SLC25A46	91137
MIM610827	*	20q11.2-q13.1	ZINC FINGER PROTEIN 335; ZNF335	63925
MIM610828	#	9q22.3	HOLOPROSENCEPHALY 7; HPE7	5727
MIM610829	#	2q14	HOLOPROSENCEPHALY 9; HPE9	2736
MIM610831	*	11q13.1	TBC1 DOMAIN FAMILY, MEMBER 10C; TBC1D10C	374403
MIM610832	#	16p12	FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	79728
MIM610833	*	20p11.2	N-ACETYLTRANSFERASE 5; NAT5	51126
MIM610834	*	3q13.2	N-ACETYLTRANSFERASE 13; NAT13	80218
MIM610835	*	15q21.3	NMDA RECEPTOR-REGULATED 2; NARG2	79664
MIM610836	%	1q41-q42	AUTISM, SUSCEPTIBILITY TO, 11; AUTS11	100188820
MIM610837	*	19q13.3	BCL2-LIKE 12; BCL2L12	83596
MIM610838	%	21p13-q11	AUTISM, SUSCEPTIBILITY TO, 12; AUTS12	100188314
MIM610839	%	2q33.3	OSTEOARTHRITIS SUSCEPTIBILITY 4; OS4	100188821
MIM610840	%	13q31.3-q32.1	MITRAL VALVE PROLAPSE, MYXOMATOUS 3; MMVP3	100034705
MIM610841	*	4p15.1	STROMAL INTERACTION MOLECULE 2; STIM2	57620
MIM610842	#	2p12	PSEUDOXANTHOMA ELASTICUM-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY	2677
MIM610843	*	22cen-q12	UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX, 7.2-KD SUBUNIT	29796
MIM610844	*	15q21.1	SPG11 GENE; SPG11	80208
MIM610845	*	6p24.3	SOLUTE CARRIER FAMILY 35 (3-PRIME-PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE TRANSPORTER), MEMBER B3; SLC35B3	51000
MIM610846	*	12q15	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 10; LRRC10	376132
MIM610847	*	6p22.1	ZINC FINGER PROTEIN 322A; ZNF322A	79692
MIM610848	*	12p11.22	RAB15 EFFECTOR PROTEIN; REP15	387849
MIM610849	*	17q21.32	TUBULIN TYROSINE LIGASE-LIKE FAMILY, MEMBER 6; TTLL6	284076
MIM610850	*	19p13.2	XPA-BINDING PROTEIN 2; XAB2	56949
MIM610851	*	4q25	CHROMOSOME 4 OPEN READING FRAME 16; C4ORF16	55435
MIM610852	#	7p14-p13	CILIARY DYSKINESIA, PRIMARY, 6; CILD6	51314
MIM610853	*	1q44	AT HOOK-CONTAINING TRANSCRIPTION FACTOR 1; AHCTF1	25909
MIM610854	^	3p22	MOVED TO 610682	 
MIM610855	*	10p12.1	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 26; ANKRD26	22852
MIM610856	*	10p11.21	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 30A; ANKRD30A	91074
MIM610857	*	12q13.2	SMALL BREAST EPITHELIAL MUCIN	118430
MIM610858	*	14q22.1	CHROMOSOME 14 OPEN READING FRAME 166; C14ORF166	51637
MIM610859	*	16q22	RGD-, LEUCINE-RICH REPEAT-, TROPOMODULIN DOMAIN-, AND PROLINE-RICH DOMAIN-CONTAINING PROTEIN	146206
MIM610860	*	1p21	AMYLO-1,6-GLUCOSIDASE, 4-ALPHA-GLUCANOTRANSFERASE; AGL	178
MIM610861	*	14q32.13	CHROMOSOME 14 OPEN READING FRAME 49; C14ORF49	161176
MIM610862	*	14q32.2	DEGENERATIVE SPERMATOCYTE, DROSOPHILA, HOMOLOG OF, 2; DEGS2	123099
MIM610863	*	3q26.3	GUANINE NUCLEOTIDE-BINDING PROTEIN, BETA-4; GNB4	59345
MIM610864	*	1q31	LQK1 PROTEIN	642946
MIM610865	*	14q24.3	FELINE LEUKEMIA VIRUS SUBGROUP C RECEPTOR 2; FLVCR2	55640
MIM610866	*	20q13.33	URIDINE/CYTIDINE KINASE-LIKE 1; UCKL1	54963
MIM610867	*	2p12	LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN 1: LRRTM1	347730
MIM610868	*	5q31.2	LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN 2; LRRTM2	26045
MIM610869	*	10q21.3	LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN 3; LRRTM3	347731
MIM610870	*	2p12	LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN 4; LRRTM4	80059
MIM610872	*	1p35.1	IBR DOMAIN-CONTAINING PROTEIN 3; IBRDC3	127544
MIM610873	%	22q13	MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 1; MENAQ1	100188822
MIM610874	*	8q24	SPERMATOGENESIS- AND CENTRIOLE-ASSOCIATED 1; SPATC1	375686
MIM610875	*	19q13.42	SAPS DOMAIN FAMILY, MEMBER 1; SAPS1	22870
MIM610876	*	6q21	HECT DOMAIN- AND ANKYRIN REPEAT-CONTAINING E3 UBIQUITIN PROTEIN LIGASE 1; HACE1	57531
MIM610877	*	22q13.33	SAPS DOMAIN FAMILY, MEMBER 2; SAPS2	9701
MIM610878	#	3p12.3	VESICOURETERAL REFLUX 2; VUR2	6092
MIM610879	*	11q13	SAPS DOMAIN FAMILY, MEMBER 3; SAPS3	55291
MIM610880	*	11q13	CHROMOSOME 11 OPEN READING FRAME 24; C11ORF24	53838
MIM610881	*	11q13	SUPPRESSOR OF VARIEGATION 4-20, DROSOPHILA, HOMOLOG OF, 1; SUV420H1	51111
MIM610882	*	9q34.3	SJOGREN SYNDROME NUCLEAR AUTOANTIGEN 1; SSNA1	8636
MIM610883	#	17p11.2	POTOCKI-LUPSKI SYNDROME; PTLS	100038247
MIM610884	*	19q13.11	CHROMOSOME 19 OPEN READING FRAME 40; C19ORF40	91442
MIM610885	*	17q21.3	ESSENTIAL MEIOTIC ENDONUCLEASE 1, S. POMBE, HOMOLOG OF, 1; EME1	146956
MIM610886	*	16p13.3	ESSENTIAL MEIOTIC ENDONUCLEASE 1, S. POMBE, HOMOLOG OF, 2; EME2	197342
MIM610887	*	4p16.2	POLYMERASE, DNA, NU; POLN	353497
MIM610888	*	11q14	GASTRIC CANCER-RELATED GENE 224	360219
MIM610889	*	5q12.1	IMPORTIN 11; IPO11	51194
MIM610890	*	5q12.3	REGULATOR OF G PROTEIN SIGNALING 7-BINDING PROTEIN; RGS7BP	401190
MIM610891	*	9q34.13	FAMILY WITH SEQUENCE SIMILARITY 102, MEMBER A; FAM102A	399665
MIM610892	*	4q13.2	SYNAPTOTAGAMIN 14-LIKE PROTEIN; SYT14L	401135
MIM610893	*	19q	CHMP FAMILY, MEMBER 2A; CHMP2A	27243
MIM610894	*	15q24.1	NEUREGULIN 4; NRG4	145957
MIM610895	*	17q21.3	WAP, FOLLISTATIN, IMMUNOGLOBULIN, KUNITZ, AND NTR DOMAINS-CONTAINING PROTEIN 2; WFIKKN2	124857
MIM610896	#	19q13.3	BRANCHIOOTORENAL SYNDROME 2; BOR2	147912
MIM610897	*	20q11.21	CHMP FAMILY, MEMBER 4B; CHMP4B	128866
MIM610898	%	11p12-p11	SUPRANUCLEAR PALSY, PROGRESSIVE, 3; PSNP3	100038248
MIM610899	*	 	CHMP FAMILY, MEMBER 4C; CHMP4C	92421
MIM610900	*	9p13.3	CHMP FAMILY, MEMBER 5; CHMP5	51510
MIM610901	*	17q25.3	CHMP FAMILY, MEMBER 6; CHMP6	79643
MIM610902	*	6q24.1	CHROMOSOME 6 OPEN READING FRAME 55; C6ORF55	51534
MIM610903	*	13q14.3	VACUOLAR PROTEIN SORTING 36, S. CEREVISIAE, HOMOLOG OF; VPS36	51028
MIM610904	*	17q21.32	SNF8, S. CEREVISIAE, HOMOLOG OF; SNF8	11267
MIM610906	%	1p31	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 4	100188823
MIM610907	*	17q21.3	VACUOLAR PROTEIN SORTING 25, S. CEREVISIAE, HOMOLOG OF; VPS25	84313
MIM610908	%	12q14.2	AUTISM, SUSCEPTIBILITY TO, 13; AUTS13	100188317
MIM610909	*	10q26.11	MINICHROMOSOME MAINTENANCE COMPLEX-BINDING PROTEIN; MCMBP	79892
MIM610911	*	3q13.3	RHO GTPase-ACTIVATING PROTEIN 31; ARHGAP31	57514
MIM610912	*	4q13.3	AMELOTIN; AMTN	401138
MIM610913	#	8p21	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2; SMDP2	6440
MIM610914	*	13q14.11	ECTO-NOX DISULFIDE-THIOL EXCHANGER 1; ENOX1	55068
MIM610915	#	1p34	OSTEOGENESIS IMPERFECTA, TYPE VIII	64175
MIM610916	*	5p15.31	NOL1/NOP2/SUN DOMAIN FAMILY, MEMBER 2; NSUN2	54888
MIM610917	*	17q11.1	RAS-ASSOCIATED PROTEIN 34; RAB34	83871
MIM610918	*	22q12.2	SELENOPROTEIN M	140606
MIM610919	*	20q13.33	GTP-BINDING PROTEIN 5; GTPBP5	26164
MIM610920	*	7q21.13	GTP-BINDING PROTEIN 10; GTPBP10	85865
MIM610921	#	16p13.3	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3	21
MIM610922	*	15q11-q13	NUCLEAR PORE ASSOCIATED PROTEIN 1; NPAP1	23742
MIM610923	*	7q33	SOLUTE CARRIER FAMILY 35 (UDP-XYLOSE/UDP-N-ACETYLGLUCOSAMINE TRANSPORTER), MEMBER B4; SLC35B4	84912
MIM610924	*	20p13	RANBP-TYPE AND C3HC4-TYPE ZINC FINGER-CONTAINING 1; RBCK1	10616
MIM610925	*	3p25.3-p24.1	INTERLEUKIN 17 RECEPTOR C; IL17RC	84818
MIM610926	%	10q11.2-q21	TOOTH AGENESIS, SELECTIVE, 5; STHAG5	100188748
MIM610927	#	1q32	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 9; SLEB9	1380
MIM610928	*	8q12-q13	SRY-BOX 17; SOX17	64321
MIM610929	*	7q22.1	ORAI CALCIUM RELEASE-ACTIVATED CALCIUM MODULATOR 2; ORAI2	80228
MIM610930	*	16p11.2	ORAI CALCIUM RELEASE-ACTIVATED CALCIUM MODULATOR 3; ORAI3	93129
MIM610931	*	8q23-q24	ZINC FINGER GENE IN AUTOIMMUNE THYROID DISEASE 1; ZFAT1	57623
MIM610932	*	12q12	TWINFILIN, DROSOPHILA, HOMOLOG OF, 1; TWF1	5756
MIM610933	*	9q33.3-q34.11	LEUCINE-RICH REPEAT- AND STERILE ALPHA MOTIF-CONTAINING 1; LRSAM1	90678
MIM610934	*	7q35	NEWBORN OVARY HOMEOBOX, MOUSE, HOMOLOG OF; NOBOX	135935
MIM610935	*	17q25.3	LIGAND-GATED ION CHANNEL, ZINC-ACTIVATED, 1; LGICZ1	353174
MIM610936	*	9q21.31	PHOSPHOSERINE AMINOTRANSFERASE 1; PSAT1	29968
MIM610937	*	16q12.2	RPGRIP1-LIKE; RPGRIP1L	23322
MIM610938	#	7q11.2	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7	948
MIM610939	*	11q13.1	MICRO RNA 192; MIRN192	406967
MIM610940	*	1q41	MICRO RNA 194-1; MIRN194-1	406969
MIM610941	*	11q13.1	MICRO RNA 194-2; MIRN194-2	406970
MIM610942	*	9q21.11	MICRO RNA 204; MIR204	406987
MIM610943	*	1q41	MICRO RNA 215; MIRN215	406997
MIM610944	*	2p16.1	MICRO RNA 216; MIRN216	406998
MIM610945	*	20q13.3	MICRO RNA 296; MIRN296	407022
MIM610946	*	6p12.2	MICRO RNA 133B; MIRN133B	442890
MIM610947	#	12p13.3-p11.2	CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	4040
MIM610948	%	3p14.1-q12.3	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 7	100188825
MIM610949	*	1q32.2	SYNAPTOTAGMIN 14; SYT14	255928
MIM610950	*	14q23.1	SYNAPTOTAGMIN 16; SYT16	83851
MIM610951	#	4q28.1-q28.2	CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	256471
MIM610952	*	20p11.2	CROOKED NECK PRE-mRNA SPLICING FACTOR-LIKE 1; CRNKL1	51340
MIM610953	*	15q22.31	PIF1, S. CEREVISIAE, HOMOLOG OF; PIF1	80119
MIM610954	#	18q21.2	PITT-HOPKINS SYNDROME; PTHS	6925
MIM610955	*	1p34.3	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 3; TRAPPC3	27095
MIM610956	*	1q25.1	ASPARTYL-tRNA SYNTHETASE 2; DARS2	55157
MIM610957	*	12p11.21	TYROSYL-tRNA SYNTHETASE 2; YARS2	51067
MIM610958	*	4q21.23	1-@ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 9; AGPAT9	84803
MIM610959	*	14q32.31	MICRO RNA 376A-1; MIRN376A-1	494325
MIM610960	*	14q32.31	MICRO RNA 376A-2; MIRN376A-2	664615
MIM610961	*	14q32.31	MICRO RNA 376-B; MIRN376B	574435
MIM610962	*	1q21.2	SMG5, C. ELEGANS, HOMOLOG OF; SMG5	23381
MIM610963	*	17p13.3	SMG6, C. ELEGANS, HOMOLOG OF; SMG6	23293
MIM610964	*	1q25	SMG7, C. ELEGANS, HOMOLOG OF; SMG7	9887
MIM610965	#	16p13.3-p13.13	XFE PROGEROID SYNDROME	2072
MIM610966	*	16q12.2	FAT MASS- AND OBESITY-ASSOCIATED GENE; FTO	79068
MIM610967	#	 	OSTEOGENESIS IMPERFECTA, TYPE V; OI5	387733
MIM610968	#	 	OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	60681
MIM610969	*	17p13	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 1; TRAPPC1	58485
MIM610970	*	16q22.1-q22.2	TRAFFICKING PROTEIN PARTICLE COMPLEX 2-LIKE; TRAPPC2L	51693
MIM610971	*	11q23.3	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 4; TRAPPC4	51399
MIM610972	*	1p36.32	ADHERENS JUNCTION-ASSOCIATED PROTEIN 1; AJAP1	55966
MIM610973	*	10p12.1	MEMBRANE PROTEIN, PALMITOYLATED 7; MPP7	143098
MIM610974	*	18q11.2	ZINC FINGER PROTEIN 521; ZNF521	25925
MIM610975	*	17q11.2	SKIN-, EMBRYO-, BRAIN-, AND OOCYTE-SPECIFIC HOMEOBOX	645832
MIM610976	*	22q13.1	APOLIPOPROTEIN B mRNA EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3H; APOBEC3H	164668
MIM610977	*	4p16.3	TETRACYCLINE TRANSPORTER-LIKE PROTEIN	10227
MIM610978	#	14q13	CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESS	7080
MIM610979	*	15q15.3	HISTIDINE ACID PHOSPHATASE DOMAIN-CONTAINING PROTEIN 2A; HISPPD2A	9677
MIM610980	*	11p15.5	KCNQ1 DOWNSTREAM NEIGHBOR; KCNQ1DN	55539
MIM610981	*	22q13.2	WWBP2 N-TERMINAL-LIKE PROTEIN; WBP2NL	164684
MIM610982	*	14q32.33	INVERTED FORMIN 2; INF2	64423
MIM610983	*	14q32.31	MICRO RNA 368; MIRN368	442913
MIM610984	#	4q25	COMPLEMENT FACTOR I DEFICIENCY; CFID	3426
MIM610985	*	11p15.2-p15.1	UBIQUITIN E2 VARIANT AND LACTATE/MALATE DEHYDROGENASE DOMAINS-CONTAINING PROTEIN; UEVLD	55293
MIM610986	*	15q26.3	LEUCINE-RICH REPEAT KINASE 1; LRRK1	79705
MIM610987	*	10q11.23	N-ACYLSPHINGOSINE AMIDOHYDROLASE 2C; ASAH2C	653308
MIM610988	#	6p21.3	LEPROSY, SUSCEPTIBILITY TO, 4; LPRS4	4049
MIM610989	*	7q21.3-q22.1	LEMUR TYROSINE KINASE 2; LMTK2	22853
MIM610990	*	6p21.3	KIAA1949 GENE; KIAA1949	170954
MIM610991	*	2q35	OBSCURIN-LIKE 1; OBSL1	23363
MIM610992	#	9q21.31	PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	29968
MIM610993	*	12q22	UBIQUITIN-SPECIFIC PROTEASE 44; USP44	84101
MIM610994	*	 	KUA GENE	387521
MIM610995	*	2p13.3	PRENYLCYSTEINE OXIDASE 1; PCYOX1	51449
MIM610996	*	20p11	D-TYROSYL-tRNA DEACYLASE 1, S. CEREVISIAE, HOMOLOG OF; DTD1	92675
MIM610997	%	17q21-q22	PROSTATE CANCER, HEREDITARY, 9	100188826
MIM610998	*	16p13.3	METEORIN; METRN	79006
MIM610999	*	10p11	ENHANCER OF POLYCOMB, DROSOPHILA, HOMOLOG OF, 1; EPC1	80314
MIM611000	*	2q23.1	ENHANCER OF POLYCOMB, DROSOPHILA, HOMOLOG OF, 2; EPC2	26122
MIM611001	*	1p35.3-p33	CHROMOSOME 1 OPEN READING FRAME 149; C1ORF149	64769
MIM611002	*	16p13.3	CHROMOSOME 16 OPEN READING FRAME 30; C16ORF30	79652
MIM611003	%	10q22	SMOKING AS A QUANTITATIVE TRAIT LOCUS 1; SQTL1	100188827
MIM611004	%	22q12	SMOKING AS A QUANTITATIVE TRAIT LOCUS 2; SQTL2	100188828
MIM611005	*	18q21.2	MEX3, C. ELEGANS, HOMOLOG OF, C; MEX3C	51320
MIM611006	*	9q21.2-q22.1	IRON-SULFUR CLUSTER ASSEMBLY 1, S. CEREVISIAE, HOMOLOG OF; ISCA1	81689
MIM611007	*	1q22	MEX3, C. ELEGANS, HOMOLOG OF, A; MEX3A	92312
MIM611008	*	15q25.2	MEX3, C. ELEGANS, HOMOLOG OF, B; MEX3B	84206
MIM611009	*	19p13.3	MEX3, C. ELEGANS, HOMOLOG OF, D; MEX3D	399664
MIM611010	%	11p15	FIBROMATOSIS, GINGIVAL, 4; GINGF4	100124414
MIM611011	*	19p13.3	CHROMOSOME 19 OPEN READING FRAME 6; C19ORF6	91304
MIM611012	*	1q25	REGULATOR OF G PROTEIN SIGNALING-LIKE 1; RGSL1	353299
MIM611014	%	18q21.2	HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 8; HYT8	100188321
MIM611015	%	7q31	AUTISM, SUSCEPTIBILITY TO, 9; AUTS9	4233
MIM611016	%	7q36	AUTISM, SUSCEPTIBILITY TO, 10; AUTS10	2020
MIM611017	*	10q22.1	TRYPSIN DOMAIN-CONTAINING PROTEIN 1; TYSND1	219743
MIM611018	*	2p13.3	POLYADENYLATE-BINDING PROTEIN-INTERACTING PROTEIN 2B; PAIP2B	400961
MIM611019	*	7q36	ATPase, H+ TRANSPORTING, LYSOSOMAL, 9-KD, V0 SUBUNIT E2; ATP6V0E2	155066
MIM611020	*	17q23.2	MICRO RNA 21; MIR21	406991
MIM611021	*	3q26.1	NMD3, S. CEREVISIAE, HOMOLOG OF; NMD3	51068
MIM611022	#	11q23	DEAFNESS, AUTOSOMAL RECESSIVE 24; DFNB24	5962
MIM611023	*	14q23.1	tRNA METHYLTRANSFERASE 5, S. CEREVISIAE, HOMOLOG OF; TRMT5	57570
MIM611024	*	19q13.4	ZINC FINGER PROTEIN 667; ZNF667	63934
MIM611025	*	10p12.1	CHROMOSOME 10 OPEN READING FRAME 63; C10ORF63	219670
MIM611026	*	16q23	FATTY ACID 2-HYDROXYLASE; FA2H	79152
MIM611027	*	16q11.2	SHC SH2 DOMAIN-BINDING PROTEIN 1; SHCBP1	79801
MIM611028	*	6q14.1	TRANSMEMBRANE PROTEIN 30A; TMEM30A	55754
MIM611029	*	14q23.1	TRANSMEMBRANE PROTEIN 30B; TMEM30B	161291
MIM611030	*	3q12	TRANSMEMBRANE PROTEIN 30C; TMEM30C	644444
MIM611031	%	16q13-q22.1	EPISODIC KINESIGENIC DYSKINESIA 2; EKD2	100124415
MIM611032	*	1q41	SPERMATOGENESIS-ASSOCIATED PROTEIN 17; SPATA17	128153
MIM611033	*	11p15.5	CHROMOSOME 11 OPEN READING FRAME 21; C11ORF21	29125
MIM611034	*	6p21.3	SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 3; SLC17A3	10786
MIM611035	*	2p14	CHROMOSOME 2 OPEN READING FRAME 13; C2ORF13	200558
MIM611036	*	12q12	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 13; SLC2A13	114134
MIM611037	*	3p14.3	SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, PHOSPHATE CARRIER), MEMBER 26; SLC25A26	115286
MIM611038	#	18q21.3	MICROPHTHALMIA, ISOLATED 3; MCOP3	30062
MIM611039	*	12p13.3	SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 14; SLC2A14	144195
MIM611040	#	11q23	MICROPHTHALMIA, ISOLATED 5; MCOP5	83552
MIM611041	*	17q24-q25	TRIPARTITE MOTIF-CONTAINING PROTEIN 47; TRIM47	91107
MIM611042	*	1q21	LATE CORNIFIED ENVELOPE-LIKE PROLINE-RICH 1; LELP1	149018
MIM611043	*	1p36.11	LIN28, C. ELEGANS, HOMOLOG OF, A; LIN28A	79727
MIM611044	*	6q21	LIN28, C. ELEGANS, HOMOLOG OF, B; LIN28B	389421
MIM611045	*	17q21	GLUCOSE-6-PHOSPHATASE, CATALYTIC, 3; G6PC3	92579
MIM611046	%	8q12-q13	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 2	100188829
MIM611047	*	6q24.2-q25.3	RETINOIC ACID EARLY TRANSCRIPT 1L; RAET1L	154064
MIM611048	*	19q13.2	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 15A; PPP1R15A	23645
MIM611049	*	6p21.3	SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER 2; SLC17A2	10246
MIM611050	*	7q33	LEUCINE ZIPPER PROTEIN 6; LUZP6	767558
MIM611051	*	3q28	COILED-COIL DOMAIN-CONTAINING PROTEIN 50; CCDC50	152137
MIM611052	*	16p11.2	SET DOMAIN-CONTAINING PROTEIN 1A; SETD1A	9739
MIM611053	*	9p13.1	RUN AND SH3 DOMAIN-CONTAINING 2; RUSC2	9853
MIM611054	*	11q13.3	PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, F POLYPEPTIDE-INTERACTING PROTEIN ALPHA-1; PPFIA1	8500
MIM611055	*	12q24.31	SET DOMAIN-CONTAINING PROTEIN 1B; SETD1B	23067
MIM611056	*	2q37.3	SELENOCYSTEINE LYASE; SCLY	51540
MIM611058	*	3q26.2-q27	PEROXISOME BIOGENESIS FACTOR 5-LIKE; PEX5L	51555
MIM611059	*	3p21.1	WD REPEAT-CONTAINING PROTEIN 82; WDR82	80335
MIM611060	*	18q21.1	SET-BINDING PROTEIN 1; SETBP1	26040
MIM611061	*	7p22	FAMILY WITH SEQUENCE SIMILARITY 20, MEMBER C; FAM20C	56975
MIM611062	*	17q24.2	FAMILY WITH SEQUENCE SIMILARITY 20, MEMBER A; FAM20A	54757
MIM611063	*	1q25	FAMILY WITH SEQUENCE SIMILARITY 20, MEMBER B; FAM20B	9917
MIM611064	#	12q14.3	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 5	11213
MIM611065	*	4q22.1	PROTEIN PHOSPHATASE, PP2C DOMAIN-CONTAINING, 1K; PPM1K	152926
MIM611066	*	16q22.3	PH DOMAIN AND LEUCINE-RICH REPEAT PROTEIN PHOSPHATASE-LIKE; PHLPPL	23035
MIM611067	#	1p36	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4; DSMA4	57449
MIM611068	*	22q13	SMALL NUCLEOLAR RNA, C/D BOX, 43; SNORD43	26807
MIM611069	*	22q13	RNA, U86 SMALL NUCLEOLAR	116936
MIM611070	*	22q13	SMALL NUCLEOLAR RNA, C/D BOX, 83A; SNORD83A	116937
MIM611071	*	22q13	SMALL NUCLEOLAR RNA, C/D BOX, 83B; SNORD83B	116938
MIM611072	*	11p13	DPH4, S. CEREVISIAE, HOMOLOG OF; DPH4	120526
MIM611073	%	8p12-q22	ALZHEIMER DISEASE 12	100188830
MIM611074	*	11q24.1	BRAIN-SPECIFIC HOMEOBOX, MOUSE, HOMOLOG OF; BSX	390259
MIM611075	*	1p21.2	DPH5, S. CEREVISIAE, HOMOLOG OF; DPH5	51611
MIM611076	*	12q22-q23.1	5-PRIME-@NUCLEOTIDASE DOMAIN-CONTAINING PROTEIN 3; NT5DC3	51559
MIM611077	*	3p25.1	COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 4; CHCHD4	131474
MIM611078	*	9p24.3	COBALAMIN SYNTHETASE W DOMAIN-CONTAINING PROTEIN 1; CBWD1	55871
MIM611079	*	2q13-q14.1	COBALAMIN SYNTHETASE W DOMAIN-CONTAINING PROTEIN 2; CBWD2	150472
MIM611080	*	9q13	COBALAMIN SYNTHETASE W DOMAIN-CONTAINING PROTEIN 3; CBWD3	445571
MIM611081	#	2q37.1	INFLAMMATORY BOWEL DISEASE 10; IBD10	55054
MIM611082	*	22q12.1	MIAT GENE; MIAT	440823
MIM611083	*	8q13.1	ALCOHOL DEHYDROGENASE, IRON-CONTAINING, 1; ADHFE1	137872
MIM611084	*	2q13-q14.1	FORKHEAD BOX D4-LIKE 1; FOXD4L1	200350
MIM611085	*	9p11.2	FORKHEAD BOX D4-LIKE 2; FOXD4L2	100036519
MIM611086	*	9q13	FORKHEAD BOX D4-LIKE 3; FOXD4L3	286380
MIM611087	#	17q23.3	POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	92335
MIM611088	*	12q13.12	COILED-COIL DOMAIN-CONTAINING PROTEIN 65; CCDC65	85478
MIM611089	*	3p25.3	MYOTUBULARIN-RELATED PROTEIN 14; MTMR14	64419
MIM611090	#	1p34-p33	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 12; MRT12	100101420, 6487
MIM611091	#	5p15-p14	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5; MRT5	100188831, 54888
MIM611092	#	6q21	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	2898
MIM611093	#	8p12, 8p22	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7; MRT7	7991
MIM611094	%	10q22	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 8; MRT8	100101423
MIM611095	%	14q11.2-q12	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	100101424
MIM611096	%	16p12-q12	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10; MRT10	100101425
MIM611097	%	19q13.2-q13.3	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 11; MRT11	100101426
MIM611098	*	7q21	SIX-TRANSMEMBRANE EPITHELIAL ANTIGEN OF PROSTATE 4; STEAP4	79689
MIM611099	*	2p25-p24	PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 6; PDIA6	10130
MIM611100	%	8q24	PROSTATE CANCER, HEREDITARY, 10; HPC10	100188834
MIM611101	*	1p36	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY G, MEMBER 5; PLEKHG5	57449
MIM611102	#	15q15.3	DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY	100240731, 117155, 161497
MIM611103	*	3q26	ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 9; ACAD9	28976
MIM611104	*	12p11.2	FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 4; FGD4	121512
MIM611105	#	1q25.1	LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	55157
MIM611106	*	6q25.1	ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 12D; ZC3H12D	340152
MIM611107	%	1p21.1-p13.3	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4; MRT4	100009675
MIM611108	*	7p12.2	VON WILLEBRAND FACTOR C DOMAIN-CONTAINING PROTEIN 2; VWC2	375567
MIM611109	%	4q32.3	CINNAMON ODOR, PLEASANTNESS OF	100188835
MIM611110	*	21q21	CHROMOSOME 21 OPEN READING FRAME 7; C21ORF7	56911
MIM611111	*	6q13	DEVELOPMENTAL PLURIPOTENCY-ASSOCIATED GENE 5; DPPA5	340168
MIM611112	*	19q13.3	DAPPER, ANTAGONIST OF BETA-CATENIN, 3; DACT3	147906
MIM611113	*	16p13.3	CEMENTUM PROTEIN 1; CEMP1	752014
MIM611114	*	19q13.33	MICRO RNA 150; MIR150	406942
MIM611115	*	11q11	VON WILLEBRAND FACTOR C AND EGF DOMAIN-CONTAINING PROTEIN; VWCE	220001
MIM611116	*	14q12	MICRO RNA 208A; MIR208A	406990
MIM611117	*	11q13.4	PROTEIN PHOSPHATASE METHYLESTERASE 1; PPME1	51400
MIM611118	*	16p13.3	NUCLEAR PRELAMIN A RECOGNITION FACTOR-LIKE; NARFL	64428
MIM611119	*	7p15.3	KELCH-LIKE 7; KLHL7	55975
MIM611120	*	20p12.3-p12.1	SERINE PALMITOYLTRANSFERASE, LONG-CHAIN BASE SUBUNIT 3; SPTLC3	55304
MIM611121	*	14q32.13	CALMIN; CLMN	79789
MIM611122	*	3p25.1	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 28; ANKRD28	23243
MIM611123	*	1p34.3	EPHRIN RECEPTOR EphA10; EPHA10	284656
MIM611124	*	4q28.1-q28.2	MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 8; MFSD8	256471
MIM611125	*	18q21-q22	DERMATAN SULFATE EPIMERASE-LIKE; DSEL	92126
MIM611126	#	3q26	ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 9, DEFICIENCY OF	28976
MIM611127	*	1p13.3	UBIQUITIN-LIKE 4B; UBL4B	164153
MIM611128	*	14q21	MAM DOMAIN-CONTAINING GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR 2; MDGA2	161357
MIM611129	*	10q24.32	CHROMOSOME 10 OPEN READING FRAME 26; C10ORF26	54838
MIM611130	*	8p21.3	CHMP FAMILY, MEMBER 7; CHMP7	91782
MIM611131	#	15q23	RETINITIS PIGMENTOSA 37; RP37	10002
MIM611132	*	2p23.2	RIBOKINASE; RBKS	64080
MIM611133	*	2q12-qter	SMALL NUCLEOLAR RNA, C/D BOX, 82; SNORD82	25826
MIM611134	#	12q21.3	MECKEL SYNDROME, TYPE 4; MKS4	80184
MIM611135	*	4p14	KLOTHO, BETA; KLB	152831
MIM611136	#	5q34-q35	EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 5; EJM5	2554
MIM611137	*	14q11.2	PROTEASOME SUBUNIT, BETA-TYPE, 11; PSMB11	122706
MIM611138	*	9q34	SPERMATID PERINUCLEAR RNA-BINDING PROTEIN; STRBP	55342
MIM611139	%	9p21	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 8; CHDS8	100188836
MIM611140	*	16p13.3	TELOMERE MAINTENANCE 2, S. CEREVISIAE, HOMOLOG OF; TELO2	9894
MIM611141	*	 	MINDBOMB, DROSOPHILA, HOMOLOG OF, 2; MIB2	142678
MIM611142	*	11p11.2	CYTOSKELETON-ASSOCIATED PROTEIN 5; CKAP5	9793
MIM611143	*	4q21.2	COILED-COIL DOMAIN-CONTAINING PROTEIN 98; CCDC98	84142
MIM611144	*	10q26.13	FAMILY WITH SEQUENCE SIMILARITY 175, MEMBER B; FAM175B	23172
MIM611145	*	8q24.11	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 8; SLC30A8	169026
MIM611146	*	1q41	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 10; SLC30A10	55532
MIM611147	%	2q31	PAROXYSMAL NONKINESIGENIC DYSKINESIA 2; PNKD2	100188328
MIM611148	*	2p22-p21	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 6; SLC30A6	55676
MIM611149	*	1p21.2	SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 7; SLC30A7	148867
MIM611150	*	22q13	ATAXIN 10; ATXN10	25814
MIM611151	*	22q11.21	tRNA METHYLTRANSFERASE 2, S. CEREVISIAE, HOMOLOG OF, A; TRMT2A	27037
MIM611152	%	1q21	ALZHEIMER DISEASE 13; AD13	100188837
MIM611153	*	9q22.3	XPA GENE; XPA	7507
MIM611154	%	1q25	ALZHEIMER DISEASE 14; AD14	100188754
MIM611155	%	3q22-q24	ALZHEIMER DISEASE 15; AD15	100188838
MIM611156	*	9p24	ENDOPLASMIC RETICULUM METALLOPEPTIDASE 1; ERMP1	79956
MIM611157	*	20q13.33	CHROMOSOME 20 OPEN READING FRAME 20; C20ORF20	55257
MIM611158	*	12q13.13	KERATIN 77; KRT77	374454
MIM611159	*	12q13.13	KERATIN 78; KRT78	196374
MIM611160	*	12q13.13	KERATIN 79; KRT79	338785
MIM611161	*	12q13.13	KERATIN 80; KRT80	144501
MIM611162	#	17q21-q22, 17cen-q11.2, 1q23.2, 1q22, 11q23-q24, 7q11.2, 6p21.3, 4q28.2-q31.1, 3p21.3, 2q14-q21, 1q32, 19p13.3-p13.2	MALARIA, SUSCEPTIBILITY TO	114609, 1154, 1378, 2213, 2532, 2993, 2995, 3383, 4843, 6521, 7124, 948
MIM611163	*	 	TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 2; TOX2	84969
MIM611164	*	3q13.3	ARGININE-FIFTY HOMEOBOX; ARGFX	503582
MIM611165	*	 	DIVERGENT-PAIRED RELATED HOMEOBOX; DPRX	503834
MIM611166	*	 	TETRAPEPTIDE REPEAT HOMEOBOX 1; TPRX1	284355
MIM611167	*	 	TETRAPEPTIDE REPEAT HOMEOBOX-LIKE; TPRXL	348825
MIM611168	*	 	DOUBLE HOMEOBOX A; DUXA	503835
MIM611169	*	 	CATION CHANNEL, SPERM-ASSOCIATED, BETA; CATSPERB	79820
MIM611170	*	7q21.2	STERILE ALPHA MOTIF DOMAIN-CONTAINING 9-LIKE; SAMD9L	219285
MIM611171	*	 	KIAA1598 GENE; KIAA1598	57698
MIM611172	*	1p36	MICRO RNA 34A; MIR34A	407040
MIM611173	*	2q35	MICRO RNA 375; MIRN375	494324
MIM611174	#	 	HAMAMY SYNDROME; HMMS	10265
MIM611175	*	 	OBG-LIKE ATPase 1; OLA1	29789
MIM611176	*	 	CHROMOSOME 14 OPEN READING FRAME 100; C14ORF100	51528
MIM611177	*	3q24-q26	INTRAFLAGELLAR TRANSPORT 80, CHLAMYDOMONAS, HOMOLOG OF; IFT80	57560
MIM611178	*	 	GALANIN-LIKE PEPTIDE; GALP	85569
MIM611179	*	 	SHROOM FAMILY MEMBER 1; SHROOM1	134549
MIM611180	*	9q34	COFACTOR OF BRCA1; COBRA1	25920
MIM611181	*	 	ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 10; ACAD10	80724
MIM611182	#	16q22.1	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIh; CDG2H	84342
MIM611183	*	 	C3ORF10 GENE; C3ORF10	55845
MIM611184	*	 	FAMILY WITH SEQUENCE SIMILARITY 38, MEMBER A; FAM38A	9780
MIM611185	%	6p21	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 6; RLS6	100302512
MIM611186	*	1q22	MICRO RNA 9-1; MIRN9-1	407046
MIM611187	*	5q14.3	MICRO RNA 9-2; MIR9-2	407047
MIM611188	*	15q26.1	MICRO RNA 9-3; MIRN9-3	407051
MIM611189	*	 	MICRO RNA 197; MIRN197	406974
MIM611190	*	 	MICRO RNA 346; MIRN346	442911
MIM611191	*	19q13.33	MICRO RNA 125A; MIR125A	406910
MIM611192	*	16q24.3	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 11; ANKRD11	29123
MIM611193	*	 	RIBOSOMAL RNA-PROCESSING 15, S. CEREVISIAE, HOMOLOG OF; RRP15	51018
MIM611194	*	 	RUN AND FYVE DOMAINS-CONTAINING PROTEIN 3; RUFY3	22902
MIM611195	*	 	JANUS KINASE AND MICROTUBULE-INTERACTING PROTEIN 1; JAKMIP1	152789
MIM611196	*	 	ZING FINGER MIZ-DOMAIN CONTAINING 2; ZMIZ2	83637
MIM611197	*	 	JANUS KINASE AND MICROTUBULE-INTERACTING PROTEIN 2; JAKMIP2	9832
MIM611198	*	 	CHROMOSOME 10 OPEN READING FRAME 39; C10ORF39	282973
MIM611199	*	 	DNTT-INTERACTING PROTEIN 2; DNTTIP2	30836
MIM611200	*	 	TUDOR DOMAIN-CONTAINING PROTEIN 6; TDRD6	221400
MIM611201	*	 	KELCH-LIKE 9; KLHL9	55958
MIM611202	*	 	N-ACYLSPHINGOSINE AMIDOHYDROLASE 2; ASAH2	56624
MIM611203	*	 	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 5; DNAJC5	80331
MIM611204	*	 	COILED-COIL DOMAIN-CONTAINING PROTEIN 88C; CCDC88C	440193
MIM611205	*	 	COILED-COIL DOMAIN-CONTAINING PROTEIN 88B; CCDC88B	283234
MIM611206	*	10q22.2	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 9; DNAJC9	23234
MIM611207	*	 	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 1; DNAJC1	64215
MIM611208	*	 	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN L-LIKE; HNRNPLL	92906
MIM611209	#	17q25.1	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	9382
MIM611210	*	 	PDZ-BINDING KINASE; PBK	55872
MIM611211	*	11q13.4	RECEPTOR EXPRESSED IN LYMPHOID TISSUES; RELT	84957
MIM611212	*	 	RELT-LIKE 1; RELL1	768211
MIM611213	*	 	RELT-LIKE 2; RELL2	285613
MIM611214	*	 	TSR1, 20S rRNA ACCUMULATION, S. CEREVISIAE, HOMOLOG OF; TSR1	55720
MIM611215	*	 	PRADER-WILLI REGION NONCODING RNA 1; PWRN1	791114
MIM611216	*	 	UBX DOMAIN-CONTAINING 2; UBXD2	23190
MIM611217	*	 	PRADER-WILLI REGION NONCODING RNA 2; PWRN2	791115
MIM611218	*	17q12	GASDERMIN A; GSDMA	284110
MIM611219	*	15q25-q26	UNC45, C. ELEGANS, HOMOLOG OF, A; UNC45A	55898
MIM611220	*	 	UNC45, C. ELEGANS, HOMOLOG OF, B; UNC45B	146862
MIM611221	*	17q21	GASDERMIN B; GSDMB	55876
MIM611223	*	1q44	V-AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 3; AKT3	10000
MIM611224	*	2p11.2	SUCCINATE-CoA LIGASE, ALPHA SUBUNIT; SUCLG1	8802
MIM611225	#	8p12-p11.21	SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	11160, 140906
MIM611226	*	 	ARMADILLO REPEAT-CONTAINING PROTEIN 3; ARMC3	219681
MIM611227	*	 	HYDROGEN VOLTAGE-GATED CHANNEL 1; HVCN1	84329
MIM611228	#	6q21	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J; CMT4J	9896
MIM611229	*	2p16.2	ENDOPLASMIC RETICULUM LECTIN 1; ERLEC1	27248
MIM611230	*	 	NON-SMC CONDENSIN II COMPLEX SUBUNIT H2; NCAPH2	29781
MIM611231	*	 	CLAUDIN 8; CLDN8	9073
MIM611232	*	 	CLAUDIN 12; CLDN12	9069
MIM611233	*	 	ARGININE-RICH PROTEIN MUTATED IN EARLY STAGE TUMORS-LIKE 1; ARMETL1	441549
MIM611234	*	 	FAMILY WITH SEQUENCE SIMILARITY 84, MEMBER A; FAM84A	151354
MIM611235	*	 	TRANSMEMBRANE PROTEIN 38A; TMEM38A	79041
MIM611236	*	 	TRANSMEMBRANE PROTEIN 38B; TMEM38B	55151
MIM611237	*	6p21	BTB/POZ DOMAIN-CONTAINING PROTEIN 9; BTBD9	114781
MIM611238	*	8q12	COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 7; CHCHD7	79145
MIM611239	*	 	G PROTEIN-REGULATED INDUCER OF NEURITE OUTGROWTH 1; GPRIN1	114787
MIM611240	*	 	G PROTEIN-REGULATED INDUCER OF NEURITE OUTGROWTH 2; GPRIN2	9721
MIM611241	*	 	G PROTEIN-REGULATED INDUCER OF NEURITE OUTGROWTH 3; GPRIN3	285513
MIM611242	%	20p13	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 5; RLS5	100188839
MIM611243	*	 	tRNA-WYBUTOSINE-SYNTHESIZING PROTEIN 1, S. CEREVISIAE, HOMOLOG OF; TYW1	55253
MIM611244	*	 	tRNA METHYLTRANSFERASE 12, S. CEREVISIAE, HOMOLOG OF; TRMT12	55039
MIM611245	*	 	tRNA-WYBUTOSINE-SYNTHESIZING PROTEIN 3, S. CEREVISIAE, HOMOLOG OF; TYW3	127253
MIM611246	*	 	LEUCINE CARBOXYL METHYLTRANSFERASE 2; LCMT2	9836
MIM611247	%	16p12	MAJOR AFFECTIVE DISORDER 4; MAFD4	100126593
MIM611248	*	 	KELCH DOMAIN-CONTAINING 3; KLHDC3	116138
MIM611249	*	22q13	MICRO RNA LET7B; MIRNLET7B	406884
MIM611250	*	 	MICRO RNA LET7E; MIRNLET7E	406887
MIM611251	*	1p36.22	PATCHED DOMAIN-CONTAINING PROTEIN 2; PTCHD2	57540
MIM611252	%	14q12-q21	SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	724107
MIM611253	*	 	KINESIN FAMILY MEMBER 27; KIF27	55582
MIM611254	*	 	KINESIN FAMILY MEMBER 7; KIF7	374654
MIM611255	*	 	NADPH OXIDASE ACTIVATOR 1; NOXA1	10811
MIM611256	*	 	NADPH OXIDASE ORGANIZER 1; NOXO1	124056
MIM611257	*	 	TRANSMEMBRANE PROTEIN 132D; TMEM132D	121256
MIM611258	*	 	TUDOR DOMAIN-CONTAINING PROTEIN 7; TDRD7	23424
MIM611259	*	6p22.3	CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 1-LIKE 1; CDKAL1	54901
MIM611260	*	 	THREONINE SYNTHASE-LIKE 1; THNSL1	79896
MIM611261	*	 	THREONINE SYNTHASE-LIKE 2; THNSL2	55258
MIM611262	*	 	DEOXYHYPUSINE HYDROXYLASE; DOHH	83475
MIM611263	#	3q24-q26	ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	57560
MIM611264	*	 	CHROMOSOME 6 OPEN READING FRAME 173; C6ORF173	387103
MIM611265	*	 	PEROXISOMAL PROLIFERATOR-ACTIVATED RECEPTOR ALPHA-INTERACTING COFACTOR COMPLEX, 285-KD SUBUNIT	85441
MIM611266	*	 	POTE ANKYRIN DOMAIN FAMILY, MEMBER K, PSEUDOGENE; POTEKP	440915
MIM611267	*	 	OLFACTORY RECEPTOR, FAMILY 51, SUBFAMILY E, MEMBER 1; OR51E1	143503
MIM611268	*	 	OLFACTORY RECEPTOR, FAMILY 51, SUBFAMILY E, MEMBER 2; OR51E2	81285
MIM611269	*	 	NUCLEOLAR PROTEIN WITH MIF4G DOMAIN 1; NOM1	64434
MIM611270	*	 	N-ETHYLMALEIMIDE-SENSITIVE FACTOR ATTACHMENT PROTEIN, BETA; NAPB	63908
MIM611271	*	 	KINESIN FAMILY MEMBER 18A; KIF18A	81930
MIM611272	*	 	ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 5; ZKSCAN5	23660
MIM611273	*	15q23	LBX1 COREPRESSOR 1, MOUSE, HOMOLOG OF; LBXCOR1	390598
MIM611274	%	 	GLAUCOMA 1, OPEN ANGLE, N; GLC1N	777645
MIM611275	*	 	BCL2/ADENOVIRUS E1B 19-KD PROTEIN-INTERACTING PROTEIN 2-LIKE; BNIPL	149428
MIM611276	%	 	GLAUCOMA 1, OPEN ANGLE, H; GLC1H	399564
MIM611277	#	5q31.1-q33.1	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 3; GEFSP3	2566
MIM611278	*	 	KINESIN FAMILY MEMBER 12; KIF12	113220
MIM611279	*	1q31	KINESIN FAMILY MEMBER 14; KIF14	9928
MIM611280	*	 	KELCH DOMAIN-CONTAINING PROTEIN 2; KLHDC2	23588
MIM611281	*	 	KELCH DOMAIN-CONTAINING PROTEIN 1; KLHDC1	122773
MIM611282	*	 	DYNAMIN-BINDING PROTEIN; DNMBP	23268
MIM611283	#	11q25	ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY	27034
MIM611285	*	 	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 5; KCTD5	54442
MIM611286	*	 	RNA TERMINAL PHOSPHATE CYCLASE DOMAIN-CONTAINING PROTEIN 1; RTCD1	8634
MIM611287	*	 	CORNICHON, DROSOPHILA, HOMOLOG OF; CNIH	10175
MIM611288	*	 	CORNICHON, DROSOPHILA, HOMOLOG OF, 2; CNIH2	254263
MIM611289	*	 	LEUCINE-RICH ALPHA-2-GLYCOPROTEIN 1; LRG1	116844
MIM611290	*	2q35	NONHOMOLOGOUS END-JOINING FACTOR 1; NHEJ1	79840
MIM611291	#	2q35	SEVERE COMBINED IMMUNODEFICIENCY WITH MICROCEPHALY, GROWTH RETARDATION, AND SENSITIVITY TO IONIZING RADIATION	79840
MIM611292	*	 	RETINALDEHYDE-BINDING PROTEIN 1-LIKE 1; RLBP1L1	157807
MIM611293	*	 	COILED-COIL DOMAIN-CONTAINING PROTEIN 86; CCDC86	79080
MIM611294	*	 	ONE CUT HOMEOBOX 3; ONECUT3	390874
MIM611295	*	 	KELCH-LIKE 24; KLHL24	54800
MIM611296	*	 	CHROMOSOME 5 OPEN READING FRAME 39; C5ORF39	389289
MIM611297	*	8q23	ODD-SKIPPED-RELATED 2; OSR2	116039
MIM611298	*	 	KIAA1324	57535
MIM611299	*	 	KIAA1333	55632
MIM611300	*	 	La RIBONUCLEOPROTEIN DOMAIN FAMILY, MEMBER 6; LARP6	55323
MIM611301	*	 	CHROMOSOME 17 OPEN READING FRAME 70; C17ORF70	80233
MIM611302	#	17p13	SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE; SPAX2	100126095
MIM611303	*	16p13.13	C-TYPE LECTIN DOMAIN FAMILY 16, MEMBER A; CLEC16A	23274
MIM611304	*	 	TRANSMEMBRANE PROTEIN 159; TMEM159	57146
MIM611305	*	 	ACTIN-BINDING LIM PROTEIN FAMILY, MEMBER 3; ABLIM3	22885
MIM611306	*	 	SCAVENGER RECEPTOR CLASS A, MEMBER 5; SCARA5	286133
MIM611307	#	11p14.3	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L; LGMD2L	203859
MIM611309	*	 	CHROMOSOME 10 OPEN READING FRAME; C10ORF10	11067
MIM611310	*	 	PHOSPHOSERYL-tRNA KINASE; PSTK	118672
MIM611312	*	 	CORNULIN; CRNN	49860
MIM611313	*	10q26.13	ARMS2 GENE; ARMS2	387715
MIM611314	*	 	CHROMOSOME 15 OPEN READING FRAME 21; C15ORF21	283651
MIM611315	*	 	ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 20; ZSCAN20	7579
MIM611316	*	 	SOLUTE CARRIER FAMILY 12 (SODIUM/POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 8; SLC12A8	84561
MIM611317	*	 	PHOSPHATIDYLINOSITOL 3-KINASE, REGULATORY SUBUNIT 5; PIK3R5	23533
MIM611318	*	3q21-q25	MEDIATOR COMPLEX SUBUNIT 12-LIKE; MED12L	116931
MIM611319	*	 	FAMILY WITH SEQUENCE SIMILARITY 14, MEMBER A; FAM14A	83982
MIM611320	*	 	FAMILY WITH SEQUENCE SIMILARITY 14, MEMBER B; FAM14B	122509
MIM611321	*	 	CALSYNTENIN 1; CLSTN1	22883
MIM611322	*	16q12.1	DNAJ/HSP40 HOMOLOG, SUBFAMILY A, MEMBER 2; DNAJA2	10294
MIM611323	*	 	CALSYNTENIN 2; CLSTN2	64084
MIM611324	*	 	CALSYNTENIN 3; CLSTN3	9746
MIM611325	*	 	TRANSFORMING GROWTH FACTOR-BETA REGULATOR 4; TBRG4	9238
MIM611326	*	 	CELL CYCLE PROGRESSION 1; CCPG1	9236
MIM611327	*	 	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 4; DNAJB4	11080
MIM611328	*	 	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 5; DNAJB5	25822
MIM611329	*	 	SMALL CAJAL BODY-SPECIFIC RNA 18; SCARNA18	677765
MIM611330	*	 	SMALL NUCLEOLAR RNA, H/ACA BOX, 12; SNORA12	677800
MIM611331	*	 	SMALL NUCLEOLAR RNA, H/ACA BOX, 74B; SNORA74B	677841
MIM611332	*	 	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 6; DNAJB6	10049
MIM611333	*	 	SMALL NUCLEOLAR RNA, H/ACA BOX, 45; SNORA45	677826
MIM611334	*	 	SMALL NUCLEOLAR RNA, H/ACA BOX, 81; SNORA81	677847
MIM611335	*	 	SMALL NUCLEOLAR RNA, H/ACA BOX, 5C; SNORA5C	677796
MIM611336	*	 	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 7; DNAJB7	150353
MIM611337	*	 	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 8; DNAJB8	165721
MIM611338	*	 	AUTOPHAGY 4, S. CEREVISIAE, HOMOLOG OF, B; ATG4B	23192
MIM611339	*	 	AUTOPHAGY 4, S. CEREVISIAE, HOMOLOG OF, C; ATG4C	84938
MIM611340	*	 	AUTOPHAGY 4, S. CEREVISIAE, HOMOLOG OF, D; ATG4D	84971
MIM611341	*	 	DNAJ/HSP40 HOMOLOG, SUBFAMILY B, MEMBER 11; DNAJB11	51726
MIM611342	*	 	CHROMOSOME 9 OPEN READING FRAME 64; C9ORF64	84267
MIM611343	*	 	CHROMOSOME 9 OPEN READING FRAME 103; C9ORF103	414328
MIM611344	*	 	RAS AND EF-HAND DOMAINS-CONTAINING PROTEIN; RASEF	158158
MIM611345	*	 	INTEGRATOR COMPLEX SUBUNIT 1; INTS1	26173
MIM611346	*	 	INTEGRATOR COMPLEX SUBUNIT 2; INTS2	57508
MIM611347	*	 	INTEGRATOR COMPLEX SUBUNIT 3; INTS3	65123
MIM611348	*	 	INTEGRATOR COMPLEX SUBUNIT 4; INTS4	92105
MIM611349	*	 	INTEGRATOR COMPLEX SUBUNIT 5; INTS5	80789
MIM611350	*	 	INTEGRATOR COMPLEX SUBUNIT 7; INTS7	25896
MIM611351	*	 	INTEGRATOR COMPLEX SUBUNIT 8; INTS8	55656
MIM611352	*	 	INTEGRATOR COMPLEX SUBUNIT 9; INTS9	55756
MIM611353	*	 	INTEGRATOR COMPLEX SUBUNIT 10; INTS10	55174
MIM611354	*	 	CLEAVAGE AND POLYADENYLATION-SPECIFIC FACTOR 3-LIKE; CPSF3L	54973
MIM611355	*	 	INTEGRATOR COMPLEX SUBUNIT 12; INTS12	57117
MIM611356	*	 	G KINASE-ANCHORING PROTEIN 1; GKAP1	80318
MIM611357	*	 	FAMILY WITH SEQUENCE SIMILARITY 46, MEMBER A; FAM46A	55603
MIM611358	*	17q11	RING FINGER PROTEIN 135; RNF135	84282
MIM611359	*	11p11.2	ACTIVATING MOLECULE IN BECLIN 1-REGULATED AUTOPHAGY; AMBRA1	55626
MIM611360	*	15q25-q26	FANCI GENE; FANCI	55215
MIM611361	*	 	UBIQUITIN-ACTIVATING ENZYME E1-LIKE 2; UBE1L2	55236
MIM611362	*	 	UBIQUITIN-CONJUGATING ENZYME E2Z; UBE2Z	65264
MIM611363	#	7p15-p14	ATRIAL SEPTAL DEFECT 4; ASD4	57057
MIM611364	%	5q12-q14	MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	100126594
MIM611365	*	 	TRANSMEMBRANE PROTEIN 183B; TMEM183B	653659
MIM611366	*	 	CHROMOSOME 12 OPEN READING FRAME 10; C12ORF10	60314
MIM611367	*	 	ASPARTYL AMINOPEPTIDASE; DNPEP	23549
MIM611368	*	1q24.1	MAELSTROM, DROSOPHILA, HOMOLOG OF; MAEL	84944
MIM611369	#	19p13.3	LETHAL CONGENITAL CONTRACTURAL SYNDROME 3; LCCS3	23396
MIM611370	*	 	FLJ10986	55277
MIM611371	*	 	ZINC FINGER PROTEIN 653; ZNF653	115950
MIM611372	*	 	STROMAL MEMBRANE-ASSOCIATED PROTEIN 1; SMAP1	60682
MIM611373	*	 	LIVER-EXPRESSED ANTIMICROBIAL PEPTIDE 2; LEAP2	116842
MIM611374	*	 	MICRO RNA 34B; MIRN34B	407041
MIM611375	*	 	MICRO RNA 34C; MIRN34C	407042
MIM611376	%	8q23-q24	MUNGAN SYNDROME; MGS	100126595
MIM611377	#	17q22	BRACHYDACTYLY, TYPE B2; BDB2	9241
MIM611378	#	19p13.3-p13.2	MACULAR DEGENERATION, AGE-RELATED, 9; ARMD9	718
MIM611379	*	12q13.12	DISCO-INTERACTING PROTEIN 2, DROSOPHILA, HOMOLOG OF, B; DIP2B	57609
MIM611380	*	10p15.3	DISCO-INTERACTING PROTEIN 2, DROSOPHILA, HOMOLOG OF, C; DIP2C	22982
MIM611383	#	9q32-q34	USHER SYNDROME, TYPE IID; USH2D	25861
MIM611386	*	 	ACTIVITY-DEPENDENT NEUROPROTECTOR HOMEOBOX; ADNP	23394
MIM611387	*	 	CXC CHEMOKINE LIGAND 17; CXCL17	284340
MIM611388	*	 	DEOXYNUCLEOTIDYLTRANSFERASE, TERMINAL, INTERACTING PROTEIN 1; DNTTIP1	116092
MIM611389	*	 	CHROMOSOME 6, OPEN READING FRAME 49; C6ORF49	29964
MIM611390	#	2q33-q34	SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3	100379201
MIM611391	#	20p12.1-p11.23	CATARACT, CORTICAL, JUVENILE-ONSET	631
MIM611392	*	 	CHROMOSOME 10 OPEN READING FRAME 22; C10ORF22	84890
MIM611393	*	 	FAMILY WITH SEQUENCE SIMILARITY 110, MEMBER A; FAM110A	83541
MIM611394	*	 	FAMILY WITH SEQUENCE SIMILARITY 110, MEMBER B; FAM110B	90362
MIM611395	*	 	FAMILY WITH SEQUENCE SIMILARITY 110, MEMBER C; FAM110C	642273
MIM611396	*	 	ADIPOGENIN; ADIG	149685
MIM611397	*	 	TETRATRICOPEPTIDE REPEAT, ANKYRIN REPEAT, AND COILED-COIL-CONTAINING PROTEIN 1; TANC1	85461
MIM611398	*	 	GROWTH ARREST-SPECIFIC 2-LIKE 2; GAS2L2	246176
MIM611399	*	 	SODIUM CHANNEL AND CLATHRIN LINKER 1; SCLT1	132320
MIM611400	*	12q13.13	HOX TRANSCRIPT ANTISENSE RNA; HOTAIR	100124700
MIM611401	*	 	CHROMOSOME 6 OPEN READING FRAME 15; C6ORF15	29113
MIM611402	*	 	DOCKING PROTEIN 6; DOK6	220164
MIM611403	%	17q21	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 6	100188840
MIM611404	*	 	CHROMOSOME 6 OPEN READING FRAME 21; C6ORF21	259215
MIM611405	*	 	RNA TERMINAL PHOSPHATE CYCLASE-LIKE 1; RCL1	10171
MIM611406	*	 	DYNEIN, CYTOPLASMIC 1, LIGHT INTERMEDIATE CHAIN 2; DYNC1LI2	1783
MIM611407	#	10q22.1-q23	CARDIOMYOPATHY, DILATED, 1W; CMD1W	7414
MIM611408	*	6q14.1	LCA5 GENE; LCA5	167691
MIM611409	*	15q11.2-q12	OCA2 GENE	4948
MIM611410	*	6p22.3-p21.32	FAMILY WITH SEQUENCE SIMILARITY 65, MEMBER B; FAM65B	9750
MIM611411	*	 	CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 1, ALPHA; CAMKK1	84254
MIM611412	*	1q25	N-ACETYLNEURAMINATE PYRUVATE LYASE; NPL	80896
MIM611413	*	 	DISCS LARGE-ASSOCIATED PROTEIN 3; DLGAP3	58512
MIM611414	*	19p13.12	CALRETICULIN 3; CALR3	125972
MIM611415	*	 	POLYMERASE (DNA-DIRECTED), DELTA 3, ACCESSORY SUBUNIT; POLD3	10714
MIM611416	*	 	TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 3; TOX3	27324
MIM611417	*	 	SMALL G PROTEIN SIGNALING MODULATOR 1; SGSM1	129049
MIM611418	*	 	SMALL G PROTEIN SIGNALING MODULATOR 2; SGSM2	9905
MIM611419	*	6p21.3	CHROMOSOME 6 OPEN READING FRAME 1; C6ORF1	221491
MIM611420	*	 	CDKN1A-INTERACTING ZINC FINGER PROTEIN 1; CIZ1	25792
MIM611421	*	16p11.2	SNF2-RELATED CBP ACTIVATOR PROTEIN; SRCAP	10847
MIM611422	*	 	MEIOTIC NUCLEAR DIVISION 1, S. CEREVISIAE. HOMOLOG OF; MND1	84057
MIM611423	*	 	CENTROSOMAL PROTEIN, 135-KD; CEP135	9662
MIM611424	*	9q34.3	ZINC FINGER MYND DOMAIN-CONTAINING PROTEIN 19; ZMYND19	116225
MIM611425	*	 	CENTROSOMAL BRCA2-INTERACTING PROTEIN; CNTROB	116840
MIM611427	*	 	METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1-LIKE, NADP(+)-DEPENDENT; MTHFD1L	25902
MIM611428	*	 	DOWNSTREAM NEIGHBOR OF SON; DONSON	29980
MIM611429	*	 	CHROMOSOME 3 OPEN READING FRAME 35; C3ORF35	339883
MIM611430	*	 	TETRATRICOPEPTIDE REPEAT DOMAIN 21A; TTC21A	199223
MIM611431	#	15q13.2	LEGIUS SYNDROME	161742
MIM611432	*	9p24	DEDICATOR OF CYTOKINESIS 8; DOCK8	81704
MIM611433	*	 	SERINE/THREONINE/TYROSINE KINASE 1; STYK1	55359
MIM611434	*	 	CYTOKINE-DEPENDENT HEMATOPOIETIC CELL LINKER; CLNK	116449
MIM611435	*	5q35.3	DOCKING PROTEIN 3; DOK3	79930
MIM611436	*	 	CARBONIC ANHYDRASE XIII; CA13	377677
MIM611437	*	 	DUAL-SPECIFICITY PHOSPHATASE 19; DUSP19	142679
MIM611438	*	 	TAXILIN, BETA; TXLNB	167838
MIM611439	*	 	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 22; ZBTB22	9278
MIM611440	*	 	WD REPEAT-CONTAINING PROTEIN 46; WDR46	9277
MIM611441	*	 	DOUBLE HOMEOBOX PROTEIN 1; DUX1	26584
MIM611442	*	 	DOUBLE HOMEOBOX PROTEIN 2; DUX2	26583
MIM611443	*	 	DOUBLE HOMEOBOX PROTEIN 3; DUX3	26582
MIM611444	*	 	DOUBLE HOMEOBOX PROTEIN 5; DUX5	26581
MIM611445	*	 	DYNAMIN 3; DNM3	26052
MIM611446	*	 	DUAL-SPECIFICITY PHOSPHATASE 18; DUSP18	150290
MIM611447	*	 	Y BOX-BINDING PROTEIN 2; YBX2	51087
MIM611448	*	 	BMS1, RIBOSOME ASSEMBLY PROTEIN, S. CEREVISIAE, HOMOLOG OF; BMS1	9790
MIM611449	*	 	EXPORTIN 4; XPO4	64328
MIM611450	*	3p14.3	PXK DOMAIN-CONTAINING SERINE/THREONINE KINASE; PXK	54899
MIM611451	#	11q13.3-q13.4	DEAFNESS, AUTOSOMAL RECESSIVE 63; DFNB63	220074
MIM611452	^	13q14.12-q14.2	MOVED TO 278150	 
MIM611453	*	20q12	DYSBINDIN DOMAIN-CONTAINING 2; DBNDD2	55861
MIM611455	*	1p33	KINOCILIN; KNCN	148930
MIM611456	%	 	TREMOR, HEREDITARY ESSENTIAL, 3; ETM3	101027378
MIM611457	*	1p34.1	FORKHEAD BOX O6	100132074
MIM611458	*	3p21.33	GALACTOSIDASE, BETA-1; GLB1	2720
MIM611459	*	 	SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 7; SLC10A7	84068
MIM611460	*	 	FAMILY WITH SEQUENCE SIMILARITY 79, MEMBER A; FAM79A	127262
MIM611461	*	14q11.2	SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 17; SLC22A17	51310
MIM611462	*	 	CHROMOSOME 17 OPEN READING FRAME 38; C17ORF38	146850
MIM611463	*	17p13.1	SPERMIDINE/SPERMINE N(1)-ACETYLTRANSFERASE 2; SAT2	112483
MIM611464	*	 	MON1, S. CEREVISIAE, HOMOLOG OF, A; MON1A	84315
MIM611465	#	2p21	GALLBLADDER DISEASE 4; GBD4	64241
MIM611466	*	17q21.3	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY M, MEMBER 1; PLEKHM1	9842
MIM611467	*	1p22.2	GUANYLATE-BINDING PROTEIN 5: GBP5	115362
MIM611468	*	 	BRAIN-DERIVED NEUROTROPHIC FACTOR, OPPOSITE STRAND; BDNFOS	497258
MIM611469	%	8q24	COLORECTAL CANCER, SUSCEPTIBILITY TO, 2; CRCS2	100188841
MIM611470	*	 	GLUTAMATE-AMMONIA LIGASE (GLUTAMINE SYNTHETASE) DOMAIN-CONTAINING 1; GLULD1	51557
MIM611471	*	 	ACID PHOSPHATASE 6, LYSOPHOSPHATIDE; ACP6	51205
MIM611472	*	2q23.1	METHYL-CpG-BINDING DOMAIN PROTEIN 5; MBD5	55777
MIM611473	*	 	EMBRYONIC STEM CELL-RELATED PROTEIN	790952
MIM611474	*	 	HRAS-LIKE SUPPRESSOR FAMILY, MEMBER 5; HRASLS5	117245
MIM611475	*	15q15.1	RNA POLYMERASE II-ASSOCIATED PROTEIN 1; RPAP1	26015
MIM611476	*	1p22.1	RNA POLYMERASE II-ASSOCIATED PROTEIN 2; RPAP2	79871
MIM611477	*	12q13.11	RNA POLYMERASE II-ASSOCIATED PROTEIN 3; RPAP3	79657
MIM611478	*	7q22	METHYLPHOSPHATE CAPPING ENZYME; MEPCE	56257
MIM611479	*	2p23.3	XPA-BINDING PROTEIN 1; XAB1	11321
MIM611480	*	19q13.33	PIH1 DOMAIN-CONTAINING PROTEIN 1; PIH1D1	55011
MIM611481	*	7q22.1	UFM1-SPECIFIC PEPTIDASE 1; UFSP1	402682
MIM611482	*	4q35.1	UFM1-SPECIFIC PEPTIDASE 2; UFSP2	55325
MIM611483	*	5q32	YIP1 DOMAIN FAMILY, MEMBER 5; YIPF5	81555
MIM611484	*	11q13	YIP1-INTERACTING FACTOR, S. CEREVISIAE, HOMOLOG OF, A; YIF1A	10897
MIM611485	*	19p13.1	CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 12; CYP4F12	66002
MIM611486	*	10q26.3	SYNAPTONEMAL COMPLEX CENTRAL ELEMENT PROTEIN 1; SYCE1	93426
MIM611487	*	19p13.13	SYNAPTONEMAL COMPLEX CENTRAL ELEMENT PROTEIN 2; SYCE2	256126
MIM611488	#	9q32-q33	MACULAR DEGENERATION, AGE-RELATED, 10; ARMD10	7099
MIM611489	#	14q32.1	CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	866
MIM611490	#	16p13	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 4; OPTB4	1186
MIM611491	*	7p22.1	RAS ASSOCIATION AND DILUTE DOMAINS PROTEIN; RADIL	55698
MIM611492	*	8q22	CARBONIC ANHYDRASE II; CA2	760
MIM611493	#	21q22.1	ATRIAL FIBRILLATION, FAMILIAL, 4; ATFB4	9992
MIM611494	%	4q25	ATRIAL FIBRILLATION, FAMILIAL, 5; ATFB5	100188842
MIM611495	*	19p13.12	CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 22; CYP4F22	126410
MIM611496	*	20q13.2-q13.3	GATA-BINDING PROTEIN 5; GATA5	140628
MIM611497	#	17q21.3	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 6; OPTB6	9842
MIM611498	#	16p13.3	NEPHRONOPHTHISIS 7; NPHP7	84662
MIM611499	*	7q21.11	BETA-GLUCURONIDASE; GUSB	2990
MIM611500	*	6p21.32	MICRO RNA 219-1; MIRN219-1	407002
MIM611501	*	1p36	CALMODULIN-BINDING TRANSCRIPTION ACTIVATOR 1; CAMTA1	23261
MIM611502	*	5p15.2-q12.3	CENTROMERIC PROTEIN K; CENPK	64105
MIM611503	*	1q25.1	CENTROMERIC PROTEIN L; CENPL	91687
MIM611504	*	2p23.3	CENTROMERIC PROTEIN O; CENPO	79172
MIM611505	*	9q22.31	CENTROMERIC PROTEIN P; CENPP	401541
MIM611506	*	6p12.3	CENTROMERIC PROTEIN Q; CENPQ	55166
MIM611507	*	4q22-q24	CDGSH IRON SULFUR DOMAIN PROTEIN 2; CISD2	493856
MIM611508	*	17p13.2	CALMODULIN-BINDING TRANSCRIPTION ACTIVATOR 2; CAMTA2	23125
MIM611509	*	16q23.2	CENTROMERIC PROTEIN N; CENPN	55839
MIM611510	*	16q22.1	CENTROMERIC PROTEIN T; CENPT	80152
MIM611511	*	4q35.1	MLF1-INTERACTING PROTEIN; MLF1IP	79682
MIM611512	*	2p11.2	LYSINE-SPECIFIC DEMETHYLASE 3A; KDM3A	55818
MIM611513	*	7p15-p14	NEUROGENIC DIFFERENTIATION 6; NEUROD6	63974
MIM611514	*	1p31.3	G PROTEIN-COUPLED RECEPTOR 177; GPR177	79971
MIM611515	%	21q22	FEBRILE SEIZURES, FAMILIAL, 7; FEB7	100049160
MIM611516	*	3p21	NICOLIN 1; NICN1	84276
MIM611517	*	19p13.1	CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 11; CYP4F11	57834
MIM611518	*	2q36.2	DEDICATOR OF CYTOKINESIS 10; DOCK10	55619
MIM611519	*	17q11.2	POLYMERASE DELTA-INTERACTING PROTEIN 2; POLDIP2	26073
MIM611520	*	22q13.2	POLYMERASE DELTA-INTERACTING PROTEIN 3; POLDIP3	84271
MIM611521	#	19p13.2	TYROSINE KINASE 2 DEFICIENCY	7297
MIM611523	#	6q16.1	PONTOCEREBELLAR HYPOPLASIA, TYPE 6; PCH6	57038
MIM611524	*	6q16.1	ARGINYL-tRNA SYNTHETASE 2; RARS2	57038
MIM611525	*	11q13	POLYMERASE (DNA-DIRECTED), DELTA 4; POLD4	57804
MIM611526	*	4p16.3	NOP14, S. CEREVISIAE, HOMOLOG OF; NOP14	8602
MIM611527	*	4q24	Na+/H+ EXCHANGER DOMAIN-CONTAINING PROTEIN 1; NHEDC1	150159
MIM611528	#	17q21	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 12; ARVD12	3728
MIM611529	*	19q13.2	CYTOCHROME P450, FAMILY 2, SUBFAMILY S, POLYPEPTIDE 1; CYP2S1	29785
MIM611530	*	5q12.3	NEUROLYSIN; NLN	57486
MIM611531	*	12p13	ESSENTIAL FOR MITOTIC GROWTH 1, S. CEREVISIAE, HOMOLOG OF; EMG1	10436
MIM611532	*	9p13	NUCLEOLAR PROTEIN 6; NOL6	65083
MIM611533	*	6p23	NUCLEOLAR PROTEIN 7; NOL7	51406
MIM611534	*	9q22.32	NUCLEOLAR PROTEIN 8; NOL8	55035
MIM611535	%	2q22-q24	MAJOR AFFECTIVE DISORDER 5; MAFD5	100188843
MIM611536	%	6q23-q24	MAJOR AFFECTIVE DISORDER 6; MAFD6	100188844
MIM611537	*	20q11.2-q12	CATENIN, BETA-LIKE, 1; CTNNBL1	56259
MIM611538	*	19p13.2	OLFACTORY RECEPTOR, FAMILY 7, SUBFAMILY D, MEMBER 4; OR7D4	125958
MIM611539	*	1p31	FORKHEAD BOX D3; FOXD3	27022
MIM611540	*	1p31.3	SH3-DOMAIN GRB2-LIKE (ENDOPHILIN)-INTERACTING PROTEIN 1; SGIP1	84251
MIM611541	*	1q21.3	SORTING NEXIN 27; SNX27	81609
MIM611542	*	5q11-q13	ARYLSULFATASE B; ARSB	411
MIM611543	%	12q	CAVITARY OPTIC DISC ANOMALIES	100188845
MIM611544	#	22q11.2-q12.1	CATARACT, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE 3; CATCN3	1414
MIM611545	*	19p13.1	CYTOCHROME P450, FAMILY 4, SUBFAMILY F, POLYPEPTIDE 8; CYP4F8	11283
MIM611546	*	4q25	ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 6; ELOVL6	79071
MIM611547	%	12q14.3	STATURE QUANTITATIVE TRAIT LOCUS 9; STQTL9	 
MIM611548	#	7q35	PREMATURE OVARIAN FAILURE 5; POF5	135935
MIM611549	*	13q32.3	SODIUM LEAK CHANNEL, NONSELECTIVE; NALCN	259232
MIM611550	*	6p21.3	NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NCR3	259197
MIM611551	*	2q13	FIBULIN 7; FBLN7	129804
MIM611552	*	8q24.3	NICOTINATE PHOSPHORIBOSYLTRANSFERASE DOMAIN-CONTAINING 1; NAPRT1	93100
MIM611553	#	3p25	NOONAN SYNDROME 5; NS5	5894
MIM611554	#	3p25	LEOPARD SYNDROME 2	5894
MIM611556	#	19q13.3	GLYCOGEN STORAGE DISEASE 0, MUSCLE	2997
MIM611557	*	19q13.1	UROPLAKIN 1A; UPK1A	11045
MIM611558	*	11q23.3	UROPLAKIN 2; UPK2	7379
MIM611559	*	22q13.31	UROPLAKIN 3A; UPK3A	7380
MIM611560	#	16q12.2	JOUBERT SYNDROME 7; JBTS7	23322
MIM611561	#	16q12.2	MECKEL SYNDROME, TYPE 5; MKS5	23322
MIM611562	*	16p13.3	SEPTIN 12; SEPT12	124404
MIM611563	*	7p13	SEPTIN 13; SEPT13	641977
MIM611564	*	16q24	BTG3-ASSOCIATED NUCLEAR PROTEIN; BANP	54971
MIM611565	*	4q27	KIAA1109 GENE; KIAA1109	84162
MIM611566	*	7p21.2	PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE 1-LIKE 1; PRPS1L1	221823
MIM611567	*	20p12	MACRO DOMAIN-CONTAINING 2; MACROD2	140733
MIM611568	*	8q23	GOLGI-LOCALIZED SYNTAPHILIN-RELATED PROTEIN	55638
MIM611569	*	13q14	CYTOSKELETON-ASSOCIATED PROTEIN 2; CKAP2	26586
MIM611570	*	9q22.2-q22.3	FRUCTOSE-1,6-BISPHOSPHATASE 1; FBP1	2203
MIM611571	%	16q22.1-q23.1	OTOSCLEROSIS 4; OTSC4	286751
MIM611572	%	6q13-q16.1	OTOSCLEROSIS 7; OTSC7	399516
MIM611573	*	10q11.2	SPHINGOMYELIN SYNTHASE 1; SGMS1	259230
MIM611574	*	4q25	SPHINGOMYELIN SYNTHASE 2; SGMS2	166929
MIM611575	*	10q22.2	STERILE ALPHA MOTIF DOMAIN-CONTAINING 8; SAMD8	142891
MIM611576	*	2q31	MICRO RNA 10B; MIR10B	406903
MIM611577	*	17p13.1	LYSINE-SPECIFIC DEMETHYLASE 6B; KDM6B	23135
MIM611578	*	1p21.2	FERRIC CHELATE REDUCTASE 1; FRRS1	391059
MIM611579	*	16p13.3	TRANSMEMBRANE PROTEIN 114; TMEM114	283953
MIM611580	*	14q11.2	FAMILY WITH SEQUENCE SIMILARITY 12, MEMBER A; FAM12A	10876
MIM611582	*	14q11.2	FAMILY WITH SEQUENCE SIMILARITY 12, MEMBER B; FAM12B	64184
MIM611583	*	2q11.2	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 5A; ARID5A	10865
MIM611584	#	22q13	WAARDENBURG SYNDROME, TYPE 2E; WS2E	6663
MIM611585	*	12q24.2	TESCALCIN, MOUSE, HOMOLOG OF; TESC	54997
MIM611586	*	17q21	COMPLEMENT COMPONENT 1, q SUBCOMPONENT-LIKE 1; C1QL1	10882
MIM611587	*	10q24.1	RHO GTPase-ACTIVATING PROTEIN 19; ARHGAP19	84986
MIM611588	#	9q31	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	2218
MIM611589	*	22q13.31	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 5; PNPLA5	150379
MIM611590	#	17q21-q22	RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	6521
MIM611591	*	4q13.3	PRO-PLATELET BASIC PROTEIN-LIKE 2; PPBPL2	10895
MIM611592	*	6p25.1	PHENYLALANYL-tRNA SYNTHETASE 2, MITOCHONDRIAL; FARS2	10667
MIM611593	*	4q13.3	SUBMAXILLARY GLAND ANDROGEN-REGULATED PROTEIN 3, MOUSE, HOMOLOG OF, B; SMR3B	10879
MIM611594	*	2p11.2	UBIQUITIN-SPECIFIC PROTEASE 39; USP39	10713
MIM611595	*	18q23	THIOREDOXIN-LIKE 4A; TXNL4A	10907
MIM611596	*	14q11.2	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 4; DHRS4	10901
MIM611597	#	3q21-q25	CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES 1	8419
MIM611598	%	4q27	CELIAC DISEASE, SUSCEPTIBILITY TO, 6; CELIAC6	100188846
MIM611599	*	6p12.2	MICRO RNA 206; MIR206	406989
MIM611600	*	1p34.1	PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 3; RIMS3	9783
MIM611601	*	20q13.3	PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 4; RIMS4	140730
MIM611602	*	12q24.33	RIMS-BINDING PROTEIN 2; RIMBP2	23504
MIM611603	#	12q12-q14	LISSENCEPHALY 3; LIS3	7846
MIM611604	*	10q21-q22	ENDOPLASMIC RETICULUM LIPID RAFT-ASSOCIATED PROTEIN 1; ERLIN1	10613
MIM611605	*	8p11.2	ENDOPLASMIC RETICULUM LIPID RAFT-ASSOCIATED PROTEIN 2; ERLIN2	11160
MIM611606	*	7q32.2	MICRO RNA 96; MIR96	407053
MIM611607	*	7q32.2	MICRO RNA 182; MIR182	406958
MIM611608	*	7q32.2	MICRO RNA 183; MIR183	406959
MIM611609	*	1q42.2	SIPA1-LIKE PROTEIN 2; SIPA1L2	57568
MIM611610	*	11q13.4	PHOSPHOGLUCOMUTASE 2-LIKE 1; PGM2L1	283209
MIM611611	*	15q24	S-PHASE CYCLIN A-ASSOCIATED PROTEIN IN THE ENDOPLASMIC RETICULUM; SCAPER	49855
MIM611612	*	14q11.2	THIAMINE TRIPHOSPHATASE; THTPA	79178
MIM611613	*	13q33	KDEL MOTIF-CONTAINING 1; KDELC1	79070
MIM611614	*	4q21	UTP3, S. CEREVISIAE, HOMOLOG OF; UTP3	57050
MIM611615	#	9q31	CARDIOMYOPATHY, DILATED, 1X; CMD1X	2218
MIM611616	*	1p36.33-p36.21	NAD KINASE; NADK	65220
MIM611617	*	2q37.1	EF-HAND DOMAIN FAMILY, MEMBER D1; EFHD1	80303
MIM611619	*	6p21.33	MICRO RNA 877; MIRN877	100126314
MIM611620	*	3q27.1	MICRO RNA 1224; MIRN1224	100187716
MIM611621	*	16p13.3	MICRO RNA 1225; MIRN1225	100188847
MIM611622	*	3q25	IQ MOTIF-CONTAINING PROTEIN J; IQCJ	654502
MIM611623	*	12p13.31	NECAP ENDOCYTOSIS-ASSOCIATED PROTEIN 1; NECAP1	25977
MIM611624	*	1p36.13	NECAP ENDOCYTOSIS-ASSOCIATED PROTEIN 2; NECAP2	55707
MIM611625	*	20q13.33	CHROMOSOME 20 OPEN READING FRAME 11; C20ORF11	54994
MIM611626	*	13q12.11	M-PHASE PHOSPHOPROTEIN 8; MPHOSPH8	54737
MIM611627	*	17p13.3	FAMILY WITH SEQUENCE SIMILARITY 57, MEMBER A; FAM57A	79850
MIM611628	*	1q31	NEURON NAVIGATOR 1; NAV1	89796
MIM611629	*	12q21.1	NEURON NAVIGATOR 3; NAV3	89795
MIM611630	%	4q13.2-q21.3	EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	100188848
MIM611631	%	9q21-q22	EPILEPSY, FAMILIAL TEMPORAL LOBE, 4; ETL4	100144434
MIM611632	*	1p36.3	UbiA PRENYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 1; UBIAD1	29914
MIM611633	*	15q15.1	RTF1, S. CEREVISIAE, HOMOLOG OF; RTF1	23168
MIM611634	%	3p24.2-p23	FEBRILE SEIZURES, FAMILIAL, 9; FEB9	100188849
MIM611635	*	12q13	NEUROGENIC DIFFERENTIATION 4; NEUROD4	58158
MIM611636	*	11q14.3-q21	N-ACETYLATED ALPHA-LINKED ACIDIC DIPEPTIDASE 2; NAALAD2	10003
MIM611637	%	4p16	PRIMARY LATERAL SCLEROSIS, ADULT, 1; PLSA1	100240702
MIM611638	#	7q36	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5; MCOPCB5	6469
MIM611639	*	19p13.2	ZINC FINGER GATA-LIKE PROTEIN 1; ZGLP1	100125288
MIM611640	*	10q26.2	FIBRONECTIN TYPE III AND ANKYRIN REPEAT DOMAINS 1; FANK1	92565
MIM611641	*	11q24.2	CANCER SUSCEPTIBILITY GENE HEPN1; HEPN1	641654
MIM611642	*	11q24	HEPATOCYTE CELL ADHESION MOLECULE; HEPACAM	220296
MIM611643	*	6p21.33-p21.31	ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 4; ZKSCAN4	387032
MIM611644	%	4q31.3-q32.3	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 9; HSCR9	100188850
MIM611645	*	4q22-q24	CXXC FINGER PROTEIN 4; CXXC4	80319
MIM611646	*	2q36	SPHK1-INTERACTING PROTEIN; SPHKAP	80309
MIM611647	*	1q42.2	ARV1, S. CEREVISIAE, HOMOLOG OF; ARV1	64801
MIM611648	*	5q21.1	HISTIDINE ACID PHOSPHATASE DOMAIN-CONTAINING PROTEIN 1; HISPPD1	23262
MIM611649	*	10p13	CHROMOSOME 10 OPEN READING FRAME 97; C10ORF97	80013
MIM611651	*	22q11.2-q13.2	PHOSPHOLIPASE A2, GROUP III; PLA2G3	50487
MIM611652	*	4q25	PHOSPHOLIPASE A2, GROUP XIIA; PLA2G12A	81579
MIM611653	*	10q22.1	PHOSPHOLIPASE A2, GROUP XIIB; PLA2G12B	84647
MIM611654	*	8q13.2	CENTROSOME SPINDLE POLE-ASSOCIATED PROTEIN 1; CSPP1	79848
MIM611655	*	2q33.1	GPI DEACYLASE	80055
MIM611656	*	1p13.2	SUPPRESSOR OF IKK-EPSILON	80143
MIM611657	*	1p36.22	SPRY DOMAIN- AND SOCS BOX-CONTAINING 1; SPSB1	80176
MIM611658	*	12p13.31	SPRY DOMAIN- AND SOCS BOX-CONTAINING 2; SPSB2	84727
MIM611659	*	16p13.3	SPRY DOMAIN- AND SOCS BOX-CONTAINING 3; SPSB3	90864
MIM611660	*	3q23	SPRY DOMAIN- AND SOCS BOX-CONTAINING 4; SPSB4	92369
MIM611661	*	17q21	DBF4, S. CEREVISIAE, HOMOLOG OF, B; DBF4B	80174
MIM611662	*	3p26.2	EOSINOPHIL GRANULE ONTOGENY	100126791
MIM611663	*	20p13	TBC1 DOMAIN FAMILY, MEMBER 20; TBC1D20	128637
MIM611664	#	12q22	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 7; SHEP7	4254
MIM611665	*	12q22-q23	DEAD/H BOX 54; DDX54	79039
MIM611666	*	9p24.1	PPAP2 DOMAIN-CONTAINING PROTEIN 2; PPAPDC2	403313
MIM611667	*	12q13.2	SPERMATOGENESIS-ASSOCIATED SERINE-RICH PROTEIN 2; SPATS2	65244
MIM611668	*	16p13.3	CORONIN 7; CORO7	79585
MIM611669	*	19p13.3	tRNA METHYLTRANSFERASE 1, S. CEREVISIAE, HOMOLOG OF; TRMT1	55621
MIM611670	*	19p13.1	INOSITOL-3-PHOSPHATE SYNTHASE 1; ISYNA1	51477
MIM611671	*	3q29	PHOSPHATIDYLINOSITOL GLYCAN, CLASS Z; PIGZ	80235
MIM611672	*	17q11.1	SOLUTE CARRIER FAMILY 46 (FOLATE TRANSPORTER), MEMBER 1; SLC46A1	113235
MIM611673	*	1q25	CHROMOSOME 1 OPEN READING FRAME 25; C1ORF25	81627
MIM611674	*	22q11.1	X KELL BLOOD GROUP PRECURSOR-RELATED FAMILY, MEMBER 3; XKR3	150165
MIM611675	*	16q24.1	KIAA0513 GENE; KIAA0513	9764
MIM611676	*	4q11	PHOSDUCIN-LIKE 2; PDCL2	132954
MIM611677	*	1q44	OLFACTORY RECEPTOR, FAMILY 13, SUBFAMILY G, MEMBER 1; OR13G1	441933
MIM611678	*	2q11.2	PHOSDUCIN-LIKE 3; PDCL3	79031
MIM611679	*	17p12	F-BOX AND WD40 DOMAIN PROTEIN 10; FBXW10	10517
MIM611680	*	1q32.2	SPECIFICALLY ANDROGEN-REGULATED GENE	79098
MIM611681	*	12q11	A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 20; ADAMTS20	80070
MIM611682	*	6q26-q27	LIPOPROTEIN(a)-LIKE 2; LPAL2	80350
MIM611683	*	17q25	FRUCTOSAMINE 3-KINASE-RELATED PROTEIN	79672
MIM611684	*	12q24.1	SQUAMOUS CELL CARCINOMA ANTIGEN RECOGNIZED BY T CELLS 3; SART3	9733
MIM611685	*	6p21.3	RING FINGER PROTEIN 8; RNF8	9025
MIM611686	*	7q21	CAS1 DOMAIN-CONTAINING PROTEIN 1; CASD1	64921
MIM611687	*	6q13	CHROMOSOME 6 OPEN READING FRAME 221; C6ORF221	154288
MIM611688	*	6q13	KH HOMOLOGY DOMAIN-CONTAINING PROTEIN 1; KHDC1	80759
MIM611689	*	6q13	OOCYTE-EXPRESSED PROTEIN, DOG, HOMOLOG OF; OOEP	441161
MIM611690	*	11p13	PROLINE-RICH GAMMA-CARBOXYGLUTAMIC ACID PROTEIN 4; PRRG4	79056
MIM611691	*	9q32	SUSHI, VON WILLEBRAND FACTOR TYPE A, EGF, AND PENTRAXIN DOMAINS-CONTAINING 1; SVEP1	79987
MIM611692	*	9q33.3	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 34; ZBTB34	403341
MIM611693	*	11q24.1	ADIPOCYTE-SPECIFIC ADHESION MOLECULE	79827
MIM611695	*	15q15.2	TAU TUBULIN KINASE 2; TTBK2	146057
MIM611696	*	11q13.1	SOLUTE CARRIER FAMILY 22, MEMBER 20; SLC22A20	440044
MIM611697	*	6p25.2	CHROMOSOME 6 OPEN READING FRAME 85; C6ORF85	63027
MIM611698	*	11q12.3	SOLUTE CARRIER FAMILY 22, MEMBER 24; SLC22A24	283238
MIM611699	*	12q24.1	SV2-RELATED PROTEIN; SVOP	55530
MIM611700	*	7q34	SV2-RELATED PROTEIN-LIKE; SVOPL	136306
MIM611701	*	17p13.2	SPINSTER, DROSOPHILA, HOMOLOG OF, 3; SPNS3	201305
MIM611703	*	1p36	ZINC FINGER PROTEIN 436; ZNF436	80818
MIM611704	*	4q13.2	TRANSMEMBRANE PROTEASE, SERINE 11A; TMPRSS11A	339967
MIM611705	#	2q31	MYOPATHY, EARLY-ONSET, WITH FATAL CARDIOMYOPATHY	7273
MIM611706	%	10q22-q23	MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	100188851
MIM611707	*	11q23.3	MYELIN PROTEIN ZERO-LIKE 3; MPZL3	196264
MIM611708	*	14q32.31	MICRO RNA 431; MIRN431	574038
MIM611709	*	14q32.31	MICRO RNA 127; MIRN127	406914
MIM611710	*	14q32.31	MICRO RNA 136; MIRN136	406927
MIM611711	*	14q32.31	MICRO RNA 433; MIRN433	574034
MIM611712	*	19q13.2	HOMEODOMAIN-INTERACTING PROTEIN KINASE 4; HIPK4	147746
MIM611713	*	1p34.1	TCTEX1 DOMAIN-CONTAINING 4; TCTEX1D4	343521
MIM611714	*	9q33.3	GTPase-ACTIVATING PROTEIN AND VPS9 DOMAINS 1; GAPVD1	26130
MIM611715	*	4q12	STEROID 5-ALPHA-REDUCTASE 3; SRD5A3	79644
MIM611716	*	12q24.3	ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A2; ATP6V0A2	23545
MIM611718	#	4q25	HYPOMAGNESEMIA 4, RENAL; HOMG4	1950
MIM611719	#	3q23	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	56945
MIM611720	*	14q24.3	CHROMOSOME 14 OPEN READING FRAME 4; C14ORF4	64207
MIM611721	#	10q22.1	COMBINED SAPOSIN DEFICIENCY	5660
MIM611722	#	10q22.1	KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY	5660
MIM611723	*	21q22.2-q22.3	CHROMOSOME 21 OPEN READING FRAME 24; C21ORF24	400866
MIM611724	#	6p25.3	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 8; SHEP8	100188852
MIM611725	*	7q11.21	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 7; KCTD7	154881
MIM611726	#	7q11.21	EPILEPSY, PROGRESSIVE MYOCLONIC 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS; EPM3	154881
MIM611727	*	1q24.3	CHROMOSOME 1 OPEN READING FRAME 76; C1ORF76	148753
MIM611728	*	11p13-p12	PROTEIN OBSERVED WITH RICTOR 2	79899
MIM611729	*	11q12-q13	KINESIN LIGHT CHAIN 2; KLC2	64837
MIM611730	*	2q14	ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 5; EPB41L5	57669
MIM611731	*	5q21-q22	APC GENE; APC	324
MIM611732	*	6p23	MEMBRANE-BOUND O-ACETYLTRANSFERASE DOMAIN-CONTAINING 1; MBOAT1	154141
MIM611734	*	1p13.2	WD REPEAT-CONTAINING PROTEIN 77; WDR77	79084
MIM611735	*	3p23-p21	CUB DOMAIN-CONTAINING PROTEIN 1; CDCP1	64866
MIM611736	*	2p25.1	GREB1 PROTEIN	9687
MIM611737	*	2q13	SEPTIN 10; SEPT10	151011
MIM611738	%	20p12.3	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 7; BMND7	100188853
MIM611739	%	11p12	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 8; BMND8	100188854
MIM611740	*	11q22.3-q23.1	BETA-CAROTENE DIOXYGENASE 2; BCDO2	83875
MIM611741	*	7q35	CATION CHANNEL, AMILORIDE-SENSITIVE, NEURONAL 3; ACCN3	9311
MIM611742	#	20q11.2	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 9; SHEP9	434
MIM611743	*	12p13.31	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY G, MEMBER 6; PLEKHG6	55200
MIM611744	*	4q31.2	OTU DOMAIN-CONTAINING PROTEIN 4; OTUD4	54726
MIM611745	*	8q13	VCP/p47 COMPLEX-INTERACTING PROTEIN 1; VCPIP1	80124
MIM611746	*	22q13	SIGNAL PEPTIDE-, CUB DOMAIN-, AND EGF-LIKE DOMAINS-CONTAINING PROTEIN 1; SCUBE1	80274
MIM611747	*	11p15.5	SIGNAL PEPTIDE-, CUB DOMAIN-, AND EGF-LIKE DOMAINS-CONTAINING PROTEIN 2; SCUBE2	57758
MIM611748	*	1q21.2	OTU DOMAIN-CONTAINING PROTEIN 7B; OTUD7B	56957
MIM611749	*	10q26.13	ZINC FINGER- AND RAN-BINDING DOMAIN-CONTAINING PROTEIN 1; ZRANB1	54764
MIM611750	*	1p34.3-p34.1	SYNCOILIN 1; SYNC1	81493
MIM611751	*	2p22-p21	THUMP DOMAIN-CONTAINING 2; THUMPD2	80745
MIM611752	*	2q14.1-q14.3	CHROMOSOME 2 OPEN READING FRAME 40; C2ORF40	84417
MIM611753	*	17q23.1	TRANSMEMBRANE PROTEIN 49; TMEM49	81671
MIM611754	*	4q32.2	ALPHA-AMINOADIPATE AMINOTRANSFERASE; AADAT	51166
MIM611755	#	12q21.3	LEBER CONGENITAL AMAUROSIS 10; LCA10	80184
MIM611756	*	5p15.2	ROPN1-LIKE PROTEIN; ROPN1L	83853
MIM611757	*	3q21.1	RHOPHILIN-ASSOCIATED TAIL PROTEIN 1; ROPN1	54763
MIM611758	*	1p36.13	OTU DOMAIN-CONTAINING PROTEIN 3; OTUD3	23252
MIM611759	*	7p14-p13	STARD3 N-TERMINAL-LIKE; STARD3NL	83930
MIM611760	*	13q21.1	PROTOCADHERIN 17; PCDH17	27253
MIM611761	*	16p13.3	LIPASE MATURATION FACTOR 1; LMF1	64788
MIM611762	#	19q13.4	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	91662
MIM611763	*	2p23.1	LIMB BUD AND HEART DEVELOPMENT, MOUSE, HOMOLOG OF; LBH	81606
MIM611764	*	19q13	CORNIFELIN; CNFN	84518
MIM611765	*	2p13.1	ASPARTIC PEPTIDASE, RETROVIRAL-LIKE 1; ASPRV1	151516
MIM611766	*	15q22.31	MITOCHONDRIAL METHIONYL-tRNA FORMYLTRANSFERASE; MTFMT	123263
MIM611767	*	9q34.3	MICRO RNA 126; MIR126	406913
MIM611768	*	 	MICRO RNA 335; MIRN335	442904
MIM611769	*	3p22	MICRO RNA 128-2; MIRN128-2	406916
MIM611770	*	8p21	NK2, DROSOPHILA, HOMOLOG OF, 6; NKX2-6	137814
MIM611771	#	19q13.2	LIPOPROTEIN GLOMERULOPATHY; LPG	348
MIM611772	*	1q23	NUF2, S. CEREVISIAE, HOMOLOG OF; NUF2	83540
MIM611773	#	13q34	ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS; HANAC	1282
MIM611774	*	2q21	MICRO RNA 128-1; MIR128-1	406915
MIM611775	#	19q13.2	KAWASAKI DISEASE	80271
MIM611776	*	6q16.1	NADH DEHYDROGENASE 1 ALPHA SUBCOMPLEX, ASSEMBLY FACTOR 4; NDUFAF4	29078
MIM611777	#	3p22.3	BRUGADA SYNDROME 2; BRGDA2	23171, 781
MIM611778	*	3p22.3	GLYCEROL-3-PHOSPHATE DEHYDROGENASE 1-LIKE; GPD1L	23171
MIM611779	*	14q21.3	FIBROUS SHEATH CABYR-BINDING PROTEIN	84075
MIM611780	*	11p15.5	KIAA1542 GENE	57661
MIM611781	*	8q13.3	PR DOMAIN-CONTAINING PROTEIN 14; PRDM14	63978
MIM611782	*	11q23	DOWN SYNDROME CELL ADHESION MOLECULE-LIKE 1; DSCAML1	57453
MIM611783	#	2p21-p16	ERYTHROCYTOSIS, FAMILIAL, 4; ECYT4	2034
MIM611784	*	6q21	GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 6; GTF3C6	112495
MIM611785	*	7p15.3	ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 5; ABCB5	340273
MIM611786	*	2p22-p21	MEDIATOR OF CELL MOTILITY 1; MEMO1	51072
MIM611787	*	2p25.2	CYTIDINE MONOPHOSPHATE (UMP-CMP) KINASE 2, MITOCHONDRIAL; CMPK2	129607
MIM611788	#	10q22-q24	AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6	59
MIM611789	*	4q24	NA+/H+ EXCHANGER DOMAIN-CONTAINING PROTEIN 2; NHEDC2	133308
MIM611790	*	3p21.33-p21.32	MYOSIN VIIA- AND RAB-INTERACTING PROTEIN; MYRIP	25924
MIM611791	*	10p12.1	PATCHED DOMAIN-CONTAINING PROTEIN 3; PTCHD3	374308
MIM611792	*	4p15.2	ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 4; ZCCHC4	29063
MIM611793	*	17q21.31	LSM12, S. CEREVISIAE, HOMOLOG OF; LSM12	124801
MIM611794	*	14q32.31	MICRO RNA 369; MIR369	442914
MIM611795	*	5q33.1	MICRO RNA 145; MIR145	406937
MIM611796	*	15q21.3	SECRETOGRANIN III; SCG3	29106
MIM611797	*	20q11.22	UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX CHAPERONE; UQCC	55245
MIM611798	*	8q24.2	EFR3, S. CEREVISIAE, HOMOLOG OF, A; EFR3A	23167
MIM611799	*	4p15.3	LIGAND-DEPENDENT NUCLEAR RECEPTOR COREPRESSOR-LIKE PROTEIN; LCORL	254251
MIM611800	*	2p21	THYROID ADENOMA-ASSOCIATED GENE; THADA	63892
MIM611801	*	17q12	PER1-LIKE DOMAIN-CONTAINING PROTEIN 1; PERLD1	93210
MIM611802	*	17q12	CHROMOSOME 17 OPEN READING FRAME 37; C17ORF37	84299
MIM611803	*	16q12.1	INTEGRIN-ALPHA FG-GAP REPEAT-CONTAINING PROTEIN 1; ITFG1	81533
MIM611804	#	1p36.2-p34	ELLIPTOCYTOSIS 1; EL1	2035
MIM611805	*	6p12	ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 5; ELOVL5	60481
MIM611806	*	10q24	ARSENIC (+3 OXIDATION STATE) METHYLTRANSFERASE; AS3MT	57412
MIM611807	*	1q23.2	TIP41-LIKE PROTEIN; TIPRL	261726
MIM611809	#	11q13	BESTROPHINOPATHY, AUTOSOMAL RECESSIVE; ARB	7439
MIM611810	*	19p13.1	USH1C-BINDING PROTEIN 1; USHBP1	83878
MIM611811	*	19p13.1	ZINC FINGER PROTEIN 333; ZNF333	84449
MIM611812	#	1p35	46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	54361
MIM611813	*	1p34.2	ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 1; ELOVL1	64834
MIM611814	*	6p24.2	ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 2; ELOVL2	54898
MIM611815	*	10q24.32	ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 3; ELOVL3	83401
MIM611817	*	12p13.2-p12.3	KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY K, MEMBER 1; KLRK1	22914
MIM611818	#	3p25	LONG QT SYNDROME 9; LQT9	859
MIM611819	#	11q23	LONG QT SYNDROME 10; LQT10	6330
MIM611820	#	7q21-q22	LONG QT SYNDROME 11; LQT11	10142
MIM611821	*	4q21.1	MITOCHONDRIAL RIBOSOMAL PROTEIN L1; MRPL1	65008
MIM611822	*	6p21.3	MITOCHONDRIAL RIBOSOMAL PROTEIN L2; MRPL2	51069
MIM611823	*	19p13.2	MITOCHONDRIAL RIBOSOMAL PROTEIN L4; MRPL4	51073
MIM611824	*	1q21	MITOCHONDRIAL RIBOSOMAL PROTEIN L9; MRPL9	65005
MIM611825	*	17q21.3	MITOCHONDRIAL RIBOSOMAL PROTEIN L10; MRPL10	124995
MIM611826	*	11q13.3	MITOCHONDRIAL RIBOSOMAL PROTEIN L11; MRPL11	65003
MIM611827	*	6p21.3	MITOCHONDRIAL RIBOSOMAL PROTEIN L14; MRPL14	64928
MIM611828	*	8q11.2-q13	MITOCHONDRIAL RIBOSOMAL PROTEIN L15; MRPL15	29088
MIM611829	*	11q12-q13.1	MITOCHONDRIAL RIBOSOMAL PROTEIN L16; MRPL16	54948
MIM611830	*	11p15.5-p15.4	MITOCHONDRIAL RIBOSOMAL PROTEIN L17; MRPL17	63875
MIM611831	*	6q25.3	MITOCHONDRIAL RIBOSOMAL PROTEIN L18; MRPL18	29074
MIM611832	*	2p11.2-q11.2	MITOCHONDRIAL RIBOSOMAL PROTEIN L19; MRPL19	9801
MIM611833	*	1p36.3-p35.2	MITOCHONDRIAL RIBOSOMAL PROTEIN L20; MRPL20	55052
MIM611834	*	11q13.2	MITOCHONDRIAL RIBOSOMAL PROTEIN L21; MRPL21	219927
MIM611835	*	5q33	MITOCHONDRIAL RIBOSOMAL PROTEIN L22; MRPL22	29093
MIM611836	*	1q21-q22	MITOCHONDRIAL RIBOSOMAL PROTEIN L24; MRPL24	79590
MIM611837	*	17q21.3-q22	MITOCHONDRIAL RIBOSOMAL PROTEIN L27; MRPL27	51264
MIM611838	*	2q11.2	MITOCHONDRIAL RIBOSOMAL PROTEIN L30; MRPL30	51263
MIM611839	*	7p14	MITOCHONDRIAL RIBOSOMAL PROTEIN L32; MRPL32	64983
MIM611840	*	19p13.1	MITOCHONDRIAL RIBOSOMAL PROTEIN L34; MRPL34	64981
MIM611841	*	2p11.2	MITOCHONDRIAL RIBOSOMAL PROTEIN L35; MRPL35	51318
MIM611842	*	5p15.3	MITOCHONDRIAL RIBOSOMAL PROTEIN L36; MRPL36	64979
MIM611843	*	1p32.1	MITOCHONDRIAL RIBOSOMAL PROTEIN L37; MRPL37	51253
MIM611844	*	17q23-q25	MITOCHONDRIAL RIBOSOMAL PROTEIN L38; MRPL38	64978
MIM611845	*	21q11.2-q21	MITOCHONDRIAL RIBOSOMAL PROTEIN L39; MRPL39	54148
MIM611846	*	9q34.3	MITOCHONDRIAL RIBOSOMAL PROTEIN L41; MRPL41	64975
MIM611847	*	12q22	MITOCHONDRIAL RIBOSOMAL PROTEIN L42; MRPL42	28977
MIM611848	*	10q24	MITOCHONDRIAL RIBOSOMAL PROTEIN L43; MRPL43	84545
MIM611849	*	2q36	MITOCHONDRIAL RIBOSOMAL PROTEIN L44; MRPL44	65080
MIM611850	*	17q21.31	MITOCHONDRIAL RIBOSOMAL PROTEIN L45; MRPL45	84311
MIM611851	*	15q24-q25	MITOCHONDRIAL RIBOSOMAL PROTEIN L46; MRPL46	26589
MIM611852	*	3q26.3	MITOCHONDRIAL RIBOSOMAL PROTEIN L47; MRPL47	57129
MIM611853	*	11q13.2	MITOCHONDRIAL RIBOSOMAL PROTEIN L48; MRPL48	51642
MIM611854	*	9q31.1	MITOCHONDRIAL RIBOSOMAL PROTEIN L50; MRPL50	54534
MIM611855	*	12p13.3-p13.1	MITOCHONDRIAL RIBOSOMAL PROTEIN L51; MRPL51	51258
MIM611856	*	14q11.2	MITOCHONDRIAL RIBOSOMAL PROTEIN L52; MRPL52	122704
MIM611857	*	2p12	MITOCHONDRIAL RIBOSOMAL PROTEIN L53; MRPL53	116540
MIM611858	*	19p13.3	MITOCHONDRIAL RIBOSOMAL PROTEIN L54; MRPL54	116541
MIM611859	*	1q42.13	MITOCHONDRIAL RIBOSOMAL PROTEIN L55; MRPL55	128308
MIM611861	*	15q24.1	ADP-DEPENDENT GLUCOKINASE; ADPGK	83440
MIM611862	#	1q23.2	WHITE BLOOD CELL COUNT QUANTITATIVE TRAIT LOCUS 1; WBCQ1	2532
MIM611863	%	4p16-p15	MICROTIA WITH NASOLACRIMAL DUCT IMPERFORATION AND EYE COLOBOMA	100188855
MIM611864	*	7q11.2	ARMADILLO REPEAT-CONTAINING 10; ARMC10	83787
MIM611865	*	22q13.3	L3MBT-LIKE 2; L3MBTL2	83746
MIM611866	*	12p13.31	RETINOL-BINDING PROTEIN 5; RBP5	83758
MIM611867	#	22q11.2	CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	100188856
MIM611868	#	2p15	PROSTATE CANCER, HEREDITARY, 12; HPC12	23301
MIM611869	*	16p11.	RAB GTPase-BINDING EFFECTOR PROTEIN 2; RABEP2	79874
MIM611870	*	9p22.2	CENTLEIN; CNTLN	54875
MIM611871	*	8q21.3	FAMILY WITH SEQUENCE SIMILARITY 82, MEMBER B; FAM82B	51115
MIM611872	*	2p22.2	FAMILY WITH SEQUENCE SIMILARITY 82, MEMBER A1; FAM82A1	151393
MIM611873	*	15q15.1	FAMILY WITH SEQUENCE SIMILARITY 82, MEMBER A2; FAM82A2	55177
MIM611874	*	1q32.3	NEURON-DERIVED NEUROTROPHIC FACTOR; NENF	29937
MIM611875	#	12p13.3	BRUGADA SYNDROME 3; BRGDA3	775
MIM611876	#	10p12	BRUGADA SYNDROME 4; BRGDA4	783
MIM611877	*	7q21.3-q22.1	BAI1-ASSOCIATED PROTEIN 2-LIKE 1; BAIAP2L1	55971
MIM611878	#	15q22.1	CARDIOMYOPATHY, DILATED, 1Y; CMD1Y	7168
MIM611879	#	3p21.3-p14.3	CARDIOMYOPATHY, DILATED, 1Z; CMD1Z	7134
MIM611880	#	19q13.4	CARDIOMYOPATHY, DILATED, 2A; CMD2A	7137
MIM611881	#	16p11.2	GLYCOGEN STORAGE DISEASE XII; GSD12	226
MIM611882	*	1p36.11	PROLINE-RICH NUCLEAR RECEPTOR COACTIVATOR 2; PNRC2	55629
MIM611883	*	10q25.3-q26.2	BRCA2- AND CDKN1A-INTERACTING PROTEIN; BCCIP	56647
MIM611884	#	7p21	CILIARY DYSKINESIA, PRIMARY, 7; CILD7	8701
MIM611885	*	8q24.3	SHANK-ASSOCIATED RH DOMAIN INTERACTOR; SHARPIN	81858
MIM611887	*	7q11.23	UROPLAKIN 3B; UPK3B	80761
MIM611888	*	19q13.1	ETS2 REPRESSOR FACTOR; ERF	2077
MIM611889	*	1p34.3	S100P-BINDING PROTEIN; S100PBP	64766
MIM611890	#	9q34	LETHAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; LAAHD	2733
MIM611891	%	9p21	AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 3; AAA3	100188857
MIM611892	%	9p21	ANEURYSM, INTRACRANIAL BERRY, 6; ANIB6	100188858
MIM611893	*	19q13.1	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY G, MEMBER 2; PLEKHG2	64857
MIM611894	*	16q22.1	MICRO RNA 140; MIRN140	406932
MIM611895	#	14q11.2	AMYOTROPHIC LATERAL SCLEROSIS 9; ALS9	283
MIM611896	*	14q32.2	RETROTRANSPOSON-LIKE GENE 1; RTL1	388015
MIM611897	%	2q11-q14	NANOPHTHALMOS 3; NNO3	100187717
MIM611898	*	17q25.3	ENDO-BETA-N-ACETYLGLUCOSAMINIDASE	64772
MIM611899	*	14q32.33	MICRO RNA 203; MIRN203	406986
MIM611900	*	18p11.2	METALLOPHOSPHOESTERASE 1; MPPE1	65258
MIM611901	*	1p36.3	VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 1; VWA1	64856
MIM611902	*	7q31-q32	COILED-COIL DOMAIN-CONTAINING PROTEIN 136; CCDC136	64753
MIM611903	*	19q13.41	ZINC FINGER PROTEIN 649; ZNF649	65251
MIM611904	*	11q23.2	CHROMOSOME 11 OPEN READING FRAME 34; C11ORF34	349633
MIM611905	*	2p23.3	FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 4; FNDC4	64838
MIM611906	*	1p35.1	FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 5; FNDC5	252995
MIM611907	%	19q13	EPISODIC ATAXIA, TYPE 7; EA7	100188859
MIM611908	*	3p21.1	RFT1, S. CEREVISIAE, HOMOLOG OF; RFT1	91869
MIM611909	*	3q26	FIBRONECTIN DOMAIN III-CONTAINING PROTEIN 3B; FNDC3B	64778
MIM611910	*	10q23.3	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 12; SLC16A12	387700
MIM611911	*	12q24.1	IRON-SULFUR CLUSTER SCAFFOLD, E. COLI, HOMOLOG OF; ISCU	23479
MIM611912	*	1q32.1	NUCLEAR CASEIN KINASE AND CYCLIN-DEPENDENT KINASE SUBSTRATE 1; NUCKS1	64710
MIM611913	#	16p11.2	CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	100187724
MIM611914	*	7p21-p15	TSC22 DOMAIN FAMILY, MEMBER 4; TSC22D4	81628
MIM611915	*	7p11.2	EGFR-COAMPLIFIED AND OVEREXPRESSED PROTEIN	81552
MIM611916	*	3q21	COLLAGEN, TYPE XXIX, ALPHA-1; COL29A1	256076
MIM611917	*	16p12.1	JUMONJI DOMAIN-CONTAINING PROTEIN 5; JMJD5	79831
MIM611918	^	19p13.3	MOVED TO 601869	 
MIM611919	*	14q24.3	MYC-ASSOCIATED PROTEIN WITH JMJC DOMAIN	79697
MIM611920	%	10q23-q24	C-REACTIVE PROTEIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; CRPQTL1	100188860
MIM611921	*	6q15	GAP JUNCTION PROTEIN, BETA-7; GJB7	375519
MIM611922	*	10p11.21	GAP JUNCTION PROTEIN, DELTA-4; GJD4	219770
MIM611923	*	1p34.3	GAP JUNCTION PROTEIN, ALPHA-9; GJA9	81025
MIM611924	*	6q15	GAP JUNCTION PROTEIN, ALPHA-10; GJA10	84694
MIM611925	*	7q22.1	GAP JUNCTION PROTEIN, GAMMA-3; GJC3	349149
MIM611927	*	8q24.3	FAMILY WITH SEQUENCE SIMILARITY, MEMBER H; FAM83H	286077
MIM611928	#	10q11.2	PROSTATE CANCER, HEREDITARY, 13; HPC13	4477
MIM611930	*	1q23.1	INTERFERON-STIMULATED EXONUCLEASE GENE 20-KD-LIKE 2; ISG20L2	81875
MIM611931	*	3q26.1	PROTEIN PHOSPHATASE 1-LIKE; PPM1L	151742
MIM611932	*	10q21.1	CDGSH IRON SULFUR DOMAIN PROTEIN 1; CISD1	55847
MIM611933	*	17q12	CDGSH IRON SULFUR DOMAIN PROTEIN 3; CISD3	284106
MIM611934	%	10p11.22	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 5; EIG5	100188861
MIM611935	*	2q23.2	MMADHC GENE; MMADHC	27249
MIM611936	#	3q29	CHROMOSOME 3q29 DUPLICATION SYNDROME	100188862
MIM611937	*	14q32.33	IMMUNOGLOBULIN HEAVY CHAIN DIVERSITY GENE 3-3; IGHD3-3	28501
MIM611938	#	1p13.3-p11	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	845
MIM611939	*	14q32.33	IMMUNOGLOBULIN HEAVY CHAIN VARIABLE GENE 3-23; IGHV3-23	28442
MIM611940	*	8p12	MEMBRANE-BOUND O-ACETYLTRANSFERASE DOMAIN-CONTAINING 4; MBOAT4	619373
MIM611941	*	8q24.13	ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 2; ATAD2	29028
MIM611942	#	16p13.3	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6; ECA6	8912
MIM611943	#	3q29	RIDDLE SYNDROME	165918
MIM611944	%	6q16.2-q22.1	LYMPHEDEMA, HEREDITARY, IB	100188865
MIM611945	%	8p21.1-q13.3	SPASTIC PARAPLEGIA 37, AUTOSOMAL DOMINANT; SPG37	100049159
MIM611946	*	19p13	UBX DOMAIN-CONTAINING GENE 1; UBXD1	80700
MIM611947	*	11q23.3	NLR FAMILY MEMBER X1; NLRX1	79671
MIM611949	*	2p25.1	MEMBRANE-BOUND O-ACYLTRANSFERASE DOMAIN-CONTAINING 2; MBOAT2	129642
MIM611950	*	12p13	MEMBRANE-BOUND O-ACYLTRANSFERASE DOMAIN-CONTAINING 5; MBOAT5	10162
MIM611951	*	19q13.2	B9 DOMAIN-CONTAINING PROTEIN 2; B9D2	80776
MIM611952	*	8q24.3	VACUOLAR PROTEIN SORTING 28, YEAST, HOMOLOG OF; VPS28	51160
MIM611953	#	20p11.2	MACULAR DEGENERATION, AGE-RELATED, 11; ARMD11	1471
MIM611954	*	19q13.41	MICRO RNA 373; MIRN373	442918
MIM611955	%	17q12	PROSTATE CANCER, HEREDITARY, 11; HPC11	 
MIM611956	*	3q13.2	CHROMOSOME 3 OPEN READING FRAME 52; C3ORF52	79669
MIM611957	*	5q33.1	MICRO RNA 378; MIRN378	494327
MIM611958	%	11q13	PROSTATE CANCER, HEREDITARY, 14; HPC14	100188867
MIM611959	%	19q13.4	PROSTATE CANCER, HEREDITARY, 15; HPC15	100188868
MIM611960	#	1q32.1	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7	1116
MIM611963	*	4p14-p11	ACYL-CoA THIOESTERASE 7-LIKE	344967
MIM611964	*	16q22.1	CYTOCHROME b5, TYPE B (OUTER MITOCHONDRIAL MEMBRANE); CYB5B	80777
MIM611965	*	3p14.1	THO COMPLEX, SUBUNIT 7; THOC7	80145
MIM611966	*	8q24.3	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 9; TRAPPC9	83696
MIM611967	*	4q22.1	KELCH-LIKE 8; KLHL8	57563
MIM611968	*	10q22-q23	CLEAVAGE STIMULATION FACTOR, 3-PRIME PRE-RNA, SUBUNIT 2, 64-KD, TAU VARIANT; CSTF2T	23283
MIM611969	*	11p15.5	HCCA2 GENE; HCCA2	81532
MIM611970	*	2q14.2	MKI67-INTERACTING NUCLEOLAR PHOSPHOPROTEIN; MKI67IP	84365
MIM611971	*	9q34	MITOCHONDRIAL RIBOSOMAL PROTEIN S2; MRPS2	51116
MIM611972	*	2p11.2-q11.2	MITOCHONDRIAL RIBOSOMAL PROTEIN S5; MRPS5	64969
MIM611973	*	21q21.3-q22.1	MITOCHONDRIAL RIBOSOMAL PROTEIN S6; MRPS6	64968
MIM611974	*	17q23-q25	MITOCHONDRIAL RIBOSOMAL PROTEIN S7; MRPS7	51081
MIM611975	*	2q12.1	MITOCHONDRIAL RIBOSOMAL PROTEIN S9; MRPS9	64965
MIM611976	*	6p21.1-p12.1	MITOCHONDRIAL RIBOSOMAL PROTEIN S10; MRPS10	55173
MIM611977	*	15q25	MITOCHONDRIAL RIBOSOMAL PROTEIN S11; MRPS11	64963
MIM611978	*	1q23-q25	MITOCHONDRIAL RIBOSOMAL PROTEIN S14; MRPS14	63931
MIM611979	*	1p35-p34.1	MITOCHONDRIAL RIBOSOMAL PROTEIN S15; MRPS15	64960
MIM611980	*	7p11-q11.21	MITOCHONDRIAL RIBOSOMAL PROTEIN S17; MRPS17	51373
MIM611981	*	6p21.3	MITOCHONDRIAL RIBOSOMAL PROTEIN S18A; MRPS18A	55168
MIM611982	*	6p21.3	MITOCHONDRIAL RIBOSOMAL PROTEIN S18B; MRPS18B	28973
MIM611983	*	4q21.23	MITOCHONDRIAL RIBOSOMAL PROTEIN S18C; MRPS18C	51023
MIM611984	*	1q21	MITOCHONDRIAL RIBOSOMAL PROTEIN S21; MRPS21	54460
MIM611985	*	17q22-q23	MITOCHONDRIAL RIBOSOMAL PROTEIN S23; MRPS23	51649
MIM611986	*	7p14	MITOCHONDRIAL RIBOSOMAL PROTEIN S24; MRPS24	64951
MIM611987	*	3p25	MITOCHONDRIAL RIBOSOMAL PROTEIN S25; MRPS25	64432
MIM611988	*	20p13	MITOCHONDRIAL RIBOSOMAL PROTEIN S26; MRPS26	64949
MIM611989	*	5q13.2	MITOCHONDRIAL RIBOSOMAL PROTEIN S27; MRPS27	23107
MIM611990	*	8q21.1-q21.3	MITOCHONDRIAL RIBOSOMAL PROTEIN S28; MRPS28	28957
MIM611991	*	5p12-q11	MITOCHONDRIAL RIBOSOMAL PROTEIN S30; MRPS30	10884
MIM611992	*	13q13.3	MITOCHONDRIAL RIBOSOMAL PROTEIN S31; MRPS31	10240
MIM611993	*	7q32-q34	MITOCHONDRIAL RIBOSOMAL PROTEIN S33; MRPS33	51650
MIM611994	*	16q13-q21	MITOCHONDRIAL RIBOSOMAL PROTEIN S34; MRPS34	65993
MIM611995	*	12q21.1-q21.3	MITOCHONDRIAL RIBOSOMAL PROTEIN S35; MRPS35	60488
MIM611996	*	5q12.1	MITOCHONDRIAL RIBOSOMAL PROTEIN S36; MRPS36	92259
MIM611997	*	13q12.11	MITOCHONDRIAL RIBOSOMAL PROTEIN 63; MRP63	78988
MIM611998	*	19p13.3	cAMP RESPONSIVE ELEMENT-BINDING PROTEIN 3-LIKE 3; CREB3L3	84699
MIM611999	*	17q11.2	RAB11 FAMILY-INTERACTING PROTEIN 4; RAB11FIP4	84440
MIM612000	*	11p15.4	TRIPARTITE MOTIF-CONTAINING PROTEIN 66; TRIM66	9866
MIM612001	#	15q13.3	CHROMOSOME 15q13.3 DELETION SYNDROME	100188869
MIM612002	*	1p31.2	DEP DOMAIN-CONTAINING PROTEIN 1; DEPDC1	55635
MIM612003	*	2q37.1	GRB10-INTERACTING GYF PROTEIN 2; GIGYF2	26058
MIM612004	#	7p15.2	THROMBOCYTOPENIA 4; THC4	54205
MIM612005	%	1q31	CELIAC DISEASE, SUSCEPTIBILITY TO, 7; CELIAC7	100301522
MIM612006	%	2q11-q12	CELIAC DISEASE, SUSCEPTIBILITY TO, 8; CELIAC8	100188870
MIM612007	%	3p21	CELIAC DISEASE, SUSCEPTIBILITY TO, 9; CELIAC9	100188871
MIM612008	%	3q25-q26	CELIAC DISEASE, SUSCEPTIBILITY TO, 10; CELIAC10	100188872
MIM612009	%	3q28	CELIAC DISEASE, SUSCEPTIBILITY TO, 11; CELIAC11	100188873
MIM612010	%	6q25.3	CELIAC DISEASE, SUSCEPTIBILITY TO, 12; CELIAC12	100188874
MIM612011	%	12q24	CELIAC DISEASE, SUSCEPTIBILITY TO, 13; CELIAC13	100188875
MIM612012	*	14q24.1	ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 26; ZFYVE26	23503
MIM612013	*	4p15.3	COILED-COIL AND C2 DOMAINS-CONTAINING PROTEIN 2A; CC2D2A	57545
MIM612014	*	2q24.3	TETRATRICOPEPTIDE REPEAT DOMAIN 21B; TTC21B	79809
MIM612015	#	3p21.1	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE In; CDG1N	91869
MIM612016	#	1q42.2	COENZYME Q10 DEFICIENCY, PRIMARY, 4; COQ10D4	56997
MIM612017	%	11q14-q22	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 3; IHPS3	100188876
MIM612018	#	10q23.3	CATARACT, JUVENILE, WITH MICROCORNEA AND GLUCOSURIA	387700
MIM612019	*	22q12.3	INTESTINE-SPECIFIC HOMEOBOX; ISX	91464
MIM612020	#	19p13.3	SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39	10908
MIM612021	*	8q21.3	OTU DOMAIN-CONTAINING PROTEIN 6B; OTUD6B	51633
MIM612022	*	10p12.2	OTU DOMAIN-CONTAINING PROTEIN 1; OTUD1	220213
MIM612023	*	1q32.1	YOD1 OTU DEUBIQUITINATING ENZYME 1, S. CEREVISIAE, HOMOLOG OF; YOD1	55432
MIM612024	*	15q13.3	OTU DOMAIN-CONTAINING PROTEIN 7A; OTUD7A	161725
MIM612025	*	6q24-q25	IODOTYROSINE DEIODINASE; IYD	389434
MIM612026	*	4q25	La RIBONUCLEOPROTEIN DOMAIN FAMILY, MEMBER 7; LARP7	51574
MIM612027	*	12q13.13	GRP1-ASSOCIATED SCAFFOLD PROTEIN; GRASP	160622
MIM612028	*	14q12	FAT-INDUCING TRANSCRIPT 1	161247
MIM612029	*	20q13.12	FAT-INDUCING TRANSCRIPT 2	128486
MIM612030	%	8p22	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 9; CHDS9	100188877
MIM612031	*	12q13.3	INHIBIN, BETA E; INHBE	83729
MIM612032	*	2p22.3	DPY30, C. ELEGANS, HOMOLOG OF: DPY30	84661
MIM612033	*	16p11.2	CHROMOSOME 16 OPEN READING FRAME 53; C16ORF53	79447
MIM612034	*	19p13.3	APC2 GENE; APC2	10297
MIM612035	*	6p21.1	ALANYL-tRNA SYNTHETASE 2; AARS2	57505
MIM612036	*	1p32.2	PROLYL-tRNA SYNTHETASE 2; PARS2	25973
MIM612037	*	1p36.12	MITOCHONDRIAL UBIQUITIN LIGASE ACTIVATOR OF NFKB 1; MUL1	79594
MIM612038	*	7p22.2	TRANSMEMBRANE EMP24 PROTEIN TRANSPORT DOMAIN-CONTAINING PROTEIN 4; TMED4	222068
MIM612039	*	15q14	1-@ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 7; AGPAT7	254531
MIM612040	*	16q12.2	LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE 2; LPCAT2	54947
MIM612041	*	4p16.3	RING FINGER PROTEIN 212; RNF212	285498
MIM612042	#	4p16.3	RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1; RRQTL1	285498
MIM612043	*	19q13.41	MICRO RNA 371; MIRN371	442916
MIM612044	*	19q13.41	MICRO RNA 372; MIRN372	442917
MIM612045	*	5p13	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 3; C1QTNF3	114899
MIM612046	*	12q21.3	E2F TRANSCRIPTION FACTOR 7; E2F7	144455
MIM612047	*	11p15.1	E2F TRANSCRIPTION FACTOR 8; E2F8	79733
MIM612048	*	3p25	TRANSMEMBRANE PROTEIN 43; TMEM43	79188
MIM612049	*	3q12.1	MYC-INDUCED NUCLEAR ANTIGEN; MINA	84864
MIM612050	*	5q31.3	NEDD4 FAMILY-INTERACTING PROTEIN 1; NDFIP1	80762
MIM612051	*	16q21	BRAIN-EXPRESSED, ASSOCIATED WITH NEDD4; BEAN	146227
MIM612052	#	15q25.1, 15q25.1	SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3	1136, 1138
MIM612053	*	2p21	ZINC FINGER PROTEIN 36-LIKE 2; ZFP36L2	678
MIM612054	*	2q35	REQUIRED FOR CELL DIFFERENTIATION 1, S. POMBE, HOMOLOG OF; RQCD1	9125
MIM612055	*	15q22.2	RIBOSOMAL PROTEIN S27-LIKE; RPS27L	51065
MIM612056	*	7p22.3	GOLGI TO ER TRAFFIC PROTEIN 4, S. CEREVISIAE, HOMOLOG OF; GET4	51608
MIM612057	*	9q34.3	CHROMOSOME 9 OPEN READING FRAME 140; C9ORF140	89958
MIM612058	*	22q13.31	SORTING AND ASSEMBLY MACHINERY COMPONENT 50, S. CEREVISIAE, HOMOLOG OF; SAMM50	25813
MIM612059	*	5q33.2	La RIBONUCLEOPROTEIN DOMAIN FAMILY, MEMBER 1; LARP1	23367
MIM612060	*	16q23.1	ZINC FINGER AND RING FINGER PROTEIN 1; ZNRF1	84937
MIM612061	*	7p15.1	ZINC FINGER AND RING FINGER PROTEIN 2; ZNRF2	223082
MIM612062	*	22q12.1	ZINC FINGER AND RING FINGER PROTEIN 3; ZNRF3	84133
MIM612063	*	19p13.3	ZINC FINGER AND RING FINGER PROTEIN 4; ZNRF4	148066
MIM612064	*	7q22.1	GRB10-INTERACTING GYF PROTEIN 1; GIGYF1	64599
MIM612065	*	3q21	POLY(ADP-RIBOSE) POLYMERASE 9; PARP9	83666
MIM612066	*	3q21	POLY(ADP-RIBOSE) POLYMERASE 15; PARP15	165631
MIM612067	#	2q31.3	DYSTONIA 16; DYT16	8575
MIM612068	*	17p13.1	PHOSPHOINOSITIDE-INTERACTING REGULATOR OF TRANSIENT RECEPTOR POTENTIAL CHANNELS	644139
MIM612069	#	1p36.2	AMYOTROPHIC LATERAL SCLEROSIS 10, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	23435
MIM612070	*	17q11.2	MICRO RNA 144; MIRN144	406936
MIM612071	*	17q11.2	MICRO RNA 451; MIRN451	574411
MIM612072	*	17q25.1	MIF4G DOMAIN-CONTAINING PROTEIN; MIF4GD	57409
MIM612073	#	13q12.2-q13	MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH METHYLMALONIC ACIDURIA); MTDPS5	8803
MIM612074	*	7q32.1	RNA-BINDING MOTIF PROTEIN 28; RBM28	55131
MIM612075	#	8q23.1	MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY); MTDPS8A	50484
MIM612076	#	4p16-p15.3	HYPOURICEMIA, RENAL, 2; RHUC2	56606
MIM612077	*	17p13.3	MICRO RNA 22; MIRN22	407004
MIM612078	*	16q24	ZINC FINGER PROTEIN 469; ZNF469	84627
MIM612079	#	7q32.1	ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME	55131
MIM612080	*	5q31.1	UBIQUINOL-CYTOCHROME c REDUCTASE, COMPLEX III SUBUNIT VII, 9.5-KD; UQCRQ	27089
MIM612081	*	16q22.1	INTERLEUKIN 34; IL34	146433
MIM612082	*	19q13.2	CAPICUA, DROSOPHILA, HOMOLOG OF; CIC	23152
MIM612083	%	14q24.3	MUSCLE STRENGTH QUANTITATIVE TRAIT LOCUS 1	100192311
MIM612084	*	3q29	ORGANIC SOLUTE TRANSPORTER, ALPHA	200931
MIM612085	*	15q21	ORGANIC SOLUTE TRANSPORTER, BETA	123264
MIM612086	*	18q21.3	MINOR HISTOCOMPATIBILITY ANTIGEN, SERPIN DOMAIN-CONTAINING; HMSD	284293
MIM612087	*	12p13.31	C-TYPE LECTIN DOMAIN FAMILY 2, MEMBER A; CLEC2A	387836
MIM612088	*	12p13	C-TYPE LECTIN DOMAIN FAMILY 12, MEMBER A; CLEC12A	160364
MIM612089	%	13q13.1	HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM	100188880
MIM612090	*	1p36.33	MICRO RNA 200A; MIR200A	406983
MIM612091	*	1p36.33	MICRO RNA 200B; MIRN200B	406984
MIM612092	*	12p13.31	MICRO RNA 200C; MIR200C	406985
MIM612093	*	12p13.31	MICRO RNA 141; MIR141	406933
MIM612094	*	1p36.33	MICRO RNA 429; MIRN429	554210
MIM612095	#	4p15.3	RETINITIS PIGMENTOSA 41; RP41	8842
MIM612096	%	9p13.1-q21.11	OTOSCLEROSIS 8; OTSC8	100151644
MIM612098	#	15q14	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11; CMH11	70
MIM612099	%	9p21	TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 2	100188881
MIM612100	#	7q35-q36	AUTISM, SUSCEPTIBILITY TO, 15; AUTS15	26047
MIM612101	*	4p15.2	PHOSPHATIDYLINOSITOL 4-KINASE, TYPE 2, BETA; PI4K2B	55300
MIM612102	*	3p21.1	MICRO RNA LET7G; MIRNLET7G	406890
MIM612103	*	2q32.3	OLIGONUCLEOTIDE/OLIGOSACCHARIDE-BINDING FOLD-CONTAINING PROTEIN 2A; OBFC2A	64859
MIM612104	*	12q13.3	OLIGONUCLEOTIDE/OLIGOSACCHARIDE-BINDING FOLD-CONTAINING PROTEIN 2B; OBFC2B	79035
MIM612105	*	10q23	KILLIN; KLLN	100144748
MIM612106	*	1p36	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 40; ZBTB40	9923
MIM612107	*	20q13.3	SOLUTE CARRIER FAMILY 17, MEMBER 9	63910
MIM612108	%	2q24-q32	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 1; FGQTL1	100499165
MIM612109	#	4p16.1	OCULOAURICULAR SYNDROME	3166
MIM612110	%	13q14	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 9; BMND9	100188882
MIM612111	*	5q23.1	TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 8; TNFAIP8	25816
MIM612112	*	1q21.2-q21.3	TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 8-LIKE 2; TNFAIP8L2	79626
MIM612113	%	8q24	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 10; BMND10	100188883
MIM612114	%	6q25	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 11; BMND11	100188884
MIM612115	*	3p21-p13	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 3; ARHGEF3	50650
MIM612116	*	17p11.2	UBIQUITIN-SPECIFIC PROTEASE 22; USP22	23326
MIM612117	*	5q33.1	MICRO RNA 143; MIR143	406935
MIM612118	*	12p13.33	IQ MOTIF- AND SEC7 DOMAIN-CONTAINING PROTEIN 3; IQSEC3	440073
MIM612119	%	11q23	TREHALASE DEFICIENCY	11181
MIM612120	*	3p25	CELL DEATH-INDUCING DFFA-LIKE EFFECTOR C; CIDEC	63924
MIM612121	*	6p21.31	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 1; PNPLA1	285848
MIM612122	*	9q34.3	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 7; PNPLA7	375775
MIM612123	*	7q31	PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 8; PNPLA8	50640
MIM612124	#	11p15.1	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12; CMH12	8048
MIM612125	*	19q13.1	SERTA DOMAIN-CONTAINING 3; SERTAD3	29946
MIM612126	#	1p35-p31.3	GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	6513
MIM612127	*	4q22.1	17-@BETA-HYDROXYSTEROID DEHYDROGENASE XIII; HSD17B13	345275
MIM612128	*	17q12	RAS-LIKE, FAMILY 10, MEMBER B; RASL10B	91608
MIM612129	*	8p12	INDOLEAMINE 2,3-DIOXYGENASE 2; IDO2	169355
MIM612130	*	7q22.1	GENE AMPLIFIED IN ESOPHAGEAL CANCER 1; GAEC1	100126794
MIM612131	*	2q31.1	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 9; DHRS9	10170
MIM612132	#	14q13	ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL DOMINANT	4792
MIM612133	*	7q22.1	TRANSCRIPTION FACTOR NFE4; NFE4	58160
MIM612134	*	15q23	GLUCURONIC ACID EPIMERASE; GLCE	26035
MIM612135	*	18q12.2	CALCIUM-BINDING TYROSINE PHOSPHORYLATION-REGULATED PROTEIN; CABYR	26256
MIM612136	*	6q22.33	ENOYL COENZYME A HYDRATASE DOMAIN-CONTAINING PROTEIN 1; ECHDC1	55862
MIM612137	*	6q22.1-q22.33	RING FINGER PROTEIN 146; RNF146	81847
MIM612138	#	8q24	EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	5339
MIM612139	*	8q13.1-q13.2	PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE-DEPENDENT RAC EXCHANGER 2; PREX2	80243
MIM612140	*	7p11.2	SEPTIN 14; SEPT14	346288
MIM612141	*	5q22	ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1-LIKE 4A; EPB41L4A	64097
MIM612142	*	11q24.1	MICRO RNA LET7A2; MIRLET7A2	406882
MIM612143	*	22q13.31	MICRO RNA LET7A3; MIRNLET7A3	406883
MIM612144	*	21q21.1	MICRO RNA LET7C; MIRLET7C	406885
MIM612145	*	9q22.32	MICRO RNA LET7D; MIRNLET7D	406886
MIM612146	*	9q22.32	MICRO RNA LET7F1; MIRNLET7F1	406888
MIM612147	*	16q11.2	MYOSIN LIGHT CHAIN KINASE 3; MYLK3	91807
MIM612148	*	12q14.1	MICRO RNA LET7I; MIRNLET7I	406891
MIM612149	*	22q13.1	RNA-BINDING MOTIF PROTEIN 9; RBM9	23543
MIM612150	*	7q22.1	MICRO RNA 25; MIR25	407014
MIM612151	*	3p22.2	MICRO RNA 26A1; MIR26A1	407015
MIM612152	*	2q35	MICRO RNA 26B; MIR26B	407017
MIM612153	*	19p13.12	MICRO RNA 27A; MIRN27A	407018
MIM612154	*	3q28	MICRO RNA 28; MIRN28	407020
MIM612155	*	9p21.3	MICRO RNA 31; MIRN31	407035
MIM612156	*	22q13.2	MICRO RNA 33A; MIR33A	407039
MIM612157	*	12q13.1	SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 1; SENP1	29843
MIM612158	#	1q42-q43	CARDIOMYOPATHY, DILATED, 1AA; CMD1AA	88
MIM612159	*	12q24.1	RABPHILIN 3A; RPH3A	22895
MIM612160	#	2q32.3-q34	HISTIOCYTOMA, ANGIOMATOID FIBROUS	1385
MIM612161	%	11q24-q25	ANEURYSM, INTRACRANIAL BERRY, 7; ANIB7	100188885
MIM612162	%	14q23	ANEURYSM, INTRACRANIAL BERRY, 8; ANIB8	100188886
MIM612163	*	11q13.2	TWO-PORE SEGMENT CHANNEL 2; TPCN2	219931
MIM612164	#	9q34.1	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4; EIEE4	6709, 6812, 9863
MIM612165	%	4q32-q34	RETINITIS PIGMENTOSA 29; RP29	54110
MIM612166	*	14q11.2	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 2; SLC39A2	29986
MIM612167	*	3p21.33	WD REPEAT-CONTAINING PROTEIN 48; WDR48	57599
MIM612168	*	19p13.3	SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 3; SLC39A3	29985
MIM612169	*	1q23	Fc FRAGMENT OF IgG, LOW AFFINITY IIc, RECEPTOR FOR; FCGR2C	9103
MIM612170	*	12q12	MUCIN 19, OLIGOMERIC; MUC19	283463
MIM612171	*	2q23	REPRIMO; RPRM	56475
MIM612172	*	12q13.12	DEAD BOX POLYPEPTIDE 23; DDX23	9416
MIM612173	*	2q34	SPERM-ASSOCIATED ANTIGEN 16; SPAG16	79582
MIM612174	*	2q37.1	CALCIUM-BINDING PROTEIN 39; CAB39	51719
MIM612175	*	13q14.2	CALCIUM-BINDING PROTEIN 39-LIKE PROTEIN; CAB39L	81617
MIM612176	*	1p32.1	MYB-LIKE, SWIRM, AND MPN DOMAINS-CONTAINING PROTEIN 1; MYSM1	114803
MIM612177	*	14q22.1	RNA, 7SL, CYTOPLASMIC 1; RN7SL1	6029
MIM612178	*	1p13.3	CHROMOSOME 1 OPEN READING FRAME 59; C1ORF59	113802
MIM612179	*	14q22.1	RNA, 7SL, CYTOPLASMIC 2; RN7SL2	378706
MIM612180	*	14q22.1	RNA, 7SL, CYTOPLASMIC 3; RN7SL3	378707
MIM612181	*	3q13.3	MUCIN 13, CELL SURFACE-ASSOCIATED; MUC13	56667
MIM612182	*	8p23.1-p21.3	N-ACETYLTRANSFERASE 2; NAT2	10
MIM612183	*	15q14-q15	G PROTEIN-COUPLED RECEPTOR 176; GPR176	11245
MIM612184	*	16p13.3	CASK-INTERACTING PROTEIN 1; CASKIN1	57524
MIM612185	*	17q25.1	CASK-INTERACTING PROTEIN 2; CASKIN2	57513
MIM612186	*	15q21.2	DMX-LIKE 2; DMXL2	23312
MIM612187	*	12q13	HEME-RESPONSIVE GENE 1	55652
MIM612188	*	15q15.1	VACUOLAR PROTEIN SORTING 39, YEAST, HOMOLOG OF; VPS39	23339
MIM612189	*	10q21.1	PHENAZINE BIOSYNTHESIS-LIKE PROTEIN DOMAIN-CONTAINING PROTEIN; PBLD	64081
MIM612190	*	16p13.3	MTOR-ASSOCIATED PROTEIN LST8; MLST8	64223
MIM612191	*	9p13.3	PC3 PROSTATE CANCER CELL-SECRETED MICROPROTEIN	692094
MIM612192	*	6p22.1	ZINC FINGER PROTEIN 57, MOUSE, HOMOLOG OF; ZFP57	346171
MIM612193	*	5q12-q13	CARDIOMYOPATHY-ASSOCIATED PROTEIN 5; CMYA5	202333
MIM612194	*	9p22.1	RAS-RELATED GTP-BINDING PROTEIN A; RRAGA	10670
MIM612195	*	2p23.3	ABHYDROLASE DOMAIN-CONTAINING 1; ABHD1	84696
MIM612196	*	15q26.1	ABHYDROLASE DOMAIN-CONTAINING 2; ABHD2	11057
MIM612197	*	18q11.1	ABHYDROLASE DOMAIN-CONTAINING 3; ABHD3	171586
MIM612199	#	 	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC	80169
MIM612200	*	3q24	CHROMOSOME 3 OPEN READING FRAME 58; C3ORF58	205428
MIM612201	#	1p36.2	ATRIAL FIBRILLATION, FAMILIAL, 6; ATFB6	4878
MIM612202	*	8p22	SRY-BOX 7; SOX7	83595
MIM612203	*	4q21-q22	NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 5; NAP1L5	266812
MIM612204	*	2q35	AUTOPHAGY 9, S. CEREVISIAE, HOMOLOG OF, A; ATG9A	79065
MIM612205	*	7q35-36	AUTOPHAGY 9, S. CEREVISIAE, HOMOLOG OF, B; ATG9B	285973
MIM612206	*	11p13	FOUR-JOINTED BOX, DROSOPHILA, HOMOLOG OF, 1; FJX1	24147
MIM612207	*	5p13.3	GOLGI PHOSPHOPROTEIN 3; GOLPH3	64083
MIM612208	*	1q21.2	GOLGI PHOSPHOPROTEIN 3-LIKE; GOLPH3L	55204
MIM612209	*	2p24.2	MESOGENIN 1; MSGN1	343930
MIM612210	*	6p24.3	HIGHLY UPREGULATED IN LIVER CANCER; HULC	728655
MIM612211	*	17p13.3	TUMOR SUPPRESSOR CANDIDATE 5; TUSC5	286753
MIM612212	*	2q12.2	PLASMINOGEN-LIKE A; PLGLA	285189
MIM612213	*	19q13.32	SEMINAL PLASMA PROTEIN, BOVINE, HOMOLOG OF, 1; BSPH1	100131137
MIM612214	*	22q11.2	RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 4; RGL4	266747
MIM612215	*	8q13	SMALL NUCLEOLAR RNA HOST GENE 6; SNHG6	641638
MIM612216	*	8q13	SMALL NUCLEOLAR RNA, C/D BOX, 87; SNORD87	641648
MIM612217	*	6p21.31	CHROMOSOME 6 OPEN READING FRAME 106; C6ORF106	64771
MIM612218	*	3q23	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 38; ZBTB38	253461
MIM612219	#	22q12	EWING SARCOMA; ES	2130
MIM612220	*	12p13.3	BETA-1,4-N-ACETYLGALACTOSAMINYLTRANSFERASE 3; B4GALNT3	283358
MIM612221	%	3q23	STATURE QUANTITATIVE TRAIT LOCUS 10; STQTL10	100270794
MIM612222	*	16q24.3	GALACTOSAMINE-6-SULFATE SULFATASE; GALNS	2588
MIM612223	%	7q21	STATURE QUANTITATIVE TRAIT LOCUS 11; STQTL11	100270795
MIM612224	%	4q31	STATURE QUANTITATIVE TRAIT LOCUS 12; STQTL12	100301523
MIM612225	#	7q32	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 9; MODY9	5078
MIM612226	%	4p15.3	STATURE QUANTITATIVE TRAIT LOCUS 13; STQTL13	100270796
MIM612227	#	7q32	DIABETES MELLITUS, KETOSIS-PRONE; KPD	5078
MIM612228	%	20q11.22	STATURE QUANTITATIVE TRAIT LOCUS 14; STQTL14	100270797
MIM612229	#	18q21.1	COLORECTAL CANCER, SUSCEPTIBILITY TO, 3; CRCS3	4092
MIM612230	%	10p14	COLORECTAL CANCER, SUSCEPTIBILITY TO, 5; CRCS5	100188887
MIM612231	%	8q23	COLORECTAL CANCER, SUSCEPTIBILITY TO, 6; CRCS6	100187710
MIM612232	%	11q23	COLORECTAL CANCER, SUSCEPTIBILITY TO, 7; CRCS7	100187711
MIM612233	#	2q33.1	LEUKODYSTROPHY, HYPOMYELINATING, 4; HLD4	3329
MIM612234	*	10q24.33	CALCIUM HOMEOSTASIS MODULATOR 1; CALHM1	255022
MIM612235	*	10q24.33	CALCIUM HOMEOSTASIS MODULATOR 2; CALHM2	51063
MIM612236	*	12p11.22	ENDOPLASMIC RETICULUM-GOLGI INTERMEDIATE COMPARTMENT PROTEIN 2; ERGIC2	51290
MIM612237	#	17q11.1-q11.2, 9q22, 3q11-q12	CHONDROSARCOMA, EXTRASKELETAL MYXOID	10342, 8013, 8148
MIM612238	%	9q31.2-q34.2	SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 4; IS4	100190785
MIM612239	%	17q25.3	SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 5; IS5	100190985
MIM612240	#	12p13	ATRIAL FIBRILLATION, FAMILIAL, 7; ATFB7	3741
MIM612241	%	3p21.3	INFLAMMATORY BOWEL DISEASE 12; IBD12	100188952
MIM612242	#	10q23	CHROMOSOME 10q23 DELETION SYNDROME	 
MIM612243	*	6q24.1	G PROTEIN-COUPLED RECEPTOR 126; GPR126	57211
MIM612244	#	7q21.1	INFLAMMATORY BOWEL DISEASE 13; IBD13	5243
MIM612245	#	7q32	INFLAMMATORY BOWEL DISEASE 14; IBD14	3663
MIM612246	*	2q24	CD302 ANTIGEN; CD302	9936
MIM612247	#	4p16.3	CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS; CAN	2261
MIM612248	*	19p13.2	ZINC FINGER PROTEIN 627; ZNF627	199692
MIM612249	*	7p21.3	THROMBOSPONDIN TYPE-1 DOMAIN-CONTAINING PROTEIN 7A; THSD7A	221981
MIM612250	*	1q24.2	G PROTEIN-COUPLED RECEPTOR 161: GPR161	23432
MIM612251	#	7q32	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 10; SLEB10	3663
MIM612252	*	12p13.31	C-TYPE LECTIN DOMAIN FAMILY 9, MEMBER A; CLEC9A	283420
MIM612253	#	2q32.2-q32.3	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 11; SLEB11	6775
MIM612254	%	8p23.1	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 12; SLEB12	100190928
MIM612255	%	10q21	INFLAMMATORY BOWEL DISEASE 15; IBD15	100190929
MIM612256	*	19p13.2	MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE 1; MAST1	22983
MIM612257	*	1p34.1	MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE 2; MAST2	23139
MIM612258	*	19p13.11	MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE 3; MAST3	23031
MIM612259	%	9q32	INFLAMMATORY BOWEL DISEASE 16; IBD16	100190930
MIM612260	#	3p22-p21.3	MYD88 DEFICIENCY; MYD88D	4615
MIM612261	#	1p31.3	INFLAMMATORY BOWEL DISEASE 17; IBD17	149233
MIM612262	%	5p13.1	INFLAMMATORY BOWEL DISEASE 18; IBD18	100190931
MIM612263	%	20q11.2	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 7; CMM7	100190932
MIM612264	*	17q23.2	MANNOSE RECEPTOR, C-TYPE, 2; MRC2	9902
MIM612265	*	9q22.31	FAMILY WITH SEQUENCE SIMILARITY 120, MEMBER A; FAM120A	23196
MIM612266	*	6q26-q27	FAMILY WITH SEQUENCE SIMILARITY 120, MEMBER B; FAM120B	84498
MIM612267	#	11q13.2	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 10; SHEP10	219931
MIM612268	*	14q24.3	TUBULIN TYROSINE LIGASE-LIKE FAMILY, MEMBER 5; TTLL5	23093
MIM612269	#	15q11.2-q12	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5	2562
MIM612270	*	14q32.33	CELL DIVISION CYCLE-ASSOCIATED PROTEIN 4; CDCA4	55038
MIM612271	#	9p23	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 11; SHEP11	100190933, 7306
MIM612274	%	15q24-q25	CILIARY DYSKINESIA, PRIMARY, 8; CILD8	100190786
MIM612275	*	17q12-q21.1	GAMETOGENETIN-BINDING PROTEIN 2; GGNBP2	79893
MIM612276	*	1p34.2	YRDC DOMAIN-CONTAINING PROTEIN; YRDC	79693
MIM612277	*	9q34.2	ADAMTS-LIKE PROTEIN 2; ADAMTSL2	9719
MIM612278	#	5q33.1	INFLAMMATORY BOWEL DISEASE 19; IBD19	100190926, 345611
MIM612279	%	8p23-p21	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 6; GEFSP6	100190787
MIM612280	*	1p34	FUCOSIDASE, ALPHA-L, 1; FUCA1	2517
MIM612281	#	5q33	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE, NIPAL4-RELATED	348938
MIM612282	*	2q32.1	ZINC FINGER PROTEIN 804A; ZNF804A	91752
MIM612283	*	2q13-q14	PROTEIN C; PROC	5624
MIM612284	#	4p15.3	MECKEL SYNDROME, TYPE 6; MKS6	57545
MIM612285	#	4p15.3	JOUBERT SYNDROME 9; JBTS9	57545
MIM612286	#	5q35	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1; NPHLOP1	6569
MIM612287	#	17q25.1	NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2; NPHLOP2	9368
MIM612288	%	10q23-q24	INFLAMMATORY BOWEL DISEASE 20; IBD20	100190788
MIM612290	#	7p15-p14	MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATE	3199
MIM612291	#	3q11.2	JOUBERT SYNDROME 8; JBTS8	200894
MIM612292	#	8q24.1-q24.3	BIRK-BAREL MENTAL RETARDATION DYSMORPHISM SYNDROME	51305
MIM612293	%	1p31.3-p31.1	POROKERATOSIS 5; POROK5	100190982
MIM612294	*	11p13	DEP DOMAIN-CONTAINING PROTEIN 7; DEPDC7	91614
MIM612295	*	11p14.1-p13	CHROMOSOME 11 OPEN READING FRAME 46; C11ORF46	120534
MIM612296	*	11p14.1-p13	LOC283267 GENE	283267
MIM612297	*	11p13	CHROMOSOME 11 OPEN READING FRAME 41; C11ORF41	25758
MIM612298	*	11p13	TRIPARTITE MOTIF-CONTAINING PROTEIN 44; TRIM44	54765
MIM612299	*	11p13	COMM DOMAIN-CONTAINING PROTEIN 9; COMMD9	29099
MIM612300	#	11p13	CD59 DEFICIENCY	966
MIM612301	#	18q22.1	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	8792
MIM612302	*	10q26.3	G PROTEIN-COUPLED RECEPTOR 123; GPR123	84435
MIM612303	*	4p15.2	G PROTEIN-COUPLED RECEPTOR 125; GPR125	166647
MIM612304	#	2q13-q14	THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	5624
MIM612305	*	19p13.3	EMR4, MOUSE, HOMOLOG OF; EMR4	326342
MIM612306	%	5q13	THYROID-STIMULATING HORMONE LEVEL QUANTITATIVE TRAIT LOCUS 1; TSHQTL1	100190789
MIM612307	*	3q12.2	G PROTEIN-COUPLED RECEPTOR 128; GPR128	84873
MIM612308	*	17p13.1	ZINC FINGER AND BTB DOMAIN-CONTAINING 4; ZBTB4	57659
MIM612309	*	1q23	COAGULATION FACTOR V; F5	2153
MIM612310	#	2p12	PREMATURE OVARIAN FAILURE 6; POF6	344018
MIM612311	%	2q21.1	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 5	100190790
MIM612312	%	13q12.11	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 6	100190791
MIM612313	#	2q32-q33	CHROMOSOME 2q32-q33 DELETION SYNDROME	100190983
MIM612314	*	10q24-q25	GLUTATHIONE S-TRANSFERASE, OMEGA-2; GSTO2	119391
MIM612315	*	12q13.13	KERATIN 6C; KRT6C	286887
MIM612316	*	1p36.33	ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 3A; ATAD3A	55210
MIM612317	*	1p36.33	ATPase FAMILY, AAA DOMAIN-CONTAINING, MEMBER 3B; ATAD3B	83858
MIM612318	#	12q13	PSEUDOFOLLICULITIS BARBAE	9119
MIM612319	#	16q21-q23.1	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE; SPG35	79152
MIM612320	*	1p32	CUB DOMAIN-CONTAINING PROTEIN 2; CDCP2	200008
MIM612321	*	11p14.1	DOUBLECORTIN DOMAIN-CONTAINING PROTEIN 5; DCDC5	100506627
MIM612322	*	2q33.3	FAST KINASE DOMAIN-CONTAINING PROTEIN 2; FASTKD2	22868
MIM612323	*	11p13	INNER MITOCHONDRIAL MEMBRANE PEPTIDASE, SUBUNIT 1, S. CEREVISIAE, HOMOLOG OF; IMMP1L	196294
MIM612324	*	11p14.1	COILED-COIL DOMAIN-CONTAINING PROTEIN 34; CCDC34	91057
MIM612325	*	6p12.3	INTESTINAL CELL KINASE; ICK	22858
MIM612326	*	16q24.3	TRANSCRIPTION FACTOR 25; TCF25	22980
MIM612327	*	6q16	MANNOSIDASE, ENDO-ALPHA; MANEA	79694
MIM612328	*	11p13	COILED-COIL DOMAIN-CONTAINING PROTEIN 73: CCDC73	493860
MIM612329	*	6q13	MICRO RNA 30A; MIR30A	407029
MIM612330	*	11p14.1	MICRO RNA 610; MIRN610	693195
MIM612331	*	19q13.33	LIN7, C. ELEGANS, HOMOLOG OF, B; LIN7B	64130
MIM612332	*	11p14.1	LIN7, C. ELEGANS, HOMOLOG OF, C; LIN7C	55327
MIM612333	*	10q24.2-q25.1	PROGRAMMED CELL DEATH 11; PDCD11	22984
MIM612334	*	7q22.1	N-ACYL PHOSPHATIDYLETHANOLAMINE-HYDROLYZING PHOSPHOLIPASE D; NAPEPLD	222236
MIM612335	%	4p16-p15	SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT; SPG38	100049707
MIM612336	#	3q11.2	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT; THPH5	5627
MIM612337	#	1q42-q44	CHROMOSOME 1q43-q44 DELETION SYNDROME	100190984
MIM612338	*	20p11.1	GAMMA-GLUTAMYLTRANSFERASE, LIGHT CHAIN 1; GGTLC1	92086
MIM612339	*	22q11.2	GAMMA-GLUTAMYLTRANSFERASE, LIGHT CHAIN 2; GGTLC2	91227
MIM612340	*	22q11.2	GAMMA-GLUTAMYLTRANSFERASE, LIGHT CHAIN 3; GGTLC3	728226
MIM612341	*	17p13.2	GAMMA-GLUTAMYLTRANSFERASE 6; GGT6	124975
MIM612342	*	20q11.2	GAMMA-GLUTAMYLTRANSFERASE 7; GGT7	2686
MIM612343	%	4q22	MUSICAL APTITUDE QUANTITATIVE TRAIT LOCUS	100192307
MIM612344	*	2q31.2-q31.3	ZINC FINGER PROTEIN 385B; ZNF385B	151126
MIM612345	#	2q31.2	CHROMOSOME 2q31.2 DELETION SYNDROME	100192308
MIM612346	*	22q11.2	GAMMA-GLUTAMYLTRANSFERASE 1; GGT1	2678
MIM612347	#	21q22.1-q22.2	JERVELL AND LANGE-NIELSEN SYNDROME 2; JLNS2	3753
MIM612348	%	8p12	THROMBOPHILIA, FAMILIAL, DUE TO DECREASED RELEASE OF TISSUE PLASMINOGEN ACTIVATOR; THPH9	5327
MIM612349	*	12q24.1	PHENYLALANINE HYDROXYLASE; PAH	5053
MIM612350	#	11p11.2	SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	91252
MIM612351	*	2p11.2	FORKHEAD BOX I3; FOXI3	344167
MIM612352	*	10q23	STAM-BINDING PROTEIN-LIKE 1; STAMBPL1	57559
MIM612353	%	18p11.3	POROKERATOSIS 6; POROK6	100196911
MIM612354	%	18p11	INFLAMMATORY BOWEL DISEASE 21; IBD21	100192312
MIM612355	*	11p15.3	MICAL C TERMINUS-LIKE PROTEIN; MICALCL	84953
MIM612356	#	22q11	HEPARIN COFACTOR II DEFICIENCY	3053
MIM612357	%	10q21	MAJOR AFFECTIVE DISORDER 8; MAFD8	100196912
MIM612358	*	3q27	KININOGEN 1; KNG1	3827
MIM612359	#	11q23, 1p36.1-p35	COWDEN-LIKE SYNDROME	5728, 6390, 6392
MIM612360	*	20p12.1	CHROMOSOME 20 OPEN READING FRAME 7; C20ORF7	79133
MIM612361	%	2q32.1	SCHIZOPHRENIA 14	100196913
MIM612362	#	5q15-q21	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 12; BMIQ12	5122
MIM612365	%	 	GAMMA GLUTAMYLTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1	 
MIM612366	%	 	GAMMA GLUTAMYLTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2	 
MIM612367	%	1p36	ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2	100196914
MIM612368	%	6p22	ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 3	100196915
MIM612369	%	10q21	ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 4	100196916
MIM612370	#	8q12.1	HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA; HH5	55636
MIM612371	#	22q12	MAJOR AFFECTIVE DISORDER 7; MAFD7	7494
MIM612372	%	12p13.3	MAJOR AFFECTIVE DISORDER 9; MAFD9	100196917
MIM612373	*	10q22.1	SOLUTE CARRIER FAMILY 29 (NUCLEOSIDE TRANSPORTER), MEMBER 3: SLC29A3	55315
MIM612374	*	5q31.2	TRANSMEMBRANE PROTEIN 173; TMEM173	340061
MIM612375	*	1q41	AXIN INTERACTOR, DORSALIZATION-ASSOCIATED; AIDA	64853
MIM612376	#	17q21.1	ACUTE PROMYELOCYTIC LEUKEMIA; APL	5914
MIM612377	*	13q22	COMM DOMAIN-CONTAINING PROTEIN 6; COMMD6	170622
MIM612378	%	6q23	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 13; SLEB13	100196918
MIM612379	#	4q12	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq; CDG1Q	79644
MIM612380	%	17q21.2	INFLAMMATORY BOWEL DISEASE 22; IBD22	100240732
MIM612381	%	1q32.1	INFLAMMATORY BOWEL DISEASE 23; IBD23	100240733
MIM612382	*	5p15.31	MEDIATOR COMPLEX SUBUNIT 10; MED10	84246
MIM612383	*	17p13.2	MEDIATOR COMPLEX SUBUNIT 11; MED11	400569
MIM612384	*	1p35.3	MEDIATOR COMPLEX SUBUNIT 18; MED18	54797
MIM612385	*	11q12.1	MEDIATOR COMPLEX SUBUNIT 19; MED19	219541
MIM612386	*	18q21.3	FERROCHELATASE; FECH	2235
MIM612387	#	6p21.3	SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	56244
MIM612388	%	10q22.3	SARCOIDOSIS, SUSCEPTIBILITY TO, 3; SS3	100196919
MIM612389	#	3p25.1	PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	80746
MIM612390	#	19q13.4	PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C	79042
MIM612392	*	8q22.1	CHROMOSOME 8 OPEN READING FRAME 38; C8ORF38	137682
MIM612393	*	15q25.2	WAS PROTEIN HOMOLOGY REGION 2 DOMAIN-CONTAINING PROTEIN 1; WHDC1	123720
MIM612394	#	7q22	BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	8985
MIM612395	*	22q13	CHOLINE KINASE, BETA; CHKB	1120
MIM612396		2p25	ALLANTOICASE; ALLC	55821
MIM612397	*	3p24.3	DUAL INTRACELLULAR VON WILLEBRAND FACTOR DOMAIN A-CONTAINING PROTEIN	344875
MIM612398	*	12q21.1	RAB-ASSOCIATED PROTEIN RAB21; RAB21	23011
MIM612399	*	19p13.3	TRANSDUCIN-LIKE ENHANCER OF SPLIT 6; TLE6	79816
MIM612400	#	 	OSTEOARTHRITIS SUSCEPTIBILITY 5; OS5	8200
MIM612401	%	3p24.3	OSTEOARTHRITIS SUSCEPTIBILITY 6; OS6	100286836
MIM612402	*	3p21.31	ALS2 C-TERMINAL-LIKE PROTEIN; ALS2CL	259173
MIM612403	*	13q12.2	RAS-LIKE, FAMILY 11, MEMBER A; RASL11A	387496
MIM612404	*	4q12	RAS-LIKE, FAMILY 11, MEMBER B; RASL11B	65997
MIM612405	*	4q12	ADP-RIBOSYLATION FACTOR-LIKE 9; ARL9	132946
MIM612406	%	20p11.2-q13.12	DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE; DYT17	100216344
MIM612407	*	1q31.2	REGULATOR OF G PROTEIN SIGNALING 21; RGS21	431704
MIM612408	*	13q12.11	PARASPECKLE COMPONENT 1; PSPC1	55269
MIM612409	*	11q13	RNA-BINDING MOTIF PROTEIN 14; RBM14	10432
MIM612410	%	18p11.23	PSORIASIS SUSCEPTIBILITY 10; PSORS10	503613
MIM612411	*	4q28.1	FAT TUMOR SUPPRESSOR, DROSOPHILA, HOMOLOG OF, 4; FAT4	79633
MIM612412	*	21q22.3	CHROMOSOME 21 OPEN READING FRAME 56; C21ORF56	84221
MIM612413	*	11q23.1-q23.2	RNA-BINDING MOTIF PROTEIN 7; RBM7	10179
MIM612414	*	11q13.3-q13.4	LEUCINE-RICH TRANSMEMBRANE O-METHYLTRANSFERASE; LRTOMT	220074
MIM612415	*	5q35.3	RAS-ASSOCIATED PROTEIN 24; RAB24	53917
MIM612416	#	4q35	FACTOR XI DEFICIENCY	2160
MIM612417	%	22q13	NARCOLEPSY 4, SUSCEPTIBILITY TO; NRCLP4	100216484
MIM612418	*	8q21.11	TRANSMEMBRANE PROTEIN 70; TMEM70	54968
MIM612419	*	19p13.11	CARTILAGE INTERMEDIATE LAYER PROTEIN 2; CILP2	148113
MIM612420	*	10q25.3	ACTIN FILAMENT-ASSOCIATED PROTEIN 1-LIKE PROTEIN 2; AFAP1L2	84632
MIM612421	%	20p11.22	ALOPECIA, ANDROGENETIC, 3; AGA3	100217387
MIM612422	#	1q32	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 3; RCM3	7139
MIM612423	#	4q35	PREKALLIKREIN DEFICIENCY	3818
MIM612424	*	6q12	EYES SHUT, DROSOPHILA, HOMOLOG OF; EYS	346007
MIM612425	*	2q33.1	SHUGOSHIN-LIKE 2; SGOL2	151246
MIM612426	*	16p13.13	CHROMOSOME 16 OPEN READING FRAME 75; C16ORF75	116028
MIM612427	*	14q24.2	RNA-BINDING MOTIF PROTEIN 25; RBM25	58517
MIM612428	*	20q13.31	RNA-BINDING MOTIF PROTEIN 38; RBM38	55544
MIM612429	*	5q33.1	ZINC FINGER PROTEIN 300; ZNF300	91975
MIM612430	*	5q33.1	RNA-BINDING MOTIF PROTEIN 22; RBM22	55696
MIM612431	%	4q12-q13.1	DEAFNESS, AUTOSOMAL DOMINANT 27; DFNA27	23722
MIM612432	*	7p15.1	WAS/WASL-INTERACTING PROTEIN FAMILY, MEMBER 3; WIPF3	644150
MIM612433	%	1q43-q44	DEAFNESS, AUTOSOMAL RECESSIVE 45; DFNB45	449483
MIM612434	*	16q24.1	CYSTEINE-RICH SECRETORY PROTEIN, LCCL DOMAIN-CONTAINING, 2; CRISPLD2	83716
MIM612435	*	15q26	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 3A1; SLCO3A1	28232
MIM612436	*	20q13.33	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 4A1; SLCO4A1	28231
MIM612437	#	12q12	EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B	144165
MIM612439	*	22q13.2	ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 3; ARFGAP3	26286
MIM612441	*	17q25.3	ALPHA-1,6-@MANNOSYL-GLYCOPROTEIN BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, ISOZYME B; MGAT5B	146664
MIM612442	*	3q21.1	SECRETION DEFICIENT 22, S. CEREVISIAE, HOMOLOG OF, A; SEC22A	26984
MIM612443	^	16q23	MOVED TO 612319	 
MIM612444	#	17q25	CILIARY DYSKINESIA, PRIMARY, 9; CILD9	64446
MIM612446	#	5p13	COMPLEMENT COMPONENT 6 DEFICIENCY; C6D	729
MIM612447	#	11q23.1	SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	7704
MIM612448	%	8q24.13-q24.22	AGE-RELATED HEARING IMPAIRMENT 1; ARHI1	100233147
MIM612449	*	2p24.2	GEN1, DROSOPHILA, HOMOLOG OF; GEN1	348654
MIM612450	*	6q24	HBS1-LIKE PROTEIN; HBS1L	10767
MIM612451	*	20q13	RING FINGER PROTEIN 114; RNF114	55905
MIM612452	*	17q21.31	KAT8 REGULATORY NSL COMPLEX SUBUNIT 1; KANSL1	284058
MIM612453	*	5q23.2	MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 10; MEGF10	84466
MIM612454	*	15q22.31	MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 11; MEGF11	84465
MIM612455	*	11p14.2	SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 12; SLC5A12	159963
MIM612456	*	12p13.2	APOLIPOPROTEIN L DOMAIN-CONTAINING 1; APOLD1	81575
MIM612457	*	15q24	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 3B; ARID3B	10620
MIM612458	*	7q22	ACTIN-LIKE 6B; ACTL6B	51412
MIM612459	%	2q14.1	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 13; BMIQ13	100233157
MIM612460	%	16q12.2	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 14; BMIQ14	100233158
MIM612461	*	8q24	ACTIVITY-REGULATED CYTOSKELETON-ASSOCIATED PROTEIN; ARC	23237
MIM612462	#	20q13.2	PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C	2778
MIM612463	#	 	PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP	2778
MIM612464	*	5q14.3	ARRESTIN DOMAIN-CONTAINING 3; ARRDC3	57561
MIM612465	*	13q22.2	TBC1 DOMAIN FAMILY, MEMBER 4; TBC1D4	9882
MIM612466	*	1p22.2	GUANYLATE-BINDING PROTEIN 4; GBP4	115361
MIM612467	*	1p22.2	GUANYLATE-BINDING PROTEIN 6; GBP6	163351
MIM612468	*	1p22.2	GUANYLATE-BINDING PROTEIN 7; GBP7	388646
MIM612469	#	11p13-p12	WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, MENTAL RETARDATION, AND OBESITY SYNDROME; WAGRO	100233159
MIM612470	*	1p32.3	BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR, ATF-LIKE, 3; BATF3	55509
MIM612471	*	5p13	ALANINE-GLYOXYLATE AMINOTRANSFERASE 2; AGXT2	64902
MIM612472	*	14q11.1	METHYLTRANSFERASE-LIKE 3; METTL3	56339
MIM612473	*	8p21.2	PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN 4	157310
MIM612474	#	1q21.1	CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	100217370
MIM612475	#	1q21.1	CHROMOSOME 1q21.1 DUPLICATION SYNDROME	100217371
MIM612476	*	14q24	BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR, ATF-LIKE; BATF	10538
MIM612477	*	3q29	IQ MOTIF-CONTAINING PROTEIN G; IQCG	84223
MIM612478	*	20q11.22	N-TERMINAL EF-HAND CALCIUM-BINDING PROTEIN 3; NECAB3	63941
MIM612480	*	3q25.31	TCDD-INDUCIBLE POLY(ADP-RIBOSE) POLYMERASE; TIPARP	25976
MIM612481	*	7q34	POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 12; PARP12	64761
MIM612482	*	17q23.2	RING FINGER PROTEIN 43; RNF43	54894
MIM612483	*	11q14.3-q21	FAT TUMOR SUPPRESSOR, DROSOPHILA, HOMOLOG OF, 3; FAT3	120114
MIM612484	*	14q11.2	RIBONUCLEASE A FAMILY 7; RNASE7	84659
MIM612485	*	14q11.2	RIBONUCLEASE A FAMILY, 8; RNASE8	122665
MIM612486	*	4q31.3	DACHSOUS, DROSOPHILA, HOMOLOG OF, 2; DCHS2	54798
MIM612487	*	14q11.2	RING FINGER PROTEIN 31; RNF31	55072
MIM612488	*	9p13	RING FINGER PROTEIN 38; RNF38	152006
MIM612489	*	20p13-p12.1	RING FINGER PROTEIN 24; RNF24	11237
MIM612490	*	2p11.2	RING FINGER PROTEIN 181; RNF181	51255
MIM612491	*	11p13	APAF1-INTERACTING PROTEIN; APIP	51074
MIM612492	*	12q23-q24	UBIQUITIN-SPECIFIC PROTEASE 30; USP30	84749
MIM612493	*	7q36.3	CANOPY 1, ZEBRAFISH, HOMOLOG OF; CNPY1	285888
MIM612494	*	1p36.13	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 10-LIKE PROTEIN; ARHGEF10L	55160
MIM612495	*	6q14.1	UBIQUITIN-CONJUGATING ENZYME E2C-BINDING PROTEIN; UBE2CBP	90025
MIM612496	*	1p36.13	RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 19; ARHGEF19	128272
MIM612497	*	5q13.3	TRANSFORMING GROWTH FACTOR-BETA-INDUCIBLE NUCLEAR PROTEIN 1	10412
MIM612498	*	14q32.33	ADENYLOSUCCINATE SYNTHASE-LIKE 1; ADSSL1	122622
MIM612499	*	5q12.1	DIMETHYLADENOSINE TRANSFERASE 1-LIKE; DIMT1L	27292
MIM612500	*	17q21.1	DEAD BOX POLYPEPTIDE 52; DDX52	11056
MIM612501	*	15q23	UBIQUITIN-CONJUGATING ENZYME E2Q 2; UBE2Q2	92912
MIM612502	*	2p25.3	COLLECTIN 11; COLEC11	78989
MIM612503	*	17q24.2	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 5; ABCA5	23461
MIM612504	*	17q24.2	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 6; ABCA6	23460
MIM612505	*	17q24.2	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 8; ABCA8	10351
MIM612506	*	9p22.1	UBIQUITIN-CONJUGATING ENZYME E2R 2; UBE2R2	54926
MIM612507	*	17q24.2	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 9; ABCA9	10350
MIM612508	*	17q24.2	ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 10; ABCA10	10349
MIM612509	*	6p21.1	ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 10; ABCC10	89845
MIM612510	*	7q36	ATP-BINDING CASSETTE, SUBFAMILY F, MEMBER 2; ABCF2	10061
MIM612511	*	1p31.3	MICRO RNA 101-1; MIRN101-1	406893
MIM612512	*	9p24.1	MICRO RNA 101-2; MIRN101-2	406894
MIM612513	#	2p16.1-p15	CHROMOSOME 2p16.1-p15 DELETION SYNDROME	100240740
MIM612514	%	7q35-q36	SPECIFIC LANGUAGE IMPAIRMENT 4; SLI4	100233227
MIM612515	*	2q22.3-q35	DDB1- AND CUL4-ASSOCIATED FACTOR 17; DCAF17	80067
MIM612516	*	15q24	UVEAL AUTOANTIGEN WITH COILED-COIL DOMAINS AND ANKYRIN REPEATS; UACA	55075
MIM612517	*	14q21.3	KINTOUN, MEDAKA, HOMOLOG OF; KTU	55172
MIM612518	#	14q21.3	CILIARY DYSKINESIA, PRIMARY, 10; CILD10	55172
MIM612519	*	6q23.3	SOLUTE CARRIER FAMILY 35, MEMBER D3; SLC35D3	340146
MIM612520	#	12q24.2	DIABETES MELLITUS, INSULIN-DEPENDENT, 20; IDDM20	6927
MIM612521	%	6q25	DIABETES MELLITUS, INSULIN-DEPENDENT, 21; IDDM21	 
MIM612522	#	3p21	DIABETES MELLITUS, INSULIN-DEPENDENT, 22; IDDM22	1234
MIM612523	*	15q22.31	IQ MOTIF-CONTAINING PROTEIN H: IQCH	64799
MIM612524	*	6p21	RIBONUCLEASE P/MRP, 21-KD SUBUNIT; RPP21	79897
MIM612525	%	16q24.3	PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 5; IHPS5	100270639
MIM612526	#	7q31.1	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	857
MIM612527	#	15q	DIAMOND-BLACKFAN ANEMIA 4; DBA4	6218
MIM612528	#	3q29-qter	DIAMOND-BLACKFAN ANEMIA 5; DBA5	6165
MIM612529	#	11q22.3-q23	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA2; AI2A2	9313
MIM612530	#	1q41-q42	CHROMOSOME 1q41-q42 DELETION SYNDROME	100529242
MIM612531	*	12q21.1	THAP DOMAIN-CONTAINING PROTEIN 2; THAP2	83591
MIM612532	*	1p36.31	THAP DOMAIN-CONTAINING PROTEIN 3; THAP3	90326
MIM612533	*	2q37.3	THAP DOMAIN-CONTAINING PROTEIN 4; THAP4	51078
MIM612534	*	7q31.1	THAP DOMAIN-CONTAINING PROTEIN 5; THAP5	168451
MIM612535	*	4q21.1	THAP DOMAIN-CONTAINING PROTEIN 6; THAP6	152815
MIM612536	*	19q13.12	THAP DOMAIN-CONTAINING PROTEIN 8; THAP8	199745
MIM612537	*	4q21.22	THAP DOMAIN-CONTAINING PROTEIN 9; THAP9	79725
MIM612538	*	15q23	THAP DOMAIN-CONTAINING PROTEIN 10; THAP10	56906
MIM612539	#	3q25.31	SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42	9197
MIM612540	#	12q11-q12	MYOPATHY, CONGENITAL, COMPTON-NORTH	1272
MIM612541	#	17q21	NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	92579
MIM612542	#	19q13.3	VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; B12QTL1	2524
MIM612543	*	17q25.3	UBIQUITIN-SPECIFIC PROTEASE 36; USP36	57602
MIM612544	*	4p16	ACTIN-BINDING LIM PROTEIN FAMILY, MEMBER 2; ABLIM2	84448
MIM612545	*	7q11.23	WILLIAMS-BEUREN SYNDROME CHROMOSOME REGION 26; WBSCR26	171022
MIM612546	*	7q11.23	WILLIAMS-BEUREN SYNDROME CHROMOSOME REGION 27; WBSCR27	155368
MIM612547	*	7q11.23	WILLIAMS-BEUREN SYNDROME CHROMOSOME REGION 28; WBSCR28	135886
MIM612548	*	7q11.23	TRIPARTITE MOTIF-CONTAINING PROTEIN 50; TRIM50	135892
MIM612549	*	7q11.23	TRIPARTITE MOTIF-CONTAINING PROTEIN 73; TRIM73	375593
MIM612550	*	7q11.23	TRIPARTITE MOTIF-CONTAINING PROTEIN 74; TRIM74	378108
MIM612551	#	22q12.3	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO; FSGS4	8542
MIM612552	*	22q13.33	ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 4; ZBED4	9889
MIM612553	*	14q32.31	MICRO RNA 370; MIR370	442915
MIM612554	%	5p15.33-p15.2	MYOPIA 16, AUTOSOMAL DOMINANT; MYP16	100270641
MIM612555	#	13q12.3	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2	675
MIM612556	#	3q27	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; ADIPQTL1	9370
MIM612557	%	9q34.1	LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 3	100270642
MIM612558	%	6p25	LEUKEMIA, CHRONIC LYMPHOCYTIC SUSCEPTIBILITY TO, 4	100270643
MIM612559	%	11q24.1	LEUKEMIA, CHRONIC LYMPHOCYTIC SUSCEPTIBILITY TO, 5	100270644
MIM612560	#	14q13.3	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12	254170
MIM612561	#	1p22.1	DIAMOND-BLACKFAN ANEMIA 6; DBA6	6125
MIM612562	#	1p36.1-p35	DIAMOND-BLACKFAN ANEMIA 7; DBA7	6135
MIM612563	#	2p25	DIAMOND-BLACKFAN ANEMIA 8; DBA8	6201
MIM612564	*	2q11.2	THIOREDOXIN DOMAIN-CONTAINING PROTEIN 9; TXNDC9	10190
MIM612565	*	11q13.1	RAS-ASSOCIATED PROTEIN RAB1B; RAB1B	81876
MIM612566	%	20q13	INFLAMMATORY BOWEL DISEASE 24; IBD24	100270798
MIM612567	#	21q22.1	INFLAMMATORY BOWEL DISEASE 25, AUTOSOMAL RECESSIVE; IBD25	100270799, 3588
MIM612568	*	12q22	SPIC TRANSCRIPTION FACTOR; SPIC	121599
MIM612569	*	10q21.3	CELL DIVISION CYCLE AND APOPTOSIS REGULATOR 1; CCAR1	55749
MIM612570	*	5q23-q31	FIBRILLIN 2; FBN2	2201
MIM612571	%	5p15.33	LUNG CANCER SUSCEPTIBILITY 3; LNCR3	100271687
MIM612572	#	 	RETINITIS PIGMENTOSA 46; RP46	3420
MIM612573	%	12q24.31	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 1; MPVQTL1	100271867
MIM612574	%	3p21-p13	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 2; MPVQTL2	100271868
MIM612575	%	17q11.2	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 3; MPVQTL3	100271869
MIM612576	#	17p13.3-p13.1	SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 3; SHFLD3	100270800
MIM612577	#	6q21	AMYOTROPHIC LATERAL SCLEROSIS 11; ALS11	9896
MIM612578	%	8q21.13	STATURE QUANTITATIVE TRAIT LOCUS 15; STQTL15	100270801
MIM612579	%	15q22.32	STATURE QUANTITATIVE TRAIT LOCUS 16; STQTL16	100270802
MIM612580	#	16q24.3	MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	1013
MIM612581	#	11q24.2	MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	84623
MIM612582	#	6pter-p24	CHROMOSOME 6pter-p24 DELETION SYNDROME	100270803
MIM612583	*	16p11.2	SPINSTER, DROSOPHILA, HOMOLOG OF, 1; SPNS1	83985
MIM612584	*	17p13.2	SPINSTER, DROSOPHILA, HOMOLOG OF, 2; SPNS2	124976
MIM612585	*	5p15.33	CLPTM1-LIKE PROTEIN; CLPTM1L	81037
MIM612586	%	2q33.1	ANEURYSM, INTRACRANIAL BERRY, 9; ANIB9	100271688
MIM612587	%	8q12.1	ANEURYSM, INTRACRANIAL BERRY, 10; ANIB10	100271689
MIM612588	*	6q22-q23	BCL2-ASSOCIATED TRANSCRIPTION FACTOR 1; BCLAF1	9774
MIM612589	%	14q22.2	COLORECTAL CANCER, SUSCEPTIBILITY TO, 8; CRCS8	100271690
MIM612590	%	16q22.1	COLORECTAL CANCER, SUSCEPTIBILITY TO, 9; CRCS9	100329169
MIM612591	#	19q13.1	COLORECTAL CANCER, SUSCEPTIBILITY TO, 10; CRCS10	100271691
MIM612592	%	20p12.3	COLORECTAL CANCER, SUSCEPTIBILITY TO, 11; CRCS11	100271692
MIM612593	%	6p21.33	LUNG CANCER SUSCEPTIBILITY 4; LNCR4	100271693
MIM612594	%	10p15.1	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 2; MS2	100271694
MIM612595	%	5p13.2	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 3; MS3	100271695
MIM612596	%	1p36	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 4; MS4	100271696
MIM612597	*	11q22-q23	CYTOTOXIC AND REGULATORY T-CELL MOLECULE; CRTAM	56253
MIM612598	*	1p32-p31	RING FINGER PROTEIN 11; RNF11	26994
MIM612599	%	5q31.1-q33.1	PSORIASIS SUSCEPTIBILITY 11; PSORS11	100271719
MIM612600	*	17p13.3	RNA METHYLTRANSFERASE-LIKE 1; RNMTL1	55178
MIM612601	*	19q13.4	RET FINGER PROTEIN-LIKE 4A; RFPL4A	342931
MIM612602	*	3p21.1	RNA-BINDING MOTIF PROTEIN 15B; RBM15B	29890
MIM612603	*	1q21	LATE CORNIFIED ENVELOPE PROTEIN 1A; LCE1A	353131
MIM612604	*	1q21	LATE CORNIFIED ENVELOPE PROTEIN 1B; LCE1B	353132
MIM612605	*	1q21	LATE CORNIFIED ENVELOPE 1C; LCE1C	353133
MIM612606	*	1q21	LATE CORNIFIED ENVELOPE PROTEIN 1D; LCE1D	353134
MIM612607	*	1q21	LATE CORNIFIED ENVELOPE PROTEIN 1E; LCE1E	353135
MIM612608	*	1q21	LATE CORNIFIED ENVELOPE PROTEIN 1F; LCE1F	353137
MIM612609	*	1q21	LATE CORNIFIED ENVELOPE PROTEIN 2A; LCE2A	353139
MIM612610	*	1q21	LATE CORNIFIED ENVELOPE PROTEIN 2B; LCE2B	26239
MIM612611	*	1q21	LATE CORNIFIED ENVELOPE PROTEIN 2C; LCE2C	353140
MIM612612	*	1q21	LATE CORNIFIED ENVELOPE PROTEIN 2D; LCE2D	353141
MIM612613	*	1q21	LATE CORNIFIED ENVELOPE PROTEIN 3A; LCE3A	353142
MIM612614	*	1q21	LATE CORNIFIED ENVELOPE PROTEIN 3B; LCE3B	353143
MIM612615	*	1q21	LATE CORNIFIED ENVELOPE PROTEIN 3C; LCE3C	353144
MIM612616	*	1q21	LATE CORNIFIED ENVELOPE PROTEIN 3D; LCE3D	84648
MIM612617	*	1q21	LATE CORNIFIED ENVELOPE PROTEIN 3E; LCE3E	353145
MIM612618	*	1q21	LATE CORNIFIED ENVELOPE PROTEIN 4A; LCE4A	199834
MIM612619	*	1q21	LATE CORNIFIED ENVELOPE PROTEIN 5A; LCE5A	254910
MIM612620	*	4q13.3	RAS ASSOCIATION DOMAIN FAMILY, MEMBER 6; RASSF6	166824
MIM612621	#	6p21.3	MENTAL RETARDATION, AUTOSOMAL DOMINANT 5; MRD5	8831
MIM612622	%	4q27	DIABETES MELLITUS, INSULIN-DEPENDENT, 23; IDDM23	100271697
MIM612623	#	7q21	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 2; MVCD2	2056
MIM612624	#	17q23	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3; MVCD3	1636
MIM612625	*	6q13	LMBR1 DOMAIN-CONTAINING PROTEIN 1: LMBRD1	55788
MIM612626	#	15q26-qter	CHROMOSOME 15q26-qter DELETION SYNDROME	100271921
MIM612627	%	1p36.12-p35.1	SEIZURES, BENIGN FAMILIAL INFANTILE, 4; BFIS4	100271922
MIM612628	#	2q14.2	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 4; MVCD4	3557
MIM612629	%	11q23-q24	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 4; ADIPQTL4	100271698
MIM612630	#	2q11-q13	HAIR MORPHOLOGY 1; HRM1	10913
MIM612631	#	9q34.1	ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO	203
MIM612632	%	15q22-q23	USHER SYNDROME, TYPE IH; USH1H	100271837
MIM612633	#	7q21.3	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 5; MVCD5	5444
MIM612634	#	6q25.3	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6	6648
MIM612635	#	6p21.3	MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 7; MVCD7	3077
MIM612636	*	2q35	CHROMOSOME 2 OPEN READING FRAME 21; C2ORF21	285175
MIM612637	%	3q26.2-q26.33	FEBRILE SEIZURES, FAMILIAL, 10	100271923
MIM612638	*	19p13.3	NADH DEHYDROGENASE 1 ALPHA SUBCOMPLEX, 11; NDUFA11	126328
MIM612639	%	12q15	INFLAMMATORY BOWEL DISEASE 26; IBD26	100271838
MIM612640	*	10q22.1	CHROMOSOME 10 OPEN READING FRAME 27; C10ORF27	219793
MIM612641	*	8p11.2	ANKYRIN 1; ANK1	286
MIM612642	%	11p14.2-q12.3	DEAFNESS, AUTOSOMAL DOMINANT 59; DFNA59	100271924
MIM612643	#	13q12	DEAFNESS, AUTOSOMAL DOMINANT 3B; DFNA3B	10804
MIM612644	#	1p35.1	DEAFNESS, AUTOSOMAL DOMINANT 2B; DFNA2B	2707
MIM612645	#	13q12	DEAFNESS, AUTOSOMAL RECESSIVE 1B; DFNB1B	10804
MIM612646	*	7p21.1	METASTASIS-ASSOCIATED GENE IN COLON CANCER 1; MACC1	346389
MIM612647	*	6q22.1	RADIAL SPOKE HEAD 4, CHLAMYDOMONAS, HOMOLOG OF, A; RSPH4A	345895
MIM612648	*	6p21.1	RADIAL SPOKE HEAD 9, CHLAMYDOMONAS, HOMOLOG OF; RSPH9	221421
MIM612649	#	6q22.1	CILIARY DYSKINESIA, PRIMARY, 11; CILD11	345895
MIM612650	#	6p21.1	CILIARY DYSKINESIA, PRIMARY, 12; CILD12	221421
MIM612651	#	6p12.3	ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	22858
MIM612652	^	10q24.3	MOVED TO 219150	 
MIM612653	#	17q21-q22	SPHEROCYTOSIS, TYPE 4; SPH4	6521
MIM612654	*	12q24.1	TRICHOPLEIN; TCHP	84260
MIM612655	*	6p24.1	TBC1 DOMAIN FAMILY, MEMBER 7; TBC1D7	51256
MIM612656	#	5p13	EPISODIC ATAXIA, TYPE 6; EA6	6507
MIM612657	#	4p15.3	CONE-ROD DYSTROPHY 12; CORD12	8842
MIM612658	*	6p21.1	TIGHT JUNCTION-ASSOCIATED PROTEIN 1; TJAP1	93643
MIM612659	*	6q22.2	REGULATORY FACTOR X, 6; RFX6	222546
MIM612660	*	15q21.3	REGULATORY FACTOR X, 7; RFX7	64864
MIM612661	*	17p13	WD REPEAT-CONTAINING PROTEIN ANTISENSE TO TP53; WRAP53	55135
MIM612662	*	12q21.1	TBC1 DOMAIN FAMILY, MEMBER 15; TBC1D15	64786
MIM612663	*	5q31.2	TRAF-INTERACTING PROTEIN WITH FORKHEAD-ASSOCIATED DOMAIN, FAMILY MEMBER B; TIFAB	497189
MIM612664	*	12p12	RAS-LIKE AND ESTROGEN-REGULATED GROWTH INHIBITOR; RERG	85004
MIM612665	*	19q13.31	TESTIS-EXPRESSED GENE 101; TEX101	83639
MIM612666	*	1q32.1	DUAL SERINE/THREONINE AND TYROSINE PROTEIN KINASE; DSTYK	25778
MIM612667	*	2q37.1	HOLLIDAY JUNCTION RECOGNITION PROTEIN; HJURP	55355
MIM612668	*	12p13.2	TASTE RECEPTOR, TYPE 2, MEMBER 43; TAS2R43	259289
MIM612669	*	12p13.2	TASTE RECEPTOR, TYPE 2, MEMBER 31; TAS2R31	259290
MIM612670	^	4q22	MOVED TO 138900	100272224
MIM612671	#	6p21	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4	100272225, 10786
MIM612672	*	2p23.3	RAS-ASSOCIATED PROTEIN RAB10; RAB10	10890
MIM612673	*	9q33.2	RAS-ASSOCIATED PROTEIN RAB14; RAB14	51552
MIM612674	#	20p11.21	POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT; PHARC	26090
MIM612675	*	15q25.2	SMALL CAJAL BODY-SPECIFIC RNA 15; SCARNA15	677778
MIM612676	*	4p15.31	QUINOID DIHYDROPTERIDINE REDUCTASE; QDPR	5860
MIM612677	*	1q21-q23	PYRIN AND HIN DOMAIN FAMILY, MEMBER 1; PYHIN1	149628
MIM612678	*	1q21	TRINUCLEOTIDE REPEAT-CONTAINING GENE 4; TNRC4	11189
MIM612679	*	18q12	BRUNO-LIKE 4; BRUNOL4	56853
MIM612680	*	19p13	BRUNO-LIKE 5; BRUNOL5	60680
MIM612681	*	15q24	BRUNO-LIKE 6; BRUNOL6	60677
MIM612682	*	1p36.22	DORSAL REPULSIVE AXON GUIDANCE PROTEIN	374946
MIM612683	*	17p12	TEKTIN 3; TEKT3	64518
MIM612684	*	14q24.3	ISTHMIN 2, ZEBRAFISH, HOMOLOG OF; ISM2	145501
MIM612685	*	19p13.2	KIAA1543 GENE; KIAA1543	57662
MIM612686	*	11p15.1	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY A, MEMBER 7; PLEKHA7	144100
MIM612687	*	5q21.1	RGM DOMAIN FAMILY, MEMBER B; RGMB	285704
MIM612688	*	3q29	RING FINGER PROTEIN 168; RNF168	165918
MIM612689	*	19p13.3	TIGHT JUNCTION PROTEIN 3; TJP3	27134
MIM612690	#	15q15	SPHEROCYTOSIS, TYPE 5; SPH5	2038
MIM612691	#	6q16.3-q22.1	POLYMICROGYRIA, BILATERAL OCCIPITAL	100294715
MIM612692	#	17q23	AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE; AGM6	974
MIM612693	*	9q34.11	UBIQUITIN-RELATED MODIFIER 1, S. CEREVISIAE, HOMOLOG OF; URM1	81605
MIM612694	*	19q13.33	ATP-BINDING DOMAIN PROTEIN 3; ATPBD3	90353
MIM612695	*	5q31	VAULT RNA 1-1; VTRNA1-1	56664
MIM612696	*	5q31	VAULT RNA 1-2; VTRNA1-2	56663
MIM612697	*	5q31	VAULT RNA 1-3; VTRNA1-3	56662
MIM612698	*	18q12.2	MICRO RNA 187; MIR187	406963
MIM612699	*	22q11.21	RIMS-BINDING PROTEIN 3; RIMBP3	85376
MIM612700	*	22q11.21	RIMS-BINDING PROTEIN 3B; RIMBP3B	440804
MIM612701	*	22q11.21	RIMS-BINDING PROTEIN 3C; RIMBP3C	150221
MIM612702	#	10q24	HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	2253
MIM612703	#	1p32	MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE; MCPH7	6491
MIM612704	*	2p11.2	RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 1; RGPD1	400966
MIM612705	*	2p11.2	RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 2; RGPD2	729857
MIM612706	*	2q12.3-q13	RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 3; RGPD3	653489
MIM612707	*	2q12.3-q13	RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 4; RGPD4	285190
MIM612708	*	2q12.3-q13	RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 5; RGPD5	84220
MIM612709	*	2q12.3-q13	RANBP2-LIKE AND GRIP DOMAIN-CONTAINING PROTEIN 6; RGPD6	729540
MIM612711	*	2q12.3	GRIP AND COILED-COIL DOMAIN-CONTAINING PROTEIN 2; GCC2	9648
MIM612712	#	14q23.3	LEBER CONGENITAL AMAUROSIS 13; LCA13	145226
MIM612713	#	4p12-q12	KAHRIZI SYNDROME; KHRZ	79644
MIM612714	#	20q11.21	EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIAL HYPEROSTOSIS	84701
MIM612715	%	12q21-q23	DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 2; DUH2	100301525
MIM612716	#	2p14-p12	DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	6697
MIM612717	%	10q21.1	MYOPIA 15, AUTOSOMAL DOMINANT; MYP15	100294716
MIM612718	#	15q15.3	ARGININE:GLYCINE AMIDINOTRANSFERASE DEFICIENCY	2628
MIM612719	*	11q22.3-q23.3	6-@PYRUVOYL-TETRAHYDROPTERIN SYNTHASE; PTS	5805
MIM612720	*	5q11.2	DEAH BOX POLYPEPTIDE 29; DHX29	54505
MIM612721	*	2q35	REGULATED ENDOCRINE-SPECIFIC PROTEIN 18	389075
MIM612722	*	8p21.1	ELONGATION PROTEIN 3, S. CEREVISIAE, HOMOLOG OF; ELP3	55140
MIM612723	*	2p21	PLECKSTRIN HOMOLOGY DOMAIN-CONTAINING PROTEIN, FAMILY H, MEMBER 2; PLEKHH2	130271
MIM612724	*	9q22.3	ALDOLASE B, FRUCTOSE-BISPHOSPHATE; ALDOB	229
MIM612725	*	9q33.3	PROTEIN PHOSPHATASE 6, CATALYTIC SUBUNIT; PPP6C	5537
MIM612727	%	16q23	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 13; BMND13	100294717
MIM612728	%	1p33-p32	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 14; BMND14	100294718
MIM612729	%	8q23	LEAN BODY MASS QUANTITATIVE TRAIT LOCUS 1; LBMQTL1	100294719
MIM612730	*	20q13.13	SOLUTE CARRIER FAMILY 9 (SODIUM/HYDROGEN EXCHANGER), MEMBER 8; SLC9A8	23315
MIM612732	*	3q12	COPROPORPHYRINOGEN OXIDASE; CPOX	1371
MIM612733	*	22q12	THO COMPLEX, SUBUNIT 5; THOC5	8563
MIM612734	*	10q24	TLX1 DIVERGENT GENE	100038246
MIM612735	*	6p21.3	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR BETA-3; HLA-DRB3	3125
MIM612736	#	19p13.3	GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	2593
MIM612737	%	7p15	STATURE QUANTITATIVE TRAIT LOCUS 17; STQTL17	100301526
MIM612738	*	3q13.2	SOLUTE CARRIER FAMILY 9, MEMBER 10; SLC9A10	285335
MIM612739	*	6q15-q16.2	SPERM ACROSOME-ASSOCIATED PROTEIN 1; SPACA1	81833
MIM612740	#	9q34	PORPHYRIA, ACUTE HEPATIC	210
MIM612741	*	16q24.3	SNAIL, DROSOPHILA, HOMOLOG OF, 3; SNAI3	333929
MIM612742	*	1q31.3	MICRO RNA 181A1; MIR181A1	406995
MIM612743	*	9q33.3	MICRO RNA 181A2; MIR181A2	406954
MIM612744	*	1q31.3	MICRO RNA 181B1; MIR181B1	406955
MIM612745	*	9q33.3	MICRO RNA 181B2; MIR181B2	406956
MIM612746	*	19p13.3	MICRO RNA 181C; MIR181C	406957
MIM612747	*	22q12.1	TUFTELIN-INTERACTING PROTEIN 11; TFIP11	24144
MIM612748	*	10p11.23	LYSOZYME-LIKE 2; LYZL2	119180
MIM612749	*	17q12	SPERM ACROSOME-ASSOCIATED PROTEIN 3; SPACA3	124912
MIM612750	*	3p21.33	LYSOZYME-LIKE 4; LYZL4	131375
MIM612751	*	17q11.2	LYSOZYME-LIKE 6; LYZL6	57151
MIM612752	*	5q31.3	CXXC FINGER PROTEIN 5; CXXC5	51523
MIM612753	*	18q21.32	COLLAGEN AND CALCIUM-BINDING EGF DOMAIN-CONTAINING PROTEIN 1; CCBE1	147372
MIM612754	*	10q26.3	GLUTAREDOXIN 3; GLRX3	10539
MIM612755	*	12q24.13	MITOCHONDRIAL DISTRIBUTION AND MORPHOLOGY 20, YEAST, HOMOLOG OF	80018
MIM612756	*	17q23.3	TESTICULAR CELL ADHESION MOLECULE 1; TCAM1	146771
MIM612757	*	8q24.3	GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED HIGH DENSITY LIPOPROTEIN-BINDING PROTEIN 1; GPIHBP1	338328
MIM612758	*	4p15.32	TRANSMEMBRANE ANTERIOR POSTERIOR TRANSFORMATION 1; TAPT1	202018
MIM612759	%	2q24.1	SYNESTHESIA	100301527
MIM612760	*	3p21	SNF-RELATED KINASE; SNRK	54861
MIM612761	*	4q22-q23	SWI/SNF-RELATED, MATRIX-ASSOCIATED ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, DEAD/H BOX-CONTAINING, 1; SMARCAD1	56916
MIM612762	*	2p25	SUPPRESSOR OF TY 7-LIKE; SUPT7L	9913
MIM612763	*	1q24-q25	TRANSCRIPTIONAL ADAPTOR 1-LIKE; TADA1L	117143
MIM612764	*	3q21.3	ISY1 SPLICING FACTOR, S. CEREVISIAE, HOMOLOG OF; ISY1	57461
MIM612765	*	22q12.2	SFI1, YEAST, HOMOLOG OF; SFI1	9814
MIM612766	*	19p13.11	CHROMOSOME 19 OPEN READING FRAME 62; C19ORF62	29086
MIM612767	*	3q25.2	DEAH BOX POLYPEPTIDE 36; DHX36	170506
MIM612768	*	4q32.1	FOLLICULIN-INTERACTING PROTEIN 2; FNIP2	57600
MIM612769	*	11q13.1	NONCODING RNA 84; NCRNA00084	283131
MIM612770	*	22q12	PHOSPHATIDYLSERINE DECARBOXYLASE; PISD	23761
MIM612771	*	15q15	DUAL OXIDASE MATURATION FACTOR 1; DUOXA1	90527
MIM612772	*	15q15	DUAL OXIDASE MATURATION FACTOR 2; DUOXA2	405753
MIM612773	*	19q13.2	BASAL CELL ADHESION MOLECULE; BCAM	4059
MIM612774	*	12p13.2	TASTE RECEPTOR, TYPE 2, MEMBER 46; TAS2R46	259292
MIM612775	#	8p11, 8p11.23	CONE-ROD DYSTROPHY 9; CORD9	8754
MIM612778	*	3p21.3-p21.2	SET DOMAIN-CONTAINING PROTEIN 2; SETD2	29072
MIM612779	*	1p22	DIHYDROPYRIMIDINE DEHYDROGENASE; DPYD	1806
MIM612780	#	1q23.2	SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE; SESAMES	3766
MIM612781	#	7p15-p14, 17q22-q24	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB; IGHD1B	2688, 2692
MIM612782	#	12q24	IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT 1	84876
MIM612783	#	11p15.5	IMMUNE DYSFUNCTION WITH T-CELL INACTIVATION DUE TO CALCIUM ENTRY DEFECT 2	6786
MIM612784	*	15q15.3	HUNTINGTIN-INTERACTING PROTEIN K	25764
MIM612786	*	10p11.2	CYCLIN Y; CCNY	219771
MIM612787	*	2p16.1	PSEUDOURIDYLATE SYNTHASE 10; PUS10	150962
MIM612788	*	6p25	FORKHEAD BOX Q1; FOXQ1	94234
MIM612789	%	8p22-p21.3	DEAFNESS, AUTOSOMAL RECESSIVE 71; DFNB71	100302513
MIM612790	*	5q13.2	RGNEF, MOUSE, HOMOLOG OF	64283
MIM612791	*	6p22.1	ZINC FINGER PROTEIN WITH KRAB AND SCAN DOMAINS 3; ZKSCAN3	80317
MIM612792	*	8q22	PHOSPHATIDYLSERINE SYNTHASE 1; PTDSS1	9791
MIM612793	*	8q22	PHOSPHATIDYLSERINE SYNTHASE 2; PTDSS2	81490
MIM612794	#	15q14	ATRIAL SEPTAL DEFECT 5; ASD5	70
MIM612795	%	11q12-q13.1	POLYUNSATURATED FATTY ACIDS PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; PUFAQTL1	100302559
MIM612796	%	13q13.3	INFLAMMATORY BOWEL DISEASE 27; IBD27	100302059
MIM612797	#	15q21-q23	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12; HDLCQ12	3990
MIM612799	*	16p13.1-p11.2	GLUTAMYL-tRNA SYNTHETASE 2; EARS2	124454
MIM612800	*	13q34	CYSTEINYL-tRNA SYNTHETASE 2; CARS2	79587
MIM612801	*	1q41	ISOLEUCYL-tRNA SYNTHETASE 2; IARS2	55699
MIM612802	*	6p21.3	VALYL-tRNA SYNTHETASE 2; VARS2	57176
MIM612803	*	11q14.1	ASPARAGINYL-tRNA SYNTHETASE 2; NARS2	79731
MIM612804	*	19q13.2	SERYL-tRNA SYNTHETASE 2; SARS2	54938
MIM612805	*	1q21.2	THREONYL-tRNA SYNTHETASE 2; TARS2	80222
MIM612806	*	1q21.1	G PROTEIN-COUPLED RECEPTOR 89B; GPR89B	51463
MIM612807	*	19q13.2	LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 1; LRFN1	57622
MIM612808	*	6p21.2	LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 2; LRFN2	57497
MIM612809	*	19q13.2	LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 3; LRFN3	79414
MIM612810	*	11q13.1	LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 4; LRFN4	78999
MIM612811	*	14q21.2	LEUCINE-RICH REPEAT AND FIBRONECTIN TYPE III DOMAIN-CONTAINING PROTEIN 5; LRFN5	145581
MIM612812	*	5q35.2	PROFILIN 3; PFN3	345456
MIM612813	#	15q26.1	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	176
MIM612814	*	4q11-q12	SPERMATOGENESIS-ASSOCIATED PROTEIN 18; SPATA18	132671
MIM612815	*	11p15.1	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 13; ZDHHC13	54503
MIM612816	*	17q21.33	UTP18, S. CEREVISIAE, HOMOLOG OF; UTP18	51096
MIM612817	*	12q21.2	KRR1, YEAST, HOMOLOG OF; KRR1	11103
MIM612818	*	15q15.1	NUCLEOLAR AND SPINDLE-ASSOCIATED PROTEIN 1; NUSAP1	51203
MIM612819	*	12q24.33	NUCLEOLAR COMPLEX-ASSOCIATED PROTEIN 4, S. CEREVISIAE, HOMOLOG OF; NOC4L	79050
MIM612820	*	15q22	NEUROPLASTIN; NPTN	27020
MIM612821	*	1q21.1	G PROTEIN-COUPLED RECEPTOR 89A; GPR89A	653519
MIM612822	*	12q23.2-q23.3	UTP20, S. CEREVISIAE, HOMOLOG OF; UTP20	27340
MIM612823	*	11q21	TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1D; TAF1D	79101
MIM612824	*	22q12	SEC14-LIKE 3; SEC14L3	266629
MIM612825	*	22q12	SEC14-LIKE 4; SEC14L4	284904
MIM612826	*	14q22.1	SPHINGOSINE-1-PHOSPHATE PHOSPHATASE 1; SGPP1	81537
MIM612827	*	2q36.1	SPHINGOSINE-1-PHOSPHATE PHOSPHATASE 2; SGPP2	130367
MIM612828	*	2p22.2	CCAAT/ENHANCER-BINDING PROTEIN, ZETA; CEBPZ	10153
MIM612829	*	5q13	RAS-ASSOCIATED PROTEIN RAB3C; RAB3C	115827
MIM612830	*	1p36.1	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 3; DHRS3	9249
MIM612831	*	4q21	17-@BETA-HYDROXYSTEROID DEHYDROGENASE XI; HSD17B11	51170
MIM612832	*	19q13.33	17-@BETA-HYDROXYSTEROID DEHYDROGENASE XIV; HSD17B14	51171
MIM612833	*	14q23.1	SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 7; DHRS7	51635
MIM612834	*	11q23.3	PLECKSTRIN HOMOLOGY-LIKE DOMAIN, FAMILY B, MEMBER 1; PHLDB1	23187
MIM612835	*	3q25.31	PHOSPHOLIPASE C, ETA-1; PLCH1	23007
MIM612836	*	1p36.32	PHOSPHOLIPASE C, ETA-2; PLCH2	9651
MIM612837	*	16q13	COQ9, S. CEREVISIAE, HOMOLOG OF; COQ9	57017
MIM612838	#	19q13.1	BRUGADA SYNDROME 5; BRGDA5	6324
MIM612839	*	4q24	TET ONCOGENE FAMILY, MEMBER 2; TET2	54790
MIM612840	#	11q12	LEUKOCYTE ADHESION DEFICIENCY, TYPE III; LAD3	83706
MIM612841	%	1p21.1-q21.3	HYPOTRICHOSIS 5; HYPT5	100302560
MIM612842	*	22q12.3	RASD FAMILY, MEMBER 2; RASD2	23551
MIM612844	*	17p13.1	SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 3; SENP3	26168
MIM612845	*	3q29	SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 5; SENP5	205564
MIM612846	*	3q12.3	SENTRIN-SPECIFIC PROTEASE FAMILY, MEMBER 7; SENP7	57337
MIM612847	#	10q22-q24	SPONDYLOEPIMETAPHYSEAL DYSPLASIA, PAKISTANI TYPE	9060
MIM612848	*	19q12-q13.2	SUCCINATE DEHYDROGENASE COMPLEX ASSEMBLY FACTOR 1; SDHAF1	644096
MIM612849	*	4q12	UBIQUITIN-SPECIFIC PEPTIDASE 46; USP46	64854
MIM612850	*	6p25.2	TUBULIN, BETA-2B; TUBB2B	347733
MIM612851	%	14q11.2	NARCOLEPSY 5, SUSCEPTIBILITY TO; NRCLP5	100302514
MIM612852	#	2q14.2	OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	3557
MIM612853	%	2p14-p13	RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 7	100302561
MIM612854	*	9q34.3	SEC16, S. CEREVISIAE, HOMOLOG OF, A; SEC16A	9919
MIM612855	*	1q25.2	SEC16, S. CEREVISIAE, HOMOLOG OF, B; SEC16B	89866
MIM612856	*	9q33.1	ASTROTACTIN 2; ASTN2	23245
MIM612857	*	10q22.3	PLACENTA-SPECIFIC GENE 9; PLAC9	219348
MIM612858	%	8q24.31	OROFACIAL CLEFT 12; OFC12	100302515
MIM612859	*	3q13.3	T-CELL IMMUNORECEPTOR WITH IMMUNOGLOBULIN AND ITIM DOMAINS; TIGIT	201633
MIM612860	*	9q34.3	QUIESCIN Q6 SULFHYDRYL OXIDASE 2; QSOX2	169714
MIM612861	*	5q35.2	NOP16, S. CEREVISIAE, HOMOLOG OF; NOP16	51491
MIM612862	%	6p21.3	PULMONARY HYPERTENSION, CHRONIC THROMBOEMBOLIC, WITHOUT DEEP VEIN THROMBOSIS, SUSCEPTIBILITY TO	100302516
MIM612863	#	6q25, 6q24-q25	CHROMOSOME 6q24-q25 DELETION SYNDROME	100505391, 23118
MIM612864	*	15q15	PHOSPHOLIPASE A2, GROUP IVD; PLA2G4D	283748
MIM612865	*	9q34.11	PHOSPHATIDYLINOSITOL 4-PHOSPHATE-5-KINASE-LIKE 1; PIP5KL1	138429
MIM612866	*	1p21.3	ALG14, S. CEREVISIAE, HOMOLOG OF; ALG14	199857
MIM612869	*	10q26	ATTRACTIN-LIKE 1; ATRNL1	26033
MIM612870	*	6q14	PLECKSTRIN HOMOLOGY DOMAIN-INTERACTING PROTEIN; PHIP	55023
MIM612871	*	1p35.2	Na+/K+ TRANSPORTING ATPase-INTERACTING 1; NKAIN1	79570
MIM612872	*	8q12.13	Na+/K+ TRANSPORTING ATPase-INTERACTING 3; NKAIN3	286183
MIM612873	*	20q13.33	Na+/K+ TRANSPORTING ATPase-INTERACTING 4; NKAIN4	128414
MIM612874	#	11pter-p13	ERYTHROCYTE AMP DEAMINASE DEFICIENCY	272
MIM612875		1q12-q21.3	GONADOTROPIN-RELEASING HORMONE RECEPTOR 2; GNRHR2	114814
MIM612876	%	 	SPINOCEREBELLAR ATAXIA 9; SCA9	140451
MIM612877	#	18q12.1-q12.2	CARDIOMYOPATHY, DILATED, 1BB; CMD1BB	1829
MIM612878	*	11q22.3	EXOPHILIN 5; EXPH5	23086
MIM612879	*	9q21.11	MAM DOMAIN-CONTAINING 2; MAMDC2	256691
MIM612880	*	11q14	SYNAPTOTAGMIN-LIKE 2; SYTL2	54843
MIM612881	%	5q14.3-q15	HETEROTOPIA, PERIVENTRICULAR, ASSOCIATED WITH CHROMOSOME 5q DELETION	100302682
MIM612882	%	6q21	MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 2; MENAQ2	100302562
MIM612883	%	9q31.2	MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 3; MENAQ3	100302563
MIM612884	%	19q13.4	MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 2; MENOQ2	100302517
MIM612885	%	20p12.3	MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 3; MENOQ3	100302518
MIM612886	%	5q35.2	MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 4; MENOQ4	100302519
MIM612887	*	4q21.1	SEPTIN 11; SEPT11	55752
MIM612888	*	1p22.2	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8B; LRRC8B	23507
MIM612889	*	1p22.2	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8C; LRRC8C	84230
MIM612890	*	1p22.2	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8D; LRRC8D	55144
MIM612891	*	19p13.2	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 8E; LRRC8E	80131
MIM612892	%	6p22.1	STATURE QUANTITATIVE TRAIT LOCUS 18; STQTL18	100302683
MIM612893	%	6p21.31	STATURE QUANTITATIVE TRAIT LOCUS 19; STQTL19	100302684
MIM612894	%	13q14.3	STATURE QUANTITATIVE TRAIT LOCUS 20; STQTL20	100302685
MIM612895	*	17p13.3	NUCLEOREDOXIN; NXN	64359
MIM612896	*	17q11.2	RAD52 MOTIF-CONTAINING PROTEIN 1; RDM1	201299
MIM612897	*	16p11.2	SEPTIN 1; SEPT1	1731
MIM612898	*	9q34.13	COENZYME Q4, S. CEREVISIAE, HOMOLOG OF; COQ4	51117
MIM612899	#	3q13.3-q21	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 8; EIG8	846
MIM612900	#	9p24.3	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 2; CPSQ2	23189
MIM612901	*	20q13.3	TUBULIN, BETA-1; TUBB1	81027
MIM612902	*	9q34	LIPOCALIN 8; LCN8	138307
MIM612903	*	9q34	LIPOCALIN 9; LCN9	392399
MIM612904	*	9q34	LIPOCALIN 10; LCN10	414332
MIM612905	*	9q34	LIPOCALIN 12; LCN12	286256
MIM612906	*	6q24.3	RAS-ASSOCIATED PROTEIN RAB32; RAB32	10981
MIM612907	*	3p25.1	tRNA NUCLEOTIDYLTRANSFERASE, CCA-ADDING, 1; TRNT1	51095
MIM612908	#	6p24	KERATOSIS PALMOPLANTARIS STRIATA II; PPKS2	1832
MIM612909	*	2q21.1	RAS-ASSOCIATED PROTEIN RAB6C; RAB6C	84084
MIM612910	*	17p13	PHD FINGER PROTEIN 23; PHF23	79142
MIM612911	*	3p21.31	NADH DEHYDROGENASE 1 ALPHA SUBCOMPLEX, ASSEMBLY FACTOR 3; NDUFAF3	25915
MIM612912	*	17q11.2	TRANSMEMBRANE PROTEIN 97; TMEM97	27346
MIM612914	*	19q13.2	MEDIATOR COMPLEX SUBUNIT 29; MED29	55588
MIM612915	*	6p21.1	MEDIATOR COMPLEX SUBUNIT 20; MED20	9477
MIM612918	#	 	CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	5290
MIM612919	*	7p11.2	LanC-LIKE 2; LANCL2	55915
MIM612920	*	21q22.3	THROMBOSPONDIN-TYPE LAMININ G DOMAIN AND EAR REPEATS; TSPEAR	54084
MIM612921	#	2q35	THREE M SYNDROME 2; 3M2	23363
MIM612922	#	1q32	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2; AHUS2	4179
MIM612923	#	4q25	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3; AHUS3	3426
MIM612924	#	6p21.3	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4	629
MIM612925	#	19p13.3-p13.2	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5	718
MIM612926	#	20p11.2	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6; AHUS6	7056
MIM612927	*	7p14.3	AVL9, S. CEREVISIAE, HOMOLOG OF; AVL9	23080
MIM612928	*	19q13.42	ISOCHORISMATASE DOMAIN-CONTAINING 2; ISOC2	79763
MIM612929	%	19q13.31-q33	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 3	100302686
MIM612930	*	2q36.3	PHOSPHOTYROSINE INTERACTION DOMAIN-CONTAINING 1; PID1	55022
MIM612931	*	7p13-p12.3	PHOSPHOGLYCERATE MUTASE 2; PGAM2	5224
MIM612932	#	17pter-p12	GLYCOGEN STORAGE DISEASE XIII; GSD13	2027
MIM612933	#	11p15.4	GLYCOGEN STORAGE DISEASE XI; GSD11	3939
MIM612934	^	1p31	GLYCOGEN STORAGE DISEASE XIV; GSD14	5236
MIM612935	*	17p11.2	MYOSIN PHOSPHATASE RHO-INTERACTING PROTEIN; MPRIP	23164
MIM612936	#	7q22.1	SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50	9179
MIM612937	#	1q12-q21	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Io; CDG1O	54344
MIM612938	#	16q12.2	GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLY DEATH; GDFD	79068
MIM612939	*	19q13.42	HEAT-SHOCK 70-KD PROTEIN-BINDING PROTEIN 1; HSPBP1	23640
MIM612940	#	17q25.3	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	5831
MIM612941	*	2q23.3	PRECURSOR mRNA-PROCESSING FACTOR 40, S. CEREVISIAE, HOMOLOG OF, A; PRPF40A	55660
MIM612942	*	1q22	RAS-ASSOCIATED PROTEIN RAB25; RAB25	57111
MIM612943	#	7p15.3	RETINITIS PIGMENTOSA 42; RP42	55975
MIM612944	*	6q27	RIBONUCLEASE T2; RNASET2	8635
MIM612945	*	19q13.2-q13.3	RAS-ASSOCIATED PROTEIN RAB4B; RAB4B	53916
MIM612949	#	2q24	HYPOMYELINATION, GLOBAL CEREBRAL	8604
MIM612950	%	20q13	PSORIASIS SUSCEPTIBILITY 12; PSORS12	 
MIM612951	#	6q27	LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	8635
MIM612952	#	20q11.2	AICARDI-GOUTIERES SYNDROME 5; AGS5	25939
MIM612953	#	22q13.1	PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	8398
MIM612954	#	10q25.2-q26.2	MYOPATHY, MYOFIBRILLAR 6, MFM6	9531
MIM612955	#	20q11.2	LONG QT SYNDROME 12; LQT12	6640
MIM612956	#	7q36.2	VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 2; VF2	1804
MIM612957	%	1p36.12	VITAMIN B6 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; B6QTL1	100302718
MIM612958	*	17q22-q24.2	TRANSLATIONAL ACTIVATOR OF MITOCHONDRIALLY ENCODED CYTOCHROME c OXIDASE SUBUNIT I; TACO1	51204
MIM612959	*	8q22.1	EPITHELIAL SPLICING REGULATORY PROTEIN 1; ESRP1	54845
MIM612960	*	16q22.1	EPITHELIAL SPLICING REGULATORY PROTEIN 2; ESRP2	80004
MIM612961	#	13q11-q12	MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3	2254
MIM612962	*	16p12.2	DYNACTIN 5; DCTN5	84516
MIM612963	*	8p12-p11	DYNACTIN 6; DCTN6	10671
MIM612964	#	9q33	PREMATURE OVARIAN FAILURE 7; POF7	2516
MIM612965	#	9q33	46,XY SEX REVERSAL 3; SRXY3	2516
MIM612966	*	20q13.3	RAS-ASSOCIATED PROTEIN RAB22A; RAB22A	57403
MIM612967	%	17q23.2-q25.1	BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 15; BMIQ15	100302719
MIM612968	%	1p34.3-p32.2	CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 3; CATC3	100302720
MIM612969	*	16p13	TIGGER TRANSPOSABLE ELEMENT-DERIVED GENE 7; TIGD7	91151
MIM612970	*	1q21.1	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 23; NBPF23	100302292
MIM612971	*	10q24.3	PDZ DOMAIN-CONTAINING 7; PDZD7	79955
MIM612972	*	2q37.1	TIGGER TRANSPOSABLE ELEMENT-DERIVED GENE 1; TIGD1	200765
MIM612973	*	4q22.1	TIGGER TRANSPOSABLE ELEMENT-DERIVED GENE 2; TIGD2	166815
MIM612974	*	8q24.12	DEP DOMAIN-CONTAINING PROTEIN 6; DEPDC6	64798
MIM612975	#	12p12.1-p11.23	SHORT SLEEPER	79365
MIM612976	%	3p26.1-p25.1	AGE-RELATED HEARING IMPAIRMENT 2; ARHI2	100302721
MIM612977	*	4q12	DCN1 DOMAIN-CONTAINING PROTEIN 4; DCUN1D4	23142
MIM612978	*	14q12	PRECEREBELLIN 3; CBLN3	643866
MIM612979	*	20q13.12	SYS1 GOLGI-LOCALIZED INTEGRAL MEMBRANE PROTEIN, S. CEREVISIAE, HOMOLOG OF; SYS1	90196
MIM612980	*	15q24	IMP3, S. CEREVISIAE, HOMOLOG OF; IMP3	55272
MIM612981	*	2q21.1	IMP4, S. CEREVISIAE, HOMOLOG OF; IMP4	92856
MIM612982	*	11p15.5	MICRO RNA 210; MIR210	406992
MIM612983	*	7q22	MICRO RNA 106B; MIR106B	406900
MIM612984	*	7q22	MICRO RNA 93; MIR93	407050
MIM612985	*	16q12.2	IROQUOIS HOMEOBOX PROTEIN 3; IRX3	79191
MIM612986	*	12q23-q24.1	E1A-LIKE INHIBITOR OF DIFFERENTIATION 3; EID3	493861
MIM612987	*	10q26.13	NON-SMC ELEMENT 4, S. CEREVISIAE, HOMOLOG OF, A; NSMCE4A	54780
MIM612988	*	11q14.1-q21	TRANSMEMBRANE PROTEIN 126A; TMEM126A	84233
MIM612989	#	11q14.1-q21	OPTIC ATROPHY 7; OPA7	84233
MIM612990	*	20q11.21	ADDITIONAL SEX COMBS-LIKE 1; ASXL1	171023
MIM612991	*	2p23.3	ADDITIONAL SEX COMBS-LIKE 2; ASXL2	55252
MIM612992	*	1p36	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 3; NBPF3	84224
MIM612993	*	3q12.1	FILAMIN A-INTERACTING PROTEIN 1-LIKE; FILIP1L	11259
MIM612994	*	4p15.33	RAS-ASSOCIATED PROTEIN 28; RAB28	9364
MIM612995	*	 	TRANSFER RNA VALINE 2; TRNAV2	7240
MIM612996	*	 	TRANSFER RNA LYSINE 2; TRNAK2	790966
MIM612997	#	11q13.1	SPERMATOGENIC FAILURE 7; SPGF7	117144, 117155, 161497
MIM612998	#	6q25	EMERY-DREIFUSS MUSCULAR DYSTROPHY 4, AUTOSOMAL DOMINANT; EDMD4	23345
MIM612999	#	14q23	EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT; EDMD5	23224
MIM613000	#	17q12-q21	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL; FNEPPK	3868
MIM613002	#	4q35	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 2	7098
MIM613003	#	12q21.1	ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 7	121278
MIM613004	*	4p16.3	HUNTINGTIN; HTT	3064
MIM613006	%	10q23.31	DIABETES MELLITUS, INSULIN-DEPENDENT, 24; IDDM24	100303715
MIM613007	%	6p21.3	BILIARY CIRRHOSIS, PRIMARY, 2; PBC2	100303716
MIM613008	%	1p31.2	BILIARY CIRRHOSIS, PRIMARY, 3; PBC3	100303717
MIM613009	*	4p15.2	O-PHOSPHOSERINE tRNA-SELENOCYSTEINE tRNA SYNTHASE; SEPSECS	51091
MIM613010	*	9q21.1	RIBOFLAVIN KINASE; RFK	55312
MIM613011	#	5q32	LYMPHOPROLIFERATIVE SYNDROME, EBV-ASSOCIATED, AUTOSOMAL, 1	3702
MIM613012	*	3q21.3	UROCANASE DOMAIN-CONTAINING PROTEIN 1; UROC1	131669
MIM613013	#	4p12	NEUROBLASTOMA, SUSCEPTIBILITY TO, 2; NBLST2	8929
MIM613014	#	2p23	NEUROBLASTOMA, SUSCEPTIBILITY TO, 3; NBLST3	238
MIM613015	%	6p22	NEUROBLASTOMA, SUSCEPTIBILITY TO, 4; NBLST4	100306937
MIM613016	%	2q35	NEUROBLASTOMA, SUSCEPTIBILITY TO, 5; NBLST5	100306938
MIM613017	%	1q21.1	NEUROBLASTOMA, SUSCEPTIBILITY TO, 6; NBLST6	100306939
MIM613018	*	16q22.1-q22.3	TYROSINE AMINOTRANSFERASE; TAT	6898
MIM613019	*	11q13.1	SUCCINATE DEHYDROGENASE COMPLEX ASSEMBLY FACTOR 2; SDHAF2	54949
MIM613020	^	1p36.1	CATARACT, AGE-RELATED CORTICAL, 2; ARCC2	1969
MIM613021	#	12p13	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2; BESC2	6337
MIM613022	*	7p14-p13	OXOGLUTARATE DEHYDROGENASE; OGDH	4967
MIM613023	*	1q44	CENTROSOMAL PROTEIN, 170-KD; CEP170	9859
MIM613024	%	6p21.33	FOLLICULAR LYMPHOMA, SUSCEPTIBILITY TO, 1; FL1	100306940, 8915
MIM613025	%	15q13	SCHIZOPHRENIA 13; SCZD13	100329170
MIM613026	#	19q13.11	CHROMOSOME 19q13.11 DELETION SYNDROME	100306978
MIM613027	#	16p12.1-p11.2	GLYCOGEN STORAGE DISEASE IXc; GSD9C	5261
MIM613028	#	10q23.31	GLIOMA SUSCEPTIBILITY 2; GLM2	5728
MIM613029	#	13q12.3	GLIOMA SUSCEPTIBILITY 3; GLM3	675
MIM613030	%	9p21.3	GLIOMA SUSCEPTIBILITY 5; GLM5	100415894
MIM613031	%	20q13.33	GLIOMA SUSCEPTIBILITY 6; GLM6	100415895
MIM613033	%	5p15.33	GLIOMA SUSCEPTIBILITY 8; GLM8	100316847
MIM613036	*	9q34.3	PEPTIDASE, MITOCHONDRIAL PROCESSING, ALPHA; PMPCA	23203
MIM613037	*	9q34.3	INOSITOL POLYPHOSPHATE-5-PHOSPHATASE, 72-KD; INPP5E	56623
MIM613038	#	3p11	PITUITARY HORMONE DEFICIENCY, COMBINED, 1; CPHD1	5449
MIM613039	*	1q21	CHROMODOMAIN HELICASE DNA-BINDING PROTEIN 1-LIKE; CHD1L	9557
MIM613040	*	8q24.21	COILED-COIL DOMAIN-CONTAINING PROTEIN 26; CCDC26	137196
MIM613041	*	12p13.31	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A1; FAM90A1	55138
MIM613042	*	8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A3; FAM90A3	389611
MIM613043	*	8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A5; FAM90A5	441315
MIM613044	*	8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A7; FAM90A7	441317
MIM613045	*	8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A8; FAM90A8	441324
MIM613046	*	8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A9; FAM90A9	441327
MIM613047	*	8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A10; FAM90A10	441328
MIM613048	*	8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A12; FAM90A12	645879
MIM613049	*	8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A13; FAM90A13	441314
MIM613050	*	8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A14; FAM90A14	645651
MIM613051	*	8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A15; FAM90A15	389630
MIM613052	*	8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A18; FAM90A18	441326
MIM613053	*	8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A19; FAM90A19	728753
MIM613054	*	8p23.1	FAMILY WITH SEQUENCE SIMILARITY 90, MEMBER A20; FAM90A20	728430
MIM613055	%	16q22	ATRIAL FIBRILLATION, FAMILIAL, 8; ATFB8	100306979
MIM613056	*	7q34	LUC7, S. CEREVISIAE, HOMOLOG OF, 2; LUC7L2	51631
MIM613057	*	12q14.1	MICRO RNA 26A2; MIR26A2	407016
MIM613058	%	1q42	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 2; BCC2	100307119
MIM613059	%	5p15.33	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 3; BCC3	100307120
MIM613060	#	1p36.3	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10	2563
MIM613061	%	12q13	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 4; BCC4	100307121
MIM613062	%	9p21	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 5; BCC5	100307122
MIM613063	%	7q32	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 6; BCC6	100307123
MIM613064	%	11q13.5	DERMATITIS, ATOPIC, 7; ATOD7	100310755
MIM613065	%	10q21, 22q11.21	LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL	100310785, 613
MIM613066	*	11q24-q25	PBX/KNOTTED 1 HOMEOBOX 2; PKNOX2	63876
MIM613067	%	7p12.2	LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 2	100310786
MIM613068	#	11q13.3-q13.5	NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	2348
MIM613069	*	6q26	PHD FINGER PROTEIN 10; PHF10	55274
MIM613070	#	22q13	LIVER FAILURE, INFANTILE, TRANSIENT; LFIT	55687
MIM613071	#	16p13-p12	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3	6340
MIM613072	*	18q12-q21	LIPOXYGENASE HOMOLOGY DOMAIN-CONTAINING 1; LOXHD1	125336
MIM613073	#	20q11.2-q13.1	METAPHYSEAL ANADYSPLASIA 2; MANDP2	4318
MIM613074	#	7q32.2	DEAFNESS, AUTOSOMAL DOMINANT 50; DFNA50	407053
MIM613075	#	20p11.22	MACROCEPHALY, ALOPECIA, CUTIS LAXA, AND SCOLIOSIS	54453
MIM613076	#	16p13.3-p13.12	MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARING LOSS, AND DEVELOPMENTAL DELAY	2671
MIM613077	#	8q23.1	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 5; PEOA5	50484
MIM613078	#	5q31	NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD	10111
MIM613079	#	18q12-q21	DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77	125336
MIM613080	#	17q25	46,XY SEX REVERSAL 5; SRXY5	84733
MIM613081	*	6p22.3	LYSINE-SPECIFIC DEMETHYLASE 1B; KDM1B	221656
MIM613082	*	16q24.1	ATPase, Ca(2+)-TRANSPORTING, TYPE 2C, MEMBER 2; ATP2C2	9914
MIM613083	*	21q22.11	LISTERIN E3 UBIQUITIN PROTEIN LIGASE 1; LTN1	26046
MIM613084	*	2p24	MYELIN TRANSCRIPTION FACTOR 1-LIKE; MYT1L	23040
MIM613085	%	14q24.3	GLAUCOMA 3, PRIMARY CONGENITAL, C; GLC3C	399565
MIM613086	#	14q24	GLAUCOMA 3, PRIMARY CONGENITAL, D; GLC3D	4053
MIM613087	#	4q32-q33	ATRIAL SEPTAL DEFECT 6; ASD6	7092
MIM613088	%	9q21	PELVIC ORGAN PROLAPSE, SUSCEPTIBILITY TO, 2	100312955
MIM613090	#	1p36	BARTTER SYNDROME, TYPE 4B	1187, 1188
MIM613091	#	11q13.5	ASPHYXIATING THORACIC DYSTROPHY 3; ATD3	79659
MIM613092	#	1q32	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 2; HNFJ2	5972
MIM613093	#	10q24	CONE DYSTROPHY 4; COD4	5146
MIM613094	#	8q22.1	MICROPHTHALMIA, ISOLATED 4; MCOP4	392255
MIM613095	#	4q21-q23	POLYCYSTIC KIDNEY DISEASE 2; PKD2	5311
MIM613096	%	12q23-q24	SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36	791228
MIM613097	#	11q12	TOOTH AGENESIS, SELECTIVE, 6; STHAG6	4054
MIM613098	#	16q24.3	INCREASED ANALGESIA FROM KAPPA-OPIOID RECEPTOR AGONIST, FEMALE-SPECIFIC	4157
MIM613099	#	16q24.3	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 5; CMM5	4157
MIM613100	#	19q13.3	GLAUCOMA 1, OPEN ANGLE, O; GLC1O	4909
MIM613101	#	 	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL5	6813
MIM613102	#	18q12.1	HYPOTRICHOSIS AND RECURRENT SKIN VESICLES	1825
MIM613103	*	12q24.23	SERINE/ARGININE REPETITIVE MATRIX PROTEIN 4; SRRM4	84530
MIM613104	*	9q34.2	CHROMOSOME 9 OPEN READING FRAME 7; C9ORF7	11094
MIM613105	#	6p21.1-cen	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2; CACD2	5961
MIM613106	%	22q12	VERTIGO, BENIGN RECURRENT, 2; BRV2	100313948
MIM613107	#	1p22	NEUTROPENIA, SEVERE CONGENITAL, 2, AUTOSOMAL DOMINANT; SCN2	2672
MIM613108	#	12p13.2-p12.3	CANDIDIASIS, FAMILIAL, 4; CANDF4	64581
MIM613109	*	5q31.3-q33.1	GM2 ACTIVATOR; GM2A	2760
MIM613110	*	20q11.2-q12	BLADDER CANCER-ASSOCIATED PROTEIN; BLCAP	10904
MIM613111	*	20q13.1	CATHEPSIN A; CTSA	5476
MIM613112	#	20q13.3	MACROTHROMBOCYTOPENIA, AUTOSOMAL DOMINANT, TUBB1-RELATED	81027
MIM613113	*	17q11.2	NEUROFIBROMIN 1; NF1	4763
MIM613114	*	5p15.1	FAMILY WITH SEQUENCE SIMILARITY 134, MEMBER B; FAM134B	54463
MIM613115	#	5p15.1	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B	54463
MIM613116	#	3q27	THROMBOPHILIA DUE TO HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY; THPH11	3273
MIM613117	*	6q15	SMALL NUCLEOLAR RNA, C/D BOX, 50A; SNORD50A	26799
MIM613118	#	1q23-q25	ANTITHROMBIN III DEFICIENCY; AT3D	462
MIM613119	#	11q13-q14	BRUGADA SYNDROME 6; BRGDA6	10008
MIM613120	#	11q23.3	BRUGADA SYNDROME 7; BRGDA7	55800
MIM613121	*	1p32-p31	NEXILIN, RAT, HOMOLOG OF; NEXN	91624
MIM613122	#	1p32-p31	CARDIOMYOPATHY, DILATED, 1CC; CMD1CC	91624
MIM613123	#	15q24-q25	BRUGADA SYNDROME 8; BRGDA8	10021
MIM613125	*	11p15.3	NUCLEAR RECEPTOR-INTERACTING PROTEIN 3; NRIP3	56675
MIM613126	*	1p13.1	PROLINE/SERINE-RICH COILED-COIL PROTEIN 1; PSRC1	84722
MIM613127	*	11q13.4	CHORDIN-LIKE 2; CHRDL2	25884
MIM613128	*	10q24.33	OLIGONUCLEOTIDE/OLIGOSACCHARIDE-BINDING FOLD-CONTAINING PROTEIN 1; OBFC1	79991
MIM613129	*	17p13.1	CONSERVED TELOMERE MAINTENANCE COMPONENT 1; CTC1	80169
MIM613130	*	17q25.1	CHROMOSOME 17 OPEN READING FRAME 106; C17ORF106	100134934
MIM613131	*	5q11.2	MICRO RNA 449A; MIR449A	554213
MIM613132	*	5q11.2	MICRO RNA 449B; MIR449B	693123
MIM613133	*	1p13.2	TETRASPANIN 2; TSPAN2	10100
MIM613134	*	15q24.3	TETRASPANIN 3; TSPAN3	10099
MIM613135	#	5p15.3	PARKINSONISM-DYSTONIA, INFANTILE; PKDYS	6531
MIM613136	*	4q23	TETRASPANIN 5; TSPAN5	10098
MIM613137	*	12p13.32	TETRASPANIN 9; TSPAN9	10867
MIM613138	*	7q31	TETRASPANIN 12; TSPAN12	23554
MIM613139	*	7p21.1	TETRASPANIN 13; TSPAN13	27075
MIM613140	*	10q22.1	TETRASPANIN 15; TSPAN15	23555
MIM613141	*	7q11.23	DELTEX, DROSOPHILA, HOMOLOG OF, 2; DTX2	113878
MIM613142	*	12q13.3	DELTEX, DROSOPHILA, HOMOLOG OF, 3; DTX3	196403
MIM613143	*	3q21	DTX3-LIKE; DTX3L	151636
MIM613144	%	 	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 3; CACD3	100653393
MIM613145	%	1q21-q23	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 14; SLEB14	100322878
MIM613146	*	15q25.1	MICRO RNA 184; MIR184	406960
MIM613147	*	1q32.2	MICRO RNA 205; MIR205	406988
MIM613148	#	11q23.3	INFLAMMATORY BOWEL DISEASE 28, AUTOSOMAL RECESSIVE; IBD28	3587
MIM613149	*	9p21	CDKN2B ANTISENSE RNA; CDKN2BAS	100048912
MIM613150	#	14q24.3	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2; MDDGA2	29954
MIM613151	#	1p34-p33	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 3; MDDGB3	55624
MIM613152	#	9q31	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4; MDDGB4	2218
MIM613153	#	19q13.3	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	79147
MIM613154	#	22q12.3-q13.1	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6; MDDGA6	9215
MIM613155	#	9q34.1	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	10585
MIM613156	#	14q24.3	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2; MDDGB2	29954
MIM613157	#	1p34-p33	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3; MDDGC3	55624
MIM613158	#	14q24.3	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2; MDDGC2	29954
MIM613159	#	22q13.31-q13.33	NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1; NPHPL1	63929
MIM613160	*	12p13.3	VON WILLEBRAND FACTOR; VWF	7450
MIM613161	#	22q11.2	BETA-UREIDOPROPIONASE DEFICIENCY	51733
MIM613162	#	10q24.3-q25.1	SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45	100322879
MIM613163	#	16p13.3	GABA-TRANSAMINASE DEFICIENCY	18
MIM613164	%	1q32	PARKINSON DISEASE 16; PARK16	100359403
MIM613165	*	17q25.3	CALCIUM-ACTIVATED NUCLEOTIDASE 1; CANT1	124583
MIM613166	*	4q31.23	DOUBLECORTIN-LIKE KINASE 2; DCLK2	166614
MIM613167	*	3p22.3	DOUBLECORTIN-LIKE KINASE 3; DCLK3	85443
MIM613168	*	17pter-p12	SERPIN PEPTIDASE INHIBITOR, CLADE F, MEMBER 2; SERPINF2	5345
MIM613169	*	3p21.31	KELCH DOMAIN-CONTAINING PROTEIN 8B; KLHDC8B	200942
MIM613170	*	1p34.1	TETRASPANIN 1; TSPAN1	10103
MIM613171	*	10q25.2	RNA-BINDING MOTIF PROTEIN 20; RBM20	282996
MIM613172	#	10q25.2	CARDIOMYOPATHY, DILATED, 1DD; CMD1DD	282996
MIM613173	*	1p31.1	NEURONAL GROWTH REGULATOR 1; NEGR1	257194
MIM613174	#	5p13	CHROMOSOME 5p13 DUPLICATION SYNDROME	100379202
MIM613175	*	17q22	CHROMOSOME 17 OPEN READING FRAME 71; C17ORF71	55181
MIM613176	*	19q13.31	CHROMOSOME 19 OPEN READING FRAME 61; C19ORF61	56006
MIM613177	#	19q13.1-q13.2	CUTIS LAXA WITH SEVERE PULMONARY, GASTROINTESTINAL, AND URINARY ABNORMALITIES	8425
MIM613178	*	18q21.1	KIAA0427 GENE; KIAA0427	9811
MIM613179	#	14q13.1	PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	4860
MIM613180	#	22q11	POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	51807
MIM613181	*	1q21.2	BolA, E. COLI, HOMOLOG OF, 1; BOLA1	51027
MIM613182	*	16p11.2	BolA, E. COLI, HOMOLOG OF, 2; BOLA2	552900
MIM613183	*	2p13.1	BolA, E. COLI, HOMOLOG OF, 3; BOLA3	388962
MIM613184	*	11p15.4	TRIPARTITE MOTIF-CONTAINING PROTEIN 68; TRIM68	55128
MIM613185	*	Chr.4	MICRO RNA 95; MIR95	407052
MIM613186	*	11q24.1	MICRO RNA 100; MIR100	406892
MIM613187	*	5q34	MICRO RNA 103-1; MIR103-1	406895
MIM613188	*	20p13	MICRO RNA 103-2; MIR103-2	406896
MIM613189	*	10q23.31	MICRO RNA 107; MIR107	406901
MIM613190	*	16q24.1	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 50; LRRC50	123872
MIM613191	*	10q22.2	DUAL-SPECIFICITY PHOSPHATASE 13; DUSP13	51207
MIM613192	#	8q24.3	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	83696
MIM613193	#	16q24.1	CILIARY DYSKINESIA, PRIMARY, 13; CILD13	123872
MIM613194	#	11q13	RETINITIS PIGMENTOSA 50; RP50	7439
MIM613195	#	15q24	WEILL-MARCHESANI-LIKE SYNDROME	170691
MIM613196	*	2p15-p13	EWING TUMOR-ASSOCIATED ANTIGEN 1; ETAA1	54465
MIM613197	*	12q24.13	TRAF-TYPE ZINC FINGER DOMAIN-CONTAINING 1; TRAFD1	10906
MIM613198	*	19q13.42	SUPPRESSOR OF VARIEGATION 4-20, DROSOPHILA, HOMOLOG OF, 2; SUV420H2	84787
MIM613199	*	16p13.1-p12	TAO KINASE 2; TAOK2	9344
MIM613200	*	 	PDS5, REGULATOR OF COHESION MAINTENANCE, S. CEREVISIAE, HOMOLOG OF, A; PDS5A	23244
MIM613201	*	16.13.3	CHROMOSOME TRANSMISSION FIDELITY FACTOR 18, S. CEREVISIAE, HOMOLOG OF; CHTF18	63922
MIM613202	*	 	CHROMOSOME TRANSMISSION FIDELITY FACTOR 8, S. CEREVISIAE, HOMOLOG OF; CHTF8	54921
MIM613203	*	8q24.12	DEFECTIVE IN SISTER CHROMATID COHESION 1, S. CEREVISIAE, HOMOLOG OF; DSCC1	79075
MIM613204	#	12q13	MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	3679
MIM613205	#	 	MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED	4000
MIM613206	#	1q41-q42	SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	57165
MIM613207	%	9q33	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 8; ASRT8	100415896
MIM613208	*	3p25	XPC GENE	7508
MIM613209	*	6q25.3	TRANSMEMBRANE PROTEIN 181; TMEM181	57583
MIM613210	*	9q34.3	WD REPEAT-CONTAINING PROTEIN 85; WDR85	92715
MIM613211	#	15q21.3	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA3; AI2A3	256764
MIM613212	*	17q21.31	ALANYL-tRNA SYNTHETASE DOMAIN-CONTAINING 1; AARSD1	80755
MIM613213	*	22q13.31-qter	CYTOCHROME b5 REDUCTASE 3; CYB5R3	1727
MIM613214	*	15q21.3	WD REPEAT-CONTAINING PROTEIN 72; WDR72	256764
MIM613215	#	17p13.3	CHROMOSOME 17p13.3 DUPLICATION SYNDROME	100379203
MIM613216	#	15q13-q14	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C	4308
MIM613217	#	2p21	DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL; DIAR5	4072
MIM613218	*	18q23	CYTOCHROME b5, TYPE A (MICROSOMAL); CYB5A	1528
MIM613219	%	7p15-p13	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 2; FGQTL2	100379216
MIM613220	*	2p25.3	TRANSMEMBRANE PROTEIN 18; TMEM18	129787
MIM613221	*	11q12.1	MITOCHONDRIAL CARRIER HOMOLOG 2; MTCH2	23788
MIM613222	*	4p13	GLUCOSAMINE-6-PHOSPHATE DEAMINASE 2; GNPDA2	132789
MIM613223	#	4p14	LEPROSY, SUSCEPTIBILITY TO, 5; LPRS5	7096
MIM613224	#	1p13.2	NOONAN SYNDROME 6; NS6	4893
MIM613225	#	6p25-p24	FACTOR XIII, A SUBUNIT, DEFICIENCY OF	2162
MIM613226	*	19q13.32	ZINC FINGER PROTEIN 296; ZNF296	162979
MIM613227	#	8q11-q12	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 3; CAMRQ3	767
MIM613228	*	4q32-q33	ASPARTYLGLUCOSAMINIDASE; AGA	175
MIM613229	#	13q31	TRICHOTILLOMANIA; TTM	114798
MIM613230	*	19cen-q13.11	PEPTIDASE D; PEPD	5184
MIM613231	*	14q32.33	KINESIN FAMILY MEMBER 26A; KIF26A	26153
MIM613232	*	19q13.12	RNA-BINDING MOTIF PROTEIN 42; RBM42	79171
MIM613233	%	11q21-q22	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 3; FGQTL3	100379217
MIM613234	*	3q26.3	NEUTRAL CHOLESTEROL ESTER HYDROLASE 1; NCEH1	57552
MIM613235	#	1q31-q32.1	FACTOR XIII, B SUBUNIT, DEFICIENCY OF	2165
MIM613236	*	17p11.2	POTASSIUM CHANNEL, INWARDLY RECTIFYING, SUBFAMILY J, MEMBER 18; KCNJ18	100134444
MIM613237	#	14q32.33	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5; FSGS5	64423
MIM613238	%	2q36.1-q36.3	SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 3; SPDA3	100379218
MIM613239	#	17p11.2	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2	100134444
MIM613240	*	2q32.1	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 1C; PPP1R1C	151242
MIM613242	*	6q24.3-q25.3	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 14C; PPP1R14C	81706
MIM613243	#	3p21.3-p14.3	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13; CMH13	7134
MIM613244	#	2p21	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 8; HNPCC8	4072
MIM613245	*	19q13.3-q13.4	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 12C; PPP1R12C	54776
MIM613246	*	12q13.2	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 1A; PPP1R1A	5502
MIM613247	*	19p13.3	PERILIPIN 4; PLIN4	729359
MIM613248	*	19p13.3	PERILIPIN 5; PLIN5	440503
MIM613249	*	10p12.3	ENDOGENOUS BORNA-LIKE N ELEMENT-CONTAINING PROTEIN 1; EBLN1	340900
MIM613250	*	3p14-p13	ENDOGENOUS BORNA-LIKE N ELEMENT-CONTAINING PROTEIN 2; EBLN2	55096
MIM613251	#	14q12	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 14; CMH14	4624
MIM613252	#	14q12	CARDIOMYOPATHY, DILATED, 1EE; CMD1EE	4624
MIM613254	#	12q14	TUBEROUS SCLEROSIS 2; TSC2	3458
MIM613255	#	10q22.1-q23	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15; CMH15	7414
MIM613256	*	15q15.1	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 14D; PPP1R14D	54866
MIM613257	*	1q32.1	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 15B; PPP1R15B	84919
MIM613258	*	18q21.	CHROMOSOME 18 OPEN READING FRAME 54; C18ORF54	162681
MIM613259	*	1q21	REPETIN; RPTN	126638
MIM613260	*	1q21	KERATINOCYTE PROLINE-RICH PROTEIN; KPRP	448834
MIM613261	*	15q21.3	PROTOGENIN, CHICKEN, HOMOLOG OF; PRTG	283659
MIM613262	*	15q21.3	RIBOSOMAL PROTEIN L24 DOMAIN-CONTAINING PROTEIN 1; RSL24D1	51187
MIM613263	*	6q15	SMALL NUCLEOLAR RNA HOST GENE 5; SNHG5	387066
MIM613264	*	6q15	SMALL NUCLEOLAR RNA, C/D BOX; SNORD50B	692088
MIM613265	#	20q13.2-q13.3	WAARDENBURG SYNDROME, TYPE 4B; WS4B	1908
MIM613266	#	22q13	WAARDENBURG SYNDROME, TYPE 4C; WS4C	6663
MIM613267	%	18q21.2-q21.3	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3; FECD3	100380873
MIM613268	#	20p13-p12	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4; FECD4	83959
MIM613269	%	5q33.1-q35.2	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 5; FECD5	100380874
MIM613270	#	10p11.2	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6; FECD6	6935
MIM613271	%	9p24.1-p22.1	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 7; FECD7	100380875
MIM613272	*	1q41	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 3; KCTD3	51133
MIM613273	*	9q32	CHROMOSOME 9 OPEN READING FRAME 80; C9ORF80	58493
MIM613274	*	18q12.2	MOLYBDENUM COFACTOR SULFURASE; MOCOS	55034
MIM613275	*	20q11.22-q12	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 16B; PPP1R16B	26051
MIM613276	*	16q13	CHROMOSOME 16 OPEN READING FRAME 57; C16ORF57	79650
MIM613277	*	11q13	TRANSMEMBRANE PROTEIN 216; TMEM216	51259
MIM613278	*	16p13.3	SLX4, S. CEREVISIAE, HOMOLOG OF; SLX4	84464
MIM613279	*	14q31.3	ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 14: ZC3H14	79882
MIM613280	#	 	HYPERMANGANESEMIA WITH DYSTONIA, POLYCYTHEMIA, AND CIRRHOSIS; HMDPC	55532
MIM613281	*	16q12.1	SORTING NEXIN 20; SNX20	124460
MIM613282	%	22q13	FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1; NAFLD1	100380876
MIM613283	*	4p13	GLUTAREDOXIN, CYSTEINE-RICH, 1; GRXCR1	389207
MIM613284	%	22q12-q13	HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3; HCHGQ3	100381206
MIM613285	#	4p13	DEAFNESS, AUTOSOMAL RECESSIVE 25; DFNB25	389207
MIM613286	#	19q13.4	CARDIOMYOPATHY, DILATED, 1FF; CMD1FF	7137
MIM613287	#	16q22	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N; CMT2N	16
MIM613288	*	16p11.2	TRIPARTITE MOTIF-CONTAINING PROTEIN 72; TRIM72	493829
MIM613289	*	13q21	ATAXIN 8; ATXN8	724066
MIM613290	%	6p22.3	HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO; CIHL	100381207
MIM613291	#	13q33	BILE ACID MALABSORPTION, PRIMARY; PBAM	6555
MIM613292	*	1q31.3	DENN/MADD DOMAIN-CONTAINING PROTEIN 1B; DENND1B	163486
MIM613293	*	5q35.1	SH3 AND PX DOMAINS-CONTAINING PROTEIN 2B; SH3PXD2B	285590
MIM613294	*	19q13.32	SUMO1-ACTIVATING ENZYME, SUBUNIT 1; SAE1	10055
MIM613295	*	19q12	UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 2; UBA2	10054
MIM613296	*	8q22.1	LYSOSOME-ASSOCIATED PROTEIN, TRANSMEMBRANE 4, BETA; LAPTM4B	55353
MIM613297	*	5p15.2	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 6; MARCH6	10299
MIM613298	*	15q26.1	CHROMOSOME 15 OPEN READING FRAME 42; C15ORF42	90381
MIM613299	*	4q22.1	FAMILY WITH SEQUENCE SIMILARITY 13, MEMBER A; FAM13A	10144
MIM613300	*	4q22.1	FAM13A OPPOSITE STRAND; FAM13AOS	285512
MIM613301	*	7q31.32	FEZ FAMILY ZINC FINGER PROTEIN 1; FEZF1	389549
MIM613302	*	7q22.1	AlkB, E. COLI, HOMOLOG OF, 4; ALKBH4	54784
MIM613303	*	17p11.2	AlkB, E. COLI, HOMOLOG OF, 5; ALKBH5	54890
MIM613304	*	19q13.12	AlkB, E. COLI, HOMOLOG OF, 6; ALKBH6	84964
MIM613305	*	19p13.3	AlkB, E. COLI, HOMOLOG OF, 7; ALKBH7	84266
MIM613306	*	11q22.3	AlkB, E. COLI, HOMOLOG OF, 8; ALKBH8	91801
MIM613307	#	9q34.3, 9q34.3	DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	286262
MIM613308	#	6p	DIAMOND-BLACKFAN ANEMIA 9; DBA9	6204
MIM613309	#	12q	DIAMOND-BLACKFAN ANEMIA 10; DBA10	6231
MIM613310	#	7q31	EXUDATIVE VITREORETINOPATHY 5; EVR5	23554
MIM613311	*	6p25.1	LYR MOTIF-CONTAINING PROTEIN 4; LYRM4	57128
MIM613312	#	6q22-q23	HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2	5167
MIM613313	#	19q13	HEMOCHROMATOSIS, TYPE 2B; HFE2B	57817
MIM613314	*	2q35	RIBOSOMAL PROTEIN L37A; RPL37A	6168
MIM613315	*	12q13.2	RIBOSOMAL PROTEIN L41; RPL41	6171
MIM613316	*	10q11.22-q11.23	WD REPEAT- AND FYVE DOMAIN-CONTAINING PROTEIN 4; WDFY4	57705
MIM613317	*	14q11.2	DDB1- AND CUL4-ASSOCIATED FACTOR 11; DCAF11	80344
MIM613318	%	8q22.3	MIYOSHI MUSCULAR DYSTROPHY 2; MMD2	100505381
MIM613319	#	11p14.3	MIYOSHI MUSCULAR DYSTROPHY 3; MMD3	203859
MIM613321	*	12q12	GLUCOSIDE XYLOSYLTRANSFERASE 1; GXYLT1	283464
MIM613322	*	3p13	GLUCOSIDE XYLOSYLTRANSFERASE 2; GXYLT2	727936
MIM613323	*	10q11.22	FERM AND PDZ DOMAINS-CONTAINING PROTEIN 2; FRMPD2	143162
MIM613324	*	13q12.12	SPERMATOGENESIS-ASSOCIATED PROTEIN 13; SPATA13	221178
MIM613325	#	19p13.2	RHABDOID TUMOR PREDISPOSITION SYNDROME 2; RTPS2	6597
MIM613326	*	8q22	DIHYDROPYRIMIDINASE; DPYS	1807
MIM613327	#	17q21	LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	284119
MIM613328		15q11-q21.1	ROIFMAN-CHITAYAT SYNDROME	100462676
MIM613329	#	7q21.3-q22	PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY	5054
MIM613330	#	4p16.1	SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	579
MIM613331	*	4q32.2-q32.3	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 1; MARCH1	55016
MIM613332	*	19p13.2	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 2; MARCH2	51257
MIM613333	*	5q23.2	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 3; MARCH3	115123
MIM613334	*	2q24.2	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 7; MARCH7	64844
MIM613335	*	10q11.21	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 8; MARCH8	220972
MIM613336	*	12q14.1	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 9; MARCH9	92979
MIM613337	*	17q23.2	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 10; MARCH10	162333
MIM613338	*	5p15.1	MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 11; MARCH11	441061
MIM613339	%	10q21.3-q22.3	EPILEPSY, HOT WATER, 1; HWE1	100415903
MIM613340	%	4q24-q28	EPILEPSY, HOT WATER, 2; HWE2	100415904
MIM613341	#	4q31	LEBER CONGENITAL AMAUROSIS 14; LCA14	9227
MIM613344	*	7q34	KIAA1549 GENE; KIAA1549	57670
MIM613345	#	17q23.1-q25.3	HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2	6329
MIM613346	*	16p13.12	SHISA, XENOPUS, HOMOLOG OF, 9; SHISA9	729993
MIM613347	#	13q12.3	PANCREATIC CANCER, SUSCEPTIBILITY TO, 2	675
MIM613348	#	16p12	PANCREATIC CANCER, SUSCEPTIBILITY TO, 3	79728
MIM613349	*	10q26	ORNITHINE AMINOTRANSFERASE; OAT	4942
MIM613350	*	20p13	SOLUTE CARRIER FAMILY 52 (RIBOFLAVIN TRANSPORTER), MEMBER 3; SLC52A3	113278
MIM613351	*	6q22-q24	RHO GTPase-ACTIVATING PROTEIN 18; ARHGAP18	93663
MIM613352	*	3q25.32	ARGININE/SERINE-RICH COILED-COIL PROTEIN 1; RSRC1	51319
MIM613353	#	5q32	MONONEUROPATHY OF THE MEDIAN NERVE, MILD; MNMN	79628
MIM613354	*	9q34.3	TAPERIN; TPRN	286262
MIM613355	#	17q23.1-q23.2	CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	100415941
MIM613356	*	7p14.3	TLR4 INTERACTOR WITH LEUCINE-RICH REPEATS	9865
MIM613357	*	9q34.1	FIBRINOGEN C DOMAIN-CONTAINING PROTEIN 1; FIBCD1	84929
MIM613358	*	19q13.33	ALDEHYDE DEHYDROGENASE 16 FAMILY, MEMBER A1; ALDH16A1	126133
MIM613359	*	2q23.1-q23.2	LY6/PLAUR DOMAIN-CONTAINING PROTEIN 6; LYPD6	130574
MIM613360	*	1p13.3	DAMAGE-REGULATED AUTOPHAGY MODULATOR 2; DRAM2	128338
MIM613361	*	6q22.3	CHROMOSOME 6 OPEN READING FRAME 192; C6ORF192	116843
MIM613362	*	14q32.31	CDK2-INTERACTING PROTEIN; CINP	51550
MIM613363	*	9q34.11	WD REPEAT-CONTAINING PROTEIN 34; WDR34	89891
MIM613364	%	11p14.1-p11.2	SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT; SPG41	100359402
MIM613365	*	5q21.1	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 6A1; SLCO6A1	133482
MIM613366	*	4q21.3	SOLUTE CARRIER FAMILY 10 (SODIUM/BILE ACID COTRANSPORTER FAMILY), MEMBER 6; SLC10A6	345274
MIM613367	*	4q21.22	LIN54, C. ELEGANS, HOMOLOG OF; LIN54	132660
MIM613368	*	11q13	CARNOSINE SYNTHASE 1; CARNS1	57571
MIM613369	*	17q23.3	DEAD BOX POLYPEPTIDE 42; DDX42	11325
MIM613370	#	11p15.5	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10; MODY10	3630
MIM613371	%	4q34.3-q35.1	SPINOCEREBELLAR ATAXIA 30; SCA30	100359393
MIM613372	*	6q16.1	KIAA0776 GENE; KIAA0776	23376
MIM613373	*	3q27.1	YEATS DOMAIN-CONTAINING PROTEIN 2; YEATS2	55689
MIM613374	*	16p11.2	COILED-COIL DOMAIN-CONTAINING PROTEIN 101; CCDC101	112869
MIM613375	#	8p23-p22	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11; MODY11	640
MIM613376	#	5q11.2	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC; HMN2C	8988
MIM613377	*	5q32	SH3 DOMAIN-CONTAINING RING FINGER PROTEIN 2; SH3RF2	153769
MIM613378	*	13q32.3	AIG2-LIKE DOMAIN-CONTAINING PROTEIN 1; A2LD1	87769
MIM613379	*	5p15.2	CARBOXYMETHYLENEBUTENOLIDASE-LIKE PROTEIN; CMBL	134147
MIM613380	*	10q26.13	H6 FAMILY HOMEOBOX 3; HMX3	340784
MIM613381	*	21q22.3	CYSTATHIONINE BETA-SYNTHASE; CBS	875
MIM613382	#	12p12.1-p11.2	BRACHYDACTYLY, TYPE E2; BDE2	5744
MIM613383	*	22q13.1	ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 54; ANKRD54	129138
MIM613384	*	3q25.31	CYCLIN L1; CCNL1	57018
MIM613385	#	20q11.22-q11.23	AUTOIMMUNE DISEASE, SYNDROMIC MULTISYSTEM	83737
MIM613386	*	13q12.3	PROTEASOME MATURATION PROTEIN; POMP	51371
MIM613387	%	11q23	FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2; NAFLD2	100462725
MIM613388	#	5q35	FANCONI RENOTUBULAR SYNDROME 2; FRTS2	6569
MIM613389	*	12p12	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 1C1; SLCO1C1	53919
MIM613390	#	17q22	FANCONI ANEMIA, COMPLEMENTATION GROUP O; FANCO	5889
MIM613391	#	12q21.2	DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	374462
MIM613392	%	17p12-q11.2	DEAFNESS, AUTOSOMAL RECESSIVE 85; DFNB85	100359399
MIM613393	#	2p13	BIRBECK GRANULE DEFICIENCY	50489
MIM613394	*	3p21.32	MICRO RNA 138-1; MIR138-1	406929
MIM613395	*	16q13	MICRO RNA 138-2; MIR138-2	406930
MIM613396	*	21q22.2	DOWN SYNDROME CRITICAL REGION GENE 8; DSCR8	84677
MIM613397	*	12q14	ADVILLIN; AVIL	10677
MIM613398	#	12p11	WARSAW BREAKAGE SYNDROME	1663
MIM613399	#	17q22	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3; BROVCA3	5889
MIM613400	*	2p25.3	ACIREDUCTONE DIOXYGENASE 1; ADI1	55256
MIM613401	*	14q24.3	VPS33B-INTERACTING PROTEIN, APICAL-BASOLATERAL POLARITY REGULATOR; VIPAR	63894
MIM613402	#	19q13.4	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 10; EIEE10	11284
MIM613403	*	2q11	TRANSMEMBRANE PROTEIN 127; TMEM127	55654
MIM613404	#	14q24.3	ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2; ARCS2	63894
MIM613405	*	9q34.11	MICRO RNA 2861; MIR2861	100422910
MIM613406	#	15q24	CHROMOSOME 15q24 DELETION SYNDROME	100502567
MIM613407	%	13q14.11	LEPROSY, SUSCEPTIBILITY TO, 6; LPRS6	100499166
MIM613408	*	13q14.11	COILED-COIL DOMAIN-CONTAINING PROTEIN 122; CCDC122	160857
MIM613409	*	13q14.11	CHROMOSOME 13 OPEN READING FRAME 31; C13ORF31	144811
MIM613410	#	3q24	AUTISM, SUSCEPTIBILITY TO, 16; AUTS16	285195
MIM613411	#	13q34	OGUCHI DISEASE 2	6011
MIM613412	%	5q22	ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	100499167
MIM613413	*	7p21.3	TRANSMEMBRANE PROTEIN 106B; TMEM106B	54664
MIM613414	*	 	INTERLEUKIN 17 RECEPTOR E-LIKE; IL17REL	400935
MIM613415	*	15q15	CREATINE KINASE, MITOCHONDRIAL 1A; CKMT1A	548596
MIM613416	*	7p21.3	SCINDERIN; SCIN	85477
MIM613417	*	13q13.3	FAMILY WITH SEQUENCE SIMILARITY 48, MEMBER A; FAM48A	55578
MIM613418	#	9q34.11	BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15; BMND15	100422910
MIM613419	*	19q13.43	ZINC FINGER- AND SCAN DOMAIN-CONTAINING PROTEIN 4; ZSCAN4	201516
MIM613420	*	18q11.2	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING 1; KCTD1	284252
MIM613421	*	12q24.11	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING 10; KCTD10	83892
MIM613422	*	17q25.1	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING 2; KCTD2	23510
MIM613423	*	5q31.3	POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING 16; KCTD16	57528
MIM613424	#	15q14	CARDIOMYOPATHY, DILATED, 1R; CMD1R	70
MIM613425	*	2p24.1-p23.1	CHROMOSOME 2 OPEN READING FRAME 71; C2ORF71	388939
MIM613426	#	14q12	CARDIOMYOPATHY, DILATED, 1S; CMD1S	4625
MIM613427	*	10q22.1	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 16; ANAPC16	119504
MIM613428	#	2p24.1-p23.1	RETINITIS PIGMENTOSA 54; RP54	388939
MIM613429	*	15q15.2	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 2; HAUS2	55142
MIM613430	*	4p16.3	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 3; HAUS3	79441
MIM613431	*	14q11.2	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 4; HAUS4	54930
MIM613432	*	19q13.12	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 5; HAUS5	23354
MIM613433	*	9p22.1	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 6; HAUS6	54801
MIM613434	*	19p13.11	HAUS AUGMIN-LIKE COMPLEX, SUBUNIT 8; HAUS8	93323
MIM613435	#	10p15-p14	AMYOTROPHIC LATERAL SCLEROSIS 12; ALS12	10133
MIM613436	#	11q13.3-q13.4	AUTISM, SUSCEPTIBILITY TO, 17; AUTS17	22941
MIM613437	*	19p13.11	FCH DOMAIN ONLY PROTEIN 1; FCHO1	23149
MIM613438	*	5q13.2	FCH DOMAIN ONLY PROTEIN 2; FCHO2	115548
MIM613439	*	1q44	CONSORTIN; CNST	163882
MIM613440	%	2q37.1	STATURE QUANTITATIVE TRAIT LOCUS 21; STQTL21	100502568
MIM613441	*	22q11.2-qter	TRANSCOBALAMIN II; TCN2	6948
MIM613442	*	16p13.3	PENTRAXIN 4, LONG; PTX4	390667
MIM613443	#	5q14	MENTAL RETARDATION, STEREOTYPIC MOVEMENTS, EPILEPSY, AND/OR CEREBRAL MALFORMATIONS	4208
MIM613444	#	 	CHROMOSOME 16p11.2 DELETION SYNDROME, 220-KB	100859928
MIM613445	^	7p13-p12	MYOSIN IG; MYO1G	64005
MIM613446	*	5q23.2	CENTROSOMAL PROTEIN, 120-KD; CEP120	153241
MIM613447	*	3q13.2	SPINDLE- AND CENTRIOLE-ASSOCIATED PROTEIN 1; SPICE1	152185
MIM613448	*	13q21.33-q22.1	CHROMOSOME 13 OPEN READING FRAME 37; C13ORF37	440145
MIM613449	*	2q21.1	FAMILY WITH SEQUENCE SIMILARITY 128, MEMBER A; FAM128A	653784
MIM613450	*	2q21.1	FAMILY WITH SEQUENCE SIMILARITY 128, MEMBER B; FAM128B	80097
MIM613451	#	11p11.2	FRONTONASAL DYSPLASIA 2; FND2	60529
MIM613452	*	19q13.1	CATION CHANNEL, SPERM-ASSOCIATED, GAMMA; CATSPERG	57828
MIM613453	#	6p25	DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91	5269
MIM613454	#	14q13	RETT SYNDROME, CONGENITAL VARIANT	2290
MIM613455	*	1q42	MELANOMA INHIBITORY ACTIVITY FAMILY, MEMBER 3; MIA3	375056
MIM613456	#	12q21.3-q22	FRONTONASAL DYSPLASIA 3; FND3	8092
MIM613457	#	14q11-q22	CHROMOSOME 14q11-q22 DELETION SYNDROME	100505392
MIM613458	#	16p13.3	CHROMOSOME 16p13.3 DUPLICATION SYNDROME	100505393
MIM613459	%	3q25.3	BIRTH WEIGHT QUANTITATIVE TRAIT LOCUS 2; BWQTL2	100502569
MIM613460	%	3q21	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 6; FGQTL6	100499168
MIM613461	*	1p31	LEPTIN RECEPTOR OVERLAPPING TRANSCRIPT; LEPROT	54741
MIM613462	%	7p21.2	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 4; FGQTL4	100499169
MIM613463	#	2p23.3-p23.2, 2p23.3-p23.2	FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 5; FGQTL5	2646
MIM613464	#	14q32.1	RETINITIS PIGMENTOSA 51; RP51	123016
MIM613465	*	1q24	NONMETASTATIC CELLS 7, PROTEIN EXPRESSED IN; NME7	29922
MIM613466	*	1q23.3	PREFOLDIN 2; PFDN2	5202
MIM613468	*	8p22-p21.3	N-ACYLSPHINGOSINE AMIDOHYDROLASE 1; ASAH1	427
MIM613470	#	19q13.1	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY	2821
MIM613471	#	1q42.1	REYNOLDS SYNDROME	3930
MIM613472	*	15q24.1	UNC51-LIKE KINASE 3; ULK3	25989
MIM613473	*	18q21.3	WD REPEAT-CONTAINING PROTEIN 7; WDR7	23335
MIM613474	*	2q35	ZINC FINGER AN1 DOMAIN-CONTAINING PROTEIN 2B; ZFAND2B	130617
MIM613475	*	6p21.1	RIBOSOMAL RNA-PROCESSING FACTOR, 36-KD, S. CEREVISIAE, HOMOLOG OF; RRP36	88745
MIM613476	*	2q32.2	MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 6; MFSD6	54842
MIM613477	#	9q33-q34	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5; EIEE5	6709, 6812, 9863
MIM613478	*	19q13.42	COILED-COIL DOMAIN-CONTAINING PROTEIN 106; CCDC106	29903
MIM613479	*	17q25.3	5-@AZACYTIDINE-INDUCED GENE 1, MOUSE, HOMOLOG OF; AZI1	22994
MIM613480	#	1q41-q42	LYMPHEDEMA, HEREDITARY, IC	57165
MIM613481	*	12q24.31	COILED-COIL DOMAIN-CONTAINING PROTEIN 62: CCDC62	84660
MIM613482	*	1p36.33	CYCLIN L2; CCNL2	81669
MIM613483	*	8q13	BASIC HELIX-LOOP-HELIX FAMILY, MEMBER E22; BHLHE22	27319
MIM613484	*	1p36.13	SPEN, DROSOPHILA, HOMOLOG OF; SPEN	23013
MIM613485	#	11q24	LONG QT SYNDROME 13; LQT13	3762
MIM613486	*	17p11.2	MICRO RNA 33B; MIR33B	693120
MIM613487	*	17p13.3	MICRO RNA 212; MIR212	406994
MIM613488	#	12q13.1-q13.2	MYXOID LIPOSARCOMA	1649
MIM613489	#	16q22.1	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	25839
MIM613490	#	14q32.1	ALPHA-1-ANTITRYPSIN DEFICIENCY	5265
MIM613491	*	19p13.3	ALKALINE CERAMIDASE 1; ACER1	125981
MIM613492	*	9p22.1	ALKALINE CERAMIDASE 2; ACER2	340485
MIM613493	#	16p11.2	IMMUNODEFICIENCY, COMMON VARIABLE, 3; CVID3	930
MIM613494	#	22q13.1-q13.31	IMMUNODEFICIENCY, COMMON VARIABLE, 4; CVID4	115650
MIM613495	#	11q13	IMMUNODEFICIENCY, COMMON VARIABLE, 5; CVID5	931
MIM613496	#	11p	IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6	975
MIM613497	*	10q23.31	LIPASE A, LYSOSOMAL ACID; LIPA	3988
MIM613498	%	17p13	SEX HORMONE-BINDING GLOBULIN CIRCULATING LEVEL QUANTITATIVE TRAIT LOCUS; SXGQTL1	100528025
MIM613499	*	6p22.2	HISTONE GENE CLUSTER 1, H2A HISTONE FAMILY, MEMBER A; HIST1H2AA	221613
MIM613500	#	22q11.21	AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE; AGM2	3543
MIM613501	#	19q13.2	AGAMMAGLOBULINEMIA 3, AUTOSOMAL RECESSIVE; AGM3	973
MIM613502	#	10q23.2	AGAMMAGLOBULINEMIA 4, AUTOSOMAL RECESSIVE; AGM4	29760
MIM613503	*	6p21.32	MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ ALPHA-2; HLA-DQA2	3118
MIM613504	*	14q32.33	ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 21; ZFYVE21	79038
MIM613505	*	9q34.3	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 26; LRRC26	389816
MIM613506	#	9q34.13	AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5	56262
MIM613507	#	3q24-q25.1	GLYCOGEN STORAGE DISEASE XV; GSD15	2992
MIM613508	#	12q24.1	SODIUM SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1; SSQTL1	59341
MIM613509	#	4q21	CHROMOSOME 4q21 DELETION SYNDROME	100528026
MIM613510	*	11q13.4	CHROMOSOME 11 OPEN READING FRAME 59; C11ORF59	55004
MIM613511	*	5q33.1	SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 9; SPINK9	643394
MIM613512	*	1q32.1	ZINC FINGER BED DOMAIN-CONTAINING PROTEIN 6; ZBED6	100381270
MIM613513	*	1q32.1	ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 11A; ZC3H11A	9877
MIM613514	*	1q43	ZONA PELLUCIDA GLYCOPROTEIN 4; ZP4	57829
MIM613515	*	 	AUTOPHAGY 14, S. CEREVISIAE, HOMOLOG OF; ATG14	22863
MIM613516	*	 	KIAA0226 GENE; KIAA0226	9711
MIM613517	#	2q37.1	MICROPHTHALMIA, ISOLATED 6; MCOP6	646960
MIM613520	*	 	FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 6; FGD6	55785
MIM613521	*	1p34	UROPORPHYRINOGEN DECARBOXYLASE; UROD	7389
MIM613522	*	7q31.3-q32	OPSIN 1, SHORT-WAVE-SENSITIVE; OPN1SW	611
MIM613523	#	8p11	CHROMOSOME 8p11 MYELOPROLIFERATIVE SYNDROME	100529119
MIM613524	*	1q43-q44	SEROLOGICALLY DEFINED COLON CANCER ANTIGEN 8; SDCCAG8	10806
MIM613525	*	 	SEEK1 GENE	170679
MIM613526	*	 	SPR1 GENE	170680
MIM613527	*	2p23.3	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 27; DNAJC27	51277
MIM613528	*	11p15.4	SYNAPTOTAGMIN 9; SYT9	143425
MIM613529	*	15q21.1	CENTROSOMAL PROTEIN, 152-KD; CEP152	22995
MIM613530	%	3p25.1-p23	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1H; LGMD1H	100529230
MIM613531	*	 	PHOSPHATASE AND TENSIN HOMOLOG PSEUDOGENE; PTENP1	11191
MIM613532	*	 	RAS-ASSOCIATED PROTEIN RAB8B; RAB8B	51762
MIM613533	#	17q21.31	CHROMOSOME 17q21.31 DUPLICATION SYNDROME	100529226
MIM613534	*	 	FANCD2/FANCI-ASSOCIATED NUCLEASE 1; FAN1	22909
MIM613535	*	 	KIAA0319-LIKE; KIAA0319L	79932
MIM613536	*	 	LEUCINE-, GLUTAMATE-, AND LYSINE-RICH PROTEIN 1; LEKR1	389170
MIM613537	*	 	NLR FAMILY, CASPASE RECRUITMENT DOMAIN-CONTAINING 5; NLRC5	84166
MIM613538	*	 	FEM1, C. ELEGANS, HOMOLOG OF, A; FEM1A	55527
MIM613539	*	 	FEM1, C. ELEGANS, HOMOLOG OF, B; FEM1B	10116
MIM613540	*	14q13.1	SERINE PALMITOYLTRANSFERASE, SMALL SUBUNIT, A; SPTSSA	171546
MIM613541	*	12q24.31	CHROMOSOME 12 OPEN READING FRAME 65; C12ORF65	91574
MIM613542	*	 	MITOCHONDRIAL TRANSLATIONAL RELEASE FACTOR 1-LIKE; MTRF1L	54516
MIM613543	*	 	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY, MEMBER 5A1; SLCO5A1	81796
MIM613544	#	6q11-q14	CHROMOSOME 6q11-q14 DELETION SYNDROME	100529221
MIM613545	%	1p34-p32	MACROSTOMIA, ISOLATED	100529231
MIM613546	#	15q21.1	AROMATASE DEFICIENCY	1588
MIM613547	%	16q24	STATURE QUANTITATIVE TRAIT LOCUS 22; STQTL22	100529227
MIM613548	%	1p32	STATURE QUANTITATIVE TRAIT LOCUS 23; STQTL23	100529222
MIM613549	%	2p16	STATURE QUANTITATIVE TRAIT LOCUS 24; STQTL24	100529223
MIM613550	#	8q21.13-q22.1	NEPHRONOPHTHISIS 11; NPHP11	91147
MIM613551	#	11q24	AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6; AIS6	54414
MIM613552	*	7q11.23	PIGEON, DROSOPHILA, HOMOLOG OF; PION	54103
MIM613553	*	22q13.31-q13.33	X-PROLYL AMINOPEPTIDASE 3; XPNPEP3	63929
MIM613554	#	12p13.3	VON WILLEBRAND DISEASE, TYPE 2; VWD2	7450
MIM613555	*	 	TET ONCOGENE FAMILY, MEMBER 3; TET3	200424
MIM613556	*	 	MICRO RNA 659; MIR659	724029
MIM613557	^	1p13.1	MOVED TO 604213	 
MIM613558	#	9q21.11	DEAFNESS, AUTOSOMAL DOMINANT 51; DFNA51	 
MIM613559	#	12q24.31	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	91574
MIM613560	*	 	METHYLTRANSFERASE-LIKE 11A; METTL11A	28989
MIM613561	#	12p11.21	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	51067
MIM613562	*	 	Fc RECEPTOR-LIKE PROTEIN 6; FCRL6	343413
MIM613563	#	11q23.3	NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA; NSLL	867
MIM613564	#	2p12-p11.2	CHROMOSOME 2p12-p11.2 DELETION SYNDROME	100529243
MIM613565	*	1p36.3	UBIQUITINATION FACTOR E4B; UBE4B	10277
MIM613566	#	19p13.13-p13.12	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6; HBFQTL6	10661
MIM613567	*	 	ZINC FINGER, MYM-TYPE 6; ZMYM6	9204
MIM613568	*	 	ZINC FINGER, MYM-TYPE 4; ZMYM4	9202
MIM613569	*	 	SAD1 AND UNC84 DOMAIN-CONTAINING PROTEIN 2; SUN2	25777
MIM613570	*	 	CHROMOSOME 2 OPEN READING FRAME 43; C2ORF43	60526
MIM613571	#	7q11.2	DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	5447
MIM613572	*	 	G PROTEIN-COUPLED RECEPTOR, FAMILY C, GROUP 6, MEMBER A; GPRC6A	222545
MIM613573	#	1q23.3	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1; EDSS1	81607
MIM613574	*	9p22.3	TETRATRICOPEPTIDE REPEAT DOMAIN 39B; TTC39B	158219
MIM613575	#	3p12-q13	RETINITIS PIGMENTOSA 55; RP55	84100
MIM613576	%	7p21.2-p14.3	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2	100505394
MIM613577	*	16p13.3	TBC1 DOMAIN FAMILY, MEMBER 24; TBC1D24	57465
MIM613578	*	9p13	PROTEASE, SERINE, 3; PRSS3	5646
MIM613579	*	12p13.31-p31.2	C-TYPE LECTIN DOMAIN FAMILY 6, MEMBER A; CLEC6A	93978
MIM613580	*	2p15	CHROMOSOME 2 OPEN READING FRAME 86; C2ORF86	51057
MIM613581	#	3q11.2	RETINITIS PIGMENTOSA 56; RP56	50939
MIM613582	#	17q25	RETINITIS PIGMENTOSA 57; RP57	5148
MIM613583	*	19q13.12	WD REPEAT-CONTAINING PROTEIN 62; WDR62	284403
MIM613584	*	 	ALDEHYDE DEHYDROGENASE 1 FAMILY, MEMBER L2; ALDH1L2	160428
MIM613585	*	 	TRANSMEMBRANE PROTEIN 147; TMEM147	10430
MIM613586	*	 	NIN1/RPN12-BINDING PROTEIN 1, S. CEREVISIAE, HOMOLOG OF; NOB1	28987
MIM613587	#	8p23	OCCULT MACULAR DYSTROPHY; OCMD	94137
MIM613588	*	 	C-TYPE LECTIN DOMAIN FAMILY 3, MEMBER A; CLEC3A	10143
MIM613589	#	1p21.3-p13.1	LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; LDLCQ6	6272
MIM613590	*	6p22.1	BUTYROPHILIN, SUBFAMILY 2, MEMBER A1; BTN2A1	11120
MIM613591	*	6p22.1	BUTYROPHILIN, SUBFAMILY 2, MEMBER A2; BTN2A2	10385
MIM613592	*	6p22.1	BUTYROPHILIN, SUBFAMILY 2, MEMBER A3; BTN2A3	54718
MIM613593	*	6p22.1	BUTYROPHILIN, SUBFAMILY 3, MEMBER A1; BTN3A1	11119
MIM613594	*	6p22.1	BUTYROPHILIN, SUBFAMILY 3, MEMBER A2; BTN3A2	11118
MIM613595	*	6p22.1	BUTYROPHILIN, SUBFAMILY 3, MEMBER A3; BTN3A3	10384
MIM613596	*	2p15	FAMILY WITH SEQUENCE SIMILARITY 161, MEMBER A; FAM161A	84140
MIM613597	*	10q24.2	DIHYDRODIPICOLINATE SYNTHASE-LIKE, MITOCHONDRIAL; DHDPSL	112817
MIM613598	*	2p24.1-p22.3	ZINC FINGER PROTEIN 513; ZNF513	130557
MIM613599	*	20p11.21	ABHYDROLASE DOMAIN-CONTAINING PROTEIN 12; ABHD12	26090
MIM613602	*	2p24.1	WD REPEAT-CONTAINING PROTEIN 35; WDR35	57539
MIM613603	#	4q32.1-q32.2	CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	100529228
MIM613604	#	16q12.2-p11.2	CHROMOSOME 16p12.2-p11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	100526742
MIM613605	*	10q25.2	NONCODING RNA 81; NCRNA00081	92482
MIM613606	%	1p33-p31.1	FORSYTHE-WAKELING SYNDROME; FWS	100529224
MIM613607	*	6q22.33	THYMOCYTE-EXPRESSED MOLECULE INVOLVED IN SELECTION; THEMIS	387357
MIM613608	%	5p15.31-p15.1	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3	100529229
MIM613609	*	6p21.3	HFE GENE; HFE	3077
MIM613610	#	2p24.1	CRANIOECTODERMAL DYSPLASIA 2; CED2	57539
MIM613611	#	1q32	CHOANAL ATRESIA AND LYMPHEDEMA	5784
MIM613612	#	7q31	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi; CDG2I	10466
MIM613613	*	14q11.2	MICRO RNA 208B; MIR208B	100126336
MIM613614	*	20q11.22	MICRO RNA 499; MIR499	574501
MIM613615	#	 	SENIOR-LOKEN SYNDROME 7; SLSN7	10806
MIM613616	#	10q24.2	HYPEROXALURIA, PRIMARY, TYPE III; HP3	112817
MIM613617	#	2p24.1-p22.3	RETINITIS PIGMENTOSA 58; RP58	130557
MIM613618	#	17q23.1-q23.2	CHROMOSOME 17q23.1-q23.2 DUPLICATION SYNDROME	100526743
MIM613619	*	22q11	SCAVENGER RECEPTOR CLASS F, MEMBER 2; SCARF2	91179
MIM613620	*	16p11.2	TBC1 DOMAIN FAMILY, MEMBER 10B; TBC1D10B	26000
MIM613621	*	14q12	NUCLEOTIDE-BINDING PROTEIN-LIKE PROTEIN; NUBPL	80224
MIM613622	*	11q24.2	FAD-DEPENDENT OXIDOREDUCTASE DOMAIN-CONTAINING PROTEIN 1; FOXRED1	55572
MIM613624	*	15q25.3	ZINC FINGER PROTEIN 592; ZNF592	9640
MIM613625	#	2p21-p16.3	FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2; F5F8D2	90411
MIM613629	*	18p11.22, 18p11.22	FAMILY WITH SEQUENCE SIMILARITY 38, MEMBER B; FAM38B	63895
MIM613630	#	10q24	COCOON SYNDROME	1147
MIM613631	*	10q11.22	FAMILY WITH SEQUENCE SIMILARITY 21, MEMBER C; FAM21C	253725
MIM613632	*	9p24.3	WAS PROTEIN FAMILY HOMOLOG 1; WASH1	100287171
MIM613633	*	9q33.2	DENN/MADD DOMAIN-CONTAINING PROTEIN 1A; DENND1A	57706
MIM613634	*	19p13.3	DENN/MADD DOMAIN-CONTAINING PROTEIN 1C; DENND1C	79958
MIM613635	*	7p22.1	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 1; EIF2AK1	27102
MIM613636	%	11p14	TUBERCULIN SKIN TEST REACTIVITY, ABSENCE OF	100526790
MIM613637	%	5p15	TUBERCULIN SKIN TEST REACTIVITY QUANTITATIVE TRAIT LOCUS	100526823
MIM613638	#	19p13.13	CHROMOSOME 19p13.13 DELETION SYNDROME	100526791
MIM613639	*	12q24.33	G PROTEIN-COUPLED RECEPTOR 133; GPR133	283383
MIM613640	#	14q24.3-q31	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	9517
MIM613641	#	16q22.2-q22.3	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB	3735
MIM613642	#	5p15	CARDIOMYOPATHY, DILATED, 1GG; CMD1GG	6389
MIM613643	#	4p14	PARKINSON DISEASE 5, AUTOSOMAL DOMINANT; PARK5	7345
MIM613644	*	12p13.1	ACTIVATING TRANSCRIPTION FACTOR 7-INTERACTING PROTEIN; ATF7IP	55729
MIM613645	*	16p13.13	ACTIVATING TRANSCRIPTION FACTOR 7-INTERACTING PROTEIN 2; ATF7IP2	80063
MIM613646	#	19p13.2	METHYLMALONIC ACIDURIA DUE TO TRANSCOBALAMIN RECEPTOR DEFECT	51293
MIM613647	#	7p22.1	SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	9907
MIM613648	*	14q32	MATERNALLY EXPRESSED GENE 8; MEG8	79104
MIM613649	*	14q32	SMALL NUCLEOLAR RNA, C/D BOX, 112; SNORD112	692215
MIM613650	*	14q32	SMALL NUCLEOLAR RNA, C/D BOX, 113-1; SNORD113-1	767561
MIM613651	*	 	SMALL NUCLEOLAR RNA, C/D BOX, 114-1; SNORD114-1	767577
MIM613652	#	 	C1q DEFICIENCY; C1QD	712, 713, 714
MIM613653	*	7p22.1	ADAPTOR-RELATED PROTEIN COMPLEX 5, ZETA-1 SUBUNIT; AP5Z1	9907
MIM613654	*	14q32	MICRO RNA 380; MIR380	494329
MIM613655	*	10q25.3	POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 18; KCNK18	338567
MIM613656	#	10q25.3	MIGRAINE, WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13; MGR13	338567
MIM613657	#	15q26.1	D-2-@HYDROXYGLUTARIC ACIDURIA 2	3418
MIM613658	%	2q36.2	RAJAB SYNDROME	100528027
MIM613659	#	5q21-q22	GASTRIC CANCER	324
MIM613660	#	10q23.1	CONE-ROD DYSTROPHY 15; CORD15	92211
MIM613661	#	13q14.3	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	440138
MIM613662	#	15q25	MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	5428
MIM613663	*	3p13	SHQ1, S. CEREVISIAE, HOMOLOG OF; SHQ1	55164
MIM613664	*	11q12.1	SMOOTHELIN-LIKE 1; SMTNL1	219537
MIM613665	*	1q23.2	DUFFY ANTIGEN RECEPTOR FOR CHEMOKINES; DARC	2532
MIM613666	*	13q14.3	ALG11, S. CEREVISIAE, HOMOLOG OF; ALG11	440138
MIM613667	*	6q21	SINE OCULIS-BINDING PROTEIN, DROSOPHILA, HOMOLOG OF; SOBP	55084
MIM613668	#	11q21	MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	9440
MIM613669	*	10p11.23	MITOCHONDRIAL POLY(A) POLYMERASE; MTPAP	55149
MIM613670	#	3p14.1	MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND AUTISTIC FEATURES	27086
MIM613671	#	6q21	MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	55084
MIM613672	#	10p11.23	SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	55149
MIM613673	#	19p13.13-p13.12	ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE IV; CDAN4	10661
MIM613674	#	8q12-q13	VESICOURETERAL REFLUX 3; VUR3	64321
MIM613675	#	17q11.2	CHROMOSOME 17q11.2 DELETION SYNDROME, 1.4-MB	100852404
MIM613676	#	13q12.2	SECKEL SYNDROME 4; SCKL4	55835
MIM613677	#	 	HYPERALDOSTERONISM, FAMILIAL, TYPE III	3762
MIM613679	#	11p11-q12	PROTHROMBIN DEFICIENCY, CONGENITAL	2147
MIM613680	#	16p13.3	MICROCEPHALY, MENTAL RETARDATION, AND DISTINCTIVE FACIES, WITH CARDIAC AND GENITOURINARY MALFORMATIONS	100529147
MIM613681	#	2q31.1	CHROMOSOME 2q31.1 DUPLICATION SYNDROME	100529099
MIM613682	*	22q11.21-q11.22	MICRO RNA 130B; MIR130B	406920
MIM613683	*	1q22	SOLUTE CARRIER FAMILY 50 (SUGAR TRANSPORTER), MEMBER 1; SLC50A1	55974
MIM613684	#	22q13	RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	2033
MIM613685	%	9p23-p21.2	DEAFNESS, AUTOSOMAL RECESSIVE 83; DFNB83	100359400
MIM613686	#	17p13.2	SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4	84667
MIM613687	*	12q23	CHROMOSOME 12 OPEN READING FRAME 48; C12ORF48	55010
MIM613688	#	7q35-q36	LONG QT SYNDROME 2; LQT2	3757, 84920
MIM613689	%	22q12.3-q13.1	MAMMARY-DIGITAL-NAIL SYNDROME; MDNS	100529148
MIM613690	#	19q13.4	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7; CMH7	7137
MIM613691	*	22q13.31	GRAM DOMAIN-CONTAINING PROTEIN 4; GRAMD4	23151
MIM613692	*	1q23.3	ZINC FINGER CCHC DOMAIN-CONTAINING PROTEIN 11; ZCCHC11	23318
MIM613693	#	21q22.1	LONG QT SYNDROME 6; LQT6	9992
MIM613694	#	14q24.3	CARDIOMYOPATHY, DILATED, 1U; CMD1U	5663
MIM613695	#	21q22.1-q22.2	LONG QT SYNDROME 5; LQT5	3753
MIM613696	*	11q14.3	UPSTREAM BINDING TRANSCRIPTION FACTOR (RNA POLYMERASE I)-LIKE 1; UBTFL1	642623
MIM613697	#	1q31-q42	CARDIOMYOPATHY, DILATED, 1V; CMD1V	5664
MIM613698	*	3p21.31	SOLUTE CARRIER FAMILY 25 (CARNITINE/ACYLCARNITINE TRANSLOCASE), MEMBER 20; SLC25A20	788
MIM613699	*	9q34.3	GLYCOSYLTRANSFERASE 6 DOMAIN-CONTAINING 1; GLT6D1	360203
MIM613700	#	22q11.2	SUPERNUMERARY DER(22)t(8;22) SYNDROME	100529149
MIM613701	*	16q22.1	MICRO RNA 328; MIR328	442901
MIM613702	#	12p13.1	KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT; KFS3	9573
MIM613703	#	12p13.1, 8q22.1	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6; MCOPCB6	392255, 9573
MIM613704	#	12p13.1	MICROPHTHALMIA, ISOLATED 7; MCOP7	9573
MIM613705	#	2q32.2-q33	OROFACIAL CLEFT 10; OFC10	7341
MIM613706	#	7q34	NOONAN SYNDROME 7; NS7	673
MIM613707	#	7q34	LEOPARD SYNDROME 3	673
MIM613708	#	 	NEUROPATHY, HEREDITARY SENSORY, TYPE ID; HSN1D	51062
MIM613709	*	1q32.1	EUKARYOTIC TRANSLATION INITIATION FACTOR 2D; EIF2D	1939
MIM613710	#	 	THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY TYPE); THMD4	60386
MIM613711	#	5p13.1-p12	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 3; HSCR3	2668
MIM613712	#	20q13.2-q13.3	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 4; HSCR4	1908
MIM613713	*	13q34	PCI DOMAIN-CONTAINING PROTEIN 2; PCID2	55795
MIM613714	*	11p15.1	B7 HOMOLOG 6	374383
MIM613715	*	13q12.2	POLYMERASE I, RNA, SUBUNIT D; POLR1D	51082
MIM613716	*	8q24.3	MICRO RNA 661; MIR661	724031
MIM613717	#	13q12.2	TREACHER COLLINS SYNDROME 2; TCS2	51082
MIM613718	#	12q14.3	DEAFNESS, AUTOSOMAL RECESSIVE 74; DFNB74	253827
MIM613719	*	12q14.3	METHIONINE SULFOXIDE REDUCTASE B3; MSRB3	253827
MIM613720	#	20q13.3	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7; EIEE7	3785
MIM613721	#	2q23-q24.3	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	6326
MIM613722	#	20p12	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	23236
MIM613723	#	8q24	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Q; LGMD2Q	5339
MIM613724	#	1p32	LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	6342
MIM613725	*	6p12.3	SOLUTE CARRIER FAMILY 25, MEMBER 17; SLC25A27	9481
MIM613726	*	4q12-q13, 3p22.1	ANOCTAMIN 10; ANO10	55129
MIM613727	*	15q22.31	KELCH REPEAT AND BTB/POZ DOMAINS-CONTAINING PROTEIN 13: KBTBD13	390594
MIM613728	#	 	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10	55129
MIM613729	#	 	CHROMOSOME 7q11.23 DELETION SYNDROME, DISTAL, 1.2-MB	100653380
MIM613730	#	11q25	HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS	83700
MIM613731	#	3q21-q24	RETINITIS PIGMENTOSA 4; RP4	6010
MIM613732	^	 	MOVED TO 256040	 
MIM613733	*	11q13	MEN1 GENE; MEN1	4221
MIM613734	*	2q21.2	COILED-COIL DOMAIN-CONTAINING PROTEIN 115; CCDC115	84317
MIM613735	#	1p32-p31	CHROMOSOME 1p32-p31 DELETION SYNDROME	100532738
MIM613736	#	19q13.1	ACNE INVERSA, FAMILIAL, 2; ACNINV2	55851
MIM613737	#	14q24.3	ACNE INVERSA, FAMILIAL, 3; ACNINV3	5663
MIM613738	*	7q21.2	ALKYLGLYCEROL MONOOXYGENASE; AGMO	392636
MIM613739	*	11q25	THYMOCYTE NUCLEAR PROTEIN 1; THYN1	29087
MIM613740	#	12q22	CARDIOMYOPATHY, DILATED, 1T; CMD1T	7112
MIM613741	*	 	GLYCOGEN PHOSPHORYLASE, LIVER; PYGL	5836
MIM613742	*	 	GLUCOSE-6-PHOSPHATASE, CATALYTIC; G6PC	2538
MIM613743	#	 	ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE	1583
MIM613744	#	 	SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51	23431
MIM613745	*	 	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 10; ANAPC10	10393
MIM613746	*	 	BREAST CANCER ANTIESTROGEN RESISTANCE 4; BCAR4	400500
MIM613747	*	 	KINESIN FAMILY MEMBER 24; KIF24	347240
MIM613748	*	 	COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 3; CHCHD3	54927
MIM613749	*	 	ZINC FINGER PROTEIN 260; ZNF260	339324
MIM613750	#	 	RETINITIS PIGMENTOSA 27; RP27	4901
MIM613751	#	 	HETEROTAXY, VISCERAL, 4, AUTOSOMAL; HTX4	93
MIM613752	#	 	HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	191
MIM613753	*	 	MICRO RNA 211; MIR211	406993
MIM613754	*	 	RING FINGER PROTEIN 187; RNF187	149603
MIM613755	*	 	MICRO RNA 326; MIR326	442900
MIM613756	#	 	RETINITIS PIGMENTOSA 49; RP49	1259
MIM613757	#	 	MACULAR DEGENERATION, AGE-RELATED, 6; ARMD6	84839
MIM613758	#	 	RETINITIS PIGMENTOSA 47; RP47	6295
MIM613759	#	 	INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	8772
MIM613760	*	 	SOLUTE CARRIER FAMILY 36, MEMBER 4; SLC36A4	120103
MIM613761	#	 	MACULAR DEGENERATION, AGE-RELATED, 5; ARMD5	2074
MIM613762	#	 	46,XY SEX REVERSAL 6; SRXY6	4214
MIM613763	#	 	CATARACT, POSTERIOR POLAR, 2; CTPP2	1410
MIM613764	*	 	SECRETORY CARRIER MEMBRANE PROTEIN 4; SCAMP4	113178
MIM613765	#	 	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 9; CMH9	7273
MIM613766	*	 	SECRETORY CARRIER MEMBRANE PROTEIN 5; SCAMP5	192683
MIM613767	#	 	RETINITIS PIGMENTOSA 45; RP45	1258
MIM613768	*	 	RING FINGER PROTEIN 213; RNF213	57674
MIM613769	#	 	RETINITIS PIGMENTOSA 44; RP44	5995
MIM613770	*	 	PLACENTA-SPECIFIC GENE 4; PLAC4	191585
MIM613771	*	 	TRANSMEMBRANE PROTEIN 205; TMEM205	374882
MIM613772	*	 	KELCH-LIKE 14; KLHL14	57565
MIM613773	*	 	IMMUNOGLOBULIN SUPERFAMILY, MEMBER 9B; IGSF9B	22997
MIM613774	*	 	CALMODULIN-REGULATED SPECTRIN-ASSOCIATED PROTEIN 1; CAMSAP1	157922
MIM613775	*	 	CALMODULIN-REGULATED SPECTRIN-ASSOCIATED PROTEIN 1-LIKE 1; CAMSAP1L1	23271
MIM613776	#	 	CHROMOSOME 17p13.1 DELETION SYNDROME	100653374
MIM613777	*	 	FAD-DEPENDENT OXIDOREDUCTASE DOMAIN-CONTAINING PROTEIN 2; FOXRED2	80020
MIM613778	#	 	MACULAR DEGENERATION, AGE-RELATED, 8; ARMD8	387715
MIM613779	#	 	COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D	718
MIM613780	#	 	AORTIC ANEURYSM, FAMILIAL THORACIC 7; AAT7	4638
MIM613781	*	 	COILED-COIL DOMAIN-CONTAINING PROTEIN 125; CCDC125	202243
MIM613782	*	 	METHIONINE SULFOXIDE REDUCTASE B2; MSRB2	22921
MIM613783	#	 	COMPLEMENT COMPONENT C1s DEFICIENCY; C1SD	716
MIM613784	#	 	MACULAR DEGENERATION, AGE-RELATED, 12; ARMD12	1524
MIM613785	*	 	COMPLEMENT COMPONENT 1, r SUBCOMPONENT; C1R	715
MIM613786	*	 	MICRO RNA 148A; MIR148A	406940
MIM613787	*	 	MICRO RNA 148B; MIR148B	442892
MIM613788	*	 	MICRO RNA 152; MIR152	406943
MIM613789	#	 	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II; C8D2	732
MIM613790	#	 	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I; C8D1	731
MIM613791	#	 	MASP2 DEFICIENCY	10747
MIM613792	#	 	CHROMOSOME 3pter-p25 DELETION SYNDROME	100653385
MIM613793	#	 	BLOOD GROUP, CROMER SYSTEM; CROM	1604
MIM613794	#	 	RETINITIS PIGMENTOSA 20; RP20	6121
MIM613795	#	 	LOEYS-DIETZ SYNDROME, TYPE 3; LDS3	4088
MIM613796	#	 	MYCOBACTERIAL AND VIRAL INFECTIONS, SUSCEPTIBILITY TO, AUTOSOMAL RECESSIVE	6772
MIM613797	*	 	PROTEASE, SERINE, 33; PRSS33	260429
MIM613798	*	 	COILED-COIL DOMAIN-CONTAINING PROTEIN 39; CCDC39	339829
MIM613799	*	 	COILED-COIL DOMAIN-CONTAINING PROTEIN 40; CCDC40	55036
MIM613800	#	 	MEIER-GORLIN SYNDROME 2; MGORS2	5000
MIM613801	#	 	RETINITIS PIGMENTOSA 40; RP40	5158
MIM613802	*	 	MALECTIN; MLEC	9761
MIM613803	#	 	MEIER-GORLIN SYNDROME 3; MGORS3	23594
MIM613804	#	 	MEIER-GORLIN SYNDROME 4; MGORS4	81620
MIM613805	#	 	MEIER-GORLIN SYNDROME 5; MGORS5	990
MIM613806	%	 	CHOLANGITIS, PRIMARY SCLEROSING; PSC	100653366
MIM613807	#	 	CILIARY DYSKINESIA, PRIMARY, 14; CILD14	339829
MIM613808	#	 	CILIARY DYSKINESIA, PRIMARY, 15; CILD15	55036
MIM613809	#	 	RETINITIS PIGMENTOSA 39; RP39	7399
MIM613810	#	 	RETINITIS PIGMENTOSA 43; RP43	5145
MIM613811	#	 	PONTOCEREBELLAR HYPOPLASIA, TYPE 2D; PCH2D	51091
MIM613812	#	 	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3	9420
MIM613813	*	 	MOUSE DOUBLE MINUTE 1 HOMOLOG; MDM1	56890
MIM613814	*	 	TETRATRICOPEPTIDE REPEAT DOMAIN 19; TTC19	54902
MIM613815	*	 	CYTOCHROME P450, FAMILY 21, SUBFAMILY A, POLYPEPTIDE 2; CYP21A2	1589
MIM613816	*	 	UBIQUITIN PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 7; UBR7	55148
MIM613817	*	 	SPERMATOGENESIS-ASSOCIATED SERINE-RICH PROTEIN 2-LIKE; SPATS2L	26010
MIM613818	#	 	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7; MDDGC7	1605
MIM613819	#	 	ASPHYXIATING THORACIC DYSTROPHY 4; ATD4	79809
MIM613820	#	 	NEPHRONOPHTHISIS 12; NPHP12	79809
MIM613821	*	 	PROTEIN PHOSPHATASE 3, REGULATORY SUBUNIT B, BETA; PPP3R2	5535
MIM613822	*	 	PROTEIN PHOSPHATASE 4, REGULATORY SUBUNIT 2; PPP4R2	151987
MIM613823	#	 	SECKEL SYNDROME 5; SCKL5	22995
MIM613824	#	 	NEPHRONOPHTHISIS 9; NPHP9	284086
MIM613825	#	 	COMPLEMENT COMPONENT 9 DEFICIENCY; C9D	735
MIM613826	#	 	LEBER CONGENITAL AMAUROSIS 6; LCA6	57096
MIM613827	#	 	RETINITIS PIGMENTOSA 48; RP48	2979
MIM613828	%	 	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 8; GEFSP8	100653381
MIM613829	#	 	LEBER CONGENITAL AMAUROSIS 7; LCA7	1406
MIM613830	#	 	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D; CSNB1D	9187
MIM613831	*	 	UBIQUITIN PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 3; UBR3	130507
MIM613832	#	 	EPILEPSY, PROGRESSIVE MYOCLONIC 5; EPM5	166336
MIM613833	*	 	KAT8 REGULATORY NSL COMPLEX SUBUNIT 1-LIKE PROTEIN; KANSL1L	151050
MIM613834	#	 	MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	59
MIM613835	#	 	LEBER CONGENITAL AMAUROSIS 8; LCA8	23418
MIM613836	%	 	ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 5; ADIPQTL5	100653375
MIM613837	#	 	LEBER CONGENITAL AMAUROSIS 11; LCA11	3614
MIM613838	#	 	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16; CMH16	51778
MIM613839	#	 	MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	1719
MIM613840	*	 	ZINC FINGER PROTEIN 304; ZNF304	57343
MIM613841	*	 	UBINUCLEIN 2; UBN2	254048
MIM613842	*	 	GDNF-INDUCIBLE ZINC FINGER PROTEIN 1; GZF1	64412
MIM613843	#	 	LEBER CONGENITAL AMAUROSIS 15; LCA15	7287
MIM613844	*	 	UBIQUINOL-CYTOCHROME C REDUCTASE HINGE PROTEIN; UQCRH	7388
MIM613845	#	 	HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS	54938
MIM613846	*	 	TECTONIC FAMILY, MEMBER 2; TCTN2	79867
MIM613847	*	 	TECTONIC FAMILY, MEMBER 3; TCTN3	26123
MIM613848	#	 	OSTEOGENESIS IMPERFECTA, TYPE X	871
MIM613849	#	 	OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	121340
MIM613850	#	 	INOSINE TRIPHOSPHATASE DEFICIENCY	3704
MIM613851	*	 	PROLINE-RICH MEMBRANE ANCHOR 1; PRIMA1	145270
MIM613852	#	 	FUCOSYLTRANSFERASE 6 DEFICIENCY	2528
MIM613853	#	 	TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 2; DTGA2	55997
MIM613854	#	 	TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 3; DTGA3	2657
MIM613855	#	 	EPISODIC ATAXIA, TYPE 5; EA5	785
MIM613856	#	 	ACHROMATOPSIA 4; ACHM4	2780
MIM613857	%	 	OROFACIAL CLEFT 13; OFC13	100653367
MIM613858	*	 	PROTEASE, SERINE, 56; PRSS56	646960
MIM613859	*	 	UROMODULIN-LIKE 1; UMODL1	89766
MIM613860	#	 	IMMUNODEFICIENCY DUE TO FICOLIN 3 DEFICIENCY	8547
MIM613861	#	 	RETINITIS PIGMENTOSA 59; RP59	79947
MIM613862	#	 	RETINITIS PIGMENTOSA 38; RP38	10461
MIM613863	#	 	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7	6335
MIM613864	*	 	ZINC FINGER PROTEIN 317; ZNF317	57693
MIM613865	#	 	DEAFNESS, AUTOSOMAL RECESSIVE 61; DFNB61	375611
MIM613866	*	 	HRAS-LIKE SUPPRESSOR 2; HRASLS2	54979
MIM613867	*	 	PHOSPHOLIPASE A2, GROUP XVI; PLA2G16	11145
MIM613868	*	 	SOLUTE CARRIER FAMILY 14 (UREA TRANSPORTER), MEMBER 1; SLC14A1	6563
MIM613869	#	 	MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED	1410
MIM613870	#	 	HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	1889
MIM613871	*	 	FUMARYLACETOACETATE HYDROLASE; FAH	2184
MIM613872	*	 	COAGULATION FACTOR X; F10	2159
MIM613873	#	 	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17; CMH17	57158
MIM613874	#	 	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18; CMH18	5350
MIM613875	#	 	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 19; CMH19	125972
MIM613876	#	 	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20; CMH20	91624
MIM613877	#	 	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4; FPLD4	5346
MIM613878	*	 	COAGULATION FACTOR VII; F7	2155
MIM613879	*	 	THYROTROPIN-RELEASING HORMONE; TRH	7200
MIM613880	*	 	BROMO-ADJACENT HOMOLOGY DOMAIN-CONTAINING PROTEIN 1; BAHD1	22893
MIM613881	#	 	CARDIOMYOPATHY, DILATED, 1HH; CMD1HH	9531
MIM613882	#	 	HYPOMAGNESEMIA 6, RENAL; HOMG6	54805
MIM613883	*	 	KELL BLOOD GROUP METALLOENDOPEPTIDASE; KEL	3792
MIM613884	#	 	CHROMOSOME 13q14 DELETION SYNDROME	100653382
MIM613885	#	 	MECKEL SYNDROME, TYPE 8; MKS8	79867
MIM613886	#	 	OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY	4915
MIM613887	#	 	CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 4; CATC4	23424
MIM613888	*	 	RAS HOMOLOG GENE FAMILY, MEMBER T1; RHOT1	55288
MIM613889	*	 	RAS HOMOLOG GENE FAMILY, MEMBER T2; RHOT2	89941
MIM613890	*	 	3-@BETA-HYDROXYSTEROID DEHYDROGENASE 2; HSD3B2	3284
MIM613891	*	 	URIDINE MONOPHOSPHATE SYNTHETASE; UMPS	7372
MIM613892	*	 	DPY19-LIKE 1; DPY19L1	23333
MIM613893	*	 	DPY19-LIKE 2; DPY19L2	283417
MIM613894	*	 	DPY19-LIKE 3; DPY19L3	147991
MIM613895	*	 	DPY19-LIKE 4; DPY19L4	286148
MIM613896	*	 	BISPHOSPHOGLYCERATE MUTASE; BPGM	669
MIM613897	*	 	FANCF GENE; FANCF	2188
MIM613898	*	 	3-@HYDROXY-3-METHYLGLUTARYL-CoA LYASE; HMGCL	3155
MIM613899	*	 	FANCC GENE; FANCC	2176
MIM613900	*	 	TRANSGLUTAMINASE 6; TGM6	343641
MIM613901	*	 	CHROMOSOME 22 OPEN READING FRAME 28; C22ORF28	51493
MIM613902	*	 	ZINC FINGER PROTEIN 503; ZNF503	84858
MIM613903	*	 	ZINC FINGER PROTEIN 540; ZNF540	163255
MIM613904	*	 	ZINC FINGER PROTEIN 569; ZNF569	148266
MIM613905	*	 	ZINC FINGER PROTEIN 606; ZNF606	80095
MIM613906	*	 	ZINC FINGER PROTEIN 641; ZNF641	121274
MIM613907	*	 	ZINC FINGER PROTEIN 652; ZNF652	22834
MIM613908	#	 	SPINOCEREBELLAR ATAXIA 35; SCA35	343641
MIM613909	%	 	SPINOCEREBELLAR ATAXIA 32; SCA32	100653368
MIM613910	*	 	ZINC FINGER PROTEIN 480; ZNF480	147657
MIM613911	*	 	ZINC FINGER PROTEIN 496; ZNF496	84838
MIM613912	#	 	COMPLEMENT FACTOR D DEFICIENCY; CFDD	1675
MIM613914	*	 	ZINC FINGER PROTEIN 746; ZNF746	155061
MIM613915	*	 	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 42: ZBTB42	100128927
MIM613916	#	 	DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89	100653376
MIM613917	*	 	MUCIN 22; MUC22	100507679
MIM613918	*	 	HLA COMPLEX GROUP 22; HCG22	285834
MIM613919	*	 	KINESIN FAMILY MEMBER 6; KIF6	221458
MIM613920	*	 	CHROMOSOME 2 OPEN READING FRAME 64; C2ORF64	493753
MIM613921	*	 	LIPASE FAMILY, MEMBER J; LIPJ	142910
MIM613922	*	 	LIPASE FAMILY, MEMBER K; LIPK	643414
MIM613923	*	 	LIPASE FAMILY, MEMBER M; LIPM	340654
MIM613924	*	 	LIPASE FAMILY, MEMBER N; LIPN	643418
MIM613925	#	 	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	220296
MIM613926	#	 	MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	220296
MIM613927	*	 	COMPLEMENT COMPONENT 2; C2	717
MIM613928	*	 	DIFFUSE PANBRONCHIOLITIS CRITICAL REGION GENE 1; DPCR1	135656
MIM613929	*	 	SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 4; SPINK4	27290
MIM613930	%	 	ALOPECIA-MENTAL RETARDATION SYNDROME 3; APMR3	100653369
MIM613931	*	 	TARGET OF EGR1; TOE1	114034
MIM613932	*	 	TNNI3-INTERACTING KINASE; TNNI3K	51086
MIM613933	%	 	ACETYL-CoA CARBOXYLASE DEFICIENCY; ACACAD	31
MIM613934	*	 	TRANSMEMBRANE PROTEIN 25; TMEM25	84866
MIM613935	*	 	TRANSMEMBRANE PROTEIN 74; TMEM74	157753
MIM613936	*	 	TRANSMEMBRANE PROTEIN 102; TMEM102	284114
MIM613937	*	 	TRANSMEMBRANE PROTEIN 184C; TMEM184C	55751
MIM613938	%	 	PARASOMNIA, SLEEPWALKING TYPE; PSMNSW	100653383
MIM613939	*	 	SPERMATOGENESIS-ASSOCIATED PROTEIN 20; SPATA20	64847
MIM613940	*	 	SPERMATOGENESIS-ASSOCIATED PROTEIN 5; SPATA5	166378
MIM613941	*	 	SERINE PROTEASE INHIBITOR, KUNITZ-TYPE, 3; SPINT3	10816
MIM613942	*	 	SAD1 AND UNC84 DOMAIN-CONTAINING PROTEIN 5; SUN5	140732
MIM613943	#	 	ICHTHYOSIS, LAMELLAR, 4; LI4	643418
MIM613944	%	 	IgA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	100653384
MIM613945	*	 	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 5, BETA; DNAJC5B	85479
MIM613946	*	 	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 5, GAMMA; DNAJC5G	285126
MIM613947	*	 	SPERMATOGENESIS-ASSOCIATED PROTEIN 6; SPATA6	54558
MIM613948	*	 	SPERMATOGENESIS-ASSOCIATED PROTEIN 8; SPATA8	145946
MIM613949	#	 	OKT4 EPITOPE DEFICIENCY	920
MIM613950	#	 	SCHIZOPHRENIA 15; SCZD15	85358
MIM613951	#	 	FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	84464
MIM613952	*	 	FAMILY WITH SEQUENCE SIMILARITY 46, MEMBER C; FAM46C	54855
MIM613953	#	 	CANDIDIASIS, FAMILIAL, 5; CANDF5	23765
MIM613954	#	 	AMYOTROPHIC LATERAL SCLEROSIS 14, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS14	7415
MIM613955	#	 	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 2; PLCA2	133396
MIM613956	#	 	CANDIDIASIS, FAMILIAL, 6; CANDF6	112744
MIM613957	#	 	SPERMATOGENIC FAILURE 8; SPGF8	2516
MIM613958	#	 	SPERMATOGENIC FAILURE 9; SPGF9	283417
MIM613959	#	 	SCHIZOPHRENIA 16; SCZD16	 
MIM613960	#	 	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE III	4689
MIM613961	*	 	TASTE RECEPTOR, TYPE 2, MEMBER 19; TAS2R19	259294
MIM613962	*	 	TASTE RECEPTOR, TYPE 2, MEMBER 20; TAS2R20	259295
MIM613963	*	 	TASTE RECEPTOR, TYPE 2, MEMBER 30; TAS2R30	259293
MIM613964	*	 	TASTE RECEPTOR, TYPE 2, MEMBER 40; TAS2R40	259286
MIM613965	*	 	TASTE RECEPTOR, TYPE 2, MEMBER 41; TAS2R41	259287
MIM613966	*	 	TASTE RECEPTOR, TYPE 2, MEMBER 42; TAS2R42	353164
MIM613967	*	 	TASTE RECEPTOR, TYPE 2, MEMBER 45; TAS2R45	259291
MIM613968	*	 	TASTE RECEPTOR, TYPE 2, MEMBER 60; TAS2R60	338398
MIM613969	%	 	MYOPIA 19, AUTOSOMAL DOMINANT; MYP19	100653370
MIM613970	#	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 6; MRD6	2904
MIM613971	^	 	EPILEPSY WITH NEURODEVELOPMENTAL DEFECTS; EPND	2903
MIM613972	#	 	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 6; CMM6	7517
MIM613973	*	 	MAB21 DOMAIN-CONTAINING PROTEIN 1; MB21D1	115004
MIM613974	*	 	DEAD BOX POLYPEPTIDE 60; DDX60	55601
MIM613975	*	 	INTERFERON-INDUCED PROTEIN 44-LIKE; IFI44L	10964
MIM613976	*	 	FANCE GENE; FANCE	2178
MIM613977	#	 	CYANOSIS, TRANSIENT NEONATAL; TNCY	3048
MIM613978	#	 	HEMOGLOBIN H DISEASE; HBH	3039, 3040
MIM613979	*	 	PRECURSOR mRNA-PROCESSING FACTOR 6, S. CEREVISIAE, HOMOLOG OF; PRPF6	24148
MIM613980	#	 	ATRIAL FIBRILLATION, FAMILIAL, 9; ATFB9	3759
MIM613981	#	 	HYPOTRICHOSIS 3; HYPT3	121391
MIM613982	#	 	OSTEOGENESIS IMPERFECTA, TYPE VI; OI6	5176
MIM613983	#	 	RETINITIS PIGMENTOSA 60; RP60	24148
MIM613984	*	 	FANCD2 GENE; FANCD2	2177
MIM613985	#	 	BETA-THALASSEMIA	3043
MIM613986	#	 	PITUITARY HORMONE DEFICIENCY, COMBINED, 6; CPHD6	5015
MIM613987	#	 	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 2; DKCB2	55651
MIM613988	#	 	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 3; DKCB3	55135
MIM613989	#	 	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 2; DKCA2	7015
MIM613990	#	 	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 3; DKCA3	26277
MIM613991	*	 	CDC42-BINDING PROTEIN KINASE, GAMMA; CDC42BPG	55561
MIM613992	*	 	PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B, DELTA; PPP2R2D	55844
MIM613993	*	 	MYOSIN, LIGHT CHAIN 7, REGULATORY; MYL7	58498
MIM613994	*	 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 4; NBPF4	148545
MIM613995	*	 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 5; NBPF5	100507044
MIM613996	*	 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 6; NBPF6	653149
MIM613997	*	 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 7; NBPF7	343505
MIM613998	*	 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 8; NBPF8	728841
MIM613999	*	 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 9; NBPF9	400818
MIM614000	*	 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 10; NBPF10	100132406
MIM614001	*	 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 11; NBPF11	200030
MIM614003	*	 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 14; NBPF14	25832
MIM614005	*	 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 16; NBPF16	728936
MIM614006	*	 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 19; NBPF19	641589
MIM614007	*	 	NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 20; NBPF20	641590
MIM614008	#	 	NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	8815
MIM614009	#	 	BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13	6915
MIM614010	*	 	INOSITOL MONOPHOSPHATASE DOMAIN-CONTAINING PROTEIN 1; IMPAD1	54928
MIM614011	*	 	ENDOGENOUS RETROVIRUS GROUP K, MEMBER 4; ERVK-4	60359
MIM614012	*	 	ENDOGENOUS RETROVIRUS GROUP K, MEMBER 5; ERVK-5	60358
MIM614013	*	 	ENDOGENOUS RETROVIRUS GROUP K, MEMBER 7; ERVK-7	449619
MIM614014	*	 	RIBONUCLEASE A FAMILY, 9; RNASE9	390443
MIM614015	*	 	DIACYLGLYCEROL LIPASE, ALPHA; DAGLA	747
MIM614016	*	 	DIACYLGLYCEROL LIPASE, BETA; DAGLB	221955
MIM614017	#	 	CILIARY DYSKINESIA, PRIMARY, 16; CILD16	83544
MIM614018	#	 	EPILEPSY, PROGRESSIVE MYOCLONIC 6; EPM6	9570
MIM614019	#	 	LISSENCEPHALY 4; LIS4	54820
MIM614020	#	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14; MRT14	9524
MIM614021	%	 	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 3; CPVT3	100653371
MIM614022	#	 	ATRIAL FIBRILLATION, FAMILIAL, 10; ATFB10	6331
MIM614023	#	 	PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	5723
MIM614024	#	 	PROTEIN Z DEFICIENCY	8858
MIM614025	#	 	HEPATIC LIPASE DEFICIENCY	3990
MIM614026	*	 	KINESIN FAMILY MEMBER 26B; KIF26B	55083
MIM614027	*	 	INSULINOMA-ASSOCIATED 2; INSM2	84684
MIM614028	#	 	HYPERALPHALIPOPROTEINEMIA 2; HALP2	345
MIM614029	*	 	SPEEDY, XENOPUS, HOMOLOG OF, A; SPDYA	245711
MIM614030	*	 	SPEEDY, XENOPUS, HOMOLOG OF, C; SPDYC	387778
MIM614031	*	 	RAN-BINDING PROTEIN 10; RANBP10	57610
MIM614032	*	 	TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 4; TOX4	9878
MIM614033		 	HYDROXYACYL GLUTATHIONE HYDROLASE DEFICIENCY	3029
MIM614034	#	 	HEME OXYGENASE 1 DEFICIENCY; HMOX1D	3162
MIM614035	#	 	DEAFNESS, AUTOSOMAL RECESSIVE 29; DFNB29	23562
MIM614036		 	ALPHA-2-MACROGLOBULIN DEFICIENCY; A2MD	2
MIM614037		 	LEUKOTRIENE C4 SYNTHASE DEFICIENCY	4056
MIM614038	#	 	LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	2624
MIM614039	#	 	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS; CDCBM	10381
MIM614040	*	 	ZINC FINGER PROTEIN 467; ZNF467	168544
MIM614041	*	 	RB1 GENE; RB1	5925
MIM614042	#	 	MOYAMOYA DISEASE 5; MYMY5	59
MIM614043	*	 	LEUCINE-RICH REPEAT IN FLII-INTERACTING PROTEIN 2; LRRFIP2	9209
MIM614044		 	TRYPSINOGEN DEFICIENCY	5644
MIM614045	*	 	FAMILY WITH SEQUENCE SIMILARITY 129, MEMBER B; FAM129B	64855
MIM614046	*	 	ARGININE- AND GLUTAMATE-RICH PROTEIN 1; ARGLU1	55082
MIM614047	*	 	METHYLENETETRAHYDROFOLATE DEHYDROGENASE 2-LIKE, NADP(+)-DEPENDENT; MTHFD2L	441024
MIM614048	*	 	KIAA1324-LIKE; KIAA1324L	222223
MIM614049	#	 	ATRIAL FIBRILLATION, FAMILIAL, 11; ATFB11	2702
MIM614050	#	 	ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12	10060
MIM614052	#	 	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	54968
MIM614053	#	 	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3; MC5DN3	514
MIM614054	*	 	RIBOSOMAL MODIFICATION PROTEIN RimK-LIKE FAMILY, MEMBER B; RIMKLB	57494
MIM614056	*	 	PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 26; PPP1R26	9858
MIM614057	*	 	MICRO RNA 409; MIR409	574413
MIM614058	*	 	KETOHEXOKINASE; KHK	3795
MIM614059	*	 	MICRO RNA 338; MIR338	442906
MIM614060	*	 	HOXA DISTAL TRANSCRIPT ANTISENSE RNA; HOTTIP	100316868
MIM614061	*	 	OLFACTOMEDIN 4; OLFM4	10562
MIM614062	*	 	CDC42-BINDING PROTEIN KINASE, BETA; CDC42BPB	9578
MIM614063	#	 	N-ACETYLASPARTATE DEFICIENCY; NACED	339983
MIM614064	*	 	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 24; ZBTB24	9841
MIM614065	#	 	MYOPATHY, DISTAL, 4; MPD4	2318
MIM614066	#	 	SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	10717
MIM614067	#	 	SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE; SPG52	11154
MIM614068	*	 	INTRAFLAGELLAR TRANSPORT 43, CHLAMYDOMONAS, HOMOLOG OF; IFT43	112752
MIM614069	#	 	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2; ICF2	9841
MIM614070	#	 	PSORIASIS SUSCEPTIBILITY 13; PSORS13	10758
MIM614071	*	 	MYOCARDIAL ZONULA ADHERENS PROTEIN; MYZAP	100820829
MIM614072	#	 	HERMANSKY-PUDLAK SYNDROME 3; HPS3	84343
MIM614073	#	 	HERMANSKY-PUDLAK SYNDROME 4; HPS4	89781
MIM614074	#	 	HERMANSKY-PUDLAK SYNDROME 5; HPS5	11234
MIM614075	#	 	HERMANSKY-PUDLAK SYNDROME 6; HPS6	79803
MIM614076	#	 	HERMANSKY-PUDLAK SYNDROME 7; HPS7	84062
MIM614077	#	 	HERMANSKY-PUDLAK SYNDROME 8; HPS8	388552
MIM614078	#	 	CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	54928
MIM614079	#	 	ASPERGILLOSIS, SUSCEPTIBILITY TO	64581
MIM614080	#	 	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	23556
MIM614081	#	 	ANHAPTOGLOBINEMIA; AHP	3240
MIM614082	#	 	FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	2189
MIM614083	#	 	FANCONI ANEMIA, COMPLEMENTATION GROUP L; FANCL	55120
MIM614084	*	 	WEE1, S. POMBE, HOMOLOG OF, 2; WEE2	494551
MIM614085	*	 	CHROMOSOME 12 OPEN READING FRAME 32; C12ORF32	83695
MIM614086	*	 	IDAS	345643
MIM614087	#	 	FANCONI ANEMIA, COMPLEMENTATION GROUP M; FANCM	57697
MIM614088	*	 	INTRACELLULAR ADHESION MOLECULE 4; ICAM4	3386
MIM614089	#	 	ATRIAL SEPTAL DEFECT 3; ASD3	4624
MIM614090	#	 	SICK SINUS SYNDROME 3, SUSCEPTIBILITY TO; SSS3	4624
MIM614091	#	 	SHORT RIB-POLYDACTYLY SYNDROME, TYPE V; SRPS5	57539
MIM614092	*	 	RAB-INTERACTING LYSOSOMAL PROTEIN-LIKE 1; RILPL1	353116
MIM614093	*	 	RAB-INTERACTING LYSOSOMAL PROTEIN-LIKE 2; RILPL2	196383
MIM614094	*	 	MARVEL DOMAIN-CONTAINING PROTEIN 3; MARVELD3	91862
MIM614095	*	 	PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL; PCK2	5106
MIM614096	#	 	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8	57505
MIM614097	#	 	ACATALASEMIA	847
MIM614099	#	 	CRANIOECTODERMAL DYSPLASIA 3; CED3	112752
MIM614101	%	 	PLASMA FIBRONECTIN DEFICIENCY	2335
MIM614102	#	 	IMMUNOGLOBULIN KAPPA LIGHT CHAIN DEFICIENCY; IGKCD	3514
MIM614104	#	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 7; MRD7	1859
MIM614105	#	 	METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; MMSDHD	4329
MIM614106	*	 	MUSCULAR LMNA-INTERACTING PROTEIN; MLIP	90523
MIM614107	*	 	KARYOPHERIN ALPHA-7; KPNA7	402569
MIM614108	*	 	BPI FOLD-CONTAINING PROTEIN, FAMILY B, MEMBER 2; BPIFB2	80341
MIM614109	*	 	BPI FOLD-CONTAINING PROTEIN, FAMILY C; BPIFC	254240
MIM614110	*	 	BPI FOLD-CONTAINING PROTEIN, FAMILY B, MEMBER 6; BPIFB6	128859
MIM614111	#	 	PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD	5162
MIM614112	*	 	MICRO RNA 320A; MIR320A	407037
MIM614113	#	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 2; MRD2	81704
MIM614114	#	 	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	9702
MIM614115	#	 	CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	10319
MIM614116	#	 	NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	1786
MIM614117	*	 	EXOCYST COMPLEX COMPONENT 3-LIKE 1; EXOC3L1	283849
MIM614118	*	 	TEASHIRT ZINC FINGER HOMEOBOX 2; TSHZ2	128553
MIM614119	*	 	TEASHIRT ZINC FINGER HOMEOBOX 3; TSHZ3	57616
MIM614120	#	 	HYDROLETHALUS SYNDROME 2; HLS2	374654
MIM614121	*	 	POLY(A) POLYMERASE-ASSOCIATED DOMAIN-CONTAINING PROTEIN 4; PAPD4	167153
MIM614122	#	 	CHITOTRIOSIDASE DEFICIENCY; CHITD	1118
MIM614123	*	 	TRANSMEMBRANE AND COILED-COIL DOMAINS PROTEIN 1; TMCO1	54499
MIM614124	*	 	GLYCEROPHOSPHOCHOLINE PHOSPHODIESTERASE GDE1, S. CEREVISIAE, HOMOLOG OF; GPCPD1	56261
MIM614125	*	 	DEVELOPMENTAL PLURIPOTENCY-ASSOCIATED GENE 4; DPPA4	55211
MIM614126	*	 	MOLYBDENUM COFACTOR SULFURASE C-TERMINAL DOMAIN-CONTAINING PROTEIN 1; MOSC1	64757
MIM614127	*	 	MOLYBDENUM COFACTOR SULFURASE C-TERMINAL DOMAIN-CONTAINING PROTEIN 2; MOSC2	54996
MIM614128	#	 	LACTATE DEHYDROGENASE B DEFICIENCY; LDHBD	3945
MIM614129	#	 	DEAFNESS, AUTOSOMAL RECESSIVE 81; DFNB81	100653390
MIM614130	*	 	ADENOSINE DEAMINASE DOMAIN-CONTAINING PROTEIN 1, TESTIS-SPECIFIC; ADAD1	132612
MIM614131	#	 	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6; FSGS6	4643
MIM614132	^	 	CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME; CFSMR	54499
MIM614133	*	 	HEPACAM FAMILY MEMBER 2; HEPACAM2	253012
MIM614134	#	 	STICKLER SYNDROME, TYPE IV; STL4	1297
MIM614135	#	 	EPIPHYSEAL DYSPLASIA, MULTIPLE, 6; EDM6	1297
MIM614136	*	 	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 8; TRAPPC8	22878
MIM614137	*	 	BET3, S. CEREVISIAE, HOMOLOG-LIKE; BET3L	100128327
MIM614138	*	 	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 11; TRAPPC11	60684
MIM614139	*	 	TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 12; TRAPPC12	51112
MIM614140	*	 	SPERM ANTIGEN WITH CALPONIN HOMOLOGY AND COILED-COIL DOMAINS 1-LIKE; SPECC1L	23384
MIM614141	*	 	TRIPARTITE MOTIF-CONTAINING PROTEIN 2; TRIM2	23321
MIM614142	*	 	CUE DOMAIN-CONTAINING PROTEIN 2; CUEDC2	79004
MIM614143	*	 	IGF-LIKE FAMILY RECEPTOR 1; IGFLR1	79713
MIM614144	*	 	B9 DOMAIN-CONTAINING PROTEIN 1; B9D1	27077
MIM614145	*	 	COILED-COIL DOMAIN-CONTAINING PROTEIN 8; CCDC8	83987
MIM614146	*	 	CHROMOSOME 20 OPEN READING FRAME 194; C20ORF194	25943
MIM614147	*	 	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 8; C1QTNF8	390664
MIM614148	*	 	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 9B; C1QTNF9B	387911
MIM614149	%	 	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 9; NDNC9	100682325
MIM614150	*	 	PROTEIN KINASE DOMAIN-CONTAINING PROTEIN, CYTOPLASMIC, MOUSE, HOMOLOG OF; PKDCC	91461
MIM614151	*	 	RING FINGER AND WD REPEAT DOMAINS-CONTAINING PROTEIN 3; RFWD3	55159
MIM614152	#	 	DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64	56616
MIM614153	#	 	SPINOCEREBELLAR ATAXIA 36; SCA36	10528
MIM614154	*	 	NOP56, S. CEREVISIAE, HOMOLOG OF; NOP56	10528
MIM614155	*	 	MICRO RNA 1292; MIR1292	100302138
MIM614156	#	 	HYPERBILIVERDINEMIA; HBLVD	57171, 644
MIM614157	#	 	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 10; NDNC10	8323
MIM614158		 	BLEEDING DISORDER, PLATELET-TYPE, 14; BDPLT14	6916
MIM614159	*	 	ZINC FINGER PROTEIN 644; ZNF644	84146
MIM614160	#	 	MUSCLE HYPERTROPHY; MSLHP	2660
MIM614161	*	 	PR DOMAIN-CONTAINING PROTEIN 5; PRDM5	11107
MIM614162	#	 	CANDIDIASIS, FAMILIAL, 7; CANDF7	6772
MIM614163	#	 	DELAYED SLEEP PHASE SYNDROME, SUSCEPTIBILITY TO; DSPS	15
MIM614164	%	 	GLUTATHIONE PEROXIDASE DEFICIENCY; GPXD	2876
MIM614165	#	 	PARAGANGLIOMAS 5; PGL5	6389
MIM614166	%	 	MYOPIA 20, AUTOSOMAL DOMINANT; MYP20	100682326
MIM614167	#	 	MYOPIA 21, AUTOSOMAL DOMINANT; MYP21	84146
MIM614168	*	 	PHOSPHOENOLPYRUVATE CARBOXYKINASE 1, SOLUBLE; PCK1	5105
MIM614169	*	 	NEUROBEACHIN-LIKE 2; NBEAL2	23218
MIM614170	#	 	BRITTLE CORNEA SYNDROME 2; BCS2	11107
MIM614171	#	 	HERMANSKY-PUDLAK SYNDROME 9; HPS9	26258
MIM614172	#	 	DENDRITIC CELL, MONOCYTE, B LYMPHOCYTE, AND NATURAL KILLER LYMPHOCYTE DEFICIENCY; DCML	2624
MIM614173	#	 	JOUBERT SYNDROME 13; JBTS13	79600
MIM614174	*	 	MEIOSIS-EXPRESSED GENE 1, MOUSE, HOMOLOG OF; MEIG1	644890
MIM614175	#	 	MECKEL SYNDROME, TYPE 10; MKS10	80776
MIM614176	*	 	ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 28; ZFYVE28	57732
MIM614177	*	 	EF-HAND CALCIUM-BINDING DOMAIN-CONTAINING PROTEIN 4A; EFCAB4A	283229
MIM614178	*	 	EF-HAND CALCIUM-BINDING DOMAIN-CONTAINING PROTEIN 4B; EFCAB4B	84766
MIM614179	*	 	IMMUNOGLOBULIN SUPERFAMILY CONTAINING LEUCINE-RICH REPEAT 2; ISLR2	57611
MIM614180	#	 	RETINITIS PIGMENTOSA 61; RP61	7401
MIM614181	#	 	RETINITIS PIGMENTOSA 62; RP62	4117
MIM614182	*	 	HEART OF GLASS, ZEBRAFISH, HOMOLOG OF, 1; HEG1	57493
MIM614183	*	 	DIS3 MITOTIC CONTROL, S. CEREVISIAE, HOMOLOG-LIKE; DIS3L	115752
MIM614184	*	 	DIS3 MITOTIC CONTROL, S. CEREVISIAE, HOMOLOG-LIKE 2; DIS3L2	129563
MIM614185	#	 	GELEOPHYSIC DYSPLASIA 2; GPHYSD2	2200
MIM614186	#	 	LEBER CONGENITAL AMAUROSIS 16; LCA16	3769
MIM614187	%	 	HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	100682260
MIM614188	#	 	CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	3590
MIM614189	*	 	GOLGIN A7 FAMILY, MEMBER B; GOLGA7B	401647
MIM614190	#	 	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 3; PPNAD3	8622
MIM614191	*	 	DEP DOMAIN-CONTAINING PROTEIN 5; DEPDC5	9681
MIM614192	#	 	MACROCEPHALY, MACROSOMIA, FACIAL DYSMORPHISM SYNDROME; MMFD	84282
MIM614193	#	 	TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 2; TFQTL2	3077
MIM614194	*	 	DEDICATOR OF CYTOKINESIS 6; DOCK6	57572
MIM614195	#	 	CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME; CAASDS	30813
MIM614196	#	 	NEPHROTIC SYNDROME, TYPE 6; NPHS6	5800
MIM614197	*	 	MITOCHONDRIAL CALCIUM UNIPORTER; MCU	90550
MIM614198	#	 	MYASTHENIC SYNDROME, CONGENITAL, ACETAZOLAMIDE-RESPONSIVE	6329
MIM614199	#	 	NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES; NPHS5	3913
MIM614201	#	 	BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11	51206
MIM614202	#	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	11253
MIM614203	#	 	PARKINSON DISEASE 17; PARK17	55737
MIM614204	#	 	PUSTULAR PSORIASIS, GENERALIZED; PSORP	26525
MIM614205	#	 	THREE M SYNDROME 3; 3M3	83987
MIM614206	*	 	CHROMATIN TARGET OF PRMT1; CHTOP	26097
MIM614207	#	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 17; MRT17	100689013
MIM614208	%	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16; MRT16	100689014
MIM614209	#	 	MECKEL SYNDROME, TYPE 9; MKS9	27077
MIM614210	%	 	LUNG CANCER SUSCEPTIBILITY 5; LNCR5	100682395
MIM614211	%	 	DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33	29779
MIM614212	#	 	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	1376
MIM614213	#	 	NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	547
MIM614214	*	 	KELCH-LIKE 6; KLHL6	89857
MIM614215	*	 	ACTIVATING SIGNAL COINTEGRATOR 1 COMPLEX, SUBUNIT 1; ASCC1	51008
MIM614216	*	 	ACTIVATING SIGNAL COINTEGRATOR 1 COMPLEX, SUBUNIT 2; ASCC2	84164
MIM614217	*	 	ACTIVATING SIGNAL COINTEGRATOR 1 COMPLEX, SUBUNIT 3; ASCC3	10973
MIM614218	*	 	WD REPEAT-CONTAINING PROTEIN 81; WDR81	124997
MIM614219	#	 	ADAMS-OLIVER SYNDROME 2; AOS2	57572
MIM614220	%	 	BILIARY CIRRHOSIS, PRIMARY, 4; PBC4	100689215
MIM614221	%	 	BILIARY CIRRHOSIS, PRIMARY, 5; PBC5	100689212
MIM614222	#	 	WARBURG MICRO SYNDROME 3; WARBM3	22931
MIM614223	%	 	NARCOLEPSY 6, SUSCEPTIBILITY TO; NRCLP6	100689216
MIM614224	#	 	RETINAL ARTERIAL MACROANEURYSM WITH SUPRAVALVULAR PULMONIC STENOSIS; RAMSVPS	3490
MIM614225	#	 	WARBURG MICRO SYNDROME 2; WARBM2	25782
MIM614226	#	 	HOLOPROSENCEPHALY 11; HPE11	50937
MIM614227	%	 	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 3; HNFJ3	100689490
MIM614228	#	 	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	1778
MIM614229	#	 	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	255928
MIM614230	#	 	CHROMOSOME 8q21.11 DELETION SYNDROME	100689491
MIM614231	#	 	MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME; MEDS	51124
MIM614232	*	 	11-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II; HSD11B2	3291
MIM614233	%	 	HYPERPIGMENTATION, FAMILIAL PROGRESSIVE, 1; FPH1	 
MIM614234	*	 	CHROMOSOME 1 OPEN READING FRAME 88; C1ORF88	128344
MIM614235	*	 	PDZ DOMAIN-CONTAINING PROTEIN 8; PDZD8	118987
MIM614236	*	 	SOLUTE CARRIER FAMILY 38 (AMINO ACID TRANSPORTER), MEMBER 7; SLC38A7	55238
MIM614237	%	 	HYPOTRICHOSIS 9; HYPT9	100736250
MIM614238	%	 	HYPOTRICHOSIS 10; HYPT10	100736251
MIM614239	*	 	FAMILY WITH SEQUENCE SIMILARITY 109, MEMBER A; FAM109A	144717
MIM614240	*	 	FAMILY WITH SEQUENCE SIMILARITY 109, MEMBER B; FAM109B	150368
MIM614241	*	 	LYSOCARDIOLIPIN ACYLTRANSFERASE 1; LCLAT1	253558
MIM614242	*	 	SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 9; SLC16A9	220963
MIM614243	*	 	5-@OXOPROLINASE (ATP-HYDROLYZING); OPLAH	26873
MIM614244	*	 	PYRIDOXAL-DEPENDENT DECARBOXYLASE DOMAIN-CONTAINING PROTEIN 1; PDXDC1	23042
MIM614245	*	 	ACYL-CoA SYNTHETASE FAMILY, MEMBER 3; ACSF3	197322
MIM614246	*	 	N-ALPHA-ACETYLTRANSFERASE 60, NatF CATALYTIC SUBUNIT; NAA60	79903
MIM614247	*	 	MICRO RNA 519D; MIR519D	574480
MIM614248	*	 	PSEUDOPODIUM-ENRICHED ATYPICAL KINASE 1	79834
MIM614249	#	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 18; MRT18	9439
MIM614250	#	 	NARCOLEPSY 7; NRCLP7	4340
MIM614251	#	 	PARKINSON DISEASE 18; PARK18	1981
MIM614252	%	 	ANEURYSM, INTRACRANIAL BERRY, 11; ANIB11	100750328
MIM614253	^	 	AMELOGENESIS IMPERFECTA AND GINGIVAL FIBROMATOSIS SYNDROME; AIGFS	54757
MIM614254	#	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 8; MRD8	2902
MIM614255	#	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	547
MIM614256	#	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 10; MRD10	10369
MIM614257	#	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 11; MRD11	2036
MIM614258	*	 	POLYMERASE III, RNA, SUBUNIT A; POLR3A	11128
MIM614259	*	 	WD REPEAT-CONTAINING PROTEIN 65; WDR65	149465
MIM614260	*	 	CHROMOSOME 9 OPEN READING FRAME 72; C9ORF72	203228
MIM614263	*	 	BACE1 ANTISENSE RNA: BACE1AS	100379571
MIM614264	*	 	RHO GTPase-ACTIVATING PROTEIN 30; ARHGAP30	257106
MIM614265	#	 	COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	197322
MIM614266	#	 	BARRETT ESOPHAGUS	115908, 4481, 51008
MIM614267	*	 	ACYL-CoA THIOESTERASE 6; ACOT6	641372
MIM614268	*	 	G PROTEIN-COUPLED RECEPTOR 115; GPR115	221393
MIM614269	*	 	G PROTEIN-COUPLED RECEPTOR 153; GPR153	387509
MIM614270	*	 	COILED-COIL DOMAIN-CONTAINING PROTEIN 108; CCDC108	255101
MIM614271	*	 	COILED-COIL DOMAIN-CONTAINING PROTEIN 137; CCDC137	339230
MIM614272	*	 	FAST KINASE DOMAIN-CONTAINING PROTEIN 5; FASTKD5	60493
MIM614273	*	 	OLFACTORY RECEPTOR, FAMILY 4, SUBFAMILY C, MEMBER 46; OR4C46	119749
MIM614274	*	 	STRAWBERRY NOTCH, DROSOPHILA, HOMOLOG OF, 1; SBNO1	55206
MIM614275	*	 	ZINC FINGER PROTEIN 565; ZNF565	147929
MIM614276	*	 	PHOSPHOLIPASE C-LIKE 2; PLCL2	23228
MIM614277	*	 	UBIQUITIN-CONJUGATING ENZYME 2W; UBE2W	55284
MIM614278	#	 	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE DEFICIENCY; PAFAD	7941
MIM614279	#	 	46,XY SEX REVERSAL 8; SRXY8	1109, 1646
MIM614280	%	 	EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	100750238
MIM614281	*	 	ENDOTHELIAL CELL ADHESION MOLECULE; ESAM	90952
MIM614282	*	 	STROMAL CELL-DERIVED FACTOR 4; SDF4	51150
MIM614283	*	 	GLUCOCORTICOID-INDUCED TRANSCRIPT 1; GLCCI1	113263
MIM614284	#	 	STICKLER SYNDROME, TYPE V; STL5	1298
MIM614285	*	 	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 9; C1QTNF9	338872
MIM614286	#	 	MYELODYSPLASTIC SYNDROME; MDS	171023, 23451, 2624, 54790
MIM614287	*	 	OFC1 CANDIDATE GENE 1; OFCC1	266553
MIM614288	*	 	ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 11; ACAD11	84129
MIM614289	*	 	SUPPRESSOR OF LIN12-LIKE 2; SEL1L2	80343
MIM614290	#	 	TETRASOMY 18p	100750329
MIM614291	#	 	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4; BROVCA4	5892
MIM614292	#	 	MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION; MCVD	55214
MIM614293	#	 	HYDATIDIFORM MOLE, RECURRENT, 2; HYDM2	154288
MIM614294	#	 	CHROMOSOME 15q25 DELETION SYNDROME	100820632
MIM614295	*	 	BICAUDAL C, DROSOPHILA, HOMOLOG OF, 1; BICC1	80114
MIM614296	#	 	WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	54790, 7466
MIM614297	*	 	CHROMOSOME 19 OPEN READING FRAME 12; C19ORF12	83636
MIM614298	#	 	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	83636
MIM614299	#	 	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2; MMDS2	388962
MIM614300	#	 	HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	132
MIM614301	*	 	ATAXIN 1-LIKE; ATXN1L	342371
MIM614303	#	 	EDICT SYNDROME; EDICT	406960
MIM614304	*	 	MICRO RNA 137; MIR137	406928
MIM614305	#	 	SCLEROSTEOSIS 2; SOST2	4038
MIM614306	#	 	COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	6334
MIM614307	#	 	ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	23600
MIM614308	*	 	FORMIMINOTRANSFERASE N-TERMINAL SUBDOMAIN-CONTAINING GENE	348751
MIM614309	*	 	METHYLTRANSFERASE-LIKE 19; METTL19	152992
MIM614310	*	 	CENTROSOMAL PROTEIN, 70-KD; CEP70	80321
MIM614311	*	 	SYNAPSE DIFFERENTIATION-INDUCED GENE 1; SYNDIG1	79953
MIM614312	*	 	ZINC FINGER MYND-CONTAINING PROTEIN 15; ZMYND15	84225
MIM614313	*	 	ACYL-CoA THIOESTERASE 1; ACOT1	641371
MIM614314	*	 	ACYL-CoA THIOESTERASE 4; ACOT4	122970
MIM614315	*	 	ACYL-CoA THIOESTERASE 12; ACOT12	134526
MIM614316	*	 	VTI1, S. CEREVISIAE, HOMOLOG OF, A; VTI1A	143187
MIM614317	%	 	VESICOURETERAL REFLUX 4; VUR4	100820757
MIM614318	%	 	VESICOURETERAL REFLUX 5; VUR5	100820760
MIM614319	%	 	VESICOURETERAL REFLUX 6; VUR6	100820763
MIM614320	#	 	PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4	672
MIM614321	#	 	MYOPATHY, DISTAL, TATEYAMA TYPE; MPDT	859
MIM614322	#	 	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12	100820764
MIM614324	#	 	OVARIAN DYSGENESIS 3; ODG3	29893
MIM614325	#	 	PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	9378
MIM614326	#	 	FEINGOLD SYNDROME 2; FGLDS2	407975
MIM614327	#	 	TUMOR PREDISPOSITION SYNDROME; TPDS	8314
MIM614328	#	 	INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL; NISBD	6868
MIM614329	%	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 31; MRT31	100852399
MIM614330	*	 	COMPLEMENT COMPONENT 1, q SUBCOMPONENT-LIKE 2; C1QL2	165257
MIM614331	#	 	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6; HNPCC6	7048
MIM614332	#	 	SCHIZOPHRENIA 17; SCZD17	9378
MIM614333	%	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29; MRT29	100852393
MIM614334	*	 	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 13; DNAJC13	23317
MIM614335	#	 	ARTHROGRYPOSIS, DISTAL, TYPE 1B; DA1B	4604
MIM614336	*	 	PRESEQUENCE TRANSLOCASE-ASSOCIATED MOTOR 16, S. CEREVISIAE, HOMOLOG OF; PAM16	51025
MIM614337	#	 	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4	5395
MIM614338	%	 	PANCREATIC LIPASE DEFICIENCY; PNLIPD	5406
MIM614339	%	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 32; MRT32	100852400
MIM614340	#	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27; MRT27	100852397
MIM614341	%	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33; MRT33	100852394
MIM614342	%	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30; MRT30	100852401
MIM614343	%	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19; MRT19	100852395
MIM614344	%	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 23; MRT23	100852398
MIM614345	%	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24; MRT24	100852402
MIM614346	%	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25; MRT25	100852403
MIM614347	%	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28; MRT28	100852396
MIM614348	*	 	CHROMOSOME 6 OPEN READING FRAME 105; C6ORF105	84830
MIM614349	*	 	ZINC FINGER PROTEIN 638; ZNF638	27332
MIM614350	#	 	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5; HNPCC5	2956
MIM614351	*	 	NUCLEOPORIN, 93-KD; NUP93	9688
MIM614352	*	 	NUCLEOPORIN, 205-KD; NUP205	23165
MIM614353	*	 	HAS2 ANTISENSE RNA 1; HAS2AS1	594842
MIM614354	*	 	PRO2268 GENE	55390
MIM614355	*	 	ACYL-CoA SYNTHETASE SHORT CHAIN FAMILY, MEMBER 1; ACSS1	84532
MIM614356	*	 	ACYL-CoA SYNTHETASE SHORT CHAIN FAMILY, MEMBER 3; ACSS3	79611
MIM614357	*	 	ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 1; ACSM1	116285
MIM614358	*	 	ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 2A; ACSM2A	123876
MIM614359	*	 	ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 2B; ACSM2B	348158
MIM614360	*	 	ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 4; ACSM4	341392
MIM614361	*	 	ACYL-CoA SYNTHETASE MEDIUM CHAIN FAMILY, MEMBER 5; ACSM5	54988
MIM614362	*	 	ACYL-CoA SYNTHETASE, BUBBLEGUM FAMILY, MEMBER 1; ACSBG1	23205
MIM614363	*	 	ACYL-CoA SYNTHETASE, BUBBLEGUM FAMILY, MEMBER 2; ACSBG2	81616
MIM614364	*	 	ACETOACETYL-CoA SYNTHETASE; AACS	65985
MIM614365	*	 	AMINOADIPATE-SEMIALDEHYDE DEHYDROGENASE; AASDH	132949
MIM614366	*	 	POLYMERASE III, RNA, SUBUNIT B; POLR3B	55703
MIM614367	*	 	ADAPTOR-RELATED PROTEIN COMPLEX 5, BETA-1 SUBUNIT; AP5B1	91056
MIM614368	*	 	ADAPTOR-RELATED PROTEIN COMPLEX 5, MU-1 SUBUNIT; AP5M1	55745
MIM614369	#	 	PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	79784
MIM614370	#	 	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 5; SMDP5	1439
MIM614371	#	 	DENGUE VIRUS, SUSCEPTIBILITY TO	30835
MIM614372	#	 	MANNOSE-BINDING PROTEIN DEFICIENCY	4153
MIM614373	#	 	AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE; ALS16	10280
MIM614374	#	 	BLOOD GROUP, CHIDO/RODGERS SYSTEM	720
MIM614375	%	 	AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 4; AAA4	100859927
MIM614376	#	 	ASPHYXIATING THORACIC DYSTROPHY 5; ATD5	57728
MIM614377	#	 	NEPHRONOPHTHISIS 13; NPHP13	57728
MIM614378	#	 	CRANIOECTODERMAL DYSPLASIA 4; CED4	57728
MIM614379	#	 	COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD	721
MIM614380	#	 	COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD	720
MIM614381	#	 	LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD8	55703
MIM614382	#	 	BACTEREMIA, SUSCEPTIBILITY TO, 1; BACTS1	114609
MIM614383	#	 	BACTEREMIA, SUSCEPTIBILITY TO, 2; BACTS2	1154
MIM614384	*	 	MICRO RNA 492; MIR492	574449
MIM614385	#	 	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 7; HNPCC7	27030
MIM614386	*	 	PROLINE-RICH TRANSMEMBRANE PROTEIN 2; PRRT2	112476
MIM614387	*	 	ZINC FINGER PROTEIN 526; ZNF526	116115
MIM614388	#	 	ENCEPHALOPATHY, LETHAL, DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION; EMPF	10059
MIM614389	#	 	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 1; RPRGL1	2153
MIM614390	#	 	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 2; RPRGL2	2147
MIM614391	#	 	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 3; RPRGL3	308
MIM614392	*	 	TUDOR DOMAIN-CONTAINING PROTEIN 3; TDRD3	81550
MIM614393	*	 	CHROMOSOME 6 OPEN READING FRAME 130; C6ORF130	221443
MIM614394	*	 	INTRAFLAGELLAR TRANSPORT 20, CHLAMYDOMONAS, HOMOLOG OF: IFT20	90410
MIM614395	#	 	GRAFT-VERSUS-HOST DISEASE, SUSCEPTIBILITY TO; GVHDS	3586
MIM614396	*	 	G-PATCH DOMAIN-CONTAINING PROTEIN 8; GPATCH8	23131
MIM614397	*	 	MAJOR FACILITATOR SUPERFAMILY DOMAIN-CONTAINING PROTEIN 2A; MFSD2A	84879
MIM614398	*	 	KIAA1462 GENE; KIAA1462	57608
MIM614399	#	 	MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET; EMARDD	84466
MIM614400	#	 	GLUCOCORTICOID THERAPY, RESPONSE TO; GCTR	113263
MIM614401	#	 	ACCELERATED TUMOR FORMATION, SUSCEPTIBILITY TO; ACTFS	4193
MIM614402	#	 	MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	11023
MIM614403	*	 	RHOMBOID 5, DROSOPHILA, HOMOLOG OF, 1; RHBDF1	64285
MIM614404	*	 	RHOMBOID 5, DROSOPHILA, HOMOLOG OF, 2; RHBDF2	79651
MIM614405	*	 	DEAH BOX POLYPEPTIDE 33; DHX33	56919
MIM614406	*	 	SLP ADAPTOR- AND CSK-INTERACTING MEMBRANE PROTEIN; SCIMP	388325
MIM614408	#	 	MYOPATHY, CENTRONUCLEAR, 3; CNM3	4618
MIM614409	#	 	SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	100861438
MIM614410	*	 	ACTIN FILAMENT-ASSOCIATED PROTEIN 1-LIKE 1; AFAP1L1	134265
MIM614411	#	 	GLYCEROL QUANTITATIVE TRAIT LOCUS; GLYCQTL	364
MIM614412	*	 	CHROMOSOME 3 OPEN READING FRAME 77; C3ORF77	375337
MIM614413	*	 	AMINOACYLASE 3; ACY3	91703
MIM614414	%	 	DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96	100861440
MIM614415	#	 	CHILBLAIN LUPUS 2; CHBL2	25939
MIM614416	#	 	RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES; RHFCA	56603
MIM614417	#	 	EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5	57094
MIM614418	#	 	FEBRILE SEIZURES, FAMILIAL, 11; FEB11	57094
MIM614419	#	 	ASPARTATE AMINOTRANSFERASE, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1	2805
MIM614420	#	 	SYSTEMIC LUPUS ERYTHEMATOSUS 16; SLEB16	1776
MIM614421	^	 	WEAVER SYNDROME 2; WVS2	2146
MIM614422	%	 	CATARACT, CONGENITAL, CERULEAN TYPE, 5; CCA5	100861439
MIM614423	*	 	TRANSMEMBRANE PROTEIN 237; TMEM237	65062
MIM614424	#	 	JOUBERT SYNDROME 14; JBTS14	65062
MIM614425	*	 	TELO2-INTERACTING PROTEIN 1; TTI1	9675
MIM614426	*	 	TELO2-INTERACTING PROTEIN 2; TTI2	80185
MIM614427	*	 	TEASHIRT ZINC FINGER HOMEOBOX 1; TSHZ1	10194
MIM614428	*	 	TRANSCRIPTION FACTOR AP2-EPSILON; TFAP2E	339488
MIM614429	#	 	VENTRICULAR SEPTAL DEFECT 1; VSD1	2626
MIM614430	#	 	ATRIOVENTRICULAR SEPTAL DEFECT 4; AVSD4	2626
MIM614431	#	 	VENTRICULAR SEPTAL DEFECT 2; VSD2	10370
MIM614432	#	 	VENTRICULAR SEPTAL DEFECT 3; VSD3	1482
MIM614433	#	 	ATRIAL SEPTAL DEFECT 8; ASD8	10370
MIM614434	#	 	CUTIS LAXA, AUTOSOMAL DOMINANT 2; ADCL2	10516
MIM614435	#	 	HYPOPLASTIC LEFT HEART SYNDROME 2; HLHS2	1482
MIM614436	#	 	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P	90678
MIM614437	#	 	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB; ARCL1B	30008
MIM614438	#	 	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B	5831
MIM614439	*	 	ADP-RIBOSYLATION FACTOR-LIKE 14; ARL14	80117
MIM614440	*	 	PLECKSTRIN AND SEC7 DOMAINS-CONTAINING PROTEIN 3; PSD3	23362
MIM614441	#	 	HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2; PHOAR2	6578
MIM614442	*	 	PLECKSTRIN AND SEC7 DOMAINS-CONTAINING PROTEIN 4; PSD4	23550
MIM614443	*	 	EBNA1-BINDING PROTEIN 2; EBNA1BP2	10969
MIM614444	*	 	RAL GUANINE NUCLEOTIDE EXCHANGE FACTOR WITH PH DOMAIN AND SH3 DOMAIN-BINDING MOTIF 1; RALGPS1	9649
MIM614445	*	 	DEVELOPMENTAL PLURIPOTENCY-ASSOCIATED GENE 2; DPPA2	151871
MIM614446	*	 	ATPase, CLASS II, TYPE 9B; ATP9B	374868
MIM614447	*	 	G0/G1 SWITCH GENE 2; G0S2	50486
MIM614448	*	 	GEMININ COILED-COIL DOMAIN-CONTAINING PROTEIN; GMNC	647309
MIM614449	*	 	PROTOCADHERIN 20; PCDH20	64881
MIM614450	#	 	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	7067
MIM614451	*	 	ELONGATION OF VERY LONG CHAIN FATTY ACIDS-LIKE 7; ELOVL7	79993
MIM614452	*	 	ATPASE FAMILY, AAA DOMAIN-CONTAINING, MEMBER 1; ATAD1	84896
MIM614453	*	 	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 7; LRRC7	57554
MIM614454	*	 	UBIQUITIN PROTEIN LIGASE E3C; UBE3C	9690
MIM614455	#	 	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E; CMTDIE	64423
MIM614456	#	 	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8; CMM8	 
MIM614457	#	 	ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	6785
MIM614458	#	 	THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE); THMD5	27010
MIM614459	*	 	TRANSMEMBRANE PROTEIN 138; TMEM138	51524
MIM614460	*	 	UBIQUITIN-SPECIFIC PROTEASE 47; USP47	55031
MIM614461	*	 	CHROMOSOME 6 OPEN READING FRAME 125; C6ORF125	84300
MIM614462	#	 	PYRUVATE DEHYDROGENASE LIPOIC ACID SYNTHETASE DEFICIENCY; PDHLD	11019
MIM614463	*	 	NMYC DOWNSTREAM-REGULATED GENE 4; NDRG4	65009
MIM614464	#	 	JOUBERT SYNDROME 15; JBTS15	95681
MIM614465	#	 	JOUBERT SYNDROME 16; JBTS16	51524
MIM614466	#	 	CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 6; CHDS6	 
MIM614467	^	 	MOVED TO 212350	 
MIM614468	#	 	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	5336
MIM614469	*	 	SERRATE RNA EFFECTOR MOLECULE, ARABIDOPSIS, HOMOLOG OF; SRRT	51593
MIM614470	#	 	AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IV; ALPS4	4893
MIM614471	*	 	UBIQUITIN-SPECIFIC PROTEASE 19; USP19	10869
MIM614472	*	 	RING FINGER PROTEIN 123; RNF123	63891
MIM614473	#	 	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2	368
MIM614474	#	 	ATRIOVENTRICULAR SEPTAL DEFECT 5; AVSD5	2627
MIM614475	#	 	ATRIAL SEPTAL DEFECT 9; ASD9	2627
MIM614476	*	 	THROMBOSPONDIN TYPE-1 DOMAIN-CONTAINING PROTEIN 4; THSD4	79875
MIM614477	*	 	CHROMOSOME 8 OPEN READING FRAME 37; C8ORF37	157657
MIM614478	*	 	CHROMOSOME 12 OPEN READING FRAME 62; C12ORF62	84987
MIM614479	*	 	MALONYL CoA:ACP ACYLTRANSFERASE, MITOCHONDRIAL; MCAT	27349
MIM614480	#	 	HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI	2819
MIM614481	*	 	ATXN7 ANTISENSE RNA 1; ATXN7AS1	100861563
MIM614482	#	 	CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	9197
MIM614483	#	 	PORENCEPHALY 2; POREN2	1284
MIM614484	*	 	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 13; ANAPC13	25847
MIM614485	#	 	TRIGONOCEPHALY 2; TRIGNO2	158326
MIM614486	#	 	THROMBOPHILIA DUE TO THROMBOMODULIN DEFECT; THPH12	7056
MIM614487	#	 	SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE; SPAX5	10939
MIM614488	*	 	MICRO RNA 1258; MIR1258	100302172
MIM614489	*	 	MICRO RNA 616; MIR616	693201
MIM614490	#	 	BLOOD GROUP, JUNIOR SYSTEM; JR	9429
MIM614491	#	 	PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B	65266
MIM614492	#	 	PSEUDOHYPOALDOSTERONISM, TYPE IIC; PHA2C	65125
MIM614493	#	 	WISKOTT-ALDRICH SYNDROME 2; WAS2	7456
MIM614494	%	 	RETINITIS PIGMENTOSA 63; RP63	100862681
MIM614495	#	 	PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D	26249
MIM614496	#	 	PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	8452
MIM614497	#	 	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 7; MCOPCB7	 
MIM614498	#	 	RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	221927
MIM614499	#	 	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34; MRT34	8738
MIM614500	#	 	CONE-ROD DYSTROPHY 16; CORD16	157657
MIM614501	#	 	PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM; PMRED	79753
MIM614502	*	 	CHROMOSOME 9 OPEN READING FRAME 116; C9ORF116	138162
MIM614503	*	 	KELCH DOMAIN-CONTAINING PROTEIN 8A; KLHDC8A	55220
MIM614504	#	 	USHER SYNDROME, TYPE IIIB; USH3B	3035
MIM614505	*	 	FK506-BINDING PROTEIN 14; FKBP14	55033
MIM614506	*	 	BRCA1-ASSOCIATED ATM ACTIVATOR 1; BRAT1	221927
MIM614507	#	 	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ir; CDG1R	1650
MIM614508	#	 	MIRROR MOVEMENTS 2; MRMV2	5888
MIM614509	*	 	MICRO RNA 99A; MIR99A	407055
MIM614510	*	 	MICRO RNA 99B; MIR99B	407056
MIM614511	*	 	MYOD FAMILY INHIBITOR DOMAIN-CONTAINING PROTEIN; MDFIC	29969
MIM614512	*	 	TORSIN A-INTERACTING PROTEIN 1; TOR1AIP1	26092
MIM614513	*	 	TORSIN A-INTERACTING PROTEIN 2; TOR1AIP2	163590
MIM614514	#	 	THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE; THPH6	5627
MIM614515	*	 	G PROTEIN-COUPLED RECEPTOR 179; GPR179	440435
MIM614517	*	 	ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR-LIKE PROTEIN 2; ARNTL2	56938
MIM614518	*	 	GATA ZINC FINGER DOMAIN-CONTAINING PROTEIN 1; GATAD1	57798
MIM614519	#	 	HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH	1284, 1636
MIM614521	#	 	THROMBOCYTHEMIA 3; THCYT3	3717
MIM614522	*	 	KELCH-LIKE 12; KLHL12	59349
MIM614523	*	 	MICRO RNA 489; MIR489	574442
MIM614524	#	 	FIBROCHONDROGENESIS 2; FBCG2	1302
MIM614525	*	 	NFATC2-INTERACTING PROTEIN; NFATC2IP	84901
MIM614526	#	 	CHROMOSOME 17q12 DUPLICATION SYNDROME	100884129
MIM614527	#	 	CHROMOSOME 17q12 DELETION SYNDROME	100884130
MIM614528	*	 	HIF1A ANTISENSE RNA 1; HIF1AAS1	100750246
MIM614529	*	 	HIF1A ANTISENSE RNA 2; HIF1AAS2	100750247
MIM614530	*	 	NADH-UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX, 12; NDUFA12	55967
MIM614531	*	 	RASGEF DOMAIN FAMILY, MEMBER 1A; RASGEF1A	221002
MIM614532	*	 	RASGEF DOMAIN FAMILY, MEMBER 1B; RASGEF1B	153020
MIM614533	*	 	CELL DIVISION CYCLE 26, S. CEREVISIAE, HOMOLOG OF; CDC26	246184
MIM614534	*	 	ANAPHASE-PROMOTING COMPLEX SUBUNIT 11; ANAPC11	51529
MIM614535	*	 	ZINC FINGER SWIM DOMAIN-CONTAINING PROTEIN 7; ZSWIM7	125150
MIM614536	*	 	SWIM-TYPE ZINC FINGER DOMAIN-CONTAINING PROTEIN 7-ASSOCIATED PROTEIN 1; SWSAP1	126074
MIM614537	*	 	CHROMOSOME 10 OPEN READING FRAME 11; C10ORF11	83938
MIM614538	*	 	MICRO RNA 570; MIR570	693155
MIM614539	*	 	HELICASE, DNA, B; HELB	92797
MIM614540	^	 	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 3; IBGC3	6575
MIM614541	#	 	CHROMOSOME 16q22 DELETION SYNDROME	100874527
MIM614542	*	 	FAMILY WITH SEQUENCE SIMILARITY 69, MEMBER A; FAM69A	388650
MIM614543	*	 	FAMILY WITH SEQUENCE SIMILARITY 69, MEMBER B; FAM69B	138311
MIM614544	*	 	FAMILY WITH SEQUENCE SIMILARITY 69, MEMBER C; FAM69C	125704
MIM614545	*	 	CHROMOSOME 19 OPEN READING FRAME 63; C19ORF63	284361
MIM614546	#	 	EFAVIRENZ, POOR METABOLISM OF	1555
MIM614547	*	 	FAMILY WITH SEQUENCE SIMILARITY 103, MEMBER A1; FAM103A1	83640
MIM614548	*	 	SERINE INCORPORATOR 1; SERINC1	57515
MIM614549	*	 	SERINE INCORPORATOR 2; SERINC2	347735
MIM614550	*	 	SERINE INCORPORATOR 4; SERINC4	619189
MIM614551	*	 	SERINE INCORPORATOR 5; SERINC5	256987
MIM614552	*	 	XYLOSIDE XYLOSYLTRANSFERASE 1; XXYLT1	152002
MIM614553	*	 	N6 ADENINE-SPECIFIC DNA METHYLTRANSFERASE 1, PUTATIVE; N6AMT1	29104
MIM614554	*	 	FAMILY WITH SEQUENCE SIMILARITY 32, MEMBER A; FAM32A	26017
MIM614555	*	 	FERM DOMAIN-CONTAINING PROTEIN 6; FRMD6	122786
MIM614556	*	 	AT-RICH INTERACTION DOMAIN-CONTAINING PROTEIN 1B; ARID1B	57492
MIM614557	#	 	EHLERS-DANLOS SYNDROME WITH PROGRESSIVE KYPHOSCOLIOSIS, MYOPATHY, AND HEARING LOSS; EDSKMH	55033
MIM614558	#	 	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13; EIEE13	6334
MIM614559	#	 	INFANTILE CEREBELLAR-RETINAL DEGENERATION; ICRD	50
MIM614560	*	 	MAU2 CHROMATID COHESION FACTOR, C. ELEGANS, HOMOLOG OF; MAU2	23383
MIM614562	#	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12; MRD12	57492
MIM614563	#	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 13; MRD13	1778
MIM614564	#	 	CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL; FCTCS	545
MIM614565	#	 	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E; CSNB1E	440435
MIM614566	*	 	DYNEIN, AXONEMAL, ASSEMBLY FACTOR 3; DNAAF3	352909
MIM614567	*	 	DIAPHANOUS, DROSOPHILA, HOMOLOG OF, 3; DIAPH3	81624
MIM614568	*	 	UNC13, C. ELEGANS, HOMOLOG OF, C; UNC13C	440279
MIM614570	*	 	KINESIN FAMILY MEMBER 18B; KIF18B	146909
MIM614571	*	 	CHROMOSOME 5 OPEN READING FRAME 42; C5ORF42	65250
MIM614572	*	 	ZINC FINGER PROTEIN 42; ZFP42	132625
MIM614573	*	 	G PROTEIN-COUPLED RECEPTOR 158; GPR158	57512
MIM614574	*	 	ROGDI, DROSOPHILA, HOMOLOG OF; ROGDI	79641
MIM614576	#	 	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	57511
MIM614577	*	 	PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 3; PAQR3	152559
MIM614578	*	 	PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 4; PAQR4	124222
MIM614579	*	 	PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 6; PAQR6	79957
MIM614580	*	 	PROGESTIN AND ADIPOQ RECEPTOR FAMILY, MEMBER 9; PAQR9	344838
MIM614581	*	 	MONOCYTE-TO-MACROPHAGE DIFFERENTIATION-ASSOCIATED PROTEIN 2; MMD2	221938
MIM614582	#	 	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	11222
MIM614583	#	 	BARAITSER-WINTER SYNDROME 2; BRWS2	71
MIM614584	*	 	PROLYL 4-HYDROXYLASE, TRANSMEMBRANE; P4HTM	54681
MIM614585	*	 	FERREDOXIN 1-LIKE PROTEIN; FDX1L	112812
MIM614586	*	 	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 5; ZDHHC5	25921
MIM614587	*	 	ChaC, E. COLI, HOMOLOG OF, 1; CHAC1	79094
MIM614588	%	 	DYSTONIA 21; DYT21	100885773
MIM614589	*	 	TETRATRICOPEPTIDE REPEAT DOMAIN 37; TTC37	9652
MIM614590	%	 	PODOCONIOSIS, SUSCEPTIBILITY TO; PDCOS	100885774
MIM614591	*	 	CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 16; CEACAM16	388551
MIM614592	#	 	BENT BONE DYSPLASIA SYNDROME; BBDS	2263
MIM614593	*	 	KIAA0430 GENE; KIAA0430	9665
MIM614594	#	 	PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES	162514
MIM614595	#	 	PREECLAMPSIA/ECLAMPSIA 5; PEE5	10699
MIM614596	*	 	MICRO RNA 302A; MIR302A	407028
MIM614597	*	 	MICRO RNA 302B; MIR302B	442894
MIM614598	*	 	MICRO RNA 302C; MIR302C	442895
MIM614599	*	 	MICRO RNA 302D; MIR302D	442896
MIM614600	*	 	MICRO RNA 367; MIR367	442912
MIM614601	*	 	ZINC FINGER PROTEIN 326; ZNF326	284695
MIM614602	#	 	TRICHOHEPATOENTERIC SYNDROME 2; THES2	6499
MIM614603	*	 	DDHD DOMAIN-CONTAINING PROTEIN 1; DDHD1	80821
MIM614604	*	 	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 7; ZDHHC7	55625
MIM614605	*	 	ZINC FINGER DHHC DOMAIN-CONTAINING PROTEIN 21; ZDHHC21	340481
MIM614606	*	 	FOCADHESIN; FOCAD	54914
MIM614607	#	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 14; MRD14	8289
MIM614608	#	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 15; MRD15	6598
MIM614609	#	 	MENTAL RETARDATION, AUTOSOMAL DOMINANT 16; MRD16	6597
MIM614610	*	 	KN MOTIF- AND ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 2; KANK2	25959
MIM614611	*	 	KN MOTIF- AND ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 3; KANK3	256949
MIM614612	*	 	KN MOTIF- AND ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 4; KANK4	163782
MIM614613	#	 	ACRODYSOSTOSIS 2, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS2	5144
MIM614614	#	 	DEAFNESS, AUTOSOMAL DOMINANT 4B; DFNA4B	388551
MIM614615	#	 	JOUBERT SYNDROME 17; JBTS17	65250
MIM614616	#	 	DIARRHEA 6; DIAR6	2984
MIM614617	#	 	DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86	100887823
MIM614618	#	 	HYPEREKPLEXIA 3; HKPX3	9152
MIM614619	#	 	HYPEREKPLEXIA 2; HKPX2	2743
MIM614620	*	 	INTRAFLAGELLAR TRANSPORT 140, CHLAMYDOMONAS, HOMOLOG OF; IFT140	9742
MIM614621	#	 	UV-SENSITIVE SYNDROME 2; UVSS2	1161
MIM614622	%	 	KERATOCONUS 5; KTCN5	100885801
MIM614623	%	 	KERATOCONUS 6; KTCN6	100885802
MIM614624	*	 	MITOCHONDRIAL ASSEMBLY OF RIBOSOMAL LARGE SUBUNIT 1; MALSU1	115416
MIM614625	*	 	DIFFERENTIATION-ANTAGONIZING NONCODING RNA; DANCR	57291
MIM614626	*	 	SMALL NUCLEOLAR RNA, H/ACA BOX, 26; SNORA26	677810
MIM614627	*	 	MICRO RNA 4449; MIR4449	100616436
MIM614628	%	 	KERATOCONUS 8; KTCN8	100885803
MIM614629	%	 	KERATOCONUS 7; KTCN7	100887822
MIM614630	*	 	ANDROGLOBIN; ADGB	79747
MIM614631	*	 	ISOPRENOID SYNTHASE DOMAIN-CONTAINING PROTEIN; ISPD	729920
MIM614632	*	 	UV-STIMULATED SCAFFOLD PROTEIN A; UVSSA	57654
MIM614633	*	 	VACUOLAR PROTEIN SORTING 54, S. CEREVISIAE, HOMOLOG OF; VPS54	51542
MIM614634	*	 	KIAA1377 GENE; KIAA1377	57562
MIM614635	*	 	LONG INTERGENIC NONCODING RNA 538; LINC00538	100861504
MIM614636	*	 	MYOSIN IH; MYO1H	283446
MIM614637	*	 	DESUMOYLATING ISOPEPTIDASE 1; DESI1	27351
MIM614638	*	 	DESUMOYLATING ISOPEPTIDASE 2; DESI2	51029
MIM614639	*	 	ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 46; ZBTB46	140685
MIM614640	#	 	UV-SENSITIVE SYNDROME 3; UVSS3	57654
MIM614641	*	 	LYSOSOME-ASSOCIATED MEMBRANE PROTEIN 5; LAMP5	24141
MIM614642	*	 	START DOMAIN-CONTAINING PROTEIN 9; STARD9	57519
MIM614643	#	 	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	729920
MIM614644	%	 	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 4; MPVQTL4	100887753
MIM614645	%	 	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 5; MPVQTL5	100887752
MIM614646	%	 	MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 6; MPVQTL6	100887751
MIM614647	*	 	COQ6, S. CEREVISIAE, HOMOLOG OF; COQ6	51004
MIM614648	*	 	RALY-LIKE PROTEIN; RALYL	138046
MIM614649	*	 	RING FINGER PROTEIN 170; RNF170	81790
MIM614650	#	 	COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	51004
MIM614651	#	 	COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2	23590
MIM614652	#	 	COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	57107
MIM614653	#	 	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6	667
MIM614654	#	 	COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	57017
MIM614655	%	 	STUTTERING, FAMILIAL PERSISTENT, 3; STUT3	100909386
MIM614656	*	 	KIAA1274 GENE; KIAA1274	27143
MIM614657	*	 	ANGIOMOTIN-LIKE 1; AMOTL1	154810
MIM614658	*	 	ANGIOMOTIN-LIKE 2; AMOTL2	51421
MIM614659	*	 	FAMILY WITH SEQUENCE SIMILARITY 123, MEMBER A; FAM123A	219287
MIM614660	*	 	PROTEIN ASSOCIATED WITH TOPOISOMERASE II, S. CEREVISIAE, HOMOLOG OF, 1; PATL1	219988
MIM614661	*	 	PROTEIN ASSOCIATED WITH TOPOISOMERASE II, S. CEREVISIAE, HOMOLOG OF, 2; PATL2	197135
MIM614662	#	 	CORTISONE REDUCTASE DEFICIENCY 2; CORTRD2	3290
MIM614663	*	 	HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN ASSOCIATED WITH LETHAL YELLOW, MOUSE, HOMOLOG OF; RALY	22913
MIM614664	*	 	TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-LIKE PROTEIN 4; TREML4	285852
MIM614665	#	 	MECONIUM ILEUS	2984
MIM614666	*	 	COILED-COIL DOMAIN-CONTAINING PROTEIN 78; CCDC78	124093
MIM614667	*	 	MITOCHONDRIAL TRANSLATION OPTIMIZATION 1, S. CEREVISIAE, HOMOLOG OF; MTO1	25821
MIM614668	%	 	STUTTERING, FAMILIAL PERSISTENT, 4; STUT4	100909385
MIM614669	#	 	AURICULOCONDYLAR SYNDROME 2; ARCND2	5332
MIM614671	#	 	CHROMOSOME 16p11.2 DUPLICATION SYNDROME	100909384
MIM614672	#	 	CARDIOMYOPATHY, DILATED, 2B; CMD2B	57798
MIM614673	#	 	MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8	9662
MIM614674	#	 	PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	3350
MIM614675	#	 	BONE MARROW FAILURE, FAMILIAL; BMFF	6731
MIM614676	%	 	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 21; CMH21	100909387
MIM614677	*	 	COILED-COIL DOMAIN-CONTAINING PROTEIN 103; CCDC103	388389
MIM614678	#	 	PONTOCEREBELLAR HYPOPLASIA, TYPE 1B; PCH1B	51010
MIM614679	#	 	CILIARY DYSKINESIA, PRIMARY, 17; CILD17	388389
MIM614680	#	 	INFLUENZA, SEVERE, SUSCEPTIBILITY TO	 
MIM614681	*	 	AMINOGLYCOSIDE PHOSPHOTRANSFERASE DOMAIN-CONTAINING PROTEIN 1; AGPHD1	123688
MIM614682	*	 	ALANINE-GLYOXYLATE AMINOTRANSFERASE 2-LIKE 1; AGXT2L1	64850
MIM614683	*	 	ALANINE-GLYOXYLATE AMINOTRANSFERASE 2-LIKE 2; AGXT2L2	85007
MIM614685	*	 	ZINC FINGER PROTEIN 597; ZNF597	146434
MIM614686	*	 	FAMILY WITH SEQUENCE SIMILARITY 50, MEMBER B; FAM50B	26240
MIM614689	#	 	SOLUBLE INTERLEUKIN-6 RECEPTOR, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS	 
MIM614690	*	 	CHROMOSOME 4 OPEN READING FRAME 48; C4ORF48	401115
MIM614691	#	 	CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 5; CATC5	55750
MIM614693	*	 	ATM INTERACTOR; ATMIN	23300
MIM614694	*	 	REGULATION OF NUCLEAR PRE-mRNA DOMAIN-CONTAINING PROTEIN 1B; RPRD1B	58490
MIM614695	*	 	REGULATION OF NUCLEAR PRE-mRNA DOMAIN-CONTAINING 2; RPRD2	23248
MIM614696	#	 	AMYOTROPHIC LATERAL SCLEROSIS 17; ALS17	25978
MIM614697	*	 	KATANIN, p60 SUBUNIT, A-LIKE PROTEIN 2; KATNAL2	83473
MIM614698	*	 	CYTOCHROME c OXIDASE 20, S. CEREVISIAE, HOMOLOG OF; COX20	116228
MIM614699	#	 	IMMUNODEFICIENCY, COMMON VARIABLE, 7; CVID7	1380
MIM614700	#	 	IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8	987
MIM614701	#	 	CORNELIA DE LANGE SYNDROME 4; CDLS4	5885
MIM614702	#	 	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10; COXPD10	25821
MIM614703	*	 	SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 2B; SRGAP2B	647135
MIM614704	*	 	SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 2C; SRGAP2C	653464
MIM614706	#	 	CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	2896
MIM614707	#	 	BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	79581
MIM614708	*	 	SIGNAL PEPTIDE-, CUB DOMAIN-, AND EGF-LIKE DOMAINS-CONTAINING PROTEIN 3; SCUBE3	222663
MIM614709	*	 	LYR MOTIF-CONTAINING PROTEIN 1; LYRM1	57149
MIM614710	*	 	FAMILY WITH SEQUENCE SIMILARITY 72, MEMBER A; FAM72A	729533
MIM614711	*	 	FAMILY WITH SEQUENCE SIMILARITY 72, MEMBER B; FAM72B	653820
MIM614712	*	 	FAMILY WITH SEQUENCE SIMILARITY 72, MEMBER D; FAM72D	728833
MIM614713	*	 	RAS ASSOCIATION DOMAIN FAMILY, MEMBER 10; RASSF10	644943
MIM614715	*	 	TRANSMEMBRANE AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 2; TMIGD2	126259
MIM614716	*	 	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 16B; LRRC16B	90668
MIM614717	*	 	ANAPHASE-PROMOTING COMPLEX, SUBUNIT 15; ANAPC15	25906
MIM614718	*	 	CHROMOSOME 15 OPEN READING FRAME 23; C15ORF23	90417
MIM614719	*	 	POTASSIUM CHANNEL MODULATORY FACTOR 1; KCMF1	56888
MIM614720	*	 	CYCLIN-DEPENDENT KINASE 19; CDK19	23097
MIM614721	*	 	TSPY-LIKE 5; TSPYL5	85453
MIM614722	*	 	MICRO RNA 3120; MIR3120	100422882
MIM614723	#	 	ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY; APRTD	353
MIM614724	*	 	CENTROSOMAL PROTEIN, 63-KD; CEP63	80254
MIM614725	*	 	SERINE ACTIVE SITE-CONTAINING PROTEIN 1; SERAC1	84947
MIM614726	*	 	TRANSMEMBRANE PROTEIN 165; TMEM165	55858
MIM614727	#	 	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk; CDG2K	55858
MIM614728	#	 	SECKEL SYNDROME 6; SCKL6	80254
MIM614729	*	 	COP9, SUBUNIT 6; COPS6	10980
MIM614730	*	 	PHOSPHATIDYLINOSITOL GLYCAN, CLASS O; PIGO	84720
MIM614731	#	 	PROSTATE CANCER, HEREDITARY, 2; HPC2	60528
MIM614732	#	 	INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES	1028
MIM614733	*	 	MICRO RNA 193A; MIR193A	406968
MIM614734	*	 	MICRO RNA 193B; MIR193B	574455
MIM614735	*	 	MICRO RNA 365A; MIR365A	100126355
MIM614736	#	 	GLUCOCORTICOID DEFICIENCY 4; GCCD4	23530
MIM614737	*	 	BRAIN PROTEIN 44; BRP44	25874
MIM614738	*	 	BRAIN PROTEIN 44-LIKE; BRP44L	51660
MIM614739	#	 	3-@METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	84947
MIM614740	#	 	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7; BCC7	7157
MIM614741	#	 	MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY; MPYCD	51660
MIM614742	#	 	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1	7015
MIM614743	#	 	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2; PFBMFT2	7012
MIM614744	#	 	FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	3211
MIM614745	#	 	BLOOD GROUP, JOHN MILTON HAGEN SYSTEM	8482
MIM614746	%	 	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 5; UAQTL5	100996934
MIM614747	%	 	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 6; UAQTL6	100996935
MIM614748	#	 	INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL	3675
MIM614749	#	 	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	84720
MIM614750	#	 	MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 2; CMSTA2	1798
MIM614751	#	 	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VB; HMN5B	65055
MIM614752	#	 	INTERLEUKIN 6, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS	3570
MIM614753	#	 	SOTOS SYNDROME 2; SOTOS2	4784
MIM614754	*	 	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR 3; DMRT3	58524
MIM614755	*	 	MICRO RNA 520H; MIR520H	574493
MIM614756	#	 	CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	23261
MIM614757	*	 	INTERFERON-INDUCED TRANSMEMBRANE PROTEIN 5; IFITM5	387733
MIM614758	*	 	DYNACTIN 4; DCTN4	51164
MIM614759	*	 	COILED-COIL DOMAIN-CONTAINING PROTEIN 11; CCDC11	220136
MIM614760	*	 	PQ LOOP REPEAT-CONTAINING PROTEIN 2; PQLC2	54896
MIM614761	*	 	GLYCINE N-ACYLTRANSFERASE-LIKE 1; GLYATL1	92292
MIM614762	*	 	GLYCINE N-ACYLTRANSFERASE-LIKE 2; GLYATL2	219970
MIM614763	*	 	GLYCINE N-ACYLTRANSFERASE-LIKE 3; GLYATL3	389396
MIM614764	*	 	KATANIN p60 SUBUNIT A-LIKE 1; KATNAL1	84056
MIM614765	*	 	STRIATIN, CALMODULIN-BINDING PROTEIN; STRN	6801
MIM614766	*	 	STRIATIN, CALMODULIN-BINDING PROTEIN 3; STRN3	29966
MIM614767	*	 	STRIATIN, CALMODULIN-BINDING PROTEIN 4; STRN4	29888
MIM614768	*	 	TRANSMEMBRANE PROTEIN 66; TMEM66	51669
MIM614769	*	 	CYTOCHROME C OXIDASE ASSEMBLY FACTOR 1, S. CEREVISIAE, HOMOLOG OF; COA1	55744
MIM614770	*	 	PET100, S. CEREVISIAE, HOMOLOG OF; PET100	100131801
MIM614771	*	 	PET117, S. CEREVISIAE, HOMOLOG OF; PET117	100303755
MIM614772	*	 	CHROMOSOME 1 OPEN READING FRAME 31; C1ORF31	388753
MIM614773	*	 	MSS51 MITOCHONDRIAL TRANSLATIONAL ACTIVATOR, S. CEREVISIAE, HOMOLOG OF; MSS51	118490
MIM614774	*	 	PENTATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 1; PTCD1	26024
MIM614775	*	 	CYTOCHROME C OXIDASE ASSEMBLY FACTOR 3; COA3	28958
MIM614776	*	 	SIK FAMILY KINASE 3; SIK3	23387
MIM614777	*	 	MMS19 NUCLEOTIDE EXCISION REPAIR, S. CEREVISIAE, HOMOLOG OF; MMS19	64210
MIM614778	*	 	FAMILY WITH SEQUENCE SIMILARITY 96, MEMBER B; FAM96B	51647
MIM614779	#	 	HETEROTAXY, VISCERAL, 6, AUTOSOMAL; HTX6	220136
MIM614780	*	 	SORTING NEXIN 10; SNX10	29887
MIM614781	*	 	TECTONIN BETA-PROPELLER REPEAT-CONTAINING 1; TECPR1	25851
MIM614782	#	 	TREMOR, HEREDITARY ESSENTIAL, 4; ETM4	2521
MIM614783	*	 	POC1 CENTRIOLAR PROTEIN, CHLAMYDOMONAS, HOMOLOG OF, A; POC1A	25886
MIM614784	*	 	POC1 CENTRIOLAR PROTEIN, CHLAMYDOMONAS, HOMOLOG OF, B; POC1B	282809
MIM614785	*	 	MITOCHONDRIAL FISSION FACTOR; MFF	56947
MIM614786	*	 	TRANSMEMBRANE PROTEIN 207; TMEM207	131920
MIM614787	*	 	POGO TRANSPOSABLE ELEMENT WITH ZNF DOMAIN; POGZ	23126
MIM614788	*	 	FYVE, RhoGEF, AND PH DOMAIN-CONTAINING PROTEIN 5; FGD5	152273
MIM614789	*	 	EGF DOMAIN-SPECIFIC O-LINKED N-ACETYLGLUCOSAMINE TRANSFERASE; EOGT	285203
MIM614790	*	 	WT1-INTERACTING PROTEIN; WTIP	126374
MIM614791	*	 	MICRO RNA 199B; MIR199B	406978
MIM614792	*	 	TRANSMEMBRANE AND UBIQUITIN-LIKE DOMAIN-CONTAINING PROTEIN 1; TMUB1	83590
MIM614793	*	 	MIXED-LINEAGE KINASE 4	84451
MIM614794	*	 	1-@ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 3; AGPAT3	56894
MIM614795	*	 	1-@ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 4; AGPAT4	56895
MIM614796	*	 	1-@ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 5; AGPAT5	55326
MIM614797	*	 	PELLINO, DROSOPHILA, HOMOLOG OF, 1; PELI1	57162
MIM614798	*	 	PELLINO, DROSOPHILA, HOMOLOG OF, 2; PELI2	57161
MIM614799	*	 	CHROMOSOME 1 OPEN READING FRAME 109; C1ORF109	54955
MIM614800	#	 	SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	51594
MIM614801	*	 	MALE-SPECIFIC LETHAL 1, DROSOPHILA, HOMOLOG OF; MSL1	339287
MIM614802	*	 	MALE-SPECIFIC LETHAL 2, DROSOPHILA, HOMOLOG OF; MSL2	55167
MIM614803	*	 	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR A1; DMRTA1	63951
MIM614804	*	 	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR A2; DMRTA2	63950
MIM614805	*	 	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR B1; DMRTB1	63948
MIM614806	*	 	DOUBLESEX- AND MAB3-RELATED TRANSCRIPTION FACTOR C2; DMRTC2	63946
MIM614807	#	 	MYOPATHY, CENTRONUCLEAR, 4; CNM4	124093
MIM614808	#	 	AMYOTROPHIC LATERAL SCLEROSIS 18; ALS18	5216
MIM614809	#	 	CFHR5 DEFICIENCY	81494
MIM614810	#	 	MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 5; MS5	7132
MIM614811	*	 	L-3-HYDROXYPROLINE DEHYDRATASE, TRANS; L3HYPDH	112849
MIM614812	*	 	NUCLEAR PROTEIN, TRANSCRIPTIONAL REGULATOR, 1; NUPR1	26471
MIM614813	#	 	SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS; SOFT	25886
MIM614814	#	 	ADAMS-OLIVER SYNDROME 3; AOS3	3516
MIM614815	#	 	JOUBERT SYNDROME 18; JBTS18	26123
MIM614816	#	 	LOEYS-DIETZ SYNDROME, TYPE 4; LDS4	7042
MIM614817	#	 	INTERSTITIAL NEPHRITIS, KARYOMEGALIC; KMIN	22909
MIM614818	*	 	FURRY, DROSOPHILA, HOMOLOG OF; FRY	10129
MIM614819	#	 	WEILL-MARCHESANI SYNDROME 3; WMS3	4053
MIM614820	#	 	ALTERNATING HEMIPLEGIA OF CHILDHOOD 2; AHC2	478
MIM614821	*	 	PTCSC3 GENE; PTCSC3	100886964
MIM614822	#	 	SPERMATOGENIC FAILURE 10; SPGF10	124404
MIM614823	#	 	AORTIC VALVE DISEASE 2; AOVD2	4091
MIM614824	*	 	ADAPTOR-RELATED PROTEIN COMPLEX 5, SIGMA-1 SUBUNIT; AP5S1	55317
MIM614825	*	 	RALBP1-ASSOCIATED EPS DOMAIN-CONTAINING PROTEIN 1; REPS1	85021
MIM614826	%	 	NYSTAGMUS 7, CONGENITAL, AUTOSOMAL DOMINANT; NYS7	101055624
MIM614827	*	 	DNAJ/HSP40 HOMOLOG, SUBFAMILY C, MEMBER 11; DNAJC11	55735
MIM614828	*	 	GLYCOSYLTRANSFERASE-LIKE DOMAIN-CONTAINING PROTEIN 2; GTDC2	84892
MIM614829	*	 	CHROMOSOME 4 OPEN READING FRAME 26; C4ORF26	152816
MIM614830	#	 	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8; MDDGA8	84892
MIM614831	#	 	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13; SCAR13	2911
MIM614832	#	 	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA4; AI2A4	152816, 54959
MIM614833	#	 	POLYMICROGYRIA WITH SEIZURES; PMGYS	25914
MIM614835	*	 	ACTIN, BETA-LIKE, 2; ACTBL2	345651
MIM614836	%	 	HUMAN HERPESVIRUS 8, SUSCEPTIBILITY TO; HHV8S	101056702
MIM614837	#	 	HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA; HH8	84634
MIM614838	#	 	HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9	26012
MIM614839	#	 	HYPOGONADOTROPIC HYPOGONADISM 10 WITH OR WITHOUT ANOSMIA; HH10	6866
MIM614840	#	 	HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA; HH11	6870
MIM614841	#	 	HYPOGONADOTROPIC HYPOGONADISM 12 WITH OR WITHOUT ANOSMIA; HH12	2796
MIM614842	#	 	HYPOGONADOTROPIC HYPOGONADISM 13 WITH OR WITHOUT ANOSMIA; HH13	3814
MIM614844	#	 	NEPHRONOPHTHISIS 14; NPHP14	23090
MIM614845	#	 	NEPHRONOPHTHISIS 15; NPHP15	22897
MIM614846	#	 	TETRASOMY 15q26	101060869
MIM614847	#	 	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12	6513
MIM614848	*	 	CENTROSOMAL PROTEIN, 164-KD; CEP164	22897
MIM614850	#	 	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 4	148022
MIM614851	#	 	SECKEL SYNDROME 7; SCKL7	51199
MIM614853	*	 	CYTOKINE RECEPTOR-LIKE FACTOR 3; CRLF3	51379
MIM614854	*	 	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 59; LRRC59	55379
MIM614855	*	 	TBC1 DOMAIN FAMILY, MEMBER 14; TBC1D14	57533
MIM614856	#	 	OSTEOGENESIS IMPERFECTA, TYPE XIII; OI13	649
MIM614857	#	 	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE; MAHCJ	5826
MIM614858	#	 	HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA; HH14	55717
MIM614859	#	 	PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	5193
MIM614861	#	 	DEAFNESS, AUTOSOMAL RECESSIVE 98; DFNB98	54084
MIM614862	#	 	PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER); PBD4A	5190
MIM614863	#	 	PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	5190
MIM614864	*	 	HEAT REPEAT-CONTAINING PROTEIN 2; HEATR2	54919
MIM614866	#	 	PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER); PBD5A	5828
MIM614867	#	 	PEROXISOME BIOGENESIS DISORDER 5B; PBD5B	5828
MIM614868	#	 	T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AND AUTOIMMUNITY WITH OR WITHOUT CARDIAC MALFORMATIONS; TIIAC	6789
MIM614869	#	 	USHER SYNDROME, TYPE IJ; USH1J	10518
MIM614870	#	 	PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	5192
MIM614871	#	 	PEROXISOME BIOGENESIS DISORDER 6B; PBD6B	5192
MIM614872	#	 	PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	55670
MIM614873	#	 	PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	55670
MIM614874	#	 	CILIARY DYSKINESIA, PRIMARY, 18; CILD18	54919
MIM614876	#	 	PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	9409
MIM614877	#	 	PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	9409
MIM614878	#	 	AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION, PLCG2-ASSOCIATED; APLAID	5336
MIM614879	#	 	PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	5191
MIM614880	#	 	HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA; HH15	9394
MIM614881	#	 	SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5; DSMA5	3300
MIM614882	#	 	PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	8504
MIM614883	#	 	PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER); PBD11A	5194
MIM614885	#	 	PEROXISOME BIOGENESIS DISORDER 11B; PBD11B	5194
MIM614886	#	 	PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER); PBD12A	5824
MIM614887	#	 	PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER); PBD13A	5195
MIM614895	#	 	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F; CMT4F	 
MIM614896	#	 	SINOATRIAL NODE DYSFUNCTION AND DEAFNESS; SANDD	776
MIM614897	#	 	HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA; HH16	10371
MIM614901	*	 	BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE KINASE; BCKDK	10295
MIM614902	*	 	RHO GTPase-ACTIVATING PROTEIN 33; ARHGAP33	115703
MIM614903	*	 	SORTING NEXIN 16; SNX16	64089
MIM614904	*	 	SORTING NEXIN 7; SNX7	51375
MIM614905	*	 	SORTING NEXIN 8; SNX8	29886
MIM614906	*	 	SORTING NEXIN 11; SNX11	29916
MIM614907	*	 	PRECURSOR mRNA-PROCESSING FACTOR 39, S. CEREVISIAE, HOMOLOG OF; PRPF39	55015
MIM614908	*	 	CHROMOSOME 11 OPEN READING FRAME 73; C11ORF73	51501
MIM614909	*	 	TRANSMEMBRANE PROTEIN 174; TMEM174	134288
MIM614910	*	 	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 6; C1QTNF6	114904
MIM614911	*	 	C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 4; C1QTNF4	114900
MIM614912	*	 	TRAB DOMAIN-CONTAINING PROTEIN 2A; TRABD2A	129293
MIM614913	*	 	TRAB DOMAIN-CONTAINING PROTEIN 2B; TRABD2B	388630
MIM614914	*	 	MICRO RNA 298; MIR298	100126296
MIM614917	*	 	REQUIRED FOR MEIOTIC NUCLEAR DIVISION 1, S. CEREVISIAE, HOMOLOG OF; RMND1	55005
MIM614918	*	 	PENTATRICOPEPTIDE REPEAT DOMAIN-CONTAINING PROTEIN 3; PTCD3	55037
MIM614919	*	 	NITRIC OXIDE-ASSOCIATED PROTEIN 1; NOA1	84273
MIM614925	*	 	OTOGELIN-LIKE PROTEIN; OTOGL	283310
